PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fernando, ATP; Andrabi, S; Cizmecioglu, O; Zhu, C; Livingston, DM; Higgins, JMG; Schaffhausen, BS; Roberts, TM				Fernando, A. T. Pores; Andrabi, S.; Cizmecioglu, O.; Zhu, C.; Livingston, D. M.; Higgins, J. M. G.; Schaffhausen, B. S.; Roberts, T. M.			Polyoma small T antigen triggers cell death via mitotic catastrophe	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; MIDDLE-T; KINETOCHORE LOCALIZATION; SPINDLE ORIENTATION; SIMIAN-VIRUS-40; PP2A; ARREST; COHESION; PHOSPHORYLATION; HOLOENZYMES	Polyoma small T antigen (PyST), an early gene product of the polyoma virus, has been shown to cause cell death in a number of mammalian cells in a protein phosphatase 2A (PP2A)-dependent manner. In the current study, using a cell line featuring regulated expression of PyST, we found that PyST arrests cells in mitosis. Live-cell and immunofluorescence studies showed that the majority of the PyST expressing cells were arrested in prometaphase with almost no cells progressing beyond metaphase. These cells exhibited defects in chromosomal congression, sister chromatid cohesion and spindle positioning, thereby resulting in the activation of the spindle assembly checkpoint. Prolonged mitotic arrest then led to cell death via mitotic catastrophe. Cell cycle inhibitors that block cells in G1/S prevented PyST-induced death. PyST-induced cell death that occurs during M is not dependent on p53 status. These data suggested, and our results confirmed, that PP2A inhibition could be used to preferentially kill cancer cells with p53 mutations that proliferate normally in the presence of cell cycle inhibitors.	[Fernando, A. T. Pores; Andrabi, S.; Cizmecioglu, O.; Livingston, D. M.; Roberts, T. M.] Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Fernando, A. T. Pores; Cizmecioglu, O.; Roberts, T. M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhu, C.; Higgins, J. M. G.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Higgins, J. M. G.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Schaffhausen, B. S.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Newcastle University - UK; Tufts University	Roberts, TM (corresponding author), Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	shaida.andrabi@kashmiruniversity.ac.in; thomas_roberts@dfci.harvard.edu	Cizmecioglu, Onur/AAA-6289-2020; Cizmecioglu, Onur/AAF-5874-2020; Andrabi, Shaida/ABB-8795-2020	Cizmecioglu, Onur/0000-0002-7608-6950; Andrabi, Shaida/0000-0002-4114-4401; Higgins, Jonathan/0000-0001-6622-8268	National Institutes of Health PO1 grant [CA50661]; National Institutes of Health RO1 grant [CA30002, CA34722]; Ramalingaswami fellowship; CREST fellowship; Association for International Cancer Research; NATIONAL CANCER INSTITUTE [R37CA030002, R01CA034722, R37CA034722, P01CA050661, R01CA030002] Funding Source: NIH RePORTER; Worldwide Cancer Research [11-0775] Funding Source: researchfish	National Institutes of Health PO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramalingaswami fellowship; CREST fellowship; Association for International Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Worldwide Cancer Research	This work was supported by an National Institutes of Health PO1 grant CA50661 to TMR, BSS and DML; and an RO1 grant to TMR (CA30002) and BSS (CA34722); and a Ramalingaswami fellowship and a CREST fellowship to SA. JMGH is supported by the Association for International Cancer Research, and is a Scholar of the Leukemia and Lymphoma Society. We thank Drs Jennifer Spangle and Meera Bhanu for their helpful comments on this manuscript.	Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Andrabi S, 2011, J VIROL, V85, P10649, DOI 10.1128/JVI.05034-11; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2002, CELL CYCLE, V1, P375, DOI 10.4161/cc.1.6.259; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen HH, 2003, CELL DEATH DIFFER, V10, P516, DOI 10.1038/sj.cdd.4401171; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Gaillard S, 2001, J VIROL, V75, P9799, DOI 10.1128/JVI.75.20.9799-9807.2001; Gjoerup O, 2001, J VIROL, V75, P9142, DOI 10.1128/JVI.75.19.9142-9155.2001; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Hwang JH, 2013, J BIOL CHEM, V288, P32064, DOI 10.1074/jbc.M113.497644; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2012, CURR MOL MED, V12, P268, DOI 10.2174/156652412799218930; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kochupurakkal BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068509; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li S, 2009, ONCOGENE, V28, P390, DOI 10.1038/onc.2008.393; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Moule MG, 2004, P NATL ACAD SCI USA, V101, P14063, DOI 10.1073/pnas.0405533101; Mullane KP, 1998, MOL CELL BIOL, V18, P7556, DOI 10.1128/MCB.18.12.7556; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; O'Shea CC, 2005, CELL CYCLE, V4, P449, DOI 10.4161/cc.4.3.1555; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schaffhausen BS, 2009, VIROLOGY, V384, P304, DOI 10.1016/j.virol.2008.09.042; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Swingle Mark, 2007, V365, P23; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Taylor SS, 2001, J CELL SCI, V114, P4385; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Yang CS, 2005, MOL CELL BIOL, V25, P1298, DOI 10.1128/MCB.25.4.1298-1308.2005; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; ZHENG B, 1991, J BIOL CHEM, V266, P10031; Zhou J, 2003, J BIOL CHEM, V278, P8617, DOI 10.1074/jbc.M211181200; Zhu M, 2013, J CELL BIOL, V200, P773, DOI 10.1083/jcb.201207050; ZHU Z, 1984, J VIROL, V51, P170, DOI 10.1128/JVI.51.1.170-180.1984	52	9	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2483	2492		10.1038/onc.2014.192	http://dx.doi.org/10.1038/onc.2014.192			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998850	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000354190400007
J	Ulmer, JE; Vilen, EM; Namburi, RB; Benjdia, A; Beneteau, J; Malleron, A; Bonnaffe, D; Driguez, PA; Descroix, K; Lassalle, G; Le Narvor, C; Sandstrom, C; Spillmann, D; Berteau, O				Ulmer, Jonathan E.; Vilen, Eric Morssing; Namburi, Ramesh Babu; Benjdia, Alhosna; Beneteau, Julie; Malleron, Annie; Bonnaffe, David; Driguez, Pierre-Alexandre; Descroix, Karine; Lassalle, Gilbert; Le Narvor, Christine; Sandstrom, Corine; Spillmann, Dorothe; Berteau, Olivier			Characterization of Glycosaminoglycan (GAG) Sulfatases from the Human Gut Symbiont Bacteroides thetaiotaomicron Reveals the First GAG-specific Bacterial Endosulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Chondroitin Sulfate; Enzyme Mechanism; Glycosaminoglycan; Heparan Sulfate; Bacteroides thetaiotaomicron; Bacterial Metabolism; Enzyme Mechanism; Microbiota; Sulfatase	CHONDROITIN SULFATE; FLAVOBACTERIUM-HEPARINUM; RECOMBINANT EXPRESSION; MATURATING ENZYMES; MOLECULAR-CLONING; 2-O-SULFATASE; COFACTOR; FITNESS; COLI	Background: Sulfatases are emerging as key adaptive tools of commensal bacteria to their host. Results: The first bacterial endo-O-sulfatase and three exo-O-sulfatases from the human commensal Bacteroides thetaiotaomicron, specific for glycosaminoglycans, have been discovered and characterized. Conclusion: Commensal bacteria possess a unique array of highly specific sulfatases to metabolize host glycans. Significance: Bacterial sulfatases are much more diverse than anticipated. Despite the importance of the microbiota in human physiology, the molecular bases that govern the interactions between these commensal bacteria and their host remain poorly understood. We recently reported that sulfatases play a key role in the adaptation of a major human commensal bacterium, Bacteroides thetaiotaomicron, to its host (Benjdia, A., Martens, E. C., Gordon, J. I., and Berteau, O. (2011) J. Biol. Chem. 286, 25973-25982). We hypothesized that sulfatases are instrumental for this bacterium, and related Bacteroides species, to metabolize highly sulfated glycans (i.e. mucins and glycosaminoglycans (GAGs)) and to colonize the intestinal mucosal layer. Based on our previous study, we investigated 10 sulfatase genes induced in the presence of host glycans. Biochemical characterization of these potential sulfatases allowed the identification of GAG-specific sulfatases selective for the type of saccharide residue and the attachment position of the sulfate group. Although some GAG-specific bacterial sulfatase activities have been described in the literature, we report here for the first time the identity and the biochemical characterization of four GAG-specific sulfatases. Furthermore, contrary to the current paradigm, we discovered that B. thetaiotaomicron possesses an authentic GAG endosulfatase that is active at the polymer level. This type of sulfatase is the first one to be identified in a bacterium. Our study thus demonstrates that bacteria have evolved more sophisticated and diverse GAG sulfatases than anticipated and establishes how B. thetaiotaomicron, and other major human commensal bacteria, can metabolize and potentially tailor complex host glycans.	[Ulmer, Jonathan E.; Benjdia, Alhosna; Beneteau, Julie; Berteau, Olivier] INRA, ChemSyBio, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Ulmer, Jonathan E.; Benjdia, Alhosna; Beneteau, Julie; Berteau, Olivier] AgroParisTech, ChemSyBio, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Vilen, Eric Morssing; Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Namburi, Ramesh Babu; Spillmann, Dorothe] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden; [Malleron, Annie; Bonnaffe, David; Le Narvor, Christine] Univ Paris 11, ICMMO, LabEx LERMIT, G2M,LCOM,UMR 8182,CNRS,UPS, F-91405 Orsay, France; [Driguez, Pierre-Alexandre; Descroix, Karine; Lassalle, Gilbert] Sanofi R&D, Early Candidate Unit, F-31036 Toulouse, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Swedish University of Agricultural Sciences; Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sanofi-Aventis; Sanofi France	Spillmann, D (corresponding author), Uppsala Univ, IMBIM, SE-75123 Uppsala, Sweden.	dorothe.spillmann@imbim.uu.se; olivier.berteau@jouy.inra.fr	Benjdia, Alhosna/AAM-7415-2021; Berteau, Olivier/AAF-9080-2019	Benjdia, Alhosna/0000-0002-3544-2541; Berteau, Olivier/0000-0002-3434-5168	European Community within a consortium PolyModE [KBBE-2007-3-3-07]; Swedish Cancer Foundation; Foundation for Proteoglycan Research at Uppsala University	European Community within a consortium PolyModE; Swedish Cancer Foundation; Foundation for Proteoglycan Research at Uppsala University	This work was supported in part by European Community within a consortium PolyModE KBBE-2007-3-3-07.; Supported by grants from the Swedish Cancer Foundation and the Foundation for Proteoglycan Research at Uppsala University.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; DeBeer T, 1996, EUR J BIOCHEM, V240, P789; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Driguez PA, 2013, MODERN SYNTHETIC MET, P191; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Gargiulo V, 2009, GLYCOBIOLOGY, V19, P1485, DOI 10.1093/glycob/cwp123; Guerrini M, 2002, GLYCOBIOLOGY, V12, P713, DOI 10.1093/glycob/cwf084; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; HWA V, 1992, APPL ENVIRON MICROB, V58, P869, DOI 10.1128/AEM.58.3.869-876.1992; JAURAND G, 1994, CARBOHYD RES, V255, P295, DOI 10.1016/S0008-6215(00)90986-8; Karamanos NK, 2013, FEBS J, V280, P2119, DOI 10.1111/febs.12262; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Loft KJ, 2009, CHEMBIOCHEM, V10, P565, DOI 10.1002/cbic.200800656; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lubineau A, 1999, EUR J ORG CHEM, V1999, P2523; Malleron A, 2012, CARBOHYD RES, V353, P96, DOI 10.1016/j.carres.2012.03.033; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; PETITOU M, 1988, J BIOL CHEM, V263, P8685; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Viskov C, 2009, J THROMB HAEMOST, V7, P1143, DOI 10.1111/j.1538-7836.2009.03447.x; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297	43	58	64	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24289	24303		10.1074/jbc.M114.573303	http://dx.doi.org/10.1074/jbc.M114.573303			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002587	Green Published, hybrid			2022-12-25	WOS:000341505600025
J	Bernatik, O; Sedova, K; Schille, C; Ganji, RS; Cervenka, I; Trantirek, L; Schambony, A; Zdrahal, Z; Bryja, V				Bernatik, Ondrej; Sedova, Katerina; Schille, Carolin; Ganji, Ranjani Sri; Cervenka, Igor; Trantirek, Lukas; Schambony, Alexandra; Zdrahal, Zbynek; Bryja, Vitezslav			Functional Analysis of Dishevelled-3 Phosphorylation Identifies Distinct Mechanisms Driven by Casein Kinase 1 epsilon and Frizzled5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Mass Spectrometry (MS); Phosphorylation; Post-translational Modification (PTM); Wnt Pathway; Casein Kinase 1E; Dishevelled-3; Frizzled5	PLANAR CELL POLARITY; BETA-CATENIN; WNT/BETA-CATENIN; PDZ DOMAIN; I-EPSILON; WNT PATHWAY; PROTEIN; DROSOPHILA; DVL; FAMILY	Background: Phosphorylation of Dishevelled (Dvl) by casein kinase 1E (CK1E) is a key event in Wnt signal transduction. Results: Dvl3 residues phosphorylated by CK1E were identified by proteomics and analyzed functionally. Conclusion: Individual phosphorylation events control different aspects of Dvl biology. Significance: CK1E and Fzd5, a Wnt receptor, act on Dvl via distinct mechanism, suggesting that CK1E is not directly downstream of Frizzled5. Dishevelled-3 (Dvl3), a key component of the Wnt signaling pathways, acts downstream of Frizzled (Fzd) receptors and gets heavily phosphorylated in response to pathway activation by Wnt ligands. Casein kinase 1E (CK1E) was identified as the major kinase responsible for Wnt-induced Dvl3 phosphorylation. Currently it is not clear which Dvl residues are phosphorylated and what is the consequence of individual phosphorylation events. In the present study we employed mass spectrometry to analyze in a comprehensive way the phosphorylation of human Dvl3 induced by CK1E. Our analysis revealed >50 phosphorylation sites on Dvl3; only a minority of these sites was found dynamically induced after co-expression of CK1E, and surprisingly, phosphorylation of one cluster of modified residues was down-regulated. Dynamically phosphorylated sites were analyzed functionally. Mutations within PDZ domain (S280A and S311A) reduced the ability of Dvl3 to activate TCF/LEF (T-cell factor/lymphoid enhancer factor)-driven transcription and induce secondary axis in Xenopus embryos. In contrast, mutations of clustered Ser/Thr in the Dvl3 C terminus prevented ability of CK1E to induce electrophoretic mobility shift of Dvl3 and its even subcellular localization. Surprisingly, mobility shift and subcellular localization changes induced by Fzd5, a Wnt receptor, were in all these mutants indistinguishable from wild type Dvl3. In summary, our data on the molecular level (i) support previous the assumption that CK1E acts via phosphorylation of distinct residues as the activator as well as the shut-off signal of Wnt/-catenin signaling and (ii) suggest that CK1E acts on Dvl via different mechanism than Fzd5.	[Bernatik, Ondrej; Ganji, Ranjani Sri; Cervenka, Igor; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bernatik, Ondrej; Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Sedova, Katerina; Zdrahal, Zbynek] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Sedova, Katerina; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol CEITEC, Res Grp Prote, Brno 62500, Czech Republic; [Schille, Carolin; Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Trantirek, Lukas] Masaryk Univ, Cent European Inst Technol CEITEC, Struct Biol Program, Brno 62500, Czech Republic; [Trantirek, Lukas] Univ Utrecht, NL-3584 CH Utrecht, Netherlands	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Masaryk University Brno; University of Erlangen Nuremberg; Masaryk University Brno; Utrecht University	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Bryja, Vítězslav/P-4217-2019; Bryja, Vít?zslav/H-1925-2014; Zdrahal, Zbynek/D-9491-2012; Trantirek, Lukas/F-9923-2014; Ganji, Ranjani/AGD-5702-2022	Bryja, Vítězslav/0000-0002-9136-5085; Bryja, Vít?zslav/0000-0002-9136-5085; Bernatik, Ondrej/0000-0002-2188-332X; Zdrahal, Zbynek/0000-0003-3044-5548; Schambony, Alexandra/0000-0001-8771-5487	Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Czech Science Foundation [204/09/0498, 13-31488P]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/20.0042]; project CEITEC (Central European Institute of Technology) from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; CEITEC Open Access project - Ministry of Education, Youth, and Sports of the Czech Republic [LM2011020]; German Research Foundation (DFG) [SCHA 965/6-1]; VIDI-Career Development (Netherlands Organization for Scientific Research)	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; project CEITEC (Central European Institute of Technology) from European Regional Development Fund; CEITEC Open Access project - Ministry of Education, Youth, and Sports of the Czech Republic; German Research Foundation (DFG)(German Research Foundation (DFG)); VIDI-Career Development (Netherlands Organization for Scientific Research)	This work was supported by grants from the Ministry of Education, Youth, and Sports of the Czech Republic (MSM0021622430), the Czech Science Foundation (204/09/0498; 13-31488P), and from the European Social Fund and the state budget of the Czech Republic (CZ.1.07/2.3.00/20.0042). The MS/MS analysis was supported by the project CEITEC (Central European Institute of Technology) (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund and by a CEITEC Open Access project (LM2011020) funded by the Ministry of Education, Youth, and Sports of the Czech Republic under the activity "Projects of major infrastructures for research, development and innovations." In vivo work was supported by a research grant from the German Research Foundation (DFG; to A. S. (SCHA 965/6-1)).; Supported by VIDI-Career Development (Netherlands Organization for Scientific Research).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bryja V, 2005, STEM CELLS, V23, P965, DOI 10.1634/stemcells.2004-0174; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; CHAKRABARTI A, 1992, DEVELOPMENT, V115, P355; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Ma Li, 2010, J Mol Signal, V5, P19, DOI 10.1186/1750-2187-5-19; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nieuwkoop P. D., 1975, NORMAL TABLES XENOPU, P162; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Singh J, 2010, GENE DEV, V24, P2157, DOI 10.1101/gad.1961010; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Smietana K, 2011, ACTA BIOCHIM POL, V58, P243; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu CC, 2012, J PROTEOME RES, V11, P3829, DOI 10.1021/pr300314d; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847	53	41	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23520	23533		10.1074/jbc.M114.590638	http://dx.doi.org/10.1074/jbc.M114.590638			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993822	Green Published, hybrid			2022-12-25	WOS:000341505000023
J	Miyata, K; Ramaseshadri, P; Zhang, YJ; Segers, G; Bolognesi, R; Tomoyasu, Y				Miyata, Keita; Ramaseshadri, Parthasarathy; Zhang, Yuanji; Segers, Gerrit; Bolognesi, Renata; Tomoyasu, Yoshinori			Establishing an In Vivo Assay System to Identify Components Involved in Environmental RNA Interference in the Western Corn Rootworm	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN; DSRNA; GENE; YELLOW; EVOLUTION; CELLS; EBONY	The discovery of environmental RNA interference (RNAi), in which gene expression is suppressed via feeding with double-stranded RNA (dsRNA) molecules, opened the door to the practical application of RNAi-based techniques in crop pest management. The western corn rootworm (WCR, Diabrotica virgifera virgifera) is one of the most devastating corn pests in North America. Interestingly, WCR displays a robust environmental RNAi response, raising the possibility of applying an RNAi-based pest management strategy to this pest. Understanding the molecular mechanisms involved in the WCR environmental RNAi process will allow for determining the rate limiting steps involved with dsRNA toxicity and potential dsRNA resistance mechanisms in WCR. In this study, we have established a two-step in vivo assay system, which allows us to evaluate the involvement of genes in environmental RNAi in WCR. We show that laccase 2 and ebony, critical cuticle pigmentation/tanning genes, can be used as marker genes in our assay system, with ebony being a more stable marker to monitor RNAi activity. In addition, we optimized the dsRNA dose and length for the assay, and confirmed that this assay system is sensitive to detect well-known RNAi components such as Dicer-2 and Argonaute-2. We also evaluated two WCR sid1- like (sil) genes with this assay system. This system will be useful to quickly survey candidate systemic RNAi genes in WCR, and also will be adaptable for a genome-wide RNAi screening to give us an unbiased view of the environmental/systemic RNAi pathway in WCR.	[Miyata, Keita; Tomoyasu, Yoshinori] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Ramaseshadri, Parthasarathy; Zhang, Yuanji; Segers, Gerrit; Bolognesi, Renata] Monsanto Co, Div Biotechnol, Chesterfield, MO USA	University System of Ohio; Miami University; Monsanto	Tomoyasu, Y (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	tomoyay@MiamiOH.edu	Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454	Miami University; Monsanto Company	Miami University; Monsanto Company	This work was in part supported by Miami University. Miami University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Monsanto Company funded the work. PR, YZ, GS and RB, scientists employed by Monsanto Company were involved in study design, decision to publish, and preparation of the manuscript.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Devos Y, 2013, TRANSGENIC RES, V22, P269, DOI 10.1007/s11248-012-9657-4; Dunbar MW, 2013, J ECON ENTOMOL, V106, P168, DOI 10.1603/EC11291; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Hinas A, 2012, CURR BIOL, V22, P1938, DOI 10.1016/j.cub.2012.08.020; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jose AM, 2012, P NATL ACAD SCI USA, V109, P14520, DOI 10.1073/pnas.1201153109; Kobayashi I, 2012, INSECT BIOCHEM MOLEC, V42, P148, DOI 10.1016/j.ibmb.2011.11.007; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rocheleau CE, 2012, CURR BIOL, V22, pR873, DOI 10.1016/j.cub.2012.08.039; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tomoyasu Y, 2009, CURR BIOL, V19, P2057, DOI 10.1016/j.cub.2009.11.014; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	50	56	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101661	10.1371/journal.pone.0101661	http://dx.doi.org/10.1371/journal.pone.0101661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003334	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700049
J	Perkins, SM; Shinohara, ET; DeWees, T; Frangoul, H				Perkins, Stephanie M.; Shinohara, Eric T.; DeWees, Todd; Frangoul, Haydar			Outcome for Children with Metastatic Solid Tumors over the Last Four Decades	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; HISTOLOGY WILMS-TUMOR; INTERGROUP RHABDOMYOSARCOMA; EWINGS-SARCOMA; ONCOLOGY GROUP; 13-CIS-RETINOIC ACID; PROGNOSTIC-FACTORS; CHEMOTHERAPY; TRIAL; OSTEOSARCOMA	Background: Outcomes for pediatric solid tumors have significantly improved over the last 30 years. However, much of this improvement is due to improved outcome for patients with localized disease. Here we evaluate overall survival (OS) for pediatric patients with metastatic disease over the last 40 years. Procedure: The United States Surveillance, Epidemiology, and End Results (SEER) database was used to conduct this study. Patients diagnosed between 0 and 18 years of age with metastatic Ewings sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma or Wilms tumor were included in the analysis. Results: 3,009 patients diagnosed between 1973-2010 met inclusion criteria for analysis. OS at 10 years for patients diagnosed between 1973-1979, 1980-1989, 1990-1999 and 2000-2010 was 28.3%, 37.2%, 44.7% and 49.3%, respectively (p<0.001). For patients diagnosed between 2000-2010, 10-year OS for patients with Ewing sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma and Wilms tumor was 30.6%, 54.4%, 29.3%, 27.5%, and 76.6%, respectively, as compared to 13.8%, 25.1%, 13.6%, 17.9% and 57.1%, respectively, for patients diagnosed between 1973-1979. OS for neuroblastoma significantly increased with each decade. For patients with osteosarcoma and Ewing sarcoma, there was no improvement in OS over the last two decades. There was no improvement in outcome for patients with rhabdomyosarcoma or Wilms tumor over the last 30 years. Conclusions: OS for pediatric patients with metastatic solid tumors has significantly improved since the 1970s. However, outcome has changed little for some malignancies in the last 20-30 years. These data underscore the importance of continued collaboration and studies to improve outcome for these patients.	[Perkins, Stephanie M.; DeWees, Todd] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Shinohara, Eric T.] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Frangoul, Haydar] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Washington University (WUSTL); Vanderbilt University; Vanderbilt University	Frangoul, H (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	Haydar.frangoul@vanderbilt.edu		DeWees, Todd/0000-0003-3897-3011				Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; BRESLOW NE, 1986, CANCER-AM CANCER SOC, V58, P2501, DOI 10.1002/1097-0142(19861201)58:11<2501::AID-CNCR2820581125>3.0.CO;2-V; Carli M, 2004, J CLIN ONCOL, V22, P4787, DOI 10.1200/JCO.2004.04.083; CRIST W, 1995, J CLIN ONCOL, V13, P610, DOI 10.1200/JCO.1995.13.3.610; Dome JS, 2006, J CLIN ONCOL, V24, P2352, DOI 10.1200/JCO.2005.04.7852; Green DM, 2013, J PEDIATR SURG, V48, P14, DOI 10.1016/j.jpedsurg.2012.10.012; Green DM, 1996, MED PEDIATR ONCOL, V26, P147; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; JAFFE N, 1976, CANCER, V38, P1925, DOI 10.1002/1097-0142(197611)38:5<1925::AID-CNCR2820380510>3.0.CO;2-J; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kalapurakal JA, 2004, LANCET ONCOL, V5, P37, DOI 10.1016/S1470-2045(03)01322-6; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MAURER HM, 1993, CANCER-AM CANCER SOC, V71, P1904, DOI 10.1002/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X; MAURER HM, 1988, CANCER-AM CANCER SOC, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Seibel NL, 2007, CANCER, V109, P1646, DOI 10.1002/cncr.22553; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	26	50	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100396	10.1371/journal.pone.0100396	http://dx.doi.org/10.1371/journal.pone.0100396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003594	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700006
J	Church, JE; Trieu, J; Sheorey, R; Chee, AYM; Naim, T; Baum, DM; Ryall, JG; Gregorevic, P; Lynch, GS				Church, Jarrod E.; Trieu, Jennifer; Sheorey, Radhika; Chee, Annabel Y. -M.; Naim, Timur; Baum, Dale M.; Ryall, James G.; Gregorevic, Paul; Lynch, Gordon S.			Functional beta-Adrenoceptors Are Important for Early Muscle Regeneration in Mice through Effects on Myoblast Proliferation and Differentiation	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; BETA-2-ADRENERGIC RECEPTOR; IN-VITRO; CLENBUTEROL; EXPRESSION; INJURY; HYPERTROPHY; FIBERS; REPAIR; GENE	Muscles can be injured in different ways and the trauma and subsequent loss of function and physical capacity can impact significantly on the lives of patients through physical impairments and compromised quality of life. The relative success of muscle repair after injury will largely determine the extent of functional recovery. Unfortunately, regenerative processes are often slow and incomplete, and so developing novel strategies to enhance muscle regeneration is important. While the capacity to enhance muscle repair by stimulating beta(2)-adrenoceptors (beta-ARs) using beta(2)-AR agonists (beta(2)-agonists) has been demonstrated previously, the exact role beta-ARs play in regulating the regenerative process remains unclear. To investigate beta-AR-mediated signaling in muscle regeneration after myotoxic damage, we examined the regenerative capacity of tibialis anterior and extensor digitorum longus muscles from mice lacking either beta(1)-AR (beta(1)-KO) and/or beta(2)-ARs (beta(2)-KO), testing the hypothesis that muscles from mice lacking the beta(2)-AR would exhibit impaired functional regeneration after damage compared with muscles from beta(1)-KO or beta(1)/b(2)-AR null (beta(1)/beta(2)-KO) KO mice. At 7 days post-injury, regenerating muscles from beta(1)/beta(2)-KO mice produced less force than those of controls but muscles from beta(1)-KO or beta(2)-KO mice did not exhibit any delay in functional restoration. Compared with controls, beta(1)/beta(2)-KO mice exhibited an enhanced inflammatory response to injury, which delayed early muscle regeneration, but an enhanced myoblast proliferation later during regeneration ensured a similar functional recovery (to controls) by 14 days post-injury. This apparent redundancy in the beta-AR signaling pathway was unexpected and may have important implications for manipulating beta-AR signaling to improve the rate, extent and efficacy of muscle regeneration to enhance functional recovery after injury.	[Church, Jarrod E.; Trieu, Jennifer; Sheorey, Radhika; Chee, Annabel Y. -M.; Naim, Timur; Baum, Dale M.; Ryall, James G.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Lab Muscle Res & Therapeut Dev, Melbourne, Vic, Australia	University of Melbourne; Baker Heart and Diabetes Institute	Lynch, GS (corresponding author), Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Ryall, James/J-9771-2019; Gregorevic, Paul/AAH-6040-2021; Lynch, Gordon/G-9553-2015	Ryall, James/0000-0003-4702-1143; Gregorevic, Paul/0000-0002-7418-8945; Lynch, Gordon/0000-0001-9220-9810; Church, Jarrod/0000-0001-8266-4043	National Health and Medical Research Council (NHMRC) of Australia [509313, 1026231]; Association Francaise contre les Myopathies (AFM, France); NHMRC Career Development Fellowship; NHMRC Overseas Postdoctoral Fellowship; Pfizer Senior Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (AFM, France)(Association Francaise contre les Myopathies); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Overseas Postdoctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Senior Research Fellowship	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (Project grants: 509313; 1026231). JEC was supported by a postdoctoral fellowship from the Association Francaise contre les Myopathies (AFM, France). PG was supported by a NHMRC Career Development Fellowship and formerly a Pfizer Senior Research Fellowship. JGR is supported by a NHMRC Overseas Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Beitzel F, 2004, J APPL PHYSIOL, V96, P1385, DOI 10.1152/japplphysiol.01081.2003; Beitzel F, 2007, AM J PHYSIOL-ENDOC M, V293, pE932, DOI 10.1152/ajpendo.00175.2007; Boost KA, 2007, ACTA ANAESTH SCAND, V51, P900, DOI 10.1111/j.1399-6576.2007.01363.x; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bunn JR, 2004, J ORTHOP RES, V22, P1336, DOI 10.1016/j.orthres.2004.03.013; CAIRNS SP, 1993, BRIT J PHARMACOL, V110, P1133, DOI 10.1111/j.1476-5381.1993.tb13932.x; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Delday MI, 1997, AM J PHYSIOL-ENDOC M, V272, pE941, DOI 10.1152/ajpendo.1997.272.5.E941; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; EMERY PW, 1984, BIOSCIENCE REP, V4, P83, DOI 10.1007/BF01120827; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Gregorevic P, 2004, J PHYSIOL-LONDON, V558, P549, DOI 10.1113/jphysiol.2004.066217; Ha TNV, 1999, BRIT J PHARMACOL, V126, P1717, DOI 10.1038/sj.bjp.0702482; Harcourt LJ, 2005, AM J PATHOL, V166, P1131, DOI 10.1016/S0002-9440(10)62333-4; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Izeboud CA, 1999, INFLAMM RES, V48, P497, DOI 10.1007/s000110050493; Jones SW, 2004, J PHARMACOL EXP THER, V311, P1225, DOI 10.1124/jpet.104.071589; KIM YS, 1991, BIOCHEM PHARMACOL, V42, P1783, DOI 10.1016/0006-2952(91)90516-8; Kiriazis H, 2008, BRIT J PHARMACOL, V153, P684, DOI 10.1038/sj.bjp.0707622; Lang CH, 2008, J TRAUMA, V64, P477, DOI 10.1097/01.TA.0000249375.43015.01; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; MALTIN CA, 1993, AM J PHYSIOL, V265, pE176, DOI 10.1152/ajpendo.1993.265.1.E176; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Ryall JG, 2008, J APPL PHYSIOL, V105, P165, DOI 10.1152/japplphysiol.00317.2007; Ryall JG, 2010, CLIN EXP PHARMACOL P, V37, P397, DOI 10.1111/j.1440-1681.2009.05312.x; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Van Miert ASJPAM, 2002, VET RES COMMUN, V26, P111, DOI 10.1023/A:1014043601287	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101379	10.1371/journal.pone.0101379	http://dx.doi.org/10.1371/journal.pone.0101379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000590	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300039
J	Girod, M; Enjalbert, Q; Brunet, C; Antoine, R; Lemoine, J; Lukac, I; Radman, M; Krisko, A; Dugourd, P				Girod, Marion; Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Lemoine, Jerome; Lukac, Iva; Radman, Miroslav; Krisko, Anita; Dugourd, Philippe			Structural Basis of Protein Oxidation Resistance: A Lysozyme Study	PLOS ONE			English	Article							2-DIMENSIONAL LIQUID-CHROMATOGRAPHY; CARBONYLATED PROTEINS; CONTAINING PEPTIDES; ESCHERICHIA-COLI; IDENTIFICATION; SITES; MITOCHONDRIA	Accumulation of oxidative damage in proteins correlates with aging since it can cause irreversible and progressive degeneration of almost all cellular functions. Apparently, native protein structures have evolved intrinsic resistance to oxidation since perfectly folded proteins are, by large most robust. Here we explore the structural basis of protein resistance to radiation-induced oxidation using chicken egg white lysozyme in the native and misfolded form. We study the differential resistance to oxidative damage of six different parts of native and misfolded lysozyme by a targeted tandem/mass spectrometry approach of its tryptic fragments. The decay of the amount of each lysozyme fragment with increasing radiation dose is found to be a two steps process, characterized by a double exponential evolution of their amounts: the first one can be largely attributed to oxidation of specific amino acids, while the second one corresponds to further degradation of the protein. By correlating these results to the structural parameters computed from molecular dynamics (MD) simulations, we find the protein parts with increased root-mean-square deviation (RMSD) to be more susceptible to modifications. In addition, involvement of amino acid side-chains in hydrogen bonds has a protective effect against oxidation Increased exposure to solvent of individual amino acid side chains correlates with high susceptibility to oxidative and other modifications like side chain fragmentation. Generally, while none of the structural parameters alone can account for the fate of peptides during radiation, together they provide an insight into the relationship between protein structure and susceptibility to oxidation.	[Girod, Marion; Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Lemoine, Jerome; Dugourd, Philippe] Univ Lyon, F-69622 Lyon, France; [Girod, Marion; Lemoine, Jerome] Univ Lyon 1, CNRS, UMR 5280, Inst Sci Anal, F-69365 Lyon, France; [Enjalbert, Quentin; Brunet, Claire; Antoine, Rodolphe; Dugourd, Philippe] Univ Lyon 1, CNRS, UMR 5306, Inst Lumiere Matiere, F-69365 Lyon, France; [Lukac, Iva; Radman, Miroslav; Krisko, Anita] Mediterranean Inst Life Sci, Split, Croatia; [Lukac, Iva] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 5UX, Merseyside, England; [Radman, Miroslav] Univ Paris 05, Fac Med, INSERM, U1001, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Liverpool John Moores University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Krisko, A (corresponding author), Mediterranean Inst Life Sci, Split, Croatia.	anita.krisko@medils.hr; philippe.dugourd@univ-lyon1.fr	Antoine, Rodolphe/I-5571-2019; Dugourd, Philippe/H-6574-2018; lemoine, jerome/C-4272-2014; Radman, Miroslav/HDM-5955-2022	Antoine, Rodolphe/0000-0001-5682-8550; Dugourd, Philippe/0000-0003-4395-1140; lemoine, jerome/0000-0002-5497-6880; Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148; Lukac, Iva/0000-0003-1160-4806; GIROD, Marion/0000-0003-0728-2111	European Research Council under the European Union [320659]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results (PD) has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013 Grant agreement No 320659). AK, MR and PD thank the CNRS (Centre National de la Recherche Scientifique) Franco-Croatian international laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAESTR VERS 9 3; Bauer F, 2007, FEBS LETT, V581, P1555, DOI 10.1016/j.febslet.2007.03.012; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Dasgupta J, 2003, PROTEIN ENG, V16, P489, DOI 10.1093/protein/gzg070; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; FERGUSON DL, 1992, PLANT PHYSIOL, V100, P529, DOI 10.1104/pp.100.1.529; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Guo J, 2011, J PROTEOMICS, V74, P2360, DOI 10.1016/j.jprot.2011.07.013; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krisko A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003810; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kristensen BK, 2004, PHYTOCHEMISTRY, V65, P1839, DOI 10.1016/j.phytochem.2004.04.007; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; Madian AG, 2010, J PROTEOME RES, V9, P1330, DOI 10.1021/pr900890k; MAISONNEUVE E, 2009, PLOS ONE, V4; Meany DL, 2007, PROTEOMICS, V7, P1150, DOI 10.1002/pmic.200600450; Milic I, 2013, ANAL CHEM, V85, P156, DOI 10.1021/ac302356z; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Orioli M, 2005, J CHROMATOGR B, V827, P109, DOI 10.1016/j.jchromb.2005.04.025; Rao RSP, 2011, PROTEOMICS, V11, P4166, DOI 10.1002/pmic.201100223; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G	29	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101642	10.1371/journal.pone.0101642	http://dx.doi.org/10.1371/journal.pone.0101642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999730	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300065
J	Ishida, H; Matsumoto, A				Ishida, Hisashi; Matsumoto, Atsushi			Free-Energy Landscape of Reverse tRNA Translocation through the Ribosome Analyzed by Electron Microscopy Density Maps and Molecular Dynamics Simulations	PLOS ONE			English	Article							ELONGATION-FACTOR-G; SARCIN-RICIN LOOP; EF-G; MESSENGER-RNA; BIOMOLECULAR SIMULATIONS; CRYOELECTRON MICROSCOPY; PRETRANSLOCATION STATE; INTERSUBUNIT ROTATION; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE	To understand the mechanism of reverse tRNA translocation in the ribosome, all-atom molecular dynamics simulations of the ribosome-tRNAs-mRNA-EFG complex were performed. The complex at the post-translocational state was directed towards the translocational and pre-translocational states by fitting the complex into cryo-EM density maps. Between a series of the fitting simulations, umbrella sampling simulations were performed to obtain the free-energy landscape. Multistep structural changes, such as a ratchet-like motion and rotation of the head of the small subunit were observed. The free-energy landscape showed that there were two main free-energy barriers: one between the post-translocational and intermediate states, and the other between the pre-translocational and intermediate states. The former corresponded to a clockwise rotation, which was coupled to the movement of P-tRNA over the P/E-gate made of G1338, A1339 and A790 in the small subunit. The latter corresponded to an anticlockwise rotation of the head, which was coupled to the location of the two tRNAs in the hybrid state. This indicates that the coupled motion of the head rotation and tRNA translocation plays an important role in opening and closing of the P/E-gate during the ratchet-like movement in the ribosome. Conformational change of EF-G was interpreted to be the result of the combination of the external motion by L12 around an axis passing near the sarcin-ricin loop, and internal hinge-bending motion. These motions contributed to the movement of domain IV of EF-G to maintain its interaction with A/P-tRNA.	[Ishida, Hisashi] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto, Japan; Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Kyoto, Japan	Japan Atomic Energy Agency; Japan Atomic Energy Agency	Ishida, H (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto, Japan.	ishida.hisashi@jaea.go.jp			Japan Society of the Promotion of Science (JSPS) KAKENHI [22570165]; Japan Atomic Energy Agency	Japan Society of the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Atomic Energy Agency(Japan Atomic Energy Agency)	H. I. was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society of the Promotion of Science (JSPS) KAKENHI (22570165) and Japan Atomic Energy Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi NM, 2005, RNA, V11, P1624, DOI 10.1261/rna.2118105; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Auffinger P, 2007, J CHEM THEORY COMPUT, V3, P1851, DOI 10.1021/ct700143s; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Brilot AF, 2013, P NATL ACAD SCI USA, V110, P20994, DOI 10.1073/pnas.1311423110; Chasles M., 1830, B SCI MATHEMATIQUES, V4, P321; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dlugosz M, 2011, BIOPOLYMERS, V95, P616, DOI 10.1002/bip.21619; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Garcia-Ortega L, 2010, NUCLEIC ACIDS RES, V38, P4108, DOI 10.1093/nar/gkq151; Guo Z, 2012, P NATL ACAD SCI US; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hockney R.W., 1998, COMPUTER SIMULATION; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ishida H, 2014, PROTEINS EARLY VIEW, DOI [10.1002/prot.24553, DOI 10.1002/PROT.24553]; Ishida H, 2011, PROG NUCL SCI TECHNO, V2, P470, DOI DOI 10.15669/PNST.2.470; Ishida H, 2010, J COMPUT CHEM, V31, P2317, DOI 10.1002/jcc.21525; Ishida H, 2008, BIOPHYS J, V95, P5962, DOI 10.1529/biophysj.108.134890; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Lehninger A., 1993, PRINCIPLES BIOCH; Li W, 2011, PROTEINS, V79, P1478, DOI 10.1002/prot.22976; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martyna GJ, 1996, MOL PHYS, V87, P1117, DOI 10.1080/00268979600100761; Matsumoto A, 2009, STRUCTURE, V17, P1605, DOI 10.1016/j.str.2009.09.017; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vaiana AC, 2006, BIOCHIMIE, V88, P1061, DOI 10.1016/j.biochi.2006.06.006; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou R, 1996, J CHEM PHYS, V87, P1117	75	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101951	10.1371/journal.pone.0101951	http://dx.doi.org/10.1371/journal.pone.0101951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999999	Green Published, gold			2022-12-25	WOS:000338637300107
J	Jang, J; Di, DYW; Lee, A; Unno, T; Sadowsky, MJ; Hur, HG				Jang, Jeonghwan; Di, Doris Y. W.; Lee, Anna; Unno, Tatsuya; Sadowsky, Michael J.; Hur, Hor-Gil			Seasonal and Genotypic Changes in Escherichia coli Phylogenetic Groups in the Yeongsan River Basin of South Korea	PLOS ONE			English	Article							POPULATION-STRUCTURE; GROUP B2; VIRULENCE; DIVERSITY; STRAINS; PCR; WATER; ANIMALS; DNA; PERSISTENCE	With 3,480 E. coli strains isolated from the Yeongsan River basin, South Korea, correlations between phylogenetic groups and horizontal fluorophore enhanced rep-PCR (HFERP) genotypes were examined, and environmental factors affecting E. coli phylogenetic groups in the river water were determined. Interestingly, multidimentional scaling (MDS) analyses based on HFERP DNA fingerprint data indicated that E. coli in phylogenetic groups A and B1 were uniquely clustered. Results of self-organized maps (SOMs) analyses also indicated that E. coli phylogenetic groups were seasonally affected by water temperature, with greater occurrences of phylogenetic groups A and B1 in low and high temperature seasons, respectively. The presence of E. coli in phylogenetic groups A and B1 were inversely related. Furthermore, redundancy analysis (RDA) revealed that phylogenetic group B1 correlated positively with temperature, strain diversity, and biochemical oxygen demand (BOD) but negatively with phylogenetic group A. Results of this study indicated that while E. coli strains could be clustered based on their genotypes and environment conditions, their phylogenetic groups did not change in relation to the same conditions. The distributional differences of phylogenetic groups among E. coli populations in different environments may be caused by different genomic adaptability and plasticity of E. coli strains belonging to each phylogenetic group. Although several previous studies have reported different E. coli ecological structures depending on their origins, this study is a first description of the specific environmental factors affecting E. coli phylogenetic groups in river water.	[Jang, Jeonghwan; Di, Doris Y. W.; Lee, Anna; Hur, Hor-Gil] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea; [Hur, Hor-Gil] Gwangju Inst Sci & Technol, Int Environm Anal & Educ Ctr, Kwangju, South Korea; [Unno, Tatsuya] Jeju Natl Univ, Coll Mol Life Sci, Cheju, South Korea; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Jeju National University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hur, HG (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea.	hghur@gist.ac.kr	Jang, Jeonghwan/AAD-9837-2020; Sadowsky, Michael/J-2507-2016; Unno, Tatsuya/C-1522-2012	Sadowsky, Michael/0000-0001-8779-2781; Unno, Tatsuya/0000-0003-2373-2100; DI, DORIS YOONG WEN/0000-0002-0503-9030	National Research Foundation of Korea - Korean Government (MEST) [NRF: 2011-0029860]; GSR(GIST Specialized Research) Project; Gwangju Regional Environmental Technology Development Center [10-2-70-73]	National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); GSR(GIST Specialized Research) Project; Gwangju Regional Environmental Technology Development Center	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF: 2011-0029860) and the GSR(GIST Specialized Research) Project through a grant provided by GIST in 2014. The authors also wish to acknowledge a grant-in-aid for research from the Gwangju Regional Environmental Technology Development Center (10-2-70-73).	Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; CIEBIN BW, 1995, APPL ENVIRON MICROB, V61, P3940, DOI 10.1128/AEM.61.11.3940-3942.1995; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Gevrey M, 2004, FRESHWATER BIOL, V49, P208, DOI 10.1046/j.1365-2426.2003.01174.x; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; GORDON DM, 2004, ESCHERICHIA COLI SAL; GOULLET P, 1989, J GEN MICROBIOL, V135, P135; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Jang J, 2011, ENVIRON MICROBIOL, V13, P3103, DOI 10.1111/j.1462-2920.2011.02541.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2001, INFECT IMMUN, V69, P5363, DOI 10.1128/IAI.69.9.5363-5374.2001; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson LK, 2004, APPL ENVIRON MICROB, V70, P4478, DOI 10.1128/AEM.70.8.4478-4485.2004; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Park YS, 2003, CONSERV BIOL, V17, P1748, DOI 10.1111/j.1523-1739.2003.00430.x; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Ratajczak M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-222; Sadowsky MJ, 2011, FECAL BACTERIA, P295; Sambrook J, 2001, MOL CLONING LAB MANU; Smilauer JLaP, MULTIVARIATE ANAL EC; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tuang FN, 1999, FEMS MICROBIOL LETT, V177, P249, DOI 10.1111/j.1574-6968.1999.tb13740.x; Tudesque L, 2008, WATER RES, V42, P732, DOI 10.1016/j.watres.2007.08.001; Unno T, 2009, APPL ENVIRON MICROB, V75, P5659, DOI 10.1128/AEM.00443-09; USEPA, 2006, 1603 USEPA; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Weber M, 2011, ISME J, V5, P918, DOI 10.1038/ismej.2010.180	48	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100585	10.1371/journal.pone.0100585	http://dx.doi.org/10.1371/journal.pone.0100585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999864	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300010
J	Li, Q; Zhao, WN; Wei, YM; Han, X; Han, ZY; Zhang, YB; Qi, SX; Xu, YG				Li, Qi; Zhao, WenNa; Wei, YaMei; Han, Xu; Han, ZhanYing; Zhang, YanBo; Qi, ShunXiang; Xu, YongGang			Analysis of Incidence and Related Factors of Hemorrhagic Fever with Renal Syndrome in Hebei Province, China	PLOS ONE			English	Article								Background: Hemorrhagic fever with renal syndrome (HFRS) is an important infectious disease in Hebei province, China. The average annual incidence is 3.10/100000. Although the incidence of HFRS is stable with a general decline in trend since 2004, an increase in the trend was observed in 2011. Few studies have been conducted to investigate the underlying risk factors for this disease. Methods: The epidemiological data of HFRS and the population data, meteorology, and remote sensing aspects of cities in Hebei province from 1999 to 2011 were collected. The epidemiological data included the population density in the region, seasonal data and rat density and rat's virus carriage rate. The data were analyzed by descriptive study, correlation analysis and multivariate linear analysis. Results: There were 26837 cases of HFRS was reported from 1999 to 2011. The infection occurred mainly in males, aged 20 similar to 49 years, who were farmers. Rattus norvegicus was the main host animal. The incidence of HFRS was related to NDVI value, rat density and rat's virus carriage rate by multiple linear regression (F = 25.936, P<0.01). The pseudo- R-2 value for the model was 0.644. Conclusion: The incidence of HFRS was related to NDVI value, rat density and rat's virus carriage rate. Control of these factors should be used to prevent HFRS in Hebei province.	[Li, Qi; Zhao, WenNa; Wei, YaMei; Han, Xu; Han, ZhanYing; Zhang, YanBo; Qi, ShunXiang; Xu, YongGang] Hebei Prov Ctr Dis Prevent & Control, Inst Viral Dis Prevent & Control, Shijiazhuang, Hebei Province, Peoples R China		Li, Q (corresponding author), Hebei Prov Ctr Dis Prevent & Control, Inst Viral Dis Prevent & Control, Shijiazhuang, Hebei Province, Peoples R China.	liqinew@126.com			Natural Science Foundation of Hebei province, PR China [C2007000944]; Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China [07276101D-114]	Natural Science Foundation of Hebei province, PR China(Natural Science Foundation of Hebei Province); Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China	The authors gratefully acknowledge financial support from the Natural Science Foundation of Hebei province, PR China (No. C2007000944) and Hebei Province Science and Technology and Development Plan Program of Hebei Province, PR China (No. 07276101D-114) (http://www.hebstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Dong Yi, 2009, Zhongguo Xuexichongbing Fangzhi Zazhi, V21, P98; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; [方立群 Fang Liqun], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P265; Lin T, 2002, CHINA PUBLIC HLTH, V18, P104; Liu J, 2012, EPIDEMIOL INFECT, V1, P1, DOI DOI 10.5897/AJB12.763; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Luo CW, 2003, CHINESE J VECTOR BIO, V14, P451; Luo L, 2005, MODERN PREVENTIVE ME, V32, P205; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Wen Liang, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P263; Zhang Yong-Zhen, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P466; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; 陈化新, 2002, [中华流行病学杂志, Chinese Journal of Epidemiology], V23, P63; 陈化新, 1999, [中国公共卫生, China Public Health], V15, P616	16	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101348	10.1371/journal.pone.0101348	http://dx.doi.org/10.1371/journal.pone.0101348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000390	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300036
J	Lukasse, M; Helbig, A; Benth, JS; Eberhard-Gran, M				Lukasse, Mirjam; Helbig, Anne; Benth, Jurate Saltyte; Eberhard-Gran, Malin			Antenatal Maternal Emotional Distress and Duration of Pregnancy	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; INTERNATIONAL DIAGNOSTIC INTERVIEW; NORWEGIAN-MOTHER; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL STRESS; SYSTEMATIC ANALYSIS; GESTATIONAL-AGE; GLOBAL REPORT; CHILD-COHORT; TIME TRENDS	Objective(s): We sought to prospectively study the association between antenatal emotional distress and gestational length birth well as preterm birth. Study Design: We followed up 40,077 primiparous women in the Norwegian Mother and Child Cohort Study. Emotional distress was reported in a short form of the Hopkins Symptom Checklist-25 (SCL-5) at 17 and 30 weeks of gestation. Gestational length at birth, obtained from the Medical Birth Registry of Norway, was used as continuous (gestational length in days) and categorized (early preterm (22-31 weeks) and late preterm (32-36 weeks) versus term birth (>= 37 weeks)) outcome, using linear and logistic regression analysis, respectively. Births were divided into spontaneous and provider-initiated. Results: Of all women, 7.4% reported emotional distress at 17 weeks, 6.0% at 30 weeks and 5.1% had a preterm birth. All measurements of emotional distress at 30 weeks were significantly associated with a reduction of gestational length, in days, for provider-initiated births at term. Emotional distress at 30 weeks showed a reduced duration of pregnancy at birth of 2.40 days for provider-initiated births at term. An increase in emotional distress from 17 to 30 weeks was associated with a reduction of gestational length at birth of 2.13 days for provider-initiated births at term. Sustained high emotional distress was associated with a reduction of gestational length at birth of 2.82 days for provider-initiated births. Emotional distress did not increase the risk of either early or late preterm birth. Conclusion: Emotional distress at 30 weeks, an increase in emotional distress from 17 to 30 weeks and sustained high levels of emotional distress were associated with a reduction in gestational length in days for provider-initiated term birth. We found no significant association between emotional distress and the risk of preterm birth.	[Lukasse, Mirjam] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Lukasse, Mirjam] Oslo & Akershus Univ, Coll Appl Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Helbig, Anne] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Helbig, Anne] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Benth, Jurate Saltyte] Univ Oslo, Inst Clin Med, Lorenskog, Norway; [Benth, Jurate Saltyte] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway; [Eberhard-Gran, Malin] Akershus Univ Hosp, Div Mental Hlth, Norwegian Inst Publ Hlth, Lorenskog, Norway; [Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway	Norwegian University of Science & Technology (NTNU); Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Lukasse, M (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	Mirjam.Lukasse@hioa.no			Norwegian Research Council [204292]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Mirjam Lukasse received a postdoctoral fellowship from the Norwegian Research Council, Grant no. 204292 (http://www.forskningsradet.no/no/Forsiden/1173185591033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; [Anonymous], BORN TOO SOON GLOB A; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chen MJ, 2011, AM J OBSTET GYNECOL, V205, P402, DOI 10.1016/j.ajog.2011.05.003; Class QA, 2011, PSYCHOSOM MED, V73, P234, DOI 10.1097/PSY.0b013e31820a62ce; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Dunkel Schetter C, 2009, CURR DIR PSYCHOL SCI, V4; Dunkel-Schetter C., 2011, HDB STRESS SCI BIOL, P321; Entringer S, 2010, STRESS, V13, P258, DOI 10.3109/10253890903349501; Eriksen W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-290; Field T, 2010, INFANT BEHAV DEV, V33, P23, DOI 10.1016/j.infbeh.2009.10.004; Glynn LM, 2008, HEALTH PSYCHOL, V27, P43, DOI 10.1037/0278-6133.27.1.43; Glynn LM, 2004, J PSYCHOSOM RES, V56, P47, DOI 10.1016/S0022-3999(03)00133-8; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Harville E, 2010, OBSTET GYNECOL SURV, V65, P713, DOI 10.1097/OGX.0b013e31820eddbe; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mackey MC, 2000, J ADV NURS, V32, P666, DOI 10.1046/j.1365-2648.2000.01526.x; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Morken NH, 2011, EUR J OBSTET GYN R B, V159, P310, DOI 10.1016/j.ejogrb.2011.08.006; Morken NH, 2008, ACTA OBSTET GYN SCAN, V87, P1374, DOI 10.1080/00016340802491508; NETTELBLADT P, 1993, SOC PSYCH PSYCH EPID, V28, P130, DOI 10.1007/BF00801743; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d; Penacoba-Puente C, 2011, ACTA OBSTET GYN SCAN, V90, P1030, DOI 10.1111/j.1600-0412.2011.01208.x; Profit J, 2010, PEDIATRICS, V125, P320, DOI 10.1542/peds.2008-3140; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Tambs K, 2009, TWIN RES HUM GENET, V12, P158, DOI 10.1375/twin.12.2.158; Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0; Teixeira C, 2009, J AFFECT DISORDERS, V119, P142, DOI 10.1016/j.jad.2009.03.005; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; Yoder BA, 2008, OBSTET GYNECOL, V111, P814, DOI 10.1097/AOG.0b013e31816499f4	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101682	10.1371/journal.pone.0101682	http://dx.doi.org/10.1371/journal.pone.0101682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000409	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300070
J	Novotna, A; Korhonova, M; Bartonkova, I; Soshilov, AA; Denison, MS; Bogdanova, K; Kolar, M; Bednar, P; Dvorak, Z				Novotna, Aneta; Korhonova, Martina; Bartonkova, Iveta; Soshilov, Anatoly A.; Denison, Michael S.; Bogdanova, Katerina; Kolar, Milan; Bednar, Petr; Dvorak, Zdenek			Enantiospecific Effects of Ketoconazole on Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							HUMAN GLUCOCORTICOID-RECEPTOR; PREGNANE-X-RECEPTOR; CELL-LINE; DIABETES-MELLITUS; GENE-EXPRESSION; HEPATIC-INJURY; CYP3A4; INHIBITION; INDUCTION; CONSTRUCTION	Azole antifungal ketoconazole (KET) was demonstrated to activate aryl hydrocarbon receptor (AhR). Since clinically used KET is a racemic mixture of two cis-enantiomers (2R,4S)-(+)-KET and (2S,4R)-(-)-KET,we examined the effects of KET enantiomers on AhR signaling pathway. (+)-KET dose-dependently activated AhR in human gene reporter cell line AZ-AHR,and displayed 5-20x higher agonist activity (efficacy),as compared to (-)-KET; both enantiomers were AhR antagonists with equal potency (IC50). Consistently,(+)-KET strongly induced CYP1A1 mRNA and protein in human HepG2 cells,while (-)-KET exerted less than 10% of (+)-KET activity. In primary human hepatocytes,both enantiomers preferentially induced CYP1A2 over CYP1A1 mRNA and protein,and the potency of (+)-KET was slightly higher as compared to (-)-KET. Ligand binding assay with guinea pig liver cytosols revealed that both (+)-KET and (-)-KET are weak ligands of AhR that displaced [H-3]-TCDD with comparable potency. Similarly,both enantiomers weakly transformed AhR to DNA-binding form with similar potency,as showed by EMSA,in guinea pig liver cytosolic extracts and nuclear extracts from mouse Hepa-1 cells. We also examined effects of KET on glucocorticoid receptor (GR),a regulator of AhR activity. Both KET enantiomers antagonized GR with similar potency,as revealed by gene reporter assay in AZ-GR cell line and down-regulation of tyrosine aminotransferase mRNA in human hepatocytes. Finally,we demonstrate enantiospecific antifungal activities of KET enantiomers in six Candida spp. strains. In conclusion,the significance of current study is providing the first evidence of enatiospecific effects of cis-enantiomers of ketoconazole on AhR-CYP1A pathway.	[Novotna, Aneta; Korhonova, Martina; Bartonkova, Iveta; Bednar, Petr; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Soshilov, Anatoly A.; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Bogdanova, Katerina; Kolar, Milan] Palacky Univ, Fac Med & Dent, Dept Microbiol, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; University of California System; University of California Davis; Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022; Kolář, Milan/AAB-4423-2021; KOLÁŘ, Milan/ACL-9884-2022	Grycova, Aneta/0000-0002-2134-1125; Kolář, Milan/0000-0003-4621-8868; KOLÁŘ, Milan/0000-0003-4621-8868; Dvorak, Zdenek/0000-0002-3938-3585; Bogdanova, Katerina/0000-0003-3014-2213; Bednar, Petr/0000-0001-7070-6015	Czech Science Agency [GACR 13-01809S]; U. S. National Institute of Environmental Health Sciences;  [PrF-2014-004]	Czech Science Agency; U. S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); 	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] (to ZD); a Superfund Research Grant from the U. S. National Institute of Environmental Health Sciences (to MSD); and by the student project [PrF-2014-004] (to ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allqvist A, 2007, EUR J CLIN PHARMACOL, V63, P173, DOI 10.1007/s00228-006-0230-z; Arakaki R, 2010, EXPERT OPIN INV DRUG, V19, P185, DOI 10.1517/13543780903381411; Babin M, 2005, TOXICOL IN VITRO, V19, P899, DOI 10.1016/j.tiv.2005.06.037; BENSON GD, 1988, DIGEST DIS SCI, V33, P240, DOI 10.1007/BF01535739; BERCOFF E, 1985, GUT, V26, P636, DOI 10.1136/gut.26.6.636; Boxenbaum H, 1999, J PHARM PHARM SCI, V2, P47; Castro-Puyana M, 2006, J CHROMATOGR A, V1114, P170, DOI 10.1016/j.chroma.2006.02.030; DANESHMEND TK, 1988, CLIN PHARMACOKINET, V14, P13, DOI 10.2165/00003088-198814010-00002; DENISON MS, 2002, CURR PROTOC TOXICOL, pCH4; Dilmaghanian S, 2004, CHIRALITY, V16, P79, DOI 10.1002/chir.10294; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Dvorak Z, 2011, TOXICOL LETT, V202, P129, DOI 10.1016/j.toxlet.2011.01.027; Hasselberg Linda, 2005, Comp Hepatol, V4, P2, DOI 10.1186/1476-5926-4-2; Jack SM, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-29; Korashy HM, 2007, TOXICOL SCI, V97, P32, DOI 10.1093/toxsci/kfm012; Monostory K, 2011, CURR DRUG METAB, V12, P154, DOI 10.2174/138920011795016854; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; PONT A, 1984, ARCH INTERN MED, V144, P2150, DOI 10.1001/archinte.144.11.2150; ROTSTEIN DM, 1992, J MED CHEM, V35, P2818, DOI 10.1021/jm00093a015; Schwartz SL, 2008, CLIN THER, V30, P1081, DOI 10.1016/j.clinthera.2008.05.021; SONINO N, 1991, CLIN ENDOCRINOL, V35, P347, DOI 10.1111/j.1365-2265.1991.tb03547.x; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; STRICKER BHC, 1986, J HEPATOL, V3, P399, DOI 10.1016/S0168-8278(86)80495-0; Sun GB, 2005, TOXICOL LETT, V155, P277, DOI 10.1016/j.toxlet.2004.10.006; Svecova L, 2008, DRUG METAB DISPOS, V36, P339, DOI 10.1124/dmd.107.018341; Vrzal R, 2008, EUR J PHARMACOL, V581, P244, DOI 10.1016/j.ejphar.2007.11.059	27	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101832	10.1371/journal.pone.0101832	http://dx.doi.org/10.1371/journal.pone.0101832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000292	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300092
J	Chauhan, JS; Dhanda, SK; Singla, D; Agarwal, SM; Raghava, GPS				Chauhan, Jagat Singh; Dhanda, Sandeep Kumar; Singla, Deepak; Agarwal, Subhash M.; Raghava, Gajendra P. S.		Open Source Drug Discovery Consort	QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; LUNG-CANCER; MOLECULAR DOCKING; SMO ALGORITHM; ATP-BINDING; IMPROVEMENTS; DERIVATIVES; PROTEIN	Overexpression of EGFR is responsible for causing a number of cancers, including lung cancer as it activates various downstream signaling pathways. Thus, it is important to control EGFR function in order to treat the cancer patients. It is well established that inhibiting ATP binding within the EGFR kinase domain regulates its function. The existing quinazoline derivative based drugs used for treating lung cancer that inhibits the wild type of EGFR. In this study, we have made a systematic attempt to develop QSAR models for designing quinazoline derivatives that could inhibit wild EGFR and imidazothiazoles/pyrazolopyrimidines derivatives against mutant EGFR. In this study, three types of prediction methods have been developed to design inhibitors against EGFR (wild, mutant and both). First, we developed models for predicting inhibitors against wild type EGFR by training and testing on dataset containing 128 quinazoline based inhibitors. This dataset was divided into two subsets called wild_train and wild_valid containing 103 and 25 inhibitors respectively. The models were trained and tested on wild_train dataset while performance was evaluated on the wild_valid called validation dataset. We achieved a maximum correlation between predicted and experimentally determined inhibition (IC50) of 0.90 on validation dataset. Secondly, we developed models for predicting inhibitors against mutant EGFR (L858R) on mutant_train, and mutant_valid dataset and achieved a maximum correlation between 0.834 to 0.850 on these datasets. Finally, an integrated hybrid model has been developed on a dataset containing wild and mutant inhibitors and got maximum correlation between 0.761 to 0.850 on different datasets. In order to promote open source drug discovery, we developed a webserver for designing inhibitors against wild and mutant EGFR along with providing standalone (http://osddlinux.osdd.net/) and Galaxy (http://osddlinux.osdd.net:8001) version of software. We hope our webserver (http://crdd.osdd.net/oscadd/ntegfr/) will play a vital role in designing new anticancer drugs.	[Chauhan, Jagat Singh; Dhanda, Sandeep Kumar; Singla, Deepak; Raghava, Gajendra P. S.] Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India; [Open Source Drug Discovery Consort] CSIR, OSDD Consortium, Delhi, India; [Agarwal, Subhash M.] Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Agarwal, SM (corresponding author), Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India.	smagarwal@yahoo.com; raghava@imtech.res.in	Agarwal, Subhash Mohan/L-3162-2019; Raghava, Gajendra P.S./AAA-2413-2022; Singla, Deepak/C-9629-2015; Raghava, Gajendra/B-1717-2009; Dhanda, Sandeep Kumar/J-8471-2016	Raghava, Gajendra P.S./0000-0002-8902-2876; Singla, Deepak/0000-0003-0131-7950; Dhanda, Sandeep Kumar/0000-0003-1381-7434; Agarwal, Subhash Mohan/0000-0001-6685-789X	Council of Scientific and Industrial Research (CSIR) [BSC0121]; Department of Biotechnology (DBT) [BTISNET]; Indian Council of Medical Research (ICMR) Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR) Government of India(Indian Council of Medical Research (ICMR))	The authors are thankful to the Council of Scientific and Industrial Research (CSIR) (project open source drug discovery (OSDD) and GENESIS BSC0121), Department of Biotechnology (DBT) (project BTISNET) and Indian Council of Medical Research (ICMR) Government of India for financial. SMA is thankful to Department of Biotechnology-IYBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Du HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022367; Fidanze SD, 2010, BIOORG MED CHEM LETT, V20, P2452, DOI 10.1016/j.bmcl.2010.03.015; Garg A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-125; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hou TJ, 2003, J CHEM INF COMP SCI, V43, P273, DOI 10.1021/ci025552a; Hubbard RD, 2009, BIOORG MED CHEM LETT, V19, P1718, DOI 10.1016/j.bmcl.2009.01.086; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; Merlo Valentina, 2011, Front Biosci (Schol Ed), V3, P501, DOI 10.2741/s168; Mitsudomi T, 2010, JPN J CLIN ONCOL, V40, P101, DOI 10.1093/jjco/hyp174; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nandi S, 2010, MOL DIVERS, V14, P27, DOI 10.1007/s11030-009-9137-9; Noolvi MN, 2013, J SAUDI CHEM SOC, V17, P361, DOI 10.1016/j.jscs.2011.04.017; Pasha FA, 2010, J MOL MODEL, V16, P263, DOI 10.1007/s00894-009-0534-x; Platt J., 1998, SEQUENTIAL MINIMAL O; Raghav D, 2013, INTERDISCIP SCI, V5, P60, DOI 10.1007/s12539-013-0149-x; Shevade SK, 2000, IEEE T NEURAL NETWOR, V11, P1188, DOI 10.1109/72.870050; Shibata T, 1996, TUMOR BIOL, V17, P168, DOI 10.1159/000217979; Singh SK, 2006, EUR J MED CHEM, V41, P1310, DOI 10.1016/j.ejmech.2006.06.010; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; THOMPSON AM, 1995, J MED CHEM, V38, P3780, DOI 10.1021/jm00019a007; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vema A, 2003, BIOORGAN MED CHEM, V11, P4643, DOI 10.1016/S0968-0896(03)00482-6; Vulpetti Anna, 2004, Farmaco (Lausanne), V59, P759; Wakeling AE, 1996, BREAST CANCER RES TR, V38, P67, DOI 10.1007/BF01803785; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang GZ, 2010, REPRODUCTIVE HEALTH AND GENDER EQUALITY: METHOD, MEASUREMENT, AND IMPLICATIONS, P1; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	38	33	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101079	10.1371/journal.pone.0101079	http://dx.doi.org/10.1371/journal.pone.0101079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992720	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400040
J	Raghavan, RK; Neises, D; Goodin, DG; Andresen, DA; Ganta, RR				Raghavan, Ram K.; Neises, Daniel; Goodin, Douglas G.; Andresen, Daniel A.; Ganta, Roman R.			Bayesian Spatio-Temporal Analysis and Geospatial Risk Factors of Human Monocytic Ehrlichiosis	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; TICK; DISTRIBUTIONS; EPIDEMIOLOGY; CHAFFEENSIS; IXODIDAE; HABITAT; ACARI	Variations in spatio-temporal patterns of Human Monocytic Ehrlichiosis (HME) infection in the state of Kansas, USA were examined and the relationship between HME relative risk and various environmental, climatic and socio-economic variables were evaluated. HME data used in the study was reported to the Kansas Department of Health and Environment between years 2005-2012, and geospatial variables representing the physical environment [National Land cover/Land use, NASA Moderate Resolution Imaging Spectroradiometer (MODIS)], climate [NASA MODIS, Prediction of Worldwide Renewable Energy (POWER)], and socio-economic conditions (US Census Bureau) were derived from publicly available sources. Following univariate screening of candidate variables using logistic regressions, two Bayesian hierarchical models were fit; a partial spatio-temporal model with random effects and a spatio-temporal interaction term, and a second model that included additional covariate terms. The best fitting model revealed that spatio-temporal autocorrelation in Kansas increased steadily from 2005-2012, and identified poverty status, relative humidity, and an interactive factor, 'diumal temperature range x mixed forest area' as significant county-level risk factors for HME. The identification of significant spatio-temporal pattern and new risk factors are important in the context of HME prevention, for future research in the areas of ecology and evolution of HME, and as well as climate change impacts on tick-borne diseases.	[Raghavan, Ram K.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Neises, Daniel] Kansas Dept Hlth & Environm, Bur Epidemiol & Publ Hlth Informat, Topeka, KS USA; [Goodin, Douglas G.] Kansas State Univ, Coll Arts & Sci, Dept Geog, Manhattan, KS 66506 USA; [Andresen, Daniel A.] Kansas State Univ, Coll Engn, Dept Comp & Informat Sci, Manhattan, KS 66506 USA; [Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu		Raghavan, Ram/0000-0002-2657-3398	National Institutes of Health, USA [AI070908]; Kansas State Veterinary Diagnostic Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State Veterinary Diagnostic Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA grant # AI070908 and Kansas State Veterinary Diagnostic Laboratory. This manuscript is contribution number 14-205-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BAYESIAN DIS MAPPING; Berger KA, 2013, INT J REMOTE SENS, V34, P73, DOI 10.1080/01431161.2012.705447; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Eckman RS, 2012, APPL ENERG, V90, P206, DOI 10.1016/j.apenergy.2011.03.001; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Gelman A, 2004, BAYESIAN DATA ANAL, P283; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Godfrey ER, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-35; Goodin DouglasG., 2004, CLIMATE WEATHER ATLA; Gray JS, 2009, INTERDISCIPLINARY PE, V2009; HAIR JA, 1975, J MED ENTOMOL, V12, P37, DOI 10.1093/jmedent/12.1.37; Hosmer DW, 1990, MODEL BUILDING STRAT, P91; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Lawson A.B., 2013, BAYESIAN DIS MAPPING, V32; Manangan JS, 2007, VECTOR-BORNE ZOONOT, V7, P563, DOI 10.1089/vbz.2007.0116; Ochanda H., 2006, International Journal of Tropical Insect Science, V26, P101, DOI 10.1079/IJT2006107; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Pavelites JJ, 2011, FORENSIC SCI MED PAT, V7, P287, DOI 10.1007/s12024-010-9219-0; Raghavan RK, 2013, GEOSPATIAL HEALTH, V7, P169, DOI 10.4081/gh.2013.78; Raghavan RK, VECTOR BORNE ZOONOTI; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2; SCHWARTZ MD, 1995, ANN ASSOC AM GEOGR, V85, P553, DOI 10.1111/j.1467-8306.1995.tb01812.x; Stefanoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045511; Suss J, 2008, PARASITOL RES, V103, pS157; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wimberly MC, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-15; Yabsley MJ, 2005, AM J TROP MED HYG, V72, P840, DOI 10.4269/ajtmh.2005.72.840; Yoder JA, 2012, INT J ACAROL, V38, P334, DOI 10.1080/01647954.2011.647073	35	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100850	10.1371/journal.pone.0100850	http://dx.doi.org/10.1371/journal.pone.0100850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992684	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400032
J	Jiang, WW; Kong, LL; Ni, QF; Lu, YT; Ding, WZ; Liu, GQ; Pu, LY; Tang, WB; Kong, LB				Jiang, Weiwei; Kong, Liangliang; Ni, Qingfeng; Lu, Yeting; Ding, Wenzhou; Liu, Guoqing; Pu, Liyong; Tang, Weibing; Kong, Lianbao			miR-146a Ameliorates Liver Ischemia/Reperfusion Injury by Suppressing IRAK1 and TRAF6	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECEPTOR 4; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; T-CELLS; INFLAMMATION; MICRORNAS; SIZE; IMMUNITY	A critical role of the Toll-like receptor(TLR) and its downstream molecules, including IL-1 receptor-associated kinase 1(IRAK1) and tumor necrosis factor receptor-associated factor 6(TRAF6), in the pathogenesis of liver ischemia/reperfusion (I/R) injury has been documented. Recently a microRNA, miR-146a, was identified as a potent negative regulator of the TLR signaling pathway. In this study, we investigated the role of miR-146a to attenuate TLR signaling and liver I/R injury in vivo and in vitro. miR-146a was decreased in mice Kupffer cells following hepatic I/R, whereas IRAK1 and TRAF6 increased. Overexpression of miR-146a directly decreased IRAK1 and TRAF6 expression and attenuated the release of proinflammatory cytokines through the inactivation of NF-kappa B P65 in hypoxia/reoxygenation (H/R)-induced macrophages, RAW264.7 cells. Knockdown experiments demonstrated that IRAK1 and TRAF6 are two potential targets for reducing the release of proinflammatory cytokines. Moreover, co-culture assays indicated that miR-146a decreases the apoptosis of hepatocytes after H/R. In vivo administration of Ago-miR-146a, a stable version of miR-146a in vivo, protected against liver injury in mice after I/R via inactivation of the TLR signaling pathway. We conclude that miR-146a ameliorates liver ischemia/reperfusion injury in vivo and hypoxia/reoxygenation injury in vitro by directly suppressing IRAK1 and TRAF6.	[Jiang, Weiwei; Liu, Guoqing; Tang, Weibing] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Neonatal Surg, Nanjing, Jiangsu, Peoples R China; [Kong, Liangliang; Ni, Qingfeng; Lu, Yeting; Ding, Wenzhou; Pu, Liyong; Kong, Lianbao] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Kong, LB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	lbkong@njmu.edu.cn			National Natural Science Foundation of China [81100318, 81270483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81100318, 81270483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arias-Diaz J, 2009, LAB INVEST, V89, P433, DOI 10.1038/labinvest.2009.3; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298; Chen Q, 2013, TRANSPL P, V45, P492, DOI 10.1016/j.transproceed.2012.10.045; de Creus A, 2005, J IMMUNOL, V174, P2037, DOI 10.4049/jimmunol.174.4.2037; Ellett JD, 2009, LIVER TRANSPLANT, V15, P1101, DOI 10.1002/lt.21782; Jiang W, 2011, TRANSPL P, V43, P1462, DOI 10.1016/j.transproceed.2011.01.191; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Liang TB, 2003, TRANSPLANTATION, V75, P673, DOI 10.1097/01.TP.0000048490.24429.89; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu L, 2009, INT IMMUNOPHARMACOL, V9, P549, DOI 10.1016/j.intimp.2009.01.020; Luan X, 2012, TRANSPL P, V44, P937, DOI 10.1016/j.transproceed.2011.11.001; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Nace GW, 2013, HEPATOLOGY, V58, P374, DOI 10.1002/hep.26346; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Onoe T, 2013, TRANSPLANTATION, V95, P1521, DOI 10.1097/TP.0b013e31829150a4; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tan S, 1998, CRIT CARE MED, V26, P1089, DOI 10.1097/00003246-199806000-00034; Theodoraki K, 2012, WORLD J SURG, V36, P2895, DOI 10.1007/s00268-012-1779-6; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tukov FF, 2006, TOXICOL IN VITRO, V20, P1488, DOI 10.1016/j.tiv.2006.04.005; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu JD, 2010, J HEPATOL, V53, P73, DOI 10.1016/j.jhep.2010.01.032; Yang ZF, 2004, AM J TRANSPLANT, V4, P196, DOI 10.1046/j.1600-6143.2003.00313.x; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yuan P, 2013, NEUROL SCI, V34, P1133, DOI 10.1007/s10072-012-1199-2; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P1856, DOI 10.1161/ATVBAHA.112.252619; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	43	64	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101530	10.1371/journal.pone.0101530	http://dx.doi.org/10.1371/journal.pone.0101530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987958	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100109
J	Monahan, WB; Fisichelli, NA				Monahan, William B.; Fisichelli, Nicholas A.			Climate Exposure of US National Parks in a New Era of Change	PLOS ONE			English	Article							VULNERABILITY; CONSERVATION; ECOSYSTEMS; IMPACTS; MANAGEMENT	US national parks are challenged by climate and other forms of broad-scale environmental change that operate beyond administrative boundaries and in some instances are occurring at especially rapid rates. Here, we evaluate the climate change exposure of 289 natural resource parks administered by the US National Park Service (NPS), and ask which are presently (past 10 to 30 years) experiencing extreme (<5th percentile or >95th percentile) climates relative to their 19012012 historical range of variability (HRV). We consider parks in a landscape context (including surrounding 30 km) and evaluate both mean and inter-annual variation in 25 biologically relevant climate variables related to temperature, precipitation, frost and wet day frequencies, vapor pressure, cloud cover, and seasonality. We also consider sensitivity of findings to the moving time window of analysis (10, 20, and 30 year windows). Results show that parks are overwhelmingly at the extreme warm end of historical temperature distributions and this is true for several variables (e. g., annual mean temperature, minimum temperature of the coldest month, mean temperature of the warmest quarter). Precipitation and other moisture patterns are geographically more heterogeneous across parks and show greater variation among variables. Across climate variables, recent inter-annual variation is generally well within the range of variability observed since 1901. Moving window size has a measureable effect on these estimates, but parks with extreme climates also tend to exhibit low sensitivity to the time window of analysis. We highlight particular parks that illustrate different extremes and may facilitate understanding responses of park resources to ongoing climate change. We conclude with discussion of how results relate to anticipated future changes in climate, as well as how they can inform NPS and neighboring land management and planning in a new era of change.	[Monahan, William B.; Fisichelli, Nicholas A.] Natl Pk Serv, Ft Collins, CO 80525 USA	United States Department of the Interior	Monahan, WB (corresponding author), Natl Pk Serv, Ft Collins, CO 80525 USA.	Bill_Monahan@nps.gov			National Park Service; NASA [10-BIOCLIM10-0034]	National Park Service; NASA(National Aeronautics & Space Administration (NASA))	Support for this study was provided by the National Park Service, and by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Carter LM, 2014, SE CARIBBEAN CLIMATE, P396, DOI DOI 10.7930/J0NP22CB; Cole DN, 1996, ECOL APPL, V6, P168, DOI 10.2307/2269562; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dolanc CR, 2013, GLOBAL ECOL BIOGEOGR, V22, P264, DOI 10.1111/j.1466-8238.2011.00748.x; Fisichelli N, 2012, GLOBAL CHANGE BIOL, V18, P3455, DOI 10.1111/j.1365-2486.2012.02785.x; Fisichelli NA, 2014, FOREST ECOL MANAG, V327, P31, DOI 10.1016/j.foreco.2014.04.033; Fritts H. C., 1976, TREE RINGS CLIMATE; Garfin G, 2014, SW CLIMATE CHANGE IM, P462, DOI DOI 10.7930/J08G8HMN; Hameed SO, 2013, J ENVIRON MANAGE, V121, P37, DOI 10.1016/j.jenvman.2013.02.034; Hansen AJ, 2014, ECOL APPL, V24, P484, DOI 10.1890/13-0905.1; Hansen AJ, 2011, BIOSCIENCE, V61, P363, DOI 10.1525/bio.2011.61.5.5; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hijmans R, 2006, BIOCLIM AML VERSION; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Horton R, 2014, CLIMATE CHANGE IMPAC; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Kareiva PC, 2008, PRELIMINARY REV ADAP, P622; Keane RE, 2009, FOREST ECOL MANAG, V258, P1025, DOI 10.1016/j.foreco.2009.05.035; Klausmeyer KR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00044.1; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Leong J-A, 2014, CLIMATE CHANGE IMPAC, P537, DOI DOI 10.7930/J0W66HPM; LEVINS R, 1966, AM SCI, V54, P421; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Magness DR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00200.1; Menne MJ, 2013, US HIST CLIMATOLOGY; MetOffice, 2014, CLIM AV; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; National Academy of Public Administration, 2010, STRENGTH AM BEST ID; National Park Service, 2013, NPSCAPE STAND OP PRO; National Park Service, 2004, PROGR STAND PARK PLA; National Park Service, 2011, NPSCAPE NPS BOUND DE; National Park Service (US), 2010, CLIM CHANG RESP STRA; National Park System Advisory Board, 2012, REV LEOP RES STEW NA; National Parks Second Century Commission, 2009, ADV NAT PARK ID SCI; Nordstrom R, 2014, NATL CLIMATE ASSESSM, P418; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; R Core Team, 2014, R LANG ENV STAT COMP; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [DOI 10.7930/J0KW5CXT, 10.7930/J0KW5CXT]	50	50	50	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101302	10.1371/journal.pone.0101302	http://dx.doi.org/10.1371/journal.pone.0101302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988483	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100075
J	Nevoral, J; Petr, J; Gelaude, A; Bodart, JF; Kucerova-Chrpova, V; Sedmikova, M; Krejcova, T; Kolbabova, T; Dvorakova, M; Vyskocilova, A; Weingartova, I; Krivohlavkova, L; Zalmanova, T; Jilek, F				Nevoral, Jan; Petr, Jaroslav; Gelaude, Armance; Bodart, Jean-Francois; Kucerova-Chrpova, Veronika; Sedmikova, Marketa; Krejcova, Tereza; Kolbabova, Tereza; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Krivohlavkova, Lenka; Zalmanova, Tereza; Jilek, Frantisek			Dual Effects of Hydrogen Sulfide Donor on Meiosis and Cumulus Expansion of Porcine Cumulus-Oocyte Complexes	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; AKT PROTEIN-KINASE; MEIOTIC MATURATION; PIG OOCYTES; MOUSE OOCYTES; MAP KINASE; FOLLICULAR DEVELOPMENT; GASEOUS TRANSMITTER; CELLS; ACTIVATION	Hydrogen sulfide (H2S) has been revealed to be a signal molecule with second messenger action in the somatic cells of many tissues, including the reproductive tract. The aim of this study was to address how exogenous H2S acts on the meiotic maturation of porcine oocytes, including key maturation factors such as MPF and MAPK, and cumulus expansion intensity of cumulus-oocyte complexes. We observed that the H2S donor, Na2S, accelerated oocyte in vitro maturation in a dose-dependent manner, following an increase of MPF activity around germinal vesicle breakdown. Concurrently, the H2S donor affected cumulus expansion, monitored by hyaluronic acid production. Our results suggest that the H2S donor influences oocyte maturation and thus also participates in the regulation of cumulus expansion. The exogenous H2S donor apparently affects key signal pathways of oocyte maturation and cumulus expansion, resulting in faster oocyte maturation with little need of cumulus expansion.	[Nevoral, Jan; Kucerova-Chrpova, Veronika; Sedmikova, Marketa; Krejcova, Tereza; Kolbabova, Tereza; Dvorakova, Marketa; Vyskocilova, Alena; Weingartova, Ivona; Krivohlavkova, Lenka; Zalmanova, Tereza; Jilek, Frantisek] Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic; [Petr, Jaroslav] Res Inst Anim Prod, Prague, Czech Republic; [Gelaude, Armance; Bodart, Jean-Francois] Univ Lille 1, Lab Regulat Signaux Div, IFR 147, EA 4479, F-59655 Villeneuve Dascq, France	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Universite de Lille - ISITE; Universite de Lille	Nevoral, J (corresponding author), Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic.	nevoral@af.czu.cz	Bodart, Jean-François Laurent/AAZ-2075-2021; Sedmíková, Markéta/B-5768-2018; Krejcova, Tereza/AAX-1542-2021	Bodart, Jean-François Laurent/0000-0002-6113-7700; Sedmíková, Markéta/0000-0003-0947-4256; Krejcova, Tereza/0000-0001-5840-9499	National Agency of Agriculture Sciences [NAZV QI 101A166]; Czech ministry of Agriculture [MZeRO 0714]; Czech University of Life Sciences in Prague [CIGA 20122038, CIGA 20122034, CIGA 20132035]	National Agency of Agriculture Sciences; Czech ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences in Prague	This work was supported by the National Agency of Agriculture Sciences (NAZV QI 101A166), the Czech ministry of Agriculture (MZeRO 0714) and the Czech University of Life Sciences in Prague (CIGA 20122038, CIGA 20122034, CIGA 20132035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger M, 2004, MOL REPROD DEV, V69, P11, DOI 10.1002/mrd.20151; Bagg MA, 2009, REPROD FERT DEVELOP, V21, P796, DOI 10.1071/RD08165; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; Dragovic RA, 2005, ENDOCRINOLOGY, V146, P2798, DOI 10.1210/en.2005-0098; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fan HY, 2002, MOL REPROD DEV, V63, P480, DOI 10.1002/mrd.10194; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; Ghasemi M, 2012, BIOCHEM PHARMACOL, V83, P1261, DOI 10.1016/j.bcp.2012.01.026; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; HAMPL A, 1995, DEVELOPMENT, V121, P925; Han ZB, 2006, REPRODUCTION, V132, P749, DOI 10.1530/REP-06-0055; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Huang Y, 2010, TOHOKU J EXP MED, V221, P125, DOI 10.1620/tjem.221.125; Jezova M, 2001, ANIM REPROD SCI, V65, P115, DOI 10.1016/S0378-4320(00)00219-0; Jilek F, 2001, REPROD DOMEST ANIM, V36, P139, DOI 10.1046/j.1439-0531.2001.d01-27.x; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kimura N, 2002, BIOL REPROD, V66, P707, DOI 10.1095/biolreprod66.3.707; Kubelka M, 2000, BIOL REPROD, V62, P292, DOI 10.1095/biolreprod62.2.292; Liang R, 2007, REPROD TOXICOL, V24, P89, DOI 10.1016/j.reprotox.2007.04.002; Liang R, 2006, CHINESE MED J-PEKING, V119, P1877, DOI 10.1097/00029330-200611020-00006; Mard SA, 2012, DIGEST DIS SCI, V57, P1496, DOI 10.1007/s10620-012-2051-5; MOTLIK J, 1976, J EXP ZOOL, V198, P155, DOI 10.1002/jez.1401980205; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; MOTLIK J, 1986, THERIOGENOLOGY, V25, P87, DOI 10.1016/0093-691X(86)90185-8; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagyova E, 2000, BIOL REPROD, V63, P1149, DOI 10.1095/biolreprod63.4.1149; Njie-Mbye YF, 2012, EXP EYE RES, V98, P16, DOI 10.1016/j.exer.2012.03.001; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; PETTERS RM, 1993, J REPROD FERTIL, P61; PROCHAZKA R, 1991, J REPROD FERTIL, V93, P569, DOI 10.1530/jrf.0.0930569; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Srilatha B, 2009, J SEX MED, V6, P1875, DOI 10.1111/j.1743-6109.2009.01291.x; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wassarman P.M., 1988, P69; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Yokoo M, 2010, J REPROD DEVELOP, V56, P15, DOI 10.1262/jrd.09-173E; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322	45	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e99613	10.1371/journal.pone.0099613	http://dx.doi.org/10.1371/journal.pone.0099613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984032	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000012
J	Owens, P; Pickup, MW; Novitskiy, SV; Giltnane, JM; Gorska, AE; Hopkins, CR; Hong, CC; Moses, HL				Owens, P.; Pickup, M. W.; Novitskiy, S. V.; Giltnane, J. M.; Gorska, A. E.; Hopkins, C. R.; Hong, C. C.; Moses, H. L.			Inhibition of BMP signaling suppresses metastasis in mammary cancer	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN-6; TUMOR-ASSOCIATED MACROPHAGES; TGF-BETA RECEPTOR; BREAST-CANCER; PROSTATE-CANCER; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; EPITHELIAL-CELLS; HAIR-FOLLICLES; EXPRESSION	Bone morphogenetic proteins (BMPs) are secreted cytokines/growth factors that have differing roles in cancer. BMPs are overexpressed in human breast cancers, but loss of BMP signaling in mammary carcinomas can accelerate metastasis. We show that human breast cancers display active BMP signaling, which is rarely downregulated or homozygously deleted. We hypothesized that systemic inhibition of BMP signaling in both the tumor and the surrounding microenvironment could prevent tumor progression and metastasis. To test this hypothesis, we used DMH1, a BMP antagonist, in MMTV. PyVmT expressing mice. Treatment with DMH1 reduced lung metastasis and the tumors were less proliferative and more apoptotic. In the surrounding tumor microenvironment, treatment with DMH1 altered fibroblasts, lymphatic vessels and macrophages to be less tumor promoting. These results indicate that inhibition of BMP signaling may successfully target both the tumor and the surrounding microenvironment to reduce tumor burden and metastasis.	[Owens, P.; Pickup, M. W.; Novitskiy, S. V.; Gorska, A. E.; Moses, H. L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Owens, P.; Pickup, M. W.; Novitskiy, S. V.; Gorska, A. E.; Moses, H. L.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Giltnane, J. M.; Moses, H. L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hopkins, C. R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Hopkins, C. R.] Vanderbilt Univ, Coll Arts & Sci, Dept Chem, Nashville, TN 37235 USA; [Hong, C. C.] Vet Affairs TVHS, Res Med, Nashville, TN USA; [Hong, C. C.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Owens, P (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 2220 Pierce Ave,Preston Res Bldg 692, Nashville, TN 37232 USA.	philip.owens@vanderbilt.edu			DoD BCRP postdoctoral fellowship [W81XWH-09-1-0421]; NIH/NHLBI [RO1HL104040]; VA Merit Award [101BX000771]; NIH [CA085492, CA102162]; Robert J and Helen C Kleberg Foundation; TJ Martell Foundation;  [CA068485]; NATIONAL CANCER INSTITUTE [R01CA102162, R01CA085492, P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000771] Funding Source: NIH RePORTER	DoD BCRP postdoctoral fellowship; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J and Helen C Kleberg Foundation; TJ Martell Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank the members of the Moses laboratory for critically reading the manuscript. We thank Dr Connor Lynch for help with tissue acquisition. PO has been supported by DoD BCRP postdoctoral fellowship grant number W81XWH-09-1-0421. CCH is supported by NIH/NHLBI grants RO1HL104040 and VA Merit Award # 101BX000771. This work is supported by NIH grants CA085492, CA102162, the Robert J and Helen C Kleberg Foundation and the TJ Martell Foundation to HLM. Grant number CA068485 provided core laboratory support.	Alarmo EL, 2008, ANN ONCOL, V19, P308, DOI 10.1093/annonc/mdm453; Alarmo EL, 2006, GENE CHROMOSOME CANC, V45, P411, DOI 10.1002/gcc.20307; Alarmo EL, 2007, BREAST CANCER RES TR, V103, P239, DOI 10.1007/s10549-006-9362-1; Alarmo EL, 2013, MODERN PATHOL, V26, P10, DOI 10.1038/modpathol.2012.128; Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Calva-Cerqueira D, 2010, HUM MOL GENET, V19, P4654, DOI 10.1093/hmg/ddq396; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen JC, 2013, INT J MOL SCI, V14, P88, DOI 10.3390/ijms14010088; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cross EE, 2011, ACS CHEM BIOL, V6, P952, DOI 10.1021/cb200205z; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Ehata S, 2013, PATHOL INT, V63, P287, DOI 10.1111/pin.12067; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hong JH, 2009, IMMUNOLOGY, V128, pe442, DOI 10.1111/j.1365-2567.2008.02998.x; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Ketolainen JM, 2010, BREAST CANCER RES TR, V124, P377, DOI 10.1007/s10549-010-0808-0; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwan KM, 2004, GENESIS, V39, P10, DOI 10.1002/gene.20021; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; Langenfeld E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061256; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lee GT, 2011, MOL IMMUNOL, V48, P1540, DOI 10.1016/j.molimm.2011.04.019; Lee GT, 2010, J BIOL CHEM, V285, P39401, DOI 10.1074/jbc.M110.103705; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Owens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067533; Owens P, 2012, P NATL ACAD SCI USA, V109, P2814, DOI 10.1073/pnas.1101139108; Owens P, 2010, AM J PATHOL, V176, P122, DOI 10.2353/ajpath.2010.090081; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Pickup MW, 2013, CANCER RES, V73, P5336, DOI 10.1158/0008-5472.CAN-13-0012; Rodriguez-Martinez A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-80; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079	59	76	78	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2437	2449		10.1038/onc.2014.189	http://dx.doi.org/10.1038/onc.2014.189			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998846	Green Accepted			2022-12-25	WOS:000354190400003
J	Wu, DW; Lee, MC; Hsu, NY; Wu, TC; Wu, JY; Wang, YC; Cheng, YW; Chen, CY; Lee, H				Wu, D-W; Lee, M-C; Hsu, N-Y; Wu, T-C; Wu, J-Y; Wang, Y-C; Cheng, Y-W; Chen, C-Y; Lee, H.			FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-kappa B/Slug-mediated PUMA reduction	ONCOGENE			English	Article							P53-MEDIATED APOPTOSIS; TUMOR SUPPRESSION; E6 ONCOPROTEIN; GENE; INACTIVATION; EXPRESSION; SURVIVAL; PATHWAY; GROWTH; TRANSACTIVATION	Fragile histidine triad (FHIT) loss by the two-hit mechanism of loss of heterozygosity and promoter hypermethylation commonly occurrs in non-small cell lung cancer (NSCLC) and may confer cisplatin resistance in NSCLC cells. However, the underlying mechanisms of FHIT loss in cisplatin resistance and the response to cisplatin-based chemotherapy in NSCLC patients have not yet been reported. In the present study, inhibition concentration of 50% cell viability induced by cisplatin (IC50) and soft agar growth and invasion capability were increased and decreased in FHIT-knockdown and -overexpressing cells, respectively. Mechanistically, Slug transcription is upregulated by AKT/NF-kappa B activation due to FHIT loss and, in turn, Slug suppresses PUMA expression; this decrease of PUMA by FHIT loss is responsible for cisplatin resistance. In addition, cisplatin resistance due to FHIT loss can be conquered by AKT inhibitor-perifosine in xenograft tumors. Among NSCLC patients, low FHIT, high p-AKT, high Slug and low PUMA were correlated with shorter overall survival, relapse-free survival and poorer response to cisplatin-based chemotherapy. Therefore, the AKT inhibitor perifosine might potentially overcome the resistance to cisplatin-based chemotherapy in NSCLC patients with low-FHIT tumors, and consequently improve the outcome.	[Wu, D-W; Hsu, N-Y; Cheng, Y-W; Lee, H.] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Lee, M-C] Taichung Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taichung, Taiwan; [Wu, T-C; Wang, Y-C] Chung Shan Med Univ Hosp, Div Chest Med, Taichung 40201, Taiwan; [Wu, T-C; Wang, Y-C] Chung Shan Med Univ, Sch Med, Taichung 40201, Taiwan; [Wu, J-Y] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Div Thorac Surg, Taichung, Taiwan; [Wu, J-Y] Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Chen, C-Y] China Med Univ Hosp, Dept Surg, Taichung, Taiwan	Taipei Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, H (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Room 5,12F,3 Pk St, Taipei, Taiwan.	hl@tmu.edu.tw			National Health Research Institute [NHRI96-TD-G-111-006, NHRI97-TD-G-111-006]; National Science Council of Taiwan, ROC [100-2314-B-038-043-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Health Research Institute (NHRI96-TD-G-111-006; NHRI97-TD-G-111-006) and the National Science Council (100-2314-B-038-043-MY3) of Taiwan, ROC.	Andriani F, 2006, NEOPLASIA, V8, P9, DOI 10.1593/neo.05517; Andriani F, 2012, J THORAC ONCOL, V7, P631, DOI 10.1097/JTO.0b013e318244aed0; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Cha HS, 2010, EXP MOL MED, V42, P428, DOI 10.3858/emm.2010.42.6.044; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Jayachandran G, 2007, CANCER RES, V67, P10379, DOI 10.1158/0008-5472.CAN-07-0677; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Ji L, 1999, CANCER RES, V59, P3333; Joannes A, 2010, ONCOGENE, V29, P1203, DOI 10.1038/onc.2009.418; Kim CH, 2006, INT J CANCER, V118, P1692, DOI 10.1002/ijc.21573; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mimori K, 2006, CANCER RES, V66, P2683, DOI 10.1158/0008-5472.CAN-05-2509; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nishizaki M, 2004, CANCER RES, V64, P5745, DOI 10.1158/0008-5472.CAN-04-0195; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Sozzi G, 1997, CANCER RES, V57, P2121; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Toledo G, 2004, MODERN PATHOL, V17, P440, DOI 10.1038/modpathol.3800081; Tseng JE, 1999, CANCER RES, V59, P4798; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang J, 2006, CANCER LETT, V235, P18, DOI 10.1016/j.canlet.2005.03.058; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Wu HH, 2010, CLIN CANCER RES, V16, P5200, DOI 10.1158/1078-0432.CCR-10-0020; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898; Zhang F, 2012, CELL REP, V2, P1272, DOI 10.1016/j.celrep.2012.09.023; Zienolddiny S, 2001, BRIT J CANCER, V84, P226, DOI 10.1054/bjoc.2000.1528	39	32	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2505	2515		10.1038/onc.2014.184	http://dx.doi.org/10.1038/onc.2014.184			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998847				2022-12-25	WOS:000354190400009
J	Kaniewski, D; Van Campo, E; Morhange, C; Guiot, J; Zviely, D; Le Burel, S; Otto, T; Artzy, M				Kaniewski, David; Van Campo, Elise; Morhange, Christophe; Guiot, Joel; Zviely, Dov; Le Burel, Sabine; Otto, Thierry; Artzy, Michal			Vulnerability of Mediterranean Ecosystems to Long-Term Changes along the Coast of Israel	PLOS ONE			English	Article							SEA-LEVEL RISE; HOLOCENE CLIMATE VARIABILITY; HAIFA BAY; SHORELINE MIGRATION; WATER AVAILABILITY; MIDDLE-EAST; FUTURE; FOREST; DROUGHT; FLORIDA	Although human activity is considered to be a major driving force affecting the distribution and dynamics of Mediterranean ecosystems, the full consequences of projected climate variability and relative sea-level changes on fragile coastal ecosystems for the next century are still unknown. It is unclear how these waterfront ecosystems can be sustained, as well as the services they provide, when relative sea-level rise and global warming are expected to exert even greater pressures in the near future (drought, habitat degradation and accelerated shoreline retreat). Haifa Bay, northern Israel, has recorded a landward sea invasion, with a maximum sea penetration 4,000 years ago, during an important period of urban development and climate instability. Here, we examine the cumulative pressure of climate shifts and relative sea-level changes in order to investigate the patterns and mechanisms behind forest replacement by an open-steppe. We provide a first comprehensive and integrative study for the southern Levant that shows that (i) human impact, through urbanization, has been the main driver behind ecological erosion in the past 4,000 years; (ii) climate pressures have reinforced this impact; and (iii) local coastal changes have played a decisive role in eroding ecosystem resilience. These three parameters, which have closely interacted during the last 4,000 years in Haifa Bay, clearly indicate that for an efficient management of the coastal habitats, anthropogenic pressures linked to urban development must be reduced in order to mitigate the predicted effects of Global Change.	[Kaniewski, David; Van Campo, Elise; Le Burel, Sabine; Otto, Thierry] Univ Toulouse 3, Lab Ecol Fonct & Environm EcoLab, F-31062 Toulouse, France; [Kaniewski, David; Van Campo, Elise; Le Burel, Sabine; Otto, Thierry] CNRS, Lab Ecol Fonct & Environm EcoLab, Toulouse, France; [Kaniewski, David; Morhange, Christophe] Inst Univ France, Paris, France; [Morhange, Christophe; Guiot, Joel] Aix Marseille Univ, Ctr Rech & Enseignement Geosci Environm CEREGE, CNRS, Unite Mixte 34, Aix En Provence, France; [Zviely, Dov; Artzy, Michal] Univ Haifa, Leon Recanati Inst Maritime Studies, IL-31999 Haifa, Israel; [Artzy, Michal] Univ Haifa, Hatter Lab, IL-31999 Haifa, Israel	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Haifa; University of Haifa	Kaniewski, D (corresponding author), Univ Toulouse 3, Lab Ecol Fonct & Environm EcoLab, F-31062 Toulouse, France.	david.kaniewski@univ-tlse3.fr	Zviely, Dov/GPK-6194-2022; Kaniewski, David/AAT-2607-2021; Guiot, Joel/G-7818-2011	Kaniewski, David/0000-0001-6569-3184; Guiot, Joel/0000-0001-7345-4466; Otto, Thierry/0000-0003-2854-6454	Institut Universitaire de France; CLIMSORIENT; Geoarchaeology of ancient harbours projects; Mistrals-ENVIMED-GEOISRAEL program; Hatter Laboratory; Recanati Institute for Maritime Studies, University of Haifa; Investissements d'Avenir [ANR-11-LABEX-0061]; French Government project of the French National Research Agency (ANR) through the A*Midex project [ANR-11-IDEX-0001-02]	Institut Universitaire de France; CLIMSORIENT; Geoarchaeology of ancient harbours projects; Mistrals-ENVIMED-GEOISRAEL program; Hatter Laboratory; Recanati Institute for Maritime Studies, University of Haifa; Investissements d'Avenir(French National Research Agency (ANR)); French Government project of the French National Research Agency (ANR) through the A*Midex project(French National Research Agency (ANR))	Support was provided by the Institut Universitaire de France, CLIMSORIENT and Geoarchaeology of ancient harbours projects, the Mistrals-ENVIMED-GEOISRAEL program, and by the Hatter Laboratory, Recanati Institute for Maritime Studies, University of Haifa. This work is also a contribution to the Labex OT-Med (ANR-11-LABEX-0061) funded by the "Investissements d'Avenir", French Government project of the French National Research Agency (ANR) through the A*Midex project (ANR-11-IDEX-0001-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY E. J, 2009, DEV MARINE GEOLOGY, V4; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bernhardt CE, 2012, GEOLOGY, V40, P615, DOI 10.1130/G33012.1; Cazenave A, 2001, GEOPHYS RES LETT, V28, P1607, DOI 10.1029/2000GL012628; Chenoweth J, 2011, WATER RESOUR RES, V47, DOI [10.1029/2010WR010269, 10.1029/2011WR010602]; DANIN A, 1981, ANALES JARD BOT MADR, V37, P269; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Faegri K., 1898, J BIOGEOGR, V12, P238; Fiorentino G, 2008, PALAEOGEOGR PALAEOCL, V266, P51, DOI 10.1016/j.palaeo.2008.03.034; Grafe K.-U., 2003, SEPM SPECIAL PUBLICA, V75, P229; Guiot J, 2009, CLIM PAST, V5, P571, DOI 10.5194/cp-5-571-2009; Kafle HK, 2009, CLIMATIC CHANGE, V96, P63, DOI 10.1007/s10584-009-9578-2; Kaniewski D, 2008, P NATL ACAD SCI USA, V105, P13941, DOI 10.1073/pnas.0803533105; Kaniewski D, 2010, QUATERNARY RES, V74, P207, DOI 10.1016/j.yqres.2010.07.010; Kaniewski D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03540; Kaniewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071004; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Langgut D, 2014, PALYNOLOGY, V38, P280, DOI 10.1080/01916122.2014.906001; Langgut D, 2013, TEL AVIV, V40, P149, DOI 10.1179/033443513X13753505864205; Lichter M, 2010, CELL ORIG LIFE EXTRE, V15, P3, DOI 10.1007/978-90-481-8569-6_1; Litt T, 2012, QUATERNARY SCI REV, V49, P95, DOI 10.1016/j.quascirev.2012.06.012; Marcos M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004820; Milano M, 2013, WATER RESOURCES NATU, V26, P1; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Porat Naomi, 2008, Israel Journal of Earth Sciences, V57, P21, DOI 10.1560/IJES.57.1.21; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schilman B, 2001, PALAEOGEOGR PALAEOCL, V176, P157, DOI 10.1016/S0031-0182(01)00336-4; Schilman Bettina, 2002, Israel Journal of Earth Sciences, V51, P181, DOI 10.1560/504G-007U-5NKY-GUN1; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Soltani S, 2012, CLIMATIC CHANGE, V110, P187, DOI 10.1007/s10584-011-0146-1; Sowers J, 2011, CLIMATIC CHANGE, V104, P599, DOI 10.1007/s10584-010-9835-4; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Stewart IS, 2009, PHYS GEOGRAPHY MEDIT, P385; Suppan P, 2008, ENVIRON SCI ENG, P47, DOI 10.1007/978-3-540-85047-2_5; Williams K, 2003, J COASTAL RES, V19, P1116; Williams K, 1999, ECOLOGY, V80, P2045, DOI 10.1890/0012-9658(1999)080[2045:SLRACF]2.0.CO;2; Zviely D, 2007, MAR GEOL, V238, P61, DOI 10.1016/j.margeo.2006.12.003; Zviely D, 2006, HOLOCENE, V16, P849, DOI 10.1191/0959683606hol977rp; Zviely D, 2009, GEO-MAR LETT, V29, P93, DOI 10.1007/s00367-008-0126-2	43	14	15	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102090	10.1371/journal.pone.0102090	http://dx.doi.org/10.1371/journal.pone.0102090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003703	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700106
J	Teh, X; Khosravi, Y; Lee, WC; Leow, AHR; Loke, MF; Vadivelu, J; Goh, KL				Teh, Xinsheng; Khosravi, Yalda; Lee, Woon Ching; Leow, Alex Hwong Ruey; Loke, Mun Fai; Vadivelu, Jamuna; Goh, Khean Lee			Functional and Molecular Surveillance of Helicobacter pylori Antibiotic Resistance in Kuala Lumpur	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; CLARITHROMYCIN RESISTANCE; FLUOROQUINOLONE RESISTANCE; POINT MUTATIONS; GYRA MUTATIONS; FRXA GENES; ERADICATION; METRONIDAZOLE; MANAGEMENT; QUADRUPLE	Background: Helicobacter pylori is the etiological agent for diseases ranging from chronic gastritis and peptic ulcer disease to gastric adenocarcinoma and primary gastric B-cell lymphoma. Emergence of resistance to antibiotics possesses a challenge to the effort to eradicate H. pylori using conventional antibiotic-based therapies. The molecular mechanisms that contribute to the resistance of these strains have yet to be identified and are important for understanding the evolutional pattern and selective pressure imposed by the environment. Methods and Findings: H. pylori was isolated from 102 patients diagnosed with gastrointestinal diseases, who underwent endoscopy at University Malaya Medical Centre (UMMC). The isolates were tested for their susceptibility on eleven antibiotics using Etest. Based on susceptibility test, 32.3% of the isolates were found to have primary metronidazole resistance; followed by clarithromycin (6.8%) and fluoroquinolones (6.8%). To further investigate the resistant strains, mutational patterns of gene rdxA, frxA, gyrA, gyrB, and 23S rRNA were studied. Consistent with the previous reports, metronidazole resistance was prevalent in the local population. However, clarithromycin, fluoroquinolone and multi-drug resistance were shown to be emerging. Molecular patterns correlated well with phenotypic data. Interestingly, multi-drug resistant (MDR) strains were found to be associated with higher minimum inhibitory concentration (MIC) than their single-drug resistant (SDR) counterparts. Most importantly, clarithromycin-resistant strains were suggested to have a higher incidence for developing multi-drug resistance. Conclusion: Data from this study highlighted the urgency to monitor closely the prevalence of antibiotic resistance in the Malaysian population; especially that of clarithromycin and multi-drug resistance. Further study is needed to understand the molecular association between clarithromycin resistance and multi-drug resistance in H. pylori. The report serves a reminder that a strict antibiotic usage policy is needed in Malaysia and other developing countries (especially those where H. pylori prevalence remained high).	[Teh, Xinsheng; Khosravi, Yalda; Lee, Woon Ching; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Leow, Alex Hwong Ruey; Goh, Khean Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Goh, Khean-Lee/B-6404-2009; Loke, Mun Fai/B-1060-2011; Leow, Alex HR/B-1626-2017; VADIVELU, JAMUNARANI S/B-8696-2010	Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; Leow, Alex HR/0000-0003-1752-0435; VADIVELU, JAMUNARANI S/0000-0001-7322-3676	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant [UM.C/625/1/HIR/MOE/CHAN/02]	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) Grant (UM.C/625/1/HIR/MOE/CHAN/02, HIR Account No: H-50001-A00014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo S, 2011, REV ESP QUIM, V24, P32; Ahmad N, 2011, HELICOBACTER, V16, P47, DOI 10.1111/j.1523-5378.2010.00816.x; Ahmad N, 2009, WORLD J GASTROENTERO, V15, P3161, DOI 10.3748/wjg.15.3161; Bago J, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-13; Baldwin CM, 2009, DRUGS, V69, P1373, DOI 10.2165/00003495-200969100-00007; Binh TT, 2013, J CLIN GASTROENTEROL, V47, P233, DOI 10.1097/MCG.0b013e3182676e2b; Chang WL, 2012, HELICOBACTER, V17, P210, DOI 10.1111/j.1523-5378.2012.00935.x; Corry JEL, 2003, HDB CULTURE MEDIA FO, Vxiv; Cuadrado-Lavin A, 2012, J ANTIMICROB CHEMOTH, V67, P170, DOI 10.1093/jac/dkr410; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Farhana F, 2009, TROP BIOMED, V26, P262; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Gao W, 2010, HELICOBACTER, V15, P460, DOI 10.1111/j.1523-5378.2010.00788.x; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Gerrits MM, 2004, J MED MICROBIOL, V53, P1123, DOI 10.1099/jmm.0.45701-0; GISBERT JP, 2008, GASTROENTEROLOGY S1, V134, pA333; Goh KL, 2012, ALIMENT PHARM THER, V35, P1486, DOI 10.1111/j.1365-2036.2012.05120.x; Goh KL, 2012, ALIMENT PHARM THER, V35, P1097, DOI 10.1111/j.1365-2036.2012.05054.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 2011, HELICOBACTER, V16, P241, DOI 10.1111/j.1523-5378.2011.00841.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han FC, 2007, RES MICROBIOL, V158, P38, DOI 10.1016/j.resmic.2006.10.001; Hansomburana Piyathida, 2012, J Med Assoc Thai, V95 Suppl 3, pS28; Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Ho SL, 2010, J DIGEST DIS, V11, P101, DOI 10.1111/j.1751-2980.2010.00423.x; Katelaris PH, 2002, GASTROENTEROLOGY, V123, P1763, DOI 10.1053/gast.2002.37051; Kese D, 2009, HEPATO-GASTROENTEROL, V56, P925; Khan R, 2004, ANTIMICROB AGENTS CH, V48, P3567, DOI 10.1128/AAC.48.9.3567-3569.2004; Kim N, 2011, GASTROENTEROLOGY, V140, pS881; Lee JH, 2005, ANTIMICROB AGENTS CH, V49, P1600, DOI 10.1128/AAC.49.4.1600-1603.2005; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Liu ZQ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-81; Lui SY, 2003, J CLIN MICROBIOL, V41, P5011, DOI 10.1128/JCM.41.11.5011-5014.2003; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2012, THER ADV GASTROENTER, V5, P103, DOI 10.1177/1756283X11432492; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Paul R, 2001, ANTIMICROB AGENTS CH, V45, P962, DOI 10.1128/AAC.45.3.962-965.2001; Qua CS, 2010, J DIGEST DIS, V11, P244, DOI 10.1111/j.1751-2980.2010.00445.x; Rimbara E, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2011.00912.x; Saravolatz LD, 2003, CLIN INFECT DIS, V37, P1210, DOI 10.1086/378809; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HJ, 2008, J DIGEST DIS, V9, P186, DOI 10.1111/j.1751-2980.2008.00344.x; Tangmankongworakoon Nathaya, 2003, Journal of the Medical Association of Thailand, V86, pS439; Tankovic J, 2003, ANTIMICROB AGENTS CH, V47, P3942, DOI 10.1128/AAC.47.12.3942-3944.2003; Wang LH, 2010, WORLD J GASTROENTERO, V16, P2272, DOI 10.3748/wjg.v16.i18.2272; [WHO] World Health Organization, 2011, AG CLASS IARC MON, V1-102; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Wuppenhorst N, 2011, J ANTIMICROB CHEMOTH, V66, P222, DOI 10.1093/jac/dkq405; Zullo A, 2011, GUT, V60, P1604, DOI 10.1136/gut.2010.231233	51	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101481	10.1371/journal.pone.0101481	http://dx.doi.org/10.1371/journal.pone.0101481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003707	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700034
J	Huang, HL; Kung, PT; Chiu, CF; Wang, YH; Tsai, WC				Huang, Hsiu-Ling; Kung, Pei-Tseng; Chiu, Chang-Fang; Wang, Yueh-Hsin; Tsai, Wen-Chen			Factors Associated with Lung Cancer Patients Refusing Treatment and Their Survival: A National Cohort Study under a Universal Health Insurance in Taiwan	PLOS ONE			English	Article							SEX-ASSOCIATED DIFFERENCES; BREAST-CANCER; STAGE; COMORBIDITY; PROGNOSIS; RESECTION; AUTONOMY; VALUES	Background: Lung cancer is the leading cause mortality among all cancers in Taiwan. Although Taiwan offers National Health Insurance (NHI), occasionally, patients refuse treatment. This study examined the patient characteristics and factors associated with lung cancer patients refusing cancer treatment in four months after cancer diagnosed and compared the survival differences between treated and non-treated patients. Methods: The study included 38584 newly diagnosed lung cancer patients between 2004 and 2008, collected from the Taiwan Cancer Registry, which was linked with NHI research database and Cause of Death data set. Logistic regression was conducted to analyze factors associated with treatment refusal. The Cox proportional hazards model was used to examine the effects of treatment and non-treatment on patient survival and the factors affecting non-treatment patient survival. Results: Among the newly diagnosed cancer patients, older adults, or those who had been diagnosed with other catastrophic illnesses, an increased pre-cancer Charlson Comorbidity Index (CCI) score, and advanced stage cancer exhibited an increased likelihood of refusing treatment. Compared with treated patients, non-treated patients showed an increased mortality risk of 2.09 folds. The 1-year survival rate of treated patients (53.32%) was greater than that of non-treated patients (21.44%). Among the non-treated patients, those who were older, resided in lowly urbanized areas, had other catastrophic illnesses, a CCI score of >= 4, advanced cancer, or had received a diagnosis from a private hospital exhibited an increased mortality risk. Conclusions: Despite Taiwan's NHI system, some lung cancer patients choose not to receive cancer treatment and the mortality rate for non-treated patients is significantly higher than that of patients who undergo treatment. Therefore, to increase the survival rate of cancer patients, treatment refusal should be addressed.	[Huang, Hsiu-Ling; Wang, Yueh-Hsin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Huang, Hsiu-Ling] Minist Hlth & Welf, Hosp & Social Welf Org Adm Commiss, Taipei, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chiu, Chang-Fang] China Med Univ, Dept Internal Med, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789; Wang, Yueh-Hsin/0000-0002-1282-5945	China Medical University [CMU100-ASIA-9, DOH101-HP-1501]; Asia University; Taiwan Health Promotion Administration	China Medical University(China Medical University); Asia University; Taiwan Health Promotion Administration	This study was supported by grants (CMU100-ASIA-9, DOH101-HP-1501) from China Medical University, Asia University, and the Taiwan Health Promotion Administration. The authors are grateful for use of the National Health Insurance Research Database and the Cancer Register Files provided by Statistic Center of Department of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. China Medical University's website: http://english.cmu.edu.tw/. Asia University's website: http://www.asia.edu.tw/EN/. Health Promotion Administration's website: http://www.hpa.gov.tw/English/Index.aspx.	Brown JS, 1996, THORAX, V51, P564, DOI 10.1136/thx.51.6.564; Chadha AS, 2005, ANTICANCER RES, V25, P3517; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035809; Chu F-YS, 2012, COMPLEMENTARY ALTERN; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ferguson MK, 2000, ANN THORAC SURG, V69, P245, DOI 10.1016/S0003-4975(99)01078-4; FERGUSON MK, 1990, J CLIN ONCOL, V8, P1402, DOI 10.1200/JCO.1990.8.8.1402; Hedestig O, 2003, CANCER NURS, V26, P55, DOI 10.1097/00002820-200302000-00008; HUCHCROFT SA, 1993, CANCER CAUSE CONTROL, V4, P179; Huijer M, 2000, J MED ETHICS, V26, P358, DOI 10.1136/jme.26.5.358; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Khakwani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089426; Konigsberg RD, 2011, TIME, V177, P77; Konigsberg Ruth Davis, 2011, Time, V177, P72; Kowalski LP, 2000, EUR J CANCER, V36, P1032, DOI 10.1016/S0959-8049(00)00054-X; Kutlay H, 2003, ACTA CHIR BELG, V103, P293; LEECHIONG TL, 1993, CLIN CHEST MED, V14, P453; Lin JH, 2011, CANCER PREV RES, V4, P1360, DOI 10.1158/1940-6207.CAPR-11-0380; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Ma HX, 2011, LUNG CANCER, V74, P164, DOI 10.1016/j.lungcan.2011.03.005; Marshall CA, 2013, PSYCHO-ONCOLOGY, V22, P470, DOI 10.1002/pon.2108; Mystakidou K, 2007, INT J PSYCHIAT MED, V37, P201, DOI 10.2190/0509-7332-388N-566W; Ou SHI, 2008, CANCER-AM CANCER SOC, V112, P2011, DOI 10.1002/cncr.23397; Radley A, 2009, MORTALITY, V14, P309, DOI DOI 10.1080/13576270903257422; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sensky T, 2002, BRIT MED J, V325, P175, DOI 10.1136/bmj.325.7357.175; Shubha R, 2007, J Psychosoc Nurs Ment Health Serv, V45, P24, DOI 10.3928/02793695-20070801-06; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon TG, 2012, EUROPEAN J RADIOLOGY; Taiwan Cancer Registry, 2008, CANC STAT; Taiwan National Health Insurance Administration MoHW, 2013, STAT SURVEYS; Tsai W-C, 2012, EXPLORING REASONS NO; Turner D, 2013, PSYCHO-ONCOLOGY, V22, P12, DOI 10.1002/pon.2050; van Kleffens T, 2004, SOC SCI MED, V58, P2325, DOI 10.1016/j.socscimed.2003.08.027; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Warnakulasuriya S, 2007, ORAL ONCOL, V43, P982, DOI 10.1016/j.oraloncology.2006.11.021; World Health Organization, 2008, CANC MORT MORB; Yim J, 2012, J EPIDEMIOL COMMUN H, V66, P37, DOI 10.1136/jech.2009.104554	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101731	10.1371/journal.pone.0101731	http://dx.doi.org/10.1371/journal.pone.0101731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999633	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300080
J	Zhang, X; Woolley, DG; Swinnen, SP; Feys, H; Meesen, R; Wenderoth, N				Zhang, Xue; Woolley, Daniel G.; Swinnen, Stephan P.; Feys, Hilde; Meesen, Raf; Wenderoth, Nicole			Changes in Corticomotor Excitability and Intracortical Inhibition of the Primary Motor Cortex Forearm Area Induced by Anodal tDCS	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE CORTICAL STIMULATION; STROKE PATIENTS; SILENT PERIOD; CORTICOCORTICAL INHIBITION; EFFECTIVE CONNECTIVITY; HUMANS; FACILITATION; MODULATION	Objective: Previous studies have investigated how tDCS over the primary motor cortex modulates excitability in the intrinsic hand muscles. Here, we tested if tDCS changes corticomotor excitability and/or cortical inhibition when measured in the extensor carpi radialis (ECR) and if these aftereffects can be successfully assessed during controlled muscle contraction. Methods: We implemented a double blind cross-over design in which participants (n = 16) completed two sessions where the aftereffects of 20 min of 1 mA (0.04 mA/cm(2)) anodal vs sham tDCS were tested in a resting muscle, and two more sessions where the aftereffects of anodal vs sham tDCS were tested in an active muscle. Results: Anodal tDCS increased corticomotor excitability in ECR when aftereffects were measured with a low-level controlled muscle contraction. Furthermore, anodal tDCS decreased short interval intracortical inhibition but only when measured at rest and after non-responders (n = 2) were removed. We found no changes in the cortical silent period. Conclusion: These findings suggest that targeting more proximal muscles in the upper limb with anodal tDCS is achievable and corticomotor excitability can be assessed in the presence of a low-level controlled contraction of the target muscle.	[Zhang, Xue; Woolley, Daniel G.; Swinnen, Stephan P.; Meesen, Raf; Wenderoth, Nicole] Katholieke Univ Leuven, Dept Kinesiol, Motor Control Lab, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Feys, Hilde] Katholieke Univ Leuven, Res Grp Neuromotor Rehabil, Dept Rehabil Sci, Leuven, Belgium; [Meesen, Raf] Hasselt Univ, Biomed Res Inst, REVAL Rehabil Res Ctr, Hasselt, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; Hasselt University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wenderoth, N (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Motor Control Lab, Movement Control & Neuroplast Res Grp, Leuven, Belgium.	nicole.wenderoth@hest.ethz.ch	Cuypers, Koen/N-9918-2018; Wenderoth, Nicole/D-7262-2015; Meesen, Raf L/F-2582-2019	Wenderoth, Nicole/0000-0002-3246-9386; Meesen, Raf L/0000-0002-7938-3758	Flanders Fund for Scientific Research [G. 0758.10]	Flanders Fund for Scientific Research(FWO)	This work was funded by the Flanders Fund for Scientific Research (Project G. 0758.10). Xue Zhang is a pre-doctoral fellow of the Flanders Fund for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1999, J PHYSIOL-LONDON, V514, P895, DOI 10.1111/j.1469-7793.1999.895ad.x; Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Bradnam LV, 2010, J NEUROPHYSIOL, V103, P2382, DOI 10.1152/jn.01046.2009; Byblow WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0033882, DOI 10.1371/JOURNAL.-PONE.0033882]; Cash RFH, 2013, J NEUROPHYSIOL, V109, P106, DOI 10.1152/jn.00584.2011; Cengiz B, 2013, EXP BRAIN RES, V225, P321, DOI 10.1007/s00221-012-3369-0; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Edwards DJ, 2009, RESTOR NEUROL NEUROS, V27, P199, DOI 10.3233/RNN-2009-0470; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Hendy AM, 2013, MED SCI SPORT EXER, V45, P1721, DOI 10.1249/MSS.0b013e31828d2923; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; MacKinnon CD, 2005, ANN NEUROL, V58, P516, DOI 10.1002/ana.20599; Marquez CMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027292; Martin PG, 2006, CLIN NEUROPHYSIOL, V117, P2684, DOI 10.1016/j.clinph.2006.08.008; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Nilsson J, 1997, J CLIN NEUROPHYSIOL, V14, P136, DOI 10.1097/00004691-199703000-00006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALMER E, 1992, J PHYSIOL-LONDON, V448, P397, DOI 10.1113/jphysiol.1992.sp019048; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pennisi G, 1999, STROKE, V30, P2666, DOI 10.1161/01.STR.30.12.2666; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rutiku R, 2013, EUR J NEUROSCI, V38, P3768, DOI 10.1111/ejn.12374; Sanger TD, 2001, J PHYSIOL-LONDON, V530, P307, DOI 10.1111/j.1469-7793.2001.0307l.x; Shimizu T, 1999, CLIN NEUROPHYSIOL, V110, P575, DOI 10.1016/S1388-2457(98)00081-9; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Squeri V, 2014, IEEE T NEUR SYS REH, V22, P312, DOI 10.1109/TNSRE.2013.2250521; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stinear CM, 2004, MOVEMENT DISORD, V19, P1312, DOI 10.1002/mds.20160; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101496	10.1371/journal.pone.0101496	http://dx.doi.org/10.1371/journal.pone.0101496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999827	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300050
J	Ruda, VM; Chandwani, R; Sehgal, A; Bogorad, RL; Akinc, A; Charisse, K; Tarakhovsky, A; Novobrantseva, TI; Koteliansky, V				Ruda, Vera M.; Chandwani, Rohit; Sehgal, Alfica; Bogorad, Roman L.; Akinc, Akin; Charisse, Klaus; Tarakhovsky, Alexander; Novobrantseva, Tatiana I.; Koteliansky, Victor			The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo	PLOS ONE			English	Article							LIPID-LIKE MATERIALS; MICRORNA TARGETS; GENE-REGULATION; MESSENGER-RNAS; PROTEINS; SIRNAS; MIRNAS; THERAPEUTICS; DELIVERY; MECHANISMS	Argonaute 2 (Ago2) is the only mammalian Ago protein capable of mRNA cleavage. It has been reported that the activity of the short interfering RNA targeting coding sequence (CDS), but not 3' untranslated region (3'UTR) of an mRNA, is solely dependent on Ago2 in vitro. These studies utilized extremely high doses of siRNAs and overexpressed Ago proteins, as well as were directed at various highly expressed reporter transgenes. Here we report the effect of Ago2 in vivo on targeted knockdown of several endogenous genes by siRNAs, targeting both CDS and 39UTR. We show that siRNAs targeting CDS lose their activity in the absence of Ago2, whereas both Ago1 and Ago3 proteins contribute to residual 3'UTR-targeted siRNA-mediated knockdown observed in the absence of Ago2 in mouse liver. Our results provide mechanistic insight into two components mediating RNAi under physiological conditions: mRNA cleavage dependent and independent. In addition our results contribute a novel consideration for designing most efficacious siRNA molecules with the preference given to 3'UTR targeting as to harness the activity of several Ago proteins.	[Ruda, Vera M.; Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sehgal, Alfica; Akinc, Akin; Charisse, Klaus; Novobrantseva, Tatiana I.] Alnylam Pharmaceut, Cambridge, MA 02139 USA; [Chandwani, Rohit; Tarakhovsky, Alexander] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	Ruda, VM (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	rudavera@gmail.com; v.kotelianski@skolkovotech.ru		Chandwani, Rohit/0000-0003-4781-6069	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	This work was supported by Alnylam Pharmaceuticals. No additional funding was received for this study. Alnylam employees were collaborators on this project. Alnylam Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Foster DJ, 2012, RNA, V18, P557, DOI 10.1261/rna.031120.111; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; John M, 2007, NATURE, V449, P745, DOI 10.1038/nature06179; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mescalchin A, 2010, RNA, V16, P2529, DOI 10.1261/rna.2204610; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishihara T, 2013, NUCL ACIDS RES; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Shi HF, 2007, RNA, V13, P1132, DOI 10.1261/rna.474707; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vickers TA, 2009, NUCLEIC ACIDS RES, V37, P6927, DOI 10.1093/nar/gkp735; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133	52	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101749	10.1371/journal.pone.0101749	http://dx.doi.org/10.1371/journal.pone.0101749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992693	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400112
J	Walia, GK; Gupta, V; Aggarwal, A; Asghar, M; Dudbridge, F; Timpson, N; Singh, NS; Kumar, MR; Kinra, S; Prabhakaran, D; Reddy, KS; Chandak, GR; Smith, GD; Ebrahim, S				Walia, Gagandeep Kaur; Gupta, Vipin; Aggarwal, Aastha; Asghar, Mohammad; Dudbridge, Frank; Timpson, Nicholas; Singh, Nongmaithem Suraj; Kumar, M. Ravi; Kinra, Sanjay; Prabhakaran, Dorairaj; Reddy, K. Srinath; Chandak, Giriraj Ratan; Smith, George Davey; Ebrahim, Shah			Association of Common Genetic Variants with Lipid Traits in the Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE RISK; LOCI; CHOLESTEROL; LINKAGE; OBESITY	Genome-wide association studies (GWAS) have been instrumental in identifying novel genetic variants associated with altered plasma lipid levels. However, these quantitative trait loci have not been tested in the Indian population, where there is a poorly understood and growing burden of cardiometabolic disorders. We present the association of six single nucleotide polymorphisms in 1671 sib pairs (3342 subjects) with four lipid traits: total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C). We also investigated the interaction effects of gender, location, fat intake and physical activity. Each copy of the risk allele of rs964184 at APOA1 was associated with 1.06 mmol/l increase in triglycerides (SE = 0.049; p = 0.006), rs3764261 at CETP with 1.02 mmol/l increase in both total cholesterol (SE = 0.042; p = 0.017) and HDL-C (SE = 0.041; p = 0.008), rs646776 at CELSR2-PSRC1-SORT1 with 0.96 mmol/l decrease in cholesterol (SE = 0.043; p = 0.0003) and 0.15 mmol/l decrease in LDL-C levels (SE = 0.043; p = 0.0003) and rs2954029 at TRIB1 with 1.02 mmol/l increase in HDL-C (SE = 0.039; p = 0.047). A combined risk score of APOA1 and CETP loci predicted an increase of 1.25 mmol/l in HDL-C level (SE = 0.312; p = 0.0007). Urban location and sex had strong interaction effects on the genetic association of most of the studied loci with lipid traits. To conclude, we validated four genetic variants (identified by GWAS in western populations) associated with lipid traits in the Indian population. The interaction effects found here may explain the sex-specific differences in lipid levels and their heritability. Urbanization appears to influence the nature of the association with GWAS lipid loci in this population. However, these findings will require replication in other Indian populations.	[Walia, Gagandeep Kaur; Aggarwal, Aastha; Ebrahim, Shah] PHFI, SANCD, New Delhi, India; [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi 110007, India; [Asghar, Mohammad] Rajiv Gandhi Univ, Dept Anthropol, Itanagar, Arunachal Prade, India; [Dudbridge, Frank; Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Timpson, Nicholas; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Singh, Nongmaithem Suraj; Kumar, M. Ravi; Chandak, Giriraj Ratan] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Prabhakaran, Dorairaj; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India; University of Delhi; Rajiv Gandhi University, Itanagar; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Public Health Foundation of India	Walia, GK (corresponding author), PHFI, SANCD, New Delhi, India.	gkaurw@gmail.com; udaiig@gmail.com	Timpson, Nicholas John/O-7548-2015; Fox, Laura J/C-6249-2016; Gupta, Vipin/D-1704-2014; Prabhakaran, Dorairaj/B-4147-2011; Attrill, Lauren/V-1688-2018; Aggarwal, Aastha/AAT-1347-2020; Davey Smith, George/A-7407-2013	Timpson, Nicholas John/0000-0002-7141-9189; Gupta, Vipin/0000-0002-0607-5543; Prabhakaran, Dorairaj/0000-0002-3172-834X; Aggarwal, Aastha/0000-0002-8180-8743; Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Chandak, Giriraj Ratan/0000-0002-3095-9453; nongmaithem, suraj/0000-0001-5390-0449; Reddy, K Srinath/0000-0003-3416-3548; s, hema/0000-0002-3440-9475	Wellcome Trust [GR070797MF, 083541/Z/07/Z, 089645/Z/09/Z]; Medical Research Council [G0600705, G1000718] Funding Source: researchfish; MRC [G1000718, G0600705] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Indian Migration Study was funded by the Wellcome Trust (grant number GR070797MF). The genetic work was funded by a project grant from the Wellcome Trust (083541/Z/07/Z). GDS was supported by a Wellcome Trust Sabbatical Award (089645/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Braun TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037056; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chitra Uma, 2012, Indian Heart J, V64, P28, DOI 10.1016/S0019-4832(12)60007-8; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; El-Hazmi MAF, 2001, ANN SAUDI MED, V21, P21, DOI 10.5144/0256-4947.2001.21; Frank D., 2013, PLOS GENET, V9; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gottesman O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046419; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; HASKELL WL, 1984, PREV MED, V13, P23, DOI 10.1016/0091-7435(84)90038-0; Isaacs A, 2013, ARTERIOSCL THROM VAS, V33, P2233, DOI 10.1161/ATVBAHA.113.301236; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kruglyak L, 1999, P NATL ACAD SCI USA, V96, P1170, DOI 10.1073/pnas.96.4.1170; Lu YC, 2010, ATHEROSCLEROSIS, V213, P200, DOI 10.1016/j.atherosclerosis.2010.08.053; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Muendlein A, 2009, ATHEROSCLEROSIS, V206, P494, DOI 10.1016/j.atherosclerosis.2009.02.040; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-155; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; Saleheen D, 2010, CIRC-CARDIOVASC GENE, V3, P348, DOI 10.1161/CIRCGENETICS.109.906180; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schierer A, 2012, PHARMACOGENET GENOM, V22, P95, DOI 10.1097/FPC.0b013e32834dc9ef; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yajnik CS, 2001, NUTR REV, V59, P1; Zhang L, 2010, J CLIN ENDOCR METAB, V95, P1793, DOI 10.1210/jc.2009-2348; Zhang LX, 2012, BIOMED ENVIRON SCI, V25, P305, DOI 10.3967/0895-3988.2012.03.008	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101688	10.1371/journal.pone.0101688	http://dx.doi.org/10.1371/journal.pone.0101688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991929	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000341253400106
J	Xavier, FE; Blanco-Rivero, J; Sastre, E; Caracuel, L; Callejo, M; Balfagon, G				Xavier, Fabiano E.; Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria			Tranilast Increases Vasodilator Response to Acetylcholine in Rat Mesenteric Resistance Arteries through Increased EDHF Participation	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; K+ CHANNELS; MAST-CELLS; DEPENDENT RELAXATION; HYPERTENSIVE-RATS; SMALL-CONDUCTANCE; OXIDATIVE STRESS	Background and Purpose: Tranilast, in addition to its capacity to inhibit mast cell degranulation, has other biological effects, including inhibition of reactive oxygen species, cytokines, leukotrienes and prostaglandin release. In the current study, we analyzed whether tranilast could alter endothelial function in rat mesenteric resistance arteries (MRA). Experimental Approach: Acetylcholine-induced relaxation was analyzed in MRA (untreated and 1-hour tranilast treatment) from 6 month-old Wistar rats. To assess the possible participation of endothelial nitric oxide or prostanoids, acetylcholine-induced relaxation was analyzed in the presence of L-NAME or indomethacin. The participation of endothelium-derived hyperpolarizing factor (EDHF) in acetylcholine-induced response was analyzed by preincubation with TRAM-34 plus apamin or by precontraction with a high K+ solution. Nitric oxide (NO) and superoxide anion levels were measured, as well as vasomotor responses to NO donor DEA-NO and to large conductance calcium-activated potassium channel opener NS1619. Key Results: Acetylcholine-induced relaxation was greater in tranilast-incubated MRA. Acetylcholine-induced vasodilation was decreased by L-NAME in a similar manner in both experimental groups. Indomethacin did not modify vasodilation. Preincubation with a high K+ solution or TRAM-34 plus apamin reduced the vasodilation to ACh more markedly in tranilast-incubated segments. NO and superoxide anion production, and vasodilator responses to DEA-NO or NS1619 remained unmodified in the presence of tranilast. Conclusions and Implications: Tranilast increased the endothelium-dependent relaxation to acetylcholine in rat MRA. This effect is independent of the nitric oxide and cyclooxygenase pathways but involves EDHF, and is mediated by an increased role of small conductance calcium-activated K+ channels.	[Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Callejo, Maria; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fis, Madrid, Spain; [Blanco-Rivero, Javier; Sastre, Esther; Caracuel, Laura; Balfagon, Gloria] Inst Invest Sanitaria IdIPaz, Madrid, Spain; [Xavier, Fabiano E.] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Fisiol & Farmacol, Recife, PE, Brazil	Autonomous University of Madrid; Universidade Federal de Pernambuco	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fis, Madrid, Spain.	gloria.balfagon@uam.es	Xavier, Fabiano Elias/G-1253-2012; Blanco-Rivero, Javier/J-6118-2014; Xavier, Fabiano/G-1253-2012	Xavier, Fabiano Elias/0000-0003-2028-2562; Blanco-Rivero, Javier/0000-0001-7232-2314; Xavier, Fabiano/0000-0002-1387-8491; Balfagon Calvo, Gloria/0000-0001-9477-7950	Ministerio de Ciencia e Innovacion [SAF 2009-10374]; Ministerio de Economia y Competitivida [SAF 2012-38530]; Fundacion Mapfre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitivida; Fundacion Mapfre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Ministerio de Ciencia e Innovacion (SAF 2009-10374), Ministerio de Economia y Competitivida (SAF 2012-38530), and Fundacion Mapfre. F.E. Xavier is recipient of research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras-Lopez R, 2008, J PHYSIOL BIOCHEM, V64, P115, DOI 10.1007/BF03168239; AZUMA H, 1976, BRIT J PHARMACOL, V58, P483, DOI 10.1111/j.1476-5381.1976.tb08614.x; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Briones AM, 2000, BRIT J PHARMACOL, V131, P185, DOI 10.1038/sj.bjp.0703552; Cahill PA, 2001, PHARMACOL THERAPEUT, V89, P273, DOI 10.1016/S0163-7258(01)00128-0; COHEN RA, 1995, CIRCULATION, V92, P3337, DOI 10.1161/01.CIR.92.11.3337; Dalsgaard T, 2010, BRIT J PHARMACOL, V160, P1496, DOI 10.1111/j.1476-5381.2010.00803.x; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Feletou M, 2011, MORGAN CLAYPOOL LIFE; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feng J, 2008, CIRCULATION, V118, pS46, DOI 10.1161/CIRCULATIONAHA.107.755827; Ferrer M, 1999, GEN PHARMACOL, V33, P35, DOI 10.1016/S0306-3623(98)00259-6; GARLAND CJ, 1992, BRIT J PHARMACOL, V105, P429, DOI 10.1111/j.1476-5381.1992.tb14270.x; Hishikawa K, 1996, J CARDIOVASC PHARM, V28, P200, DOI 10.1097/00005344-199608000-00004; HOJO M, 1994, ANN ALLERGY, V73, P21; HWA JJ, 1994, AM J PHYSIOL, V266, pH952, DOI 10.1152/ajpheart.1994.266.3.H952; Jain N, 2001, INDIAN J PEDIATR, V4, P31; Jones SE, 2004, J DIABETES COMPLICAT, V18, P309, DOI 10.1016/j.jdiacomp.2004.02.002; KHAN SA, 1993, J PHARMACOL EXP THER, V267, P1327; Konneh M, 1998, TRANILAST KISSEI PHA, V1, P141; Lagaud GJL, 1999, J PHARMACOL EXP THER, V290, P832; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Mansouri K, 2011, MED HYPOTHESES, V76, P217, DOI 10.1016/j.mehy.2010.09.034; MIYACHI Y, 1987, J PHARMACOBIO-DYNAM, V10, P255, DOI 10.1248/bpb1978.10.255; MORI H, 1995, JPN J PHARMACOL, V67, P279, DOI 10.1254/jjp.67.279; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Onoue S, 2013, EUR J PHARM BIOPHARM; Pae HO, 2008, BIOCHEM BIOPH RES CO, V371, P361, DOI 10.1016/j.bbrc.2008.04.054; Platten M, 2003, BIOCHEM PHARMACOL, V66, P1263, DOI 10.1016/S0006-2952(03)00449-0; Ribatti D, 2012, CURR MED CHEM, V19, P955, DOI 10.2174/092986712799320655; Sastre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073232; Sastre E, 2012, SHOCK, V38, P328, DOI 10.1097/SHK.0b013e31826240ba; Schemann M, 2013, GASTROENTEROLOGY, V144, P698, DOI 10.1053/j.gastro.2013.01.040; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Shiota N, 2010, BRIT J PHARMACOL, V159, P626, DOI 10.1111/j.1476-5381.2009.00561.x; Takala J, 1996, BRIT J ANAESTH, V77, P50, DOI 10.1093/bja/77.1.50; Tan SM, 2011, NEPHROL DIAL TRANSPL, V26, P100, DOI 10.1093/ndt/gfq355; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vanhoutte PM, 2003, CIRC J, V67, P572; WALDRON GJ, 1994, BRIT J PHARMACOL, V112, P831, DOI 10.1111/j.1476-5381.1994.tb13154.x; Wenceslau CF, 2011, J VASC RES, V48, P316, DOI 10.1159/000322576; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wulff H, 2013, J CARDIOVASC PHARM, V61, P102, DOI 10.1097/FJC.0b013e318279ba20; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Xavier FE, 2011, EUR J PHARMACOL, V654, P280, DOI 10.1016/j.ejphar.2011.01.007; Xavier FE, 2010, CLIN SCI, V119, P283, DOI 10.1042/CS20090536; Xavier FE, 2004, BRIT J PHARMACOL, V143, P215, DOI 10.1038/sj.bjp.0705919; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001; Yang X, 2014, J PHARMACOL SCI, V124, P18, DOI 10.1254/jphs.13151FP	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100356	10.1371/journal.pone.0100356	http://dx.doi.org/10.1371/journal.pone.0100356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992476	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400022
J	Rougerie, R; Kitching, IJ; Haxaire, J; Miller, SE; Hausmann, A; Hebert, PDN				Rougerie, Rodolphe; Kitching, Ian J.; Haxaire, Jean; Miller, Scott E.; Hausmann, Axel; Hebert, Paul D. N.			Australian Sphingidae - DNA Barcodes Challenge Current Species Boundaries and Distributions	PLOS ONE			English	Article							LEPIDOPTERA; BIODIVERSITY; DIVERSITY; ENDEMISM; MOTHS; FAUNA	Main Objective: We examine the extent of taxonomic and biogeographical uncertainty in a well-studied group of Australian Lepidoptera, the hawkmoths (Sphingidae). Methods: We analysed the diversity of Australian sphingids through the comparative analysis of their DNA barcodes, supplemented by morphological re-examinations and sequence information from a nuclear marker in selected cases. The results from the analysis of Australian sphingids were placed in a broader context by including conspecifics and closely related taxa from outside Australia to test taxonomic boundaries. Results: Our results led to the discovery of six new species in Australia, one case of erroneously synonymized species, and three cases of synonymy. As a result, we establish the occurrence of 75 species of hawkmoths on the continent. The analysis of records from outside Australia also challenges the validity of current taxonomic boundaries in as many as 18 species, including Agrius convolvuli (Linnaeus, 1758), a common species that has gained adoption as a model system. Our work has revealed a higher level of endemism than previously recognized. Most (90%) Australian sphingids are endemic to the continent (45%) or to Australia, the Pacific Islands and the Papuan and Wallacean regions (45%). Only seven species (10%) have ranges that extend beyond this major biogeographical boundary toward SE Asia and other regions of the Old World. Main Conclusions: This study has established that overlooked cryptic diversity and inaccurate species delineation produced significant misconceptions concerning diversity and distribution patterns in a group of insects that is considered well known taxonomically. Because DNA barcoding represents a straightforward way to test taxonomic boundaries, its implementation can improve the accuracy of primary diversity data in biogeography and conservation studies.	[Rougerie, Rodolphe; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Kitching, Ian J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Haxaire, Jean] Museum Natl Hist Nat Paris, Le Roc, Laplume, France; [Miller, Scott E.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Hausmann, Axel] Bavarian State Collect Zool, Sect Lepidoptera, Munich, Germany	University of Guelph; Natural History Museum London; Museum National d'Histoire Naturelle (MNHN); Smithsonian Institution; Smithsonian National Museum of Natural History	Rougerie, R (corresponding author), INRA, Zool Forestiere UR633, Orleans, France.	rrougeri@gmail.com	Rougerie, Rodolphe/D-2930-2009; Hebert, Paul DN/C-4161-2013	Rougerie, Rodolphe/0000-0003-0937-2815; Hebert, Paul DN/0000-0002-3081-6700; Miller, Scott/0000-0002-4138-1378	government of Canada through Genome Canada; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)	government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from the government of Canada through Genome Canada (www.genomecanada.ca) and the Ontario Genomics Institute (www.ontariogenomics.ca) in support of the International Barcode of Life project (www.iBOL.org), and by the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Beck J, 2006, BIOL J LINN SOC, V89, P455, DOI 10.1111/j.1095-8312.2006.00686.x; Brechlin Ronald, 2010, Entomo-Satsphingia, V3, P66; Brechlin Ronald, 2001, Arthropoda, V9, P6; Chapman AD, 2009, NUMBERS LIVING SPECI; Cranston PS, 2010, ANNU REV ENTOMOL, V55, P55, DOI 10.1146/annurev-ento-112408-085348; Darge P., 1975, Bulletin Soc Ent France, V80, P179; Eitschberger Ulf, 2001, Neue Entomologische Nachrichten, V52, P3; Gehring PS, 2012, ECOL EVOL, V2, P1468, DOI 10.1002/ece3.269; Godfray HCJ, 2006, TRENDS ECOL EVOL, V21, P603, DOI DOI 10.1016/J.TREE.2006.06.010; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Haxaire J., 2007, EUROPEAN ENTOMOLOGIS, V1, P7; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holloway J. D., 2011, Malayan Nature Journal, V63, P1; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Lane David, 2011, Nachrichten des Entomologischen Vereins Apollo, V31, P227; Lees DC, 2014, MOL ECOL RESOUR, V14, P286, DOI 10.1111/1755-0998.12178; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lomolino MV, 2004, CONSERVATION BIOGEOG, P293; Marin J, 2013, BIOL J LINN SOC, V110, P427, DOI 10.1111/bij.12132; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; Moulds MS, 2014, EUROPEAN ENTOMOLOGIS, V5, P11; Moulds MS, 1996, CHECKLIST LEPIDOPTER, P529; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Parks DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069885; Peters J, 2001, LOCAL HUMAN SWEET PO; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Riddle Brett R., 2011, P47; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riotte J.C.E., 1979, Entomologische Zeitschrift, V89, P225; Roe Amanda D., 2010, P1; Romero D, 2014, J BIOGEOGR, V41, P111, DOI 10.1111/jbi.12189; Rougerie R, 2012, INVERTEBR SYST, V26, P445, DOI 10.1071/IS12029; Rougerie R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043920; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Sharma P, 2013, ZOOTAXA, V3702, P79, DOI 10.11646/zootaxa.3702.1.5; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tuttle JP, 2012, EUROPEAN ENTOMOLOGIS, V1, P65; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wakamura S, 1996, APPL ENTOMOL ZOOL, V31, P171, DOI 10.1303/aez.31.171; Williams J., 2001, BIODIVERSITY AUSTR S; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	56	31	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101108	10.1371/journal.pone.0101108	http://dx.doi.org/10.1371/journal.pone.0101108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987846	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100060
J	Zaharieva, MM; Kirilov, M; Chai, MQ; Berger, SM; Konstantinov, S; Berger, MR				Zaharieva, Maya M.; Kirilov, Milen; Chai, Minquang; Berger, Stefan M.; Konstantinov, Spiro; Berger, Martin R.			Reduced Expression of the Retinoblastoma Protein Shows That the Related Signaling Pathway Is Essential for Mediating the Antineoplastic Activity of Erufosine	PLOS ONE			English	Article							ABL TYROSINE KINASE; CELL-CYCLE; C-ABL; TUMOR-SUPPRESSOR; INDUCED APOPTOSIS; RB; CANCER; ALKYLPHOSPHOCHOLINE; GENE; LEUKEMIA	Erufosine is a new antineoplastic agent of the group of alkylphosphocholines, which interferes with signal transduction and induces apoptosis in various leukemic and tumor cell lines. The present study was designed to examine for the first time the mechanism of resistance to erufosine in malignant cells with permanently reduced expression of the retinoblastoma (Rb) protein. Bearing in mind the high number of malignancies with reduced level of this tumor-suppressor, this investigation was deemed important for using erufosine, alone or in combination, in patients with compromised RB1 gene expression. For this purpose, clones of the leukemic T-cell line SKW-3 were used, which had been engineered to constantly express differently low Rb levels. The alkylphosphocholine induced apoptosis, stimulated the expression of the cyclin dependent kinase inhibitor p27(Kip1) and inhibited the synthesis of cyclin D3, thereby causing a G(2) phase cell cycle arrest and death of cells with wild type Rb expression. In contrast, Rb-deficiency impeded the changes induced by eru-fosine in the expression of these proteins and abrogated the induction of G(2) arrest, which was correlated with reduced antiproliferative and anticlonogenic activities of the compound. In conclusion, analysis of our results showed for the first time that the Rb signaling pathway is essential for mediating the antineoplastic activity of erufosine and its efficacy in patients with malignant diseases may be predicted by determining the Rb status.	[Zaharieva, Maya M.; Berger, Martin R.] German Canc Res Ctr, Toxicol & Chemotherapy Unit, Heidelberg, Germany; [Kirilov, Milen; Chai, Minquang] German Canc Res Ctr, Dept Mol Biol Cell 1, Heidelberg, Germany; [Berger, Stefan M.] Cent Inst Mental Hlth, Dept Mol Biol, Mannheim, Germany; [Konstantinov, Spiro] Med Univ Sofia, Fac Pharm, Dept Pharmacol Pharmacotherapy & Toxicol, Lab Mol Pharmacol & Expt Chemotherapy, Sofia, Bulgaria	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Central Institute of Mental Health; Medical University Sofia	Berger, MR (corresponding author), German Canc Res Ctr, Toxicol & Chemotherapy Unit, Heidelberg, Germany.	M.Berger@dkfz-heidelberg.de	Zaharieva, Maya Margaritova/ABH-8344-2020	Zaharieva, Maya Margaritova/0000-0001-8548-5649	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	One of the authors (MMZ) was funded by the Alexander von Humboldt Foundation. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azkargorta M, 2006, PROTEOMICS, V6, pS42, DOI 10.1002/pmic.200500438; BENEDICT WF, 1990, J CLIN INVEST, V85, P988, DOI 10.1172/JCI114575; Berger MR, 2003, ANN NY ACAD SCI, V1010, P307, DOI 10.1196/annals.1299.054; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Borges HL, 2007, ONCOGENE, V26, P3868, DOI 10.1038/sj.onc.1210157; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Celeghini C, 2011, INVEST NEW DRUG, V29, P392, DOI 10.1007/s10637-009-9370-1; Chabner B, 2011, GOODMAN GILMANS PHAR; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dean JL, 2010, ONCOGENE, V29, P68, DOI 10.1038/onc.2009.313; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dineva IK, 2012, J CANCER RES CLIN, V138, P1909, DOI 10.1007/s00432-012-1271-6; EIBL H, 1992, PROG EXP TUMOR RES, V34, P1; Erdlenbruch B, 1999, CANCER CHEMOTH PHARM, V44, P484, DOI 10.1007/s002800051122; Fiegl M, 2008, CANCER CHEMOTH PHARM, V62, P321, DOI 10.1007/s00280-007-0612-7; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gudas JM, 1999, MOL CELL BIOL, V19, P612; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; Jendrossek V, 2003, ONCOGENE, V22, P2621, DOI 10.1038/sj.onc.1206355; Jendrossek V, 2002, CANCER CHEMOTH PHARM, V50, P71, DOI 10.1007/s00280-002-0440-8; Kapoor V, 2012, CANCER LETT, V319, P39, DOI 10.1016/j.canlet.2011.12.032; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Konigs SK, 2010, LEUKEMIA RES, V34, P1064, DOI 10.1016/j.leukres.2009.12.003; Konstantinov SM, 1998, INT J CANCER, V77, P778, DOI 10.1002/(SICI)1097-0215(19980831)77:5<778::AID-IJC18>3.0.CO;2-Y; Konstantinov SM, 1998, CANCER CHEMOTH PHARM, V41, P210; Konstantinov SM, 1999, BRIT J HAEMATOL, V107, P365, DOI 10.1046/j.1365-2141.1999.01700.x; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martelli AM, 2010, LEUKEMIA, V24, P687, DOI 10.1038/leu.2010.32; Mayhew CN, 2004, ONCOGENE, V23, P4107, DOI 10.1038/sj.onc.1207503; Metcalf RA, 2010, MODERN PATHOL, V23, P420, DOI 10.1038/modpathol.2009.173; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Oberle C, 2005, BIOL CHEM, V386, P237, DOI 10.1515/BC.2005.029; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Ouillette P, 2010, CLIN CANCER RES, V16, P835, DOI 10.1158/1078-0432.CCR-09-2534; Pusapati RV, 2014, MOL CARCINOG, V49, P152; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Reed CA, 2010, J BIOL CHEM, V285, P1089, DOI 10.1074/jbc.M109.043380; Reed MF, 2007, J SURG RES, V142, P364, DOI 10.1016/j.jss.2007.03.038; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Seeley SL, 2007, CANCER LETT, V245, P205, DOI 10.1016/j.canlet.2006.01.028; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Troncone G, 2009, CANCER CYTOPATHOL, V117, P522, DOI 10.1002/cncy.20050; Wang JYJ, 2001, ACTA ONCOL, V40, P689; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WELCH PJ, 1995, GENE DEV, V9, P31, DOI 10.1101/gad.9.1.31; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Yosifov DY, 2007, CANCER BIOL THER, V6, P930, DOI 10.4161/cbt.6.6.4188; Yosifov DY, 2011, CANCER CHEMOTH PHARM, V67, P13, DOI 10.1007/s00280-010-1273-5; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Zaharieva MM, 2007, ANN NY ACAD SCI, V1095, P182, DOI 10.1196/annals.1397.022	65	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100950	10.1371/journal.pone.0100950	http://dx.doi.org/10.1371/journal.pone.0100950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987858	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100052
J	Ursing, J; Rombo, L; Rodrigues, A; Aaby, P; Kofoed, PE				Ursing, Johan; Rombo, Lars; Rodrigues, Amabelia; Aaby, Peter; Kofoed, Poul-Erik			Malaria Transmission in Bissau, Guinea-Bissau between 1995 and 2012: Malaria Resurgence Did Not Negatively Affect Mortality	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; UNCOMPLICATED MALARIA; CHILDREN; CHLOROQUINE; AGE; QUININE; AREA; AMODIAQUINE; MORBIDITY; AFRICA	INTRODUCTION: As Plasmodium falciparum prevalence decreases in many parts of Sub-Saharan Africa, so does immunity resulting in larger at risk populations and increased risk of malaria resurgence. In Bissau, malaria prevalence decreased from ?50% to 3% between 1995 and 2003. The epidemiological characteristics of P. falciparum malaria within Bandim health and demographic surveillance site (population similar to 100000) between 1995 and 2012 are described. METHODS AND FINDINGS: The population was determined by census. 3603 children aged <15 years that were enrolled in clinical trials at the Bandim health centre (1995-2012) were considered incident cases. The mean annual malaria incidence per thousand children in 1995-1997, 1999-2003, 2007, 2011, 2012 were as follows; age <5 years 22 -> 29 -> 4 -> 9 -> 3, age 5-9 years 15 -> 28 -> 4 -> 33 -> 12, age 10-14 years 9 -> 15 -> 1 -> 45 -> 19. There were 4 campaigns (2003-2010) to increase use of insecticide treated bed nets (ITN) amongst children <5 years. An efficacious high-dose chloroquine treatment regime was routinely used until artemisinin based combination therapy (ACT) was introduced in 2008. Long lasting insecticide treated bed nets (LLIN) were distributed in 2011. By 2012 there was 1 net per 2 people and 97% usage. All-cause mortality decreased from post-war peaks in 1999 until 2012 in all age groups and was not negatively affected by malaria resurgence. CONCLUSION: The cause of decreasing malaria incidence (1995-2007) was probably multifactorial and coincident with the use of an efficacious high-dose chloroquine treatment regime. Decreasing malaria prevalence created a susceptible group of older children in which malaria resurged, highlighting the need to include all age groups in malaria interventions. ACT did not hinder malaria resurgence. Mass distribution of LLINs probably curtailed malaria epidemics. All-cause mortality was not negatively affected by malaria resurgence.	[Ursing, Johan; Rodrigues, Amabelia; Aaby, Peter; Kofoed, Poul-Erik] Projecto Saude Bandim, Indepth Network, Bissau, Guinea Bissau; [Ursing, Johan; Rombo, Lars] Karolinska Univ Hosp, Dept Med, Infect Dis Unit, Malaria Res Lab, Stockholm, Sweden; [Ursing, Johan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden; [Rombo, Lars] Malarsjukhuset, Dept Infect Dis, Eskilstuna, Sweden; [Rombo, Lars] Sormland Cty Council, Clin Res Ctr, Eskilstuna, Sweden; [Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Kolding Hospital	Ursing, J (corresponding author), Projecto Saude Bandim, Indepth Network, Bissau, Guinea Bissau.	johan.ursing@karolinska.se; pekofoed@dadlnet.dk		Aaby, Peter/0000-0001-8331-1389; Ursing, Johan/0000-0002-5508-9327	Anthony Cerami and Ann Dunne Foundation for World Health; Stockholms Lans Landsting [K0603-2010]	Anthony Cerami and Ann Dunne Foundation for World Health; Stockholms Lans Landsting	This work was supported by awards from the Anthony Cerami and Ann Dunne Foundation for World Health and Stockholms Lans Landsting (K0603-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Kofoed PE, 2003, T ROY SOC TROP MED H, V97, P429, DOI 10.1016/S0035-9203(03)90078-2; Kofoed PE, 2003, ACTA TROP, V86, P67, DOI 10.1016/S0001-706X(03)00018-4; Kofoed PE, 2002, T ROY SOC TROP MED H, V96, P304, DOI 10.1016/S0035-9203(02)90107-0; Kofoed PE, 2002, T ROY SOC TROP MED H, V96, P185, DOI 10.1016/S0035-9203(02)90298-1; Kofoed PE, 1997, T ROY SOC TROP MED H, V91, P462, DOI 10.1016/S0035-9203(97)90286-8; Kofoed PE, 1999, T ROY SOC TROP MED H, V93, P547, DOI 10.1016/S0035-9203(99)90377-2; Kofoed PE, 2002, AM J TROP MED HYG, V67, P28, DOI 10.4269/ajtmh.2002.67.28; Kofoed PE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-148; Kofoed PE, 2007, T ROY SOC TROP MED H, V101, P231, DOI 10.1016/j.trstmh.2006.05.008; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rodrigues A, 2013, AVALIACAO IMPACTO CA; Rodrigues A, 2010, EVALUATION CHANGES M; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Sodemann M, 1999, AM J TROP MED HYG, V61, P336, DOI 10.4269/ajtmh.1999.61.336; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Ursing J, 2007, INFECT GENET EVOL, V7, P555, DOI 10.1016/j.meegid.2007.03.006; Ursing J, 2007, AM J TROP MED HYG, V76, P844, DOI 10.4269/ajtmh.2007.76.844; Ursing J, 2011, J INFECT DIS, V203, P109, DOI 10.1093/infdis/jiq001; Ursing J, 2009, ANTIMICROB AGENTS CH, V53, P180, DOI 10.1128/AAC.01111-08	35	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101167	10.1371/journal.pone.0101167	http://dx.doi.org/10.1371/journal.pone.0101167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984039	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000062
J	Meister, J; Le Duc, D; Ricken, A; Burkhardt, R; Thiery, J; Pfannkuche, H; Polte, T; Grosse, J; Schoneberg, T; Schulz, A				Meister, Jaroslawna; Le Duc, Diana; Ricken, Albert; Burkhardt, Ralph; Thiery, Joachim; Pfannkuche, Helga; Polte, Tobias; Grosse, Johannes; Schoeneberg, Torsten; Schulz, Angela			The G Protein-coupled Receptor P2Y(14) Influences Insulin Release and Smooth Muscle Function in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Gene Knockout; Glucose Metabolism; Pancreatic Islet; Signal Transduction	UDP-GLUCOSE; EXPRESSION ANALYSIS; GPR105 KIAA0001; P2Y RECEPTORS; CELLS; GENE; ISLETS; SENSITIVITY; DEFICIENCY; ACTIVATION	Background: The relevance of the widely expressed GPCR P2Y(14) is only partially understood. Results: Analysis of P2Y(14)-KO mice revealed decreased gastrointestinal emptying, reduced glucose tolerance, and insulin release. Conclusion: P2Y(14) function is required for proper intestine emptying and adequate glucose response. Significance: P2Y(14) plays a role in smooth muscle function and maintaining energy homeostasis by influencing insulin release. UDP sugars were identified as extracellular signaling molecules, assigning a new function to these compounds in addition to their well defined role in intracellular substrate metabolism and storage. Previously regarded as an orphan receptor, the G protein-coupled receptor P2Y(14) (GPR105) was found to bind extracellular UDP and UDP sugars. Little is known about the physiological functions of this G protein-coupled receptor. To study its physiological role, we used a gene-deficient mouse strain expressing the bacterial LacZ reporter gene to monitor the physiological expression pattern of P2Y(14). We found that P2Y(14) is mainly expressed in pancreas and salivary glands and in subpopulations of smooth muscle cells of the gastrointestinal tract, blood vessels, lung, and uterus. Among other phenotypical differences, knock-out mice showed a significantly impaired glucose tolerance following oral and intraperitoneal glucose application. An unchanged insulin tolerance suggested altered pancreatic islet function. Transcriptome analysis of pancreatic islets showed that P2Y(14) deficiency significantly changed expression of components involved in insulin secretion. Insulin secretion tests revealed a reduced insulin release from P2Y(14)-deficient islets, highlighting P2Y(14) as a new modulator of proper insulin secretion.	[Meister, Jaroslawna; Le Duc, Diana; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Meister, Jaroslawna; Schulz, Angela] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Fac Med, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany; [Burkhardt, Ralph; Thiery, Joachim] Univ Leipzig, Inst Lab Med, Fac Med, D-04103 Leipzig, Germany; [Pfannkuche, Helga] Univ Leipzig, Inst Vet Physiol, Fac Vet Med, D-04109 Leipzig, Germany; [Polte, Tobias] UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, D-04318 Leipzig, Germany; [Polte, Tobias] Univ Leipzig, Med Ctr, Dept Dermatol Venerol & Allergol, D-04109 Leipzig, Germany; [Grosse, Johannes] Takeda Cambridge Ltd, Cambridge CB4 0PZ, England	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de		Burkhardt, Ralph/0000-0003-1924-1202; Le Duc, Diana/0000-0001-7289-2552	Deutsche Forschungsgemeinschaft [Scho 624/7-1, FOR 748]; IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung) [FZ: 01EO1001]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung)	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho 624/7-1, FOR 748 and the IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung, FZ: 01EO1001).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Alsaqati M, 2014, BRIT J PHARMACOL, V171, P701, DOI 10.1111/bph.12473; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Bassil AK, 2009, AM J PHYSIOL-GASTR L, V296, pG923, DOI 10.1152/ajpgi.90363.2008; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Charlton ME, 1997, BRAIN RES, V764, P141, DOI 10.1016/S0006-8993(97)00438-1; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Engel KMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029400; Freeman K, 2001, GENOMICS, V78, P124, DOI 10.1006/geno.2001.6662; Gao ZG, 2010, BIOCHEM PHARMACOL, V79, P873, DOI 10.1016/j.bcp.2009.10.024; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Hamel M, 2011, J BIOMOL SCREEN, V16, P1098, DOI 10.1177/1087057111415525; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Kook SH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.218; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lu YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE50, DOI 10.1152/ajpendo.00596.2005; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Mitsukawa K, 2008, CELL MOL LIFE SCI, V65, P1796, DOI 10.1007/s00018-008-8153-8; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Radenkovic G, 2010, CELL TISSUE RES, V340, P427, DOI 10.1007/s00441-010-0957-9; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Schuit FC, 1996, HORM RES, V46, P99, DOI 10.1159/000185004; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322; Scrivens M, 2005, PHARMACOL RES, V51, P533, DOI 10.1016/j.phrs.2005.02.001; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Shimoda H, 2000, ARCH HISTOL CYTOL, V63, P217, DOI 10.1679/aohc.63.217; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; Thor D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-46; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556	56	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23353	23366		10.1074/jbc.M114.580803	http://dx.doi.org/10.1074/jbc.M114.580803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993824	Green Published, hybrid			2022-12-25	WOS:000341505000011
J	Knowlden, SA; Capece, T; Popovic, M; Chapman, TJ; Rezaee, F; Kim, M; Georas, SN				Knowlden, Sara A.; Capece, Tara; Popovic, Milan; Chapman, Timothy J.; Rezaee, Fariba; Kim, Minsoo; Georas, Steve N.			Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; HIGH ENDOTHELIAL VENULES; LUNG FIBROSIS; AUTOTAXIN EXPRESSION; LYSOPHOSPHOLIPASE-D; MOLECULAR-CLONING; PROMOTES; IDENTIFICATION; ACTIVATION	Lysophosphatidic acid (LPA) and the LPA-generating enzyme autotaxin (ATX) have been implicated in lymphocyte trafficking and the regulation of lymphocyte entry into lymph nodes. High local concentrations of LPA are thought to be present in lymph node high endothelial venules, suggesting a direct influence of LPA on cell migration. However, little is known about the mechanism of action of LPA, and more work is needed to define the expression and function of the six known G protein-coupled receptors (LPA 1-6) in T cells. We studied the effects of 18:1 and 16:0 LPA on naive CD4+ T cell migration and show that LPA induces CD4+ T cell chemorepulsion in a Transwell system, and also improves the quality of non-directed migration on ICAM-1 and CCL21 coated plates. Using intravital two-photon microscopy, lpa2-/- CD4+ T cells display a striking defect in early migratory behavior at HEVs and in lymph nodes. However, later homeostatic recirculation and LPA-directed migration in vitro were unaffected by loss of lpa2. Taken together, these data highlight a previously unsuspected and non-redundant role for LPA2 in intranodal T cell motility, and suggest that specific functions of LPA may be manipulated by targeting T cell LPA receptors.	[Knowlden, Sara A.; Capece, Tara; Popovic, Milan; Kim, Minsoo; Georas, Steve N.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Chapman, Timothy J.; Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Rezaee, Fariba] Univ Rochester, Med Ctr, Dept Pediat, Div Pediat Pulm Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Georas, SN (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Steve_Georas@urmc.rochester.edu	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Capece, Tara/0000-0001-9282-0273; Chapman, Timothy/0000-0002-2337-2136	NIH [R01 HL071933, P30 ES001247, HL018208, F32 HL110718, K12 HD068373, T32 AI007285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110718, R01HL087088, R01HL071933, P01HL018208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the following funding sources: NIH R01 HL071933 and P30 ES001247 (SG); NIH HL018208 (MK); NIH F32 HL110718 (TC); NIH K12 HD068373 (FR); and T32 AI007285 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Balazs L, 2001, AM J PHYSIOL-REG I, V280, pR466, DOI 10.1152/ajpregu.2001.280.2.R466; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chen CG, 2012, ATHEROSCLEROSIS, V222, P74, DOI 10.1016/j.atherosclerosis.2012.02.010; Chen RJ, 2012, INT J CANCER, V131, P789, DOI 10.1002/ijc.26476; Chen SU, 2010, ENDOCRINOLOGY, V151, P369, DOI 10.1210/en.2009-0779; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cui MZ, 2011, CLIN LIPIDOL, V6, P413, DOI 10.2217/CLP.11.38; Emo J, 2012, J IMMUNOL, V188, P3784, DOI 10.4049/jimmunol.1102956; Gan L, 2011, BIOCHEM BIOPH RES CO, V409, P7, DOI 10.1016/j.bbrc.2011.04.084; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Guo H, 2013, ARCH GYNECOL OBSTET, V287, P131, DOI 10.1007/s00404-012-2479-z; Hayashi M, 2012, CANC LETT; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hope JM, 2009, GYNECOL ONCOL, V112, P215, DOI 10.1016/j.ygyno.2008.09.019; Huang LS, 2013, AM J RESP CELL MOL B; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jeong KJ, 2008, EXP MOL MED, V40, P607, DOI 10.3858/emm.2008.40.6.607; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Knowlden S GS, 2012, ATLAS GENET CYTOGENE; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lai YJ, 2010, MOL CELL BIOL, V30, P5582, DOI 10.1128/MCB.00134-10; Lay MDH, 2009, J IMMUNOL, V182, P902, DOI 10.4049/jimmunol.182.2.902; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nikitopoulou I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070941; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Oda SK, 2013, CANCER IMMUNOL RES, V1, P245, DOI 10.1158/2326-6066.CIR-13-0043-T; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Orosa B, 2014, ANN RHEUM DIS, V73, P298, DOI 10.1136/annrheumdis-2012-202832; Palmeri D, 2004, J LEUKOCYTE BIOL, V75, P910, DOI 10.1189/jlb.0903408; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Perrakis A, 2014, J LIPID RES; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Ren B, 2011, BLOOD, V117, P6036, DOI 10.1182/blood-2010-12-326017; Rivera-Lopez CM, 2008, ANGIOGENESIS, V11, P301, DOI 10.1007/s10456-008-9113-5; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tang N, 2014, J CELL MOL MED, V18, P156, DOI 10.1111/jcmm.12178; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Zaslavsky A, 2006, BBA-MOL CELL BIOL L, V1761, P1200, DOI 10.1016/j.bbalip.2006.08.011; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-114; Zheng YH, 2001, J IMMUNOL, V166, P2317, DOI 10.4049/jimmunol.166.4.2317; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	67	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101655	10.1371/journal.pone.0101655	http://dx.doi.org/10.1371/journal.pone.0101655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003200	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700048
J	Watanabe, LA; Vallinoto, M; Neto, NA; Muriel-Cunha, J; Saint-Paul, U; Schneider, H; Sampaio, I				Watanabe, Luciana Almeida; Vallinoto, Marcelo; Neto, Nils Asp; Muriel-Cunha, Janice; Saint-Paul, Ulrich; Schneider, Horacio; Sampaio, Iracilda			The Past and Present of an Estuarine-Resident Fish, the "Four-Eyed Fish'' Anableps anableps (Cyprinodontiformes, Anablepidae), Revealed by mtDNA Sequences	PLOS ONE			English	Article							GENETIC-STRUCTURE; AMAZON BASIN; PERFORMANCE; DIVERGENCE; CONSERVATION; ALGORITHMS; SPECIATION; DISPERSAL; CLIMATE; MAXIMUM	Historical events, such as changes in sea level during the Pleistocene glacial cycles, had a strong impact on coastal habitats, limiting connectivity and promoting the genetic divergence of various species. In this study, we evaluated the influence of climate oscillations and the possibility of estuary function as a barrier to gene flow among populations of the four-eyed fish, Anableps anableps. This species is fully estuarine-resident, has internal fertilization, is viviparous and does not migrate across long distances. These features make the four-eyed fish an excellent model for the study of evolutionary processes related to genetic differentiation of species and populations in estuaries. The evolutionary history of A. anableps was inferred from phylogeographic and population analyses using sequences of the mitochondrial DNA Control Region of 13 populations distributed in the Amazon and Northeast Coast of Brazil from Calcoene (Amapa) to Parnaiba (Piaui). The 83 retrieved haplotypes show a pattern of four distinct mitochondrial lineages, with up to 3.4% nucleotide divergence among them. The evolutionary reconstruction suggests that these lineages diverged recently in the late Pleistocene/early Holocene after the Atlantic Ocean reaching current levels. Analysis of variability, neutrality and the genetic expansion pattern revealed that the lineages have distinct characteristics, which were shaped by the different geomorphological features of coastal regions combined with sea level oscillations over a very long period of time. Only few neighboring populations show a discreet gene flow. This study may also be helpful for designing new experiments to better understand the geomorphological evolutionary history of the estuaries of the Amazon and the Northeast Coast of Brazil using estuarine-resident species as a model.	[Watanabe, Luciana Almeida; Vallinoto, Marcelo; Muriel-Cunha, Janice; Schneider, Horacio; Sampaio, Iracilda] Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Filogen & Bioinformat, Belem, Para, Brazil; [Neto, Nils Asp] Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Geol Costeira, Belem, Para, Brazil; [Saint-Paul, Ulrich] Univ Bremen, Ctr Marine Trop Ecol, D-28359 Bremen, Germany	Universidade Federal do Para; Universidade Federal do Para; University of Bremen	Sampaio, I (corresponding author), Univ Fed Para UFPA, Inst Estudos Costeiros, Lab Filogen & Bioinformat, Campus Braganca, Belem, Para, Brazil.	ira@ufpa.br	Vallinoto, Marcelo/J-3086-2012; Asp, Nils/J-6226-2012; SAMPAIO, IRACILDA/J-6514-2012; Schneider, Horacio/J-7131-2012; Vallinoto, Marcelo/ABF-9834-2021	Vallinoto, Marcelo/0000-0002-3465-3830; Asp, Nils/0000-0002-6468-6158; SAMPAIO, IRACILDA/0000-0002-2137-4656; Schneider, Horacio/0000-0002-5987-6395; Vallinoto, Marcelo/0000-0002-3465-3830; Muriel-Cunha, Janice/0000-0002-8267-6068	CNPq [306233/2009-6, 473341/2010-7, 305645/2009-9]; DAAD/CAPES [BEX 11447/13-3]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by CNPq, grants 306233/2009-6 (to I.S.), 473341/2010-7 and 305645/2009-9 (to H.S.). www.cnpq.br; DAAD/CAPES, grant BEX 11447/13-3, www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beheregaray LB, 2001, MOL ECOL, V10, P2849, DOI 10.1046/j.1365-294X.2001.t01-1-01406.x; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; Butler A.J., 1999, SEAGRASS AUSTR STRAT; Chenoweth SF, 2003, MOL ECOL, V12, P2387, DOI 10.1046/j.1365-294X.2003.01921.x; Chenoweth SF, 1998, P ROY SOC B-BIOL SCI, V265, P415, DOI 10.1098/rspb.1998.0310; Cohen Marcelo C. L., 2005, Wetlands Ecology and Management, V13, P433, DOI 10.1007/s11273-004-0413-2; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Domingues VS, 2007, MOL ECOL, V16, P3592, DOI 10.1111/j.1365-294X.2007.03405.x; Donaldson KA, 1999, MOL PHYLOGENET EVOL, V13, P208, DOI 10.1006/mpev.1999.0625; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; El-Robrini E, 1992, REGISTRO OSCILACOES, P73; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faulks LK, 2010, CONSERV GENET, V11, P921, DOI 10.1007/s10592-009-9936-7; Filho PWMS, 2006, J COASTAL RES, P306; Franzinelli E., 1992, EVOLUTION LITTORAUX, P203; Ghedotti MJ, 2003, CHECK LIST FRESHWATE, P582; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Miranda L.B., 2012, PRINCIPIOS OCEANOGRA; Nascimento F.L., 2008, B MUSEU PARAENSE EMI, V3, P229; Nelson JS, 1984, FISHES WORLD; Page TJ, 2010, J FISH BIOL, V77, P2093, DOI 10.1111/j.1095-8649.2010.02821.x; Rambaut A, 2009, TRACER; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rossetti DF, 2008, HOLOCENE, V18, P923, DOI 10.1177/0959683608091798; SALATI E, 1984, SCIENCE, V225, P129, DOI 10.1126/science.225.4658.129; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santa Brigida EL, 2007, J BRAZ BIOL, V67, P919; Schwab I R, 2001, Trans Am Ophthalmol Soc, V99, P145; SIVAK JG, 1976, VISION RES, V16, P531, DOI 10.1016/0042-6989(76)90035-3; Souza Filho P.W.M., 2005, REV BRAS GEOFISICA, V23, P427, DOI DOI 10.1590/S0102-261X2005000400006; Souza Filho PWM, 2000, REV BRASILEIRA GEOCI, V30, P527; Souza PWM, 2009, LECT NOTES EARTH SCI, V107, P347; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres AM, 2006, EROSAO PROGRADACAO L, P1; Turner CL, 1938, J MORPHOL, V62, P323, DOI 10.1002/jmor.1050620208; Waters JM, 2007, SYST BIOL, V56, P271, DOI 10.1080/10635150701313855; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	51	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101727	10.1371/journal.pone.0101727	http://dx.doi.org/10.1371/journal.pone.0101727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003185	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700057
J	Lin, TY; Chou, CF; Chung, HY; Chiang, CY; Li, CH; Wu, JL; Lin, HJ; Pai, TW; Hu, CH; Tzou, WS				Lin, Tzung-Yi; Chou, Chi-Fu; Chung, Hsin-Yu; Chiang, Chia-Yin; Li, Chung-Hao; Wu, Jen-Leih; Lin, Han-Jia; Pai, Tun-Wen; Hu, Chin-Hwa; Tzou, Wen-Shyong			Hypoxia-Inducible Factor 2 Alpha Is Essential for Hepatic Outgrowth and Functions via the Regulation of leg1 Transcription in the Zebrafish Embryo	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; HIPPEL-LINDAU PROTEIN; LIVER DEVELOPMENT; ENDODERM FORMATION; GROWTH-FACTOR; FACTOR-I; MESODERMAL SIGNALS; DIGESTIVE ORGANS; CELL-CYCLE; HOMEOSTASIS	The liver plays a vital role in metabolism, detoxification, digestion, and the maintenance of homeostasis. During development, the vertebrate embryonic liver undergoes a series of morphogenic processes known as hepatogenesis. Hepatogenesis can be separated into three interrelated processes: endoderm specification, hepatoblast differentiation, and hepatic outgrowth. Throughout this process, signaling molecules and transcription factors initiate and regulate the coordination of cell proliferation, apoptosis, differentiation, intercellular adhesion, and cell migration. Hifs are already recognized to be essential in embryonic development, but their role in hepatogenesis remains unknown. Using the zebrafish embryo as a model organism, we report that the lack of Hif2-alpha but not Hif1-alpha blocks hepatic outgrowth. While Hif2-alpha is not involved in hepatoblast specification, this transcription factor regulates hepatocyte cell proliferation during hepatic outgrowth. Furthermore, we demonstrated that the lack of Hif2-alpha can reduce the expression of liver-enriched gene 1 (leg1), which encodes a secretory protein essential for hepatic outgrowth. Additionally, exogenous mRNA expression of leg1 can rescue the small liver phenotype of hif2-alpha morphants. We also showed that Hif2-alpha directly binds to the promoter region of leg1 to control leg1 expression. Interestingly, we discovered overrepresented, high-density Hif-binding sites in the potential upstream regulatory sequences of leg1 in teleosts but not in terrestrial mammals. We concluded that hif2-alpha is a key factor required for hepatic outgrowth and regulates leg1 expression in zebrafish embryos. We also proposed that the hif2-alpha-leg1 axis in liver development may have resulted from the adaptation of teleosts to their environment.	[Lin, Tzung-Yi; Chou, Chi-Fu; Chung, Hsin-Yu; Chiang, Chia-Yin; Li, Chung-Hao; Lin, Han-Jia; Hu, Chin-Hwa] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Tzou, Wen-Shyong] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan	National Taiwan Ocean University; Academia Sinica - Taiwan; National Taiwan Ocean University; National Taiwan Ocean University	Tzou, WS (corresponding author), Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan.	wstzou@ntou.edu.tw	Hu, Chin-Hwa/D-1178-2009; Tzou, Wen-Shyong/H-4517-2014	Hu, Chin-Hwa/0000-0001-9582-2303; Tzou, Wen-Shyong/0000-0002-6726-1390; Lin, Han-Jia/0000-0002-4929-6573	National Science Council, Taiwan, R.O.C. [NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019-001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019-001]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This work was supported by the National Science Council, Taiwan, R.O.C. (Grant Nos. NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019-001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019-001) and the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Barriga EH, 2013, J CELL BIOL, V201, P759, DOI 10.1083/jcb.201212100; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022910; Chang CT, 2013, TOXICOL APPL PHARM, V270, P174, DOI 10.1016/j.taap.2013.04.010; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fradette C, 2003, BRIT J PHARMACOL, V140, P1146, DOI 10.1038/sj.bjp.0705543; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Imanirad P, 2014, STEM CELL RES, V12, P24, DOI 10.1016/j.scr.2013.09.006; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kawasaki I, 2013, MOL CELLS, V36, P410, DOI 10.1007/s10059-013-0170-2; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Latimer AJ, 2008, DEV DYNAM, V237, P3904, DOI 10.1002/dvdy.21794; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Li YH, 2010, J BIOL CHEM, V285, P41001, DOI 10.1074/jbc.M110.138743; Liao W, 2000, DEVELOPMENT, V127, P4303; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Marneros AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003573; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Niu XB, 2010, SCI CHINA LIFE SCI, V53, P455, DOI 10.1007/s11427-010-0078-4; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Ramakrishnan SK, 2014, MOL CELL BIOL, V34, P1208, DOI 10.1128/MCB.01441-13; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Reiter JF, 2001, DEVELOPMENT, V128, P125; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sun CF, 2011, GEN COMP ENDOCR, V172, P409, DOI 10.1016/j.ygcen.2011.04.005; Takahashi R, 2004, BIOCHEM BIOPH RES CO, V317, P84, DOI 10.1016/j.bbrc.2004.03.010; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058858; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsai SM, 2013, TRANSGENIC RES, V22, P301, DOI 10.1007/s11248-012-9636-9; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu RMK, 2012, ENVIRON SCI TECHNOL, V46, P9112, DOI 10.1021/es301758c; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012; Zorn A. M., 2008, STEMBOOK	89	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101980	10.1371/journal.pone.0101980	http://dx.doi.org/10.1371/journal.pone.0101980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000307	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300109
J	Ouyang, W; Chen, SY; Cai, GQ; Hao, FH				Ouyang, Wei; Chen, Siyang; Cai, Guanqing; Hao, Fanghua			Dryland Soil Hydrological Processes and Their Impacts on the Nitrogen Balance in a Soil-Maize System of a Freeze-Thawing Agricultural Area	PLOS ONE			English	Article							NONPOINT-SOURCE POLLUTION; USE EFFICIENCY; CROPPING SYSTEM; WINTER-WHEAT; WATER-USE; GROWTH; MODEL; DYNAMICS; CROPS; FERTILIZATION	Understanding the fates of soil hydrological processes and nitrogen (N) is essential for optimizing the water and N in a dryland crop system with the goal of obtaining a maximum yield. Few investigations have addressed the dynamics of dryland N and its association with the soil hydrological process in a freeze-thawing agricultural area. With the daily monitoring of soil water content and acquisition rates at 15, 30, 60 and 90 cm depths, the soil hydrological process with the influence of rainfall was identified. The temporal-vertical soil water storage analysis indicated the local albic soil texture provided a stable soil water condition for maize growth with the rainfall as the only water source. Soil storage water averages at 0-20, 20-40 and 40-60 cm were observed to be 490.2, 593.8, and 358 m(3) ha(-1), respectively, during the growing season. The evapo-transpiration (ET), rainfall, and water loss analysis demonstrated that these factors increased in same temporal pattern and provided necessary water conditions for maize growth in a short period. The dry weight and N concentration of maize organs (root, leaf, stem, tassel, and grain) demonstrated the N accumulation increased to a peak in the maturity period and that grain had the most N. The maximum N accumulative rate reached about 500 mg m(-2) d(-1) in leaves and grain. Over the entire growing season, the soil nitrate N decreased by amounts ranging from 48.9 kg N ha(-1) to 65.3 kg N ha(-1) over the 90 cm profile and the loss of ammonia-N ranged from 9.79 to 12.69 kg N ha(-1). With soil water loss and N balance calculation, the N usage efficiency (NUE) over the 0-90 cm soil profile was 43%. The soil hydrological process due to special soil texture and the temporal features of rainfall determined the maize growth in the freeze-thawing agricultural area.	[Ouyang, Wei; Cai, Guanqing; Hao, Fanghua] Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China; [Chen, Siyang] Marine Monitoring & Forecasting Ctr Zhejiang, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University	Ouyang, W (corresponding author), Beijing Normal Univ, State Key Lab Water Environm Simulat, Sch Environm, Beijing 100875, Peoples R China.	wei@itc.nl	Ou-Yang, Wei/AGS-1930-2022; ouyang, wei/AAM-8141-2020	wei, ouyang/0000-0002-5851-056X	National Natural Science Foundation of China [41371018, 51121003]; Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China [2012BAD15B05]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We are grateful for assistance with the data requirements of the Bawujiu Farm in Heilongjiang Province. The research discussed in this paper benefited from financial support provided by the National Natural Science Foundation of China (Grant No. 41371018, 51121003), the Supporting Program of the "Twelfth Five-year'' Plan for Sci & Tech Research of China (2012BAD15B05), and The Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseng S, 2001, PLANT SOIL, V233, P127, DOI 10.1023/A:1010381602223; Binder DL, 2002, SOIL SCI SOC AM J, V66, P531, DOI 10.2136/sssaj2002.0531; Bonato O, 1999, ECOL MODEL, V124, P11, DOI 10.1016/S0304-3800(99)00146-5; Buckley C, 2013, ENVIRON SCI POLICY, V25, P118, DOI 10.1016/j.envsci.2012.10.002; Caliskan S, 2008, FIELD CROP RES, V108, P126, DOI 10.1016/j.fcr.2008.04.005; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Dorner J, 2009, SOIL TILL RES, V102, P225, DOI 10.1016/j.still.2008.07.004; DORIOZ JM, 1994, WATER RES, V28, P395, DOI 10.1016/0043-1354(94)90277-1; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Favaretto N, 2012, SOIL SCI SOC AM J, V76, P575, DOI 10.2136/sssaj2011.0223; Ferrant S, 2011, J HYDROL, V406, P1, DOI 10.1016/j.jhydrol.2011.05.026; Friend AD, 1997, ECOL MODEL, V95, P249, DOI 10.1016/S0304-3800(96)00034-8; Gheysari M, 2009, AGR WATER MANAGE, V96, P946, DOI 10.1016/j.agwat.2009.01.005; Grzebisz W, 2013, PLANT SOIL, V368, P23, DOI 10.1007/s11104-012-1574-z; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058188; Hao FH, 2013, J HYDROL, V486, P412, DOI 10.1016/j.jhydrol.2013.02.008; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; Jackson JE, 1991, USERS GUIDE PRINCIPA; Katerji N, 2013, AGR WATER MANAGE, V130, P14, DOI 10.1016/j.agwat.2013.08.005; KEENEY DR, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P1; Kerbiriou PJ, 2013, PLANT SOIL, V371, P281, DOI 10.1007/s11104-013-1672-6; Kersebaum KC, 2003, PHYS CHEM EARTH, V28, P537, DOI 10.1016/S1474-7065(03)00090-1; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Kovacs GJ, 2005, PHYS CHEM EARTH, V30, P209, DOI 10.1016/j.pce.2004.08.022; Lam QD, 2012, J HYDROL, V438, P137, DOI 10.1016/j.jhydrol.2012.03.011; Lewis DR, 2003, AGR SYST, V76, P159, DOI 10.1016/S0308-521X(02)00032-X; Lteif A, 2010, PLANT SOIL, V333, P105, DOI 10.1007/s11104-010-0326-1; Matejek B, 2010, PLANT SOIL, V337, P93, DOI 10.1007/s11104-010-0503-2; MEISINGER JJ, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P85; Moreau P, 2013, AGR SYST, V118, P41, DOI 10.1016/j.agsy.2013.02.007; Moroizumi T, 2009, AGR WATER MANAGE, V96, P160, DOI 10.1016/j.agwat.2008.07.007; Murungu FS, 2011, SOIL TILL RES, V112, P58, DOI 10.1016/j.still.2010.11.005; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Ouyang W, 2013, SCI TOTAL ENVIRON, V450, P129, DOI 10.1016/j.scitotenv.2013.02.016; Ouyang W, 2012, SCI TOTAL ENVIRON, V432, P412, DOI 10.1016/j.scitotenv.2012.06.017; Overman AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072810; Panda RK, 2003, J FOOD AGRIC ENVIRON, V1, P308; Pask AJD, 2012, FIELD CROP RES, V126, P104, DOI 10.1016/j.fcr.2011.09.021; Quemada M, 2013, AGR ECOSYST ENVIRON, V174, P1, DOI 10.1016/j.agee.2013.04.018; Razzaghi F, 2012, AGR WATER MANAGE, V109, P20, DOI 10.1016/j.agwat.2012.02.002; Schroder JL, 2011, SOIL SCI SOC AM J, V75, P957, DOI 10.2136/sssaj2010.0187; SHOJI S, 1991, SOIL SCI SOC AM J, V55, P1468, DOI 10.2136/sssaj1991.03615995005500050045x; Sierra J, 2003, PLANT SOIL, V256, P333, DOI 10.1023/A:1026106208320; Strullu L, 2011, FIELD CROP RES, V121, P381, DOI 10.1016/j.fcr.2011.01.005; Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140; Vazquez N, 2006, AGR ECOSYST ENVIRON, V112, P313, DOI 10.1016/j.agee.2005.07.009; Wang XB, 2010, AGR WATER MANAGE, V97, P1344, DOI 10.1016/j.agwat.2010.03.016; Wegehenkel M, 2006, ECOL MODEL, V190, P116, DOI 10.1016/j.ecolmodel.2005.02.020; Yang YG, 2011, J HYDROL, V409, P149, DOI 10.1016/j.jhydrol.2011.08.013	50	3	3	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101282	10.1371/journal.pone.0101282	http://dx.doi.org/10.1371/journal.pone.0101282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000400	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300029
J	Rieger, D; Assinger, A; Einfinger, K; Sokolikova, B; Geiger, M				Rieger, Daniela; Assinger, Alice; Einfinger, Katrin; Sokolikova, Barbora; Geiger, Margarethe			Protein C Inhibitor (PCI) Binds to Phosphatidylserine Exposing Cells with Implications in the Phagocytosis of Apoptotic Cells and Activated Platelets	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; SURFACE; INTERNALIZATION; LYMPHOCYTES; MACROPHAGES; NEUTROPHILS; MECHANISM; MONOCYTES; EXPOSURE	Protein C Inhibitor (PCI) is a secreted serine protease inhibitor, belonging to the family of serpins. In addition to activated protein C PCI inactivates several other proteases of the coagulation and fibrinolytic systems, suggesting a regulatory role in hemostasis. Glycosaminoglycans and certain negatively charged phospholipids, like phosphatidylserine, bind to PCI and modulate its activity. Phosphatidylerine (PS) is exposed on the surface of apoptotic cells and known as a phagocytosis marker. We hypothesized that PCI might bind to PS exposed on apoptotic cells and thereby influence their removal by phagocytosis. Using Jurkat T-lymphocytes and U937 myeloid cells, we show here that PCI binds to apoptotic cells to a similar extent at the same sites as Annexin V, but in a different manner as compared to live cells (defined spots on similar to 10-30% of cells). PCI dose dependently decreased phagocytosis of apoptotic Jurkat cells by U937 macrophages. Moreover, the phagocytosis of PS exposing, activated platelets by human blood derived monocytes declined in the presence of PCI. In U937 cells the expression of PCI as well as the surface binding of PCI increased with time of phorbol ester treatment/macrophage differentiation. The results of this study suggest a role of PCI not only for the function and/or maturation of macrophages, but also as a negative regulator of apoptotic cell and activated platelets removal.	[Rieger, Daniela; Einfinger, Katrin; Sokolikova, Barbora; Geiger, Margarethe] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Assinger, Alice] Med Univ Vienna, Ctr Phsiol & Pharmacol, Dept Physiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Geiger, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Assinger, Alice/0000-0002-5670-5910; Geiger, Margarethe/0000-0003-2021-5319	Austrian Science Fund FWF [P 20248-B09, P 22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (www.fwf.ac.at) Projects P 20248-B09 and P 22792-B11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Assinger A, 2010, ATHEROSCLEROSIS, V212, P153, DOI 10.1016/j.atherosclerosis.2010.05.010; Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Callahan MK, 2003, J LEUKOCYTE BIOL, V74, P846, DOI 10.1189/jlb.0902433; Carroll VA, 1997, ARTERIOSCL THROM VAS, V17, P114, DOI 10.1161/01.ATV.17.1.114; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P581, DOI 10.1161/01.ATV.0000012782.59850.41; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Kenis H, 2006, EXP CELL RES, V312, P719, DOI 10.1016/j.yexcr.2005.11.023; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kuhn, 1990, ELUCIDATING STRUCTUR; Lemarie A, 2006, J PHARMACOL EXP THER, V316, P304, DOI 10.1124/jpet.105.092874; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Nilsson G, 2007, THROMB RES, V120, P237, DOI 10.1016/j.thromres.2006.10.004; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Schuster C, 2007, BIOCHEM PHARMACOL, V74, P1424, DOI 10.1016/j.bcp.2007.07.017; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; SUZUKI K, 1987, J BIOL CHEM, V262, P611; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Watanabe R, 2000, AM J HEMATOL, V65, P35, DOI 10.1002/1096-8652(200009)65:1<35::AID-AJH6>3.0.CO;2-1; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101794	10.1371/journal.pone.0101794	http://dx.doi.org/10.1371/journal.pone.0101794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000564	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300087
J	Gavioli, M; Lara, A; Almeida, PWM; Lima, AM; Damasceno, DD; Rocha-Resende, C; Ladeira, M; Resende, RR; Martinelli, PM; Melo, MB; Brum, PC; Fontes, MAP; Santos, RAS; Prado, MAM; Guatimosim, S				Gavioli, Mariana; Lara, Aline; Almeida, Pedro W. M.; Lima, Augusto Martins; Damasceno, Denis D.; Rocha-Resende, Cibele; Ladeira, Marina; Resende, Rodrigo R.; Martinelli, Patricia M.; Melo, Marcos Barrouin; Brum, Patricia C.; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Prado, Marco A. M.; Guatimosim, Silvia			Cholinergic Signaling Exerts Protective Effects in Models of Sympathetic Hyperactivity-Induced Cardiac Dysfunction	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; PROTEIN EXPRESSION; HEART; SURVIVAL; HYPERTROPHY; CARVEDILOL; RECEPTORS; EXERCISE; DEFICITS; IMPROVES	Cholinergic control of the heart is exerted by two distinct branches; the autonomic component represented by the parasympathetic nervous system, and the recently described non-neuronal cardiomyocyte cholinergic machinery. Previous evidence has shown that reduced cholinergic function leads to deleterious effects on the myocardium. Yet, whether conditions of increased cholinergic signaling can offset the pathological remodeling induced by sympathetic hyperactivity, and its consequences for these two cholinergic axes are unknown. Here, we investigated two models of sympathetic hyperactivity: i) the chronic beta-adrenergic receptor stimulation evoked by isoproterenol (ISO), and ii) the alpha(2A)/alpha(2C)-drenergic receptor knockout (KO) mice that lack pre-synaptic adrenergic receptors. In both models, cholinergic signaling was increased by administration of the cholinesterase inhibitor, pyridostigmine. First, we observed that isoproterenol produces an autonomic imbalance characterized by increased sympathetic and reduced parasympathetic tone. Under this condition transcripts for cholinergic proteins were upregulated in ventricular myocytes, indicating that non-neuronal cholinergic machinery is activated during adrenergic overdrive. Pyridostigmine treatment prevented the effects of ISO on autonomic function and on the ventricular cholinergic machinery, and inhibited cardiac remodeling. alpha(2A)/alpha(2C)-KO mice presented reduced ventricular contraction when compared to wild-type mice, and this dysfunction was also reversed by cholinesterase inhibition. Thus, the cardiac parasympathetic system and non-neuronal cardiomyocyte cholinergic machinery are modulated in opposite directions under conditions of increased sympathetic drive or ACh availability. Moreover, our data support the idea that pyridostigmine by restoring ACh availability is beneficial in heart disease.	[Gavioli, Mariana; Lara, Aline; Almeida, Pedro W. M.; Lima, Augusto Martins; Damasceno, Denis D.; Rocha-Resende, Cibele; Ladeira, Marina; Melo, Marcos Barrouin; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Guatimosim, Silvia] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Resende, Rodrigo R.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem, Belo Horizonte, MG, Brazil; [Martinelli, Patricia M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Lima, Augusto Martins; Melo, Marcos Barrouin; Peliky Fontes, Marco Antonio; Souza Santos, Robson A.; Guatimosim, Silvia] Univ Fed Minas Gerais, Natl Inst Sci & Technol Nanobiopharmaceut, Belo Horizonte, MG, Brazil; [Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Prado, Marco A. M.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Dept Anat & Cell Biol,Dept Physiol & Pharmacol, London, ON, Canada	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Western University (University of Western Ontario)	Guatimosim, S (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	guatimosim@icb.ufmg.br	Fontes, Marco Antônio Peliky/AAT-7570-2021; Rocha-Resende, Cibele/CAI-0845-2022; Brum, Patricia C/E-6605-2011; Rocha-Resende, Cibele/CAF-4462-2022; Prado, Marco Antonio Maximo/K-7638-2013; Martinelli, Patricia/H-6341-2014; Santos, Robson A S/C-9336-2011; Guatimosim, Silvia/AAN-7441-2021; Lima, Augusto Martins/D-7730-2015	Fontes, Marco Antônio Peliky/0000-0003-4525-3565; Brum, Patricia C/0000-0002-4750-6506; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Santos, Robson A S/0000-0001-8738-5852; Guatimosim, Silvia/0000-0001-8386-3722; Gavioli, Mariana/0000-0001-9413-9019; Martins Lima, Augusto/0000-0002-0461-1226; Rocha-Resende, Cibele/0000-0002-5109-0654	NIH from the Fogarty International Center [R03TW008425]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX [APQ-04334-10]; National Institute of Science and Technology in Nanobiopharmaceutics; Heart and Stroke Foundation of Ontario [NA6656]; CNPq; FOGARTY INTERNATIONAL CENTER [R03TW008425] Funding Source: NIH RePORTER	NIH from the Fogarty International Center; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX; National Institute of Science and Technology in Nanobiopharmaceutics; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants from NIH R03TW008425 from the Fogarty International Center (Guatimosim S), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, PRONEX (APQ-04334-10) and National Institute of Science and Technology in Nanobiopharmaceutics. MAMP is supported by the Heart and Stroke Foundation of Ontario (Grant-in aid NA6656). Gavioli, M is recipient of CNPq PhD fellowship at the Post-graduation Program in Biological Science: Physiology and Pharmacology at UFMG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro CH, 2005, HYPERTENSION, V46, P937, DOI 10.1161/01.HYP.0000175813.04375.8a; Ferreira AJ, 2007, LIFE SCI, V81, P916, DOI 10.1016/j.lfs.2007.07.022; Freeling J, 2008, EXP PHYSIOL, V93, P75, DOI 10.1113/expphysiol.2007.039784; Gava E, 2012, REGUL PEPTIDES, V175, P30, DOI 10.1016/j.regpep.2012.01.001; Guatimosim S, 2001, AM J PHYSIOL-CELL PH, V280, pC1327, DOI 10.1152/ajpcell.2001.280.5.C1327; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Kakinuma Y, 2009, FEBS J, V276, P5111, DOI 10.1111/j.1742-4658.2009.07208.x; Kanazawa H, 2010, J CLIN INVEST, V120, P408, DOI 10.1172/JCI39778; LaCroix C, 2008, AM J PHYSIOL-HEART C, V294, pH810, DOI 10.1152/ajpheart.00724.2007; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lataro RM, 2013, AM J PHYSIOL-REG I, V305, pR908, DOI 10.1152/ajpregu.00102.2013; Marques FD, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/795452; Marques FD, 2011, HYPERTENSION, V57, P477, DOI 10.1161/HYPERTENSIONAHA.110.167346; NEGRAO CE, 1992, BRAZ J MED BIOL RES, V25, P1045; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Oliveira EA, 2005, EUR J PHARMACOL, V520, P135, DOI 10.1016/j.ejphar.2005.07.026; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rana OR, 2010, AUTON NEUROSCI-BASIC, V156, P82, DOI 10.1016/j.autneu.2010.04.011; Rocha-Resende C, 2012, J MOL CELL CARDIOL, V53, P206, DOI 10.1016/j.yjmcc.2012.05.003; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Sabino JPJ, 2013, AUTON NEUROSCI-BASIC, V173, P58, DOI 10.1016/j.autneu.2012.11.007	31	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100179	10.1371/journal.pone.0100179	http://dx.doi.org/10.1371/journal.pone.0100179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992197	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400020
J	Karahalios, A; Simpson, JA; Baglietto, L; MacInnis, RJ; Hodge, AM; Giles, GG; English, DR				Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; MacInnis, Robert J.; Hodge, Allison M.; Giles, Graham G.; English, Dallas R.			Change in Body Size and Mortality: Results from the Melbourne Collaborative Cohort Study	PLOS ONE			English	Article							INTENTIONAL WEIGHT-LOSS; ALL-CAUSE MORTALITY; MASS INDEX; OLD-AGE; WAIST CIRCUMFERENCE; RISK; OBESITY; DEATH; ASSOCIATION; HYPERTENSION	Background: The association between change in weight or body mass index, and mortality is widely reported, however, both measures fail to account for fat distribution. Change in waist circumference, a measure of central adiposity, in relation to mortality has not been studied extensively. Methods: We investigated the association between mortality and changes in directly measured waist circumference, hips circumference and weight from baseline (1990-1994) to wave 2 (2003-2007) in a prospective cohort study of people aged 40-69 years at baseline. Cox regression, with age as the time metric and follow-up starting at wave 2, adjusted for confounding variables, was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for change in body size in relation to mortality from all causes, cardiovascular disease and cancer. Results: There were 1465 deaths (109 cancer, 242 cardiovascular disease) identified during an average 7.7 years of follow-up from 21 298 participants. Compared to minimal increase in body size, loss of waist circumference (HR: 1.26; 95% CI: 1.09-1.47), weight (1.80; 1.54-2.11), or hips circumference (1.35; 1.15-1.57) were associated with an increased risk of all-cause mortality, particularly for older adults. Weight loss was associated with cardiovascular disease mortality (2.40; 1.57-3.65) but change in body size was not associated with obesity-related cancer mortality. Conclusion: This study confirms the association between weight loss and increased mortality from all-causes for older adults. Based on evidence from observational cohort studies, weight stability may be the recommended option for most adults, especially older adults.	[Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; English, Dallas R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Karahalios, Amalia; Simpson, Julie A.; Baglietto, Laura; MacInnis, Robert J.; Hodge, Allison M.; Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia	University of Melbourne; Cancer Council Victoria	Karahalios, A (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	emily.karahalios@unimelb.edu.au	Simpson, Julie A/P-7299-2014; Baglietto, Laura/AAB-9051-2019; English, Dallas/AAH-5005-2019	English, Dallas/0000-0001-7828-8188; Baglietto, Laura/0000-0002-8193-7529; Simpson, Julie/0000-0002-2660-2013; Giles, Graham/0000-0003-4946-9099; MacInnis, Robert/0000-0002-1627-5047; Hodge, Allison/0000-0001-5464-2197	National Health & Medical Research Council (NHMRC) [209057, 251533]; Vic-Health [1998-0406]; NHMRC Centre of Research Excellence [1035261]; Australian Brewers' Foundation; Australian Postgraduate Award	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Vic-Health; NHMRC Centre of Research Excellence(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Brewers' Foundation; Australian Postgraduate Award(Australian Government)	This work was supported by National Health & Medical Research Council (NHMRC) [grant numbers 209057, 251533], Vic-Health (grant number 1998-0406), NHMRC Centre of Research Excellence [grant number 1035261]. Further infrastructure support was provided by the Cancer Council Victoria, and funding was received from the Australian Brewers' Foundation to collect alcohol data in wave 2. AK is funded by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales CW, 2008, J AM MED DIR ASSOC, V9, P302, DOI 10.1016/j.jamda.2008.01.006; Bamia C, 2010, J INTERN MED, V268, P133, DOI 10.1111/j.1365-2796.2010.02219.x; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Blanton CA, 1999, P SOC EXP BIOL MED, V221, P153, DOI 10.1046/j.1525-1373.1999.d01-70.x; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Hollander EL, 2013, J AM MED DIR ASSOC, V14, P187, DOI 10.1016/j.jamda.2012.09.023; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Donini LM, 2012, J NUTR HEALTH AGING, V16, P89, DOI 10.1007/s12603-011-0073-x; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Giles G G, 2002, IARC Sci Publ, V156, P69; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Karahalios A, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-6; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Lee CG, 2011, J AM GERIATR SOC, V59, P233, DOI 10.1111/j.1532-5415.2010.03245.x; Lohman T. G., 1998, ANTROPOMETRIC STANDA; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; McLennan W, 1996, INTRO SOCIO EC INDEX; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Peeters A, 2007, ANN SURG, V246, P1028, DOI 10.1097/SLA.0b013e31814a6929; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poirier P, 2005, HYPERTENSION, V45, P363, DOI 10.1161/01.HYP.0000155463.90018.dc; Richman EL, 2010, J INTERN MED, V268, P103, DOI 10.1111/j.1365-2796.2010.02227.x; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Simonsen MK, 2008, NUTR REV, V66, P375, DOI 10.1111/j.1753-4887.2008.00047.x; Sjostrom CD, 1999, OBES RES, V7, P477; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; StataCorp, 2009, STAT STAT SOFTW REL; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99672	10.1371/journal.pone.0099672	http://dx.doi.org/10.1371/journal.pone.0099672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988430	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100017
J	Lu, MC; Yan, ST; Yin, WY; Koo, M; Lai, NS				Lu, Ming-Chi; Yan, Shih-Tang; Yin, Wen-Yao; Koo, Malcolm; Lai, Ning-Sheng			Risk of Rheumatoid Arthritis in Patients with Type 2 Diabetes: A Nationwide Population-Based Case-Control Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; SMOKING; IMMUNE; INFLAMMATION; PREVALENCE; MARKERS	Objective: Type 2 diabetes is associated with chronic, low-grade inflammation and could potentially trigger the progression of other, more prominent inflammatory diseases such as rheumatoid arthritis (RA). Therefore, we aimed to investigate the risk of incident RA in Taiwanese patients with type 2 diabetes using a population-based health claims database. Methods: This nationwide, population-based, case-control study used administrative data to identify 1,416 patients with RA (age >= 20 years) as cases and 7,080 controls that were frequency-matched for sex, 10-year age group, and year of catastrophic illness certificate application date (index year). All subjects were retrospectively traced back, up to 13 years prior to the index year, for their first diagnosis of type 2 diabetes. Logistic regression analysis was conducted to quantify the association between incident RA and type 2 diabetes. Results: The odds of developing RA were significantly higher in female (odds ratio [OR] 1.46, 95% confidence interval [95% CI] 1.24-1.72) but not in male (OR 1.00, 95% CI 0.72-1.37) patients who had previously diagnosed with type 2 diabetes. Subgroup analysis indicated that the odds of developing RA were more prominent in younger females (20 to 44 years of age) with type 2 diabetes. In addition, the odds of developing RA in female patients with type 2 diabetes were higher in those with a shorter time interval between the diagnosis of type 2 diabetes and RA. Conclusions: This large nationwide, population-based, case-control study showed an elevated risk of RA in female Taiwanese patients with type 2 diabetes. Our findings were consistent with the hypothesis that chronic low-grade inflammation in type 2 diabetes may elicit the development of RA in genetically susceptible individuals.	[Lu, Ming-Chi; Lai, Ning-Sheng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Yin, Wen-Yao; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yan, Shih-Tang] Dalin Tzu Chi Hosp, Div Endocrinol & Metab, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Yin, Wen-Yao] Dalin Tzu Chi Hosp, Div Gen Surg, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Dalin Tzu Chi Hosp, Dept Med Res, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Koo, M (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; [Anonymous], 2013, NAT HLTH INS RES DAT; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CALDWELL JR, 1991, SEMIN ARTHRITIS RHEU, V21, P1, DOI 10.1016/0049-0172(91)90051-Z; Cefalu WT, 2009, DIABETES, V58, P307, DOI 10.2337/db08-1656; Chen MF, 2010, FORMOSAN J RHEUMATOL, V24, P64; Chung SJ, 2011, YONSEI MED J, V52, P113, DOI 10.3349/ymj.2011.52.1.113; Dessein PH, 2004, J RHEUMATOL, V31, P867; Dubreuil M, 2014, RHEUMATOLOGY, V53, P346, DOI 10.1093/rheumatology/ket343; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Kim EJ, 2013, RHEUMATOL INT, V33, P2135, DOI 10.1007/s00296-013-2670-y; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Mancuso CA, 2007, ARTHRIT RHEUM-ARTHR, V57, P672, DOI 10.1002/art.22689; Mirjafari H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3476; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Su CC, 2013, J RHEUMATOL, V40, P1513, DOI 10.3899/jrheum.121259; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van Steenbergen HW, 2013, ARTHRITIS RHEUM-US, V65, P2219, DOI 10.1002/art.38013; Vasunilashorn S, 2013, J OBES, V2013; VOIGT LF, 1994, EPIDEMIOLOGY, V5, P525; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187	35	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101528	10.1371/journal.pone.0101528	http://dx.doi.org/10.1371/journal.pone.0101528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988532	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100107
J	Sturtzel, C; Testori, J; Schweighofer, B; Bilban, M; Hofer, E				Sturtzel, Caterina; Testori, Julia; Schweighofer, Bernhard; Bilban, Martin; Hofer, Erhard			The Transcription Factor MEF2C Negatively Controls Angiogenic Sprouting of Endothelial Cells Depending on Oxygen	PLOS ONE			English	Article							VEGF-INDUCED ANGIOGENESIS; GROWTH-FACTOR RECEPTORS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ALPHA(2)-MACROGLOBULIN; NOTCH; IDENTIFICATION; DETERMINES; DISEASE; PLASMA	The MADS box transcription factor MEF2C has been detected by us to be upregulated by the angiogenic factors VEGF-A and bFGF in endothelial cells. We have here investigated its potential role for angiogenesis. MEF2C was surprisingly found to strongly inhibit angiogenic sprouting, whereas a dominant negative mutant rather induced sprouting. The factor mainly affected migratory processes of endothelial cells, but not proliferation. In gene profiling experiments we delineated the alpha-2-macroglobulin gene to be highly upregulated by MEF2C. Further data confirmed that MEF2C in endothelial cells indeed induces alpha-2-macroglobulin mRNA as well as the secretion of alpha-2-macroglobulin and that conditioned supernatants of cells overexpressing MEF2C inhibit sprouting. Alpha-2-macroglobulin mediates, at least to a large extent, the inhibitory effects of MEF2C as is shown by knockdown of alpha-2-macroglobulin mRNA by lentiviral shRNA expression which reduces the inhibitory effect. However, under hypoxic conditions the VEGF-A/bFGF-mediated upregulation of MEF2C is reduced and the production of alpha-2-macroglobulin largely abolished. Taken together, this suggests that the MEF2C/alpha-2-macroglobulin axis functions in endothelial cells as a negative feed-back mechanism that adapts sprouting activity to the oxygen concentration thus diminishing inappropriate and excess angiogenesis.	[Sturtzel, Caterina; Testori, Julia; Schweighofer, Bernhard; Hofer, Erhard] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hofer, E (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	erhard.hofer@meduniwien.ac.at		Bilban, Martin/0000-0001-7043-7142; Sturtzel, Caterina/0000-0003-1002-5634	Austrian Academy of Sciences [22689]; Austrian Science Fund [P-21291-B11]; European Commission [FP7-Health-2009-222995]; DOC-fFORTE fellowship of the Austrian Academy of Sciences	Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); DOC-fFORTE fellowship of the Austrian Academy of Sciences	This project was supported by grants of the Austrian Academy of Sciences (22689), the Austrian Science Fund (P-21291-B11) and the European Commission (FP7-Health-2009-222995). CS was a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Cante-Barrett K, 2013, ONCOGENE; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; de Lorenc LB, 2005, CLIN CHEM LAB MED, V43, P1183, DOI 10.1515/CCLM.2005.205; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fontana V, 2011, BASIC CLIN PHARMACOL, V109, P130, DOI 10.1111/j.1742-7843.2011.00698.x; Green MR, 2012, MOL CLONING LAB MANU, Vxxxiii, P1161; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Mathew S, 2003, BIOCHEM J, V374, P123, DOI 10.1042/BJ20021655; MEHL JW, 1964, SCIENCE, V145, P821, DOI 10.1126/science.145.3634.821; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Rivera CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024887; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Tchetverikov I, 2004, ANN RHEUM DIS, V63, P881, DOI 10.1136/ard.2003.013243; Testori J, 2011, BLOOD, V117, P2735, DOI 10.1182/blood-2010-07-293209; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Wang WY, 2010, BLOOD, V115, P2971, DOI 10.1182/blood-2009-05-224824; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; WOJTA J, 1989, J BIOL CHEM, V264, P2846; Xu ZH, 2012, AM J PATHOL, V180, P2548, DOI 10.1016/j.ajpath.2012.02.021; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao DZ, 2011, INT J CANCER, V128, P2602, DOI 10.1002/ijc.25600	44	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101521	10.1371/journal.pone.0101521	http://dx.doi.org/10.1371/journal.pone.0101521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988463	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100106
J	Gao, J; Ohtsubo, M; Hotta, Y; Minoshima, S				Gao, Jie; Ohtsubo, Masafumi; Hotta, Yoshihiro; Minoshima, Shinsei			Oligomerization of Optineurin and Its Oxidative Stressor E50K Mutation-Driven Covalent Cross-Linking: Possible Relationship with Glaucoma Pathology	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; RETINAL GANGLION-CELLS; PROTEIN-PROTEIN INTERACTIONS; BLUE NATIVE ELECTROPHORESIS; OPEN-ANGLE GLAUCOMA; ALZHEIMERS-DISEASE; GOLGI-APPARATUS; GLOBAL DATA; TNF-ALPHA	The optineurin gene, OPTN, is one of the causative genes of primary open-angle glaucoma. Although oligomerization of optineurin in cultured cells was previously observed by gel filtration analysis and blue native gel electrophoresis (BNE), little is known about the characteristics of optineurin oligomers. Here, we aimed to analyze the oligomeric state of optineurin and factors affecting oligomerization, such as environmental stimuli or mutations in OPTN. Using BNE or immunoprecipitation followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we demonstrated that both endogenous and transfected optineurin exist as oligomers, rather than monomers, in NIH3T3 cells. We also applied an in situ proximity ligation assay to visualize the self-interaction of optineurin in fixed HeLaS3 cells and found that the optineurin oligomers were localized diffusely in the cytoplasm. Optineurin oligomers were usually detected as a single band of a size equal to that of the optineurin monomer upon SDS-PAGE, while an additional protein band of a larger size was observed when cells were treated with H2O2. We showed that larger protein complex is optineurin oligomers by immunoprecipitation and termed it covalent optineurin oligomers. In cells expressing OPTN bearing the most common glaucoma-associated mutation, E50K, covalent oligomers were formed even without H2O2 stimulation. Antioxidants inhibited the formation of E50K-induced covalent oligomers to various degrees. A series of truncated constructs of OPTN was used to reveal that covalent oligomers may be optineurin trimers and that the ubiquitin-binding domain is essential for formation of these trimers. Our results indicated that optineurin trimers may be the basic unit of these oligomers. The oligomeric state can be affected by many factors that induce covalent bonds, such as H2O2 or E50K, as demonstrated here; this provides novel insights into the pathogenicity of E50K. Furthermore, regulation of the oligomeric state should be studied in the future.	[Gao, Jie; Ohtsubo, Masafumi; Minoshima, Shinsei] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Basic Med Photon Lab, Dept Photomed Genom, Hamamatsu, Shizuoka 4313192, Japan; [Gao, Jie; Hotta, Yoshihiro] Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ohtsubo, M (corresponding author), Hamamatsu Univ Sch Med, Med Photon Res Ctr, Basic Med Photon Lab, Dept Photomed Genom, Hamamatsu, Shizuoka 4313192, Japan.	masa.oh@hama-med.ac.jp	Hotta, Yoshihiro/O-5115-2019	Hotta, Yoshihiro/0000-0003-4052-5066	JSPS KAKENHI [24592622]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS KAKENHI Grant Number 24592622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; GRANT AJ, 1992, BIOCHIM BIOPHYS ACTA, V1134, P203, DOI 10.1016/0167-4889(92)90177-D; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Meng QF, 2012, MOL BIOL REP, V39, P5867, DOI 10.1007/s11033-011-1397-7; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Stroissnigg H, 2002, EXP CELL RES, V278, P133, DOI 10.1006/excr.2002.5567; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Swaab DF, 1998, PROG BRAIN RES, V117, P343; Tanito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049680; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wang CX, 2013, CELL BIOL I IN PRESS; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	57	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101206	10.1371/journal.pone.0101206	http://dx.doi.org/10.1371/journal.pone.0101206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983867	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000068
J	Liu, YW; Ni, BX; Lin, Y; Chen, XG; Fang, Z; Zhao, LY; Hu, ZB; Zhang, FX				Liu, Yaowu; Ni, Bixian; Lin, Yuan; Chen, Xin-guang; Fang, Zhen; Zhao, Liyan; Hu, Zhibin; Zhang, Fengxiang			Genetic Polymorphisms in ZFHX3 Are Associated with Atrial Fibrillation in a Chinese Han Population	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; VARIANTS; STAT3	Background: The gene zinc finger homeobox 3 (ZFHX3) encodes a transcription factor with cardiac expression and its genetic variants are associated with atrial fibrillation (AF). We aimed to explore the associations between single nucleotide polymorphisms (SNPs) of ZFHX3 and the risk of AF in a Chinese Han population. Methods: We genotyped eight SNPs, including seven potentially functional SNPs and one previously reported SNP by using the middle-throughput iPLEX Sequenom MassARRAY platform. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated in logistic regression models. Results: We enrolled a total of 1,593 Chinese Han origin individuals in the study, including 597 AF patients and 996 non-AF controls. Logistic regression analyses revealed that potentially functional SNPs rs6499600 and rs16971436 were associated with a decreased risk of AF (adjusted OR = 0.73, 95% CI: 0.63-0.86, P = 1.07610(-4); adjusted OR = 0.74, 95% CI: 0.56-0.98, P = 0.039, respectively). In addition, rs2106261 showed a robust association with an increased risk of AF (adjusted OR = 1.71, 95% CI: 1.46-2.00, P = 1.85610(-11)). After multiple comparisons, rs16971436 conferred a borderline significant association with the risk of AF. Stratification analysis indicated that the risks of AF were statistically different among subgroups of age for rs2106261, and the effect for rs16971436 was more evident in subgroups of patients with coronary artery disease. Conclusion: In summary, our study investigated the role of genetic variants of ZFHX3 in AF and two SNPs (rs2106261, rs6499600) showed significant associations while rs16971436 conferred a borderline significant association with AF risk in Chinese Han populations. However, further large and functional studies are warranted to confirm our findings.	[Liu, Yaowu; Chen, Xin-guang; Fang, Zhen; Zhao, Liyan; Zhang, Fengxiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Ni, Bixian; Lin, Yuan; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhibin_hu@njmu.edu.cn; njzfx6@163.com	Zhang, Fengxiang/Z-2807-2019		National Natural Science Foundation of China [81170160]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University [IRT-004]; Six Peak Talents Foundation of Jiangsu Province [2011-WS-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Six Peak Talents Foundation of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (Grant 81170160), the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University (No. IRT-004), and the Six Peak Talents Foundation of Jiangsu Province (No. 2011-WS-071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBARINO CG, 1994, MOL CELL PROBE, V8, P423, DOI 10.1006/mcpr.1994.1060; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Greenwood TA, 2003, GENOMICS, V82, P511, DOI 10.1016/S0888-7543(03)00142-3; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; Li C, 2011, HUM GENET, V129, P239, DOI 10.1007/s00439-010-0912-6; Lubitz Steven A, 2010, Heart Fail Clin, V6, P239, DOI 10.1016/j.hfc.2009.12.004; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Psaty BM, 1997, CIRCULATION, V96, P2455; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Sinner MF, 2011, CARDIOVASC RES, V89, P701, DOI 10.1093/cvr/cvr001; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Toko H, 2010, J MOL CELL CARDIOL, V49, P113, DOI 10.1016/j.yjmcc.2010.03.020; Tsai CT, 2008, HEART RHYTHM, V5, P1285, DOI 10.1016/j.hrthm.2008.05.012; Wilke T, 2013, EUROPACE, V15, P486, DOI 10.1093/europace/eus333	23	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101318	10.1371/journal.pone.0101318	http://dx.doi.org/10.1371/journal.pone.0101318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983873	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000088
J	Lundhede, TH; Jacobsen, JB; Hanley, N; Fjeldsa, J; Rahbek, C; Strange, N; Thorsen, BJ				Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Hanley, Nick; Fjeldsa, Jon; Rahbek, Carsten; Strange, Niels; Thorsen, Bo Jellesmark			Public Support for Conserving Bird Species Runs Counter to Climate Change Impacts on Their Distributions	PLOS ONE			English	Article							CHOICE; BIODIVERSITY; PREFERENCES; VALUATION; BENEFITS; VELOCITY; COSTS	There is increasing evidence that global climate change will alter the spatiotemporal occurrences and abundances of many species at continental scales. This will have implications for efficient conservation of biodiversity. We investigate if the general public in Denmark are willing to pay for the preservation of birds potentially immigrating and establishing breeding populations due to climate change to the same extent that they are for native species populations currently breeding in Denmark, but potentially emigrating due to climate change. We find that Danish citizens are willing to pay much more for the conservation of birds currently native to Denmark, than for bird species moving into the country - even when they are informed about the potential range shifts associated with climate change. The only exception is when immigrating species populations are under pressure at European level. Furthermore, people believing climate change to be man-made and people more knowledgeable about birds tended to have higher WTP for conservation of native species, relative to other people, whereas their preferences for conserving immigrant species generally resembled those of other people. Conservation investments rely heavily on public funding and hence on public support. Our results suggest that cross-country coordination of conservation efforts under climate change will be challenging in terms of achieving an appropriate balance between cost-effectiveness in adaptation and the concerns of a general public who seem mostly worried about protecting currently-native species.	[Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Strange, Niels; Thorsen, Bo Jellesmark] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Lundhede, Thomas Hedemark; Jacobsen, Jette Bredahl; Fjeldsa, Jon; Rahbek, Carsten; Strange, Niels; Thorsen, Bo Jellesmark] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Hanley, Nick] Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Fjeldsa, Jon; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of St Andrews; University of Copenhagen	Lundhede, TH (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark.	thlu@ifro.ku.dk	Thorsen, Bo Jellesmark J/K-8770-2014; Rahbek, Carsten/L-1129-2013; Jacobsen, Jette Bredahl/C-9354-2015; Fjeldså, Jon/A-9699-2013; Strange, Niels/AAB-5155-2020	Thorsen, Bo Jellesmark J/0000-0002-3305-8343; Rahbek, Carsten/0000-0003-4585-0300; Jacobsen, Jette Bredahl/0000-0002-1313-6228; Fjeldså, Jon/0000-0003-0790-3600; Strange, Niels/0000-0002-8842-8022; Lundhede, Thomas/0000-0003-3226-8338; Hanley, Nick/0000-0002-1362-3499	Danish Council for Independent Research, Social Science [75-07-0240]; Danish National Research Foundation	Danish Council for Independent Research, Social Science; Danish National Research Foundation(Danmarks Grundforskningsfond)	The authors acknowledge the Danish Council for Independent Research, Social Science for financial support (Grant no. 75-07-0240) and the Danish National Research Foundation for support to the Centre for Macroecology, Evolution and Climate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Campbell D, J ENV PLANN IN PRESS; CARSON RT, 1993, AM J AGR ECON, V75, P1263, DOI 10.2307/1243469; Christie M, 2006, ECOL ECON, V58, P304, DOI 10.1016/j.ecolecon.2005.07.034; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Danish Data Protection Agency, DAN ACT PROC PERS DA; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Greene W.H, 2007, NLOGIT 4 0; Greene William H., 2012, ECONOMETRIC ANAL, Vseventh; Hanley N., 2009, PRICING NATURE COST; Hanley N, 2009, J ENVIRON MANAGE, V90, P1404, DOI 10.1016/j.jenvman.2008.08.008; Huntley B., 2007, CLIMATIC ATLAS EUROP; Jacobsen JB, 2008, ENVIRON RESOUR ECON, V39, P247, DOI 10.1007/s10640-007-9107-6; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Krutilla J, 1975, EC NATURAL ENV; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Lundhede T, 2012, INT J CULT POLICY, P1; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McFadden D, 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Meyerhoff J, 2014, ENVIRON RESOUR ECON, V58, P35, DOI 10.1007/s10640-013-9688-1; Moilanen A, 2011, BIOL CONSERV, V144, P1719, DOI 10.1016/j.biocon.2011.03.007; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nunes PALD, 2001, ECOL ECON, V39, P203, DOI 10.1016/S0921-8009(01)00233-6; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Scarpa R, 2008, AUST J AGR RESOUR EC, V52, P253, DOI 10.1111/j.1467-8489.2007.00436.x; The European Society for Opinion and Market Research (ESOMAR), ICC ESOMAR COD MARK; The National Committee for Health Research Ethics, 2012, ACT RES ETH REV HLTH; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Train K., 2005, APPL SIMULATION METH, P1, DOI [10.1007/1-4020-3684-1_1, DOI 10.1007/1-4020-3684-1_1]; Train K. E., 2003, DISCRETE CHOICE METH; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; von Haefen RH, 2005, AM J AGR ECON, V87, P1061, DOI 10.1111/j.1467-8276.2005.00794.x; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; Wilhelm-Rechmann A, 2014, ORYX, V48, P71, DOI 10.1017/S0030605312000257; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	43	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101281	10.1371/journal.pone.0101281	http://dx.doi.org/10.1371/journal.pone.0101281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24984055	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000339635000082
J	Roset, MS; Ibanez, AE; de Souza, JA; Spera, JM; Minatel, L; Oliveira, SC; Giambartolomei, GH; Cassataro, J; Briones, G				Roset, Mara S.; Ibanez, Andres E.; de Souza Filho, Job Alves; Spera, Juan M.; Minatel, Leonardo; Oliveira, Sergio C.; Giambartolomei, Guillermo H.; Cassataro, Juliana; Briones, Gabriel			Brucella Cyclic beta-1,2-Glucan Plays a Critical Role in the Induction of Splenomegaly in Mice	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; VIRULENCE FACTOR; MOLECULAR-CLONING; BALB/C MICE; ABORTUS; MELITENSIS; INFECTION; PROTEIN; INFLAMMATION; SALMONELLA	Brucella, the etiological agent of animal and human brucellosis, is a bacterium with the capacity to modulate the inflammatory response. Cyclic beta-1,2-glucan (C beta G) is a virulence factor key for the pathogenesis of Brucella as it is involved in the intracellular life cycle of the bacteria. Using comparative studies with different C beta G mutants of Brucella, cgs (C beta G synthase), cgt (C beta G transporter) and cgm (C beta G modifier), we have identified different roles for this polysaccharide in Brucella. While anionic C beta G is required for bacterial growth in low osmolarity conditions, the sole requirement for a successful Brucella interaction with mammalian host is its transport to periplasmic space. Our results uncover a new role for C beta G in promoting splenomegaly in mice. We showed that C beta G-dependent spleen inflammation is the consequence of massive cell recruitment (monocytes, dendritics cells and neutrophils) due to the induction of pro-inflammatory cytokines such as IL-12 and TNF-alpha and also that the reduced splenomegaly response observed with the cgs mutant is not the consequence of changes in expression levels of the characterized Brucella PAMPs LPS, flagellin or OMP16/19. Complementation of cgs mutant with purified C beta G increased significantly spleen inflammation response suggesting a direct role for this polysaccharide.	[Roset, Mara S.; Spera, Juan M.; Minatel, Leonardo; Cassataro, Juliana; Briones, Gabriel] Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Rodolfo Ugalde, Inst Tecnol Chascomus IIB INTECH, Buenos Aires, DF, Argentina; [Ibanez, Andres E.; Giambartolomei, Guillermo H.] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Inmunogenet,INIGEM CONICET, Buenos Aires, DF, Argentina; [de Souza Filho, Job Alves; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Minas Gerais	Roset, MS (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Inst Invest Biotecnol Rodolfo Ugalde, Inst Tecnol Chascomus IIB INTECH, Buenos Aires, DF, Argentina.	mroset@iibintech.com.ar; gbriones@iibintech.com.ar	Oliveira, Sergio Costa/AAG-5408-2021	Oliveira, Sergio Costa/0000-0003-4062-5577; Alves de Souza Filho, Job/0000-0002-6592-2378; Roset, Mara/0000-0003-0487-199X; Briones, Gabriel/0000-0002-4500-9848; Cassataro, Juliana/0000-0002-7122-869X	Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina [PICT 2006-1208, PICT 2011-1772]; CONICET [PIP1142010010031401]	Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Buenos Aires, Argentina (PICT 2006-1208, PICT 2011-1772,), CONICET (PIP1142010010031401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 1997, MICROBIOL-SGM, V143, P1115, DOI 10.1099/00221287-143-4-1115; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; CHEERS C, 1980, CELL IMMUNOL, V49, P168, DOI 10.1016/0008-8749(80)90066-0; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; De Iannino NI, 1998, J BACTERIOL, V180, P4392; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DOUGLAS CJ, 1982, J BACTERIOL, V152, P1265; ENRIGHT FM, 1990, VET IMMUNOL IMMUNOP, V26, P171, DOI 10.1016/0165-2427(90)90065-Z; Ferguson GP, 2004, P NATL ACAD SCI USA, V101, P5012, DOI 10.1073/pnas.0307137101; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GEREMIA RA, 1987, J BACTERIOL, V169, P880, DOI 10.1128/jb.169.2.880-884.1987; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Martirosyan A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002983; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Pappas G, 2006, EXPERT OPIN INV DRUG, V15, P1141, DOI 10.1517/13543784.15.10.1141; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Roset MS, 2006, J BACTERIOL, V188, P5003, DOI 10.1128/JB.00086-06; Roset MS, 2004, INFECT IMMUN, V72, P2263, DOI 10.1128/IAI.72.4.2263-2271.2004; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Verger JM, 1988, TECHNIQUES BRUCELLOS; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996	35	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101279	10.1371/journal.pone.0101279	http://dx.doi.org/10.1371/journal.pone.0101279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983999	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000081
J	Li, B; Flaveny, CA; Giambelli, C; Fei, DL; Han, L; Hang, BI; Bai, F; Pei, XH; Nose, V; Burlingame, O; Capobianco, AJ; Orton, D; Lee, E; Robbins, DJ				Li, Bin; Flaveny, Colin A.; Giambelli, Camilla; Fei, Dennis Liang; Han, Lu; Hang, Brian I.; Bai, Feng; Pei, Xin-Hai; Nose, Vania; Burlingame, Oname; Capobianco, Anthony J.; Orton, Darren; Lee, Ethan; Robbins, David J.			Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis	PLOS ONE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; ADENOMATOUS POLYPOSIS; DOWN-REGULATION; MURINE MODEL; E-CADHERIN; CYCLIN D1; APC GENE; COLON; PHOSPHORYLATION	Mutations in the WNT-pathway regulator ADENOMATOUS POLYPOSIS COLI (APC) promote aberrant activation of the WNT pathway that is responsible for APC-associated diseases such as Familial Adenomatous Polyposis (FAP) and 85% of spontaneous colorectal cancers (CRC). FAP is characterized by multiple intestinal adenomas, which inexorably result in CRC. Surprisingly, given their common occurrence, there are few effective chemotherapeutic drugs for FAP. Here we show that the FDA-approved, anti-helminthic drug Pyrvinium attenuates the growth of WNT-dependent CRC cells and does so via activation of CK1 alpha. Furthermore, we show that Pyrvinium can function as an in vivo inhibitor of WNT-signaling and polyposis in a mouse model of FAP: APC(min) mice. Oral administration of Pyrvinium, a CK1 alpha agonist, attenuated the levels of WNT-driven biomarkers and inhibited adenoma formation in APC(min) mice. Considering its well-documented safe use for treating enterobiasis in humans, our findings suggest that Pyrvinium could be repurposed for the clinical treatment of APC-associated polyposes.	[Li, Bin; Flaveny, Colin A.; Giambelli, Camilla; Fei, Dennis Liang; Han, Lu; Bai, Feng; Pei, Xin-Hai; Capobianco, Anthony J.; Robbins, David J.] Univ Miami, Mol Oncol Program, Dept Surg, Miami, FL 33152 USA; [Pei, Xin-Hai; Capobianco, Anthony J.; Robbins, David J.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Robbins, David J.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Nose, Vania] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Burlingame, Oname] Univ Miami, Dept Pathol, Jackson Hlth Syst, Miami, FL USA; [Hang, Brian I.; Lee, Ethan] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Orton, Darren] Stemsynergy Therapeut Inc, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Vanderbilt University	Robbins, DJ (corresponding author), Univ Miami, Mol Oncol Program, Dept Surg, Miami, FL 33152 USA.	drobbins@med.miami.edu	Pei, Xin-Hai/P-1812-2014	Li, Bin/0000-0001-9341-4672; Capobianco, Anthony/0000-0002-3706-6797; pei, xin-hai/0000-0001-6441-1691; Fei, Dennis Liang/0000-0002-1953-0584	NIH [5R01-CA-082628]; University of Miami Women's Cancer Association; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103926, R01GM081635] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Women's Cancer Association; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the NIH: 5R01-CA-082628, the University of Miami Women's Cancer Association, and the Sylvester Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; AMBROZE WL, 1995, SEMIN SURG ONCOL, V11, P423, DOI 10.1002/ssu.2980110610; Arango D, 2001, CANCER RES, V61, P4910; Augenlicht LH, 1997, CANCER RES, V57, P1769; Baba S, 1998, Nihon Geka Gakkai Zasshi, V99, P336; BANDYOPADHYAY A K, 1966, Bulletin of the Calcutta School of Tropical Medicine, V14, P134; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BLAIR LS, 1968, LAB ANIM CARE, V18, P314; Burn J, 2011, CANCER PREV RES, V4, P655, DOI 10.1158/1940-6207.CAPR-11-0106; CERDA AP, 1993, REV INVEST CLIN, V45, P493; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Church JM, 1996, DIS COLON RECTUM, V39, P584, DOI 10.1007/BF02058717; Cohen B, 2010, EUR EARLY CHILD EDUC, V18, P1, DOI 10.1080/13502930903519993; Cunningham C, 1996, BRIT J SURG, V83, P321, DOI 10.1002/bjs.1800830309; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerlier D, 1986, J IMMUNOLOGICAL METH; GOLDBERG MT, 1984, TOXICOL APPL PHARM, V74, P293, DOI 10.1016/0041-008X(84)90154-6; GRODEN J, 1993, AM J HUM GENET, V52, P263; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Herendeen JM, 2003, ANN PHARMACOTHER, V37, P1664, DOI 10.1345/aph.1C489; JAGELMAN DG, 1991, WORLD J SURG, V15, P47, DOI 10.1007/BF01658960; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Keller JJ, 2003, CANCER BIOL THER, V2, pS140; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; LAKE RS, 1982, J TOXICOL ENV HEALTH, V10, P255, DOI 10.1080/15287398209530248; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Mahmoud NN, 1998, SURGERY, V124, P225, DOI 10.1016/S0039-6060(98)70124-2; Mazaki T, 1996, INT J ONCOL, V9, P579; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MORGAN GP, 1995, GUT, V36, P153, DOI 10.1136/gut.36.1.153-c; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakamura Y, 1991, Princess Takamatsu Symp, V22, P285; Okuno Scott, 2006, Curr Treat Options Oncol, V7, P438, DOI 10.1007/s11864-006-0019-4; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Paoni NF, 2003, PHYSL GENOMICS, P15; Paulsen JE, 2000, SCAND J GASTROENTERO, V35, P534; Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448; Ramsay RG, 2005, DNA CELL BIOL, V24, P21, DOI 10.1089/dna.2005.24.21; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; Rice PL, 2003, MOL CANCER THER, V2, P885; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Santini D L, 1999, J Assoc Acad Minor Phys, V10, P68; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Venerando A, 2013, BIOCHEM J, V452, P131, DOI 10.1042/BJ20121140; Wallace MH, 1998, BRIT J SURG, V85, P742; Wallace MH, 1999, ANN ONCOL, V10, P201, DOI 10.1023/A:1008323206601; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951	60	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101969	10.1371/journal.pone.0101969	http://dx.doi.org/10.1371/journal.pone.0101969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003333	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700094
J	Martinez-Aquino, A; Ceccarelli, FS; Eguiarte, LE; Vazquez-Dominguez, E; de Leon, GPP				Martinez-Aquino, Andres; Sara Ceccarelli, Fadia; Eguiarte, Luis E.; Vazquez-Dominguez, Ella; Perez-Ponce de Leon, Gerardo			Do the Historical Biogeography and Evolutionary History of the Digenean Margotrema spp. across Central Mexico Mirror Those of Their Freshwater Fish Hosts (Goodeinae)?	PLOS ONE			English	Article							GEOGRAPHIC RANGE; PHYLOGENY; DIVERSIFICATION; PHYLOGEOGRAPHY; MITOCHONDRIAL; COSPECIATION; DISPERSAL; INFERENCE; PATTERNS; TREES	Host-parasite systems provide an ideal platform to study evolution at different levels, including codivergence in a historical biogeography context. In this study we aim to describe biogeographic and codivergent patterns and associated processes of the Goodeinae freshwater fish and their digenean parasite (Margotrema spp.) over the last 6.5 Ma (million years), identifying the main factors (host and/or hydrogeomorphology) that influenced the evolution of Margotrema. We obtained a species tree for Margotrema spp. using DNA sequence data from mitochondrial and nuclear molecular markers (COI and ITS1, respectively) and performed molecular dating to discern divergence events within the genus. The dispersal-extinction-cladogenesis (DEC) model was used to describe the historical biogeography of digeneans and applied to cophylogenetic analyses of Margotrema and their goodeine hosts. Our results showed that the evolutionary history of Margotrema has been shaped in close association with its geographic context, especially with the geological history of central Mexico during the Pleistocene. Host-specificity has been established at three levels of historical association: a) Species-Species, represented by Xenotaenia resolanae-M. resolanae exclusively found in the Cuzalapa River Basin; b) Species-Lineage, represented by Characodon audax-M. bravoae Lineage II, exclusive to the Upper and Middle Mezquital River Basin, and c) Tribe-Lineage, including two instances of historical associations among parasites and hosts at the taxonomical level of tribe, one represented by Ilyodontini-M. bravoae Lineage I (distributed across the Ayuquila and Balsas River Basins), and another comprised of Girardinichthyini/Chapalichthyini-M. bravoae Lineage III, found only in the Lerma River Basin. We show that the evolutionary history of the parasites is, on several occasions, in agreement with the phylogenetic and biogeographic history of their hosts. A series of biogeographic and host-parasite events explain the codivergence patterns observed, in which cospeciation and colonisation via host-switching and vicariant plus dispersal events are appreciated, at different times during the diversification history of both associates, particularly during the Pleistocene.	[Martinez-Aquino, Andres] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Martinez-Aquino, Andres; Perez-Ponce de Leon, Gerardo] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Sara Ceccarelli, Fadia] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Buenos Aires, DF, Argentina; [Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Vazquez-Dominguez, Ella] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Aquino, A (corresponding author), UNLP, FCNyM, Museo La Plata, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina.	maandres_@hotmail.com	Ceccarelli, F. Sara/L-3208-2019; de León, Gerardo Pérez Ponce/U-3869-2017	de León, Gerardo Pérez Ponce/0000-0001-6472-5113; Vazquez-Dominguez, Ella/0000-0001-6131-2014; Ceccarelli, Fadia Sara/0000-0003-4117-7366	Consejo Nacional de Ciencia y Tecnologia (CONACyT) within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; CONACYT [207983]; Universidad Nacional Autonoma de Mexico (UNAM-DGAPA); Consejo Nacional de Ciencia y Tecnologia (CONACyT) [83043]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM) [IN202111, IN204514]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM-DGAPA)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	AMA was supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACyT) to obtain his PhD degree within Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico, and actually his research is supported by a postdoctoral grant from CONACYT (# 207983). FSC was supported by a postdoctoral fellowships provided by Universidad Nacional Autonoma de Mexico (UNAM-DGAPA). GPPL was supported by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT 83043) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-UNAM IN 202111 and IN204514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2014, TRENDS ECOL EVOL, V29, P82, DOI 10.1016/j.tree.2013.11.003; alvarez Del Villar V. J., 1972, ANALES ESCUELA NACL, V19, P155; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Charleston MA, 2011, TREEMAP 3B; Charleston NA, 2006, J BIOMED INFORM, V39, P62, DOI 10.1016/j.jbi.2005.08.006; Choudhury A, 2002, J PARASITOL, V88, P1045, DOI 10.1645/0022-3395(2002)088[1045:VKHSAC]2.0.CO;2; Curran SS, 2011, J PARASITOL, V97, P661, DOI 10.1645/GE-2641.1; Dominguez-Dominguez O., 2010, VIVIPAROUS FISHES, P13; Dominguez-Dominguez O, 2006, J BIOGEOGR, V33, P1437, DOI 10.1111/j.1365-2699.2006.01526.x; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2010, GENEIOUS V5 0 4; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Ferrari L, 1999, GEOLOGY, V27, P303, DOI 10.1130/0091-7613(1999)027<0303:STPOCA>2.3.CO;2; Ferrari L, 2004, GEOLOGY, V32, P77, DOI 10.1130/G19887.1; Froeschke G, 2014, ADV PARASIT, V84, P209, DOI 10.1016/B978-0-12-800099-1.00004-1; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heneghan C, 2011, DATA MED DEVICE RECA; Hijmans R.J., 2012, DIVA GIS; Hoberg E.P., 2000, Bulletin of the Scandinavian Society for Parasitology, V10, P19; HOBERG EP, 1992, CAN J ZOOL, V70, P703, DOI 10.1139/z92-105; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Huyse T, 2003, INT J PARASITOL, V33, P1679, DOI 10.1016/S0020-7519(03)00253-4; Keller-Schmidt S, 2011, EVALUATION HOST PARA; Maddison WP, 2011, MESQUITE MODULAR SYS; Martinez-Aquino A, 2013, ZOOL J LINN SOC-LOND, V168, P1, DOI 10.1111/zoj.12027; Mateos M, 2002, EVOLUTION, V56, P972; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Miller R.R., 1986, P487; Minckley W.L., 1986, P519; Morand S., 2010, BIOGEOGRAPHY HOST PA; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Page RDM, 1996, SYST BIOL, V45, P151, DOI 10.2307/2413612; de Leon GPP, 2007, SYST PARASITOL, V68, P49, DOI 10.1007/s11230-006-9081-3; Perez-Ponce de Leon G, 2005, J BIOGEOGR, V32, P645, DOI 10.1111/j.1365-2699.2005.01218.x; Perez-Rodriguez R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-223; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rannala B, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P120; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Sanmartin Isabel, 2012, Evolution Education and Outreach, V5, P555; Ceccarelli FS, 2013, MOL PHYLOGENET EVOL, V69, P142, DOI 10.1016/j.ympev.2013.05.001; Thompson J. N., 2005, INTERSPEC INTERACT	52	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101700	10.1371/journal.pone.0101700	http://dx.doi.org/10.1371/journal.pone.0101700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999998	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300075
J	Nordberg, N; Olsson, I; Carlsson, M; Hu, GZ; Westholm, JO; Ronne, H				Nordberg, Niklas; Olsson, Ida; Carlsson, Mattias; Hu, Guo-Zhen; Westholm, Jakub Orzechowski; Ronne, Hans			The Histone Demethylase Activity of Rph1 is Not Essential for Its Role in the Transcriptional Response to Nutrient Signaling	PLOS ONE			English	Article							JMJC-DOMAIN; STRESS-RESPONSE; LIFE-SPAN; FAMILY; METHYLATION; YEAST; PROTEIN; H3K36; GIS1; TRIMETHYLATION	Rph1 and Gis1 are two related yeast zinc finger proteins that function as downstream effectors in the Ras/PKA, TOR and Sch9 nutrient signaling pathways. Both proteins also contain JmjC histone demethylase domains, but only Rph1 is known to be an active enzyme, demethylating lysine 36 of histone H3. We have studied to what extent the demethylase activity of Rph1 contributes to its role in nutrient signaling by performing gene expression microarray experiments on a yeast strain containing a catalytically inactive allele of RPH1. We find that the enzymatic activity of Rph1 is not essential for its role in growth phase dependent gene regulation. However, the ability of Rph1 to both activate and repress transcription is partially impaired in the active site mutant, indicating that the demethylase activity may enhance its function in vivo. Consistent with this, we find that the Rph1 mutation and a deletion of the histone H3 methylase Set2 affect the same target genes in opposite directions. Genes that are differentially expressed in the Rph1 mutant are also enriched for binding of Rpd3, a downstream effector in silencing, to their promoters. The expression of some subtelomeric genes and genes involved in sporulation and meiosis are also affected by the mutation, suggesting a role for Rph1-dependent demethylation in regulating these genes. A small set of genes are more strongly affected by the active site mutation, indicating a more pronounced role for the demethylase activity in their regulation by Rph1.	[Nordberg, Niklas; Olsson, Ida; Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden; [Nordberg, Niklas; Westholm, Jakub Orzechowski] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden.	Hans.Ronne@slu.se		Westholm, Jakub/0000-0002-6849-6220; Ronne, Hans/0000-0002-1645-6091	Swedish Research Council VR [621-2007-5079, 521-2011-3157]; Swedish Cancer Society	Swedish Research Council VR(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants to HR from the Swedish Research Council VR (621-2007-5079, 521-2011-3157) and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cameroni E, 2004, CELL CYCLE, V3, P462; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chang Y, 2010, BIOCHEM J, V433, P295; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Crona F, 2013, DEV BIOL, V373, P453, DOI 10.1016/j.ydbio.2012.11.011; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Huang F, 2010, J BIOL CHEM, V285, P24548, DOI 10.1074/jbc.M110.117333; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liang CY, 2013, MOL BIOL CELL, V24, P3251, DOI 10.1091/mbc.E12-11-0820; Liang CY, 2011, NUCLEIC ACIDS RES, V39, P4151, DOI 10.1093/nar/gkr040; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Polytarchou C, 2008, MOL CELL BIOL, V28, P7451, DOI 10.1128/MCB.00688-08; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tamaru H, 2010, GENE DEV, V24, P1465, DOI 10.1101/gad.1941010; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tompa R, 2007, GENETICS, V175, P585, DOI 10.1534/genetics.106.067751; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Vandamme J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002647; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Westholm JO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031577; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yu Y, 2010, FEMS YEAST RES, V10, P793, DOI 10.1111/j.1567-1364.2010.00680.x; Zhang NS, 2010, J BIOL CHEM, V285, P6465, DOI 10.1074/jbc.M109.073288; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	73	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e95078	10.1371/journal.pone.0095078	http://dx.doi.org/10.1371/journal.pone.0095078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999627	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300001
J	Rohlmann, A; Schwachmeyer, V; Graichen, F; Bergmann, G				Rohlmann, Antonius; Schwachmeyer, Verena; Graichen, Friedmar; Bergmann, Georg			Spinal Loads during Post-Operative Physiotherapeutic Exercises	PLOS ONE			English	Article							VERTEBRAL BODY REPLACEMENT; IN-VIVO; INTRADISCAL PRESSURE; MUSCLE FORCES; LUMBAR SPINE; IMPLANT	After spinal surgery, physiotherapeutic exercises are performed to achieve a rapid return to normal life. One important aim of treatment is to regain muscle strength, but it is known that muscle forces increase the spinal loads to potentially hazardous levels. It has not yet been clarified which exercises cause high spinal forces and thus endanger the surgical outcome. The loads on vertebral body replacements were measured in 5 patients during eleven physiotherapeutic exercises, performed in the supine, prone, or lateral position or on all fours (kneeling on the hands and knees). Low resultant forces on the vertebral body replacement were measured for the following exercises: lifting one straight leg in the supine position, abduction of the leg in the lateral position, outstretching one leg in the all-fours position, and hollowing the back in the all-fours position. From the biomechanical point of view, these exercises can be performed shortly after surgery. Implant forces similar or even greater than those for walking were measured during: lifting both legs, lifting the pelvis in the supine position, outstretching one arm with or without simultaneously outstretching the contralateral leg in the all-fours position, and arching the back in the all-fours position. These exercises should not be performed shortly after spine surgery.	[Rohlmann, Antonius; Schwachmeyer, Verena; Graichen, Friedmar; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohlmann, A (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	antonius.rohlmann@charite.de	Rohlmann, Antonius/E-4778-2011; Schwachmeyer, Verena/O-6745-2014	Rohlmann, Antonius/0000-0002-0083-2793; 	Deutsche Forschungsgemeinschaft [Ro 581/18-1]; Deutsche Arthrose-Hilfe e.V., Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe e.V., Frankfurt	This study was funded by the Deutsche Forschungsgemeinschaft (project: Ro 581/18-1) and the Deutsche Arthrose-Hilfe e.V., Frankfurt. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann G, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898831; CAPPOZZO A, 1984, Journal of Orthopaedic Research, V1, P292; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; de Zee M, 2007, J BIOMECH, V40, P1219, DOI 10.1016/j.jbiomech.2006.05.030; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; MARRAS WS, 1984, SPINE, V9, P176, DOI 10.1097/00007632-198403000-00008; McGill SM, 2013, ERGONOMICS, V56, P293, DOI 10.1080/00140139.2012.752528; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Rohlmann A, 2014, GAIT POSTURE, V39, P750, DOI 10.1016/j.gaitpost.2013.10.010; Rohlmann A, 2013, EUR SPINE J, V22, P2575, DOI 10.1007/s00586-013-3057-1; Rohlmann A, 2012, CLIN BIOMECH, V27, P754, DOI 10.1016/j.clinbiomech.2012.04.006; Rohlmann A, 2002, PHYS THER, V82, P44, DOI 10.1093/ptj/82.1.44; Rohlmann A, 2008, SPINE, V33, P1170, DOI 10.1097/BRS.0b013e3181722d52; Rohlmann A, 2007, MED ENG PHYS, V29, P580, DOI 10.1016/j.medengphy.2006.06.012; Rohlmann A, 2014, EUR SPINE J, V23, P666, DOI 10.1007/s00586-013-3087-8; Rohlmann A, 2013, J BIOMECH, V46, P511, DOI 10.1016/j.jbiomech.2012.10.022; Rohlmann A, 2011, SPINE J, V11, P870, DOI 10.1016/j.spinee.2011.06.017; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Rohlmann A, 2008, CLIN BIOMECH, V23, P147, DOI 10.1016/j.clinbiomech.2007.09.011; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Shirazi-Adl A, 2005, EUR SPINE J, V14, P381, DOI 10.1007/s00586-004-0779-0; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102005	10.1371/journal.pone.0102005	http://dx.doi.org/10.1371/journal.pone.0102005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999808	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300113
J	Sepehr, S; Rahmani-Badi, A; Babaie-Naiej, H				Sepehr, Shayesteh; Rahmani-Badi, Azadeh; Babaie-Naiej, Hamta			Unsaturated Fatty Acid, cis-2-Decenoic Acid, in Combination with Disinfectants or Antibiotics Removes Pre-Established Biofilms Formed by Food-Related Bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; IN-VITRO; MECHANISMS; PENETRATION; LIMITATION; RESISTANCE	Biofilm formation by food-related bacteria and food-related pathogenesis are significant problems in the food industry. Even though much disinfection and mechanical procedure exist for removal of biofilms, they may fail to eliminate preestablished biofilms. cis-2 decenoic acid (CDA), an unsaturated fatty acid messenger produced by Pseudomonas aeruginosa, is reportedly capable of inducing the dispersion of established biofilms by multiple types of microorganisms. However, whether CDA has potential to boost the actions of certain antimicrobials is unknown. Here, the activity of CDA as an inducer of pre-established biofilms dispersal, formed by four main food pathogens; Staphylococcus aureus, Bacillus cereus, Salmonella enterica and E. coli, was measured using both semi-batch and continuous cultures bioassays. To assess the ability of CDA combined biocides treatments to remove pre-established biofilms formed on stainless steel discs, CFU counts were performed for both treated and untreated cultures. Eradication of the biofilms by CDA combined antibiotics was evaluated using crystal violet staining. The effect of CDA combined treatments (antibiotics and disinfectants) on biofilm surface area and bacteria viability was evaluated using fluorescence microscopy, digital image analysis and LIVE/DEAD staining. MICs were also determined to assess the probable inhibitory effects of CDA combined treatments on the growth of tested microorganisms' planktonic cells. Treatment of pre-established biofilms with only 310 nM CDA resulted in at least two-fold increase in the number of planktonic cells in all cultures. While antibiotics or disinfectants alone exerted a trivial effect on CFU counts and percentage of surface area covered by the biofilms, combinational treatments with both 310 nM CDA and antibiotics or disinfectants led to approximate 80% reduction in biofilm biomass. These data suggests that combined treatments with CDA would pave the way toward developing new strategies to control biofilms with widespread applications in industry as well as medicine.	[Sepehr, Shayesteh; Rahmani-Badi, Azadeh; Babaie-Naiej, Hamta] Alzahra Univ, Dept Biol, Tehran, Iran	Alzahra University	Rahmani-Badi, A (corresponding author), Alzahra Univ, Dept Biol, Tehran, Iran.	a.rahmanibadi@gmail.com	Soudi, Mohammad Reza/T-8744-2019	Soudi, Mohammad Reza/0000-0002-5823-5465				Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 1997, 1276 EN; Campanac C, 2002, ANTIMICROB AGENTS CH, V46, P1469, DOI 10.1128/AAC.46.5.1469-1474.2002; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; Cloete TE, 1998, BIODEGRADATION, V9, P23, DOI 10.1023/A:1008216209206; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Desbois AP, 2008, APPL MICROBIOL BIOT, V81, P755, DOI 10.1007/s00253-008-1714-9; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gilbert P, 2002, J APPL MICROBIOL, V92, p98S, DOI 10.1046/j.1365-2672.92.5s1.5.x; Jennings JA, 2012, CLIN ORTHOP RELAT R, V470, P2663, DOI 10.1007/s11999-012-2388-2; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Musk DJ, 2008, J APPL MICROBIOL, V105, P380, DOI 10.1111/j.1365-2672.2008.03751.x; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; Poppele EH, 2003, J MICROBIOL METH, V55, P607, DOI 10.1016/S0167-7012(03)00198-2; Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054; Simoes M, 2005, WATER RES, V39, P5142, DOI 10.1016/j.watres.2005.09.028; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Verran J, 2008, ADV APPL MICROBIOL, V64, P223, DOI 10.1016/S0065-2164(08)00408-5; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x	26	36	36	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101677	10.1371/journal.pone.0101677	http://dx.doi.org/10.1371/journal.pone.0101677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000301	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300069
J	Yadav, NS; Singh, VK; Singh, D; Jha, B				Yadav, Narendra Singh; Singh, Vijay Kumar; Singh, Dinkar; Jha, Bhavanath			A Novel Gene SbSI-2 Encoding Nuclear Protein from a Halophyte Confers Abiotic Stress Tolerance in E-coli and Tobacco	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SALT-TOLERANCE; SALICORNIA-BRACHIATA; TRANSGENIC TOBACCO; EXTREME HALOPHYTE; RESPONSIVE GENE; ABSCISIC-ACID; THELLUNGIELLA-HALOPHILA; DEHYDRATION TOLERANCE; TRANSCRIPTION FACTORS	Salicornia brachiata is an extreme halophyte that grows luxuriantly in coastal marshes. Previously, we have reported isolation and characterization of ESTs from Salicornia with large number of novel/unknown salt-responsive gene sequences. In this study, we have selected a novel salt-inducible gene SbSI-2 (Salicornia brachiata salt-inducible-2) for functional characterization. Bioinformatics analysis revealed that SbSI-2 protein has predicted nuclear localization signals and a strong protein-protein interaction domain. Transient expression of the RFP: SbSI2 fusion protein confirmed that SbSI-2 is a nuclear localized protein. Genomic organization study showed that SbSI-2 is intronless and has a single copy in Salicornia genome. Quantitative RT-PCR analysis revealed higher SbSI-2 expression under salt stress and desiccation conditions. The SbSI-2 gene was transformed in E. coli and tobacco for functional characterization. pET28a-SbSI-2 recombinant E. coli cells showed higher tolerance to desiccation and salinity compared to vector alone. Transgenic tobacco plants overexpressing SbSI-2 have improved salt-and osmotic tolerance, accompanied by better growth parameters, higher relative water content, elevated accumulation of compatible osmolytes, lower Na+ and ROS accumulation and lesser electrolyte leakage than the wild-type. Overexpression of the SbSI-2 also enhanced transcript levels of ROS-scavenging genes and some stress-related transcription factors under salt and osmotic stresses. Taken together, these results demonstrate that SbSI-2 might play an important positive modulation role in abiotic stress tolerance. This identifies SbSI-2 as a novel determinant of salt/osmotic tolerance and suggests that it could be a potential bioresource for engineering abiotic stress tolerance in crop plants.	[Yadav, Narendra Singh; Singh, Vijay Kumar; Singh, Dinkar; Jha, Bhavanath] Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India; [Jha, Bhavanath] CSIR, Acad Sci & Innovat Res, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Jha, B (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Discipline Marine Biotechnol & Ecol, Bhavnagar 364002, Gujarat, India.	bjha@csmcri.org	Singh, Vijay Kumar/G-6839-2013; Yadav, Narendra Singh/C-3330-2013	Singh, Vijay Kumar/0000-0003-4872-4545; Yadav, Narendra Singh/0000-0003-0122-173X	Council of Scientific and Industrial Research (CSIR), New Delhi [BSC0109]	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial assistance received from Council of Scientific and Industrial Research (CSIR) (www.csir.res.in), New Delhi (BSC0109: SIMPLE) is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, PLANT MOL BIOL, V51, P363, DOI 10.1023/A:1022043000516; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Agarwal PK, 2010, MOL BIOL REP, V37, P981, DOI 10.1007/s11033-009-9774-1; Amtmann A, 2005, PLANT PHYSIOL, V138, P127, DOI 10.1104/pp.105.059972; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen SH, 2007, DNA SEQUENCE, V18, P61, DOI 10.1080/10425170601108555; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cvikrova M, 2012, PLANT SCI, V182, P49, DOI 10.1016/j.plantsci.2011.01.016; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gu LL, 2011, MOL BIOL REP, V38, P5285, DOI 10.1007/s11033-011-0678-5; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Guo XH, 2010, MOL BIOL REP, V37, P1183, DOI 10.1007/s11033-009-9484-8; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; He YA, 2012, J EXP BOT, V63, P1511, DOI 10.1093/jxb/err389; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Jha A, 2011, MOL BIOL REP, V38, P1965, DOI 10.1007/s11033-010-0318-5; Jha B, 2012, MAR BIOTECHNOL, V14, P782, DOI 10.1007/s10126-012-9442-7; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jha B, 2009, GENES GENET SYST, V84, P111, DOI 10.1266/ggs.84.111; Jin HC, 2010, MOL BIOL REP, V37, P745, DOI 10.1007/s11033-009-9590-7; Knowlton AA, 1996, J BIOSCIENCE, V21, P123, DOI 10.1007/BF02703103; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kore-eda S, 2004, GENE, V341, P83, DOI 10.1016/j.gene.2004.06.037; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li HY, 2009, GENE, V433, P65, DOI 10.1016/j.gene.2008.12.007; Li SO, 2010, PLANT CELL ENVIRON, V33, P117, DOI 10.1111/j.1365-3040.2009.02063.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; LYNCH J, 1984, PLANTA, V161, P295, DOI 10.1007/BF00398718; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mehta PA, 2005, THEOR APPL GENET, V110, P416, DOI 10.1007/s00122-004-1801-y; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Reddy PCO, 2008, PLANT SCI, V175, P372, DOI 10.1016/j.plantsci.2008.05.012; Reddy PS, 2010, MOL GENET GENOMICS, V283, P243, DOI 10.1007/s00438-010-0518-7; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Shukla PS, 2012, J PLANT GROWTH REGUL, V31, P195, DOI 10.1007/s00344-011-9231-y; Singh D, 2014, PLANT BIOTECHNOL REP, V8, P325, DOI 10.1007/s11816-014-0324-5; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verslues PE, 2007, PLANT MOL BIOL, V64, P205, DOI 10.1007/s11103-007-9145-z; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang ZI, 2004, PLANT SCI, V166, P609, DOI 10.1016/j.plantsci.2003.10.030; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yadav NS, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-188; Yadav NS, 2012, MOL BIOL REP, V39, P1943, DOI 10.1007/s11033-011-0941-9; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Zhang L, 2001, GENE, V267, P193, DOI 10.1016/S0378-1119(01)00403-6; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhu NQ, 2001, J NAT PROD, V64, P627, DOI 10.1021/np000483k; Zou M, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/680673; Zouari N, 2007, GENE, V404, P61, DOI 10.1016/j.gene.2007.08.021	80	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101926	10.1371/journal.pone.0101926	http://dx.doi.org/10.1371/journal.pone.0101926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999628	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300104
J	Adiredjo, AL; Navaud, O; Munos, S; Langlade, NB; Lamaze, T; Grieu, P				Adiredjo, Afifuddin Latif; Navaud, Olivier; Munos, Stephane; Langlade, Nicolas B.; Lamaze, Thierry; Grieu, Philippe			Genetic Control of Water Use Efficiency and Leaf Carbon Isotope Discrimination in Sunflower (Helianthus annuus L.) Subjected to Two Drought Scenarios	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL ANALYSIS; TRANSPIRATION EFFICIENCY; ENVIRONMENT INTERACTIONS; PHOTOSYNTHETIC CAPACITY; BIOMASS PRODUCTIVITY; STOMATAL CONDUCTANCE; GENOTYPIC VARIATION; PLANT HEIGHT; GAS-EXCHANGE	High water use efficiency (WUE) can be achieved by coordination of biomass accumulation and water consumption. WUE is physiologically and genetically linked to carbon isotope discrimination (CID) in leaves of plants. A population of 148 recombinant inbred lines (RILs) of sunflower derived from a cross between XRQ and PSC8 lines was studied to identify quantitative trait loci (QTL) controlling WUE and CID, and to compare QTL associated with these traits in different drought scenarios. We conducted greenhouse experiments in 2011 and 2012 by using 100 balances which provided a daily measurement of water transpired, and we determined WUE, CID, biomass and cumulative water transpired by plants. Wide phenotypic variability, significant genotypic effects, and significant negative correlations between WUE and CID were observed in both experiments. A total of nine QTL controlling WUE and eight controlling CID were identified across the two experiments. A QTL for phenotypic response controlling WUE and CID was also significantly identified. The QTL for WUE were specific to the drought scenarios, whereas the QTL for CID were independent of the drought scenarios and could be found in all the experiments. Our results showed that the stable genomic regions controlling CID were located on the linkage groups 06 and 13 (LG06 and LG13). Three QTL for CID were co-localized with the QTL for WUE, biomass and cumulative water transpired. We found that CID and WUE are highly correlated and have common genetic control. Interestingly, the genetic control of these traits showed an interaction with the environment (between the two drought scenarios and control conditions). Our results open a way for breeding higher WUE by using CID and marker-assisted approaches and therefore help to maintain the stability of sunflower crop production.	[Adiredjo, Afifuddin Latif; Grieu, Philippe] Univ Toulouse, INP ENSAT, AGIR, INPT INRA,UMR 1248, Castanet Tolosan, France; [Adiredjo, Afifuddin Latif] Brawijaya Univ, Fac Agr, Dept Agron, Plant Breeding Lab, Malang, Indonesia; [Navaud, Olivier; Lamaze, Thierry] Univ Toulouse, UPS Toulouse 3, CESBIO, UMR 5126, Toulouse, France; [Munos, Stephane; Langlade, Nicolas B.] INRA, LIPM, UMR 441, F-31326 Castanet Tolosan, France; [Munos, Stephane; Langlade, Nicolas B.] CNRS, LIPM, UMR 2594, Castanet Tolosan, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Brawijaya University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Grieu, P (corresponding author), Univ Toulouse, INP ENSAT, AGIR, INPT INRA,UMR 1248, Castanet Tolosan, France.	grieu@ensat.fr	Navaud, Olivier/S-1491-2016; MUNOS, STEPHANE/ABE-6062-2020; Langlade, Nicolas/C-6191-2008	Navaud, Olivier/0000-0003-4270-4690; Langlade, Nicolas/0000-0002-5651-1446; Adiredjo, Afifuddin Latif/0000-0002-3297-8439; Munos, Stephane/0000-0003-0261-2759	French Government Scholarship (Bourse du gouvernement Francais, BGF); Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN)	French Government Scholarship (Bourse du gouvernement Francais, BGF); Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN)	The work was supported by a French Government Scholarship (Bourse du gouvernement Francais, BGF) and a co-funding by Directorate general of Higher Education, Ministry of Education and Culture, Republic of Indonesia (Beasiswa Luar Negeri, BLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaarani GR, 2004, THEOR APPL GENET, V109, P1353, DOI 10.1007/s00122-004-1770-1; Austin DF, 1996, GENOME, V39, P957, DOI 10.1139/g96-120; Blum A, 1996, PLANT GROWTH REGUL, V20, P135, DOI 10.1007/BF00024010; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Brendel O, 2008, TREE GENET GENOMES, V4, P263, DOI 10.1007/s11295-007-0107-z; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Ceccarelli M, 2007, GENOME, V50, P429, DOI 10.1139/G07-019; CECCARELLI S, 1991, EUPHYTICA, V56, P169, DOI 10.1007/BF00042061; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chen J, 2011, PLANT CELL ENVIRON, V34, P2009, DOI 10.1111/j.1365-3040.2011.02397.x; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; CONDON AG, 1992, AUST J AGR RES, V43, P935, DOI 10.1071/AR9920935; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; CONDON AG, 1990, AUST J PLANT PHYSIOL, V17, P9, DOI 10.1071/PP9900009; CONDON AG, 1993, AUST J AGR RES, V44, P1693, DOI 10.1071/AR9931693; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Diab AA, 2004, THEOR APPL GENET, V109, P1417, DOI 10.1007/s00122-004-1755-0; DINGKUHN M, 1991, AUST J AGR RES, V42, P1123, DOI 10.1071/AR9911123; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Erice G, 2011, ENVIRON EXP BOT, V72, P123, DOI 10.1016/j.envexpbot.2011.02.013; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Feng JH, 2013, G3-GENES GENOM GENET, V3, P31, DOI 10.1534/g3.112.004846; Forster BP, 2004, ANN APPL BIOL, V144, P157, DOI 10.1111/j.1744-7348.2004.tb00329.x; Hall A. E., 1994, Plant Breeding Reviews, V12, P81; Hao Z, 2009, PLANT BREEDING, V128, P337, DOI 10.1111/j.1439-0523.2009.01642.x; Hausmann NJ, 2005, EVOLUTION, V59, P81; Impa SM, 2005, CROP SCI, V45, P2517, DOI 10.2135/cropsci2005.0119; Jourjon MF, 2005, BIOINFORMATICS, V21, P128, DOI 10.1093/bioinformatics/bth481; Juenger TE, 2005, PLANT CELL ENVIRON, V28, P697, DOI 10.1111/j.1365-3040.2004.01313.x; Julier B., 2010, SUSTAINABLE USE GENE; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Lambrides CJ, 2004, CROP SCI, V44, P1642, DOI 10.2135/cropsci2004.1642; Lauteri M, 1997, FUNCT ECOL, V11, P675, DOI 10.1046/j.1365-2435.1997.00140.x; Lauteri M., 1993, Stable isotopes and plant carbon-water relations., P93; Laza MR, 2006, CROP SCI, V46, P763, DOI 10.2135/cropsci2005.05.0084; Li CY, 1999, PLANT SOIL, V214, P165, DOI 10.1023/A:1004708815973; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; Lincoln S.E., 1993, CONSTRUCTING GENETIC, V3; MARTIN B, 1988, PLANT PHYSIOL, V88, P213, DOI 10.1104/pp.88.1.213; MARTIN B, 1989, SCIENCE, V243, P1725, DOI 10.1126/science.243.4899.1725; Mian MAR, 1996, CROP SCI, V36, P1252, DOI 10.2135/cropsci1996.0011183X003600050030x; Misra SC, 2010, AGR WATER MANAGE, V97, P57, DOI 10.1016/j.agwat.2009.08.014; MORGAN JA, 1993, CROP SCI, V33, P178, DOI 10.2135/cropsci1993.0011183X003300010032x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Rebetzke G, 2008, THEOR APPL GENET, V118, P123, DOI 10.1007/s00122-008-0882-4; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Reynolds MP, 2000, FIELD CROP RES, V66, P37, DOI 10.1016/S0378-4290(99)00077-5; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/BF00221905; Richards RA, 2002, CROP SCI, V42, P111, DOI 10.2135/cropsci2002.0111; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Rizza F, 2012, FIELD CROP RES, V125, P49, DOI 10.1016/j.fcr.2011.09.001; Rytter RM, 2005, J AGRON CROP SCI, V191, P426, DOI 10.1111/j.1439-037X.2005.00162.x; Saranga Y, 2001, GENOME RES, V11, P1988, DOI 10.1101/gr.157201; Saranga Y, 2004, PLANT CELL ENVIRON, V27, P263, DOI 10.1111/j.1365-3040.2003.01134.x; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; Schlighting CD, 1998, PHENOTYPIC EVOLUTION; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Teulat B, 2002, THEOR APPL GENET, V106, P118, DOI 10.1007/s00122-002-1028-8; Teulat B, 1998, THEOR APPL GENET, V96, P688, DOI 10.1007/s001220050790; This D, 2010, RICE, V3, P72, DOI 10.1007/s12284-010-9036-9; Ungerer MC, 2003, GENETICS, V165, P353; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Vincourt P, 2012, THEOR APPL GENET, V125, P909, DOI 10.1007/s00122-012-1882-y; Wright G. C., 1993, Stable isotopes and plant carbon-water relations., P247; Xu Y, 1997, PLANT ANIMAL GENOME, P149; Xu Yunbi, 2002, P109, DOI 10.1079/9780851996011.0109; Xu YB, 2009, THEOR APPL GENET, V118, P1065, DOI 10.1007/s00122-009-0963-z; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104	79	30	35	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101218	10.1371/journal.pone.0101218	http://dx.doi.org/10.1371/journal.pone.0101218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992022	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000341253400051
J	Ibanez, F; Levy, J; Tamborindeguy, C				Ibanez, Freddy; Levy, Julien; Tamborindeguy, Cecilia			Transcriptome Analysis of "Candidatus Liberibacter solanacearum'' in Its Psyllid Vector, Bactericera cockerelli	PLOS ONE			English	Article							AFFECTED CARROTS; UNITED-STATES; ZEBRA CHIP; 1ST REPORT; GENOME; ENDOSYMBIONTS; SEQUENCE; DISEASE; POTATO; DNA	"Candidatus Liberibacter solanacearum'' (Lso) is an emergent pathogen of carrots in Europe and solanaceous plants in North and Central America and New Zealand. This bacterium is closely related to other pathogenic Candidatus Liberibacter spp., all vectored by psyllids. In order to understand the molecular interaction of this pathogen and its psyllid vector, Bactericera cockerelli, Illumina sequencing of psyllid harboring Lso was performed to determine if this approach could be used to assess the bacterial transcriptome in this association. Prior to sequencing, psyllid RNA was purified and insect and bacterial rRNA were removed. Mapping of reads to Lso genome revealed that over 92% of the bacterial genes were expressed in the vector, and that the COG categories Translation and Post-translational modification, protein turnover, chaperone functions were the most expressed functional categories. Expression levels of selected Lso genes were confirmed by RT-qPCR. The transcriptomic analysis also helped correct Lso genome annotation by identifying the expression of genes that were not predicted in the genome sequencing effort.	[Ibanez, Freddy; Tamborindeguy, Cecilia] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Levy, Julien] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@ag.tamu.edu	levy, julien G./I-9904-2019	levy, julien G./0000-0002-1422-2195	NIFA-AFRI [2012-67013-19431]; Texas A&M University WSGI Catalyst; Texas A&M University-CONACYT: Collaborative Research Grant Program [9577]	NIFA-AFRI; Texas A&M University WSGI Catalyst; Texas A&M University-CONACYT: Collaborative Research Grant Program	Funding for this work was provided by NIFA-AFRI grant 2012-67013-19431, Texas A&M University 2012 WSGI Catalyst and 2011 Texas A&M University-CONACYT: Collaborative Research Grant Program Project No: 9577. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Fernandez A, 2012, PLANT DIS, V96, P581, DOI 10.1094/PDIS-10-11-0878-PDN; Bell JK, 2002, EUR J BIOCHEM, V269, P4176, DOI 10.1046/j.1432-1033.2002.03075.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Callaway E, 2008, NATURE, V452, P148, DOI 10.1038/452148a; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Crosslin J. M., 2010, PLANT HLTH PROG; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; ISHIKAWA H, 1987, J MOL EVOL, V24, P205, DOI 10.1007/BF02111233; ISHIKAWA H, 1984, INSECT BIOCHEM, V14, P417, DOI 10.1016/0020-1790(84)90098-2; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Liu S, 2012, PLOS ONE, P7; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2010, PLANT DIS, V94, P639, DOI 10.1094/PDIS-94-5-0639A; Munyaneza JE, 2009, PLANT DIS, V93, P552, DOI 10.1094/PDIS-93-5-0552A; Munyaneza J. E., 2007, PLANT SCI, V59, P30; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nelson WR, 2013, EUR J PLANT PATHOL, V135, P633, DOI 10.1007/s10658-012-0121-3; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SLAUGHTER JC, 1968, BIOCHEM J, V109, P749, DOI 10.1042/bj1090749; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Stoll S, 2009, ENVIRON MICROBIOL, V11, P877, DOI 10.1111/j.1462-2920.2008.01808.x; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Wilson ACC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-50; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yan Q, 2013, MOL PLANT PATHOL	48	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100955	10.1371/journal.pone.0100955	http://dx.doi.org/10.1371/journal.pone.0100955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992557	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400038
J	Jin, Y; Diaz, B; Colomer, M; Sebastian-Galles, N				Jin, Yu; Diaz, Begona; Colomer, Marc; Sebastian-Galles, Nuria			Oscillation Encoding of Individual Differences in Speech Perception	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; MISMATCH NEGATIVITY MMN; THETA OSCILLATION; BRAIN POTENTIALS; SOUNDS; RESPONSES; MEMORY; ADULTS; REPRESENTATION; SCHIZOPHRENIA	Individual differences in second language (L2) phoneme perception (within the normal population) have been related to speech perception abilities, also observed in the native language, in studies assessing the electrophysiological response mismatch negativity (MMN). Here, we investigate the brain oscillatory dynamics in the theta band, the spectral correlate of the MMN, that underpin success in phoneme learning. Using previous data obtained in an MMN paradigm, the dynamics of cortical oscillations while perceiving native and unknown phonemes and nonlinguistic stimuli were studied in two groups of participants classified as good and poor perceivers (GPs and PPs), according to their L2 phoneme discrimination abilities. The results showed that for GPs, as compared to PPs, processing of a native phoneme change produced a significant increase in theta power. Stimulus time-locked analysis event-related spectral perturbation (ERSP) showed differences for the theta band within the MMN time window (between 70 and 240 ms) for the native deviant phoneme. No other significant difference between the two groups was observed for the other phoneme or nonlinguistic stimuli. The dynamic patterns in the theta-band may reflect early automatic change detection for familiar speech sounds in the brain. The behavioral differences between the two groups may reflect individual variations in activating brain circuits at a perceptual level.	[Jin, Yu; Diaz, Begona; Colomer, Marc; Sebastian-Galles, Nuria] Pompeu Fabra Univ, Ctr Brain & Cognit, Dept Technol, Speech Acquisit & Percept Grp, Barcelona, Spain	Pompeu Fabra University; University of Barcelona	Diaz, B (corresponding author), Pompeu Fabra Univ, Ctr Brain & Cognit, Dept Technol, Speech Acquisit & Percept Grp, Barcelona, Spain.	begona.diaz@upf.edu	Díaz, Begona/H-5854-2012; Sebastian-Galles, Nuria/A-4215-2008	Díaz, Begona/0000-0003-1628-4901; Sebastian-Galles, Nuria/0000-0001-6938-2498; Colomer, Marc/0000-0002-4337-0373	European Community's Seventh Framework Programme (FP7): ERG [323961]; Spanish Ministerio de Economia y Competitividad [PSI 2012 - 34071]; Catalan Government [SGR 2009-1521]; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) under REA [328671]; Generalitat de Catalunya	European Community's Seventh Framework Programme (FP7): ERG; Spanish Ministerio de Economia y Competitividad(Spanish Government); Catalan Government; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) under REA; Generalitat de Catalunya(Generalitat de Catalunya)	This research was supported by grants from the European Community's Seventh Framework Programme (FP7/2007-2013): ERG grant agreement number 323961, the Spanish Ministerio de Economia y Competitividad (PSI 2012 - 34071), and the Catalan Government (SGR 2009-1521) to N. Sebastian-Galles, and the People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7/2007-2013) under REA grant agreement nu 328671 to B. Diaz. N. Sebastian-Galles received the "ICREA Academia'' Prize for Excellence in Research, funded by the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1987, BIOL PSYCHOL, V24, P197, DOI 10.1016/0301-0511(87)90002-0; AALTONEN O, 1993, BRAIN LANG, V44, P139, DOI 10.1006/brln.1993.1009; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; Dima D, 2012, SCHIZOPHR RES, V135, P23, DOI 10.1016/j.schres.2011.12.024; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Fuentemilla L, 2008, BRAIN RES, V1220, P93, DOI 10.1016/j.brainres.2007.07.079; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; GUION S, 2007, 2 LANGUAGE SPEECH LE, P57; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; Harrington M., 1992, STUDIES 2 LANGUAGE A, V14, P25, DOI [10.1017/S0272263100010457, DOI 10.1017/S0272263100010457]; Hsiao FJ, 2009, BIOL PSYCHOL, V81, P58, DOI 10.1016/j.biopsycho.2009.01.007; Jakoby H, 2011, PSYCHOPHYSIOLOGY, V48, P1516, DOI 10.1111/j.1469-8986.2011.01227.x; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; Ko D, 2012, J CLIN NEUROL, V8, P35, DOI 10.3988/jcn.2012.8.1.35; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Liasis A, 2001, COGNITIVE BRAIN RES, V11, P227, DOI 10.1016/S0926-6410(00)00077-X; Majerus S, 2008, COGNITION, V107, P395, DOI 10.1016/j.cognition.2007.10.003; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Mei LL, 2008, NEUROREPORT, V19, P215, DOI 10.1097/WNR.0b013e3282f46ea9; Miyake A, 1998, FOREIGN LANGUAGE LEARNING, P339; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Moyer A., 1999, STUD SECOND LANG ACQ, V21, P81, DOI [DOI 10.1017/S0272263199001035, https://doi.org/10.1017/S0272263199001035]; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Naatanen R., 1979, ORIENTING REFLEX HUM, P61; Oknina LB, 2005, SCHIZOPHR RES, V76, P25, DOI 10.1016/j.schres.2004.10.003; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Rinne T, 1999, NEUROIMAGE, V10, P620, DOI 10.1006/nimg.1999.0495; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Sebastian-Galles N, 2005, TWENTY-FIRST CENTURY PSYCHOLINGUISTICS: FOUR CORNERSTONES, P279; Sebastian-Galles N, 2012, J NEUROLINGUIST, V25, P150, DOI 10.1016/j.jneuroling.2011.11.001; Sharma A, 1999, J ACOUST SOC AM, V106, P1078, DOI 10.1121/1.428048; Sharma A, 1994, J ACOUST SOC AM, V95, P3011; Takegata R, 2005, COGNITIVE BRAIN RES, V25, P169, DOI 10.1016/j.cogbrainres.2005.05.006; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; Winkler I, 2005, J COGNITIVE NEUROSCI, V17, P320, DOI 10.1162/0898929053124866; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, HUM BRAIN MAPP, V28, P995, DOI 10.1002/hbm.20330; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	57	11	11	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100901	10.1371/journal.pone.0100901	http://dx.doi.org/10.1371/journal.pone.0100901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992269	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400036
J	Park, S; Kim, JI; Lee, I; Lee, S; Hwang, MW; Bae, JY; Heo, J; Kim, D; Jang, SI; Kim, H; Cheong, HJ; Song, JW; Song, KJ; Baek, LJ; Park, MS				Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Kim, Hyejin; Cheong, Hee Jin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong			Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice	PLOS ONE			English	Article							H1N1 VIRUS-INFECTIONS; NEURAMINIDASE INHIBITOR RWJ-270201; IN-VITRO; A VIRUS; ANTIVIRAL THERAPY; CELL-CULTURE; MODEL; T-705; RIBAVIRIN; EFFICACY	Antiviral drugs are being used for therapeutic purposes against influenza illness in humans. However, antiviral-resistant variants often nullify the effectiveness of antivirals. Combined medications, as seen in the treatment of cancers and other infectious diseases, have been suggested as an option for the control of antiviral-resistant influenza viruses. Here, we evaluated the therapeutic value of combination therapy against oseltamivir-resistant 2009 pandemic influenza H1N1 virus infection in DBA/2 mice. Mice were treated for five days with favipiravir and peramivir starting 4 hours after lethal challenge. Compared with either monotherapy, combination therapy saved more mice from viral lethality and resulted in increased antiviral efficacy in the lungs of infected mice. Furthermore, the synergism between the two antivirals, which was consistent with the survival outcomes of combination therapy, indicated that favipiravir could serve as a critical agent of combination therapy for the control of oseltamivir-resistant strains. Our results provide new insight into the feasibility of favipiravir in combination therapy against oseltamivir-resistant influenza virus infection.	[Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Hyejin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Hyejin; Song, Jin-Won; Song, Ki-Joon; Baek, Luck Ju; Park, Man-Seong] Korea Univ, Inst Viral Dis, Seoul 136705, South Korea; [Park, Sehee; Kim, Jin Il; Lee, Ilseob; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Park, Man-Seong] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Gangwon Do, South Korea; [Cheong, Hee Jin] Korea Univ, Coll Med, Guro Hosp, Div Infect Dis, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Hallym University; Korea University; Korea University Medicine (KU Medicine)	Park, MS (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea.	ms0392@korea.ac.kr	Kim, Young-jin/GSD-3168-2022; Song, Jin/HHS-8731-2022; Park, Man-Seong/AAF-1207-2020	Kim, Jin Il/0000-0001-8833-2138; Cheong, Hee Jin/0000-0002-2532-1463	Korea Healthcare Technology RAMP;D Project of the Ministry of Health Welfare [A103001]	Korea Healthcare Technology RAMP;D Project of the Ministry of Health Welfare	This study was supported by grant from the Korea Healthcare Technology R&D Project of the Ministry of Health & Welfare (Grant No. A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Bantia S, 2010, ANTIVIR RES, V88, P276, DOI 10.1016/j.antiviral.2010.09.020; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Chao DL, 2013, INFLUENZA OTHER RESP, V7, P58, DOI 10.1111/irv.12043; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Govorkova EA, 2010, VIRUSES-BASEL, V2, P1510, DOI 10.3390/v2081510; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Gulick R, 1998, AIDS, V12, pS17; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; 이일섭, 2013, Journal of Bacteriology and Virology, V43, P9, DOI 10.4167/jbv.2013.43.1.9; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jonges M, 2009, ANTIVIR RES, V83, P290, DOI 10.1016/j.antiviral.2009.07.003; Kim JI, 2013, J MICROBIOL, V51, P866, DOI 10.1007/s12275-013-3428-7; Kim JI, 2013, J VIROL, V87, P7539, DOI 10.1128/JVI.00373-13; Kiso M, 2011, J VIROL, V85, P4667, DOI 10.1128/JVI.00047-11; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Kiso M, 2010, P NATL ACAD SCI USA, V107, P882, DOI 10.1073/pnas.0909603107; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Lee S, 2013, J MICROBIOL, V51, P676, DOI 10.1007/s12275-013-3384-2; Nguyen HT, 2010, ANTIMICROB AGENTS CH, V54, P3671, DOI 10.1128/AAC.00581-10; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Park Sehee, 2012, Journal of Bacteriology and Virology, V42, P284, DOI 10.4167/jbv.2012.42.4.284; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; Park S, 2012, J MICROBIOL, V50, P1067, DOI 10.1007/s12275-012-2541-3; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shetty AK, 2012, EXPERT REV ANTI-INFE, V10, P123, DOI [10.1586/eri.11.174, 10.1586/ERI.11.174]; Sidwell RW, 2001, ANTIMICROB AGENTS CH, V45, P749, DOI 10.1128/AAC.45.3.749-757.2001; Smee DF, 2002, CHEMOTHERAPY, V48, P88, DOI 10.1159/000057668; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smee DF, 2012, ANTIVIR RES, V96, P13, DOI 10.1016/j.antiviral.2012.07.002; Smee DF, 2010, ANTIVIR RES, V88, P38, DOI 10.1016/j.antiviral.2010.07.003; Smee DF, 2010, ANTIMICROB AGENTS CH, V54, P126, DOI 10.1128/AAC.00933-09; Smee DF, 2009, J ANTIMICROB CHEMOTH, V64, P741, DOI 10.1093/jac/dkp274; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; Tarbet EB, 2012, ANTIVIR RES, V94, P103, DOI 10.1016/j.antiviral.2012.03.001; Tsiodras S, 2007, BMJ-BRIT MED J, V334, P293, DOI 10.1136/bmj.39105.428981.BE; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wong DDY, 2012, J VIROL, V86, P10558, DOI 10.1128/JVI.00985-12; Yun NE, 2008, VIROLOGY, V374, P198, DOI 10.1016/j.virol.2007.12.029	50	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101325	10.1371/journal.pone.0101325	http://dx.doi.org/10.1371/journal.pone.0101325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992479	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400062
J	Jonas, A; Sumbi, V; Mwinga, S; DeKlerk, M; Tjituka, F; Penney, S; Jordan, MR; Desta, T; Tang, AM; Hong, SY				Jonas, Anna; Sumbi, Victor; Mwinga, Samson; DeKlerk, Michael; Tjituka, Francina; Penney, Scott; Jordan, Michael R.; Desta, Tiruneh; Tang, Alice M.; Hong, Steven Y.			HIV Drug Resistance Early Warning Indicators in Namibia with Updated World Health Organization Guidance	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TREATMENT INTERRUPTIONS; ADHERENCE; PROTEASE; OUTCOMES; PREDICTORS; MORTALITY; PROGRAMS; SURVIVAL	Background: In response to concerns about the emergence of HIV drug resistance (HIVDR), the World Health Organization (WHO) has developed a comprehensive set of early warning indicators (EWIs) to monitor HIV drug resistance and good programme practice at antiretroviral therapy (ART) sites. Methods: In 2012, Namibia utilized the updated WHO EWI guidance and abstracted data from adult and pediatric patients from 50 ART sites for the following EWIs: 1. On-time Pill Pick-up, 2. Retention in Care, 3. Pharmacy Stock-outs, 4. Dispensing Practices, and 5. Virological Suppression. Results: Data for EWIs one through four were abstracted and validated. EWI 5 - Virological Suppression was not included due to poor data entry at many sites. On-time Pill Pick-up national estimate was 87.9% (87.2-88.7) of patients picking up pills on time for adults and 90.0% (88.9-90.9) picking up pills on time for pediatrics. Retention in Care national estimate was 82% of patients retained on ART after 12 months for adults and 83% for pediatrics. Pharmacy Stock-outs national estimate was 99% of months without a stock-out for adults and 97% for pediatrics. Dispensing Practices national estimate was 0.01% (0.003-0.064) of patients dispensed mono-or dual-therapy for adults and 0.25% (0.092-0.653) for pediatrics. Conclusions: The successful 2012 EWI exercise provides Namibia a solid evidence base, which can be used to make national statements about programmatic functioning and possible HIVDR. This evidence base will serve to contextualize results from Namibia's surveys of HIVDR, which involves genotype testing. EWI abstraction has prompted the national program and its counterparts to engage sites in dialogue regarding the need to strengthen adherence and retention of patients on ART. The EWI collection process and EWI results will serve to optimize patient care and support Namibia in making evidence-based recommendations and take action to minimize the emergence of preventable HIVDR.	[Jonas, Anna; DeKlerk, Michael] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Sumbi, Victor; Mwinga, Samson; Tjituka, Francina] Management Sci Hlth, Strengthening Pharmaceut Syst, Windhoek, Namibia; [Penney, Scott; Jordan, Michael R.; Tang, Alice M.; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Desta, Tiruneh] World Hlth Org Namibia, Klein Windhoek, Namibia	Massachusetts Department of Public Health; Tufts University; Tufts Medical Center; World Health Organization	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org		Sumbi, Victor/0000-0001-6474-2642	Republic of Namibia Ministry of Health and Social Services; National Institutes of Health [NIH L30 AI080268-02, NIH 1K23AI097010-01A1, NIH K23 AI074423-05, NIH P30 AI42853-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, K23AI097010, K23AI074423] Funding Source: NIH RePORTER	Republic of Namibia Ministry of Health and Social Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Republic of Namibia Ministry of Health and Social Services, National Institutes of Health, NIH L30 AI080268-02 (SYH), NIH 1K23AI097010-01A1 (SYH), NIH K23 AI074423-05 (MRJ), and NIH P30 AI42853-10 (AMT). Travel expenses for this study were supported in part by the Harold Williams Tufts Medical Student Research Fellowship (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD FACTB; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Dzangare J, 2012, CLIN INFECT DIS, V54, pS313, DOI 10.1093/cid/cir1014; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jones A, 2013, PLOS ONE, V8; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; WHO, 2012, REP ASS WHO HIV DRUG; World Health Organization, 2010, WHO IND MON HIV DRUG	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100539	10.1371/journal.pone.0100539	http://dx.doi.org/10.1371/journal.pone.0100539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988387	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100033
J	Wilson, SC; Eybatov, TM; Amano, M; Jepson, PD; Goodman, SJ				Wilson, Susan C.; Eybatov, Tariel M.; Amano, Masao; Jepson, Paul D.; Goodman, Simon J.			The Role of Canine Distemper Virus and Persistent Organic Pollutants in Mortality Patterns of Caspian Seals (Pusa caspica)	PLOS ONE			English	Article							PHOCA-VITULINA; POLYCHLORINATED-BIPHENYLS; HARBOR SEAL; ENVIRONMENTAL CONTAMINANTS; PHOCOENA-PHOCOENA; COPLANAR PCBS; GROWTH; ORGANOCHLORINE; AGE; INFECTION	Persistent organic pollutants are a concern for species occupying high trophic levels since they can cause immunosuppression and impair reproduction. Mass mortalities due to canine distemper virus (CDV) occurred in Caspian seals (Pusa caspica), in spring of 1997, 2000 and 2001, but the potential role of organochlorine exposure in these epizootics remains undetermined. Here we integrate Caspian seal mortality data spanning 1971-2008, with data on age, body condition, pathology and blubber organochlorine concentration for carcases stranded between 1997 and 2002. We test the hypothesis that summed PCB and DDT concentrations contributed to CDV associated mortality during epizootics. We show that age is the primary factor explaining variation in blubber organochlorine concentrations, and that organochlorine burden, age, sex, and body condition do not account for CDV infection status (positive/negative) of animals dying in epizootics. Most animals (57%, n = 67) had PCB concentrations below proposed thresholds for toxic effects in marine mammals (17 mu g/g lipid weight), and only 3 of 67 animals had predicted TEQ values exceeding levels seen to be associated with immune suppression in harbour seals (200 pg/g lipid weight). Mean organonchlorine levels were higher in CDV-negative animals indicating that organochlorines did not contribute significantly to CDV mortality in epizootics. Mortality monitoring in Azerbaijan 1971-2008 revealed bi-annual stranding peaks in late spring, following the annual moult and during autumn migrations northwards. Mortality peaks comparable to epizootic years were also recorded in the 1970s-1980s, consistent with previous undocumented CDV outbreaks. Gompertz growth curves show that Caspian seals achieve an asymptotic standard body length of 126-129 cm (n = 111). Males may continue to grow slowly throughout life. Mortality during epizootics may exceed the potential biological removal level (PBR) for the population, but the low frequency of epizootics suggest they are of secondary importance compared to anthropogenic sources of mortality such as fishing by-catch.	[Wilson, Susan C.] Tara Seal Res Ctr, Killyleagh, County Down, North Ireland; [Eybatov, Tariel M.] Inst Geol, Baku, Azerbaijan; [Amano, Masao] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Jepson, Paul D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Goodman, Simon J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	Azerbaijan National Academy of Sciences (ANAS); Nagasaki University; Zoological Society of London; University of Leeds	Wilson, SC (corresponding author), Tara Seal Res Ctr, Killyleagh, County Down, North Ireland.	suewilson@sealresearch.org; s.j.goodman@leeds.ac.uk	Amano, Masao/J-9778-2019	Amano, Masao/0000-0001-9495-5315; Goodman, Simon/0000-0003-4118-8575	World Bank ECOTOX project; Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal' [165-15-024]; Grants-in-Aid for Scientific Research [25281008] Funding Source: KAKEN	World Bank ECOTOX project; Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal'; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Investigation of the mass mortalities, pathology and toxicology analyses were funded by the World Bank ECOTOX project. The Darwin Initiative project 'Quantification and Elimination of Threats to the Caspian seal' (ref: 165-15-024) funded collection of data from Azerbaijan 2006-2009. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1977, J FISH RES BOARD CAN, V34, P937, DOI 10.1139/f77-146; ADDISON RF, 1973, J FISH RES BOARD CAN, V30, P595, DOI 10.1139/f73-106; Allchin C, 1997, P 1 BION WORKSH BORD, P101; Amano M, 2000, ADV ECOL RES, V31, P449, DOI 10.1016/S0065-2504(00)31024-8; AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; Anan Y, 2002, ARCH ENVIRON CON TOX, V42, P354, DOI 10.1007/s00244-001-0004-7; Beckmen KB, 1999, SCI TOTAL ENVIRON, V231, P183, DOI 10.1016/S0048-9697(99)00094-7; Brock PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067132; Chabot D, 2002, MAR ECOL PROG SER, V227, P25, DOI 10.3354/meps227025; Chapsky KK, 1965, MARINE MAMMALS, P122; DESWART RL, 1995, INFECT AGENT DIS, V4, P125; DESWART RL, 1995, CHEMOSPHERE, V31, P4289, DOI 10.1016/0045-6535(95)00298-M; deSwart RL, 1996, ENVIRON HEALTH PERSP, V104, P823, DOI 10.1289/ehp.96104s4823; DESWART RL, 1995, CLIN EXP IMMUNOL, V101, P480; Dmitrieva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067074; Espeland O, 1997, MAR ENVIRON RES, V44, P315, DOI 10.1016/S0141-1136(97)00010-X; Eybatov T, 1997, P 1 BION WORKSH BORD, P95; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Forsyth MA, 1998, VET REC, V143, P662; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Green Nicholas, 1996, Organohalogen Compounds, V29, P453; Hadjiev DB, 1995, MORPHOLOGIA ZYBNOVO; Hall AJ, 2006, BIOL CONSERV, V131, P221, DOI 10.1016/j.biocon.2006.04.008; Hall AJ, 1999, ENVIRON POLLUT, V106, P203, DOI 10.1016/S0269-7491(99)00073-1; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P704, DOI 10.1289/ehp.8222; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harkonen T, 2008, IUCN 2013 RED LIST T; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harkonen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043130; Harkonen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000887; HELLE E, 1976, Ambio, V5, P261; HELLE E, 1976, Ambio, V5, P188; Helle E, 1990, AMBIO, V7, P16; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Kajiwara N, 2002, ENVIRON POLLUT, V117, P391, DOI 10.1016/S0269-7491(01)00200-7; Kajiwara N, 2008, ENVIRON POLLUT, V152, P431, DOI 10.1016/j.envpol.2007.06.075; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Krylov V.I., 1990, Finnish Game Research, V47, P32; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; LAW RJ, 1994, MAR POLLUT BULL, V29, P235, DOI 10.1016/0025-326X(94)90415-4; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Mariner JC, 2003, VET REC, V152, P641, DOI 10.1136/vr.152.21.641; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Murphy S, 2006, ACTA ZOOL-STOCKHOLM, V87, P315, DOI 10.1111/j.1463-6395.2006.00245.x; Murphy Sinead, 2012, Endangered Species Research, V16, P149, DOI 10.3354/esr00392; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Nilssen K.T., 1997, Journal of Northwest Atlantic Fishery Science, V22, P17; Ohashi K, 2001, VET MICROBIOL, V82, P203, DOI 10.1016/S0378-1135(01)00371-6; OLSSON M, 1994, SCI TOTAL ENVIRON, V154, P217, DOI 10.1016/0048-9697(94)90089-2; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; R Core Team, 2013, R LANG ENV STAT COMP; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Reijnders PJH, 2003, N P TOX ENV, P55; REIJNDERS PJH, 1986, NATURE, V324, P456, DOI 10.1038/324456a0; ROSS PS, 1995, ENVIRON HEALTH PERSP, V103, P162, DOI 10.2307/3432272; ROSS PS, 1994, VET IMMUNOL IMMUNOP, V42, P331, DOI 10.1016/0165-2427(94)90077-9; Ross PS, 1996, AQUAT TOXICOL, V34, P71, DOI 10.1016/0166-445X(95)00031-X; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stolen MK, 2002, MAR MAMMAL SCI, V18, P348, DOI 10.1111/j.1748-7692.2002.tb01042.x; SWART RD, 1994, AMBIO, V23, P155; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; TANABE S, 1987, INT J ENVIRON AN CH, V29, P199, DOI 10.1080/03067318708079836; TANABE S, 1987, ENVIRON POLLUT, V47, P147, DOI 10.1016/0269-7491(87)90044-3; TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8; Watanabe M, 1999, ARCH ENVIRON CON TOX, V37, P396, DOI 10.1007/s002449900531; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2; Yablonskaya E.A., 1994, CASPIAN SEA	71	17	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99265	10.1371/journal.pone.0099265	http://dx.doi.org/10.1371/journal.pone.0099265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987857	Green Published, gold			2022-12-25	WOS:000341354100012
J	Ramlochansingh, C; Branoner, F; Chagnaud, BP; Straka, H				Ramlochansingh, Carlana; Branoner, Francisco; Chagnaud, Boris P.; Straka, Hans			Efficacy of Tricaine Methanesulfonate (MS-222) as an Anesthetic Agent for Blocking Sensory-Motor Responses in Xenopus laevis Tadpoles	PLOS ONE			English	Article							NEUROACTIVE DRUGS; NEURONS; PAIN; FROG; INPUTS	Anesthetics are drugs that reversibly relieve pain, decrease body movements and suppress neuronal activity. Most drugs only cover one of these effects; for instance, analgesics relieve pain but fail to block primary fiber responses to noxious stimuli. Alternately, paralytic drugs block synaptic transmission at neuromuscular junctions, thereby effectively paralyzing skeletal muscles. Thus, both analgesics and paralytics each accomplish one effect, but fail to singularly account for all three. Tricaine methanesulfonate (MS-222) is structurally similar to benzocaine, a typical anesthetic for anamniote vertebrates, but contains a sulfate moiety rendering this drug more hydrophilic. MS-222 is used as anesthetic in poikilothermic animals such as fish and amphibians. However, it is often argued that MS-222 is only a hypnotic drug and its ability to block neural activity has been questioned. This prompted us to evaluate the potency and dynamics of MS-222-induced effects on neuronal firing of sensory and motor nerves alongside a defined motor behavior in semi-intact in vitro preparations of Xenopus laevis tadpoles. Electrophysiological recordings of extraocular motor discharge and both spontaneous and evoked mechanosensory nerve activity were measured before, during and after administration of MS-222, then compared to benzocaine and a known paralytic, pancuronium. Both MS-222 and benzocaine, but not pancuronium caused a dose-dependent, reversible blockade of extraocular motor and sensory nerve activity. These results indicate that MS-222 as benzocaine blocks the activity of both sensory and motor nerves compatible with the mechanistic action of effective anesthetics, indicating that both caine-derivates are effective as single-drug anesthetics for surgical interventions in anamniotes.	[Ramlochansingh, Carlana; Branoner, Francisco; Chagnaud, Boris P.; Straka, Hans] Univ Munich, Dept Biol 2, Planegg, Germany	University of Munich	Straka, H (corresponding author), Univ Munich, Dept Biol 2, Planegg, Germany.	straka@lmu.de			German Science Foundation [CRC 870, TP B12]; German Federal Ministry of Education and Research [01 EO 0901]; Munich Center for Neurosciences - Brain and Mind (MCN); Graduate School for Systemic Neurosciences (GSN)	German Science Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center for Neurosciences - Brain and Mind (MCN); Graduate School for Systemic Neurosciences (GSN)	The authors CR FB BPC and HS acknowledge financial support from the German Science Foundation (CRC 870, TP B12), the German Federal Ministry of Education and Research under the Grant code 01 EO 0901, the Munich Center for Neurosciences - Brain and Mind (MCN) and the Graduate School for Systemic Neurosciences (GSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds DEW, 2002, BIOL BULL, V203, P188, DOI 10.2307/1543388; Bai CX, 2003, NEUROSCI LETT, V337, P41, DOI 10.1016/S0304-3940(02)01288-0; Beck JC, 2004, METHOD CELL BIOL, V76, P385; Biesdorf S, 2008, J NEUROPHYSIOL, V99, P1758, DOI 10.1152/jn.01207.2007; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Cakir Y, 2005, PHARMACOL REP, V57, P467; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Drexler B, 2010, CURR MED CHEM, V17, P4538, DOI 10.2174/092986710794183042; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gentz EJ, 2007, ILAR J, V48, P255, DOI 10.1093/ilar.48.3.255; Guenette SA, 2008, J AM ASSOC LAB ANIM, V47, P35; Guenette SA, 2013, EXP ANIM TOKYO, V62, P87; Hasegawa T, 2004, J MEMBRANE BIOL, V199, P119, DOI 10.1007/s00232-004-0677-8; Lafortune M., 2001, Journal of Herpetological Medicine and Surgery, V11, P13; Lalonde-Robert V, 2012, J AM ASSOC LAB ANIM, V51, P464; Lambert FM, 2008, J NEUROSCI, V28, P8086, DOI 10.1523/JNEUROSCI.1288-08.2008; Lambert FM, 2012, CURR BIOL, V22, P1649, DOI 10.1016/j.cub.2012.07.019; LETCHER J, 1995, J AM VET MED ASSOC, V207, P80; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; Machin KL, 1999, J ZOO WILDLIFE MED, V30, P2; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; Parker Brian M, 2006, Cleve Clin J Med, V73 Suppl 1, pS13; Ramlochansingh C, 2011, NEUROTOX RES, V20, P263, DOI 10.1007/s12640-011-9239-x; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; SIMMONDS MA, 1987, NEUROPHARMACOLOGY, V26, P923, DOI 10.1016/0028-3908(87)90071-2; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; Smith JM, 2000, CONTEMP TOP LAB ANIM, V39, P39; STEDMAN TL, 1995, STEDMANS MED DICT; Stevens Craig W., 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P33, DOI 10.1016/j.cvex.2010.09.007; Stockman J, 2013, VET ANAESTH ANALG, V40, P35, DOI 10.1111/j.1467-2995.2012.00739.x; Stoskopf M, 2008, AM COLL LAB, P519; STOSKOPF MK, 1994, INVEST OPHTH VIS SCI, V35, P775; STRAKA H, 1993, EUR J NEUROSCI, V5, P251, DOI 10.1111/j.1460-9568.1993.tb00491.x; Straka H, 2004, PROG NEUROBIOL, V73, P259, DOI 10.1016/j.pneurobio.2004.05.003; Straka H, 2012, DEV NEUROBIOL, V72, P649, DOI 10.1002/dneu.20965; SU PC, 1979, ANESTHESIOLOGY, V50, P199, DOI 10.1097/00000542-197903000-00006; WASS JA, 1974, LAB ANIM SCI, V24, P669; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zornik E, 2008, J NEUROSCI, V28, P612, DOI 10.1523/JNEUROSCI.4754-07.2008	41	52	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101606	10.1371/journal.pone.0101606	http://dx.doi.org/10.1371/journal.pone.0101606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984086	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000122
J	Ubertini, V; Norelli, G; D'Arcangelo, D; Gurtner, A; Cesareo, E; Baldari, S; Gentileschi, MP; Piaggio, G; Nistico, P; Soddu, S; Facchiano, A; Bossi, G				Ubertini, V.; Norelli, G.; D'Arcangelo, D.; Gurtner, A.; Cesareo, E.; Baldari, S.; Gentileschi, M. P.; Piaggio, G.; Nistico, P.; Soddu, S.; Facchiano, A.; Bossi, G.			Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist	ONCOGENE			English	Article							CANCER-RELATED INFLAMMATION; NECROSIS-FACTOR-ALPHA; LI-FRAUMENI-SYNDROME; KAPPA-B ACTIVATION; REGULATORY REGIONS; GENE-EXPRESSION; IL-1 RECEPTOR; TUMOR MALIGNANCY; MESSENGER-RNA; IN-VIVO	The TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor malignancy. Here we report that mutant (mut) p53 promotes tumor malignancy by suppressing the expression of a natural occurring anti-inflammatory cytokine, the secreted interleukin-1 receptor antagonist (sIL-1Ra, IL1RN). We show that mutp53 but not wild-type (wt) p53 suppresses the sIL-1Ra production in conditioned media of cancer cells. Moreover, mutp53, but not wtp53, binds physically the sIL-1Ra promoter and the protein-protein interaction with the transcriptional corepressor MAFF (v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein F) is required for mutp53-induced sIL-1Ra suppression. Remarkably, when exposed to IL-1 beta (IL-1 beta) inflammatory stimuli, mutp53 sustains a ready-to-be-activated in vitro and in vivo cancer cells' response through the sIL-1Ra repression. Taken together, these results identify sIL-1Ra as a novel mutp53 target gene, whose suppression might be required to generate a chronic pro-inflammatory tumor microenvironment through which mutp53 promotes tumor malignancy.	[Ubertini, V.; Norelli, G.; Gurtner, A.; Baldari, S.; Gentileschi, M. P.; Piaggio, G.; Nistico, P.; Soddu, S.] Regina Elena Inst Canc Res, Expt Oncol Labs, I-00158 Rome, Italy; [D'Arcangelo, D.; Cesareo, E.; Facchiano, A.] IRCCS, Ist Dermopat Immacolata IDI, Rome, Italy; [Bossi, G.] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, I-00158 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Bossi, G (corresponding author), Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Via Messi Oro 156, I-00158 Rome, Italy.	bossi@ifo.it	Baldari, Silvia/AAA-5959-2021; D'Arcangelo, Daniela/K-6533-2016; Bossi, Gianluca/ABH-6846-2020; Soddu, Silvia/K-2467-2018; Soddu, Silvia/ABH-6774-2020; gurtner, aymone/AAB-8843-2020; Gurtner, Aymone/J-7217-2018; Bossi, Gianluca/B-9394-2017; Bossi, Gianluca/G-8375-2016; Piaggio, Giulia/AAD-7336-2022; Nisticò, Paola/B-2862-2018; Piaggio, Giulia/J-7214-2018; Maria Pia, Gentileschi/J-2637-2017; Facchiano, Antonio/J-4744-2012; Facchiano, Antonio/K-5984-2016	Baldari, Silvia/0000-0001-7982-9468; D'Arcangelo, Daniela/0000-0002-7862-3289; Bossi, Gianluca/0000-0002-2947-1063; Soddu, Silvia/0000-0001-8526-0044; Soddu, Silvia/0000-0001-8526-0044; gurtner, aymone/0000-0002-7661-9059; Gurtner, Aymone/0000-0002-7661-9059; Bossi, Gianluca/0000-0002-2947-1063; Bossi, Gianluca/0000-0002-2947-1063; Nisticò, Paola/0000-0003-4409-2261; Piaggio, Giulia/0000-0003-2114-1892; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Antonio/0000-0002-4243-2392	Associazione Italiana Ricerca sul Cancro (AICR) (IG) [8804, 13234]; Associazione Italiana Ricerca sul Cancro (AICR) (MFAG) [11752]; Associazione Italiana Ricerca sul Cancro (AICR) (RC) [3.5-2013]	Associazione Italiana Ricerca sul Cancro (AICR) (IG)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (AICR) (MFAG)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (AICR) (RC)(Fondazione AIRC per la ricerca sul cancro)	We thank Dr S Bacchetti, Dr FL Graham and Dr G D'Orazi for critical reading of the manuscript; Dr C Gabay for providing pRa-1680-Luc vector; and Dr G Tolstonog for ENCODE in silico analyses on the sIL-1Ra promoter. This work was supported with grants from Associazione Italiana Ricerca sul Cancro (AICR) to GB (IG no. 8804), AG (MFAG no. 11752), PG (IG no. 13234), and AF (RC 3.5-2013). We thank the Proteomic Facility for Complex Potein Muxture (CPM) Analisys at ISS, Rome.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; CHIRIVI RGS, 1993, CANCER RES, V53, P5051; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; D'Arcangelo D, 2002, CIRC RES, V91, pE4, DOI 10.1161/01.RES.0000036753.50601.E9; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Jenkins JK, 1997, J IMMUNOL, V158, P748; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kimura T, 1999, BIOCHEM BIOPH RES CO, V264, P86, DOI 10.1006/bbrc.1999.1487; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li YJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-87; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Notterman DA, 2001, CANCER RES, V61, P3124; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; SMITH MF, 1992, J IMMUNOL, V149, P2000; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; ULICH TR, 1992, AM J PATHOL, V141, P61; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; WU S, 1994, GYNECOL ONCOL, V53, P59, DOI 10.1006/gyno.1994.1088; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	44	51	52	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2493	2504		10.1038/onc.2014.191	http://dx.doi.org/10.1038/onc.2014.191			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998848				2022-12-25	WOS:000354190400008
J	Guan, YJ; Yang, X; Yang, WT; Charbonneau, C; Chen, Q				Guan, Yingjie; Yang, Xu; Yang, Wentian; Charbonneau, Cherie; Chen, Qian			Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development	FASEB JOURNAL			English	Article						mechanotransduction; mTOR; chondrocyte; Shp2	LONGITUDINAL BONE-GROWTH; CHONDROCYTE DIFFERENTIATION; MATRIX DEFORMATION; CELL-GROWTH; PLATE; COMPLEX; MTOR; MECHANOTRANSDUCTION; STRESS; PROLIFERATION	Mechanical stress regulates development by modulating cell signaling and gene expression. However, the cytoplasmic components mediating mechanotransduction remain unclear. In this study, elimination of muscle contraction during chicken embryonic development resulted in a reduction in the activity of mammalian target of rapamycin (mTOR) in the cartilaginous growth plate. Inhibition of mTOR activity led to significant inhibition of chondrocyte proliferation, cartilage tissue growth, and expression of chondrogenic genes, including Indian hedgehog (Ihh), a critical mediator of mechanotransduction. Conversely, cyclic loading (1 Hz, 5% matrix deformation) of embryonic chicken growth plate chondrocytes in 3-dimensional (3D) collagen scaffolding induced sustained activation of mTOR. Mechanical activation of mTOR occurred in serum-free medium, indicating that it is independent of growth factor or nutrients. Treatment of chondrocytes with Rapa abolished mechanical activation of cell proliferation and Ihh gene expression. Cyclic loading of chondroprogenitor cells deficient in SH2-containing protein tyrosine phosphatase 2 (Shp2) further enhanced mechanical activation of mTOR, cell proliferation, and chondrogenic gene expression. This result suggests that Shp2 is an antagonist of mechanotransduction through inhibition of mTOR activity. Our data demonstrate that mechanical activation of mTOR is necessary for cell proliferation, chondrogenesis, and cartilage growth during bone development, and that mTOR is an essential mechanotransduction component modulated by Shp2 in the cytoplasm.-Guan, Y., Yang, X., Yang, W., Charbonneau, C., Chen, Q. Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development.	[Guan, Yingjie; Yang, Xu; Yang, Wentian; Charbonneau, Cherie; Chen, Qian] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthopaed,Cell & Mol Biol Lab, Providence, RI 02903 USA; [Yang, Xu] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Orthopaed, Qingdao 266071, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Qingdao University	Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthopaed, 1 Hoppin St,Suite 402, Providence, RI 02903 USA.	qian_chen@brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618	U.S. National Institutes of Health (NIH) [GM104937, AG017021]; National Science Foundation (NSF) of China [81271978]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017021] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank C. Phornphutkul for helpful discussion and critical reading of the manuscript. This work is supported by the U.S. National Institutes of Health (NIH; grants GM104937 and AG017021) and the National Science Foundation (NSF) of China (grant 81271978).	Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; CARTER DR, 1987, CLIN ORTHOP RELAT R, P237; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Dane B, 2009, CLIN EXP OBSTET GYN, V36, P259; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Duke PJ, 1999, ADV SPACE RES-SERIES, V24, P821, DOI 10.1016/S0273-1177(99)00077-0; Forriol F, 2005, CLIN ORTHOP RELAT R, P14, DOI 10.1097/01.blo.0000156001.78631.e9; Forwood MR, 2001, OSTEOPOROSIS INT, V12, P77, DOI 10.1007/s001980170161; Germiller JA, 1997, J ORTHOP RES, V15, P362, DOI 10.1002/jor.1100150308; Godin LM, 2007, BIOMECH MODEL MECHAN, V6, P391, DOI 10.1007/s10237-006-0059-5; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Henderson JH, 2002, BONE, V31, P645, DOI 10.1016/S8756-3282(02)00911-0; Holstein JH, 2008, BRIT J PHARMACOL, V154, P1055, DOI 10.1038/bjp.2008.167; Ji BH, 2010, MED HYPOTHESES, V74, P871, DOI 10.1016/j.mehy.2009.11.026; Kanbe K, 2007, J BONE MINER RES, V22, P318, DOI 10.1359/JBMR.061104; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Moore DC, 2003, J ORTHOP RES, V21, P489, DOI 10.1016/s0736-0266(02)00234-6; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Phornphutkul C, 2009, J ORTHOP RES, V27, P1157, DOI 10.1002/jor.20894; PINES M, 1991, POULTRY SCI, V70, P1806, DOI 10.3382/ps.0701806; Pitsillides AA, 2006, J ANAT, V208, P417, DOI 10.1111/j.1469-7580.2006.00556.x; PROVINE RR, 1980, DEV PSYCHOBIOL, V13, P151, DOI 10.1002/dev.420130207; Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x; Robling AG, 2009, MED SCI SPORT EXER, V41, P2044, DOI 10.1249/MSS.0b013e3181a8c702; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SCHNEIDERMAN R, 1986, J ORTHOPAED RES, V4, P393, DOI 10.1002/jor.1100040402; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sibonga JD, 2000, BONE, V27, P535, DOI 10.1016/S8756-3282(00)00352-5; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Spankuch B, 2006, CANCER RES, V66, P5836, DOI 10.1158/0008-5472.CAN-06-0343; Sparks C. A., ONCOGENE, V29, P3733; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Stuermer A, 2007, EUR J CELL BIOL, V86, P37, DOI 10.1016/j.ejcb.2006.09.002; Ueki M, 2008, ANN BIOMED ENG, V36, P793, DOI 10.1007/s10439-008-9462-7; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Zito CI, 2007, J BIOL CHEM, V282, P6946, DOI 10.1074/jbc.M608338200	51	25	25	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4470	4481		10.1096/fj.14-252783	http://dx.doi.org/10.1096/fj.14-252783			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002119	Green Published			2022-12-25	WOS:000342222700024
J	Bai, XH; Chen, HJ; Jiang, YL; Wen, ZS; Huang, YB; Cheng, W; Li, Q; Qi, L; Zhang, JR; Chen, YX; Zhou, CZ				Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Wen, Zhensong; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Zhang, Jing-Ren; Chen, Yuxing; Zhou, Cong-Zhao			Structure of Pneumococcal Peptidoglycan Hydrolase LytB Reveals Insights into the Bacterial Cell Wall Remodeling and Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Enzyme Structure; Peptidoglycan; Streptococcus; Structural Biology; Cell Wall Remodeling	CRYSTAL-STRUCTURE; N-ACETYLGLUCOSAMINIDASE; LISTERIA-MONOCYTOGENES; MUREIN HYDROLASE; VIRULENCE FACTOR; AUTOLYSIN LYTA; DOMAIN; ACID; PROTEIN; SPECIFICITY	Background: The pneumococcal endo--N-acetylglucosaminidase LytB is required for cell division and colonization. Results: Structural analysis revealed that the catalytic domain of LytB consists of three structurally distinct modules. Conclusion: All three modules of LytB are necessary for its optimal activity toward peptidoglycan hydrolysis and for pneumococcal adhesion to respiratory epithelial cells. Significance: Provided is the structural insight into LytB-mediated pneumococcal cell wall remodeling and pathogenesis. Streptococcus pneumoniae causes a series of devastating infections in humans. Previous studies have shown that the endo--N-acetylglucosaminidase LytB is critical for pneumococcal cell division and nasal colonization, but the biochemical mechanism of LytB action remains unknown. Here we report the 1.65 crystal structure of the catalytic domain (residues Lys-375-Asp-658) of LytB (termed LytB(CAT)), excluding the choline binding domain. LytB(CAT) consists of three structurally independent modules: SH3b, WW, and GH73. These modules form a T-shaped pocket that accommodates a putative tetrasaccharide-pentapeptide substrate of peptidoglycan. Structural comparison and simulation revealed that the GH73 module of LytB harbors the active site, including the catalytic residue Glu-564. In vitro assays of hydrolytic activity indicated that LytB prefers the peptidoglycan from the lytB-deficient pneumococci, suggesting the existence of a specific substrate of LytB in the immature peptidoglycan. Combined with in vitro cell-dispersing and in vivo cell separation assays, we demonstrated that all three modules are necessary for the optimal activity of LytB. Further functional analysis showed that the full catalytic activity of LytB is required for pneumococcal adhesion to and invasion into human lung epithelial cells. Structure-based alignment indicated that the unique modular organization of LytB is highly conserved in its orthologs from Streptococcus mitis group and Gemella species. These findings provided structural insights into the pneumococcal cell wall remodeling and novel hints for the rational design of therapeutic agents against pneumococcal growth and thereby the related diseases.	[Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wen, Zhensong; Zhang, Jing-Ren] Tsinghua Univ, Sch Med, Ctr Infect Dis Res, Beijing 100084, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Zhang, JR (corresponding author), Tsinghua Univ, Sch Med, Ctr Infect Dis Res, Beijing 100084, Peoples R China.	zhanglab@tsinghua.edu.cn; cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2013CB835300, 2014CB910100, 2012CB518702]; National Natural Science Foundation of China [31270781, U1332114]; Grand Challenges Exploration of the Bill and Melinda Gates Foundation [OPP1021992]; Tsinghua University Collaborative Research Program [2011Z23153]; Center for Marine Medicine and Rescue of Tsinghua University Grant [20124812029]; Collaborative Innovation Center for Biotherapy; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grand Challenges Exploration of the Bill and Melinda Gates Foundation; Tsinghua University Collaborative Research Program; Center for Marine Medicine and Rescue of Tsinghua University Grant; Collaborative Innovation Center for Biotherapy; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Ministry of Science and Technology of China Grants 2013CB835300, 2014CB910100, and 2012CB518702, National Natural Science Foundation of China Grants 31270781 and U1332114, Grand Challenges Exploration of the Bill and Melinda Gates Foundation Grant OPP1021992, Tsinghua University Collaborative Research Program Grant 2011Z23153, Center for Marine Medicine and Rescue of Tsinghua University Grant 20124812029, the 2011 Collaborative Innovation Center for Biotherapy, and the Fundamental Research Funds for the Central Universities.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atilano ML, 2014, ELIFE, V3, DOI 10.7554/eLife.02277; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Tornero C, 2002, J MOL BIOL, V321, P163, DOI 10.1016/S0022-2836(02)00596-X; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez R, 2000, RES MICROBIOL, V151, P437, DOI 10.1016/S0923-2508(00)00172-8; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MOSSER JL, 1970, J BIOL CHEM, V245, P287; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musher DM, 2010, PRINCIPLES PRACTICE, P2623; Neidhardt F. C., 1990, PHYSL BACTERIAL CELL, P507; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paton James C., 2008, P421; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Romero P, 2007, J BIOL CHEM, V282, P17729, DOI 10.1074/jbc.M611795200; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varea J, 2000, J BIOL CHEM, V275, P26842; Vollmer W, 2007, MOL BIOL STREPTOCOCC, P531; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vos P, 2011, FIRMICUTES, V3, DOI [DOI 10.1007/978-0-387-68489-5, 10.1007/978-0-387-68489-5]; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yuan ZQ, 2011, IMMUNOL RES, V51, P108, DOI 10.1007/s12026-011-8234-x; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	64	37	39	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23403	23416		10.1074/jbc.M114.579714	http://dx.doi.org/10.1074/jbc.M114.579714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002590	Green Published, hybrid			2022-12-25	WOS:000341505000015
J	Miles, ZD; Roberts, SA; McCarty, RM; Bandarian, V				Miles, Zachary D.; Roberts, Sue A.; McCarty, Reid M.; Bandarian, Vahe			Biochemical and Structural Studies of 6-Carboxy-5,6,7,8-tetrahydropterin Synthase Reveal the Molecular Basis of Catalytic Promiscuity within the Tunnel-fold Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Kinetics; Enzyme Mechanism; Enzyme Structure; Enzyme Turnover	6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE; SYNECHOCOCCUS SP PCC-7942; TETRAHYDROBIOPTERIN BIOSYNTHESIS; SEPIAPTERIN REDUCTASE; ENZYMATIC-SYNTHESIS; KINETIC-DATA; UDP-GLUCOSE; 6-PYRUVOYL-TETRAHYDROPTERIN; EVOLUTION; GLUCOSYLTRANSFERASE	Background: The bacterial homolog, 6-carboxy-5,6,7,8-tetrahydropterin synthase, of the eukaryotic 6-pyruvoyltetrahydropterin synthase enzyme acts on the same substrate but produces different products. Results: Structural and biochemical studies trace the differential reactivity to four residues. Conclusion: Differential reactivity between the enzyme homologs is a result of small changes in the enzyme active site. Significance: This work furthers our understanding of how novel activities may arise from common protein-folds. 6-Pyruvoyltetrahydropterin synthase (PTPS) homologs in both mammals and bacteria catalyze distinct reactions using the same 7,8-dihydroneopterin triphosphate substrate. The mammalian enzyme converts 7,8-dihydroneopterin triphosphate to 6-pyruvoyltetrahydropterin, whereas the bacterial enzyme catalyzes the formation of 6-carboxy-5,6,7,8-tetrahydropterin. To understand the basis for the differential activities we determined the crystal structure of a bacterial PTPS homolog in the presence and absence of various ligands. Comparison to mammalian structures revealed that although the active sites are nearly structurally identical, the bacterial enzyme houses a His/Asp dyad that is absent from the mammalian protein. Steady state and time-resolved kinetic analysis of the reaction catalyzed by the bacterial homolog revealed that these residues are responsible for the catalytic divergence. This study demonstrates how small variations in the active site can lead to the emergence of new functions in existing protein folds.	[Miles, Zachary D.; Roberts, Sue A.; McCarty, Reid M.; Bandarian, Vahe] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Bandarian, V (corresponding author), 1041 E Lowell St, Tucson, AZ 85721 USA.	vahe@email.arizona.edu			DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM008804, R01GM072623] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, NIGMS Grant P41GM103393.	Bracher A, 1998, J BIOL CHEM, V273, P28132, DOI 10.1074/jbc.273.43.28132; BURGISSER DM, 1995, J MOL BIOL, V253, P358, DOI 10.1006/jmbi.1995.0558; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 1998, BBA-GEN SUBJECTS, V1379, P53, DOI 10.1016/S0304-4165(97)00081-0; Choi YK, 2001, FEBS LETT, V502, P73, DOI 10.1016/S0014-5793(01)02667-9; Chung HJ, 2000, BBA-GEN SUBJECTS, V1524, P183, DOI 10.1016/S0304-4165(00)00156-2; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng H, 2000, J BIOL CHEM, V275, P30139, DOI 10.1074/jbc.M004464200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GHISLA S, 1990, EUR J BIOCHEM, V187, P651, DOI 10.1111/j.1432-1033.1990.tb15349.x; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; Iino T, 2000, ARCH BIOCHEM BIOPHYS, V373, P442, DOI 10.1006/abbi.1999.1561; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; Kong JS, 2006, FEBS LETT, V580, P4900, DOI 10.1016/j.febslet.2006.08.006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee YG, 2010, APPL ENVIRON MICROB, V76, P7658, DOI 10.1128/AEM.01083-10; MAHARAJ G, 1990, BIOCHEMISTRY-US, V29, P4554, DOI 10.1021/bi00471a008; MATSUBARA M, 1966, BIOCHIM BIOPHYS ACTA, V122, P202, DOI 10.1016/0926-6593(66)90062-2; McCarty RM, 2012, BIOORG CHEM, V43, P15, DOI 10.1016/j.bioorg.2012.01.001; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P2301, DOI 10.1021/bi9001437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILSTIEN S, 1989, BIOCHEM BIOPH RES CO, V165, P845, DOI 10.1016/S0006-291X(89)80043-9; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAR H, 1994, EMBO J, V13, P1255, DOI 10.1002/j.1460-2075.1994.tb06377.x; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phillips G, 2012, ACS CHEM BIOL, V7, P197, DOI 10.1021/cb200329f; Ploom T, 1999, J MOL BIOL, V286, P851, DOI 10.1006/jmbi.1998.2511; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Schomaker V, 1998, ACTA CRYSTALLOGR B, V54, P507, DOI 10.1107/S0108768198003243; SMITH GK, 1987, ARCH BIOCHEM BIOPHYS, V255, P254, DOI 10.1016/0003-9861(87)90392-4; SWITCHENKO AC, 1984, BIOCHEM BIOPH RES CO, V120, P754, DOI 10.1016/S0006-291X(84)80171-0; TAKIKAWA SI, 1986, EUR J BIOCHEM, V161, P295, DOI 10.1111/j.1432-1033.1986.tb10446.x; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; VAN QL, 1988, BIOCHEM BIOPH RES CO, V151, P512, DOI 10.1016/0006-291X(88)90623-7; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23641	23652		10.1074/jbc.M114.555680	http://dx.doi.org/10.1074/jbc.M114.555680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990950	Green Published, hybrid			2022-12-25	WOS:000341505000032
J	Morroni, C; Heartwell, S; Edwards, S; Zieman, M; Westhoff, C				Morroni, Chelsea; Heartwell, Stephen; Edwards, Sharon; Zieman, Mimi; Westhoff, Carolyn			The Impact of Oral Contraceptive Initiation on Young Women's Condom Use in 3 American Cities: Missed Opportunities for Intervention	PLOS ONE			English	Article							DUAL-METHOD USE; UNINTENDED PREGNANCY; UNITED-STATES; HIV; RISK; IMPLANTS; CONSISTENCY; DISPARITIES; PREVENTION; PATTERNS	Purpose: To describe women's condom use and assess predictors of consistent condom use and dual method use in the 6 months after the initiation of oral contraception (OC). Methods: We conducted a planned secondary cohort analysis among women less than 25 years of age initiating oral contraceptives at public family planning clinics in Atlanta, Dallas and New York City, USA, as part of a randomized trial. These clinics provide care to predominantly African American or Hispanic women of low socioeconomic status. Participants completed interviews at enrollment and at 6 months after OC start. We used multivariate logistic regression to assess factors associated with consistent condom and dual method use at 6 months. Results: 1281 participants met the inclusion criteria for this analysis. At enrollment prior to OC start, 28% were consistent condom users. In the six months after initiation of oral contraception, only 14% always used a condom and 4% always used dual methods. In multivariate analysis, receiving basic advice to always use a condom after OC initiation from a provider during the baseline clinic consultation was associated with a 50% increase in the odds of using condoms consistently. Only 28% of participants were given this condom use advice. Conclusions: This study documents a decline in women's condom consistent use subsequent to initiation of the oral contraceptive and suggests that opportunities for positive intervention around condom use among women starting hormonal methods are being missed. Basic condom use advice, which is neither time consuming nor resource dependent, was associated with increased consistent use and should be immediately implemented in all family planning services.	[Morroni, Chelsea] UCL, Inst Global Hlth, Inst Womens Hlth, London, England; [Heartwell, Stephen] Susan Thompson Buffet Fdn, Omaha, NE USA; [Edwards, Sharon] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [Zieman, Mimi] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Westhoff, Carolyn] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	University of London; University College London; Icahn School of Medicine at Mount Sinai; Emory University; Columbia University	Morroni, C (corresponding author), UCL, Inst Global Hlth, Inst Womens Hlth, London, England.	c.morroni@ucl.ac.uk		Morroni, Chelsea/0000-0002-2026-6039	National Institutes of Health (NIH) [HD42413]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institutes of Health (NIH) Grant Number HD42413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2004, B WORLD HEALTH ORGAN, V82, P180; Anderson JE, 2003, JAIDS-J ACQ IMM DEF, V34, P195, DOI 10.1097/00126334-200310010-00010; Bearinger LH, 2003, J ADOLESCENT HEALTH, V32, P340, DOI 10.1016/S1054-139X(03)00018-1; BERENSON AB, 1995, AM J OBSTET GYNECOL, V172, P1128, DOI 10.1016/0002-9378(95)91471-4; Centers for Disease Control, 2010, SEX TRANSM DIS SURV; Crosby RA, 2001, J ADOLESCENT HEALTH, V28, P410, DOI 10.1016/S1054-139X(00)00210-X; Cushman LF, 1998, FAM PLANN PERSPECT, V30, P240, DOI 10.2307/2991611; Darney PD, 1999, AM J OBSTET GYNECOL, V180, P929, DOI 10.1016/S0002-9378(99)70664-2; Eisenberg DL, 2012, INFECT DIS OBSTET GY; Ethier KA, 2003, SEX TRANSM INFECT, V79, P408, DOI 10.1136/sti.79.5.408; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Ford CA, 2004, PERSPECT SEX REPRO H, V36, P258, DOI 10.1363/3625804; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P48, DOI 10.1363/3904807; Goldstein RL, 2012, J ADOLESCENT HEALTH, P1; HUMPHRIES HO, 1994, SEX TRANSM DIS, V21, P217, DOI 10.1097/00007435-199407000-00007; JONES J, 2012, CIVIL ENG, V82, P20; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; Lopez LM, 2013, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD010662.PUB2.REVIEW; Martinez Gladys, 2011, Vital Health Stat 23, P1; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Mosher William D, 2004, Adv Data, P1; Mosher William D, 2010, Vital Health Stat 23, P1; Ott MA, 2002, PERSPECT SEX REPRO H, V34, P6, DOI 10.2307/3030227; Pazol K., 2011, Morbidity and Mortality Weekly Report, V60, P414; Pazol K, 2010, PUBLIC HEALTH REP, V125, P208, DOI 10.1177/003335491012500209; PLICHTA SB, 1992, J ADOLESCENT HEALTH, V13, P506, DOI 10.1016/1054-139X(92)90015-4; Polaneczky M, 1999, AM J OBSTET GYNECOL, V181, P1270, DOI 10.1016/S0002-9378(99)70121-3; Riehman KS, 1998, FAM PLANN PERSPECT, V30, P212, DOI 10.2307/2991606; Roye CF, 1998, J ADOLESCENT HEALTH, V23, P205, DOI 10.1016/S1054-139X(97)00264-4; Sangi-Haghpeykar H, 2005, PERSPECT SEX REPRO H, V37, P184, DOI 10.1363/3718405; SangiHaghpeykar H, 1997, FAM PLANN PERSPECT, V29, P67, DOI 10.2307/2953364; SANTELLI JS, 1995, FAM PLANN PERSPECT, V27, P74, DOI 10.2307/2135909; Sayegh MA, 2006, J ADOLESCENT HEALTH, V39, P388, DOI 10.1016/j.jadohealth.2005.12.027; Sieving Renee E, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.10.003; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Westhoff C, 2007, OBSTET GYNECOL, V109, P1270, DOI 10.1097/01.AOG.0000264550.41242.f2; WHO, 2012, HORM CONTR HIV TECHN; Wilson TE, 2003, SEX TRANSM DIS, V30, P809, DOI 10.1097/01.OLQ.0000086617.41012.14	40	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101804	10.1371/journal.pone.0101804	http://dx.doi.org/10.1371/journal.pone.0101804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003504	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700068
J	Devanathan, S; Whitehead, T; Schweitzer, GG; Fettig, N; Kovacs, A; Korach, KS; Finck, BN; Shoghi, KI				Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; Shoghi, Kooresh I.			An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis	PLOS ONE			English	Article							ER-ALPHA; GLUCOSE-HOMEOSTASIS; TISSUE DISTRIBUTION; ADIPOSE-TISSUE; BETA; EXPRESSION; GENE; MUSCLE; PATHWAYS; CELLS	Estrogen exerts diverse biological effects in multiple tissues in both animals and humans. Much of the accumulated knowledge on the role of estrogen receptor (ER) in the heart has been obtained from studies using ovariectomized mice, whole body ER gene knock-out animal models, ex vivo heart studies, or from isolated cardiac myocytes. In light of the wide systemic influence of ER signaling in regulating a host of biological functions in multiple tissues, it is difficult to infer the direct role of ER on the heart. Therefore, we developed a mouse model with a cardiomyocyte-specific deletion of the ER alpha allele (cs-ER alpha(-/-)). Male and female cs-ER alpha(-/-) mice with age/sex-matched wild type controls were examined for differences in cardiac structure and function by echocardiogram and differential gene expression microarray analysis. Our study revealed sex-differences in structural parameters in the hearts of cs-ER alpha(-/-) mice, with minimal functional differences. Analysis of microarray data revealed differential variations in the expression of 208 genes affecting multiple transcriptional networks. Furthermore, we report sex-specific differences in the expression of 56 genes. Overall, we developed a mouse model with cardiac-specific deletion of ER alpha to characterize the role of ER alpha in the heart independent of systemic effects. Our results suggest that ER alpha is involved in controlling the expression of diverse genes and networks in the cardiomyocyte in a sex-dependent manner.	[Devanathan, Sriram; Whitehead, Timothy; Fettig, Nicole; Shoghi, Kooresh I.] Washington Univ, Dept Radiol, St Louis, MO 63130 USA; [Schweitzer, George G.; Finck, Brian N.] Washington Univ, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO USA; [Kovacs, Attila] Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO USA; [Korach, Kenneth S.] NIEHS, Lab Reprod & Dev Toxicol, Receptor Biol Sect, NIH, Res Triangle Pk, NC 27709 USA; [Shoghi, Kooresh I.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Shoghi, Kooresh I.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL); Washington University (WUSTL)	Shoghi, KI (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63130 USA.	shoghik@wustl.edu	Shoghi, Kooresh/H-7398-2014; devanathan, sriram/H-6519-2014	Shoghi, Kooresh/0000-0003-3204-457X; Finck, Brian/0000-0001-5411-3674; Korach, Kenneth/0000-0002-7765-418X	National Institutes of Health (NIH) [R01-EB012284]; NIH [R01-DK085298, Z01ES70065, T32-HL007275, P30-DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081, R01HL119225, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK085298, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was partially supported by research funds from the National Institutes of Health (NIH, http://www.nih.gov) grant number R01-EB012284 to KIS, NIH grant number R01-DK085298 to KIS, intramural NIH research funding Z01ES70065 to KSK, and intramural funds available to KIS. GGS was supported by NIH training grant T32-HL007275. The work utilized core services available through the Washington University School of Medicine Diabetes Research Center (DRC) supported by NIH grant number P30-DK020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2012, HYPERTENSION, V60, P1070, DOI 10.1161/HYPERTENSIONAHA.111.190389; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Barros RPA, 2006, P NATL ACAD SCI USA, V103, P1605, DOI 10.1073/pnas.0510391103; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; CaulinGlaser T, 1997, CIRC RES, V81, P885; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Farhat MY, 1996, J PHARMACOL EXP THER, V276, P652; Gabel SA, 2005, J MOL CELLULAR CARDI, V38; Gorres BK, 2011, J APPL PHYSIOL, V110, P1046, DOI 10.1152/japplphysiol.00541.2010; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Nathan L, 1997, ANNU REV PHARMACOL, V37, P477, DOI 10.1146/annurev.pharmtox.37.1.477; Nilsson S, 2002, CRIT REV BIOCHEM MOL, V37, P1, DOI 10.1080/10409230290771438; O'Malley BW, 2005, MOL ENDOCRINOL, V19, P1402, DOI 10.1210/me.2004-0480; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Tamhane AC, 2000, STAT DATA ANAL ELEME; Tsutsumi S, 2008, J ENDOCRINOL, V199, P267, DOI 10.1677/JOE-07-0292; Wang MJ, 2009, AM J PHYSIOL-REG I, V296, pR972, DOI 10.1152/ajpregu.00045.2009; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Wend K, 2013, J CELL BIOCHEM, V114, P1306, DOI 10.1002/jcb.24470	37	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101900	10.1371/journal.pone.0101900	http://dx.doi.org/10.1371/journal.pone.0101900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000186	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300099
J	Kleine, M; Riemer, M; Krech, T; DeTemple, D; Jager, MD; Lehner, F; Manns, MP; Klempnauer, J; Borlak, J; Bektas, H; Vondran, FWR				Kleine, Moritz; Riemer, Marc; Krech, Till; DeTemple, Daphne; Jaeger, Mark D.; Lehner, Frank; Manns, Michael P.; Klempnauer, Juergen; Borlak, Juergen; Bektas, Hueseyin; Vondran, Florian W. R.			Explanted Diseased Livers - A Possible Source of Metabolic Competent Primary Human Hepatocytes	PLOS ONE			English	Article							CRYOPRESERVATION; TRANSPLANTATION; MODELS; OPTIMIZATION; CULTURES; TIME	Being an integral part of basic, translational and clinical research, the demand for primary human hepatocytes (PHH) is continuously growing while the availability of tissue resection material for the isolation of metabolically competent PHH remains limited. To overcome current shortcomings, this study evaluated the use of explanted diseased organs from liver transplantation patients as a potential source of PHH. Therefore, PHH were isolated from resected surgical specimens (Rx-group; n = 60) and explanted diseased livers obtained from graft recipients with low labMELD-score (Ex-group; n = 5). Using established protocols PHH were subsequently cultured for a period of 7 days. The viability and metabolic competence of cultured PHH was assessed by the following parameters: morphology and cell count (CyQuant assay), albumin synthesis, urea production, AST-leakage, and phase I and II metabolism. Both groups were compared in terms of cell yield and metabolic function, and results were correlated with clinical parameters of tissue donors. Notably, cellular yields and viabilities were comparable between the Rx- and Ex-group and were 5.3 +/- 0.5 and 2.9 +/- 0.7x10(6) cells/g liver tissue with 84.3 +/- 1.3 and 76.0 +/- 8.6% viability, respectively. Moreover, PHH isolated from the Rx- or Ex-group did not differ in regards to loss of cell number in culture, albumin synthesis, urea production, AST-leakage, and phase I and II metabolism (measured by the 7-ethoxycoumarin-O-deethylase and uracil-5'-diphosphate-glucuronyltransferase activity). Likewise, basal transcript expressions of the CYP monooxygenases 1A1, 2C8 and 3A4 were comparable as was their induction when treated with a cocktail that consisted of 3-methylcholantren, rifampicin and phenobarbital, with increased expression of CYP 1A1 and 3A4 mRNA while transcript expression of CYP 2C8 was only marginally changed. In conclusion, the use of explanted diseased livers obtained from recipients with low labMELD-score might represent a valuable source of metabolically competent PHH which are comparable in viability and function to cells obtained from specimens following partial liver resection.	[Kleine, Moritz; Riemer, Marc; DeTemple, Daphne; Jaeger, Mark D.; Lehner, Frank; Klempnauer, Juergen; Bektas, Hueseyin; Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany; [Krech, Till] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Manns, Michael P.; Vondran, Florian W. R.] German Ctr Infect Res DZIF, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; German Center for Infection Research; Hannover Medical School	Vondran, FWR (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, Hannover, Germany.	Vondran.Florian@MH-Hannover.de			B. Braun-Stiftung (Melsungen, Germany); Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany) [2010_A49]; "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC); German Virtual Liver Network [0316154]	B. Braun-Stiftung (Melsungen, Germany); Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany); "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC); German Virtual Liver Network	This study partially was funded by B. Braun-Stiftung (Melsungen, Germany), Else Kroner-Fresenius-Stiftung (Bad Homburg v.d.H., Germany; 2010_A49) and "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie'' (FULAC). JB received funding from the German Virtual Liver Network (Grant 0316154) which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre E., 2002, Cell and Tissue Banking, V3, P223; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Borlak R, 2003, TOXICOL APPL PHARM, V188, P81, DOI 10.1016/S0041-008X(02)00075-3; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Dolle L, 2010, J HEPATOL, V52, P117, DOI 10.1016/j.jhep.2009.10.009; Freeman RB, 2006, LIVER TRANSPLANT, V12, pS128, DOI 10.1002/lt.20979; Fuller BJ, 2013, CRYOLETTERS, V34, P432; Gramignoli R, 2013, CELL TRANSP IN PRESS; Gramignoli R, 2013, STEM CELL RES, V11, P563, DOI 10.1016/j.scr.2013.03.002; GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Harring TR, 2011, CLIN LIVER DIS, V15, P879, DOI 10.1016/j.cld.2011.08.006; Hewitt NJ, 2010, METHODS MOL BIOL, V640, P83, DOI 10.1007/978-1-60761-688-7_4; Katenz E, 2007, LIVER TRANSPLANT, V13, P38, DOI 10.1002/lt.20921; Kehr DC, 2012, TRANSPL P, V44, P999, DOI 10.1016/j.transproceed.2012.03.006; Kirchberg J, 2013, LANGENBECK ARCH SURG, V398, P931, DOI 10.1007/s00423-013-1117-y; Krause P, 2013, CELL TRANSP IN PRESS; LeCluyse EL, 2012, CRIT REV TOXICOL, V42, P501, DOI 10.3109/10408444.2012.682115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd T. D. R., 2004, Cell and Tissue Banking, V5, P81, DOI 10.1023/B:CATB.0000034079.10985.bd; Nguyen TH, 2009, CURR GENE THER, V9, P136, DOI 10.2174/156652309787909481; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Ramboer E, 2013, DRUG METAB REV, V45, P196, DOI 10.3109/03602532.2012.756010; Rogue A, 2012, DRUG METAB DISPOS, V40, P151, DOI 10.1124/dmd.111.042028; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Tariq H, 2012, INFECT GENET EVOL, V12, P13, DOI 10.1016/j.meegid.2011.10.009; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x	29	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101386	10.1371/journal.pone.0101386	http://dx.doi.org/10.1371/journal.pone.0101386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999631	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300040
J	Melchior, C; Loeuillard, E; Marion-Letellier, R; Nicol, L; Mulder, P; Guerin, C; Bole-Feysot, C; Aziz, M; Dechelotte, P; Vera, P; Savoye, G; Savoye-Collet, C				Melchior, Chloe; Loeuillard, Emilien; Marion-Letellier, Rachel; Nicol, Lionel; Mulder, Paul; Guerin, Charlene; Bole-Feysot, Christine; Aziz, Moutaz; Dechelotte, Pierre; Vera, Pierre; Savoye, Guillaume; Savoye-Collet, Celine			Magnetic Resonance Colonography for Fibrosis Assessment in Rats with Chronic Colitis	PLOS ONE			English	Article							INTESTINAL FIBROSIS; CROHNS-DISEASE; INFLAMMATION; RESPONSES; COX-2; MODEL; MRI	Background: Magnetic resonance colonography (MRC) has been developed to assess inflammatory bowel diseases. We aimed to assess the feasibility of MRC in rats with TNBS-induced chronic colitis and to confront imaging results with fibrosis and stenosing features of the model. Materials and Methods: Chronic colitis was induced in 12 rats by weekly intra-rectal injection of increasing doses of TNBS for 6 weeks, while 8 control rats received the vehicle. At week 7, MRC was performed. Fibrosis scores were assessed and fibrosis mediators measured. Results: Chronic colitis was associated with significant body weight loss (p<0.0001) and higher colon weight/length compared to controls (p = 0.0004). Fibrosis mediators and histological scores were significantly higher in rats with TNBS than in controls: alpha-SMA expression (0.9 versus 0.61, p = 0.0311) and fibrosis score (p = 0.0308). Colon wall thickness was higher in rats with TNBS than in controls: maximal thickness (2.38 versus 0.74 mm, p<0.0001) and minimal thickness (1.33 versus 0.48 mm, p<0.0001). Wall signal intensity on T2w images was higher in rats with TNBS than in controls (9040 versus 6192, p = 0.0101) and correlated with fibrosis score (r = 0.5214; p = 0.04). Luminal narrowing was higher in rats with TNBS (50.08 versus 10.33%, p<0.0001) and correlated with a-SMA expression (r = 0.5618; p = 0.01). Stenosis was observed in 7/9 rats with TNBS and in no controls (p = 0.0053). Conclusions: MRC is feasible and easily distinguishes rats with colitis from controls. MRC signs correlated with fibrosis parameters. MRC evaluation may be part of a new anti-fibrosis drug assessment in experimental models of chronic colitis.	[Melchior, Chloe; Loeuillard, Emilien; Marion-Letellier, Rachel; Guerin, Charlene; Bole-Feysot, Christine; Dechelotte, Pierre; Savoye, Guillaume] Univ Rouen, Inst Biomed Res, INSERM, UMR 1073, Rouen, France; [Melchior, Chloe; Savoye, Guillaume] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Nicol, Lionel; Mulder, Paul] Univ Rouen, Inst Biomed Res, INSERM, U644, Rouen, France; [Aziz, Moutaz] Rouen Univ Hosp, Dept Pathol, Rouen, France; [Dechelotte, Pierre] Rouen Univ Hosp, Dept Nutr, Rouen, France; [Vera, Pierre; Savoye-Collet, Celine] Rouen Univ Hosp, Dept Radiol, Rouen, France; [Vera, Pierre; Savoye-Collet, Celine] Univ Rouen, QUANTIF LITIS EA 4108, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; CHU de Rouen; Universite de Rouen Normandie	Marion-Letellier, R (corresponding author), Univ Rouen, Inst Biomed Res, INSERM, UMR 1073, Rouen, France.	marion_rachel@hotmail.com	Marion-Letellier, Rachel/ABB-8213-2021	Marion-Letellier, Rachel/0000-0002-3006-5943; Mulder, Paul/0000-0002-5936-5704; Loeuillard, Emilien/0000-0002-3650-8100; Melchior, Chloe/0000-0002-8146-1540; Savoye, Guillaume/0000-0002-9200-2067	MSD (Merck Sharp and Dohme)	MSD (Merck Sharp and Dohme)(Merck & Company)	This work was supported by a grant from MSD (Merck Sharp and Dohme). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2013, INFLAMM BOWEL DIS, V19, P683, DOI 10.1097/MIB.0b013e3182802c32; Adler J, 2011, RADIOLOGY, V259, P127, DOI 10.1148/radiol.10091648; Breynaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068876; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Charpentier C, 2012, INFLAMM BOWEL DIS, V18, P1940, DOI 10.1002/ibd.22897; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes Jacques, 2013, Gastroenterol Hepatol (N Y), V9, P103; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Ibrahim A, 2011, CLIN NUTR, V30, P678, DOI 10.1016/j.clnu.2011.05.002; Kohnke T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/748160; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Mansson LE, 2012, AM J PHYSIOL-GASTR L, V303, pG311, DOI 10.1152/ajpgi.00038.2012; Mbodji K, 2013, J NUTR BIOCHEM, V24, P700, DOI 10.1016/j.jnutbio.2012.03.022; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mustafi D, 2010, MAGN RESON MED, V63, P922, DOI 10.1002/mrm.22229; Ordas I, 2011, GASTROENTEROLOGY, V140, pS73; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Richert ND, 1999, NEUROLOGY, V53, pS29; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Savoye-Collet C, 2011, INFLAMM BOWEL DIS, V17, P1751, DOI 10.1002/ibd.21568; Stidham RW, 2011, GASTROENTEROLOGY, V141, P819, DOI 10.1053/j.gastro.2011.07.027	30	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100921	10.1371/journal.pone.0100921	http://dx.doi.org/10.1371/journal.pone.0100921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000184	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300019
J	Zambuzzi, WF; Bonfante, EA; Jimbo, R; Hayashi, M; Andersson, M; Alves, G; Takamori, ER; Beltrao, PJ; Coelho, PG; Granjeiro, JM				Zambuzzi, Willian F.; Bonfante, Estevam A.; Jimbo, Ryo; Hayashi, Mariko; Andersson, Martin; Alves, Gutemberg; Takamori, Esther R.; Beltrao, Paulo J.; Coelho, Paulo G.; Granjeiro, Jose M.			Nanometer Scale Titanium Surface Texturing Are Detected by Signaling Pathways Involving Transient FAK and Src Activations	PLOS ONE			English	Article							PHOSPHATE-COATED IMPLANTS; OSTEOBLAST ADHESION; IN-VIVO; ENHANCED OSSEOINTEGRATION; BONE INTEGRATION; BEHAVIOR; CELLS; DIFFERENTIATION; ORGANIZATION; FIBRONECTIN	Background: It is known that physico/chemical alterations on biomaterial surfaces have the capability to modulate cellular behavior, affecting early tissue repair. Such surface modifications are aimed to improve early healing response and, clinically, offer the possibility to shorten the time from implant placement to functional loading. Since FAK and Src are intracellular proteins able to predict the quality of osteoblast adhesion, this study evaluated the osteoblast behavior in response to nanometer scale titanium surface texturing by monitoring FAK and Src phosphorylations. Methodology: Four engineered titanium surfaces were used for the study: machined (M), dual acid-etched (DAA), resorbable media microblasted and acid-etched (MBAA), and acid-etch microblasted (AAMB). Surfaces were characterized by scanning electron microscopy, interferometry, atomic force microscopy, x-ray photoelectron spectroscopy and energy dispersive X-ray spectroscopy. Thereafter, those 4 samples were used to evaluate their cytotoxicity and interference on FAK and Src phosphorylations. Both Src and FAK were investigated by using specific antibody against specific phosphorylation sites. Principal Findings: The results showed that both FAK and Src activations were differently modulated as a function of titanium surfaces physico/chemical configuration and protein adsorption. Conclusions: It can be suggested that signaling pathways involving both FAK and Src could provide biomarkers to predict osteoblast adhesion onto different surfaces.	[Zambuzzi, Willian F.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil; [Bonfante, Estevam A.] Univ Sao Paulo, Fac Odontol Bauru, Sao Paulo, Brazil; [Jimbo, Ryo; Hayashi, Mariko] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Andersson, Martin] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Alves, Gutemberg] Univ Fed Fluminense, Dept Cell & Mol Biol, Inst Biol, Niteroi, RJ, Brazil; [Takamori, Esther R.] Excell Biomed Serv, Rio De Janeiro, Brazil; [Beltrao, Paulo J.; Granjeiro, Jose M.] Natl Inst Metrol Qual & Technol INMETRO, Rio De Janeiro, Brazil; [Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Malmo University; Chalmers University of Technology; Universidade Federal Fluminense; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); New York University	Zambuzzi, WF (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil.	wzambuzzi@ibb.unesp.br; jmgranjeiro@inmetro.gov.br	Bonfante, Estevam/F-7238-2012; Zambuzzi, Willian/ABD-8339-2020; Zambuzzi, Willian Fernando/F-9519-2012; Coelho, Paulo G/B-2999-2014; Alves, Gutemberg G/E-2742-2013; Granjeiro, Jose/D-8289-2012	Bonfante, Estevam/0000-0001-6867-8350; Zambuzzi, Willian Fernando/0000-0002-4149-5965; Coelho, Paulo G/0000-0001-8347-6124; Alves, Gutemberg G/0000-0003-0016-4809; , Martin/0000-0003-1523-4697; Granjeiro, Jose/0000-0002-8027-8293; Miranda da Silva Iwakami Beltrao, Paulo Jose/0000-0002-2449-248X	Fapesp; CNPq; Faperj	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was funded by Fapesp, CNPq and Faperj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x; Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x; Chuang SK, 2006, J DENT RES, V85, P1147, DOI 10.1177/154405910608501216; Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; Malaspina TSD, 2009, ARCH ORAL BIOL, V54, P642, DOI 10.1016/j.archoralbio.2009.03.011; Esposito M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003815.pub3; Frojd V, 2008, INT J ORAL MAX SURG, V37, P561, DOI 10.1016/j.ijom.2008.01.020; Gemini-Piperni S, 2014, BIOTECHNOL BIOENG, V111, P1900, DOI 10.1002/bit.25246; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Jimbo R, 2012, J DENT RES, V91, P1172, DOI 10.1177/0022034512463240; Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911; Jimbo R, 2008, CLIN IMPLANT DENT R, V10, P55, DOI 10.1111/j.1708-8208.2007.00061.x; Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029; Jimbo R, 2011, ACTA BIOMATER, V7, P4229, DOI 10.1016/j.actbio.2011.07.017; Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052; Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054; Marin C, 2012, CLIN ORAL IMPLAN RES, V23, P119, DOI 10.1111/j.1600-0501.2010.02155.x; Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641; Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479; Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001; Monjo M, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/181024; Raes F, 2012, CLIN ORAL IMPLAN RES, V23, P602, DOI 10.1111/j.1600-0501.2011.02178.x; Saruwatari L, 2005, J BONE MINER RES, V20, P2002, DOI 10.1359/JBMR.050703; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Shapira L, 2009, CLIN ORAL IMPLAN RES, V20, P50, DOI 10.1111/j.1600-0501.2008.01594.x; Sommerfeldt DW, 2001, BIOCHEM BIOPH RES CO, V285, P355, DOI 10.1006/bbrc.2001.5198; Sul YT, 2010, INT J NANOMED, V5, P87; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wennerberg A, 2009, ACTA ODONTOL SCAND, V67, P333, DOI 10.1080/00016350903188325; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; WLODARSKI KH, 1986, CALCIFIED TISSUE INT, V39, P382, DOI 10.1007/BF02555175; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337; Zambuzzi WF, 2011, J BIOMED MATER RES A, V97A, P193, DOI 10.1002/jbm.a.32933; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236; Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008	39	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e95662	10.1371/journal.pone.0095662	http://dx.doi.org/10.1371/journal.pone.0095662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999733	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300002
J	Brooks, LR; Pals, HL; Enix, CL; Woolaver, RA; Paul, ED; Lowry, CA; Tsai, PS				Brooks, Leah R.; Pals, Heide L.; Enix, Courtney L.; Woolaver, Rachel A.; Paul, Evan D.; Lowry, Christopher A.; Tsai, Pei-San			Fibroblast Growth Factor 8 Deficiency Compromises the Functional Response of the Serotonergic System to Stress	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; GONADOTROPIN-RELEASING-HORMONE; ANXIETY-LIKE BEHAVIOR; DIFFERENTIAL INVOLVEMENT; DEVELOPING MIDBRAIN; NEURONS; FGF8; MICE; EXPRESSION; RECEPTORS	Functionally heterogeneous populations of serotonergic neurons, located within the dorsal raphe nucleus (DR), play a role in stress-related behaviors and neuropsychiatric illnesses such as anxiety and depression. Abnormal development of these neurons may permanently alter their structure and connections, making the organism more susceptible to anxiety-related disorders. A factor that critically regulates the development of serotonergic neurons is fibroblast growth factor 8 (Fgf8). In this study, we used acute restraint stress followed by behavioral testing to examine whether Fgf8 signaling during development is important for establishing functional stress- and anxiety-related DR neurocircuits in adulthood. Wild-type and heterozygous male mice globally hypomorphic for Fgf8 were exposed to acute restraint stress and then tested for anxiety-like behavior on the elevated plus-maze. Further, we measured c-Fos immunostaining as a marker of serotonergic neuronal activation and tissue 5-hydroxyindoleacetic acid concentrations as a marker of serotonin functional output. Results showed that Fgf8 hypomorphs exhibited 1) an exaggerated response of DR anxiety-promoting circuits and 2) a blunted response of a DR panic-inhibiting circuit to stress, effects that together were associated with increased baseline anxiety-like behavior. Overall, our results provide a neural substrate upon which Fgf8 deficiency could affect stress response and support the hypothesis that developmental disruptions of serotonergic neurons affect their postnatal functional integrity.	[Brooks, Leah R.; Pals, Heide L.; Enix, Courtney L.; Woolaver, Rachel A.; Paul, Evan D.; Lowry, Christopher A.; Tsai, Pei-San] Univ Colorado, Integrat Physiol & Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Brooks, LR (corresponding author), Univ Colorado, Integrat Physiol & Ctr Neurosci, Boulder, CO 80309 USA.	leah.brooks@colorado.edu		Tsai, Pei-San/0000-0002-8650-647X; Paul, Evan/0000-0002-7011-8050	National Institutes of Health [R01 HD042634, R01 MH086539]; University of Colorado Boulder; Undergraduate Research Opportunities Program (UROP) Assistantship grants; Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative; UROP/Howard Hughes Medical Institute (HHMI) Individual Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Boulder; Undergraduate Research Opportunities Program (UROP) Assistantship grants; Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative; UROP/Howard Hughes Medical Institute (HHMI) Individual Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01 HD042634 to PST and R01 MH086539 to CAL (http://www.nih.gov/). LRB was supported by a Sigma Xi Grants-in-Aid of Research (http://www.sigmaxi.org/programs/giar/) and a summer graduate school fellowship from the University of Colorado Boulder (http://www.colorado.edu/GraduateSchool/funding/). HLP, CLE, and RAW were supported by Undergraduate Research Opportunities Program (UROP) Assistantship grants (http://enrichment.colorado.edu/urop/). HLP was supported by a Biological Undergraduate Research Skills & Training (BURST) grant from the Biological Sciences Initiative, and CLE was supported by a UROP/Howard Hughes Medical Institute (HHMI) Individual Grant (http://enrichment.colorado.edu/urop/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2005, NEUROSCIENCE, V133, P983, DOI 10.1016/j.neuroscience.2005.03.025; Bailey JD, 2006, J NEUROENDOCRINOL, V18, P1, DOI 10.1111/j.1365-2826.2005.01361.x; Bailey KR, 2007, PHARMACOL BIOCHEM BE, V86, P8, DOI 10.1016/j.pbb.2006.11.024; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Boxer AL, 1999, J NEUROPHYSIOL, V82, P3367, DOI 10.1152/jn.1999.82.6.3367; Brooks Leah R, 2014, Behav Brain Res, V264, P74, DOI 10.1016/j.bbr.2014.01.053; Brooks LR, 2010, ENDOCRINE, V38, P174, DOI 10.1007/s12020-010-9366-9; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Evans AK, 2008, EUR J PHARMACOL, V590, P136, DOI 10.1016/j.ejphar.2008.06.014; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Ferrer I, 1996, MOL BRAIN RES, V38, P91, DOI 10.1016/0169-328X(95)00334-O; Forster GL, 2008, EUR J NEUROSCI, V28, P299, DOI 10.1111/j.1460-9568.2008.06333.x; Gardner KL, 2009, NEUROSCIENCE, V163, P991, DOI 10.1016/j.neuroscience.2009.07.055; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Greenwood BN, 2008, PSYCHOPHARMACOLOGY, V199, P209, DOI 10.1007/s00213-008-1167-y; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hale MW, 2012, CELL MOL NEUROBIOL, V32, P695, DOI 10.1007/s10571-012-9827-1; Hale MW, 2011, J CHEM NEUROANAT, V41, P219, DOI 10.1016/j.jchemneu.2011.05.002; Hale MW, 2011, EXP NEUROL, V227, P264, DOI 10.1016/j.expneurol.2010.11.012; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; HEINRICHS SC, 1994, NEUROPSYCHOPHARMACOL, V11, P179, DOI 10.1038/sj.npp.1380104; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; JAMES MD, 1989, NEUROENDOCRINOLOGY, V49, P561, DOI 10.1159/000125169; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; Johnson PL, 2008, J PSYCHOPHARMACOL, V22, P642, DOI 10.1177/0269881107082900; Johnson PL, 2005, J PSYCHOPHARMACOL, V19, P327, DOI 10.1177/0269881105053281; Johnson PL, 2004, ANN NY ACAD SCI, V1018, P58, DOI 10.1196/annals.1296.006; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kirby LG, 1997, BRAIN RES, V760, P218, DOI 10.1016/S0006-8993(97)00287-4; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Neufeld-Cohen A, 2010, MOL PSYCHIATR, V15, P426, DOI 10.1038/mp.2009.115; Partanen J, 2007, J NEUROCHEM, V101, P1185, DOI 10.1111/j.1471-4159.2007.04463.x; Paul ED, 2013, J PSYCHOPHARMACOL; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen R.G., 1985, DESIGN ANAL EXPT; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sapolsky R, 2003, SCI AM, V289, P86, DOI 10.1038/scientificamerican0903-86; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Sommer W, 2001, NEUROPSYCHOPHARMACOL, V24, P430, DOI 10.1016/S0893-133X(00)00210-4; Spannuth BM, 2011, NEUROSCIENCE, V179, P104, DOI 10.1016/j.neuroscience.2011.01.042; Spiacci A, 2012, NEUROSCIENCE, V227, P350, DOI 10.1016/j.neuroscience.2012.09.061; Stone EA, 1996, PHARMACOL BIOCHEM BE, V55, P215, DOI 10.1016/S0091-3057(96)00070-6; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Tanaka M, 1983, Kurume Med J, V30, P35; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Toyoda R, 2010, DEVELOPMENT, V137, P3439, DOI 10.1242/dev.055392; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; WANG QP, 1992, BRAIN RES BULL, V29, P943; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	63	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101420	10.1371/journal.pone.0101420	http://dx.doi.org/10.1371/journal.pone.0101420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992493	Green Submitted, gold, Green Published			2022-12-25	WOS:000341253400070
J	Cheng, YZ; Zhang, H; Chen, RP; Yang, F; Li, W; Chen, LS; Lin, SD; Liang, GX; Cai, DH; Chen, H				Cheng, Yanzhen; Zhang, Hua; Chen, Rongping; Yang, Fan; Li, Wei; Chen, Lishu; Lin, Shaoda; Liang, Ganxiong; Cai, Dehong; Chen, Hong			Cardiometabolic Risk Profiles Associated with Chronic Complications in Overweight and Obese Type 2 Diabetes Patients in South China	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; PREVALENCE; MELLITUS; DISEASE; RETINOPATHY; DIAGNOSIS; STROKE; ADULTS	Background: Type 2 diabetes is often accompanied by altered cardiometabolic risk profiles, including abdominal obesity, hypertension, and dyslipidaemia. The association of altered cardiometabolic risk profiles with chronic complications of diabetes is not well investigated. Methods: We recruited 2954 type 2 diabetes patients with a body mass index >= 25 kg/m(2) who visited the diabetes clinics of 62 hospitals in 21 cities in Guangdong province of China from August 2011 to March 2012. Demographic characteristics, personal and family medical histories, and data on chronic complications of diabetes were collected. Clinical examinations and laboratory assessment were conducted. Results: Abdominal obesity was found in 91.6% of the study population, elevated blood pressure in 78.3%; elevated serum triacylglycerols in 57.8%, and reduced serum HDL-C in 55.9%. Among the cardiometabolic risk factors, elevated blood pressure was significantly associated with almost all the chronic complications of diabetes. After adjusting for age, gender, duration of diabetes, and HbA1c, elevated blood pressure was significantly associated with diabetic retinopathy (OR 1.63, 95% CI: 1.22-2.19), diabetic nephropathy (OR 3.16, 95% CI: 2.25-4.46), cardiovascular disease (OR 2.71, 95% CI: 1.70-4.32), and stroke (OR 1.90, 95% CI: 1.15-3.12). Abdominal adiposity was significantly associated with diabetic nephropathy (OR 1.39, 95% CI: 1.11-1.74). Elevated triacylglycerols was significantly associated with diabetic retinopathy (OR 1.29, 95% CI: 1.05-1.58) and diabetic nephropathy (OR 1.30, 95% CI: 1.05-1.58). Reduced HDL-C was significantly associated with stroke (OR 1.41, 95% CI: 1.05-1.88). Conclusions: Altered cardiometabolic risk profiles, and elevated blood pressure in particular, were significantly associated with chronic complications in overweight and obese patients with type 2 diabetes. Future studies on the prevention of chronic complications of diabetes might make lowering blood pressure a primary target.	[Cheng, Yanzhen; Zhang, Hua; Chen, Rongping; Yang, Fan; Cai, Dehong; Chen, Hong] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Yang, Fan] Gulin Med Univ, Affiliated Hosp, Dept Endocrinol, Guilin, Peoples R China; [Li, Wei] Wu Jing Zong Dui Hosp Guangdong Prov, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Chen, Lishu] Shantou Univ, Affiliated Hosp 2, Coll Med, Dept Endocrinol, Shantou, Peoples R China; [Lin, Shaoda] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Endocrinol, Shantou, Peoples R China; [Liang, Ganxiong] Peoples Hosp Zhongshan City, Dept Endocrinol, Zhongshan, Peoples R China	Southern Medical University - China; Shantou University; Shantou University	Chen, H (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	rubychq@163.com			Diabetes Society of Guangdong Provincial Medical Association [2011-DM-01]	Diabetes Society of Guangdong Provincial Medical Association	This study was supported by the Diabetes Society of Guangdong Provincial Medical Association and a special grant for overweight and obese type 2 diabetic patients in Guangdong province (No. 2011-DM-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PLease update this information in the Financial Disclosure.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bonora E, 2004, DIABETIC MED, V21, P52, DOI 10.1046/j.1464-5491.2003.01068.x; Cederholm J, 2010, J HYPERTENS, V28, P2026, DOI 10.1097/HJH.0b013e32833c8b75; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gillow JT, 1999, BRIT J OPHTHALMOL, V83, P1083, DOI 10.1136/bjo.83.9.1083; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27; ISHIHARA M, 1987, DIABETES CARE, V10, P20, DOI 10.2337/diacare.10.1.20; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Litwak L, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-57; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Medical Association, 2002, J Postgrad Med, V48, P206; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692; Zhao WH, 2013, DIABETES CARE, V36, P3287, DOI 10.2337/dc13-0189; Zhao WH, 2013, J CLIN ENDOCR METAB, V98, P3653, DOI 10.1210/jc.2013-1757	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101289	10.1371/journal.pone.0101289	http://dx.doi.org/10.1371/journal.pone.0101289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992024	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400059
J	Chirombo, J; Lowe, R; Kazembe, L				Chirombo, James; Lowe, Rachel; Kazembe, Lawrence			Using Structured Additive Regression Models to Estimate Risk Factors of Malaria: Analysis of 2010 Malawi Malaria Indicator Survey Data	PLOS ONE			English	Article							BURDEN; CLIMATE; WOMEN	Background: After years of implementing Roll Back Malaria (RBM) interventions, the changing landscape of malaria in terms of risk factors and spatial pattern has not been fully investigated. This paper uses the 2010 malaria indicator survey data to investigate if known malaria risk factors remain relevant after many years of interventions. Methods: We adopted a structured additive logistic regression model that allowed for spatial correlation, to more realistically estimate malaria risk factors. Our model included child and household level covariates, as well as climatic and environmental factors. Continuous variables were modelled by assuming second order random walk priors, while spatial correlation was specified as a Markov random field prior, with fixed effects assigned diffuse priors. Inference was fully Bayesian resulting in an under five malaria risk map for Malawi. Results: Malaria risk increased with increasing age of the child. With respect to socio-economic factors, the greater the household wealth, the lower the malaria prevalence. A general decline in malaria risk was observed as altitude increased. Minimum temperatures and average total rainfall in the three months preceding the survey did not show a strong association with disease risk. Conclusions: The structured additive regression model offered a flexible extension to standard regression models by enabling simultaneous modelling of possible nonlinear effects of continuous covariates, spatial correlation and heterogeneity, while estimating usual fixed effects of categorical and continuous observed variables. Our results confirmed that malaria epidemiology is a complex interaction of biotic and abiotic factors, both at the individual, household and community level and that risk factors are still relevant many years after extensive implementation of RBM activities.	[Chirombo, James] Univ Malawi, Chancellor Coll, Zomba, Malawi; [Chirombo, James] UNC Project, Lilongwe, Malawi; [Lowe, Rachel] Inst Catala Ciencies Clima IC3, Barcelona, Spain; [Lowe, Rachel] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy; [Kazembe, Lawrence] Univ Namibia, Dept Stat & Populat Studies, Windhoek, Namibia	University of Malawi; Institut Catala de Ciencies del Clima (IC3); University of Barcelona; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Namibia	Chirombo, J (corresponding author), Univ Malawi, Chancellor Coll, Zomba, Malawi.	jjchirombo@gmail.com	Lowe, Rachel/H-1658-2015; Lowe, Rachel/GXN-3278-2022	Lowe, Rachel/0000-0003-3939-7343; Chirombo, James/0000-0003-3132-3710	Health Research Capacity Strengthening Initiative (HRCSI)	Health Research Capacity Strengthening Initiative (HRCSI)	The study was supported by a grant from the Health Research Capacity Strengthening Initiative (HRCSI) for JC MSc studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MALAWI MALARIA INDIC; Auta A, 2012, N AM J MED SCI, V4, P40, DOI 10.4103/1947-2714.92903; Belitz C, 2009, BAYESX SOFTW BAYES I; Bennett A, 2013, AM J TROP MED HYG, V89, P840, DOI 10.4269/ajtmh.13-0028; Djinjalamala F, 2006, EPIDEMIOLOGY MALAWI; Fahrmeir L, 2009, J STAT PLAN INFER, V139, P843, DOI 10.1016/j.jspi.2008.05.036; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Haque U, 2014, LANCET GLOB HEALTH, V2, pE98, DOI 10.1016/S2214-109X(13)70176-1; Hastie TJ., 1990, GEN ADDITIVE MODELS; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kazembe LN, 2007, ACTA TROP, V102, P126, DOI 10.1016/j.actatropica.2007.04.012; Kazembe LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011180; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Kneib T, 2011, BAYESX R UT ACC SOFT; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Mathanga DP., 2007, INT J EQUITY HLTH, V6, P22, DOI [10.1186/1475-9276-6-22, DOI 10.1186/1475-9276-6-22]; McCullagh P, 1989, GEN LINEAR MODELS; MEASURE DHS, 2013, MAL IND SURV; National Malaria Control Programme (NMCP), 2011, MAL STRAT PLAN 2011; National Malaria Control Programme (NMCP) [Malawi] and ICE International, 2010, MAL MAL IND SURV MIS; Nkurunziza H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-234; Nkurunziza H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-114; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Simon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-458; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28; Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101116	10.1371/journal.pone.0101116	http://dx.doi.org/10.1371/journal.pone.0101116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991915	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400042
J	Cossetti, C; Lugini, L; Astrologo, L; Saggio, I; Fais, S; Spadafora, C				Cossetti, Cristina; Lugini, Luana; Astrologo, Letizia; Saggio, Isabella; Fais, Stefano; Spadafora, Corrado			Soma-to-Germline Transmission of RNA in Mice Xenografted with Human Tumour Cells: Possible Transport by Exosomes	PLOS ONE			English	Article							GENE-TRANSFER; INHERITANCE; SPERMATOZOA; VESICLES; ORIGIN	Mendelian laws provide the universal founding paradigm for the mechanism of genetic inheritance through which characters are segregated and assorted. In recent years, however, parallel with the rapid growth of epigenetic studies, cases of inheritance deviating from Mendelian patterns have emerged. Growing studies underscore phenotypic variations and increased risk of pathologies that are transgenerationally inherited in a non-Mendelian fashion in the absence of any classically identifiable mutation or predisposing genetic lesion in the genome of individuals who develop the disease. Non-Mendelian inheritance is most often transmitted through the germline in consequence of primary events occurring in somatic cells, implying soma-to-germline transmission of information. While studies of sperm cells suggest that epigenetic variations can potentially underlie phenotypic alterations across generations, no instance of transmission of DNA-or RNA-mediated information from somatic to germ cells has been reported as yet. To address these issues, we have now generated a mouse model xenografted with human melanoma cells stably expressing EGFP-encoding plasmid. We find that EGFP RNA is released from the xenografted human cells into the bloodstream and eventually in spermatozoa of the mice. Tumor-released EGFP RNA is associated with an extracellular fraction processed for exosome purification and expressing exosomal markers, in all steps of the process, from the xenografted cancer cells to the spermatozoa of the recipient animals, strongly suggesting that exosomes are the carriers of a flow of information from somatic cells to gametes. Together, these results indicate that somatic RNA is transferred to sperm cells, which can therefore act as the final recipients of somatic cell-derived information.	[Cossetti, Cristina; Spadafora, Corrado] Ist Super Sanita, SBGSA, I-00161 Rome, Italy; [Lugini, Luana; Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy; [Astrologo, Letizia; Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Spadafora, C (corresponding author), Ist Super Sanita, SBGSA, Viale Regina Elena 299, I-00161 Rome, Italy.	cspadaf@tin.it	Lugini, Luana/J-8672-2016; Saggio, Isabella/H-2417-2015; Cossetti, Cristina/K-5034-2016; Fais, Stefano/J-8638-2016	Lugini, Luana/0000-0002-8778-2601; Cossetti, Cristina/0000-0002-8809-4149; Fais, Stefano/0000-0001-9060-2766; Spadafora, Corrado/0000-0002-5743-3224; saggio, isabella/0000-0002-9497-7415	Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression"; Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy	Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression"; Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy	This work was supported by grants from the Italian Ministry of Health "Endogenous Reverse Transcriptase as tumour marker and causative agent of tumour onset and progression", "Endogenous Reverse Transcriptase in tumour onset and progression and in tumour therapy" to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cavalli G, 2006, DEVELOPMENT, V133, P2089, DOI 10.1242/dev.02402; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Etheridge Alton, 2013, Frontiers in Genetics, V4, P115, DOI 10.3389/fgene.2013.00115; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Goodrich R, 2007, ARCH ANDROLOGY, V53, P161, DOI 10.1080/01485010701216526; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Niu YD, 2008, J GENET GENOMICS, V35, P701, DOI 10.1016/S1673-8527(08)60225-8; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Piersanti S, 2006, CALCIFIED TISSUE INT, V78, P372, DOI 10.1007/s00223-006-0001-y; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sciamanna I, 2003, BIOCHEM BIOPH RES CO, V312, P1039, DOI 10.1016/j.bbrc.2003.11.024; Sciamanna I, 2009, GENE, V448, P180, DOI 10.1016/j.gene.2009.07.011; Sharma A, 2012, PROG BIOPH MOL BIOL, DOI [10.1016/j.pbiomolbio, DOI 10.1016/J.PBIOMOLBIO]; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Stoeger R, 2008, BIOESSAYS, V30, P156, DOI DOI 10.1002/bies.20700; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Weismann A, 1893, GERM PLASM THEORY HE; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Zaccagnini G, 1998, BIOL REPROD, V59, P1549, DOI 10.1095/biolreprod59.6.1549	41	95	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101629	10.1371/journal.pone.0101629	http://dx.doi.org/10.1371/journal.pone.0101629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992257	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400100
J	Das, S; Roy, P; Pal, R; Auddy, RG; Chakraborti, AS; Mukherjee, A				Das, Suvadra; Roy, Partha; Pal, Rajat; Auddy, Runa Ghosh; Chakraborti, Abhay Sankar; Mukherjee, Arup			Engineered Silybin Nanoparticles Educe Efficient Control in Experimental Diabetes	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; STREPTOZOTOCIN; SILYMARIN; ANTIOXIDANT; LIVER; RAT; INSULIN; INHIBITION; HEMOGLOBIN	Silybin, is one imminent therapeutic for drug induced hepatotoxicity, human prostrate adenocarcinoma and other degenerative organ diseases. Recent evidences suggest that silybin influences gluconeogenesis pathways favorably and is beneficial in the treatment of type 1 and type 2 diabetes. The compound however is constrained due to solubility (0.4 mg/mL) and bioavailabilty limitations. Appropriate nanoparticle design for silybin in biocompatible polymers was thus proposed as a probable solution for therapeutic inadequacy. New surface engineered biopolymeric nanoparticles with high silybin encapsulation efficiency of 92.11% and zeta potential of + 21 mV were designed. Both the pure compound and the nanoparticles were evaluated in vivo for the first time in experimental diabetic conditions. Animal health recovered substantially and the blood glucose levels came down to near normal values after 28 days treatment schedule with the engineered nanoparticles. Restoration from hyperglycemic damage condition was traced to serum insulin regeneration. Serum insulin recovered from the streptozotocin induced pancreatic damage levels of 0.17 +/- 0.01 mu g/lit to 0.57 +/- 0.11 mu g/lit after nanoparticle treatment. Significant reduction in glycated hemoglobin level, and restoration of liver glycogen content were some of the other interesting observations. Engineered silybin nanoparticle assisted recovery in diabetic conditions was reasoned due to improved silybin dissolution, passive transport in nanoscale, and restoration of antioxidant status.	[Das, Suvadra; Roy, Partha; Auddy, Runa Ghosh; Mukherjee, Arup] Univ Calcutta, Dept Chem Technol, Kolkata 700073, W Bengal, India; [Pal, Rajat; Chakraborti, Abhay Sankar] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Auddy, Runa Ghosh; Chakraborti, Abhay Sankar; Mukherjee, Arup] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Kolkata, W Bengal, India; [Roy, Partha] Univ Malaysia Pahang, Fac Technol Pharmaceutical, Pekan, Pahang, Malaysia	University of Calcutta; University of Calcutta; University of Calcutta; Universiti Malaysia Pahang	Mukherjee, A (corresponding author), Univ Calcutta, Dept Chem Technol, Kolkata 700073, W Bengal, India.	arupm1234@gmail.com	Roy, Partha/GNP-6565-2022	Roy, Partha/0000-0002-9641-6136	DST PURSE, Govt of India; Center for Research in Nanoscience and Nanotechnology; Technical Education Quality Improvement program (TEQIP) University of Calcutta	DST PURSE, Govt of India; Center for Research in Nanoscience and Nanotechnology; Technical Education Quality Improvement program (TEQIP) University of Calcutta	SD would like to thank DST PURSE, Govt of India for a grant of SRF extended fellowship and PR would like to thank the Council of Scientific and Industrial Research, India for a Research Associateship. Authors would also like to acknowledge the funds made available for the manuscript editing and the related software supports extended by the Center for Research in Nanoscience and Nanotechnology and the Technical Education Quality Improvement program (TEQIP) University of Calcutta. The academic research funding supports had no bearing in the study design, data collection and analysis, preparation of the manuscript and a decision to publish results.	Aebi H, 1984, Methods Enzymol, V105, P121; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Barwal I, 2013, COLLOID SURFACE B, V101, P510, DOI 10.1016/j.colsurfb.2012.07.005; BELLAMY LJ, 1975, INFRARED SPECTRA COM, P107; BENNETT RA, 1981, CANCER RES, V41, P2786; Bertelsen M, 2001, DIABETOLOGIA, V44, P605, DOI 10.1007/s001250051667; Bhattacharyya J, 1998, INT J BIOL MACROMOL, V23, P11, DOI 10.1016/S0141-8130(98)00006-3; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; COHEN MP, 1994, METHOD ENZYMOL, V231, P65; Das S, 2013, CHEM PHARM BULL, V61, P125, DOI 10.1248/cpb.c12-00475; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FALLOUH NA, 1986, INT J PHARM, V28, P125; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; GOLDSTEIN DE, 1986, CLIN CHEM, V32, pB64; Guigas B, 2007, CELL PHYSIOL BIOCHEM, V20, P925, DOI 10.1159/000110453; HII CST, 1985, J ENDOCRINOL, V107, P1, DOI 10.1677/joe.0.1070001; Hoh CSL, 2007, J AGR FOOD CHEM, V55, P2532, DOI 10.1021/jf063156c; Huseini HF, 2006, PHYTOTHER RES, V20, P1036, DOI 10.1002/ptr.1988; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jariyapamornkoon N, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-171; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kvasnicka F, 2003, J CHROMATOGR A, V990, P239, DOI 10.1016/S0021-9673(02)01971-4; Li LJ, 2010, NANO TODAY, V5, P296, DOI 10.1016/j.nantod.2010.06.007; Lirussi F, 2002, DIABETES NUTR METAB, V15, P222; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005; LOVEN D, 1986, DIABETES, V35, P503, DOI 10.2337/diabetes.35.5.503; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maghrani M, 2004, J ETHNOPHARMACOL, V91, P309, DOI 10.1016/j.jep.2004.01.008; Malekinejad H, 2012, PHYTOMEDICINE, V19, P583, DOI 10.1016/j.phymed.2012.02.009; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McAnuff MA, 2005, W INDIAN MED J, V54, P97; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Murali R, 2013, BIOCHIMIE, V95, P1848, DOI 10.1016/j.biochi.2013.06.013; MURAT JC, 1974, CLIN CHEM, V20, P1576; Nielsen SE, 1998, XENOBIOTICA, V28, P389, DOI 10.1080/004982598239498; NUKATSUKA M, 1990, J PHARMACOBIO-DYNAM, V13, P259, DOI 10.1248/bpb1978.13.259; Pillai SI, 2013, EUR J MED CHEM, V63, P109, DOI 10.1016/j.ejmech.2013.02.002; Piskula MK, 1998, J NUTR, V128, P1172, DOI 10.1093/jn/128.7.1172; Pradeep K, 2007, EUR J PHARMACOL, V560, P110, DOI 10.1016/j.ejphar.2006.12.023; Roy P, 2013, PHARM RES-DORDR, V30, P1252, DOI 10.1007/s11095-012-0964-5; Saliou C, 1998, FEBS LETT, V440, P8, DOI 10.1016/S0014-5793(98)01409-4; Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003; Sersen F, 2006, FITOTERAPIA, V77, P525, DOI 10.1016/j.fitote.2006.06.005; Shivanna N, 2013, J DIABETES COMPLICAT, V27, P103, DOI 10.1016/j.jdiacomp.2012.10.001; Soto C, 2004, LIFE SCI, V75, P2167, DOI 10.1016/j.lfs.2004.04.019; Soto C, 2010, PHYTOMEDICINE, V17, P1090, DOI 10.1016/j.phymed.2010.04.011; Soto CP, 1998, COMP BIOCHEM PHYS C, V119, P125, DOI 10.1016/S0742-8413(97)00198-9; Sozmen EY, 2001, ARCH MED RES, V32, P283, DOI 10.1016/S0188-4409(01)00285-5; STRANDELL E, 1988, MOL CELL ENDOCRINOL, V59, P83, DOI 10.1016/0303-7207(88)90198-0; TJALVE H, 1976, J ENDOCRINOL, V69, P455, DOI 10.1677/joe.0.0690455; UCHIGATA Y, 1982, J BIOL CHEM, V257, P6084; Velussi M, 1997, J HEPATOL, V26, P871, DOI 10.1016/S0168-8278(97)80255-3; Vengerovskii AI, 2007, B EXP BIOL MED+, V144, P53, DOI 10.1007/s10517-007-0252-2; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6; VIALETTES B, 1982, DIABETOLOGIA, V22, P264, DOI 10.1007/BF00281303; Wang Q, 2012, J ASIAN NAT PROD RES, V14, P413, DOI 10.1080/10286020.2012.657180; *WHO, 2013, DIABETES; Wu JT, 1996, J CLIN LAB ANAL, V10, P21, DOI 10.1002/(SICI)1098-2825(1996)10:1<21::AID-JCLA5>3.0.CO;2-O; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599; Yan SF, 2011, EUR J PHARM BIOPHARM, V78, P336, DOI 10.1016/j.ejpb.2010.12.031; Zhuang J, 2010, INT J NANOMED, V5, P407; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	70	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101818	10.1371/journal.pone.0101818	http://dx.doi.org/10.1371/journal.pone.0101818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991800	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400121
J	Dinis, M; Plainvert, C; Kovarik, P; Longo, M; Fouet, A; Poyart, C				Dinis, Marcia; Plainvert, Celine; Kovarik, Pavel; Longo, Magalie; Fouet, Agnes; Poyart, Claire			The Innate Immune Response Elicited by Group A Streptococcus Is Highly Variable among Clinical Isolates and Correlates with the emm Type	PLOS ONE			English	Article							PYOGENES; HOST; SUPERANTIGEN; SUSCEPTIBILITY; MACROPHAGES; CELLS; RECOGNITION; INFECTION; SURVIVAL; INSIGHT	Group A Streptococcus (GAS) infections remain a significant health care problem due to high morbidity and mortality associated with GAS diseases, along with their increasing worldwide prevalence. Macrophages play a key role in the control and clearance of GAS infections. Moreover, pro-inflammatory cytokines production and GAS persistence and invasion are related. In this study we investigated the correlation between the GAS clinical isolates genotypes, their known clinical history, and their ability to modulate innate immune response. We constituted a collection of 40 independent GAS isolates representative of the emm types currently prevalent in France and responsible for invasive (57.5%) and non-invasive (42.5%) clinical manifestations. We tested phagocytosis and survival in mouse bone marrow-derived macrophages and quantified the pro-inflammatory mediators (IL-6, TNF-alpha) and type I interferon (INF-beta) production. Invasive emm89 isolates were more phagocytosed than their non-invasive counterparts, and emm89 isolates more than the other isolates. Regarding the survival, differences were observed depending on the isolate emm type, but not between invasive and non-invasive isolates within the same emm type. The level of inflammatory mediators produced was also emm type-dependent and mostly invasiveness status independent. Isolates of the emm1 type were able to induce the highest levels of both pro-inflammatory cytokines, whereas emm89 isolates induced the earliest production of IFN-beta. Finally, even within emm types, there was a variability of the innate immune responses induced, but survival and inflammatory mediator production were not linked.	[Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] INSERM, Inst Cochin, Unite FRM Barrieres & Pathogenes, U 1016, Paris, France; [Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] CNRS, UMR 8104, Paris, France; [Dinis, Marcia; Plainvert, Celine; Longo, Magalie; Fouet, Agnes; Poyart, Claire] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Plainvert, Celine; Poyart, Claire] CNRS, Paris, France; [Plainvert, Celine; Poyart, Claire] Hop Univ Paris Ctr, AP HP, Paris, France; [Poyart, Claire] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Poyart, Claire] CNRS 2172, Paris, France; [Kovarik, Pavel] Univ Vienna, Max F Perutz Labs, Vienna, Austria	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Poyart, C (corresponding author), INSERM, Inst Cochin, Unite FRM Barrieres & Pathogenes, U 1016, Paris, France.	claire.poyart@cch.aphp.fr	Kovarik, Pavel/D-1184-2014; POYART, Claire/P-4225-2017; Plainvert, Céline/P-4218-2017	Kovarik, Pavel/0000-0003-2956-0944; POYART, Claire/0000-0003-2158-6293; Fouet, Agnes/0000-0001-7715-9157; Dinis, Marcia/0000-0001-8734-4276	ERA Pathogenomic INSERM [ANR-08-MIEN-015]; CNRS; Universite Paris Descartes; Institut de Veille Sanitaire; Austrian Science Fund (FWF) [P 24540] Funding Source: researchfish	ERA Pathogenomic INSERM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Institut de Veille Sanitaire; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERA Pathogenomic (Grant No ANR-08-MIEN-015) INSERM, CNRS, Universite Paris Descartes, Institut de Veille Sanitaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Commons R, 2008, J MED MICROBIOL, V57, P1238, DOI 10.1099/jmm.0.2008/001156-0; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Goldmann O, 2004, INDIAN J MED RES, V119, P141; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Goldmann O, 2010, J PATHOL, V220, P521, DOI 10.1002/path.2664; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Gustafsson MCU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003323; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Lintges M, 2007, INT J MED MICROBIOL, V297, P471, DOI 10.1016/j.ijmm.2007.03.015; Lintges M, 2010, J INFECT DIS, V202, P20, DOI 10.1086/653082; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Medina E, 2003, J INFECT DIS, V187, P597, DOI 10.1086/373998; Medina E, 2003, INFECT IMMUN, V71, P5376, DOI 10.1128/IAI.71.9.5376-5380.2003; Medina E, 2002, MICROB PATHOGENESIS, V33, P307, DOI 10.1006/mpat.2002.0532; Medina E, 2001, J INFECT DIS, V184, P846, DOI 10.1086/323292; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Norrby-Teglund A, 2000, EUR J IMMUNOL, V30, P3247, DOI 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Plainvert C, 2011, CLIN MICROBIOL INFEC, P702; Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sriskandan S, 2007, INT J BIOCHEM CELL B, V39, P12, DOI 10.1016/j.biocel.2006.08.009; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stollerman GH, 2008, CLIN INFECT DIS, V46, P1038, DOI 10.1086/529194; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101464	10.1371/journal.pone.0101464	http://dx.doi.org/10.1371/journal.pone.0101464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991887	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400074
J	Lu, XL; Lin, QA; Lin, M; Duan, P; Ye, LL; Chen, J; Chen, XM; Zhang, LF; Xue, XY				Lu, Xulian; Lin, Qiaoai; Lin, Mao; Duan, Ping; Ye, Lulu; Chen, Jun; Chen, Xiangmin; Zhang, Lifang; Xue, Xiangyang			Multiple-Integrations of HPV16 Genome and Altered Transcription of Viral Oncogenes and Cellular Genes Are Associated with the Development of Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; INTRAEPITHELIAL NEOPLASIA; UP-REGULATION; ANOGENITAL LESIONS; FUSION TRANSCRIPTS; CARCINOMA-CELLS; GENITAL TUMORS; MYC LOCUS; EXPRESSION; E6	The constitutive expression of the high-risk HPV E6 and E7 viral oncogenes is the major cause of cervical cancer. To comprehensively explore the composition of HPV16 early transcripts and their genomic annotation, cervical squamous epithelial tissues from 40 HPV16-infected patients were collected for analysis of papillomavirus oncogene transcripts (APOT). We observed different transcription patterns of HPV16 oncogenes in progression of cervical lesions to cervical cancer and identified one novel transcript. Multiple-integration events in the tissues of cervical carcinoma (CxCa) are significantly more often than those of low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL). Moreover, most cellular genes within or near these integration sites are cancer-associated genes. Taken together, this study suggests that the multiple-integrations of HPV genome during persistent viral infection, which thereby alters the expression patterns of viral oncogenes and integration-related cellular genes, play a crucial role in progression of cervical lesions to cervix cancer.	[Lu, Xulian; Lin, Qiaoai; Lin, Mao; Chen, Jun; Zhang, Lifang] Wenzhou Med Univ, Dept Microbiol & Immunol, Wenzhou, Zhejiang, Peoples R China; [Ye, Lulu; Xue, Xiangyang] Wenzhou Med Univ, Inst Mol Virol & Immunol, Wenzhou, Zhejiang, Peoples R China; [Lu, Xulian] Zhuji Peoples Hosp Zhejiang Prov, Dept Pathol, Zhuji, Zhejiang, Peoples R China; [Lin, Mao] Jinan Univ, Fuda Canc Hosp Affiliated, Coll Med, Guangzhou, Guangdong, Peoples R China; [Duan, Ping] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiangmin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Jinan University; Wenzhou Medical University; Wenzhou Medical University	Xue, XY (corresponding author), Wenzhou Med Univ, Inst Mol Virol & Immunol, Wenzhou, Zhejiang, Peoples R China.	wzxxy001@163.com			National Natural Science Foundation of China [81001343, 81172463]; Department of Education of Zhejiang Province [Y200907403]; Wenzhou Science and Technology Bureau [Y20090103, Y20100175, H20100063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Zhejiang Province; Wenzhou Science and Technology Bureau	This work is supported by grants from the National Natural Science Foundation of China (81001343, 81172463), the Department of Education of Zhejiang Province (Y200907403) and Wenzhou Science and Technology Bureau (Y20090103, Y20100175 and H20100063). These sponsors provided the funding for the experiments and the collection of specimens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahrouki AA, 2012, ULTRASOUND MED BIOL, V38, P1958, DOI 10.1016/j.ultrasmedbio.2012.07.009; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badaracco G, 2002, J MED VIROL, V67, P574, DOI 10.1002/jmv.10141; Borelli I, 2013, EUR J HUM GENET, V21, P154, DOI 10.1038/ejhg.2012.150; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; CORNELISSEN MTE, 1990, J GEN VIROL, V71, P1243, DOI 10.1099/0022-1317-71-5-1243; Dall KL, 2008, CANCER RES, V68, P8249, DOI 10.1158/0008-5472.CAN-08-1741; Dictor M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-1; DOEBERITZ MV, 1991, P NATL ACAD SCI USA, V88, P1411, DOI 10.1073/pnas.88.4.1411; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Flohe Leopold, 2007, V44, P1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Galvan SC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-580; Giaginis C, 2009, HISTOL HISTOPATHOL, V24, P761, DOI 10.14670/HH-24.761; Guzman VB, 2008, HUM MOL GENET, V17, P1838, DOI 10.1093/hmg/ddn077; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; HSU EM, 1993, INT J CANCER, V55, P397, DOI 10.1002/ijc.2910550311; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kelley ML, 2005, J VIROL, V79, P3737, DOI 10.1128/JVI.79.6.3737-3747.2005; Klaes R, 1999, CANCER RES, V59, P6132; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Liu SS, 2008, TUMOR BIOL, V29, P105, DOI 10.1159/000135690; Luke-Glaser S, 2010, EMBO J, V29, P795, DOI 10.1038/emboj.2009.371; Martin LM, 2013, CANCER LETT, V335, P19, DOI 10.1016/j.canlet.2013.01.046; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nijhuis ER, 2007, J CLIN PATHOL, V60, P824, DOI 10.1136/jcp.2005.036038; Nishimura A, 2000, J VIROL, V74, P3752, DOI 10.1128/JVI.74.8.3752-3760.2000; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Schwartz S, 2008, FRONT BIOSCI-LANDMRK, V13, P5880, DOI 10.2741/3123; SMOTKIN D, 1989, J VIROL, V63, P1441, DOI 10.1128/JVI.63.3.1441-1447.1989; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Wang XH, 2011, INT J CANCER, V129, P1362, DOI 10.1002/ijc.25800; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zheng ZM, 2011, BBA-GENE REGUL MECH, V1809, P668, DOI 10.1016/j.bbagrm.2011.05.005; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629	61	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e97588	10.1371/journal.pone.0097588	http://dx.doi.org/10.1371/journal.pone.0097588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992025	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400003
J	Miranda, JA; Shepard, KN; McClintock, SK; Liu, RC				Miranda, Jason A.; Shepard, Kathryn N.; McClintock, Shannon K.; Liu, Robert C.			Adult Plasticity in the Subcortical Auditory Pathway of the Maternal Mouse	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; BRAIN-STEM RESPONSE; IN-HOUSE MICE; CORTICOFUGAL MODULATION; POSTMENOPAUSAL WOMEN; COMMUNICATION CALLS; INBRED STRAINS; TONOTOPIC MAP; FOOD-INTAKE; EXPERIENCE	Subcortical auditory nuclei were traditionally viewed as non-plastic in adulthood so that acoustic information could be stably conveyed to higher auditory areas. Studies in a variety of species, including humans, now suggest that prolonged acoustic training can drive long-lasting brainstem plasticity. The neurobiological mechanisms for such changes are not well understood in natural behavioral contexts due to a relative dearth of in vivo animal models in which to study this. Here, we demonstrate in a mouse model that a natural life experience with increased demands on the auditory system - motherhood - is associated with improved temporal processing in the subcortical auditory pathway. We measured the auditory brainstem response to test whether mothers and pup-naive virgin mice differed in temporal responses to both broadband and tone stimuli, including ultrasonic frequencies found in mouse pup vocalizations. Mothers had shorter latencies for early ABR peaks, indicating plasticity in the auditory nerve and the cochlear nucleus. Shorter interpeak latency between waves IV and V also suggest plasticity in the inferior colliculus. Hormone manipulations revealed that these cannot be explained solely by estrogen levels experienced during pregnancy and parturition in mothers. In contrast, we found that pup-care experience, independent of pregnancy and parturition, contributes to shortening auditory brainstem response latencies. These results suggest that acoustic experience in the maternal context imparts plasticity on early auditory processing that lasts beyond pup weaning. In addition to establishing an animal model for exploring adult auditory brainstem plasticity in a neuroethological context, our results have broader implications for models of perceptual, behavioral and neural changes that arise during maternity, where subcortical sensorineural plasticity has not previously been considered.	[Miranda, Jason A.; Shepard, Kathryn N.; Liu, Robert C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Miranda, Jason A.; Shepard, Kathryn N.; Liu, Robert C.] Ctr Behav Neurosci, Atlanta, GA USA; [Shepard, Kathryn N.] Emory Univ, Grad Program Neurosci, Atlanta, GA 30322 USA; [McClintock, Shannon K.] Emory Univ, Inst Quantitat Theory & Methods, Atlanta, GA 30322 USA; [Liu, Robert C.] Ctr Translat Social Neurosci, Atlanta, GA USA	Emory University; Emory University; Emory University	Miranda, JA (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	jason.miranda2@pfizer.com	Liu, Robert/B-2339-2015; Miranda, Jason/B-8043-2009; Pileggi, Shannon/L-1320-2016	Liu, Robert/0000-0003-2450-8194; Miranda, Jason/0000-0002-1459-2022; Pileggi, Shannon/0000-0002-7732-4164	National Institute of Deafness and Communication Disorders [DC008343]; Center for Behavioral Neuroscience under the STC Program of the National Science Foundation [IBN-9876754]; NIH Institutional Research and Academic Career Development Award [K12 GM000680]; NIH National Research Service Award Institutional Research Training Grant [T32 GM08605-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605, K12GM000680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008343] Funding Source: NIH RePORTER	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Center for Behavioral Neuroscience under the STC Program of the National Science Foundation; NIH Institutional Research and Academic Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Institutional Research Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for the authors' research was provided by the National Institute of Deafness and Communication Disorders Grant DC008343 (J.A.M. and R.C.L.), the Center for Behavioral Neuroscience under the STC Program of the National Science Foundation (IBN-9876754), the NIH Institutional Research and Academic Career Development Award K12 GM000680 (J.A.M.) and the NIH National Research Service Award Institutional Research Training Grant T32 GM08605-14 (K.N.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mana D, 2008, NEUROSCIENCE, V153, P881, DOI 10.1016/j.neuroscience.2008.02.077; Allen PD, 2010, BEHAV NEUROSCI, V124, P265, DOI 10.1037/a0018913; Banerjee SB, 2013, FRONT NEUROENDOCRIN, V34, P300, DOI 10.1016/j.yfrne.2013.07.008; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Caruso S, 2003, FERTIL STERIL, V79, P556, DOI 10.1016/S0015-0282(02)04763-5; Caruso S, 2000, MENOPAUSE, V7, P178, DOI 10.1097/00042192-200007030-00008; Charitidi K, 2010, NEUROSCIENCE, V165, P923, DOI 10.1016/j.neuroscience.2009.11.020; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; COLEMAN JR, 1994, HEARING RES, V80, P209, DOI 10.1016/0378-5955(94)90112-0; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; DUBUC PU, 1985, P SOC EXP BIOL MED, V180, P468; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1989, ETHOLOGY, V80, P81; EHRET G, 1987, NATURWISSENSCHAFTEN, V74, P47, DOI 10.1007/BF00367047; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; EHRET G, 1994, J PHYSIOLOGY-PARIS, V88, P315, DOI 10.1016/0928-4257(94)90012-4; Ehret G, 2009, PHYSIOL BEHAV, V96, P428, DOI 10.1016/j.physbeh.2008.11.005; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Guimaraes P, 2006, P NATL ACAD SCI USA, V103, P14246, DOI 10.1073/pnas.0606891103; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; HERNANDEZPEON R, 1956, SCIENCE, V123, P331, DOI 10.1126/science.123.3191.331; Hoormann J, 2004, NEUROREPORT, V15, P1539, DOI 10.1097/01.wnr.0000134932.89313.3b; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; HUNTER KP, 1987, HEARING RES, V30, P207, DOI 10.1016/0378-5955(87)90137-7; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; JEWETT DL, 1970, ELECTROEN CLIN NEURO, V28, P609, DOI 10.1016/0013-4694(70)90203-8; Ji WQ, 2007, J NEUROSCI, V27, P4910, DOI 10.1523/JNEUROSCI.5528-06.2007; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Khaliq Farah, 2003, Indian Journal of Physiology and Pharmacology, V47, P393; King AJ, 2011, NEUROSCI BIOBEHAV R, V35, P2129, DOI 10.1016/j.neubiorev.2011.03.008; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Krishnan A, 2010, BRAIN LANG, V114, P193, DOI 10.1016/j.bandl.2010.05.004; Krishnan A, 2010, J NEUROLINGUIST, V23, P81, DOI 10.1016/j.jneuroling.2009.09.001; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; MCCORMACK JT, 1974, J ENDOCRINOL, V62, P101, DOI 10.1677/joe.0.0620101; McGinley MJ, 2012, J NEUROSCI, V32, P9301, DOI 10.1523/JNEUROSCI.0272-12.2012; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Miasnikov AA, 2008, NEUROBIOL LEARN MEM, V90, P443, DOI 10.1016/j.nlm.2008.05.010; Miranda JA, 2009, HEARING RES, V252, P21, DOI 10.1016/j.heares.2009.04.014; Newman JD, 2007, BEHAV BRAIN RES, V182, P155, DOI 10.1016/j.bbr.2007.02.011; Numan Michael, 2006, Behav Cogn Neurosci Rev, V5, P163, DOI 10.1177/1534582306288790; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Pauli-Magnus D, 2007, NEUROSCIENCE, V149, P673, DOI 10.1016/j.neuroscience.2007.08.010; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; Remage-Healey L, 2010, P NATL ACAD SCI USA, V107, P3852, DOI 10.1073/pnas.0906572107; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; SANES DH, 1985, DEV BRAIN RES, V22, P255, DOI 10.1016/0165-3806(85)90177-4; SANES DH, 1985, J NEUROSCI, V5, P1152; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2012, NEUROSCI BIOBEHAV R, V36, P969, DOI 10.1016/j.neubiorev.2011.11.006; Swain JE, 2008, J CHILD PSYCHOL PSYC, V49, P1042, DOI 10.1111/j.1469-7610.2008.01963.x; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; WADE GN, 1979, PHYSIOL BEHAV, V22, P583, DOI 10.1016/0031-9384(79)90028-3; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Wu SH, 2002, HEARING RES, V168, P43, DOI 10.1016/S0378-5955(02)00375-1; Yan J, 2001, NEUROREPORT, V12, P3313, DOI 10.1097/00001756-200110290-00033; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; YOVANOF S, 1983, NEUROSCI LETT, V36, P291, DOI 10.1016/0304-3940(83)90015-0; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	92	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101630	10.1371/journal.pone.0101630	http://dx.doi.org/10.1371/journal.pone.0101630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992362	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400101
J	Sadleir, KR; Eimer, WA; Kaufman, RJ; Osten, P; Vassar, R				Sadleir, Katherine R.; Eimer, William A.; Kaufman, Randal J.; Osten, Pavel; Vassar, Robert			Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2 alpha Does Not Block A beta-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; UNFOLDED PROTEIN RESPONSE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; PATHOGENIC MUTATION; CLEAVING ENZYME-1; MAMMALIAN-CELLS; TRANSGENIC MICE; UPSTREAM AUGS; SYNAPSE LOSS	beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) initiates the production of beta-amyloid (A beta), the major constituent of amyloid plaques in Alzheimer's disease (AD). BACE1 is elevated similar to 2-3 fold in AD brain and is concentrated in dystrophic neurites near plaques, suggesting BACE1 elevation is A beta-dependent. Previously, we showed that phosphorylation of the translation initiation factor eIF2 alpha de-represses translation of BACE1 mRNA following stress such as energy deprivation. We hypothesized that stress induced by A beta might increase BACE1 levels by the same translational mechanism involving eIF2 alpha phosphorylation. To test this hypothesis, we used three different genetic strategies to determine the effects of reducing eIF2 alpha phosphorylation on A beta-dependent BACE1 elevation in vitro and in vivo: 1) a two-vector adeno-associated virus (AAV) system to express constitutively active GADD34, the regulatory subunit of PP1c eIF2 alpha phosphatase; 2) a non-phosphorylatable eIF2 alpha S51A knockin mutation; 3) a BACE1-YFP transgene lacking the BACE1 mRNA 59 untranslated region (UTR) required for eIF2 alpha translational regulation. The first two strategies were used in primary neurons and 5XFAD transgenic mice, while the third strategy was employed only in 5XFAD mice. Despite very effective reduction of eIF2 alpha phosphorylation in both primary neurons and 5XFAD brains, or elimination of eIF2 alpha-mediated regulation of BACE1-YFP mRNA translation in 5XFAD brains, A beta-dependent BACE1 elevation was not decreased. Additionally, robust inhibition of eIF2 alpha phosphorylation did not block A beta-dependent APP elevation in primary neurons, nor did it reduce amyloid pathology in 5XFAD mice. We conclude that amyloid-associated BACE1 elevation is not caused by translational derepression via eIF2 alpha phosphorylation, but instead appears to involve a post-translational mechanism. These definitive genetic results exclude a role for eIF2 alpha phosphorylation in A beta-dependent BACE1 and APP elevation. We suggest a vicious pathogenic cycle wherein Ab42 toxicity induces peri-plaque BACE1 and APP accumulation in dystrophic neurites leading to exacerbated A beta production and plaque progression.	[Sadleir, Katherine R.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Eimer, William A.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; Sanford Burnham Prebys Medical Discovery Institute; Cold Spring Harbor Laboratory	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X; Eimer, William/0000-0003-1067-9339	National Institutes of Health [R01 AG030142]; NIH [DK042394, DK088227, HL052173, 5T32AG00026]; NRSA [F32AG033445]; Northwestern University Cell Imaging Facility; Cancer Center [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088227, R01DK042394, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030142, F32AG033445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Cell Imaging Facility; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health R01 AG030142 to Dr. Robert Vassar, NIH grants DK042394, DK088227 and HL052173 to Dr. Randal Kaufman, NRSA F32AG033445 to Dr. Katherine Sadleir, NIH training grant 5T32AG00026 to Dr. Katherine Sadleir, and the Northwestern University Cell Imaging Facility and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKRAM A, 2007, NEUROBIOL AGING; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chen GJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-3; Chu J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-1; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Devi L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.59; Devi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077335; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He B, 1996, J VIROL, V70, P84, DOI 10.1128/JVI.70.1.84-90.1996; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Mayginnes JP, 2006, J VIROL METHODS, V137, P193, DOI 10.1016/j.jviromet.2006.06.011; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Sorensen AT, 2008, HIPPOCAMPUS; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tanzi RE, 2012, COLD SPRING HARB PER, V2; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035	72	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101643	10.1371/journal.pone.0101643	http://dx.doi.org/10.1371/journal.pone.0101643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992504	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400102
J	Yu, LL; Tan, XL; Jiang, BJ; Sun, XG; Gu, SL; Han, TF; Hou, WS				Yu, Lili; Tan, Xiaoli; Jiang, Bingjun; Sun, Xuegang; Gu, Shoulai; Han, Tianfu; Hou, Wensheng			A Peroxisomal Long-Chain Acyl-CoA Synthetase from Glycine max Involved in Lipid Degradation	PLOS ONE			English	Article							COENZYME-A SYNTHETASE; DRAFT GENOME SEQUENCE; FATTY-ACID; 1 LACS1; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; STORAGE; OIL; MUTANT; REVEALS	Seed storage oil, in the form of triacylglycerol (TAG), is degraded to provide carbon and energy during germination and early seedling growth by the fatty acid beta-oxidation in the peroxisome. Although the pathways for lipid degradation have been uncovered, understanding of the exact involved enzymes in soybean is still limited. Long-chain acyl-CoA synthetase (ACSL) is a critical enzyme that activates free fatty acid released from TAG to form the fatty acyl-CoA. Recent studies have shown the importance of ACSL in lipid degradation and synthesis, but few studies were focused on soybean. In this work, we cloned a ACSL gene from soybean and designated it as GmACSL2. Sequence analysis revealed that GmACSL2 encodes a protein of 733 amino acid residues, which is highly homologous to the ones in other higher plants. Complementation test showed that GmACSL2 could restore the growth of an ACS-deficient yeast strain (YB525). Co-expression assay in Nicotiana benthamiana indicated that GmACSL2 is located at peroxisome. Expression pattern analysis showed that GmACSL2 is highly expressed in germinating seedling and strongly induced 1 day after imbibition, which indicate that GmACSL2 may take part in the seed germination. GmACSL2 overexpression in yeast and soybean hairy root severely reduces the contents of the lipids and fatty acids, compared with controls in both cells, and enhances the beta-oxidation efficiency in yeast. All these results suggest that GmACSL2 may take part in fatty acid and lipid degradation. In conclusion, peroxisomal GmACSL2 from Glycine max probably be involved in the lipid degradation during seed germination.	[Yu, Lili; Jiang, Bingjun; Sun, Xuegang; Han, Tianfu; Hou, Wensheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Yu, Lili; Tan, Xiaoli; Gu, Shoulai] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Yu, Lili] Xinxiang Med Coll, Immunol Res Ctr, Sch Basic Med Sci, Dept Immunol, Xinxiang, Henan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jiangsu University; Xinxiang Medical University	Hou, WS (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	houwensheng@caas.cn	Jiang, Bingjun/GWQ-4354-2022	Yu, Lili/0000-0001-5832-1024	Major Science and Technology Projects of China [2013ZX08010-004]; CAAS (Chinease academy of Agriculture Sciences) Innovation Project	Major Science and Technology Projects of China; CAAS (Chinease academy of Agriculture Sciences) Innovation Project	This work was supported by the Major Science and Technology Projects of China (2013ZX08010-004) and the CAAS (Chinease academy of Agriculture Sciences) Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2008, PLANT CELL PHYSIOL, V49, P526, DOI 10.1093/pcp/pcn027; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Byfield GE, 2006, CROP SCI, V46, P840, DOI 10.2135/cropsci2005.06-0172; Cao D, 2009, PLANT CELL TISS ORG, V96, P45, DOI 10.1007/s11240-008-9458-x; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen MX, 2012, PLANT CELL ENVIRON, V35, P2155, DOI 10.1111/j.1365-3040.2012.02546.x; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chia TYP, 2005, J EXP BOT, V56, P1285, DOI 10.1093/jxb/eri129; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Groot P H, 1976, Adv Lipid Res, V14, P75; Hayashi M, 2006, BBA-MOL CELL RES, V1763, P1382, DOI 10.1016/j.bbamcr.2006.08.014; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jessen D, 2011, PLANT J, V68, P715, DOI 10.1111/j.1365-313X.2011.04722.x; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; JONES EW, 1977, GENETICS, V85, P23; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kelly AA, 2013, PLANT BIOTECHNOL J, V11, P355, DOI 10.1111/pbi.12021; Khurana P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-57; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Larson TR, 2002, PLANT J, V32, P519, DOI 10.1046/j.1365-313X.2002.01440.x; Lin Y, 2004, PLANT PHYSIOL, V135, P814, DOI 10.1104/pp.103.036772; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Paz MM, 2004, EUPHYTICA, V136, P167, DOI 10.1023/B:EUPH.0000030670.36730.a4; Pongdontri P, 2001, PLANT MOL BIOL, V47, P717, DOI 10.1023/A:1013652014744; Pulsifer IP, 2012, PLANT PHYSIOL BIOCH, V51, P31, DOI 10.1016/j.plaphy.2011.10.003; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Su, 2004, J JINZHOU MED COLL, V25, P43, DOI DOI 10.3969/J.ISSN.1674-0424.2004.06.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THAKUR MS, 1989, ENZYME MICROB TECH, V11, P252, DOI 10.1016/0141-0229(89)90101-4; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Vickers CE, 2007, BIOTECHNOL LETT, V29, P1793, DOI 10.1007/s10529-007-9467-6; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; XiuLan W, 2008, PLANT J, V57, P473; Yu L, 2010, INT J BIOL, V2, pP111; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x; Zhu F, 2009, CHINESE J OIL CROP S, V3; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	50	16	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100144	10.1371/journal.pone.0100144	http://dx.doi.org/10.1371/journal.pone.0100144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992019	Green Submitted, gold, Green Published			2022-12-25	WOS:000341253400019
J	Fusco, D; Barnum, TJ; Bruno, AE; Luft, JR; Snell, EH; Mukherjee, S; Charbonneau, P				Fusco, Diana; Barnum, Timothy J.; Bruno, Andrew E.; Luft, Joseph R.; Snell, Edward H.; Mukherjee, Sayan; Charbonneau, Patrick			Statistical Analysis of Crystallization Database Links Protein Physico-Chemical Features with Crystallization Mechanisms	PLOS ONE			English	Article							STRUCTURAL GENOMICS; CRYSTAL CONTACTS; PHASE-BEHAVIOR; SEQUENCE; ENTROPY; PREDICTION; INTERFACES; LESSONS; PURIFICATION; PROPENSITY	X-ray crystallography is the predominant method for obtaining atomic-scale information about biological macromolecules. Despite the success of the technique, obtaining well diffracting crystals still critically limits going from protein to structure. In practice, the crystallization process proceeds through knowledge-informed empiricism. Better physico-chemical understanding remains elusive because of the large number of variables involved, hence little guidance is available to systematically identify solution conditions that promote crystallization. To help determine relationships between macromolecular properties and their crystallization propensity, we have trained statistical models on samples for 182 proteins supplied by the Northeast Structural Genomics consortium. Gaussian processes, which capture trends beyond the reach of linear statistical models, distinguish between two main physico-chemical mechanisms driving crystallization. One is characterized by low levels of side chain entropy and has been extensively reported in the literature. The other identifies specific electrostatic interactions not previously described in the crystallization context. Because evidence for two distinct mechanisms can be gleaned both from crystal contacts and from solution conditions leading to successful crystallization, the model offers future avenues for optimizing crystallization screens based on partial structural information. The availability of crystallization data coupled with structural outcomes analyzed through state-of-the-art statistical models may thus guide macromolecular crystallization toward a more rational basis.	[Fusco, Diana] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC USA; [Fusco, Diana; Barnum, Timothy J.; Charbonneau, Patrick] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Barnum, Timothy J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bruno, Andrew E.] SUNY Buffalo, Ctr Computat Res, Buffalo, NY 14260 USA; [Luft, Joseph R.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY USA; [Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Mukherjee, Sayan] Duke Univ, Dept Comp Sci, Dept Stat Sci, Durham, NC 27706 USA; [Mukherjee, Sayan] Duke Univ, Dept Math, Durham, NC 27706 USA; [Charbonneau, Patrick] Duke Univ, Dept Phys, Durham, NC 27706 USA	Duke University; Duke University; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Duke University; Duke University; Duke University	Charbonneau, P (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	patrick.charbonneau@duke.edu	Snell, Edward/G-2055-2018; Fusco, Diana/AAU-3915-2020	Snell, Edward/0000-0001-8714-3191; Charbonneau, Patrick/0000-0001-7174-0821; Barnum, Timothy/0000-0002-9363-9844; Mukherjee, Sayan/0000-0002-6715-3920	Protein Structure Initiative of the National Institutes of Health, NIGMS [U54 GM094597]; NIH [R01GM088396]; National Science Foundation [NSF DMR-1055586, NSF CHE-1062607]; Division Of Materials Research [1055586] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1209155] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM088396] Funding Source: NIH RePORTER	Protein Structure Initiative of the National Institutes of Health, NIGMS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sample preparation and data acquisition were supported in part by the Protein Structure Initiative of the National Institutes of Health, NIGMS grant U54 GM094597. Crystallization screening results and meta data was supplied from the University of Buffalo Center for Computational Resources (CCR) through research supported by NIH R01GM088396 (EHS, JRL, and AEB). DF and PC acknowledge support from National Science Foundation Grant No. NSF DMR-1055586. TJB acknowledges REU support from National Science Foundation Grant NSF CHE-1062607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bianchi E, 2011, PHYS CHEM CHEM PHYS, V13, P6397, DOI 10.1039/c0cp02296a; Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Cieslik M, 2009, ACTA CRYSTALLOGR D, V65, P500, DOI 10.1107/S0907444909009500; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Dasgupta S, 1997, PROTEINS, V28, P494, DOI 10.1002/(SICI)1097-0134(199708)28:4<494::AID-PROT4>3.0.CO;2-A; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Dijkstra M, 1998, PHYS REV LETT, V81, P2268, DOI 10.1103/PhysRevLett.81.2268; Dill KA, 2005, ANNU REV BIOPH BIOM, V34, P173, DOI 10.1146/annurev.biophys.34.040204.144517; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Eiler S, 2001, PROTEIN EXPRES PURIF, V22, P165, DOI 10.1006/prep.2001.1409; Fusco D, 2014, SOFT MATTER, V10, P290, DOI 10.1039/c3sm52175c; Fusco D, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012721; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Janin J, 1995, PROG BIOPHYS MOL BIO, V64, P145, DOI 10.1016/S0079-6107(96)00001-6; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kurgan L, 2009, NATURAL SCI, V1, P93; Kurgan L, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-50; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Lawrence ND, 2005, LECT NOTES ARTIF INT, V3635, P56, DOI 10.1007/11559887_4; Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; McPherson A., 1999, CRYSTALLIZATION BIOL; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Newman J, 2012, ACTA CRYSTALLOGR F, V68, P253, DOI 10.1107/S1744309112002618; OOSAWA F, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740346; Price II WN, 2011, MICROB INFORM EXP, V1, P1; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Rosenbaum D, 1996, PHYS REV LETT, V76, P150, DOI 10.1103/PhysRevLett.76.150; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rupp B, 2004, METHODS, V34, P390, DOI 10.1016/j.ymeth.2004.03.031; Saven JG, 2010, CURR OPIN COLLOID IN, V15, P13, DOI 10.1016/j.cocis.2009.06.002; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1123, DOI 10.1107/S0907444908028047; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; VRIJ A, 1976, PURE APPL CHEM, V48, P471, DOI 10.1351/pac197648040471; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Zhang F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148101; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhuang TD, 2011, J AM CHEM SOC, V133, P20571, DOI 10.1021/ja208972h; Zucker FH, 2010, J STRUCT BIOL, V171, P64, DOI 10.1016/j.jsb.2010.03.016	60	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101123	10.1371/journal.pone.0101123	http://dx.doi.org/10.1371/journal.pone.0101123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988076	gold, Green Submitted, Green Published			2022-12-25	WOS:000341354100062
J	Stewart, MKG; Plante, I; Bechberger, JF; Naus, CC; Laird, DW				Stewart, Michael K. G.; Plante, Isabelle; Bechberger, John F.; Naus, Christian C.; Laird, Dale W.			Mammary Gland Specific Knockdown of the Physiological Surge in Cx26 during Lactation Retains Normal Mammary Gland Development and Function	PLOS ONE			English	Article							MEDIATED GENE DELETION; JUNCTIONAL COMMUNICATION; CONNEXIN 30; EXPRESSION; MOUSE; PERMEABILITY; CHANNELS	Connexin26 (Cx26) is the major Cx protein expressed in the human mammary gland and is up-regulated during pregnancy while remaining elevated throughout lactation. It is currently unknown if patients with loss-of-function Cx26 mutations that result in hearing loss and skin diseases have a greater susceptibility to impaired breast development. To investigate if Cx26 plays a critical role in mammary gland development and differentiation, a novel Cx26 conditional knockout mouse model was generated by crossing Cx26(fl/fl) mice with mice expressing Cre under the beta-Lactoglobulin promoter. Conditional knockdown of Cx26 from the mammary gland resulted in a dramatic reduction in detectable gap junction plaques confirmed by a significant similar to 65-70% reduction in Cx26 mRNA and protein throughout parturition and lactation. Interestingly, this reduction was accompanied by a decrease in mammary gland Cx30 gap junction plaques at parturition, while no change was observed for Cx32 or Cx43. Whole mount, histological and immunofluorescent assessment of breast tissue revealed comparatively normal lobuloalveolar development following pregnancy in the conditionally knockdown mice compared to control mice. In addition, glands from genetically-modified mice were capable of producing milk proteins that were evident in the lumen of alveoli and ducts at similar levels as controls, suggesting normal gland function. Together, our results suggest that low levels of Cx26 expression throughout pregnancy and lactation, and not the physiological surge in Cx26, is sufficient for normal gland development and function.	[Stewart, Michael K. G.; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Plante, Isabelle] INRS Inst Armand Frappier, Laval, PQ, Canada; [Bechberger, John F.; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); University of Quebec; Institut national de la recherche scientifique (INRS); University of British Columbia; Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015; Plante, Isabelle/AAK-5997-2021	Laird, Dale W/0000-0002-4568-3285; Plante, Isabelle/0000-0003-2080-6450	Canadian Breast Cancer Foundation; Ontario Graduate Scholarship; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (CCN and DWL) and the Ontario Graduate Scholarship, Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit and the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer (MKGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chanson M, 1998, J CELL BIOL, V141, P1267, DOI 10.1083/jcb.141.5.1267; Chin NP, 2013, J HUM LACT, V29, P564, DOI 10.1177/0890334413476921; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; Dicke N, 2011, J CELL SCI, V124, P2806, DOI 10.1242/jcs.084186; El-Saghir JA, 2011, INT J DEV BIOL, V55, P773, DOI 10.1387/ijdb.113372je; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HARRIS S, 1991, DEV GENET, V12, P299, DOI 10.1002/dvg.1020120407; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Locke D, 2004, EXP CELL RES, V298, P643, DOI 10.1016/j.yexcr.2004.05.003; Locke D, 2007, CELL TISSUE RES, V328, P97, DOI 10.1007/s00441-006-0301-6; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; Mittal B., 2003, INDIAN J HUM GENET, V9, P40; Monaghan P, 1996, EXP CELL RES, V223, P29, DOI 10.1006/excr.1996.0055; Nelles E, 1996, P NATL ACAD SCI USA, V93, P9565, DOI 10.1073/pnas.93.18.9565; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Plante I, 2008, DEV BIOL, V318, P312, DOI 10.1016/j.ydbio.2008.03.033; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Schutz M, 2010, HUM MOL GENET, V19, P4759, DOI 10.1093/hmg/ddq402; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Serre-Beinier V, 2002, BIOL CELL, V94, P477, DOI 10.1016/S0248-4900(02)00024-2; Stewart MKG, 2013, BIOCHEM J, V449, P401, DOI 10.1042/BJ20121070; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; White TW, 2000, BRAIN RES REV, V32, P181, DOI 10.1016/S0165-0173(99)00079-X; Yuan TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019233	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101546	10.1371/journal.pone.0101546	http://dx.doi.org/10.1371/journal.pone.0101546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988191	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000341354100111
J	Stuit, SM; Paffen, CLE; van der Smagt, MJ; Verstraten, FAJ				Stuit, Sjoerd M.; Paffen, Chris L. E.; van der Smagt, Maarten J.; Verstraten, Frans A. J.			Image-Based Grouping during Binocular Rivalry Is Dictated by Eye-Of-Origin	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ORIENTATION; DEPTH	Prolonged viewing of dichoptically presented images with different content results in perceptual alternations known as binocular rivalry. This phenomenon is thought to be the result of competition at a local level, where local rivalry zones interact to give rise to a single, global dominant percept. Certain perceived combinations that result from this local competition are known to last longer than others, which is referred to as grouping during binocular rivalry. In recent years, the phenomenon has been suggested to be the result of competition at both eye-and image-based processing levels, although the exact contribution from each level remains elusive. Here we use a paradigm designed specifically to quantify the contribution of eye-and image-based processing to grouping during rivalry. In this paradigm we used sine-wave gratings as well as upright and inverted faces, with and without binocular disparity-based occlusion. These stimuli and conditions were used because they are known to result in processing at different stages throughout the visual processing hierarchy. Specifically, more complex images were included in order to maximize the potential contribution of image-based grouping. In spite of this, our results show that increasing image complexity did not lead to an increase in the contribution of image-based processing to grouping during rivalry. In fact, the results show that grouping was primarily affected by the eye-of-origin of the image parts, irrespective of stimulus type. We suggest that image content affects grouping during binocular rivalry at low-level processing stages, where it is intertwined with eye-of-origin information.	[Stuit, Sjoerd M.; Paffen, Chris L. E.; van der Smagt, Maarten J.; Verstraten, Frans A. J.] Univ Utrecht, Helmholtz Inst, Div Expt Psychol, Neurosci & Cognit Utrecht, Utrecht, Netherlands; [Verstraten, Frans A. J.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Utrecht University; University of Sydney	Stuit, SM (corresponding author), Univ Utrecht, Helmholtz Inst, Div Expt Psychol, Neurosci & Cognit Utrecht, Utrecht, Netherlands.	sjoerdstuit@gmail.com		van der Smagt, Maarten/0000-0003-2772-6429; Verstraten, Frans/0000-0002-5487-1755				Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Arnold DH, 2009, J VISION, V9, DOI 10.1167/9.5.4; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Ekman P., 1976, PICTURES FACIAL AFFE; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knapen T, 2007, VISION RES, V47, P3269, DOI 10.1016/j.visres.2007.09.005; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Lee SH, 2004, TRENDS COGN SCI, V8, P148, DOI 10.1016/j.tics.2004.02.009; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; Palmer SE, 1996, PSYCHON B REV, V3, P75, DOI 10.3758/BF03210743; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Silver MA, 2007, VISION RES, V47, P532, DOI 10.1016/j.visres.2006.10.011; Stuit SM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00117; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; WHITTLE P, 1968, PERCEPT PSYCHOPHYS, V4, P183, DOI 10.3758/BF03210465; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714	35	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e95327	10.1371/journal.pone.0095327	http://dx.doi.org/10.1371/journal.pone.0095327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987847	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100004
J	Chen, L; Munoz-Antonia, T; Cress, WD				Chen, Lu; Munoz-Antonia, Teresita; Cress, W. Douglas			Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ZINC-FINGER PROTEINS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; TRANSCRIPTION; METASTASIS; COMPLEXES; KAP-1; PHOSPHORYLATION; ADENOCARCINOMA	In previous work, we demonstrated that transcription factor Trim28 (Tripartite motif containing 28) plays a tumor-suppressor role in early-staged adenocarcinoma of the lung due to its ability to restrain transcription of cell cycle-regulating genes. Herein we examine Trim28's role in the epithelial-to-mesenchymal transition (EMT) which is strongly implicated in cancer metastasis. We found that Trim28 plays a role in TGF-beta-induced EMT in non-small cell lung cancer cells. Silencing Trim28 with inhibitory RNAs alters the expression of numerous EMT markers, such as E-cadherin and N-cadherin, whereas overexpression of Trim28 has an opposite effect. Trim28 expression is induced following TGF-beta treatment at both protein and mRNA levels. Trim28 deficiency impairs TGF-beta-induced EMT and decreases cell migration and invasion. Finally, we demonstrate that the expression of Trim28 affects the acetylation and methylation of histones on E-cadherin and N-cadherin promoters. These results suggest that Trim28 contributes to EMT and might be important for tumor metastasis in lung cancer. Taken together with our previous work these results suggest a model in which Trim28 is a tumor suppressor early in the transformation process in lung cancer, but in later stages it functions as an oncogene.	[Chen, Lu; Munoz-Antonia, Teresita; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	Douglas.Cress@moffitt.org			National Cancer Institute [CA119997, CA163068]; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P50CA119997, P30CA076292, U54CA163068] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (CA119997 and CA163068) and the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lin LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073033; Ma YH, 2010, J BIOL CHEM, V285, P9813, DOI 10.1074/jbc.M109.091496; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	36	62	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101040	10.1371/journal.pone.0101040	http://dx.doi.org/10.1371/journal.pone.0101040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983967	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000050
J	Komrskova, P; Susor, A; Malik, R; Prochazkova, B; Liskova, L; Supolikova, J; Hladky, S; Kubelka, M				Komrskova, Pavla; Susor, Andrej; Malik, Radek; Prochazkova, Barbora; Liskova, Lucie; Supolikova, Jaroslava; Hladky, Stepan; Kubelka, Michal			Aurora Kinase A Is Not Involved in CPEB1 Phosphorylation and cyclin B1 mRNA Polyadenylation during Meiotic Maturation of Porcine Oocytes	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION; MOUSE OOCYTES; C-MOS; TRANSLATIONAL REGULATION; CHROMOSOME CONDENSATION; XENOPUS PUMILIO; PIG OOCYTES; MAP KINASE; A KINASE	Regulation of mRNA translation by cytoplasmic polyadenylation is known to be important for oocyte maturation and further development. This process is generally controlled by phosphorylation of cytoplasmic polyadenylation element binding protein 1 (CPEB1). The aim of this study is to determine the role of Aurora kinase A in CPEB1 phosphorylation and the consequent CPEB1-dependent polyadenylation of maternal mRNAs during mammalian oocyte meiosis. For this purpose, we specifically inhibited Aurora kinase A with MLN8237 during meiotic maturation of porcine oocytes. Using poly(A)-test PCR method, we monitored the effect of Aurora kinase A inhibition on poly(A)-tail extension of long and short cyclin B1 encoding mRNAs as markers of CPEB1-dependent cytoplasmic polyadenylation. Our results show that inhibition of Aurora kinase A activity impairs neither cyclin B1 mRNA polyadenylation nor its translation and that Aurora kinase A is unlikely to be involved in CPEB1 activating phosphorylation.	[Komrskova, Pavla; Susor, Andrej; Prochazkova, Barbora; Liskova, Lucie; Supolikova, Jaroslava; Hladky, Stepan; Kubelka, Michal] Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Malik, Radek] Acad Sci Czech Republic, Inst Mol Genet, Libechov, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kubelka, M (corresponding author), Acad Sci Czech Republic, Inst Anim Physiol & Genet, Libechov, Czech Republic.	kubelka@iapg.cas.cz	Prochazkova, Barbora/G-7133-2014; Malik, Radek/G-3578-2014	Malik, Radek/0000-0002-6783-1146	Czech Science Foundation [P502/10/0944, 13- 12291S, P502/12/2201]; IAPG AS CR, v.v.i. [67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); IAPG AS CR, v.v.i.	This work was supported by grant from the Czech Science Foundation P502/10/0944 (http://www.gacr.cz/) and by Institutional Research Concept 67985904 (IAPG AS CR, v.v.i., http://www.iapg.cas.cz/), AS was also supported by grant from the Czech Science Foundation 13- 12291S and MK was also supported by grant from the Czech Science Foundation P502/12/2201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; De Luca M, 2006, CELL CYCLE, V5, P296; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hodgman R, 2001, DEVELOPMENT, V128, P2815; Hong X, 2014, CANC CHEMOTHER PHARM; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Jelinkova L, 2006, BIOL REPROD, V74, P905, DOI 10.1095/biolreprod.105.047886; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim KC, 2013, NEUROCHEM RES, V38, P1960, DOI 10.1007/s11064-013-1102-4; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kubelka M, 2002, MOL REPROD DEV, V63, P110, DOI 10.1002/mrd.10176; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Kuo PW, 2011, DIFFERENTIATION, V81, P133, DOI 10.1016/j.diff.2010.11.001; Lioutas A, 2014, CELL CYCLE, V13, P499, DOI 10.4161/cc.27781; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Liskova L, 2010, REPROD FERT DEVELOP, V22, P644, DOI 10.1071/RD09068; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Motlik J, 1996, ZYGOTE, V4, P247, DOI 10.1017/S0967199400003166; Murai S, 2010, DEV BIOL, V341, P205, DOI 10.1016/j.ydbio.2010.02.027; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Nechama M, 2013, MOL CELL BIOL, V33, P48, DOI 10.1128/MCB.00904-12; Nishimura Y, 2010, ANIM SCI J, V81, P444, DOI 10.1111/j.1740-0929.2010.00755.x; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; SALLES FJ, 1995, PCR METH APPL, V4, P317; Saskova A, 2008, CELL CYCLE, V7, P2368, DOI 10.4161/cc.6361; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Solc P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101014; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Tremblay K, 2005, BIOL REPROD, V72, P1037, DOI 10.1095/biolreprod.104.034793; Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wu JM, 2013, P NATL ACAD SCI USA, V110, pE1779, DOI 10.1073/pnas.1220523110; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	54	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101222	10.1371/journal.pone.0101222	http://dx.doi.org/10.1371/journal.pone.0101222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983972	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000070
J	Wu, MM; Xiao, H; Ren, WK; Yin, J; Tan, B; Liu, G; Li, L; Nyachoti, CM; Xiong, X; Wu, GY				Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Tan, Bie; Liu, Gang; Li, Lili; Nyachoti, Charles Martin; Xiong, Xia; Wu, Guoyao			Therapeutic Effects of Glutamic Acid in Piglets Challenged with Deoxynivalenol	PLOS ONE			English	Article							RIBOTOXIC STRESS-RESPONSE; ACTIVATED PROTEIN-KINASE; CELL-CYCLE ARREST; T-2 TOXIN; TRICHOTHECENE MYCOTOXINS; GASTROINTESTINAL-TRACT; SMALL-INTESTINE; AMINO-ACIDS; SUPPLEMENTATION; EXPRESSION	The mycotoxin deoxynivalenol (DON), one of the most common food contaminants, primarily targets the gastrointestinal tract to affect animal and human health. This study was conducted to examine the protective function of glutamic acid on intestinal injury and oxidative stress caused by DON in piglets. Twenty-eight piglets were assigned randomly into 4 dietary treatments (7 pigs/treatment): 1) uncontaminated control diet (NC), 2) NC+DON at 4 mg/kg (DON), 3) NC+2% glutamic acid (GLU), and 4) NC+2% glutamic acid + DON at 4 mg/kg (DG). At day 15, 30 and 37, blood samples were collected to determine serum concentrations of CAT (catalase), T-AOC (total antioxidant capacity), H2O2 (hydrogen peroxide), NO (nitric oxide), MDA (maleic dialdehyde), DAO (diamine oxidase) and D-lactate. Intestinal morphology, and the activation of Akt/mTOR/4EBP1 signal pathway, as well as the concentrations of H2O2, MDA, and DAO in kidney, liver and small intestine, were analyzed at day 37. Results showed that DON significantly (P<0.05) induced oxidative stress in piglets, while this stress was remarkably reduced with glutamic acid supplementation according to the change of oxidative parameters in blood and tissues. Meanwhile, DON caused obvious intestinal injury from microscopic observations and permeability indicators, which was alleviated by glutamic acid supplementation. Moreover, the inhibition of DON on Akt/mTOR/4EBP1 signal pathway was reduced by glutamic acid supplementation. Collectively, these data suggest that glutamic acid may be a useful nutritional regulator for DON-induced damage manifested as oxidative stress, intestinal injury and signaling inhibition.	[Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Tan, Bie; Liu, Gang; Li, Lili; Xiong, Xia; Wu, Guoyao] Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Minist Agr,Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock,Key Lab Ag, Changsha, Hunan, Peoples R China; [Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Nyachoti, Charles Martin] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Manitoba; Texas A&M University System; Texas A&M University College Station	Xiong, X (corresponding author), Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Minist Agr,Inst Subtrop Agr, Hunan Prov Engn Res Ctr Hlth Livestock,Key Lab Ag, Changsha, Hunan, Peoples R China.	xx@isa.ac.cn	YIN, Jie/H-3578-2019; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liu, Gang/0000-0002-9475-5134	National Key Basic Research of China [2009CB118806]; National Natural Science Foundation of China [31272463, 31072042]; Hunan Provincial Natural Science Foundation of China [12JJ2014, 13JJ2034]; Chinese Academy of Sciences [2011T2S15]	National Key Basic Research of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was jointly supported by grants from the National Key Basic Research of China (NO. 2009CB118806), the National Natural Science Foundation of China (NO. 31272463 and NO. 31072042), Hunan Provincial Natural Science Foundation of China (NO. 12JJ2014, 13JJ2034) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant No. 2011T2S15. Meanwhile, the authors also give their profound admiration and respect to the many researchers in this field and in their lab, whose dedication and hard work make it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSEN PN, 1964, NATURE, V204, P1195, DOI 10.1038/2041195a0; Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; AE D, 2006, FUSARIUM MYCOTOXINS; Beutheu S, 2013, CLIN NUTR; Blachier F, 1999, DIGESTION, V60, P349, DOI 10.1159/000007682; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; BRAGG LE, 1991, J SURG RES, V50, P228, DOI 10.1016/0022-4804(91)90183-M; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CANNON M, 1976, BIOCHEM J, V160, P137, DOI 10.1042/bj1600137; Eriksen GS, 2004, ANIM FEED SCI TECH, V114, P205, DOI 10.1016/j.anifeedsci.2003.08.008; Felicia W, 2007, ANIM FEED SCI TECHNO, V137, P363; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084533; Frankic T, 2006, FOOD CHEM TOXICOL, V44, P1838, DOI 10.1016/j.fct.2006.06.002; Fujita T, 2007, LIFE SCI, V80, P1846, DOI 10.1016/j.lfs.2007.02.017; Goossens J, 2013, FOOD CHEM TOXICOL, V57, P54, DOI 10.1016/j.fct.2013.03.009; Hou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060374; Hu CAA, 2008, AMINO ACIDS, V35, P665, DOI 10.1007/s00726-008-0075-0; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Klunker LR, 2013, J ANIM SCI, V91, P276, DOI 10.2527/jas.2012-5453; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li FQ, 1999, NAT TOXINS, V7, P93, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<93::AID-NT45>3.0.CO;2-5; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Namikawa T, 2012, ONCOLOGY-BASEL, V82, P147, DOI 10.1159/000336799; Ngampongsa S, 2013, J TOXICOL SCI, V38, P495, DOI 10.2131/jts.38.495; Nossol C, 2013, MYCOTOXIN RES, V29, P245, DOI 10.1007/s12550-013-0177-8; Obremski K, 2008, POL J VET SCI, V11, P339; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Packer RA, 2012, J VET INTERN MED, V26, P905, DOI 10.1111/j.1939-1676.2012.00936.x; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Reeds PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE408, DOI 10.1152/ajpendo.1997.273.2.E408; Ren WK, 2013, AMINO ACIDS, V45, P947, DOI 10.1007/s00726-013-1551-8; Ren WK, 2013, BRIT J NUTR, V110, P1053, DOI 10.1017/S0007114512006101; Ren WK, 2013, AMINO ACIDS, V45, P555, DOI 10.1007/s00726-013-1490-4; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Ruth MR, 2013, AMINO ACIDS, V45, P581; Sanden C, 2013, INT IMMUNOPHARMACOL, V15, P121, DOI 10.1016/j.intimp.2012.11.012; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; van Meijl LEC, 2010, MOL NUTR FOOD RES, V54, P1568, DOI 10.1002/mnfr.200900438; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Watford M, 2008, J NUTR, V138, p2003S, DOI 10.1093/jn/138.10.2003S; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; WU GY, 1994, J NUTR, V124, P2437, DOI 10.1093/jn/124.12.2437; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Yang HS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050921, 10.1371/journal.pone.0029051]; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Zhang J, 2013, AMINO ACIDS, V45, P1169, DOI 10.1007/s00726-013-1573-2; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	59	60	68	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100591	10.1371/journal.pone.0100591	http://dx.doi.org/10.1371/journal.pone.0100591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984001	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000031
J	Yang, CC; Yao, CA; Lin, YR; Yang, JC; Chien, CT				Yang, Chih-Ching; Yao, Chien-An; Lin, Yi-Ruu; Yang, Jyh-Chin; Chien, Chiang-Ting			Deep-Sea Water Containing Selenium Provides Intestinal Protection against Duodenal Ulcers through the Upregulation of Bcl-2 and Thioredoxin Reductase 1	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; SHUMIYA CATARACT RAT; OXIDATIVE STRESS; DRINKING-WATER; MAGNESIUM; APOPTOSIS; DISEASE; SEAWATER; MICE; ISCHEMIA/REPERFUSION	Deep-sea water (DSW), which is rich in micronutrients and minerals and with antioxidant and anti-inflammatory qualities, may be developed as marine drugs to provide intestinal protection against duodenal ulcers. We determined several characteristics in the modified DSW. We explored duodenal pressure, oxygenation, microvascular blood flow, and changes in pH and oxidative redox potential (ORP) values within the stomach and duodenum in response to tap water (TW, hardness: 2.48 ppm), DSW600 (hardness: 600 ppm), and DSW1200 (hardness: 1200 ppm) in Wistar rats and analyzed oxidative stress and apoptosis gene expressions by cDNA and RNA microarrays in the duodenal epithelium. We compared the effects of drinking DSW, MgCl2, and selenium water on duodenal ulcers using pathologic scoring, immunohistochemical analysis, and Western blotting. Our results showed DSW has a higher pH value, lower ORP value, higher scavenging H2O2 and HOCl activity, higher Mg2+ concentrations, and micronutrients selenium compared with TW samples. Water infusion significantly increased intestinal pressure, O-2 levels, and microvascular blood flow in DSW and TW groups. Microarray showed DSW600, DSW1200, selenium water upregulated antioxidant and anti-apoptotic genes and downregulated proapoptotic gene expression compared with the TW group. Drinking DSW600, DSW1200, and selenium water but not Mg2+ water significantly enhanced Bcl-2 and thioredoxin reductase 1 expression. Bax/Bcl-2/caspase 3/poly-(ADP-ribose)-polymerase signaling was activated during the pathogenesis of duodenal ulceration. DSW drinking reduced ulcer area as well as apoptotic signaling in acetic acid-induced duodenal ulcers. DSW, which contains selenium, provides intestinal protection against duodenal ulcers through the upregulation of Bcl-2 and thioredoxin reductase 1.	[Yang, Chih-Ching] Execut Yuan, Minist Hlth & Welf, Dept Planning, Taipei, Taiwan; [Yang, Chih-Ching] Natl Yang Ming Univ, Dept Internal Med, Taipei 112, Taiwan; [Yao, Chien-An] Natl Taiwan Univ, Dept Family Med, Hosp & Coll Med, Taipei 10764, Taiwan; [Lin, Yi-Ruu] Stone & Resource Ind Res & Dev Ctr, Div Water Resources, Hualien, Taiwan; [Yang, Jyh-Chin] Natl Taiwan Univ, Dept Internal Med, Hosp & Coll Med, Taipei 10764, Taiwan; [Chien, Chiang-Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan Normal University	Yang, JC (corresponding author), Natl Taiwan Univ, Dept Internal Med, Hosp & Coll Med, Taipei 10764, Taiwan.	jcyang47@ntu.edu.tw		Yao, Chien-An/0000-0001-8074-6379; YANG, JYH-CHIN/0000-0003-4219-0685	Water Resources Division, Stone & Resource Industry RD Center [SRDC-160-B1-168(101)]; National Science Council of the Republic of China [NSC 102-2320-B-003-001-MY3]	Water Resources Division, Stone & Resource Industry RD Center; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	Grant support: This work was majorly supported by Water Resources Division, Stone & Resource Industry R&D Center (SRDC-160-B1-168(101)) and partly by the National Science Council of the Republic of China (NSC 102-2320-B-003-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasciano V, 2003, MAGNESIUM RES, V16, P281; Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Boehler CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071525; Chen DL, 2011, TRANSL RES, V157, P306, DOI 10.1016/j.trsl.2010.12.012; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chen IS, 2013, J CHIN MED ASSOC, V76, P95, DOI 10.1016/j.jcma.2012.10.008; Cheung Dae Young, 2009, Korean J Gastroenterol, V54, P285; Chien CT, 2005, AM J TRANSPLANT, V5, P1194, DOI 10.1111/j.1600-6143.2005.00826.x; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Drago F, 1999, LIFE SCI, V64, P2341, DOI 10.1016/S0024-3205(99)00187-3; Fu ZY, 2012, J MED FOOD, V15, P535, DOI 10.1089/jmf.2011.2007; Garcia-Miranda P, 2010, EXP PHYSIOL, V223, P451; Hataguchi Y, 2005, EUR J CLIN NUTR, V59, P1093, DOI 10.1038/sj.ejcn.1602218; Hein J, 2011, CLIN DRUG INVEST, V31, P655, DOI 10.2165/11590270-000000000-00000; Hoffman-Goetz L, 2007, J NEUROIMMUNOL, V187, P94, DOI 10.1016/j.jneuroim.2007.04.012; Hunt RH, 2011, DIGEST DIS, V29, P465, DOI 10.1159/000332211; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Kawada M, 2012, J MED MICROBIOL DI S, VS1; Kawahara K, 2007, MED HYPOTHESES, V68, P1429, DOI 10.1016/j.mehy.2006.10.025; Kimata Hajime, 2002, Acta Medica (Hradec Kralove), V45, P83; Kohda K, 1999, GUT, V44, P456, DOI 10.1136/gut.44.4.456; KURATA JH, 1985, GASTROENTEROLOGY, V88, P96, DOI 10.1016/S0016-5085(85)80139-6; Lahner E, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2011.00892.x; LeonBarua R, 1997, CLIN INFECT DIS, V25, P1013, DOI 10.1086/516079; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Miyamura M, 2004, BIOL PHARM BULL, V27, P1784, DOI 10.1248/bpb.27.1784; Nagai N, 2007, CURR EYE RES, V32, P439, DOI 10.1080/02713680701329339; Nagai N, 2006, BIOL PHARM BULL, V29, P1234, DOI 10.1248/bpb.29.1234; Nasri H, 2007, BRATISL MED J, V108, P506; Proksch E, 2005, INT J DERMATOL, V44, P151, DOI 10.1111/j.1365-4632.2005.02079.x; Radhakrishnan G, 2009, BIOCHEM BIOPH RES CO, V387, P25, DOI 10.1016/j.bbrc.2009.06.073; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Sieron A, 2001, Pol Merkur Lekarski, V10, P113; Sostek MB, 2011, CURR MED RES OPIN, V27, P847, DOI 10.1185/03007995.2011.555756; SZABO S, 1978, AM J PATHOL, V93, P273; Trigona WL, 2006, BIOCHEM J, V394, P207, DOI 10.1042/BJ20050712; Wang Y, 2013, FOOD CHEM TOXICOL, V58, P61, DOI 10.1016/j.fct.2013.04.013; Yang JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/248585; Yang LC, 2008, J NUTR, V138, P2084, DOI 10.3945/jn.108.090985; Yang SY, 2013, BIOL TRACE ELEM RES, V153, P237, DOI 10.1007/s12011-013-9649-0; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009	44	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e96006	10.1371/journal.pone.0096006	http://dx.doi.org/10.1371/journal.pone.0096006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984066	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000002
J	Zingg, JM; Libinaki, R; Meydani, M; Azzi, A				Zingg, Jean-Marc; Libinaki, Roksan; Meydani, Mohsen; Azzi, Angelo			Modulation of Phosphorylation of Tocopherol and Phosphatidylinositol by hTAP1/SEC14L2-Mediated Lipid Exchange	PLOS ONE			English	Article							SCAVENGER RECEPTOR EXPRESSION; SUPERNATANT PROTEIN FACTOR; HUMAN SEC14P-LIKE PROTEINS; VITAMIN-E; ALPHA-TOCOPHEROL; GENE-EXPRESSION; ATHEROSCLEROSIS PROGRESSION; CELL-PROLIFERATION; MAMMARY-GLAND; OXIDIZED LDL	The vitamin E derivative, alpha-tocopheryl phosphate (alpha TP), is detectable in cultured cells, plasma and tissues in small amounts, suggesting the existence of enzyme(s) with alpha-tocopherol (alpha T) kinase activity. Here, we characterize the production of alpha TP from alpha T and [gamma-P-32]-ATP in primary human coronary artery smooth muscle cells (HCA-SMC) using separation by thin layer chromatography (TLC) and subsequent analysis by Ultra Performance Liquid Chromatography (UPLC). In addition to alpha T, although to a lower amount, also gamma T is phosphorylated. In THP-1 monocytes, gamma TP inhibits cell proliferation and reduces CD36 scavenger receptor expression more potently than alpha TP. Both alpha TP and gamma TP activate the promoter of the human vascular endothelial growth factor (VEGF) gene with similar potency, whereas alpha T and gamma T had no significant effect. The recombinant human tocopherol associated protein 1 (hTAP1, hSEC14L2) binds both alpha T and alpha TP and stimulates phosphorylation of alpha T possibly by facilitating its transport and presentation to a putative alpha T kinase. Recombinant hTAP1 reduces the in vitro activity of the phosphatidylinositol-3-kinase gamma (PI3K gamma) indicating the formation of a stalled/inactive hTAP1/PI3K gamma heterodimer. The addition of alpha T, beta T, gamma T, delta dT or alpha TP differentially stimulates PI3K gamma, suggesting facilitated egress of sequestered PI from hTAP1 to the enzyme. It is suggested that the continuous competitive exchange of different lipophilic ligands in hTAPs with cell enzymes and membranes may be a way to make these lipophiles more accessible as substrates for enzymes and as components of specific membrane domains.	[Zingg, Jean-Marc; Meydani, Mohsen; Azzi, Angelo] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Vasc Biol Lab, Boston, MA 02111 USA; [Libinaki, Roksan] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Tufts University; United States Department of Agriculture (USDA); Monash University	Zingg, JM (corresponding author), Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Vasc Biol Lab, Boston, MA 02111 USA.	Jean-Marc.Zingg@tufts.edu	Zingg, Jean-Marc/H-6960-2019		Swiss National Science Foundation; US Department of Agriculture [58-1950-0-014]; Phosphagenics, Ltd.	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US Department of Agriculture(United States Department of Agriculture (USDA)); Phosphagenics, Ltd.	This study was supported in part by the Swiss National Science Foundation (AA, JMZ), by grants from US Department of Agriculture, under Agreement No. 58-1950-0-014 (MM, JMZ) and by a research fellowship from Phosphagenics, Ltd. (JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SR, 1949, ANN NY ACAD SCI, V52; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Bankaitis VA, 2007, ADV ENZYME REGUL, V47, P27, DOI 10.1016/j.advenzreg.2006.12.007; Bankaitis Vytas A, 2012, Adv Biol Regul, V52, P115, DOI 10.1016/j.jbior.2011.11.001; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Birringer M, 2010, MOL NUTR FOOD RES, V54, P588, DOI 10.1002/mnfr.200900457; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cockcroft S, 2011, CRIT REV BIOCHEM MOL, V46, P89, DOI 10.3109/10409238.2010.538664; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Curwin AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055388; De Pascale MC, 2006, ARCH BIOCHEM BIOPHYS, V447, P97, DOI 10.1016/j.abb.2006.02.002; Dutra RC, 2011, BR J PHARM; Eyre NS, 2007, J LIPID RES, V48, P528, DOI 10.1194/jlr.M600255-JLR200; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghosh R, 2011, BIOFACTORS, V37, P290, DOI 10.1002/biof.180; Gianello R, 2005, FREE RADICAL BIO MED, V39, P970, DOI 10.1016/j.freeradbiomed.2005.05.016; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Inoue M, 2001, ARTERIOSCL THROM VAS, V21, P560, DOI 10.1161/01.ATV.21.4.560; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; KAGAN VE, 1990, METHOD ENZYMOL, V186, P355; Kearns BG, 1998, TRENDS CELL BIOL, V8, P276, DOI 10.1016/S0962-8924(98)01281-1; Kempna P, 2004, J BIOL CHEM, V279, P50700, DOI 10.1074/jbc.M410800200; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Kempna P, 2003, IUBMB LIFE, V55, P103, DOI 10.1080/1521654031000095756; Kono N, 2013, SCIENCE; Lemaire-Ewing S, 2010, MOL NUTR FOOD RES, V54, P631, DOI 10.1002/mnfr.200900445; Libinaki R, 2010, CLIN EXP PHARMACOL P, V37, P587, DOI 10.1111/j.1440-1681.2010.05356.x; Marlier A, 2009, MECH DEVELOP, V126, P91, DOI 10.1016/j.mod.2008.12.003; McCary CA, 2012, BIOCHEM J, V441, P189, DOI 10.1042/BJ20111318; Mokashi V, 2005, ARCH BIOCHEM BIOPHYS, V433, P474, DOI 10.1016/j.abb.2004.10.002; Moldovan L, 2005, EXP SUPPL, V94, P127; Munteanu A, 2006, J BIOL CHEM, V281, P6489, DOI 10.1074/jbc.M508799200; Munteanu A, 2004, BIOCHEM BIOPH RES CO, V318, P311, DOI 10.1016/j.bbrc.2004.04.028; Munteanu A, 2007, IUBMB LIFE, V59, P771, DOI 10.1080/15216540701697420; Nakai K, 2011, EXP DERMATOL, V20, P388, DOI 10.1111/j.1600-0625.2010.01223.x; Nakayama S, 2003, J INVEST DERMATOL, V121, P406, DOI 10.1046/j.1523-1747.2003.12351.x; Negis Y, 2005, IUBMB LIFE, V57, P23, DOI 10.1080/15216540500058980; Negis Y, 2007, BIOCHEM BIOPH RES CO, V359, P348, DOI 10.1016/j.bbrc.2007.05.094; Negis Y, 2006, ARCH BIOCHEM BIOPHYS, V450, P63, DOI 10.1016/j.abb.2006.02.027; Nell S, 2007, FREE RADICAL RES, V41, P930, DOI 10.1080/10715760701416988; Neuzil J, 2006, BIOCHEM BIOPH RES CO, V343, P1113, DOI 10.1016/j.bbrc.2006.03.052; Ni J, 2005, CANCER RES, V65, P9807, DOI 10.1158/0008-5472.CAN-05-1334; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Nishio K, 2011, FREE RADICAL BIO MED, V50, P1794, DOI 10.1016/j.freeradbiomed.2011.03.021; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Pepper MS, 2000, DEV DYNAM, V218, P507, DOI 10.1002/1097-0177(200007)218:3<507::AID-DVDY1012>3.0.CO;2-5; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Ren B, 2011, BLOOD, V117, P6036, DOI 10.1182/blood-2010-12-326017; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rossiter H, 2007, FASEB J, V21, P3994, DOI 10.1096/fj.07-8720com; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2006, ACTA CRYSTALLOGR F, V62, P1156, DOI 10.1107/S1744309106041728; Shan L, 2011, INFLAMMATION; Shiau CW, 2006, J BIOL CHEM, V281, P11819, DOI 10.1074/jbc.M511015200; Shibata N, 2001, P NATL ACAD SCI USA, V98, P2244, DOI 10.1073/pnas.041620398; Smolarek AK, 2011, NUTRIENTS, V3, P962, DOI 10.3390/nu3110962; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Upadhyay J, 2009, BIOINFORMATION, V3, P326, DOI 10.6026/97320630003326; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Zingg JM, 2007, MINI-REV MED CHEM, V7, P543; Zingg JM, 2012, BIOFACTORS, V38, P24, DOI 10.1002/biof.198; Zingg JM, 2010, FREE RADICAL BIO MED, V49, P1989, DOI 10.1016/j.freeradbiomed.2010.09.034; Zingg JM, 2010, MOL NUTR FOOD RES, V54, P679, DOI 10.1002/mnfr.200900404; Zingg JM, 2008, BIOCHIMIE, V90, P1703, DOI 10.1016/j.biochi.2008.07.008; Zingg JM, 2006, PHYTOCHEMICALS NUTR, P175	70	19	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101550	10.1371/journal.pone.0101550	http://dx.doi.org/10.1371/journal.pone.0101550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983950	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000119
J	Burnett, BJ; Altman, RB; Ferguson, A; Wasserman, MR; Zhou, Z; Blanchard, SC				Burnett, Benjamin J.; Altman, Roger B.; Ferguson, Angelica; Wasserman, Michael R.; Zhou, Zhou; Blanchard, Scott C.			Direct Evidence of an Elongation Factor-Tu/Ts.GTP.Aminoacyl-tRNA Quaternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein; Guanine Nucleotide Exchange Factor (GEF); Protein Synthesis; Translation; Translation Elongation Factor; Elongation Factor Ts; Elongation Factor Tu; Guanosine Nucleotide Exchange Factor; Ternary Complex	AMINOACYL-TRANSFER-RNA; DIFFERENT GROWTH-RATES; CENTER-DOT-GTP; FACTOR TU-GTP; FACTOR EF-TU; ESCHERICHIA-COLI; FACTOR-TS; TERNARY COMPLEX; NUCLEOTIDE EXCHANGE; BACTERIAL RIBOSOME	Background: Elongation factor-Tu (EF-Tu) chaperones aminoacyl-tRNA (aa-tRNA) to the elongating ribosome as a ternary complex with GTP. Results: EF-Ts facilitates EF-TuGTP binding to aa-tRNA through direct, transient interactions. Conclusion: EF-Ts accelerates the formation and decay of ternary complex through the formation of a transient EF-Tu/TsGTPaa-tRNA quaternary complex. Significance: These newly described interactions of EF-Ts may serve to regulate ternary complex abundance in the cell. During protein synthesis, elongation factor-Tu (EF-Tu) bound to GTP chaperones the entry of aminoacyl-tRNA (aa-tRNA) into actively translating ribosomes. In so doing, EF-Tu increases the rate and fidelity of the translation mechanism. Recent evidence suggests that EF-Ts, the guanosine nucleotide exchange factor for EF-Tu, directly accelerates both the formation and dissociation of the EF-Tu-GTP-Phe-tRNA(Phe) ternary complex (Burnett, B. J., Altman, R. B., Ferrao, R., Alejo, J. L., Kaur, N., Kanji, J., and Blanchard, S. C. (2013) J. Biol. Chem. 288, 13917-13928). A central feature of this model is the existence of a quaternary complex of EF-Tu/TsGTPaa-tRNA(aa). Here, through comparative investigations of phenylalanyl, methionyl, and arginyl ternary complexes, and the development of a strategy to monitor their formation and decay using fluorescence resonance energy transfer, we reveal the generality of this newly described EF-Ts function and the first direct evidence of the transient quaternary complex species. These findings suggest that EF-Ts may regulate ternary complex abundance in the cell through mechanisms that are distinct from its guanosine nucleotide exchange factor functions.	[Burnett, Benjamin J.; Altman, Roger B.; Wasserman, Michael R.; Zhou, Zhou; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Ferguson, Angelica; Blanchard, Scott C.] Weill Cornell Med Coll, Triinst Program Chem Biol, New York, NY 10065 USA	Cornell University; Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, Triinst Program Chem Biol, 1300 York Ave, New York, NY 10065 USA.	scb2005@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Altman, Russ/0000-0003-3859-2905	National Institutes of Health [GM079238, GM098859, MH099491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238, R01GM098859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC012026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079238, GM098859, and MH099491 (to S. C. B.).	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BREMER H, 1996, ESCHERICHIA COLI SAL, P1559; Burnett BJ, 2013, J BIOL CHEM, V288, P13917, DOI 10.1074/jbc.M113.460014; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Chapman SJ, 2012, J BIOL CHEM, V287, P1229, DOI 10.1074/jbc.M111.294850; CONDON C, 1992, EMBO J, V11, P4175, DOI 10.1002/j.1460-2075.1992.tb05511.x; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ehrenberg M, 2013, BIOCHIMIE, V95, P643, DOI 10.1016/j.biochi.2012.11.012; FERSHT A, 1985, ENZYME STRUCTURE MEC, P128; FURANO AV, 1975, P NATL ACAD SCI USA, V72, P4780, DOI 10.1073/pnas.72.12.4780; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; GORDON J, 1970, BIOCHEMISTRY-US, V9, P912, DOI 10.1021/bi00806a028; GORDON J, 1970, BIOCHEMISTRY-US, V9, P4233, DOI 10.1021/bi00823a028; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; Johansson M, 2008, CURR OPIN MICROBIOL, V11, P141, DOI 10.1016/j.mib.2008.02.015; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MIYAJIMA A, 1978, J BIOCHEM, V83, P453, DOI 10.1093/oxfordjournals.jbchem.a131932; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RIBEIRO S, 1995, ANAL BIOCHEM, V228, P330, DOI 10.1006/abio.1995.1359; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Rodnina MV, 1995, BIOCHEM CELL BIOL, V73, P1221, DOI 10.1139/o95-132; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; ROMERO G, 1985, J BIOL CHEM, V260, P6167; Sanderson LE, 2007, BIOCHEMISTRY-US, V46, P6194, DOI 10.1021/bi602548v; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; THOMPSON RC, 1982, J BIOL CHEM, V257, P6677; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wohlgemuth SE, 2013, NUCLEIC ACIDS RES, V41, P8021, DOI 10.1093/nar/gkt602; YAMAMOTO M, 1976, CELL, V8, P129, DOI 10.1016/0092-8674(76)90194-X; YEGIAN CD, 1966, P NATL ACAD SCI USA, V55, P839, DOI 10.1073/pnas.55.4.839; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; ZECHMEISTER L, 1953, EXPERIENTIA, V9, P16, DOI 10.1007/BF02147696	62	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23917	23927		10.1074/jbc.M114.583385	http://dx.doi.org/10.1074/jbc.M114.583385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990941	Green Published, hybrid			2022-12-25	WOS:000341505000057
J	Andrade, K; Guerra, S; Debut, A				Andrade, Kleber; Guerra, Sara; Debut, Alexis			Fullerene-Based Symmetry in Hibiscus rosa-sinensis Pollen	PLOS ONE			English	Article								The fullerene molecule belongs to the so-called super materials. The compound is interesting due to its spherical configuration where atoms occupy positions forming a mechanically stable structure. We first demonstrate that pollen of Hibiscus rosa-sinensis has a strong symmetry regarding the distribution of its spines over the spherical grain. These spines form spherical hexagons and pentagons. The distance between atoms in fullerene is explained applying principles of flat, spherical, and spatial geometry, based on Euclid's "Elements'' book, as well as logic algorithms. Measurements of the pollen grain take into account that the true spine lengths, and consequently the real distances between them, are measured to the periphery of each grain. Algorithms are developed to recover the spatial effects lost in 2D photos. There is a clear correspondence between the position of atoms in the fullerene molecule and the position of spines in the pollen grain. In the fullerene the separation gives the idea of equal length bonds which implies perfectly distributed electron clouds while in the pollen grain we suggest that the spines being equally spaced carry an electrical charge originating in forces involved in the pollination process.	[Andrade, Kleber; Guerra, Sara; Debut, Alexis] Univ Fuerzas Armadas ESPE, Ctr Nanociencia & Nanotecnol, Sangolqui, Ecuador	Escuela Politecnica Superior del Ejercito	Andrade, K (corresponding author), Univ Fuerzas Armadas ESPE, Ctr Nanociencia & Nanotecnol, Sangolqui, Ecuador.	kgandrade@espe.edu.ec	Debut, Alexis/H-8424-2019	Debut, Alexis/0000-0002-8269-7619				Beers L, 1992, GROWING HIBISCUS; BOLICK MR, 1981, REV PALAEOBOT PALYNO, V35, P61, DOI 10.1016/0034-6667(81)90014-2; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; FOWLER PW, 1993, CHEM PHYS LETT, V202, P371, DOI 10.1016/0009-2614(93)90055-6; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Girling RD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02779; Guerra S, 2013, ESPE CIENCIA TECNOLO, V4, P57; Jha S, 2013, EARTH SYSTEMS ENC SC, V4, P117; Karton A, 2013, J PHYS CHEM A, V117, P1834, DOI 10.1021/jp312585r; Kaya Y, 2013, REV PALAEOBOT PALYNO, V189, P50, DOI 10.1016/j.revpalbo.2012.11.004; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lacourse T, 2012, REV PALAEOBOT PALYNO, V182, P55, DOI 10.1016/j.revpalbo.2012.06.007; Shaheen N, 2009, J MED PLANTS RES, V3, P921; Zhang JY, 2012, J MECH PHYS SOLIDS, V60, P1757, DOI 10.1016/j.jmps.2012.06.001	14	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102123	10.1371/journal.pone.0102123	http://dx.doi.org/10.1371/journal.pone.0102123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003375	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700113
J	Benitez, HA; Puschel, T; Lemic, D; Cacija, M; Kozina, A; Bazok, R				Benitez, Hugo A.; Pueschel, Thomas; Lemic, Darija; Cacija, Maja; Kozina, Antonela; Bazok, Renata			Ecomorphological Variation of the Wireworm Cephalic Capsule: Studying the Interaction of Environment and Geometric Shape	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; FLUCTUATING ASYMMETRY; MORPHOLOGICAL INTEGRATION; CHARACTER DISPLACEMENT; LATITUDINAL GRADIENT; INDIVIDUAL VARIATION; AGRIOTES-USTULATUS; GENUS CEROGLOSSUS; SIZE DIMORPHISM; CARABID BEETLES	Studying the association between organismal morphology and environmental conditions has been very useful to test hypothesis regarding the influence of climate on shape. It has been long recognized that different environments produce dissimilar stress levels in insects, which can be reflected on the ability of an individual to overcome these pressures and spread further. Agriotes (Coleoptera: Elateridae) species infest agricultural fields in different parts of Croatia, inhabiting different climatic conditions. Previous biological studies have indicated that there is a relationship between some Agriotes biological parameters such as density and climatic conditions such as soil moisture and temperature. However, it is still unknown how these environmental properties influence the wireworm morphological structure. This is highly relevant because the head of this species is directly involved in the mobility in the soil, thus affecting the invasive capacity of this insect. Therefore the aim of this study was to assess the association between different climatic conditions and the morphological variation of Agriotes cephalic capsule. Advanced multivariate analysis and geometric morphometric tool were applied to study the covariation between shape and environmental variables. Partial Least Squares methods were used in order to analyse the association between the wireworm head shape and three different climatic conditions: soil type, temperature and rainfall. Our results showed that there is a high covariation between the wireworm head shape and the climatic conditions. It was suggested that the observed shape-environment association could be result of the high plasticity of this species in relation to its invasive capacity.	[Benitez, Hugo A.; Pueschel, Thomas] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Benitez, Hugo A.] Univ Tarapaca, Inst Alta Invest, Casilla, Arica, Chile; [Lemic, Darija; Cacija, Maja; Kozina, Antonela; Bazok, Renata] Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia	University of Manchester; Universidad de Tarapaca; University of Zagreb	Benitez, HA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester, Lancs, England.	hugo.benitez@postgrad.manchester.ac.uk	Benítez, Hugo A/C-5077-2011; Čačija, Maja/K-3057-2018; Püschel, Thomas A/AAS-4535-2020; Bazok, Renata/G-8225-2012; Benitez, Hugo/AAI-1928-2019	Benítez, Hugo A/0000-0001-7553-9893; Čačija, Maja/0000-0001-9841-2721; Püschel, Thomas A/0000-0002-2231-2297; Bazok, Renata/0000-0003-1655-8140; Benitez, Hugo/0000-0001-7553-9893	Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS'' [178-1782066-2065]	Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS''	This research was supported by the Ministry of Science, Education and Sports of the Republic of Croatia by project: "The spatial distribution of economically important pests with the use of GIS'' (178-1782066-2065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Alibert P, 2001, ZOOL SCR, V30, P299, DOI 10.1046/j.1463-6409.2001.00068.x; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Bazok R., 2010, PHEROMONE APPL MAIZE; Bazok R, 2007, GLASILO BILJNE ZASTI, V5, P339; Benefer CM, 2013, J PEST SCI, V86, P19, DOI 10.1007/s10340-012-0454-x; Benefer CM, 2012, APPL SOIL ECOL, V53, P39, DOI 10.1016/j.apsoil.2011.11.004; Benitez H, 2008, GAYANA, V72, P131; Benitez HA, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.11; Benitez HA, 2014, BIOL J LINN SOC, V111, P110, DOI 10.1111/bij.12194; Benitez HA, 2013, CURR ZOOL, V59, P769, DOI 10.1093/czoolo/59.6.769; Benitez HA, 2013, ZOOL SCI, V30, P289, DOI 10.2108/zsj.30.289; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bouyer J, 2007, J MED ENTOMOL, V44, P788, DOI 10.1603/0022-2585(2007)44[788:PSOGPG]2.0.CO;2; Bravi R, 2013, ACTA OECOL, V52, P57, DOI 10.1016/j.actao.2013.07.007; Brunner Nina, 2005, IOBC-WPRS Bulletin, V28, P117; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Castaneda LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058920; Clarke GM, 1998, AM NAT, V152, P762, DOI 10.1086/286207; COOK DF, 1990, ANIM BEHAV, V40, P428, DOI 10.1016/S0003-3472(05)80522-6; Corti M, 2001, BIOL J LINN SOC, V73, P99, DOI [10.1006/bijl.2001.0528, 10.1111/j.1095-8312.2001.tb01349.x]; DALY HV, 1985, ANNU REV ENTOMOL, V30, P415, DOI 10.1146/annurev.en.30.010185.002215; De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P381; De Esteban-Trivigno S, 2011, AMEGHINIANA, V48, P189, DOI 10.5710/AMGH.v48i2(313); Demirci B, 2012, J VECTOR ECOL, V37, P197, DOI 10.1111/j.1948-7134.2012.00217.x; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden I., 1998, STAT ANAL SHAPE; Furlan L, 1998, J APPL ENTOMOL, V122, P71, DOI 10.1111/j.1439-0418.1998.tb01464.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Gurgel-GonCAlves R, MED VET ENTOMOLOGY, V25, P84; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Kaupp A, 1997, LARVEN KAFER MITTELE, P330; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Kovacevic Z., 1960, PROBLEMATIKA ZEMLJIS, P567; Kozina A, 2012, FACTORS TEMPORAL SPA; Kozina A, 2013, INT J BIOMETEOROL, V57, P509, DOI 10.1007/s00484-012-0577-z; Laibner S., 2000, Elateridae. Ceske a Slovenske republiky.; LANDE R, 1985, J THEOR BIOL, V117, P651, DOI 10.1016/S0022-5193(85)80245-9; LAUDER GV, 1982, J THEOR BIOL, V97, P57, DOI 10.1016/0022-5193(82)90276-4; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; LIEBHOLD AM, 1993, ANNU REV ENTOMOL, V38, P303, DOI 10.1146/annurev.en.38.010193.001511; Maceljski M, 2002, POLJOPRIVREDNAENTOMO; McCullough EL, 2013, ANIM BEHAV, V86, P977, DOI 10.1016/j.anbehav.2013.08.017; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Monteiro LR, 2010, EVOLUTION, V64, P724, DOI 10.1111/j.1558-5646.2009.00857.x; Monteiro LR, 2013, HYSTRIX, V24, P25, DOI 10.4404/hystrix-24.1-6282; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; Parker WE, 2001, AGR FOREST ENTOMOL, V3, P85, DOI 10.1046/j.1461-9563.2001.00094.x; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; PATON DC, 1989, AUST J ECOL, V14, P473, DOI 10.1111/j.1442-9993.1989.tb01457.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Piras P, 2010, BIOL J LINN SOC, V99, P632, DOI 10.1111/j.1095-8312.2009.01379.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rohlf F.J., 2013, TPSDIG V 2 17; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roy D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-135; Sanzana MJ, 2013, REV BRAS ENTOMOL, V57, P411, DOI 10.1590/S0085-56262013005000045; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; TABACHNICK RE, 1990, EVOLUTION, V44, P416, DOI 10.1111/j.1558-5646.1990.tb05209.x; Tellez TR, 2006, INT J PLANT SCI, V167, P321, DOI 10.1086/499613; Toepfer S, 2007, ENTOMOL EXP APPL, V124, P61, DOI 10.1111/j.1570-7458.2007.00549.x; Toth M, 2013, J PEST SCI, V86, P3, DOI 10.1007/s10340-012-0429-y; TOTH Z, 1984, ACTA PHYTOPATHOL HUN, V19, P13; Traugott M, 2008, SOIL BIOL BIOCHEM, V40, P342, DOI 10.1016/j.soilbio.2007.08.013; Villani MG, 1999, ANNU REV ENTOMOL, V44, P233, DOI 10.1146/annurev.ento.44.1.233; Vogelweith F, 2014, J INSECT PHYSIOL, V64, P54, DOI 10.1016/j.jinsphys.2014.03.009	82	18	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102059	10.1371/journal.pone.0102059	http://dx.doi.org/10.1371/journal.pone.0102059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003506	gold, Green Published			2022-12-25	WOS:000339242700104
J	Manabe, YC; Nonyane, BAS; Nakiyingi, L; Mbabazi, O; Lubega, G; Shah, M; Moulton, LH; Joloba, M; Ellner, J; Dorman, SE				Manabe, Yukari C.; Nonyane, Bareng A. S.; Nakiyingi, Lydia; Mbabazi, Olive; Lubega, Gloria; Shah, Maunank; Moulton, Lawrence H.; Joloba, Moses; Ellner, Jerrold; Dorman, Susan E.			Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HOSPITALIZED ADULTS; XPERT MTB/RIF; URINE ANTIGEN; SEVERE SEPSIS; LOW-COST; OUTCOMES; BURDEN	Background: Mortality in hospitalized, febrile patients in Sub-Saharan Africa is high due to HIV-infected, severely immunosuppressed patients with opportunistic co-infection, particularly disseminated tuberculosis (TB) and cryptococcal disease. We sought to determine if a positive lateral flow assay (LFA) result for urine lipoarabinomannan (LAM) and cryptococcal antigenuria was associated with mortality. Methods: 351 hospitalized, HIV-positive adults with symptoms consistent with TB and who were able to provide both urine and sputum specimens were prospectively enrolled at Mulago National Referral Hospital in Uganda as part of a prospective accuracy evaluation of the lateral flow Determine TB LAM test. Stored frozen urine was retrospectively tested for cryptococcal antigen (CRAG) using the LFA. We fitted a multinomial logistic regression model to analyze factors associated with death within 2 months after initial presentation. Results: The median CD4 of the participants was 57 (IQR: 14-179) cells/mu l and 41% (145) were microbiologically confirmed TB cases. LAM LFA was positive in 38% (134), 7% (25) were CRAG positive, and 43% (151) were positive for either test in urine. Overall, 21% (75) died within the first 2 months, and a total of 32% (114) were confirmed dead by 6 months. At 2 months, 30% of LAM or CRAG positive patients were confirmed dead compared to 15.0% of those who were negative. In an adjusted model, LAM or CRAG positive results were associated with an increased risk of death (RRR 2.29, 95% CI: 1.29, 4.05; P = 0.005). Conclusions: In hospitalized HIV-infected patients, LAM or CRAG LFA positivity was associated with subsequent death within 2 months. Further studies are warranted to examine the impact of POC diagnostic 'test and treat' approach on patient-centered outcomes.	[Manabe, Yukari C.; Nakiyingi, Lydia; Mbabazi, Olive; Lubega, Gloria] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Manabe, Yukari C.; Shah, Maunank; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Nonyane, Bareng A. S.; Moulton, Lawrence H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Joloba, Moses] Makerere Univ, Dept Microbiol, Coll Hlth Sci, Kampala, Uganda; [Ellner, Jerrold] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ellner, Jerrold] Boston Med Ctr, Boston, MA USA	Makerere University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Boston University; Boston Medical Center	Manabe, YC (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.	ymanabe@jhmi.edu	Nakiyingi, Lydia/ABG-7669-2020; Nonyane, Bareng A.S./AAC-8118-2020	Nakiyingi, Lydia/0000-0001-7263-3198; Nonyane, Bareng A.S./0000-0001-5633-7487; Joloba, Moses/0000-0002-0334-9983; Moulton, Lawrence/0000-0001-7041-7387	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN2722000900050C]; Johns Hopkins University Center for AIDS Research (National Institute of Allergy And Infectious Diseases) [1P30AI094189]; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI104830, P30AI094189] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins University Center for AIDS Research (National Institute of Allergy And Infectious Diseases); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract #HHSN2722000900050C, "TB Clinical Diagnostics Research Consortium.'' Additional Support was provided to YCM by the Johns Hopkins University Center for AIDS Research (Grant Number 1P30AI094189 from the National Institute of Allergy And Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba PA, 2011, J INFECT DEV COUNTR, V5, P377, DOI 10.3855/jidc.1096; Andama AO, 2013, JAIDS-J ACQ IMM DEF, V63, P189, DOI 10.1097/QAI.0b013e3182926f95; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Dorman S, 2012, CROI 2012 SEATTL; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, AIDS, V23, P1182, DOI 10.1097/QAD.0b013e32832be0fc; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; Munseri PJ, 2011, SCAND J INFECT DIS, V43, P696, DOI 10.3109/00365548.2011.577802; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Albuquerque MDPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-289; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Saleri N, 2009, INFECTION, V37, P142, DOI 10.1007/s15010-008-7406-7; Shah M, 2009, J ACQ IMMUN DEF SYND; Shah M, 2014, AIDS; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Van Rie A, 2013, C RETR OPP INF ATL G; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	40	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101459	10.1371/journal.pone.0101459	http://dx.doi.org/10.1371/journal.pone.0101459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000489	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300046
J	Mondal, S; Pathak, BK; Ray, S; Barat, C				Mondal, Surojit; Pathak, Bani Kumar; Ray, Sutapa; Barat, Chandana			Impact of P-Site tRNA and Antibiotics on Ribosome Mediated Protein Folding: Studies Using the Escherichia coli Ribosome	PLOS ONE			English	Article							AMINOACYLATED TRANSFER-RNAS; IN-VITRO; TRANSLATION INITIATION; DOMAIN-V; STRUCTURAL BASIS; DISTINCT ROLES; MESSENGER-RNA; BLASTICIDIN-S; BINDING; SUBUNIT	Background: The ribosome, which acts as a platform for mRNA encoded polypeptide synthesis, is also capable of assisting in folding of polypeptide chains. The peptidyl transferase center (PTC) that catalyzes peptide bond formation resides in the domain V of the 23S rRNA of the bacterial ribosome. Proper positioning of the 3' -CCA ends of the A- and P-site tRNAs via specific interactions with the nucleotides of the PTC are crucial for peptidyl transferase activity. This RNA domain is also the center for ribosomal chaperoning activity. The unfolded polypeptide chains interact with the specific nucleotides of the PTC and are released in a folding competent form. In vitro transcribed RNA corresponding to this domain (bDV RNA) also displays chaperoning activity. Results: The present study explores the effects of tRNAs, antibiotics that are A- and P-site PTC substrate analogs (puromycin and blasticidin) and macrolide antibiotics (erythromycin and josamycin) on the chaperoning ability of the E. coli ribosome and bDV RNA. Our studies using mRNA programmed ribosomes show that a tRNA positioned at the P-site effectively inhibits the ribosome's chaperoning function. We also show that the antibiotic blasticidin (that mimics the interaction between 3'-CCA end of P/P-site tRNA with the PTC) is more effective in inhibiting ribosome and bDV RNA chaperoning ability than either puromycin or the macrolide antibiotics. Mutational studies of the bDV RNA could identify the nucleotides U2585 and G2252 (both of which interact with P-site tRNA) to be important for its chaperoning ability. Conclusion: Both protein synthesis and their proper folding are crucial for maintenance of a functional cellular proteome. The PTC of the ribosome is attributed with both these abilities. The silencing of the chaperoning ability of the ribosome in the presence of P-site bound tRNA might be a way to segregate these two important functions.	[Mondal, Surojit; Pathak, Bani Kumar; Barat, Chandana] St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India; [Ray, Sutapa] Univ Calcutta, Dr BC Guha Ctr Genet Engn, Kolkata, W Bengal, India; [Ray, Sutapa] Univ Calcutta, Dept Biotechnol, Kolkata, W Bengal, India	St. Xavier's College Kolkata; University of Calcutta; University of Calcutta	Barat, C (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India.	chandanasgb@yahoo.com			Council of Scientific and Industrial Research [37(1334)/08/EMR-II]; Department of Science and Technology, Government of India [SERB/F/0643]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was financially supported by the Council of Scientific and Industrial Research [Grant number 37(1334)/08/EMR-II] and Department of Science and Technology, Government of India funded research fellowship scheme [Grant number SERB/F/0643]. S.M. is a Department of Biotechnology, Government of West Bengal, India, funded research fellow and B.K.P. is a Department of Science and Technology, Government of India funded research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; BERA AK, 1994, CURR SCI INDIA, V66, P230; BISCHOF O, 1994, J BIOL CHEM, V269, P18315; Bocchetta M, 1998, P NATL ACAD SCI USA, V95, P3525, DOI 10.1073/pnas.95.7.3525; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Di Giacco V, 2008, P NATL ACAD SCI USA, V105, P10715, DOI 10.1073/pnas.0801974105; Erlacher MD, 2006, J AM CHEM SOC, V128, P4453, DOI 10.1021/ja0588454; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fahlman RP, 2004, BIOCHEMISTRY-US, V43, P7575, DOI 10.1021/bi0495836; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; KALPAXIS DL, 1986, EUR J BIOCHEM, V154, P267, DOI 10.1111/j.1432-1033.1986.tb09392.x; Kannan K, 2011, ANN NY ACAD SCI, V1241, P33, DOI 10.1111/j.1749-6632.2011.06315.x; KINOSHITA T, 1970, J ANTIBIOT, V23, P288, DOI 10.7164/antibiotics.23.288; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Pang YH, 2013, J BIOL CHEM, V288, P19081, DOI 10.1074/jbc.M113.466748; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Polikanov YS, 2012, SCIENCE, V336, P915, DOI 10.1126/science.1218538; Rodriguez-Fonseca C, 2000, RNA, V6, P744, DOI 10.1017/S1355838200000091; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; SARKAR S, 1968, P NATL ACAD SCI USA, V60, P1479, DOI 10.1073/pnas.60.4.1479; Schafer MA, 2002, J BIOL CHEM, V277, P19095, DOI 10.1074/jbc.M108902200; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2009, NUCLEIC ACIDS RES, V37, P4033, DOI 10.1093/nar/gkp296; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Xiong LQ, 2005, ANTIMICROB AGENTS CH, V49, P281, DOI 10.1128/AAC.49.1.281-288.2005; Yan K, 2005, ANTIMICROB AGENTS CH, V49, P3367, DOI 10.1128/AAC.49.8.3367-3372.2005; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaman S, 2007, MOL MICROBIOL, V66, P1039, DOI 10.1111/j.1365-2958.2007.05975.x	51	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101293	10.1371/journal.pone.0101293	http://dx.doi.org/10.1371/journal.pone.0101293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000563	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300031
J	Barret, M; Pratico, CA; Camus, M; Beuvon, F; Jarraya, M; Nicco, C; Mangialavori, L; Chaussade, S; Batteux, F; Prat, F				Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Beuvon, Frederic; Jarraya, Mohamed; Nicco, Carole; Mangialavori, Luigi; Chaussade, Stanislas; Batteux, Frederic; Prat, Frederic			Amniotic Membrane Grafts for the Prevention of Esophageal Stricture after Circumferential Endoscopic Submucosal Dissection	PLOS ONE			English	Article							HIGH-GRADE DYSPLASIA; MUCOSAL RESECTION; BARRETTS-ESOPHAGUS; RADIOFREQUENCY ABLATION; SURFACE RECONSTRUCTION; GROWTH-FACTOR; TRANSPLANTATION; MUCOSECTOMY; THERAPY; CANCER	Background and Aims: The prevention of esophageal strictures following circumferential mucosal resection remains a major clinical challenge. Human amniotic membrane (AM) is an easily available material, which is widely used in ophthalmology due to its wound healing, anti-inflammatory and anti-fibrotic properties. We studied the effect of AM grafts in the prevention of esophageal stricture after endoscopic submucosal dissection (ESD) in a swine model. Animals and Methods: In this prospective, randomized controlled trial, 20 swine underwent a 5 cm-long circumferential ESD of the lower esophagus. In the AM Group (n = 10), amniotic membrane grafts were placed on esophageal stents; a subgroup of 5 swine (AM 1 group) was sacrificed on day 14, whereas the other 5 animals (AM 2 group) were kept alive. The esophageal stent (ES) group (n = 5) had ES placement alone after ESD. Another 5 animals served as a control group with only ESD. Results: The prevalence of symptomatic strictures at day 14 was significantly reduced in the AM group and ES groups vs. the control group (33%, 40% and 100%, respectively, p = 0.03); mean esophageal diameter was 5.8 +/- 3.6 mm, 6.8 +/- 3.3 mm, and 2.6 +/- 1.7 mm for AM, ES, and control groups, respectively. Median (range) esophageal fibrosis thickness was 0.87 mm (0.78-1.72), 1.19 mm (0.28-1.95), and 1.65 mm (0.7-1.79) for AM 1, ES, and control groups, respectively. All animals had developed esophageal strictures by day 35. Conclusions: The anti-fibrotic effect of AM on esophageal wound healing after ESD delayed the development of esophageal stricture in our model. However, this benefit was of limited duration in the conditions of our study.	[Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Mangialavori, Luigi; Chaussade, Stanislas; Prat, Frederic] Cochin Hosp, Dept Gastroenterol, Paris, France; [Barret, Maximilien; Pratico, Carlos Alberto; Camus, Marine; Beuvon, Frederic; Nicco, Carole; Chaussade, Stanislas; Batteux, Frederic; Prat, Frederic] Fac Paris Descartes, Paris, France; [Beuvon, Frederic] Cochin Hosp, Dept Pathol, Paris, France; [Jarraya, Mohamed] St Louis Hosp, Paris, France; [Nicco, Carole; Batteux, Frederic] Cochin Hosp, Dept Immunol, Paris, France; [Nicco, Carole; Batteux, Frederic] Cochin Hosp, EA 1833, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Prat, F (corresponding author), Cochin Hosp, Dept Gastroenterol, Paris, France.	frederic.prat@cch.aphp.fr	Coriat, Romain/O-7902-2017; Camus, Marine/O-8570-2017; Barret, Maximilien/O-8341-2017; Nicco, Carole/X-6726-2019; Nicco, Carole/O-8169-2017; Batteux, Frederic/O-7889-2017	Camus, Marine/0000-0003-2566-3866; Nicco, Carole/0000-0001-8211-2556; Nicco, Carole/0000-0001-8211-2556; Batteux, Frederic/0000-0002-1265-7996; Barret, Maximilien/0000-0002-0566-7870	Fondation de l'Avenir, Paris, France [ET9-553]	Fondation de l'Avenir, Paris, France	The study received funding from the Fondation de l'Avenir, Paris, France (grant number ET9-553), www.fondationdelavenir.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; AKLE CA, 1981, LANCET, V2, P1003; Apaydin BB, 2001, EUR SURG RES, V33, P225, DOI 10.1159/000049710; Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739; Barret M, 2013, SURG LAPARO ENDO PER, V23, pE182, DOI 10.1097/SLE.0b013e31828b8328; Barret M, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-8; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Chennat J, 2009, AM J GASTROENTEROL, V104, P2684, DOI 10.1038/ajg.2009.465; Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019; Ezoe Y, 2011, J CLIN GASTROENTEROL, V45, P222, DOI 10.1097/MCG.0b013e3181f39f4e; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Fraser JF, 2009, BURNS, V35, P998, DOI 10.1016/j.burns.2009.01.003; GEHANNO P, 1981, ARCH OTOLARYNGOL, V107, P145; Gunel E, 2002, PEDIATR SURG INT, V18, P24, DOI 10.1007/s003830200005; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Katada C, 2003, GASTROINTEST ENDOSC, V57, P165, DOI 10.1067/mge.2003.73; KIM JC, 1995, CORNEA, V14, P473; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Koltuksuz U, 2001, J PEDIATR SURG, V36, P1504, DOI 10.1053/jpsu.2001.27032; Lee SB, 2000, CURR EYE RES, V20, P325, DOI 10.1076/0271-3683(200004)20:4;1-5;FT325; Mizutani T, 2010, HEPATO-GASTROENTEROL, V57, P1150; Muraine M, 2006, J FR OPHTALMOL, V29, P1070, DOI 10.1016/S0181-5512(06)73902-X; Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ozcelik MF, 2004, AM J SURG, V187, P257, DOI 10.1016/j.amjsurg.2003.11.008; Prat F, 2006, ESOPHAGEAL CIRCUMFER; Rajan E, 2005, ENDOSCOPY, V37, P1111, DOI 10.1055/s-2005-870531; Roland L, 2010, PLACENTA, V31, P392, DOI 10.1016/j.placenta.2010.02.007; Sato H, 2013, GASTROINTEST ENDOSC, V78, P250, DOI 10.1016/j.gie.2013.01.008; Seewald S, 2006, ENDOSCOPY, V38, P1029, DOI 10.1055/s-2006-944527; Shaheen NJ, 2011, GASTROENTEROLOGY, V141, P460, DOI 10.1053/j.gastro.2011.04.061; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Titi M, 2012, GASTROENTEROLOGY, V143, P564, DOI 10.1053/j.gastro.2012.04.051; Turkyilmaz Z, 2005, J SURG RES, V123, P182, DOI 10.1006/j.jss.2004.08.009; Willingham FF, 2009, GASTROINTEST ENDOSC, V69, P147, DOI 10.1016/j.gie.2008.09.010; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Witteman BPL, 2009, J GASTROINTEST SURG, V13, P2104, DOI 10.1007/s11605-009-1053-x; Wu Y, 2014, SURG ENDOSC, V28, P447, DOI 10.1007/s00464-013-3210-2; Zuercher BF, 2013, SURG ENDOSC, V27, P1022, DOI 10.1007/s00464-012-2509-8	42	25	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100236	10.1371/journal.pone.0100236	http://dx.doi.org/10.1371/journal.pone.0100236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992335	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400021
J	Domingue, BW; Belsky, DW; Harris, KM; Smolen, A; McQueen, MB; Boardman, JD				Domingue, Benjamin W.; Belsky, Daniel W.; Harris, Kathleen Mullan; Smolen, Andrew; McQueen, Matthew B.; Boardman, Jason D.			Polygenic Risk Predicts Obesity in Both White and Black Young Adults	PLOS ONE			English	Article							TO-HEIGHT RATIO; POPULATION STRATIFICATION; GENETIC RISK; ADIPOSITY; LOCI; INDIVIDUALS; ASSOCIATION; VARIANTS; GENOMICS; GROWTH	Objective: To test transethnic replication of a genetic risk score for obesity in white and black young adults using a national sample with longitudinal data. Design and Methods: A prospective longitudinal study using the National Longitudinal Study of Adolescent Health Sibling Pairs (n = 1,303). Obesity phenotypes were measured from anthropometric assessments when study members were aged 18-26 and again when they were 24-32. Genetic risk scores were computed based on published genome-wide association study discoveries for obesity. Analyses tested genetic associations with body-mass index (BMI), waist-height ratio, obesity, and change in BMI over time. Results: White and black young adults with higher genetic risk scores had higher BMI and waist-height ratio and were more likely to be obese compared to lower genetic risk age-peers. Sibling analyses revealed that the genetic risk score was predictive of BMI net of risk factors shared by siblings. In white young adults only, higher genetic risk predicted increased risk of becoming obese during the study period. In black young adults, genetic risk scores constructed using loci identified in European and African American samples had similar predictive power. Conclusion: Cumulative information across the human genome can be used to characterize individual level risk for obesity. Measured genetic risk accounts for only a small amount of total variation in BMI among white and black young adults. Future research is needed to identify modifiable environmental exposures that amplify or mitigate genetic risk for elevated BMI.	[Domingue, Benjamin W.; Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Belsky, Daniel W.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Smolen, Andrew] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Boardman, JD (corresponding author), Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA.	boardman@colorado.edu	McQueen, Matthew/X-5845-2019; Belsky, Daniel/AAB-4785-2021; Belsky, Daniel/HDN-5118-2022	Belsky, Daniel/0000-0001-5463-2212; Domingue, Ben/0000-0002-3894-9049	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; NIH/NICHD [R01HD060726]; CU Population Center [R24HD066613];  [T32-AG000029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD066613, R01HD060726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000029] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CU Population Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Add Health is funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Genotyping of the Sibling Pairs data was funded by the NIH/NICHD (R01HD060726). Additional research funds were provided by the NIH/NICHD funded CU Population Center (R24HD066613). DWB is supported in part by T32-AG000029. JDB had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Belsky DW, 2013, AM J PUBLIC HEALTH, V103, P73, DOI 10.2105/AJPH.2012.301139; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Boardman JD, 2013, AM J PUBLIC HEALTH, V103, P64, DOI 10.2105/AJPH.2013.301355; Boardman JD, 2011, DEMOGRAPHY, V48, P1517, DOI 10.1007/s13524-011-0057-9; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Demerath EW, 2013, HUM HERED, V75, P175, DOI 10.1159/000351742; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Elks CE, 2012, AM J CLIN NUTR, V95, P1150, DOI 10.3945/ajcn.111.027870; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Entzel P., 2009, ADD HLTH WAVE 4 DOCU, DOI 10.17615/C6HM11; Fernandez JR, 2012, INT J OBESITY, V36, P479, DOI 10.1038/ijo.2011.236; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Harris KM, 2013, TWIN RES HUM GENET, V16, P391, DOI 10.1017/thg.2012.137; Hester JM, 2012, INT J OBESITY, V36, P465, DOI 10.1038/ijo.2011.131; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Khoury MJ, 2012, AM J PUBLIC HEALTH, V102, P34, DOI 10.2105/AJPH.2011.300299; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Llewellyn CH, 2013, JAMA PEDIAT IN PRESS; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108	35	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101596	10.1371/journal.pone.0101596	http://dx.doi.org/10.1371/journal.pone.0101596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992585	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400095
J	Jelsbak, L; Hartman, H; Schroll, C; Rosenkrantz, JT; Lemire, S; Wallrodt, I; Thomsen, LE; Poolman, M; Kilstrup, M; Jensen, PR; Olsen, JE				Jelsbak, Lotte; Hartman, Hassan; Schroll, Casper; Rosenkrantz, Jesper T.; Lemire, Sebastien; Wallrodt, Inke; Thomsen, Line E.; Poolman, Mark; Kilstrup, Mogens; Jensen, Peter R.; Olsen, John E.			Identification of Metabolic Pathways Essential for Fitness of Salmonella Typhimurium In Vivo	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; INFECTION; MACROPHAGES; EXPRESSION; VIRULENCE; REQUIRES; BIOLOGY; MODELS; GROWTH	Bacterial infections remain a threat to human and animal health worldwide, and there is an urgent need to find novel targets for intervention. In the current study we used a computer model of the metabolic network of Salmonella enterica serovar Typhimurium and identified pairs of reactions (cut sets) predicted to be required for growth in vivo. We termed such cut sets synthetic auxotrophic pairs. We tested whether these would reveal possible combined targets for new antibiotics by analyzing the performance of selected single and double mutants in systemic mouse infections. One hundred and two cut sets were identified. Sixty-three of these included only pathways encoded by fully annotated genes, and from this subset we selected five cut sets involved in amino acid or polyamine biosynthesis. One cut set (asnA/asnB) demonstrated redundancy in vitro and in vivo and showed that asparagine is essential for S. Typhimurium during infection. trpB/trpA as well as single mutants were attenuated for growth in vitro, while only the double mutant was a cut set in vivo, underlining previous observations that tryptophan is essential for successful outcome of infection. speB/speF, speC was not affected in vitro but was attenuated during infection showing that polyamines are essential for virulence apparently in a growth independent manner. The serA/glyA cut-set was found to be growth attenuated as predicted by the model. However, not only the double mutant, but also the glyA mutant, were found to be attenuated for virulence. This adds glycine production or conversion of glycine to THF to the list of essential reactions during infection. One pair (thrC/kbl) showed true redundancy in vitro but not in vivo demonstrating that threonine is available to the bacterium during infection. These data add to the existing knowledge of available nutrients in the intra-host environment, and have identified possible new targets for antibiotics.	[Jelsbak, Lotte; Schroll, Casper; Rosenkrantz, Jesper T.; Wallrodt, Inke; Thomsen, Line E.; Olsen, John E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Hartman, Hassan; Poolman, Mark] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Med & Biol Sci, Oxford OX3 0BP, England; [Lemire, Sebastien; Kilstrup, Mogens; Jensen, Peter R.] Tech Univ Denmark, Ctr Syst Microbiol, Dept Syst Biol, DK-2800 Lyngby, Denmark	University of Copenhagen; Oxford Brookes University; Technical University of Denmark	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	jeo@sund.ku.dk	Kilstrup, Mogens/AAV-2030-2021; jensen, Peter Ruhdal/AAC-4891-2019; Olsen, John Elmerdahl/N-9271-2019	Jelsbak, Lotte/0000-0002-6642-7424; Jensen, Peter Ruhdal/0000-0003-2080-2070; Olsen, John Elmerdahl/0000-0001-6225-6587; Kilstrup, Mogens/0000-0002-3900-723X; Thomsen, Line Elnif/0000-0001-5460-9178	Danish Research Council for Technology and Production [274-07-0328]	Danish Research Council for Technology and Production	The Danish Research Council for Technology and Production supported this study through grant number 274-07-0328. The funder had no role in the study design, data collation and analysis, decision to publish or preparation of the manuscript.	Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; ENOMOTO M, 1974, VIROLOGY, V60, P503, DOI 10.1016/0042-6822(74)90344-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FELL DA, 1986, BIOCHEM J, V238, P781, DOI 10.1042/bj2380781; Furst P, 2004, J NUTR, V134, p1558S, DOI 10.1093/jn/134.6.1558S; GLANVILLE EV, 1960, GENETICS, V45, P1359; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gorke B, 2008, NAT REV MICROBIOL, V6, P275; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hartman HB, 2014, MICROBIOL-SGM, V160, P1252, DOI 10.1099/mic.0.076091-0; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hove-Jensen B, 1988, J BAC, V170, P1448; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; O'Connor TJ, 2012, SCIENCE, V338, P1440, DOI 10.1126/science.1229556; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; PIZER LI, 1964, J BACTERIOL, V88, P611, DOI 10.1128/JB.88.3.611-619.1964; Poolman MG, 2006, IEE P SYST BIOL, V153, P375, DOI 10.1049/ip-syb:20060010; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; SIGWART DF, 1989, INFECT IMMUN, V57, P1858, DOI 10.1128/IAI.57.6.1858-1861.1989; Smallbone K, 2007, FEBS J, V274, P5576, DOI 10.1111/j.1742-4658.2007.06076.x; STAUFFER GV, 1989, MOL GEN GENET, V220, P154, DOI 10.1007/BF00260870; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; WALLIS TS, 1995, INFECT IMMUN, V63, P2755, DOI 10.1128/IAI.63.7.2755-2761.1995	48	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101869	10.1371/journal.pone.0101869	http://dx.doi.org/10.1371/journal.pone.0101869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992475	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400126
J	Puhl, HL; Lu, VB; Won, YJ; Sasson, Y; Hirsch, JA; Ono, F; Ikeda, SR				Puhl, Henry L., III; Lu, Van B.; Won, Yu-Jin; Sasson, Yehezkel; Hirsch, Joel A.; Ono, Fumihito; Ikeda, Stephen R.			Ancient Origins of RGK Protein Function: Modulation of Voltage-Gated Calcium Channels Preceded the Protostome and Deuterostome Split	PLOS ONE			English	Article							GTP-BINDING PROTEINS; BETA-SUBUNIT; RAS-SUPERFAMILY; CA2+ CHANNELS; FAMILY; EXPRESSION; REM2; MEMBER; SURFACE; GENE	RGK proteins, Gem, Rad, Rem1, and Rem2, are members of the Ras superfamily of small GTP-binding proteins that interact with Ca2+ channel beta subunits to modify voltage-gated Ca2+ channel function. In addition, RGK proteins affect several cellular processes such as cytoskeletal rearrangement, neuronal dendritic complexity, and synapse formation. To probe the phylogenetic origins of RGK protein-Ca2+ channel interactions, we identified potential RGK-like protein homologs in genomes for genetically diverse organisms from both the deuterostome and protostome animal superphyla. RGK-like protein homologs cloned from Danio rerio (zebrafish) and Drosophila melanogaster (fruit flies) expressed in mammalian sympathetic neurons decreased Ca2+ current density as reported for expression of mammalian RGK proteins. Sequence alignments from evolutionarily diverse organisms spanning the protostome/deuterostome divide revealed conservation of residues within the RGK G-domain involved in RGK protein - Ca-v beta subunit interaction. In addition, the C-terminal eleven residues were highly conserved and constituted a signature sequence unique to RGK proteins but of unknown function. Taken together, these data suggest that RGK proteins, and the ability to modify Ca2+ channel function, arose from an ancestor predating the protostomes split from deuterostomes approximately 550 million years ago.	[Puhl, Henry L., III; Lu, Van B.; Won, Yu-Jin; Ikeda, Stephen R.] NIAAA, Lab Mol Physiol, Sect Transmitter Signaling, NIH, Rockville, MD 20852 USA; [Ono, Fumihito] NIAAA, Lab Mol Physiol, Sect Model Synapt Syst, NIH, Rockville, MD 20852 USA; [Sasson, Yehezkel; Hirsch, Joel A.] Tel Aviv Univ, Fac Life Sci, Inst Biol Struct, Dept Biochem & Mol Biol, Ramat Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Tel Aviv University	Ikeda, SR (corresponding author), NIAAA, Lab Mol Physiol, Sect Transmitter Signaling, NIH, Rockville, MD 20852 USA.	sikeda@mail.nih.gov	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Puhl, Henry/0000-0003-3095-7201; Lu, Van/0000-0002-4880-6455; ono, fumihito/0000-0001-7532-5262; Ikeda, Stephen/0000-0002-4088-9508	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; Israel Science Foundation [1519/12]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430, ZIAAA000437] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. YS and JAH were supported by the Israel Science Foundation (grant 1519/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DelVillar K, 1996, BIOCHEM SOC T, V24, P709; Dorin D, 1995, ONCOGENE, V11, P2267; Edel MJ, 2010, CELL CYCLE, V9, P3414, DOI 10.4161/cc.9.17.12719; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; de Velasco EMF, 2009, ZEBRAFISH, V6, P259, DOI 10.1089/zeb.2009.0594; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 1997, J BIOL CHEM, V272, P21982, DOI 10.1074/jbc.272.35.21982; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hollis DM, 2012, COMP BIOCHEM PHYS B, V161, P93, DOI 10.1016/j.cbpb.2011.09.011; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ikeda SR, 2004, METHOD ENZYMOL, V389, P170; Ikeda Stephen R, 2004, Methods Mol Biol, V259, P167; Kelly K, 2005, TRENDS CELL BIOL, V15, P640, DOI 10.1016/j.tcb.2005.10.002; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; Leyris JP, 2009, FASEB J, V23, P2627, DOI 10.1096/fj.08-122135; Lu Van B, 2009, J Vis Exp, DOI 10.3791/1614; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Manning JR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000459; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Moore AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074751; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Sasson Y, 2011, J MOL BIOL, V413, P372, DOI 10.1016/j.jmb.2011.08.017; Shimizu-Nishikawa K, 2001, DEV DYNAM, V220, P74, DOI 10.1002/1097-0177(20010101)220:1<74::AID-DVDY1090>3.0.CO;2-Q; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068; Zhou WB, 2008, DEV DYNAM, V237, P3842, DOI 10.1002/dvdy.21776; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100694	10.1371/journal.pone.0100694	http://dx.doi.org/10.1371/journal.pone.0100694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992013	gold, Green Submitted, Green Published			2022-12-25	WOS:000341253400027
J	Tallman, M; Amenta, N; Delson, E; Frost, SR; Ghosh, D; Klukkert, ZS; Morrow, A; Sawyer, GJ				Tallman, Melissa; Amenta, Nina; Delson, Eric; Frost, Stephen R.; Ghosh, Deboshmita; Klukkert, Zachary S.; Morrow, Andrea; Sawyer, Gary J.			Evaluation of a New Method of Fossil Retrodeformation by Algorithmic Symmetrization: Crania of Papionins (Primates, Cercopithecidae) as a Test Case	PLOS ONE			English	Article							VIRTUAL RECONSTRUCTION; BILATERAL SYMMETRY; DEFORMATION	Diagenetic distortion can be a major obstacle to collecting quantitative shape data on paleontological specimens, especially for three-dimensional geometric morphometric analysis. Here we utilize the recently -published algorithmic symmetrization method of fossil reconstruction and compare it to the more traditional reflection & averaging approach. In order to have an objective test of this method, five casts of a female cranium of Papio hamadryas kindae were manually deformed while the plaster hardened. These were subsequently "retrodeformed" using both algorithmic symmetrization and reflection & averaging and then compared to the original, undeformed specimen. We found that in all cases, algorithmic retrodeformation improved the shape of the deformed cranium and in four out of five cases, the algorithmically symmetrized crania were more similar in shape to the original crania than the reflected & averaged reconstructions. In three out of five cases, the difference between the algorithmically symmetrized crania and the original cranium could be contained within the magnitude of variation among individuals in a single subspecies of Papio. Instances of asymmetric distortion, such as breakage on one side, or bending in the axis of symmetry, were well handled, whereas symmetrical distortion remained uncorrected. This technique was further tested on a naturally deformed and fossilized cranium of Paradolichopithecus arvernensis. Results, based on a principal components analysis and Procrustes distances, showed that the algorithmically symmetrized Paradolichopithecus cranium was more similar to other, less-deformed crania from the same species than was the original. These results illustrate the efficacy of this method of retrodeformation by algorithmic symmetrization for the correction of asymmetrical distortion in fossils. Symmetrical distortion remains a problem for all currently developed methods of retrodeformation.	[Tallman, Melissa] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA; [Tallman, Melissa; Delson, Eric; Frost, Stephen R.; Klukkert, Zachary S.] New York Consortium Evolutionary Primatol, Morphometr Grp, New York, NY USA; [Amenta, Nina; Ghosh, Deboshmita] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Delson, Eric] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA; [Delson, Eric; Klukkert, Zachary S.] New York Consortium Evolutionary Primatol, New York, NY USA; [Delson, Eric; Klukkert, Zachary S.] CUNY, Grad Ctr, PhD Program Anthropol, New York, NY USA; [Delson, Eric] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Frost, Stephen R.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Ghosh, Deboshmita] Stratovan Corp, Sacramento, CA USA; [Morrow, Andrea] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Sawyer, Gary J.] Amer Museum Nat Hist, Dept Anthropol, New York, NY 10024 USA	Grand Valley State University; University of California System; University of California Davis; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; American Museum of Natural History (AMNH); University of Oregon; Grand Valley State University; American Museum of Natural History (AMNH)	Tallman, M (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	tallmame@gvsu.edu	Klukkert, Zachary S./Y-7788-2019; Tallman, Melissa/H-3189-2019	Klukkert, Zachary S./0000-0001-5006-8810; Tallman, Melissa/0000-0003-3747-5600; Delson, Eric/0000-0002-4062-7567	National Science Foundation [05-13894, 11-17663, 99-82351, 05-13660, 11-16921]; Professional Staff Congress-City University of New York Faculty Research Award Program [669381, 664333, 665407]; National Science Foundation Integrative Graduate Education and Research Traineeship [03-33415, 09-66166]	National Science Foundation(National Science Foundation (NSF)); Professional Staff Congress-City University of New York Faculty Research Award Program; National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF))	This research was supported, in part, by National Science Foundation grants 05-13894 and 11-17663 (to N.A.), 99-82351, 05-13660 and 11-16921 (to E.D.); Professional Staff Congress-City University of New York Faculty Research Award Program grants 669381, 664333 and 665407 (to E.D.); and National Science Foundation Integrative Graduate Education and Research Traineeship grants 03-33415 and 09-66166 (to E.D. for NYCEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2014, VERTEBR PALEOBIOL PA, P209, DOI 10.1007/978-94-007-6841-3_13; Angielczyk KD, 2007, PALEOBIOLOGY, V33, P125, DOI 10.1666/06007.1; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Delson E., 1975, 6 P C REG COMN MED N, P91; Frost SR, 2003, ANAT REC PART A, V275A, P1048, DOI 10.1002/ar.a.10112; Ghosh D, 2010, COMPUT GRAPH FORUM, V29, P1681, DOI 10.1111/j.1467-8659.2010.01777.x; Golovinskiy A, 2009, LECT NOTES COMPUT SC, V5654, P170, DOI 10.1007/978-3-642-03596-8_10; Guipert G, 2014, CR PALEVOL, V13, P51, DOI 10.1016/j.crpv.2013.07.004; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Harvati K, 2004, P NATL ACAD SCI USA, V101, P1147, DOI 10.1073/pnas.0308085100; Kazhdan M., 2009, P 21 ANN CANADIAN C, P37; Keith A, 1914, J R ANTHROPOL INST G, V44, P12, DOI 10.2307/2843529; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitra NJ, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239514; Motani R, 1997, LETHAIA, V30, P221; Ogihara N, 2006, AM J PHYS ANTHROPOL, V130, P1, DOI 10.1002/ajpa.20332; Shultz AH, 1960, Z MORPHOL ANTHROPOL, V19, P149; Singleton M, 2002, J HUM EVOL, V42, P547, DOI 10.1006/jhev.2001.0539; Spencer Frank, 1990, PILTDOWN SCI FORGERY; Subsol G, 2013, AM J PHYS ANTHROPOL, V150, P266; Tschopp E, 2013, PALEONTOLOGIA ELECT; Wiley D. F., 2005, P IEEE VIS C, P1; Williams BA, 2012, AM J PHYS ANTHROPOL, V149, P1, DOI 10.1002/ajpa.22093; Williams S.H., 1990, CONTRIBUTIONS PALAEO, P46; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397; 1948, NATURE, V162, P688	30	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100833	10.1371/journal.pone.0100833	http://dx.doi.org/10.1371/journal.pone.0100833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992483	Green Published, gold			2022-12-25	WOS:000341253400030
J	Foster, SD; Griffin, DA; Dunstan, PK				Foster, Scott D.; Griffin, David A.; Dunstan, Piers K.			Twenty Years of High-Resolution Sea Surface Temperature Imagery around Australia: Inter-Annual and Annual Variability	PLOS ONE			English	Article							CLIMATE-CHANGE; MARINE ECOSYSTEMS; SMOOTHING SPLINES; LEEUWIN CURRENT; TRENDS; ICE	The physical climate defines a significant portion of the habitats in which biological communities and species reside. It is important to quantify these environmental conditions, and how they have changed, as this will inform future efforts to study many natural systems. In this article, we present the results of a statistical summary of the variability in sea surface temperature (SST) time-series data for the waters surrounding Australia, from 1993 to 2013. We partition variation in the SST series into annual trends, inter-annual trends, and a number of components of random variation. We utilise satellite data and validate the statistical summary from these data to summaries of data from long-term monitoring stations and from the global drifter program. The spatially dense results, available as maps from the Australian Oceanographic Data Network's data portal (http://www.cmar.csiro.au/geonetwork/srv/en/metadata.show?id = 51805), show clear trends that associate with oceanographic features. Noteworthy oceanographic features include: average warming was greatest off southern West Australia and off eastern Tasmania, where the warming was around 0.60C per decade for a twenty year study period, and insubstantial warming in areas dominated by the East Australian Current, but this area did exhibit high levels of inter-annual variability (long-term trend increases and decreases but does not increase on average). The results of the analyses can be directly incorporated into (biogeographic) models that explain variation in biological data where both biological and environmental data are on a fine scale.	[Foster, Scott D.; Dunstan, Piers K.] CSIROs Wealth Oceans Flagship, Hobart, Tas, Australia; [Griffin, David A.] CSIROs Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Foster, SD (corresponding author), CSIROs Wealth Oceans Flagship, Hobart, Tas, Australia.	scott.foster@csiro.au	Foster, Scott D/E-9311-2010; Dunstan, Piers K/B-7309-2016	Foster, Scott D/0000-0002-6719-8002; Dunstan, Piers K/0000-0002-2568-5945	Marine Biodiversity Hub through Australian Government's National Environmental Research Program (NERP)	Marine Biodiversity Hub through Australian Government's National Environmental Research Program (NERP)	SDF and PKD were supported by the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO Wealth from Oceans National Flagship, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Baumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067596; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Cresswell GR, 2004, MAR FRESHWATER RES, V55, P267, DOI 10.1071/MF03115; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Griffn D, 2004, DECADE SST SATELLITE; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hobday AJ, 2013, REV FISH BIOL FISHER; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Huber PJ, 1981, ROBUST STAT; Lough J., 2008, GEOPHYS RES LETT, V35; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Maslin M, 2012, NATURE, V486, P183, DOI 10.1038/486183a; Morton R, 2009, ENVIRONMETRICS, V20, P249, DOI 10.1002/env.925; Neter J., 1996, APPL LINEAR STAT MOD; O'Kane TJ, 2011, OCEAN MODEL, V38, P251, DOI 10.1016/j.ocemod.2011.04.003; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Ridgway K., 2007, GEOPHYS RES LETT, V34; Rochford D, 1988, CSIRO SEA, P45; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rousseeuw P, 2011, WIRES DATA MINING KN, V1; SAUNDERS RW, 1988, INT J REMOTE SENS, V9, P123, DOI 10.1080/01431168808954841; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; van Sebille E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051004; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Verbyla AP, 1999, J ROY STAT SOC C-APP, V48, P269, DOI 10.1111/1467-9876.00154; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353	40	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100762	10.1371/journal.pone.0100762	http://dx.doi.org/10.1371/journal.pone.0100762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988444	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100042
J	Gourraud, PA; Khankhanian, P; Cereb, N; Yang, SY; Feolo, M; Maiers, M; Rioux, JD; Hauser, S; Oksenberg, J				Gourraud, Pierre-Antoine; Khankhanian, Pouya; Cereb, Nezih; Yang, Soo Young; Feolo, Michael; Maiers, Martin; Rioux, John D.; Hauser, Stephen; Oksenberg, Jorge			HLA Diversity in the 1000 Genomes Dataset	PLOS ONE			English	Article							HIGH-RESOLUTION HLA; EXTENDED HUMAN MHC; MULTIPLE-SCLEROSIS; LINKAGE DISEQUILIBRIUM; LOCI; ASSOCIATION; ALLELES; MAP; IMMUNOGENETICS; INFORMATION	The 1000 Genomes Project aims to provide a deep characterization of human genome sequence variation by sequencing at a level that should allow the genome-wide detection of most variants with frequencies as low as 1%. However, in the major histocompatibility complex (MHC), only the top 10 most frequent haplotypes are in the 1% frequency range whereas thousands of haplotypes are present at lower frequencies. Given the limitation of both the coverage and the read length of the sequences generated by the 1000 Genomes Project, the highly variable positions that define HLA alleles may be difficult to identify. We used classical Sanger sequencing techniques to type the HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1 genes in the available 1000 Genomes samples and combined the results with the 103,310 variants in the MHC region genotyped by the 1000 Genomes Project. Using pairwise identity-by-descent distances between individuals and principal component analysis, we established the relationship between ancestry and genetic diversity in the MHC region. As expected, both the MHC variants and the HLA phenotype can identify the major ancestry lineage, informed mainly by the most frequent HLA haplotypes. To some extent, regions of the genome with similar genetic or similar recombination rate have similar properties. An MHC-centric analysis underlines departures between the ancestral background of the MHC and the genome-wide picture. Our analysis of linkage disequilibrium (LD) decay in these samples suggests that overestimation of pairwise LD occurs due to a limited sampling of the MHC diversity. This collection of HLA-specific MHC variants, available on the dbMHC portal, is a valuable resource for future analyses of the role of MHC in population and disease studies.	[Gourraud, Pierre-Antoine; Khankhanian, Pouya; Hauser, Stephen; Oksenberg, Jorge] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Cereb, Nezih; Yang, Soo Young] Histogenetics Inc, Ossining, NY USA; [Feolo, Michael] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN USA; [Rioux, John D.] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Marrow Donor Program; Universite de Montreal; Institut de Cardiologie de Montreal	Gourraud, PA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	pierreantoine.gourraud@ucsf.edu	Rioux, John D/A-9599-2015; Gourraud, Pierre-Antoine FD/O-3024-2015	Rioux, John D/0000-0001-7560-8326; Maiers, Martin/0000-0002-0198-2064; Gourraud, Pierre-Antoine/0000-0003-1131-9554	National Institute of Health [U19AI067152, RO1NS076492, RO1NS046297]; Office of Naval Research [N00014-11-1-0339]; Race to erase MS Junior Investigator Award; European Federation for Immunogenetics Julia Bodmer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046297, R01NS076492] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Race to erase MS Junior Investigator Award; European Federation for Immunogenetics Julia Bodmer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Health U19AI067152 (ARRA administrative supplement), RO1NS076492, RO1NS046297, and from the Office of Naval Research N00014-11-1-0339. PAG is a recipient of the Race to erase MS Junior Investigator Award and the European Federation for Immunogenetics Julia Bodmer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Bugawan TL, 2000, TISSUE ANTIGENS, V56, P392, DOI 10.1034/j.1399-0039.2000.560502.x; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Chaix R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000184; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Genome C, 2014, LIST SAMPL PHAS 1 IN; Genome C, 2014, 1000 GEN FTP DAT REL; Genome C, 2014, REF GEN SEQ 1000 GEN; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Khankhanian P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-626; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Major E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078410; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marsh SGE, 2012, TISSUE ANTIGENS, V80, P72, DOI 10.1111/j.1399-0039.2012.01882.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McElroy JP, 2010, HUM MOL GENET, V19, P3080, DOI 10.1093/hmg/ddq197; Meyer D, 2007, P 13 INT HIST WORKSH, V1, P653; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; NCBI, 2014, DBMHC IMM PORT; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersdorf EW, 2008, CURR OPIN IMMUNOL, V20, P588, DOI 10.1016/j.coi.2008.06.014; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Software B, 2014, BEAGL FORM DAT; Susal Caner, 2012, Methods Mol Biol, V882, P267, DOI 10.1007/978-1-61779-842-9_15; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Rood J, 2008, BONE MARROW TRANSPL, V41, P1, DOI 10.1038/sj.bmt.1705866; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	41	113	114	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97282	10.1371/journal.pone.0097282	http://dx.doi.org/10.1371/journal.pone.0097282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988075	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100006
J	Hurtado-Gonzales, JL; Loew, ER; Uy, JAC				Hurtado-Gonzales, Jorge L.; Loew, Ellis R.; Uy, J. Albert C.			Variation in the Visual Habitat May Mediate the Maintenance of Color Polymorphism in a Poeciliid Fish	PLOS ONE			English	Article							ALTERNATIVE MATING STRATEGIES; DIVERGENT SEXUAL SELECTION; LAKE VICTORIA CICHLIDS; BLUEFIN KILLIFISH; ENVIRONMENTAL VARIATION; INTRASPECIFIC VARIATION; LIGHTING ENVIRONMENT; AMBIENT LIGHT; MATE CHOICE; REEF FISH	The conspicuousness of animal signals is influenced by their contrast against the background. As such, signal conspicuousness will tend to vary in nature because habitats are composed of a mosaic of backgrounds. Variation in attractiveness could result in variation in conspecific mate choice and risk of predation, which, in turn, may create opportunities for balancing selection to maintain distinct polymorphisms. We quantified male coloration, the absorbance spectrum of visual pigments and the photic environment of Poecilia parae, a fish species with five distinct male color morphs: a drab (i.e., grey), a striped, and three colorful (i.e., blue, red and yellow) morphs. Then, using physiological models, we assessed how male color patterns can be perceived in their natural visual habitats by conspecific females and a common cichlid predator, Aequidens tetramerus. Our estimates of chromatic and luminance contrasts suggest that the three most colorful morphs were consistently the most conspicuous across all habitats. However, variation in the visual background resulted in variation in which morph was the most conspicuous to females at each locality. Likewise, the most colorful morphs were the most conspicuous morphs to cichlid predators. If females are able to discriminate between conspicuous prospective mates and those preferred males are also more vulnerable to predation, variable visual habitats could influence the direction and strength of natural and sexual selection, thereby allowing for the persistence of color polymorphisms in natural environments.	[Hurtado-Gonzales, Jorge L.; Uy, J. Albert C.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Loew, Ellis R.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA; [Uy, J. Albert C.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Syracuse University; Cornell University; University of Miami	Hurtado-Gonzales, JL (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	hurtadje@ucmail.uc.edu		Uy, J. Albert C./0000-0002-8437-5525	NSF CAREER [1137624]; College of Arts and Sciences at Syracuse University	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); College of Arts and Sciences at Syracuse University	This work was funded by a NSF CAREER grant (1137624) to JACU and the College of Arts and Sciences at Syracuse University to JACU and JLHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARCHER SN, 1990, VISION RES, V30, P225, DOI 10.1016/0042-6989(90)90038-M; ARCHER SN, 1987, VISION RES, V27, P1243, DOI 10.1016/0042-6989(87)90200-8; Banks AN, 2001, TRENDS ECOL EVOL, V16, P473, DOI 10.1016/S0169-5347(01)02245-5; Blows MW, 2003, EVOLUTION, V57, P1622, DOI 10.1111/j.0014-3820.2003.tb00369.x; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; Dalton BE, 2010, J EXP BIOL, V213, P2243, DOI 10.1242/jeb.037671; Darwin G., 1871, P423; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Fuller RC, 2005, J EVOLUTION BIOL, V18, P516, DOI 10.1111/j.1420-9101.2005.00886.x; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Fuller RC, 2004, EVOLUTION, V58, P1086; Fuller RC, 2002, P ROY SOC B-BIOL SCI, V269, P1457, DOI 10.1098/rspb.2002.2042; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Fuller RC, 2010, ANIM BEHAV, V80, P23, DOI 10.1016/j.anbehav.2010.03.017; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Gomez D, 2012, PROGRAM ANAL SPECTRO; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gray SM, 2008, P ROY SOC B-BIOL SCI, V275, P1785, DOI 10.1098/rspb.2008.0283; Hastad O, 2005, P NATL ACAD SCI USA, V102, P6391, DOI 10.1073/pnas.0409228102; HESTER FJ, 1968, VISION RES, V8, P1315, DOI 10.1016/0042-6989(68)90053-9; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; Hurtado-Gonzales JL, 2010, J EVOLUTION BIOL, V23, P1293, DOI 10.1111/j.1420-9101.2010.01995.x; Hurtado-Gonzales JL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-391; Hurtado-Gonzales JL, 2009, ANIM BEHAV, V77, P1187, DOI 10.1016/j.anbehav.2008.12.032; Kemp DJ, 2008, BIOL J LINN SOC, V95, P734, DOI 10.1111/j.1095-8312.2008.01112.x; KIRSCH M, 1989, VISION RES, V29, P389, DOI 10.1016/0042-6989(89)90003-5; Kroger RHH, 1999, VISION RES, V39, P2441, DOI 10.1016/S0042-6989(98)00256-9; Lackey ACR, 2013, J EVOLUTION BIOL, V26, P1611, DOI 10.1111/jeb.12173; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; Lettieri L, 2009, J EXP BIOL, V212, P2194, DOI 10.1242/jeb.025478; LEVINE JS, 1979, SENS PROCESS, V3, P95; LEVINE JS, 1979, SCIENCE, V204, P523, DOI 10.1126/science.432658; Liley N. R., 1966, Behaviour Suppl, V13, P1; Lindholm AK, 2004, HEREDITY, V92, P156, DOI 10.1038/sj.hdy.6800386; LIPETZ LE, 1988, VISION RES, V28, P1083, DOI 10.1016/0042-6989(88)90135-6; LOEW ER, 1994, VISION RES, V34, P1427, DOI 10.1016/0042-6989(94)90143-0; Loew ER, 2002, J EXP BIOL, V205, P927; Lythgoe J.N., 1979, ECOLOGY VISION; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; MACNICHOL EF, 1986, VISION RES, V26, P1543, DOI 10.1016/0042-6989(86)90174-4; Mansfield RJW, 1985, VIS SYST P S HON EF; Marshall N. Justin, 2003, P194, DOI 10.1007/978-0-387-22628-6_10; MCDONALD CG, 1995, J COMP PHYSIOL A, V176, P255; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; MUNTZ WRA, 1970, VISION RES, V10, P281, DOI 10.1016/0042-6989(70)90100-8; Owens GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005970; Pignatelli V, 2010, BIOL LETTERS, V6, P537, DOI 10.1098/rsbl.2009.1010; PRESS WH, 1986, NUMERICAL RECIPES AR; Rennison DJ, 2011, J EXP BIOL, V214, P3248, DOI 10.1242/jeb.057836; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Uy JAC, 2007, J EVOLUTION BIOL, V20, P1847, DOI 10.1111/j.1420-9101.2007.01378.x; Uy JAC, 2004, BEHAV ECOL, V15, P1003, DOI 10.1093/beheco/arh106; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Ward MN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-210; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; Weadick CJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S11; Weadick CJ, 2012, MOL BIOL EVOL, V29, P3045, DOI 10.1093/molbev/mss115; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	76	15	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101497	10.1371/journal.pone.0101497	http://dx.doi.org/10.1371/journal.pone.0101497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987856	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100100
J	Craig, DPA; Varnon, CA; Sokolowski, MBC; Wells, H; Abramson, CI				Craig, David Philip Arthur; Varnon, Christopher A.; Sokolowski, Michel B. C.; Wells, Harrington; Abramson, Charles I.			An Assessment of Fixed Interval Timing in Free-Flying Honey Bees (Apis mellifera ligustica): An Analysis of Individual Performance	PLOS ONE			English	Article							FORAGING BUMBLEBEES; FLOWER CONSTANCY; MEMORY DYNAMICS; REINFORCEMENT; SCHEDULES; BEHAVIOR; ECOLOGY; TIME; HUMMINGBIRDS; INVERTEBRATE	Interval timing is a key element of foraging theory, models of predator avoidance, and competitive interactions. Although interval timing is well documented in vertebrate species, it is virtually unstudied in invertebrates. In the present experiment, we used free-flying honey bees (Apis mellifera ligustica) as a model for timing behaviors. Subjects were trained to enter a hole in an automated artificial flower to receive a nectar reinforcer (i.e. reward). Responses were continuously reinforced prior to exposure to either a fixed interval (FI) 15-sec, FI 30-sec, FI 60-sec, or FI 120-sec reinforcement schedule. We measured response rate and post-reinforcement pause within each fixed interval trial between reinforcers. Honey bees responded at higher frequencies earlier in the fixed interval suggesting subject responding did not come under traditional forms of temporal control. Response rates were lower during FI conditions compared to performance on continuous reinforcement schedules, and responding was more resistant to extinction when previously reinforced on FI schedules. However, no "scalloped" or "break-and-run" patterns of group or individual responses reinforced on FI schedules were observed; no traditional evidence of temporal control was found. Finally, longer FI schedules eventually caused all subjects to cease returning to the operant chamber indicating subjects did not tolerate the longer FI schedules.	[Craig, David Philip Arthur; Varnon, Christopher A.; Abramson, Charles I.] Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA; [Sokolowski, Michel B. C.] Univ Picardie Jules Verne, Dept Psychol, Amiens, Picardy, France; [Wells, Harrington] Univ Tulsa, Dept Biol, Tulsa, OK 74104 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Tulsa	Abramson, CI (corresponding author), Oklahoma State Univ, Dept Psychol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu	Abramson, Charles/AAD-5709-2019	Abramson, Charles/0000-0001-8961-3089; Sokolowski, Michel/0000-0003-0357-1629	National Science Foundation [OISE-1043057]	National Science Foundation(National Science Foundation (NSF))	Parts of this work and its publication have been supported by a grant from the National Science Foundation (OISE-1043057). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson C. I., 1990, INVERTEBRATE LEARNIN; Abramson CI, 2010, ETHOLOGY, V116, P843, DOI 10.1111/j.1439-0310.2010.01796.x; ABRAMSON CI, 1988, J EXP ANAL BEHAV, V50, P483, DOI 10.1901/jeab.1988.50-483; ABRAMSON CI, 1995, J COMP PSYCHOL, V109, P390, DOI 10.1037/0735-7036.109.4.390; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Agostino PV, 2011, FRONTIERS INTEGRATIV, V5, P1; AMBLER S, 1976, J MATH PSYCHOL, V14, P53, DOI 10.1016/0022-2496(76)90014-6; BARRETT JE, 1974, J EXP ANAL BEHAV, V22, P561, DOI 10.1901/jeab.1974.22-561; BITTERMAN ME, 1965, AM PSYCHOL, V20, P396, DOI 10.1037/h0022328; BOGDANY FJ, 1978, BEHAV ECOL SOCIOBIOL, V3, P323, DOI 10.1007/BF00303198; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BUTLER CG, 1945, J EXP BIOL, V21, P5; CHENG K, 1993, J EXP PSYCHOL ANIM B, V19, P56, DOI 10.1037/0097-7403.19.1.56; Chittka Lars, 2004, P165; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Craig DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046729; DEWS PB, 1969, J EXP ANAL BEHAV, V12, P191, DOI 10.1901/jeab.1969.12-191; DEWS PB, 1978, J EXP ANAL BEHAV, V29, P67, DOI 10.1901/jeab.1978.29-67; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; DUKICH TD, 1973, J EXP ANAL BEHAV, V20, P281, DOI 10.1901/jeab.1973.20-281; Edgington E.S., 2007, RANDOMIZATION TESTS; ELSMORE TF, 1971, PSYCHON SCI, V23, P371, DOI 10.3758/BF03336158; Endress P. K., 1994, DIVERSITY EVOLUTIONA; ESKIN RM, 1960, AM J PSYCHOL, V73, P417, DOI 10.2307/1420180; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; GILL FB, 1988, ECOLOGY, V69, P1933, DOI 10.2307/1941170; Greggers U, 1997, ANIM LEARN BEHAV, V25, P458, DOI 10.3758/BF03209852; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; Grice JW, 2011, OBSERVATION ORIENTED MODELING: ANALYSIS OF CAUSE IN THE BEHAVIORAL SCIENCES, P1; Grice JW, 2012, BEHAV SCI-BASEL, V2, P1, DOI 10.3390/bs2010001; GROSSMANN KE, 1973, J EXP ANAL BEHAV, V20, P105, DOI 10.1901/jeab.1973.20-105; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Henderson J, 2006, CURR BIOL, V16, P512, DOI 10.1016/j.cub.2006.01.054; Higa JJ, 2004, BEHAV PROCESS, V67, P501, DOI 10.1016/j.beproc.2004.08.007; Hill PSM, 2001, ANIM BEHAV, V62, P729, DOI 10.1006/anbe.2001.1775; HILLS TT, 2003, METH NE FRO NEUROSCI, P77; Hut RA, 2011, PHILOS T R SOC B, V366, P2141, DOI 10.1098/rstb.2010.0409; JOHNSON DL, 1966, ANIM BEHAV, V14, P261, DOI 10.1016/S0003-3472(66)80081-7; Kleniginna P. R., 1979, BIOL PSYCHOL, V21, P14; KOLTERMANN R, 1971, Z VERGL PHYSIOL, V75, P49, DOI 10.1007/BF00335137; LAURENT E, 1985, BEHAV PROCESS, V10, P159, DOI 10.1016/0376-6357(85)90128-7; LEJEUNE H, 1991, LEARN MOTIV, V22, P84, DOI 10.1016/0023-9690(91)90018-4; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Linnaeus C, 1756, CALENDARIUM FLORAE; LOWE CF, 1977, J EXP ANAL BEHAV, V28, P189, DOI 10.1901/jeab.1977.28-189; MacDonald CJ, 2005, FUNCTIONAL NEURAL ME, P401; MARDEN JH, 1981, PHYSIOL ENTOMOL, V6, P431, DOI 10.1111/j.1365-3032.1981.tb00658.x; MECHNER F, 1963, J EXP ANAL BEHAV, V6, P323, DOI 10.1901/jeab.1963.6-323; MORSE WH, 1956, ANN NY ACAD SCI, V65, P303, DOI 10.1111/j.1749-6632.1956.tb49641.x; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Percival MS., 1965, FLORAL BIOL; Perry CJ, 2013, WIRES COGN SCI, V4, P561, DOI 10.1002/wcs.1248; Raine NE, 2007, ENTOMOL GEN, V29, P179; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Richelle M., 1980, TIME ANIMAL BEHAV; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sanderson CE, 2006, ETHOLOGY, V112, P937, DOI 10.1111/j.1439-0310.2006.01245.x; Saunders D.S., 1976, INSECT CLOCKS; SCHNEIDE.BA, 1969, J EXP ANAL BEHAV, V12, P677, DOI 10.1901/jeab.1969.12-677; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Sokolowski MBC, 2010, J NEUROSCI METH, V188, P235, DOI 10.1016/j.jneumeth.2010.02.013; Stephens D.W., 1986, pi; Talton LE, 1999, BEHAV PROCESS, V45, P193, DOI 10.1016/S0376-6357(99)00018-2; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; WADDINGTON KD, 1979, AM NAT, V114, P179, DOI 10.1086/283467; Wagner AE, 2013, J EXP BIOL, V216, P1131, DOI 10.1242/jeb.064881; Wainselboim AJ, 2003, J COMP PHYSIOL A, V189, P39, DOI 10.1007/s00359-002-0373-z; WELLS H, 1994, J APICULT RES, V33, P219, DOI 10.1080/00218839.1994.11100875; WELLS H, 1992, ECOL ENTOMOL, V17, P280, DOI 10.1111/j.1365-2311.1992.tb01059.x; WELLS H, 1983, J ANIM ECOL, V52, P829, DOI 10.2307/4457; WELLS H, 1986, J ANIM ECOL, V55, P881, DOI 10.2307/4422; WENNER AM, 1969, SCIENCE, V164, P84, DOI 10.1126/science.164.3875.84; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	79	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101262	10.1371/journal.pone.0101262	http://dx.doi.org/10.1371/journal.pone.0101262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983960	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000080
J	Fan, J; He, RL; Zhang, YB; Jin, XH				Fan, Jie; He, Runli; Zhang, Yinbo; Jin, Xiaohua			Systematic Significance of Leaf Epidermal Features in Holcoglossum (Orchidaceae)	PLOS ONE			English	Article							COMPARATIVE VEGETATIVE ANATOMY; MOLECULAR PHYLOGENETICS; AERIDINAE; EVOLUTION; TAXONOMY; VANDEAE; PLANTS; WAXES	Determining the generic delimitations within Aeridinae has been a significant issue in the taxonomy of Orchidaceae, and Holcoglossum is a typical case. We investigated the phylogenetic utility of the morphological traits of leaf epidermis in the taxonomy of Holcoglossum s.l. by using light and scanning electron microscopy to analyze 38 samples representing 12 species of Holcoglossum, with five species from five closely related genera, such as Ascocentrum, Luisia, Papilionanthe, Rhynchostylis and Vanda. Our results indicated that Holcoglossum can be distinguished from the related genera based on cuticular wax characteristics, and the inclusion of Holcoglossum himalaicum in Holcoglossum is supported by the epidermis characteristics found by LM and SEM. The percentage of the tetracytic, brachyparacytic, and laterocytic stomata types as well as the stomata index and certain combinations of special wax types support infrageneric clades and phylogenetic relationships that have been inferred from molecular data. Laterocytic and polarcytic stomata are perhaps ecological adaptations to the strong winds and ample rains in the alpine region of the Hengduanshan Mountains.	[Fan, Jie; He, Runli] Shanxi Univ Tradit Chinese Med, Coll Chinese Med, Taiyuan, Peoples R China; [Zhang, Yinbo] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Peoples R China; [Jin, Xiaohua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Shanxi University; Chinese Academy of Sciences; Institute of Botany, CAS	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaohuajin@ibcas.ac.cn						BARANOVA M, 1992, BOT REV, V58, P49, DOI 10.1007/BF02858543; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Carlsward BS, 2006, BOT J LINN SOC, V151, P165, DOI 10.1111/j.1095-8339.2006.00502.x; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Carpenter KJ, 2005, AM J BOT, V92, P1595, DOI 10.3732/ajb.92.10.1595; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson EA, 1987, P 12 WORLD ORCH C TO, P35; Christenson Eric A., 1998, Lindleyana, V13, P121; DAS S, 1992, BANGLADESH J BOTANY, V21, P65; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Gan Y, 2010, BOT STUD, V51, P325; GARAY L A, 1974, Botanical Museum Leaflets Harvard University, V23, P369; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Gardiner LM, 2013, BOT J LINN SOC, V173, P549, DOI 10.1111/boj.12102; Gardiner LM, 2012, PHYTOTAXA, V61, P47, DOI 10.11646/phytotaxa.61.1.4; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2004, NOVON, V14, P178; Jin XH, 2007, NORD J BOT, V25, P125, DOI 10.1111/j.2007.0107-055X.00018.x; Jin XiaoHua, 2004, Kew Bulletin, V59, P633, DOI 10.2307/4110926; Kaushik P, 1978, THESIS PANJAB U CHAN; Liu ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024864; Pansarin Emerson R., 2008, Boletim de Botanica da Universidade de Sao Paulo, V26, P79; Pridgeon A.M., 2014, GENERA ORCHIDACEARUM, V6; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stern WL, 2006, BOT J LINN SOC, V152, P91, DOI 10.1111/j.1095-8339.2006.00548.x; TOMLINSON P B, 1974, Taxon, V23, P109, DOI 10.2307/1218094; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439; TSI ZH, 1999, FLORA REIPUBLICAE PO, V19, P269; Wayne MM, 1996, BOT J LINN SOC, V120, P89; Wilkinson, 1979, PLANT SURFACE MAINLY, P97; WILLIAMS NH, 1979, BOT J LINN SOC, V78, P41, DOI 10.1111/j.1095-8339.1979.tb02185.x; Xiang XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052050; Yang Y, 2012, SYST BOT, V37, P861, DOI 10.1600/036364412X656518	38	6	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101557	10.1371/journal.pone.0101557	http://dx.doi.org/10.1371/journal.pone.0101557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983996	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000120
J	Dahmani, R; Just, PA; Delay, A; Canal, F; Finzi, L; Prip-Buus, C; Lambert, M; Sujobert, P; Buchet-Poyau, K; Miller, E; Cavard, C; Marmier, S; Terris, B; Billaud, M; Perret, C				Dahmani, R.; Just, P-A; Delay, A.; Canal, F.; Finzi, L.; Prip-Buus, C.; Lambert, M.; Sujobert, P.; Buchet-Poyau, K.; Miller, E.; Cavard, C.; Marmier, S.; Terris, B.; Billaud, M.; Perret, C.			A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR LKB1; SPLICE VARIANT; CANCER; MUSCLE; INACTIVATION; REVEALS; PATHWAY; LINK	The LKB1 tumor suppressor gene encodes a master kinase that coordinates the regulation of energetic metabolism and cell polarity. We now report the identification of a novel isoform of LKB1 (named Delta N-LKB1) that is generated through alternative transcription and internal initiation of translation of the LKB1 mRNA. The Delta N-LKB1 protein lacks the N-terminal region and a portion of the kinase domain. Although Delta N-LKB1 is catalytically inactive, it potentiates the stimulating effect of LKB1 on the AMP-activated protein kinase (AMPK) metabolic sensor through a direct interaction with the regulatory autoinhibitory domain of AMPK. In contrast, Delta N-LKB1 negatively interferes with the LKB1 polarizing activity. Finally, combining in vitro and in vivo approaches, we showed that Delta N-LKB1 has an intrinsic oncogenic property. Delta N-LKB1 is expressed solely in the lung cancer cell line, NCI-H460. Silencing of Delta N-LKB1 decreased the survival of NCI-H460 cells and inhibited their tumorigenicity when engrafted in nude mice. In conclusion, we have identified a novel LKB1 isoform that enhances the LKB1-controlled AMPK metabolic activity but inhibits LKB1-induced polarizing activity. Both the LKB1 tumor suppressor gene and the oncogene Delta N-LKB1 are expressed from the same locus and this may account for some of the paradoxical effects of LKB1 during tumorigenesis.	[Dahmani, R.; Just, P-A; Canal, F.; Finzi, L.; Prip-Buus, C.; Lambert, M.; Sujobert, P.; Cavard, C.; Marmier, S.; Terris, B.; Perret, C.] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Dahmani, R.; Just, P-A; Canal, F.; Finzi, L.; Prip-Buus, C.; Lambert, M.; Sujobert, P.; Cavard, C.; Marmier, S.; Terris, B.; Perret, C.] CNRS, UMR8104, Paris, France; [Dahmani, R.; Just, P-A; Canal, F.; Finzi, L.; Prip-Buus, C.; Lambert, M.; Sujobert, P.; Cavard, C.; Marmier, S.; Terris, B.; Perret, C.] Univ Paris 05, Paris, France; [Dahmani, R.; Just, P-A; Canal, F.; Finzi, L.; Cavard, C.; Marmier, S.; Terris, B.; Perret, C.] LNCC, Equipe Labellisee, Paris, France; [Delay, A.; Buchet-Poyau, K.; Billaud, M.] UJF, INSERM, Inst Albert Bonniot, CRI,U823, F-38706 La Tronche, France; [Miller, E.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Terris, B.] Hop Cochin, Pathol Unit, F-75674 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Boston University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Billaud, M (corresponding author), UJF, INSERM, Inst Albert Bonniot, CRI,U823, F-38706 La Tronche, France.	Marc.Billaud@ujf-grenoble.fr; christine.perret@inserm.fr	Terris, Benoit/P-1497-2017; PRIP-BUUS, Carina/P-9084-2017; Perret-Mayeux, Christine/L-3297-2017; JUST, Pierre-Alexandre/P-1972-2017; sujobert, pierre/N-8149-2017	Miller, Edward/0000-0002-2156-5962; perret, christine/0000-0003-4710-7051; Prip-Buus, Carina/0000-0002-2153-7857	INSERM; LNCC (France) 'Equipe labelisee Ligue Nationale Contre le Cancer'; INCA grants; LABEX Who amI?; LNCC fellowship	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); LNCC (France) 'Equipe labelisee Ligue Nationale Contre le Cancer'; INCA grants; LABEX Who amI?; LNCC fellowship	We thank Graham Hardie and Simon Hawley (University of Dundee, Dundee, UK) for their helpful comments and valuable scientific input into our work and also for their kindness in providing us with different antibodies and reagents to measure the LKB1-controlled AMPK activity and to test the role of Delta N-LKB1 on different ARKs. We are also grateful to Christelle Forcet, Nicolas Aznar and Maya Ghawitian from Billaud's laboratory for their help with the analysis of LKB1-induced polarizing activity. We are indebted to Benoit Viollet and Marc Foretz for providing us with AMPK plasmids and helpful discussions. We thank Pascal Maire (from Inserm U1016, Paris, France) and all people of the team for helpful discussions, suggestions and critical reading of the manuscript. We are grateful to Helene Blons (HEGP, Paris, France) and Sylvie Grazzeri (Inserm U823, Grenoble, France) for providing the lung cancer cell lines and some lung tumors, respectively. We also thank Veronique Lenoir and Catherine Esnous for technical help in fatty acid oxidation experiments, and animal facility of Institut Cochin for maintenance of mouse colonies. Core fundings came from INSERM, grants from LNCC (France) 'Equipe labelisee Ligue Nationale Contre le Cancer', INCA grants and LABEX Who amI?. RD was funded by an LNCC fellowship.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kottakis F, 2012, CELL RES, V22, P1617, DOI 10.1038/cr.2012.108; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rose AJ, 2009, J PHYSIOL-LONDON, V587, P1547, DOI 10.1113/jphysiol.2008.167528; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	33	16	16	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2337	2346		10.1038/onc.2014.182	http://dx.doi.org/10.1038/onc.2014.182			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24998845				2022-12-25	WOS:000353824800007
J	Dan, HC; Ebbs, A; Pasparakis, M; Van Dyke, T; Basseres, DS; Baldwin, AS				Dan, Han C.; Ebbs, Aaron; Pasparakis, Manolis; Van Dyke, Terry; Basseres, Daniela S.; Baldwin, Albert S.			Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by I kappa B Kinase alpha (IKK alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; DOMAIN PHOSPHORYLATION; FEEDBACK INHIBITION; GENETIC-ANALYSIS; CANCER; PTEN; RHEB; TUMORIGENESIS; SUPPRESSION; BETA	The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through phosphorylation of different downstream substrates. A key effector of Akt is the mammalian target of rapamycin (mTOR). Akt is known to stimulate mTORC1 activity through phosphorylation of tuberous sclerosis complex 2 (TSC2) and PRAS40, both negative regulators of mTOR activity. We previously reported that I kappa B kinase alpha (IKK alpha), a component of the kinase complex that leads to NF-kappa B activation, plays an important role in promoting mTORC1 activity downstream of activated Akt. Here, we demonstrate IKK alpha-dependent regulation of mTORC1 using multiple PTEN null cancer cell lines and an animal model with deletion of IKK alpha. Importantly, IKK alpha is shown to phosphorylate mTOR at serine 1415 in a manner dependent on Akt to promote mTORC1 activity. These results demonstrate that IKK alpha is an effector of Akt in promoting mTORC1 activity.	[Dan, Han C.; Ebbs, Aaron; Basseres, Daniela S.; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany; [Van Dyke, Terry] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Dan, Han C.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu	Pasparakis, Manolis/N-4350-2019; Bassères, Daniela S/C-6623-2013; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Bassères, Daniela S/0000-0001-7745-3567; Pasparakis, Manolis/0000-0002-9870-0966	National Institutes of Health [CA75080, AI35098, CA73756, K99CA149178]; Department of Defense Postdoctoral (DOD) Fellowship [PC060420]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [K99CA149178, R01CA073756, R01CA075080, R00CA149178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Postdoctoral (DOD) Fellowship(United States Department of Defense); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA75080 (to A. S. B.), AI35098 (to A. S. B.), CA73756 (to A. S. B.), and K99CA149178 (to H. C. D.). Additional support was provided by Department of Defense Postdoctoral (DOD) Fellowship PC060420 (to H. C. D.) and by the Samuel Waxman Cancer Research Foundation (to A. S. B.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dan HC, 2008, J IMMUNOL, V180, P7582, DOI 10.4049/jimmunol.180.11.7582; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinis JM, 2012, MOL CELL BIOL, V32, P2479, DOI 10.1128/MCB.00106-12; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Ozes ON, 1999, NATURE, V401, P82; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	58	82	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25227	25240		10.1074/jbc.M114.554881	http://dx.doi.org/10.1074/jbc.M114.554881			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24990947	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000341985300042
J	Lee, T; Di Paola, D; Malina, A; Mills, JR; Kreps, A; Grosse, F; Tang, HL; Zannis-Hadjopoulos, M; Larsson, O; Pelletier, J				Lee, Teresa; Di Paola, Domenic; Malina, Abba; Mills, John R.; Kreps, Amina; Grosse, Frank; Tang, Hengli; Zannis-Hadjopoulos, Maria; Larsson, Ola; Pelletier, Jerry			Suppression of the DHX9 Helicase Induces Premature Senescence in Human Diploid Fibroblasts in a p53-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; WERNER SYNDROME PROTEIN; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; CELL-CYCLE ARREST; GENE-EXPRESSION; IN-VIVO; MOLECULAR DETERMINANTS; CHECKPOINT RESPONSE; DEPENDENT MANNER	DHX9 is an ATP-dependent DEXH box helicase with a multitude of cellular functions. Its ability to unwind both DNA and RNA, as well as aberrant, noncanonical polynucleotide structures, has implicated it in transcriptional and translational regulation, DNA replication and repair, and maintenance of genome stability. We report that loss of DHX9 in primary human fibroblasts results in premature senescence, a state of irreversible growth arrest. This is accompanied by morphological defects, elevation of senescence-associated beta-galactosidase levels, and changes in gene expression closely resembling those encountered during replicative (telomere-dependent) senescence. Activation of the p53 signaling pathway was found to be essential to this process. ChIP analysis and investigation of nascent DNA levels revealed that DHX9 is associated with origins of replication and that its suppression leads to a reduction of DNA replication. Our results demonstrate an essential role of DHX9 in DNA replication and normal cell cycle progression.	[Lee, Teresa; Di Paola, Domenic; Malina, Abba; Mills, John R.; Kreps, Amina; Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Grosse, Frank] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden	McGill University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); State University System of Florida; Florida State University; McGill University; McGill University; Karolinska Institutet	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca		Malina, Abba/0000-0002-8511-9005; Larsson, Ola/0000-0003-1412-1308	National Institutes of Health [CA163291]; Canadian Institutes of Health Research [MOP-115126]; Swedish Research Council; Swedish Cancer Society; Strategic Training Initiative in Chemical Biology; Systems Biology training program fellowships from the Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R56CA094233, R01CA163291, R01CA094233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Strategic Training Initiative in Chemical Biology; Systems Biology training program fellowships from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA163291 (to J. P.). This work was also supported by Canadian Institutes of Health Research Grant MOP-115126, the Swedish Research Council and Swedish Cancer Society grants (to O. L.), and the Strategic Training Initiative in Chemical Biology and the Systems Biology training program fellowships from the Canadian Institutes of Health Research (to T. L.).	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Darzynkiewicz Z., 2001, CURR PROTOCOL CYTOM, V2; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Paola D, 2006, CANCER RES, V66, P5094, DOI 10.1158/0008-5472.CAN-05-3951; Di Paola D, 2012, J CELL BIOCHEM, V113, P1333, DOI 10.1002/jcb.24006; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fu VX, 2004, J BIOL CHEM, V279, P52218, DOI 10.1074/jbc.M405015200; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Jain A, 2013, NUCLEIC ACIDS RES, V41, P10345, DOI 10.1093/nar/gkt804; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Jee HJ, 2013, CANCER LETT, V335, P175, DOI 10.1016/j.canlet.2013.02.012; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; KOHN RR, 1975, SCIENCE, V188, P203, DOI 10.1126/science.188.4185.203-b; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu MZ, 2013, GENE DEV, V27, P2543, DOI 10.1101/gad.224170.113; Liu Z, 2007, EXP CELL RES, V313, P3743, DOI 10.1016/j.yexcr.2007.07.037; Luo HM, 2013, INT J ONCOL, V43, P1999, DOI 10.3892/ijo.2013.2141; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mills JR, 2013, BLOOD, V121, P3402, DOI 10.1182/blood-2012-06-434365; Monasor A, 2013, CELL CYCLE, V12, P1948, DOI 10.4161/cc.25017; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Pichierri P, 2011, AGING-US, V3, P311, DOI 10.18632/aging.100293; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Robles SJ, 1999, BIOCHEM PHARMACOL, V58, P675, DOI 10.1016/S0006-2952(99)00127-6; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Taylor WR, 1999, ONCOGENE, V18, P283, DOI 10.1038/sj.onc.1202516; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016; Zhang SS, 1997, J BIOL CHEM, V272, P11487; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; ZHANG SS, 1991, J BIOL CHEM, V266, P20483; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	75	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22798	22814		10.1074/jbc.M114.568535	http://dx.doi.org/10.1074/jbc.M114.568535			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990949	Green Published, hybrid			2022-12-25	WOS:000341017200024
J	Lingappan, K; Srinivasan, C; Jiang, WW; Wang, LH; Couroucli, XI; Moorthy, B				Lingappan, Krithika; Srinivasan, Chandra; Jiang, Weiwu; Wang, Lihua; Couroucli, Xanthi I.; Moorthy, Bhagavatula			Analysis of the Transcriptome in Hyperoxic Lung Injury and Sex-Specific Alterations in Gene Expression	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NF-KAPPA-B; CELL-DEATH; OXYGEN-TOXICITY; MOUSE LUNG; PULMONARY-FIBROSIS; GENDER-DIFFERENCES; OXIDATIVE-STRESS; UNITED-STATES; DISEASE	Exposure to high concentration of oxygen (hyperoxia) leads to lung injury in experimental animal models and plays a role in the pathogenesis of diseases such as Acute Respiratory Distress Syndrome (ARDS) and Bronchopulmonary dysplasia (BPD) in humans. The mechanisms responsible for sex differences in the susceptibility towards hyperoxic lung injury remain largely unknown. The major goal of this study was to characterize the changes in the pulmonary transcriptome following hyperoxia exposure and further elucidate the sex-specific changes. Male and female (8-10 wk) wild type (WT) (C57BL/6J) mice were exposed to hyperoxia (FiO(2)>0.95) and gene expression in lung tissues was studied at 48 h. A combination of fold change >= 1.4 and false discovery rate (FDR) <5% was used to define differentially expressed genes (DEGs). Overrepresentation of gene ontology terms representing biological processes and signaling pathway impact analysis (SPIA) was performed. Comparison of DEG profiles identified 327 genes unique to females, 585 unique to males and 1882 common genes. The major new findings of this study are the identification of new candidate genes of interest and the sex-specific transcriptomic changes in hyperoxic lung injury. We also identified DEGs involved in signaling pathways like MAP kinase and NF-kappa B which may explain the differences in sex-specific susceptibility to hyperoxic lung injury. These findings highlight changes in the pulmonary transcriptome and sex-specific differences in hyperoxic lung injury, and suggest new pathways, whose components could serve as sex-specific biomarkers and possible therapeutic targets for acute lung injury (ALI)/acute respiratory distress (ARDS) in humans.	[Lingappan, Krithika; Jiang, Weiwu; Wang, Lihua; Couroucli, Xanthi I.; Moorthy, Bhagavatula] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA; [Srinivasan, Chandra] Univ Texas Med Sch Houston, Dept Pediat, Div Pediat Cardiol, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Lingappan, K (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.	lingappa@bcm.edu			National Institutes of Health (NIH) [ES-019689, ES-001932, HL-087174, HL-112516, HL-088343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112516, R01HL087174, R01HL088343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019689, R01ES009132, P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institutes of Health (NIH) ES-019689, ES-001932, HL-087174, and HL-112516 to B. M. and HL-088343 to X. C. (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, CHEST, V130, P724, DOI 10.1378/chest.130.3.724; Ambalavanan N, 2011, PEDIATRICS, V128, pE1216, DOI 10.1542/peds.2011-1142; BANNAI S, 1989, J BIOL CHEM, V264, P18480; Barazzone C, 1998, AM J RESP CELL MOL, V19, P573, DOI 10.1165/ajrcmb.19.4.3173; Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089; Barinaga M, 1996, SCIENCE, V274, P724, DOI 10.1126/science.274.5288.724; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bhattacharya S, 2012, AM J RESP CRIT CARE, V186, P349, DOI 10.1164/rccm.201203-0406OC; BRYAN CL, 1988, CLIN CHEST MED, V9, P141; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2007, FREE RADICAL BIO MED, V42, P433, DOI 10.1016/j.freeradbiomed.2006.11.021; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; CLARK JM, 1971, PHARMACOL REV, V23, P37; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONDER JC, 1985, P NATL ACAD SCI USA, V82, P6315, DOI 10.1073/pnas.82.18.6315; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Hamon I, 2011, ARCH PEDIATRIE, V18, P247, DOI 10.1016/j.arcped.2010.12.004; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Hilgendorff A, 2014, AM J RESP CELL MOL, V50, P233, DOI 10.1165/rcmb.2013-0014TR; Horowitz S, 1999, CHEST, V116, p64S, DOI 10.1378/chest.116.suppl_1.64S; Howden R, 2012, AM J RESP CELL MOL, V46, P470, DOI 10.1165/rcmb.2011-0204OC; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; HUDAK BB, 1993, PHARMACOGENETICS, V3, P135, DOI 10.1097/00008571-199306000-00003; Jacobson JR, 2009, TRANSL RES, V154, P219, DOI 10.1016/j.trsl.2009.07.012; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kobayashi S, 2012, FREE RADICAL BIO MED, V53, P2197, DOI 10.1016/j.freeradbiomed.2012.09.040; KRAYBILL EN, 1989, J PEDIATR-US, V115, P115, DOI 10.1016/S0022-3476(89)80345-2; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; O'Reilly MA, 1998, AM J RESP CELL MOL, V18, P43, DOI 10.1165/ajrcmb.18.1.2950m; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Park HS, 2013, AM J RESP CELL MOL, V48, P105, DOI 10.1165/rcmb.2012-0043OC; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Perkowski S, 2003, AM J RESP CELL MOL, V28, P682, DOI 10.1165/rcmb.4692; Popescu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082421; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; R Core Team, 2021, R LANG ENV STAT COMP; Reddy AJ, 2009, J CELL MOL MED, V13, P1784, DOI 10.1111/j.1582-4934.2008.00581.x; Rhodes L, 2005, J ASTHMA, V42, P777, DOI 10.1080/02770900500308387; Romashko J, 2003, FREE RADICAL BIO MED, V35, P978, DOI 10.1016/S0891-5849(03)00494-5; Shaw GM, 2013, SEMIN PERINATOL, V37, P85, DOI 10.1053/j.semperi.2013.01.004; Slaughter JL, 2011, J PERINATOL, V31, P635, DOI 10.1038/jp.2010.213; Speyer CL, 2005, AM J PHYSIOL-CELL PH, V288, pC881, DOI 10.1152/ajpcell.00467.2004; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vento M, 2009, ANTIOXID REDOX SIGN, V11, P2945, DOI 10.1089/ars.2009.2671; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Yao Q, 2005, AM J PHYSIOL-LUNG C, V289, pL307, DOI 10.1152/ajplung.00030.2005	66	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101581	10.1371/journal.pone.0101581	http://dx.doi.org/10.1371/journal.pone.0101581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003466	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700041
J	Verma, SK; Alim, A				Verma, Sushant Kumar; Alim, Abdul			Differential Activity of Stanniocalcin in Male and Female Fresh Water Teleost Mastacembelus armatus (Lacepede) during Gonadal Maturation	PLOS ONE			English	Article							HETEROPNEUSTES-FOSSILIS BLOCH; SERUM-CALCIUM LEVEL; BREAM SPARUS-AURATA; SEASONAL-CHANGES; REPRODUCTIVE-CYCLE; INORGANIC-PHOSPHATE; STANNIUS CORPUSCLES; PIMEPHALES-PROMELAS; MOLECULAR-CLONING; PLASMA CALCIUM	The present study was carried out to analyze the differences in the activity of hormone stanniocalcin (STC) between male and female fishes of Mastacembelus armatus during their gonadal cycle. A large variation in nuclear diameter of cells of corpuscles of Stannius (CS) were recorded in relation to testicular cycle as well as ovarian cycle which indicates that the cellular activity varied with different phases of reproductive cycle in both male and female fish. Similar changes in nuclear diameter of CS cells were also observed after 17alpha-methyltestosterone administration in males and 17 beta-estradiol administrations in females. A positive correlation was observed between plasma STC levels, gonadosomatic index (GSI) and the sex steroids in both sexes, suggesting that STC has a role in the processes involved in gonadal development. In addition females showed remarkable changes in plasma calcium level during gonadal cycle while no such change for males were observed. In females the plasma calcium level estimated during different phases of reproductive cycle indicates positive correlation between plasma level of calcium and gonad growth. Thus hyperactivity of CS cells was noted in both male and female fishes during gonadal cycle along with the differences in the activity of STC as well. In female it may act as hypocalcemic factor and bring the level of calcium to normal which increases during preparatory and pre spawning phases to fulfill the increased demand of calcium for vitellogenesis. However data of male fishes indicated that plasma STC concentration varied widely during gonadal cycle but showed no consistent relationship to plasma calcium level.	[Verma, Sushant Kumar; Alim, Abdul] Ranchi Univ, Cooperat Coll, Ranchi, Jharkhand, India	Ranchi University	Verma, SK (corresponding author), Ranchi Univ, Cooperat Coll, Ranchi, Jharkhand, India.	vermasushant2008@gmail.com	Verma, Sushant/AAU-1890-2020					Adebiyi FA, 2013, FISH PHYSIOL BIOCHEM, V39, P547, DOI 10.1007/s10695-012-9718-x; AHMAD N, 1990, ARCH BIOL, V101, P285; BALBONTIN F, 1978, COMP BIOCHEM PHYS A, V61, P617, DOI 10.1016/0300-9629(78)90138-X; Bedjargi PRC, 2014, INT J RES FISH AQUA, V4, P63; BJORNSSON BT, 1985, J COMP PHYSIOL B, V155, P347, DOI 10.1007/BF00687477; Clark MS, 2002, J MOL ENDOCRINOL, V28, P111, DOI 10.1677/jme.0.0280111; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; FONTAINE M, 1964, CR HEBD ACAD SCI, V259, P875; Fuentes J, 2007, AM J PHYSIOL-REG I, V293, pR956, DOI 10.1152/ajpregu.00111.2007; Gillespie DK, 2004, ECOTOX ENVIRON SAFE, V58, P90, DOI 10.1016/j.ecoenv.2003.09.005; Guerreiro PM, 2002, J ENDOCRINOL, V173, P377, DOI 10.1677/joe.0.1730377; Guerreiro PM, 2001, AM J PHYSIOL-REG I, V281, pR855, DOI 10.1152/ajpregu.2001.281.3.R855; Guerriero G, 2005, ZOOL STUD, V44, P228; Guerriero G, 1998, ITAL J ZOOL, V65, P223, DOI 10.1080/11250009809386818; Hang XM, 2005, GEN COMP ENDOCR, V144, P188, DOI 10.1016/j.ygcen.2005.05.008; Hiroi O, 1970, B FAC FISH HOKKAIDO, V2, P179; Istria M, 1974, STEROIDS LIPID RES, V5, P42; JOHNSON DW, 1972, GEN COMP ENDOCR, V19, P7, DOI 10.1016/0016-6480(72)90002-0; Jones C, 1996, J ENDOCRINOL, V34, P393; LAFEBER FPJG, 1988, GEN COMP ENDOCR, V69, P19, DOI 10.1016/0016-6480(88)90048-2; Lee WK, 2002, AQUACULTURE, V207, P169, DOI 10.1016/S0044-8486(01)00728-1; Li Wei-guo, 1999, Zoological Research, V20, P147; LU MQ, 1994, AM J PHYSIOL-REG I, V267, pR1356, DOI 10.1152/ajpregu.1994.267.5.R1356; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; MAYERGOSTAN N, 1992, GEN COMP ENDOCR, V86, P10, DOI 10.1016/0016-6480(92)90120-9; NATH P, 1992, Indian Journal of Experimental Biology, V30, P464; Oguri M, 1967, B JAPAN SOC SCI FISH, V33, P161; PANDEY AC, 1988, GEN COMP ENDOCR, V69, P467, DOI 10.1016/0016-6480(88)90039-1; POLZONETTI A, 1983, GEN COMP ENDOCR, V54, P372; Shin J, 2008, ZOOL SCI, V25, P728, DOI 10.2108/zsj.25.728; Singh S., 1990, Boletim de Fisiologia Animal (Sao Paulo), V14, P81; SO YP, 1979, GEN COMP ENDOCR, V37, P143, DOI 10.1016/0016-6480(79)90101-1; Srivastav AK, 1996, GEN COMP ENDOCR, V104, P37, DOI 10.1006/gcen.1996.0138; Srivastav SK, 1998, BRAZ J MED BIOL RES, V31, P1069, DOI 10.1590/S0100-879X1998000800006; SRIVASTAVA SJ, 1994, ANN ENDOCRINOL-PARIS, V55, P197; SUBHEDAR N, 1979, Z MIKROSK ANAT FORSC, V93, P74; SUNDELL K, 1992, J COMP PHYSIOL B, V162, P489; SWARUP K, 1986, ZOOL ANZ, V217, P402; Swarup K, 1985, RECENT ADV ZOOLOGY, P89; URASA FM, 1985, CELL TISSUE RES, V241, P219, DOI 10.1007/BF00214644; Verma SK, 2010, J THREAT TAXA, V2, P992, DOI DOI 10.11609/JOTT.O2223.992-3; Verma SK, 2013, IND STR RES J, DOI [10.9780/22307850, DOI 10.9780/22307850]; Wagner GF, 1998, AM J PHYSIOL-REG I, V274, pR1177, DOI 10.1152/ajpregu.1998.274.4.R1177; Wagner GF, 2006, J EXP ZOOL PART A, V305A, P769, DOI 10.1002/jez.a.313; Wang DS, 2005, FISH PHYSIOL BIOCHEM, V31, P255, DOI 10.1007/s10695-006-0033-2; WOODHEAD PM, 1968, J MAR BIOL ASSOC UK, V48, P81, DOI 10.1017/S0025315400032434; Woodhead PMJ, 1964, IONAF ENV S SER, V117-175	47	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101439	10.1371/journal.pone.0101439	http://dx.doi.org/10.1371/journal.pone.0101439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003342	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700031
J	Ahmed, S; Salim, M; Chauhan, BS				Ahmed, Sharif; Salim, Muhammad; Chauhan, Bhagirath S.			Effect of Weed Management and Seed Rate on Crop Growth under Direct Dry Seeded Rice Systems in Bangladesh	PLOS ONE			English	Article							SUPPRESSION; DENSITY; COMPETITION; WHEAT	Weeds are a major constraint to the success of dry-seeded rice (DSR). The main means of managing these in a DSR system is through chemical weed control using herbicides. However, the use of herbicides alone may not be sustainable in the long term. Approaches that aim for high crop competitiveness therefore need to be exploited. One such approach is the use of high rice seeding rates. Experiments were conducted in the aman (wet) seasons of 2012 and 2013 in Bangladesh to evaluate the effect of weed infestation level (partially-weedy and weed-free) and rice seeding rate (20, 40, 60, 80, and 100 kg ha(-1)) on weed and crop growth in DSR. Under weed-free conditions, higher crop yields (5.1 and 5.2 t ha(-1) in the 2012 and 2013 seasons, respectively) were obtained at the seeding rate of 40 kg ha(-1) and thereafter, yield decreased slightly beyond 40 kg seed ha(-1). Under partially-weedy conditions, yield increased by 30 to 33% (2.0-2.2 and 2.9-3.2 t ha(-1) in the 2012 and 2013 seasons, respectively) with increase in seeding rate from 20 to 100 kg ha(-1). In the partially-weedy plots, weed biomass decreased by 41-60% and 54-56% at 35 days after sowing and at crop anthesis, respectively, when seeding rate increased from 20 to 100 kg ha(-1). Results from our study suggest that increasing seeding rates in DSR can suppress weed growth and reduce grain yield losses from weed competition.	[Ahmed, Sharif] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines; [Ahmed, Sharif; Salim, Muhammad] Bangladesh Agr Univ, Div Agron, Mymensingh, Bangladesh; [Chauhan, Bhagirath S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Toowoomba, Qld, Australia	CGIAR; International Rice Research Institute (IRRI); Bangladesh Agricultural University (BAU); University of Queensland	Ahmed, S (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines.	s.ahmed@irri.org	Ahmed, Sharif/L-8113-2017; Chauhan, Bhagirath/G-8892-2014	Ahmed, Sharif/0000-0003-3678-3345; Chauhan, Bhagirath/0000-0003-1540-4668	International Fund for Agricultural Development (IFAD); Cereal Systems Initiative for South Asia (CSISA, Bangladesh)	International Fund for Agricultural Development (IFAD); Cereal Systems Initiative for South Asia (CSISA, Bangladesh)	International Fund for Agricultural Development (IFAD) and Cereal Systems Initiative for South Asia (CSISA, Bangladesh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Khaliq, 2012, Pakistan Journal of Weed Science Research, V18, P167; Anwar P, 2011, AFR J BIOTECHNOL, V10, P15259, DOI 10.5897/AJB11.060; Arce GD, 2009, WEED TECHNOL, V23, P17, DOI 10.1614/WT-08-060.1; Azmi M., 2005, Rice is life: scientific perspectives for the 21st century. Proceedings of the World Rice Research Conference held in Tsukuba, Japan, 4-7 November 2004, P196; Buhler DD, 2000, WEED SCI, V48, P274, DOI 10.1614/0043-1745(2000)048[0274:TAPCTA]2.0.CO;2; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2011, FIELD CROP RES, V121, P226, DOI 10.1016/j.fcr.2010.12.008; Chauhan BS, 2011, FIELD CROP RES, V121, P105, DOI 10.1016/j.fcr.2010.11.019; Chauhan BS, 2010, FIELD CROP RES, V117, P177, DOI 10.1016/j.fcr.2010.02.014; Chauhan BS, 2012, CROP PROT, V38, P57, DOI 10.1016/j.cropro.2012.03.010; Choudhury BU, 2009, FIELD CROPS RES, V100, P229; Fischer AJ, 2000, WEED SCI, V48, P225, DOI 10.1614/0043-1745(2000)048[0225:HREOAE]2.0.CO;2; Gibson KD, 2002, WEED RES, V42, P351, DOI 10.1046/j.1365-3180.2002.00295.x; Kirkland KJ, 2000, WEED TECHNOL, V14, P692, DOI 10.1614/0890-037X(2000)014[0692:ACSRWH]2.0.CO;2; Kristensen L, 2008, WEED SCI, V56, P97, DOI 10.1614/WS-07-065.1; Lemerle D, 2004, J AGR SCI-CAMBRIDGE, V142, P395, DOI 10.1017/S002185960400454X; Mortensen D.A., 1998, INTEGRATED WEED SOIL, P293; Ni HW, 2004, WEED SCI, V52, P142, DOI 10.1614/P2002-148; O'Donovan JT, 2001, WEED SCI, V49, P746, DOI 10.1614/0043-1745(2001)049[0746:BSRITE]2.0.CO;2; Olsen J, 2005, WEED RES, V45, P316, DOI 10.1111/j.1365-3180.2005.00456.x; Phuong LT, 2005, J AGRON CROP SCI, V191, P185, DOI 10.1111/j.1439-037X.2005.00151.x; Place GT, 2009, WEED TECHNOL, V23, P497, DOI 10.1614/WT-08-134.1; Rao AN, 2007, ADV AGRON, V93, P153, DOI 10.1016/S0065-2113(06)93004-1; Shamsudduha M, 2009, HYDROL EARTH SYST SC, V13, P2373, DOI 10.5194/hess-13-2373-2009; Singh S, 2008, CROP PROT, V27, P660, DOI 10.1016/j.cropro.2007.09.012; Singh Y, 2008, DIRECT SEEDING RICE; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Weiner J, 2001, J APPL ECOL, V38, P784, DOI 10.1046/j.1365-2664.2001.00634.x; Zhao DL, 2007, FIELD CROP RES, V100, P327, DOI 10.1016/j.fcr.2006.08.007	29	28	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101919	10.1371/journal.pone.0101919	http://dx.doi.org/10.1371/journal.pone.0101919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000520	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300102
J	Chen, Y; Yang, LL; Liu, Y; Yang, HS; Wang, XW; Chen, DY				Chen, Yu; Yang, Lili; Liu, Yang; Yang, Haisong; Wang, Xinwei; Chen, Deyu			Surgical Results and Prognostic Factors of Anterior Cervical Corpectomy and Fusion for Ossification of the Posterior Longitudinal Ligament	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; FLOATING METHOD; FOLLOW-UP; SPINE; MYELOPATHY; DECOMPRESSION; COMPLICATIONS; SURGERY	Background: Mechanism of ossification of the posterior longitudinal ligament (OPLL) has not been elucidated clearly. Surgical decompression is usually necessary for the patients with neurological symptoms. Anterior decompression and resection of OPLL seems to be a radical surgical option, because the spinal cord is compressed from the anterior direction. Methods: Among 229 patients who underwent ACF for OPLL between January 2001 and December 2007 in our hospital, a total of 133 patients responded to the invitation and made return visits, with a follow-up rate of 58.1%. For these patients, clinical data were collected from medical and operative records. Neurological status were evaluated by using the Japanese Orthopedic Association (JOA) scoring system. Radiological evaluations including C2-7 lordotic angle, sagittal vertical axis (SVA), occupying rate of OPLL, double-layer sign and high-intensity zone were obtained from all the patients. Complications and causes of revision surgery were also investigated. Correlations between the long-term surgical outcome and various prognostic factors were statistically analyzed. Findings: Eighty-four males and forty-nine females completed the follow-up, with a mean age at operation of 56.8 years. The overall average JOA score significantly increased, with a mean recovery rate of 64.1% 614.2%. The mean C2-7 lordotic angle and SVA were also significantly improved, and fusion rate was satisfactory. The incidence of complications was consistent to the previous reports and most of them were controllable by suitable treatments. Multiple regression analysis showed that number of corpectmies and preoperative JOA score were important predictors of surgical outcome. Conclusions: ACF is a reliable and effective method for treating OPLL patients in terms of neurological recovery, maintenance of radiological parameters, fusion rate and complications. Number of corpectomies and preoperative JOA score are important predictors for the clinical outcome when this procedure is used.	[Chen, Yu; Yang, Lili; Liu, Yang; Yang, Haisong; Wang, Xinwei; Chen, Deyu] Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China	Naval Medical University	Wang, XW (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Spine Surg, Shanghai, Peoples R China.	wxwspine@126.com; surgchenyu@163.com						Cardoso MJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10278; Chen Y. J., 2013, 2013 IEEE 15th International Symposium and Exhibition on Advanced Packaging Materials (APM 2013), P102, DOI 10.1109/ISAPM.2013.6510393; Chen Y, 2009, EUR SPINE J, V18, P1541, DOI 10.1007/s00586-009-1029-2; Chen Y, 2009, INT ORTHOP, V33, P477, DOI 10.1007/s00264-008-0542-y; Choi S, 2005, J SPINAL DISORD TECH, V18, P309, DOI 10.1097/01.bsd.0000161236.94894.fc; Fujimura Y, 1998, ARCH ORTHOP TRAUM SU, V117, P471, DOI 10.1007/s004020050296; Harker RJ, 2000, SPINE, V25, P2646; Hida Kazutoshi, 1997, Neurologia Medico-Chirurgica, V37, P173, DOI 10.2176/nmc.37.173; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180; Iwasaki M, 2007, SPINE, V32, P654, DOI 10.1097/01.brs.0000257566.91177.cb; IZAWA K, 1980, Journal of the Japanese Orthopaedic Association, V54, P461; Jain SK, 2005, NEUROL INDIA, V53, P283; Li H, 2008, EUR SPINE J, V17, P1277, DOI 10.1007/s00586-008-0740-8; Li H, 2011, SPINE J, V11, P1049, DOI 10.1016/j.spinee.2011.09.008; LIU K-C, 1990, Journal of the Japanese Orthopaedic Association, V64, P401; Masaki Y, 2007, J SPINAL DISORD TECH, V20, P7, DOI 10.1097/01.bsd.0000211260.28497.35; Matsunaga S, 1999, SPINE, V24, P937, DOI 10.1097/00007632-199905150-00002; Matsuoka T, 2001, SPINE, V26, P241, DOI 10.1097/00007632-200102010-00008; Mizuno J, 2001, Neurosurg Focus, V10, pE6; Nakamura M, 1998, SPINE, V23, P38, DOI 10.1097/00007632-199801010-00008; Odate S, 2012, J SPINAL DISORD TECH, V25, P133, DOI 10.1097/BSD.0b013e318211fc35; Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168; Okamoto K, 2004, J BONE MINER METAB, V22, P612, DOI 10.1007/s00774-004-0531-1; Sakai K, 2012, SPINE, V37, P367, DOI 10.1097/BRS.0b013e31821f4a51; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Shin JH, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10270; TAKETOMI E, 1992, SPINE, V17, pS55; Tani T, 2002, SPINE, V27, P2491, DOI 10.1097/00007632-200211150-00013; Terayama K, 1984, EPIDEMIOLOGICAL STUD, P55; Tomita T, 1994, EPIDEMIOLOGICAL STUD, P101; Tsukimoto H., 1960, ARCH JPN CHIR, V29, P1003; Yamaura I, 1999, CLIN ORTHOP RELAT R, P27, DOI 10.1097/00003086-199902000-00004	34	22	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102008	10.1371/journal.pone.0102008	http://dx.doi.org/10.1371/journal.pone.0102008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000183	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300115
J	Chiu, CH; Chao, A				Chiu, Chun-Huo; Chao, Anne			Distance-Based Functional Diversity Measures and Their Decomposition: A Framework Based on Hill Numbers	PLOS ONE			English	Article							RAOS QUADRATIC ENTROPY; PHYLOGENETIC DIVERSITY; PARTITIONING DIVERSITY; ECOSYSTEM-FUNCTION; BIODIVERSITY; COMMUNITIES; PATTERNS; EVENNESS; INDEXES; DISSIMILARITIES	Hill numbers (or the "effective number of species'') are increasingly used to characterize species diversity of an assemblage. This work extends Hill numbers to incorporate species pairwise functional distances calculated from species traits. We derive a parametric class of functional Hill numbers, which quantify "the effective number of equally abundant and (functionally) equally distinct species'' in an assemblage. We also propose a class of mean functional diversity (per species), which quantifies the effective sum of functional distances between a fixed species to all other species. The product of the functional Hill number and the mean functional diversity thus quantifies the (total) functional diversity, i.e., the effective total distance between species of the assemblage. The three measures (functional Hill numbers, mean functional diversity and total functional diversity) quantify different aspects of species trait space, and all are based on species abundance and species pairwise functional distances. When all species are equally distinct, our functional Hill numbers reduce to ordinary Hill numbers. When species abundances are not considered or species are equally abundant, our total functional diversity reduces to the sum of all pairwise distances between species of an assemblage. The functional Hill numbers and the mean functional diversity both satisfy a replication principle, implying the total functional diversity satisfies a quadratic replication principle. When there are multiple assemblages defined by the investigator, each of the three measures of the pooled assemblage (gamma) can be multiplicatively decomposed into alpha and beta components, and the two components are independent. The resulting beta component measures pure functional differentiation among assemblages and can be further transformed to obtain several classes of normalized functional similarity (or differentiation) measures, including N-assemblage functional generalizations of the classic Jaccard, Sorensen, Horn and Morisita-Horn similarity indices. The proposed measures are applied to artificial and real data for illustration.	[Chiu, Chun-Huo; Chao, Anne] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University	Chao, A (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	chao@stat.nthu.edu.tw		CHIU, CHUN-HUO/0000-0002-7096-2278	National Tsing Hua University, Taiwan; National Science Council, Taiwan [100-2118-M007-006-MY3]	National Tsing Hua University, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan. Contract number: 100-2118-M007-006-MY3 (http://web1.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT J ECOL, DOI DOI 10.1155/2012/478728; Bernard-Verdier M, 2013, J VEG SCI, V24, P877, DOI 10.1111/jvs.12048; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Carboni M, 2010, J PLANT ECOL, V3, P139, DOI 10.1093/jpe/rtp037; Carboni M, 2013, J VEG SCI, V24, P932, DOI 10.1111/jvs.12095; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Champely S, 2002, ENVIRON ECOL STAT, V9, P167, DOI 10.1023/A:1015170104476; Chao A, 2014, ANN REV ECO IN PRESS; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dukes JS, 2001, OIKOS, V94, P468, DOI 10.1034/j.1600-0706.2001.940309.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Escalas A, 2013, ENVIRON MICROBIOL, V15, P2642, DOI 10.1111/1462-2920.12156; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guiasu RC, 2011, NAT SCI, V3, P795, DOI DOI 10.4236/NS.2011.39104; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1152; Kosman E, 2014, EUR J PLANT PATHOL, V138, P467, DOI 10.1007/s10658-013-0323-3; Kosman E, 2007, NEW PHYTOL, V174, P683, DOI 10.1111/j.1469-8137.2007.02031.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; MacArthur R.H., 1972, pvii; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marshall A.M., 1979, INEQUALITIES THEORY; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, OIKOS, V116, P1422, DOI 10.1111/j.2007.0030-1299.15894.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Petchey OL, 2009, OIKOS, V118, P1118, DOI 10.1111/j.1600-0706.2009.17403.x; Pla L., 2012, FUNCTIONAL DIVERSITY, P27, DOI 10.1007/978-94-007-2648-2_3; Podani J, 2007, OIKOS, V116, P1427, DOI 10.1111/j.2007.0030-1299.16160.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reeve R, 2014, ARXIV14046520 CORN U; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Ricotta C, 2006, THEOR POPUL BIOL, V70, P237, DOI 10.1016/j.tpb.2006.06.003; Ricotta C, 2012, METHODS ECOL EVOL, V3, P519, DOI 10.1111/j.2041-210X.2011.00178.x; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Schmera D, 2009, AQUAT ECOL, V43, P157, DOI 10.1007/s10452-007-9152-9; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Vile D, 2006, ECOL LETT, V9, P1061, DOI 10.1111/j.1461-0248.2006.00958.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weiher Evan, 2011, P175; Weikard HP, 2006, DIVERS DISTRIB, V12, P215, DOI 10.1111/j.1366-9516.2006.00234.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	87	92	93	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100014	10.1371/journal.pone.0100014	http://dx.doi.org/10.1371/journal.pone.0100014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000299	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300006
J	Krellman, JW; Ruiz, HH; Marciano, VA; Mondrow, B; Croll, SD				Krellman, Jason W.; Ruiz, Henry H.; Marciano, Veronica A.; Mondrow, Bracha; Croll, Susan D.			Behavioral and Neuroanatomical Abnormalities in Pleiotrophin Knockout Mice	PLOS ONE			English	Article							GROWTH-ASSOCIATED MOLECULE; LONG-TERM POTENTIATION; HB-GAM; ENTORHINAL CORTEX; SYNAPTIC-TRANSMISSION; BINDING PROTEIN; HIPPOCAMPAL LTP; TEST BATTERIES; EXPRESSION; MOUSE	Pleiotrophin (PTN) is an extracellular matrix-associated protein with neurotrophic and neuroprotective effects that is involved in a variety of neurodevelopmental processes. Data regarding the cognitive-behavioral and neuroanatomical phenotype of pleiotrophin knockout (KO) mice is limited. The purpose of this study was to more fully characterize this phenotype, with emphasis on the domains of learning and memory, cognitive-behavioral flexibility, exploratory behavior and anxiety, social behavior, and the neuronal and vascular microstructure of the lateral entorhinal cortex (EC). PTN KOs exhibited cognitive rigidity, heightened anxiety, behavioral reticence in novel contexts and novel social interactions suggestive of neophobia, and lamina-specific decreases in neuronal area and increases in neuronal density in the lateral EC. Initial learning of spatial and other associative tasks, as well as vascular density in the lateral EC, was normal in the KOs. These data suggest that the absence of PTN in vivo is associated with disruption of specific cognitive and affective processes, raising the possibility that further study of PTN KOs might have implications for the study of human disorders with similar features.	[Krellman, Jason W.] CUNY, Grad Ctr, Neuropsychol Doctoral Subprogram, New York, NY USA; [Croll, Susan D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ruiz, Henry H.; Marciano, Veronica A.; Mondrow, Bracha; Croll, Susan D.] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Croll, Susan D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Regeneron	Krellman, JW (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	jason.krellman@mountsinai.org	Ruiz, Henry H./AAA-1872-2020	Ruiz, Henry H./0000-0002-0213-6759; Croll, Susan/0000-0002-3949-1877	CUNY	CUNY	This work was funded in part by a CUNY doctoral student research grant paid directly to the applicant (JWK). Remaining funding came from faculty start-up funds provided by CUNY and paid to the doctoral faculty member (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Birrell JM, 2000, J NEUROSCI, V20, P4320; Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Crawley JN, 2007, BEHAV PHENOTYPING TR, DOI [10.1002/0470119055, DOI 10.1002/0470119055]; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Dai ZS, 1996, SEMIN NEUROSCI, V8, P97, DOI 10.1006/smns.1996.0013; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; del Olmo N, 2009, GROWTH FACTORS, V27, P189, DOI 10.1080/08977190902906859; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gramage E, 2013, ADDICT BIOL, V18, P19, DOI 10.1111/j.1369-1600.2011.00362.x; Gramage E, 2010, ADDICT BIOL, V15, P403, DOI 10.1111/j.1369-1600.2009.00202.x; HAMPTON BS, 1992, MOL BIOL CELL, V3, P85, DOI 10.1091/mbc.3.1.85; Hardman R, 1997, BRAIN RES, V758, P187, DOI 10.1016/S0006-8993(97)00223-0; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Hoistad M, 2008, NEUROIMAGE, V40, P1016, DOI 10.1016/j.neuroimage.2007.12.043; Huang CC, 2001, REV NEUROSCIENCE, V12, P51; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; KOCH M, 1991, BEHAV BRAIN RES, V42, P99, DOI 10.1016/S0166-4328(05)80044-0; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lauri SE, 1998, EUR J NEUROSCI, V10, P188; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Meunier M, 2006, J NEUROSCI, V26, P7718, DOI 10.1523/JNEUROSCI.1949-06.2006; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pavlov I, 2006, NEUROSCIENCE, V139, P505, DOI 10.1016/j.neuroscience.2005.11.070; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; PENG HB, 1995, J NEUROSCI, V15, P3027; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; RAULO E, 1992, J BIOL CHEM, V267, P11408; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Rauvala H, 1997, PROG NEUROBIOL, V52, P127, DOI 10.1016/S0301-0082(97)00007-5; Sadamatsu Miyuki, 2006, Congenital Anomalies, V46, P1, DOI 10.1111/j.1741-4520.2006.00094.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; TAKEDA A, 1995, NEUROSCIENCE, V68, P57, DOI 10.1016/0306-4522(95)00110-5; Taravini IRE, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-40; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Yang S, 2013, NEUROSCI LETT, V539, P86, DOI 10.1016/j.neulet.2013.01.046; Yeh HJ, 1998, J NEUROSCI, V18, P3699; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100597	10.1371/journal.pone.0100597	http://dx.doi.org/10.1371/journal.pone.0100597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000129	Green Published, gold			2022-12-25	WOS:000338637300011
J	Li, N; Sun, CY; Zhou, B; Xing, H; Ma, D; Chen, G; Weng, DH				Li, Na; Sun, Chaoyang; Zhou, Bo; Xing, Hui; Ma, Ding; Chen, Gang; Weng, Danhui			Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; HUMAN HEPATOMA-CELLS; DNA; INHIBITION; 8-OHDG; RISK	Objective: The role of Quercetin in ovarian cancer treatment remains controversial, and the mechanism is unknown. The aim of this study was to investigate the therapeutic effects of Quercetin in combination with Cisplatin and other antineoplastic drugs in ovarian cancer cells both in vitro and in vivo, along with the molecular mechanism of action. Methods: Quercetin treatment at various concentrations was examined in combination with Cisplatin, taxol, Pirarubicin and 5-Fu in human epithelial ovarian cancer C13* and SKOV3 cells. CCK8 assay and Annexin V assay were for cell viability and apoptosis analysis, immunofluorescence assay, DCFDA staining and realtime PCR were used for reactive oxygen species (ROS)-induced injury detection and endogenous antioxidant enzymes expression. Athymic BALB/c-nu nude mice were injected with C13*cells to obtain a xenograft model for in vivo studies. Immunohistochemical analysis was carried out to evaluate the ROS-induced injury and SOD1 activity of xenograft tumors. Results: Contrary to the pro-apoptotic effect of high concentration (40 mu M-100 mu M) of Quercetin, low concentrations (5 mu M-30 mu M) of Quercetin resulted in varying degrees of attenuation of cytotoxicity of Cisplatin treatment when combined with Cisplatin. Similar anti-apoptotic effects were observed when Quercetin was combined with other anti-neoplastic agents: Taxol, Pirarubicin and 5-Fluorouracil (5-Fu). Low concentrations of Quercetin were observed to suppress ROS-induced injury, reduce intracellular ROS level and increase the expression of endogenous antioxidant enzymes, suggesting a ROS-mediated mechanism of attenuating anti-neoplastic drugs. In xenogeneic model, Quercetin led to a substantial reduction of therapeutic efficacy of Cisplatin along with enhancing the endogenous antioxidant enzyme expression and reducing ROS-induced damage in xenograft tumor tissue. Conclusion: Taken together, these data suggest that Quercetin at low concentrations attenuate the therapeutic effects of Cisplatin and other anti-neoplastic drugs in ovarian cancer cells by reducing ROS damage. Quercetin supplementation during ovarian cancer treatment may detrimentally affect therapeutic response.	[Li, Na; Sun, Chaoyang; Zhou, Bo; Ma, Ding; Chen, Gang; Weng, Danhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Xing, Hui] Hubei Univ Arts & Sci, Affiliated Hosp 1, Xiangyang Cent Hosp, Dept Obstet & Gynecol, Xiangyang, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Arts & Science	Chen, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	gumpc@126.com; weng.dh@gmail.com			National Basic Research Program of China (973 Program) [2009CB521808]; National Nature and Science Foundation of China [81230038, 81272859, 81025011, 81090414, 81000979, 81101962]; Nature and Science Foundation of Hubei Province [2011CBD542]; Fundamental Research Funds for the Central Universities [HUST: 2012TS058]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 Program, 2009CB521808); National Nature and Science Foundation of China (81230038; 81272859; 81025011; 81090414; 81000979; 81101962); Nature and Science Foundation of Hubei Province (2011CBD542); Fundamental Research Funds for the Central Universities (HUST: 2012TS058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, CANCER RES, V61, P1862; Chang YF, 2006, NUTR CANCER, V55, P201, DOI 10.1207/s15327914nc5502_12; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Egert S, 2008, J NUTR, V138, P1615, DOI 10.1093/jn/138.9.1615; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Gates MA, 2009, INT J CANCER, V124, P1918, DOI 10.1002/ijc.24151; GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hollman PCH, 1997, CANCER LETT, V114, P139, DOI 10.1016/S0304-3835(97)04644-2; Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Ramos AM, 2008, BIOCHEM PHARMACOL, V75, P1912, DOI 10.1016/j.bcp.2008.02.007; Robaszkiewicz A, 2007, CELL BIOL INT, V31, P1245, DOI 10.1016/j.cellbi.2007.04.009; Samuel T, 2012, ANTICANCER RES, V32, P61; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010	21	53	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100314	10.1371/journal.pone.0100314	http://dx.doi.org/10.1371/journal.pone.0100314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999622	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300008
J	Meng, HY; Jiang, L; Xu, BS; Guo, WZ; Li, JL; Zhu, XQ; Qi, XQ; Duan, LX; Meng, XB; Fan, YL; Zhang, CY				Meng, Hongyan; Jiang, Ling; Xu, Bosi; Guo, Wenzhu; Li, Jinglai; Zhu, Xiuqing; Qi, Xiaoquan; Duan, Lixin; Meng, Xianbin; Fan, Yunliu; Zhang, Chunyi			Arabidopsis Plastidial Folylpolyglutamate Synthetase Is Required for Seed Reserve Accumulation and Seedling Establishment in Darkness	PLOS ONE			English	Article							ONE-CARBON METABOLISM; PISUM-SATIVUM-L; HIGHER-PLANTS; TETRAHYDROFOLATE BIOSYNTHESIS; FOLATE POLYGLUTAMYLATION; CELL ELONGATION; GERMINATION; THALIANA; GROWTH; ACID	Interactions among metabolic pathways are important in plant biology. At present, not much is known about how folate metabolism affects other metabolic pathways in plants. Here we report a T-DNA insertion mutant (atdfb-3) of the plastidial folylpolyglutamate synthetase gene (AtDFB) was defective in seed reserves and skotomorphogenesis. Lower carbon (C) and higher nitrogen (N) content in the mutant seeds than that of the wild type were indicative of an altered C and N partitioning capacity. Higher levels of organic acids and sugars were detected in the mutant seeds compared with the wild type. Further analysis revealed that atdfb-3 seeds contained less total amino acids and individual Asn and Glu as well as NO3-. These results indicate significant changes in seed storage in the mutant. Defects in hypocotyl elongation were observed in atdfb-3 in darkness under sufficient NO3- conditions, and further enhanced under NO3- limited conditions. The strong expression of AtDFB in cotyledons and hypocotyl during early developmental stage was consistent with the mutant sensitivity to limited NO3- during a narrow developmental window. Exogenous 5-formyl-tetrahydrofolate completely restored the hypocotyl length in atdfb-3 seedlings with NO3- as the sole N source. Further study demonstrated that folate profiling and N metabolism were perturbed in atdfb-3 etiolated seedlings. The activity of enzymes involved in N reduction and assimilation was altered in atdfb-3. Taken together, these results indicate that AtDFB is required for seed reserves, hypocotyl elongation and N metabolism in darkness, providing novel insights into potential associations of folate metabolism with seed reserve accumulation, N metabolism and hypocotyl development in Arabidopsis.	[Meng, Hongyan; Jiang, Ling; Xu, Bosi; Fan, Yunliu; Zhang, Chunyi] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Jiang, Ling; Fan, Yunliu; Zhang, Chunyi] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Guo, Wenzhu] Huazhong Agr Univ, Wuhan, Peoples R China; [Li, Jinglai; Zhu, Xiuqing] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Qi, Xiaoquan; Duan, Lixin; Meng, Xianbin] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Huazhong Agricultural University; Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, CY (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangchunyi@caas.cn	Qi, Xiaoquan/G-1545-2010	Qi, Xiaoquan/0000-0001-7175-115X	National Basic Research Program of China [2013CB127003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (grant no. 2013CB127003 to C.Z.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar TA, 2010, PLANT J, V64, P256, DOI 10.1111/j.1365-313X.2010.04330.x; Andre C, 2007, PLANT PHYSIOL, V145, P1670, DOI 10.1104/pp.107.108340; ANDREW KN, 1995, ANAL CHIM ACTA, V314, P33, DOI 10.1016/0003-2670(95)00269-6; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baud Sebastien, 2008, Arabidopsis Book, V6, pe0113, DOI 10.1199/tab.0113; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Blochl A, 2007, J PLANT PHYSIOL, V164, P1093, DOI 10.1016/j.jplph.2006.10.010; Canas RA, 2006, PLANTA, V224, P83, DOI 10.1007/s00425-005-0196-6; Cernac A, 2006, PLANT PHYSIOL, V141, P745, DOI 10.1104/pp.106.079574; CHAN PY, 1986, PLANT CELL PHYSIOL, V27, P431; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; Collakova E, 2008, PLANT CELL, V20, P1818, DOI 10.1105/tpc.108.058701; Conklin PL, 2013, J EXP BOT, V64, P2793, DOI 10.1093/jxb/ert140; Cowling RJ, 1999, J EXP BOT, V50, P1351, DOI 10.1093/jexbot/50.337.1351; Eastmond PJ, 2000, P NATL ACAD SCI USA, V97, P5669, DOI 10.1073/pnas.97.10.5669; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Fait A, 2011, PLANT PHYSIOL, V157, P1026, DOI 10.1104/pp.111.179986; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Francisco P, 2010, J PLANT PHYSIOL, V167, P890, DOI 10.1016/j.jplph.2010.01.006; Gambonnet B, 2001, J SCI FOOD AGR, V81, P835, DOI 10.1002/jsfa.870; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2011, ANNU REV PLANT BIOL, V62, P105, DOI 10.1146/annurev-arplant-042110-103819; HEATH JD, 1986, PLANTA, V169, P304, DOI 10.1007/BF00392124; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; Jiang L, 2013, PLANT PHYSIOL, V161, P971, DOI 10.1104/pp.112.203430; Josse EM, 2008, CURR BIOL, V18, pR1144, DOI 10.1016/j.cub.2008.10.034; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Mehrshahi P, 2010, PLANT J, V64, P267, DOI 10.1111/j.1365-313X.2010.04336.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; ONEAL D, 1973, ARCH BIOCHEM BIOPHYS, V159, P113, DOI 10.1016/0003-9861(73)90435-9; Penfield S, 2005, BIOCHEM SOC T, V33, P380, DOI 10.1042/BST0330380; Penfield S, 2004, PLANT CELL, V16, P2705, DOI 10.1105/tpc.104.024711; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; REED LS, 1979, J AGR FOOD CHEM, V27, P995, DOI 10.1021/jf60225a048; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; ROOS AJ, 1971, BIOCHEM J, V125, P17, DOI 10.1042/bj1250017; Sahr T, 2005, BIOCHEM SOC T, V33, P758, DOI 10.1042/BST0330758; Srivastava AC, 2011, PLANT PHYSIOL, V155, P1237, DOI 10.1104/pp.110.168278; Takahashi M, 2001, PLANT PHYSIOL, V126, P731, DOI 10.1104/pp.126.2.731; To Jennifer P C, 2002, BMC Plant Biol, V2, P4, DOI 10.1186/1471-2229-2-4; Van Wilder V, 2009, NEW PHYTOL, V182, P137, DOI 10.1111/j.1469-8137.2008.02707.x; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Yu L, 2010, J EXP BOT, V61, P1625, DOI 10.1093/jxb/erq028	56	14	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101905	10.1371/journal.pone.0101905	http://dx.doi.org/10.1371/journal.pone.0101905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000295	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300100
J	Monzen, S; Hosoda, M; Osanai, M; Tokonami, S				Monzen, Satoru; Hosoda, Masahiro; Osanai, Minoru; Tokonami, Shinji			Radiation Dose Reduction Efficiency of Buildings after the Accident at the Fukushima Daiichi Nuclear Power Station	PLOS ONE			English	Article							EVACUEES; CS-137	Numerous radionuclides were released from the Fukushima Daiichi Nuclear Power Station (F1-NPS) in Japan following the magnitude 9.0 earthquake and tsunami on March 11, 2011. Local residents have been eager to calculate their individual radiation exposure. Thus, absorbed dose rates in the indoor and outdoor air at evacuation sites in the Fukushima Prefecture were measured using a gamma-ray measuring devices, and individual radiation exposure was calculated by assessing the radiation dose reduction efficiency (defined as the ratio of absorbed dose rate in the indoor air to the absorbed dose rate in the outdoor air) of wood, aluminum, and reinforced concrete buildings. Between March 2011 and July 2011, dose reduction efficiencies of wood, aluminum, and reinforced concrete buildings were 0.55 +/- 0.04, 0.15 +/- 0.02, and 0.19 +/- 0.04, respectively. The reduction efficiency of wood structures was 1.4 times higher than that reported by the International Atomic Energy Agency. The efficiency of reinforced concrete was similar to previously reported values, whereas that of aluminum structures has not been previously reported. Dose reduction efficiency increased in proportion to the distance from F1-NPS at 8 of the 18 evacuation sites. Time variations did not reflect dose reduction efficiencies at evacuation sites although absorbed dose rates in the outdoor air decreased. These data suggest that dose reduction efficiency depends on structure types, levels of contamination, and evacuee behaviors at evacuation sites.	[Monzen, Satoru; Hosoda, Masahiro; Osanai, Minoru] Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan; [Tokonami, Shinji] Hirosaki Univ, Res Inst Radiat Emergency Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Monzen, S (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	monzens@cc.hirosaki-u.ac.jp	Tokonami, Shinji/AAH-6042-2020; Monzen, Satoru/AAF-9870-2021; monzen, satoru/F-1468-2013	Monzen, Satoru/0000-0003-2436-8048; monzen, satoru/0000-0003-2436-8048; Tokonami, Shinji/0000-0002-6617-7402	Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University; Hirosaki University Institutional Research	Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University; Hirosaki University Institutional Research	This study was supported by a Grant for Education Program for Professionals in Radiation Emergency Medicine in Hirosaki University (2011-2012), Grant for Hirosaki University Institutional Research (2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE S, 1981, J NUCL SCI TECHNOL, V18, P21, DOI 10.3327/jnst.18.21; Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Hosoda M, 2013, ENVIRON INT, V61, P73, DOI 10.1016/j.envint.2013.09.013; Hosoda M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02283; Hosoda M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00087; IAEA, 1979, IAEATECDOC225, pP 53; International Atomic Energy Agency, 2000, IAEATECODC1162; Katata G, 2012, J ENVIRON RADIOACTIV, V111, P2, DOI 10.1016/j.jenvrad.2011.09.011; Machart P, 2007, J ENVIRON RADIOACTIV, V97, P70, DOI 10.1016/j.jenvrad.2007.05.003; Minato S., 1978, REP GOV IND RES I NA, V27, P384; Monzen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027761; Prohl G, 2006, J ENVIRON RADIOACTIV, V91, P41, DOI 10.1016/j.jenvrad.2006.08.004; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Tsukada H, 2008, J ENVIRON RADIOACTIV, V99, P875, DOI 10.1016/j.jenvrad.2007.11.014; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245	15	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101650	10.1371/journal.pone.0101650	http://dx.doi.org/10.1371/journal.pone.0101650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999992	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300067
J	Wang, Y; Chen, F; Le, B; Stepp, DW; Fulton, DJR				Wang, Yusi; Chen, Feng; Le, Brian; Stepp, David W.; Fulton, David J. R.			Impact of Nox5 Polymorphisms on Basal and Stimulus-Dependent ROS Generation	PLOS ONE			English	Article							OXIDASE 5 NOX5; NADPH OXIDASE; NOX1-DEFICIENT MICE; OXIDATIVE STRESS; REACTIVE OXYGEN; BLOOD-VESSELS; CANCER CELLS; EXPRESSION; DISEASE; HYPERTENSION	Nox5 is an EF-hand containing, calcium-dependent isoform of the NADPH oxidase family of reactive oxygen species (ROS) generating enzymes. Altered expression and activity of Nox5 has been reported in cardiovascular diseases and cancers but the absence of Nox5 in rodents has precluded a greater understanding of its physiological and pathophysiological roles. Multiple polymorphisms have been identified within the coding sequence of human Nox5, but whether this translates into altered enzyme function is unknown. Herein, we have generated 15 novel mutants of Nox5 beta to evaluate the effect of exonic SNPs on basal and stimulated enzyme activity. Compared to the WT enzyme, ROS production was unchanged or slightly modified in the majority of mutants, but significantly decreased in 7. Focusing on M77K, Nox5 activity was dramatically reduced in unstimulated cells and following challenge with both calcium- and phosphorylation-dependent stimuli despite equivalent levels of expression. The M77K mutation did not influence the Nox5 phosphorylation or the ability to bind Hsp90, but in cell-free assays with excess co-factors and calcium, ROS production was dramatically reduced. A more conservative substitution M77V arising from another SNP yielded a different profile of enzyme activity and suggests a critical role of M77 in calcium-dependent ROS production. Two C-terminal mutants, R530H and G542R, were observed that had little to no activity and relatively high minor allele frequency (MAF). In conclusion, we have identified 7 missense SNPs in Nox5 that result in little or no enzyme activity. Whether humans with dysfunctional Nox5 variants have altered physiology or disease remains to be determined.	[Wang, Yusi; Chen, Feng; Le, Brian; Stepp, David W.; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Stepp, David W.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Fulton, David J. R.] Georgia Regents Univ, Dept Pharmacol, Augusta, GA USA	University System of Georgia; Augusta University; Nanjing Medical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fulton, DJR (corresponding author), Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA.	dfulton@gru.edu	Chen, Feng/E-1133-2011		National Institutes of Health [P01 HL101902-01A1, R01HL092446]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092446, P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health P01 HL101902-01A1 (DF), R01HL092446 (DS, DF), and by a Postdoctoral Fellowship from the AHA (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P676, DOI 10.1161/CIRCGENETICS.112.963314; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Deffert C, 2012, J PATHOL, V228, P341, DOI 10.1002/path.4061; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hahn NE, 2012, AM J PATHOL, V180, P2222, DOI 10.1016/j.ajpath.2012.02.018; Holterman CE, 2014, J AM SOC NEPHROL, V25, P784, DOI 10.1681/ASN.2013040371; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lim SC, 2009, DIABETOLOGIA, V52, P1343, DOI 10.1007/s00125-009-1368-x; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nielsen R, 2010, NATURE, V467, P1050, DOI 10.1038/4671050a; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Pandey D, 2012, AM J PHYSIOL-HEART C, V302, pH1919, DOI 10.1152/ajpheart.00910.2011; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Zhang Q, 2008, ARTERIOSCL THROM VAS, V28, P1627, DOI 10.1161/ATVBAHA.108.168278	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100102	10.1371/journal.pone.0100102	http://dx.doi.org/10.1371/journal.pone.0100102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992705	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400016
J	Zhou, QY; Gui, SY; Zhou, Q; Wang, Y				Zhou, Qiaoyun; Gui, Shuyu; Zhou, Qing; Wang, Yuan			Melatonin Inhibits the Migration of Human Lung Adenocarcinoma A549 Cell Lines Involving JNK/MAPK Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; LIGHT-CHAIN KINASE; JUNCTION-ASSOCIATED PROTEIN; RHO-ASSOCIATED KINASE; PLASMA OSTEOPONTIN; OCCLUDIN EXPRESSION; SIGNAL-TRANSDUCTION; PROSTATE-CANCER; COLON-CANCER; IN-VITRO	Objective: Melatonin, an indolamine produced and secreted predominately by the pineal gland, exhibits a variety of physiological functions, possesses antioxidant and antitumor properties. But, the mechanisms for the anti-cancer effects are unknown. The present study explored the effects of melatonin on the migration of human lung adenocarcinoma A549 cells and its mechanism. Methods: MTT assay was employed to measure the viability of A549 cells treated with different concentrations of melatonin. The effect of melatonin on the migration of A549 cells was analyzed by wound healing assay. Occludin location was observed by immunofluorescence. The expression of occludin, osteopontin (OPN), myosin light chain kinase (MLCK) and phosphorylation of myosin light chain (MLC), JNK were detected by western blots. Results: After A549 cells were treated with melatonin, the viability and migration of the cells were inhibited significantly. The relative migration rate of A549 cells treated with melatonin was only about 20% at 24 h. The expression level of OPN, MLCK and phosphorylation of MLC of A549 cells were reduced, while the expression of occludin was conversely elevated, and occludin located on the cell surface was obviously increased. The phosphorylation status of JNK in A549 cells was also reduced when cells were treated by melatonin. Conclusions: Melatonin significantly inhibits the migration of A549 cells, and this may be associated with the down-regulation of the expression of OPN, MLCK, phosphorylation of MLC, and up-regulation of the expression of occludin involving JNK/MAPK pathway.	[Zhou, Qiaoyun; Gui, Shuyu] Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China; [Zhou, Qing; Wang, Yuan] Anhui Med Univ, Mol Biol Lab, Hefei, Anhui, Peoples R China; [Zhou, Qing; Wang, Yuan] Anhui Med Univ, Dept Biochem, Hefei, Anhui, Peoples R China; [Gui, Shuyu; Zhou, Qing; Wang, Yuan] Anhui Med Univ, Key Lab Gene Res Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Gui, SY (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China.	guishuyu@126.com; wangyuan@ahmu.edu.cn			National Natural Science Foundation of China [81272399]; Natural Science Foundation of Anhui Province [90413116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by National Natural Science Foundation of China (No. 81272399) and Natural Science Foundation of Anhui Province (No. 90413116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHENBEL IF, 1954, CANCER, V71, P1954, DOI DOI 10.1002/1097-0142(19930315)71:6; AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Bellon A, 2007, J PINEAL RES, V42, P214, DOI 10.1111/j.1600-079X.2006.00408.x; Benitez-King G, 2009, HISTOL HISTOPATHOL, V24, P789, DOI 10.14670/HH-24.789; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonnefont-Rousselot D, 2011, J PINEAL RES, V50, P328, DOI 10.1111/j.1600-079X.2010.00847.x; Bramwell VHC, 2005, CANCER BIOL THER, V4, P1336, DOI 10.4161/cbt.4.12.2166; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; CHAMBERS AF, 1992, ANTICANCER RES, V12, P43; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Cos S, 1998, CANCER RES, V58, P4383; Dai M, 2008, J PINEAL RES, V44, P121, DOI 10.1111/j.1600-079X.2007.00498.x; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dominguez-Rodriguez A, 2011, INT J CARDIOL, V149, P382, DOI 10.1016/j.ijcard.2011.02.070; Dziadziuszko R, 2008, CLIN LUNG CANCER, V9, P78, DOI 10.3816/CLC.2008.n.012; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Fornas O, 2000, HORM RES, V53, P251, DOI 10.1159/000023575; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia-Navarro A, 2007, J PINEAL RES, V43, P195, DOI 10.1111/j.1600-079X.2007.00463.x; Gonzalez A, 2011, J PINEAL RES, V50, P250, DOI 10.1111/j.1600-079X.2010.00834.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grant SG, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000982; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Hoover KB, 1998, AM J PATHOL, V153, P1767, DOI 10.1016/S0002-9440(10)65691-X; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Kimura Y, 1997, AM J PATHOL, V151, P45; Kishi H, 2000, J BIOL CHEM, V275, P1414, DOI 10.1074/jbc.275.2.1414; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117; Mao LL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2794; Martinez-Campa CM, 2008, CANCER LETT, V268, P272, DOI 10.1016/j.canlet.2008.04.001; Mediavilla MD, 1999, LIFE SCI, V65, P415, DOI 10.1016/S0024-3205(99)00262-3; Messina G, 2010, J RES MED SCI, V15, P225; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Oates AJ, 1996, ONCOGENE, V13, P97; Ortiz-Lopez L, 2009, J PINEAL RES, V46, P15, DOI 10.1111/j.1600-079X.2008.00600.x; Padillo FJ, 2010, J PINEAL RES, V49, P264, DOI 10.1111/j.1600-079X.2010.00791.x; Papadopoulos MC, 2001, NEUROPATH APPL NEURO, V27, P384, DOI 10.1046/j.0305-1846.2001.00341.x; Petty RD, 2004, CLIN CANCER RES, V10, P3237, DOI 10.1158/1078-0432.CCR-03-0503; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Proietti S, 2011, J PINEAL RES, V50, P150, DOI 10.1111/j.1600-079X.2010.00824.x; Ramankulov A, 2007, PROSTATE, V67, P330, DOI 10.1002/pros.20540; Ramirez-Rodriguez G, 2007, J PINEAL RES, V42, P180, DOI 10.1111/j.1600-079X.2006.00404.x; REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Srinivasan V, 2008, INTEGR CANCER THER, V7, P189, DOI 10.1177/1534735408322846; Tam CW, 2007, J PINEAL RES, V42, P191, DOI 10.1111/j.1600-079X.2006.00406.x; Tobioka H, 2004, VIRCHOWS ARCH, V445, P472, DOI 10.1007/s00428-004-1054-9; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Um HJ, 2011, J PINEAL RES, V50, P359, DOI 10.1111/j.1600-079X.2010.00851.x; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang R, 2008, CLIN CANCER RES, V14, P6396, DOI 10.1158/1078-0432.CCR-07-5113	63	55	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101132	10.1371/journal.pone.0101132	http://dx.doi.org/10.1371/journal.pone.0101132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992189	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400044
J	Schneider, KA; Escalante, AA				Schneider, Kristan A.; Escalante, Ananias A.			A Likelihood Approach to Estimate the Number of Co-Infections	PLOS ONE			English	Article							MULTIPLE INFECTIONS; PYRIMETHAMINE RESISTANCE; STAPHYLOCOCCUS-AUREUS; EVOLUTION; VIRULENCE; HITCHHIKING; SULFADOXINE; EXPRESSION; MUTATIONS; ECOLOGY	The number of co-infections of a pathogen (multiplicity of infection or MOI) is a relevant parameter in epidemiology as it relates to transmission intensity. Notably, such quantities can be built into a metric in the context of disease control and prevention. Having applications to malaria in mind, we develop here a maximum-likelihood (ML) framework to estimate the quantities of interest at low computational and no additional costs to study designs or data collection. We show how the ML estimate for the quantities of interest and corresponding confidence-regions are obtained from multiple genetic loci. Assuming specifically that infections are rare and independent events, the number of infections per host follows a conditional Poisson distribution. Under this assumption, we show that a unique ML estimate for the parameter (l) describing MOI exists which is found by a simple recursion. Moreover, we provide explicit formulas for asymptotic confidence intervals, and show that profile-likelihood-based confidence intervals exist, which are found by a simple two-dimensional recursion. Based on the confidence intervals we provide alternative statistical tests for the MOI parameter. Finally, we illustrate the methods on three malaria data sets. The statistical framework however is not limited to malaria.	[Schneider, Kristan A.] Univ Appl Sci Mittweida, Dept MNI, Mittweida, Germany; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Escalante, Ananias A.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Schneider, KA (corresponding author), Univ Appl Sci Mittweida, Dept MNI, Mittweida, Germany.	kristan.schneider@hs-mittweida.de		Escalante, Ananias/0000-0002-1532-3430; Schneider, Kristan/0000-0003-4138-1180	U.S. National Institutes of Health [1U19AI089702, R01GM084320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by U.S. National Institutes of Health grants 1U19AI089702 and R01GM084320 to AAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Ben-Ami F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-97; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Davison A., 2003, STAT MODELS; Durbin R., 1998, BIOL SEQUENCE ANAL P; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; Klein EY, 2012, P ROY SOC B-BIOL SCI, V279, P3834, DOI 10.1098/rspb.2012.1064; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Lively CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-64; Matussek A, 2011, J CLIN MICROBIOL, V49, P3647, DOI 10.1128/JCM.00389-11; McCollum AM, 2008, ANTIMICROB AGENTS CH, V52, P4089, DOI 10.1128/AAC.00623-08; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schjorring S, 2003, P ROY SOC B-BIOL SCI, V270, P189, DOI 10.1098/rspb.2002.2233; Schneider KA, 2011, J MATH BIOL, V62, P789, DOI 10.1007/s00285-010-0353-9; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Theron A, 2004, PARASITOLOGY, V129, P571, DOI 10.1017/S0031182004005943; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wacker Mark A, 2012, Malar J, V11, P180, DOI 10.1186/1475-2875-11-180	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97899	10.1371/journal.pone.0097899	http://dx.doi.org/10.1371/journal.pone.0097899			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988302	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100008
J	Inouye, H; Liu, JL; Makowski, L; Palmisano, M; Burghammer, M; Riekel, C; Kirschner, DA				Inouye, Hideyo; Liu, Jiliang; Makowski, Lee; Palmisano, Marilena; Burghammer, Manfred; Riekel, Christian; Kirschner, Daniel A.			Myelin Organization in the Nodal, Paranodal, and Juxtaparanodal Regions Revealed by Scanning X-Ray Microdiffraction	PLOS ONE			English	Article							LAEVIS PERIPHERAL-NERVE; MEMBRANE-STRUCTURE; PROTEIN ZERO; INTERNODAL MYELIN; BASIC-PROTEIN; P0 PROTEIN; SHEATH; SCATTERING; MICROSCOPE; DISORDER	X-ray diffraction has provided extensive information about the arrangement of lipids and proteins in multilamellar myelin. This information has been limited to the abundant inter-nodal regions of the sheath because these regions dominate the scattering when x-ray beams of 100 mm diameter or more are used. Here, we used a 1 mm beam, raster-scanned across a single nerve fiber, to obtain detailed information about the molecular architecture in the nodal, paranodal, and juxtaparanodal regions. Orientation of the lamellar membrane stacks and membrane periodicity varied spatially. In the juxtaparanode-internode, 198-202 angstrom-period membrane arrays oriented normal to the nerve fiber axis predominated, whereas in the paranode-node, 205-208 angstrom-period arrays oriented along the fiber direction predominated. In parts of the sheath distal to the node, multiple sets of lamellar reflections were observed at angles to one another, suggesting that the myelin multilayers are deformed at the Schmidt-Lanterman incisures. The calculated electron density of myelin in the different regions exhibited membrane bilayer profiles with varied electron densities at the polar head groups, likely due to different amounts of major myelin proteins (P0 glycoprotein and myelin basic protein). Scattering from the center of the nerve fibers, where the x-rays are incident en face (perpendicular) to the membrane planes, provided information about the lateral distribution of protein. By underscoring the heterogeneity of membrane packing, microdiffraction analysis suggests a powerful new strategy for understanding the underlying molecular foundation of a broad spectrum of myelinopathies dependent on local specializations of myelin structure in both the PNS and CNS.	[Inouye, Hideyo; Liu, Jiliang; Makowski, Lee] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Makowski, Lee] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Palmisano, Marilena] Univ Vita Salute San Raffaele, Div Cell Biol & Genet, Milan, Italy; [Burghammer, Manfred; Riekel, Christian] European Synchrotron Res Facil, Grenoble, France; [Kirschner, Daniel A.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Northeastern University; Northeastern University; Vita-Salute San Raffaele University; Boston College	Kirschner, DA (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	kirschnd@bc.edu		Liu, Jiliang/0000-0002-3491-3452; Kirschner, Daniel/0000-0003-3498-1452	Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation); L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation) [ELA2008-009C4, ELA2010-042C5]; Boston College Institutional Research Funds; Northeastern University	Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation); L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation); Boston College Institutional Research Funds; Northeastern University	This research was supported by the Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (ARSEP Foundation), L'Association Europeenne contre les Leucodystrophies -ELA (ELA Foundation, grant numbers ELA2008-009C4, ELA2010-042C5), Boston College Institutional Research Funds (DAK), and Northeastern University (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 2011, LANGMUIR, V27, P8216, DOI 10.1021/la2014336; Arroyo EJ, 1999, J NEUROCYTOL, V28, P333, DOI 10.1023/A:1007009613484; Avila RL, 2005, J NEUROPATH EXP NEUR, V64, P976, DOI 10.1097/01.jnen.0000186925.95957.dc; Avila RL, 2010, J BIOL CHEM, V285, P42001, DOI 10.1074/jbc.M110.166967; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bear RS, 1936, J OPT SOC AM, V26, P363, DOI 10.1364/JOSA.26.000363; Bear RS, 1936, J OPT SOC AM, V26, P206, DOI 10.1364/JOSA.26.000206; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; BLAUROCK AE, 1976, J MOL BIOL, V103, P421, DOI 10.1016/0022-2836(76)90321-1; BLAUROCK AE, 1966, BIOPHYS J, V6, P305, DOI 10.1016/S0006-3495(66)86658-4; CASPAR DLD, 1971, NATURE-NEW BIOL, V231, P46, DOI 10.1038/newbio231046a0; Cifuentes-Diaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014533; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; Ducic T, 2011, J STRUCT BIOL, V173, P202, DOI 10.1016/j.jsb.2010.10.001; Fasano A, 2008, J NEUROCHEM, V107, P291, DOI 10.1111/j.1471-4159.2008.05598.x; FERNANDEZMORAN H, 1957, J BIOPHYS BIOCHEM CY, V3, P725, DOI 10.1083/jcb.3.5.725; Hammersley A. P., 1997, ESRF97HA02T; Hasse B, 2002, J NEUROSCI RES, V69, P227, DOI 10.1002/jnr.10287; HIRANO A, 1982, J NEUROCYTOL, V11, P861, DOI 10.1007/BF01148304; HOLLINGSHEAD CJ, 1981, J CELL BIOL, V89, P631, DOI 10.1083/jcb.89.3.631; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; Inouye H, 1999, BIOPHYS J, V76, P423, DOI 10.1016/S0006-3495(99)77209-7; Inouye H, 2009, MOL AGGREGATION NUCL, P75; Kirschner D., 1984, MYELIN, P51; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; Kirschner DA, 2004, MYELIN BIOL DISORDER, V1, P523; Kirschner Daniel A., 1992, P3; KOSARAS B, 1990, J NEUROCYTOL, V19, P187, DOI 10.1007/BF01217297; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; MACKENZIE ML, 1984, J NEUROCYTOL, V13, P1043, DOI 10.1007/BF01148601; MUGNAINI E, 1977, J NEUROCYTOL, V6, P647, DOI 10.1007/BF01176378; NELANDER JC, 1978, J MOL BIOL, V118, P497, DOI 10.1016/0022-2836(78)90287-5; Peters A, 1991, FINE STRUCTURE NERVO, pxviii; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RAND RP, 1979, NATURE, V279, P258, DOI 10.1038/279258a0; RITCHIE JM, 1977, P NATL ACAD SCI USA, V74, P211, DOI 10.1073/pnas.74.1.211; ROBERTSON JD, 1958, J BIOPHYS BIOCHEM CY, V4, P39, DOI 10.1083/jcb.4.1.39; Salem M, 2010, ACTA CRYSTALLOGR F, V66, P225, DOI 10.1107/S1744309109054037; Schmitt FO, 1935, RADIOLOGY, V25, P131; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroer CG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090801; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Smith JL, 2012, CURR OPIN STRUC BIOL, V22, P602, DOI 10.1016/j.sbi.2012.09.001; SUZUKI M, 1969, LAB INVEST, V20, P444; Thompson AJ, 2002, J NEUROSCI RES, V67, P766, DOI 10.1002/jnr.10167; Trapp BD, 2004, MYELIN BIOL DISORDER, P3; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Xie B, 2007, INT J MASS SPECTROM, V268, P304, DOI 10.1016/j.ijms.2007.08.007; Yagi N, 2009, J PHYS C SER, V272, P1	52	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100592	10.1371/journal.pone.0100592	http://dx.doi.org/10.1371/journal.pone.0100592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984037	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000032
J	Stodden, GR; Lindberg, ME; King, ML; Paquet, M; MacLean, JA; Mann, JL; DeMayo, FJ; Lydon, JP; Hayashi, K				Stodden, G. R.; Lindberg, M. E.; King, M. L.; Paquet, M.; MacLean, J. A.; Mann, J. L.; DeMayo, F. J.; Lydon, J. P.; Hayashi, K.			Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment	ONCOGENE			English	Article							E-CADHERIN EXPRESSION; DIFFERENT HISTOLOGIC TYPES; UTERINE SEROUS CARCINOMA; NF-KAPPA-B; ENDOMETRIAL CARCINOMA; HUMAN BREAST; MICROARRAY ANALYSIS; CANCER DEVELOPMENT; GASTRIC-CARCINOMA; ADHESION	Type II endometrial carcinomas (ECs) are estrogen independent, poorly differentiated tumors that behave in an aggressive manner. As TP53 mutation and CDH1 inactivation occur in 80% of human endometrial type II carcinomas, we hypothesized that mouse uteri lacking both Trp53 and Cdh1 would exhibit a phenotype indicative of neoplastic transformation. Mice with conditional ablation of Cdh1 and Trp53 (Cdh1(d/d)Trp53(d/d)) clearly demonstrate architectural features characteristic of type II ECs, including focal areas of papillary differentiation, protruding cytoplasm into the lumen (hobnailing) and severe nuclear atypia at 6 months of age. Further, Cdh1(d/d)Trp53(d/d) tumors in 12-month-old mice were highly aggressive, and metastasized to nearby and distant organs within the peritoneal cavity, such as abdominal lymph nodes, mesentery and peri-intestinal adipose tissues, demonstrating that tumorigenesis in this model proceeds through the universally recognized morphological intermediates associated with type II endometrial neoplasia. We also observed abundant cell proliferation and complex angiogenesis in the uteri of Cdh1(d/d)Trp53(d/d) mice. Our microarray analysis found that most of the genes differentially regulated in the uteri of Cdh1(d/d)Trp53(d/d) mice were involved in inflammatory responses. CD163 and Arg1, markers for tumor-associated macrophages, were also detected and increased in the uteri of Cdh1(d/d)Trp53(d/d) mice, suggesting that an inflammatory tumor microenvironment with immune cell recruitment is augmenting tumor development in Cdh1(d/d)Trp53(d/d) uteri. Further, inflammatory mediators secreted from CDH1-negative, TP53 mutant endometrial cancer cells induced normal macrophages to express inflammatory-related genes through activation of nuclear factor-kappa B signaling. These results indicate that absence of CDH1 and TP53 in endometrial cells initiates chronic inflammation, promotes tumor microenvironment development following the recruitment of macrophages and promotes aggressive ECs.	[Stodden, G. R.; Lindberg, M. E.; King, M. L.; MacLean, J. A.; Hayashi, K.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Paquet, M.] Univ Montreal St Hyacinthe, Dept Pathol & Microbiol, Quebec City, PQ, Canada; [Mann, J. L.] So Illinois Univ, Sch Med, Dept Pathol, Springfield, IL USA; [DeMayo, F. J.; Lydon, J. P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Baylor College of Medicine	Hayashi, K (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, 1135 Lincoln Dr, Carbondale, IL 62901 USA.	khayashi@siumed.edu	DeMayo, Francesco/C-6255-2019; Paquet, Marilene/L-3414-2019	DeMayo, Francesco/0000-0002-9480-7336; Paquet, Marilene/0000-0002-3562-4636; Hayashi, Kanako/0000-0002-5028-799X	NIH/NCI [R15CA179214]; ACS-IL [139038]; NIH/NICHD [R15HD065584, U54HD007495]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD065584] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA179214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103311] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS-IL; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Jenny Zadeh at the University of Illinois at Urbana-Champaign Biotechnology Center for microarray analysis. This work was supported by NIH/NCI R15CA179214 and ACS-IL 139038 (to KH), NIH/NICHD R15HD065584 (to JAM) and NIH/NICHD U54HD007495 (to FJD and JPL).	Acharya S, 2005, LANCET ONCOL, V6, P961, DOI 10.1016/S1470-2045(05)70463-0; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; AMBROS RA, 1995, HUM PATHOL, V26, P1260, DOI 10.1016/0046-8177(95)90203-1; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; CLETONJANSEN AM, 1994, GENE CHROMOSOME CANC, V9, P101, DOI 10.1002/gcc.2870090205; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Goff BA, 2005, GYNECOL ONCOL, V98, P341, DOI 10.1016/j.ygyno.2005.07.006; GRAFF JR, 1995, CANCER RES, V55, P5195; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hermani Alexander, 2006, Exp Cell Res, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Holcomb K, 2002, OBSTET GYNECOL, V100, P1290, DOI 10.1016/S0029-7844(02)02391-8; Horn LC, 2007, ANN DIAGN PATHOL, V11, P297, DOI 10.1016/j.anndiagpath.2007.05.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koyuncuoglu M, 2012, GYNECOL ONCOL, V125, P208, DOI 10.1016/j.ygyno.2011.12.433; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Lindberg ME, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109462; Llobet D, 2009, J CLIN PATHOL, V62, P777, DOI 10.1136/jcp.2008.056101; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marchetti A, 2005, EUR J GYNAECOL ONCOL, V26, P479; Maxwell GL, 2005, CLIN CANCER RES, V11, P4056, DOI 10.1158/1078-0432.CCR-04-2001; Mazieres J, 2013, LUNG CANCER, V82, P231, DOI 10.1016/j.lungcan.2013.07.016; Medvedev AE, 1999, J BIOL CHEM, V274, P9342, DOI 10.1074/jbc.274.14.9342; MOLL R, 1993, AM J PATHOL, V143, P1731; Moon A, 2008, MOL CANCER RES, V6, P1544, DOI 10.1158/1541-7786.MCR-08-0189; Moreno-Bueno G, 2003, CANCER RES, V63, P5697; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; OKA H, 1993, CANCER RES, V53, P1696; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Reardon SN, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.098871; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; Risinger JI, 2003, CANCER RES, V63, P6; Samarnthai N, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/162363; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Shaco-Levy R, 2008, ACTA OBSTET GYN SCAN, V87, P868, DOI 10.1080/00016340802253775; SHERMAN ME, 1992, AM J SURG PATHOL, V16, P600, DOI 10.1097/00000478-199206000-00008; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soong R, 1996, BRIT J CANCER, V74, P562, DOI 10.1038/bjc.1996.401; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Wu ZY, 2005, WORLD J GASTROENTERO, V11, P3139, DOI 10.3748/wjg.v11.i20.3139; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	86	13	14	2	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2471	2482		10.1038/onc.2014.193	http://dx.doi.org/10.1038/onc.2014.193			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998851	Green Accepted			2022-12-25	WOS:000354190400006
J	Lenoir, M; Sugawara, M; Kaur, J; Ball, LJ; Overduin, M				Lenoir, Marc; Sugawara, Masae; Kaur, Jaswant; Ball, Linda J.; Overduin, Michael			Structural Insights into the Activation of the RhoA GTPase by the Lymphoid Blast Crisis (Lbc) Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Guanine Nucleotide Exchange Factor (GEF); Nuclear Magnetic Resonance; Oncogene; Protein Structure; Protein-Protein Interaction; Ras Homolog Gene Family; Member A (RhoA); Rho GTPases; AKAP; Lbc	GUANINE-NUCLEOTIDE-EXCHANGE; PROTEIN-KINASE-A; AKAP-LBC; P115 RHOGEF; CYCLIC-AMP; PH DOMAINS; SCATTERING; COMPLEX; BINDING; DH	Background: The Lbc oncoprotein stimulates deregulated GTPase activity in RhoA. Results: Although the Lbc DH domain can independently activate GTP exchange by RhoA, its PH domain also presents surfaces for DH and activated RhoA interaction. Conclusion: Multiple sites on both structural domains of the Lbc scaffold control RhoA. Significance: New sites for mechanism-based design of modulators of Lbc action are revealed. The small GTPase RhoA promotes deregulated signaling upon interaction with lymphoid blast crisis (Lbc), the oncogenic form of A-kinase anchoring protein 13 (AKAP13). The onco-Lbc protein is a hyperactive Rho-specific guanine nucleotide exchange factor (GEF), but its structural mechanism has not been reported despite its involvement in cardiac hypertrophy and cancer causation. The pleckstrin homology (PH) domain of Lbc is located at the C-terminal end of the protein and is shown here to specifically recognize activated RhoA rather than lipids. The isolated dbl homology (DH) domain can function as an independent activator with an enhanced activity. However, the DH domain normally does not act as a solitary Lbc interface with RhoA-GDP. Instead it is negatively controlled by the PH domain. In particular, the DH helical bundle is coupled to the structurally dependent PH domain through a helical linker, which reduces its activity. Together the two domains form a rigid scaffold in solution as evidenced by small angle x-ray scattering and H-1,C-13,N-15-based NMR spectroscopy. The two domains assume a chair shape with its back possessing independent GEF activity and the PH domain providing a broad seat for RhoA-GTP docking rather than membrane recognition. This provides structural and dynamical insights into how DH and PH domains work together in solution to support regulated RhoA activity. Mutational analysis supports the bifunctional PH domain mediation of DH-RhoA interactions and explains why the tandem domain is required for controlled GEF signaling.	[Lenoir, Marc; Sugawara, Masae; Kaur, Jaswant; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Ball, Linda J.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Ball, Linda J.] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	University of Birmingham; University of Oxford; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Overduin, M (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	m.overduin@bham.ac.uk	Ball, Linda J/E-8454-2011; Overduin, Michael/AAG-3632-2020	Ball, Linda J/0000-0002-0948-6954; Overduin, Michael/0000-0002-3114-6585; Lenoir, Marc/0000-0001-7410-2323	Wellcome Trust; European Union Bio-NMR; BBSRC [BB/H024697/1, BB/E013198/1, BB/I013865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/10714, BB/I013865/1, BB/E013198/1, BB/H024697/1, BB/C511513/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union Bio-NMR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sara Whittaker and the staff of The Henry Wellcome Building for Biological NMR Spectroscopy (HWB. NMR), which is funded by the Wellcome Trust and European Union Bio-NMR; Shurene Bishop (Structural Genomics Consortium, Oxford, UK); Mitsuhiko Ikura (University of Toronto); John D. Scott (University of Washington) for discussions and constructs; and Ruben Abagyan and Irina Kufareva (University of California, San Diego) for the MODA software.	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; del Vescovo CD, 2013, MOL CELL BIOL, V33, P14, DOI 10.1128/MCB.00887-12; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Klussmann E., 2014, European Patent, Patent No. 2682118; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rogers R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.057; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz MA, 1996, EMBO J, V15, P6525, DOI 10.1002/j.1460-2075.1996.tb01043.x; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Sugawara M, 2009, BIOMOL NMR ASSIGN, V3, P215, DOI 10.1007/s12104-009-9178-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TOKSOZ D, 1994, ONCOGENE, V9, P621; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wirtenberger M, 2006, CARCINOGENESIS, V27, P593, DOI 10.1093/carcin/bgi245; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	55	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23992	24004		10.1074/jbc.M114.561787	http://dx.doi.org/10.1074/jbc.M114.561787			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993829	Green Published, hybrid			2022-12-25	WOS:000341505000063
J	Costa, L; Rodrigues, MS; Benseny-Cases, N; Mayeux, V; Chevrier, J; Comin, F				Costa, Luca; Rodrigues, Mario S.; Benseny-Cases, Nuria; Mayeux, Veronique; Chevrier, Joel; Comin, Fabio			Spectroscopic Investigation of Local Mechanical Impedance of Living Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; NANOMECHANICAL PROPERTIES; FIBROBLASTS; AFM	We studied nanoscale mechanical properties of PC12 living cells with a Force Feedback Microscope using two experimental approaches. The first one consists in measuring the local mechanical impedance of the cell membrane while simultaneously mapping the cell morphology at constant force. As the interaction force is increased, we observe the appearance of the submembrane cytoskeleton. We compare our findings with the outcome of other techniques. The second experimental approach consists in a spectroscopic investigation of the cell while varying the tip indentation into the membrane and consequently the applied force. At variance with conventional dynamic Atomic Force Microscopy techniques, here it is not mandatory to work at the first oscillation eigenmode of the cantilever: the excitation frequency of the tip can be chosen arbitrary leading then to new spectroscopic AFM techniques. We found in this way that the mechanical response of the PC12 cell membrane is found to be frequency dependent in the 1 kHz - 10 kHz range. In particular, we observe that the damping coefficient consistently decreases when the excitation frequency is increased.	[Costa, Luca; Comin, Fabio] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Costa, Luca] Univ Grenoble 1, Grenoble, France; [Rodrigues, Mario S.] Univ Lisbon, Fac Ciencia, Ctr Fis Mat Condensada, Dept Fis, P-1699 Lisbon, Portugal; [Benseny-Cases, Nuria; Mayeux, Veronique] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Chevrier, Joel] CNRS, Inst NEEL, Grenoble, France; [Chevrier, Joel] Univ Grenoble Alpes, Inst NEEL, Grenoble, France	European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade de Lisboa; University of Leeds; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Costa, L (corresponding author), European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France.	luca.costa@esrf.fr	Benseny-Cases, Nuria/M-6443-2018; Rodrigues, Mario S/C-1151-2013; Costa, Luca/K-6429-2014	Benseny-Cases, Nuria/0000-0003-4603-6829; Rodrigues, Mario S/0000-0002-0468-1910; Costa, Luca/0000-0002-4527-0034; Chevrier, Joel/0000-0001-5609-6863	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/69201/2010. COST Action TD 1002]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding provided by Fundacao para a Ciencia e Tecnologia SFRH/BPD/69201/2010. COST Action TD 1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Braet F, 1998, APPL PHYS A-MATER, V66, pS575, DOI 10.1007/s003390051204; Brown AEX, 2009, BIOPHYS J, V96, P1952, DOI 10.1016/j.bpj.2008.11.032; Cartagena A, 2014, BIOPHYS J, V106, P1033, DOI 10.1016/j.bpj.2013.12.037; Chang CT, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412500327; Costa L, 2014, ARXIV14045277; Costa L, 2013, J MOL RECOGNIT, V26, P689, DOI 10.1002/jmr.2328; de Beer S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/32/325703; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Garcia R, 2012, NAT NANOTECHNOL, V7, P217, DOI [10.1038/nnano.2012.38, 10.1038/NNANO.2012.38]; Guzman HV, 2013, ACS NANO, V7, P3198, DOI 10.1021/nn4012835; Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6; Hofmann UG, 1997, J STRUCT BIOL, V119, P84, DOI 10.1006/jsbi.1997.3868; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/NNANO.2009.77, 10.1038/nnano.2009.77]; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Kiracofe D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/48/485502; Le Grimellec C, 1998, BIOPHYS J, V75, P695, DOI 10.1016/S0006-3495(98)77559-9; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050292; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Martinez-Martin D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198101; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; RADMACHER M, 1993, BIOPHYS J, V64, P735, DOI 10.1016/S0006-3495(93)81433-4; Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/nnano.2011.186, 10.1038/NNANO.2011.186]; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Rodrigues MS, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766172; Rodrigues MS, 2013, J APPL PHYS IN PRESS; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sokolov I, 2013, METHODS, V60, P202, DOI 10.1016/j.ymeth.2013.03.037; Viero C, 2006, CELL CALCIUM, V40, P383, DOI 10.1016/j.ceca.2006.04.007	35	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101687	10.1371/journal.pone.0101687	http://dx.doi.org/10.1371/journal.pone.0101687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999625	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300072
J	Heindorf, M; Kadari, M; Heider, C; Skiebe, E; Wilharm, G				Heindorf, Magdalena; Kadari, Mahendar; Heider, Christine; Skiebe, Evelyn; Wilharm, Gottfried			Impact of Acinetobacter baumannii Superoxide Dismutase on Motility, Virulence, Oxidative Stress Resistance and Susceptibility to Antibiotics	PLOS ONE			English	Article							BIOFILM FORMATION; BACTERICIDAL ANTIBIOTICS; ESCHERICHIA-COLI; DEATH PATHWAY; GALLERIA-MELLONELLA; ABIOTIC SURFACES; CELL-DEATH; PATHOGENESIS; INFECTION; INVOLVEMENT	Acinetobacter baumannii is a Gram-negative bacterium appearing as an opportunistic pathogen in hospital settings. Superoxide dismutase (SOD) contributes to virulence in several pathogenic bacteria by detoxifying reactive oxygen species released in the course of host defense reactions. However, the biological role of SODs in A. baumannii has not yet been elucidated. Here, we inactivated in A. baumannii ATCC 17978 gene A1S_2343, encoding a putative SOD of the Fe-Mn type by transposon insertion, resulting in mutant ATCC 17978 sod2343::Km. The mutation was also introduced in two naturally competent A. baumannii isolates by transformation with chromosomal DNA derived from mutant ATCC 17978 sod2343::Km. We demonstrate that inactivation of sod2343 leads to significant motility defects in all three A. baumannii strains. The mutant strains were more susceptible to oxidative stress compared to their parental strains. Susceptibility to colistin and tetracycline was increased in all mutant strains while susceptibility of the mutants to gentamicin, levofloxacin and imipenem was strain-dependent. In the Galleria mellonella infection model the mutant strains were significantly attenuated. In conclusion, sod2343 plays an important role in motility, resistance to oxidative stress, susceptibility to antibiotics and virulence in A. baumannii.	[Heindorf, Magdalena; Kadari, Mahendar; Heider, Christine; Skiebe, Evelyn; Wilharm, Gottfried] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute	Wilharm, G (corresponding author), Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany.	wilharmg@rki.de		Wilharm, Gottfried/0000-0002-1771-6799	Lund University, Sweden; Robert Koch-Institute, Germany	Lund University, Sweden; Robert Koch-Institute, Germany	Mahendar Kadari was supported by an ERASMUS stipend of Lund University, Sweden, and Magdalena Heindorf was supported by a PhD stipend of the Robert Koch-Institute, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsan Marcella, 2010, J Clin Outcomes Manag, V17, P363; Alvarez-Lerma F, 2012, DRUGS, V72, P447, DOI 10.2165/11599520-000000000-00000; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Burger RM, 2009, J INORG BIOCHEM, V103, P1273, DOI 10.1016/j.jinorgbio.2009.07.009; Canvin J, 1996, FEMS MICROBIOL LETT, V136, P215, DOI 10.1016/0378-1097(96)84203-0; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Chatti A, 2012, WORLD J MICROB BIOT, V28, P129, DOI 10.1007/s11274-011-0801-8; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; Feld L, 2012, APPL ENVIRON MICROB, V78, P4353, DOI 10.1128/AEM.00324-12; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Hwang S, 2013, J ANTIBIOT, V66, P351, DOI 10.1038/ja.2013.20; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LANGFORD PR, 1992, J GEN MICROBIOL, V138, P517, DOI 10.1099/00221287-138-3-517; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McNamara M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-45; Mendez JA, 2012, J PROTEOME RES, V11, P5678, DOI 10.1021/pr300496c; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pour NK, 2011, FEMS IMMUNOL MED MIC, V62, P328, DOI 10.1111/j.1574-695X.2011.00818.x; Pournaras S, 2014, ANTIMICROB AGENTS CH, V58, P828, DOI 10.1128/AAC.01439-13; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Qiu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040019; Qiu HY, 2009, INFECT IMMUN, V77, P1015, DOI 10.1128/IAI.01029-08; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Sanjay MK, 2011, INDIAN J MICROBIOL, V51, P326, DOI 10.1007/s12088-011-0074-9; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Shin BJ, 2008, J MICROBIOL, V46, P300, DOI 10.1007/s12275-007-0212-6; Silva JP, 2010, DRUG DISCOV THER, V4, P144; Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; SMITH MW, 1992, J MOL EVOL, V34, P175; STABEL TJ, 1994, VET MICROBIOL, V38, P307, DOI 10.1016/0378-1135(94)90149-X; Tang YL, 2012, VET MICROBIOL, V158, P360, DOI 10.1016/j.vetmic.2012.02.028; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vidal R, 1996, MICROBIOS, V86, P49; Vila J, 2012, EXPERT OPIN PHARMACO, V13, P2319, DOI 10.1517/14656566.2012.729820; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13	56	52	56	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101033	10.1371/journal.pone.0101033	http://dx.doi.org/10.1371/journal.pone.0101033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000585	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300023
J	Yamashita, S; Ogawa, K; Ikei, T; Fujiki, T; Katakura, Y				Yamashita, Shuntaro; Ogawa, Kaori; Ikei, Takahiro; Fujiki, Tsukasa; Katakura, Yoshinori			FOXO3a Potentiates hTERT Gene Expression by Activating c-MYC and Extends the Replicative Life-Span of Human Fibroblast	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; CELLULAR SENESCENCE; SIRT1; TELOMERASE; CELLS; PATHWAY; BINDING; CANCER; IDENTIFICATION; TUMORIGENESIS	In our previous studies, we reported that SIRT1 prevents cellular senescence in human fibroblast, and that SIRT1-induced inhibition of cellular senescence is due to enhanced hTERT gene expression. In this study, we investigate the molecular mechanisms behind SIRT1-induced potentiation of hTERT transcription and show that FOXO3a functions downstream of SIRT1 and prevents the induction of cellular senescence by enhancing hTERT gene expression. Furthermore, we found that FOXO3a-induced potentiation of hTERT gene expression is regulated in a c-MYC/E-box dependent manner. In addition, we found that FOXO3a binds to the novel binding element in the c-MYC promoter, and this interaction activates the transcription of the c-MYC gene. The resulting increase in c-MYC leads to higher levels of c-MYC recruited to the hTERT promoter and, in turn, activates hTERT gene expression. Taken together, this pathway might constitute the molecular basis for the anti-senescence effects of SIRT1 and FOXO3a.	[Yamashita, Shuntaro; Katakura, Yoshinori] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 812, Japan; [Ogawa, Kaori; Ikei, Takahiro; Katakura, Yoshinori] Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Higashi Ku, Fukuoka 812, Japan; [Fujiki, Tsukasa; Katakura, Yoshinori] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 812, Japan.	katakura@grt.kyushu-u.ac.jp			JSPS KAKENHI [24580190, 25.4465]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24580190, 25.4465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323; Katakura Y, 2009, J BIOCHEM, V146, P87, DOI 10.1093/jb/mvp046; Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Madonna R, 2011, EUR HEART J, V32, P1190, DOI 10.1093/eurheartj/ehq450; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021	29	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101864	10.1371/journal.pone.0101864	http://dx.doi.org/10.1371/journal.pone.0101864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000517	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300094
J	Kapur, A; Schneider, JA; Heard, D; Mukherjee, S; Schumm, P; Oruganti, G; Laumann, EO				Kapur, Abhinav; Schneider, John A.; Heard, Daniel; Mukherjee, Sayan; Schumm, Phil; Oruganti, Ganesh; Laumann, Edward O.			A Digital Network Approach to Infer Sex Behavior in Emerging HIV Epidemics	PLOS ONE			English	Article							INDIAN MEN; RISK; PREVENTION; TRANSMISSION; METAANALYSIS; PARTNERS; POSITION	Purpose: Improve the ability to infer sex behaviors more accurately using network data. Methods: A hybrid network analytic approach was utilized to integrate: (1) the plurality of reports from others tied to individual(s) of interest; and (2) structural features of the network generated from those ties. Network data was generated from digitally extracted cell-phone contact lists of a purposeful sample of 241 high-risk men in India. These data were integrated with interview responses to describe the corresponding individuals in the contact lists and the ties between them. HIV serostatus was collected for each respondent and served as an internal validation of the model's predictions of sex behavior. Results: We found that network-based model predictions of sex behavior and self-reported sex behavior had limited correlation (54% agreement). Additionally, when respondent sex behaviors were re-classified to network model predictions from self-reported data, there was a 30.7% decrease in HIV seroprevalence among groups of men with lower risk behavior, which is consistent with HIV transmission biology. Conclusion: Combining the relative completeness and objectivity of digital network data with the substantive details of classical interview and HIV biomarker data permitted new analyses and insights into the accuracy of self-reported sex behavior.	[Kapur, Abhinav] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Schneider, John A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Schneider, John A.; Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Heard, Daniel; Mukherjee, Sayan] Duke Univ, Dept Stat Sci, Durham, NC USA; [Oruganti, Ganesh] SHARE India, Publ Hlth Management Inst, Hyderabad, Andhra Pradesh, India; [Laumann, Edward O.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Duke University; University of Chicago	Schneider, JA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jschnei1@medicine.bsd.uchicago.edu		Schumm, Phil/0000-0002-3050-2429; Mukherjee, Sayan/0000-0002-6715-3920	National Institutes of Health [R21HD068352, R21AI098599-01]; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098599] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1209155] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded in part by the National Institutes of Health (R21HD068352 and R21AI098599-01) and the American Foundation for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adafruit, 2012, SIM READ; Adams J, 2007, SOC NETWORKS, V29, P44, DOI 10.1016/j.socnet.2005.11.009; Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; Aral SO, 2002, SEX TRANSM DIS, V29, P530, DOI 10.1097/00007435-200209000-00006; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bates D., 2009, LME4 LINEAR MIXED EF; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Borgatti SP, 2003, J APPL BEHAV SCI, V39, P337, DOI DOI 10.1177/0021886303258111; Brewer DD, 2006, SEX TRANSM DIS, V33, P277, DOI 10.1097/01.olq.0000204746.58160.c1; Brewer DD, 2005, SEX TRANSM DIS, V32, P189, DOI 10.1097/01.olq.0000154492.98350.90; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Dandona L, 2006, BMC MED, V4, P1, DOI DOI 10.1186/1741-7015-4-7; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Helleringer S, 2011, AIDS, V25, P503, DOI 10.1097/QAD.0b013e3283434485; Hemmige V, 2011, AIDS PATIENT CARE ST, V25, P725, DOI 10.1089/apc.2011.0079; Hoff PD, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P303; IANNOTTI RJ, 1992, J YOUTH ADOLESCENCE, V21, P375, DOI 10.1007/BF01537024; Kadushin C, 2005, SOC NETWORKS, V27, P139, DOI 10.1016/j.socnet.2005.01.005; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; KRACKHARDT D, 1987, SOC NETWORKS, V9, P109, DOI 10.1016/0378-8733(87)90009-8; Marsden P.V., 2005, STRUCTURAL ANAL SOCI, P8, DOI DOI 10.1017/CBO9780511811395.002; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Morrison DM, 2007, PREV SCI, V8, P274, DOI 10.1007/s11121-007-0075-4; NACO Minsitry of Health and Family Welfare, 2007, NACO GUIDL HIV TEST; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pequegnat W, 2000, SEX TRANSM DIS, V27, P127, DOI 10.1097/00007435-200003000-00001; Peterman TA, 2000, SEX TRANSM DIS, V27, P446, DOI 10.1097/00007435-200009000-00004; Schneider JA, 2012, SOC SCI MED, V75, P1192, DOI 10.1016/j.socscimed.2012.05.022; Schneider JA, 2012, AIDS BEHAV, V16, P350, DOI 10.1007/s10461-011-9982-2; Simoni JM, 2011, AIDS BEHAV, V15, P1589, DOI 10.1007/s10461-011-9963-5; Snyder H, 2012, AIDS EDUC PREV, V24, P309, DOI 10.1521/aeap.2012.24.4.309; Valente TW, 2010, SOC NETWORKS, V32, P212, DOI 10.1016/j.socnet.2010.03.003; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198	41	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101416	10.1371/journal.pone.0101416	http://dx.doi.org/10.1371/journal.pone.0101416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992340	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400069
J	Skaug, EA; Madssen, E; Aspenes, ST; Wisloff, U; Ellingsen, O				Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind			Cardiovascular Risk Factors Have Larger Impact on Endothelial Function in Self-Reported Healthy Women than Men in the HUNT3 Fitness Study	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; PEAK OXYGEN-UPTAKE; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; SEX-DIFFERENCES; BLOOD-PRESSURE; HEART-DISEASE; MORTALITY; ARTERY	Background: Several studies suggest that cardiovascular risk factors comprising the metabolic syndrome have larger effects on the development of cardiovascular disease in women than in men. A recent study in self-reported healthy subjects demonstrated a marked gender difference in endothelial dysfunction that may be an important precursor of manifest cardiovascular disease. The aim of the present study was to determine whether the association between endothelial function and cardiovascular risk factors is different in self-reported healthy women compared to self-reported healthy men. Methods and Results: Associations between endothelial function (flow mediated dilation, FMD, of the brachial artery measured by ultrasound), anthropometric variables, peak oxygen uptake (VO2peak), blood pressure, serum lipids, blood glucose and a questionnaire on general health and lifestyle including smoking status were studied by logistic and linear regression in 2 528 women and 2 211 men aged 20-89 years, free from self-reported cardiovascular disease. In women with hyperglycemia, endothelial dysfunction (FMD <= 0%) occurred twice as frequently as in male counterparts. The presence of the metabolic syndrome, high blood pressure and low VO2peak increased the prevalence of endothelial dysfunction more in women than in men. Conclusion: Endothelial dysfunction is more strongly associated with cardiovascular risk factors in self-reported healthy women than in self-reported healthy men. This finding could explain why the metabolic syndrome, and especially hyperglycemia, is associated with higher cardiovascular risk and a worse prognosis in women.	[Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skaug, Eli-Anne; Madssen, Erik; Aspenes, Stian Thoresen; Wisloff, Ulrik; Ellingsen, Oyvind] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Madssen, Erik; Ellingsen, Oyvind] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skaug, EA (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	eli-anne.skaug@ntnu.no	Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St. Olavs Hospital; Norwegian State Railways	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators; Foundation for Cardiovascular Research at St. Olavs Hospital; Norwegian State Railways	The study was supported with grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, Norwegian Research Council Funding for Outstanding Young Investigators, the Foundation for Cardiovascular Research at St. Olavs Hospital, and Norwegian State Railways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Blum A, 2009, GENDER MED, V6, P410, DOI 10.1016/j.genm.2009.09.005; Borch-Johnsen K, 1999, LANCET, V354, P617; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; Chan SY, 2003, J AM COLL CARDIOL, V42, P1037, DOI 10.1016/S0735-1097(03)00927-6; Ciambrone G, 2011, CURR PHARM DESIGN, V17, P1079, DOI 10.2174/138161211795656945; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cordero A, 2009, PREV MED, V48, P134, DOI 10.1016/j.ypmed.2008.10.024; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Engberding N, 2012, HYPERTENS RES, V35, P251, DOI 10.1038/hr.2011.210; Goel A, 2007, CARDIOVASC RES, V76, P351, DOI 10.1016/j.cardiores.2007.06.029; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Held C, 2007, CIRCULATION, V115, P1371, DOI 10.1161/CIRCULATIONAHA.106.661405; Hu R, 2008, CLIN CARDIOL, V31, P525, DOI 10.1002/ClC.20314; Iglseder B, 2005, STROKE, V36, P1212, DOI 10.1161/01.STR.0000166196.31227.91; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Levit RD, 2011, CARDIOL REV, V19, P60, DOI 10.1097/CRD.0b013e31820987b5; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mellbin LG, 2010, EUR J CARDIOV PREV R, V17, pS9, DOI 10.1097/01.hjr.0000368192.24732.2f; MORRIS JN, 1953, LANCET, V265, P1053; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; Petersen JL, 2010, CIRC-CARDIOVASC QUAL, V3, P165, DOI 10.1161/CIRCOUTCOMES.109.864447; Poredos P, 1999, ANGIOLOGY, V50, P201, DOI 10.1177/000331979905000304; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Rossi R, 2008, HYPERTENSION, V52, P865, DOI 10.1161/HYPERTENSIONAHA.108.110478; Rudnicka AR, 2011, J THROMB HAEMOST, V9, P2337, DOI 10.1111/j.1538-7836.2011.04517.x; Skaug EA, 2013, EUR J PREV CARDIOL, V20, P531, DOI 10.1177/2047487312444234; Smilowitz NR, 2011, AM HEART J, V161, P681, DOI 10.1016/j.ahj.2010.12.022; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Suzuki T, 2008, AM HEART J, V156, P405, DOI 10.1016/j.ahj.2008.02.022; Tjonna AE, 2010, J EPIDEMIOL COMMUN H, V64, P690, DOI 10.1136/jech.2008.084467; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	45	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101371	10.1371/journal.pone.0101371	http://dx.doi.org/10.1371/journal.pone.0101371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991924	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400066
J	Huang, CL; Xue, M; Chen, HL; Jiao, J; Herschman, HR; O'Keefe, RJ; Zhang, XP				Huang, Chunlan; Xue, Ming; Chen, Hongli; Jiao, Jing; Herschman, Harvey R.; O'Keefe, Regis J.; Zhang, Xinping			The Spatiotemporal Role of COX-2 in Osteogenic and Chondrogenic Differentiation of Periosteum-Derived Mesenchymal Progenitors in Fracture Repair	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CHONDROCYTE DIFFERENTIATION; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; PROSTAGLANDIN E-2; STEM-CELLS; BMP2 ACTIVITY; PATHWAY; MICE	Periosteum provides a major source of mesenchymal progenitor cells for bone fracture repair. Combining cell-specific targeted Cox-2 gene deletion approaches with in vitro analyses of the differentiation of periosteum-derived mesenchymal progenitor cells (PDMPCs), here we demonstrate a spatial and temporal role for Cox-2 function in the modulation of osteogenic and chondrogenic differentiation of periosteal progenitors in fracture repair. Prx1Cre-targeted Cox-2 gene deletion in mesenchyme resulted in marked reduction of intramembraneous and endochondral bone repair, leading to accumulation of poorly differentiated mesenchyme and immature cartilage in periosteal callus. In contrast, Col2Cre-targeted Cox-2 gene deletion in cartilage resulted in a deficiency primarily in cartilage conversion into bone. Further cell culture analyses using Cox-2 deficient PDMPCs demonstrated reduced osteogenic differentiation in monolayer cultures, blocked chondrocyte differentiation and hypertrophy in high density micromass cultures. Gene expression microarray analyses demonstrated downregulation of a key set of genes associated with bone/cartilage formation and remodeling, namely Sox9, Runx2, Osx, MMP9, VDR and RANKL. Pathway analyses demonstrated dysregulation of the HIF-1, PI3K-AKT and Wnt pathways in Cox-2 deficient cells. Collectively, our data highlight a crucial role for Cox-2 from cells of mesenchymal lineages in modulating key pathways that control periosteal progenitor cell growth, differentiation, and angiogenesis in fracture repair.	[Huang, Chunlan; Xue, Ming; Chen, Hongli; O'Keefe, Regis J.; Zhang, Xinping] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14627 USA; [Jiao, Jing; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhang, XP (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14627 USA.	Xinping_Zhang@URMC.rochester.edu	Jiao, Jing/F-5354-2015		Musculoskeletal Transplant Foundation; NYSTEM [N08G-495, N09G346]; National Institutes of Health [R21 DE021513, RC1 AR058435, AR R01 AR048681, P50 AR054041]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048681, P50AR054041, RC1AR058435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021513] Funding Source: NIH RePORTER	Musculoskeletal Transplant Foundation; NYSTEM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by grants from the Musculoskeletal Transplant Foundation (XPZ), NYSTEM N08G-495 (XPZ) and N09G346 (XPZ), and the National Institutes of Health (R21 DE021513 to XPZ, RC1 AR058435 to XPZ, AR R01 AR048681 to XPZ and RJO, P50 AR054041 to RJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, EXPERT REV CLIN IMMU, V5, P145, DOI 10.1586/1744666X.5.2.145; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ALLEN HL, 1980, ACTA ORTHOP SCAND, V51, P595, DOI 10.3109/17453678008990848; ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Chappuis V, 2012, BONE, V51, P800, DOI 10.1016/j.bone.2012.07.017; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Colnot C, 2012, J ORTHOP RES, V30, P1869, DOI 10.1002/jor.22181; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2003, J ORTHOP RES, V21, P670, DOI 10.1016/S0736-0266(03)00003-2; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Huang C, 2013, MOL THER; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kellinsalmi M, 2007, EUR J PHARMACOL, V572, P102, DOI 10.1016/j.ejphar.2007.06.030; Lau KHW, 2013, BONE, V53, P369, DOI 10.1016/j.bone.2013.01.003; Lee CM, 2007, J CELL PHYSIOL, V212, P182, DOI 10.1002/jcp.21017; Lee CM, 2010, J BONE MINER METAB, V28, P8, DOI 10.1007/s00774-009-0096-0; Li CJ, 2011, BONE, V48, P286, DOI 10.1016/j.bone.2010.09.020; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Malizos KN, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.07.030; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Ninomiya T, 2011, EUR J PHARMACOL, V650, P396, DOI 10.1016/j.ejphar.2010.10.021; Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100; Regard J. B., 2012, COLD SPRING HARB PER, V4; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Robertson G, 2006, BONE, V39, P767, DOI 10.1016/j.bone.2006.04.006; Schipani E, 2001, GENE DEV, V15, P2865; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Wang Q, 2011, BONE, V48, P524, DOI 10.1016/j.bone.2010.10.178; Wang Q, 2010, AM J PATHOL, V177, P3100, DOI 10.2353/ajpath.2010.100060; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yaqub Sheraz, 2008, Critical Reviews in Oncogenesis, V14, P57; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	56	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100079	10.1371/journal.pone.0100079	http://dx.doi.org/10.1371/journal.pone.0100079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988184	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100023
J	White, MR; Kandel, R; Tripathi, S; Condon, D; Qi, L; Taubenberger, J; Hartshorn, KL				White, Mitchell R.; Kandel, Ruth; Tripathi, Shweta; Condon, David; Qi, Li; Taubenberger, Jeffrey; Hartshorn, Kevan L.			Alzheimer's Associated beta-Amyloid Protein Inhibits Influenza A Virus and Modulates Viral Interactions with Phagocytes	PLOS ONE			English	Article							HUMAN NEUTROPHIL DEFENSINS; DISEASE; PEPTIDE; RESPONSES; RECEPTOR	Accumulation of beta-Amyloid (beta A) is a key pathogenetic factor in Alzheimer's disease; however, the normal function of beta A is unknown. Recent studies have shown that beta A can inhibit growth of bacteria and fungi. In this paper we show that beta A also inhibits replication of seasonal and pandemic strains of H3N2 and H1N1 influenza A virus (IAV) in vitro. The 42 amino acid fragment of beta A (beta A42) had greater activity than the 40 amino acid fragment. Direct incubation of the virus with beta A42 was needed to achieve optimal inhibition. Using quantitative PCR assays beta A42 was shown to reduce viral uptake by epithelial cells after 45 minutes and to reduce supernatant virus at 24 hours post infection. beta A42 caused aggregation of IAV particles as detected by light transmission assays and electron and confocal microscopy. beta A42 did not stimulate neutrophil H2O2 production or extracellular trap formation on its own, but it increased both responses stimulated by IAV. In addition, beta A42 increased uptake of IAV by neutrophils. beta A42 reduced viral protein synthesis in monocytes and reduced IAV-induced interleukin-6 production by these cells. Hence, we demonstrate for the first time that beta A has antiviral activity and modulates viral interactions with phagocytes.	[White, Mitchell R.; Tripathi, Shweta; Condon, David; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kandel, Ruth] Harvard Univ, Sch Med, Hebrew Senior Life, Boston, MA USA; [Qi, Li; Taubenberger, Jeffrey] NIAID, Bethesda, MD 20892 USA	Boston University; Harvard University; Harvard Medical School; Hebrew SeniorLife; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hartshorn, KL (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	khartsho@bu.edu	Taubenberger, Jeffery/AAQ-1407-2021		National Institutes of Health [AI-83222, HL 069031]; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986, P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the National Institutes of Health Grant numbers AI-83222 (KLH)and HL 069031 (KLH) and NIH intramural funds (JKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; HARTSHORN KL, 1990, BLOOD, V75, P218; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Larvie M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/929803; Lee RM, 2006, SCAND J IMMUNOL, V63, P81, DOI 10.1111/j.1365-3083.2005.01714.x; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Papareddy P, 2012, J PEPT SCI, V18, P183, DOI 10.1002/psc.1439; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shinya K, 2011, J VIROL, V85, P4673, DOI 10.1128/JVI.00148-11; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Zhang JD, 2011, J NEUROIMMUNE PHARM, V6, P650, DOI 10.1007/s11481-011-9259-6	28	119	120	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101364	10.1371/journal.pone.0101364	http://dx.doi.org/10.1371/journal.pone.0101364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988208	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100079
J	Cleaver, JE				Cleaver, James E.			Tritiated Thymidine: Xeroderma Pigmentosum and DNA Repair	FASEB JOURNAL			English	Editorial Material							DEOXYRIBONUCLEIC-ACID; MAMMALIAN CELLS; HELA-CELLS; CHROMOSOME DUPLICATION; PYRIMIDINE DIMERS; CLONAL GROWTH; TRITIUM; IRRADIATION; MUTANTS; AUTORADIOGRAPHY		Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cleaver, JE (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	jcleaver@cc.ucsf.edu						Bishop JM., 2003, WIN NOBEL PRIZE UNEX; BUSCH D, 1989, MUTAGENESIS, V4, P349, DOI 10.1093/mutage/4.5.349; CLEAVER J, 1967, THYMIDINE METABOLISM; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CLEAVER JE, 1972, SCIENCE, V177, P996, DOI 10.1126/science.177.4053.996; CLEAVER JE, 1969, P NATL ACAD SCI USA, V63, P428, DOI 10.1073/pnas.63.2.428; DJORDJEVIC B, 1967, RADIAT RES, V32, P327, DOI 10.2307/3572227; DREW RM, 1962, RADIAT RES, V16, P303, DOI 10.2307/3571160; DREW RM, 1959, RADIAT RES, V11, P535, DOI 10.2307/3570807; ELKIND MM, 1976, BIOCHEM BIOPH RES CO, V68, P691, DOI 10.1016/0006-291X(76)91200-6; FEINENDEGEN LE, 1960, EXP CELL RES, V19, P443, DOI 10.1016/0014-4827(60)90054-9; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; GILBERT CW, 1965, NATURE, V208, P159, DOI 10.1038/208159a0; Howard A, 1953, HEREDITY           S, V6, P261; HUGHES WL, 1958, P NATL ACAD SCI USA, V44, P476, DOI 10.1073/pnas.44.5.476; KAVENOFF R, 1973, CHROMOSOMA, V41, P1, DOI 10.1007/BF00284071; LAJTHA LG, 1963, J CELL COMPAR PHYSL, V62, P143; LAJTHA LG, 1958, RADIAT RES, V8, P1, DOI 10.2307/3570530; LAJTHA LG, 1958, NATURE, V181, P1609, DOI 10.1038/1811609a0; LAJTHA LG, 1959, LAB INVEST, V8, P214; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; OLIVER R, 1960, NATURE, V186, P91, DOI 10.1038/186091a0; PAINTER RB, 1990, RADIAT RES, V121, P117, DOI 10.2307/3577494; PAINTER RB, 1964, NATURE, V201, P409, DOI 10.1038/201409a0; PAINTER RB, 1961, RADIAT RES, V14, P653, DOI 10.2307/3570905; PAINTER RB, 1959, RADIAT RES, V11, P206, DOI 10.2307/3570659; PERRY RP, 1961, BIOCHIM BIOPHYS ACTA, V49, P47, DOI 10.1016/0006-3002(61)90868-X; PERRY RP, 1960, EXP CELL RES, V20, P216, DOI 10.1016/0014-4827(60)90240-8; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; RASMUSSEN RE, 1964, NATURE, V203, P1360, DOI 10.1038/2031360a0; REGAN JD, 1968, BIOPHYS J, V8, P319, DOI 10.1016/S0006-3495(68)86490-2; ROWLEY J, 1963, NATURE, V197, P251, DOI 10.1038/197251a0; STRAUSS BS, 1958, RADIAT RES, V8, P234, DOI 10.2307/3570480; Taylor J. H., 1991, TRENDS BIOCHEM SCI, V19, P479; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TAYLOR JH, 1989, BIOESSAYS, V10, P121, DOI 10.1002/bies.950100407; THOMPSON LH, 1970, P NATL ACAD SCI USA, V66, P377, DOI 10.1073/pnas.66.2.377; THOMPSON LH, 1980, SOMAT CELL GENET, V6, P391, DOI 10.1007/BF01542791; TROSKO JE, 1967, PHOTOCHEM PHOTOBIOL, V6, P215, DOI 10.1111/j.1751-1097.1967.tb08806.x	39	1	1	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2742	2745		10.1096/fj.14-0702ufm	http://dx.doi.org/10.1096/fj.14-0702ufm			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24990958				2022-12-25	WOS:000337949400002
J	Fisher, LA; Wang, L; Wu, L; Peng, AM				Fisher, Laura A.; Wang, Ling; Wu, Lan; Peng, Aimin			Phosphatase 1 Nuclear Targeting Subunit Is an Essential Regulator of M-phase Entry, Maintenance, and Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Mitosis; Phosphatase; Phosphoprotein Phosphatase 1 (PP1); Xenopus; APC; C; Pnuts	PROTEIN PHOSPHATASE-1; CYTOSTATIC FACTOR; METAPHASE ARREST; GREATWALL KINASE; MITOTIC EXIT; AURORA-B; PNUTS; MITOSIS; ANAPHASE; DEPHOSPHORYLATION	Background: Mitotic progression is regulated by reversible protein phosphorylation involving kinases and phosphatases. Results: Pnuts functions as a master regulator of mitosis by modulating PP1; Pnuts expression peaks in mitosis and is degraded at mitotic exit. Conclusion: This study reveals the function and regulation of a new and essential mitotic regulator. Significance: This study improves our understanding of M-phase regulation. Mitotic progression is regulated largely through dynamic and reversible protein phosphorylation that is modulated by opposing actions of protein kinases and phosphatases. In this study, we show that phosphatase 1 nuclear targeting subunit (Pnuts) functions as a master regulator of mitosis by modulating protein phosphatase 1 (PP1). Overexpression of Pnuts in Xenopus egg extracts inhibited both mitotic and meiotic exit. Immunodepletion of Pnuts from egg extracts revealed its essential functions in mitotic entry and maintenance. The level of Pnuts oscillates during the cell cycle and peaks in mitosis. Pnuts destruction during M-phase exit is mediated by the anaphase-promoting complex/cyclosome (APC/C)-targeted ubiquitination and proteolysis, and conserved destruction motifs of Pnuts. Disruption of Pnuts degradation delayed M-phase exit, suggesting it as an important mechanism to permit M-phase exit.	[Fisher, Laura A.; Wang, Ling; Wu, Lan; Peng, Aimin] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu			National Institutes of Health [1R01CA172574, 5P20GM103489]; NATIONAL CANCER INSTITUTE [R01CA172574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA172574 and 5P20GM103489 (to A. P.).	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Crane Richard F., 2006, V322, P435; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Kavela S, 2013, CANCER RES, V73, P205, DOI 10.1158/0008-5472.CAN-12-1394; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lee SJ, 2009, EXP MOL MED, V41, P189, DOI 10.3858/emm.2009.41.3.022; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng AM, 2011, J BIOL CHEM, V286, P28996, DOI 10.1074/jbc.M111.257121; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Philpott Anna, 2004, V296, P95; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	47	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23745	23752		10.1074/jbc.M114.572149	http://dx.doi.org/10.1074/jbc.M114.572149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002584	hybrid, Green Published			2022-12-25	WOS:000341505000042
J	Lopez-Perrote, A; Alatwi, HE; Torreira, E; Ismail, A; Ayora, S; Downs, JA; Llorca, O				Lopez-Perrote, Andres; Alatwi, Hanan E.; Torreira, Eva; Ismail, Amani; Ayora, Silvia; Downs, Jessica A.; Llorca, Oscar			Structure of Yin Yang 1 Oligomers That Cooperate with RuvBL1-RuvBL2 ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAINS; ELECTRON-MICROSCOPY; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; YY1; COMPLEX; PROTEIN; DNA; REPAIR; CELLS	Yin Yang 1 (YY1) is a transcription factor regulating proliferation and differentiation and is involved in cancer development. Oligomers of recombinant YY1 have been observed before, but their structure and DNA binding properties are not well understood. Here we find that YY1 assembles several homo-oligomeric species built from the association of a bell-shaped dimer, a process we characterized by electron microscopy. Moreover, we find that YY1 self-association also occurs in vivo using bimolecular fluorescence complementation. Unexpectedly, these oligomers recognize several DNA substrates without the consensus sequence for YY1 in vitro, and DNA binding is enhanced in the presence of RuvBL1-RuvBL2, two essential AAA+ ATPases. YY1 oligomers bind RuvBL1-RuvBL2 hetero-oligomeric complexes, but YY1 interacts preferentially with RuvBL1. Collectively, these findings suggest that YY1-RuvBL1-RuvBL2 complexes could contribute to functions beyond transcription, and we show that YY1 and the ATPase activity of RuvBL2 are required for RAD51 foci formation during homologous recombination.	[Lopez-Perrote, Andres; Torreira, Eva; Llorca, Oscar] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Alatwi, Hanan E.; Ismail, Amani; Downs, Jessica A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Ayora, Silvia] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sussex; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Downs, JA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	J.A.Downs@sussex.ac.uk; ollorca@cib.csic.es	Ayora, Silvia/D-2552-2009; Llorca, Oscar/K-1144-2014; Llorca, Oscar/P-2784-2019	Ayora, Silvia/0000-0003-3121-1786; Llorca, Oscar/0000-0001-5705-0699; Llorca, Oscar/0000-0001-5705-0699; Ismail, Amani/0000-0002-1997-6826; Downs, Jessica/0000-0002-6600-849X; Lopez-Perrote, Andres/0000-0001-7872-3442	Spanish Government [SAF2011-22988, BES-2009-014133, BFU2012-39879-C02-02]; Cancer Research UK [CEA-C7905]; Cancer Research UK [16417] Funding Source: researchfish	Spanish Government(Spanish GovernmentEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by the Spanish Government (SAF2011-22988 (to O. L.), BES-2009-014133 (to A. L.-P.), BFU2012-39879-C02-02 (to S. A.)) and by Cancer Research UK (CEA-C7905 (to J. A. D.)).	Atchison ML, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00045; Bao YH, 2011, CELL, V144, P158, DOI 10.1016/j.cell.2010.12.024; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Doetsch M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044125; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Ishii H, 2012, INT J ONCOL, V40, P1575, DOI 10.3892/ijo.2012.1362; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; LEWIS BA, 1995, J VIROL, V69, P1628, DOI 10.1128/JVI.69.3.1628-1636.1995; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nano N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0399; Nicholson Sarah, 2011, Critical Reviews in Oncogenesis, V16, P245; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Zecchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048440	49	26	27	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22614	22629		10.1074/jbc.M114.567040	http://dx.doi.org/10.1074/jbc.M114.567040			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990942	Green Published, hybrid			2022-12-25	WOS:000341017200008
J	Meng, Y; Lin, S; Liu, SF; Fan, X; Li, GR; Meng, YF				Meng, Yao; Lin, Sen; Liu, Shuangfeng; Fan, Xiang; Li, Gangrui; Meng, Yanfa			A Novel Method for Simultaneous Production of Two Ribosome-Inactivating Proteins, alpha-MMC and MAP30, from Momordica charantia L.	PLOS ONE			English	Article							IN-VITRO; ANTITUMOR; INHIBITION; EXPRESSION; APOPTOSIS; PROGRESS; SEEDS	Alpha-momorcharin (alpha-MMC) and momordica anti-HIV protein (MAP30) from Momordica charantia L. have been confirmed to possess anti-tumor and anti-virus activities. Traditional purification methods of these two ribosome-inactivating proteins (RIPs) were separate which was time consuming and cost effective as well as low efficient. In order to obtain sufficient samples for researches, a strategy combining ion-exchange and gel filtration chromatography was developed and optimized in this study. Using this novel purification method, averagely 1162 mg of alpha-MMC and 535 mg of MAP30 were obtained from 400 g of Momordica charantia L seeds. The homogeneities of them were assessed by electrophoresis analysis. Determination of molecular weights of alpha-MMC and MAP30 were 28.585 kDa and 29.094 kDa by MALDI-TOF/TOF and pl were 9.02 and 9.12, respectively. The single glycoproteins were identified by Periodate-Schiff's base (PAS) and the saccharide content was tested to be 1.25% and 1.1% by anthrone-sulfuric acid method. Biological activities were evidenced by their ability to inhibit proliferation of lung adenocarcinoma A549 cell and to convert supercoiled plasmid pUC18 into relaxed forms. Finally, we also found that both two RIPs exhibited no superoxide dismutase (SOD) activity.	[Meng, Yao; Liu, Shuangfeng] Chengdu Med Coll, Sch Med Lab Sci, Chengdu, Peoples R China; [Lin, Sen] Chengdu Med Coll, Dept Histol & Embryol & Neurobiol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu, Peoples R China; [Fan, Xiang; Li, Gangrui; Meng, Yanfa] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Anim Dis Prevent & Food Safety Key Lab Sichuan Pr, Chengdu 610064, Peoples R China	Chengdu Medical College; Chengdu Medical College; Sichuan University	Meng, YF (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Anim Dis Prevent & Food Safety Key Lab Sichuan Pr, Chengdu 610064, Peoples R China.	yfmeng0902@scu.edu.cn			Sichuan provincial department of education [13ZB0091, 201313705020]; Sichuan province health department [130301]	Sichuan provincial department of education; Sichuan province health department	This work was financially supported by Sichuan provincial department of education (Grant No. 13ZB0091, No. 201313705020) and Sichuan province health department (Grant No. 130301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bian XX, 2010, BIOTECHNOL LETT, V32, P883, DOI 10.1007/s10529-010-0242-8; Bourinbaiar AS, 1996, BIOCHEM BIOPH RES CO; Budilova J, 2006, J SEP SCI, V29, P1613, DOI 10.1002/jssc.200500458; de Virgilio M, 2010, TOXINS, V2, P2699, DOI 10.3390/toxins2112699; DOERNER KC, 1990, ANAL BIOCHEM, V187, P147, DOI 10.1016/0003-2697(90)90433-A; Fan J, 2009, MOL BIOL REP, V36, P381, DOI 10.1007/s11033-007-9191-2; Fan JM, 2008, MOL BIOTECHNOL, V39, P79, DOI 10.1007/s12033-008-9034-y; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041592; Fang EF, 2012, CANCER LETT, V324, P66, DOI 10.1016/j.canlet.2012.05.005; Fong WP, 1996, LIFE SCI, V59, P901, DOI 10.1016/0024-3205(96)00388-8; GRAHAM D, 1965, ANAL BIOCHEM, V11, P246, DOI 10.1016/0003-2697(65)90012-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee K, 2009, J SEP SCI, V32, P1237, DOI 10.1002/jssc.200800672; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; LEEHUANG S, 1990, FEBS LETT, V272, P12, DOI 10.1016/0014-5793(90)80438-O; Li ME, 2009, ACTA BIOCH BIOPH SIN, V41, P792, DOI 10.1093/abbs/gmp068; Li XD, 1997, PROTEIN EXPRES PURIF, V10, P27, DOI 10.1006/prep.1996.0706; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Meng Y, 2012, INT J NANOMED, V7, P3133, DOI 10.2147/IJN.S30631; Mukherjee P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-207; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Park SW, 2004, PLANTA, V219, P1093, DOI 10.1007/s00425-004-1357-8; Schreiber CA, 1999, FERTIL STERIL, V72, P686, DOI 10.1016/S0015-0282(99)00302-7; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Sun YT, 2001, BIOCHEM BIOPH RES CO, V287, P983, DOI 10.1006/bbrc.2001.5689; Tumer NE, 2012, CURR TOP MICROBIOL, V357, P1, DOI 10.1007/82_2011_174	30	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101998	10.1371/journal.pone.0101998	http://dx.doi.org/10.1371/journal.pone.0101998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003606	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700097
J	Quilodran, CS; Currat, M; Montoya-Burgos, JI				Quilodran, Claudio S.; Currat, Mathias; Montoya-Burgos, Juan I.			A General Model of Distant Hybridization Reveals the Conditions for Extinction in Atlantic Salmon and Brown Trout	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; CLONAL REPRODUCTION; TRUTTA L.; SALAR L.; HYBRIDS; INTROGRESSION; FISH; REPLACEMENT; POLYPLOIDY; ESCULENTA	Interspecific hybridization is common in nature but can be increased in frequency or even originated by human actions, such as species introduction or habitat modification, which may threaten species persistence. When hybridization occurs between distantly related species, referred to as "distant hybridization,'' the resulting hybrids are generally infertile or fertile but do not undergo chromosomal recombination during gametogenesis. Here, we present a model describing this frequent but poorly studied interspecific hybridization to assess its consequences on parental species and to anticipate the conditions under which they can reach extinction. Our general model fully incorporates three important processes: density-dependent competition, dominance/recessivity inheritance of traits and assortative mating. We demonstrate its use and flexibility by assessing population extinction risk between Atlantic salmon and brown trout in Norway, whose interbreeding has recently increased due to farmed fish releases into the wild. We identified the set of conditions under which hybridization may threaten salmonid species. Thanks to the flexibility of our model, we evaluated the effect of an additional risk factor, a parasitic disease, and showed that the cumulative effects dramatically increase the extinction risk. The consequences of distant hybridization are not genetically, but demographically mediated. Our general model is useful to better comprehend the evolution of such hybrid systems and we demonstrated its importance in the field of conservation biology to set up management recommendations when this increasingly frequent type of hybridization is in action.	[Quilodran, Claudio S.; Currat, Mathias] Univ Geneva, Dept Genet & Evolut, Lab Anthropol Genet & Peopling Hist AGP, Geneva, Switzerland; [Quilodran, Claudio S.; Montoya-Burgos, Juan I.] Univ Geneva, Lab Mol Phylogeny & Evolut Vertebrates, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva; University of Geneva	Currat, M (corresponding author), Univ Geneva, Dept Genet & Evolut, Lab Anthropol Genet & Peopling Hist AGP, Geneva, Switzerland.	mathias.currat@unige.ch		Quilodran, Claudio/0000-0001-7197-9154; Montoya-Burgos, Juan I./0000-0001-9080-9820	CADMOS; SNSF; Canton de Geneve; G. and A. Claraz donation; CONICYT-Becas Chile; iGE3 student salary award	CADMOS; SNSF(Swiss National Science Foundation (SNSF)); Canton de Geneve; G. and A. Claraz donation; CONICYT-Becas Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); iGE3 student salary award	This study was financed by a fellowship from CADMOS granted to JIMB and MC and partly supported by grants from the SNSF, the Canton de Geneve and the G. and A. Claraz donation to JIMB. CSQ acknowledges support from CONICYT-Becas Chile and from the iGE3 student salary award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Alvarez D, 2011, CAN J FISH AQUAT SCI, V68, P953, DOI [10.1139/F2011-004, 10.1139/F11-004, 10.1139/f2011-004]; Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Bakke TA, 1999, PARASITOLOGY, V119, P467, DOI 10.1017/S0031182099004990; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Birkhead TR, 2007, TRENDS ECOL EVOL, V22, P266, DOI 10.1016/j.tree.2007.02.004; Castillo AGF, 2007, MOL ECOL, V16, P1741, DOI 10.1111/j.1365-294X.2007.03257.x; Castillo AGF, 2008, AQUACULTURE, V278, P31, DOI 10.1016/j.aquaculture.2008.03.029; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAWLEY RM, 1987, COPEIA, P275, DOI 10.2307/1445762; Ferdy JB, 2002, AM NAT, V160, P74, DOI 10.1086/340606; Galbreath PF, 1995, AQUACULTURE, V137, P299, DOI 10.1016/0044-8486(95)01115-3; Garcia-Vazquez E, 2004, AQUACULTURE, V234, P77, DOI 10.1016/j.aquaculture.2004.01.017; Garcia-Vazquez E, 2003, FRESHWATER BIOL, V48, P1100, DOI 10.1046/j.1365-2427.2003.01068.x; GRAY AK, 1993, AQUACULTURE, V112, P125, DOI 10.1016/0044-8486(93)90439-6; Gugsa L, 2006, PLANT CELL REP, V25, P1287, DOI 10.1007/s00299-006-0200-z; Heggenes J, 2007, J FISH BIOL, V71, P1069, DOI 10.1111/j.1095-8649.2007.01573.x; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; HINDAR K, 1994, CONSERV BIOL, V8, P881, DOI 10.1046/j.1523-1739.1994.08030863-10.x; Horreo JL, 2011, J HERED, V102, P237, DOI 10.1093/jhered/esq130; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Jansson H, 1997, CAN J FISH AQUAT SCI, V54, P2033, DOI 10.1139/cjfas-54-9-2033; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; Jonsson B, 2011, FISH FISH SER, V33, P1, DOI 10.1007/978-94-007-1189-1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Kierzkowski P, 2011, ANN ZOOL FENN, V48, P56, DOI 10.5735/086.048.0106; Konishi M, 2004, CONSERV GENET, V5, P463, DOI 10.1023/B:COGE.0000041027.64785.77; Krysanov, 2000, J ICHTHYOL, V40, P298; Lampert KP, 2009, FUND APPL LIMNOL, V174, P245, DOI 10.1127/1863-9135/2009/0174-0245; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Liu SJ, 2010, SCI CHINA LIFE SCI, V53, P416, DOI 10.1007/s11427-010-0057-9; Lode T, 2001, J ZOOL SYST EVOL RES, V39, P91; MaCCulloch RD, 1995, GENOME, V38, P1057, DOI 10.1139/g95-141; MANTOVANI B, 1992, EVOLUTION, V46, P783, DOI 10.1111/j.1558-5646.1992.tb02084.x; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rodriguez DJ, 1996, J THEOR BIOL, V180, P189, DOI 10.1006/jtbi.1996.0095; Rozhnov V.V., 1993, Lutreola (Moscow), V1, P10; Satake A, 2012, THEOR ECOL-NETH, V5, P283, DOI 10.1007/s12080-011-0128-y; Som C, 2006, EVOL ECOL RES, V8, P1235; Urke HA, 2010, FISH PHYSIOL BIOCHEM, V36, P845, DOI 10.1007/s10695-009-9359-x; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wilbur Henry M., 1996, P75; WILBUR HM, 1976, ECOLOGY, V57, P1289, DOI 10.2307/1935053; YOUNGSON AF, 1993, CAN J FISH AQUAT SCI, V50, P1986, DOI 10.1139/f93-221	50	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101736	10.1371/journal.pone.0101736	http://dx.doi.org/10.1371/journal.pone.0101736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003336	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700058
J	Chu, SC; Hsieh, YS; Yu, CC; Lai, YY; Chen, PN				Chu, Shu-Chen; Hsieh, Yih-Shou; Yu, Cheng-Chia; Lai, Yi-Yeh; Chen, Pei-Ni			Thymoquinone Induces Cell Death in Human Squamous Carcinoma Cells via Caspase Activation-Dependent Apoptosis and LC3-II Activation-Dependent Autophagy	PLOS ONE			English	Article							ORAL-CANCER CELLS; CYCLE ARREST; TUMOR-GROWTH; IN-VITRO; INDUCTION; INVASION; HEAD; GENERATION; TIGAR; A549	Background: Thymoquinone (TQ), an active component of Nigella sativa or black cumin, elicits cytotoxic effects on various cancer cell lines. However, the anti-cancer effects of TQ on head and neck squamous cell carcinoma (HNSCC) remain unclear. Methodology/Principal Findings: In this study, TQ elicited a strong cytotoxic effect on SASVO3, a highly malignant HNSCC cell line. The mechanisms of this cytotoxic effect were concentration dependent. TQ also induced apoptotic cell death in SASVO3 cells as indicated by an increase in Bax expression and caspase-9 activation. Apoptosis was possibly caspase-9 dependent because the exposure of cells to a caspase-9 inhibitor partially prevented cell death. The exposed cells also showed increased levels of autophagic vacuoles and LC3-II proteins, which are specific autophagy markers. Cell viability assay results further revealed that bafilomycin-A1, an autophagy inhibitor, enhanced TQ cytotoxicity; by comparison, Annexin V and propidium-iodide staining assay results showed that this inhibitor did not promote apoptosis. TQ treatment also increased the accumulation of autophagosomes. Using a lentivirus-shRNA system for LC3 silencing, we found that cell viability was eradicated in autophagy-defective cells. An in vivo BALB/c nude mouse xenograft model further showed that TQ administered by oral gavage reduced tumor growth via induced autophagy and apoptosis. Conclusions: These findings indicated that TQ induced cell death in oral cancer cells via two distinct anti-neoplastic activities that can induce apoptosis and autophagy. Therefore, TQ is a promising candidate in phytochemical-based, mechanistic, and pathway-targeted cancer prevention strategies.	[Chu, Shu-Chen] Cent Taiwan Univ Sci & Technol, Inst & Dept Food Sci, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Inst Oral Sci, Sch Dent, Taichung, Taiwan; [Hsieh, Yih-Shou; Lai, Yi-Yeh; Chen, Pei-Ni] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Hsieh, Yih-Shou; Chen, Pei-Ni] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Central Taiwan University Science & Technology; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, PN (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	peini@csmu.edu.tw			National Science Council, Republic of China [NSC 98-2313-B-040-004-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grants of National Science Council, Republic of China (NSC 98-2313-B-040-004-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel-Salam BKA, 2012, ALLERGOL IMMUNOPATH, V40, P336, DOI 10.1016/j.aller.2011.07.002; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; BOXENBAUM H, 1995, J CLIN PHARMACOL, V35, P957, DOI 10.1002/j.1552-4604.1995.tb04011.x; Chen CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-100; Chen PN, 2006, CHEM-BIOL INTERACT, V163, P218, DOI 10.1016/j.cbi.2006.08.003; Chen PN, 2005, NUTR CANCER, V53, P232, DOI 10.1207/s15327914nc5302_12; Chen PN, 2011, J AGR FOOD CHEM, V59, P3836, DOI 10.1021/jf1049408; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046641; Gewirtz DA, 2013, AUTOPHAGY, V9, P1263, DOI 10.4161/auto.25233; Ho YS, 2001, INT J CANCER, V91, P393, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1070&gt;3.0.CO;2-#; Hsieh YS, 2013, FOOD CHEM TOXICOL, V62, P908, DOI 10.1016/j.fct.2013.10.021; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Huang AC, 2013, INT J ONCOL, V43, P485, DOI 10.3892/ijo.2013.1952; INGS RMJ, 1990, XENOBIOTICA, V20, P1201, DOI 10.3109/00498259009046839; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kasten F H, 1990, Int J Periodontics Restorative Dent, V10, P68; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mohammadzadeh M, 2013, INTEGR CANCER THER, V12, P496, DOI 10.1177/1534735413485417; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Racoma IO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072882; Raghavan D, 1997, EUR J CANCER, V33, P566, DOI 10.1016/S0959-8049(96)00510-2; Speirs CK, 2011, AM J CANCER RES, V1, P43; Stumm S, 2004, ONCOLOGY-BASEL, V66, P101, DOI 10.1159/000077435; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng HH, 2012, INTEGR CANCER THER, V11, P267, DOI 10.1177/1534735411417128; WONG DYK, 1990, J ORAL MAXIL SURG, V48, P385, DOI 10.1016/0278-2391(90)90436-6; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Xu MY, 2013, FOOD CHEM TOXICOL, V59, P703, DOI 10.1016/j.fct.2013.06.059; Yang F, 2012, J PHARMACOL SCI, V119, P214, DOI 10.1254/jphs.11235FP; Yang WL, 2012, J SURG ONCOL, V106, P680, DOI 10.1002/jso.23184; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	42	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101579	10.1371/journal.pone.0101579	http://dx.doi.org/10.1371/journal.pone.0101579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000169	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300059
J	Corbani, AC; Hachey, MH; Desrochers, A				Corbani, Aude Catherine; Hachey, Marie-Helene; Desrochers, Andre			Food Provisioning and Parental Status in Songbirds: Can Occupancy Models Be Used to Estimate Nesting Performance?	PLOS ONE			English	Article							OVENBIRD SEIURUS-AUROCAPILLUS; THROATED BLUE WARBLERS; EXTRA-PAIR PATERNITY; BOREAL FOREST; HABITAT FRAGMENTATION; REPRODUCTIVE INDEX; BREEDING SUCCESS; JYNX-TORQUILLA; MOBBING CALLS; BIRDS	Indirect methods to estimate parental status, such as the observation of parental provisioning, have been problematic due to potential biases associated with imperfect detection. We developed a method to evaluate parental status based on a novel combination of parental provisioning observations and hierarchical modeling. In the summers of 2009 to 2011, we surveyed 393 sites, each on three to four consecutive days at Foret Montmorency, Quebec, Canada. We assessed parental status of 2331 adult songbirds based on parental food provisioning. To account for imperfect detection of parental status, we applied MacKenzie et al.'s (2002) two-state hierarchical model to obtain unbiased estimates of the proportion of sites with successfully nesting birds, and the proportion of adults with offspring. To obtain an independent evaluation of detection probability, we monitored 16 active nests in 2010 and conducted parental provisioning observations away from them. The probability of detecting food provisioning was 0.31 when using nest monitoring, a value within the 0.11 to 0.38 range that was estimated by two-state models. The proportion of adults or sites with broods approached 0.90 and varied depending on date during the sampling season and year, exemplifying the role of eastern boreal forests as highly productive nesting grounds for songbirds. This study offers a simple and effective sampling design for studying avian reproductive performance that could be implemented in national surveys such as breeding bird atlases.	[Corbani, Aude Catherine; Hachey, Marie-Helene; Desrochers, Andre] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada	Laval University	Corbani, AC (corresponding author), Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada.	audecorbani@yahoo.fr			NSERC (Natural Sciences and Engineering Research Council of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC (Natural Sciences and Engineering Research Council of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arlettaz R, 2010, J ORNITHOL, V151, P889, DOI 10.1007/s10336-010-0527-7; Ball JR, 2012, AUK, V129, P438, DOI 10.1525/auk.2012.11224; Barba E, 2009, BIRD STUDY, V56, P187, DOI 10.1080/00063650902792049; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Beauchesne P, 1991, THESIS U LAVAL QUEBE; Belisle M, 2002, LANDSCAPE ECOL, V17, P219, DOI 10.1023/A:1020260326889; BEST LB, 1977, AUK, V94, P308; Betts MG, 2005, ETHOLOGY, V111, P821, DOI 10.1111/j.1439-0310.2005.01109.x; Blancher P., 2005, BOREAL FOREST REGION; BRADLEY DW, 1985, AUK, V102, P493, DOI 10.1093/auk/102.3.493; Burnham KP, 2002, MULTIMODEL INFERENCE; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Dalley KL, 2008, CAN J ZOOL, V86, P1203, DOI 10.1139/Z08-104; Dalley KL, 2009, CONDOR, V111, P314, DOI 10.1525/cond.2009.080104; Darveau M, 1997, ECOL APPL, V7, P572, DOI 10.1890/1051-0761(1997)007[0572:FPATRO]2.0.CO;2; Desrochers A, 2002, ANIM BEHAV, V64, P709, DOI 10.1006/anbe.2002.4013; Donovan TM, 2002, J FIELD ORNITHOL, V73, P329, DOI 10.1648/0273-8570-73.4.329; Doran PJ, 2005, J FIELD ORNITHOL, V76, P227, DOI 10.1648/0273-8570-76.3.227; Environment Canada, 2012, CAN CLIM NORM 1971 2; ESRI, 2009, ARCGIS 9 3 1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Freitag A, 2001, BIRD STUDY, V48, P102, DOI 10.1080/00063650109461207; Gauthier J., 1996, BREEDING BIRDS QUEBE; Geiser S, 2008, J ORNITHOL, V149, P597, DOI 10.1007/s10336-008-0305-y; Goodbred CO, 1996, WILSON BULL, V108, P467; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gunn JS, 2000, J FIELD ORNITHOL, V71, P472, DOI 10.1648/0273-8570-71.3.472; HINDE RA, 1954, PROC R SOC SER B-BIO, V142, P331, DOI 10.1098/rspb.1954.0029; Hines, 2017, OCCUPANCY ESTIMATION; Ibarzabal J, 2005, CAN J FOREST RES, V35, P374, DOI 10.1139/X04-169; Ibarzabal J, 2001, CAN J FOREST RES, V31, P117, DOI 10.1139/cjfr-31-1-117; JOHNSON EJ, 1982, AUK, V99, P148, DOI 10.2307/4086031; Jones SL, 2007, MAYFIELD MEASUREMENT; KNAPTON RW, 1984, WILSON BULL, V96, P594; Laberge G, 2010, POSSIBILITE FORESTIE; Lack D., 1966, POPULATION STUDIES B; LACK DAVID, 1940, AUK, V57, P169; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Morgan MR, 2010, AUK, V127, P86, DOI 10.1525/auk.2009.09132; Newton I, 1989, LIFETIME REPROD BIRD; Orians G.H., 1979, P155; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; PINKOWSKI BC, 1978, WILSON BULL, V90, P84; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rangen SA, 2000, WILDLIFE SOC B, V28, P110; Reed LP, 2007, WILSON J ORNITHOL, V119, P350, DOI 10.1676/06-050.1; ROBBINS CS, 1981, STUDIES AVIAN BIOL, V6, P275; ROBBINS CS, 1981, STUD AVIAN BIOL, V6, P301; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Robinson SK, 2001, CONSERV BIOL, V15, P1763, DOI 10.1046/j.1523-1739.2001.00226.x; RODENHOUSE NL, 1992, ECOLOGY, V73, P357, DOI 10.2307/1938747; Rodewald AD, 2001, AUK, V118, P1018, DOI 10.1642/0004-8038(2001)118[1018:ANSIFL]2.0.CO;2; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Sallabanks R, 2000, WILDLIFE SOC B, V28, P1144; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Seagle SW, 2005, ECOLOGY, V86, P1531, DOI 10.1890/03-0770; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; Vatka E, 2011, GLOBAL CHANGE BIOL, V17, P3002, DOI 10.1111/j.1365-2486.2011.02430.x; VICKERY PD, 1992, AUK, V109, P697, DOI 10.2307/4088145; VILLARD MA, 1993, AUK, V110, P759; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	69	2	2	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101765	10.1371/journal.pone.0101765	http://dx.doi.org/10.1371/journal.pone.0101765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999969	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300082
J	Cox, R; Korjoukov, I; de Boer, M; Talamini, LM				Cox, Roy; Korjoukov, Ilia; de Boer, Marieke; Talamini, Lucia M.			Sound Asleep: Processing and Retention of Slow Oscillation Phase-Targeted Stimuli	PLOS ONE			English	Article							EVOKED-POTENTIALS; BRAIN ACTIVITY; K-COMPLEX; SLEEP; MEMORY; EEG; SPINDLES; REPETITION; SHIFTS; WAVES	The sleeping brain retains some residual information processing capacity. Although direct evidence is scarce, a substantial literature suggests the phase of slow oscillations during deep sleep to be an important determinant for stimulus processing. Here, we introduce an algorithm for predicting slow oscillations in real-time. Using this approach to present stimuli directed at both oscillatory up and down states, we show neural stimulus processing depends importantly on the slow oscillation phase. During ensuing wakefulness, however, we did not observe differential brain or behavioral responses to these stimulus categories, suggesting no enduring memories were formed. We speculate that while simpler forms of learning may occur during sleep, neocortically based memories are not readily established during deep sleep.	[Cox, Roy; de Boer, Marieke; Talamini, Lucia M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cox, Roy; de Boer, Marieke; Talamini, Lucia M.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Korjoukov, Ilia] Okazolab Ltd, London, England	University of Amsterdam; University of Amsterdam	Cox, R (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.cox@uva.nl	Cox, Roy/I-1753-2019	Cox, Roy/0000-0002-3667-9049	Dutch National Science Foundation (NWO) [452-08-013]	Dutch National Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch National Science Foundation (NWO - www.nwo.nl), grant 452-08-013 to LMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Arzi A, 2012, NAT NEUROSCI; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bergmann TO, 2012, J NEUROSCI, V32, P243, DOI 10.1523/JNEUROSCI.4792-11.2012; Bourquin NMP, 2012, NEUROIMAGE, V62, P1800, DOI 10.1016/j.neuroimage.2012.04.055; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cote KA, 2000, J SLEEP RES, V9, P19, DOI 10.1046/j.1365-2869.2000.00188.x; Cox R, 2014, NEUROIMAGE, V99, P103, DOI 10.1016/j.neuroimage.2014.05.028; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Deffenbacher KA, 1981, AM J PSYCHOL; Elton M, 1997, J SLEEP RES, V6, P78, DOI 10.1046/j.1365-2869.1997.00033.x; EMMONS WH, 1956, AM J PSYCHOL, V69, P76, DOI 10.2307/1418117; FOX BH, 1952, J EXP PSYCHOL, V43, P75, DOI 10.1037/h0057555; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Hauner KK, 2013, NAT NEUROSCI; Iber C., 2007, AASM MANUAL SCORING; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; Menicucci D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007601; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2002, J NEUROSCI, V22, P10941; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Oudiette D, 2013, TRENDS COGN SCI REGU; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch BH, 2006, J COGNITIVE NEUROSCI, V18, P793, DOI 10.1162/jocn.2006.18.5.793; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schabus M, 2012, FRONTIERS NEUROLOGY, V3; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; UJSZASZI J, 1988, ELECTROEN CLIN NEURO, V69, P516, DOI 10.1016/0013-4694(88)90163-0; Valderrama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033477; van Ast VA, 2014, PSYCHONEUROENDOCRINO, V41, P97, DOI 10.1016/j.psyneuen.2013.12.007; van Dongen EV, 2012, P NATL ACAD SCI USA, V109, P10575, DOI 10.1073/pnas.1201072109; WOOD JM, 1992, PSYCHOL SCI, V3, P236, DOI 10.1111/j.1467-9280.1992.tb00035.x	50	41	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101567	10.1371/journal.pone.0101567	http://dx.doi.org/10.1371/journal.pone.0101567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999803	gold, Green Published			2022-12-25	WOS:000338637300057
J	Esposito, S; Zampiero, A; Pugni, L; Tabano, S; Pelucchi, C; Ghirardi, B; Terranova, L; Miozzo, M; Mosca, F; Principi, N				Esposito, Susanna; Zampiero, Alberto; Pugni, Lorenza; Tabano, Silvia; Pelucchi, Claudio; Ghirardi, Beatrice; Terranova, Leonardo; Miozzo, Monica; Mosca, Fabio; Principi, Nicola			Genetic Polymorphisms and Sepsis in Premature Neonates	PLOS ONE			English	Article							EXPRESSION PROFILES; INCREASING PROTEIN; INNATE IMMUNITY; INTERLEUKIN-1; INFECTION; VARIANTS; NEWBORN; VIRUS; ZINC; METALLOPROTEINASES	Identifying single nucleotide polymorphisms (SNPs) in the genes involved in sepsis may help to clarify the pathophysiology of neonatal sepsis. The aim of this study was to evaluate the relationships between sepsis in pre-term neonates and genes potentially involved in the response to invasion by infectious agents. The study involved 101 pre-term neonates born between June 2008 and May 2012 with a diagnosis of microbiologically confirmed sepsis, 98 pre-term neonates with clinical sepsis and 100 randomly selected, otherwise healthy pre-term neonates born during the study period. During the study, 47 SNPs in 18 candidate genes were genotyped on Guthrie cards using an ABI PRISM 7900 HT Fast real-time and MAssARRAY for nucleic acids instruments. Genotypes CT and TT of rs1143643 (the IL1 beta gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEF beta 1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both). Among the patients with bacteriologically confirmed sepsis, only genotype GG of rs2664349 (the MMP-16 gene) showed a significant association with an increased risk (p = 0.02). Genotypes GG of rs2569190 (the CD14 gene) and AT of rs4073 (the IL8 gene) were associated with a significantly increased risk of developing severe sepsis (p = 0.05 and p = 0.01). Genotype AG of rs1800629 (the LTA gene) and genotypes CC and CT of rs1341023 (the BPI gene) were associated with a significantly increased risk of developing Gram-negative sepsis (p = 0.04, p = 0.04 and p = 0.03). These results show that genetic variability seems to play a role in sepsis in pre-term neonates by influencing susceptibility to and the severity of the disease, as well as the risk of having disease due to specific pathogens.	[Esposito, Susanna; Zampiero, Alberto; Terranova, Leonardo; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Pugni, Lorenza; Ghirardi, Beatrice; Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Neonatal Intens Care Unit, Milan, Italy; [Tabano, Silvia; Miozzo, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Genet Unit, Milan, Italy; [Pelucchi, Claudio] IRCCS, Mario Negri Inst Pharmacol Res, Dept Epidemiol Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Miozzo, Monica Rosa/AAC-6401-2022; Mosca, Fabio/C-5826-2017; Terranova, Leonardo/C-4348-2017; Tabano, Silvia/P-1498-2017; Esposito, Susanna/K-3475-2016	Miozzo, Monica Rosa/0000-0002-6523-4575; Mosca, Fabio/0000-0001-6477-0299; Terranova, Leonardo/0000-0003-3596-104X; Esposito, Susanna/0000-0003-4103-2837; Pelucchi, Claudio/0000-0003-1425-8945; Tabano, Silvia Maria/0000-0002-5260-6691	Italian Ministry of Health (Bando Giovani Ricercatori)	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy)	Italian Ministry of Health (Bando Giovani Ricercatori 2009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bochud PY, 2007, LANCET INFECT DIS, V7, P531, DOI 10.1016/S1473-3099(07)70185-8; Casabonne D, 2011, HAEMATOL-HEMATOL J, V96, P323, DOI 10.3324/haematol.2010.031161; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, P1427, DOI 10.1136/adc.2007.134205; Chen Q, 2009, CRIT CARE S1, V13, P354; Chen QX, 2007, GENES IMMUN, V8, P439, DOI 10.1038/sj.gene.6364401; Chirico G, 2009, J MATERN-FETAL NEO M, V22, P46, DOI 10.1080/14767050903192192; Chung LP, 2011, CRIT REV CL LAB SCI, V48, P250, DOI 10.3109/10408363.2011.641517; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; European Medicines Agency, 2010, M NEON PAED SEPS EMA; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hadchouel A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003188; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Jabandziev P, 2014, CRIT CARE, V18, DOI 10.1186/cc13174; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Lee HM, 2004, J PERIODONTOL, V75, P453, DOI 10.1902/jop.2004.75.3.453; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Levy O, 1999, PEDIATRICS, V104, P1327, DOI 10.1542/peds.104.6.1327; Ma PG, 2002, CRIT CARE MED, V30, P1046, DOI 10.1097/00003246-200205000-00015; Mehta K, 2013, INDIAN PEDIATR, V50, P390, DOI 10.1007/s13312-013-0120-2; Michalek J, 2007, INTENS CARE MED, V33, P2158, DOI 10.1007/s00134-007-0860-3; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; Namath A, 2009, CRIT CARE CLIN, V25, P835, DOI 10.1016/j.ccc.2009.06.004; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Nupponen I, 2002, PEDIATR RES, V51, P670, DOI 10.1203/01.PDR.0000017477.64723.9D; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; Read RC, 2003, ANN INTERN MED, V138, P534, DOI 10.7326/0003-4819-138-7-200304010-00009; Sastre JBL, 2002, J PERINAT MED, V30, P149; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Shu Q, 2006, SHOCK, V26, P365, DOI 10.1097/01.shk.0000224722.65929.58; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; *VERM OXF NETW, 1993, VERM OXF NETW DAT MA; Watanabe E, 2010, CRIT CARE MED, V38, P181, DOI 10.1097/CCM.0b013e3181bc805d; Weitkamp JH, 2000, INFECTION, V28, P92, DOI 10.1007/s150100050053; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081329; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Zhang AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071237	46	32	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101248	10.1371/journal.pone.0101248	http://dx.doi.org/10.1371/journal.pone.0101248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000179	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300027
J	Chandra, S; Narang, R; Sreenivas, V; Bhatia, J; Saluja, D; Srivastava, K				Chandra, Sudhir; Narang, Rajiv; Sreenivas, Vishnubhatla; Bhatia, Jagriti; Saluja, Daman; Srivastava, Kamna			Association of Angiotensin II Type 1 Receptor (A1166C) Gene Polymorphism and Its Increased Expression in Essential Hypertension: A Case-Control Study	PLOS ONE			English	Article							BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; UP-REGULATION; RISK; SYSTEM; AT(1); EPIDEMIOLOGY; METAANALYSIS; KIDNEY	Objectives: Hypertension is one of the major cardiovascular diseases. It affects nearly 1.56 billion people worldwide. The present study is about a particular genetic polymorphism (A1166C), gene expression and protein expression of the angiotensin II type I receptor (AT1R) (SNP ID: rs5186) and its association with essential hypertension in a Northern Indian population. Methods: We analyzed the A1166C polymorphism and expression of AT1R gene in 250 patients with essential hypertension and 250 normal healthy controls. Results: A significant association was found in the AT1R genotypes (AC+CC) with essential hypertension (chi(2) = 22.48, p = 0.0001). Individuals with CC genotypes were at 2.4 times higher odds (p = 0.0001) to develop essential hypertension than individuals with AC and AA genotypes. The statistically significant intergenotypic variation in the systolic blood pressure was found higher in the patients with CC (169.4 +/- 36.3 mmHg) as compared to that of AA (143.5 +/- 28.1 mmHg) and AC (153.9 +/- 30.5 mmHg) genotypes (p = 0.0001). We found a significant difference in the average delta-CT value (p = 0.0001) wherein an upregulated gene expression (approximately 16 fold) was observed in case of patients as compared to controls. Furthermore, higher expression of AT1R gene was observed in patients with CC genotype than with AC and AA genotypes. A significant difference (p = 0.0001) in the protein expression of angiotensin II Type 1 receptor was also observed in the plasma of patients (1.49 +/- 0.27) as compared to controls (0.80 +/- 0.24). Conclusion: Our findings suggest that C allele of A1166C polymorphism in the angiotensin II type 1 receptor gene is associated with essential hypertension and its upregulation could play an important role in essential hypertension.	[Chandra, Sudhir; Saluja, Daman; Srivastava, Kamna] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Narang, Rajiv] All India Inst Med Sci, Dept Cardiol, New Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Bhatia, Jagriti] All India Inst Med Sci, Dept Pharmacol, New Delhi, India	University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Srivastava, K (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	kamna_srivastava@hotmail.com		Srivastava, Kamna/0000-0003-4318-9483	B R Ambedkar Centre for Biomedical Research, University of Delhi, India	B R Ambedkar Centre for Biomedical Research, University of Delhi, India	This work was supported by Departmental grant, DR. B R Ambedkar Centre for Biomedical Research, University of Delhi, India to Dr. Kamna Srivastava and Prof. Daman Saluja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan B, 2003, EXP MOL MED, V35, P545, DOI 10.1038/emm.2003.71; Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Behravan Javad, 2006, DARU-Journal of Pharmaceutical Sciences, V14, P82; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Ceolotto G, 2011, AM J HYPERTENS, V24, P241, DOI 10.1038/ajh.2010.211; Dampney RAL, 2002, CLIN EXP PHARMACOL P, V29, P467, DOI 10.1046/j.1440-1681.2002.03658.x; Devi N, 2012, IOSR J DENT MED SCI, V2, P11; Farrag W, 2011, MOL CELL BIOCHEM, V351, P13, DOI 10.1007/s11010-010-0706-0; GUO DF, 1994, BIOCHEM BIOPH RES CO, V200, P313, DOI 10.1006/bbrc.1994.1450; Gupta R, 1996, J HUM HYPERTENS, V10, P465; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Gupta R, 1997, J INDIAN MED ASSOC, V97, P74; Hu J, 2009, CLIN EXP HYPERTENS, V31, P49, DOI 10.1080/10641960802409788; Irijanto F, 2009, MAJ KEDOKT INDON, V59, P357; Jiang ZN, 2001, CHINESE MED J-PEKING, V114, P1249; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Kannel WB, 2003, HYPERTENSION, V42, P453, DOI 10.1161/01.HYP.0000093382.69464.C4; Katovich MJ, 1999, AM J PHYSIOL-HEART C, V277, pH1260, DOI 10.1152/ajpheart.1999.277.3.H1260; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kikuya M, 2003, HYPERTENS RES, V26, P141, DOI 10.1291/hypres.26.141; Kooffreh Mary Esien, 2013, Indian J Hum Genet, V19, P213, DOI 10.4103/0971-6866.116120; Li NF, 2010, HEART, V96, pA8, DOI 10.1136/hrt.2010.208967.23; Li X, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P292; Liang MY, 2009, AM J PHYSIOL-RENAL, V297, pF553, DOI 10.1152/ajprenal.00045.2009; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Liu Y, 2002, HYPERTENS RES, V25, P515; Mehri S, 2012, MOL BIOL REP, V39, P4059, DOI 10.1007/s11033-011-1187-2; Mehri S, 2011, J RENIN-ANGIO-ALDO S, V12, P595, DOI 10.1177/1470320310391833; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Nickenig G, 1997, CIRCULATION, V95, P473; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; Niu WQ, 2010, HYPERTENS RES, V33, P1137, DOI 10.1038/hr.2010.156; Pende A, 2008, CELL BIOCHEM FUNCT, V26, P493, DOI 10.1002/cbf.1472; Poch E, 2001, HYPERTENSION, V38, P1204, DOI 10.1161/hy1101.099479; Poirier O, 1998, J HYPERTENS, V16, P1443, DOI 10.1097/00004872-199816100-00007; Qureshi AI, 2002, STROKE, V33, P2781, DOI 10.1161/01.STR.0000039402.05613.0F; RAIZADA MK, 1993, J NEUROCHEM, V60, P1949, DOI 10.1111/j.1471-4159.1993.tb13426.x; Ramu P, 2011, INT J HUM GENET, V11, P31, DOI 10.1080/09723757.2011.11886120; Reja V, 2006, CLIN EXP PHARMACOL P, V33, P690, DOI 10.1111/j.1440-1681.2006.04420.x; Rodgers Anthony, 2000, Journal of Hypertension, V18, pS3; Srivastava K, 2012, J PHARM PHARM SCI, V15, P399, DOI 10.18433/J3KW3B; Srivastava K, 2012, GENET TEST MOL BIOMA, V16, P174, DOI 10.1089/gtmb.2011.0155; Sugimoto K, 2004, HYPERTENS RES, V27, P551, DOI 10.1291/hypres.27.551; Tabara Y, 2002, J HYPERTENS, V20, P651, DOI 10.1097/00004872-200204000-00022; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang WYS, 1997, CLIN GENET, V51, P31; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; Zhu YC, 2003, CLIN EXP PHARMACOL P, V30, P911, DOI 10.1111/j.1440-1681.2003.03942.x	52	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101502	10.1371/journal.pone.0101502	http://dx.doi.org/10.1371/journal.pone.0101502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992666	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400080
J	Gratton, C; Lee, TG; Nomura, EM; D'Esposito, M				Gratton, Caterina; Lee, Taraz G.; Nomura, Emi M.; D'Esposito, Mark			Perfusion MRI Indexes Variability in the Functional Brain Effects of Theta-Burst Transcranial Magnetic Stimulation	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PRIMARY MOTOR CORTEX; INTERINDIVIDUAL VARIABILITY; CORTICAL PLASTICITY; REPETITIVE TMS; NETWORK DYNAMICS; FREQUENCY; CONNECTIVITY; RESONANCE; RESPONSES	Transcranial Magnetic Stimulation (TMS) is an important tool for testing causal relationships in cognitive neuroscience research. However, the efficacy of TMS can be variable across individuals and difficult to measure. This variability is especially a challenge when TMS is applied to regions without well-characterized behavioral effects, such as in studies using TMS on multi-modal areas in intrinsic networks. Here, we examined whether perfusion fMRI recordings of Cerebral Blood Flow (CBF), a quantitative measure sensitive to slow functional changes, reliably index variability in the effects of stimulation. Twenty-seven participants each completed four combined TMS-fMRI sessions during which both resting state Blood Oxygen Level Dependent (BOLD) and perfusion Arterial Spin Labeling (ASL) scans were recorded. In each session after the first baseline day, continuous theta-burst TMS (TBS) was applied to one of three locations: left dorsolateral prefrontal cortex (L dlPFC), left anterior insula/frontal operculum (L aI/fO), or left primary somatosensory cortex (L S1). The two frontal targets are components of intrinsic networks and L S1 was used as an experimental control. CBF changes were measured both before and after TMS on each day from a series of interleaved resting state and perfusion scans. Although TBS led to weak selective increases under the coil in CBF measurements across the group, individual subjects showed wide variability in their responses. TBS-induced changes in rCBF were related to TBS-induced changes in functional connectivity of the relevant intrinsic networks measured during separate resting-state BOLD scans. This relationship was selective: CBF and functional connectivity of these networks were not related before TBS or after TBS to the experimental control region (S1). Furthermore, subject groups with different directions of CBF change after TBS showed distinct modulations in the functional interactions of targeted networks. These results suggest that CBF is a marker of individual differences in the effects of TBS.	[Gratton, Caterina] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gratton, C (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	cgratton@berkeley.edu		Lee, Taraz/0000-0002-3186-8625	National Institutes of Health [NIH MH63901, NS79698]; Department of Defense (NDSEG fellowship); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (NDSEG fellowship)(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH MH63901 and NS79698) and the Department of Defense (NDSEG fellowship to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2005, INT REV NEUROBIOL, V66, P213, DOI 10.1016/S0074-7742(05)66007-2; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baudewig J, 2001, NEUROREPORT, V12, P3543, DOI 10.1097/00001756-200111160-00034; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Higo T, 2011, P NATL ACAD SCI USA, V108, P4230, DOI 10.1073/pnas.1013361108; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Johnson JS, 2012, J NEUROPHYSIOL, V107, P2383, DOI 10.1152/jn.00707.2011; Johnson JS, 2010, BRAIN TOPOGR, V22, P281, DOI 10.1007/s10548-009-0118-1; Kemna LJ, 2003, NEUROSCI LETT, V336, P85, DOI 10.1016/S0304-3940(02)01195-3; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Krivanekova L, 2013, BRAIN STIMUL, V6, P330, DOI 10.1016/j.brs.2012.06.004; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Lee L, 2003, J NEUROSCI, V23, P5308; Li XB, 2004, BIOL PSYCHIAT, V55, P882, DOI 10.1016/j.biopsych.2004.01.017; Liang Z, 2013, NEUROIMAGE; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Martin PG, 2006, CLIN NEUROPHYSIOL, V117, P2684, DOI 10.1016/j.clinph.2006.08.008; Moisa M, 2010, NEUROIMAGE, V49, P612, DOI 10.1016/j.neuroimage.2009.07.010; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Myers L., 2004, ENCY STAT SCI, DOI [10.1002/0471667196.ess5050, DOI 10.1002/0471667196.ESS5050]; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; Orosz A, 2012, NEUROIMAGE, V61, P599, DOI 10.1016/j.neuroimage.2012.03.084; Pleger B, 2006, J NEUROSCI, V26, P1945, DOI 10.1523/JNEUROSCI.4097-05.2006; Rahnev D, 2013, J NEUROPHYSIOL, V110, P1811, DOI 10.1152/jn.00209.2013; Reithler J, 2011, PROG NEUROBIOL, V94, P149, DOI 10.1016/j.pneurobio.2011.04.004; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rounis E, 2005, NEUROIMAGE, V26, P164, DOI 10.1016/j.neuroimage.2005.01.037; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Siebner HR, 2003, BRAIN, V126, P2710, DOI 10.1093/brain/awg282; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Strafella AP, 2001, J NEUROPHYSIOL, V85, P2624, DOI 10.1152/jn.2001.85.6.2624; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; van der Werf YD, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-145; Vercammen A, 2010, J PSYCHIATR RES, V44, P725, DOI 10.1016/j.jpsychires.2009.12.011; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Watanabe T, 2013, HUMAN BRAIN MAPPING; Wig GS, 2005, NAT NEUROSCI, V8, P1228, DOI 10.1038/nn1515; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Yoo WK, 2008, NEUROIMAGE, V39, P1886, DOI 10.1016/j.neuroimage.2007.10.035; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	87	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101430	10.1371/journal.pone.0101430	http://dx.doi.org/10.1371/journal.pone.0101430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992641	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400071
J	Hendricks, JM; Lowe, DC; Hardy, ME				Hendricks, Jay M.; Lowe, Diana C.; Hardy, Michele E.			Differential Induction of Isolated Lymphoid Follicles in the Gut by 18 beta-Glycyrrhetinic Acid	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; GLYCYRRHIZIN; MATURATION; PATHWAYS; CELLS; ACTIVATION; EXPRESSION; MICROBIOTA; IMMUNITY	18 beta-glycyrrhetinic acid (GRA) is a pharmacologically active component of licorice root with documented immunomodulatory properties. We reported that GRA administered orally to mice induces B cell recruitment to isolated lymphoid follicles (ILF) in the small intestine and shortens the duration of rotavirus antigen shedding. ILF are dynamic lymphoid tissues in the gut acquired post-natally upon colonization with commensal bacteria and mature through B cell recruitment to the follicles, resulting in up-regulation of IgA synthesis in response to changes in the composition of microbiota. In this study, we investigated potential mechanisms by which GRA induces ILF maturation in the ileum and the colon using mice depleted of enteric bacteria and a select group of mice genetically deficient in pattern recognition receptors. The data show GRA was unable to induce ILF maturation in ileums of mice devoid of commensal bacteria, MyD88(-/-) or NOD2(-/-) mice, but differentially induced ILF in colons. Increased expression of chemokine and chemokine receptor genes that modulate B and T cell recruitment to the mucosa were in part dependent on NOD2, TLR, and signaling adaptor protein MyD88. Together the results suggest GRA induces ILF through cooperative signals provided by bacterial ligands under normal conditions to induce B cell recruitment to ILF to the gut, but that the relative contribution of these signals differ between ileum and colon.	[Hendricks, Jay M.; Hardy, Michele E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Lowe, Diana C.] Montana State Univ, Bozeman, MT 59717 USA	Washington State University; Montana State University System; Montana State University Bozeman	Hardy, ME (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	mhardy@vetmed.wsu.edu			Public Health Service [AT004986]; National Center for Research Resources (Montana State University) Washington State University [RR020185-09]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Center for Research Resources (Montana State University) Washington State University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Public Health Service grant AT004986 to MEH and National Center for Research Resources RR020185-09 (Montana State University) Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bordbar N, 2012, CELL IMMUNOL, V280, P44, DOI 10.1016/j.cellimm.2012.11.013; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chang YL, 2010, ACTA PHARMACOL SIN, V31, P546, DOI 10.1038/aps.2010.34; Chen GY, 2009, CURR BIOL, V19, pR171, DOI 10.1016/j.cub.2008.12.027; Eberl G, 2010, TRENDS IMMUNOL, V31, P50, DOI 10.1016/j.it.2009.11.004; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Glaysher BR, 2007, IMMUNOLOGY, V120, P336, DOI 10.1111/j.1365-2567.2006.02508.x; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hardy ME, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-96; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Hendricks JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049491; Hooper LV, 2011, CELL, V147, P486, DOI 10.1016/j.cell.2011.10.004; Hua H, 2012, INT IMMUNOPHARMACOL, V12, P518, DOI 10.1016/j.intimp.2012.01.006; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Kao TC, 2010, J AGR FOOD CHEM, V58, P8623, DOI 10.1021/jf101841r; Kim J, 2013, PHYTOMEDICINE, V20, P951, DOI 10.1016/j.phymed.2013.04.008; Kiss EA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00124; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knoop KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00084; Knoop KA, 2011, AM J PATHOL, V179, P1861, DOI 10.1016/j.ajpath.2011.06.004; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Soulier A, 2013, BLOOD, V122, P3288, DOI 10.1182/blood-2013-03-489138; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Ukil A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029062; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Velaga S, 2009, J IMMUNOL, V182, P2610, DOI 10.4049/jimmunol.0801141; Wang CY, 2011, J AGR FOOD CHEM, V59, P7726, DOI 10.1021/jf2013265; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036	42	0	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100878	10.1371/journal.pone.0100878	http://dx.doi.org/10.1371/journal.pone.0100878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992099	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400035
J	Hong, SW; Choi, EB; Min, TK; Kim, JH; Kim, MH; Jeon, SG; Lee, BJ; Gho, YS; Jee, YK; Pyun, BY; Kim, YK				Hong, Sung-Wook; Choi, Eun-Byul; Min, Taek-Ki; Kim, Ji-Hyun; Kim, Min-Hye; Jeon, Seong Gyu; Lee, Byung-Jae; Gho, Yong Song; Jee, Young-Koo; Pyun, Bok-Yang; Kim, Yoon-Keun			An Important Role of alpha-Hemolysin in Extracellular Vesicles on the Development of Atopic Dermatitis Induced by Staphylococcus aureus	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; KERATINOCYTE APOPTOSIS; METHICILLIN-RESISTANT; EPITHELIAL-CELLS; DEATH PATHWAY; TOXIN; SKIN; DISEASE; INFLAMMATION; MECHANISMS	Skin barrier disruption and dermal inflammation are key phenotypes of atopic dermatitis (AD). Staphylococcus aureus secretes extracellular vesicles (EVs), which are involved in AD pathogenesis. Here, we evaluated the role of EVs-associated alpha-hemolysin derived from S. aureus in AD pathogenesis. alpha-hemolysin production from S. aureus was detected using western blot analyses. The cytotoxic activity of alpha-hemolysin on HaCaT keratinocytes was evaluated by measuring cell viability after treating cells with soluble and EVs-associated alpha-hemolysin. To determine the type of cell death, HaCaT keratinocytes were stained with annexin V and 7-AAD. The in vivo effects of alpha-hemolysin were evaluated by application of soluble and EV-associated alpha-hemolysin on the mouse skin. The present study showed that increased alpha-hemolysin was produced by S. aureus colonized on AD patients compared to healthy subjects. alpha-hemolysin production was also related to AD severity. In addition, EV-associated alpha-hemolysin was more cytotoxic to HaCaT keratinocytes than soluble alpha-hemolysin, and alpha-hemolysin-negative EVs did not induce keratinocyte death. EV-associated alpha-hemolysin induced necrosis, but soluble alpha-hemolysin induced apoptosis of keratinocytes. In vivo, skin barrier disruption and epidermal hyperplasia were induced by soluble and EV-associated alpha-hemolysin. However, AD-like dermal inflammation was only caused by EV-associated alpha-hemolysin. Moreover, neither skin barrier disruption nor AD-like skin inflammation was induced by alpha-hemolysin-negative EVs. Taken together, alpha-Hemolysin secreted from S. aureus, particularly the EV-associated form, induces both skin barrier disruption and AD-like skin inflammation, suggesting that EV-associated alpha-hemolysin is a novel diagnostic and therapeutic target for the control of AD.	[Hong, Sung-Wook; Choi, Eun-Byul; Kim, Ji-Hyun; Jeon, Seong Gyu; Gho, Yong Song] Pohang Univ Sci & Technol, POSTECH, Dept Life Sci, Pohang, South Korea; [Min, Taek-Ki; Pyun, Bok-Yang] Sooncheonhyang Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Dept Med, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Inst Convergence Med, Seoul, South Korea; [Lee, Byung-Jae] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Allergy & Clin Immunol, Seoul, South Korea; [Jee, Young-Koo] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea	Pohang University of Science & Technology (POSTECH); Soonchunhyang University; Ewha Womans University; Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Dankook University	Pyun, BY (corresponding author), Sooncheonhyang Univ, Coll Med, Dept Pediat, Seoul, South Korea.	bypyun@hosp.sch.ac.kr; juinea@ewha.ac.kr		Jee, Young-Koo/0000-0001-5800-8038	Korea Ministry of Health & Welfare, Republic of Korea [HI 13C 0040-010013]	Korea Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Korea Ministry of Health & Welfare, Republic of Korea (HI 13C 0040-010013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bin LH, 2012, J ALLERGY CLIN IMMUN, V130, P683, DOI 10.1016/j.jaci.2012.06.019; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kim YR, 2010, BIOCHEM BIOPH RES CO, V399, P607, DOI 10.1016/j.bbrc.2010.07.122; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Ohlsen K, 1998, ANTIMICROB AGENTS CH, V42, P2817, DOI 10.1128/AAC.42.11.2817; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Prince LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031506; Radjainia M, 2010, P NATL ACAD SCI USA, V107, P14070, DOI 10.1073/pnas.1006473107; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; SATO H, 1987, INFECT IMMUN, V55, P909, DOI 10.1128/IAI.55.4.909-915.1987; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Semic-Jusufagic A, 2007, J ALLERGY CLIN IMMUN, V119, P930, DOI 10.1016/j.jaci.2006.12.639; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	36	54	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100499	10.1371/journal.pone.0100499	http://dx.doi.org/10.1371/journal.pone.0100499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992681	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400024
J	Shen, Y; Wang, J; Wu, JW; Qu, WK; Wang, CX; Gao, X; Zhou, Y; Wang, AX; Wu, SL; Zhao, XQ				Shen, Yuan; Wang, Jing; Wu, Jianwei; Qu, Weikai; Wang, Chunxue; Gao, Xiang; Zhou, Yong; Wang, Anxin; Wu, Shouling; Zhao, Xingquan			Elevated Plasma Total Cholesterol Level Is Associated with the Risk of Asymptomatic Intracranial Arterial Stenosis	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; TRANSCRANIAL DOPPLER; CEREBRAL ATHEROSCLEROSIS; STROKE; SEVERITY; THERAPY; DISEASE	Background: Intracranial arterial stenosis (ICAS) is one of the most common causes of stroke, and dyslipidemia was one of the most common risk factors related to ICAS. However, the correlation between the plasma total cholesterol level (PTC) and ICAS, especially asymptomatic ICAS (AICAS) is not clear. Materials and Methods: 5,300 participants were enrolled in this study. The diagnosis of AICAS was made by transcranial Doppler ultrasonography. The participants were then divided into 5 essentially equal-sized groups based on their PTC levels. The multivariate logistic regression was used to analyze the correlation between the PTC level and the prevalence of AICAS. Results: 13.0% of the participants were diagnosed with AICAS. The prevalence of AICAS gradually increased with the increasing PTC level. After adjusted by the possible confounding factors, the Odds Ratios (OR) of the AICAS prevalence between the 1st quintile group and the other 4 groups were 1.13, 1.23, 1.63 and 1.75 with 95% confident intervals (CI) of 0.84-1.52, 0.91-1.66, 1.20-2.22 and 1.23-2.47, respectively. The further subgroup analysis revealed that the PTC level was stronger for males (OR 1.42 95% CI 1.23-1.64), regarding the prevalence of AICAS. Conclusions: In this large community-based study, the prevalence of AICAS is 13.0%, subjects with higher PTC levels showed a mild increase in the prevalence of AICAS. The PTC level is an independent risk factor of AICAS. Males seem to be significantly more vulnerable to the risk of AICAS.	[Shen, Yuan; Wang, Jing; Wu, Jianwei; Wang, Chunxue; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Qu, Weikai] Univ Toledo, Med Ctr, Dept Surg, Toledo, OH 43606 USA; [Gao, Xiang] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; University System of Ohio; University of Toledo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; , Xiang/0000-0003-2617-6509; Wu, Jian/0000-0002-3394-1507	Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2008BAI52B03]; National Natural Science Foundation of China [81202279]; Beijing Municipal ST Commission [D101107049310005, Z121100005512016]; National Science and Technology Major Project of China [2011BAI08B02]; Capital Health research and Development of Special [2011-2004-03]; 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction [2011ZX09307-001-06]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal ST Commission; National Science and Technology Major Project of China; Capital Health research and Development of Special; 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction	This work is supported by grants from the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (No. 2008BAI52B03), the National Natural Science Foundation of China (No. 81202279), Beijing Municipal S&T Commission (D101107049310005, Z121100005512016), National Science and Technology Major Project of China (2011BAI08B02), the Capital Health research and Development of Special (No. Capital 2011-2004-03) and the 12th Five-Year Plan for "New Drugs Innovation and Development'' National Science and Technology Major Project: Clinical Resource Biobank Construction (2011ZX09307-001-06). Beijing Municipal Science & Technology Commission (No. D111107003111007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Kim BS, 2010, ATHEROSCLEROSIS, V212, P682, DOI 10.1016/j.atherosclerosis.2010.07.007; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Papadakis JA, 1998, CARDIOVASC RES, V40, P265, DOI 10.1016/S0008-6363(98)00222-3; Pu YH, 2013, STROKE, V44, P2109, DOI 10.1161/STROKEAHA.113.001522; Rajkumar C, 1997, J AM COLL CARDIOL, V30, P350, DOI 10.1016/S0735-1097(97)00191-5; Sirimarco G, 2011, STROKE, V42, P2131, DOI 10.1161/STROKEAHA.110.609727; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065229; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101232	10.1371/journal.pone.0101232	http://dx.doi.org/10.1371/journal.pone.0101232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992466	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400054
J	Tseng, CH				Tseng, Chin-Hsiao			Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; PROSTATE-CANCER; NATIONAL COHORT; MORTALITY; SMOKING; EPIDEMIOLOGY; PREVALENCE	Background: The trend of lung cancer incidence in Taiwan is unknown, and the association between type 2 diabetes/insulin use and lung cancer is rarely studied. Methods: The trends of lung cancer incidence in 1979-2007 in the Taiwanese general population were calculated. A random sample of 1,000,000 subjects covered by the National Health Insurance in 2005 was recruited. A total of 494,002 men and 502,948 women and without lung cancer were followed for the annual cumulative incidence of lung cancer in 2005, with calculation of the risk ratios between diabetic and non-diabetic subjects. Logistic regression estimated the adjusted odds ratios for risk factors. Results: The trends increased significantly in both sexes (P<0.0001). The sex-specific annual cumulative incidence increased with age in either the diabetic or non-diabetic subjects, but the risk ratios attenuated with age. In logistic regressions, diabetes was associated with a significantly higher risk, with odds ratios (95% confidence interval) for diabetes duration <1, 1-3, 3-5 and >= 5 years versus non-diabetes of 2.189 (1.498-3.200), 1.420 (1.014-1.988), 1.545 (1.132-2.109), and 1.329 (1.063-1.660), respectively. Such an association was not related to a higher detection with chest X-ray examination. Insulin use and medications including oral anti-diabetic drugs, statin, fibrate, and anti-hypertensive agents were not significantly associated with lung cancer. Age, male sex, and chronic obstructive pulmonary disease were positively; but dyslipidemia, stroke and higher socioeconomic status were negatively associated with lung cancer. Conclusions: Diabetes is significantly associated with a higher risk of lung cancer, but insulin use does not increase the risk.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123	National Science Council of Taiwan [NSC102-2314-B-002-067]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council (NSC102-2314-B-002-067) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bureau of Health Promotion, 2010, CANC REG ANN REP 200; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Klabunde CN, 2012, ANN FAM MED, V10, P102, DOI 10.1370/afm.1340; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P298; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lee MY, 2012, METABOLISM, V61, P242, DOI 10.1016/j.metabol.2011.06.020; Reddy Chakravarthy, 2011, Hosp Pract (1995), V39, P107, DOI 10.3810/hp.2011.10.929; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2009, OPEN DIABETES J, V2, P18; Tseng CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086517; Tseng CH, 2014, CLIN GENITOURIN CANC, V12, pE7, DOI 10.1016/j.clgc.2013.08.004; Tseng CH, 2013, DIABETES RES CLIN PR, V102, P193, DOI 10.1016/j.diabres.2013.10.019; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2013, CLIN GENITOURIN CANC, V11, P508, DOI 10.1016/j.clgc.2013.04.019; Tseng CH, 2013, DIABETES-METAB RES, V29, P515, DOI 10.1002/dmrr.2422; Tseng CH, 2013, HEPATOL INT, V7, P693, DOI 10.1007/s12072-012-9405-0; Tseng CH, 2013, J CLIN GASTROENTEROL, V47, pE60, DOI 10.1097/MCG.0b013e31827245eb; Tseng CH, 2013, PANCREAS, V42, P42, DOI 10.1097/MPA.0b013e3182571ba9; Tseng CH, 2012, METABOLISM, V61, P1003, DOI 10.1016/j.metabol.2011.11.015; Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	30	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101553	10.1371/journal.pone.0101553	http://dx.doi.org/10.1371/journal.pone.0101553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991802	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400089
J	Xu, SQ; Wu, HJ; Nie, H; Yue, L; Jiang, HD; Xiao, S; Li, Y				Xu, Shengqiang; Wu, Hongjin; Nie, Huan; Yue, Lei; Jiang, Huadong; Xiao, Sheng; Li, Yu			AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; NON-CPG METHYLATION; CASPASE-INDEPENDENT DEATH; MITOCHONDRIAL RELEASE; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; HISTONE H2B; STRESS; MST; PHOSPHORYLATION	Apoptosis-inducing factor (AIF) plays a crucial role in caspase-independent programmed cell death by triggering chromatin condensation and DNA fragmentation. Therefore, it might be involved in cell homeostasis and tumor development. In this study, we report significant AIF downregulation in the majority of renal cell carcinomas (RCC). In a group of RCC specimens, 84% (43 out of 51) had AIF downregulation by immunohistochemistry stain. Additional 10 kidney tumors, including an oxyphilic adenoma, also had significant AIF downregulation by Northern blot analysis. The mechanisms of the AIF downregulation included both AIF deletion and its promoter methylation. Forced expression of AIF in RCC cell lines induced massive apoptosis. Further analysis revealed that AIF interacted with STK3, a known regulator of apoptosis, and enhanced its phosphorylation at Thr180. These results suggest that AIF downregulation is a common event in kidney tumor development. AIF loss may lead to decreased STK3 activity, defective apoptosis and malignant transformation.	[Xu, Shengqiang; Wu, Hongjin; Nie, Huan; Yue, Lei; Jiang, Huadong; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Xu, Shengqiang; Xiao, Sheng] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harbin Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Xiao, S (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA.	sxiao@rics.bwh.harvard.edu; liyugene@hit.edu.cn	Wu, Hongjin/AAF-6122-2019	Wu, Hongjin/0000-0002-2053-7441	Heilongjiang Province Department of Education in China; Heilongjiang Province Department of Science and Technology [LC04C02]; China Scholarship Council	Heilongjiang Province Department of Education in China; Heilongjiang Province Department of Science and Technology; China Scholarship Council(China Scholarship Council)	This work was financed by grants from Heilongjiang Province Department of Education in China (http://www.hlje.net/), and LC04C02 Returned Overseas Personnel Fund from Heilongjiang Province Department of Science and Technology (http://www.hljkjt.gov.cn/) and Support from China Scholarship Council (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Baritaud M, 2010, CELL CYCLE, V9, P3166, DOI 10.4161/cc.9.16.12552; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Davison JM, 1998, AM J PATHOL, V153, P1401, DOI 10.1016/S0002-9440(10)65727-6; De Souza PM, 2002, BLOOD, V99, P3432, DOI 10.1182/blood.V99.9.3432; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kook SH, 2007, APOPTOSIS, V12, P1289, DOI 10.1007/s10495-007-0056-x; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu SS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-58; Lohse CM, 2002, AM J CLIN PATHOL, V118, P877, DOI 10.1092/5PWP08HKHX0LY56L; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Onishi T, 2002, BJU INT, V90, P32, DOI 10.1046/j.1464-410X.2002.02798.x; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1997, EXP CELL RES, V236, P397, DOI 10.1006/excr.1997.3733; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang S, 2009, CANCER LETT, V282, P77, DOI 10.1016/j.canlet.2009.03.008; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3	44	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100824	10.1371/journal.pone.0100824	http://dx.doi.org/10.1371/journal.pone.0100824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992339	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400029
J	Zhou, J; Qu, XD; Li, ZY; Wei-Ji; Liu, Q; Ma, YH; He, JJ				Zhou, Jie; Qu, Xiao-Dong; Li, Zhi-Yun; Wei-Ji; Liu, Qi; Ma, Yi-Hui; He, Jiao-Jiang			Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson's Disease Models	PLOS ONE			English	Article							NATURAL-PRODUCTS; INFLAMMATORY PROCESS; DOPAMINE NEURONS; ACTIVATION; MICROGLIA; BRAIN; ANTIOXIDANT; ASTROCYTES; EXPRESSION; MPTP	Salvianolic acid B (SalB), a bioactive compound isolated from the plant-derived medicinal herb Danshen, has been shown to exert various anti-oxidative and anti-inflammatory activities in several neurological disorders. In this study, we sought to investigate the potential protective effects and associated molecular mechanisms of SalB in Parkinson's disease (PD) models. To determine the neuroprotective effects of SalB in vitro, MPP+-or lipopolysaccharide (LPS)-induced neuronal injury was achieved using primary cultures with different compositions of neurons, microglia and astrocytes. Our results showed that SalB reduced both LPS- and MPP+-induced toxicity of dopamine neurons in a dose-dependent manner. Additionally, SalB treatment inhibited the release of microglial pro-inflammatory cytokines and resulted in an increase in the expression and release of glial cell line-derived neurotrophic factor (GDNF) from astrocytes. Western blot analysis illustrated that SalB increased the expression and nuclear translocation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2). The knockdown of Nrf2 using specific small interfering RNA (siRNA) partially reversed the SalB-induced GDNF expression and anti-inflammatory activity. Moreover, SalB treatment significantly attenuated dopaminergic (DA) neuronal loss, inhibited neuroinflammation, increased GDNF expression and improved the neurological function in MPTP-treated mice. Collectively, these findings demonstrated that SalB protects DA neurons by an Nrf-2 -mediated dual action: reducing microglia activation-mediated neuroinflammation and inducing astrocyte activation-dependent GDNF expression. Importantly the present study also highlights critical roles of glial cells as targets for developing new strategies to alter the progression of neurodegenerative disorders.	[Zhou, Jie; Qu, Xiao-Dong; Li, Zhi-Yun; Wei-Ji; Liu, Qi; Ma, Yi-Hui; He, Jiao-Jiang] Lanzhou Gen Hosp, Lanzhou Command PLA, Dept Neurosurg, Lanzhou, Gansu, Peoples R China		Li, ZY (corresponding author), Lanzhou Gen Hosp, Lanzhou Command PLA, Dept Neurosurg, Lanzhou, Gansu, Peoples R China.	lizy_lzpla@163.com						Campos HC, 2011, CNS NEUROL DISORD-DR, V10, P239; Cao W, 2012, CHIN J INTEGR MED, V18, P316, DOI [10.1007/s11655-012-1052-8, 10.1007/s11655-011-012-1052-8]; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chen SC, 2011, THROMB RES, V128, P560, DOI 10.1016/j.thromres.2011.08.032; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Darlington Cynthia L, 2005, Curr Opin Investig Drugs, V6, P700; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deguil J, 2007, J NEUROSCI RES, V85, P2017, DOI 10.1002/jnr.21318; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Di Stefano A, 2011, CURR PHARM DESIGN, V17, P3482, DOI 10.2174/138161211798194495; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Houghton PJ, 2005, NEUROSIGNALS, V14, P6, DOI 10.1159/000085382; Iannaccone S, 2013, PARKINSONISM RELAT D, V19, P47, DOI 10.1016/j.parkreldis.2012.07.002; Imanshahidi M, 2006, PHYTOTHER RES, V20, P427, DOI 10.1002/ptr.1898; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Katagiri N, 2010, BRAIN RES, V1321, P133, DOI 10.1016/j.brainres.2010.01.049; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; KOPIN IJ, 1988, MT SINAI J MED, V55, P43; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lipski J, 2011, PROG NEUROBIOL, V94, P389, DOI 10.1016/j.pneurobio.2011.06.005; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; MARZATICO F, 1993, NEUROCHEM RES, V18, P1101, DOI 10.1007/BF00966691; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mythri RB, 2012, RECENT PATENTS ENDOC, V6, P181, DOI 10.2174/187221412802481793; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Ossola B, 2011, NEUROPHARMACOLOGY, V61, P574, DOI 10.1016/j.neuropharm.2011.04.030; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Rojas P, 2011, J NUTR BIOCHEM, V22, P937, DOI 10.1016/j.jnutbio.2010.08.005; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stanic D, 2004, BRAIN RES, V1023, P83, DOI 10.1016/j.brainres.2004.07.012; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; Tian LL, 2008, INT J BIOCHEM CELL B, V40, P409, DOI 10.1016/j.biocel.2007.08.005; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tsai MK, 2010, TOXICOL APPL PHARM, V242, P155, DOI 10.1016/j.taap.2009.10.002; Tufekci K. U., 2011, PARKINSONS DIS, V2011; Wang ZS, 2013, CELL MOL NEUROBIOL, V33, P921, DOI 10.1007/s10571-013-9958-z; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Zeng G, 2010, BIOL PHARM BULL, V33, P1337, DOI 10.1248/bpb.33.1337; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhao Y, 2011, J ONCOL, V2011, DOI 10.1155/2011/534548; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	62	28	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101668	10.1371/journal.pone.0101668	http://dx.doi.org/10.1371/journal.pone.0101668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991814	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400105
J	Frost, CL; Pollock, SW; Smith, JE; Hughes, WOH				Frost, Crystal L.; Pollock, Steven W.; Smith, Judith E.; Hughes, William O. H.			Wolbachia in the Flesh: Symbiont Intensities in Germ-Line and Somatic Tissues Challenge the Conventional View of Wolbachia Transmission Routes	PLOS ONE			English	Article							HORIZONTAL TRANSFER; CASTE DIFFERENTIATION; STRAINS; ANTS; INFECTIONS; PREVALENCE; EXPRESSION; PIPIENTIS; DYNAMICS; INVASION	Symbionts can substantially affect the evolution and ecology of their hosts. The investigation of the tissue-specific distribution of symbionts (tissue tropism) can provide important insight into host-symbiont interactions. Among other things, it can help to discern the importance of specific transmission routes and potential phenotypic effects. The intracellular bacterial symbiont Wolbachia has been described as the greatest ever panzootic, due to the wide array of arthropods that it infects. Being primarily vertically transmitted, it is expected that the transmission of Wolbachia would be enhanced by focusing infection in the reproductive tissues. In social insect hosts, this tropism would logically extend to reproductive rather than sterile castes, since the latter constitute a dead-end for vertically transmission. Here, we show that Wolbachia are not focused on reproductive tissues of eusocial insects, and that non-reproductive tissues of queens and workers of the ant Acromyrmex echinatior, harbour substantial infections. In particular, the comparatively high intensities of Wolbachia in the haemolymph, fat body, and faeces, suggest potential for horizontal transmission via parasitoids and the faecal-oral route, or a role for Wolbachia modulating the immune response of this host. It may be that somatic tissues and castes are not the evolutionary dead-end for Wolbachia that is commonly thought.	[Frost, Crystal L.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Pollock, Steven W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Smith, Judith E.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England; [Hughes, William O. H.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Liverpool; University of York - UK; University of Salford; University of Sussex	Frost, CL (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	clfrost@liv.ac.uk		Smith, Judith/0000-0002-2206-3534	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Natural Environment Research Council [NE/F000677/1] Funding Source: researchfish; NERC [NE/F000677/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study was provided by the Biotechnology and Biological Sciences Research Council (awarded to CLF and WOHH) and the Natural Environment Research Council (awarded to WOHH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen SB, 2012, J EVOLUTION BIOL, V25, P1340, DOI 10.1111/j.1420-9101.2012.02521.x; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; Armitage SAO, 2010, J INSECT PHYSIOL, V56, P780, DOI 10.1016/j.jinsphys.2010.01.009; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baer B, 2005, INSECT SOC, V52, P298, DOI 10.1007/s00040-005-0809-x; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Dedeine F, 2005, MOL ECOL, V14, P1543, DOI 10.1111/j.1365-294X.2005.02499.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Graff J, 2007, MOL ECOL, V16, P675, DOI 10.1111/j.1365-294X.2007.03162.x; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Holldobler B., 1990, pi; Holldobler B, 2008, SUPERORGANISM BEAUTY; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Hughes WOH, 2010, P ROY SOC B-BIOL SCI, V277, P609, DOI 10.1098/rspb.2009.1415; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Ijichi N, 2002, APPL ENVIRON MICROB, V68, P4074, DOI 10.1128/AEM.68.8.4074-4080.2002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Mueller AK, 2010, INT J PARASITOL, V40, P1229, DOI 10.1016/j.ijpara.2010.05.005; Paterson S, 2011, MOL ECOL, V20, P869, DOI 10.1111/j.1365-294X.2010.04991.x; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; SACCHI L, 1985, J INVERTEBR PATHOL, V46, P139, DOI 10.1016/0022-2011(85)90142-9; SACCHI L, 1988, INT J INSECT MORPHOL, V17, P437, DOI 10.1016/0020-7322(88)90023-2; Sacchi L, 2010, TISSUE CELL, V42, P328, DOI 10.1016/j.tice.2010.07.009; Schiott M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-156; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Socolovschi C, 2009, VET RES, V40, DOI 10.1051/vetres/2009017; Stahlhut JK, 2010, MOL ECOL, V19, P1940, DOI 10.1111/j.1365-294X.2010.04572.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Team R. D. C., 2005, LANG ENV STAT COMP; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Borm S, 2003, MOL PHYLOGENET EVOL, V26, P102, DOI 10.1016/S1055-7903(02)00298-1; Van Borm S, 2001, J EVOLUTION BIOL, V14, P805, DOI 10.1046/j.1420-9101.2001.00321.x; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 1997, P NATL ACAD SCI USA, V94, P11154, DOI 10.1073/pnas.94.21.11154; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	58	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e95122	10.1371/journal.pone.0095122	http://dx.doi.org/10.1371/journal.pone.0095122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988478	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000341354100003
J	Giannoni-Guzman, MA; Giray, T; Agosto-Rivera, JL; Stevison, BK; Freeman, B; Ricci, P; Brown, EA; Abramson, CI				Giannoni-Guzman, Manuel A.; Giray, Tugrul; Agosto-Rivera, Jose Luis; Stevison, Blake K.; Freeman, Brett; Ricci, Paige; Brown, Erika A.; Abramson, Charles I.			Ethanol-Induced Effects on Sting Extension Response and Punishment Learning in the Western Honey Bee (Apis mellifera)	PLOS ONE			English	Article							PRIMER PHEROMONE; SOCIAL INSECTS; BEHAVIORAL DISINHIBITION; INHIBITORY CONTROL; INDUCED ANALGESIA; CARNICA POLL.; ETHYL OLEATE; ALCOHOL; PAIN; L.	Acute ethanol administration is associated with sedation and analgesia as well as behavioral disinhibition and memory loss but the mechanisms underlying these effects remain to be elucidated. During the past decade, insects have emerged as important model systems to understand the neural and genetic bases of alcohol effects. However, novel assays to assess ethanol's effects on complex behaviors in social or isolated contexts are necessary. Here we used the honey bee as an especially relevant model system since bees are typically exposed to ethanol in nature when collecting standing nectar crop of flowers, and there is recent evidence for independent biological significance of this exposure for social behavior. Bee's inhibitory control of the sting extension response (SER) and a conditioned-place aversion assay were used to study ethanol effects on analgesia, behavioral disinhibition, and associative learning. Our findings indicate that although ethanol, in a dose-dependent manner, increases SER thresholds (analgesic effects), it disrupts the ability of honey bees to inhibit SER and to associate aversive stimuli with their environment. These results suggest that ethanol's effects on analgesia, behavioral disinhibition and associative learning are common across vertebrates and invertebrates. These results add to the use of honey bees as an ethanol model to understand ethanol's effects on complex, socially relevant behaviors.	[Stevison, Blake K.; Freeman, Brett; Ricci, Paige; Brown, Erika A.; Abramson, Charles I.] Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA; [Giannoni-Guzman, Manuel A.; Giray, Tugrul; Agosto-Rivera, Jose Luis] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Puerto Rico; University of Puerto Rico Rio Piedras	Abramson, CI (corresponding author), Oklahoma State Univ, Lab Behav Biol & Comparat Psychol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu		, Charles/0000-0001-8961-3089; Giray, Tugrul/0000-0003-4383-4681	NSF [DBI 0552717, DBI 1263327]; FIPI [2012-0051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1263327] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); FIPI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by NSF grants DBI 0552717 and DBI 1263327 to CIA and by FIPI grant 2012-0051 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2013, BEHAV SCI-BASEL, V3, P55, DOI 10.3390/bs3010055; Abramson CI, 2004, PSYCHOL REP, V94, P1107, DOI 10.2466/pr0.94.3c.1107-1115; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; Abramson CI, 2007, TRENDS ALCOHOL ABUSE, P197; Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Avalos A, 2014, BEHAV ECOLOGY SOCIOB; Balderrama N., 1987, P121; BOADA J, 1981, PHARMACOL RES COMMUN, V13, P673, DOI 10.1016/S0031-6989(81)80055-0; Bozic J, 2006, ALCOHOL, V38, P179, DOI 10.1016/j.alcohol.2006.01.005; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BROWN RA, 1977, J ABNORM PSYCHOL, V86, P179, DOI 10.1037/0021-843X.86.2.179; BUSHMAN BJ, 1990, PSYCHOL BULL, V107, P341, DOI 10.1037/0033-2909.107.3.341; Cakmak I, 2009, B INSECTOL, V62, P99; Cakmak I, 2009, ANIM BEHAV, V77, P1273, DOI 10.1016/j.anbehav.2009.01.032; Castillo C, 2012, J INSECT PHYSIOL, V58, P1112, DOI 10.1016/j.jinsphys.2012.05.010; Castillo C, 2012, INSECT BIOCHEM MOLEC, V42, P404, DOI 10.1016/j.ibmb.2012.02.002; Caswell AJ, 2013, EXP PSYCHOL, V60, P324, DOI 10.1027/1618-3169/a000202; Charlet K, 2013, ADDICT BIOL, DOI 10.1111/adb.12045; Cingolani P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-666; Curran HV, 1999, CONSCIOUS COGN, V8, P497, DOI 10.1006/ccog.1999.0417; CUTTER HSG, 1976, J STUD ALCOHOL, V37, P273, DOI 10.15288/jsa.1976.37.273; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Dudley R, 2004, INTEGR COMP BIOL, V44, P315, DOI 10.1093/icb/44.4.315; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Galindo-Cardona A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-65; Gameiro GH, 2003, LIFE SCI, V73, P3351, DOI 10.1016/j.lfs.2003.06.024; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Garfinkel SN, 2006, PSYCHOPHARMACOLOGY, V188, P498, DOI 10.1007/s00213-006-0480-6; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Giray T, 2000, BEHAV ECOL, V11, P44, DOI 10.1093/beheco/11.1.44; Giray T, 2007, J INSECT PHYSIOL, V53, P691, DOI 10.1016/j.jinsphys.2007.03.016; Grant NK, 2005, ALCOHOL ALCOHOLISM, V40, P373, DOI 10.1093/alcalc/agh177; Gulick D, 2007, ALCOHOL CLIN EXP RES, V31, P1528, DOI 10.1111/j.1530-0277.2007.00458.x; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Heinz AJ, 2011, NAT REV NEUROSCI, V12, P400, DOI 10.1038/nrn3042; Hendler RA, 2013, CURR TOP BEHAV NEURO, V13, P489, DOI 10.1007/7854_2011_135; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hranitz JM, 2010, ALCOHOL, V44, P275, DOI 10.1016/j.alcohol.2010.02.003; Ikeda K, 2002, NEUROSCI RES, V44, P121, DOI 10.1016/S0168-0102(02)00094-9; Johansson AK, 2000, PHYSIOL BEHAV, V70, P453, DOI 10.1016/S0031-9384(00)00284-5; KEVAN PG, 1988, J APICULT RES, V27, P26, DOI 10.1080/00218839.1988.11100777; Keys TE, 1963, HIST SURG ANESTHESIA, pxxx; KOLMES SA, 1989, J NEW YORK ENTOMOL S, V97, P218; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Lee H, 2009, INT J ENV RES PUB HE, V6, P2783, DOI 10.3390/ijerph6112783; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Mixson TA, 2010, PSYCHOL REP, V106, P701, DOI 10.2466/PR0.106.3.701-717; MOGIL JS, 1993, BRAIN RES, V602, P126, DOI 10.1016/0006-8993(93)90251-H; Morozova TV, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-239; Moss HB, 2013, SOC WORK PUBLIC HLTH, V28, P175, DOI 10.1080/19371918.2013.758987; Mussig L, 2010, J NEUROSCI, V30, P7817, DOI 10.1523/JNEUROSCI.5543-09.2010; Mullin F. J., 1934, AM J PHYSIOL, V109, P77; NUNEZ J, 1983, PHARMACOL BIOCHEM BE, V19, P921, DOI 10.1016/0091-3057(83)90391-X; Perrino AC, 2008, ALCOHOL CLIN EXP RES, V32, P952, DOI 10.1111/j.1530-0277.2008.00653.x; POHORECKY LA, 1987, LIFE SCI, V41, P1289, DOI 10.1016/0024-3205(87)90208-6; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rivera-Marchand B, 2012, EVOLUTIONARY APPL; Rivera-Marchand B, 2008, ENTOMOL EXP APPL, V129, P1, DOI 10.1111/j.1570-7458.2008.00747.x; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; Sanders SH, 1985, ANN BEHAV MED, V7, P3; Scholz H, 2013, CURR TOP BEHAV NEURO, V13, P433, DOI 10.1007/7854_2011_128; Sokolowski MBC, 2012, ALCOHOL CLIN EXP RES, V36, P1568, DOI 10.1111/j.1530-0277.2012.01770.x; STEWART SH, 1995, PSYCHOPHARMACOLOGY, V119, P261, DOI 10.1007/BF02246289; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tedjakumala SR, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00221; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Tokuda K, 2013, NEUROSCI LETT, V537, P40, DOI 10.1016/j.neulet.2013.01.018; Tracy JI, 1999, NEUROPSYCHOLOGY, V13, P282, DOI 10.1037/0894-4105.13.2.282; Uribe-Rubio J. L., 2013, Open Journal of Ecology, V3, P279; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wang J, 2010, J NEUROSCI, V30, P10187, DOI 10.1523/JNEUROSCI.2268-10.2010; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105; Wolff HG, 1942, J PHARMACOL EXP THER, V75, P38	78	15	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100894	10.1371/journal.pone.0100894	http://dx.doi.org/10.1371/journal.pone.0100894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988309	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100048
J	Stoeckle, MY; Thaler, DS				Stoeckle, Mark Y.; Thaler, David S.			DNA Barcoding Works in Practice but Not in (Neutral) Theory	PLOS ONE			English	Article							MITOCHONDRIAL GENETIC DIVERSITY; POPULATION-SIZE; MUTATIONS; EVOLUTION; SELECTION; PHYLOGEOGRAPHY; INTROGRESSION; DYNAMICS; PATTERNS; CLOCK	Background: DNA barcode differences within animal species are usually much less than differences among species, making it generally straightforward to match unknowns to a reference library. Here we aim to better understand the evolutionary mechanisms underlying this usual "barcode gap'' pattern. We employ avian barcode libraries to test a central prediction of neutral theory, namely, intraspecific variation equals 2 N mu, where N is population size and mu is mutations per site per generation. Birds are uniquely suited for this task: they have the best-known species limits, are well represented in barcode libraries, and, most critically, are the only large group with documented census population sizes. In addition, we ask if mitochondrial molecular clock measurements conform to neutral theory prediction of clock rate equals mu. Results: Intraspecific COI barcode variation was uniformly low regardless of census population size (n = 142 species in 15 families). Apparent outliers reflected lumping of reproductively isolated populations or hybrid lineages. Re-analysis of a published survey of cytochrome b variation in diverse birds (n = 93 species in 39 families) further confirmed uniformly low intraspecific variation. Hybridization/gene flow among species/populations was the main limitation to DNA barcode identification. Conclusions/Significance: To our knowledge, this is the first large study of animal mitochondrial diversity using actual census population sizes and the first to test outliers for population structure. Our finding of universally low intraspecific variation contradicts a central prediction of neutral theory and is not readily accounted for by commonly proposed ad hoc modifications. We argue that the weight of evidence-low intraspecific variation and the molecular clock-indicates neutral evolution plays a minor role in mitochondrial sequence evolution. As an alternate paradigm consistent with empirical data, we propose extreme purifying selection, including at synonymous sites, limits variation within species and continuous adaptive selection drives the molecular clock.	[Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Thaler, David S.] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Thaler, David S.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Rockefeller University; Columbia University; Columbia University	Stoeckle, MY (corresponding author), Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA.	mark.stoeckle@rockefeller.edu; david.thaler@gmail.com	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by The Alfred P. Sloan Foundation (www.sloan.org) (MYS, DST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Barker FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046403; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; Chesser RT, 2013, AUK, V130, P558, DOI 10.1525/auk.2013.130.3.1; Consortium for the Barcode of Life Database Working Group, 2009, DAT STAND BARCODE RE; Coyne JA, 2004, SPECIATION; Crow J. F., 2009, INTRO POPULATION GEN; Dabrowski A, 2005, CONSERV GENET, V6, P843, DOI 10.1007/s10592-005-9028-2; del Hoyo J, 2013, HDB BIRDS WORLD; Duret L, 2008, NAT ED, V1, P218; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gill F, 2014, IOC WORLD BIRD LIST; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hartl Daniel L., 1997; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick P. W., 2011, GENETICS POPULATIONS; Hill GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1314; Ho S., 2008, NATURE ED, V1, P168; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kazancioglu E, 2014, ECOL LETT, V17, P22, DOI 10.1111/ele.12195; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2011, MOL ECOL RESOUR, V11, P1045, DOI 10.1111/j.1755-0998.2011.03049.x; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Kuhn T. S., 1962, STRUCTURE SCI REVOLU; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lanfear R, 2014, TRENDS ECOL EVOL, V29, P33, DOI 10.1016/j.tree.2013.09.009; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058; Lewontin R. C., 1974, The genetic basis of evolutionary change.; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mila B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040541; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Neher RA, 2013, ANNU REV ECOL EVOL S, V44, P195, DOI 10.1146/annurev-ecolsys-110512-135920; Newton I., 2003, SPECIATION BIOGEOGRA; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Parmakelis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061970; Partners in Flight Science Committee, 2013, POP EST DAT VERS 201; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Piganeau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004396; Pyle P., 1997, IDENTIFICATION GUI 1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Sonsthagen SA, 2012, ECOL EVOL, V2, P1278, DOI 10.1002/ece3.240; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Stoeckle MY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02635; Stoeckle MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043992; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wetlands International, 2002, WETL INT GLOB SER, V12; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129; Zhang RY, 2012, MOL PHYLOGENET EVOL, V65, P562, DOI 10.1016/j.ympev.2012.07.011	71	34	36	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100755	10.1371/journal.pone.0100755	http://dx.doi.org/10.1371/journal.pone.0100755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988408	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100041
J	Tracey, JA; Sheppard, J; Zhu, J; Wei, FW; Swaisgood, RR; Fisher, RN				Tracey, Jeff A.; Sheppard, James; Zhu, Jun; Wei, Fuwen; Swaisgood, Ronald R.; Fisher, Robert N.			Movement-Based Estimation and Visualization of Space Use in 3D for Wildlife Ecology and Conservation	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; HOME-RANGE; 3-DIMENSIONAL MOVEMENTS; CLASSIFICATION; PATTERNS; SEAGRASS; BEHAVIOR; AREA	Advances in digital biotelemetry technologies are enabling the collection of bigger and more accurate data on the movements of free-ranging wildlife in space and time. Although many biotelemetry devices record 3D location data with x, y, and z coordinates from tracked animals, the third z coordinate is typically not integrated into studies of animal spatial use. Disregarding the vertical component may seriously limit understanding of animal habitat use and niche separation. We present novel movement-based kernel density estimators and computer visualization tools for generating and exploring 3D home ranges based on location data. We use case studies of three wildlife species - giant panda, dugong, and California condor - to demonstrate the ecological insights and conservation management benefits provided by 3D home range estimation and visualization for terrestrial, aquatic, and avian wildlife research.	[Tracey, Jeff A.; Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA; [Sheppard, James; Swaisgood, Ronald R.] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Zhu, Jun] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Zhu, Jun] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Wei, Fuwen] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	United States Department of the Interior; United States Geological Survey; Zoological Society of San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Zoology, CAS	Tracey, JA (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA 92101 USA.	jatracey@usgs.gov	Fisher, Robert/AAA-7301-2022; Swaisgood, Ronald R/AAL-3198-2020	Fisher, Robert/0000-0002-2956-3240; Swaisgood, Ronald R/0000-0001-5353-2148	Sempra Energy; U.S. Geological Survey	Sempra Energy; U.S. Geological Survey(United States Geological Survey)	This research was funded by Sempra Energy and the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EA, 2007, FLATLAND ROMANCE MAN; [Anonymous], 2014, REG EARTH SYST PRED; ASTER GDEM Validation Team, 2011, ASTER GLOBAL DIGITAL; Bailleul F, 2010, ECOL MODEL, V221, P1665, DOI 10.1016/j.ecolmodel.2010.04.001; Belant JL, 2012, FRONT ECOL ENVIRON, V10, P11, DOI 10.1890/12.WB.003; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Berg HC, 1983, RANDOM WALKS BIOL, Vix; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cogan Christopher B., 2012, Open Ornithology Journal, V5, P82; Davis RW, 2013, DEEP-SEA RES PT II, V88-89, P65, DOI 10.1016/j.dsr2.2012.07.006; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Grech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017993; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Hagihara R, 2011, J EXP MAR BIOL ECOL, V399, P173, DOI 10.1016/j.jembe.2011.01.001; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hijmans R.J., 2012, R PACKAGE; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; IUCN, 2013, IUCN RED LIST THREAT; Jenness JS, 2004, WILDLIFE SOC B, V32, P829, DOI 10.2193/0091-7648(2004)032[0829:CLSAFD]2.0.CO;2; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lanyon Janet M., 2006, Aquatic Mammals, V32, P196, DOI 10.1578/AM.32.2.2006.196; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Manly B.F.J., 2002, RESOURCE SELECTION A; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H, 2002, DUGONG STATUS REPORT; MESERVE PL, 1977, J MAMMAL, V58, P549, DOI 10.2307/1380003; Microwave Telemetry Inc., 2014, VERT GPS ACC HOR GPS; National Renewable Energy Laboratory, 2004, INT WIND RES MAPS; Nie YG, 2012, ANIM BEHAV, V84, P39, DOI 10.1016/j.anbehav.2012.03.026; North American Development Bank, 2013, 201335 BD N AM DEV B; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Rideout BA, 2012, J WILDLIFE DIS, V48, P95, DOI 10.7589/0090-3558-48.1.95; Rogers D, 2012, ECOL INFORM, V7, P1, DOI 10.1016/j.ecoinf.2011.10.003; SCHROEDER W, 2003, VISUALIZATION TOOLKI; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Silverman B.W., 1986, DENSITY ESTIMATION S; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Snyder N, 2000, CALIFORNIA CONDOR; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; Tachikawa T, 2011, INT GEOSCI REMOTE SE, P3657, DOI 10.1109/IGARSS.2011.6050017; Terborgh J, 1992, DIVERSITY TROPICAL R; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Wang K, 2010, SENSORS-BASEL, V10, P9647, DOI 10.3390/s101109647; Wedding LM, 2011, MAR ECOL PROG SER, V427, P219, DOI 10.3354/meps09119; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zhang ZJ, 2014, INTEGR ZOOL, V9, P46, DOI 10.1111/1749-4877.12030; [No title captured]; [No title captured]	64	37	38	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101205	10.1371/journal.pone.0101205	http://dx.doi.org/10.1371/journal.pone.0101205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988114	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100070
J	Zhang, YN; Qiu, ZP; Wei, L; Tang, RQ; Lian, BF; Zhao, YJ; He, XH; Xie, L				Zhang, Yuannv; Qiu, Zhaoping; Wei, Lin; Tang, Ruqi; Lian, Baofeng; Zhao, Yingjun; He, Xianghuo; Xie, Lu			Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma	PLOS ONE			English	Article							FACTOR-KAPPA-B; RECURRENT MUTATIONS; SOMATIC MUTATIONS; DOWN-REGULATION; LIVER-CANCER; METASTASIS; INVASION; STEATOSIS; DISCOVERY; GENOMICS	Background: Recently, a number of studies have performed genome or exome sequencing of hepatocellular carcinoma (HCC) and identified hundreds or even thousands of mutations in protein-coding genes. However, these studies have only focused on a limited number of candidate genes, and many important mutation resources remain to be explored. Principal Findings: In this study, we integrated mutation data obtained from various sources and performed pathway and network analysis. We identified 113 pathways that were significantly mutated in HCC samples and found that the mutated genes included in these pathways contained high percentages of known cancer genes, and damaging genes and also demonstrated high conservation scores, indicating their important roles in liver tumorigenesis. Five classes of pathways that were mutated most frequently included (a) proliferation and apoptosis related pathways, (b) tumor microenvironment related pathways, (c) neural signaling related pathways, (d) metabolic related pathways, and (e) circadian related pathways. Network analysis further revealed that the mutated genes with the highest betweenness coefficients, such as the well-known cancer genes TP53, CTNNB1 and recently identified novel mutated genes GNAL and the ADCY family, may play key roles in these significantly mutated pathways. Finally, we highlight several key genes (e.g., RPS6KA3 and PCLO) and pathways (e.g., axon guidance) in which the mutations were associated with clinical features. Conclusions: Our workflow illustrates the increased statistical power of integrating multiple studies of the same subject, which can provide biological insights that would otherwise be masked under individual sample sets. This type of bioinformatics approach is consistent with the necessity of making the best use of the ever increasing data provided in valuable databases, such as TCGA, to enhance the speed of deciphering human cancers.	[Zhang, Yuannv; Qiu, Zhaoping; Wei, Lin; Tang, Ruqi; Zhao, Yingjun; He, Xianghuo] Shanghai Jiao Tong Univ Sch Med, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China; [Lian, Baofeng; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	He, XH (corresponding author), Shanghai Jiao Tong Univ Sch Med, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China.	xhhe@shsci.org; xielu@scbit.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	National 973 Key Basic Research Program [2013CB910504]; National Natural Science Foundation of China [81125016]; Key Infectious Disease Project [2012ZX10002-009013]; State Key Laboratory of Oncogenes and Related Genes [90-13-01]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Infectious Disease Project; State Key Laboratory of Oncogenes and Related Genes	This work was supported by grants obtained from the National 973 Key Basic Research Program (2013CB910504); National Natural Science Foundation of China (81125016); Key Infectious Disease Project (2012ZX10002-009013); and State Key Laboratory of Oncogenes and Related Genes (90-13-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bai J, 2011, HUM PATHOL, V42, P375, DOI 10.1016/j.humpath.2010.09.003; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cefalu AB, 2013, ARTERIOSCL THROM VAS, V33, P2021, DOI 10.1161/ATVBAHA.112.301101; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gasper G, 2004, BASIC HYPERGEOMETRIC, Vxxvi; Ge CQ, 2013, J INT MED RES, V41, P284, DOI 10.1177/0300060513476436; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ho M, 2011, BIODRUGS, V25, P275, DOI 10.2165/11595360-000000000-00000; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ikeda A, 2014, GASTROENTEROLOGY, V146, P222, DOI 10.1053/j.gastro.2013.09.025; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Leonardi GC, 2012, INT J ONCOL, V40, P1733, DOI 10.3892/ijo.2012.1408; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Nault JC, 2014, J HEPATOL, V60, P224, DOI 10.1016/j.jhep.2013.08.019; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-51; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang YM, 2003, BIOINFORMATICS, V19, P2311, DOI 10.1093/bioinformatics/btg300; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhang GW, 2012, J INVEST SURG, V25, P93, DOI 10.3109/08941939.2011.606875; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhou L, 2012, ONCOL REP, V28, P874, DOI 10.3892/or.2012.1880	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100854	10.1371/journal.pone.0100854	http://dx.doi.org/10.1371/journal.pone.0100854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988079	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100046
J	Joy, A; Ramesh, A; Smirnov, I; Reiser, M; Misra, A; Shapiro, WR; Mills, GB; Kim, S; Feuerstein, BG				Joy, Anna; Ramesh, Archana; Smirnov, Ivan; Reiser, Mark; Misra, Anjan; Shapiro, William R.; Mills, Gordon B.; Kim, Seungchan; Feuerstein, Burt G.			AKT Pathway Genes Define 5 Prognostic Subgroups in Glioblastoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MOLECULAR SUBTYPES; IDH1; ACTIVATION; CANCER; MTOR; PHOSPHORYLATION; DEGRADATION; ABERRATIONS; SUBCLASSES	Activity of GFR/PI3K/AKT pathway inhibitors in glioblastoma clinical trials has not been robust. We hypothesized variations in the pathway between tumors contribute to poor response. We clustered GBM based on AKT pathway genes and discovered new subtypes then characterized their clinical and molecular features. There are at least 5 GBM AKT subtypes having distinct DNA copy number alterations, enrichment in oncogenes and tumor suppressor genes and patterns of expression for PI3K/AKT/mTOR signaling components. Gene Ontology terms indicate a different cell of origin or dominant phenotype for each subgroup. Evidence suggests one subtype is very sensitive to BCNU or CCNU ( median survival 5.8 vs. 1.5 years; BCNU/CCNU vs other treatments; respectively). AKT subtyping advances previous approaches by revealing additional subgroups with unique clinical and molecular features. Evidence indicates it is a predictive marker for response to BCNU or CCNU and PI3K/AKT/mTOR pathway inhibitors. We anticipate Akt subtyping may help stratify patients for clinical trials and augment discovery of class-specific therapeutic targets.	[Joy, Anna; Misra, Anjan; Shapiro, William R.; Feuerstein, Burt G.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Ramesh, Archana] Univ Washington, Tacoma, WA USA; [Smirnov, Ivan] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Reiser, Mark] Arizona State Univ, Dept Math & Stat Sci, Tempe, AZ USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kim, Seungchan] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Feuerstein, Burt G.] Univ Arizona, Coll Med, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Washington; University of Washington Tacoma; University of California System; University of California San Francisco; Arizona State University; Arizona State University-Tempe; University of Texas System; UTMD Anderson Cancer Center; Translational Genomics Research Institute; University of Arizona	Joy, A (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	anna.joy@dignityhealth.org	Feuerstein, Burt G/A-5186-2015	Feuerstein, Burt G/0000-0001-7276-8842; Kim, Seungchan/0000-0003-4183-4338	NIH [1 K01 NS064952-01A1]; Barrow Neurological Foundation; Diane and Bruce Halle Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K01NS064952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barrow Neurological Foundation; Diane and Bruce Halle Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 1 K01 NS064952-01A1 (AJ); Barrow Neurological Foundation and Diane and Bruce Halle Fund (BJF, AJ, AM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burton EC, 2002, CANCER RES, V62, P6205; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; DeAngelis LM, 2011, J CLIN ONCOL, V29, P4473, DOI 10.1200/JCO.2011.37.5873; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Everitt B. S., 2006, CAMBRIDGE DICT STAT; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; French PEL, 2012, NEURO-ONCOLOGY, V14; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kutner M., 2005, APPL LINEAR STAT MOD; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Mittler MA, 1996, J NEUROSURG, V85, P1091, DOI 10.3171/jns.1996.85.6.1091; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakai D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002566; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	54	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100827	10.1371/journal.pone.0100827	http://dx.doi.org/10.1371/journal.pone.0100827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984002	gold, Green Published			2022-12-25	WOS:000339635000041
J	Kroeker, KJ; Gaylord, B; Hill, TM; Hosfelt, JD; Miller, SH; Sanford, E				Kroeker, Kristy J.; Gaylord, Brian; Hill, Tessa M.; Hosfelt, Jessica D.; Miller, Seth H.; Sanford, Eric			The Role of Temperature in Determining Species' Vulnerability to Ocean Acidification: A Case Study Using Mytilus galloprovincialis	PLOS ONE			English	Article							CLIMATE-CHANGE; SEAWATER ACIDIFICATION; FILTRATION-RATE; BLUE MUSSELS; IMPACTS; PH; CALCIFICATION; OYSTER; CO2; LIMITATION	Ocean acidification (OA) is occurring across a backdrop of concurrent environmental changes that may in turn influence species' responses to OA. Temperature affects many fundamental biological processes and governs key reactions in the seawater carbonate system. It therefore has the potential to offset or exacerbate the effects of OA. While initial studies have examined the combined impacts of warming and OA for a narrow range of climate change scenarios, our mechanistic understanding of the interactive effects of temperature and OA remains limited. Here, we use the blue mussel, Mytilus galloprovincialis, as a model species to test how OA affects the growth of a calcifying invertebrate across a wide range of temperatures encompassing their thermal optimum. Mussels were exposed in the laboratory to a factorial combination of low and high pCO(2) (400 and 1200 mu atm CO2) and temperatures (12, 14, 16, 18, 20, and 24 degrees C) for one month. Results indicate that the effects of OA on shell growth are highly dependent on temperature. Although high CO2 significantly reduced mussel growth at 14 degrees C, this effect gradually lessened with successive warming to 20 degrees C, illustrating how moderate warming can mediate the effects of OA through temperature's effects on both physiology and seawater geochemistry. Furthermore, the mussels grew thicker shells in warmer conditions independent of CO2 treatment. Together, these results highlight the importance of considering the physiological and geochemical interactions between temperature and carbonate chemistry when interpreting species' vulnerability to OA.	[Kroeker, Kristy J.; Gaylord, Brian; Hill, Tessa M.; Hosfelt, Jessica D.; Miller, Seth H.; Sanford, Eric] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Gaylord, Brian; Sanford, Eric] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Hill, Tessa M.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kroeker, KJ (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	kjkroeker@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104; Kroeker, Kristy/0000-0002-5766-1999	UC Multicampus Research Programs & Initiatives Grant; NSF [OCE-0927255, OCE-1220648]; Directorate For Geosciences [1220648, 1041089] Funding Source: National Science Foundation	UC Multicampus Research Programs & Initiatives Grant; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a UC Multicampus Research Programs & Initiatives Grant (to TMH, BG, ES, ADR) and NSF (OCE-0927255 to BG, TMH, ES, ADR; OCE-1220648 to ES, BG, TMH, ADR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis A, 2007, AM J PHYSIOL-REG I, V293; Baayen RH, 2010, LANGUAGER DATA SETS; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; Braby CE, 2006, MAR BIOL, V148, P1249, DOI 10.1007/s00227-005-0177-0; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Chan VBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078945; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dowd WW, 2013, J EXP BIOL, V216, P502, DOI 10.1242/jeb.076620; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fields PA, 2012, J EXP BIOL, V215, P1106, DOI 10.1242/jeb.062273; Frieder CA, 2014, GLOBAL CHANGE BIOL, V20, P754, DOI 10.1111/gcb.12485; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; GREENAWAY P, 1971, J EXP BIOL, V54, P609; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jokiel PL, 2011, B MAR SCI, V87, P639, DOI 10.5343/bms.2010.1107; JORGENSEN CB, 1990, MAR ECOL PROG SER, V64, P89, DOI 10.3354/meps064089; Fernandez-Reiriz MJ, 2012, MAR ECOL PROG SER, V454, P65, DOI 10.3354/meps09660; Kittner C, 2005, MAR ECOL PROG SER, V305, P147, DOI 10.3354/meps305147; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Logan CA, 2012, MAR ECOL PROG SER, V450, P93, DOI 10.3354/meps09491; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; O'Donnell MJ, 2013, NAT CLIM CHANGE, V3, P587, DOI 10.1038/NCLIMATE1846; Pansch C, 2014, GLOBAL CHANGE BIOL, V20, P765, DOI 10.1111/gcb.12478; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pearson GA, 1998, ECOLOGY, V79, P1725; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; RAO KP, 1953, BIOL BULL, V104, P171, DOI 10.2307/1538791; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Riisgard HU, 2007, MAR ECOL PROG SER, V343, P141, DOI 10.3354/meps06930; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; WALSH C., 2013, HIER PART HIERARCHIC; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	73	52	52	4	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100353	10.1371/journal.pone.0100353	http://dx.doi.org/10.1371/journal.pone.0100353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984016	Green Published, gold			2022-12-25	WOS:000339635000021
J	Lee, KM; Yang, SJ; Choi, JH; Park, CS				Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung			Functional Effects of a Pathogenic Mutation in Cereblon (CRBN) on the Regulation of Protein Synthesis via the AMPK-mTOR Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Gene Knockout; Mammalian Target of Rapamycin (mTOR); Protein Synthesis; Signal Transduction; Cereblon; Mental Deficit; Nonsense Mutation	TERM SYNAPTIC PLASTICITY; MAMMALIAN TARGET; TRANSLATIONAL CONTROL; DEPENDENT TRANSLATION; TUBEROUS-SCLEROSIS; MENTAL-RETARDATION; RAPAMYCIN PATHWAY; MEMORY FORMATION; CELLULAR-ENERGY; KINASE	Background: Deficiency or nonsense mutation of CRBN causes memory deficits. Results: Truncated CRBN has insufficient affinity for AMPK and cannot modulate the AMPK-mTOR pathway. Conclusion: CRBN modulates protein synthesis through the AMPK-mTOR pathway, and may be critical for certain forms of memory encoding. Significance: Our findings suggest the first plausible mechanism for the phenotype resulting from the CRBN mutation. Initially identified as a protein implicated in human mental deficit, cereblon (CRBN) was recently recognized as a negative regulator of adenosine monophosphate-activated protein kinase (AMPK) in vivo and in vitro. Here, we present results showing that CRBN can effectively regulate new protein synthesis through the mammalian target of rapamycin (mTOR) signaling pathway, a downstream target of AMPK. Whereas deficiency of Crbn repressed protein translation via activation of the AMPK-mTOR cascade in Crbn-knock-out mice, ectopic expression of the wild-type CRBN increased protein synthesis by inhibiting endogenous AMPK. Unlike the wild-type CRBN, a mutant CRBN found in human patients, which lacks the last 24 amino acids, failed to rescue mTOR-dependent repression of protein synthesis in Crbn-deficient mouse fibroblasts. These results provide the first evidence that Crbn can activate the protein synthesis machinery through the mTOR signaling pathway by inhibiting AMPK. In light of the fact that protein synthesis regulated by mTOR is essential for various forms of synaptic plasticity that underlie the cognitive functions of the brain, the results of this study suggest a plausible mechanism for CRBN involvement in higher brain function in humans, and they may help explain how a specific mutation in CRBN can affect the cognitive ability of patients.	[Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung] Gwangju Inst Sci & Technol GIST, Natl Leading Res Lab, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Park, CS (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Cell Dynam Res Ctr, Kwangju 500712, South Korea.	cspark@gist.ac.kr		Park, Chul-Seung/0000-0003-0209-1412	Ministry for Health and Welfare [HI13C1412]; National Leading Research Laboratories [2011-0028665]; Ministry of Science, ICT & Future Planning/National Research Foundation of Korea [2007-0056157]	Ministry for Health and Welfare; National Leading Research Laboratories; Ministry of Science, ICT & Future Planning/National Research Foundation of Korea	This work was supported by grants for the Korea Healthcare Technology Research and Development Project (HI13C1412), Ministry for Health and Welfare, the National Leading Research Laboratories (2011-0028665), and the Science Research Center of Excellence Program (2007-0056157) of Ministry of Science, ICT & Future Planning/National Research Foundation of Korea (to C. S. P.).	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; STANTON PK, 1984, J NEUROSCI, V4, P3080; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	37	20	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23343	23352		10.1074/jbc.M113.523423	http://dx.doi.org/10.1074/jbc.M113.523423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993823	hybrid, Green Published			2022-12-25	WOS:000341505000010
J	Chen, YY; Chuang, PY; Chen, CP; Chiu, YH; Lo, HF; Cheong, ML; Huang, JY; Kuo, PL; Chen, HW				Chen, Yao-Yu; Chuang, Pei-Yun; Chen, Chie-Pein; Chiu, Yueh-Ho; Lo, Hsiao-Fan; Cheong, Mei-Leng; Huang, Jyun-Yuang; Kuo, Pao-Lin; Chen, Hungwen			Functional Antagonism between High Temperature Requirement Protein A (HtrA) Family Members Regulates Trophoblast Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; EXPRESSION; CELLS; ENDOMETRIUM; PROTEOLYSIS; ATTACHMENT; INHIBITOR; PROTEASES; MODEL	Human trophoblast invasion of decidualized endometrium is essential for placentation and is tightly regulated and involves trophoblast-decidual cell interaction. High temperature requirement A4 (HtrA4) is a secreted serine protease highly expressed in the invasive extravillous trophoblasts that invade decidua. In contrast, both HtrA1 and HtrA3 have been shown to inhibit trophoblast invasion. Here we provide evidence that decidua-secreted HtrA1 and HtrA3 antagonize HtrA4-mediated trophoblast invasion. We demonstrated that HtrA1 and HtrA3 interact with and degrade HtrA4 and thereby inhibit trophoblast-like JAR cell invasion. Specifically, HtrA1 and HtrA3 expression is up-regulated under decidualization conditions in endometrial stromal and epithelial cells, T-HESCs and Ishikawa cells, respectively. Conditioned media from these two cell lines after decidualization treatment suppress HtrA4-expressing JAR cell invasion in an HtrA1- or HtrA3-dependent manner. Co-culture of the HtrA4-expressing JAR cells with decidualization stimuli-treated T-HESC or Ishikawa monolayer also impairs JAR cell invasion, which can be reversed by HtrA1 or HtrA3 knockdown, supporting that HtrA1 and HtrA3 are crucial for trophoblast-decidual cell interaction in the control of trophoblast invasion. Our study reveals a novel regulatory mechanism of trophoblast invasion through physical and functional interaction between HtrA family members.	[Chen, Yao-Yu; Chuang, Pei-Yun; Chiu, Yueh-Ho; Lo, Hsiao-Fan; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei 104, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei 106, Taiwan; [Huang, Jyun-Yuang; Kuo, Pao-Lin] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 704, Taiwan; [Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	National Taiwan University; Mackay Memorial Hospital; Cathay General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022; CHEN, CHEN/HDM-6657-2022		Ministry of Science and Technology [103-2311-B-001-024]; Academia Sinica, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants (to H. C.) from the Ministry of Science and Technology (103-2311-B-001-024) and Academia Sinica, Taiwan.	Ajayi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.046; Benirschke K., 2001, PATHOLOGY HUMAN PLAC, P171; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Gellersen B, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106724; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Irwin JC, 2001, J CLIN ENDOCR METAB, V86, P2060, DOI 10.1210/jc.86.5.2060; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Uchida H, 2012, J BIOL CHEM, V287, P4441, DOI 10.1074/jbc.M111.286138; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang H, 2013, TISSUE ENG PART C-ME, V19, P676, DOI [10.1089/ten.tec.2012.0616, 10.1089/ten.TEC.2012.0616]; Wang H, 2012, MOL HUM REPROD, V18, P33, DOI 10.1093/molehr/gar064; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	26	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22958	22968		10.1074/jbc.M114.576744	http://dx.doi.org/10.1074/jbc.M114.576744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25002585	Green Published, hybrid			2022-12-25	WOS:000341017200035
J	Gao, HT; Ai, ZR; Yu, HL; Wu, HY; Liu, XH				Gao, Haitao; Ai, Zhengrong; Yu, Hailiang; Wu, Hongyan; Liu, Xianghua			Analysis of Internal Crack Healing Mechanism under Rolling Deformation	PLOS ONE			English	Article							EVOLUTION; IRON; FEM	A new experimental method, called the 'hole filling method', is proposed to simulate the healing of internal cracks in rolled workpieces. Based on the experimental results, the evolution in the microstructure, in terms of diffusion, nucleation and recrystallisation were used to analyze the crack healing mechanism. We also validated the phenomenon of segmented healing. Internal crack healing involves plastic deformation, heat transfer and an increase in the free energy introduced by the cracks. It is proposed that internal cracks heal better under high plastic deformation followed by slow cooling after rolling. Crack healing is controlled by diffusion of atoms from the matrix to the crack surface, and also by the nucleation and growth of ferrite grain on the crack surface. The diffusion mechanism is used to explain the source of material needed for crack healing. The recrystallisation mechanism is used to explain grain nucleation and growth, accompanied by atomic migration to the crack surface.	[Gao, Haitao; Ai, Zhengrong; Wu, Hongyan; Liu, Xianghua] Northeastern Univ, State Key Lab Rolling & Automat, Shenyang, Peoples R China; [Yu, Hailiang] Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW 2522, Australia; [Yu, Hailiang] Shenyang Univ, Sch Mech Engn, Shenyang, Peoples R China	Northeastern University - China; University of Wollongong; Shenyang University	Yu, HL (corresponding author), Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW 2522, Australia.	hailiang@uow.edu.au	YU, Hailiang/B-5977-2009	YU, Hailiang/0000-0001-7959-0717; Gao, Haitao/0000-0001-6224-0032	Vice-Chancellor's Fellowship Grant; URC small grant at the University of Wollongong; National Natural Science Foundation of China [51105071]	Vice-Chancellor's Fellowship Grant; URC small grant at the University of Wollongong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Vice-Chancellor's Fellowship Grant and URC small grant at the University of Wollongong, and the National Natural Science Foundation of China through Grant 51105071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Li XG., 2002, ACTA METALL SIN-ENGL, V15, P385; Liu Xiang-hua, 2009, Journal of Iron and Steel Research, V21, P36; Liu XH, 2010, MATER MANUF PROCESS, V25, P161, DOI 10.1080/10426910903158256; [孟凡莹 Meng Fanying], 2010, [塑性工程学报, Journal of Plasticity Engineering], V17, P136; Wei D, 2006, J MATER PROCESS TECH, V177, P233, DOI 10.1016/j.jmatprotec.2006.04.067; Wei DB, 2004, SCRIPTA MATER, V51, P583, DOI 10.1016/j.scriptamat.2004.05.032; Wei DB, 2013, COMP MATER SCI, V69, P270, DOI 10.1016/j.commatsci.2012.11.043; [肖亚航 XIAO Yahang], 2008, [机械工程材料, Materials for Mechanical Engineering], V32, P13; Yu HL, 2013, INT J ADV MANUF TECH, V67, P1161, DOI 10.1007/s00170-012-4556-7; Yu HL, 2009, J MATER PROCESS TECH, V209, P2876, DOI 10.1016/j.jmatprotec.2008.06.045; Yu HL, 2009, MATER MANUF PROCESS, V24, P570, DOI 10.1080/10426910902746895; Yu HL, 2014, METALL MATER TRANS A, V45A, P1001, DOI 10.1007/s11661-013-2049-4; [袁朝龙 YUAN Chaolong], 2006, [塑性工程学报, Journal of plasticity engineering], V13, P53; Zhang HL, 2004, MAT SCI ENG A-STRUCT, V382, P171, DOI 10.1016/j.msea.2004.04.069; [张永军 ZHANG Yongjun], 2008, [塑性工程学报, Journal of Plasticity Engineering], V15, P122; Zhao XP, 1996, CHIN J MAT RES, V10, P101; Zheng XG, 2013, MAT SCI ENG A-STRUCT, V561, P52, DOI 10.1016/j.msea.2012.10.080; Zhou YZ, 2004, MATER LETT, V58, P1732, DOI 10.1016/j.matlet.2003.10.049; 周本濂, 1997, 材料研究学报, V11, P576	19	8	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101907	10.1371/journal.pone.0101907	http://dx.doi.org/10.1371/journal.pone.0101907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003518	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700087
J	Trojanowicz, B; Ulrich, C; Seibert, E; Fiedler, R; Girndt, M				Trojanowicz, Bogusz; Ulrich, Christof; Seibert, Eric; Fiedler, Roman; Girndt, Matthias			Uremic Conditions Drive Human Monocytes to Pro-Atherogenic Differentiation via an Angiotensin-Dependent Mechanism	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITOR; II-INDUCED ATHEROSCLEROSIS; CHEMOATTRACTANT PROTEIN-1; CARDIOVASCULAR-DISEASE; VASCULAR INFLAMMATION; CHRONIC-HEMODIALYSIS; RENAL-FAILURE; HUMAN PLASMA; MACROPHAGES; EXPRESSION	Aims: Elevated expression levels of monocytic-ACE have been found in haemodialysis patients. They are not only epidemiologically linked with increased mortality and cardiovascular disease, but may also directly participate in the initial steps of atherosclerosis. To further address this question we tested the role of monocytic-ACE in promotion of atherosclerotic events in vitro under conditions mimicking those of chronic renal failure. Methods and Results: Treatment of human primary monocytes or THP-1 cells with uremic serum as well as PMA-induced differentiation led to significantly up-regulated expression of ACE, further increased by additional treatment with LPS. Functionally, these monocytes revealed significantly increased adhesion and transmigration through endothelial monolayers. Overexpression of ACE in transfected monocytes or THP-1 cells led to development of more differentiated, macrophage-like phenotype with up-regulated expression of Arg1, MCSF, MCP-1 and CCR2. Expression of pro-inflammatory cytokines TNF alpha and IL-6 were also noticeably up-regulated. ACE overexpression resulted in significantly increased adhesion and transmigration properties. Transcriptional screening of ACE-overexpressing monocytes revealed noticeably increased expression of Angiotensin II receptors and adhesion-as well as atherosclerosis-related ICAM-1 and VCAM1. Inhibition of monocyte ACE or AngII-receptor signalling led to decreased adhesion potential of ACE-overexpressing cells. Conclusions: Taken together, these data demonstrate that uremia induced expression of monocytic-ACE mediates the development of highly pro-atherogenic cells via an AngII-dependent mechanism.	[Trojanowicz, Bogusz; Ulrich, Christof; Seibert, Eric; Fiedler, Roman; Girndt, Matthias] Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany	Martin Luther University Halle Wittenberg	Trojanowicz, B (corresponding author), Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany.	bogusz.trojanowicz@uk-halle.de	Trojanowicz, Bogusz/I-3042-2019; Girndt, Matthias/M-1436-2019	Trojanowicz, Bogusz/0000-0001-7429-381X; Girndt, Matthias/0000-0003-2823-0847	University Halle (Saale)	University Halle (Saale)	This work was supported by intramural funding of the University Halle (Saale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi S, 2011, NEPHROL DIAL TRANSPL, V26, P832, DOI 10.1093/ndt/gfq524; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Chen XF, 2013, ARTERIOSCL THROM VAS, V33, P2075, DOI 10.1161/ATVBAHA.113.301777; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x; Guerin AP, 2001, CIRCULATION, V103, P987; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; KITAZONO T, 1995, CIRCULATION, V91, P1129, DOI 10.1161/01.CIR.91.4.1129; Kogai J, 2008, HYPERTENS RES, V31, P1791, DOI 10.1291/hypres.31.1791; Kohlstedt K, 2011, BASIC RES CARDIOL, V106, P205, DOI 10.1007/s00395-010-0137-9; Kojima C, 2007, J PHARMACOL EXP THER, V323, P855, DOI 10.1124/jpet.107.127944; Lal Hind, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P109, DOI 10.2174/187152507780363223; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Mizobuchi M, 2011, AM J NEPHROL, V34, P256, DOI 10.1159/000330188; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; O'Brien KD, 2002, CIRCULATION, V106, P2224, DOI 10.1161/01.CIR.0000035655.45453.D2; Okumoto S, 2009, THER APHER DIAL, V13, P205, DOI 10.1111/j.1744-9987.2009.00658.x; Ouimet T, 2012, MOL PHARMACEUT, V9, P850, DOI 10.1021/mp2003863; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Petrov MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049290; Pletinck A, 2013, J AM SOC NEPHROL, V24, P1981, DOI 10.1681/ASN.2012030281; Pourcet B, 2013, TRENDS CARDIOVAS MED, V23, P143, DOI 10.1016/j.tcm.2012.10.003; Rafatian N, 2013, AM J PHYSIOL-HEART C, V305, pH1309, DOI 10.1152/ajpheart.00826.2012; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Simolin MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-10; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; Tyralla K, 2003, KIDNEY INT, V63, pS80, DOI 10.1046/j.1523-1755.63.s84.1.x; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Ulrich C, 2011, CLIN J AM SOC NEPHRO, V6, P505, DOI 10.2215/CJN.06870810; Ulrich C, 2010, NEPHROL DIAL TRANSPL, V25, P2265, DOI 10.1093/ndt/gfq012; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R., 2014, J AM SOC NEPHROL; Wiesner P, 2013, J LIPID RES, V54, P1877, DOI 10.1194/jlr.M036343; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yusuf S, 2000, NEW ENGL J MED, V342, P145	57	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102137	10.1371/journal.pone.0102137	http://dx.doi.org/10.1371/journal.pone.0102137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003524	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700114
J	Michinaga, S; Nagase, M; Matsuyama, E; Yamanaka, D; Seno, N; Fuka, M; Yamamoto, Y; Koyama, Y				Michinaga, Shotaro; Nagase, Marina; Matsuyama, Emi; Yamanaka, Daisuke; Seno, Naoki; Fuka, Mayu; Yamamoto, Yui; Koyama, Yutaka			Amelioration of Cold Injury-Induced Cortical Brain Edema Formation by Selective Endothelin ETB Receptor Antagonists in Mice	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; GROWTH-FACTOR; BARRIER BREAKDOWN; ASTROCYTES; EXPRESSION; ISCHEMIA; AGONIST; ACTIVATION; STROKE; MATRIX-METALLOPROTEINASE-9	Brain edema is a potentially fatal pathological condition that often occurs in stroke and head trauma. Following brain insults, endothelins (ETs) are increased and promote several pathophysiological responses. This study examined the effects of ETB antagonists on brain edema formation and disruption of the blood-brain barrier in a mouse cold injury model (Five-to six-week-old male ddY mice). Cold injury increased the water content of the injured cerebrum, and promoted extravasation of both Evans blue and endogenous albumin. In the injury area, expression of prepro-ET-1 mRNA and ET-1 peptide increased. Intracerebroventricular (ICV) administration of BQ788 (ETB antagonist), IRL-2500 (ETB antagonist), or FR139317 (ETA antagonist) prior to cold injury significantly attenuated the increase in brain water content. Bolus administration of BQ788, IRL-2500, or FR139317 also inhibited the cold injury-induced extravasation of Evans blue and albumin. Repeated administration of BQ788 and IRL-2500 beginning at 24 h after cold injury attenuated both the increase in brain water content and extravasation of markers. In contrast, FR139317 had no effect on edema formation when administrated after cold injury. Cold injury stimulated induction of glial fibrillary acidic protein-positive reactive astrocytes in the injured cerebrum. Induction of reactive astrocytes after cold injury was attenuated by ICV administration of BQ788 or IRL-2500. These results suggest that ETB receptor antagonists may be an effective approach to ameliorate brain edema formation following brain insults.	[Michinaga, Shotaro; Nagase, Marina; Matsuyama, Emi; Yamanaka, Daisuke; Seno, Naoki; Fuka, Mayu; Yamamoto, Yui; Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Osaka, Japan		Koyama, Y (corresponding author), Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Osaka, Japan.	koyamay@osaka-ohtani.ac.jp		Michinaga, Shotaro/0000-0002-4052-7507	JPSP [21590108]	JPSP	This work was supported by a Grant-in-Aid for Scientific Research (C) from the JPSP (http://www.jsps.go.jp/english/e-grants/index.html) (grant No. 21590108). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036051-00104; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Kaundal RK, 2012, DRUG DISCOV TODAY, V17, P793, DOI 10.1016/j.drudis.2012.02.017; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; Koyama Y, 2012, MAPAN-J METROL SOC I, V27, P1, DOI 10.1007/s12647-012-0009-x; Koyama Y, 2011, NEUROSCIENCE, V192, P689, DOI 10.1016/j.neuroscience.2011.05.058; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Koyama Y, 2010, J PHARMACOL SCI, V114, P433, DOI 10.1254/jphs.10195FP; Leonard MG, 2012, BRAIN RES, V1464, P14, DOI 10.1016/j.brainres.2012.05.005; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; OURY TD, 1993, J BIOL CHEM, V268, P15394; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Schinelli S, 2006, CURR MED CHEM, V13, P627, DOI 10.2174/092986706776055652; Shields J, 2011, TRANSL STROKE RES, V2, P633, DOI 10.1007/s12975-011-0129-6; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Wajima D, 2013, BRAIN RES, V1519, P127, DOI 10.1016/j.brainres.2013.05.002; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257	47	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102009	10.1371/journal.pone.0102009	http://dx.doi.org/10.1371/journal.pone.0102009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000290	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300116
J	Bai, YS; Hassler, J; Ziyar, A; Li, P; Wright, Z; Menon, R; Omenn, GS; Cavalcoli, JD; Kaufman, RJ; Sartor, MA				Bai, Yongsheng; Hassler, Justin; Ziyar, Ahdad; Li, Philip; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Kaufman, Randal J.; Sartor, Maureen A.			Novel Bioinformatics Method for Identification of Genome-Wide Non-Canonical Spliced Regions Using RNA-Seq Data	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; XBP1 MESSENGER-RNA; ER STRESS; HEPATIC STEATOSIS; READ ALIGNMENT; BREAST-CANCER; IRE1-ALPHA; EXPRESSION; ULTRAFAST	Setting: During endoplasmic reticulum (ER) stress, the endoribonuclease (RNase) Ire1 alpha initiates removal of a 26 nt region from the mRNA encoding the transcription factor Xbp1 via an unconventional mechanism (atypically within the cytosol). This causes an open reading frame-shift that leads to altered transcriptional regulation of numerous downstream genes in response to ER stress as part of the unfolded protein response (UPR). Strikingly, other examples of targeted, unconventional splicing of short mRNA regions have yet to be reported. Objective: Our goal was to develop an approach to identify non-canonical, possibly very short, splicing regions using RNA-Seq data and apply it to ER stress-induced Ire1 alpha heterozygous and knockout mouse embryonic fibroblast (MEF) cell lines to identify additional Ire1 alpha targets. Results: We developed a bioinformatics approach called the Read-Split-Walk (RSW) pipeline, and evaluated it using two Ire1 alpha heterozygous and two Ire1 alpha-null samples. The 26 nt non-canonical splice site in Xbp1 was detected as the top hit by our RSW pipeline in heterozygous samples but not in the negative control Ire1 alpha knockout samples. We compared the Xbp1 results from our approach with results using the alignment program BWA, Bowtie2, STAR, Exonerate and the Unix "grep" command. We then applied our RSW pipeline to RNA-Seq data from the SKBR3 human breast cancer cell line. RSW reported a large number of non-canonical spliced regions for 108 genes in chromosome 17, which were identified by an independent study. Conclusions: We conclude that our RSW pipeline is a practical approach for identifying non-canonical splice junction sites on a genome-wide level. We demonstrate that our pipeline can detect novel splice sites in RNA-Seq data generated under similar conditions for multiple species, in our case mouse and human.	[Bai, Yongsheng; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Bai, Yongsheng; Wright, Zachary; Menon, Rajasree; Omenn, Gilbert S.; Cavalcoli, James D.; Sartor, Maureen A.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Hassler, Justin; Ziyar, Ahdad; Li, Philip; Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Sartor, Maureen A.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Bai, Yongsheng] Univ Wisconsin, Morgridge Inst Res, Madison, WI USA; [Omenn, Gilbert S.] Univ Michigan, Dept Internal Med & Human Genet, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Inst Syst Biol, Seattle, WA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Institute for Systems Biology (ISB)	Kaufman, RJ (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	rkaufman@sanfordburnham.org; sartorma@umich.edu	Sartor, Maureen/L-2902-2019	Omenn, Gilbert S./0000-0002-8976-6074; Menon, Rajasree/0000-0001-6280-9639	National Institutes of Health [DK042394, DK088227, HL052173]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394, R01DK088227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this work were supported by National Institutes of Health grants DK042394, DK088227 and HL052173 (RJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2005, GENOME RES, V15, P111, DOI 10.1101/gr.3108805; Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1311; Liu SL, 2013, J PROTEOME RES, V12, P45, DOI 10.1021/pr300985j; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183aIJ, 10.1021/pr301183a]; Menon R, 2014, J PROTEOME RES, V13, P212, DOI 10.1021/pr400773v; Niwa M, 2005, GENOME BIOL, V6; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Tang SJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-116; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang EY, 2013, J PROTEOME RES, V12, P2805, DOI 10.1021/pr4001527; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S10	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100864	10.1371/journal.pone.0100864	http://dx.doi.org/10.1371/journal.pone.0100864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991935	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400034
J	Ma, B; Yu, XL; Ma, F; Li, ZB; Wu, FQ				Ma, Bo; Yu, Xiaoling; Ma, Fan; Li, Zhanbin; Wu, Faqi			Effects of Crop Canopies on Rain Splash Detachment	PLOS ONE			English	Article							COVERS	Crops are one of the main factors affecting soil erosion in sloping fields. To determine the characteristics of splash erosion under crop canopies, corn, soybean, millet, and winter wheat were collected, and the relationship among splash erosion, rainfall intensity, and throughfall intensity under different crop canopies was analyzed through artificial rainfall experiments. The results showed that, the mean splash detachment rate on the ground surface was 390.12g/m(2).h, which was lower by 67.81% than that on bare land. The inhibiting effects of crops on splash erosion increased as the crops grew, and the ability of the four crops to inhibit splash erosion was in the order of winter wheat>corn>soybeans>millet. An increase in rainfall intensity could significantly enhance the occurrence of splash erosion, but the ability of crops to inhibit splash erosion was 13% greater in cases of higher rainfall intensity. The throughfall intensity under crop canopies was positively related to the splash detachment rate, and this relationship was more significant when the rainfall intensity was 40 mm/h. Splash erosion tended to occur intensively in the central row of croplands as the crop grew, and the non-uniformity of splash erosion was substantial, with splash erosion occurring mainly between the rows and in the region directly under the leaf margin. This study has provided a theoretical basis for describing the erosion mechanisms of cropland and for assisting soil erosion prediction as well as irrigation and fertilizer management in cultivated fields.	[Ma, Bo; Li, Zhanbin] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Ma, Bo; Yu, Xiaoling; Wu, Faqi] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Ma, Fan] Ningxia Acad Agr & Forestry Sci, Inst Desertificat Control, Yinchuan, Ningxia Hui Aut, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Northwest A&F University - China	Wu, FQ (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	wufaqi@263.net			National Basic Research Program of China (973 Program) [2007CB407201-5]; National Natural Science Foundation of China [41330858]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research for this thesis has been supported by the National Basic Research Program of China (973 Program, 2007CB407201-5) and the National Natural Science Foundation of China under Grant No. 41330858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CHINA SOIL SYSTEMIC; ARMSTRONG CL, 1987, T ASAE, V30, P688; Ellison W. D., 1944, AGRIC ENGINEERING, V25, P131; ELLISON W. D., 1947, Agric. Engng., V28, P197; FINNEY HJ, 1984, J AGR ENG RES, V29, P337, DOI 10.1016/0021-8634(84)90089-1; HAYNES J. L., 1940, JOUR AMER SOC AGRON, V32, P176; Jin K, 2008, CATENA, V75, P191, DOI 10.1016/j.catena.2008.06.002; JQ Xie, 2005, SLOPE LAND CHINA; Lamm RF, 2000, T ASABE, V43, P909; Ma F., 2009, EFFECTS CROP COVER S; [苗全安 Miao Quan'an], 2011, [中国水土保持科学, Science of Soil and Water Conservation], V9, P11; MORGAN RPC, 1982, T ASAE, V25, P987; MORGAN RPC, 1985, T ASAE, V28, P1135; MOSS AJ, 1987, AUST J SOIL RES, V25, P9, DOI 10.1071/SR9870009; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; QUINN NW, 1983, T ASAE, V26, P1445; SREENIVAS L., 1947, SOIL SCI SOC AMER PROC, V12, P471; Tang K., 2004, SOIL WATER CONSERVAT; Wu FQ, 2001, DYNAMIC MECH EROSION	19	21	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99717	10.1371/journal.pone.0099717	http://dx.doi.org/10.1371/journal.pone.0099717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992386	Green Published, Green Submitted			2022-12-25	WOS:000341253400013
J	Nault, BA; Kain, WC; Wang, P				Nault, Brian A.; Kain, Wendy C.; Wang, Ping			Seasonal Changes in Thrips tabaci Population Structure in Two Cultivated Hosts	PLOS ONE			English	Article							CYTOCHROME-OXIDASE I; ONION THRIPS; THYSANOPTERA THRIPIDAE; LINDEMAN THYSANOPTERA; PHYLOGENETIC ANALYSIS; REPRODUCTIVE FORMS; DIFFERENTIATION; RESISTANCE; SEQUENCES; FIELDS	Thrips tabaci is a major pest of high-value vegetable crops and understanding its population genetics will advance our knowledge about its ecology and management. Mitochondrial cytochrome oxidase subunit I (COI) gene sequence was used as a molecular marker to analyze T. tabaci populations from onion and cabbage fields in New York. Eight COI haplotypes were identified in 565 T. tabaci individuals collected from these fields. All T. tabaci were thelytokous and genetically similar to those originating from hosts representing seven plant families spanning five continents. The most dominant haplotype was NY-HT1, accounting for 92 and 88% of the total individuals collected from onion fields in mid-summer in 2005 and 2007, respectively, and 100 and 96% of the total in early fall in 2005 and 2007, respectively. In contrast, T. tabaci collected from cabbage fields showed a dynamic change in population structure from mid-summer to early fall. In mid-summer, haplotype NY-HT2 was highly abundant, accounting for 58 and 52% of the total in 2005 and 2007, respectively, but in early fall it decreased drastically to 15 and 7% of the total in 2005 and 2007, respectively. Haplotype NY-HT1 accounted for 12 and 46% of the total in cabbage fields in mid-summer of 2005 and 2007, respectively, but became the dominant haplotype in early fall accounting for 81 and 66% of the total in 2005 and 2007, respectively. Despite the relative proximity of onion and cabbage fields in the western New York landscape, T. tabaci populations differed seasonally within each cropping system. Differences may have been attributed to better establishment of certain genotypes on specific hosts or differing colonization patterns within these cropping systems. Future studies investigating temporal changes in T. tabaci populations on their major hosts in these ecosystems are needed to better understand host-plant utilization and implications for population management.	[Nault, Brian A.; Kain, Wendy C.; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Nault, BA (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ban6@cornell.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dorit RL, 2001, CURR PROTOC MOL BIOL, V56; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; Jenser G., 2001, Acta Phytopathologica et Entomologica Hungarica, V36, P365; JUKES T H, 1969, P21; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Kobayashi K, 2012, J ECON ENTOMOL, V105, P555, DOI 10.1603/EC11320; Larentzaki E, 2007, J ECON ENTOMOL, V100, P1194, DOI 10.1603/0022-0493(2007)100[1194:OLAHFO]2.0.CO;2; MORISON G. D., 1957, TRANS ROY ENT SOC LONDON, V109, P467; Nault BA, 2008, ARTHROPOD MANAGEMENT, V33, pE19; Nault BA, 2006, ARTHROPOD MANAGEMENT, V31, pE39; NAULT BA, 2010, ARTHROPOD MANAGEMENT, V35, pE13; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; NORTH RC, 1986, ENVIRON ENTOMOL, V15, P520, DOI 10.1093/ee/15.3.520; Parrella Michael P., 1997, P595; Shelton AM, 2008, J ECON ENTOMOL, V101, P438, DOI 10.1603/0022-0493(2008)101[438:AICOOT]2.0.CO;2; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; Shelton AM, 2003, J ECON ENTOMOL, V96, P1843, DOI 10.1603/0022-0493-96.6.1843; Smith EA, 2011, ENVIRON ENTOMOL, V40, P194, DOI 10.1603/EN10246; Srinivasan R, 2011, J ENTOMOL SCI, V46, P191, DOI 10.18474/0749-8004-46.3.191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	33	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101791	10.1371/journal.pone.0101791	http://dx.doi.org/10.1371/journal.pone.0101791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992484	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400118
J	Tan, XQ; Cheng, XL; Zhang, L; Wu, BW; Liu, QH; Meng, J; Xu, HY; Cao, JM				Tan, Xiao-Qiu; Cheng, Xiu-Li; Zhang, Li; Wu, Bo-Wei; Liu, Qing-Hua; Meng, Jie; Xu, Hai-Yan; Cao, Ji-Min			Multi-Walled Carbon Nanotubes Impair Kv4.2/4.3 Channel Activities, Delay Membrane Repolarization and Induce Bradyarrhythmias in the Rat	PLOS ONE			English	Article							POTASSIUM CHANNELS; ATRIAL-FIBRILLATION; K+ CHANNELS; IN-VITRO; MECHANISMS; SUBUNITS; KCHIP2; NANOTOXICOLOGY; INACTIVATION; ARRHYTHMIAS	Purpose: The potential hazardous effects of multi-walled carbon nanotubes (MWCNTs) on cardiac electrophysiology are seldom evaluated. This study aimed to investigate the impacts of MWCNTs on the Kv4/I-to channel, action potential and heart rhythm and the underlying mechanisms. Methods: HEK293 cells were engineered to express Kv4.2 or Kv4.3 with or without KChIP2 expression. A series of approaches were introduced to analyze the effects of MWCNTs on Kv4/I-to channel kinetics, current densities, expression and trafficking. Transmission electron microscopy was performed to observe the internalization of MWCNTs in HEK293 cells and rat cardiomyocytes. Current clamp was employed to record the action potentials of isolated rat cardiomyocytes. Surface ECG and epicardial monophasic action potentials were recorded to monitor heart rhythm in rats in vivo. Vagal nerve discharge monitoring and H&E staining were also performed. Results: Induction of MWCNTs into the cytosole through pipette solution soon accelerated the decay of I-Kv4 in HEK293 cells expressing Kv4.2/4.3 and KChIP2, and promoted the recovery from inactivation when Kv4.2 or Kv4.3 was expressed alone. Longer exposure (6 h) to MWCNTs decreased the I-Kv4.2 density, Kv4.2/Kv4.3 (but not KChIP2) expression and trafficking towards the plasma membrane in HEK293 cells. In acutely isolated rat ventricular myocytes, pipette MWCNTs also quickly accelerated the decay of I-Kv4 and prolonged the action potential duration (APD). Intravenous infusion of MWCNTs (2 mg/rat) induced atrioventricular (AV) block and even cardiac asystole. No tachyarrhythmia was observed after MWCNTs administration. MWCNTs did not cause coronary clot but induced myocardial inflammation and increased vagus discharge. Conclusions: MWCNTs suppress Kv4/I-to channel activities likely at the intracellular side of plasma membrane, delay membrane repolarization and induce bradyarrhythmia. The delayed repolarization, increased vagus output and focal myocardial inflammation may partially underlie the occurrence of bradyarrhythmias induced by MWCNTs. The study warns that MWCNTs are hazardous to cardiac electrophysiology.	[Tan, Xiao-Qiu; Cheng, Xiu-Li; Cao, Ji-Min] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Physiol, Beijing 100730, Peoples R China; [Zhang, Li; Wu, Bo-Wei] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Liu, Qing-Hua] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Meng, Jie; Xu, Hai-Yan] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Biomed Engn, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Physiol, Beijing 100730, Peoples R China.	caojimin@126.com	Liu, Qinghua/HCH-3099-2022		(973 program) from the Ministry of Science and Technology (MOST) of China [2011CB93350]; Natural Science Foundation of China (NSFC) [81071072, 31171088]	(973 program) from the Ministry of Science and Technology (MOST) of China; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants 2011CB93350 (973 program) from the Ministry of Science and Technology (MOST) of China, 81071072 and 31171088 from the Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gavello D, 2012, NANOTOXICOLOGY, V6, P47, DOI 10.3109/17435390.2011.553294; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Inoue K, 2008, EXP BIOL MED, V233, P1583, DOI 10.3181/0805-RM-179; IRISAWA H, 1964, JPN J PHYSIOL, V14, P165; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Liu QH, 2012, J CARDIOVASC PHARM, V59, P37, DOI 10.1097/FJC.0b013e3182350bcc; Meng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038995; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Ohya S, 1997, FEBS LETT, V420, P47, DOI 10.1016/S0014-5793(97)01483-X; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schultz JH, 2005, J MOL CELL CARDIOL, V39, P269, DOI 10.1016/j.yjmcc.2005.02.025; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Tang SX, 2012, J APPL TOXICOL, V32, P900, DOI 10.1002/jat.2748; Wako K, 2010, J TOXICOL SCI, V35, P437, DOI 10.2131/jts.35.437; Xu HF, 2010, J NANOSCI NANOTECHNO, V10, P7406, DOI 10.1166/jnn.2010.2830; Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhao YL, 2008, NAT NANOTECHNOL, V3, P191, DOI 10.1038/nnano.2008.77	34	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101545	10.1371/journal.pone.0101545	http://dx.doi.org/10.1371/journal.pone.0101545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992664	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400087
J	Young, AM; Halgin, DS; DiClemente, RJ; Sterk, CE; Havens, JR				Young, April M.; Halgin, Daniel S.; DiClemente, Ralph J.; Sterk, Claire E.; Havens, Jennifer R.			Will HIV Vaccination Reshape HIV Risk Behavior Networks? A Social Network Analysis of Drug Users' Anticipated Risk Compensation	PLOS ONE			English	Article							EFFICACY TRIAL; INFECTIOUS-DISEASE; IMPACT; ACCEPTABILITY; VACCINES; SEX; PARTICIPANTS; PERCEPTIONS; PREVENTION; EPIDEMIC	Background: An HIV vaccine could substantially impact the epidemic. However, risk compensation (RC), or post-vaccination increase in risk behavior, could present a major challenge. The methodology used in previous studies of risk compensation has been almost exclusively individual-level in focus, and has not explored how increased risk behavior could affect the connectivity of risk networks. This study examined the impact of anticipated HIV vaccine-related RC on the structure of high-risk drug users' sexual and injection risk network. Methods: A sample of 433 rural drug users in the US provided data on their risk relationships (i.e., those involving recent unprotected sex and/or injection equipment sharing). Dyad-specific data were collected on likelihood of increasing/initiating risk behavior if they, their partner, or they and their partner received an HIV vaccine. Using these data and social network analysis, a "post-vaccination network" was constructed and compared to the current network on measures relevant to HIV transmission, including network size, cohesiveness (e.g., diameter, component structure, density), and centrality. Results: Participants reported 488 risk relationships. Few reported an intention to decrease condom use or increase equipment sharing (4% and 1%, respectively). RC intent was reported in 30 existing risk relationships and vaccination was anticipated to elicit the formation of five new relationships. RC resulted in a 5% increase in risk network size (n = 142 to n = 149) and a significant increase in network density. The initiation of risk relationships resulted in the connection of otherwise disconnected network components, with the largest doubling in size from five to ten. Conclusions: This study demonstrates a new methodological approach to studying RC and reveals that behavior change following HIV vaccination could potentially impact risk network connectivity. These data will be valuable in parameterizing future network models that can determine if network-level change precipitated by RC would appreciably impact the vaccine's population-level effectiveness.	[Young, April M.] Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA; [Young, April M.; Havens, Jennifer R.] Univ Kentucky, Ctr Drug & Alcohol Res, Lexington, KY USA; [Halgin, Daniel S.] Univ Kentucky, Gatton Coll Business & Econ, LINKS Ctr Social Network Anal, Lexington, KY USA; [DiClemente, Ralph J.; Sterk, Claire E.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA	University of Kentucky; University of Kentucky; University of Kentucky; Emory University	Young, AM (corresponding author), Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA.	april.young@uky.edu	Young, April/I-9518-2012; Halgin, Daniel/AHE-6070-2022	Young, April/0000-0003-3969-3249; Havens, Jennifer/0000-0002-1753-7280	National Institute on Drug Abuse [R01DA024598, R01DA033862]; National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health [UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024598, R01DA033862] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (Grant numbers R01DA024598, R01DA033862; http://www.drugabuse.gov/) and the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health (Grant number UL1TR000117; http://www.ncats.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2013, AM J PUBLIC HEALTH, V103, P322, DOI 10.2105/AJPH.2012.300908; Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78; Andersson KM, 2011, VACCINE, V29, P6107, DOI 10.1016/j.vaccine.2011.06.076; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Barrington C, 2008, CULT HEALTH SEX, V10, P391, DOI 10.1080/13691050801898877; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Blower S., 2003, AIDS Reviews, V5, P113; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; Bogard E, 2002, J ACQ IMMUN DEF SYND, V29, P132, DOI 10.1097/00042560-200202010-00004; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Coyle S, 1998, PUBLIC HLTH REP, V113, P20; Crosby RA, 2006, INT J STD AIDS, V17, P180, DOI 10.1258/095646206775809204; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Dombrowski Kirk, 2013, World J AIDS, V3, P1; Dombrowski K, 2013, SUBST USE MISUSE, V48, P1485, DOI 10.3109/10826084.2013.796987; Fonseca MGP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011736; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Guest G, 2005, AIDS CARE, V17, P46, DOI 10.1080/09540120412331305124; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Havens Jennifer R, 2013, Am J Public Health, V103, pe44, DOI 10.2105/AJPH.2012.300874; Helleringer S, 2009, DEMOGR RES, V21, P428, DOI 10.4054/DemRes.2009.21.15; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; Jenkins RA, 2005, JAIDS-J ACQ IMM DEF, V40, P592, DOI 10.1097/01.qai.0000171725.09812.a5; Kentucky Cabinet for Health and Human Services, 2010, INT EP PROF HIV AIDS; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Koniak-Griffin D, 2007, J HEALTH CARE POOR U, V18, P687, DOI 10.1353/hpu.2007.0061; Lampinen TM, 2005, CAN MED ASSOC J, V172, P479, DOI 10.1503/cmaj.1031785; Latkin CA, 2013, JAIDS-J ACQ IMM DEF, V63, pS54, DOI 10.1097/QAI.0b013e3182928e2a; MacPhail CL, 2012, QUAL HEALTH RES, V22, P668, DOI 10.1177/1049732311431944; Martin M, 2010, INT J DRUG POLICY, V21, P296, DOI 10.1016/j.drugpo.2009.12.002; MEYERS K, 1994, AM J PUBLIC HEALTH, V84, P761, DOI 10.2105/AJPH.84.5.761; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Newman PA, 2004, VACCINE, V22, P1954, DOI 10.1016/j.vaccine.2003.10.031; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P1009, DOI 10.1080/17441692.2012.692388; Newman PA, 2010, VACCINE, V28, P958, DOI 10.1016/j.vaccine.2009.10.142; Newman PA, 2009, HEALTH SERV RES, V44, P2167, DOI 10.1111/j.1475-6773.2009.01039.x; O'Connell JM, 2002, JAIDS-J ACQ IMM DEF, V31, P521, DOI 10.1097/00126334-200212150-00010; Olin J, 2006, CULT HEALTH SEX, V8, P529, DOI 10.1080/13691050600888434; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020; Wang KD, 2011, AIDS BEHAV, V15, P1298, DOI 10.1007/s10461-011-0020-1; Wasserman S., 1994, SOCIAL NETWORK ANAL; Webb PM, 1999, J ADOLESCENT HEALTH, V25, P320, DOI 10.1016/S1054-139X(99)00066-X; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Young AM, 2013, AIDS BEHAV, V17, P2341, DOI 10.1007/s10461-012-0371-2	57	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101047	10.1371/journal.pone.0101047	http://dx.doi.org/10.1371/journal.pone.0101047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3RT	24992659	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400039
J	Zhao, SR				Zhao, Shanrong			Assessment of the Impact of Using a Reference Transcriptome in Mapping Short RNA-Seq Reads	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; ACCURATE ALIGNMENT; MICROARRAYS; ALGORITHMS; TOOL	RNA-Seq has become increasingly popular in transcriptome profiling. The major challenge in RNA-Seq data analysis is the accurate mapping of junction reads to their genomic origins. To detect splicing sites in short reads, many RNA-Seq aligners use reference transcriptome to inform placement of junction reads. However, no systematic evaluation has been performed to assess or quantify the benefits of incorporating reference transcriptome in mapping RNA-Seq reads. In this paper, we have studied the impact of reference transcriptome on mapping RNA-Seq reads, especially on junction ones. The same dataset were analysed with and without RefGene transcriptome, respectively. Then a Perl script was developed to analyse and compare the mapping results. It was found that about 50-55% junction reads can be mapped to the same genomic regions regardless of the usage of RefGene model. More than one-third of reads fail to be mapped without the help of a reference transcriptome. For "Alternatively" mapped reads, i.e., those reads mapped differently with and without RefGene model, the mappings without RefGene model are usually worse than their corresponding alignments with RefGene model. For junction reads that span more than two exons, it is less likely to align them correctly without the assistance of reference transcriptome. As the sequencing technology evolves, the read length is becoming longer and longer. When reads become longer, they are more likely to span multiple exons, and thus the mapping of long junction reads is actually becoming more and more challenging without the assistance of reference transcriptome. Therefore, the advantages of using reference transcriptome in the mapping demonstrated in this study are becoming more evident for longer reads. In addition, the effect of the completeness of reference transcriptome on mapping of RNA-Seq reads is discussed.	[Zhao, Shanrong] Janssen Res & Dev LLC, Syst Pharmacol & Biomarkers, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Zhao, SR (corresponding author), Pfizer Worldwide Res & Dev, BioTherapeut Clin R&D, Clin Genet & Bioinformat, Cambridge, MA 02140 USA.	Shanrong.Zhao@pfizer.com						Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knowles DG, 2013, BIOINFORMATICS, V29, P614, DOI 10.1093/bioinformatics/btt016; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pyrkosz A.B., 2013, ARXIV13032411V1; Seok J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031440; Stein LD, 2011, CURR PROTOC BIOINFOR; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao S, 2013, ISRN BIOINFORMATICS, V2013; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	30	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101374	10.1371/journal.pone.0101374	http://dx.doi.org/10.1371/journal.pone.0101374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992027	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400067
J	Bargerstock, E; Puvenna, V; Iffland, P; Falcone, T; Hossain, M; Vetter, S; Man, SM; Dickstein, L; Marchi, N; Ghosh, C; Carvalho-Tavares, J; Janigro, D				Bargerstock, Erin; Puvenna, Vikram; Iffland, Philip; Falcone, Tatiana; Hossain, Mohammad; Vetter, Stephen; Man, Shumei; Dickstein, Leah; Marchi, Nicola; Ghosh, Chaitali; Carvalho-Tavares, Juliana; Janigro, Damir			Is Peripheral Immunity Regulated by Blood-Brain Barrier Permeability Changes?	PLOS ONE			English	Article							DENDRITIC CELLS; CEREBROSPINAL-FLUID; POSSIBLE MARKER; S-100B PROTEIN; SERUM S-100B; IN-VIVO; S100B; DISRUPTION; AUTOANTIBODIES; S100-BETA	S100B is a reporter of blood-brain barrier (BBB) integrity which appears in blood when the BBB is breached. Circulating S100B derives from either extracranial sources or release into circulation by normal fluctuations in BBB integrity or pathologic BBB disruption (BBBD). Elevated S100B matches the clinical presence of indices of BBBD (gadolinium enhancement or albumin coefficient). After repeated sub-concussive episodes, serum S100B triggers an antigen-driven production of anti-S100B autoantibodies. We tested the hypothesis that the presence of S100B in extracranial tissue is due to peripheral cellular uptake of serum S100B by antigen presenting cells, which may induce the production of auto antibodies against S100B. To test this hypothesis, we used animal models of seizures, enrolled patients undergoing repeated BBBD, and collected serum samples from epileptic patients. We employed a broad array of techniques, including immunohistochemistry, RNA analysis, tracer injection and serum analysis. mRNA for S100B was segregated to barrier organs (testis, kidney and brain) but S100B protein was detected in immunocompetent cells in spleen, thymus and lymph nodes, in resident immune cells (Langerhans, satellite cells in heart muscle, etc.) and BBB endothelium. Uptake of labeled S100B by rat spleen CD4+ or CD8+ and CD86+ dendritic cells was exacerbated by pilocarpine-induced status epilepticus which is accompanied by BBBD. Clinical seizures were preceded by a surge of serum S100B. In patients undergoing repeated therapeutic BBBD, an autoimmune response against S100B was measured. In addition to its role in the central nervous system and its diagnostic value as a BBBD reporter, S100B may integrate blood-brain barrier disruption to the control of systemic immunity by a mechanism involving the activation of immune cells. We propose a scenario where extravasated S100B may trigger a pathologic autoimmune reaction linking systemic and CNS immune responses.	[Bargerstock, Erin; Puvenna, Vikram; Iffland, Philip; Falcone, Tatiana; Hossain, Mohammad; Vetter, Stephen; Man, Shumei; Dickstein, Leah; Marchi, Nicola; Ghosh, Chaitali; Carvalho-Tavares, Juliana; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Puvenna, Vikram; Hossain, Mohammad; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Puvenna, Vikram; Hossain, Mohammad; Ghosh, Chaitali; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Dept Biomed Engn, Cleveland, OH 44106 USA; [Janigro, Damir] Flocel Inc, Cleveland, OH USA; [Iffland, Philip] Kent State Univ, Kent, OH 44242 USA; [Falcone, Tatiana] Cleveland Clin, Lerner Coll Med, Dept Psychiat, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Cleveland Clinic Foundation	Janigro, D (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Dickstein, Leah/CAF-1892-2022; Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226; Falcone, Tatiana/0000-0002-4431-6782; Ghosh, Chaitali/0000-0003-4078-0278; Dickstein, Leah/0000-0002-4779-4122; Iffland, Philip/0000-0003-2203-188X	National Institutes of Health [R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, R21HD057256]; American Heart Association [13SDG13950015]; Brain Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH093302, R42MH093302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078307, R21NS077236, R01NS043284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Brain Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: National Institutes of Health (R01NS078307, R01NS43284, R41MH093302, R21NS077236, R42MH093302, and R21HD057256 to DJ), a Scientist Development Grant from the American Heart Association (13SDG13950015), and a Brain Behavior Research Foundation grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DJ is employed by Flocel, Inc. Cleveland. Flocel, Inc. Cleveland provided support in the form of salary for author DJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Albuerne M, 1998, ANAT REC, V251, P351, DOI 10.1002/(SICI)1097-0185(199807)251:3<351::AID-AR11>3.0.CO;2-N; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bitsch A, 2004, J NEUROL, V251, P1498, DOI 10.1007/s00415-004-0580-3; Blyth BJ, 2008, ANN EMERG MED, V51, P538, DOI 10.1016/j.annemergmed.2008.01.193; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Cavalheiro EA, 2006, MODELS OF SEIZURES AND EPILEPSY, P433, DOI 10.1016/B978-012088554-1/50037-2; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; FIESCHI C, 1980, LIFE SCI, V27, P239, DOI 10.1016/0024-3205(80)90143-5; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; Iffland PH, 2013, NEUROBIOL DIS, V59, P206, DOI 10.1016/j.nbd.2013.07.006; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; John J, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-14; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2011, EPILEPSIA IN PRESS; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Marchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018200; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; McIlroy D, 2001, BLOOD, V97, P3470, DOI 10.1182/blood.V97.11.3470; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; Michalak Z, 2012, J NEUROPATH EXP NEUR, V71, P826, DOI 10.1097/NEN.0b013e31826809a6; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nishikawa Y, 2009, J CLIN EXP HEMATOP, V49, P23, DOI 10.3960/jslrt.49.23; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Osuna M, 2012, J ENDOCRINOL, V213, P231, DOI 10.1530/JOE-12-0043; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROMANGOLDSTEIN S, 1994, AM J NEURORADIOL, V15, P581; Rook GAW, 1999, BEST PRACT RES CL EN, V13, P567, DOI 10.1053/beem.1999.0044; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI [10.1089/neu.2009.0928, 10.1089/neu.2009-0928]; Sarker MH, 1998, J PHYSIOL-LONDON, V507, P909, DOI 10.1111/j.1469-7793.1998.909bs.x; Sarkis RA, 2012, EPILEPTIC DISORD, V14, P57, DOI 10.1684/epd.2012.0493; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schmidt S, 1997, BRAIN, V120, P1437, DOI 10.1093/brain/120.8.1437; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sorokina EG, 2010, ZH NEVROL PSIKHIATR, V110, P30; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tsoporis JN, 1998, J CLIN INVEST, V102, P1609, DOI 10.1172/JCI3077; Tsoporis JN, 2003, AM J PHYSIOL-HEART C, V284, pH193, DOI 10.1152/ajpheart.00161.2002; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vernino S, 2007, NEUROTHERAPEUTICS, V4, P305, DOI 10.1016/j.nurt.2007.01.007; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2008, EPILEPSY COMPREHENSI, P267; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	85	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101477	10.1371/journal.pone.0101477	http://dx.doi.org/10.1371/journal.pone.0101477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988410	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100097
J	Coetzee, V; Greeff, JM; Stephen, ID; Perrett, DI				Coetzee, Vinet; Greeff, Jaco M.; Stephen, Ian D.; Perrett, David I.			Cross-Cultural Agreement in Facial Attractiveness Preferences: The Role of Ethnicity and Gender	PLOS ONE			English	Article							MATE PREFERENCES; PHYSICAL ATTRACTIVENESS; WOMENS PREFERENCES; FACE RECOGNITION; RACE; HEALTH; BEAUTY; COLOR; JUDGMENTS; IDENTIFICATION	Previous work showed high agreement in facial attractiveness preferences within and across cultures. The aims of the current study were twofold. First, we tested cross-cultural agreement in the attractiveness judgements of White Scottish and Black South African students for own-and other-ethnicity faces. Results showed significant agreement between White Scottish and Black South African observers' attractiveness judgements, providing further evidence of strong cross-cultural agreement in facial attractiveness preferences. Second, we tested whether cross-cultural agreement is influenced by the ethnicity and/or the gender of the target group. White Scottish and Black South African observers showed significantly higher agreement for Scottish than for African faces, presumably because both groups are familiar with White European facial features, but the Scottish group are less familiar with Black African facial features. Further work investigating this discordance in cross-cultural attractiveness preferences for African faces show that Black South African observers rely more heavily on colour cues when judging African female faces for attractiveness, while White Scottish observers rely more heavily on shape cues. Results also show higher cross-cultural agreement for female, compared to male faces, albeit not significantly higher. The findings shed new light on the factors that influence cross-cultural agreement in attractiveness preferences.	[Coetzee, Vinet; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Stephen, Ian D.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Pretoria; Macquarie University; University of St Andrews	Coetzee, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vinet.coetzee@up.ac.za	Greeff, Jaco M/A-5582-2011; Stephen, Ian/ABA-6218-2021; Coetzee, Vinet/F-2155-2011	Coetzee, Vinet/0000-0003-1716-0804; Stephen, Ian/0000-0001-9714-8295; Greeff, Jaco/0000-0003-2951-6791; Perrett, David/0000-0002-6025-0939	South African National Research Foundation Scarce Skills Postdoctoral Fellowship [76454]	South African National Research Foundation Scarce Skills Postdoctoral Fellowship	VC was supported by a South African National Research Foundation Scarce Skills Postdoctoral Fellowship (Grant nr: 76454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, EVOLUTIONARY PSYCHOL, V2, P177, DOI DOI 10.1177/1474704904002001223; [Anonymous], 2007, USING MULTIVARIATE S; ANTHONY T, 1992, PERS SOC PSYCHOL B, V18, P296, DOI 10.1177/0146167292183005; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Bereczkei T, 2004, P ROY SOC B-BIOL SCI, V271, P1129, DOI 10.1098/rspb.2003.2672; Bereczkei T, 2002, PERS INDIV DIFFER, V33, P677, DOI 10.1016/S0191-8869(01)00182-9; BOTHWELL RK, 1989, PERS SOC PSYCHOL B, V15, P19, DOI 10.1177/0146167289151002; Brand A, 2012, J GEN PSYCHOL, V139, P260, DOI 10.1080/00221309.2012.703711; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; Coetzee V, 2011, EAT BEHAV, V12, P72, DOI 10.1016/j.eatbeh.2010.09.006; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Darwin G., 1871, P423; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; Garbin C. P, 2012, FZT COMPUTATOR; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Laeng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068395; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lewin R, 2004, PRINCIPLES HUMAN EVO, P400; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lowry R, 2012, SIGNIFICANCE CORRELA; Lowry R, 2012, Z P CALCULATOR; MARTIN JG, 1964, J SOC PSYCHOL, V63, P59, DOI 10.1080/00224545.1964.9922213; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Monin B, 2005, SOC COGNITION, V23, P257, DOI 10.1521/soco.2005.23.3.257; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Scottish Government, 2004, AN ETHN 2001 CENS SU; SHEPHERD JW, 1973, AM J PSYCHOL, V86, P627, DOI 10.2307/1421948; Silva AS, 2012, EVOL HUM BEHAV, V33, P491, DOI 10.1016/j.evolhumbehav.2012.01.002; Statistics South Africa, 2010, MID YEAR POP EST; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Strom MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041193; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P1, DOI 10.1017/CBO9781139049566; Zebrowitz L. A., 2011, SCI SOCIAL VISION, P3, DOI [DOI 10.1093/ACPROF:OSO/9780195333176.003.0002, 10.1093/acprof:oso/9780195333176.003.0002]; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V65, P85, DOI 10.1037/0022-3514.65.1.85; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386	57	56	57	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99629	10.1371/journal.pone.0099629	http://dx.doi.org/10.1371/journal.pone.0099629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988325	gold, Green Published			2022-12-25	WOS:000341354100016
J	Vorpahl, M; Schonhofer-Merl, S; Michaelis, C; Flotho, A; Melchior, F; Wessely, R				Vorpahl, Marc; Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Flotho, Annette; Melchior, Frauke; Wessely, Rainer			The Ran GTPase-Activating Protein (RanGAP1) Is Critically Involved in Smooth Muscle Cell Differentiation, Proliferation and Migration following Vascular Injury: Implications for Neointima Formation and Restenosis	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; COMPLEX; EXPRESSION; IMPORT; ATHEROSCLEROSIS; NUCLEOPORIN; MECHANISMS; INHIBITORS; MYOCARDIN; GROWTH	Differentiation and dedifferentiation, accompanied by proliferation play a pivotal role for the phenotypic development of vascular proliferative diseases (VPD), such as restenosis. Increasing evidence points to an essential role of regulated nucleoporin expression in the choice between differentiation and proliferation. However, whether components of the Ran GTPase cycle, which is of pivotal importance for both nucleocytoplasmic transport and for mitotic progression, are subject to similar regulation in VPD is currently unknown. Here, we show that differentiation of human coronary artery smooth muscle cell (CASMC) to a contractile phenotype by stepwise serum depletion leads to significant reduction of RanGAP1 protein levels. The inverse event, dedifferentiation of cells, was assessed in the rat carotid artery balloon injury model, a well-accepted model for neointima formation and restenosis. As revealed by temporospatial analysis of RanGAP1 expression, neointima formation in rat carotid arteries was associated with a significant upregulation of RanGAP1 expression at 3 and 7 days after balloon injury. Of note, neointimal cells located at the luminal surface revealed persistent RanGAP1 expression, as opposed to cells in deeper layers of the neointima where RanGAP1 expression was less or not detectable at all. To gain first evidence for a direct influence of RanGAP1 levels on differentiation, we reduced RanGAP1 in human coronary artery smooth muscle cells by siRNA. Indeed, downregulation of the essential RanGAP1 protein by 50% induced a differentiated, spindle-like smooth muscle cell phenotype, accompanied by an upregulation of the differentiation marker desmin. Reduction of RanGAP1 levels also resulted in a reduction of mitogen induced cellular migration and proliferation as well as a significant upregulation of the cyclin-dependent kinase inhibitor p27(KIP1), without evidence for cellular necrosis. These findings suggest that RanGAP1 plays a critical role in smooth muscle cell differentiation, migration and proliferation in vitro and in vivo. Appropriate modulation of RanGAP1 expression may thus be a strategy to modulate VPD development such as restenosis.	[Vorpahl, Marc] Univ Witten Herdecke, Dept Cardiol, HELIOS Klinikum Wuppertal, Witten, Germany; [Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Wessely, Rainer] Tech Univ Munich, Deutsch Herzzentrum Muenchen, D-80290 Munich, Germany; [Schoenhofer-Merl, Sabine; Michaelis, Cornelia; Wessely, Rainer] Tech Univ Munich, Med Klin 1, Klinikum Rechts Isar, D-80290 Munich, Germany; [Flotho, Annette; Melchior, Frauke] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Wessely, Rainer] Zentrum Herz Gefaess Lungenmed, Cologne, Germany	Helios Kliniken; Witten Herdecke University; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Vorpahl, M (corresponding author), Univ Witten Herdecke, Dept Cardiol, HELIOS Klinikum Wuppertal, Witten, Germany.	marc.vorpahl@helios-kliniken.de; rwessely@web.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797				Asally M, 2011, FEBS J, V278, P610, DOI 10.1111/j.1742-4658.2010.07982.x; CLOWES AW, 1983, LAB INVEST, V49, P208; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; Diez-Juan Antonio, 2003, Current Vascular Pharmacology, V1, P99; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Faustino RS, 2007, MOL PHARMACOL, V71, P438, DOI 10.1124/mol.105.021667; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Jaschke B, 2004, FASEB J, V18, P1285, DOI 10.1096/fj.04-1646fje; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; LIBBY P, 1984, J CELL PHYSIOL, V118, P317, DOI 10.1002/jcp.1041180315; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Okamoto E, 1996, LAB INVEST, V74, P120; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sartore S, 1999, Rev Physiol Biochem Pharmacol, V134, P235; Shi WY, 2004, DEV BIOL, V270, P106, DOI 10.1016/j.ydbio.2004.02.011; Stevenson AS, 2001, EXP CELL RES, V263, P118, DOI 10.1006/excr.2000.5107; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Wei GL, 1997, CIRC RES, V80, P418, DOI 10.1161/01.res.0000435858.35902.ea; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Wessely R, 2003, HUM MOL GENET, V12, P177, DOI 10.1093/hmg/ddg018; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5	36	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101519	10.1371/journal.pone.0101519	http://dx.doi.org/10.1371/journal.pone.0101519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988324	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100104
J	Humair, F; Kueffer, C; Siegrist, M				Humair, Franziska; Kueffer, Christoph; Siegrist, Michael			Are Non-Native Plants Perceived to Be More Risky? Factors Influencing Horticulturists' Risk Perceptions of Ornamental Plant Species	PLOS ONE			English	Article							INTRODUCTIONS; ATTITUDES; PATHWAYS; NURSERY; TRADE	Horticultural trade is recognized as an important vector in promoting the introduction and dispersal of harmful non-native plant species. Understanding horticulturists' perceptions of biotic invasions is therefore important for effective species risk management. We conducted a large-scale survey among horticulturists in Switzerland (N = 625) to reveal horticulturists' risk and benefit perceptions from ornamental plant species, their attitudes towards the regulation of non-native species, as well as the factors decisive for environmental risk perceptions and horticulturists' willingness to engage in risk mitigation behavior. Our results suggest that perceived familiarity with a plant species had a mitigating effect on risk perceptions, while perceptions of risk increased if a species was perceived to be non-native. However, perceptions of the non-native origin of ornamental plant species were often not congruent with scientific classifications. Horticulturists displayed positive attitudes towards mandatory trade regulations, particularly towards those targeted against known invasive species. Participants also expressed their willingness to engage in risk mitigation behavior. Yet, positive effects of risk perceptions on the willingness to engage in risk mitigation behavior were counteracted by perceptions of benefits from selling non-native ornamental species. Our results indicate that the prevalent practice in risk communication to emphasize the non-native origin of invasive species can be ineffective, especially in the case of species of high importance to local industries and people. This is because familiarity with these plants can reduce risk perceptions and be in conflict with scientific concepts of non-nativeness. In these cases, it might be more effective to focus communication on well-documented environmental impacts of harmful species.	[Humair, Franziska; Siegrist, Michael] ETH, Swiss Fed Inst Technol, Inst Environm Decis Consumer Behav, Zurich, Switzerland; [Kueffer, Christoph] ETH, Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Humair, F (corresponding author), ETH, Swiss Fed Inst Technol, Inst Environm Decis Consumer Behav, Zurich, Switzerland.	fhumair@ethz.ch	Kueffer, Christoph/H-6091-2013; Siegrist, Michael/A-1032-2008	Kueffer, Christoph/0000-0001-6701-0703; Siegrist, Michael/0000-0002-6139-7190				[Anonymous], 2005, EC HUM WELL BEING SY; Baan P.J., 2004, INT J RIVER BASIN MA, V2, P113, DOI [10.1080/15715124.2004.9635226, DOI 10.1080/15715124.2004.9635226]; Barbier EB, 2013, BIOSCIENCE, V63, P132, DOI 10.1525/bio.2013.63.2.9; Baskin Y, 2002, BIOSCIENCE, V52, P464, DOI 10.1641/0006-3568(2002)052[0464:TGOHNC]2.0.CO;2; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Brunel S., 2013, LATE LESSONS EARLY W, P518; Burt JW, 2007, BIOL INVASIONS, V9, P909, DOI 10.1007/s10530-007-9090-4; Chung JB, 2008, RISK ANAL, V28, P1021, DOI 10.1111/j.1539-6924.2008.01074.x; Coats VC, 2011, INVAS PLANT SCI MANA, V4, P378, DOI 10.1614/IPSM-D-10-00086.1; Conedera M, 2014, SCHWEIZERISCHE Z FOR, P6; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Dehnen-Schmutz K, 2010, SCI HORTIC-AMSTERDAM, V125, P1, DOI 10.1016/j.scienta.2010.02.017; Drew J, 2010, BIOL INVASIONS, V12, P2837, DOI 10.1007/s10530-010-9689-8; Fischer A, 2007, BIOL CONSERV, V135, P256, DOI 10.1016/j.biocon.2006.10.026; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Gagliardi JA, 2007, HORTTECHNOLOGY, V17, P39, DOI 10.21273/HORTTECH.17.1.39; Halford M., 2013, PERCEPTION INVASIVE, P31; Hobbs R.J., 2013, NOVEL ECOSYSTEMS INT, V1st ed.; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Humair F., 2014, NeoBiota, P1; Humair F, 2014, B OEPP EPPO IN PRESS, V44; Info Flora, 2014, CTR NAT DONN INF FLO; [JardinSuisse JardinSuisse UGS], 2012, PFLANZEN UNSERRE GAR; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Kowarik Ingo, 2007, V193, P29; Kueffer C., 2013, BIODIVERSITY SOC PAC, P71; Kueffer C, 2014, BIOSCIENCE IN PRESS; Landolt E., 2010, FLORA INDICATIVA; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Mack RN, 2005, HORTSCIENCE, V40, P1168, DOI 10.21273/HORTSCI.40.5.1168; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McDaniels T, 1996, GLOBAL ENVIRON CHANG, V6, P159, DOI 10.1016/0959-3780(96)00006-4; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Peters WL, 2006, EUPHYTICA, V148, P75, DOI 10.1007/s10681-006-5942-8; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Selge S, 2011, BIOL CONSERV, V144, P3089, DOI 10.1016/j.biocon.2011.09.014; Selge S, 2011, J COMMUNITY APPL SOC, V21, P297, DOI 10.1002/casp.1075; SFC - Swiss Federal Council, 2008, ORD HANDL ORG ENV; Siegrist M, 2005, RISK ANAL, V25, P211, DOI 10.1111/j.0272-4332.2005.00580.x; Siegrist M, 2013, RISK ANAL, V33, P50, DOI 10.1111/j.1539-6924.2012.01941.x; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; SLOVIC P, 1991, CAN J PUBLIC HEALTH, V82, pS15; Starfinger Uwe, 2003, Biological Invasions, V5, P323, DOI 10.1023/B:BINV.0000005573.14800.07; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Vanderhoeven S, 2011, ENVIRON MANAGE, V47, P425, DOI 10.1007/s00267-011-9621-8; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Wang M, 2011, J BEHAV FINANC, V12, P9, DOI 10.1080/15427560.2011.548760; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	53	22	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102121	10.1371/journal.pone.0102121	http://dx.doi.org/10.1371/journal.pone.0102121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003195	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700111
J	Nie, DC; Zhang, ZK; Zhou, JL; Fu, Y; Zhang, K				Nie, Da-Cheng; Zhang, Zi-Ke; Zhou, Jun-Lin; Fu, Yan; Zhang, Kui			Information Filtering on Coupled Social Networks	PLOS ONE			English	Article							OF-THE-ART; RECOMMENDER SYSTEMS; RANDOM-WALK; ALGORITHM	In this paper, based on the coupled social networks (CSN), we propose a hybrid algorithm to nonlinearly integrate both social and behavior information of online users. Filtering algorithm, based on the coupled social networks, considers the effects of both social similarity and personalized preference. Experimental results based on two real datasets, Epinions and Friendfeed, show that the hybrid pattern can not only provide more accurate recommendations, but also enlarge the recommendation coverage while adopting global metric. Further empirical analyses demonstrate that the mutual reinforcement and rich-club phenomenon can also be found in coupled social networks where the identical individuals occupy the core position of the online system. This work may shed some light on the in-depth understanding of the structure and function of coupled social networks.	[Nie, Da-Cheng; Zhou, Jun-Lin; Fu, Yan] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhang, Zi-Ke; Zhang, Kui] Chongqing Univ, Coll Commun Engn, Chongqing 630044, Peoples R China; [Zhang, Zi-Ke] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zi-Ke] Alibaba Res Inst, Hangzhou, Zhejiang, Peoples R China	University of Electronic Science & Technology of China; Chongqing University; Hangzhou Normal University; Alibaba Group	Zhang, ZK (corresponding author), Chongqing Univ, Coll Commun Engn, Chongqing 630044, Peoples R China.	zhangzike@gmail.com			NSFC [11105024, 61103109, 1147015, 11301490, 11305043]; Zhejiang Talents Project [QJC1302001]; Zhejiang Provincial Natural Science Foundation of China [LY14A050001]; EU [611272]	NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Talents Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); EU(European Commission)	NSFC: 11105024, 61103109, 1147015, 11301490 and 11305043; Zhejiang Talents Project: QJC1302001, Zhejiang Provincial Natural Science Foundation of China (No. LY14A050001), EU FP7 Project: 611272 (GROWTHCOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman A., 2000, P 33 INT C SYST SCI, P4, DOI DOI 10.1109/HICCS.2000.926814; Abu-Mostafa Y., 2012, LEARNING DATA; Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Anderberg M. R., 1973, CLUSTER ANAL APPL; [Anonymous], 2006, P ECAI WORKSHOP RECO; Bhuiyan Touhid, 2010, Journal of Emerging Technologies in Web Intelligence, V2, P291, DOI 10.4304/jetwi.2.4.291-299; Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P2, DOI 10.1111/j.1471-1842.2007.00701.x; Breese J., 1998, P 14 C UNC ART INT M, P43; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564; Celli F, 2010, LECT NOTES COMPUT SC, V6007, P346, DOI 10.1007/978-3-642-12079-4_43; Chen G, 2012, ARXIV12052822; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; De Domenico M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041022; Esslimani I, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING, P143, DOI 10.1109/ASONAM.2009.30; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Froomkin AM, 1995, J LAW COMMERCE, V15, P395; Fu F, 2008, PHYSICA A, V387, P675, DOI 10.1016/j.physa.2007.10.006; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Givoni M, 2006, TRANSPORT POLICY, V13, P386, DOI 10.1016/j.tranpol.2006.02.001; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Huang Z, 2004, ACM T INFORM SYST, V22, P116, DOI 10.1145/963770.963775; Josang A., 1998, P 21 NIST NCSC NAT I, P16; Kautz H, 1997, COMMUN ACM, V40, P63, DOI 10.1145/245108.245123; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krestel R., 2009, ACM C RECOMMENDER SY, P61, DOI [10.1145/1639714.1639726, DOI 10.1145/1639714.1639726]; Kumar R, 1998, ANN IEEE SYMP FOUND, P664, DOI 10.1109/SFCS.1998.743517; Lee D, 2008, P SIGIR 2008 WORKSH, P7; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu CJ, 2014, PATTERN RECOGN, V47, P359, DOI 10.1016/j.patcog.2013.06.023; Liu JG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016118; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091070; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Massa P, 2004, LECT NOTES COMPUT SC, V3290, P492, DOI 10.1007/978-3-540-30468-5_31; Massa P, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P17; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mild A, 2002, J RETAIL CONSUM SERV, V10, P123; Morita M., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P272; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Resnick P, 1997, COMMUN ACM, V40, P56, DOI 10.1145/245108.245121; RESNICK P, 1994, 1994 ACM C COMPUTER, P175, DOI [DOI 10.1145/192844.192905, 10.1145/192844.192905]; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI DOI 10.1145/371920.372071; Sarwar B, 2000, ACM WEBKDD 2000 WEB; Shang MS, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/68008; Sun D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.017101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tong HH, 2006, IEEE DATA MINING, P613; Walter FE, 2008, AUTON AGENT MULTI-AG, V16, P57, DOI 10.1007/s10458-007-9021-x; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; Yu AW, 2014, PROC VLDB ENDOW, V7, P401, DOI 10.14778/2732269.2732276; Zeng A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/58002; Zeng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079354; Zeng W, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40258-1; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhang ZK, 2010, PHYSICA A, V389, P179, DOI 10.1016/j.physa.2009.08.036; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2010, P NATL ACAD SCI USA, V107, P4511, DOI 10.1073/pnas.1000488107; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008; Ziegler CN, 2013, SOCIALWEB ARTIFACTS, P11	75	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101675	10.1371/journal.pone.0101675	http://dx.doi.org/10.1371/journal.pone.0101675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003525	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700051
J	Wensing, M; Huntink, E; van Lieshout, J; Godycki-Cwirko, M; Kowalczyk, A; Jager, C; Steinhauser, J; Aakhus, E; Flottorp, S; Eccles, M; Baker, R				Wensing, Michel; Huntink, Elke; van Lieshout, Jan; Godycki-Cwirko, Maciek; Kowalczyk, Anna; Jager, Cornelia; Steinhauser, Jost; Aakhus, Eivind; Flottorp, Signe; Eccles, Martin; Baker, Richard			Tailored Implementation of Evidence-Based Practice for Patients with Chronic Diseases	PLOS ONE			English	Article							HEALTH-CARE; INTERVENTIONS; BEHAVIOR; IMPROVEMENTS; INNOVATIONS; CHECKLIST; QUALITY	Background: When designing interventions and policies to implement evidence based healthcare, tailoring strategies to the targeted individuals and organizations has been recommended. We aimed to gather insights into the ideas of a variety of people for implementing evidence-based practice for patients with chronic diseases, which were generated in five European countries. Methods: A qualitative study in five countries (Germany, Netherlands, Norway, Poland, United Kingdom) was done, involving overall 115 individuals. A purposeful sample of four categories of stakeholders (healthcare professionals, quality improvement officers, healthcare purchasers and authorities, and health researchers) was involved in group interviews in each of the countries to generate items for improving healthcare in different chronic conditions per country: chronic obstructive pulmonary disease, cardiovascular disease, depression in elderly people, multi-morbidity, obesity. A disease-specific standardized list of determinants of practice in these conditions provided the starting point for these groups. The content of the suggested items was categorized in a pre-defined framework of 7 domains and specific themes in the items were identified within each domain. Results: The 115 individuals involved in the study generated 812 items, of which 586 addressed determinants of practice. These largely mapped onto three domains: individual health professional factors, patient factors, and professional interactions. Few items addressed guideline factors, incentives and resources, capacity of organizational change, or social, political and legal factors. The relative numbers of items in the different domains were largely similar across stakeholder categories within each of the countries. The analysis identified 29 specific themes in the suggested items across countries. Conclusion: The type of suggestions for improving healthcare practice was largely similar across different stakeholder groups, mainly addressing healthcare professionals, patient factors and professional interactions. As this study is one of the first of its kind, it is important that more research is done on tailored implementation strategies.	[Wensing, Michel; Huntink, Elke; van Lieshout, Jan] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Godycki-Cwirko, Maciek; Kowalczyk, Anna] Med Univ Lodz, Lodz, Poland; [Jager, Cornelia; Steinhauser, Jost] Univ Heidelberg Hosp, Heidelberg, Germany; [Aakhus, Eivind; Flottorp, Signe] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Eccles, Martin] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Baker, Richard] Univ Leicester, Leicester, Leics, England	Radboud University Nijmegen; Medical University Lodz; Ruprecht Karls University Heidelberg; Norwegian Knowledge Centre for Health Services; Newcastle University - UK; University of Leicester	Wensing, M (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands.	Michel.Wensing@radboudumc.nl	Loskamp-Huntink, Elke/F-3120-2016; Van Lieshout, J./L-4490-2015; Eccles, Martin P/AAD-4029-2020; Wensing, Michel/H-8113-2014; Aakhus, Eivind/AGO-7668-2022	Wensing, Michel/0000-0001-6569-8137; Godycki-Cwirko, Maciej/0000-0002-9204-5518; Flottorp, Signe/0000-0003-2961-7461; Kowalczyk, Anna/0000-0002-7524-2085	European Union [258837]; Netherlands Organization for Health Research (ZonMW) [200310011]; National Institute for Health Research [NF-SI-0510-10025] Funding Source: researchfish	European Union(European Commission); Netherlands Organization for Health Research (ZonMW)(Netherlands Organization for Health Research and Development); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 258837. The Netherlands Organization for Health Research (ZonMW) provided additional funding under grant 200310011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Bosch M, 2009, MED CARE RES REV, V66, p5S, DOI 10.1177/1077558709343295; Cheetham G., 2001, J EUR IND TRAIN, V25, P247, DOI DOI 10.1108/03090590110395870; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Harden RM, 2000, MED TEACH, V22, P334; Ludt S, 2012, EUR J PREV CARD 0921; May C, 2013, SOC SCI MED, V78, P26, DOI 10.1016/j.socscimed.2012.11.021; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Noordman J, 2012, PATIENT EDUC COUNS, V89, P227, DOI 10.1016/j.pec.2012.07.006; Schuster MA, 2005, MILBANK Q, V83, P843, DOI 10.1111/j.1468-0009.2005.00403.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Treweek S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-16; Weiner BJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-67; Wensing M, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-2; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-103; Wensing M, 2010, CAN MED ASSOC J, V182, pE85, DOI 10.1503/cmaj.081233; World Health Organization, 2011, NONCOMMUNICABLE DIS	25	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101981	10.1371/journal.pone.0101981	http://dx.doi.org/10.1371/journal.pone.0101981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003371	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700095
J	Aldrin-Kirk, P; Davidsson, M; Holmqvist, S; Li, JY; Bjorklund, T				Aldrin-Kirk, Patrick; Davidsson, Marcus; Holmqvist, Staffan; Li, Jia-Yi; Bjorklund, Tomas			Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; LEWY BODY DISEASE; ADENOASSOCIATED VIRAL VECTORS; PARKINSONS-DISEASE; MOUSE MODEL; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; DOPAMINE RELEASE; SUBSTANTIA-NIGRA; NEURONS	Synucleinopathies, characterized by intracellular aggregation of alpha-synuclein protein, share a number of features in pathology and disease progression. However, the vulnerable cell population differs significantly between the disorders, despite being caused by the same protein. While the vulnerability of dopamine cells in the substantia nigra to alpha-synuclein over-expression, and its link to Parkinson's disease, is well studied, animal models recapitulating the cortical degeneration in dementia with Lewy-bodies (DLB) are much less mature. The aim of this study was to develop a first rat model of widespread progressive synucleinopathy throughout the forebrain using adeno-associated viral (AAV) vector mediated gene delivery. Through bilateral injection of an AAV6 vector expressing human wild-type alpha-synuclein into the forebrain of neonatal rats, we were able to achieve widespread, robust alpha-synuclein expression with preferential expression in the frontal cortex. These animals displayed a progressive emergence of hyper-locomotion and dysregulated response to the dopaminergic agonist apomorphine. The animals receiving the alpha-synuclein vector displayed significant alpha-synuclein pathology including intra-cellular inclusion bodies, axonal pathology and elevated levels of phosphorylated alpha-synuclein, accompanied by significant loss of cortical neurons and a progressive reduction in both cortical and striatal ChAT positive interneurons. Furthermore, we found evidence of alpha-synuclein sequestered by IBA-1 positive microglia, which was coupled with a distinct change in morphology. In areas of most prominent pathology, the total alpha-synuclein levels were increased to, on average, two-fold, which is similar to the levels observed in patients with SNCA gene triplication, associated with cortical Lewy body pathology. This study provides a novel rat model of progressive cortical synucleinopathy, showing for the first time that cholinergic interneurons are vulnerable to alpha-synuclein over-expression. This animal model provides a powerful new tool for studies of neuronal degeneration in conditions of widespread cortical alpha-synuclein pathology, such as DLB, as well an attractive model for the exploration of novel biomarkers.	[Aldrin-Kirk, Patrick; Davidsson, Marcus; Holmqvist, Staffan; Li, Jia-Yi; Bjorklund, Tomas] Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden	Lund University	Bjorklund, T (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Lund, Sweden.	tomas.bjorklund@med.lu.se	Holmqvist, Staffan/AAD-4667-2020; Bjorklund, Tomas/S-7034-2019; Bjorklund, Tomas/F-5117-2013	Holmqvist, Staffan/0000-0001-6709-6666; Bjorklund, Tomas/0000-0001-7968-0034; Bjorklund, Tomas/0000-0001-7968-0034; Li, Jia-Yi/0000-0002-7770-7376; Aldrin-Kirk, Patrick/0000-0001-9163-4882; Davidsson, Marcus/0000-0003-0233-0516	Multipark; Swedish Alzheimer foundation; Swedish Parkinson's foundation; Crafoord foundation; Ahlen foundation; Kock foundation; Thuring foundation; Segerfalk foundation; Royal physiographic foundation	Multipark; Swedish Alzheimer foundation; Swedish Parkinson's foundation; Crafoord foundation; Ahlen foundation; Kock foundation; Thuring foundation; Segerfalk foundation; Royal physiographic foundation	Financial support for this study is provided by the strong research environment Multipark as well as the following foundations: The Swedish Alzheimer foundation, Swedish Parkinson's foundation, Crafoord foundation, Ahlen foundation, Kock foundation, Thuring foundation, Segerfalk foundation and the Royal physiographic foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Ding YM, 2011, P NATL ACAD SCI USA, V108, P840, DOI 10.1073/pnas.1006511108; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Gabery S, 2012, EUR J NEUROSCI, V36, P2789, DOI 10.1111/j.1460-9568.2012.08193.x; Games D, 2013, AM J PATHOL, V182, P940, DOI 10.1016/j.ajpath.2012.11.018; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hall H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064844; Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017; Heidebrink JL, 2002, J GERIATR PSYCH NEUR, V15, P182, DOI 10.1177/089198870201500402; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kornum BR, 2010, EXP NEUROL, V222, P70, DOI 10.1016/j.expneurol.2009.12.009; Kosaka K, 1996, NEUROPATHOLOGY, V16, P32, DOI 10.1111/j.1440-1789.1996.tb00152.x; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lippa CF, 1999, J NEURAL TRANSM, V106, P525, DOI 10.1007/s007020050176; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; PERRY EK, 1985, J NEUROL NEUROSUR PS, V48, P413, DOI 10.1136/jnnp.48.5.413; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Suzuki M, 2002, NEUROLOGY, V58, P1013, DOI 10.1212/WNL.58.7.1013; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; Tiraboschi P, 2000, NEUROLOGY, V54, P407, DOI 10.1212/WNL.54.2.407; Ulusoy A, 2012, NEUROBIOL DIS, V47, P367, DOI 10.1016/j.nbd.2012.05.012; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yu S, 2007, NEUROSCIENCE, V145, P539, DOI 10.1016/j.neuroscience.2006.12.028; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	63	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100869	10.1371/journal.pone.0100869	http://dx.doi.org/10.1371/journal.pone.0100869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999658	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300016
J	Garner, C; Ahn, R; Ding, YC; Steele, L; Stoven, S; Green, PH; Fasano, A; Murray, JA; Neuhausen, SL				Garner, Chad; Ahn, Richard; Ding, Yuan Chun; Steele, Linda; Stoven, Samantha; Green, Peter H.; Fasano, Alessio; Murray, Joseph A.; Neuhausen, Susan L.			Genome-Wide Association Study of Celiac Disease in North America Confirms FRMD4B as New Celiac Locus	PLOS ONE			English	Article							CROHNS-DISEASE; MICROSCOPIC COLITIS; RISK VARIANTS; UNITED-STATES; INFLAMMATION; PREVALENCE; AUTOPHAGY; ANTIGENS; GENES	We performed a genome-wide association study (GWAS) of 1550 North American celiac disease cases and 3084 controls. Twelve SNPs, distributed across four regions (3p21.31, 4q27, 6q15, 6q25), were significantly associated with disease (p-value < 1.0x10(-7)), and a further seven SNPs, across four additional regions (1q24.3, 10p15.1, 6q22.31, 17q21.32) had suggestive evidence (1.0x10(-7) < p-value < 1.0x10(-6)). This study replicated a previous suggestive association within FRMD4B (3p14.1), confirming it as a celiac disease locus. All four regions with significant associations and two regions with suggestive results (1q24.3, 10p15.1) were known disease loci. The 6q22.31 and 10p11.23 regions were not replicated. A total of 410 SNPs distributed across the eight significant and suggestive regions were tested for association with dermatitis herpetiformis and microscopic colitis. Preliminary, suggestive statistical evidence for association with the two traits was found at chromosomes 3p21.31, 6q15, 6q25, 1q24.3 and 10p11.23, with future studies being required to validate the reported associations.	[Garner, Chad; Ahn, Richard] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Ding, Yuan Chun; Steele, Linda; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Green, Peter H.] Columbia Univ, Celiac Dis Ctr, New York, NY USA; [Fasano, Alessio] MassGen Hosp Children, Ctr Celiac Res, Boston, MA USA; [Stoven, Samantha; Murray, Joseph A.] Mayo Clin, Dept Immunol, Div Gastroenterol & Hepatol, Rochester, MN USA	University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Columbia University; Harvard University; Massachusetts General Hospital; Mayo Clinic	Garner, C (corresponding author), Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA.	cgarner@uci.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; Ahn, Richard/0000-0002-9698-2752	National Institutes of Health [DK081645, R01 DK057892]; Center for Celiac Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645, R01DK057892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Celiac Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SN and CG were funded by National Institutes of Health Grant DK081645 (www.nih.gov). JAM was also supported in part by National Institutes of Health Grant R01 DK057892 (www.nih.gov). AF was supported by funds from the Center for Celiac Research (www.celiacdiseasecenter.columbia.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bonciani D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/239691; Brinar M, 2012, J CROHNS COLITIS, V6, P43, DOI 10.1016/j.crohns.2011.06.008; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Dubois PCA, 2010, NAT GENET; FALCHUK ZM, 1972, LANCET, V2, P1310; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fernandez-Banares F, 2005, EUR J GASTROEN HEPAT, V17, P1333, DOI 10.1097/00042737-200512000-00011; Garner C, 2006, HUM HERED, V61, P22, DOI 10.1159/000091833; Garner CP, 2009, HUM MOL GENET; Green PHR, 2009, CLIN GASTROENTEROL H, V7, P1210, DOI 10.1016/j.cgh.2009.07.011; Nguyen HTT, 2013, J INNATE IMMUN, V5, P434, DOI 10.1159/000345129; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Koskela RM, 2008, EUR J GASTROEN HEPAT, V20, P276, DOI 10.1097/MEG.0b013e3282f2468d; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Parmar AS, 2012, GENES IMMUN, V13, P474, DOI 10.1038/gene.2012.21; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; STOKES PL, 1972, LANCET, V2, P162; TOSI R, 1983, CLIN IMMUNOL IMMUNOP, V28, P395, DOI 10.1016/0090-1229(83)90106-X; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x	26	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101428	10.1371/journal.pone.0101428	http://dx.doi.org/10.1371/journal.pone.0101428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999842	Green Published, gold			2022-12-25	WOS:000338637300042
J	Mertl, J; Kirchnawy, C; Osorio, V; Grininger, A; Richter, A; Bergmair, J; Pyerin, M; Washuttl, M; Tacker, M				Mertl, Johannes; Kirchnawy, Christian; Osorio, Veronica; Grininger, Angelika; Richter, Alexander; Bergmair, Johannes; Pyerin, Michael; Washuettl, Michael; Tacker, Manfred			Characterization of Estrogen and Androgen Activity of Food Contact Materials by Different In Vitro Bioassays (YES, YAS, ER alpha and AR CALUX) and Chromatographic Analysis (GC-MS, HPLC-MS)	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; STYRENE OLIGOMERS; CHEMICALS; ASSAYS; PREVALIDATION; OPTIMIZATION; EXPOSURE; SCREEN; CELLS; WATER	Endocrine active substances (EAS) show structural similarities to natural hormones and are suspected to affect the human endocrine system by inducing hormone dependent effects. Recent studies with in vitro tests suggest that EAS can leach from packaging into food and may therefore pose a risk to human health. Sample migrates from food contact materials were tested for estrogen and androgen agonists and antagonists with different commonly used in vitro tests. Additionally, chemical trace analysis by GC-MS and HPLC-MS was used to identify potential hormone active substances in sample migrates. A GC-MS method to screen migrates for 29 known or potential endocrine active substances was established and validated. Samples were migrated according to EC 10/2011, concentrated by solid phase extraction and tested with estrogen and androgen responsive reporter gene assays based on yeast cells (YES and YAS) or human osteoblast cells (ER alpha and AR CALUX). A high level of agreement between the different bioassays could be observed by screening for estrogen agonists. Four out of 18 samples tested showed an estrogen activity in a similar range in both, YES and ER alpha CALUX. Two more samples tested positive in ER alpha CALUX due to the lower limits of detection in this assay. Androgen agonists could not be detected in any of the tested samples, neither with YAS nor with AR CALUX. When testing for antagonists, significant differences between yeast and human cell-based bioassays were noticed. Using YES and YAS many samples showed a strong antagonistic activity which was not observed using human cell-based CALUX assays. By GC-MS, some known or supposed EAS were identified in sample migrates that showed a biological activity in the in vitro tests. However, no firm conclusions about the sources of the observed hormone activity could be obtained from the chemical results.	[Mertl, Johannes; Kirchnawy, Christian; Osorio, Veronica; Grininger, Angelika; Richter, Alexander; Bergmair, Johannes; Pyerin, Michael; Washuettl, Michael; Tacker, Manfred] OFI Austrian Res Inst Chem & Technol, Vienna, Austria		Mertl, J (corresponding author), OFI Austrian Res Inst Chem & Technol, Vienna, Austria.	johannes.mertl@ofi.at; christian.kirchnawy@ofi.at		Bergmair, Johannes/0000-0002-4279-5281	Osterreichische Forschungsforderungsgesellschaft mbH [826796]	Osterreichische Forschungsforderungsgesellschaft mbH	This study was financed by the Osterreichische Forschungsforderungsgesellschaft mbH, in the context of the project "Xeno'' (Project 826796). The funding source was not involved in study design, collection, analysis or interpretation of data. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bohmler G., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P325, DOI 10.1007/s00003-006-0055-9; Bradley E., 2007, INVESTIGATION REACTI; CHONG YK, 1983, J AM CHEM SOC, V105, P7761, DOI 10.1021/ja00364a058; Della Seta D, 2006, HORM BEHAV, V50, P301, DOI 10.1016/j.yhbeh.2006.03.015; European Commission, 1998, FIN REP; Evans R., 2011, STATE ART ASSESSMENT; Gelmann EP, 1996, J NATL CANCER I, V88, P224, DOI 10.1093/jnci/88.5.224; Gray J, 2008, STATE EVIDENCE CONNE; Gray Jr LE, 2004, USE LAB RAT MODEL EN; Hecker Markus, 2011, Environmental Sciences Europe, V23, P15, DOI 10.1186/2190-4715-23-15; Jacobs JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082573; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kanako S, 2007, FOODS FOOD INGREDIEN, V212; Kirchnawy C, 2013, DET IDENTIF IN PRESS; Kitamura S, 2003, ENVIRON HEALTH PERSP, V111, P329, DOI 10.1289/ehp.5723; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; McGovern V, 2006, ENVIRON HEALTH PERSP, V114, pA368, DOI 10.1289/ehp.114-a368b; Muncke J, 2009, SCI TOTAL ENVIRON, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006; Muncke J, 2011, J STEROID BIOCHEM, V127, P118, DOI 10.1016/j.jsbmb.2010.10.004; OECD, 2002, SER TEST ASS; Ohyama K, 2001, ENVIRON HEALTH PERSP, V109, P699, DOI 10.2307/3454786; Pinto B, 2009, INT J HYG ENVIR HEAL, V212, P228, DOI 10.1016/j.ijheh.2008.06.004; Plotan M, 2013, FOOD CHEM, V136, P1590, DOI 10.1016/j.foodchem.2012.01.115; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Scrimshaw MD, 2004, ANAL BIOANAL CHEM, V378, P576, DOI 10.1007/s00216-003-2227-0; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Sikka SC, 2008, ASIAN J ANDROL, V10, P134, DOI 10.1111/j.1745-7262.2008.00370.x; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Svobodova K, 2010, APPL MICROBIOL BIOT, V88, P839, DOI 10.1007/s00253-010-2833-7; Swiss Federal Office of Public Health, 2011, BULLETIN, V14, P311; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Tollefsen KE, 2008, ECOTOX ENVIRON SAFE, V71, P370, DOI 10.1016/j.ecoenv.2007.10.006; van der Burg B, 2010, REPROD TOXICOL, V30, P18, DOI 10.1016/j.reprotox.2010.04.012; van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; VANDERBURG B, 1988, J CELL PHYSIOL, V134, P101, DOI 10.1002/jcp.1041340112; Wagner M, 2011, UMWELTBUNDESAMT, V84; Wagner M, 2011, J STEROID BIOCHEM, V127, P128, DOI 10.1016/j.jsbmb.2010.10.007; Wagner M, 2009, ENVIRON SCI POLLUT R, V16, P278, DOI 10.1007/s11356-009-0107-7; Yang CZ, 2011, ENVIRON HEALTH PERSP, V119, P989, DOI 10.1289/ehp.1003220; Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808	46	39	41	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100952	10.1371/journal.pone.0100952	http://dx.doi.org/10.1371/journal.pone.0100952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000404	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300021
J	Winter, PS; Bowman, CE; Villani, PJ; Dolan, TE; Hauck, NR				Winter, Peter S.; Bowman, Collin E.; Villani, Philip J.; Dolan, Thomas E.; Hauck, Nathanael R.			Systemic Acquired Resistance in Moss: Further Evidence for Conserved Defense Mechanisms in Plants	PLOS ONE			English	Article							PHYSCOMITRELLA-PATENS; DISEASE RESISTANCE; ARABIDOPSIS; INFECTION; RESPONSES; IMMUNITY	Vascular plants possess multiple mechanisms for defending themselves against pathogens. One well-characterized defense mechanism is systemic acquired resistance (SAR). In SAR, a plant detects the presence of a pathogen and transmits a signal throughout the plant, inducing changes in the expression of various pathogenesis-related (PR) genes. Once SAR is established, the plant is capable of mounting rapid responses to subsequent pathogen attacks. SAR has been characterized in numerous angiosperm and gymnosperm species; however, despite several pieces of evidence suggesting SAR may also exist in non-vascular plants 6-8, its presence in non-vascular plants has not been conclusively demonstrated, in part due to the lack of an appropriate culture system. Here, we describe and use a novel culture system to demonstrate that the moss species Amblystegium serpens does initiate a SAR-like reaction upon inoculation with Pythium irregulare, a common soilborne oomycete. Infection of A. serpens gametophores by P. irregulare is characterized by localized cytoplasmic shrinkage within 34 h and chlorosis and necrosis within 7 d of inoculation. Within 24 h of a primary inoculation (induction), moss gametophores grown in culture became highly resistant to infection following subsequent inoculation (challenge) by the same pathogen. This increased resistance was a response to the pathogen itself and not to physical wounding. Treatment with beta-1,3 glucan, a structural component of oomycete cell walls, was equally effective at triggering SAR. Our results demonstrate, for the first time, that this important defense mechanism exists in a non-vascular plant, and, together with previous studies, suggest that SAR arose prior to the divergence of vascular and non-vascular plants. In addition, this novel moss - pathogen culture system will be valuable for future characterization of the mechanism of SAR in moss, which is necessary for a better understanding of the evolutionary history of SAR in plants.	[Winter, Peter S.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Bowman, Collin E.] Indiana Univ, Sch Med, Muncie, IN USA; [Villani, Philip J.; Dolan, Thomas E.; Hauck, Nathanael R.] Butler Univ, Dept Biol Sci, Indianapolis, IN 46208 USA	Duke University; Indiana University System; Butler University	Hauck, NR (corresponding author), Butler Univ, Dept Biol Sci, Indianapolis, IN 46208 USA.	nhauck@butler.edu			Butler University Holcomb Awards Committee Faculty	Butler University Holcomb Awards Committee Faculty	This work was supported by a Butler University Holcomb Awards Committee Faculty Research Grant to N. Hauck. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Robert A., 2005, Journal of General Plant Pathology, V71, P23, DOI 10.1007/s10327-004-0154-3; Bell P. R., 1992, GREEN PLANTS THEIR O; Conrath U, 2006, PLANT SIGNAL BEHAV, V1, P179, DOI 10.4161/psb.1.4.3221; Cuming AC, 2009, NEW PHYTOL, V183, P237, DOI 10.1111/j.1469-8137.2009.02931.x; de Leon IP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-52; Eklund DM, 2010, J EXP BOT, V61, P1917, DOI 10.1093/jxb/erq080; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; KESSMANN H, 1994, ANNU REV PHYTOPATHOL, V32, P439, DOI 10.1146/annurev.py.32.090194.002255; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Krokene P, 1999, PLANT PHYSIOL, V121, P565, DOI 10.1104/pp.121.2.565; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Lehtonen MT, 2009, NEW PHYTOL, V183, P432, DOI 10.1111/j.1469-8137.2009.02864.x; Liu PP, 2011, PLANT PHYSIOL, V155, P1762, DOI 10.1104/pp.110.171694; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang PH, 2003, LETT APPL MICROBIOL, V37, P127, DOI 10.1046/j.1472-765X.2003.01353.x; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085	27	12	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101880	10.1371/journal.pone.0101880	http://dx.doi.org/10.1371/journal.pone.0101880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000589	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300095
J	Bhinder, B; Shum, D; Li, M; Ibanez, G; Vlassov, AV; Magdaleno, S; Djaballah, H				Bhinder, Bhavneet; Shum, David; Li, Mu; Ibanez, Glorymar; Vlassov, Alexander V.; Magdaleno, Susan; Djaballah, Hakim			Discovery of a Dicer-Independent, Cell-Type Dependent Alternate Targeting Sequence Generator: Implications in Gene Silencing & Pooled RNAi Screens	PLOS ONE			English	Article							MICRORNA BIOGENESIS; SYSTEMATIC ANALYSIS; INTERFERING RNAS; MAMMALIAN-CELLS; REVEALS; PATHWAY; HAIRPIN; SIRNAS; SHRNAS; EXPRESSION	There is an acceptance that plasmid-based delivery of interfering RNA always generates the intended targeting sequences in cells, making it as specific as its synthetic counterpart. However, recent studies have reported on cellular inefficiencies of the former, especially in light of emerging gene discordance at inter-screen level and across formats. Focusing primarily on the TRC plasmid-based shRNA hairpins, we reasoned that alleged specificities were perhaps compromised due to altered processing; resulting in a multitude of random interfering sequences. For this purpose, we opted to study the processing of hairpin TRCN#40273 targeting CTTN; which showed activity in a miRNA-21 gain-of-function shRNA screen, but inactive when used as an siRNA duplex. Using a previously described walk-through method, we identified 36 theoretical cleavage variants resulting in 78 potential siRNA duplexes targeting 53 genes. We synthesized and tested all of them. Surprisingly, six duplexes targeting ASH1L, DROSHA, GNG7, PRKCH, THEM4, and WDR92 scored as active. QRT-PCR analysis on hairpin transduced reporter cells confirmed knockdown of all six genes, besides CTTN; revealing a surprising 7 gene-signature perturbation by this one single hairpin. We expanded our qRT-PCR studies to 26 additional cell lines and observed unique knockdown profiles associated with each cell line tested; even for those lacking functional DICER1 gene suggesting no obvious dependence on dicer for shRNA hairpin processing; contrary to published models. Taken together, we report on a novel dicer independent, cell-type dependent mechanism for non-specific RNAi gene silencing we coin Alternate Targeting Sequence Generator (ATSG). In summary, ATSG adds another dimension to the already complex interpretation of RNAi screening data, and provides for the first time strong evidence in support of arrayed screening, and questions the scientific merits of performing pooled RNAi screens, where deconvolution of up to genome-scale pools is indispensable for target identification.	[Bhinder, Bhavneet; Shum, David; Ibanez, Glorymar; Djaballah, Hakim] Mem Sloan Kettering Canc Ctr, HTS Core Facil, New York, NY 10021 USA; [Li, Mu; Vlassov, Alexander V.; Magdaleno, Susan] Thermo Fisher Sci, Austin, TX USA	Memorial Sloan Kettering Cancer Center; Thermo Fisher Scientific	Djaballah, H (corresponding author), Mem Sloan Kettering Canc Ctr, HTS Core Facil, 1275 York Ave, New York, NY 10021 USA.	djaballh@mskcc.org		Djaballah, Hakim/0000-0002-6039-0181	Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S Wells Foundation; NIH/NCI Cancer Center Support Grant [5 P30 CA008748-44]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S Wells Foundation; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The HTS Core Facility is partially supported by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center, the William Randolph Hearst Fund in Experimental Therapeutics, the Lillian S Wells Foundation and by an NIH/NCI Cancer Center Support Grant 5 P30 CA008748-44. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Bhinder B, 2013, DRUG DISC WORLD, V14, P31; Bhinder B, 2014, COMB CHEM HIGH T SCR, V17, P98, DOI 10.2174/1386207317666140117101852; Bhinder B, 2013, COMB CHEM HIGH T SCR, V16, P665; Bhinder B, 2013, ASSAY DRUG DEV TECHN, V11, P173, DOI 10.1089/adt.2012.475; Bhinder B, 2012, COMB CHEM HIGH T SCR, V15, P686, DOI 10.2174/138620712803519671; Blainey PC, 2014, NAT METHODS, V11, P19, DOI 10.1038/nmeth.2783; Boettcher M, 2010, CURR GENOMICS, V11, P162, DOI 10.2174/138920210791110988; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chu C, 2014, PESTIC BIOC IN PRESS; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Demir Kubilay, 2012, Methods Mol Biol, V910, P1, DOI 10.1007/978-1-61779-965-5_1; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Heintze Jacob, 2013, Frontiers in Genetics, V4, P193, DOI 10.3389/fgene.2013.00193; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lavery KS, 2003, CURR OPIN DRUG DI DE, V6, P561; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Maurin T, 2012, RNA, V18, P2166, DOI 10.1261/rna.036194.112; Naik G, 2011, WSJ, VCCLVIII, pA1; Naik G, 2011, WSJ, VCCLVIII, pA16; Naito Yuki, 2013, Methods Mol Biol, V942, P57, DOI 10.1007/978-1-62703-119-6_3; Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Ramji K, 2013, MOL BIOL REP, V40, P6977, DOI 10.1007/s11033-013-2817-7; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Sachse C, 2004, ONCOGENE, V23, P8384, DOI 10.1038/sj.onc.1208072; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Shum D, 2013, COMB CHEM HIGH T SCR, V16, P791, DOI 10.2174/1386207311301010004; Shum D, 2013, ASSAY DRUG DEV TECHN, V11, P191, DOI 10.1089/adt.2012.477; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Snove O, 2004, BIOCHEM BIOPH RES CO, V319, P256, DOI 10.1016/j.bbrc.2004.04.175; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Wang XW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp864; Zumbansen Markus, 2009, J RNAi Gene Silencing, V6, P354	44	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100676	10.1371/journal.pone.0100676	http://dx.doi.org/10.1371/journal.pone.0100676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987961	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100037
J	Sharma, VK; Das, SK; Dhar, P; Hota, KB; Mahapatra, BB; Vashishtha, V; Kumar, A; Hota, SK; Norboo, T; Srivastava, RB				Sharma, Vijay K.; Das, Saroj K.; Dhar, Priyanka; Hota, Kalpana B.; Mahapatra, Bidhu B.; Vashishtha, Vivek; Kumar, Ashish; Hota, Sunil K.; Norboo, Tsering; Srivastava, Ravi B.			Domain Specific Changes in Cognition at High Altitude and Its Correlation with Hyperhomocysteinemia	PLOS ONE			English	Article							HYPOBARIC HYPOXIA; TOTAL HOMOCYSTEINE; IMPAIRMENT; PERFORMANCE; FOLATE; MEMORY	Though acute exposure to hypobaric hypoxia is reported to impair cognitive performance, the effects of prolonged exposure on different cognitive domains have been less studied. The present study aimed at investigating the time dependent changes in cognitive performance on prolonged stay at high altitude and its correlation with electroencephalogram (EEG) and plasma homocysteine. The study was conducted on 761 male volunteers of 25-35 years age who had never been to high altitude and baseline data pertaining to domain specific cognitive performance, EEG and homocysteine was acquired at altitude <= 240 m mean sea level (MSL). The volunteers were inducted to an altitude of 4200-4600 m MSL and longitudinal follow-ups were conducted at durations of 03, 12 and 18 months. Neuropsychological assessment was performed for mild cognitive impairment (MCI), attention, information processing rate, visuo-spatial cognition and executive functioning. Total homocysteine (tHcy), vitamin B-12 and folic acid were estimated. Mini Mental State Examination (MMSE) showed temporal increase in the percentage prevalence of MCI from 8.17% on 03 months of stay at high altitude to 18.54% on 18 months of stay. Impairment in visuo-spatial executive, attention, delayed recall and procedural memory related cognitive domains were detected following prolonged stay in high altitude. Increase in alpha wave amplitude in the T3, T4 and C3 regions was observed during the follow-ups which was inversely correlated (r = -0.68) to MMSE scores. The tHcy increased proportionately with duration of stay at high altitude and was correlated with MCI. No change in vitamin B-12 and folic acid was observed. Our findings suggest that cognitive impairment is progressively associated with duration of stay at high altitude and is correlated with elevated tHcy in the plasma. Moreover, progressive MCI at high altitude occurs despite acclimatization and is independent of vitamin B-12 and folic acid.	[Sharma, Vijay K.; Das, Saroj K.; Dhar, Priyanka; Hota, Kalpana B.; Vashishtha, Vivek; Kumar, Ashish; Hota, Sunil K.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, India; [Mahapatra, Bidhu B.] Populat Council, Dept Stat, New Delhi, India; [Norboo, Tsering] Ladakh Inst Prevent, Dambuchan, Leh Ladakh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR)	Hota, SK (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, 56 APO, Leh Ladakh, India.	drsunilhota@hotmail.com	Mahapatra, Bidhubhusan/M-1411-2019; Das, Saroj Kumar/W-5452-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Das, Saroj Kumar/0000-0002-5717-5333; Sharma, Vijay Kumar/0000-0002-9327-0397; Srivastava, Rakesh/0000-0003-3112-4252; Srivastava, Rakesh/0000-0002-0065-4069	DRDO	DRDO(Defence Research & Development Organisation (DRDO))	Financial support for the study was provided by DRDO. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 1998, PFLUG ARCH EUR J PHY, V436, P553, DOI 10.1007/s004240050671; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bender L., 1938, AM ORTHOPSYCHIATRIC, V3; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Curro M, 2014, NEUROCHEM R IN PRESS; Fayed N., 2006, AM J MED, V119, p168., DOI [10.1016/j.amjmed.2005.07.062, DOI 10.1016/J.AMJMED.2005.07.062]; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hota SK, 2012, INDIAN J MED RES, V136, P411; Karakas Hakki Muammer, 2006, Diagn Interv Radiol, V12, P9; Kinoshita M, 2013, EPIGENETICS-US, V8, P584, DOI 10.4161/epi.24621; Kloppenborg RP, 2011, ATHEROSCLEROSIS, V216, P461, DOI 10.1016/j.atherosclerosis.2011.02.027; Leifflen D, 1997, AVIAT SPACE ENVIR MD, V68, P993; Lezak M.D, 1995, NEUROPSYCHOLOGICAL A; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MARGOLIS RB, 1989, J PSYCHOL, V123, P179, DOI 10.1080/00223980.1989.10542974; Miller A. L., 1997, ALTERN MED REV, V2, P234; Morris MS, 2012, ADV NUTR, V3, P801, DOI 10.3945/an.112.002535; Obeid R, 2007, CLIN CHEM LAB MED, V45, P1590, DOI 10.1515/CCLM.2007.356; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; Peng QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079346; Raven JC, 1992, MANUAL RAVENS STANDA; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SHUKITTHALE B, 1994, BEHAV NEURAL BIOL, V62, P244, DOI 10.1016/S0163-1047(05)80023-8; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Singh S B, 2003, Indian J Physiol Pharmacol, V47, P52; Singh SB, 2004, INDIAN J MED RES, V120, P94; Siuda J, 2009, NEUROL NEUROCHIR POL, V43, P321; Skaiaa SC, 2006, WILD ENVIRON MED, V17, P132, DOI 10.1580/PR19-04.1; Sudduth TL, 2013, J CEREBR BLOOD F MET, V33, P708, DOI 10.1038/jcbfm.2013.1; Tu Min-Chien, 2010, Acta Neurol Taiwan, V19, P168; Vidal JS, 2008, NEUROEPIDEMIOLOGY, V30, P207, DOI 10.1159/000126914; WEST JB, 1986, FASEB J, V45, P2953; Wheatley K, 2011, J ROY ARMY MED CORPS, V157, P38, DOI 10.1136/jramc-157-01-07; World Health Organization Switzerland, 2008, WHO STEPS SURV; Wright CB, 2004, NEUROLOGY, V63, P254, DOI 10.1212/01.WNL.0000129986.19019.5D; Yelmen N, 2011, GEN PHYSIOL BIOPHYS, V30, P389, DOI 10.4149/gpb_2011_04_389; Zhang JX, 2011, HIGH ALT MED BIOL, V12, P37, DOI 10.1089/ham.2009.1085	42	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101448	10.1371/journal.pone.0101448	http://dx.doi.org/10.1371/journal.pone.0101448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988417	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100089
J	Dee, DR; Horimoto, Y; Yada, RY				Dee, Derek R.; Horimoto, Yasumi; Yada, Rickey Y.			Conserved Prosegment Residues Stabilize a Late-Stage Folding Transition State of Pepsin Independently of Ground States	PLOS ONE			English	Article							ALPHA-LYTIC PROTEASE; FYN SH3 DOMAIN; NONNATIVE INTERACTIONS; NATIVE-STATE; MULTIDOMAIN PROTEINS; KINETIC STABILITY; PHI-VALUES; ENERGY LANDSCAPES; HYDROPHOBIC CORE; CONTACT ORDER	The native folding of certain zymogen-derived enzymes is completely dependent upon a prosegment domain to stabilize the folding transition state, thereby catalyzing the folding reaction. Generally little is known about how the prosegment accomplishes this task. It was previously shown that the prosegment catalyzes a late-stage folding transition between a stable misfolded state and the native state of pepsin. In this study, the contributions of specific prosegment residues to catalyzing pepsin folding were investigated by introducing individual Ala substitutions and measuring the effects on the bimolecular folding reaction between the prosegment peptide and pepsin. The effects of mutations on the free energies of the individual misfolded and native ground states and the transition state were compared using measurements of prosegment-pepsin binding and folding kinetics. Five out of the seven prosegment residues examined yielded relatively large kinetic effects and minimal ground state perturbations upon mutation, findings which indicate that these residues form strengthened and/or non-native contacts in the transition state. These five residues are semi-to strictly conserved, while only a non-conserved residue had no kinetic effect. One conserved residue was shown to form native structure in the transition state. These results indicated that the prosegment, which is only 44 residues long, has evolved a high density of contacts that preferentially stabilize the folding transition state over the ground states. It is postulated that the prosegment forms extensive non-native contacts during the process of catalyzing correct inter-and intra-domain contacts during the final stages of folding. These results have implications for understanding the folding of multi-domain proteins and for the evolution of prosegment-catalyzed folding.	[Dee, Derek R.; Yada, Rickey Y.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Horimoto, Yasumi; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Yada, RY (corresponding author), Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Dee, Derek/AAK-5892-2020	Yada, Rickey/0000-0002-8648-2156	National Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Ontario Graduate Scholarship	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the National Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.a?sp) and the Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). DRD was also supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Cunningham EL, 2002, BIOCHEMISTRY-US, V41, P8860, DOI 10.1021/bi020214o; Dee D, 2006, BIOCHEMISTRY-US, V45, P13982, DOI 10.1021/bi061270i; Dee DR, 2011, BIOPHYS J, V101, P1699, DOI 10.1016/j.bpj.2011.08.002; Dee DR, 2010, BIOCHEMISTRY-US, V49, P365, DOI 10.1021/bi9014055; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher KE, 2007, BIOCHEMISTRY-US, V46, P640, DOI 10.1021/bi061600z; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Itoh K, 2008, P NATL ACAD SCI USA, V105, P13865, DOI 10.1073/pnas.0804512105; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jaswal SS, 2005, J MOL BIOL, V347, P355, DOI 10.1016/j.jmb.2005.01.032; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kelch BA, 2012, P NATL ACAD SCI USA, V109, P9414, DOI 10.1073/pnas.1119274109; Li L, 2000, NAT STRUCT BIOL, V7, P336; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Morton VL, 2007, J MOL BIOL, V371, P554, DOI 10.1016/j.jmb.2007.05.010; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765; Parry-Smith DJ, 1997, GENE, V211, pGC45; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2003, P NATL ACAD SCI USA, V100, P4417, DOI 10.1073/pnas.0330720100; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Raleigh DP, 2005, PROTEIN PEPTIDE LETT, V12, P117, DOI 10.2174/0929866053005809; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SERRANO L, 1992, J MOL BIOL, V224, P805, DOI 10.1016/0022-2836(92)90563-Y; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Ventura S, 2002, NAT STRUCT BIOL, V9, P485, DOI 10.1038/nsb799; Wang SL, 2014, J BIOL CHEM, V289, P697, DOI 10.1074/jbc.M113.505891; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD222, DOI 10.1093/nar/gkm800; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Zarrine-Afsar A, 2004, METHODS, V34, P41, DOI 10.1016/j.ymeth.2004.03.013; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105; Zarrine-Afsar A, 2007, J MOL BIOL, V373, P764, DOI 10.1016/j.jmb.2007.07.059; Zarrine-Afsar A, 2012, PROTEINS, V80, P858, DOI 10.1002/prot.23243	61	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101339	10.1371/journal.pone.0101339	http://dx.doi.org/10.1371/journal.pone.0101339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983988	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000090
J	Jiang, B; Song, Y; Wei, S; Liu, JH; McLoughlin, IV; Dai, LR				Jiang, Bing; Song, Yan; Wei, Si; Liu, Jun-Hua; McLoughlin, Ian Vince; Dai, Li-Rong			Deep Bottleneck Features for Spoken Language Identification	PLOS ONE			English	Article							SPEAKER; DIMENSIONALITY; SPEECH; LVCSR	A key problem in spoken language identification (LID) is to design effective representations which are specific to language information. For example, in recent years, representations based on both phonotactic and acoustic features have proven their effectiveness for LID. Although advances in machine learning have led to significant improvements, LID performance is still lacking, especially for short duration speech utterances. With the hypothesis that language information is weak and represented only latently in speech, and is largely dependent on the statistical properties of the speech content, existing representations may be insufficient. Furthermore they may be susceptible to the variations caused by different speakers, specific content of the speech segments, and background noise. To address this, we propose using Deep Bottleneck Features (DBF) for spoken LID, motivated by the success of Deep Neural Networks (DNN) in speech recognition. We show that DBFs can form a low-dimensional compact representation of the original inputs with a powerful descriptive and discriminative capability. To evaluate the effectiveness of this, we design two acoustic models, termed DBF-TV and parallel DBF-TV (PDBF-TV), using a DBF based i-vector representation for each speech utterance. Results on NIST language recognition evaluation 2009 (LRE09) show significant improvements over state-of-the-art systems. By fusing the output of phonotactic and acoustic approaches, we achieve an EER of 1.08%, 1.89% and 7.01% for 30 s, 10 s and 3 s test utterances respectively. Furthermore, various DBF configurations have been extensively evaluated, and an optimal system proposed.	[Jiang, Bing; Song, Yan; McLoughlin, Ian Vince; Dai, Li-Rong] Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Anhui, Peoples R China; [Wei, Si; Liu, Jun-Hua] Anhui USTC iFlytek Co Ltd, iFlytek Res, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Song, Y (corresponding author), Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Anhui, Peoples R China.	songy@ustc.edu.cn	McLoughlin, Ian/AAS-9081-2020; McLoughlin, Ian V/A-3674-2011	McLoughlin, Ian/0000-0001-7111-2008; McLoughlin, Ian V/0000-0001-7111-2008	National Nature Science Foundation of China [61273264]; National 973 program of China [2012CB326405]; Chinese Universities Scientific Fund [Wk2100060008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); Chinese Universities Scientific Fund	This work was partially funded by the National Nature Science Foundation of China (Grant No. 61273264), the National 973 program of China (Grant No. 2012CB326405) and Chinese Universities Scientific Fund (Grant No. Wk2100060008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YB, 2012, INT CONF SIGN PROCES, P562, DOI 10.1109/ICoSP.2012.6491550; Bielefeld B., 1994, P 14 ANN SPEECH RES; Burget L, 2006, INT CONF ACOUST SPEE, P209; Campbell WM, 2007, INT CONF ACOUST SPEE, P989; Campbell WM, 2006, COMPUT SPEECH LANG, V20, P210, DOI 10.1016/j.csl.2005.06.003; Campbell WM, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL I, PROCEEDINGS, P73; Campbell WM, 2006, P IEEE INT C AC SPEE, V1; Castaldo F., 2007, P ANN C INT SPEECH C, V7, P346; Castaldo F, 2007, IEEE T AUDIO SPEECH, V15, P1969, DOI 10.1109/TASL.2007.901823; Dahl GE, 2012, IEEE T AUDIO SPEECH, V20, P30, DOI 10.1109/TASL.2011.2134090; Dehak N., 2009, THESIS ECOLE TECHNOL; Dehak N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P864; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Diez M, 2013, P ANN C INT SPEECH C; Diez M, 2012, IEEE W SP LANG TECH, P274, DOI 10.1109/SLT.2012.6424235; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Fontaine V., 1997, P EUR C SPEECH COMM; Freund Y., 1994, UNSUPERVISED LEARNIN; Grezl F, 2007, INT CONF ACOUST SPEE, P757; Hazen T. J., 1993, P EUR BERL SEP, V2, P1303; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hubeika V, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P301; Jancik Z, 2010, ODYSSEY 2010: THE SPEAKER AND LANGUAGE RECOGNITION WORKSHOP, P215; Kenny P, 2005, IEEE T SPEECH AUDI P, V13, P345, DOI 10.1109/TSA.2004.840940; Kenny P, 2007, IEEE T AUDIO SPEECH, V15, P1435, DOI 10.1109/TASL.2006.881693; Kirchhoff K, 2002, INT CONF ACOUST SPEE, P761; Kohler MA, 2002, 2002 45TH MIDWEST SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, CONFERENCE PROCEEDINGS, P69; Martin A., 1997, P EUR C SPEECH COMM; Martin AF, 2008, P OD 2008 SPEAK LANG; Martin A, 2010, ODYSSEY 2010: THE SPEAKER AND LANGUAGE RECOGNITION WORKSHOP, P165; Matejka P, 2005, INTERSPEECH, P2237; Matrouf D, 1998, P INT C SPOK LANG PR, V98, P181; Qu Dan, 2003, P ISCA IEEE WORKSH S; Schwarz P, 2000, THESIS BRNO U TECHNO; Seide F., 2011, 2011 IEEE Workshop on Automatic Speech Recognition & Understanding (ASRU), P24, DOI 10.1109/ASRU.2011.6163899; Siniscalchi SM, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P168; Song Y, 2013, ELECTRON LETT, V49, P1569, DOI 10.1049/el.2013.1721; SUGIYAMA M, 1991, INT CONF ACOUST SPEE, P813, DOI 10.1109/ICASSP.1991.150461; Torres-Carrasquillo P.A., 2012, OD 2012 SPEAK LANG R, P209; Torres-Carrasquillo P. A., 2002, P ANN C INT SPEECH C; Torres-Carrasquillo PA, 2010, INT CONF ACOUST SPEE, P4994, DOI 10.1109/ICASSP.2010.5495080; Vair Claudio, 2006, P OD SPEAK LANG REC, P1; Ying Xu, 2010, Proceedings 7th International Symposium on Chinese Spoken Language Processing (ISCSLP 2010), P157, DOI 10.1109/ISCSLP.2010.5684492; Yu D., 2010, P NEUR INF PROC SYST; Zissman MA, 1996, IEEE T SPEECH AUDI P, V4, P31, DOI 10.1109/TSA.1996.481450	48	36	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100795	10.1371/journal.pone.0100795	http://dx.doi.org/10.1371/journal.pone.0100795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983963	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000040
J	Powolny, T; Bretagnolle, V; Aguilar, A; Eraud, C				Powolny, Thibaut; Bretagnolle, Vincent; Aguilar, Astrid; Eraud, Cyril			Sex-Related Differences in the Trade-Off between Foraging and Vigilance in a Granivorous Forager	PLOS ONE			English	Article							13-LINED GROUND-SQUIRRELS; SKYLARKS ALAUDA-ARVENSIS; PREDATION RISK; GROUP-SIZE; ANTIPREDATOR VIGILANCE; FUNCTIONAL-RESPONSE; HABITAT STRUCTURE; FARMLAND BIRDS; STUBBLE FIELDS; SPERMOPHILUS-TRIDECEMLINEATUS	The relationship between intake rate and food density can provide the foundation for models that predict the spatiotemporal distribution of organisms across a range of resource densities. The functional response, describing the relationship between resource density and intake rate is often interpreted mechanistically as the relationships between times spend searching and handling. While several functional response models incorporate anti-predator vigilance (defined here as an interruption of feeding or some other activity to visually scan the environment, directed mainly towards detecting potential predators), the impacts of environmental factors influencing directly anti-predator vigilance remains unclear. We examined the combined effects of different scenarios of predation risk and food density on time allocation between foraging and anti-predator vigilance in a granivorous species. We experimentally exposed Skylarks to various cover heights and seed densities, and measured individual time budget and pecking and intake rates. Our results indicated that time devoted to different activities varied as a function of both seed density and cover height. Foraging time increased with seed density for all cover heights. Conversely, an increased cover height resulted in a decreased foraging time. Contrary to males, the decreased proportion of time spent foraging did not translate into a foraging disadvantage for females. When vegetation height was higher, females maintained similar pecking and intake rates compared to intermediate levels, while males consistently decreased their energy gain. This difference in anti-predator responses suggests a sexually mediated strategy in the food-safety trade-off: when resource density is high a females would adopt a camouflage strategy while an escape strategy would be adopted by males. In other words, males would leave risky-areas, whereas females would stay when resource density is high. Our results suggest that increased predation risk might generate sexually mediated behavioural responses that functional response models should perhaps better consider in the future.	[Powolny, Thibaut; Eraud, Cyril] Off Natl Chasse & Faune Sauvage, Villiers En Bois, France; [Powolny, Thibaut; Bretagnolle, Vincent; Aguilar, Astrid] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Powolny, T (corresponding author), Off Natl Chasse & Faune Sauvage, Villiers En Bois, France.	thibaut.powolny@yahoo.fr			French Agence Nationale de la Recherche; Office National de la Chasse et de la Faune Sauvage	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Office National de la Chasse et de la Faune Sauvage	Funding was provided by the French Agence Nationale de la Recherche to V.B. and PhD grant from the Office National de la Chasse et de la Faune Sauvage to T.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenz CL, 1997, ETHOLOGY, V103, P945; Arenz CL, 1997, BEHAVIOUR, V134, P1101, DOI 10.1163/156853997X00421; Arenz CL, 2000, ANIM BEHAV, V59, P535, DOI 10.1006/anbe.1999.1345; Baker DJ, 2010, FUNCT ECOL, V24, P1281, DOI 10.1111/j.1365-2435.2010.01735.x; Baker DJ, 2009, IBIS, V151, P547, DOI 10.1111/j.1474-919X.2009.00941.x; Beauchamp G, 2009, ANIM BEHAV, V78, P223, DOI 10.1016/j.anbehav.2009.04.029; Bednekoff PA, 2005, ANIM BEHAV, V69, P1165, DOI 10.1016/j.anbehav.2004.07.020; Berger J, 1999, P ROY SOC B-BIOL SCI, V266, P2261, DOI 10.1098/rspb.1999.0917; Boukal DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002687; BRABRAND A, 1993, OECOLOGIA, V95, P38, DOI 10.1007/BF00649504; Breitwisch R, 1988, AUK, V106, P150; Burger Joanna, 2000, Acta Ethologica, V2, P97, DOI 10.1007/s102119900013; Butler SJ, 2005, J APPL ECOL, V42, P469, DOI 10.1111/j.1365-2664.2005.01027.x; Butler SJ, 2005, ANIM BEHAV, V69, P337, DOI 10.1016/j.anbehav.2004.06.006; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chamberlain DE, 1999, IBIS, V141, P38, DOI 10.1111/j.1474-919X.1999.tb04261.x; Cramp S., 1988, BIRDS W PALEARCTIC; Crawley M.J., 1993, GLIM ECOLOGISTS; CRESSWELL W, 1994, J ANIM ECOL, V63, P589, DOI 10.2307/5225; CRESSWELL W, 1994, ANIM BEHAV, V47, P433, DOI 10.1006/anbe.1994.1057; Cresswell W, 2003, P ROY SOC B-BIOL SCI, V270, P1069, DOI 10.1098/rspb.2003.2353; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; EKMAN J, 1987, ANIM BEHAV, V35, P445, DOI 10.1016/S0003-3472(87)80269-5; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Eraud C, 2006, BIRD STUDY, V53, P319, DOI 10.1080/00063650609461448; Fernandez G, 2010, J ORNITHOL, V151, P665, DOI 10.1007/s10336-010-0507-y; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; Fernandez-Juricic E, 2008, ETHOLOGY, V114, P105, DOI 10.1111/j.1439-0310.2007.01433.x; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Frid A, 1997, ANIM BEHAV, V53, P799, DOI 10.1006/anbe.1996.0345; Ginnett TF, 1997, OECOLOGIA, V110, P291, DOI 10.1007/s004420050162; Griesser M, 2009, BEHAV ECOL, V20, P709, DOI 10.1093/beheco/arp045; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Krause J, 2002, LIVING GROUPS; Lazarus Symond M, 1992, ANIM BEHAV, V43, P519; LIMA S. L., 1990, INTERPRETATION EXPLA, V2, P246; LIMA SL, 1987, J THEOR BIOL, V124, P303, DOI 10.1016/S0022-5193(87)80118-2; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; MCNAMARA JM, 1990, EVOL ECOL, V4, P298, DOI 10.1007/BF02270929; Meldrum GE, 2009, ANIM BEHAV, V77, P919, DOI 10.1016/j.anbehav.2008.12.023; METCALFE NB, 1984, ANIM BEHAV, V32, P981, DOI 10.1016/S0003-3472(84)80210-9; Mills GL, 1997, CONSERV BIOL, V11, P1397; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Nystrand M, 2006, BEHAV ECOL, V17, P503, DOI 10.1093/beheco/arj055; Ottoni EB, 1996, BEHAV RES METH INSTR, V28, P472, DOI 10.3758/BF03200529; Powolny T, 2012, J ORNITHOL, V153, P485, DOI 10.1007/s10336-011-0764-4; PRAVOSUDOV VV, 1995, CONDOR, V97, P1064, DOI 10.2307/1369547; Reboreda JC, 1997, ETHOLOGY, V103, P198; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Robinson RA, 1999, ECOGRAPHY, V22, P447, DOI 10.1111/j.1600-0587.1999.tb00581.x; Sharpe PB, 1998, J MAMMAL, V79, P906, DOI 10.2307/1383098; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; Smart SL, 2008, J ANIM ECOL, V77, P687, DOI 10.1111/j.1365-2656.2008.01375.x; Steenbeek R, 1999, BEHAV ECOL SOCIOBIOL, V45, P137, DOI 10.1007/s002650050547; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Whittingham MJ, 2006, J APPL ECOL, V43, P640, DOI 10.1111/j.1365-2664.2006.01186.x; Whittingham MJ, 2002, OECOLOGIA, V130, P637, DOI 10.1007/s00442-001-0850-z; Wilson JD, 1997, J APPL ECOL, V34, P1462, DOI 10.2307/2405262	69	18	18	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101598	10.1371/journal.pone.0101598	http://dx.doi.org/10.1371/journal.pone.0101598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984028	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000121
J	Cole, AJ; de Nys, R; Paul, NA				Cole, Andrew J.; de Nys, Rocky; Paul, Nicholas A.			Removing Constraints on the Biomass Production of Freshwater Macroalgae by Manipulating Water Exchange to Manage Nutrient Flux	PLOS ONE			English	Article							MARINE FISHPOND EFFLUENTS; ULVA-LACTUCA BIOFILTERS; INORGANIC CARBON; CRUDE PROTEIN; ASPARAGOPSIS-ARMATA; MANURE NUTRIENTS; GROWTH-RATE; DRY-MATTER; ALGAE; EUTROPHICATION	Freshwater macroalgae represent a largely overlooked group of phototrophic organisms that could play an important role within an industrial ecology context in both utilising waste nutrients and water and supplying biomass for animal feeds and renewable chemicals and fuels. This study used water from the intensive aquaculture of freshwater fish (Barramundi) to examine how the biomass production rate and protein content of the freshwater macroalga Oedogonium responds to increasing the flux of nutrients and carbon, by either increasing water exchange rates or through the addition of supplementary nitrogen and CO2. Biomass production rates were highest at low flow rates (0.1-1 vol.day(-1)) using raw pond water. The addition of CO2 to cultures increased biomass production rates by between 2 and 25% with this effect strongest at low water exchange rates. Paradoxically, the addition of nitrogen to cultures decreased productivity, especially at low water exchange rates. The optimal culture of Oedogonium occurred at flow rates of between 0.5-1 vol.day(-1), where uptake rates peaked at 1.09 g.m(-2).day(-1) for nitrogen and 0.13 g.m(-2).day(-1) for phosphorous. At these flow rates Oedogonium biomass had uptake efficiencies of 75.2% for nitrogen and 22.1% for phosphorous. In this study a nitrogen flux of 1.45 g.m(-2).day(-1) and a phosphorous flux of 0.6 g.m(-2).day(-1) was the minimum required to maintain the growth of Oedogonium at 16-17 g DW.m(-2).day(-1) and a crude protein content of 25%. A simple model of minimum inputs shows that for every gram of dry weight biomass production (g DW.m(-2).day(-1)), Oedogonium requires 0.09 g.m(-2).day(-1) of nitrogen and 0.04 g.m(-2).day(-1) of phosphorous to maintain growth without nutrient limitation whilst simultaneously maintaining a high-nutrient uptake rate and efficiency. As such the integrated culture of freshwater macroalgae with aquaculture for the purposes of nutrient recovery is a feasible solution for the bioremediation of wastewater and the supply of a protein resource.	[Cole, Andrew J.] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Cole, AJ (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	andrew.cole3@jcu.edu.au	Paul, Nicholas/B-6496-2009; Cole, Andrew/G-5220-2011; de Nys, Rocky/D-6741-2012; cole, andrew J/L-5764-2013	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency (ARENA); Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research project is supported by the Australian Government through the Australian Renewable Energy Agency (ARENA), and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1976, APPL ENVIRON MICROB, V31, P801, DOI 10.1128/AEM.31.6.801-806.1976; Aiking H, 2011, TRENDS FOOD SCI TECH, V22, P112, DOI 10.1016/j.tifs.2010.04.005; Angell AR, 2014, J PHYCOL, V50, P216, DOI 10.1111/jpy.12154; Aye P. A., 2013, Agriculture and Biology Journal of North America, V4, P71, DOI 10.5251/abjna.2013.4.1.71.77; Batajoo KK, 1998, ANIM FEED SCI TECH, V71, P165, DOI 10.1016/S0377-8401(97)00132-6; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Bianchi TS, 2010, SCI TOTAL ENVIRON, V408, P1471, DOI 10.1016/j.scitotenv.2009.11.047; Biller P, 2011, BIORESOURCE TECHNOL, V102, P215, DOI 10.1016/j.biortech.2010.06.028; Boland M. J., 2012, TRENDS FOOD SCI TECH; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; Bouwman L., 2011, P NATL ACAD SCI US; COHEN I, 1991, BOT MAR, V34, P475, DOI 10.1515/botm.1991.34.6.475; Cole AJ, 2014, GCB BIOENERGY, V6, P637, DOI 10.1111/gcbb.12097; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Craggs RJ, 1996, ECOL ENG, V6, P149, DOI 10.1016/0925-8574(95)00056-9; Craggs R, 2012, J APPL PHYCOL, V24, P329, DOI 10.1007/s10811-012-9810-8; Craigie JS, 2011, J APPL PHYCOL, V23, P371, DOI 10.1007/s10811-010-9560-4; Demetropoulos CL, 2004, AQUACULTURE, V235, P457, DOI 10.1016/j.aquaculture.2003.09.011; Dierick N, 2010, LIVEST SCI, V133, P154, DOI 10.1016/j.livsci.2010.06.051; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; FROSCH RA, 1992, P NATL ACAD SCI USA, V89, P800, DOI 10.1073/pnas.89.3.800; Gardiner GE, 2008, ANIM FEED SCI TECH, V141, P259, DOI 10.1016/j.anifeedsci.2007.06.011; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Grieshop CM, 2001, J AGR FOOD CHEM, V49, P2669, DOI 10.1021/jf0014009; HERRERASALDANA RE, 1990, J DAIRY SCI, V73, P2386, DOI 10.3168/jds.S0022-0302(90)78922-9; HILLMAN WS, 1978, AM SCI, V66, P442; Israel A, 1999, J APPL PHYCOL, V11, P447, DOI 10.1023/A:1008122306268; Kebede-Westhead E, 2003, J PHYCOL, V39, P1275, DOI 10.1111/j.0022-3646.2003.02-159.x; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; Korner S, 2001, AQUAT BOT, V71, P71, DOI 10.1016/S0304-3770(01)00158-9; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064168; Lewis E., 1998, PROGRAM DEV CO2 SYST; Liu DY, 2009, MAR POLLUT BULL, V58, P888, DOI 10.1016/j.marpolbul.2009.01.013; Liu SM, 2005, PROG OCEANOGR, V66, P66, DOI 10.1016/j.pocean.2005.03.009; Lowe E.A., 1995, J CLEAN PROD, V3, P47, DOI DOI 10.1016/0959-6526(95)00045-G; Mata L, 2007, J PHYCOL, V43, P1252, DOI 10.1111/j.1529-8817.2007.00421.x; Mata L, 2012, J PHYCOL, V48, P248, DOI 10.1111/j.1529-8817.2011.01083.x; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; Mendieta-Araica B, 2011, LIVEST SCI, V137, P10, DOI 10.1016/j.livsci.2010.09.021; Michalak I, 2008, J SCI FOOD AGR, V88, P1178, DOI 10.1002/jsfa.3195; MOSSE J, 1983, QUAL PLANT, V32, P225, DOI 10.1007/BF01091188; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Mulbry WW, 2001, J APPL PHYCOL, V13, P301, DOI 10.1023/A:1017545116317; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; NEORI A, 1991, BOT MAR, V34, P483, DOI 10.1515/botm.1991.34.6.483; Neveux N, 2014, BIORESOURCE TECHNOL, V155, P334, DOI 10.1016/j.biortech.2013.12.083; Neveux N, 2015, GCB BIOENERGY, V7, P673, DOI 10.1111/gcbb.12171; Nielsen MM, 2012, J APPL PHYCOL, V24, P449, DOI 10.1007/s10811-011-9767-z; Nzihou A, 2010, J IND ECOL, V14, P196, DOI 10.1111/j.1530-9290.2010.00242.x; O'Doherty JV, 2010, ANIM FEED SCI TECH, V157, P173, DOI 10.1016/j.anifeedsci.2010.03.004; Papadopoulos G, 2002, J DAIRY RES, V69, P357, DOI 10.1017/S0022029902005599; Pizarro C, 2002, J APPL PHYCOL, V14, P469, DOI 10.1023/A:1022338722952; PRICE PB, 1975, J AM OIL CHEM SOC, V52, P490, DOI 10.1007/BF02640738; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schuenhoff A, 2006, AQUACULTURE, V252, P3, DOI 10.1016/j.aquaculture.2005.11.044; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Singh AP, 2004, J DAIRY RES, V71, P66, DOI 10.1017/S0022029903006642; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Webber C. L. III, 1993, Industrial Crops and Products, V2, P27, DOI 10.1016/0926-6690(93)90007-V; Wilkie AC, 2002, BIORESOURCE TECHNOL, V84, P81, DOI 10.1016/S0960-8524(02)00003-2; WRIGLEY TJ, 1990, WATER RES, V24, P83, DOI 10.1016/0043-1354(90)90068-H; YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S; Zhang EL, 2010, J LIMNOL, V69, P235, DOI 10.4081/jlimnol.2010.235	68	33	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101284	10.1371/journal.pone.0101284	http://dx.doi.org/10.1371/journal.pone.0101284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000501	Green Published, gold, Green Accepted			2022-12-25	WOS:000338637300030
J	Di Franco, A; Bulleri, F; Pennetta, A; De Benedetto, G; Clarke, KR; Guidetti, P				Di Franco, Antonio; Bulleri, Fabio; Pennetta, Antonio; De Benedetto, Giuseppe; Clarke, K. Robert; Guidetti, Paolo			Within-Otolith Variability in Chemical Fingerprints: Implications for Sampling Designs and Possible Environmental Interpretation	PLOS ONE			English	Article							MEDITERRANEAN COASTAL FISH; LASER-ABLATION ICPMS; EARLY-LIFE TRAITS; REEF FISH; ELEMENTAL CHEMISTRY; SPATIAL VARIATION; LARVAL RETENTION; MARINE FISH; INNER-EAR; PATTERNS	Largely used as a natural biological tag in studies of dispersal/connectivity of fish, otolith elemental fingerprinting is usually analyzed by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). LA-ICP-MS produces an elemental fingerprint at a discrete time-point in the life of a fish and can generate data on within-otolith variability of that fingerprint. The presence of within-otolith variability has been previously acknowledged but not incorporated into experimental designs on the presumed, but untested, grounds of both its negligibility compared to among-otolith variability and of spatial autocorrelation among multiple ablations within an otolith. Here, using a hierarchical sampling design of spatial variation at multiple scales in otolith chemical fingerprints for two Mediterranean coastal fishes, we explore: 1) whether multiple ablations within an otolith can be used as independent replicates for significance tests among otoliths, and 2) the implications of incorporating within-otolith variability when assessing spatial variability in otolith chemistry at a hierarchy of spatial scales (different fish, from different sites, at different locations on the Apulian Adriatic coast). We find that multiple ablations along the same daily rings do not necessarily exhibit spatial dependency within the otolith and can be used to estimate residual variability in a hierarchical sampling design. Inclusion of within-otolith measurements reveals that individuals at the same site can show significant variability in elemental uptake. Within-otolith variability examined across the spatial hierarchy identifies differences between the two fish species investigated, and this finding leads to discussion of the potential for within-otolith variability to be used as a marker for fish exposure to stressful conditions. We also demonstrate that a 'cost'-optimal allocation of sampling effort should typically include some level of within-otolith replication in the experimental design. Our findings provide novel evidence to aid the design of future sampling programs and improve our general understanding of the mechanisms regulating elemental fingerprints.	[Di Franco, Antonio; Guidetti, Paolo] Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France; [Di Franco, Antonio; Guidetti, Paolo] Univ Salento, CoNISMa Consorzio Nazl Interuniv Sci Mare, Dipartimento Sci & Tecnol Biol & Ambientali DiSTe, Lab Conservat & Management Marine & Coastal Resou, Lecce, Italy; [Bulleri, Fabio] Univ Pisa, Dept Biol, Pisa, Italy; [Pennetta, Antonio; De Benedetto, Giuseppe] Univ Salento, Dipartimento Beni Culturali, Lab Spettrometria Massa Analit & Isotop, Lecce, Italy; [Clarke, K. Robert] Plymouth Marine Lab, Plymouth, Devon, England	UDICE-French Research Universities; Universite Cote d'Azur; University of Salento; University of Pisa; University of Salento; Plymouth Marine Laboratory	Di Franco, A (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France.	difry@libero.it	De Benedetto, Giuseppe Egidio/G-9470-2012; Clarke, K Robert/A-5934-2012; Di Franco, Antonio/A-8796-2010	De Benedetto, Giuseppe Egidio/0000-0002-0832-5470; Pennetta, Antonio/0000-0002-6760-9393; Bulleri, Fabio/0000-0002-7335-6791; Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	Total Foundation; Italian MIUR [2008E7KBAE]; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Total Foundation(Total SA); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Total Foundation (http://foundation.total.com/foundation/total-foundation-200090.html) and the Italian MIUR (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; CAMPANA SE, 1994, CAN J FISH AQUAT SCI, V51, P1942, DOI 10.1139/f94-196; Chang MY, 2013, FISH FISH, V14, P458, DOI 10.1111/j.1467-2979.2012.00482.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, MAR ECOL PROG SER, V102, P153, DOI 10.3354/meps102153; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Di Franco A, 2013, J SEA RES, V76, P73, DOI 10.1016/j.seares.2012.11.006; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2013, MAR ECOL PROG SER, V476, P227, DOI 10.3354/meps10117; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Fablet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027055; Gagliano M, 2004, MAR ECOL PROG SER, V278, P291, DOI 10.3354/meps278291; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Gillanders BM, 1996, MAR ECOL PROG SER, V141, P13, DOI 10.3354/meps141013; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gray CA, 2009, FISH RES, V96, P58, DOI 10.1016/j.fishres.2008.09.011; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5; Hamer PA, 2003, MAR ECOL PROG SER, V263, P261, DOI 10.3354/meps263261; Hedges KJ, 2004, J FISH BIOL, V64, P923, DOI 10.1111/j.1095-8649.2004.00353.x; Hoover RR, 2013, MAR ECOL PROG SER, V486, P247, DOI 10.3354/meps10328; Jackson JR, 2007, FISHERIES, V32, P321, DOI 10.1577/1548-8446(2007)32[321:ERTADO]2.0.CO;2; Jolivet A, 2008, ANAL BIOANAL CHEM, V392, P551, DOI 10.1007/s00216-008-2273-8; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Limburg KE, 2007, X-RAY SPECTROM, V36, P336, DOI 10.1002/xrs.980; Limburg KE, 2010, ENVIRON BIOL FISH, V89, P427, DOI 10.1007/s10641-010-9660-7; Limburg KE, 2010, CAN J FISH AQUAT SCI, V67, P597, DOI 10.1139/F10-014; MANTEL N, 1967, CANCER RES, V27, P209; Mastronuzzi G, 2003, FIELD GUID PUGL 2003, V5, P184; Mateos C, 2008, ANIM BEHAV, V75, P1629, DOI 10.1016/j.anbehav.2007.10.016; Milton DA, 1998, J FISH BIOL, V53, P785, DOI 10.1006/jfbi.1998.0745; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Papetti C, 2013, ICES J MAR SCI, V70, P387, DOI 10.1093/icesjms/fss201; Patterson HM, 1999, CORAL REEFS, V18, P171, DOI 10.1007/s003380050176; Payan P, 2004, CAN J FISH AQUAT SCI, V61, P1247, DOI 10.1139/F04-059; Payan P, 1999, AM J PHYSIOL-REG I, V277, pR123, DOI 10.1152/ajpregu.1999.277.1.R123; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, P524; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Wu D, 2011, DEV CELL, V20, P271, DOI 10.1016/j.devcel.2010.12.006; Zakharov VM, 1992, ACTA ZOOL FENN, V19, P7	54	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101701	10.1371/journal.pone.0101701	http://dx.doi.org/10.1371/journal.pone.0101701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000202	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300076
J	Fu, XL; Xiao, W; Wang, DL; Chen, M; Tan, QP; Li, L; Chen, XD; Gao, DS				Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng			Roles of Endoplasmic Reticulum Stress and Unfolded Protein Response Associated Genes in Seed Stratification and Bud Endodormancy during Chilling Accumulation in Prunus persica	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TRANSCRIPTION-FACTOR; ARABIDOPSIS-THALIANA; BINDING-PROTEIN; DORMANCY INDUCTION; JAPANESE APRICOT; VEGETATIVE BUDS; BIP; EXPRESSION; RELEASE	Dormancy mechanisms in seeds and buds arrest growth until environmental conditions are optimal for development. A genotype-specific period of chilling is usually required to release dormancy, but the underlying molecular mechanisms are still not fully understood. To discover transcriptional pathways associated with dormancy release common to seed stratification and bud endodormancy, we explored the chilling-dependent expression of 11 genes involved in endoplasmic reticulum stress and the unfolded protein response signal pathways. We propose that endoplasmic reticulum stress and the unfolded protein response impact on seed as well as bud germination and development by chilling-dependent mechanisms. The emerging discovery of similarities between seed stratification and bud endodormancy status indicate that these two processes are probably regulated by common endoplasmic reticulum stress and unfolded protein response signalling pathways. Clarification of regulatory pathways common to both seed and bud dormancy may enhance understanding of the mechanisms underlying dormancy and breeding programs may benefit from earlier prediction of chilling requirements for uniform blooming of novel genotypes of deciduous fruit tree species.	[Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Fu, Xi Ling; Xiao, Wei; Wang, Dong Ling; Chen, Min; Tan, Qiu Ping; Li, Ling; Chen, Xiu De; Gao, Dong Sheng] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University	Gao, DS (corresponding author), Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China.	dsgao@sdau.edu.cn			National Natural Science Foundation of China [31372050]; Agriculture Science Technology Achievement Transformation Fund [2012GB2C600248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Science Technology Achievement Transformation Fund	This work was supported by the National Natural Science Foundation of China (31372050) and the Agriculture Science Technology Achievement Transformation Fund (2012GB2C600248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Anderson JV, 2001, WEED SCI, V49, P581, DOI 10.1614/0043-1745(2001)049[0581:RCROTR]2.0.CO;2; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Humbert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039023; Iwata Y, 2010, PLANT BIOTECHNOL, V27, P161, DOI 10.5511/plantbiotechnology.27.161; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Leida C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035777; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Liu YM, 2012, PLANT CELL, V24, P4635, DOI 10.1105/tpc.112.101535; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MEHLENBACHER SA, 1991, J AM SOC HORTIC SCI, V116, P565, DOI 10.21273/JASHS.116.3.565; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sreekantan L, 2010, PLANT MOL BIOL, V73, P191, DOI 10.1007/s11103-010-9611-x; Srivastava R, 2013, PLANT CELL, V25, P1416, DOI 10.1105/tpc.113.110684; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Zhuang WB, 2013, PLANT BIOLOGY, V15, P233, DOI 10.1111/j.1438-8677.2012.00589.x	41	11	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101808	10.1371/journal.pone.0101808	http://dx.doi.org/10.1371/journal.pone.0101808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999812	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300089
J	Guo, R; Zhang, M; Xi, Y; Ma, YF; Liang, S; Shi, S; Miao, Y; Li, B				Guo, Rui; Zhang, M.; Xi, Yun; Ma, Yufei; Liang, Sheng; Shi, Shuo; Miao, Ying; Li, Biao			Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using Re-188: A Human Glioma Study in Mice	PLOS ONE			English	Article							CONCENTRATOR GENE-THERAPY; MEDIATED TRANSFER; TUMOR-CELLS; TARGETED RADIOTHERAPY; RADIONUCLIDE THERAPY; BREAST-CANCER; LINE; NIS; ESTABLISHMENT; EXPRESSION	Objective: To investigate the role of Re-188 in human sodium iodide symporter (hNIS) theranostic gene-mediated human glioma imaging and therapy in model mice. Methods: The human glioma cell line U87 was transfected with recombinant lentivirus encoding the hNIS gene under the control of cytomegalovirus promoter (U87-hNIS). The uptake and efflux of Re-188 were determined after incubating the cells with 188 Re. Re-188 uptake experiments in the presence of various concentrations of sodium perchlorate were carried out. In vitro cell killing tests with Re-188 were performed. U87-hNIS mediated Re-188 distribution, imaging and therapy in nude mice were also tested. Results: U87-hNIS cell line was successfully established. The uptake of Re-188 in U87-hNIS cells increased up to 26-fold compared to control cells, but was released rapidly with a half-life of approximately 4 minutes. Sodium perchlorate reduced hNIS-mediated Re-188 uptake to levels of control cell lines. U87-hNIS cells were selectively killed following exposure to 188 Re, with a survival of 21.4%, while control cells had a survival of 92.1%. Unlike in vitro studies, U87-hNIS tumor showed a markedly increased Re-188 retention even 48 hours after Re-188 injection. In the therapy study, there was a significant difference in tumor size between U87-hNIS mice (317667 mm 3) and control mice (8616153 mm 3) treated with Re-188 for 4 weeks (P < 0.01). Conclusion: The results indicate that inserting the hNIS gene into U87 cells is sufficient to induce specific Re-188 uptake, which has a cell killing effect both in vitro and in vivo. Moreover, our study, based on the function of hNIS as a theranostic gene allowing noninvasive imaging of hNIS expression by Re-188 scintigraphy, provides detailed characterization of in vivo vector biodistribution and level, localization, essential prerequisites for precise planning and monitoring of clinical gene therapy that aims to individualize gene therapy concept.	[Guo, Rui; Zhang, M.; Xi, Yun; Shi, Shuo; Miao, Ying; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Ma, Yufei; Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn			National Natural Science Foundation of China [81101071, 81271610, 81101066]; Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University [YG2013MS27]; Training Young Teachers in Colleges and Universities in Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University; Training Young Teachers in Colleges and Universities in Shanghai	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81101071, 81271610, and 81101066), http://www.nsfc. gov.cn/publish/portal0/default. htm, the Medical Engineering (Science) Cross Foundation of Shanghai Jiaotong University (YG2013MS27), http://en.sjtu.edu.cn/, the Funding Scheme for Training Young Teachers in Colleges and Universities in Shanghai, http://www. studyshanghai. org/controller. asp?action = index_en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2014, J DRUG TARGET, V22, P295, DOI 10.3109/1061186X.2013.878940; Boland A, 2000, CANCER RES, V60, P3484; Boland A, 2002, THYROID, V12, P19, DOI 10.1089/105072502753451922; Carlin S, 2000, CANCER GENE THER, V7, P1529, DOI 10.1038/sj.cgt.7700264; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Dadachova E, 2002, NUCL MED BIOL, V29, P13, DOI 10.1016/S0969-8051(01)00279-7; Darrouzet E, 2014, BBA-BIOMEMBRANES, V1838, P244, DOI 10.1016/j.bbamem.2013.08.013; Dingli D, 2004, BIOCHEM BIOPH RES CO, V325, P157, DOI 10.1016/j.bbrc.2004.09.219; Dingli D, 2003, BLOOD, V102, P489, DOI 10.1182/blood-2002-11-3390; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Gao XF, 2014, ASIAN J ANDROL, V16, P120, DOI 10.4103/1008-682X.122354; Grunwald GK, 2013, J NUCL MED, V54, P1450, DOI 10.2967/jnumed.112.115493; Guo R, 2011, NUCL MED COMMUN, V32, P402, DOI 10.1097/MNM.0b013e328344a1ad; Guo R, 2011, NUCL MED BIOL, V38, P599, DOI 10.1016/j.nucmedbio.2010.11.005; Guo R, 2010, NUCL MED COMMUN, V31, P916, DOI 10.1097/MNM.0b013e32833dedd7; Kang JH, 2004, J NUCL MED, V45, P1571; Lambert B, 2006, NUCL MED COMMUN, V27, P223, DOI 10.1097/00006231-200603000-00004; Mallick UK, 2004, NUCL MED COMMUN, V25, P873, DOI 10.1097/00006231-200409000-00003; Mandell RB, 1999, CANCER RES, V59, P661; Nakamoto Y, 2000, J NUCL MED, V41, P1898; ODONOGHUE JA, 1995, J NUCL MED, V36, P1902; Prados Michael D., 2000, Seminars in Oncology, V27, P1; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Yin HY, 2010, WORLD J GASTROENTERO, V16, P5367, DOI 10.3748/wjg.v16.i42.5367; Zuckier LS, 2004, J NUCL MED, V45, P500	27	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102011	10.1371/journal.pone.0102011	http://dx.doi.org/10.1371/journal.pone.0102011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000403	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300117
J	Vage, S; Storesund, JE; Giske, J; Thingstad, TF				Vage, Selina; Storesund, Julia E.; Giske, Jarl; Thingstad, T. Frede			Optimal Defense Strategies in an Idealized Microbial Food Web under Trade-Off between Competition and Defense	PLOS ONE			English	Article							COD GADUS-MORHUA; NUTRIENT LIMITATION; RESISTANCE; MODEL; EVOLUTION; DIVERSITY; PREDATION; PATTERNS; SIZE; COMMUNITY	Trophic mechanisms that can generate biodiversity in food webs include bottom-up (growth rate regulating) and top-down (biomass regulating) factors. The top-down control has traditionally been analyzed using the concepts of "Keystone Predation'' (KP) and "Killing-the-Winner'' (KtW), predominately occuring in discussions of macro- and micro-biological ecology, respectively. Here we combine the classical diamond-shaped food web structure frequently discussed in KP analyses and the KtW concept by introducing a defense strategist capable of partial defense. A formalized description of a trade-off between the defense-strategist's competitive and defensive ability is included. The analysis reveals a complex topology of the steady state solution with strong relationships between food web structure and the combination of trade-off, defense strategy and the system's nutrient content. Among the results is a difference in defense strategies corresponding to maximum biomass, production, or net growth rate of invading individuals. The analysis thus summons awareness that biomass or production, parameters typically measured in field studies to infer success of particular biota, are not directly acted upon by natural selection. Under coexistence with a competition specialist, a balance of competitive and defensive ability of the defense strategist was found to be evolutionarily stable, whereas stronger defense was optimal under increased nutrient levels in the absence of the pure competition specialist. The findings of success of different defense strategies are discussed with respect to SAR11, a highly successful bacterial clade in the pelagic ocean.	[Vage, Selina; Storesund, Julia E.; Giske, Jarl; Thingstad, T. Frede] Univ Bergen, Dept Biol, Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway	University of Bergen	Vage, S (corresponding author), Univ Bergen, Dept Biol, Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway.	Selina.Vage@bio.uib.no	Thingstad, Tron Frede/B-2254-2008; Giske, Jarl/A-2402-2010; Våge, Selina/ABE-3106-2020	Thingstad, Tron Frede/0000-0002-5593-819X; Giske, Jarl/0000-0001-5034-8177; Storesund, Julia E./0000-0003-4618-2324	European Research Council [250254]	European Research Council(European Research Council (ERC)European Commission)	The work was financed by the European Research Council through grant 250254 MINOS to T. Frede Thingstad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2002, AM NAT, V160, P692, DOI 10.1086/342822; AKSNES DL, 1993, ECOL MODEL, V67, P233, DOI 10.1016/0304-3800(93)90007-F; Aranguiz-Acuna A, 2011, J PLANKTON RES, V33, P469, DOI 10.1093/plankt/fbq134; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Becker S, 2012, FEMS MICROBIOL ECOL, V80, P488, DOI 10.1111/j.1574-6941.2012.01316.x; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Bowers RG, 2001, J THEOR BIOL, V212, P315, DOI 10.1006/jtbi.2001.2378; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Chisholm S. W., 1992, PRIMARY PRODUCTIVITY; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Erken M, 2011, FEMS MICROBIOL ECOL, V76, P504, DOI 10.1111/j.1574-6941.2011.01067.x; Ersel H, 2004, DEFENCE PEACE ECON, V15, P133, DOI 10.1080/1024269032000110513; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fiksen O, 2011, MAR ECOL PROG SER, V432, P207, DOI 10.3354/meps09148; Fisher R.A., 1930, GENETICAL THEORY NAT; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GISKE J, 1995, J THEOR BIOL, V173, P41, DOI 10.1016/S0022-5193(05)80003-7; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; GROVER JP, 1995, AM NAT, V145, P746, DOI 10.1086/285766; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P4863; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Joint I, 2008, ISME J, V2, P455, DOI 10.1038/ismej.2008.30; Kirchman DL, 2013, NATURE, V494, P320, DOI 10.1038/nature11951; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; KRETZSCHMAR M, 1993, THEOR POPUL BIOL, V44, P32, DOI 10.1006/tpbi.1993.1017; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Loeuille N, 2004, THEOR POPUL BIOL, V65, P285, DOI 10.1016/j.tpb.2003.12.004; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; MCCAULEY E, 1979, LIMNOL OCEANOGR, V24, P243, DOI 10.4319/lo.1979.24.2.0243; Michod RE, 2005, BIOL PHILOS, V20, P967, DOI 10.1007/s10539-005-9018-2; Michod RE, 2006, J THEOR BIOL, V239, P257, DOI 10.1016/j.jtbi.2005.08.043; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PENGERUD B, 1987, MAR ECOL PROG SER, V35, P111, DOI 10.3354/meps035111; Pennisi E, 2013, SCIENCE, V342, P790, DOI 10.1126/science.342.6160.790; Poulin FJ, 2010, J PLANKTON RES, V32, P1121, DOI 10.1093/plankt/fbp145; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; REYNOLDS CS, 1993, HYDROBIOLOGIA, V249, P183, DOI 10.1007/BF00008853; Rivkin RB, 1997, LIMNOL OCEANOGR, V42, P730, DOI 10.4319/lo.1997.42.4.0730; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x; SHERR BF, 1992, APPL ENVIRON MICROB, V58, P2381, DOI 10.1128/AEM.58.8.2381-2385.1992; Siemens DH, 2003, EVOL ECOL, V17, P247, DOI 10.1023/A:1025517229934; Steiner CF, 2003, OIKOS, V101, P569, DOI 10.1034/j.1600-0706.2003.12309.x; SUTHERS IM, 1993, ICES J MAR SCI, V50, P261, DOI 10.1006/jmsc.1993.1028; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1996, ECOLOGY, V77, P2108, DOI 10.2307/2265705; THINGSTAD TF, 1985, MAR ECOL PROG SER, V21, P47, DOI 10.3354/meps021047; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vage S, 2013, NATURE, V499, pE3, DOI 10.1038/nature12387; Vage S, 2013, ENVIRON MICROBIOL, V15, P1842, DOI 10.1111/1462-2920.12077; Van Donk E, 2011, HYDROBIOLOGIA, V668, P3, DOI 10.1007/s10750-010-0395-4; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; Ward BA, 2014, J PLANKTON RES, V36, P31, DOI 10.1093/plankt/fbt097; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921; Zhou YX, 2012, FEMS MICROBIOL ECOL, V81, P230, DOI 10.1111/j.1574-6941.2012.01371.x; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387	80	24	24	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101415	10.1371/journal.pone.0101415	http://dx.doi.org/10.1371/journal.pone.0101415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999739	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300041
J	Jiang, JH; Miyata, M; Chan, C; Ngoh, SY; Liew, WC; Saju, JM; Ng, KS; Wong, FS; Lee, YS; Chang, SF; Orban, L				Jiang, Junhui; Miyata, Masato; Chan, Candy; Ngoh, Si Yan; Liew, Woei Chang; Saju, Jolly M.; Ng, Kah Sing; Wong, Fong Sian; Lee, Yeng Sheng; Chang, Siow Foong; Orban, Laszlo			Differential Transcriptomic Response in the Spleen and Head Kidney Following Vaccination and Infection of Asian Seabass with Streptococcus iniae	PLOS ONE			English	Article							NF-KAPPA-B; TROUT ONCORHYNCHUS-MYKISS; BARRAMUNDI LATES-CALCARIFER; HATCHERY-PRODUCED LARVAE; IMMUNE-RELATED GENES; RAINBOW-TROUT; YERSINIA-RUCKERI; EXPRESSION; INNATE; PATHWAY	Vaccination is an important strategy in the protection of aquaculture species from major diseases. However, we still do not have a good understanding of the mechanisms underlying vaccine-induced disease resistance. This is further complicated by the presence of several lymphoid organs that play different roles when mounting an immune response. In this study, we attempt to elucidate some of these mechanisms using a microarray-based approach. Asian seabass (Lates calcarifer) were vaccinated against Streptococcus iniae and the transcriptomic changes within the spleen and head kidney at one and seven days post-vaccination were profiled. We subsequently challenged the seabass at three weeks post-vaccination with live S. iniae and similarly profiled the transcriptomes of the two organs after the challenge. We found that vaccination induced an early, but transient transcriptomic change in the spleens and a delayed response in the head kidneys, which became more similar to one another compared to un-vaccinated ones. When challenged with the pathogen, the spleen, but not the head kidneys, responded transcriptomically at 25-29 hours post-challenge. A unique set of genes, in particular those involved in the activation of NF-kappa B signaling, was up-regulated in the vaccinated spleens upon pathogen challenge but not in the unvaccinated spleens. A semi-quantitative PCR detection of S. iniae using metagenomic DNA extracted from the water containing the seabass also revealed that vaccination resulted in reduction of pathogen shedding. This result indicated that vaccination not only led to a successful immune defense against the infection, but also reduced the chances for horizontal transmission of the pathogen. In conclusion, we have provided a transcriptomic analysis of how the teleost spleen and head kidneys responded to vaccination and subsequent infection. The different responses from the two organs are suggestive of their unique roles in establishing a vaccine-induced disease resistance.	[Jiang, Junhui; Chan, Candy; Ngoh, Si Yan; Liew, Woei Chang; Saju, Jolly M.; Orban, Laszlo] Natl Univ Singapore, Temasek Life Sci Lab, Reprod Genom Grp, Strateg Res Program, Singapore 117548, Singapore; [Jiang, Junhui] Agrifood & Vet Author Singapore, Singapore, Singapore; [Jiang, Junhui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Miyata, Masato; Ng, Kah Sing; Wong, Fong Sian; Lee, Yeng Sheng; Chang, Siow Foong] MSD Anim Hlth Innovat, Singapore, Singapore; [Ngoh, Si Yan; Liew, Woei Chang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Anim Husb, Keszthely, Hungary; [Orban, Laszlo] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia	National University of Singapore; National University of Singapore; Merck & Company; Intervet International B.V.; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Pannonia; Murdoch University	Chang, SF (corresponding author), MSD Anim Hlth Innovat, Singapore, Singapore.	siow.foong.chang@merck.com; laszlo@tll.org.sg	Orbán, László/A-3030-2009	Orbán, László/0000-0001-5435-5948; Jiang, Junhui/0000-0003-1319-8813; Liew, Woei Chang/0000-0001-9354-1647	National Research Foundation of Singapore [NRF-CRP7-2010-01]; Strategic Research Program of Temasek Life Sciences Laboratory	National Research Foundation of Singapore(National Research Foundation, Singapore); Strategic Research Program of Temasek Life Sciences Laboratory(National University of Singapore)	This study was supported by the National Research Foundation of Singapore under its Competitive Research Programme (award No: NRF-CRP7-2010-01) and the Strategic Research Program of Temasek Life Sciences Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad I.S., 2009, Asian Fisheries Science, V22, P901; Azad IS, 2005, DIS AQUAT ORGAN, V63, P113, DOI 10.3354/dao063113; Berridge BR, 1998, J CLIN MICROBIOL, V36, P2778, DOI 10.1128/JCM.36.9.2778-2781.1998; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Bridle AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040841; Bromage ES, 1999, DIS AQUAT ORGAN, V36, P177, DOI 10.3354/dao036177; Bromage ES, 2002, DIS AQUAT ORGAN, V52, P199, DOI 10.3354/dao052199; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Colorni A, 2002, DIS AQUAT ORGAN, V49, P165, DOI 10.3354/dao049165; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Creeper JH, 2006, AUST VET J, V84, P408, DOI 10.1111/j.1751-0813.2006.00058.x; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fuller CL, 2007, MOL IMMUNOL, V44, P3173, DOI 10.1016/j.molimm.2007.01.037; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gibson-Kueh S, 2004, J FISH DIS, V27, P731, DOI 10.1111/j.1365-2761.2004.00594.x; Gibson-Kueh S, 2012, J FISH DIS, V35, P19, DOI 10.1111/j.1365-2761.2011.01319.x; Gibson-Kueh S, 2011, VET PARASITOL, V181, P106, DOI 10.1016/j.vetpar.2011.04.040; Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hich Tran Vi, 2013, International Journal of Aquatic Science, V4, P3; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Ma CY, 2013, EUR J IMMUNOL, V43, P360, DOI 10.1002/eji.201242570; Madetoja J, 2000, DIS AQUAT ORGAN, V43, P27, DOI 10.3354/dao043027; McKibben CL, 1999, DIS AQUAT ORGAN, V38, P75, DOI 10.3354/dao038075; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Ness TL, 2006, J IMMUNOL, V177, P7531, DOI 10.4049/jimmunol.177.11.7531; Osuna-Jimenez I, 2009, FISH SHELLFISH IMMUN, V26, P699, DOI 10.1016/j.fsi.2009.02.020; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ransangan J, 2010, VET MICROBIOL, V145, P153, DOI 10.1016/j.vetmic.2010.03.016; Regnstrom K, 2003, VACCINE, V21, P2307, DOI 10.1016/S0264-410X(03)00103-8; Sandford E, 2011, BMC GENOMICS, V12, P1; Shoemaker CA, 2012, AQUACULTURE, V354, P45, DOI 10.1016/j.aquaculture.2012.04.033; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Suanyuk N., 2010, Songklanakarin Journal of Science and Technology, V32, P341; Sumegi J, 2002, LEUKEMIA LYMPHOMA, V43, P1189, DOI 10.1080/10428190290026240; Sun Y, 2012, LETT APPL MICROBIOL, V55, P420, DOI 10.1111/j.1472-765X.2012.03307.x; Sun Y, 2012, FISH SHELLFISH IMMUN, V33, P1303, DOI 10.1016/j.fsi.2012.10.004; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1769, DOI 10.1681/ASN.2006050489; Toze S, 1999, WATER RES, V33, P3545, DOI 10.1016/S0043-1354(99)00071-8; Traeger T, 2008, INFECT IMMUN, V76, P5285, DOI 10.1128/IAI.00310-08; Vitiello M, 2012, MOL BIOSYST, V8, P1108, DOI 10.1039/c2mb05335g; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	65	26	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99128	10.1371/journal.pone.0099128	http://dx.doi.org/10.1371/journal.pone.0099128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992587	Green Published, gold			2022-12-25	WOS:000341253400007
J	Khedkar, GD; Jamdade, R; Naik, S; David, L; Haymer, D				Khedkar, Gulab Dattarao; Jamdade, Rahul; Naik, Suresh; David, Lior; Haymer, David			DNA Barcodes for the FIshes of the Narmada, One of India's Longest Rivers	PLOS ONE			English	Article							SPECIES DISCOVERY; GENETIC-DIVERGENCE; DIVERSITY; GAP; DELIMITATION; SPECIATION; DISTANCES; INSIGHTS; RATES	This study describes the species diversity of fishes of the Narmada River in India. A total of 820 fish specimens were collected from 17 sampling locations across the whole river basin. Fish were taxonomically classified into one of 90 possible species based on morphological characters, and then DNA barcoding was employed using COI gene sequences as a supplemental identification method. A total of 314 different COI sequences were generated, and specimens were confirmed to belong to 85 species representing 63 genera, 34 families and 10 orders. Findings of this study include the identification of five putative cryptic or sibling species and 43 species not previously known from the Narmada River basin. Five species are endemic to India and three are introduced species that had not been previously reported to occur in the Narmada River. Conversely, 43 species previously reported to occur in the Narmada were not found. Genetic diversity and distance values were generated for all of the species within genera, families and orders using Kimura's 2 parameter distance model followed by the construction of a Neighbor Joining tree. High resolution clusters generated in NJ trees aided the groupings of species corresponding to their genera and families which are in confirmation to the values generated by Automatic Barcode Gap Discovery bioinformatics platform. This aided to decide a threshold value for the discrimination of species boundary from the Narmada River. This study provides an important validation of the use of DNA barcode sequences for monitoring species diversity and changes within complex ecosystems such as the Narmada River.	[Khedkar, Gulab Dattarao; Jamdade, Rahul] Dr Babasaheb Ambedkar Marathwada Univ, Paul Hebert Ctr DNA Barcoding & Biodivers Studies, Aurangabad, Maharashtra, India; [Naik, Suresh] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [David, Lior] Hebrew Univ Jerusalem, RH Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel; [Haymer, David] Univ Hawaii, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Dr. Babasaheb Ambedkar Marathwada University (BAMU); University of Guelph; Hebrew University of Jerusalem; University of Hawaii System	Khedkar, GD (corresponding author), Dr Babasaheb Ambedkar Marathwada Univ, Paul Hebert Ctr DNA Barcoding & Biodivers Studies, Aurangabad, Maharashtra, India.	gdkhedkar@gmail.com	David, Lior/G-8754-2012; Khedkar, Gualb/AAG-9394-2021; Jamdade, Rahul Arvind/G-2947-2017	Jamdade, Rahul Arvind/0000-0001-8413-7319; David, Lior/0000-0002-6555-0594	Ministry of Food Processing Industries, Government of India, New Delhi [24/MFPI/RD/2007]	Ministry of Food Processing Industries, Government of India, New Delhi	This work is supported by Ministry of Food Processing Industries, Government of India, New Delhi under grant code 24/MFPI/R&D/2007 dated Dec 28, 2011.(www.mofpi.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Arya SC, 2001, AGR POLLUTION S ASIA, P108; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bhattacharjee MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049950; Bichain JM, 2007, MALACOLOGIA, V49, P293, DOI 10.4002/0076-2997-49.2.293; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Chakraborty M, 2014, GENE, V537, P20, DOI 10.1016/j.gene.2013.12.047; CIFRI (Central Inland Fisheries Research Institute), 1993, STUD FISH CONS NARM; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Doria RS, 1990, ENV IMPACT NARMADA S; Dubey GP., 1984, NARMADA BASIN DEV 1; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fregin S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-157; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Gleick PH, 1993, WATER CRISIS GUIDE W; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Khedkar GD, 2014, ECOHYDROLOGY, V7, P1560, DOI 10.1002/eco.1470; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottelat M., 1996, 343 WORLD BANK; Laikre L, 2010, CONSERV GENET, V11, P349, DOI 10.1007/s10592-009-0037-4; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lakra W. S., 2010, THREATENED FRESHWATE; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Persis M, 2009, MOL BIOL REP, V36, P1733, DOI 10.1007/s11033-008-9375-4; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rao K.S., 1991, Journal of the Inland Fisheries Society of India, V23, P34; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Singh SN, 1993, STUDIES FISH CONSERV, P1; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teletchea F, 2010, J FISH BIOL, V77, P257, DOI 10.1111/j.1095-8649.2010.02689.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	60	43	54	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101460	10.1371/journal.pone.0101460	http://dx.doi.org/10.1371/journal.pone.0101460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991801	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400073
J	Michel, C; Herzog, S; de Capitani, C; Burkhardt-Holm, P; Pietsch, C				Michel, Christian; Herzog, Simon; de Capitani, Christian; Burkhardt-Holm, Patricia; Pietsch, Constanze			Natural Mineral Particles Are Cytotoxic to Rainbow Trout Gill Epithelial Cells In Vitro	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; SUSPENDED CLAY KAOLIN; ONCORHYNCHUS-MYKISS; RISK-ASSESSMENT; CLIMATE-CHANGE; COHO SALMON; TOXICITY; SEDIMENT; EXPOSURE; SIZE	Worldwide increases in fluvial fine sediment are a threat to aquatic animal health. Fluvial fine sediment is always a mixture of particles whose mineralogical composition differs depending on the sediment source and catchment area geology. Nonetheless, whether particle impact in aquatic organisms differs between mineral species remains to be investigated. This study applied an in vitro approach to evaluate cytotoxicity and uptake of four common fluvial mineral particles (quartz, feldspar, mica, and kaolin; concentrations: 10, 50, 250 mg L-1) in the rainbow trout epithelial gill cell line RTgill-W1. Cells were exposed for 24, 48, 72, and 96 h. Cytotoxicity assays for cell membrane integrity (propidium iodide assay), oxidative stress (H2DCF-DA assay), and metabolic activity (MTT assay) were applied. These assays were complemented with cell counts and transmission electron microscopy. Regardless of mineral species, particles <= 2 mu m in diameter were taken up by the cells, suggesting that particles of all mineral species came into contact and interacted with the cells. Not all particles, however, caused strong cytotoxicity: Among all assays the tectosilicates quartz and feldspar caused sporadic maximum changes of 0.8-1.2-fold compared to controls. In contrast, cytotoxicity of the clay particles was distinctly stronger and even differed between the two particle types: mica induced concentration-dependent increases in free radicals, with consistent 1.6-1.8-fold-changes at the 250 mg L-1 concentration, and a dilated endoplasmic reticulum. Kaolin caused concentration-dependent increases in cell membrane damage, with consistent 1.3-1.6-fold increases at the 250 mg L-1 concentration. All effects occurred in the presence or absence of 10% fetal bovine serum. Cell numbers per se were marginally affected. Results indicate that (i.) natural mineral particles can be cytotoxic to gill epithelial cells, (ii.) their cytotoxic potential differs between mineral species, with clay particles being more cytotoxic, and (iii.) some clays might induce effects comparable to engineered nanoparticles.	[Michel, Christian; Herzog, Simon; Burkhardt-Holm, Patricia; Pietsch, Constanze] Univ Basel, Dept Environm Sci, Man Soc Environm, Programm MGU, Basel, Switzerland; [de Capitani, Christian] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Basel; University of Alberta	Burkhardt-Holm, P (corresponding author), Univ Basel, Dept Environm Sci, Man Soc Environm, Programm MGU, Basel, Switzerland.	patricia.holm@unibas.ch	Pietsch, Constanze/K-7243-2012	Pietsch, Constanze/0000-0002-3572-8945; Herzog, Simon David/0000-0003-2504-8070; Higgs, Dennis/0000-0002-0771-4642	University of Basel; Swiss National Science Foundation [K-32K1-120486, CR23I2_138025]	University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the University of Basel (www.unibas.ch) and two Swiss National Science Foundation grants (www.snsf.ch, projects K-32K1-120486 and CR23I2_138025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman NEM, 2003, HYDROL PROCESS, V17, P3225, DOI 10.1002/hyp.1384; Atteia O, 1998, ENVIRON GEOL, V34, P257, DOI 10.1007/s002540050277; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Borm Paul J. A., 2007, P1; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Busch W, 2011, J NANOPART RES, V13, P293, DOI 10.1007/s11051-010-0030-3; Cakmak GD, 2004, INT J HYG ENVIR HEAL, V207, P105, DOI 10.1078/1438-4639-00276; Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611; Christian P, 2008, ECOTOXICOLOGY, V17, P326, DOI 10.1007/s10646-008-0213-1; Dayeh VR, 2005, SMALL -SCALE FRESHWATER TOXICITY INVESTIGATIONS, VOL 1 - TOXICITY TEST METHODS, P473, DOI 10.1007/1-4020-3120-3_16; Debes PV, 2012, MOL ECOL, V21, P2574, DOI 10.1111/j.1365-294X.2012.05567.x; Delay M, 2012, ANAL BIOANAL CHEM, V402, P583, DOI 10.1007/s00216-011-5443-z; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Doshi N, 2010, J R SOC INTERFACE, V7, pS403, DOI 10.1098/rsif.2010.0134.focus; Evans DJ, 2006, GEOMORPHOLOGY, V79, P93, DOI 10.1016/j.geomorph.2005.09.018; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gao N., 2002, ANN OCCUP HYG, V46, P50; Gehr P, 2011, ENDOCYTOSIS ENV ENG; GEORGE SG, 1976, J EXP MAR BIOL ECOL, V23, P71, DOI 10.1016/0022-0981(76)90086-1; Gerbersdorf SU, 2011, J SOIL SEDIMENT, V11, P1099, DOI 10.1007/s11368-011-0373-0; GILLER PS, 1998, BIOL STREAMS RIVERS; GOLDES SA, 1988, J FISH DIS, V11, P23, DOI 10.1111/j.1365-2761.1988.tb00520.x; GOLDES SA, 1986, J FISH DIS, V9, P147, DOI 10.1111/j.1365-2761.1986.tb00996.x; Goldes SA, 1983, HISTOLOGICAL ULTRAST; Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501; Handy RD, 2007, HEALTH RISK SOC, V9, P125, DOI 10.1080/13698570701306807; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; HERBERT DWM, 1961, INT J AIR WATER POLL, V5, P46; Hetland RB, 2000, J TOXICOL ENV HEAL A, V60, P47, DOI 10.1080/009841000156583; Hildebrand H, 2010, ENVIRON POLLUT, V158, P65, DOI 10.1016/j.envpol.2009.08.021; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; HUBBARD CR, 1976, J APPL CRYSTALLOGR, V9, P169, DOI 10.1107/S0021889876010807; Irion G, 1991, BIOGEOCHEMISTRY MAJO, P265; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kemp P, 2011, HYDROL PROCESS, V25, P1800, DOI 10.1002/hyp.7940; Kiama SG, 2008, J ANAT, V213, P452, DOI 10.1111/j.1469-7580.2008.00951.x; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kuhnel D, 2009, AQUAT TOXICOL, V93, P91, DOI 10.1016/j.aquatox.2009.04.003; Kupcsik L, 2011, MAMMALIAN CELL VIABI; Lead J.R., 2007, ENV COLLOIDS PARTICL, V10, P1, DOI DOI 10.1002/9780470024539.CH1; Long JF, 2005, ENVIRON HEALTH PERSP, V113, P170, DOI 10.1289/ehp.7389; MARTENS DW, 1993, CAN J FISH AQUAT SCI, V50, P586, DOI 10.1139/f93-067; MCLEAY DJ, 1987, CAN J FISH AQUAT SCI, V44, P658, DOI 10.1139/f87-080; Michel C, 2013, CAN J FISH AQUAT SCI, V70, P630, DOI 10.1139/cjfas-2012-0376; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Moore MN, 2006, ENVIRON INT, V32, P967, DOI 10.1016/j.envint.2006.06.014; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Newcombe Charles P., 1996, North American Journal of Fisheries Management, V16, P693, DOI 10.1577/1548-8675(1996)016<0693:CSSAFA>2.3.CO;2; Owen R, 2007, ENVIRON SCI TECHNOL, V41, P5582; Owens PN, 2005, RIVER RES APPL, V21, P693, DOI 10.1002/rra.878; Pietsch C, 2011, TOXICOL APPL PHARM, V256, P24, DOI 10.1016/j.taap.2011.07.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDDING JM, 1987, T AM FISH SOC, V116, P737, DOI 10.1577/1548-8659(1987)116<737:PEOCSA>2.0.CO;2; Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Scheurer K, 2009, ENVIRON SCI POLLUT R, V16, P232, DOI 10.1007/s11356-008-0075-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schins RPF, 2002, CHEM RES TOXICOL, V15, P1166, DOI 10.1021/tx025558u; Schulze C, 2008, NANOTOXICOLOGY, V2, P51, DOI 10.1080/17435390802018378; Schwarze PE, 2007, INHAL TOXICOL, V19, P17, DOI 10.1080/08958370701490445; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; SERVIZI JA, 1991, CAN J FISH AQUAT SCI, V48, P493, DOI 10.1139/f91-063; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stringer B, 1998, J TOXICOL ENV HEAL A, V55, P31; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Van Hoecke K, 2013, NANOTOXICOLOGY, V7, P37, DOI 10.3109/17435390.2011.626566; Venables W.N., 2013, MODERN APPL STAT S; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Wang SG, 2011, TOXICOL IN VITRO, V25, P2147, DOI 10.1016/j.tiv.2011.07.007; Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140; Waters T. F., 1995, SEDIMENT STREAMS SOU; Wiesner MR, 2009, ENVIRON SCI TECHNOL, V43, P6458, DOI 10.1021/es803621k; Wilber DH, 2001, N AM J FISH MANAGE, V21, P855, DOI 10.1577/1548-8675(2001)021<0855:BEOSSA>2.0.CO;2; Zhang Y, 2008, WATER RES, V42, P2204, DOI 10.1016/j.watres.2007.11.036; Zuur Alain F., 2009, P1	88	14	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100856	10.1371/journal.pone.0100856	http://dx.doi.org/10.1371/journal.pone.0100856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991818	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000341253400033
J	Sampathkumar, R; Peters, HO; Mendoza, L; Bielawny, T; Ngugi, E; Kimani, J; Wachihi, C; Plummer, FA; Luo, M				Sampathkumar, Raghavan; Peters, Harold O.; Mendoza, Lillian; Bielawny, Thomas; Ngugi, Elizabeth; Kimani, Joshua; Wachihi, Charles; Plummer, Francis A.; Luo, Ma			Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort	PLOS ONE			English	Article							IMMUNE CONTROL; EXON-2 DNA; INFECTION; ASSOCIATIONS; RESISTANCE; PROSTITUTES; PROTECTION; ALLELES; SUSCEPTIBILITY; GENOTYPE	We examined the effect of HLA class I haplotypes on HIV-1 seroconversion and disease progression in the Pumwani sex worker cohort. This study included 595 HIV-1 positive patients and 176 HIV negative individuals. HLA-A, -B, and -C were typed to 4-digit resolution using sequence-based typing method. HLA class I haplotype frequencies were estimated using PyPop 32-0.6.0. The influence of haplotypes on time to seroconversion and CD4+ T cell decline to <200 cells/mm(3) were analyzed by Kaplan-Meier analysis using SPSS 13.0. Before corrections for multiple comparisons, three 2-loci haplotypes were significantly associated with faster seroconversion, including A*23:01-C*02:02 (p = 0.014, log rank(LR) = 6.06, false-discovery rate (FDR) = 0.056), B*42:01-C*17:01 (p = 0.01, LR = 6.60, FDR = 0.08) and B*07:02-C*07:02 (p = 0.013, LR = 6.14, FDR = 0.069). Two A*74:01 containing haplotypes, A*74:01-B*15:03 (p = 0.047, LR = 3.942, FDR = 0.068) and A*74:01-B*15:03C* 02:02 (p = 0.045, LR = 4.01, FDR = 0.072) and B*14:02-C*08:02 (p = 0.021, LR = 5.36, FDR = 0.056) were associated with slower disease progression. Five haplotypes, including A*30:02-B*45:01 (p = 0.0008, LR = 11.183, FDR = 0.013), A*30:02-C* 16:01 (p = 0.015, LR = 5.97, FDR = 0.048), B*53:01-C*04:01 (p = 0.010, LR = 6.61, FDR = 0.08), B*15:10-C*03:04 (p = 0.031, LR = 4.65, FDR = 0.062), and B*58:01-C*03:02 (p = 0.037, LR = 4.35, FDR = 0.066) were associated with faster progression to AIDS. After FDR corrections, only the associations of A*30:02-B*45:01 and A*30:02-C*16:01 with faster disease progression remained significant. Cox regression and deconstructed Kaplan-Meier survival analysis showed that the associations of haplotypes of A*23:01-C*02:02, B*07:02-C*07:02, A*74:01-B*15:03, A*74:01-B*15:03-C*02:02, B*14:02-C*08:02 and B*58:01-C*03:02 with differential seroconversion or disease progression are due to the dominant effect of a single allele within the haplotypes. The true haplotype effect was observed with A*30:02-B*45:01, A*30:02-C*16:02, B*53:01-C*04:01 B*15:10-C*03:04, and B*42:01-C*17:01. In these cases, the presence of both alleles accelerated the disease progression or seroconversion than any of the single allele within the haplotypes. Our study showed that the true effects of HLA class I haplotypes on HIV seroconversion and disease progression exist and the associations of HLA class I haplotype can also be due to the dominant effect of a single allele within the haplotype.	[Sampathkumar, Raghavan; Kimani, Joshua; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ngugi, Elizabeth; Kimani, Joshua; Wachihi, Charles] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Sampathkumar, Raghavan; Peters, Harold O.; Mendoza, Lillian; Bielawny, Thomas; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Nairobi; Public Health Agency of Canada	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca		Sampathkumar, Raghavan/0000-0003-3500-9083	National Institutes of Health; Canadian Institutes of Health Research; Bill and Melinda Gates Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the National Institutes of Health, Canadian Institutes of Health Research and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hardie RA, 2008, AIDS, V22, P2038, DOI 10.1097/QAD.0b013e328311d1a0; Hardie RA, 2008, AIDS, V22, P807, DOI 10.1097/QAD.0b013e3282f51b71; Heidari S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18608; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Luo M, 2012, MODELS OF PROTECTION AGAINST HIV/SIV: AVOIDING AIDS IN HUMANS AND MONKEYS, P169, DOI 10.1016/B978-0-12-387715-4.00006-X; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; Mackelprang RD, 2010, J INFECT DIS, V202, P1273, DOI 10.1086/656318; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Peterson TA, 2013, TISSUE ANTIGENS, V81, P93, DOI 10.1111/tan.12051; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Price P, 2001, HUM IMMUNOL, V62, P157, DOI 10.1016/S0198-8859(00)00239-1; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; SIMONSEN JN, 1990, AIDS, V4, P139, DOI 10.1097/00002030-199002000-00007; Sriwanthana B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041696; Trachtenberg EA, 2001, HIV MOL IMMUNOLOGY D; UNAIDS, 2012, GLOBAL REPORT UNAIDS; WARD FE, 1995, HIV MOL IMMUNOLOGY D, P10	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101475	10.1371/journal.pone.0101475	http://dx.doi.org/10.1371/journal.pone.0101475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992306	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400077
J	Ye, YS; Liang, XQ; Chen, YX; Li, L; Ji, YJ; Zhu, CY				Ye, Yushi; Liang, Xinqiang; Chen, Yingxu; Li, Liang; Ji, Yuanjing; Zhu, Chunyan			Carbon, Nitrogen and Phosphorus Accumulation and Partitioning, and C:N:P Stoichiometry in Late-Season Rice under Different Water and Nitrogen Managements	PLOS ONE			English	Article							CO2 ENRICHMENT FACE; N-P STOICHIOMETRY; PLANT-GROWTH; DRY-MATTER; NUTRIENT LIMITATION; TERRESTRIAL PLANTS; ELEVATED CO2; LOWLAND RICE; SOIL CARBON; RATIOS	Water and nitrogen availability plays an important role in the biogeochemical cycles of essential elements, such as carbon (C), nitrogen (N) and phosphorus (P), in agricultural ecosystems. In this study, we investigated the seasonal changes of C, N and P concentrations, accumulation, partitioning, and C:N:P stoichiometric ratios in different plant tissues (root, stem-leaf, and panicle) of late-season rice under two irrigation regimes (continuous flooding, CF; alternate wetting and drying, AWD) and four N managements (control, N0; conventional urea at 240 kg N ha(-1), UREA; controlled-release bulk blending fertilizer at 240 kg N ha(-1), BBF; polymer-coated urea at 240 kg N ha 21, PCU). We found that water and N treatments had remarkable effects on the measured parameters in different plant tissues after transplanting, but the water and N interactions had insignificant effects. Tissue C:N, N:P and C:P ratios ranged from 14.6 to 52.1, 3.1 to 7.8, and 76.9 to 254.3 over the rice growing seasons, respectively. The root and stem-leaf C:N:P and panicle C:N ratios showed overall uptrends with a peak at harvest whereas the panicle N:P and C:P ratios decreased from filling to harvest. The AWD treatment did not affect the concentrations and accumulation of tissue C and N, but greatly decreased those of P, resulting in enhanced N:P and C:P ratios. N fertilization significantly increased tissue N concentration, slightly enhanced tissue P concentration, but did not affect tissue C concentration, leading to a significant increase in tissue N:P ratio but a decrease in C:N and C:P ratios. Our results suggested that the growth of rice in the Taihu Lake region was co-limited by N and P. These findings broadened our understanding of the responses of plant C:N:P stoichiometry to simultaneous water and N managements in subtropical high-yielding rice systems.	[Ye, Yushi; Liang, Xinqiang; Li, Liang; Ji, Yuanjing] Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yingxu; Zhu, Chunyan] Zhejiang Prov Key Lab Water Pollut Control & Envi, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Liang, XQ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	liang410@zju.edu.cn	chen, ying/HHS-8254-2022		National Natural Science Foundation of China [41271314, 21077088]; National Key Science and Technology Project: Water Pollution Control and Treatment [2014ZX07101-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Project: Water Pollution Control and Treatment	This work was funded by the National Natural Science Foundation of China (No. 41271314, 21077088) and the National Key Science and Technology Project: Water Pollution Control and Treatment (2014ZX07101-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Agren GI, 2012, NEW PHYTOL, V194, P944, DOI 10.1111/j.1469-8137.2012.04114.x; Aulakh MS, 2005, ADV AGRON, V86, P341, DOI 10.1016/S0065-2113(05)86007-9; Bao SD, 2000, SOIL AGR CHEM ANAL, P268; Belanger G, 2012, FIELD CROP RES, V126, P1, DOI 10.1016/j.fcr.2011.09.016; Dordas C, 2009, EUR J AGRON, V30, P129, DOI 10.1016/j.eja.2008.09.001; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Gan YT, 2011, CROP PASTURE SCI, V62, P496, DOI 10.1071/CP10360; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Greenwood DJ, 2008, ANN BOT-LONDON, V102, P967, DOI 10.1093/aob/mcn188; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; HAYNES RJ, 1989, J SOIL SCI, V40, P773, DOI 10.1111/j.1365-2389.1989.tb01317.x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kim HY, 2011, PLANT SOIL, V342, P59, DOI 10.1007/s11104-010-0665-y; Knecht MR, 2004, TREE PHYSIOL, V24, P447, DOI 10.1093/treephys/24.4.447; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Mahajan G, 2012, FIELD CROP RES, V134, P59, DOI 10.1016/j.fcr.2012.04.011; Mao Z, 2001, WATER EFFICIENT IRRI; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Pampolino MF, 2008, SOIL SCI SOC AM J, V72, P798, DOI 10.2136/sssaj2006.0334; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; [阮新民 RUAN Xinmin], 2011, [中国土壤与肥料, Soil and Fertilizer Sciences in China], P35; Sadras VO, 2006, FIELD CROP RES, V95, P13, DOI 10.1016/j.fcr.2005.01.020; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Seneweera S, 2011, J PLANT INTERACT, V6, P35, DOI 10.1080/17429145.2010.513483; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Yang LX, 2007, FIELD CROP RES, V102, P141, DOI 10.1016/j.fcr.2007.03.004; Yang LX, 2007, FIELD CROP RES, V100, P189, DOI 10.1016/j.fcr.2006.07.003; Yang YH, 2011, PLANT SOIL, V343, P393, DOI 10.1007/s11104-011-0736-8; Ye YS, 2013, FIELD CROP RES, V144, P212, DOI 10.1016/j.fcr.2012.12.003; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060360; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750; Ziadi N, 2007, AGRON J, V99, P833, DOI 10.2134/agronj2006.0199	44	49	54	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101776	10.1371/journal.pone.0101776	http://dx.doi.org/10.1371/journal.pone.0101776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992006	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400115
J	Zhang, T; Luo, XJ; Sai, WB; Yu, MF; Li, WE; Ma, YF; Chen, WW; Zhai, K; Qin, GJ; Guo, DL; Zheng, YM; Wang, YX; Shen, JH; Ji, GJ; Liu, QH				Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Zhai, Kui; Qin, Gangjian; Guo, Donglin; Zheng, Yun-Min; Wang, Yong-Xiao; Shen, Jin-Hua; Ji, Guangju; Liu, Qing-Hua			Non-Selective Cation Channels Mediate Chloroquine-Induced Relaxation in Precontracted Mouse Airway Smooth Muscle	PLOS ONE			English	Article							TASTANT-INDUCED BRONCHODILATION; PORTAL-VEIN MYOCYTES; BK CHANNELS; CELLS; ACTIVATION; CALCIUM; RECEPTORS; EXPRESSION; CURRENTS; SIGNALS	Bitter tastants can induce relaxation in precontracted airway smooth muscle by activating big-conductance potassium channels (BKs) or by inactivating voltage-dependent L-type Ca2+ channels (VDLCCs). In this study, a new pathway for bitter tastant-induced relaxation was defined and investigated. We found nifedipine-insensitive and bitter tastant chloroquine-sensitive relaxation in epithelium-denuded mouse tracheal rings (TRs) precontracted with acetylcholine (ACH). In the presence of nifedipine (10 mu M), ACH induced cytosolic Ca2+ elevation and cell shortening in single airway smooth muscle cells (ASMCs), and these changes were inhibited by chloroquine. In TRs, ACH triggered a transient contraction under Ca2+ -free conditions, and, following a restoration of Ca2+, a strong contraction occurred, which was inhibited by chloroquine. Moreover, the ACH-activated whole-cell and single channel currents of non-selective cation channels (NSCCs) were blocked by chloroquine. Pyrazole 3 (Pyr3), an inhibitor of transient receptor potential C3 (TRPC3) channels, partially inhibited ACH-induced contraction, intracellular Ca2+ elevation, and NSCC currents. These results demonstrate that NSCCs play a role in bitter tastant-induced relaxation in precontracted airway smooth muscle.	[Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Guo, Donglin; Shen, Jin-Hua; Liu, Qing-Hua] South Cent Univ Natl, Inst Med Biol, Wuhan, Peoples R China; [Zhang, Ting; Luo, Xiao-Jing; Sai, Wen-Bo; Yu, Meng-Fei; Li, Wen-Er; Ma, Yun-Fei; Chen, Weiwei; Guo, Donglin; Shen, Jin-Hua; Liu, Qing-Hua] South Cent Univ Natl, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Peoples R China; [Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Qin, Gangjian] Northwestern Univ Feinberg, Sch Med, Feinberg Cardiovasc Res Inst, Dept Med Cardiol, Chicago, IL USA; [Guo, Donglin] Lankenau Inst Med Res, Wynnewood, PA USA; [Guo, Donglin] Main Line Hlth Heart Ctr, Wynnewood, PA USA; [Zheng, Yun-Min; Wang, Yong-Xiao] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY USA	South Central Minzu University; South Central Minzu University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Northwestern University; Feinberg School of Medicine; Lankenau Medical Center; Lankenau Institute for Medical Research; Albany Medical College	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	gj28@sun5.ibp.ac.cn; liu258q@yahoo.com	Li, Wener/AAW-5655-2020	Li, Wener/0000-0002-1753-6245; Zhai, Kui/0000-0003-4725-190X; Ji, Guangju/0000-0001-8626-3490	Ministry of Science and Technology of China [2011CB809100]; National Natural Science Foundation of China [31140087, 30971514]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122865, R01HL108232] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by: contract grant sponsor: Ministry of Science and Technology of China (http://www.most.gov.cn/eng/), contract grant number: 2011CB809100 to QHL and GJ; contract grant sponsor: National Natural Science Foundation of China (http://www.nsfc.gov.cn/), contract grant numbers: 31140087 and 30971514 to QHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Albert AP, 2002, J PHYSIOL-LONDON, V538, P717, DOI 10.1113/jphysiol.2001.013101; Albert AP, 2001, J PHYSIOL-LONDON, V536, P409, DOI 10.1111/j.1469-7793.2001.0409c.xd; An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; An SS, 2012, NAT MED, V18, P650, DOI 10.1038/nm.2734; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; EHARA T, 1988, J PHYSIOL-LONDON, V403, P117, DOI 10.1113/jphysiol.1988.sp017242; Fleischmann BK, 1997, AM J PHYSIOL-CELL PH, V272, pC341, DOI 10.1152/ajpcell.1997.272.1.C341; Fujiyama R, 1998, FEBS LETT, V434, P47, DOI 10.1016/S0014-5793(98)00949-1; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Liu QH, 2009, AM J RESP CELL MOL, V40, P663, DOI 10.1165/rcmb.2008-0323OC; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; Rueda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053321; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Torrey TW, 1931, P NATL ACAD SCI USA, V17, P591, DOI 10.1073/pnas.17.11.591; Wang YX, 1997, AM J PHYSIOL-CELL PH, V273, pC500, DOI 10.1152/ajpcell.1997.273.2.C500; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang CH, 2012, NAT MED, V18, P648, DOI 10.1038/nm.2733; Zheng YM, 2008, J VASC RES, V45, P469, DOI 10.1159/000127438	29	33	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101578	10.1371/journal.pone.0101578	http://dx.doi.org/10.1371/journal.pone.0101578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992312	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400093
J	Eliassen, S; Jorgensen, C				Eliassen, Sigrunn; Jorgensen, Christian			Extra-Pair Mating and Evolution of Cooperative Neighbourhoods	PLOS ONE			English	Article							RED-WINGED BLACKBIRDS; POLYGYNANDROUS ALPINE ACCENTORS; INCREASE OFFSPRING HETEROZYGOSITY; REPRODUCTIVE SUCCESS; LEAST FLYCATCHERS; SPERM COMPETITION; SEXUAL SELECTION; FEMALE CONTROL; RECIPROCAL ALTRUISM; FITNESS BENEFITS	Although females commonly solicit extra-pair copulations, the adaptive reason has remained elusive. We use evolutionary modelling of breeding ecology to show that females benefit because extra-pair paternity incentivizes males to shift focus from a single brood towards the entire neighbourhood, as they are likely to have offspring there. Male-male cooperation towards public goods and dear enemy effects of reduced territorial aggression evolve from selfish interests, and lead to safer and more productive neighbourhoods. The mechanism provides adaptive explanations for the common empirical observations that females engage in extra-pair copulations, that neighbours dominate as extra-pair sires, and that extra-pair mating correlates with predation mortality and breeding density. The models predict cooperative behaviours at breeding sites where males cooperate more towards public goods than females. Where maternity certainty makes females care for offspring at home, paternity uncertainty and a potential for offspring in several broods make males invest in communal benefits and public goods. The models further predict that benefits of extra-pair mating affect whole nests or neighbourhoods, and that cuckolding males are often cuckolded themselves. Derived from ecological mechanisms, these new perspectives point towards the evolution of sociality in birds, with relevance also for mammals and primates including humans.	[Eliassen, Sigrunn] Univ Bergen, Dept Biol, Bergen, Norway; [Jorgensen, Christian] Uni Res, Bergen, Norway	University of Bergen	Eliassen, S (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	sigrunn.eliassen@bio.uib.no	Jørgensen, Christian/B-4453-2009	Jørgensen, Christian/0000-0001-7087-4625	Research Council of Norway	Research Council of Norway(Research Council of Norway)	The study was funded by the Research Council of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay E, 2007, EVOL ECOL RES, V9, P855; ARCESE P, 1987, ANIM BEHAV, V35, P773, DOI 10.1016/S0003-3472(87)80114-8; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avise JC, 2011, P NATL ACAD SCI USA, V108, P7091, DOI 10.1073/pnas.1103329108; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Beckerman S., 2002, CULTURES MULTIPLE FA, P42; BELETSKY LD, 1989, P NATL ACAD SCI USA, V86, P7933, DOI 10.1073/pnas.86.20.7933; BELETSKY LD, 1986, BEHAV ECOL SOCIOBIOL, V18, P221, DOI 10.1007/BF00290826; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boonekamp JJ, 2014, ECOL LETT, V17, P599, DOI 10.1111/ele.12263; Bouwman KM, 2006, MOL ECOL, V15, P2589, DOI 10.1111/j.1365-294X.2006.02955.x; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Brown J. L., 1964, Wilson Bulletin, V76, P160; Charmantier A, 2004, BEHAV ECOL SOCIOBIOL, V56, P360, DOI 10.1007/s00265-004-0794-5; Clark CW, 2000, OX ECOL EV; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cohas A, 2008, ANIM BEHAV, V76, P87, DOI 10.1016/j.anbehav.2008.01.012; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Crocker J.G., 2004, CANELA KINSHIP RITUA; CURIO E, 1980, Z TIERPSYCHOL, V53, P139; CURIO E, 1978, Z TIERPSYCHOL, V48, P175; Darwin G., 1871, P423; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; Davies NB, 1996, ANIM BEHAV, V51, P27, DOI 10.1006/anbe.1996.0003; Delhey K, 2003, P ROY SOC B-BIOL SCI, V270, P2057, DOI 10.1098/rspb.2003.2460; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Garcia-Navas V, 2014, BEHAV ECOL, V25, P228, DOI 10.1093/beheco/art111; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Gerlach NM, 2012, P ROY SOC B-BIOL SCI, V279, P860, DOI 10.1098/rspb.2011.1547; GIBBS HL, 1990, SCIENCE, V250, P1394, DOI 10.1126/science.250.4986.1394; Grabowska-Zhang AM, 2012, BIOL LETTERS, V8, P544, DOI 10.1098/rsbl.2012.0183; Grabowska-Zhang AM, 2012, BEHAV ECOL, V23, P322, DOI 10.1093/beheco/arr189; Gray EM, 1996, BEHAV ECOL SOCIOBIOL, V38, P267, DOI 10.1007/s002650050242; Gray EM, 1997, ANIM BEHAV, V53, P625, DOI 10.1006/anbe.1996.0336; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gurven M, 2009, CURR ANTHROPOL, V50, P51, DOI 10.1086/595620; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hill CE, 2011, BEHAV ECOL, V22, P73, DOI 10.1093/beheco/arq171; HOOGLAND JL, 1981, ECOLOGY, V62, P252, DOI 10.2307/1936685; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; Hoogland JL, 1998, ANIM BEHAV, V55, P351, DOI 10.1006/anbe.1997.0575; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Houston AI, 1999, MODELS ADAPTIVE BEHA; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jacquet J, 2011, BIOL LETTERS, V7, P899, DOI 10.1098/rsbl.2011.0367; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kohda M, 2009, P R SOC B, V276, P4207, DOI 10.1098/rspb.2009.1175; Kokko H, 1999, ECOL LETT, V2, P247, DOI 10.1046/j.1461-0248.1999.00075.x; Kowalewski MM, 2010, AM J PRIMATOL, V72, P734, DOI 10.1002/ajp.20838; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Krams I, 2010, P ROY SOC B-BIOL SCI, V277, P513, DOI 10.1098/rspb.2009.1614; Krams I, 2009, ANIM BEHAV, V77, P513, DOI 10.1016/j.anbehav.2008.11.007; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Magrath MJL, 2009, CURR BIOL, V19, P792, DOI 10.1016/j.cub.2009.03.068; Malinowski B, 1929, SEXAL LIFE SAVAGES N; Mauck RA, 1999, AM NAT, V154, P99, DOI 10.1086/303216; May RM, 2006, NOTES REC ROY SOC, V60, P109, DOI 10.1098/rsnr.2005.0134; Mayer C, 2013, ECOL EVOL, V3, P694, DOI 10.1002/ece3.489; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nakamura M, 1998, ANIM BEHAV, V55, P259, DOI 10.1006/anbe.1997.0725; Nakamura M, 1998, ANIM BEHAV, V55, P277, DOI 10.1006/anbe.1997.0599; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Ostrom E., 1990, GOVERNING COMMONS EV; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; PEEK FW, 1971, WILSON BULL, V83, P383; Perry EF, 2003, CONDOR, V105, P756, DOI 10.1650/7162; Perry EF, 2008, AUK, V125, P643, DOI 10.1525/auk.2008.07001; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Reid JM, 2011, P ROY SOC B-BIOL SCI, V278, P1114, DOI 10.1098/rspb.2010.1704; Reid JM, 2011, AM NAT, V177, P177, DOI 10.1086/657977; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Robertson RJ, 2001, J ANIM ECOL, V70, P1014, DOI 10.1046/j.0021-8790.2001.00555.x; Sardell RJ, 2012, AM NAT, V179, P779, DOI 10.1086/665665; Sardell RJ, 2010, MOL ECOL, V19, P4352, DOI 10.1111/j.1365-294X.2010.04805.x; SCHOENER TW, 1987, AM ZOOL, V27, P259; Searcy WA, 1995, POLYGYNY SEXUAL SELE; SHELDON BC, 1994, ANIM BEHAV, V47, P163, DOI 10.1006/anbe.1994.1018; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; SMITH J. MAYNARD, 1965, AMER NATUR, V99, P59, DOI 10.1086/282349; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Solomon NG, 2008, RODENT SOC ECOLOGICA, P59; Soltis J, 2001, AM NAT, V158, P519, DOI 10.1086/323117; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Stapleton MK, 2007, BEHAV ECOL SOCIOBIOL, V61, P1725, DOI 10.1007/s00265-007-0404-4; Stutchbury Bridget J.M., 1998, Ornithological Monographs, V49, P103; Suter SM, 2007, P ROY SOC B-BIOL SCI, V274, P2865, DOI 10.1098/rspb.2007.0799; Suter SM, 2009, BEHAV ECOL, V20, P601, DOI 10.1093/beheco/arp037; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; Taff CC, 2013, J EVOLUTION BIOL, V26, P1392, DOI 10.1111/jeb.12141; Tarof SA, 2005, BEHAV ECOL, V16, P207, DOI 10.1093/beheco/arh155; Tarof SA, 2004, AUK, V121, P877, DOI 10.1642/0004-8038(2004)121[0877:HCANPD]2.0.CO;2; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Trivers R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P67; Tryjanowski P, 2005, ANIM BEHAV, V69, P529, DOI 10.1016/j.anbehav.2004.06.009; van Schaik C.P., 1983, Primates, V24, P211; Wagner Richard H., 1998, Ornithological Monographs, V49, P123; West RJD, BIOL J LINN IN PRESS; Westneat DF, 2013, BEHAV ECOL, V24, P598, DOI 10.1093/beheco/ars207; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Wetzel DP, 2009, MOL ECOL, V18, P2010, DOI 10.1111/j.1365-294X.2009.04114.x; Whittingham LA, 2010, MOL ECOL, V19, P2328, DOI 10.1111/j.1365-294X.2010.04640.x; WICKLER W, 1985, Z TIERPSYCHOL, V69, P250; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson RS, 2014, J EXP BIOL, V217, P545, DOI 10.1242/jeb.092056; Wink Michael, 1999, Acta Ornithologica (Warsaw), V34, P91; Wolff J.O., 2007, RODENT SOC ECOLOGICA; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Yezerinac SM, 1996, ANIM BEHAV, V52, P821, DOI 10.1006/anbe.1996.0227; YEZERINAC SM, 1995, BEHAV ECOL SOCIOBIOL, V37, P179, DOI 10.1007/BF00176715; Yezerinac SM, 1999, J AVIAN BIOL, V30, P234, DOI 10.2307/3677135	154	34	34	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99878	10.1371/journal.pone.0099878	http://dx.doi.org/10.1371/journal.pone.0099878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987839	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100020
J	Fiorentino, F; Rogers, CA; Bryan, AJ; Angelini, GD; Reeves, BC				Fiorentino, Francesca; Rogers, Chris A.; Bryan, Alan J.; Angelini, Gianni D.; Reeves, Barnaby C.			Implications of Using Different Methods to Characterise Anticoagulant Control in Patients with Second Generation Mechanical Heart Valve Prostheses	PLOS ONE			English	Article							SELF-MANAGEMENT; REPLACEMENT; CARBOMEDICS; INTENSITY; THERAPY	Objective: Characterisation of anticoagulant control is fundamental to investigations of its association with clinical outcome. Anticoagulant control depends on several factors. This paper aims to illustrate the implications of different methods for measuring and analysing anticoagulant control in patients with second generation mechanical heart valve prostheses. Methods: International normalised ratio (INR) data collected during the 10-year follow-up of a randomised controlled trial were analysed. We considered the influence of: 3 different target INR ranges; anticoagulant control expressed as the proportion of INR readings (PoR) vs. anticoagulant control follow-up time (PoT); 3 ways of describing the profile of anticoagulant control over time. Results: Different target INR ranges dramatically influenced derived measures of anticoagulant control; the PoT within the target range varied from 88% for the widest to 28% for narrowest range. Overall distributions of PoR and PoT observations were similar but differed by up to +/- 20% for individuals; PoT exceeded PoR when control was good but was less than PoR when control was poor. Classifying PoT outside the target range showed that widely varying combinations of PoT too high and too low are possible across individuals. Conclusions: Researchers' choices about methods for measuring and quantifying anticoagulant control markedly influence the values derived from INR readings. The use of different methods across studies makes it difficult or impossible to compare findings and to establish an evidence base for clinical practice. Methods for quantifying anticoagulant control should be standardised.	[Rogers, Chris A.; Bryan, Alan J.; Angelini, Gianni D.; Reeves, Barnaby C.] Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Bristol, Avon, England; [Fiorentino, Francesca; Angelini, Gianni D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England	Bristol Royal Infirmary; University of Bristol; Imperial College London	Reeves, BC (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Bristol, Avon, England.	barney.reeves@bristol.ac.uk		angelini, gianni/0000-0002-1753-3730; Reeves, Barnaby/0000-0002-5101-9487	United Kingdom National Institute for Health Research; British Heart Foundation; UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit; National Institute for Health Research [NF-SI-0611-10022] Funding Source: researchfish	United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	The research reported in this paper was supported by the United Kingdom National Institute for Health Research and the British Heart Foundation. FF is funded in part, CR and GDA in full, by the British Heart Foundation. BCR is supported in part by the UK National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar J, 1996, CIRCULATION, V94, P2107, DOI 10.1161/01.CIR.94.9.2107; [Anonymous], 1998, Br J Haematol, V101, P374; AZAR AJ, 1994, THROMB HAEMOSTASIS, V72, P347; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bryan AJ, 2007, J THORAC CARDIOV SUR, V133, P614, DOI 10.1016/j.jtcvs.2006.08.075; Butchart EG, 2002, J THORAC CARDIOV SUR, V123, P715, DOI 10.1067/mtc.2002.121162; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Grunkemeier GL, 2003, J THORAC CARDIOV SUR, V125, P290, DOI 10.1067/mtc.2003.53; Hering D, 2005, CHEST, V127, P53, DOI 10.1378/chest.127.1.53; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Koertke H, 2003, CIRCULATION, V108, P75, DOI 10.1161/01.cir.0000089185.80318.3f; Koertke H, 2000, J THROMB THROMBOLYS, V9, pS41; Kortke H, 2001, ANN THORAC SURG, V72, P44, DOI 10.1016/S0003-4975(01)02656-X; Leiria TLL, 2011, J THROMB THROMBOLYS, V31, P514, DOI 10.1007/s11239-011-0574-9; Lim KHH, 2002, J THORAC CARDIOV SUR, V123, P21, DOI 10.1067/mtc.2002.119703; LOELIGER EA, 1985, THROMB HAEMOSTASIS, V53, P155; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e98323	10.1371/journal.pone.0098323	http://dx.doi.org/10.1371/journal.pone.0098323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988447	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100010
J	Hobbs, CV; Neal, J; Conteh, S; Donnelly, L; Chen, JY; Marsh, K; Lambert, L; Orr-Gonzalez, S; Hinderer, J; Healy, S; Borkowsky, W; Penzak, SR; Chakravarty, S; Hoffman, SL; Duffy, PE				Hobbs, Charlotte V.; Neal, Jillian; Conteh, Solomon; Donnelly, Liam; Chen, Jingyang; Marsh, Kennan; Lambert, Lynn; Orr-Gonzalez, Sachy; Hinderer, Jessica; Healy, Sara; Borkowsky, William; Penzak, Scott R.; Chakravarty, Sumana; Hoffman, Stephen L.; Duffy, Patrick E.			HIV Treatments Reduce Malaria Liver Stage Burden in a Non-Human Primate Model of Malaria Infection at Clinically Relevant Concentrations In Vivo	PLOS ONE			English	Article							PLASMODIUM-CYNOMOLGI; PROTEASE INHIBITORS; SULFAMETHOXAZOLE; TRANSMISSION; FALCIPARUM; PROGUANIL; KNOWLESI	We have previously shown that the HIV protease inhibitor lopinavir-ritonavir (LPV-RTV) and the antibiotic trimethoprim sulfamethoxazole (TMP-SMX) inhibit Plasmodium liver stages in rodent malarias and in vitro in P. falciparum. Since clinically relevant levels are better achieved in the non-human-primate model, and since Plasmodium knowlesi is an accepted animal model for the study of liver stages of malaria as a surrogate for P. falciparum infection, we investigated the antimalarial activity of these drugs on Plasmodium knowlesi liver stages in rhesus macaques. We demonstrate that TMP-SMX and TMP-SMX+LPV-RTV (in combination), but not LPV-RTV alone, inhibit liver stage parasite development. Because drugs that inhibit the clinically silent liver stages target parasites when they are present in lower numbers, these results may have implications for eradication efforts.	[Hobbs, Charlotte V.; Neal, Jillian; Conteh, Solomon; Donnelly, Liam; Chen, Jingyang; Lambert, Lynn; Orr-Gonzalez, Sachy; Hinderer, Jessica; Healy, Sara; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Marsh, Kennan] AbbVie Inc, N Chicago, IL USA; [Borkowsky, William] NYU, Sch Med, Dept Pediat, Div Infect Dis & Immunol, New York, NY USA; [Penzak, Scott R.] NIAID, Ctr Clin, Dept Pharm, Clin Pharmacokinet Res Lab,NIH, Bethesda, MD 20892 USA; [Chakravarty, Sumana; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); AbbVie; New York University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanaria Inc.	Hobbs, CV (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	charlotte.hobbs@nih.gov		Hobbs, Charlotte/0000-0003-4829-0791	National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001149, ZIAAI001135, ZIGAI001047] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Division of Intramural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, RODENT MALARIA; Birkett DJ., 2010, PHARMACOKINETICS MAD; Bray R. S., 1959, Bulletin of the World Health Organization, V21, P233; Carpenter J.W., 2005, EXOTIC ANIMAL FORMUL, V3; Coatney G. Robert, 1971, PRIMATE MALARIAS, Vix; Craig WA, 1973, J INFECT DIS S, V128; DAVIDSON DE, 1976, AM J TROP MED HYG, V25, P26, DOI 10.4269/ajtmh.1976.25.26; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hobbs CV, 2013, AIDS, V27, P1674, DOI 10.1097/QAD.0b013e3283621dd4; Hobbs CV, 2012, J INFECT DIS, V206, P1706, DOI 10.1093/infdis/jis602; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Li YJ, 2011, ANTIMICROB AGENTS CH, V55, P3039, DOI 10.1128/AAC.00085-11; Nsanzabana C, 2011, ANTIMICROB AGENTS CH; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; RIECKMAN.KH, 1971, T ROY SOC TROP MED H, V65, P533, DOI 10.1016/0035-9203(71)90170-2; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sandison TG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1617; SHANKS GD, 1994, AM J TROP MED HYG, V50, P641, DOI 10.4269/ajtmh.1994.50.641; Vanderberg JP, 2014, PARASITOL INT, V63, P150, DOI 10.1016/j.parint.2013.09.010; WHO, 2013, USE ANT DRUGS TREAT	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100138	10.1371/journal.pone.0100138	http://dx.doi.org/10.1371/journal.pone.0100138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988386	gold, Green Submitted, Green Published			2022-12-25	WOS:000341354100025
J	Li, XL; Li, JJ; Guo, YL; Zhu, CG; Xu, RX; Li, S; Qing, P; Wu, NQ; Jiang, LX; Xu, B; Gao, RL				Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin			Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							3RD UNIVERSAL DEFINITION; TROPONIN-T; PROGNOSTIC VALUE; GLUCOSE CONTROL; ELEVATION; COMPLICATIONS; ASSOCIATION; PROGRESSION; PREDICTORS; INFARCTION	Background: Glycated hemoglobin (HbA1c) predicts clinical cardiovascular disease or cardiovascular mortality. However, the relationship between HbA1c and myocardial injury following elective percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (DM) has not been investigated. Objectives: The study sought to assess the relationship between HbA1c and myocardial injury following elective PCI in patients with type 2 DM. Methods: We studied a cohort of consecutive 994 diabetic patients with coronary artery disease (CAD) undergoing elective PCI. Periprocedural myocardial injury was evaluated by analysis of troponin I (cTnI). The association between preprocedural HbA1c levels and the peak values of cTnI within 24 hours after PCI was evaluated. Results: Peak postprocedural cTnI>1 x upper limit of normal (ULN), >3 x ULN and >5 x ULN were detected in 543 (54.6%), 337 (33.9%) and 245 (24.6%) respectively. In the multivariate model, higher HbA1c levels were associated with less risk of postprocedural cTnI >1 x ULN (odds ratio [OR], 0.85; 95% confidence interval [CI], 0.76-0.95; P = 0.005). There was a trend that higher HbA1c levels were associated with less risk of postprocedural cTnI >3 x ULN (OR, 0.90; 95% CI, 0.81-1.02; P = 0.088). HbA1c was not associated with the risk of postprocedural cTnI elevation above 5 x ULN (OR, 0.95; 95% CI, 0.84-1.08; P = 0.411). Conclusions: The present study provided the first line of evidence that higher preprocedural HbA1c levels were associated with less risk of myocardial injury following elective PCI in diabetic patients.	[Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin] Chinese Acad Med Sci, Div Dyslipidemia, State Key Lab Cardiovasc Dis, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Xiao-Lin; Li, Jian-Jun; Guo, Yuan-Lin; Zhu, Cheng-Gang; Xu, Rui-Xia; Li, Sha; Qing, Ping; Wu, Na-Qiong; Jiang, Li-Xin; Xu, Bo; Gao, Run-Lin] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JJ (corresponding author), Chinese Acad Med Sci, Div Dyslipidemia, State Key Lab Cardiovasc Dis, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@yahoo.com	xu, rui/GRX-5734-2022; Guo, Yuan-Lin/K-4887-2019	Guo, Yuan-Lin/0000-0002-7159-0189	National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anand DV, 2007, J AM COLL CARDIOL, V50, P2218, DOI 10.1016/j.jacc.2007.08.032; Cai QJ, 2007, AM J CARDIOL, V99, P616, DOI 10.1016/j.amjcard.2006.09.108; Colayco DC, 2011, DIABETES CARE, V34, P77, DOI 10.2337/dc10-1318; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eshaghian S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.008; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; LIBBY P, 1975, CIRCULATION, V51, P621, DOI 10.1161/01.CIR.51.4.621; Madani M, 2013, TEX HEART I J, V40, P410; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051; Nienhuis MB, 2008, CATHETER CARDIO INTE, V71, P318, DOI 10.1002/ccd.21345; Nusca A, 2012, CATHETER CARDIO INTE, V80, P377, DOI 10.1002/ccd.23185; Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Prasad A, 2006, J AM COLL CARDIOL, V48, P1765, DOI 10.1016/j.jacc.2006.04.102; Prasad A, 2013, EUR HEART J, V34, P1615, DOI 10.1093/eurheartj/eht103; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Yang DJ, 2013, J INVASIVE CARDIOL, V25, P137; Zhao WH, 2014, DIABETES CARE, V37, P428, DOI 10.2337/dc13-1525	30	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101719	10.1371/journal.pone.0101719	http://dx.doi.org/10.1371/journal.pone.0101719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988213	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100127
J	Shi, JD; Sun, J; Wang, B; Wu, MN; Zhang, J; Duan, ZQ; Wang, HX; Hu, NZ; Hu, YZ				Shi, Jiandong; Sun, Jing; Wang, Bin; Wu, Meini; Zhang, Jing; Duan, Zhiqing; Wang, Haixuan; Hu, Ningzhu; Hu, Yunzhang			Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection	FASEB JOURNAL			English	Article						deep sequencing; cytoplasmic RNA virus; miRNA machinery	CONSERVED MICRORNAS; GENE-EXPRESSION; MESSENGER-RNA; STRAIN HM175; IDENTIFICATION; ADAPTATION; GROWTH; REPLICATION; ULTRAFAST; DISCOVERY	MicroRNAs (miRNAs), including host miRNAs and viral miRNAs, play vital roles in regulating host-virus interactions. DNA viruses encode miRNAs that regulate the viral life cycle. However, it is generally believed that cytoplasmic RNA viruses do not encode miRNAs, owing to inaccessible cellular miRNA processing machinery. Here, we provide a comprehensive genome-wide analysis and identification of miRNAs that were derived from hepatitis A virus (HAV; Hu/China/H2/1982), which is a typical cytoplasmic RNA virus. Using deep-sequencing and in silico approaches, we identified 2 novel virally encoded miRNAs, named hav-miR-1-5p and hav-miR-2-5p. Both of the novel virally encoded miRNAs were clearly detected in infected cells. Analysis of Dicer enzyme silencing demonstrated that HAV-derived miRNA biogenesis is Dicer dependent. Furthermore, we confirmed that HAV mature miRNAs were generated from viral miRNA precursors (pre-miRNAs) in host cells. Notably, naturally derived HAV miRNAs were biologically and functionally active and induced post-transcriptional gene silencing (PTGS). Genomic location analysis revealed novel miRNAs located in the coding region of the viral genome. Overall, our results show that HAV naturally generates functional miRNA-like small regulatory RNAs during infection. This is the first report of miRNAs derived from the coding region of genomic RNA of a cytoplasmic RNA virus. These observations demonstrate that a cytoplasmic RNA virus can naturally generate functional miRNAs, as DNA viruses do. These findings also contribute to improved understanding of host-RNA virus interactions mediated by RNA virus-derived miRNAs.-Shi, J., Sun, J., Wang, B., Wu, M., Zhang, J., Duan, Z., Wang, H., Hu, N., Hu, Y. Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection.	[Shi, Jiandong; Sun, Jing; Wu, Meini; Zhang, Jing; Duan, Zhiqing; Wang, Haixuan; Hu, Ningzhu; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming 650118, Peoples R China; [Wang, Bin] Kunming Univ, Dept Life Sci & Biotechnol, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming University	Hu, YZ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.	huyunzhangym@126.com			National High Technology Research and Development Program (863 Program) of China [2012AA02A406]; Applied and Fundamental Research Program of Yunnan Province [2013FA025]; Innovation Team Project of Yunnan Province of China; Provincial Innovation Team for Application Research on New Types of Vaccine Adjuvant, Institute of Medical Biology, Chinese Academy of Medical Sciences [2011CI140]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Applied and Fundamental Research Program of Yunnan Province; Innovation Team Project of Yunnan Province of China; Provincial Innovation Team for Application Research on New Types of Vaccine Adjuvant, Institute of Medical Biology, Chinese Academy of Medical Sciences	The authors thank Dr. Qihan Li for advice and comments made in the course of this work. The authors also thank Yue Wang, Liping Wang, and Hongzhi Cai for technical assistance. This study was supported by grants from the National High Technology Research and Development Program (863 Program) of China (2012AA02A406), Applied and Fundamental Research Program of Yunnan Province (2013FA025), and Innovation Team Project of Yunnan Province of China, Provincial Innovation Team for Application Research on New Types of Vaccine Adjuvant, Institute of Medical Biology, Chinese Academy of Medical Sciences (2011CI140). The authors declare no conflicts of interest.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDERSON DA, 1987, J MED VIROL, V22, P35, DOI 10.1002/jmv.1890220106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; BINN LN, 1984, J CLIN MICROBIOL, V20, P28, DOI 10.1128/JCM.20.1.28-33.1984; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; COHEN JI, 1989, J VIROL, V63, P5364, DOI 10.1128/JVI.63.12.5364-5370.1989; Cullen BR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000787; Dong QH, 2012, J HERED, V103, P268, DOI 10.1093/jhered/esr127; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Frings W, 2001, J GEN VIROL, V82, P597, DOI 10.1099/0022-1317-82-3-597; GREGERSEN JP, 1988, MED MICROBIOL IMMUN, V177, P91; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Langlois RA, 2012, MOL THER, V20, P367, DOI 10.1038/mt.2011.244; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; MAO JS, 1989, J INFECT DIS, V159, P621, DOI 10.1093/infdis/159.4.621; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moore HC, 2011, RNA, V17, P555, DOI 10.1261/rna.2591611; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; PROVOST PJ, 1979, P SOC EXP BIOL MED, V160, P213, DOI 10.3181/00379727-160-40422; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Roberts APE, 2011, PROG MOL BIOL TRANSL, V102, P101, DOI 10.1016/B978-0-12-415795-8.00002-7; ROSS BC, 1989, J GEN VIROL, V70, P2805, DOI 10.1099/0022-1317-70-10-2805; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Seo GJ, 2009, VIROLOGY, V383, P183, DOI 10.1016/j.virol.2008.11.001; Shapiro JS, 2013, WIRES RNA, V4, P463, DOI 10.1002/wrna.1169; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075323; Varble A, 2011, RNA BIOL, V8, P190, DOI 10.4161/rna.8.2.13983; Varble A, 2010, P NATL ACAD SCI USA, V107, P11519, DOI 10.1073/pnas.1003115107; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu Y, 2013, INT J MOL MED, V32, P1115, DOI 10.3892/ijmm.2013.1499; Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	23	24	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4381	4393		10.1096/fj.14-253534	http://dx.doi.org/10.1096/fj.14-253534			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002121				2022-12-25	WOS:000342222700017
J	Coulson-Thomas, VJ; Gesteira, TF; Hascall, V; Kao, W				Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Hascall, Vincent; Kao, Winston			Umbilical Cord Mesenchymal Stem Cells Suppress Host Rejection THE ROLE OF THE GLYCOCALYX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Hyaluronate; Inflammation; Mesenchymal Stem Cells (MSCs); Versican	INTER-ALPHA-INHIBITOR; WEIGHT HYALURONAN PROMOTES; STIMULATED GENE-6 TSG-6; ACUTE LUNG INJURY; EXTRACELLULAR-MATRIX; HEAVY-CHAINS; MACROPHAGE ACTIVATION; TRYPSIN INHIBITOR; PROTEINS; BINDING	Background: Umbilical cord mesenchymal stem cells (UMSCs) have unique immunosuppressive properties. Results: UMSCs express a rich glycocalyx, which confers their ability to modulate both macrophages and T-regulatory cells and to lead to inflammatory cell death. Conclusion: UMSCs actively modulate inflammatory cells by suppressing the immune response and evading rejection. Significance: Engineering cells to express this rich glycocalyx could increase transplantation success. Umbilical cord mesenchymal stem cells (UMSCs) have unique immunosuppressive properties enabling them to evade host rejection and making them valuable tools for cell therapy. We previously showed that human UMSCs survive xenograft transplantation and successfully correct the corneal clouding defects associated with the mouse model for the congenital metabolic disorder mucopolysaccharidosis VII. However, the precise mechanism by which UMSCs suppress the immune system remains elusive. This study aimed to determine the key components involved in the ability of the UMSCs to modulate the inflammatory system and to identify the inflammatory cells that are regulated by the UMSCs. Our results show that human UMSCs transplanted into the mouse stroma 24 h after an alkali burn suppress the severe inflammatory response and enable the recovery of corneal transparency within 2 weeks. Furthermore, we demonstrated in vitro that UMSCs inhibit the adhesion and invasion of inflammatory cells and also the polarization of M1 macrophages. UMSCs also induced the maturation of T-regulatory cells and led to inflammatory cell death. Moreover, UMSCs exposed to inflammatory cells synthesize a rich extracellular glycocalyx composed of the chondroitin sulfate-proteoglycan versican bound to a heavy chain (HC)-modified hyaluronan (HA) matrix (HC-HA). This matrix also contains TNF-stimulated gene 6 (TSG6), the enzyme that transfers HCs to HA, and pentraxin-3, which further stabilizes the matrix. Our results, both in vivo and in vitro, show that this glycocalyx confers the ability for UMSCs to survive the host immune system and to regulate the inflammatory cells.	Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Gesteira, Tarsis Ferreira] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Hascall, Vincent] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cleveland Clinic Foundation	Coulson-Thomas, VJ (corresponding author), Univ Cincinnati, 3230 Eden Ave,ML 0838, Cincinnati, OH 45267 USA.	vcoulsonthomas@gmail.com			National Institutes of Health from NEI [RO1 EY021768]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; Hyaluronan Matrices in Vascular Pathologies - National Institutes of Health from NHLBI [P01 HL107147]; NATIONAL EYE INSTITUTE [R01EY021768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Hyaluronan Matrices in Vascular Pathologies - National Institutes of Health from NHLBI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY021768 from NEI. This work was also supported by Research to Prevent Blindness, Ohio Lions Eye Research Foundation, and by The Hyaluronan Matrices in Vascular Pathologies funded by National Institutes of Health Grant P01 HL107147 from NHLBI.	Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Cantor JO, 1999, CONNECT TISSUE RES, V40, P97, DOI 10.3109/03008209909029105; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Coulson-Thomas VJ, 2013, STEM CELLS, V31, P2116, DOI 10.1002/stem.1481; Culley FJ, 2003, EUR J IMMUNOL, V33, P1302, DOI 10.1002/eji.200323509; de la Motte CA, 2011, J HISTOCHEM CYTOCHEM, V59, P252, DOI 10.1369/0022155410397760; DIETRICH CP, 1977, J CHROMATOGR, V130, P299, DOI 10.1016/S0021-9673(00)89809-X; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fong CY, 2012, STEM CELL REV REP, V8, P195, DOI 10.1007/s12015-011-9289-8; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; STEIN M, 1992, CLIN EXP ALLERGY, V22, P19, DOI 10.1111/j.1365-2222.1992.tb00110.x; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yamagami S, 2005, CORNEA, V24, pS71, DOI 10.1097/01.ico.0000178732.42921.05; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	48	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23465	23481		10.1074/jbc.M114.557447	http://dx.doi.org/10.1074/jbc.M114.557447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24986866	hybrid, Green Published			2022-12-25	WOS:000341505000020
J	Zumbrennen-Bullough, KB; Wu, QF; Core, AB; Canali, S; Chen, WJ; Theurl, I; Meynard, D; Babitt, JL				Zumbrennen-Bullough, Kimberly B.; Wu, Qifang; Core, Amanda B.; Canali, Susanna; Chen, Wenjie; Theurl, Igor; Meynard, Delphine; Babitt, Jodie L.			MicroRNA-130a Is Up-regulated in Mouse Liver by Iron Deficiency and Targets the Bone Morphogenetic Protein (BMP) Receptor ALK2 to Attenuate BMP Signaling and Hepcidin Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Activin A Receptor; Type I (ACVR1); Bone Morphogenetic Protein (BMP); Iron Metabolism; MicroRNA (miRNA); Signal Transduction; SMAD Transcription Factor; ALK2; SMAD4; Hepcidin; miR-130a	EXPRESSION; HOMEOSTASIS; INFECTION; PATHWAY; TMPRSS6; ANEMIA; HFE; ID1	Background: Hepcidin controls systemic iron balance and is regulated by bone morphogenetic protein (BMP) signaling. Results: MicroRNA miR-130a is up-regulated by iron deficiency and targets BMP type I receptor ALK2 to suppress BMP signaling and hepcidin. Conclusion: miR-130a is a novel regulator of BMP signaling and hepcidin. Significance: This pathway may increase iron availability in the setting of iron deficiency. Systemic iron balance is controlled by the liver peptide hormone hepcidin, which is transcriptionally regulated by the bone morphogenetic protein (BMP)-SMAD pathway. In iron deficiency, liver BMP-SMAD signaling and hepcidin are suppressed as a compensatory mechanism to increase iron availability. MicroRNAs are small regulatory RNAs that have an increasingly recognized role in many biologic processes but are only recently implicated in iron homeostasis regulation. Here, we demonstrate that liver expression of the microRNA miR-130a is up-regulated by iron deficiency in mice. We identify the BMP6-SMAD signaling pathway as a functional target of miR-130a in hepatoma-derived Hep3B cells. Although the TGF-/BMP common mediator SMAD4 was previously reported to be an miR-130a target to inhibit TGF- signaling, we do not confirm SMAD4 as an miR-130a target in our biologic system. Instead, we determine that the BMP type I receptor ALK2 is a novel target of miR-130a and that miR-130a binds to two specific sites in the 3-untranslated region to reduce ALK2 mRNA stability. Moreover, we show in mice that the increased liver miR-130a during iron deficiency is associated with reduced liver Alk2 mRNA levels. Finally, we demonstrate that down-regulation of ALK2 by miR-130a has a functional effect to inhibit BMP6-induced hepcidin transcription in Hep3B cells. Our data suggest that iron deficiency increases liver miR-130a, which, by targeting ALK2, may contribute to reduce BMP-SMAD signaling, suppress hepcidin synthesis, and thereby promote iron availability.	[Zumbrennen-Bullough, Kimberly B.; Wu, Qifang; Core, Amanda B.; Canali, Susanna; Chen, Wenjie; Theurl, Igor; Meynard, Delphine; Babitt, Jodie L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Ctr Syst Biol, Program Anemia Signaling Res,Div Nephrol,Program, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Babitt, JL (corresponding author), Massachusetts Gen Hosp, 185 Cambridge St,CPZN-8208, Boston, MA 02114 USA.	babitt.jodie@mgh.harvard.edu	meynard, delphine/B-4236-2014	meynard, delphine/0000-0002-9927-5535; Theurl, Igor/0000-0003-3180-4784	National Institutes of Health [RO1-DK087727, T32 DK007540]; William F. Milton Fund from Harvard University; Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007540, R01DK087727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William F. Milton Fund from Harvard University; Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK087727 (to J. L. B.) and Training Grant T32 DK007540 (to K. Z. B. and A. B. C.). This work was also supported by the William F. Milton Fund from Harvard University and a Howard Goodman fellowship award from the Massachusetts General Hospital (to J. L. B.). J. L. B. has ownership interest in the start-up company Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital based on work cited here and in prior publications.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Castoldi M, 2012, CELL MOL LIFE SCI, V69, P3945, DOI 10.1007/s00018-012-1031-4; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Corradini E, 2010, GASTROENTEROLOGY, V139, P1721, DOI 10.1053/j.gastro.2010.07.044; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hager M, 2011, BLOOD, V118, P6649, DOI 10.1182/blood-2011-03-339978; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Li YJ, 2012, CELL METAB, V15, P895, DOI 10.1016/j.cmet.2012.04.021; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mole DR, 2010, ANTIOXID REDOX SIGN, V12, P445, DOI 10.1089/ars.2009.2790; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sakamoto N, 2007, BIOCHEM BIOPH RES CO, V357, P467, DOI 10.1016/j.bbrc.2007.03.167; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Theurl I, 2011, HAEMATOL-HEMATOL J, V96, P1761, DOI 10.3324/haematol.2011.048926; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	35	30	31	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23796	23808		10.1074/jbc.M114.577387	http://dx.doi.org/10.1074/jbc.M114.577387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002578	hybrid, Green Published			2022-12-25	WOS:000341505000047
J	Sim, L; Beeren, SR; Findinier, J; Dauvillee, D; Ball, SG; Henriksen, A; Palcic, MM				Sim, Lyann; Beeren, Sophie R.; Findinier, Justin; Dauvillee, David; Ball, Steven G.; Henriksen, Anette; Palcic, Monica M.			Crystal Structure of the Chlamydomonas Starch Debranching Enzyme Isoamylase ISA1 Reveals Insights into the Mechanism of Branch Trimming and Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE ENDOSPERM; AMYLOPECTIN BIOSYNTHESIS; HOMO-OLIGOMER; DATA QUALITY; REINHARDTII; MODEL; GLYCOGEN; MUTANTS; GRANULE; PLANTS	The starch debranching enzymes isoamylase 1 and 2 (ISA1 and ISA2) are known to exist in a large complex and are involved in the biosynthesis and crystallization of starch. It is suggested that the function of the complex is to remove misplaced branches of growing amylopectin molecules, which would otherwise prevent the association and crystallization of adjacent linear chains. Here, we investigate the function of ISA1 and ISA2 from starch producing alga Chlamydomonas. Through complementation studies, we confirm that the STA8 locus encodes for ISA2 and sta8 mutants lack the ISA1.ISA2 heteromeric complex. However, mutants retain a functional dimeric ISA1 that is able to partly sustain starch synthesis in vivo. To better characterize ISA1, we have overexpressed and purified ISA1 from Chlamydomonas reinhardtii (CrISA1) and solved the crystal structure to 2.3 angstrom and in complex with maltoheptaose to 2.4 angstrom Analysis of the homodimeric CrISA1 structure reveals a unique elongated structure with monomers connected end-to-end. The crystal complex reveals details about the mechanism of branch binding that explains the low activity of CrISA1 toward tightly spaced branches and reveals the presence of additional secondary surface carbohydrate binding sites.	[Sim, Lyann; Beeren, Sophie R.; Henriksen, Anette; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Findinier, Justin; Dauvillee, David; Ball, Steven G.] UMR 8576 CNRS USTL, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Sim, L (corresponding author), Ryerson Univ, Dept Chem & Biol, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	lya.sim@gmail.com	Beeren, Sophie R/B-6033-2015; Dauvillée, David/A-2174-2009	Beeren, Sophie R/0000-0002-6682-3603; Dauvillée, David/0000-0002-0751-9193; Henriksen, Anette/0000-0003-4051-5079; Ball, Steven/0000-0003-1629-1650	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Carlsberg Foundation.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Dauvillee D, 2000, PLANT SCI, V157, P145, DOI 10.1016/S0168-9452(00)00256-9; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1710, DOI 10.1104/pp.125.4.1710; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; LIBESSART N, 1995, PLANT CELL, V7, P1117; Lin QH, 2013, NEW PHYTOL, V200, P1009, DOI 10.1111/nph.12446; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mouille G, 1996, PLANT CELL, V8, P1353; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nelson N, 1944, J BIOL CHEM, V153, P375; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Song HN, 2010, PROTEINS, V78, P1847, DOI 10.1002/prot.22697; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075223; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p	52	36	37	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22991	23003		10.1074/jbc.M114.565044	http://dx.doi.org/10.1074/jbc.M114.565044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24993830	Green Published, hybrid			2022-12-25	WOS:000341017200038
J	Huang, R; Zhang, L; Gu, Q; Zhou, YH; Hao, YY; Zhang, K; Liu, Y; Dong, DJ; Wang, SX; Huang, ZH; Lu, S; Wu, C				Huang, Rui; Zhang, Lu; Gu, Qin; Zhou, Yi-Hua; Hao, Yingying; Zhang, Kui; Liu, Yong; Dong, Danjiang; Wang, Shixia; Huang, Zuhu; Lu, Shan; Wu, Chao			Profiles of Acute Cytokine and Antibody Responses in Patients Infected with Avian Influenza A H7N9	PLOS ONE			English	Article							C-VIRUS-INFECTION; RECEPTOR-BINDING; IP-10 PREDICTS; VIRAL RESPONSE; A(H7N9) VIRUS; T-CELLS; CHINA; FERRETS; TRANSMISSION; IMMUNIZATION	The influenza A H7N9 virus outbreak in Eastern China in the spring of 2013 represented a novel, emerging avian influenza transmission to humans. While clinical and microbiological features of H7N9 infection have been reported in the literature, the current study investigated acute cytokine and antibody responses in acute H7N9 infection. Between March 27, 2013 and April 23, 2013, six patients with confirmed H7N9 influenza infection were admitted to Drum Tower Hospital, Nanjing, China. Acute phase serum cytokine profiles were determined using a high-throughput multiplex assay. Daily H7 hemagglutinin (HA)-specific IgG, IgM, and IgA responses were monitored by ELISA. Neutralizing antibodies specific for H7N9 viruses were determined against a pseudotyped virus expressing the novel H7 subtype HA antigen. Five cytokines (IL-6, IP-10, IL-10, IFN gamma, and TNF alpha) were significantly elevated in H7N9-infected patients when compared to healthy volunteers. Serum H7 HA-specific IgG, as well as IgM and IgA responses, were detected within 8 days of disease onset and increased in a similar pattern during acute infection. Neutralizing antibodies developed shortly after the appearance of binding antibody responses and showed similar kinetics as a fraction of the total H7 HA-specific IgG responses. H7N9 infection resulted in hallmark serum cytokine increases, which correlated with fever and disease persistence. The novel finding of simultaneous development of IgG, IgM, and IgA responses in acute H7N9 infection points to the potential for live influenza viruses to elicit fast and potent protective antibodies to limit the infection.	[Huang, Rui; Zhou, Yi-Hua; Wu, Chao] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China; [Gu, Qin; Hao, Yingying; Dong, Danjiang] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Intens Care Units, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Zhang, Kui; Liu, Yong] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Liu, Yong] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Rui] Nanjing Univ Chinese Med, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Huang, Zuhu] Nanjing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Wang, Shixia; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China.	shan.lu@umassmed.edu; wuchao1962@163.com	Wu, Chao/H-3195-2019; liu, yong/AAD-1467-2019; Liu, Yong/GWQ-6163-2022		National Institutes of Health [5U01AI078073-04]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154]; Jiangsu Science and Technology Department [BL2012034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Science and Technology Department; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [5U01AI078073-04] to [SL], Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201154] to [CW], and a Special Grant from Jiangsu Science and Technology Department [BL2012034] to [CW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansour I, 2013, HUM VACCIN IMMUNOTHE, V9; Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Falconer K, 2010, SCAND J INFECT DIS, V42, P896, DOI 10.3109/00365548.2010.498019; Fouchier RAM, 2013, NATURE, V500, P150, DOI 10.1038/500150a; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Han J, 2014, MICROBES INFECT; Han JK, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.28; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Koopmans M, 2013, LANCET, V381, P1882, DOI 10.1016/S0140-6736(13)60936-8; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Qiu C, 2013, EMERG INFECT DIS, V19, P1685, DOI 10.3201/eid1910.130728; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Shen Z, 2013, CLIN MICROBIOL INFEC; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tomaras GD, 2013, P NATL ACAD SCI; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Wang Y, 2013, AM J RESP CRIT CARE, V188, P115, DOI 10.1164/rccm.201305-0936LE; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wen YM, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.18; WHO, 2013, HUM INF AV INFL A H7; Wu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082613; Wu H, 2013, N ENGL J MED; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Yang FF, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.22; Yang S, 2013, J INFECT DIS; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Yu XL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.41; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680; Zhang L, 2014, HUM VACCIN IMMUNOTHE, V10; Zhao GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092987; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu ZQ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.50	50	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101788	10.1371/journal.pone.0101788	http://dx.doi.org/10.1371/journal.pone.0101788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003343	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700067
J	Riemer, S; Muller, C; Viranyi, Z; Huber, L; Range, F				Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike			The Predictive Value of Early Behavioural Assessments in Pet Dogs - A Longitudinal Study from Neonates to Adults	PLOS ONE			English	Article							GERMAN-SHEPHERD DOGS; PRINCIPAL-COMPONENTS-ANALYSIS; POTENTIAL GUIDE DOGS; INDIVIDUAL-DIFFERENCES; INFANT TEMPERAMENT; CANIS-LUPUS; PARUS-MAJOR; GREAT TITS; PERSONALITY; STABILITY	Studies on behavioural development in domestic dogs are of relevance for matching puppies with the right families, identifying predispositions for behavioural problems at an early stage, and predicting suitability for service dog work, police or military service. The literature is, however, inconsistent regarding the predictive value of tests performed during the socialisation period. Additionally, some practitioners use tests with neonates to complement later assessments for selecting puppies as working dogs, but these have not been validated. We here present longitudinal data on a cohort of Border collies, followed up from neonate age until adulthood. A neonate test was conducted with 99 Border collie puppies aged 2-10 days to assess activity, vocalisations when isolated and sucking force. At the age of 40-50 days, 134 puppies (including 93 tested as neonates) were tested in a puppy test at their breeders' homes. All dogs were adopted as pet dogs and 50 of them participated in a behavioural test at the age of 1.5 to 2 years with their owners. Linear mixed models found little correspondence between individuals' behaviour in the neonate, puppy and adult test. Exploratory activity was the only behaviour that was significantly correlated between the puppy and the adult test. We conclude that the predictive validity of early tests for predicting specific behavioural traits in adult pet dogs is limited.	[Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab, Vienna, Austria; [Riemer, Stefanie; Mueller, Corsin; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Univ Vienna, Vienna, Austria; [Riemer, Stefanie; Mueller, Corsin] Univ Vienna, Dept Cognit Biol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna	Riemer, S (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab, Vienna, Austria.	riemer.stefanie@gmail.com		Range, Friederike/0000-0003-3127-5536; Riemer, Stefanie/0000-0001-8008-5291; Huber, Ludwig/0000-0002-0217-136X	Austrian Science Fund (FWF) [P21418]; FWF DK CogCom Programme; FWF [P21244-B17]; WWTF [CS11-005, CS11-026]; Austrian Science Fund (FWF) [P 21418] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF DK CogCom Programme; FWF(Austrian Science Fund (FWF)); WWTF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) grant P21418 to L.H. and F.R.; FWF DK CogCom Programme to S.R.; FWF grant P21244-B17 to F.R. www.fwf.ac.at; WWTF grant CS11-005 to L.H.; WWTF grant CS11-026 to Zs.V., www.wwtf.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; BEAUDET R, 1994, APPL ANIM BEHAV SCI, V40, P273, DOI 10.1016/0168-1591(94)90068-X; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Costa PT, 2000, ASSESSMENT, V7, P365, DOI 10.1177/107319110000700405; CROCKENBERG SB, 1982, INFANT BEHAV DEV, V5, P105, DOI 10.1016/S0163-6383(82)80021-0; Foyer P, 2014, APPL ANIM B IN PRESS; Foyer P, 2013, APPL ANIM BEHAV SCI, V146, P79, DOI 10.1016/j.applanim.2013.03.013; FRANCIS RC, 1990, ETHOLOGY, V86, P311, DOI 10.1111/j.1439-0310.1990.tb00439.x; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; GODDARD ME, 1984, APPL ANIM BEHAV SCI, V12, P253, DOI 10.1016/0168-1591(84)90118-7; Goddard ME, 1986, EARLY PREDICTION ADU; Heath-Lange S, 1999, AM J PRIMATOL, V47, P43, DOI 10.1002/(SICI)1098-2345(1999)47:1<43::AID-AJP5>3.0.CO;2-M; HOLM S, 1979, SCAND J STAT, V6, P65; HUBERT NC, 1982, CHILD DEV, V53, P571, DOI 10.2307/1129370; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KORNER AF, 1971, AM J ORTHOPSYCHIAT, V41, P608, DOI 10.1111/j.1939-0025.1971.tb03220.x; Korner AF, 2010, AM J ORTHOPSYCHIAT, V41, P608; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Lindsay S. R., 2000, HDB APPL DOG BEHAV T, V1; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; LOEHLIN JC, 1989, CHILD DEV, V60, P993, DOI 10.2307/1131039; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Lower SE, 2001, ANIM BEHAV, V61, P231, DOI 10.1006/anbe.2000.1545; MACDONALD K, 1983, J COMP PSYCHOL, V97, P99; MATHENY AP, 1985, DEV PSYCHOL, V21, P486, DOI 10.1037/0012-1649.21.3.486; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; Miklosi A., 2009, DOG BEHAV EVOLUTION; MIRZA SN, 1990, APPL ANIM BEHAV SCI, V28, P255, DOI 10.1016/0168-1591(90)90104-L; Overall KL, 2005, ILAR J, V46, P202, DOI 10.1093/ilar.46.2.202; Pinheiro J., 2013, R PACKAGE3, P1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riemer S, 2013, APPL ANIM BEHAV SCI, V149, P36, DOI 10.1016/j.applanim.2013.09.006; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Romeo RD, 2003, J NEUROENDOCRINOL, V15, P1185, DOI 10.1111/j.1365-2826.2003.01106.x; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Rooney NJ, 2004, APPL ANIM BEHAV SCI, V86, P123, DOI 10.1016/j.applanim.2003.12.007; Rothbart M.K., 1994, TEMPERAMENT INDIVIDU, P83, DOI DOI 10.1037/10149-003; Sachser N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0344; Saetre P, 2006, GENES BRAIN BEHAV, V5, P240, DOI 10.1111/j.1601-183X.2005.00155.x; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Scott J., 1976, GUIDE DOGS BLIND THE, P39; Scott JP., 1965, GENETICS SOCIAL BEHA; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; STEVENSON-HINDE J, 1980, Primates, V21, P66, DOI 10.1007/BF02383825; Strandberg E, 2005, LIVEST PROD SCI, V93, P33, DOI 10.1016/j.livprodsci.2004.11.004; Sussman A, 2011, DEV PSYCHOL, V47, P781, DOI 10.1037/a0022999; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; van der Waaij EH, 2008, J ANIM SCI, V86, P2853, DOI 10.2527/jas.2007-0616; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; Webster SD, 1997, P 1 INT C VET BEH ME, P20; Weinstein TAR, 2008, ANIM BEHAV, V76, P455, DOI 10.1016/j.anbehav.2008.01.024; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; WOROBEY J, 1989, DEV PSYCHOL, V25, P257, DOI 10.1037/0012-1649.25.2.257	67	33	33	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101237	10.1371/journal.pone.0101237	http://dx.doi.org/10.1371/journal.pone.0101237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003341	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000339242700022
J	Ciucci, A; Meco, D; De Stefano, I; Travaglia, D; Zannoni, GF; Scambia, G; Riccardi, R; Saran, A; Mancuso, M; Gallo, D				Ciucci, Alessandra; Meco, Daniela; De Stefano, Ilaria; Travaglia, Daniele; Zannoni, Gian Franco; Scambia, Giovanni; Riccardi, Riccardo; Saran, Anna; Mancuso, Mariateresa; Gallo, Daniela			Gender Effect in Experimental Models of Human Medulloblastoma: Does the Estrogen Receptor beta Signaling Play a Role?	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CANCER CELL-PROLIFERATION; ALPHA ER-ALPHA; DNA-REPAIR; EXPRESSION; GROWTH; ER-BETA-2; CHILDREN; SURVIVAL; NUCLEAR	Background: The male-to-female sex ratio for medulloblastoma (MB) is approximately 1.5:1, female gender being also a favorable prognostic factor. This study aimed at evaluating the impact of gender on MB tumorigenesis. Methods: In vitro activity of 17 beta-estradiol (E-2), DPN [2,3-bis(4-hydroxyphenyl)-propionitrile, a selective estrogen receptor beta (ER beta)-agonist], PPT [4,4',4 ''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol, a selective ER alpha-agonist] or DHT (5 alpha-dihydrotestosterone) was evaluated in three human MB cell lines. D283 Med cells were transplanted into athymic mice. Results: A significant expression of ERb, with little or no ER alpha, and low AR (androgen receptor) was found in MB cell lines. The compounds tested did not affect cell proliferation. In vivo, we observed a significantly lower growth of D283 Med in nude female mice compared to males. At microscopic examination, tumors from females showed a shift towards differentiation, as evaluated by lower nestin, and higher NSE (neuron-specific enolase) and GFAP (glial fibrillary acidic protein) expression compared to males. Tumors from females also showed lower Ki67 and p53 expression. The wild-type ER beta protein (ER beta 1) was lost in male tumors, while it was a permanent feature in females, and a strong negative correlation was found between Ki67 and ER beta 1 expression. Conversely, tumor levels of ER beta 2 and ER beta 5 did not significantly differ between genders. Increased levels of cyclin-dependent kinase inhibitor p21 were observed in females, suggesting that estrogen may decrease tumor growth through blocking cell cycle progression. An inhibition of the insulin-like growth factor I (IGF-I) signaling was also evident in females. Conclusion: We provides mechanistic evidence supporting the idea that ERb1 signaling may have pro-differentiation and tumor suppressive function in medulloblastomas.	[Ciucci, Alessandra; Travaglia, Daniele; Scambia, Giovanni; Gallo, Daniela] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy; [Meco, Daniela; Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Div Pediat Oncol, I-00168 Rome, Italy; [De Stefano, Ilaria] Univ Guglielmo Marconi, Dept Radiat Phys, Rome, Italy; [Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Dept Histopathol, I-00168 Rome, Italy; [Saran, Anna; Mancuso, Mariateresa] CR Casaccia, Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Lab Radiat Biol & Biomed, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Guglielmo Marconi University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Italian National Agency New Technical Energy & Sustainable Economics Development	Gallo, D (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Largo A Gemelli 8, I-00168 Rome, Italy.	d.gallo@rm.unicatt.it	Zannoni, Gian Franco/AAC-4754-2020; Gallo, Daniela/K-2518-2018	Zannoni, Gian Franco/0000-0002-4473-7560; Gallo, Daniela/0000-0002-1918-1054; Saran, Anna/0000-0002-5587-064X; Meco, Daniela/0000-0003-3488-4185; RICCARDI, RICCARDO/0000-0001-7515-6622				Ajeawung NF, 2012, CLIN INVEST MED, V35, pE246; Arai H, 2012, BRAIN TUMOR PATHOL, V29, P160, DOI 10.1007/s10014-012-0081-5; Barone TA, 2009, J NEURO-ONCOL, V95, P37, DOI 10.1007/s11060-009-9904-6; Belcher SM, 2009, ENDOCRINOLOGY, V150, P1112, DOI 10.1210/en.2008-1363; Bielecki A, 2011, NUTR CANCER, V63, P139, DOI 10.1080/01635581.2010.516867; Brandes AA, 2004, CRIT REV ONCOL HEMAT, V50, P121, DOI 10.1016/j.critrevonc.2003.08.005; Brandes AA, 2009, CRIT REV ONCOL HEMAT, V71, P165, DOI 10.1016/j.critrevonc.2009.02.002; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Chen S, 1999, ENDOCR-RELAT CANCER, V6, P149, DOI 10.1677/erc.0.0060149; Ciucci A, 2014, GYNECOL ONCOL, V132, P351, DOI 10.1016/j.ygyno.2013.12.027; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Corbert T., 1997, ANTICANCER DRUG DEV, P75; Curran EK, 2009, PEDIATR BLOOD CANCER, V52, P60, DOI 10.1002/pbc.21832; de Bont JM, 2008, INT J CANCER, V123, P594, DOI 10.1002/ijc.23558; De Stefano I, 2009, BIOCHEM PHARMACOL, V78, P1374, DOI 10.1016/j.bcp.2009.07.011; Dean SL, 2008, CEREBELLUM, V7, P38, DOI 10.1007/s12311-008-0003-6; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Eberhart CG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-19; Gallo D, 2008, J NUTR, V138, P1360, DOI 10.1093/jn/138.7.1360; Gallo D, 2012, CURR PHARM DESIGN, V18, P2734, DOI 10.2174/138161212800626139; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; HAYASHI K, 1987, ACTA PATHOL JAPON, V37, P85; Hayat MA, 2002, MICROSCOPY IMMUNOHIS, P276; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Jakab RL, 2001, J COMP NEUROL, V430, P396, DOI 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Kefalopoulou Z, 2012, J NEURO-ONCOL, V106, P23, DOI 10.1007/s11060-011-0637-y; Keles GE, 1995, ONCOL RES, V7, P493; KUMANISHI T, 1985, ACTA NEUROPATHOL, V67, P1, DOI 10.1007/BF00688118; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Lin HY, 2009, J STEROID BIOCHEM, V113, P182, DOI 10.1016/j.jsbmb.2008.12.010; Lindgren PR, 2004, MOL CELL ENDOCRINOL, V221, P97, DOI 10.1016/j.mce.2004.02.020; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mancuso M, 2011, CANCER LETT, V308, P197, DOI 10.1016/j.canlet.2011.05.004; Mancuso M, 2010, INT J CANCER, V127, P2749, DOI 10.1002/ijc.25293; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Plunkett RJ, 1999, J NEUROSURG, V90, P1072, DOI 10.3171/jns.1999.90.6.1072; PRADOS MD, 1995, INT J RADIAT ONCOL, V32, P1145, DOI 10.1016/0360-3016(94)00476-2; PRESTONMARTIN S, 1993, NEUROEPIDEMIOLOGY, V12, P270, DOI 10.1159/000110328; Ray A, 2004, CLIN CANCER RES, V10, P7613, DOI 10.1158/1078-0432.CCR-04-0499; Roger P, 2001, CANCER RES, V61, P2537; Saran A, 2009, CURR MOL MED, V9, P1046, DOI 10.2174/156652409789839080; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Saunders PTK, 2002, BRIT J CANCER, V86, P250, DOI 10.1038/sj/bjc/6600035; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Sime P J, 1989, Br J Neurosurg, V3, P89, DOI 10.3109/02688698909001030; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Sonne-Hansen K, 2005, J STEROID BIOCHEM, V93, P25, DOI 10.1016/j.jsbmb.2004.11.005; Sun T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-3; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Treeck O, 2008, BREAST CANCER RES TR, V110, P507, DOI 10.1007/s10549-007-9749-7; Treeck O, 2010, BREAST CANCER RES TR, V120, P557, DOI 10.1007/s10549-009-0413-2; Urbanska K, 2009, J CELL PHYSIOL, V219, P392, DOI 10.1002/jcp.21683; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weil MD, 1998, JAMA-J AM MED ASSOC, V279, P1474, DOI 10.1001/jama.279.18.1474; Wong NACS, 2005, J PATHOL, V207, P53, DOI 10.1002/path.1807; Workman P, 1998, BRIT J CANCER, V77, P1; Wu XL, 2012, J CELL BIOCHEM, V113, P711, DOI 10.1002/jcb.23443; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Yan M, 2011, BREAST CANCER RES TR, V126, P395, DOI 10.1007/s10549-010-0941-9; Zannoni GF, 2013, HUM PATHOL, V44, P1047, DOI 10.1016/j.humpath.2012.09.007	67	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101623	10.1371/journal.pone.0101623	http://dx.doi.org/10.1371/journal.pone.0101623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000562	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300063
J	Greenbaum, BD; Kumar, P; Libchaber, A				Greenbaum, Benjamin D.; Kumar, Pradeep; Libchaber, Albert			Using First Passage Statistics to Extract Environmentally Dependent Amino Acid Correlations	PLOS ONE			English	Article							SALT BRIDGES; PROTEINS; BIOTECHNOLOGY; PROKARYOTES; DISULFIDES; PATTERNS	In this work, we study the first passage statistics of amino acid primary sequences, that is the probability of observing an amino acid for the first time at a certain number of residues away from a fixed amino acid. By using this rich mathematical framework, we are able to capture the background distribution for an organism, and infer lengths at which the first passage has a probability that differs from what is expected. While many features of an organism's genome are due to natural selection, others are related to amino acid chemistry and the environment in which an organism lives, constraining the randomness of genomes upon which selection can further act. We therefore use this approach to infer amino acid correlations, and then study how these correlations vary across a wide range of organisms under a wide range of optimal growth temperatures. We find a nearly universal exponential background distribution, consistent with the idea that most amino acids are globally uncorrelated from other amino acids in genomes. When we are able to extract significant correlations, these correlations are reliably dependent on optimal growth temperature, across phylogenetic boundaries. Some of the correlations we extract, such as the enhanced probability of finding, for the first time, a cysteine three residues away from a cysteine or glutamic acid two residues away from an arginine, likely relate to thermal stability. However, other correlations, likely appearing on alpha helical surfaces, have a less clear physiochemical interpretation and may relate to thermal stability or unusual metabolic properties of organisms that live in a high temperature environment.	[Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol & Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Greenbaum, Benjamin D.; Libchaber, Albert] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA; [Kumar, Pradeep; Libchaber, Albert] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; [Kumar, Pradeep] Univ Arkansas, Dept Phys, Little Rock, AR 72204 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institute for Advanced Study - USA; Rockefeller University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Greenbaum, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol & Pathol, New York, NY 10029 USA.	benjamin.greenbaum@mssm.edu		Kumar, Pradeep/0000-0002-7417-9467	Simons Center for Systems Biology at the Institute for Advanced Study	Simons Center for Systems Biology at the Institute for Advanced Study	The work was supported by the Simons Center for Systems Biology at the Institute for Advanced Study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOUS D, 1983, LECT NOTES MATH, V986, P243; Aldous DJ., 1982, STOCHASTIC PROCESS A, V13, P305, DOI [10.1016/0304-4149(82)90016-3, DOI 10.1016/0304-4149(82)90016-3]; Barton LL, 2009, ADV APPL MICROBIOL, V68, P41, DOI 10.1016/S0065-2164(09)01202-7; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Bragg JG, 2006, P ROY SOC B-BIOL SCI, V273, P1293, DOI 10.1098/rspb.2005.3441; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chung K. L, 1960, MARKOV CHAINS STATIO; de Farias ST, 2002, GENOME BIOL, V3; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; FELLER W., 1971, INTRO PROBABILITY TH, VII; Greenbaum B, 2013, ARXIV13094761; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Horikoshi K., 2011, EXTREMOPHILES HDB; Keilson J., 1979, MARKOV CHAIN MODELS; Klipcan L, 2006, FEBS LETT, V580, P1672, DOI 10.1016/j.febslet.2006.02.013; Kumar P, 2013, BIOPHYS J IN PRESS; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Ladenstein R, 2008, EXTREMOPHILES, V12, P29, DOI 10.1007/s00792-007-0076-z; Ladenstein R, 2006, FEBS J, V273, P4170, DOI 10.1111/j.1742-4658.2006.05421.x; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rosato V, 2002, TRENDS GENET, V18, P278, DOI 10.1016/S0168-9525(02)02691-4; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Suhre K, 2003, J BIOL CHEM, V19, P513; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101665	10.1371/journal.pone.0101665	http://dx.doi.org/10.1371/journal.pone.0101665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000191	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300068
J	Hinchliff, CE; Smith, SA				Hinchliff, Cody E.; Smith, Stephen Andrew			Some Limitations of Public Sequence Data for Phylogenetic Inference (in Plants)	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCES; SPARSE SUPERMATRICES; ROGUE TAXA; DIVERSIFICATION; LIKELIHOOD; GENES; LIFE; TREE; MITOCHONDRIAL; HISTORY	The GenBank database contains essentially all of the nucleotide sequence data generated for published molecular systematic studies, but for the majority of taxa these data remain sparse. GenBank has value for phylogenetic methods that leverage data-mining and rapidly improving computational methods, but the limits imposed by the sparse structure of the data are not well understood. Here we present a tree representing 13,093 land plant genera-an estimated 80% of extant plant diversity-to illustrate the potential of public sequence data for broad phylogenetic inference in plants, and we explore the limits to inference imposed by the structure of these data using theoretical foundations from phylogenetic data decisiveness. We find that despite very high levels of missing data (over 96%), the present data retain the potential to inform over 86.3% of all possible phylogenetic relationships. Most of these relationships, however, are informed by small amounts of data-approximately half are informed by fewer than four loci, and more than 99% are informed by fewer than fifteen. We also apply an information theoretic measure of branch support to assess the strength of phylogenetic signal in the data, revealing many poorly supported branches concentrated near the tips of the tree, where data are sparse and the limiting effects of this sparseness are stronger. We argue that limits to phylogenetic inference and signal imposed by low data coverage may pose significant challenges for comprehensive phylogenetic inference at the species level. Computational requirements provide additional limits for large reconstructions, but these may be overcome by methodological advances, whereas insufficient data coverage can only be remedied by additional sampling effort. We conclude that public databases have exceptional value for modern systematics and evolutionary biology, and that a continued emphasis on expanding taxonomic and genomic coverage will play a critical role in developing these resources to their full potential.	[Hinchliff, Cody E.; Smith, Stephen Andrew] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hinchliff, CE (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	cody.hinchliff@gmail.com	Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531	National Science Foundation [DEB 1207915]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (http://www.nsf.gov/) award DEB 1207915 to S. A. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Chang Y, 2011, AM J BOT, V98, P839, DOI 10.3732/ajb.0900384; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chase MW, 2004, AM J BOT, V91, P1645, DOI 10.3732/ajb.91.10.1645; Chesters D, 2013, SYST BIOL; Dress AWM, 2012, MATH BIOL, V105, P65; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Govaerts R, 2003, TAXON, V52, P583, DOI 10.2307/3647457; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hinchliff CE, 2013, SYST BIOL, V62, P205, DOI 10.1093/sysbio/sys088; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Misof B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-348; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; National Center for Biotechnology Information, 2013, TAX STAT; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rambaut A, 2012, FIGTREE 1 4; Salichos L, 2014, MOL BIOL EVOL; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Smith SA, 2014, PHYX; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; Smith SA, 2012, BIOINFORMATICS, V28, P2689, DOI 10.1093/bioinformatics/bts492; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Soltis DE, 1997, ANN MO BOT GARD, V84, P1, DOI 10.2307/2399952; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis DE, 2010, ANN MO BOT GARD, V97, P514, DOI 10.3417/2009136; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2010, APPL MATH LETT, V23, P82, DOI 10.1016/j.aml.2009.08.009; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Timme RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029696; Treleaven N, 2012, GEANY	48	31	31	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e98986	10.1371/journal.pone.0098986	http://dx.doi.org/10.1371/journal.pone.0098986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999823	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300003
J	Jacquin, L; Mori, Q; Pause, M; Steffen, M; Medoc, V				Jacquin, Lisa; Mori, Quentin; Pause, Mickael; Steffen, Melanie; Medoc, Vincent			Non-Specific Manipulation of Gammarid Behaviour by P-minutus Parasite Enhances Their Predation by Definitive Bird Hosts	PLOS ONE			English	Article							2 ACANTHOCEPHALAN PARASITES; POLYMORPHUS-MINUTUS; NONHOST PREDATOR; ANTIPREDATOR BEHAVIOR; ADAPTIVE-CHANGES; FISH PREDATORS; FIELD EVIDENCE; MULTIDIMENSIONALITY; INFECTION; VULNERABILITY	Trophically-transmitted parasites often change the phenotype of their intermediate hosts in ways that increase their vulnerability to definitive hosts, hence favouring transmission. As a "collateral damage'', manipulated hosts can also become easy prey for non-host predators that are dead ends for the parasite, and which are supposed to play no role in transmission strategies. Interestingly, infection with the acanthocephalan parasite Polymorphus minutus has been shown to reduce the vulnerability of its gammarid intermediate hosts to non-host predators, whose presence triggered the behavioural alterations expected to favour trophic transmission to bird definitive hosts. Whilst the behavioural response of infected gammarids to the presence of definitive hosts remains to be investigated, this suggests that trophic transmission might be promoted by non-host predation risk. We conducted microcosm experiments to test whether the behaviour of P. minutus-infected gammarids was specific to the type of predator (i.e. mallard as definitive host and fish as non-host), and mesocosm experiments to test whether trophic transmission to bird hosts was influenced by non-host predation risk. Based on the behaviours we investigated (predator avoidance, activity, geotaxis, conspecific attraction), we found no evidence for a specific fine-tuned response in infected gammarids, which behaved similarly whatever the type of predator (mallard or fish). During predation tests, fish predation risk did not influence the differential predation of mallards that over-consumed infected gammarids compared to uninfected individuals. Overall, our results bring support for a less sophisticated scenario of manipulation than previously expected, combining chronic behavioural alterations with phasic behavioural alterations triggered by the chemical and physical cues coming from any type of predator. Given the wide dispersal range of waterbirds (the definitive hosts of P. minutus), such a manipulation whose efficiency does not depend on the biotic context is likely to facilitate its trophic transmission in a wide range of aquatic environments.	[Jacquin, Lisa; Mori, Quentin; Pause, Mickael; Steffen, Melanie; Medoc, Vincent] Univ Paris 06, Inst Ecol & Environm Sci, iEES, CNRS,UMR 7618, Paris, France; [Jacquin, Lisa] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Jacquin, Lisa] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); McGill University; McGill University	Jacquin, L (corresponding author), Univ Paris 06, Inst Ecol & Environm Sci, iEES, CNRS,UMR 7618, Paris, France.	jacquin.lisa@gmail.com	Jacquin, Lisa/H-6878-2019	Jacquin, Lisa/0000-0002-0521-6113	Pierre & Marie Curie University; Versailles-St-Quentin University; Fyssen foundation	Pierre & Marie Curie University; Versailles-St-Quentin University; Fyssen foundation	This work was funded by a grant to VM and LJ from the Pierre & Marie Curie University. LJ was funded by an ATER fellowship from the Versailles-St-Quentin University (2011-2012), and by the Fyssen foundation (2012-2013). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Baldauf SA, 2007, INT J PARASITOL, V37, P61, DOI 10.1016/j.ijpara.2006.09.003; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Bauer A, 2005, J ZOOL, V267, P39, DOI 10.1017/S0952836905007223; Beisel JN, 2010, ETHOL ECOL EVOL, V22, P265, DOI 10.1080/03949370.2010.502321; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Bollache L, 2006, ANIM BEHAV, V72, P627, DOI 10.1016/j.anbehav.2005.11.020; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; Cezilly F, 2000, PARASITOLOGY, V120, P625, DOI 10.1017/S0031182099005910; Cezilly F, 2013, J EXP BIOL, V216, P27, DOI 10.1242/jeb.074005; Cezilly F, 2010, OIKOS, V119, P1224, DOI 10.1111/j.1600-0706.2010.18579.x; Cezilly F, 2010, TRENDS PARASITOL, V26, P311, DOI 10.1016/j.pt.2010.03.009; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Coats J, 2010, BEHAVIOUR, V147, P367, DOI 10.1163/000579509X12574307194101; Dianne L, 2011, EVOLUTION, V65, P2692, DOI 10.1111/j.1558-5646.2011.01330.x; Durieux R, 2012, BEHAV PROCESS, V91, P207, DOI 10.1016/j.beproc.2012.08.002; Evans SR, 2007, ANIM BEHAV, V74, P1691, DOI 10.1016/j.anbehav.2007.03.017; Guler Y, 2010, AQUAT TOXICOL, V99, P397, DOI 10.1016/j.aquatox.2010.05.019; Hammerschmidt K, 2009, EVOLUTION, V63, P1976, DOI 10.1111/j.1558-5646.2009.00687.x; Hammond-Tooke CA, 2012, BEHAVIOUR, V149, P601, DOI 10.1163/156853912X648903; Helluy S, 2013, J EXP BIOL, V216, P67, DOI 10.1242/jeb.073213; Jacquin L, 2013, PARASITOLOGY, V140, P1310, DOI 10.1017/S0031182013000760; Kaldonski N, 2008, PARASITOLOGY, V135, P627, DOI 10.1017/S003118200800423X; Kaldonski N, 2007, ANIM BEHAV, V74, P1311, DOI 10.1016/j.anbehav.2007.02.027; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kortet R, 2010, ECOL LETT, V13, P1449, DOI 10.1111/j.1461-0248.2010.01536.x; Lafferty KD, 2013, J EXP BIOL, V216, P56, DOI 10.1242/jeb.073668; Lagrue C, 2007, ECOLOGY, V88, P2839, DOI 10.1890/06-2105.1; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; Lukacsovics F., 1959, Annales Instituti Biologici (Tihany) Hungaricae Academiae Scientiarum, V26, P31; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; Maure F, 2013, J EXP BIOL, V216, P36, DOI 10.1242/jeb.073130; Medoc V, 2008, PARASITOLOGY, V135, P977, DOI 10.1017/S0031182008004447; Medoc V, 2011, PARASITOLOGY, V138, P537, DOI 10.1017/S0031182010001617; Medoc V, 2006, INT J PARASITOL, V36, P1351, DOI 10.1016/j.ijpara.2006.07.001; Medoc V, 2011, OIKOS, V120, P1452, DOI 10.1111/j.1600-0706.2011.19585.x; Medoc V, 2009, NATURWISSENSCHAFTEN, V96, P513, DOI 10.1007/s00114-008-0503-8; Medoc V, 2009, ANIM BEHAV, V77, P1235, DOI 10.1016/j.anbehav.2009.01.029; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2003, INT J PARASITOL, V33, P1043, DOI 10.1016/S0020-7519(03)00178-4; Ness JH, 1999, OIKOS, V85, P127, DOI 10.2307/3546798; Parker GA, 2009, EVOLUTION, V63, P448, DOI 10.1111/j.1558-5646.2008.00565.x; Perrot-Minnot MJ, 2007, INT J PARASITOL, V37, P645, DOI 10.1016/j.ijpara.2006.12.005; Perrot-Minnot MJ, 2013, J EXP BIOL, V216, P134, DOI 10.1242/jeb.074146; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R, 2013, J EXP BIOL, V216, P18, DOI 10.1242/jeb.073353; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; RUMPUS AE, 1974, PARASITOLOGY, V68, P271, DOI 10.1017/S0031182000045789; Seppala O, 2008, BIOL LETTERS, V4, P663, DOI 10.1098/rsbl.2008.0335; Seppala O, 2008, P ROY SOC B-BIOL SCI, V275, P1611, DOI 10.1098/rspb.2008.0152; Tain L, 2006, P ROY SOC B-BIOL SCI, V273, P3039, DOI 10.1098/rspb.2006.3618; Thomas F, 2010, OIKOS, V119, P1230, DOI 10.1111/j.1600-0706.2010.18975.x; Thunken T, 2010, HYDROBIOLOGIA, V654, P137, DOI 10.1007/s10750-010-0377-6; Wudkevich K, 1997, J CHEM ECOL, V23, P1163, DOI 10.1023/B:JOEC.0000006393.92013.36; Zuur Alain F., 2009, P1	55	23	23	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101684	10.1371/journal.pone.0101684	http://dx.doi.org/10.1371/journal.pone.0101684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000519	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300071
J	Nickerson, KP; Homer, CR; Kessler, SP; Dixon, LJ; Kabi, A; Gordon, IO; Johnson, EE; de la Motte, CA; McDonald, C				Nickerson, Kourtney P.; Homer, Craig R.; Kessler, Sean P.; Dixon, Laura J.; Kabi, Amrita; Gordon, Ilyssa O.; Johnson, Erin E.; de la Motte, Carol A.; McDonald, Christine			The Dietary Polysaccharide Maltodextrin Promotes Salmonella Survival and Mucosal Colonization in Mice	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; DISEASE; MACROPHAGES; HOST; MECHANISMS; GROWTH; COHORT; FEEDS; RISK; PIGS	In the latter half of the 20th century, societal and technological changes led to a shift in the composition of the American diet to include a greater proportion of processed, pre-packaged foods high in fat and carbohydrates, and low in dietary fiber (a "Western diet''). Over the same time period, there have been parallel increases in Salmonella gastroenteritis cases and a broad range of chronic inflammatory diseases associated with intestinal dysbiosis. Several polysaccharide food additives are linked to bacterially-driven intestinal inflammation and may contribute to the pathogenic effects of a Western diet. Therefore, we examined the effect of a ubiquitous polysaccharide food additive, maltodextrin (MDX), on clearance of the enteric pathogen Salmonella using both in vitro and in vivo infection models. When examined in vitro, murine bone marrow-derived macrophages exposed to MDX had altered vesicular trafficking, suppressed NAPDH oxidase expression, and reduced recruitment of NADPH oxidase to Salmonella-containing vesicles, which resulted in persistence of Salmonella in enlarged Rab(7+) late endosomal vesicles. In vivo, mice consuming MDX-supplemented water had a breakdown of the anti-microbial mucous layer separating gut bacteria from the intestinal epithelium surface. Additionally, oral infection of these mice with Salmonella resulted in increased cecal bacterial loads and enrichment of lamina propria cells harboring large Rab(7+) vesicles. These findings indicate that consumption of processed foods containing the polysaccharide MDX contributes to suppression of intestinal anti-microbial defense mechanisms and may be an environmental priming factor for the development of chronic inflammatory disease.	[Nickerson, Kourtney P.; Homer, Craig R.; Kessler, Sean P.; Dixon, Laura J.; Kabi, Amrita; de la Motte, Carol A.; McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Nickerson, Kourtney P.; de la Motte, Carol A.; McDonald, Christine] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Gordon, Ilyssa O.] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Dept Anat Pathol, Cleveland, OH 44106 USA; [Johnson, Erin E.] John Carroll Univ, Dept Biol, University Hts, PA USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	McDonald, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	mcdonac2@ccf.org		McDonald, Christine/0000-0002-6745-9487; Nickerson, Kourtney/0000-0001-7852-593X	National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health; Howard Hughes Medical Institute "Med into Grad'' Initiative;  [R01DK050984];  [R01DK082437];  [R01HD061918];  [UL1TR000439]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061918] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437, R01DK050984] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Howard Hughes Medical Institute "Med into Grad'' Initiative(Howard Hughes Medical Institute); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by R01DK050984, R01DK082437 (to C.M.), R01HD061918 (to C. A. de la M.), UL1TR000439, National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, the Howard Hughes Medical Institute "Med into Grad'' Initiative, and the financial support of Gerald and Nancy Goldberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly T, 2013, AM J MED, V126, P411, DOI 10.1016/j.amjmed.2012.10.028; ALPUCHEARANDA CM, 1995, INFECT IMMUN, V63, P4456, DOI 10.1128/IAI.63.11.4456-4462.1995; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Beal J, 2012, J PEDIATR-US, V161, P354, DOI 10.1016/j.jpeds.2012.03.054; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chronakis IS, 1998, CRIT REV FOOD SCI, V38, P599, DOI 10.1080/10408699891274327; Clarke P, 2004, ARCH DIS CHILD-FETAL, V89, pF280, DOI 10.1136/adc.2003.036392; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; de Oliveira EB, 2011, SCAND J IMMUNOL, V73, P420, DOI 10.1111/j.1365-3083.2010.02501.x; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Korn L.L., 2014, MUCOSAL IMMUNOL; Martinez-Medina M, 2013, GUT; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; MERCIER JC, 1984, ARCH FR PEDIATR, V41, P709; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Montagne L, 2004, J ANIM SCI, V82, P2364; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nickerson KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052132; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rowan NJ, 1997, APPL ENVIRON MICROB, V63, P1182, DOI 10.1128/AEM.63.3.1182-1184.1997; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Sachdev AH, 2013, THER ADV CHRONIC DIS, V4, P223, DOI 10.1177/2040622313496126; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; STEWARTPHILLIPS JL, 1991, INT J IMMUNOPHARMACO, V13, P325, DOI 10.1016/0192-0561(91)90001-N; Suskind DL, 2014, J PEDIATR GASTR NUTR, V58, P87, DOI 10.1097/MPG.0000000000000103; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Ten Bruggencate SJM, 2004, GUT, V53, P530, DOI 10.1136/gut.2003.023499; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Woods CW, 2012, J PERINATOL, V32, P150, DOI 10.1038/jp.2011.105; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	38	43	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101789	10.1371/journal.pone.0101789	http://dx.doi.org/10.1371/journal.pone.0101789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000398	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300085
J	Tam, J; Cordier, GA; Borbely, JS; Alvarez, AS; Lakadamyali, M				Tam, Johnny; Alan Cordier, Guillaume; Steven Borbely, Joseph; Sandoval Alvarez, Angel; Lakadamyali, Melike			Cross-Talk-Free Multi-Color STORM Imaging Using a Single Fluorophore	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENT-PROBES; SUPERRESOLUTION MICROSCOPY; LIVE-CELL; LOCALIZATION MICROSCOPY; DIFFRACTION-LIMIT; ULTRASTRUCTURE; TOMOGRAPHY; GFP	Multi-color stochastic optical reconstruction microscopy (STORM) is routinely performed; however, the various approaches for achieving multiple colors have important caveats. Color cross-talk, limited availability of spectrally distinct fluorophores with optimal brightness and duty cycle, incompatibility of imaging buffers for different fluorophores, and chromatic aberrations impact the spatial resolution and ultimately the number of colors that can be achieved. We overcome these complexities and develop a simple approach for multi-color STORM imaging using a single fluorophore and sequential labelling. In addition, we present a simple and versatile method to locate the same region of interest on different days and even on different microscopes. In combination, these approaches enable cross-talk-free multi-color imaging of sub-cellular structures.	[Tam, Johnny; Alan Cordier, Guillaume; Steven Borbely, Joseph; Sandoval Alvarez, Angel; Lakadamyali, Melike] ICFO Inst Ciencies Foton, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Lakadamyali, M (corresponding author), ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Barcelona, Spain.	melike.lakadamyali@icfo.es	Tam, Johnny/AHD-6065-2022	Tam, Johnny/0000-0003-2300-0567; Borbely, Joseph/0000-0001-8618-1145	Fundacio CELLEX Barcelona; Systems Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; ERC-Starting grant [337191-MOTORS]; Whitaker International Fellows and Scholars Program	Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Systems Microscopy Network of Excellence consortium; ERC-Starting grant(European Research Council (ERC)); Whitaker International Fellows and Scholars Program	This work was financially supported by Fundacio CELLEX Barcelona (M.L.), the Systems Microscopy Network of Excellence consortium (call identifier number FP-7-HEALTH.2010.2.1.2.2) (M.L.), ERC-Starting grant (grant agreement number 337191-MOTORS) (M.L.), and the Whitaker International Fellows and Scholars Program (J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2012, OPT NANOSC, V1, P1, DOI DOI 10.1186/2192-2853-1-9; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/nmeth.2488, 10.1038/NMETH.2488]; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Jungmann R, 2014, NAT METHODS; Kamiyama D, 2012, DEV CELL, V23, P1103, DOI 10.1016/j.devcel.2012.10.003; Lakadamyali M, 2012, J MICROSC-OXFORD, V248, P111, DOI 10.1111/j.1365-2818.2012.03638.x; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Marsh BJ, 2013, METHOD CELL BIOL, V118, P259, DOI 10.1016/B978-0-12-417164-0.00016-1; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	35	53	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101772	10.1371/journal.pone.0101772	http://dx.doi.org/10.1371/journal.pone.0101772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000286	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300084
J	Lin, H; Yang, Y; Chen, JJ; Zhong, XJ; Liu, ZC; Lin, ZL; Chen, W; Luo, LX; Qu, B; Zhang, XY; Zheng, DY; Zhan, J; Wu, HF; Wang, ZR; Geng, Y; Xiang, W; Chen, WR; Liu, YZ				Lin, Haotian; Yang, Ye; Chen, Jingjing; Zhong, Xiaojian; Liu, Zhaochuan; Lin, Zhuoling; Chen, Wan; Luo, Lixia; Qu, Bo; Zhang, Xinyu; Zheng, Danying; Zhan, Jiao; Wu, Hanfu; Wang, Zhirong; Geng, Yu; Xiang, Wu; Chen, Weirong; Liu, Yizhi		CCPMOH Study Grp	Congenital Cataract: Prevalence and Surgery Age at Zhongshan Ophthalmic Center (ZOC)	PLOS ONE			English	Article							INFANTILE CATARACT; UNITED-KINGDOM; EYE DISEASES; CHILDREN; EPIDEMIOLOGY; CHILDHOOD	Congenital cataract (CC) is the primary cause of treatable childhood blindness. Population-based assessments of prevalence and surgery age of CC, which are critical for improving management strategies, have been unavailable in China until now. We conducted a hospital-based, cross-sectional study of the hospital charts of CC patients younger than 18 years old from January 2005 to December 2010 at Zhongshan Ophthalmic Center (ZOC) in Guangzhou, China. Residence, gender, age at surgery, hospitalization time, and the presence of other ocular abnormalities were extracted and statistically analyzed in different subgroups. The search identified 1314 patients diagnosed with CC from a total of 136154 hospitalizations, which accounted for 2.39% of all the cataract in-patients and 1.06% of the total in-patients over the six-year study period. Of the identified CC patients, 9.2% had >= 2 hospitalizations due to the necessity of additional surgeries, with a total ratio of boys to girls of 1.75:1. Based on a subgroup analysis according to age, patients 2-6 years old constituted the highest proportion (29.22%) of all hospitalized CC patients, and those 13-18 years old constituted the lowest proportion (13.47%) of the total number. The average age at surgery was 27.62 +/- 23.36 months, but CC patients <= 6 years old (especially <= 6 months old) became increasingly prevalent throughout the 6-year study period. A total of 276 cases (20.93%) of CC were associated with one or more other ocular abnormalities, the highest incidence rates were observed for exotropia (6.24%), nystagmus (6.16%), and refractive error (3.65%). In conclusion, CC patients accounted for 2.39% of all cataract in-patients in a review of 6 years of hospitalization charts from ZOC. The age at the time of surgery decreased over the 6-year study period, which probably reflects the continuing improvement of public awareness of children's eye care in China.	[Lin, Haotian; Yang, Ye; Chen, Jingjing; Zhong, Xiaojian; Liu, Zhaochuan; Lin, Zhuoling; Chen, Wan; Luo, Lixia; Qu, Bo; Zhang, Xinyu; Zheng, Danying; Zhan, Jiao; Wu, Hanfu; Wang, Zhirong; Geng, Yu; Xiang, Wu; Chen, Weirong; Liu, Yizhi; CCPMOH Study Grp] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenwr_q@aliyun.com; yizhi_liu@aliyun.com	Zhong, Xiaojian/J-9727-2016; Chen, Wei/GZK-7348-2022; liu, yi/GXE-9662-2022	Zhong, Xiaojian/0000-0002-4201-0747; 	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China [175]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]; Sun Yat-sen University of the Fundamental Research Funds for the Central Universities [12ykpy61]	Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China; Pearl River Science and Technology New Star Project of Guangzhou City; Sun Yat-sen University of the Fundamental Research Funds for the Central Universities	This study was funded by the Key Projects for Hospital Clinical Disciplines of the Ministry of Health of China in 2010-2012 (Project No. 175 in Document 439 of the Planning and Finance Secretary of the Ministry of Health), the Pearl River Science and Technology New Star (2014J2200060) Project of Guangzhou City, and the Cultivation Projects for Young Teaching Staff of Sun Yat-sen University (12ykpy61) of the Fundamental Research Funds for the Central Universities. The sponsors of the study had no role in the design of the original study protocol, data collection, data analysis, data interpretation, writing of the report, or decision to submit the manuscript for publication.	Bhatti TR, 2003, ARCH PEDIAT ADOL MED, V157, P341, DOI 10.1001/archpedi.157.4.341; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Bronsard A, 2008, OPHTHAL EPIDEMIOL, V15, P383, DOI 10.1080/09286580802488624; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Chen W, 2013, PLOS ONE, V28; Fallaha N, 2001, Ophthalmol Clin North Am, V14, P479, DOI 10.1016/S0896-1549(05)70246-7; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; France T D, 1984, J Pediatr Ophthalmol Strabismus, V21, P223; Garza-Reyes M, 2000, ARCH MED RES, V31, P500, DOI 10.1016/S0188-4409(00)00101-6; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; HILES D A, 1977, International Ophthalmology Clinics, V17, P193, DOI 10.1097/00004397-197701740-00020; HU DN, 1987, J MED GENET, V24, P584, DOI 10.1136/jmg.24.10.584; Lin H, 2013, PLOS ONE, V29; Lin HT, 2012, INT J OPHTHALMOL-CHI, V5, P638, DOI 10.3980/j.issn.2222-3959.2012.05.19; Lin HT, 2012, OPHTHALMOLOGY, V119, P2463, DOI 10.1016/j.ophtha.2012.06.046; Luo L, 2013, PLOS ONE, V24; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Nie Wen-ying, 2008, Zhonghua Yan Ke Za Zhi, V44, P497; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Rahi JS, 1999, BRIT MED J, V318, P362, DOI 10.1136/bmj.318.7180.362; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Randrianotahina HCL, 2014, NIGER J CLIN PRACT, V17, P14, DOI 10.4103/1119-3077.122824; Robin AL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1452, DOI 10.1001/jamaophthalmol.2013.765; Ruddle JB, 2013, CLIN EXP OPHTHALMOL, V41, P653, DOI 10.1111/ceo.12067; Shah MA, 2014, EUR J OPHTHALMOL, V24, P76, DOI 10.5301/ejo.5000309; Sisk RA, 2010, OPHTHALMOLOGY, V117, P2178, DOI 10.1016/j.ophtha.2010.03.062; Skalicky SE, 2013, JAMA OPHTHALMOL, V131, P1517, DOI 10.1001/jamaophthalmol.2013.5305; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014; Zhu JF, 2012, CHINESE MED J-PEKING, V125, P3654, DOI 10.3760/cma.j.issn.0366-6999.2012.20.010	30	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101781	10.1371/journal.pone.0101781	http://dx.doi.org/10.1371/journal.pone.0101781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992190	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400116
J	Grdovic, N; Dinic, S; Mihailovic, M; Uskokovic, A; Jovanovic, JA; Poznanovic, G; Wagner, L; Vidakovic, M				Grdovic, Nevena; Dinic, Svetlana; Mihailovic, Mirjana; Uskokovic, Aleksandra; Jovanovic, Jelena Arambasic; Poznanovic, Goran; Wagner, Ludwig; Vidakovic, Melita			CXC Chemokine Ligand 12 Protects Pancreatic beta-Cells from Necrosis through Akt Kinase-Mediated Modulation of Poly(ADP-ribose) Polymerase-1 Activity	PLOS ONE			English	Article							REPERFUSION INJURY; ANTAGONIST AMD3100; PROGENITOR CELLS; STEM-CELLS; RAT-LIVER; IN-VITRO; SURVIVAL; RECEPTOR; DEATH; ACTIVATION	The diabetes prevention paradigm envisages the application of strategies that support the maintenance of appropriate beta-cell numbers. Herein we show that overexpression of CXC chemokine ligand12 (CXCL12) considerably improves the viability of isolated rat Langerhans islet cells and Rin-5F pancreatic beta-cells after hydrogen peroxide treatment. In rat islets and wt cells hydrogen peroxide treatment induced necrotic cell death that was mediated by the rapid and extensive activation of poly(ADP-ribose) polymerase-1 (PARP-1). In contrast, CXCL12-overexpressing cells were protected from necrotic cell death as a result of significantly reduced PARP-1 activity. CXCL12 downstream signalling through Akt kinase was responsible for the reduction of PARP-1 activity which switched cell death from necrosis to apoptosis, providing increased protection to cells from oxidative stress. Our results offer a novel aspect of the CXCL12-mediated improvement of b-cell viability which is based on its antinecrotic action through modulation of PARP-1 activity.	[Grdovic, Nevena; Dinic, Svetlana; Mihailovic, Mirjana; Uskokovic, Aleksandra; Jovanovic, Jelena Arambasic; Poznanovic, Goran; Vidakovic, Melita] Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia; [Wagner, Ludwig] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria	University of Belgrade; Medical University of Vienna	Vidakovic, M (corresponding author), Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia.	melita@ibiss.bg.ac.rs	Vidaković, Melita/G-6747-2016; Mihailovic, Mirjana/E-6308-2015; Poznanovic, Goran/E-6349-2015; Dinic, Svetlana/C-8348-2017; Arambasic Jovanovic, Jelena/L-1415-2016	Vidaković, Melita/0000-0001-8410-6264; Mihailovic, Mirjana/0000-0002-8097-1186; Poznanovic, Goran/0000-0003-0839-7017; Dinic, Svetlana/0000-0002-7612-3117; Grdovic, Nevena/0000-0003-1504-4578; Uskokovic, Aleksandra/0000-0002-9616-1102; Arambasic Jovanovic, Jelena/0000-0002-8810-0668	Ministry of Education, Science and Technological Development of the Republic of Serbia [173020]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was financed by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 173020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Fehsel K, 2003, LAB INVEST, V83, P549, DOI 10.1097/01.LAB.0000063927.68605.FF; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Habener JF, 2012, ISLETS, V4, P188, DOI 10.4161/isl.20500; Harada N, 2004, J SURG RES, V121, P159, DOI 10.1016/j.jss.2004.04.016; Hegedus C, 2008, FEBS LETT, V582, P1672, DOI 10.1016/j.febslet.2008.04.023; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Ilhan A, 2009, MOL CELL ENDOCRINOL, V298, P1, DOI 10.1016/j.mce.2008.10.015; Jorns A, 2002, VIRCHOWS ARCH, V440, P63, DOI 10.1007/s004280100490; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kayali AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038721; Kim Ha-Yon, 2011, Korean J Hematol, V46, P244, DOI 10.5045/kjh.2011.46.4.244; Kim HY, 2010, CANCER RES TREAT, V42, P225, DOI 10.4143/crt.2010.42.4.225; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Liesveld JL, 2007, LEUKEMIA RES, V31, P1553, DOI 10.1016/j.leukres.2007.02.017; Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002; Liu Z, 2011, DIABETOLOGIA, V54, P2067, DOI 10.1007/s00125-011-2181-x; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Muller C, 2003, AM J PHYSIOL-GASTR L, V285, pG769, DOI 10.1152/ajpgi.00009.2003; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Pieper AA, 1999, P NATL ACAD SCI USA, V96, P3059, DOI 10.1073/pnas.96.6.3059; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Shaik ZP, 2007, AM J PHYSIOL-RENAL, V292, pF292, DOI 10.1152/ajprenal.00082.2006; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Tavor S, 2008, LEUKEMIA, V22, P2151, DOI 10.1038/leu.2008.238; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walker JW, 2006, BIOCHEM BIOPH RES CO, V342, P336, DOI 10.1016/j.bbrc.2006.01.145; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	46	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101172	10.1371/journal.pone.0101172	http://dx.doi.org/10.1371/journal.pone.0101172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988468	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100067
J	Sidharthan, NP; Butcher, NJ; Mitchell, DJ; Minchin, RF				Sidharthan, Neelima P.; Butcher, Neville J.; Mitchell, Deanne J.; Minchin, Rodney F.			Expression of the Orphan Cytosolic Sulfotransferase SULT4A1 and Its Major Splice Variant in Human Tissues and Cells: Dimerization, Degradation and Polyubiquitination	PLOS ONE			English	Article							PSYCHOPATHOLOGY; IDENTIFICATION; PROTEASOME; PROTECTS; BINDING	The cytosolic sulfotransferase SULT4A1 is highly conserved between mammalian species but its function remains unknown. Polymorphisms in the SULT4A1 gene have been linked to susceptibility to schizophrenia. There are 2 major SULT4A1 transcripts in humans, one that encodes full length protein (wild-type) and one that encodes a truncated protein (variant). Here, we investigated the expression of SULT4A1 in human tissues by RT-PCR and found the wild-type mRNA to be expressed mainly in the brain, gastrointestinal tract and prostate while the splice variant was more widely expressed. In human cell-lines, the wild-type transcript was found in neuronal cells, but the variant transcript was expressed in nearly all other lines examined. Western blot analysis only identified SULT4A1 protein in cells that expressed the wild-type mRNA. No variant protein was detected in cells that expressed the variant mRNA. Ectopically expressed full length SULT4A1 protein was stable while the truncated protein was not, having a half-life of approximately 3 hr. SULT4A1 was also shown to homodimerize, consistent with other SULTs that contain the consensus dimerization motif. Mutation of the dimerization motif resulted in a monomeric form of SULT4A1 that was rapidly degraded by polyubiquitination on the lysine located within the dimerization motif. These results show that SULT4A1 is widely expressed in human tissues, but mostly as a splice variant that produces a rapidly degraded protein. Dimerization protects the protein from degradation. Since many other cytosolic sulfotransferases possess the conserved lysine within the dimerization motif, homodimerization may serve, in part, to stabilize these enzymes in vivo.	[Sidharthan, Neelima P.; Butcher, Neville J.; Mitchell, Deanne J.; Minchin, Rodney F.] Univ Queensland, Lab Mol & Cellular Pharmacol, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland	Minchin, RF (corresponding author), Univ Queensland, Lab Mol & Cellular Pharmacol, Sch Biomed Sci, Brisbane, Qld, Australia.	r.minchin@uq.edu.au		Minchin, Rodney/0000-0002-3178-4835; Nair, Neelima/0000-0003-1729-2575; Butcher, Neville/0000-0002-0709-5589	National Health and Medical research Council of Australia [APP1005899]	National Health and Medical research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical research Council of Australia grant # APP1005899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2006, TOXICOL SCI, V93, P242, DOI 10.1093/toxsci/kfl050; Alnouti Y, 2011, XENOBIOTICA, V41, P187, DOI 10.3109/00498254.2010.535923; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher NJ, 2010, MOL PHARMACOL, V78, P503, DOI 10.1124/mol.110.063404; Caffrey TM, 2006, HUM MOL GENET, V15, P3529, DOI 10.1093/hmg/ddl429; Cook IT, 2010, HORM MOL BIOL CLIN I, V3, P367, DOI 10.1515/HMBCI.2010.041; Domingues SC, 2011, J NEUROCHEM, V119, P1086, DOI 10.1111/j.1471-4159.2011.07420.x; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 2000, BIOCHEM J, V346, P857, DOI 10.1042/0264-6021:3460857; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Liu Q, 2012, PRIM CARE COMPANION, V14; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Lu LY, 2009, DRUG METAB DISPOS, V37, P1083, DOI 10.1124/dmd.108.025395; Meltzer HY, 2008, SCHIZOPHR RES, V106, P258, DOI 10.1016/j.schres.2008.08.029; Minchin RF, 2008, INT J BIOCHEM CELL B, V40, P2686, DOI 10.1016/j.biocel.2007.11.010; Mitchell DJ, 2011, BBA-MOL CELL RES, V1813, P231, DOI 10.1016/j.bbamcr.2010.09.011; Mitchell DJ, 2009, MOL PHARMACOL, V76, P388, DOI 10.1124/mol.109.055442; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Petrotchenko EV, 2001, FEBS LETT, V490, P39, DOI 10.1016/S0014-5793(01)02129-9; Ramsey TL, 2011, PHARMACOGENOMICS, V12, P471, DOI [10.2217/pgs.10.205, 10.2217/PGS.10.205]; Ross HH, 2007, FEBS LETT, V581, P5923, DOI 10.1016/j.febslet.2007.11.074; Runge-Morris M, 2013, DRUG METAB REV, V45, P15, DOI 10.3109/03602532.2012.748794; Stjernschantz E, 2010, MOL CELL ENDOCRINOL, V317, P127, DOI 10.1016/j.mce.2009.12.001; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Thomae B. A., 2002, Pharmacogenomics Journal, V2, P48, DOI 10.1038/sj.tpj.6500089; Weitzner B, 2009, PROTEINS, V75, P289, DOI 10.1002/prot.22347	32	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101520	10.1371/journal.pone.0101520	http://dx.doi.org/10.1371/journal.pone.0101520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988429	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100105
J	Wang, YB; Zhang, WJ; Lin, YS; Cao, WQ; Zheng, LM; Yang, J				Wang, Yibo; Zhang, Wenjing; Lin, Yuanshao; Cao, Wenqing; Zheng, Lianming; Yang, Jun			Phosphorus, Nitrogen and Chlorophyll-a Are Significant Factors Controlling Ciliate Communities in Summer in the Northern Beibu Gulf, South China Sea	PLOS ONE			English	Article							MESODINIUM-RUBRUM; PLANKTONIC CILIATE; YELLOW SEA; CILIOPHORA; CARBON; SONG	Ciliates (protozoa) are ubiquitous components of plankton community and play important roles in aquatic ecosystems in regards of their abundance, biomass, diversity and energy turnover. Based on the stratified samples collected from the northern Beibu Gulf in August 2011, species composition, abundance, biomass, diversity and spatial pattern of planktonic ciliates were studied. Furthermore the main environmental factors controlling ciliate communities were determined. A total of 101 species belonging to 44 genera and 7 orders (i.e., Oligotrichida, Haptorida, Euplotida, Sessilida, Pleurostomatida, Scuticociliatida and Tintinnida) were identified. The variation of ciliate communities was significant at horizontal level, but that was not at vertical level. Based on cluster analysis, ciliate communities were divided into three main groups. Redundancy analysis (RDA) revealed that Group A, existing in the waters with higher concentration of phosphorus and nitrogen, was dominated by Tintinnidium primitivum. Group B in the waters with lower temperature and chlorophyll-a concentration, was dominated by Leegaardiella ovalis. Group C, existing in the waters with higher temperature and chlorophyll-a concentration, was dominated by large Strombidium spp. and Mesodinium rubrum. Combining multiple analytic methods, our results strongly supported that phosphorus, nitrogen and chlorophyll-a were the most significant factors affecting the ciliate communities in the northern Beibu Gulf in summer. Concentration of phosphorus and nitrogen primarily influenced ciliate biomass, implying a potential impact of eutrophication on ciliate growth. The correlation with chlorophyll-a concentration, on one hand indicate the response of ciliates to the food availability, and on the other hand, the ciliates containing chloroplasts or endosymbionts may contribute greatly to the chlorophyll-a.	[Wang, Yibo; Zhang, Wenjing; Lin, Yuanshao; Cao, Wenqing; Zheng, Lianming] Xiamen Univ, Lab Marine Biodivers & Global Change MBiGC, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Yang, Jun] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Aquat Ecohlth Grp, Xiamen, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, WJ (corresponding author), Xiamen Univ, Lab Marine Biodivers & Global Change MBiGC, Coll Ocean & Earth Sci, Xiamen, Peoples R China.	zhangwenjing@xmu.edu.cn	CAS, KLUEH-Cooperation/E-1148-2017; Zhang, Wenjing/H-5057-2012; CAS, KLUEH/T-5743-2019; Wang, Yibo/AAU-5681-2021; Yang, Jun/E-6680-2011; YANG, Jun/J-2819-2014; 郑, 连明/GZL-5449-2022	Zhang, Wenjing/0000-0002-2600-5040; Yang, Jun/0000-0002-7920-2777; YANG, Jun/0000-0002-5069-507X; 	National Natural Science Foundation of China [41276133]; special Research Foundation for Public Welfare Marine Program [201005012];  [GASI-03-01-02-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special Research Foundation for Public Welfare Marine Program; 	This study was supported by the National Natural Science Foundation of China (No. 41276133), the special Research Foundation for Public Welfare Marine Program (No. 201005012), and GASI-03-01-02-03 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, FREE LIVING CILIATES; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Chen S, 2008, COLLECTION RES PAPER, V1, P88; Chen SL, 2011, J OCEANOGR, V67, P709, DOI 10.1007/s10872-011-0071-y; Clarke K.R., 2001, PRIMER V5 USERMANUAL; CRAWFORD DW, 1989, MAR ECOL PROG SER, V58, P161, DOI 10.3354/meps058161; Dolan JR, 2000, FRESHWATER BIOL, V45, P227, DOI 10.1046/j.1365-2427.2000.00659.x; Feng Mei-ping, 2010, Journal of Tropical Oceanography, V29, P141; Gomez F, 2007, ACTA OECOL, V32, P188, DOI 10.1016/j.actao.2007.04.002; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hada Y., 1938, Journal of the Faculty of Science Hokkaido University Zoology, V6, P87; Hada Y., 1937, Journal of the Faculty of Science Hokkaido University Zoology, V5, P143; Hada Y., 1932, J FS HOKKAIDO U 4, V2, P37; Jiang Y, 2011, J MAR BIOL ASSOC UK, V91, P97, DOI 10.1017/S002531541000175X; Jiang Y, 2011, MAR POLLUT BULL, V62, P227, DOI 10.1016/j.marpolbul.2010.11.008; Johnson MD, 2013, J PLANKTON RES, V35, P877, DOI 10.1093/plankt/fbt028; Kim Young-Ok, 2012, Ocean Science Journal, V47, P161, DOI 10.1007/s12601-012-0016-4; Kofoid C. A., 1939, B MUS COMP ZOOL HARV, V84, P1; KOFOID CHARLES A., 1929, UNIV CALIF PUBL ZOOL, V34, P1; Leegaard C, 1915, NYTT MAG NATURV, V53, P1; [刘华雪 Liu Huaxue], 2010, [生态学报, Acta Ecologica Sinica], V30, P2340; Lynn D.H., 2008, CHARACTERIZATION CLA; McManus GB, 2004, LIMNOL OCEANOGR, V49, P308, DOI 10.4319/lo.2004.49.1.0308; MONTAGNES DJS, 1988, MAR BIOL, V99, P21, DOI 10.1007/BF00644973; Montagnes DJS, 1998, J EUKARYOT MICROBIOL, V45, P502, DOI 10.1111/j.1550-7408.1998.tb05108.x; Nie D., 1934, Report of the Marine Biological Association of China, V3, P71; Office of the State Oceanic Administration, 2006, COMPR SURV ASS TECHN; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Sanders RW, 1995, AQUAT MICROB ECOL, V9, P237, DOI 10.3354/ame009237; SMITH WO, 1979, J PHYCOL, V15, P27, DOI 10.1111/j.0022-3646.1979.00027.x; Song WB, 2000, EUR J PROTISTOL, V36, P327, DOI 10.1016/S0932-4739(00)80010-3; STOECKER DK, 1991, MAR ECOL PROG SER, V73, P245, DOI 10.3354/meps073245; STOECKER DK, 1987, ANN NY ACAD SCI, V503, P562, DOI 10.1111/j.1749-6632.1987.tb40646.x; Su Qiang, 2007, Marine Science Bulletin (Beijing), V9, P43; Sun X, 2005, HYDROGRAPHY CHINA CO, P285; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; WILHM JL, 1970, J WATER POLLUT CON F, V42, pR221; Xu DP, 2006, ACTA PROTOZOOL, V45, P17; Xu HL, 2008, J MAR BIOL ASSOC UK, V88, P1353, DOI 10.1017/S0025315408002129; Xu Runlin, 1998, Tropic Oceanology, V17, P40; [张翠霞 ZHANG Cuixia], 2010, [生态学报, Acta Ecologica Sinica], V30, P867; Zhang WC, 2002, AQUAT MICROB ECOL, V27, P249, DOI 10.3354/ame027249	43	27	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101121	10.1371/journal.pone.0101121	http://dx.doi.org/10.1371/journal.pone.0101121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987960	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100061
J	Wu, JJ; Zhou, TT; Du, GC; Zhou, JW; Chen, J				Wu, Junjun; Zhou, Tiantian; Du, Guocheng; Zhou, Jingwen; Chen, Jian			Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EFFICIENT PRODUCTION; METABOLIC NETWORK; GENE-CLUSTER; L-TYROSINE; NARINGENIN; BIOSYNTHESIS; RESVERATROL; FLAVANONES; FLAVONOIDS	Due to increasing concerns about food safety and environmental issues, bio-based production of flavonoids from safe, inexpensive, and renewable substrates is increasingly attracting attention. Here, the complete biosynthetic pathway, consisting of 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase (DAHPS), chorismate mutase/prephenate dehydrogenase (CM/PDH), tyrosine ammonia lyase (TAL), 4-coumarate: CoA ligase (4CL), chalcone synthase (CHS), chalcone isomerase (CHI), malonate synthetase, and malonate carrier protein, was constructed using pre-made modules to overproduce (2S)-naringenin from D-glucose. Modular pathway engineering strategies were applied to the production of the flavonoid precursor (2S)-naringenin from L-tyrosine to investigate the metabolic space for efficient conversion. Modular expression was combinatorially tuned by modifying plasmid gene copy numbers and promoter strengths to identify an optimally balanced pathway. Furthermore, a new modular pathway from D-glucose to L-tyrosine was assembled and re-optimized with the identified optimal modules to enable de novo synthesis of (2S)-naringenin. Once this metabolic balance was achieved, the optimum strain was capable of producing 100.64 mg/L (2S)-naringenin directly from D-glucose, which is the highest production titer from D-glucose in Escherichia coli. The fermentation system described here paves the way for the development of an economical process for microbial production of flavonoids.	[Wu, Junjun; Zhou, Tiantian; Du, Guocheng; Zhou, Jingwen; Chen, Jian] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Du, Guocheng; Zhou, Jingwen; Chen, Jian] Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Zhou, JW (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.	zhoujw1982@jiangnan.edu.cn; jchen@jiangnan.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB720806]; National Natural Science Foundation of China [31000807]; Natural Science Foundation of Jiangsu Province [BK2011004, BK2010150]; Fundamental Research Funds for the Central Universities [JUSRP51307A]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [2011046]; Program for New Century Excellent Talents in University [NCET-12-0876]; 111 Project [111-2-06]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the Major State Basic Research Development Program of China (973 Program, 2012CB720806), National Natural Science Foundation of China (31000807), the Natural Science Foundation of Jiangsu Province (BK2011004, BK2010150), the Fundamental Research Funds for the Central Universities (JUSRP51307A), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD, 2011046), the Program for New Century Excellent Talents in University (NCET-12-0876), and the 111 Project (111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Bhan N, 2013, CURR OPIN BIOTECH, V24, P1137, DOI 10.1016/j.copbio.2013.02.019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fowler ZL, 2009, APPL ENVIRON MICROB, V75, P5831, DOI 10.1128/AEM.00270-09; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Hermenean A, 2013, CHEM-BIOL INTERACT, V205, P138, DOI 10.1016/j.cbi.2013.06.016; Hwang EI, 2003, APPL ENVIRON MICROB, V69, P2699, DOI 10.1128/AEM.69.5.2699-2706.2003; Kikuchi Y, 1997, APPL ENVIRON MICROB, V63, P761, DOI 10.1128/AEM.63.2.761-762.1997; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Leonard E, 2008, MOL PHARM, V5, P257, DOI 10.1021/mp7001472; Leonard E, 2007, APPL ENVIRON MICROB, V73, P3877, DOI 10.1128/AEM.00200-07; Lim CG, 2011, APPL ENVIRON MICROB, V77, P3451, DOI 10.1128/AEM.02186-10; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Miyahisa I, 2005, APPL MICROBIOL BIOT, V68, P498, DOI 10.1007/s00253-005-1916-3; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Santos CNS, 2012, P NATL ACAD SCI USA, V109, P13538, DOI 10.1073/pnas.1206346109; Santos CNS, 2011, METAB ENG, V13, P392, DOI 10.1016/j.ymben.2011.02.002; Schroeder AC, 2008, PHYTOCHEMISTRY, V69, P1496, DOI 10.1016/j.phytochem.2008.02.007; Vannelli T, 2007, METAB ENG, V9, P142, DOI 10.1016/j.ymben.2006.11.001; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; Wu JJ, 2013, J BIOTECHNOL, V167, P404, DOI 10.1016/j.jbiotec.2013.07.030; Wu JJ, 2013, METAB ENG, V16, P48, DOI 10.1016/j.ymben.2012.11.009; Xu CW, 2013, BIOL PHARM BULL, V36, P1549, DOI 10.1248/bpb.b13-00247; Xu P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2425; Xu P, 2011, METAB ENG, V13, P578, DOI 10.1016/j.ymben.2011.06.008	26	60	68	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101492	10.1371/journal.pone.0101492	http://dx.doi.org/10.1371/journal.pone.0101492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988485	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100099
J	Catenacci, DVT; Liao, WL; Thyparambil, S; Henderson, L; Xu, P; Zhao, L; Rambo, B; Hart, J; Xiao, SY; Bengali, K; Uzzell, J; Darfler, M; Krizman, DB; Cecchi, F; Bottaro, DP; Karrison, T; Veenstra, TD; Hembrough, T; Burrows, J				Catenacci, Daniel V. T.; Liao, Wei-Li; Thyparambil, Sheeno; Henderson, Les; Xu, Peng; Zhao, Lei; Rambo, Brittany; Hart, John; Xiao, Shu-Yuan; Bengali, Kathleen; Uzzell, Jamar; Darfler, Marlene; Krizman, David B.; Cecchi, Fabiola; Bottaro, Donald P.; Karrison, Theodore; Veenstra, Timothy D.; Hembrough, Todd; Burrows, Jon			Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STORED PARAFFIN SLIDES; CELL LUNG-CANCER; C-MET; GASTRIC-CANCER; SIGNALING PATHWAY; KINASE INHIBITOR; THERAPEUTIC TARGET; PROTEIN EXPRESSION; ADENOCARCINOMA	Background: Overexpression of Met tyrosine kinase receptor is associated with poor prognosis. Overexpression, and particularly MET amplification, are predictive of response to Met-specific therapy in preclinical models. Immunohistochemistry (IHC) of formalin-fixed paraffin-embedded (FFPE) tissues is currently used to select for 'high Met' expressing tumors for Met inhibitor trials. IHC suffers from antibody non-specificity, lack of quantitative resolution, and, when quantifying multiple proteins, inefficient use of scarce tissue. Methods: After describing the development of the Liquid-Tissue-Selected Reaction Monitoring-mass spectrometry (LT-SRM-MS) Met assay, we evaluated the expression level of Met in 130 FFPE gastroesophageal cancer (GEC) tissues. We assessed the correlation of SRM Met expression to IHC and mean MET gene copy number (GCN)/nucleus or MET/CEP7 ratio by fluorescence in situ hybridization (FISH). Results: Proteomic mapping of recombinant Met identified (418)TEFTTALQR(426) as the optimal SRM peptide. Limits of detection (LOD) and quantitation (LOQ) for this peptide were 150 and 200 amol/mu g tumor protein, respectively. The assay demonstrated excellent precision and temporal stability of measurements in serial sections analyzed one year apart. Expression levels of 130 GEC tissues ranged (<150 amol/mu g to 4669.5 amol/mu g. High correlation was observed between SRM Met expression and both MET GCN and MET/CEP7 ratio as determined by FISH (n = 30; R-2 = 0.898). IHC did not correlate well with SRM (n = 44; R-2 = 0.537) nor FISH GCN (n = 31; R-2 = 0.509). A Met SRM level of >= 1500 amol/mu g was 100% sensitive (95% CI 0.69-1) and 100% specific (95% CI 0.92-1) for MET amplification. Conclusions: The Met SRM assay measured the absolute Met levels in clinical tissues with high precision. Compared to IHC, SRM provided a quantitative and linear measurement of Met expression, reliably distinguishing between non-amplified and amplified MET tumors. These results demonstrate a novel clinical tool for efficient tumor expression profiling, potentially leading to better informed therapeutic decisions for patients with GEC.	[Catenacci, Daniel V. T.; Henderson, Les; Xu, Peng; Rambo, Brittany] Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Liao, Wei-Li; Thyparambil, Sheeno; Bengali, Kathleen; Uzzell, Jamar; Darfler, Marlene; Krizman, David B.; Veenstra, Timothy D.; Hembrough, Todd; Burrows, Jon] OncoPlex Diagnost Inc, Rockville, MD USA; [Zhao, Lei; Hart, John; Xiao, Shu-Yuan] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Cecchi, Fabiola; Bottaro, Donald P.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Karrison, Theodore] Univ Chicago, Dept Hlth Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago	Catenacci, DVT (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dcatenac@medicine.bsd.uchicago.edu	Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010; Xiao, Shu-Yuan/AAR-7167-2020; Catenacci, Daniel/K-4177-2019	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334; Xiao, Shu-Yuan/0000-0003-0484-932X; zhao, lei/0000-0003-4322-6475	NIH [CA139160-01A]; CALGB/ALLIANCE YIA Award; Live Like Katie Foundation Award; Oncoplex Dx Research Collaboration; UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); NIH, National Cancer Institute, Center for Cancer Research; Oncoplex; University of Chicago; Oncoplex Dx; NATIONAL CANCER INSTITUTE [K12CA139160, ZIABC011124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALGB/ALLIANCE YIA Award; Live Like Katie Foundation Award; Oncoplex Dx Research Collaboration; UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oncoplex; University of Chicago(University of Chicago); Oncoplex Dx; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported in part by NIH K12 award (CA139160-01A), CALGB/ALLIANCE YIA Award, Live Like Katie Foundation Award, Oncoplex Dx Research Collaboration, and UCCCC (University of Chicago Comprehensive Cancer Center) Award in Precision Oncology (DVTC); the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DB). A scientific research collaborative agreement between Oncoplex and University of Chicago allowed funding for reagents, expenses towards tissue acquisition and processing, and salaries of laboratory members. The role of each individual author at Oncoplex is as previously indicated, and as employees they received salaries from Oncoplex Dx. The specific roles of each author is outlined in the author contributions section.	ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Bart K, 2014, ROCHE HALTS STUDY EX; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Catenacci DVT XP, 2012, 24 EORTC NCI AACR S; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gatenacci DVT, 2014, PERSONALIZED TREATME; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gomez-Martin C, 2013, J CLIN ONCOL, V31, P4445, DOI 10.1200/JCO.2013.48.9070; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hembrough T, 2014, QUANTIFICATION MET E; Hembrough T, 2013, J MOL DIAGN, V15, P454, DOI 10.1016/j.jmoldx.2013.03.002; Hembrough Todd, 2012, Clin Proteomics, V9, P5, DOI 10.1186/1559-0275-9-5; Herrera LJ, 2005, NEOPLASIA, V7, P75, DOI 10.1593/neo.04367; Jacobs T, 1996, LAB INVEST, V74, P88; Khoury J, 2014, ARCH PATHOL IN PRESS; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Meng ZJ, 2011, J PROTEOMICS, V74, P2650, DOI 10.1016/j.jprot.2011.04.011; Mirlacher M, 2004, MODERN PATHOL, V17, P1414, DOI 10.1038/modpathol.3800208; Oliner KS, 2012, J CLIN ONCOL, V30; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; PRIOLEAU J, 1995, NEW ENGL J MED, V332, P1521, DOI 10.1056/NEJM199506013322217; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Rickert KW, 2011, J BIOL CHEM, V286, P11218, DOI 10.1074/jbc.M110.204404; Sadiq AA, 2013, J CLIN ONCOL, V31, P1089, DOI 10.1200/JCO.2012.43.9422; Sauter G, 2003, NAT REV DRUG DISCOV, V2, P962, DOI 10.1038/nrd1254; Sehdev A, 2013, DISCOV MED, V16, P103; Shah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054014; Sharma Neelesh, 2011, Ther Adv Med Oncol, V3, pS37, DOI 10.1177/1758834011423403; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stabile LP, 2008, MOL CANCER THER, V7, P1913, DOI 10.1158/1535-7163.MCT-07-2169; Stricker T, 2011, SEMIN ONCOL, V38, P173, DOI 10.1053/j.seminoncol.2011.01.013; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111	50	46	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100586	10.1371/journal.pone.0100586	http://dx.doi.org/10.1371/journal.pone.0100586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983965	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000030
J	Lambeth, LS; Ohnesorg, T; Cummins, DM; Sinclair, AH; Smith, CA				Lambeth, Luke S.; Ohnesorg, Thomas; Cummins, David M.; Sinclair, Andrew H.; Smith, Craig A.			Development of Retroviral Vectors for Tissue-Restricted Expression in Chicken Embryonic Gonads	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; ESTROGEN-RECEPTOR; SEX DETERMINATION; OVO ELECTROPORATION; AROMATASE GENES; MESSENGER-RNA; GERM-CELLS; DMRT1; PROMOTER; ENHANCER	The chicken embryo has long been a useful model organism for studying development, including sex determination and gonadal differentiation. However, manipulating gene expression specifically in the embryonic avian gonad has been difficult. The viral vector RCASBP can be readily used for embryo-wide transgene expression; however global mis-expression using this method can cause deleterious off-target effects and embryo-lethality. In an attempt to develop vectors for the over-expression of sequences in chicken embryonic urogenital tissues, the viral vector RCANBP was engineered to contain predicted promoter sequences of gonadal-expressed genes. Several promoters were analysed and it was found that although the SF1 promoter produced a tissue-restricted expression pattern that was highest in the mesonephros and liver, it was also higher in the gonads compared to the rest of the body. The location of EGFP expression from the SF1 promoter overlapped with several key gonad-expressed sex development genes; however expression was generally low-level and was not seen in all gonadal cells. To further validate this sequence the key testis determinant DMRT1 was over-expressed in female embryos, which due to insufficient levels had no effect on gonad development. The female gene aromatase was then over-expressed in male embryos, which disrupted the testis pathway as demonstrated by a reduction in AMH protein. Taken together, although these data showed that the SF1 promoter can be used for functional studies in ovo, a stronger promoter sequence would likely be required for the functional analysis of gonad genes that require high-level expression.	[Lambeth, Luke S.; Ohnesorg, Thomas; Sinclair, Andrew H.; Smith, Craig A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sinclair, Andrew H.; Smith, Craig A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Lambeth, Luke S.; Sinclair, Andrew H.; Smith, Craig A.] Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Cummins, David M.] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lambeth, LS (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	luke.lambeth@mcri.edu.au	Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Ohnesorg, Thomas/0000-0001-9225-8911; Smith, Craig/0000-0002-1670-5545	Australian Research Council (ARC) Future Fellowship; National Health and Medical Research Council [1031214]	Australian Research Council (ARC) Future Fellowship(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (ARC) Future Fellowship awarded to CAS and The National Health and Medical Research Council (Project Grant # 1031214) awarded to TO. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; BOERKOEL CF, 1993, VIROLOGY, V195, P669, DOI 10.1006/viro.1993.1418; Busygina TV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P377, DOI 10.1023/A:1023687527201; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; COPELAND NG, 1981, CELL, V23, P51, DOI 10.1016/0092-8674(81)90269-5; Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184; Farley EK, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-17; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; FRAIZER GC, 1994, J BIOL CHEM, V269, P8892; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Islam MM, 2012, JOVE-J VIS EXP, DOI 10.3791/3792; Kolle G, 2003, DEV DYNAM, V226, P107, DOI 10.1002/dvdy.10204; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kudo T, 1999, GENE, V231, P33, DOI 10.1016/S0378-1119(99)00097-9; Lambeth LS, 2014, DEV BIOL, V389, P160, DOI 10.1016/j.ydbio.2014.02.012; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; LERNER TL, 1981, J VIROL, V40, P421, DOI 10.1128/JVI.40.2.421-430.1981; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; Nishikimi H, 2000, MOL REPROD DEV, V55, P20, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;20::AID-MRD4&gt;3.0.CO;2-E; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Sato N, 2002, J VIROL, V76, P1980, DOI 10.1128/JVI.76.4.1980-1985.2002; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shima Y, 2005, MOL ENDOCRINOL, V19, P2812, DOI 10.1210/me.2004-0431; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1999, GENE, V234, P395, DOI 10.1016/S0378-1119(99)00179-1; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Smith CA, 2009, DIFFERENTIATION, V77, P473, DOI 10.1016/j.diff.2009.02.001; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wilson NH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr628	42	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101811	10.1371/journal.pone.0101811	http://dx.doi.org/10.1371/journal.pone.0101811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003592	Green Published, gold			2022-12-25	WOS:000339242700069
J	Zhen, YM; Qin, GR; Luo, C; Jiang, HL; Yu, KQ; Chen, GH				Zhen, Yunmei; Qin, Guangrong; Luo, Cheng; Jiang, Hualiang; Yu, Kunqian; Chen, Guanghui			Exploring the RING-Catalyzed Ubiquitin Transfer Mechanism by MD and QM/MM Calculations	PLOS ONE			English	Article							E3 LIGASE ACTIVITY; MOLECULAR-DYNAMICS; DNA-DAMAGE; MASS-SPECTROMETRY; DRUG TARGETS; RESP MODEL; SUMO; RNF4; COMPLEX; CONJUGATION	Ubiquitylation is a universal mechanism for controlling cellular functions. A large family of ubiquitin E3 ligases (E3) mediates Ubiquitin (Ub) modification. To facilitate Ub transfer, RING E3 ligases bind both the substrate and ubiquitin E2 conjugating enzyme (E2) linked to Ub via a thioester bond to form a catalytic complex. The mechanism of Ub transfer catalyzed by RING E3 remains elusive. By employing a combined computational approach including molecular modeling, molecular dynamics (MD) simulations, and quantum mechanics/molecular mechanics (QM/MM) calculations, we characterized this catalytic mechanism in detail. The three-dimensional model of dimeric RING E3 ligase RNF4 RING, E2 ligase UbcH5A, Ub and the substrate SUMO2 shows close contact between the substrate and Ub transfer catalytic center. Deprotonation of the substrate lysine by D117 on UbcH5A occurs with almost no energy barrier as calculated by MD and QM/MM calculations. Then, the side chain of the activated lysine gets close to the thioester bond via a conformation change. The Ub transfer pathway begins with a nucleophilic addition that forms an oxyanion intermediate of a 4.23 kcal/mol energy barrier followed by nucleophilic elimination, resulting in a Ub modified substrate by a 5.65 kcal/mol energy barrier. These results provide insight into the mechanism of RING-catalyzed Ub transfer guiding the discovery of Ub system inhibitors.	[Zhen, Yunmei] Shantou Univ, Dept Biol, Shantou, Guangdong, Peoples R China; [Zhen, Yunmei; Qin, Guangrong; Luo, Cheng; Jiang, Hualiang; Yu, Kunqian] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Chen, Guanghui] Shantou Univ, Dept Chem, Shantou, Guangdong, Peoples R China	Shantou University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shantou University	Yu, KQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	kqyu@mail.shcnc.ac.cn; ghchen@stu.edu.cn		QIN, GUANGRONG/0000-0001-8836-1246	National High Technology Research and Development Program of China (863 Program) [2012AA020301, 2012AA01A305]; National Natural Science Foundation of China [81230076, 21210003]; Chinese Academy of Sciences [KSZD-EW-L09-4]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020301 and 2012AA01A305), the National Natural Science Foundation of China grants (81230076 and 21210003), Chinese Academy of Sciences (Project KSZD-EW-L09-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Benjamin WC, 2012, BIOCHEM J, V445, P167; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hehre WJ, 1986, AB INITIO MOL ORBITA; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Lima CD, 2012, NATURE, V489, P43, DOI 10.1038/489043a; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Markin CJ, 2010, J AM CHEM SOC, V132, P17775, DOI 10.1021/ja105267w; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Micel LN, 2013, J CLIN ONCOL, V31, P1231, DOI 10.1200/JCO.2012.44.0958; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Osula O, 2012, J MASS SPECTROM, V47, P644, DOI 10.1002/jms.2959; Parker JL, 2012, NUCL ACIDS RES; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Pruneda JN, 2012, MOL CELL; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Vyas R, 2012, CELL DEATH DIFFERENT; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu PY, 2007, EMBO J, V26, P4051, DOI 10.1038/sj.emboj.7601829; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	74	7	7	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101663	10.1371/journal.pone.0101663	http://dx.doi.org/10.1371/journal.pone.0101663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003393	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700050
J	Gandhi, K; Thera, MA; Coulibaly, D; Traore, K; Guindo, AB; Ouattara, A; Takala-Harrison, S; Berry, AA; Doumbo, OK; Plowe, CV				Gandhi, Kavita; Thera, Mahamadou A.; Coulibaly, Drissa; Traore, Karim; Guindo, Ando B.; Ouattara, Amed; Takala-Harrison, Shannon; Berry, Andrea A.; Doumbo, Ogobara K.; Plowe, Christopher V.			Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications	PLOS ONE			English	Article							STAGE MALARIA VACCINE; T-CELL EPITOPES; GENETIC DIVERSITY; AFRICAN CHILDREN; PHASE-3 TRIAL; EFFICACY; PARASITE; CANDIDATE; INFECTION; SELECTION	The malaria vaccine candidate RTS,S/AS01 is based on immunogenic regions of Plasmodium falciparum circumsporozoite protein (CSP) from the 3D7 reference strain and has shown modest efficacy against clinical disease in African children. It remains unclear what aspect(s) of the immune response elicited by this vaccine are protective. The goals of this study were to measure diversity in immunogenic regions of CSP, and to identify associations between polymorphism in CSP and the risk of P. falciparum infection and clinical disease. The present study includes data and samples from a prospective cohort study designed to measure incidence of malaria infection and disease in children in Bandiagara, Mali. A total of 769 parasite-positive blood samples corresponding to both acute clinical malaria episodes and asymptomatic infections experienced by 100 children were included in the study. Non-synonymous SNP data were generated by 454 sequencing for the T-cell epitopes, and repeat length data were generated for the B-cell epitopes of the cs gene. Cox proportional hazards models were used to determine the effect of sequence variation in consecutive infections occurring within individuals on the time to new infection and new clinical malaria episode. Diversity in the T-cell epitope-encoding regions Th2R and Th3R remained stable throughout seasons, between age groups and between clinical and asymptomatic infections with the exception of a higher proportion of 3D7 haplotypes found in the oldest age group. No associations between sequence variation and hazard of infection or clinical malaria were detected. The lack of association between sequence variation and hazard of infection or clinical malaria suggests that naturally acquired immunity to CSP may not be allele-specific.	[Gandhi, Kavita; Ouattara, Amed; Takala-Harrison, Shannon; Berry, Andrea A.; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Thera, Mahamadou A.; Coulibaly, Drissa; Traore, Karim; Guindo, Ando B.; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Science & Technology of Bamako	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Howard Hughes Med Inst, Baltimore, MD 21201 USA.	cplowe@medicine.umaryland.edu		Traore, Karim/0000-0002-9553-6611; Thera, Mahamadou A/0000-0002-2679-035X; Ouattara, Amed/0000-0003-1964-7130; Takala-Harrison, Shannon/0000-0003-4674-8500; Berry, Andrea/0000-0003-3140-3868	National Institute of Allergy and Infectious Diseases (NIAID) [N01AI85346, U19AI065683]; Fogarty International Center [D43TW001589]; National Institutes of Health; U.S. Department of Defense [W81XWH-06-1-0427]; U.S. Agency for International Development; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH) [K12RR023250]; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); U.S. Agency for International Development(United States Agency for International Development (USAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by contract N01AI85346 and cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases (NIAID), grant D43TW001589 from the Fogarty International Center, National Institutes of Health, and contract W81XWH-06-1-0427 from the U.S. Department of Defense and the U.S. Agency for International Development. CVP was supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and by the Howard Hughes Medical Institute. STH was supported by the University of Maryland Multidisciplinary Clinical Research Career Development Program (NIH grant K12RR023250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; de GA, 1989, J IMMUNOL, V142, P4000; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Jalloh A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-120; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; NARDIN EH, 1979, SCIENCE, V206, P597, DOI 10.1126/science.386511; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHOFIELD L, 1990, B WORLD HEALTH ORGAN, V68, P66; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	31	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101783	10.1371/journal.pone.0101783	http://dx.doi.org/10.1371/journal.pone.0101783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992338	Green Submitted, gold, Green Published			2022-12-25	WOS:000341253400117
J	Qin, L; Peng, D; Hu, CP; Xiang, Y; Zhou, YG; Tan, YR; Qin, XQ				Qin, Ling; Peng, Dan; Hu, Chengping; Xiang, Yang; Zhou, Yigang; Tan, Yurong; Qin, Xiaoqun			Differentiation of Th Subsets Inhibited by Nonstructural Proteins of Respiratory Syncytial Virus Is Mediated by Ubiquitination	PLOS ONE			English	Article							PEPTIDERGIC INNERVATION; EPITHELIAL-CELLS; UP-REGULATION; INFECTION; EXPRESSION; ASTHMA	Human respiratory syncytial virus (RSV), a major cause of severe respiratory diseases, constitutes an important risk factor for the development of subsequent asthma. However, the mechanism underlying RSV-induced asthma is poorly understood. Viral non-structural proteins NS1 and NS2 are critically required for RSV virulence; they strongly suppress IFN-mediated innate immunity of the host cells. In order to understand the effects of NS1 and NS2 on differentiation of Th subsets, we constructed lentiviral vectors of NS1 or NS2 to infect 16 HBE and analyzed the expression of HLA-DR, CD80 and CD86 and differentiation of Th1, Th2 and Th17 by Flow Cytometric Analysis and real-time PCR. The results showed that NS1 inhibited expression of HLA-DR, CD80 and CD86 and differentiation of Th1, Th2 and Th17 lymphocytes, which could be reversed by deleting elongin C binding domain. NS2 inhibited the differentiation of Th2 and Th17, which was reversed by proteasome inhibitors of PS-341. Our results indicated that NS1 inhibited the differentiation of T lymphocytes through its monoubiquitination to interacted proteins, while NS2 inhibited differentiation of Th2 and Th17 through ubiquitin-proteasome pathway, which may be related with the susceptibility to asthma after RSV infection.	[Qin, Ling; Hu, Chengping] Cent S Univ, Xiangya Hosp, Resp Dept, Changsha, Hunan, Peoples R China; [Peng, Dan; Xiang, Yang; Zhou, Yigang; Tan, Yurong; Qin, Xiaoqun] Cent S Univ, Xiangya Sch Med, Dept Basic Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tan, YR (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Basic Med, Changsha, Hunan, Peoples R China.	hope7@126.com			National Natural Science Foundation of China [81270065]; open platform innovation fund of Hunan universities [12K003, 13K001]; Young Teacher Fund of Central South University [2013JSJJ059, 2012QNZT111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open platform innovation fund of Hunan universities; Young Teacher Fund of Central South University	This work was supported by grant #81270065 (Yang Xiang) from National Natural Science Foundation of China; grants t #12K003 (Yang Xiang) and #13K001 (Yurong Tan) from open platform innovation fund of Hunan universities; and grants #2013JSJJ059 (Yurong Tan) and #2012QNZT111 (Qin Ling) from Young Teacher Fund of Central South University. All funders are involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bertorelli G, 1998, CLIN EXP ALLERGY, V28, P551; Finn Patricia W, 2009, Proc Am Thorac Soc, V6, P260, DOI 10.1513/pats.200807-064RM; Guo-Parke H, 2013, AM J RESP CRIT CARE, V188, P842, DOI 10.1164/rccm.201304-0750OC; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Kokuho T, 2003, VET IMMUNOL IMMUNOP, V91, P155, DOI 10.1016/S0165-2427(02)00288-X; Kurosawa S, 2003, AM J RESP CELL MOL, V28, P563, DOI 10.1165/rcmb.2002-0199OC; Mendoza L, 2010, THEOR BIOSCI, V129, P283, DOI 10.1007/s12064-010-0112-x; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Niedzwiedzka-Rystwej P, 2013, POSTEP HIG MED DOSW, V67, P371, DOI 10.5604/17322693.1048814; Papi A, 2000, J INFECT DIS, V181, P1780, DOI 10.1086/315463; Qin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027113; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tan YR, 2008, PEPTIDES, V29, P47, DOI 10.1016/j.peptides.2007.10.020; Tan YR, 2013, MOL BIOL REP, V40, P675, DOI 10.1007/s11033-012-2107-9; Tan Y, 2008, EXP PHYSIOL, V93, P1284, DOI 10.1113/expphysiol.2008.043521; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	20	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101469	10.1371/journal.pone.0101469	http://dx.doi.org/10.1371/journal.pone.0101469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992002	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400075
J	Manokhina, I; Singh, TK; Penaherrera, MS; Robinson, WP				Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.			Quantification of Cell-Free DNA in Normal and Complicated Pregnancies: Overcoming Biological and Technical Issues	PLOS ONE			English	Article							FREE FETAL DNA; MATERNAL PLASMA; HYPERMETHYLATED RASSF1A; SERUM; RISK; BLOOD; ONSET; QUANTITATION; RESTRICTION; SEQUENCES	The characterization of cell-free DNA (cfDNA) originating from placental trophoblast in maternal plasma provides a powerful tool for non-invasive diagnosis of fetal and obstetrical complications. Due to its placental origin, the specific epigenetic features of this DNA (commonly known as cell-free fetal DNA) can be utilized in creating universal 'fetal' markers in maternal plasma, thus overcoming the limitations of gender-or rhesus-specific ones. The goal of this study was to compare the performance of relevant approaches and assays evaluating the amount of cfDNA in maternal plasma throughout gestation (7.2-39.5 weeks). Two fetal- or placental-specific duplex assays (RPP30/SRY and RASSF1A/beta-Actin) were applied using two technologies, real-time quantitative PCR (qPCR) and droplet digital PCR (ddPCR). Both methods revealed similar performance parameters within the studied dynamic range. Data obtained using qPCR and ddPCR for these assays were positively correlated (total cfDNA (RPP30): R = 0.57, p = 0.001/placental cfDNA (SRY): R = 0.85, p<0.0001; placental cfDNA (RASSF1A): R = 0.75, p<0.0001). There was a significant correlation in SRY and RASSF1A results measured with qPCR (R = 0.68, p = 0.013) and ddPCR (R = 0.56, p = 0.039). Different approaches also gave comparable results with regard to the correlation of the placental cfDNA concentration with gestational age and pathological outcome. We conclude that ddPCR is a practical approach, adaptable to existing qPCR assays and well suited for analysis of cell-free DNA in plasma. However, it may need further optimization to surpass the performance of qPCR.	[Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Manokhina, Irina; Singh, Tanjot K.; Penaherrera, Maria S.; Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; Child & Family Research Institute	Manokhina, I (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	ikmanokhina@gmail.com	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174	Canada Institutes of Health Research [257450]; Child and Family Research Institutes Summer Student Fellowship	Canada Institutes of Health Research; Child and Family Research Institutes Summer Student Fellowship	This study is funded by Canada Institutes of Health Research operating grant #257450 to WPR and Child and Family Research Institutes Summer Student Fellowship for TKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Bartha JL, 2003, OBSTET GYNECOL, V101, P1135, DOI 10.1016/S0029-7844(03)00064-4; Bianchi DW, 2004, PLACENTA, V25, pS93, DOI 10.1016/j.placenta.2004.01.005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Farina A, 2004, PRENATAL DIAG, V24, P293, DOI 10.1002/pd.863; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holmberg RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073068; Hromadnikova I, 2010, DNA CELL BIOL, V29, P295, DOI 10.1089/dna.2009.0971; Hyland CA, 2009, MED J AUSTRALIA, V191, P21, DOI 10.5694/j.1326-5377.2009.tb02668.x; Jakobsen TR, 2012, PRENATAL DIAG, V32, P840, DOI 10.1002/pd.3917; Jin SN, 2012, CLIN CHEM, V58, P465, DOI 10.1373/clinchem.2011.174417; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kolialexi A, 2012, EUR J OBSTET GYN R B, V161, P34, DOI 10.1016/j.ejogrb.2011.12.025; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Lim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056787; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P184; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Muller SP, 2011, PRENATAL DIAG, V31, P1300, DOI 10.1002/pd.2889; Papandreaou Nikolaos, 2013, 2013 18 INT C DIG SI, P1; Repiska G, 2013, CLIN CHEM LAB MED, V51, P1185, DOI 10.1515/cclm-2012-0418; Stein W, 2013, EUR J OBSTET GYN R B, V166, P10, DOI 10.1016/j.ejogrb.2012.09.006; Tsui NBY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048319; Tynan JA, 2011, J MOL DIAGN, V13, P382, DOI 10.1016/j.jmoldx.2011.02.001; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vora NL, 2012, PRENATAL DIAG, V32, P912, DOI 10.1002/pd.3919; Wang E, 2013, PRENAT DIAGN, V33, P1; White HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045073; Wong D, 2013, CLIN BIOCH; Yu H, 2013, INT J MOL SCI, V14, P7571, DOI 10.3390/ijms14047571; Zejskova L, 2010, EXP MOL PATHOL, V89, P241, DOI 10.1016/j.yexmp.2010.09.002; Zeybek YG, 2013, J OBSTET GYNAECOL RE, V39, P632, DOI 10.1111/j.1447-0756.2012.02011.x; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	44	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101500	10.1371/journal.pone.0101500	http://dx.doi.org/10.1371/journal.pone.0101500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987984	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100101
J	Miao, YL; Guo, WZ; Shi, WZ; Fang, WW; Liu, Y; Liu, J; Li, BW; Wu, W; Li, YF				Miao, Yu-Liang; Guo, Wen-Zhi; Shi, Wen-Zhu; Fang, Wei-Wu; Liu, Yan; Liu, Ji; Li, Bao-Wei; Wu, Wei; Li, Yun-Feng			Midazolam Ameliorates the Behavior Deficits of a Rat Posttraumatic Stress Disorder Model through Dual 18 kDa Translocator Protein and Central Benzodiazepine Receptor and Neurosteroidogenesis	PLOS ONE			English	Article							GABA(A) RECEPTORS; CONTEXTUAL FEAR; MOUSE MODEL; ALLOPREGNANOLONE; AMYGDALA; AC-5216; ANXIETY; LIGAND; ANXIOLYTICS; ACTIVATION	Post-traumatic stress disorder (PTSD) is a debilitating anxiety disorder that may develop after an individual has experienced or witnessed a severe traumatic event. It has been shown that the 18 kDa translocator protein (TSPO) may be correlated with PTSD and that the TSPO ligand improved the behavioral deficits in a mouse model of PTSD. Midazolam, a ligand for TSPO and central benzodiazepine receptor (CBR), induces anxiolytic- and anti-depressant-like effects in animal models. The present study aimed to determine whether midazolam ameliorates PTSD behavior in rats as assessed by the single prolonged stress (SPS) model. The SPS rats received daily Sertraline (Ser) (15 mg/kg, p.o.) and midazolam (0.125, 0.25, 0.5, and 1 mg/kg, p.o.) during the exposure to SPS and behavioral assessments, which included the open field (OF) test, the contextual fear paradigm (CFP), and the elevated plus-maze (EPM). The results showed that, like Ser (15 mg/kg, p.o.), midazolam (0.25 and 0.5 mg/kg, p.o.) significantly reversed the behavioral deficiencies of the SPS rats, including PTSD-associated freezing and anxiety-like behavior but not the effects on spontaneous locomotor activity. In addition, the anti-PTSD effects of midazolam (0.5 mg/kg, p.o.) were antagonized by the TSPO antagonist PK11195 (3 mg/kg, i.p.), the CBR antagonist flumazenil (15 mg/kg, p.o.) and the inhibitor of steroidogenic enzymes finasteride (30 mg/kg, p.o.), which by themselves had no effect on PTSD-associated freezing and anxiety-like behavior. In summary, this study demonstrated that midazolam improves the behavioral deficits in the SPS model through dual TSPO and CBR and neurosteroidogenesis.	[Miao, Yu-Liang; Fang, Wei-Wu; Liu, Yan; Liu, Ji] Chinese PLA 306 Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Guo, Wen-Zhi] PLA, Beijing Mil Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Shi, Wen-Zhu] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Anesthesia & Operat Ctr, Sanya, Peoples R China; [Li, Bao-Wei; Wu, Wei] Chinese PLA 306 Hosp, Dept Head & Neck Surg Otolaryngol, Beijing, Peoples R China; [Li, Yun-Feng] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Wu, W (corresponding author), Chinese PLA 306 Hosp, Dept Head & Neck Surg Otolaryngol, Beijing, Peoples R China.	wwzwgk@163.com; lyf0619@aiyun.com			National Natural Science Foundation of China [81371204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Foundation of China (Grant No. 81371204). This foundation helped us in study design and performance of the experiment.	Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Brady KT, 2003, COMPR PSYCHIAT, V44, P360, DOI 10.1016/S0010-440X(03)00111-1; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; Cao JP, 2009, BIOSCI TRENDS, V3, P115; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; Costa B, 2012, CURR TOP MED CHEM, V12, P270, DOI 10.2174/156802612799078720; Davidson JRT, 1998, INT CLIN PSYCHOPHARM, V13, P111, DOI 10.1097/00004850-199805000-00003; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Dell'Osso L, 2010, PSYCHIAT RES, V177, P139, DOI 10.1016/j.psychres.2008.07.019; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; GABR RW, 1995, NEUROENDOCRINOLOGY, V62, P333, DOI 10.1159/000127022; Guidotti A, 2001, BRAIN RES REV, V37, P110, DOI 10.1016/S0165-0173(01)00129-1; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Kain ZN, 2007, ANESTHESIOLOGY, V107, P545, DOI 10.1097/01.anes.0000281895.81168.c3; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; Kita A, 2008, PHARMACOL BIOCHEM BE, V89, P171, DOI 10.1016/j.pbb.2007.12.006; Kita A, 2009, PROG NEURO-PSYCHOPH, V33, P1040, DOI 10.1016/j.pnpbp.2009.05.018; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Li S, 2006, PHARMACOL BIOCHEM BE, V85, P324, DOI 10.1016/j.pbb.2006.08.015; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; Paez-Martinez N, 2013, EUR J PHARMACOL, V698, P178, DOI 10.1016/j.ejphar.2012.10.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Pinna G, 2009, CURR OPIN PHARMACOL, V9, P24, DOI 10.1016/j.coph.2008.12.006; Qiu ZK, 2013, PROG NEURO-PSYCHOPH, V45, P40, DOI 10.1016/j.pnpbp.2013.04.010; Rasmusson AM, 2006, BIOL PSYCHIAT, V60, P704, DOI 10.1016/j.biopsych.2006.03.026; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Senses Elif, 2013, Middle East Journal of Anesthesiology, V22, P35; Suenaga T, 2004, INT J NEUROPSYCHOPH, V7, P299, DOI 10.1017/S1461145704004304; Szabo ST, 1999, BRIT J PHARMACOL, V126, P568, DOI 10.1038/sj.bjp.0702343; Takahashi T, 2006, PSYCHOPHARMACOLOGY, V189, P165, DOI 10.1007/s00213-006-0545-6; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; TreggiariVenzi M, 1996, INTENS CARE MED, V22, P1186, DOI 10.1007/BF01709334; Wang HN, 2009, PROG NEURO-PSYCHOPH, V33, P1458, DOI 10.1016/j.pnpbp.2009.07.031; Xue R, 2013, EUR NEUROPSYCHOPHARM, V23, P728, DOI 10.1016/j.euroneuro.2012.06.001; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4; Zhang LM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623753	51	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101450	10.1371/journal.pone.0101450	http://dx.doi.org/10.1371/journal.pone.0101450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988461	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100090
J	Pavlovic, DM; Vertes, PE; Bullmore, ET; Schafer, WR; Nichols, TE				Pavlovic, Dragana M.; Vertes, Petra E.; Bullmore, Edward T.; Schafer, William R.; Nichols, Thomas E.			Stochastic Blockmodeling of the Modules and Core of the Caenorhabditis elegans Connectome	PLOS ONE			English	Article							COMMUNITY STRUCTURE; MODEL; GRAPHS; ORGANIZATION; LOCOMOTION; MODULARITY; REVEALS	Recently, there has been much interest in the community structure or mesoscale organization of complex networks. This structure is characterised either as a set of sparsely inter-connected modules or as a highly connected core with a sparsely connected periphery. However, it is often difficult to disambiguate these two types of mesoscale structure or, indeed, to summarise the full network in terms of the relationships between its mesoscale constituents. Here, we estimate a community structure with a stochastic blockmodel approach, the Erdos-Renyi Mixture Model, and compare it to the much more widely used deterministic methods, such as the Louvain and Spectral algorithms. We used the Caenorhabditis elegans (C. elegans) nervous system (connectome) as a model system in which biological knowledge about each node or neuron can be used to validate the functional relevance of the communities obtained. The deterministic algorithms derived communities with 4-5 modules, defined by sparse inter-connectivity between all modules. In contrast, the stochastic Erdos Renyi Mixture Model estimated a community with 9 blocks or groups which comprised a similar set of modules but also included a clearly defined core, made of 2 small groups. We show that the "core-in-modules" decomposition of the worm brain network, estimated by the Erdos-Renyi Mixture Model, is more compatible with prior biological knowledge about the C. elegans nervous system than the purely modular decomposition defined deterministically. We also show that the blockmodel can be used both to generate stochastic realisations (simulations) of the biological connectome, and to compress network into a small number of super-nodes and their connectivity. We expect that the Erdos-Renyi Mixture Model may be useful for investigating the complex community structures in other (nervous) systems.	[Pavlovic, Dragana M.; Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Pavlovic, Dragana M.; Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England; [Vertes, Petra E.; Bullmore, Edward T.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Brain Mapping Unit, Cambridge, England; [Bullmore, Edward T.] Addenbrookes Hosp, GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Schafer, William R.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 2QH, England	University of Warwick; University of Warwick; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; MRC Laboratory Molecular Biology	Pavlovic, DM (corresponding author), Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England.	d.pavlovic@warwick.ac.uk	Nichols, Thomas E./N-9902-2017; Bullmore, Ed/C-1706-2012	Nichols, Thomas E./0000-0002-4516-5103; Bullmore, Ed/0000-0002-8955-8283; Schafer, William/0000-0002-6676-8034; Vertes, Petra E./0000-0002-0992-3210	MRC Industrial CASE award; GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship; Medical Research Council [MR/K020706/1]; Medical Research Council (UK); Wellcome Trust; NIH [U54MH091657-03]; MRC [MR/K020706/1, MC_U105185857] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; Medical Research Council [G0001354B, G1000183B, G0001354, 1198744, MC_U105185857] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; Wellcome Trust [103784/Z/14/Z] Funding Source: researchfish	MRC Industrial CASE award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	DMP is supported by the MRC Industrial CASE award with GlaxoSmithKline's Clinical Unit Cambridge (UK) PhD studentship. PEV is supported by Medical Research Council (grant number MR/K020706/1). ETB is employed half-time by the University of Cambridge and half-time by GlaxoSmithKline (GSK); he holds stock in GSK. The Behavioural and Clinical Neuroscience Institute is supported by the Medical Research Council (UK) and Wellcome Trust. TEN is supported by NIH U54MH091657-03 and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Altun Z, 2005, HDB C ELEGANS ANATOM; Altun ZF HD, 2009, NERVOUS SYSTEM GEN D; ANDERSON CJ, 1992, SOC NETWORKS, V14, P137, DOI 10.1016/0378-8733(92)90017-2; Bates D., 2012, IME4 LINEAR MIXED EF; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 1999, SOC NETWORKS, V21, P375; BRENNER S, 1974, GENETICS, V77, P71; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Daudin JJ, 2008, STAT COMPUT, V18, P173, DOI 10.1007/s11222-007-9046-7; Dicken P, 2002, GLOBAL NETW, V1, P89; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Doreian P, 2005, GEN BLOCKMODELING, V25; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; FRALEY C, 2006, 504 U WASH DEP STAT; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Goldenberg A., 2010, SURVEY STAT NETWORK; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Haspel G, 2011, J NEUROSCI, V31, P14611, DOI 10.1523/JNEUROSCI.2186-11.2011; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Holme P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046111; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jaakkola TS, 2001, NEU INF PRO, P129; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Latouche P, 2008, BAYESIAN METHODS GRA; Latouche P, 2011, ANN APPL STAT, V5, P309, DOI 10.1214/10-AOAS382; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250x.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250X.1971.9989788]; Luczak T., 1989, PROC S RANDOM GRAPHS, P165; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; MOREY LC, 1984, EDUC PSYCHOL MEAS, V44, P33, DOI 10.1177/0013164484441003; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Pan RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009240; Pattison P, 2007, HDB PROBABILITY THEO; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Snijders TAB, 1997, J CLASSIF, V14, P75, DOI 10.1007/s003579900004; Sporns O., 2010, NETWORKS BRAIN; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Varier S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001044; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Von Stetina Stephen E, 2006, Int Rev Neurobiol, V69, P125; Vu DQ, 2012, ARXIV12070188; WANG YJ, 1987, J AM STAT ASSOC, V82, P8, DOI 10.2307/2289119; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wood W. B., 1987, NEMATODE CAENORHABDI; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zanghi H, 2008, STRATEGIES ONLINE IN; Zanghi H, 2008, PATTERN RECOGN, V41, P3592, DOI 10.1016/j.patcog.2008.06.019	69	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97584	10.1371/journal.pone.0097584	http://dx.doi.org/10.1371/journal.pone.0097584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988196	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100007
J	Sowa, JP; Atmaca, O; Kahraman, A; Schlattjan, M; Lindner, M; Sydor, S; Scherbaum, N; Lackner, K; Gerken, G; Heider, D; Arteel, GE; Erim, Y; Canbay, A				Sowa, Jan-Peter; Atmaca, Ozgur; Kahraman, Alisan; Schlattjan, Martin; Lindner, Marion; Sydor, Svenja; Scherbaum, Norbert; Lackner, Karoline; Gerken, Guido; Heider, Dominik; Arteel, Gavin E.; Erim, Yesim; Canbay, Ali			Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling	PLOS ONE			English	Article							CONSUMPTION	Background & Objective: Currently, a major clinical challenge is to distinguish between chronic liver disease caused by metabolic syndrome (non-alcoholic fatty liver disease, NAFLD) from that caused by long term or excessive alcohol consumption (ALD). The etiology of severe liver disease affects treatment options and priorities for liver transplantation and organ allocation. Thus we compared physiologically similar NAFLD and ALD patients to detect biochemical differences for improved separation of these mechanistically overlapping etiologies. Methods: In a cohort of 31 NAFLD patients with BMI below 30 and a cohort of ALD patient with (ALDC n = 51) or without cirrhosis (ALDNC n = 51) serum transaminases, cell death markers and (adipo-) cytokines were assessed. Groups were compared with One-way ANOVA and Tukey's correction. Predictive models were built by machine learning techniques. Results: NAFLD, ALDNC or ALDC patients did not differ in demographic parameters. The ratio of alanine aminotransferase/aspartate aminotransferase - common serum parameters for liver damage - was significantly higher in the NAFLD group compared to both ALD groups (each p<0.0001). Adiponectin and tumor necrosis factor(TNF)-alpha were significantly lower in NAFLD than in ALDNC (p<0.05) or ALDC patients (p<0.0001). Significantly higher serum concentrations of cell death markers, hyaluronic acid, adiponectin, and TNF-alpha (each p<0.0001) were found in ALDC compared to ALDNC. Using machine learning techniques we were able to discern NAFLD and ALDNC (up to an AUC of 0.9118+/-0.0056) or ALDC and ALDNC (up to an AUC of 0.9846+/-0.0018), respectively. Conclusions: Machine learning techniques relying on ALT/AST ratio, adipokines and cytokines distinguish NAFLD and ALD. In addition, severity of ALD may be non-invasively diagnosed via serum cytokine concentrations.	[Sowa, Jan-Peter; Atmaca, Ozgur; Kahraman, Alisan; Schlattjan, Martin; Sydor, Svenja; Gerken, Guido; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Atmaca, Ozgur] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey; [Lindner, Marion; Scherbaum, Norbert; Erim, Yesim] Univ Duisburg Essen, Univ Hosp, LVR Clin, Essen, Germany; [Lackner, Karoline] Med Univ Graz, Inst Pathol, Graz, Austria; [Heider, Dominik] Straubing Ctr Sci, Dept Bioinformat, Straubing, Germany; [Arteel, Gavin E.] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Erim, Yesim] Univ Hosp Erlangen, Psychosomat & Psychotherapeut Dept, Erlangen, Germany	University of Duisburg Essen; Hacettepe University; University of Duisburg Essen; Medical University of Graz; University of Louisville; University of Erlangen Nuremberg	Canbay, A (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	ali.canbay@uni-due.de	Sydor, Svenja/ABG-6622-2020; Heider, Dominik/F-8545-2010; Canbay, Ali/AAL-9620-2020; Sydor, Svenja/AAV-9951-2021; Arteel, Gavin/AAE-2440-2022; Sowa, Jan-Peter/AAQ-6318-2020	Heider, Dominik/0000-0002-3108-8311; Sydor, Svenja/0000-0002-1349-8309; Arteel, Gavin/0000-0002-2253-5984; Canbay, Ali/0000-0001-6069-7899; Sowa, Jan-Peter/0000-0003-2943-0015	Deutsche Forschungsgemeinschaft (DFG) [267/8-1]; Wilhelm Laupitz Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021978] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant 267/8-1), and the Wilhelm Laupitz Foundation to A. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Beier JI, 2012, EXP BIOL MED, V237, P1, DOI 10.1258/ebm.2011.011255; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Cello JP, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.6; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Erim Y, 2007, LIVER TRANSPLANT, V13, P757, DOI 10.1002/lt.21163; Erim Y, 2006, Z PSYCHOSOM MED PSYC, V52, P341, DOI 10.13109/zptm.2006.52.4.341; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FREBOURG T, 1986, HEPATOLOGY, V6, P392, DOI 10.1002/hep.1840060310; GUECHOT J, 1995, J HEPATOL, V22, P103; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sowa JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062439; Verrijken A, 2014, HEPATOLOGY, V59, P121, DOI 10.1002/hep.26510; Vizzutti F, 2009, ANN HEPATOL, V8, P89; Wederneyer I, 2009, J HEPATOL, V50, P140, DOI 10.1016/j.jhep.2008.08.023; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010	24	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101444	10.1371/journal.pone.0101444	http://dx.doi.org/10.1371/journal.pone.0101444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988316	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100088
J	Zaiss, AK; Zuber, J; Chu, C; Machado, HB; Jiao, J; Catapang, AB; Ishikawa, TO; Gil, JS; Lowe, SW; Herschman, HR				Zaiss, Anne K.; Zuber, Johannes; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Lowe, Scott W.; Herschman, Harvey R.			Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSGENIC MICE; ARACHIDONIC-ACID; GENE-EXPRESSION; MAMMALIAN-CELLS; POLYMERASE-II; MOUSE SKIN; INFLAMMATION; HYPERALGESIA; MESSENGER	Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase 2 (COX-2), plays a critical role in many normal physiological functions and modulates a variety of pathological conditions. The ability to turn endogenous COX-2 on and off in a reversible fashion, at specific times and in specific cell types, would be a powerful tool in determining its role in many contexts. To achieve this goal, we took advantage of a recently developed RNA interference system in mice. An shRNA targeting the Cox2 mRNA 3'untranslated region was inserted into a microRNA expression cassette, under the control of a tetracycline response element (TRE) promoter. Transgenic mice containing the COX-2-shRNA were crossed with mice encoding a CAG promoter-driven reverse tetracycline transactivator, which activates the TRE promoter in the presence of tetracycline/doxycycline. To facilitate testing the system, we generated a knockin reporter mouse in which the firefly luciferase gene replaces the Cox2 coding region. Cox2 promoter activation in cultured cells from triple transgenic mice containing the luciferase allele, the shRNA and the transactivator transgene resulted in robust luciferase and COX-2 expression that was reversibly down-regulated by doxycycline administration. In vivo, using a skin inflammation-model, both luciferase and COX-2 expression were inhibited over 80% in mice that received doxycycline in their diet, leading to a significant reduction of infiltrating leukocytes. In summary, using inducible RNA interference to target COX-2 expression, we demonstrate potent, reversible Cox2 gene silencing in vivo. This system should provide a valuable tool to analyze cell type-specific roles for COX-2.	[Zaiss, Anne K.; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Zaiss, Anne K.; Chu, Chun; Machado, Hidevaldo B.; Jiao, Jing; Catapang, Arthur B.; Ishikawa, Tomo-o; Gil, Jose S.; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zuber, Johannes; Lowe, Scott W.] Cold Spring Harbor Lab, New York, NY USA; [Zuber, Johannes; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Herschman, HR (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	hherschman@mednet.ucla.edu	Jiao, Jing/F-5354-2015; Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835	National Institutes of Health [P50 CA086306-08]; American Society of Hematology (ASH); NATIONAL CANCER INSTITUTE [P50CA086306, P30CA008748, P30CA016042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology (ASH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant P50 CA086306-08 (HRH). AKZ is the recipient of an American Society of Hematology (ASH) Scholar Award. SWL is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Araldi D, 2013, P NATL ACAD SCI USA, V110, P3603, DOI 10.1073/pnas.1220668110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; CALHOUN W, 1987, AGENTS ACTIONS, V21, P306, DOI 10.1007/BF01966499; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Dixon Dan A, 2013, Recent Results Cancer Res, V191, P7, DOI 10.1007/978-3-642-30331-9_2; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; FISHER S.M, 1997, FRONT BIOSCI, V2, P482, DOI d482-500; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hay C, 1997, NEUROREPORT, V8, P1249, DOI 10.1097/00001756-199703240-00038; Herschman Harvey R, 2003, Mol Imaging Biol, V5, P286; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Ishikawa T, 2010, MOL ONCOL, V4, P347, DOI 10.1016/j.molonc.2010.06.004; Jain NK, 2008, PROSTAG LEUKOTR ESS, V79, P183, DOI 10.1016/j.plefa.2008.08.001; Kadoshima-Yamaoka K, 2009, EUR J PHARMACOL, V613, P163, DOI 10.1016/j.ejphar.2009.04.014; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2013, BIOCHEM BIOPH RES CO, V438, P249, DOI 10.1016/j.bbrc.2013.07.006; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Lazarus M, 2002, ENDOCRINOLOGY, V143, P2410, DOI 10.1210/en.143.6.2410; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Menezes GB, 2008, EUR J PHARMACOL, V598, P118, DOI 10.1016/j.ejphar.2008.08.037; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura Y, 2003, FREE RADICAL BIO MED, V35, P997, DOI 10.1016/S0891-5849(03)00440-4; Oshima M, 2005, BIOCHEM BIOPH RES CO, V330, P928, DOI 10.1016/j.bbrc.2005.03.060; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Puignero V, 1997, INFLAMMATION, V21, P431, DOI 10.1023/A:1027370504822; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Seluanov A., 2010, J VIS EXP; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; TARAYRE JP, 1989, PHARMACOL RES, V21, P385, DOI 10.1016/1043-6618(89)90156-4; Tiano HF, 2002, CANCER RES, V62, P3395; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61	54	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101263	10.1371/journal.pone.0101263	http://dx.doi.org/10.1371/journal.pone.0101263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988319	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341354100072
J	Nemeth, K; Zimmer, M; Schweinberger, SR; Vakli, P; Kovacs, G				Nemeth, Kornel; Zimmer, Marta; Schweinberger, Stefan R.; Vakli, Pal; Kovacs, Gyula			The Background of Reduced Face Specificity of N170 in Congenital Prosopagnosia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TRIAL EEG DYNAMICS; DEVELOPMENTAL PROSOPAGNOSIA; HEREDITARY PROSOPAGNOSIA; ACQUIRED PROSOPAGNOSIA; BRAIN POTENTIALS; IMPAIRED FACE; SINGLE-TRIAL; ALPHA-OSCILLATIONS; FACIAL EXPRESSION	Congenital prosopagnosia is lifelong face-recognition impairment in the absence of evidence for structural brain damage. To study the neural correlates of congenital prosopagnosia, we measured the face-sensitive N170 component of the event-related potential in three members of the same family (father (56 y), son (25 y) and daughter (22 y)) and in age-matched neurotypical participants (young controls: n = 14; 24.5 y +/- 2.1; old controls: n = 6; 57.3 y +/- 5.4). To compare the face sensitivity of N170 in congenital prosopagnosic and neurotypical participants we measured the event-related potentials for faces and phase-scrambled random noise stimuli. In neurotypicals we found significantly larger N170 amplitude for faces compared to noise stimuli, reflecting normal early face processing. The congenital prosopagnosic participants, by contrast, showed reduced face sensitivity of the N170, and this was due to a larger than normal noise-elicited N170, rather than to a smaller face-elicited N170. Interestingly, single-trial analysis revealed that the lack of face sensitivity in congenital prosopagnosia is related to a larger oscillatory power and phase-locking in the theta frequency-band (4-7 Hz, 130-190 ms) as well as to a lower intertrial jitter of the response latency for the noise stimuli. Altogether, these results suggest that congenital prosopagnosia is due to the deficit of early, structural encoding steps of face perception in filtering between face and non-face stimuli.	[Nemeth, Kornel; Zimmer, Marta; Vakli, Pal; Kovacs, Gyula] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary; [Schweinberger, Stefan R.; Kovacs, Gyula] Univ Jena, Inst Psychol, Jena, Germany; [Schweinberger, Stefan R.; Kovacs, Gyula] Univ Jena, DFG Res Unit Person Percept, Jena, Germany	Budapest University of Technology & Economics; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kovacs, G (corresponding author), Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary.	gkovacs@cogsci.bme.hu	Kovacs, Gyula/E-4781-2010; Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Hungarian Scientific Research Fund (OTKA) [PD 101499]; Deutsche Forschungsgemeinschaft [KO 3918/1-2, KO 3918/2-1]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Hungarian Scientific Research Fund (OTKA; http://www.otka.hu/; PD 101499 (Marta Zimmer)) and by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/; KO 3918/1-2, 2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Baddeley AD, 2004, DOORS PEOPLE TEST VI; Banko EM, 2011, J NEUROSCI, V31, P2663, DOI 10.1523/JNEUROSCI.2725-10.2011; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2010, PERCEPTUAL EXPERTISE, P167; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, NAT NEUROSCI, V10, P801, DOI 10.1038/nn0707-801; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Boehm SG, 2011, NEUROPSYCHOLOGIA, V49, P2082, DOI 10.1016/j.neuropsychologia.2011.03.039; Bottger D, 2002, INT J PSYCHOPHYSIOL, V45, P245, DOI 10.1016/S0167-8760(02)00031-4; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Busigny T, 2011, J NEUROPSYCHOL, V5, P1, DOI 10.1348/174866410X500116; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Dakin SC, 2002, CURR BIOL, V12, pR476, DOI 10.1016/S0960-9822(02)00960-0; Dalrymple KA, 2011, NEUROPSYCHOLOGIA, V49, P2553, DOI 10.1016/j.neuropsychologia.2011.05.003; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; de Gelder B, 2005, NEUROSCI LETT, V376, P40, DOI 10.1016/j.neulet.2004.11.047; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; DEHAAN EHF, 1991, CORTEX, V27, P489, DOI 10.1016/S0010-9452(13)80001-9; Della Sala S, 2003, CORTEX, V39, P533; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine B., 2011, OXFORD HDB FACE PERC; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Eimer M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00119; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gao L, 2009, PSYCHOPHYSIOLOGY, V46, P970, DOI 10.1111/j.1469-8986.2009.00853.x; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jemel B, 2003, NEUROREPORT, V14, P2035, DOI 10.1097/00001756-200311140-00006; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Lee Y, 2010, CORTEX, V46, P949, DOI 10.1016/j.cortex.2009.07.012; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Mohamed TN, 2009, NEUROREPORT, V20, P782, DOI 10.1097/WNR.0b013e32832b7e24; Navajas J, 2013, J NEUROSCI, V33, P1337, DOI 10.1523/JNEUROSCI.1226-12.2013; Nemeth K, CLIN NEUROS IN PRESS, V67; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P3801, DOI 10.1016/j.neuropsychologia.2011.09.039; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; Polich J, 1997, EVOKED POTENTIAL, V104, P244, DOI 10.1016/S0168-5597(97)96139-6; Ramon M, 2010, NEUROPSYCHOLOGIA, V48, P933, DOI 10.1016/j.neuropsychologia.2009.11.014; Raven J, 2000, RAVEN MAUAL SECTION; Regan D., 1989, HUMAN BRAIN ELECTROP; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Rivolta D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00045; Rivolta D, 2012, CORTEX, V48, P344, DOI 10.1016/j.cortex.2011.01.005; Rivolta D, 2010, J CLIN EXP NEUROPSYC, V32, P1002, DOI 10.1080/13803391003662710; Rossion B., 2012, OXFORD HDB ERP COMPO, P115, DOI [10.1093/oxfordhb/9780195374148.013.0064, DOI 10.1093/OXFORDHB/9780195374148.013.0064]; Rossion B, 2008, NEUROIMAGE, V40, P423, DOI 10.1016/j.neuroimage.2007.10.047; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Rousselet GA, 2007, NEUROIMAGE, V36, P843, DOI 10.1016/j.neuroimage.2007.02.052; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Sakihara K, 2012, CLIN NEUROPHYSIOL, V123, P270, DOI 10.1016/j.clinph.2011.06.023; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schneider BL, 2007, J VISION, V7, DOI 10.1167/7.4.4; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tang YY, 2008, IEEE ENG MED BIO, P4114, DOI 10.1109/IEMBS.2008.4650114; Thomas AL, 2008, ARCH CLIN NEUROPSYCH, V23, P175, DOI 10.1016/j.acn.2007.10.003; Towler J, 2012, COGN NEUROPSYCHOL, V29, P503, DOI 10.1080/02643294.2012.716757; Towler J, 2012, NEUROPSYCHOLOGIA, V50, P3588, DOI 10.1016/j.neuropsychologia.2012.10.017; Wilcox RR, 2005, INTRO ROBOUST ESTIMA; Wolff N, 2012, PSYCHOL AGING, V27, P1066, DOI 10.1037/a0029112	110	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101393	10.1371/journal.pone.0101393	http://dx.doi.org/10.1371/journal.pone.0101393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983881	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000098
J	Chakraborty, AA; Scuoppo, C; Dey, S; Thomas, LR; Lorey, SL; Lowe, SW; Tansey, WP				Chakraborty, A. A.; Scuoppo, C.; Dey, S.; Thomas, L. R.; Lorey, S. L.; Lowe, S. W.; Tansey, W. P.			A common functional consequence of tumor-derived mutations within c-MYC	ONCOGENE			English	Article							BURKITT-LYMPHOMA; MOUSE PLASMACYTOMAS; CODING REGION; ONCOGENE; PROGRESSION; SUPPRESSOR; TARGETS; BIM	The relevance of changes to the coding sequence of the c-MYC oncogene to malignancy is controversial. Overexpression of a pristine form of MYC is observed in many cancers and is sufficient to drive tumorigenesis in most contexts. Yet missense changes to MYC are found in similar to 50% of Burkitt's lymphomas, aggregate within an amino-terminal degron important for proteasomal destruction of MYC, and where examined profoundly enhance the tumorigenic properties of MYC in vitro and in vivo. Much of the controversy surrounding these mutants stems from the limited number of mutations that have been evaluated and their clustering within a single region of the MYC protein; the highly-conserved Myc box I (MbI) element. Here, by analysis of extant genomic data sets, we identify a previously unrecognized hotspot for tumor-associated MYC mutations, located in a conserved central portion of the protein. We show that, despite their distal location in MYC, mutations in this region precisely phenocopy those in MbI in terms of stability, in vitro transformation, growth-promoting properties, in vivo tumorigenesis and ability to escape p53-dependent tumor surveillance mechanisms. The striking parallels between the behavior of tumor-derived mutations in disparate regions of the MYC protein reveals that a common molecular process is disrupted by these mutations, implying an active role for these mutations in tumorigenesis and suggesting that different therapeutic strategies may be needed for treatment of lymphomas expressing wild type versus mutant forms of MYC protein.	[Chakraborty, A. A.; Scuoppo, C.; Lowe, S. W.; Tansey, W. P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chakraborty, A. A.; Dey, S.; Thomas, L. R.; Lorey, S. L.; Tansey, W. P.] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA; [Lowe, S. W.] Howard Hughes Med Inst, New York, NY USA	Cold Spring Harbor Laboratory; Vanderbilt University; Howard Hughes Medical Institute	Tansey, WP (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, 465 21st Ave South, Nashville, TN 37232 USA.	william.p.tansey@vanderbilt.edu		Tansey, William/0000-0002-3900-0978	CSHL Cancer Center [CA45508]; Vanderbilt Ingram Cancer Center [CA68485]; US Public Health Service from the NCI [CA-13106]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA068485, P30CA045508, P01CA087497] Funding Source: NIH RePORTER	CSHL Cancer Center; Vanderbilt Ingram Cancer Center; US Public Health Service from the NCI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	For reagents, we thank the CSHL Antibody Shared Resource and the Vanderbilt Antibody and Protein Shared Resource. We thank Simone Salghetti for technical assistance. This work was supported by the CSHL Cancer Center Support Grant CA45508, the Vanderbilt Ingram Cancer Center Support grant CA68485 and by US Public Health Service grant CA-13106 from the NCI (WPT/SWL) and Howard Hughes Medical Institute (SWL). SWL is an investigator in the Howard Hughes Medical Institute.	Axelson H, 1995, EUR J CANCER, V31A, P2099, DOI 10.1016/0959-8049(95)00449-1; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; CLARK HM, 1994, CANCER RES, V54, P3383; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; MURPHY W, 1986, P NATL ACAD SCI USA, V83, P2939, DOI 10.1073/pnas.83.9.2939; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; Tworkowski KA, 2008, P NATL ACAD SCI USA, V105, P6103, DOI 10.1073/pnas.0802095105; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; WESTAWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P843, DOI 10.1073/pnas.81.3.843	23	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 30	2015	34	18					2406	2409		10.1038/onc.2014.186	http://dx.doi.org/10.1038/onc.2014.186			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH2AH	24998853	Green Accepted			2022-12-25	WOS:000353824800013
J	Bhatnagar, S; Soni, MS; Wrighton, LS; Hebert, AS; Zhou, AS; Paul, PK; Gregg, T; Rabaglia, ME; Keller, MP; Coon, JJ; Attie, AD				Bhatnagar, Sushant; Soni, Mufaddal S.; Wrighton, Lindsay S.; Hebert, Alexander S.; Zhou, Amber S.; Paul, Pradyut K.; Gregg, Trillian; Rabaglia, Mary E.; Keller, Mark P.; Coon, Joshua J.; Attie, Alan D.			Phosphorylation and Degradation of Tomosyn-2 De-represses Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; NEUROTRANSMITTER RELEASE; AXONAL-TRANSPORT; BETA-CELLS; SYNAPSIN-I; PROTEIN; COMPLEX; LIGASE; INHIBITION	The abundance and functional activity of proteins involved in the formation of the SNARE complex are tightly regulated for efficient exocytosis. Tomosyn proteins are negative regulators of exocytosis. Tomosyn causes an attenuation of insulin secretion by limiting the formation of the SNARE complex. We hypothesized that glucose-dependent stimulation of insulin secretion from beta-cells must involve reversing the inhibitory action of tomosyn. Here, we show that glucose increases tomosyn protein turnover. Within 1 h of exposure to 15 mM glucose, similar to 50% of tomosyn was degraded. The degradation of tomosyn in response to high glucose was blocked by inhibitors of the proteasomal pathway. Using P-32 labeling and mass spectrometry, we showed that tomosyn-2 is phosphorylated in response to high glucose, phorbol esters, and analogs of cAMP, all key insulin secretagogues. We identified 11 phosphorylation sites in tomosyn-2. Site-directed mutagenesis was used to generate phosphomimetic (ser -> Asp) and loss-of-function (Ser -> Ala) mutants. The Ser -> Asp mutant had enhanced protein turnover compared with the Ser -> Ala mutant and wild type tomosyn-2. Additionally, the ser -> Asp tomosyn-2 mutant was ineffective at inhibiting insulin secretion. Using a proteomic screen for tomosyn-2-binding proteins, we identified Hrd-1, an E3-ubiquitin ligase. We showed that tomosyn-2 ubiquitination is increased by Hrd-1, and knockdown of Hrd-1 by short hairpin RNA resulted in increased abundance in tomosyn-2 protein levels. Taken together, our results reveal a mechanism by which enhanced phosphorylation of a negative regulator of secretion, tomosyn-2, in response to insulin secretagogues targets it to degradation by the Hrd-1 E3-ubiquitin ligase.	[Bhatnagar, Sushant; Soni, Mufaddal S.; Wrighton, Lindsay S.; Zhou, Amber S.; Paul, Pradyut K.; Gregg, Trillian; Rabaglia, Mary E.; Keller, Mark P.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Hebert, Alexander S.; Coon, Joshua J.] Univ Wisconsin, Dept Chem & Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	adattie@wisc.edu			National Institutes of Health [DK066369, DK58037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058037, R01DK066369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK066369 and DK58037 (to A. D. A.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belgardt BF, 2014, NAT CELL BIOL, V16, P210, DOI 10.1038/ncb2925; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Diaferia GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079458; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; EDDLESTONE GT, 1985, AM J PHYSIOL, V248, pC145, DOI 10.1152/ajpcell.1985.248.1.C145; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Francisco AB, 2011, J BIOL CHEM, V286, P22275, DOI 10.1074/jbc.M111.239418; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; PETRUCCI TC, 1991, J NEUROSCI, V11, P2938; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Weinberger A., 2004, REGULATORY MECH INTR, P145; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamasaki S, 2007, CELL CYCLE, V6, P1319, DOI 10.4161/cc.6.11.4277; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhou J, 2007, AM J PHYSIOL-ENDOC M, V293, pE538, DOI 10.1152/ajpendo.00070.2007	61	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25276	25286		10.1074/jbc.M114.575985	http://dx.doi.org/10.1074/jbc.M114.575985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25002582	Green Published, hybrid			2022-12-25	WOS:000341985300046
J	Ding, YT; Qu, YB; Feng, J; Wang, MZ; Han, Q; So, KF; Wu, WT; Zhou, LB				Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing			Functional Motor Recovery from Motoneuron Axotomy Is Compromised in Mice with Defective Corticospinal Projections	PLOS ONE			English	Article							BRACHIAL-PLEXUS INJURY; VENTRAL ROOT AVULSION; CERVICAL-SPINAL CORD; NITRIC-OXIDE SYNTHASE; NEUROTROPHIC FACTOR; ADULT-RAT; ELECTRICAL-STIMULATION; MULTITRAUMA POPULATION; AXONAL REGENERATION; MUSCLE AFFERENTS	Brachial plexus injury (BPI) and experimental spinal root avulsion result in loss of motor function in the affected segments. After root avulsion, significant motoneuron function is restored by re-implantation of the avulsed root. How much this functional recovery depends on corticospinal inputs is not known. Here, we studied that question using Celsr3 vertical bar Emx1 mice, in which the corticospinal tract (CST) is genetically absent. In adult mice, we tore off right C5-C7 motor and sensory roots and re-implanted the right C6 roots. Behavioral studies showed impaired recovery of elbow flexion in Celsr3 vertical bar Emx1 mice compared to controls. Five months after surgery, a reduced number of small axons, and higher G-ratio of inner to outer diameter of myelin sheaths were observed in mutant versus control mice. At early stages post-surgery, mutant mice displayed lower expression of GAP-43 in spinal cord and of myelin basic protein (MBP) in peripheral nerves than control animals. After five months, mutant animals had atrophy of the right biceps brachii, with less newly formed neuromuscular junctions (NMJs) and reduced peak-to-peak amplitudes in electromyogram (EMG), than controls. However, quite unexpectedly, a higher motoneuron survival rate was found in mutant than in control mice. Thus, following root avulsion/re-implantation, the absence of the CST is probably an important reason to hamper axonal regeneration and remyelination, as well as target re-innervation and formation of new NMJ, resulting in lower functional recovery, while fostering motoneuron survival. These results indicate that manipulation of corticospinal transmission may help improve functional recovery following BPI.	[Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Ding, Yuetong; Qu, Yibo; Feng, Jia; Wang, Meizhi; Han, Qi; So, Kwok-Fai; Wu, Wutian; Zhou, Libing] Jinan Univ, Med Key Lab Brain Funct & Dis, Guangzhou, Guangdong, Peoples R China; [So, Kwok-Fai; Wu, Wutian] Univ Hong Kong, Dept Anat, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhou, Libing] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Zhou, Libing] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China	Jinan University; Jinan University; University of Hong Kong; Jinan University; Nantong University	Wu, WT (corresponding author), Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China.	wtwu@hku.hk; tlibingzh@jnu.edu.cn		So, Kwok-Fai/0000-0003-4039-4246; Han, Qi/0000-0003-3742-159X; Zhou, Libing/0000-0002-8975-5228	National Natural Science Foundation of China [81171152]; National Basic Research Program of China (973 Program) [2011CB504402]; Foundation for High-level Talents in Higher Education of Guangdong [50524005]; Project of Internation; Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province [2013gjhz0002]; Programme of Introducing Talents of Discipline to Universities [B14036]; Fundamental Research Funds for the Central Universities [21614603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation for High-level Talents in Higher Education of Guangdong; Project of Internation; Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province; Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The National Natural Science Foundation of China (81171152, L. Zhou), National Basic Research Program of China (973 Program, 2011CB504402), Foundation for High-level Talents in Higher Education of Guangdong (50524005), Project of Internation as well as Hong Kong, Macao & Taiwan Science and Technology Cooperation Innovation Platform in Universities in Guangdong Province (2013gjhz0002), the Programme of Introducing Talents of Discipline to Universities (B14036) and Fundamental Research Funds for the Central Universities (21614603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTELLI JA, 1993, J NEUROSCI METH, V46, P203, DOI 10.1016/0165-0270(93)90068-3; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Brus-Ramer M, 2007, J NEUROSCI, V27, P13793, DOI 10.1523/JNEUROSCI.3489-07.2007; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Carlstedt T, 2000, J NEUROSURG, V93, P237, DOI 10.3171/spi.2000.93.2.0237; CARLSTEDT T, 1995, LANCET, V346, P1323, DOI 10.1016/S0140-6736(95)92342-X; Carlstedt T, 2009, NEUROSURG CLIN N AM, V20, P39, DOI 10.1016/j.nec.2008.07.020; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; Carmel JB, 2010, J NEUROSCI, V30, P10918, DOI 10.1523/JNEUROSCI.1435-10.2010; Chai H, 2000, NEUROREPORT, V11, P1249, DOI 10.1097/00001756-200004270-00021; Chakrabarty S, 2009, J NEUROSCI, V29, P8816, DOI 10.1523/JNEUROSCI.0735-09.2009; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Chu Tak-Ho, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P40; Clowry GJ, 2004, EUR J NEUROSCI, V20, P2555, DOI 10.1111/j.1460-9568.2004.03713.x; Clowry GJ, 1997, DEV BRAIN RES, V102, P197, DOI 10.1016/S0165-3806(97)00098-9; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; Dekkers J, 2002, DEV NEUROSCI-BASEL, V24, P283, DOI 10.1159/000066742; Dorsi MJ, 2010, J NEUROSURG-PEDIATR, V5, P573, DOI 10.3171/2010.3.PEDS09538; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Faglioni W, 2014, ACTA NEUROCHIR, V156, P1025, DOI 10.1007/s00701-013-1948-x; Forghani R, 2001, J NEUROSCI, V21, P3780, DOI 10.1523/JNEUROSCI.21-11-03780.2001; Fournier HD, 2005, HAND CLIN, V21, P109, DOI 10.1016/j.hcl.2004.09.001; Gibson CL, 1999, NEUROREPORT, V10, P231, DOI 10.1097/00001756-199902050-00006; Gibson CL, 2000, EXP NEUROL, V166, P422, DOI 10.1006/exnr.2000.7511; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gu HY, 2005, EXP NEUROL, V192, P89, DOI 10.1016/j.expneurol.2004.10.019; Gu HY, 2004, EUR J NEUROSCI, V19, P2123, DOI 10.1111/j.0953-816X.2004.03295.x; Hammarberg H, 2000, J COMP NEUROL, V426, P587, DOI 10.1002/1096-9861(20001030)426:4<587::AID-CNE7>3.0.CO;2-R; Han Q, 2013, NEUROSCIENCE, V253, P235, DOI 10.1016/j.neuroscience.2013.08.057; Harding DI, 1999, EUR J NEUROSCI, V11, P2237, DOI 10.1046/j.1460-9568.1999.00640.x; Hoang TX, 2006, EXP BRAIN RES, V169, P208, DOI 10.1007/s00221-005-0137-4; Hoffmann CFE, 1996, J NEUROSURG, V84, P234, DOI 10.3171/jns.1996.84.2.0234; Huze C, 2009, AM J HUM GENET, V85, P155, DOI 10.1016/j.ajhg.2009.06.015; JOOSTEN EAJ, 1992, J COMP NEUROL, V326, P133, DOI 10.1002/cne.903260112; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Midha R, 1997, NEUROSURGERY, V40, P1188; Midha Rajiv, 2004, Neurosurg Focus, V16, pE5; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; OUDEGA M, 1994, J COMP NEUROL, V347, P115, DOI 10.1002/cne.903470109; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Risling Marten, 2011, Front Neurol, V1, P159, DOI 10.3389/fneur.2010.00159; ten Donkelaar HJ, 2004, J NEUROL, V251, P1429, DOI 10.1007/s00415-004-0653-3; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; WU WT, 1994, EXP NEUROL, V129, P335, DOI 10.1006/exnr.1994.1176; WU WT, 1994, NEUROSCI LETT, V179, P157, DOI 10.1016/0304-3940(94)90958-X; Zhou LH, 2006, J NEUROTRAUM, V23, P920, DOI 10.1089/neu.2006.23.920; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	52	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101918	10.1371/journal.pone.0101918	http://dx.doi.org/10.1371/journal.pone.0101918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003601	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700088
J	Agneskog, E; Nowak, P; Steffensson, CM; Casadella, M; Noguera-Julian, M; Paredes, R; Kallander, CFR; Sonnerborg, A				Agneskog, Eva; Nowak, Piotr; Steffensson, Catharina Maijgren; Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger; Kallander, Clas F. R.; Sonnerborg, Anders			Decreased Phenotypic Susceptibility to Etravirine in Patients with Predicted Genotypic Sensitivity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 DRUG-RESISTANCE; TRANSCRIPTASE INHIBITOR RESISTANCE; REAL-TIME PCR; REVERSE-TRANSCRIPTASE; HUMAN PLASMA; ANTIRETROVIRAL THERAPY; MINORITY POPULATIONS; CLINICAL-SAMPLES; MUTATIONS	Background: A sensitive, phenotypic reverse transcriptase (RT)-based drug susceptibility assay for the detection of etravirine (ETR) resistance in patient isolates was developed and compared with the results from direct sequencing and ultra-deep pyrosequencing (UDPS). Methods: Samples were obtained from 15 patients with antiretroviral therapy (ART) failure and from five non-nucleoside reverse transcriptase inhibitor (NNRTI)-naive patients of whom four were infected by an NNRTI-resistant strain (transmitted drug resistance, TDR). In five patients, two consecutive samples (a and b) were taken for follow up of the virological response. HIV-1 RT was purified and drug susceptibility (IC50) to ETR was estimated. Direct sequencing was performed in all samples and UDPS in samples from nine patients. Results: Increased IC50 to ETR was found in samples from 13 patients where direct sequencing predicted resistance in only four. UDPS identified additional (N = 11) NNRTI resistance associated mutations (RAMs) in six of nine tested patients. During early failure, IC50 increases were observed in three of six patients without any ETR-RAMs detected by direct sequencing. In further two patients, who stopped NNRTI before sampling, increased IC50 values were found shortly after, despite absence of ETR-RAMs. In two patients who had stopped NNRTI for >1 year, a concordance between phenotype and genotypes was found. Two patients with TDR had increased IC50 despite no ETR-RAMs were detected by direct sequencing. UDPS revealed additional ETR-RAMs in four patients with a discrepancy between phenotype and direct sequencing. Conclusions: The RT-based phenotypic assay showed decreased ETR susceptibility in patients where direct sequencing predicted ETR-sensitive virus. This increased phenotypic sensitivity was to a large extent supported by UDPS and treatment history. Our method could be valuable for further studies on the phenotypic kinetics of NNRTI resistance. The clinical relevance remains to be studied in larger patient-populations.	[Agneskog, Eva; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Nowak, Piotr; Steffensson, Catharina Maijgren; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Kallander, Clas F. R.] Cavidi AB, Uppsala, Sweden; [Casadella, Maria; Noguera-Julian, Marc; Paredes, Roger] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Recerca SIDA irsiCaixa, Catalonia, Spain	Karolinska Institutet; Karolinska Institutet; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Agneskog, E (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	eva.agneskog@karolinska.se	Casadellà, Maria/L-8295-2016; Noguera-Julian, Marc/F-8651-2016; Sönnerborg, Anders/W-2011-2019	Casadellà, Maria/0000-0002-4115-2305; Noguera-Julian, Marc/0000-0002-6194-1395; Sönnerborg, Anders/0000-0001-8928-3374; Nowak, Piotr/0000-0003-2747-0734	Swedish Research Council; EU-funded FP7 CHAIN; Swedish International Developing Agency; Swedish Civil Contingencies Agency; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU-funded FP7 CHAIN; Swedish International Developing Agency; Swedish Civil Contingencies Agency; Swedish Society for Medical Research	This work was supported by the Swedish Research Council, EU-funded FP7 CHAIN, Swedish International Developing Agency, the Swedish Civil Contingencies Agency and Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agneskog E, 2013, J MED VIROL, V85, P703, DOI 10.1002/jmv.23507; Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; Basson AE, 2008, JAIDS-J ACQ IMM DEF, V49, P538, DOI 10.1097/QAI.0b013e31818d5dcf; Bertagnolio S, 2012, ANTIVIR THER, V17, P941, DOI 10.3851/IMP2320; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Chetchotisakd Ploenchan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P152, DOI 10.1177/1545109706294288; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Church JD, 2008, AIDS RES HUM RETROV, V24, P595, DOI 10.1089/aid.2007.0224; De Corte BL, 2005, J MED CHEM, V48, P1689, DOI 10.1021/jm040127p; De Luca A, 2013, J INFECT DIS; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Karlsson AC, 1998, AIDS, V12, P839, DOI 10.1097/00002030-199808000-00005; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Malmsten A, 2005, J MED VIROL, V76, P291, DOI 10.1002/jmv.20360; Malmsten A, 2003, J MED VIROL, V71, P347, DOI 10.1002/jmv.10492; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Neogi U, 2011, AIDS, V25, P1123, DOI 10.1097/QAD.0b013e328346269f; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Picchio G, 2011, AIDS RES HUM RETROV, V27, P1272, DOI 10.1089/aid.2011.0049; Shao XW, 2003, AIDS, V17, P1463, DOI 10.1097/00002030-200307040-00007; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tambuyzer L, 2011, JAIDS-J ACQ IMM DEF, V58, P18, DOI 10.1097/QAI.0b013e3182237f74; Tambuyzer L, 2010, AIDS RES HUM RETROV, V26, P1197, DOI 10.1089/aid.2009.0302; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Vingerhoets J, 2005, J VIROL, V79, P12773, DOI 10.1128/JVI.79.20.12773-12782.2005; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101508	10.1371/journal.pone.0101508	http://dx.doi.org/10.1371/journal.pone.0101508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000302	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300053
J	Boelen, L; Teutsch, S; Wilson, DP; Dolan, K; Dore, GJ; Lloyd, AR; Luciani, F				Boelen, Lies; Teutsch, Suzy; Wilson, David P.; Dolan, Kate; Dore, Greg J.; Lloyd, Andrew R.; Luciani, Fabio		HITS Investigators	Per-Event Probability of Hepatitis C Infection during Sharing of Injecting Equipment	PLOS ONE			English	Article							HEALTH-CARE WORKERS; VIRUS TRANSMISSION; RISK-FACTORS; DRUG-USERS; SEROCONVERSION; METAANALYSIS; PREVALENCE; SURVIVAL; EXPOSURE; SYRINGES	Background: Shared injecting apparatus during drug use is the premier risk factor for hepatitis C virus (HCV) transmission. Aims: To estimate the per-event probability of HCV infection during a sharing event, and the transmission probability of HCV from contaminated injecting apparatus. Methods: Estimates were obtained using a maximum likelihood method with estimated IDU and sharing events obtained from behavioural data. Settings: Cohort study in multiple correction centres in New South Wales, Australia Participants: Subjects (N = 500) with a lifetime history of injecting drug use (IDU) who were followed up between 2005 and 2012. During follow-up, interviews for risk behaviours were taken and blood sampling (HCV-antibody and RNA testing) was performed. Measurements: Self-reported frequencies of injecting drugs and sharing events, as well as other risk behaviours and details on the nature of injecting events. Findings: The best estimate of the per-event probability of infection was 0.57% (CI: 0.32-1.05%). A sensitivity analysis on the likely effect of under-reporting of sharing of the injecting apparatus indicated that the per event infection probability may be as low as 0.17% (95% CI: 0.11%-0.25%). The transmission probability was similarly shown to range up to 6%, dependent on the presumed prevalence of the virus in injecting equipment. Conclusions: The transmission probability of HCV during a sharing event is small. Hence, strategies to reduce the frequency and sharing of injecting equipment are required, as well as interventions focused on decreasing the per event risk.	[Boelen, Lies; Teutsch, Suzy; Lloyd, Andrew R.; Luciani, Fabio] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia; [Wilson, David P.; Dore, Greg J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Boelen, Lies] Univ London Imperial Coll Sci Technol & Med, Sch Med, Immunol Sect, London, England; [Dolan, Kate] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; Imperial College London; University of New South Wales Sydney	Luciani, F (corresponding author), Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.	luciani@unsw.edu.au	Dore, Gregory John/ABD-5665-2021; dolan, kate a/G-7859-2017; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Teutsch, Suzy/AAN-9071-2021	Dore, Gregory John/0000-0002-4741-2622; dolan, kate a/0000-0002-9848-807X; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Teutsch, Suzy/0000-0003-1902-2173; Luciani, Fabio/0000-0003-0666-6324; Maher, Lisa/0000-0001-6020-6519	National Health and Medical Research Council of Australia (NHMRC) [510488]; Australian Centre for HIV and Hepatitis Research (ACH2); NHMRC [1016351, 510428, 510246]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research (ACH2); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) Program grant (No. 510488), and by a grant from the Australian Centre for HIV and Hepatitis Research (ACH2). The HITS-p cohort was supported by an NHMRC Partnership Grant (No. 1016351). FL was supported by a NHMRC Early Career Fellowship (No. 510428) and AL by a NHMRC Practitioner Fellowship (No. 510246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Butler T., 2017, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Corson S, 2013, DRUG ALCOHOL DEPEN, V133, P172, DOI 10.1016/j.drugalcdep.2013.05.014; Doerrbecker J, 2011, J INFECT DIS, V204, P1830, DOI 10.1093/infdis/jir535; Dolan KA, 1998, DRUG ALCOHOL REV, V17, P153, DOI 10.1080/09595239800186951; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Indig D., 2010, 2009 NSW INMATE HLTH; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Skipper C, 2003, GUT, V52, P1500, DOI 10.1136/gut.52.10.1500; Team RDC, 2012, LANG ENV STAT COMP; Teutsch S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-633; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Tomkins SE, 2012, J VIRAL HEPATITIS, V19, P199, DOI 10.1111/j.1365-2893.2011.01543.x; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131	22	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100749	10.1371/journal.pone.0100749	http://dx.doi.org/10.1371/journal.pone.0100749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	25000496	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300014
J	Lo, HC; Yang, RB; Lee, CH				Lo, Hui-Chen; Yang, Ruey-Bing; Lee, Chien-Hsing			Guanylyl Cyclase-G Modulates Jejunal Apoptosis and Inflammation in Mice with Intestinal Ischemia and Reperfusion	PLOS ONE			English	Article							EPITHELIAL-CELL APOPTOSIS; RAT SMALL-INTESTINE; SYSTEMIC INFLAMMATION; BARRIER FUNCTION; ORPHAN RECEPTOR; PROTEIN-KINASE; MOUSE TESTIS; NITRIC-OXIDE; CYCLIC-GMP; INJURY	Background: Membrane bound guanylyl cyclase-G (mGC-G), a novel form of GC mediates ischemia and reperfusion (IR)-induced renal injury. We investigated the roles of mGC-G in intestinal IR-induced jejunal damage, inflammation, and apoptosis. Materials and methods: Male C57BL/6 wild-type (WT) and mGC-G gene knockout (KO) mice were treated with a sham operation or 45 min of superior mesenteric arterial obstruction followed by 3, 6, 12, or 24 h of reperfusion. Results: Sham-operated KO mice had significantly lower plasma nitrate and nitrite (NOx) levels and jejunal villus height, crypt depth, and protein expression of phosphorylated-nuclear factor-kappa-B (NF-kappa B), phosphorylated-c-Jun N-terminal kinases (JNK) 2/3, phosphorylated-p38, and B-cell lymphoma-2 (Bcl-2). They had significantly greater jejunal interleukin-6 mRNA, cytochrome c protein, and apoptotic index compared with sham-operated WT mice. Intestinal IR significantly decreased plasma NOx in WT mice and increased plasma NOx in KO mice. The jejunal apoptotic index and caspase 3 activities were significantly increased, and nuclear phosphorylated-NF-kappa B and phosphorylated-p38 protein were significantly decreased in WT, but not KO mice with intestinal IR. After reperfusion, KO mice had an earlier decrease in jejunal cyclic GMP, and WT mice had an earlier increase in jejunal proliferation and a later increase in cytosol inhibitor of kappa-B-alpha. Intestinal IR induced greater increases in plasma and jejunal interleukin-6 protein in WT mice and a greater increase in jejunal interleukin-6 mRNA in KO mice. Conclusions: mGC-G is involved in the maintenance of jejunal integrity and intestinal IR-induced inflammation and apoptosis. These results suggest that targeting cGMP pathway might be a potential strategy to alleviate IR-induced jejunal damages.	[Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan; [Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Chien-Hsing] Changhua Christian Hosp, Div Pediat Surg, Changhau, Taiwan; [Lee, Chien-Hsing] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan	Fu Jen Catholic University; Academia Sinica - Taiwan; Changhua Christian Hospital; Chang Jung Christian University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	rbyang@ibms.sinica.edu.tw; 27566@cch.org.tw	Lo, Hui-Chen/AAN-5906-2021; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714	National Science Council of the Republic of China [NSC 96-2320-B-309-003-MY2]; Changhua Christian Hospital [102-CCH-IRP-025]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This work is supported by the National Science Council of the Republic of China under the grant number NSC 96-2320-B-309-003-MY2 and by Changhua Christian Hospital under the grant number 102-CCH-IRP-025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2012, TRANSPLANTATION, V93, P880, DOI 10.1097/TP.0b013e31824cd59d; An SC, 2005, HISTOCHEM CELL BIOL, V123, P249, DOI 10.1007/s00418-005-0765-6; Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chen W, 2005, WORLD J GASTROENTERO, V11, P3419, DOI 10.3748/wjg.v11.i22.3419; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e; Egemnazarov B, 2009, AM J PHYSIOL-LUNG C, V296, pL462, DOI 10.1152/ajplung.90377.2008; Fukatsu K, 2004, JPEN-PARENTER ENTER, V28, P224, DOI 10.1177/0148607104028004224; Huang YH, 2006, ENDOCRINOLOGY, V147, P4792, DOI 10.1210/en.2005-1476; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Inserte J, 2011, J MOL CELL CARDIOL, V50, P903, DOI 10.1016/j.yjmcc.2011.02.013; Kuhn M, 2004, BIOCHEM J, V379, P385, DOI 10.1042/BJ20031624; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lee CH, 2012, J SURG RES, V175, P67, DOI 10.1016/j.jss.2011.02.003; Li J, 2009, J GASTROINTEST SURG, V13, P478, DOI 10.1007/s11605-008-0728-z; Li XL, 2008, TRANSPL P, V40, P3342, DOI 10.1016/j.transproceed.2008.03.167; Lin H, 2008, J AM SOC NEPHROL, V19, P339, DOI 10.1681/ASN.2007050550; Lo HC, 2001, JPEN-PARENTER ENTER, V25, P73, DOI 10.1177/014860710102500273; Murayama T, 2006, TRANSPLANTATION, V81, P1325, DOI 10.1097/01.tp.0000209167.48030.6b; Naito Y, 2002, REDOX REP, V7, P294, DOI 10.1179/135100002125000983; Noda T, 1998, AM J PHYSIOL-GASTR L, V274, pG270, DOI 10.1152/ajpgi.1998.274.2.G270; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Schleiffer R, 1996, GUT, V39, P194, DOI 10.1136/gut.39.2.194; Schulz S, 1998, J BIOL CHEM, V273, P1032, DOI 10.1074/jbc.273.2.1032; Siednienko J, 2011, CYTOKINE, V54, P282, DOI 10.1016/j.cyto.2011.02.015; Stallion A, 2005, J PEDIATR SURG, V40, P470, DOI 10.1016/j.jpedsurg.2004.11.045; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Stollenwerk MM, 2012, J SURG RES, V178, P692, DOI 10.1016/j.jss.2012.07.056; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003; Yang Q, 2013, WORLD J GASTROENTERO, V19, P4925, DOI 10.3748/wjg.v19.i30.4925; Zheng SY, 2005, WORLD J GASTROENTERO, V11, P656, DOI 10.3748/wjg.v11.i5.656; Zhou YN, 2005, PEDIATR RES, V58, P1192, DOI 10.1203/01.pdr.0000185133.65966.4e	35	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101314	10.1371/journal.pone.0101314	http://dx.doi.org/10.1371/journal.pone.0101314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992336	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400061
J	Rochfort, KD; Collins, LE; Murphy, RP; Cummins, PM				Rochfort, Keith D.; Collins, Laura E.; Murphy, Ronan P.; Cummins, Philip M.			Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions	PLOS ONE			English	Article							NF-KAPPA-B; VASCULAR ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; OXIDATIVE STRESS; MOUSE-BRAIN; NAD(P)H OXIDASE; PROTEIN-KINASE; IFN-GAMMA; IN-VITRO	Background and Objectives: Blood-brain barrier (BBB) dysfunction is an integral feature of neurological disorders and involves the action of multiple proinflammatory cytokines on the microvascular endothelial cells lining cerebral capillaries. There is still however, considerable ambiguity throughout the scientific literature regarding the mechanistic role(s) of cytokines in this context, thereby warranting a comprehensive in vitro investigation into how different cytokines may cause dysregulation of adherens and tight junctions leading to BBB permeabilization. Methods: The present study employs human brain microvascular endothelial cells (HBMvECs) to compare/contrast the effects of TNF-alpha and IL-6 on BBB characteristics ranging from the expression of interendothelial junction proteins (VE-cadherin, occludin and claudin-5) to endothelial monolayer permeability. The contribution of cytokine-induced NADPH oxidase activation to altered barrier phenotype was also investigated. Results: In response to treatment with either TNF-alpha or IL-6 (0-100 ng/ml, 0-24 hrs), our studies consistently demonstrated significant dose-and time-dependent decreases in the expression of all interendothelial junction proteins examined, in parallel with dose-and time-dependent increases in ROS generation and HBMvEC permeability. Increased expression and co-association of gp91 and p47, pivotal NADPH oxidase subunits, was also observed in response to either cytokine. Finally, cytokine-dependent effects on junctional protein expression, ROS generation and endothelial permeability could all be attenuated to a comparable extent using a range of antioxidant strategies, which included ROS depleting agents (superoxide dismutase, catalase, N-acetylcysteine, apocynin) and targeted NADPH oxidase blockade (gp91 and p47 siRNA, NSC23766). Conclusion: A timely and wide-ranging investigation comparing the permeabilizing actions of TNF-alpha and IL-6 in HBMvECs is presented, in which we demonstrate how either cytokine can similarly downregulate the expression of interendothelial adherens and tight junction proteins leading to elevation of paracellular permeability. The cytokine-dependent activation of NADPH oxidase leading to ROS generation was also confirmed to be responsible in-part for these events.	[Rochfort, Keith D.; Collins, Laura E.; Cummins, Philip M.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Murphy, Ronan P.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Murphy, Ronan P.; Cummins, Philip M.] Dublin City Univ, Ctr Prevent Med, Dublin 9, Ireland	Dublin City University; Dublin City University; Dublin City University	Cummins, PM (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	phil.cummins@dcu.ie	Rochfort, Keith/R-7009-2019; Murphy, Ronan P./V-6697-2019	Rochfort, Keith/0000-0003-1198-5952; Murphy, Ronan P./0000-0002-4579-8007	National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC)	National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC)	This work was funded by the National Development Plan/Higher Education Authority of Ireland Programme for Research in Third Level Institutes - HEA/PRTLI Cycle 4: Targeted Therapeutics & Theranostics (PMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Bamforth SD, 1996, ACTA NEUROPATHOL, V91, P624, DOI 10.1007/s004010050476; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Benardais K, 2013, NEUROSCI LETT, V555, P165, DOI 10.1016/j.neulet.2013.09.038; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Blais V, 2004, J IMMUNOL, V172, P7043, DOI 10.4049/jimmunol.172.11.7043; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3615; Cohen SS, 2013, NEUROIMMUNOMODULAT, V20, P264, DOI 10.1159/000350470; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Fitzpatrick PA, 2009, INT J BIOCHEM CELL B, V41, P2287, DOI 10.1016/j.biocel.2009.05.011; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gertzberg N, 2004, AM J PHYSIOL-LUNG C, V286, pL37, DOI 10.1152/ajplung.00116.2003; Gloor SM, 1997, BIOCHEM BIOPH RES CO, V239, P804, DOI 10.1006/bbrc.1997.7557; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griffin WS, 2010, US Neurol, V6, P19, Patent No. 61927; Guinan AF, 2013, CARDIOVASC RES, V99, P545, DOI 10.1093/cvr/cvt127; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Kerkar S, 2006, J SURG RES, V132, P40, DOI 10.1016/j.jss.2005.06.033; Lee YW, 2010, CYTOKINE, V49, P73, DOI 10.1016/j.cyto.2009.08.009; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Mark KS, 1999, LIFE SCI, V64, P1941, DOI 10.1016/S0024-3205(99)00139-3; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Muzaffar S, 2006, EUR J PHARMACOL, V538, P108, DOI 10.1016/j.ejphar.2006.03.047; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; SHARIEF MK, 1992, J NEUROIMMUNOL, V38, P27, DOI 10.1016/0165-5728(92)90087-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Sury MD, 2006, FREE RADICAL BIO MED, V41, P1372, DOI 10.1016/j.freeradbiomed.2006.07.016; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Szocs K, 2004, GEN PHYSIOL BIOPHYS, V23, P265; Tang C, 2011, PHYTOTHER RES, V25, P376, DOI 10.1002/ptr.3278; TOBOREK M, 1995, ATHEROSCLEROSIS, V117, P179, DOI 10.1016/0021-9150(95)05568-H; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Voigt A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00042; Walsh TG, 2011, J CELL PHYSIOL, V226, P3053, DOI 10.1002/jcp.22655; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang S, 2013, MOL MED REP, V7, P93, DOI 10.3892/mmr.2012.1159; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	53	139	141	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101815	10.1371/journal.pone.0101815	http://dx.doi.org/10.1371/journal.pone.0101815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992685	gold, Green Submitted, Green Published			2022-12-25	WOS:000341253400120
J	Marshall, MM; Ruzicka, JA; Taylor, EW; Hall, AR				Marshall, Michael M.; Ruzicka, Jan A.; Taylor, Ethan W.; Hall, Adam R.			Detecting DNA Depurination with Solid-State Nanopores	PLOS ONE			English	Article							DEOXYRIBONUCLEIC ACID; ABASIC SITES; SINGLE; TRANSLOCATION; MOLECULES; GENE; ELECTROPHORESIS; SEQUENCES; PROTEINS	Among the different types of DNA damage that occur endogenously in the cell, depurination is especially prevalent. These lesions can initiate mutagenesis and have been implicated in a variety of diseases, including cancer. Here, we demonstrate a new approach for the detection of depurination at the single-molecule scale using solid-state nanopores. We induce depurination in short duplex DNA using acidic conditions and observe that the presence of apurinic sites results in significantly slower dynamics during electrokinetic translocation. This procedure may be valuable as a diagnostic for in situ quantification of DNA depurination.	[Marshall, Michael M.; Ruzicka, Jan A.; Taylor, Ethan W.; Hall, Adam R.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA; [Hall, Adam R.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Hall, Adam R.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA	University of North Carolina; University of North Carolina Greensboro; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hall, AR (corresponding author), Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA.	arhall@wakehealth.edu			Wake Forest University School of Medicine; Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL	Wake Forest University School of Medicine; Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL	ARH acknowledges start-up funding from the Wake Forest University School of Medicine. JR and EWT acknowledge funding from the Dr. Arthur and Bonnie Ennis Foundation, Decatur, IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullin TI, 2008, J ANAL CHEM+, V63, P690, DOI 10.1134/S1061934808070150; Alvarez-Dominguez JR, 2013, J BIOL CHEM, V288, P11581, DOI 10.1074/jbc.M113.454744; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; An N, 2012, P NATL ACAD SCI USA, V109, P11504, DOI 10.1073/pnas.1201669109; Anderson BN, 2013, ACS NANO, V7, P1408, DOI 10.1021/nn3051677; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Evers DL, 2007, ANAL BIOCHEM, V370, P255, DOI 10.1016/j.ab.2007.06.002; Firnkes M, 2010, NANO LETT, V10, P2162, DOI 10.1021/nl100861c; FREESE EB, 1961, P NATL ACAD SCI USA, V47, P540, DOI 10.1073/pnas.47.4.540; Healy K, 2007, NANOMEDICINE-UK, V2, P459, DOI 10.2217/17435889.2.4.459; IOCONO JA, 1990, TETRAHEDRON LETT, V31, P175, DOI 10.1016/S0040-4039(00)94363-6; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; Nakamura J, 1998, CANCER RES, V58, P222; Plesa C, 2013, NANO LETT, V13, P658, DOI 10.1021/nl3042678; Shim J, 2013, SCI REP-UK, V3, DOI [10.1038/srep01389, 10.1038/srep02325]; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Skinner GM, 2009, NANO LETT, V9, P2953, DOI 10.1021/nl901370w; Smeets RMM, 2009, NANO LETT, V9, P3089, DOI 10.1021/nl803189k; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; TAMM C, 1952, J BIOL CHEM, V195, P49; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang JJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285310	34	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101632	10.1371/journal.pone.0101632	http://dx.doi.org/10.1371/journal.pone.0101632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988437	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100122
J	Taina, M; Korhonen, M; Haataja, M; Muuronen, A; Arponen, O; Hedman, M; Jakala, P; Sipola, P; Mustonen, P; Vanninen, R				Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Jakala, Pekka; Sipola, Petri; Mustonen, Pirjo; Vanninen, Ritva			Morphological and Volumetric Analysis of Left Atrial Appendage and Left Atrium: Cardiac Computed Tomography-Based Reproducibility Assessment	PLOS ONE			English	Article							STROKE; ECHOCARDIOGRAPHY; RISK; ANGIOGRAPHY; PREDICTOR; CLOSURE; FLOW	Objectives: Left atrial appendage (LAA) dilatation and morphology may influence an individual's risk for intracardiac thrombi and ischemic stroke. LAA size and morphology can be evaluated using cardiac computed tomography (cCT). The present study evaluated the reproducibility of LAA volume and morphology assessments. Methods: A total of 149 patients (47 females; mean age 60.9 +/- 10.6 years) with suspected cardioembolic stroke/transient ischemic attack underwent cCT. Image quality was rated based on four categories. Ten patients were selected from each image quality category (N = 40) for volumetric reproducibility analysis by two individual readers. LAA and left atrium (LA) volume were measured in both two-chamber (2CV) and transversal view (TV) orientation. Intertechnique reproducibility was assessed between 2CV and TV (200 measurement pairs). LAA morphology (A = Cactus, B = ChickenWing, C = WindSock, D = CauliFlower), LAA opening height, number of LAA lobes, trabeculation, and orientation of the LAA tip was analysed in all study subjects by three individual readers (447 interobserver measurement pairs). The reproducibility of volume measurements was assessed by intra-class correlation (ICC) and the reproducibility of LAA morphology assessments by Cohen's kappa. Results: The intra-observer and interobserver reproducibility of LAA and LA volume measurements was excellent (ICCs>0.9). The LAA (ICC = 0.954) and LA (ICC = 0.945) volume measurements were comparable between 2CV and TV. Morphological classification (kappa = 0.24) and assessments of LAA opening height (kappa = 0.1), number of LAA lobes (kappa = 0.16), trabeculation (kappa = 0.15), and orientation of the LAA tip (kappa = 0.37) was only slightly to fairly reproducible. Conclusions: LA and LAA volume measurements on cCT provide excellent reproducibility, whereas visual assessment of LAA morphological features is challenging and results in unsatisfactory agreement between readers.	[Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Sipola, Petri; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Korhonen, Miika; Haataja, Mika; Muuronen, Antti; Arponen, Otso; Sipola, Petri; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519). Kuopio University Hospital web site: www.psshp.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Amarenco P, 2009, CEREBROVASC DIS, V27, P97, DOI 10.1159/000200446; Anwar AM, 2010, INT J CARDIOVAS IMAG, V26, P519, DOI 10.1007/s10554-010-9593-4; Artang R, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-16; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Bauer M, 2001, Z KARDIOL, V90, P535, DOI 10.1007/s003920170121; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; Burrell LD, 2013, AM J CARDIOL, V112, P1148, DOI 10.1016/j.amjcard.2013.05.062; Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Erol B, 2011, EUR J RADIOL, V80, pE346, DOI 10.1016/j.ejrad.2010.11.008; Fagan SM, 2000, ECHOCARDIOGR-J CARD, V17, P365, DOI 10.1111/j.1540-8175.2000.tb01152.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006; Ho ICK, 2007, HEART RHYTHM, V4, P567, DOI 10.1016/j.hrthm.2007.01.014; Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794; Kamp O, 1999, EUR HEART J, V20, P979, DOI 10.1053/euhj.1998.1453; Kataoka A, 2011, INT J CARDIOL, V153, P47, DOI 10.1016/j.ijcard.2010.08.036; Kaur H, 2013, J NEMATOL, V45, P122; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Kondratyev E, 2013, EUR J RADIOL, V82, P2233, DOI 10.1016/j.ejrad.2013.08.053; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landmesser U, 2012, EUR HEART J, V33, P698, DOI 10.1093/eurheartj/ehr393; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mahabadi Amir A, 2009, J Cardiovasc Comput Tomogr, V3, P80, DOI 10.1016/j.jcct.2009.02.002; Michael KA, 2009, J CARDIOVASC ELECTR, V20, P1217, DOI 10.1111/j.1540-8167.2009.01537.x; Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Palios John, 2014, Thrombosis, V2014, P832752, DOI 10.1155/2014/832752; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Stojanovska J, 2011, AM J ROENTGENOL, V197, P631, DOI 10.2214/AJR.10.5955; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x	37	14	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101580	10.1371/journal.pone.0101580	http://dx.doi.org/10.1371/journal.pone.0101580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988467	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100115
J	Jonker, I; Klein, HC; Duivis, HE; Yolken, RH; Rosmalen, JGM; Schoevers, RA				Jonker, Iris; Klein, Hans C.; Duivis, Hester E.; Yolken, Robert H.; Rosmalen, Judith G. M.; Schoevers, Robert A.			Association between Exposure to HSV1 and Cognitive Functioning in a General Population of Adolescents. The TRAILS Study	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; C-REACTIVE PROTEIN; BIPOLAR DISORDER; SOCIOECONOMIC POSITION; PSYCHIATRIC-DISORDER; INFLAMMATORY MARKERS; INFECTIOUS AGENTS; EUTHYMIC PATIENTS; UNITED-STATES; RISK-FACTORS	Background: Infections with different herpes viruses have been associated with cognitive functioning in psychiatric patients and healthy adults. The aim of this study was to find out whether antibodies to different herpes viruses are prospectively associated with cognitive functioning in a general adolescent population. Methods: This study was performed in TRAILS, a large prospective general population cohort (N = 1084, 54% female, mean age 16.2 years (SD 0.6)). At age 16, immunoglobulin G antibodies against HSV1, HSV2, CMV and EBV were measured next to high sensitive C-Reactive Protein (hsCRP). Two years later, immediate memory and executive functioning were assessed using the 15 words task and the self ordered pointing task. Multiple linear regression analysis with bootstrapping was performed to study the association between viral infections and cognitive function, adjusting for gender, socioeconomic status, ethnicity, and cannabis use. Results: Presence of HSV1 antibodies was associated with memory function ((B = -0.272, 95% CI = -0.556 to -0.016, p = 0.047)), while the association with executive functioning did not reach statistical significance (B = 0.560, 95% CI is -0.053 to 1.184, p = 0.075). The level of HSV1 antibodies was associated with both memory function (B = -0.160, 95% CI = -0.280 to -0.039, p = 0.014) and executive functioning (B = 0.296, 95% CI = 0.011 to 0.578, p = 0.046). Other herpes viruses and hsCRP were not associated with cognitive functioning. Conclusions: Both presence and level of HSV1 antibodies are prospectively associated with reduced cognitive performance in a large cohort of adolescents.	[Jonker, Iris; Klein, Hans C.; Rosmalen, Judith G. M.; Schoevers, Robert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Duivis, Hester E.] Tilburg Univ, Dept Med & Neuropsychol, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands; [Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Yolken, Robert H.] Johns Hopkins Med Sch, Baltimore, MD USA	University of Groningen; Tilburg University; University of Groningen; Johns Hopkins University; Johns Hopkins Medicine	Jonker, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	i.jonker01@umcg.nl	yolken, robert/AAW-2556-2021; Rosmalen, Judith G.M./F-5375-2011	Rosmalen, Judith G.M./0000-0002-6393-0032; Jonker, Iris/0000-0003-2186-6834; Schoevers, Robert A/0000-0003-0760-9866	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants) [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. The authors are grateful to all adolescents, their parents and teachers who participated in this research and to everyone who worked on this project and made it possible. The funders had no role in the study design, data collections and analysis, decision to publish or preparation of the manuscript.	Amone-P'Olak K, 2009, SOC PSYCH PSYCH EPID, V44, P231, DOI 10.1007/s00127-008-0424-z; Andrie Rene P, 2010, Cardiovasc Pathol, V19, pe205, DOI 10.1016/j.carpath.2009.09.009; Archer T, 2008, NEUROTOX RES, V14, P205, DOI 10.1007/BF03033811; Ardila A, 2011, DEV PSYCHOL, V47, P984, DOI 10.1037/a0023819; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Brummett BH, 2013, PSYCHOSOM MED; Cabral GA, 1998, J NEUROIMMUNOL, V83, P116, DOI 10.1016/S0165-5728(97)00227-0; Dickerson F, 2008, BRAIN BEHAV IMMUN, V22, P1103, DOI 10.1016/j.bbi.2008.04.156; Dickerson F, 2007, SCHIZOPHR RES, V93, P261, DOI 10.1016/j.schres.2007.03.022; Dickerson F, 2012, SCHIZOPHR RES, V134, P83, DOI 10.1016/j.schres.2011.10.003; Dickerson FB, 2006, BIPOLAR DISORD, V8, P124, DOI 10.1111/j.1399-5618.2006.00288.x; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; Enders G, 2012, MED MICROBIOL IMMUN, V201, P303, DOI 10.1007/s00430-012-0232-7; Ferrier IN, 1999, BRIT J PSYCHIAT, V175, P246, DOI 10.1192/bjp.175.3.246; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Gerber SI, 2012, PROG NEURO-PSYCHOPH, V36, P110, DOI 10.1016/j.pnpbp.2011.09.003; Gimeno D, 2008, PSYCHONEUROENDOCRINO, V33, P1322, DOI 10.1016/j.psyneuen.2008.07.006; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Ho TC, 2013, J AM ACAD CHILD PSY, V52, P1076, DOI 10.1016/j.jaac.2013.07.008; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Keefe RSE, 2007, J CLIN PSYCHIAT, V68, P8; Kramer M A, 2008, Euro Surveill, V13; Krause D, 2010, WORLD J BIOL PSYCHIA, V11, P739, DOI 10.3109/15622971003653246; Krogh J, 2013, BRAIN BEHAV IMMUN; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Llorente AM, 2012, APPL NEUROPSYCH-CHIL, V1, P63, DOI 10.1080/21622965.2012.677605; Nijenhuis JT, 2001, J BIOSOC SCI, V33, P469, DOI 10.1017/S0021932001004692; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Prasad KM, 2012, SCHIZOPHRENIA BULL, V38, P1137, DOI 10.1093/schbul/sbs046; Quinn JP, 2000, PROG NEUROBIOL, V60, P167, DOI 10.1016/S0301-0082(99)00024-6; Rifai N, 2001, CLIN CHEM, V47, P403; Rosenthal SL, 1997, CLIN INFECT DIS, V24, P135, DOI 10.1093/clinids/24.2.135; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P449, DOI 10.1016/j.acn.2007.01.023; Sauerbrei Andreas, 2004, Clin Lab, V50, P425; Shirts BH, 2008, SCHIZOPHR RES, V106, P268, DOI 10.1016/j.schres.2008.07.017; SHOJI H, 1979, J NEUROL, V221, P163, DOI 10.1007/BF00313047; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Thomas P, 2013, J PSYCHIATR RES, V47, P1680, DOI 10.1016/j.jpsychires.2013.07.010; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van der Werf-Eldering MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013032; Wang H, 2011, SCHIZOPHR RES, V129, P47, DOI 10.1016/j.schres.2011.03.013; Watson AMM, 2013, PSYCHOL MED, V43, P1023, DOI 10.1017/S003329171200195X; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yolken RH, 2011, SCHIZOPHR RES, V128, P61, DOI 10.1016/j.schres.2011.01.020; Yun RJ, 2010, BRAIN IMAGING BEHAV, V4, P96, DOI 10.1007/s11682-010-9089-9; Zorrilla EP, 1996, AM J PSYCHIAT, V153, P626	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101549	10.1371/journal.pone.0101549	http://dx.doi.org/10.1371/journal.pone.0101549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983885	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000118
J	Persichetti, E; Chiasserini, D; Parnetti, L; Eusebi, P; Paciotti, S; De Carlo, C; Codini, M; Tambasco, N; Rossi, A; El Agnaf, OM; Calabresi, P; Beccari, T				Persichetti, Emanuele; Chiasserini, Davide; Parnetti, Lucilla; Eusebi, Paolo; Paciotti, Silvia; De Carlo, Claudia; Codini, Michela; Tambasco, Nicola; Rossi, Aroldo; El Agnaf, Omar M.; Calabresi, Paolo; Beccari, Tommaso			Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE MUTATIONS; PARKINSONS-DISEASE; HYDROLASES; ORIGIN; DYSFUNCTION; BIOMARKERS; AUTOPHAGY; PLASMA; CSF	Measurements of the activities of lysosomal enzymes in cerebrospinal fluid have recently been proposed as putative biomarkers for Parkinson's disease and other synucleinopathies. To define the operating procedures useful for ensuring the reliability of these measurements, we analyzed several pre-analytical factors that may influence the activity of beta-glucocerebrosidase, alpha-mannosidase, beta-mannosidase, beta-galactosidase, alpha-fucosidase, beta-hexosaminidase, cathepsin D and cathepsin E in cerebrospinal fluid. Lysosomal enzyme activities were measured by well-established fluorimetric assays in a consecutive series of patients (n = 28) with different neurological conditions, including Parkinson's disease. The precision, pre-storage and storage conditions, and freeze/thaw cycles were evaluated. All of the assays showed within-and between-run variabilities below 10%. At -20 degrees C, only cathepsin D was stable up to 40 weeks. At 280 degrees C, the cathepsin D, cathepsin E, and beta-mannosidase activities did not change significantly up to 40 weeks, while beta-glucocerebrosidase activity was stable up to 32 weeks. The beta-galactosidase and alpha-fucosidase activities significantly increased (+54.9 +/- 38.08% after 4 weeks and + 88.94 +/- 36.19% after 16 weeks, respectively). Up to four freeze/thaw cycles did not significantly affect the activities of cathepsins D and E. The beta-glucocerebrosidase activity showed a slight decrease (-14.6%) after two freeze/thaw cycles. The measurement of lysosomal enzyme activities in cerebrospinal fluid is reliable and reproducible if pre-analytical factors are accurately taken into consideration. Therefore, the analytical recommendations that ensue from this study may contribute to the establishment of actual values for the activities of cerebrospinal fluid lysosomal enzymes as putative biomarkers for Parkinson's disease and other neurodegenerative disorders.	[Persichetti, Emanuele; Paciotti, Silvia; Codini, Michela; Beccari, Tommaso] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy; [Chiasserini, Davide; Parnetti, Lucilla; De Carlo, Claudia; Tambasco, Nicola; Rossi, Aroldo; Calabresi, Paolo] Univ Perugia, Neurol Sect, Dept Med, I-06100 Perugia, Italy; [Eusebi, Paolo] Reg Hlth Author Umbria, Dept Epidemiol, Perugia, Italy; [El Agnaf, Omar M.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [El Agnaf, Omar M.] King Abdulaziz Univ, Fac Med, Jeddah 21413, Saudi Arabia; [Calabresi, Paolo] Fdn S Lucia, IRCCS, Rome, Italy	University of Perugia; University of Perugia; United Arab Emirates University; King Abdulaziz University; IRCCS Santa Lucia	Beccari, T (corresponding author), Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy.	tommaso.beccari@unipg.it	Calabresi, Paolo/G-8496-2011; paciotti, silvia/O-6070-2019; Eusebi, Paolo/O-2721-2013; Tambasco, Nicola/AAS-8795-2020; Parnetti, Lucilla/K-8258-2016; Chiasserini, Davide/K-7074-2016; Tambasco, Nicola/K-4788-2018	Calabresi, Paolo/0000-0003-0326-5509; paciotti, silvia/0000-0003-1467-0155; Eusebi, Paolo/0000-0002-0715-6396; Tambasco, Nicola/0000-0003-1497-4482; Parnetti, Lucilla/0000-0001-5722-3967; Chiasserini, Davide/0000-0002-1169-3258; Tambasco, Nicola/0000-0003-1497-4482	Michael J. Fox Foundation for Parkinson's Research; Fondazione Cassa di Risparmio di Perugia [2013-0274.021]	Michael J. Fox Foundation for Parkinson's Research; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	Michael J. Fox Foundation for Parkinson's Research (www.michaeljfox.org) - Rapid response innovation awards: CSF Lysosomal Hydrolases' Activity as Possible Marker of Parkinson's Disease, 2010-2011 and Validation of Lysosomal Enzymes Assay in CSF, 2011-2012. EP, PE received the funding. Fondazione Cassa di Risparmio di Perugia (www.fondazionecrpg.com) grant n. 2013-0274.021. TB research group received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Armstrong A, 2014, NEUROMOL MED, V16, P150, DOI 10.1007/s12017-013-8269-3; Balducci C, 2007, MOVEMENT DISORD, V22, P1481, DOI 10.1002/mds.21399; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Beratis NG, 1997, PEDIATR RES, V41, P235, DOI 10.1203/00006450-199702000-00014; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Crabtree D, 2013, J NEUROCHEM IN PRESS; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; GOI G, 1987, CLIN CHIM ACTA, V163, P215, DOI 10.1016/0009-8981(87)90025-8; GOI G, 1993, EUR NEUROL, V33, P1, DOI 10.1159/000116888; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hartonen M, 2013, J CHROMATOGR A, V1293, P142, DOI 10.1016/j.chroma.2013.04.005; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HULTBERG B, 1978, ACTA NEUROL SCAND, V57, P201, DOI 10.1111/j.1600-0404.1978.tb05867.x; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; LOMBARDO A, 1980, CLIN CHIM ACTA, V108, P337, DOI 10.1016/0009-8981(80)90339-3; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Parnetti L, 2009, NEUROBIOL DIS, V34, P484, DOI 10.1016/j.nbd.2009.03.002; Parnetti L, 2014, MOVEMENT DI IN PRESS; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; R Core Team, 2021, R LANG ENV STAT COMP; RAGHAVAN SS, 1980, AM J HUM GENET, V32, P158; SCHWAGERL AL, 1995, J NEUROCHEM, V64, P443; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; van Dijk KD, 2013, MOVEMENT DISORD, V28, P747, DOI 10.1002/mds.25495; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wayne P, 2004, EP05A2 CLIN LAB STAN; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Ziegler SG, 2007, MOL GENET METAB, V91, P195, DOI 10.1016/j.ymgme.2007.03.004; ZIMRAN A, 1989, LANCET, V2, P349	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101453	10.1371/journal.pone.0101453	http://dx.doi.org/10.1371/journal.pone.0101453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983953	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000109
J	Berti, F; Campisi, E; Toniolo, C; Morelli, L; Crotti, S; Rosini, R; Romano, MR; Pinto, V; Brogioni, B; Torricelli, G; Janulczyk, R; Grandi, G; Margarit, I				Berti, Francesco; Campisi, Edmondo; Toniolo, Chiara; Morelli, Laura; Crotti, Stefano; Rosini, Roberto; Romano, Maria Rosaria; Pinto, Vittoria; Brogioni, Barbara; Torricelli, Giulia; Janulczyk, Robert; Grandi, Guido; Margarit, Immaculada			Structure of the Type IX Group B Streptococcus Capsular Polysaccharide and Its Evolutionary Relationship with Types V and VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Genetics; Nuclear Magnetic Resonance; Polysaccharide; Streptococcus; Vaccine; Group B Streptococcus; Capsular Polysaccharide	IMMUNOCHEMICAL CHARACTERIZATION; CONFORMATIONAL EPITOPE; MOLECULAR-DYNAMICS; CONJUGATE VACCINE; SIALIC-ACID; AGALACTIAE; EPIDEMIOLOGY; DISEASE; IA; VIRULENCE	Background: The capsule of Group B Streptococcus is an important virulence factor and vaccine target. Results: Analysis of type IX polysaccharide revealed a structure similar to type V and VII structures. Conclusion: The structural and phylogenetic basis for the differentiation between types V, VII, and IX was elucidated. Significance: Determination of the type IX structure is instrumental for the development of a carbohydrate-based vaccine. The Group B Streptococcus capsular polysaccharide type IX was isolated and purified, and the structure of its repeating unit was determined. Type IX capsule 4)[NeupNAc--(23)-Galp--(14)-GlcpNAc--(16)]--GlcpNAc-(14)--Galp-(14)--Glcp-(1 appears most similar to types VII and V, although it contains two GlcpNAc residues. Genetic analysis identified differences in cpsM, cpsO, and cpsI gene sequences as responsible for the differentiation between the three capsular polysaccharide types, leading us to hypothesize that type V emerged from a recombination event in a type IX background.	[Berti, Francesco; Campisi, Edmondo; Toniolo, Chiara; Morelli, Laura; Crotti, Stefano; Rosini, Roberto; Romano, Maria Rosaria; Pinto, Vittoria; Brogioni, Barbara; Torricelli, Giulia; Janulczyk, Robert; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines Res, I-53100 Siena, Italy		Berti, F (corresponding author), Novartis Vaccines Res, Via Fiorentina 1, I-53100 Siena, Italy.	francesco.berti@novartis.com	Toniolo, Chiara/ABH-6697-2020; Morelli, Laura/J-1832-2018	Toniolo, Chiara/0000-0002-2167-2936; Morelli, Laura/0000-0001-5159-9015; Campisi, Edmondo/0000-0002-2250-3798; Grandi, Guido/0000-0001-9724-2185				BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; Brisson JR, 1997, BIOCHEMISTRY-US, V36, P3278, DOI 10.1021/bi961819l; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DIFABIO JL, 1989, CAN J CHEM, V67, P877; Edwards MS, 2008, HUM VACCINES, V4, P444, DOI 10.4161/hv.4.6.6507; Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572; Gonzalez-Outeirino J, 2005, CARBOHYD RES, V340, P1007, DOI 10.1016/j.carres.2004.12.034; Guttormsen HK, 2008, P NATL ACAD SCI USA, V105, P5903, DOI 10.1073/pnas.0710799105; Honsa E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-140; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; JENNINGS HJ, 1983, J BIOL CHEM, V258, P1793; JENNINGS HJ, 1983, BIOCHEMISTRY-US, V22, P1258, DOI 10.1021/bi00274a042; JENNINGS HJ, 1981, BIOCHEMISTRY-US, V20, P4511, DOI 10.1021/bi00519a001; JENNINGS HJ, 1984, PURE APPL CHEM, V56, P893, DOI 10.1351/pac198456070893; KOGAN G, 1995, CARBOHYD RES, V277, P1, DOI 10.1016/0008-6215(95)00195-Y; Kogan G, 1996, J BIOL CHEM, V271, P8786, DOI 10.1074/jbc.271.15.8786; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Pinto V, 2014, J PHARMACEUT BIOMED, V98, P9, DOI 10.1016/j.jpba.2014.05.004; RUBENS CE, 1987, P NATL ACAD SCI USA, V84, P7208, DOI 10.1073/pnas.84.20.7208; Safari D, 2011, GLYCOCONJUGATE J, V28, P557, DOI 10.1007/s10719-011-9354-1; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; VONHUNOLSTEIN C, 1993, INFECT IMMUN, V61, P1272, DOI 10.1128/IAI.61.4.1272-1280.1993; WESSELS MR, 1989, P NATL ACAD SCI USA, V86, P8983, DOI 10.1073/pnas.86.22.8983; WESSELS MR, 1991, J BIOL CHEM, V266, P6714; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zou W, 1999, J IMMUNOL, V163, P820; Zou W, 2001, ADV EXP MED BIOL, V491, P473	36	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23437	23448		10.1074/jbc.M114.567974	http://dx.doi.org/10.1074/jbc.M114.567974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990951	Green Published, hybrid			2022-12-25	WOS:000341505000018
J	Drusano, GL; Neely, M; Van Guilder, M; Schumitzky, A; Brown, D; Fikes, S; Peloquin, C; Louie, A				Drusano, George L.; Neely, Michael; Van Guilder, Michael; Schumitzky, Alan; Brown, David; Fikes, Steven; Peloquin, Charles; Louie, Arnold			Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; RESISTANCE; PHARMACOKINETICS; SIMULATION; EMERGENCE; MODEL; PHARMACODYNAMICS; MOXIFLOXACIN; RIFAMPIN	Rationale: Tuberculosis remains a worldwide problem, particularly with the advent of multi-drug resistance. Shortening therapy duration for Mycobacterium tuberculosis is a major goal, requiring generation of optimal kill rate and resistance-suppression. Combination therapy is required to attain the goal of shorter therapy. Objectives: Our objective was to identify a method for identifying optimal combination chemotherapy. We developed a mathematical model for attaining this end. This is accomplished by identifying drug effect interaction (synergy, additivity, antagonism) for susceptible organisms and subpopulations resistant to each drug in the combination. Methods: We studied the combination of linezolid plus rifampin in our hollow fiber infection model. We generated a fully parametric drug effect interaction mathematical model. The results were subjected to Monte Carlo simulation to extend the findings to a population of patients by accounting for between-patient variability in drug pharmacokinetics. Results: All monotherapy allowed emergence of resistance over the first two weeks of the experiment. In combination, the interaction was additive for each population (susceptible and resistant). For a 600 mg/600 mg daily regimen of linezolid plus rifampin, we demonstrated that >50% of simulated subjects had eradicated the susceptible population by day 27 with the remaining organisms resistant to one or the other drug. Only 4% of patients had complete organism eradication by experiment end. Discussion: These data strongly suggest that in order to achieve the goal of shortening therapy, the original regimen may need to be changed at one month to a regimen of two completely new agents with resistance mechanisms independent of the initial regimen. This hypothesis which arose from the analysis is immediately testable in a clinical trial.	[Drusano, George L.; Brown, David; Fikes, Steven; Louie, Arnold] Univ Florida, Inst Therapeut Innovat, Coll Med, Lake Nona, FL 32827 USA; [Neely, Michael; Van Guilder, Michael; Schumitzky, Alan] Univ So Calif, Sch Med, Lab Appl Pharmacokinet, Los Angeles, CA USA; [Peloquin, Charles] Univ Florida, Coll Pharm, Infect Dis PK Lab, Gainesville, FL USA	State University System of Florida; University of Florida; University of Southern California; State University System of Florida; University of Florida	Drusano, GL (corresponding author), Univ Florida, Inst Therapeut Innovat, Coll Med, Lake Nona, FL 32827 USA.	gdrusano@ufl.edu			National Institute of Allergy and Infectious Diseases [R01 AI079578]; Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068968] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of Allergy and Infectious Diseases (R01 AI079578); Bill and Melinda Gates Foundation TB Accelerator Program; Pfizer, Inc for the Hollow Fiber System evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, ANTIMICROB AGENTS CH, V57, P2522, DOI 10.1128/AAC.02020-12; Almeida D, 2009, ANTIMICROB AGENTS CH, V53, P4178, DOI 10.1128/AAC.00830-09; Balasubramanian V, 2012, ANTIMICROB AGENTS CH, V56, P3054, DOI 10.1128/AAC.06383-11; BLASER J, 1985, J ANTIMICROB CHEMOTH, V15, P125, DOI 10.1093/jac/15.suppl_A.125; Boeree M, 2013, 20 C RETR OPP INF MA; Boselli E, 2005, CRIT CARE MED, V33, P1529, DOI 10.1097/01.CCM.0000168206.59873.80; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Drusano GL, 2011, MBIO, V2, DOI 10.1128/mBio.00108-11; Drusano GL, 2010, MBIO, V1, DOI 10.1128/mBio.00139-10; Drusano GL, 2009, ANTIMICROB AGENTS CH, V53, P2266, DOI 10.1128/AAC.01680-08; Goutelle S, 2009, ANTIMICROB AGENTS CH, V53, P2974, DOI 10.1128/AAC.01520-08; GRECO WR, 1995, PHARMACOL REV, V47, P331; Grosset JH, 2013, AM J RESP CRIT CARE, V188, P608, DOI 10.1164/rccm.201304-0753OC; Gumbo T, 2005, ANTIMICROB AGENTS CH, V49, P3178, DOI 10.1128/AAC.49.8.3178-3181.2005; Gumbo T, 2004, J INFECT DIS, V190, P1642, DOI 10.1086/424849; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093/jac/dkg262; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Leary RH, 2001, COMPUTER, V1, P389; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; McGee B, 2009, ANTIMICROB AGENTS CH, V53, P3981, DOI 10.1128/AAC.01378-08; Neely MN, 2012, THER DRUG MONIT, V34, P467, DOI 10.1097/FTD.0b013e31825c4ba6; Peloquin C, 2003, INT J TUBERC LUNG D, V7, P3; SELKON JB, 1964, B WORLD HEALTH ORGAN, V31, P273; van Klingeren B, 2007, J CLIN MICROBIOL, V45, P2662, DOI 10.1128/JCM.00244-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, TREATM TUB GUID; Zhang M, 2012, ANTIMICROB AGENTS CH, V56, P5782, DOI 10.1128/AAC.01125-12	31	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101311	10.1371/journal.pone.0101311	http://dx.doi.org/10.1371/journal.pone.0101311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003557	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700024
J	Malaquias, JB; Ramalho, FS; Lira, ACS; Oliveira, FQ; Fernandes, FS; Godoy, WAC; Zanuncio, JC				Malaquias, Jose B.; Ramalho, Francisco S.; Lira, Aline C. S.; Oliveira, Flavia Q.; Fernandes, Francisco S.; Godoy, Wesley A. C.; Zanuncio, Jose C.			The Biology and Thermal Requirements of the Fennel Aphid Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae)	PLOS ONE			English	Article							TEMPERATURE REQUIREMENTS; PLANT-DISTRIBUTION; COTTON CULTIVARS; COLORED FIBERS; VULGARE; REPRODUCTION; LEPIDOPTERA; TORTRICIDAE; SURVIVAL; EXTRACT	The relationship between the insect development rate and temperature was established very early and represents an important ecological variable for modeling the population dynamics of insects. The accurate determination of thermal constant values and the lower and upper developmental thresholds of Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae) on fennel (Foeniculum vulgare Miller (Apiales: Apiaceae)) crops would obviously benefit the effective application of control measures. This paper is a study of the biology and thermal requirements of H. foeniculi. Winged insects were collected from fennel crops at the Embrapa Algodao in Campina Grande, Paraiba. Nymphs (age <= 24 h) produced by winged insects were subjected to constant temperatures of 15, 20, 25, 28, 30 or 33 degrees C, a photophase of 12 h and a relative humidity of 70 +/- 10%. The results of the study showed that at temperatures between 15 and 30 degrees C, H. foeniculi nymphs were able to develop normally. The four instars were found at all temperatures tested. However, temperatures of 3 and 33 degrees C were lethal to the nymphs. The nymph stage development time varied from 5 (30 degrees C) to 19 (15 degrees C) days. The influence of temperature on the development time is dependent on the instar. The base temperature (Tb) and the thermal constant (K) for the nymph stage were estimated at 11.2 degrees C and 107.5 degree-days, respectively. The shortest nymph development stage was observed at 30 degrees C, and the highest nymph viability (85.0%) was observed at 28 degrees C. This information can be used for developing phenological models based on the temperature and development rate relationships so that outbreaks of H. foeniculi in the fennel crop can be predicted, therefore improving the application of control programs targeting this fennel pest.	[Malaquias, Jose B.; Ramalho, Francisco S.; Lira, Aline C. S.; Fernandes, Francisco S.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, PB, Brazil; [Oliveira, Flavia Q.] Univ Estadual Paulista UNESP, Jaboticabal, SP, Brazil; [Godoy, Wesley A. C.] Escola Super Agr Luiz de Queiroz USP, Piracicaba, SP, Brazil; [Zanuncio, Jose C.] Univ Fed Vicosa, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade Federal de Vicosa	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Av Osvaldo Cruz, Campina Grande, PB, Brazil.	ramalhohvv@globo.com	Godoy, Wesley AC/B-9787-2012; Malaquias, José Bruno B/I-1945-2015; FS, Ramalho/AAC-8058-2019; Lira, Aline/C-2354-2017; Fernandes, Francisco/E-4608-2016	Malaquias, José Bruno B/0000-0003-3937-9575; Lira, Aline/0000-0002-8592-2068; Fernandes, Francisco/0000-0002-0592-2536	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Financiadora de Estudos e Projetos - FINEP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos - FINEP(Financiadora de Inovacao e Pesquisa (Finep))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq and Financiadora de Estudos e Projetos - FINEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Charles Ira, 2007, Cienc. Rural, V37, P1524, DOI 10.1590/S0103-84782007000600003; Abramson CI, 2006, AM J ENV SCI, V3, P9; Barbosa Leonardo Rodrigues, 2006, Acta Scientiarum Agronomy, V28, P221; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cividanes Francisco J., 2003, Neotrop. entomol., V32, P413, DOI 10.1590/S1519-566X2003000300005; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Cocu N, 2005, AGR FOREST ENTOMOL, V7, P31, DOI 10.1111/j.1461-9555.2005.00245.x; Dixon A.F.G., 1987, World Crop Pests, V2A, P269; Dixon AFG, 1997, APHID ECOLOGY OPTIMI; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; EL-AWADI M. E., 2011, NAT SCI, V9, P97; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Fernandes FS, 2012, AN ACAD BRAS CIENC, V84, P707, DOI 10.1590/S0001-37652012005000040; Ferreira RG, 2004, PESQUI AGROPECU BRAS, V39, P1265, DOI 10.1590/S0100-204X2004001200015; Funichello M., 2012, Arq. Inst. Biol., V79, P84; HADDAD L. L., 1999, METODOS ESTIMAR LIMI; HAGSTRUM DW, 1970, ANN ENTOMOL SOC AM, V63, P1385, DOI 10.1093/aesa/63.5.1385; He WP, 2011, J MED PLANTS RES, V5, P3595; Hendawy S., 2010, OZEAN J APPL SCI, V3, P113; HIGLEY LG, 1986, ENVIRON ENTOMOL, V15, P999, DOI 10.1093/ee/15.5.999; HUTCHISON WD, 1984, ENVIRON ENTOMOL, V13, P1173, DOI 10.1093/ee/13.5.1173; Jarosik V, 2002, AM NAT, V160, P497, DOI 10.1086/342077; JONES D, 1979, ENVIRON ENTOMOL, V8, P1118, DOI 10.1093/ee/8.6.1118; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lazzari SMN, 2005, REV BRAS ZOOL, V22, P891, DOI 10.1590/S0101-81752005000400013; Leite MV, 2008, CIENC AGROTEC, V32, P1394, DOI 10.1590/S1413-70542008000500006; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; LYSYK TJ, 1988, J ECON ENTOMOL, V81, P1045, DOI 10.1093/jee/81.4.1045; Malaquias JB, 2010, TURK J AGRIC FOR, V34, P235, DOI 10.3906/tar-0811-18; Nimbalkar RK, 2010, J ECOBIOTECH, V2, P29; Ozder N, 2008, J CENT EUR AGRIC, V9, P155; Ramalho FS, 2012, J ECON ENTOMOL, V105, P113, DOI 10.1603/EC11219; Ramalho FS, 2012, ANN ENTOMOL SOC AM, V105, P20, DOI 10.1603/AN11122; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; SAS Institute, 2006, SAS STAT US GUID; Singh G, 2006, FOOD CONTROL, V17, P745, DOI 10.1016/j.foodcont.2005.03.010; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Tanira MOM, 1996, PHYTOTHER RES, V10, P33, DOI 10.1002/(SICI)1099-1573(199602)10:1&lt;33::AID-PTR769&gt;3.0.CO;2-L; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WOODSON WD, 1988, ANN ENTOMOL SOC AM, V81, P252, DOI 10.1093/aesa/81.2.252	43	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100983	10.1371/journal.pone.0100983	http://dx.doi.org/10.1371/journal.pone.0100983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003593	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700015
J	Alfsnes, K; Raynaud, X; Tonjum, T; Ambur, OH				Alfsnes, Kristian; Raynaud, Xavier; Tonjum, Tone; Ambur, Ole Herman			Mathematical and Live Meningococcal Models for Simple Sequence Repeat Dynamics - Coherent Predictions and Observations	PLOS ONE			English	Article							PHASE-VARIABLE GENES; HIGH MUTATION-RATES; NEISSERIA-MENINGITIDIS; MISMATCH REPAIR; HAEMOPHILUS-INFLUENZAE; CONTINGENCY LOCI; RELATIVE CONTRIBUTIONS; ADAPTIVE EVOLUTION; DNA; RECOMBINATION	Evolvability by means of simple sequence repeat (SSR) instability is a feature under the constant influence of opposing selective pressures to expand and compress the repeat tract and is mechanistically influenced by factors that affect genetic instability. In addition to direct selection for protein expression and structural integrity, other factors that influence tract length evolution were studied. The genetic instability of SSRs that switch the expression of antibiotic resistance ON and OFF was modelled mathematically and monitored in a panel of live meningococcal strains. The mathematical model showed that the SSR length of a theoretical locus in an evolving population may be shaped by direct selection of expression status (ON or OFF), tract length dependent (alpha) and tract length independent factors (beta). According to the model an increase in alpha drives the evolution towards shorter tracts. An increase in b drives the evolution towards a normal distribution of tract lengths given that an upper and a lower limit are set. Insertion and deletion biases were shown to skew allelic distributions in both directions. The meningococcal SSR model was tested in vivo by monitoring the frequency of spectinomycin resistance OFF -> ON switching in a designed locus. The instability of a comprehensive panel of the homopolymeric SSRs, constituted of a range of 5-13 guanine nucleotides, was monitored in wildtype and mismatch repair deficient backgrounds. Both the repeat length itself and mismatch repair deficiency were shown to influence the genetic instability of the homopolymeric tracts. A possible insertion bias was observed in tracts <= G(10). Finally, an inverse correlation between the number of tract-encoded amino acids and growth in the presence of ON-selection illustrated a limitation to SSR expansion in an essential gene associated with the designed model locus and the protein function mediating antibiotic resistance.	[Alfsnes, Kristian; Tonjum, Tone; Ambur, Ole Herman] Univ Oslo, Dept Microbiol, Oslo, Norway; [Alfsnes, Kristian; Tonjum, Tone; Ambur, Ole Herman] Oslo Univ Hosp, Rigshosp, Dept Microbiol, Oslo, Norway; [Raynaud, Xavier] Univ Oslo, Dept Math, Oslo, Norway; [Ambur, Ole Herman] Akershus Univ, Dept Microbiol & Infect Control, Lorenskog, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Oslo Metropolitan University (OsloMet)	Ambur, OH (corresponding author), Univ Oslo, Dept Microbiol, Oslo, Norway.	ole.herman.ambur@ahus.no	Tønjum, Tone/J-4581-2014; Ambur, Ole Herman/O-5342-2019; Ambur, Ole/G-6641-2016	Ambur, Ole Herman/0000-0001-9870-6375; Ambur, Ole/0000-0001-9870-6375; Tonjum, Tone/0000-0002-1709-6921	Research Council of Norway; Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN)	Research Council of Norway(Research Council of Norway); Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN)	The study was supported by the Research Council of Norway by a Centre of Excellence grant (Centre for Molecular Biology and Neuroscience, CMBN) to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Ackermann M, 2006, PLOS GENET, V2, P224, DOI 10.1371/journal.pgen.0020022; Alamro M, 2014, INFECT IMMUN, V82, P2472, DOI 10.1128/IAI.01521-14; Alexander HL, 2004, INFECT IMMUN, V72, P6743, DOI 10.1128/IAI.72.11.6743-6747.2004; Alexander HL, 2004, MOL MICROBIOL, V52, P771, DOI 10.1111/j.1365-2958.2004.04013.x; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Bayliss CD, 2004, J BACTERIOL, V186, P2928, DOI 10.1128/JB.186.10.2928-2935.2004; Bayliss CD, 2004, FEMS IMMUNOL MED MIC, V40, P11, DOI 10.1016/S0928-8244(03)00325-0; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Bayliss CD, 2012, ANN NY ACAD SCI, V1267, P39, DOI 10.1111/j.1749-6632.2012.06584.x; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Belland RJ, 1997, MOL MICROBIOL, V23, P123, DOI 10.1046/j.1365-2958.1997.1971556.x; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Carroll PA, 1997, MOL MICROBIOL, V25, P1099, DOI 10.1046/j.1365-2958.1997.5371901.x; Chen Y, 2013, STRUCTURAL BIOCH STU; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; De Bolle X, 2000, MOL MICROBIOL, V35, P211, DOI 10.1046/j.1365-2958.2000.01701.x; DYBVIG K, 1993, MOL MICROBIOL, V10, P465, DOI 10.1111/j.1365-2958.1993.tb00919.x; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Galimand M, 2000, ANTIMICROB AGENTS CH, V44, P1365, DOI 10.1128/AAC.44.5.1365-1366.2000; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gu TT, 2010, GENETICS, V186, P1077, DOI 10.1534/genetics.110.121137; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Harrison OB, 2013, MICROBIOL-SGM, V159, P1920, DOI 10.1099/mic.0.068874-0; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Kandler JL, 2014, ANTIMICROB AGENTS CH, V58, P4230, DOI 10.1128/AAC.03108-14; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Martin P, 2004, MICROBIOL-SGM, V150, P3001, DOI 10.1099/mic.0.27182-0; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Morel P, 1998, P NATL ACAD SCI USA, V95, P10003, DOI 10.1073/pnas.95.17.10003; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Palmer ME, 2013, MBIO, V4, DOI 10.1128/mBio.00430-12; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Saunders NJ, 2003, MICROBIOL-SGM, V149, P485, DOI 10.1099/mic.0.25807-0; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Sia E, 1997, MOL CELL BIOL, V17; Siddique A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001277; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; STRAND M, 1995, P NATL ACAD SCI USA, V92, P10418, DOI 10.1073/pnas.92.22.10418; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Tibballs KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-7; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101637	10.1371/journal.pone.0101637	http://dx.doi.org/10.1371/journal.pone.0101637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999629	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300064
J	Luz, Y; Shamir, M				Luz, Yotam; Shamir, Maoz			The Effect of STDP Temporal Kernel Structure on the Learning Dynamics of Single Excitatory and Inhibitory Synapses	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; ASYMMETRIC HEBBIAN PLASTICITY; SYNAPTIC PLASTICITY; DENDRITIC LOCATION; SPIKING NEURONS; INPUT; COACTIVATION; DETERMINES; NETWORKS; CORTEX	Spike-Timing Dependent Plasticity (STDP) is characterized by a wide range of temporal kernels. However, much of the theoretical work has focused on a specific kernel - the "temporally asymmetric Hebbian'' learning rules. Previous studies linked excitatory STDP to positive feedback that can account for the emergence of response selectivity. Inhibitory plasticity was associated with negative feedback that can balance the excitatory and inhibitory inputs. Here we study the possible computational role of the temporal structure of the STDP. We represent the STDP as a superposition of two processes: potentiation and depression. This allows us to model a wide range of experimentally observed STDP kernels, from Hebbian to anti-Hebbian, by varying a single parameter. We investigate STDP dynamics of a single excitatory or inhibitory synapse in purely feed-forward architecture. We derive a mean-field-Fokker-Planck dynamics for the synaptic weight and analyze the effect of STDP structure on the fixed points of the mean field dynamics. We find a phase transition along the Hebbian to anti-Hebbian parameter from a phase that is characterized by a unimodal distribution of the synaptic weight, in which the STDP dynamics is governed by negative feedback, to a phase with positive feedback characterized by a bimodal distribution. The critical point of this transition depends on general properties of the STDP dynamics and not on the fine details. Namely, the dynamics is affected by the pre-post correlations only via a single number that quantifies its overlap with the STDP kernel. We find that by manipulating the STDP temporal kernel, negative feedback can be induced in excitatory synapses and positive feedback in inhibitory. Moreover, there is an exact symmetry between inhibitory and excitatory plasticity, i.e., for every STDP rule of inhibitory synapse there exists an STDP rule for excitatory synapse, such that their dynamics is identical.	[Luz, Yotam; Shamir, Maoz] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Shamir, Maoz] Ben Gurion Univ Negev, Dept Phys, Fac Nat Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Luz, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, Beer Sheva, Israel.	yotam.luz@gmail.com	SHAMIR, MAOZ/F-1641-2012	SHAMIR, MAOZ/0000-0002-1489-6704	Israel Science Foundation ISF [722/10]	Israel Science Foundation ISF(Israel Science Foundation)	This work was supported by the Israel Science Foundation ISF grant No 722/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 2002, PHYSIOL BEHAV, V77, P551, DOI 10.1016/S0031-9384(02)00933-2; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Gutig R, 2003, J NEUROSCI, V23, P3697; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hulme SR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0148; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Luz Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002334; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Standage D, 2007, BIOL CYBERN, V96, P615, DOI 10.1007/s00422-007-0152-6; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Vogels TP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00119; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	34	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101109	10.1371/journal.pone.0101109	http://dx.doi.org/10.1371/journal.pone.0101109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999634	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300024
J	Zhou, FQ; Zhuang, Y; Gong, HH; Wang, B; Wang, X; Chen, Q; Wu, L; Wan, H				Zhou, Fuqing; Zhuang, Ying; Gong, Honghan; Wang, Bo; Wang, Xing; Chen, Qi; Wu, Lin; Wan, Hui			Altered Inter-Subregion Connectivity of the Default Mode Network in Relapsing Remitting Multiple Sclerosis: A Functional and Structural Connectivity Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; BRAIN; TRACTOGRAPHY; PATHOLOGY; DEMYELINATION; DYSFUNCTION; DISABILITY; MATTERS; DEEP	Background and Purpose: Little is known about the interactions between the default mode network (DMN) subregions in relapsing-remitting multiple sclerosis (RRMS). This study used diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) to examine alterations of long white matter tracts in paired DMN subregions and their functional connectivity in RRMS patients. Methods: Twenty-four RRMS patients and 24 healthy subjects participated in this study. The fiber connections derived from DTI tractography and the temporal correlation coefficient derived from rs-fMRI were combined to examine the inter-subregion structural-functional connectivity (SC-FC) within the DMN and its correlations with clinical markers. Results: Compared with healthy subjects, the RRMS patients showed the following: 1) significantly decreased SC and increased FC in the pair-wise subregions; 2) two significant correlations in SC-FC coupling patterns, including the positive correlation between slightly increased FC value and long white matter tract damage in the PCC/PCUN-MPFC connection, and the negative correlations between significantly increased FC values and long white matter tract damage in the PCC/PCUN-bilateral mTL connections; 3) SC alterations [log(N track) of the PCC/PCUN-left IPL, RD value of the MPFC-left IPL, FA value of the PCC/PCUN-left mTL connections] correlated with EDSS, increases in the RD value of MPFC-left IPL connection was positively correlated to the MFIS; and decreases in the FA value of PCC/PCUN-right IPL connection was negatively correlated with the PASAT; 4) decreased SC (FA value of the MPFC-left IPL, track volume of the PCC/PCUN-MPFC, and log(N track) of PCC/PCUN-left mTL connections) was positively correlated with brain atrophy. Conclusions: In the connections of paired DMN subregions, we observed decreased SC and increased FC in RRMS patients. The relationship between MS-related structural abnormalities and clinical markers suggests that the disruption of this longdistance "inter-subregion'' connectivity (white matter) may significantly impact the integrity of the network's function.	[Zhou, Fuqing; Gong, Honghan; Wang, Bo; Wang, Xing; Chen, Qi; Wu, Lin] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Zhou, Fuqing; Gong, Honghan] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China; [Zhuang, Ying] Second Hosp Nanchang, Dept Oncol, Nanchang, Jiangxi, Peoples R China; [Wan, Hui] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Zhou, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	fq.chou@yahoo.com; honghan_gong@sina.com			National Science Foundation of China [81101041, 81060116, 81260217]; JiangXi Province science and technology support program [20111BBG70028-1]; Hong Kong Scholars Program [XJ2012026]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); JiangXi Province science and technology support program; Hong Kong Scholars Program	This work was supported by the National Science Foundation of China (Grant No. 81101041 for FZ, Grant No. 81060116 for HG, and Grant No. 81260217 for HG), JiangXi Province science and technology support program (Grant No. 20111BBG70028-1 for FZ), Hong Kong Scholars Program (Grant No. XJ2012026 for FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bodini B, 2011, J NEUROL NEUROSUR PS, V82, P72, DOI 10.1136/jnnp.2009.201574; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Ciccarelli O, 2007, BRAIN, V130, P2220, DOI 10.1093/brain/awm152; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Cruz-Gomez AJ, 2013, MULT SCLER; Dogonowski AM, 2013, ACTA NEUROL SCAND, V128, P328, DOI 10.1111/ane.12121; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Enzinger C, 2012, NEUROLOGY, V79, P1416, DOI 10.1212/WNL.0b013e31826d600d; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Gorgoraptis N, 2010, MULT SCLER J, V16, P555, DOI 10.1177/1352458510362440; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Horn Andreas, 2014, NEUROIMAGE; Hu B, 2011, EUR J RADIOL, V79, P101, DOI 10.1016/j.ejrad.2009.11.021; Hurwitz BJ, 2009, ANN INDIAN ACAD NEUR, V12, P226, DOI 10.4103/0972-2327.58276; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kern KC, 2011, NEUROIMAGE, V55, P1169, DOI 10.1016/j.neuroimage.2010.10.077; Khalsa S, 2013, NEUROIMAGE; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Loitfelder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042862; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Morris DM, 2008, NEUROIMAGE, V42, P1329, DOI 10.1016/j.neuroimage.2008.06.012; Pelletier D, 2004, J NEUROIMAGING, V14, p11S, DOI 10.1111/j.1552-6569.2004.tb00274.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Ramli N, 2010, J CLIN NEUROSCI, V17, P422, DOI 10.1016/j.jocn.2009.09.014; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Schoonheim MM, 2012, NEUROLOGY, V79, P1418, DOI 10.1212/WNL.0b013e31826d602e; Schoonheim MM, 2010, NEUROLOGY, V74, P1246, DOI 10.1212/WNL.0b013e3181db9957; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van Oort ESB, 2014, NEUROIMAGE, V90, P381, DOI 10.1016/j.neuroimage.2013.12.051; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou FQ, 2010, J COMPUT ASSIST TOMO, V34, P431, DOI 10.1097/RCT.0b013e3181cbf73c; Zhou FQ, 2010, J MAGN RESON IMAGING, V31, P789, DOI 10.1002/jmri.22103	56	37	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101198	10.1371/journal.pone.0101198	http://dx.doi.org/10.1371/journal.pone.0101198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999807	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300025
J	Jump, RLP; Polinkovsky, A; Hurless, K; Sitzlar, B; Eckart, K; Tomas, M; Deshpande, A; Nerandzic, MM; Donskey, CJ				Jump, Robin L. P.; Polinkovsky, Alex; Hurless, Kelly; Sitzlar, Brett; Eckart, Kevin; Tomas, Myreen; Deshpande, Abhishek; Nerandzic, Michelle M.; Donskey, Curtis J.			Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; GERM-FREE-MICE; REAL-TIME PCR; ANTIBIOTIC-TREATMENT; BACTERIA; PRIMERS; QUANTIFICATION; SUSCEPTIBILITY; ASSOCIATION; METABOLISM	Background: The intestinal microbiota protect the host against enteric pathogens through a defense mechanism termed colonization resistance. Antibiotics excreted into the intestinal tract may disrupt colonization resistance and alter normal metabolic functions of the microbiota. We used a mouse model to test the hypothesis that alterations in levels of bacterial metabolites in fecal specimens could provide useful biomarkers indicating disrupted or intact colonization resistance after antibiotic treatment. Methods: To assess in vivo colonization resistance, mice were challenged with oral vancomycin-resistant Enterococcus or Clostridium difficile spores at varying time points after treatment with the lincosamide antibiotic clindamycin. For concurrent groups of antibiotic-treated mice, stool samples were analyzed using quantitative real-time polymerase chain reaction to assess changes in the microbiota and using non-targeted metabolic profiling. To assess whether the findings were applicable to another antibiotic class that suppresses intestinal anaerobes, similar experiments were conducted with piperacillin/tazobactam. Results: Colonization resistance began to recover within 5 days and was intact by 12 days after clindamycin treatment, coinciding with the recovery bacteria from the families Lachnospiraceae and Ruminococcaceae, both part of the phylum Firmicutes. Clindamycin treatment caused marked changes in metabolites present in fecal specimens. Of 484 compounds analyzed, 146 (30%) exhibited a significant increase or decrease in concentration during clindamycin treatment followed by recovery to baseline that coincided with restoration of in vivo colonization resistance. Identified as potential biomarkers of colonization resistance, these compounds included intermediates in carbohydrate or protein metabolism that increased (pentitols, gamma-glutamyl amino acids and inositol metabolites) or decreased (pentoses, dipeptides) with clindamycin treatment. Piperacillin/tazobactam treatment caused similar alterations in the intestinal microbiota and fecal metabolites. Conclusions: Recovery of colonization resistance after antibiotic treatment coincided with restoration of several fecal bacterial metabolites. These metabolites could provide useful biomarkers indicating intact or disrupted colonization resistance during and after antibiotic treatment.	[Jump, Robin L. P.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA; [Jump, Robin L. P.; Tomas, Myreen; Donskey, Curtis J.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Polinkovsky, Alex; Hurless, Kelly; Sitzlar, Brett; Eckart, Kevin; Deshpande, Abhishek; Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA	Geriatric Research Education & Clinical Center; Case Western Reserve University	Jump, RLP (corresponding author), Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA.	robinjump@gmail.com	Jump, Robin/AAD-8364-2019		Atlantic Philanthropies, Inc.; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America; National Foundation for Infectious Diseases; National Institutes of Health [R03-AG040722]; Veterans Affairs Merit Review Program; STERIS Corporation for Infectious Diseases; Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG040722] Funding Source: NIH RePORTER	Atlantic Philanthropies, Inc.; John A. Hartford Foundation; Association of Specialty Professors; Infectious Diseases Society of America; National Foundation for Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Program(US Department of Veterans Affairs); STERIS Corporation for Infectious Diseases; Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RLPJ gratefully acknowledges the T. Franklin Williams Scholarship with funding provided by Atlantic Philanthropies, Inc.; the John A. Hartford Foundation, the Association of Specialty Professors, the Infectious Diseases Society of America and the National Foundation for Infectious Diseases. This work was supported by the National Institutes of Health (R03-AG040722 to RLPJ), by the Veterans Affairs Merit Review Program (CJD), by an unrestricted grant from the STERIS Corporation for Infectious Diseases Research Support for Investigators (RLPJ) and the Veterans Integrated Service Network 10 Geriatric Research Education and Clinical Center (VISN 10 GRECC; RLPJ, BS, CJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2012, J POSTGENOMICS DRUG, P02; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lerner A, 2013, ANTIMICROB AGENTS CH, V57, P1474, DOI 10.1128/AAC.01275-12; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2012, R LANG ENV STAT COMP; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; ROLFE RD, 1983, J INFECT DIS, V147, P227, DOI 10.1093/infdis/147.2.227; ROLFE RD, 1984, INFECT IMMUN, V45, P185, DOI 10.1128/IAI.45.1.185-191.1984; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601_5; SEGAL S, 1958, J CLIN INVEST, V37, P719, DOI 10.1172/JCI103658; Stiefel U, 2004, INFECT CONT HOSP EP, V25, P373, DOI 10.1086/502408; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; TRONICK SR, 1973, J BACTERIOL, V115, P858, DOI 10.1128/JB.115.3.858-868.1973; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vincent C, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-18; WELLING GW, 1980, J GEN MICROBIOL, V117, P57; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x	49	51	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101267	10.1371/journal.pone.0101267	http://dx.doi.org/10.1371/journal.pone.0101267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988418	Green Published, gold			2022-12-25	WOS:000341354100073
J	Sohaila, A; Tikmani, SS; Khan, IA; Atiq, H; Akhtar, ASM; Kumar, P; Kumar, K				Sohaila, Arjumand; Tikmani, Shiyam Sunder; Khan, Iqtidar Ahmed; Atiq, Huba; Akhtar, Ali Syed Muhammad; Kumar, Prem; Kumar, Kishwer			Frequency of Retinopathy of Prematurity in Premature Neonates with a Birth Weight below 1500 Grams and a Gestational Age Less than 32 Weeks: A Study from a Tertiary Care Hospital in a Lower-Middle Income Country...	PLOS ONE			English	Article							VISUAL IMPAIRMENT; RISK-FACTORS; POPULATION; INFANTS	Introduction: Retinopathy of prematurity (ROP) is a treatable cause of blindness in neonates. In Pakistan, ROP is often not recognized early because screening and treatment programs are not yet in place in most neonatal units, even in tertiary care hospitals. It is hoped that this report will help inform medical professionals of the magnitude of the problem and help to design appropriate management strategies. Objectives: The aim was to determine the frequency of ROP in premature and very low birth weight (BW) neonates (BW<1500 g and gestational age (GA) <32 weeks). Study Design: Cross-sectional study. Study Setting: Neonatal intensive care unit (NICU) of a tertiary care hospital in Karachi, Pakistan. Study Duration: From June 2009 to May 2010. Subjects and Methods: Neonates with a Birth weight (BW) <1500 g and Gestational Age (GA) <32 weeks who were admitted to the NICU and received an eye examination, or were referred for a ROP eye examination as an outpatient, were included in the study. GA was estimated from intrauterine ultrasound findings. Neonates with major congenital malformations, syndromes or congenital cataracts or tumors of the eyes, and those that died before the eye examination or did not attend the out patients department for an eye examination, were excluded. The neonatal eye examination was performed by a trained ophthalmologist at 4 or 6 weeks of age. Results: Out of 86 neonates, ROP was identified in nine neonates (10.5%) at the first eye examination. ROP was significantly associated with BW (P = 0.037), GA (P = 0.033), and chronological age (P<0.001). Conclusions: we identified ROP in 10.5% of neonates at first eye examination. Significant associations between ROP and a GA<32 weeks and a BW<1500 g were also observed. we also stress that serial follow-up of neonates at risk for ROP is important when making a final diagnosis.	[Sohaila, Arjumand; Tikmani, Shiyam Sunder; Khan, Iqtidar Ahmed; Akhtar, Ali Syed Muhammad; Kumar, Prem; Kumar, Kishwer] Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi, Pakistan; [Atiq, Huba] Aga Khan Univ Hosp, Dept Accid & Emergency, Karachi, Pakistan	Aga Khan University; Aga Khan University	Sohaila, A (corresponding author), Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi, Pakistan.	arjumand.sohaila@aku.edu	Sunder, Shiyam/N-6284-2019; Tikmani, Shiyam Sunder/AAQ-9562-2021					Aucott Susan W, 2004, J Perinatol, V24, P435; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Dutta Sourabh, 2004, Indian Pediatr, V41, P665; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Kim T, 2004, PAEDIATR PERINAT EP, V18, P130, DOI 10.1111/j.1365-3016.2003.00545.x; Maheshwari R, 1996, NATL MED J INDIA, V9, P211; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Taqui AM, 2008, J PAK MED ASS, V58; Wilkinson AR, 1996, EARLY HUM DEV, V46, P239; World Health Organization, 2000, WHO IAPB SCI M GEN; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273	15	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100785	10.1371/journal.pone.0100785	http://dx.doi.org/10.1371/journal.pone.0100785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987962	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100045
J	Ycart, B; Veziris, N				Ycart, Bernard; Veziris, Nicolas			Unbiased Estimation of Mutation Rates under Fluctuating Final Counts	PLOS ONE			English	Article							LURIA-DELBRUCK DISTRIBUTION; INDIVIDUAL BACTERIAL-CELLS; MYCOBACTERIUM-TUBERCULOSIS; PROBABILITY-DISTRIBUTION; GROWTH-RATE; MUTANTS; NUMBER; POPULATIONS; RESISTANCE	Estimation methods for mutation rates (or probabilities) in Luria-Delbruck fluctuation analysis usually assume that the final number of cells remains constant from one culture to another. We show that this leads to systematically underestimate the mutation rate. Two levels of information on final numbers are considered: either the coefficient of variation has been independently estimated, or the final number of cells in each culture is known. In both cases, unbiased estimation methods are proposed. Their statistical properties are assessed both theoretically and through Monte-Carlo simulation. As an application, the data from two well known fluctuation analysis studies on Mycobacterium tuberculosis are reexamined.	[Ycart, Bernard] Univ Grenoble Alpes, Lab Jean Kuntzmann, Grenoble, France; [Ycart, Bernard] Lab Excellence TOUCAN Toulouse Canc, Toulouse, France; [Veziris, Nicolas] Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI,Team Bacteriol E13,CR7, Paris, France; [Veziris, Nicolas] INSERM, Ctr Immunol & Malad Infect, CIMI, U1135,Team Bacteriol E13, Paris, France; [Veziris, Nicolas] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France; [Veziris, Nicolas] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Colorado State University	Ycart, B (corresponding author), Univ Grenoble Alpes, Lab Jean Kuntzmann, Grenoble, France.	Bernard.Ycart@imag.fr	veziris, nicolas/O-9783-2017	veziris, nicolas/0000-0001-5660-6544	Laboratoire d'Excellence TOUCAN (Toulouse Cancer); Fondation du Souffle; Fonds de Dotation Recherche en Sante Respiratoire	Laboratoire d'Excellence TOUCAN (Toulouse Cancer); Fondation du Souffle; Fonds de Dotation Recherche en Sante Respiratoire	Research supported by Laboratoire d'Excellence TOUCAN (Toulouse Cancer), by Fondation du Souffle and Fonds de Dotation Recherche en Sante Respiratoire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; de la Iglesia F, 2012, J VIROL, V86, P3386, DOI 10.1128/JVI.06909-11; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Dyke P, 2001, INTRO LAPLACE TRANSF; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; FU JL, 1982, MUTAT RES, V105, P363, DOI 10.1016/0165-7992(82)90108-7; Gerrish P, 2008, GENETICS, V180, P1773, DOI 10.1534/genetics.108.091777; GUPTA NK, 1974, IEEE T AUTOMAT CONTR, VAC19, P774, DOI 10.1109/TAC.1974.1100714; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hamon A, 2012, ELECTRON J STAT, V6, P1251, DOI 10.1214/12-EJS711; JAEGER G, 1995, GENETICA, V96, P217, DOI 10.1007/BF01439575; Jin JL, 2012, SCI CHINA LIFE SCI, V55, P1007, DOI 10.1007/s11427-012-4395-7; JONES ME, 1993, COMPUT BIOL MED, V23, P525, DOI 10.1016/0010-4825(93)90099-M; JONES ME, 1994, J THEOR BIOL, V166, P355, DOI 10.1006/jtbi.1994.1032; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; KENDAL WS, 1988, CANCER RES, V48, P1060; Kornarova NL, 2007, MATH BIOSCI, V210, P253, DOI 10.1016/j.mbs.2007.04.007; Koutsoumanis KP, 2013, APPL ENVIRON MICROB, V79, P2294, DOI 10.1128/AEM.03629-12; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1209, DOI 10.1128/AAC.01152-07; R Core Team, 2022, R LANG ENV STAT COMP; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SARKAR S, 1991, GENETICS, V127, P257; STEWART FM, 1994, GENETICS, V137, P1139; STEWART FM, 1990, GENETICS, V124, P175; TAN WY, 1982, SIAM J APPL MATH, V42, P719, DOI 10.1137/0142050; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; Ycart B, 2014, J APPL PROBAB STAT, V9, P12; Ycart B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080958; Zheng Q, 2005, MATH BIOSCI, V196, P198, DOI 10.1016/j.mbs.2005.03.011; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1; Zheng Q, 2007, MATH BIOSCI, V209, P500, DOI 10.1016/j.mbs.2007.03.003	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101434	10.1371/journal.pone.0101434	http://dx.doi.org/10.1371/journal.pone.0101434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988217	Green Published, gold			2022-12-25	WOS:000341354100087
J	Edger, PP; Tang, M; Bird, KA; Mayfield, DR; Conant, G; Mummenhoff, K; Koch, MA; Pires, JC				Edger, Patrick P.; Tang, Michelle; Bird, Kevin A.; Mayfield, Dustin R.; Conant, Gavin; Mummenhoff, Klaus; Koch, Marcus A.; Pires, J. Chris			Secondary Structure Analyses of the Nuclear rRNA Internal Transcribed Spacers and Assessment of Its Phylogenetic Utility across the Brassicaceae (Mustards)	PLOS ONE			English	Article							CONCERTED EVOLUTION; MOLECULAR SYSTEMATICS; WHOLE GENOME; DNA; ARABIDOPSIS; SEQUENCE; DIVERSIFICATION; IDENTIFICATION; DUPLICATIONS; POLYPLOIDY	The internal transcribed spacers of the nuclear ribosomal RNA gene cluster, termed ITS1 and ITS2, are the most frequently used nuclear markers for phylogenetic analyses across many eukaryotic groups including most plant families. The reasons for the popularity of these markers include: 1.) Ease of amplification due to high copy number of the gene clusters, 2.) Available cost-effective methods and highly conserved primers, 3.) Rapidly evolving markers (i.e. variable between closely related species), and 4.) The assumption (and/or treatment) that these sequences are non-functional, neutrally evolving phylogenetic markers. Here, our analyses of ITS1 and ITS2 for 50 species suggest that both sequences are instead under selective constraints to preserve proper secondary structure, likely to maintain complete self-splicing functions, and thus are not neutrally-evolving phylogenetic markers. Our results indicate the majority of sequence sites are co-evolving with other positions to form proper secondary structure, which has implications for phylogenetic inference. We also found that the lowest energy state and total number of possible alternate secondary structures are highly significantly different between ITS regions and random sequences with an identical overall length and Guanine-Cytosine (GC) content. Lastly, we review recent evidence highlighting some additional problematic issues with using these regions as the sole markers for phylogenetic studies, and thus strongly recommend additional markers and cost-effective approaches for future studies to estimate phylogenetic relationships.	[Edger, Patrick P.; Tang, Michelle; Bird, Kevin A.; Mayfield, Dustin R.; Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Edger, Patrick P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Conant, Gavin; Pires, J. Chris] Univ Missouri, Inst Informat, Columbia, MO USA; [Conant, Gavin] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Mummenhoff, Klaus] Univ Osnabruck, Dept Biol, Osnabruck, Germany; [Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Heidelberg, Germany	University of Missouri System; University of Missouri Columbia; University of California System; University of California Berkeley; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University Osnabruck; Ruprecht Karls University Heidelberg	Pires, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	piresjc@missouri.edu	Koch, Marcus A/A-4924-2011; Pires, J. Chris/O-5122-2014; Conant, Gavin/R-7022-2019; Edger, Patrick/AAP-3846-2021; Edger, Patrick/ABE-6442-2020	Koch, Marcus A/0000-0002-1693-6829; Pires, J. Chris/0000-0001-9682-2639; Conant, Gavin/0000-0002-8677-4933; Tang, Michelle/0000-0002-8779-8697; Mummenhoff, Klaus/0000-0002-8449-1593; Bird, Kevin/0000-0002-3174-3646	USA National Science Foundation [DEB 1146603, DBI 1110443, NPGI 1202793]; German Research Foundation (DFG) [KO2302-11/1]	USA National Science Foundation(National Science Foundation (NSF)); German Research Foundation (DFG)(German Research Foundation (DFG))	PPE and JCP acknowledge support from the USA National Science Foundation (DEB 1146603, DBI 1110443, and NPGI 1202793). M.A.K. acknowledged funding from the German Research Foundation (DFG) under the code KO2302-11/1. 1. http://www.nsf.gov/; 2. http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; DRON M, 1982, NUCLEIC ACIDS RES, V10, P7609, DOI 10.1093/nar/10.23.7609; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Edwards SV, 2009, P NATL ACAD SCI USA, V106, P8799, DOI 10.1073/pnas.0904103106; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Feodorova TA, 2010, SYST BOT, V35, P811, DOI 10.1600/036364410X539880; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; German DA, 2011, PLANT SYST EVOL, V294, P65, DOI 10.1007/s00606-011-0452-0; German DA, 2009, PLANT SYST EVOL, V283, P33, DOI 10.1007/s00606-009-0213-5; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Heenan PB, 2012, TAXON, V61, P970, DOI 10.1002/tax.615004; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Jordon-Thaden I, 2010, MOL PHYLOGENET EVOL, V55, P524, DOI 10.1016/j.ympev.2010.02.012; Kiefer M, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct158; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Koch MA., 2009, BIOL BREEDING CRUCIF, P1; Koch MA, 2007, MOL BIOL EVOL, V24, P63, DOI 10.1093/molbev/msl130; Koch MA, 2012, TAXON, V61, P1001, DOI 10.1002/tax.615007; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0_1; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Mayfield-Jones D, 2013, SEMIN CELL DEV BIOL, V24, P320, DOI 10.1016/j.semcdb.2013.02.002; Morgan JAT, 1998, J MOL EVOL, V47, P406, DOI 10.1007/PL00006398; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Team RDC, 2019, R LANG ENV STAT COMP; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wendel JF, 1998, MOL SYSTEMATICS PLAN; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90	50	20	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101341	10.1371/journal.pone.0101341	http://dx.doi.org/10.1371/journal.pone.0101341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984034	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000091
J	Tian, JW; Lei, ZC; Qiu, P; Wang, L; Tian, YQ				Tian Jiewei; Lei Zuchao; Qiu Peng; Wang Lei; Tian Yongqiang			Purification and Characterization of a Cold-Adapted Lipase from Oceanobacillus Strain PT-11	PLOS ONE			English	Article							SP-NOV; EXTREMOPHILES; ENZYMES	We isolated a moderately halophilic lipase-producing bacterium from the saline soil. Based on the morphological, physiological, chemotaxonomic and phylogenetic analysis, the isolate PT-11 was postulated to be a novel species identified as Oceanobacillus rekensis PT-11. The lipase was purified 2.50-fold by Q-Sepharose FF and SP-Sepharose FF chromatography and its molecular mass was estimated to be 23.5 kDa by SDS-PAGE. It was highly active over the broad temperature ranging from 10 to 35 degrees C and showed up to 80% of the maximum activity at 10 degrees C indicating the lipase to be a typical cold-adapted enzyme. The enzyme activity was slightly enhanced by Na+, Li+ and K+. Incubation with detergents, such as Tween-20 and Tween-80, slightly inhibited the enzyme activity; while Triton X-100decreased the enzyme activity. The enzyme was fairly stable in the presence of long-chain alcohols but was highly denatured in hydrophilic solvents such as acetone or short-chain alcohols (C1-C3).	[Tian Jiewei; Tian Yongqiang] Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Peoples R China; [Tian Jiewei; Lei Zuchao; Qiu Peng; Wang Lei] Sichuan Univ, Coll Chem Engn, Dept Pharmaceut & Biol Engn, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Tian, YQ (corresponding author), Sichuan Univ, Coll Light Ind Text & Food Engn, Key Lab Leather Chem & Engn, Chengdu 610064, Peoples R China.	yqtian@scu.edu.cn			Fundermental Research Funds for the Central University	Fundermental Research Funds for the Central University	This work was supported by "the Fundermental Research Funds for the Central University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cui XL, 2001, INT J SYST EVOL MICR, V51, P357, DOI 10.1099/00207713-51-2-357; de Champdore M, 2007, J R SOC INTERFACE, V4, P183, DOI 10.1098/rsif.2006.0174; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Florczak T, 2013, ENZYME MICROB TECH, V53, P18, DOI 10.1016/j.enzmictec.2013.03.021; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Joseph B, 2007, BIOTECHNOL MOL BIOL, V2, P039; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; Kim YO, 2012, J BIOSCI BIOENG, V114, P589, DOI 10.1016/j.jbiosc.2012.06.013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Lokendra Kumar, 2011, Biotechnology, V10, P121; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Romero CM, 2012, BIOCATAL AGRIC BIOTE, V1, P25, DOI 10.1016/j.bcab.2011.08.013; Ryu HS, 2006, APPL MICROBIOL BIOT, V70, P321, DOI 10.1007/s00253-005-0058-y; Saxena RK, 2003, J MICROBIOL METH, V52, P1, DOI 10.1016/S0167-7012(02)00161-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tesch C, 1996, J BACTERIOL, V178, P1858, DOI 10.1128/jb.178.7.1858-1865.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Yang JY, 2010, INT J SYST EVOL MICR, V60, P2409, DOI 10.1099/ijs.0.016295-0	27	10	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101343	10.1371/journal.pone.0101343	http://dx.doi.org/10.1371/journal.pone.0101343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984141	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000092
J	Kanellis, DC; Bursac, S; Tsichlis, PN; Volarevic, S; Eliopoulos, AG				Kanellis, D. C.; Bursac, S.; Tsichlis, P. N.; Volarevic, S.; Eliopoulos, A. G.			Physical and functional interaction of the TPL2 kinase with nucleophosmin	ONCOGENE			English	Article							NF-KAPPA-B; MAP KINASE; UP-REGULATION; ACTIVATE ERK; P53; PHOSPHORYLATION; SUPPRESSOR; INFLAMMATION; PROGRESSION; INDUCTION	Tumor Progression Locus 2 (TPL2) is widely recognized as a cytoplasmic mitogen-activated protein 3 kinase with a prominent role in the regulation of inflammatory and oncogenic signal transduction. Herein we report that TPL2 may also operate in the nucleus as a physical and functional partner of nucleophosmin (NPM/B23), a major nucleolar phosphoprotein with diverse cellular activities linked to malignancy. We demonstrate that TPL2 mediates the phosphorylation of a fraction of NPM at threonine 199, an event required for its proteasomal degradation and maintenance of steady-state NPM levels. Upon exposure to ultraviolet C, Tpl2 is required for the translocation of de-phosphorylated NPM from the nucleolus to the nucleoplasm. NPM is an endogenous inhibitor of HDM2:p53 interaction and knockdown of TPL2 was found to result in reduced binding of NPM to HDM2, with concomitant defects in p53 accumulation following genotoxic or ribosomal stress. These findings expand our understanding of the function of TPL2 as a negative regulator of carcinogenesis by defining a nuclear role for this kinase in the topological sequestration of NPM, linking p53 signaling to the generation of threonine 199-phosphorylated NPM.	[Kanellis, D. C.; Eliopoulos, A. G.] Univ Crete, Sch Med, Div Basic Sci, Mol & Cellular Biol Lab, Iraklion 71003, Greece; [Kanellis, D. C.; Eliopoulos, A. G.] Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Canc Biol Lab, Iraklion, Greece; [Bursac, S.; Volarevic, S.] Univ Rijeka, Sch Med, Dept Mol Med & Biotechnol, Rijeka, Croatia; [Tsichlis, P. N.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	University of Crete; University of Rijeka; Tufts Medical Center	Eliopoulos, AG (corresponding author), Univ Crete, Sch Med, Div Basic Sci, Mol & Cellular Biol Lab, Iraklion 71003, Greece.	eliopag@imbb.forth.gr	ELIOPOULOS, ARISTIDES/R-9449-2018; Kanellis, Dimitrios/AHB-0318-2022; ELIOPOULOS, ARISTIDES/ABI-6632-2020; Volarevic, Sinisa/O-4349-2018; Bursać, Slađana/Q-7894-2018	ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; Kanellis, Dimitrios/0000-0001-8690-2010; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; Volarevic, Sinisa/0000-0003-4893-389X; Bursać, Slađana/0000-0002-6478-3409	European Commission (EC) research program 'Inflammation AMP; Cancer Research in Europe' (INFLA-CARE) [223151]; EC support program 'Translational Potential' (TransPOT) [285948]; University of Crete Maria Manassaki scholarship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	European Commission (EC) research program 'Inflammation AMP; Cancer Research in Europe' (INFLA-CARE); EC support program 'Translational Potential' (TransPOT); University of Crete Maria Manassaki scholarship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Moshe Oren and Varda Rotter (Weizmann Institute, Israel), Josef Papamatheakis (FORTH/IMBB, Greece), Angeliki Malliri (Patterson Institute for Cancer Research, UK), Vassilis Gorgoulis (University of Athens Medical School, Greece) and Charalambos Spilianakis (FORTH/IMBB, Greece) for their kind gift of reagents and Marina Ioannou for excellent technical assistance. This work was supported by the European Commission (EC) research program 'Inflammation & Cancer Research in Europe' (INFLA-CARE; EC Contract 223151) to AGE and SV, the EC support program 'Translational Potential' (TransPOT; EC Contract 285948) to AGE and a University of Crete Maria Manassaki scholarship to DK.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Bursac S., 2013, BIOCHIM BIOPHYS ACTA, V1842, P817; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Chao A, 2013, J MOL MED, V91, P249, DOI 10.1007/s00109-012-0950-8; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; DeCicco-Skinner KL, 2011, ONCOGENE, V30, P389, DOI 10.1038/onc.2010.447; Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, J VIROL, V76, P4567, DOI 10.1128/JVI.76.9.4567-4579.2002; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Erny KM, 1996, ONCOGENE, V13, P2015; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Koike A, 2010, CANCER RES, V70, P6746, DOI 10.1158/0008-5472.CAN-10-0382; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lee SB, 2008, P NATL ACAD SCI USA, V105, P16584, DOI 10.1073/pnas.0807668105; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Lin CY, 2010, MOL BIOL CELL, V21, P4409, DOI 10.1091/mbc.E10-03-0239; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Lopez-Pelaez M, 2012, MOL BIOL CELL, V23, P2982, DOI 10.1091/mbc.E12-02-0135; Louvet E, 2006, MOL BIOL CELL, V17, P2537, DOI 10.1091/mbc.E05-10-0923; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Zhang MJ, 2012, FEBS J, V279, P2848, DOI 10.1111/j.1742-4658.2012.08663.x; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	60	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2516	2526		10.1038/onc.2014.183	http://dx.doi.org/10.1038/onc.2014.183			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998852				2022-12-25	WOS:000354190400010
J	Berezuk, AM; Goodyear, M; Khursigara, CM				Berezuk, Alison M.; Goodyear, Mara; Khursigara, Cezar M.			Site-directed Fluorescence Labeling Reveals a Revised N-terminal Membrane Topology and Functional Periplasmic Residues in the Escherichia coli Cell Division Protein FtsK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Electron Microscopy (EM); Escherichia coli (E; coli); Membrane Protein; Site-directed Mutagenesis; FtsK; Membrane Topology	CHROMOSOME DIMER RESOLUTION; PEPTIDOGLYCAN SYNTHESIS; BACTERIAL CYTOKINESIS; Z-RING; SEGREGATION; LOCALIZATION; TRANSPORTER; SEPTUM; DOMAIN; CYCLE	Background: FtsK is an essential membrane protein that links chromosome segregation and cell division in bacteria. Results: A revised membrane topology of FtsK highlights a large functional periplasmic loop. Conclusion: Key residues in the newly identified periplasmic loop of FtsK couple division of the cytoplasmic and outer membranes. Significance: FtsK functions as a critical checkpoint for the transition between cell growth and septation. In Escherichia coli, FtsK is a large integral membrane protein that coordinates chromosome segregation and cell division. The N-terminal domain of FtsK (FtsK(N)) is essential for division, and the C terminus (FtsK(C)) is a well characterized DNA translocase. Although the function of FtsK(N) is unknown, it is suggested that FtsK acts as a checkpoint to ensure DNA is properly segregated before septation. This may occur through modulation of protein interactions between FtsK(N) and other division proteins in both the periplasm and cytoplasm; thus, a clear understanding of how FtsK(N) is positioned in the membrane is required to characterize these interactions. The membrane topology of FtsK(N) was initially determined using site-directed reporter fusions; however, questions regarding this topology persist. Here, we report a revised membrane topology generated by site-directed fluorescence labeling. The revised topology confirms the presence of four transmembrane segments and reveals a newly identified periplasmic loop between the third and fourth transmembrane domains. Within this loop, four residues were identified that, when mutated, resulted in the appearance of cellular voids. High resolution transmission electron microscopy of these voids showed asymmetric division of the cytoplasm in the absence of outer membrane invagination or visible cell wall ingrowth. This uncoupling reveals a novel role for FtsK in linking cell envelope septation events and yields further evidence for FtsK as a critical checkpoint of cell division. The revised topology of FtsK(N) also provides an important platform for future studies on essential interactions required for this process.	[Berezuk, Alison M.; Goodyear, Mara; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	ckhursig@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada [371639]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant 371639 (to C. M. K.), Postgraduate Scholarship-Doctoral (to A. M. B.), and Undergraduate Student Research Award (to M. G.) from the Natural Sciences and Engineering Research Council of Canada.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Allard JF, 2009, P NATL ACAD SCI USA, V106, P145, DOI 10.1073/pnas.0808657106; Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2007, MOL MICROBIOL, V66, P1051, DOI 10.1111/j.1365-2958.2007.05981.x; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; BEGG KJ, 1980, J BACTERIOL, V144, P435, DOI 10.1128/JB.144.1.435-437.1980; Beveridge T.J., 2007, METHODS GEN MOL MICR, P54; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00800-13; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Demarre G, 2013, ADV EXP MED BIOL, V973, P245, DOI 10.1007/978-1-4614-5037-5_12; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Diez AA, 1997, J BACTERIOL, V179, P5878, DOI 10.1128/jb.179.18.5878-5883.1997; Dorazi R, 2000, FEBS LETT, V478, P13, DOI 10.1016/S0014-5793(00)01820-2; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Grainge I, 2010, MOL MICROBIOL, V78, P1055, DOI 10.1111/j.1365-2958.2010.07411.x; Grenga L, 2008, FEMS MICROBIOL LETT, V287, P163, DOI 10.1111/j.1574-6968.2008.01317.x; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Larue K, 2011, J BIOL CHEM, V286, P16658, DOI 10.1074/jbc.M111.228221; Lesterlin C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000288; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; NANNINGA N, 1991, MOL MICROBIOL, V5, P791, DOI 10.1111/j.1365-2958.1991.tb00751.x; NORDSTROM K, 1991, MOL MICROBIOL, V5, P769, DOI 10.1111/j.1365-2958.1991.tb00747.x; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Rothfield L, 2003, J BACTERIOL, V185, P1125, DOI 10.1128/JB.185.4.1125-1127.2003; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Thanbichler M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000331; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989; Wood JM, 2005, BIOCHEMISTRY-US, V44, P5634, DOI 10.1021/bi047383o; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001; Yu XC, 1998, J BACTERIOL, V180, P6424; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	68	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23287	23301		10.1074/jbc.M114.569624	http://dx.doi.org/10.1074/jbc.M114.569624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002583	Green Published, hybrid			2022-12-25	WOS:000341505000003
J	Thompson, MR; Sharma, S; Atianand, M; Jensen, SB; Carpenter, S; Knipe, DM; Fitzgerald, KA; Kurt-Jones, EA				Thompson, Mikayla R.; Sharma, Shruti; Atianand, Maninjay; Jensen, Soren B.; Carpenter, Susan; Knipe, David M.; Fitzgerald, Katherine A.; Kurt-Jones, Evelyn A.			Interferon gamma-inducible Protein (IFI) 16 Transcriptionally Regulates Type I Interferons and Other Interferon-stimulated Genes and Controls the Interferon Response to both DNA and RNA Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; Host-Pathogen Interaction; Innate Immunity; Interferon; Pattern Recognition Receptor (PRR); RIG-I-like Receptor (RLR); RNA; Toll-like Receptor (TLR); Transcription Regulation; Virus	CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; CYTOSOLIC-DNA; RIG-I; AIM2 INFLAMMASOME; INTRACELLULAR DNA; CYTOPLASMIC DNA; RECOGNITION; POLYMERASE; ACTIVATION	Background: IFI16 binds dsDNA and elicits a type I interferon response. Results: IFI16 knockdown cells show a decrease in interferon production and ISG expression in response to DNA and RNA ligands and cyclic dinucleotides. Conclusion: IFI16 transcriptionally regulates ISGs to enhance IFN responses to multiple IFN-inducing ligands. Significance: IFI16 has a broader role in the regulation of ISG expression. The interferon -inducible protein 16 (IFI16) has recently been linked to the detection of nuclear and cytosolic DNA during infection with herpes simplex virus-1 and HIV. IFI16 binds dsDNA via HIN200 domains and activates stimulator of interferon genes (STING), leading to TANK (TRAF family member-associated NF-B activator)-binding kinase-1 (TBK1)-dependent phosphorylation of interferon regulatory factor (IRF) 3 and transcription of type I interferons (IFNs) and related genes. To better understand the role of IFI16 in coordinating type I IFN gene regulation, we generated cell lines with stable knockdown of IFI16 and examined responses to DNA and RNA viruses as well as cyclic dinucleotides. As expected, stable knockdown of IFI16 led to a severely attenuated type I IFN response to DNA ligands and viruses. In contrast, expression of the NF-B-regulated cytokines IL-6 and IL-1 was unaffected in IFI16 knockdown cells, suggesting that the role of IFI16 in sensing these triggers was unique to the type I IFN pathway. Surprisingly, we also found that knockdown of IFI16 led to a severe attenuation of IFN- and the IFN-stimulated gene retinoic acid-inducible gene I (RIG-I) in response to cyclic GMP-AMP, a second messenger produced by cyclic GMP-AMP synthase (cGAS) as well as RNA ligands and viruses. Analysis of IFI16 knockdown cells revealed compromised occupancy of RNA polymerase II on the IFN- promoter in these cells, suggesting that transcription of IFN-stimulated genes is dependent on IFI16. These results indicate a broader role for IFI16 in the regulation of the type I IFN response to RNA and DNA viruses in antiviral immunity.	[Thompson, Mikayla R.; Sharma, Shruti; Atianand, Maninjay; Carpenter, Susan; Fitzgerald, Katherine A.; Kurt-Jones, Evelyn A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Jensen, Soren B.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Aarhus University; Harvard University; Harvard Medical School	Kurt-Jones, EA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Lazare Res Bldg,Rm 226,364 Plantat St, Worcester, MA 01605 USA.	evelyn.kurt-jones@umassmed.edu	Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020	Atianand, Maninjay/0000-0003-4135-2515; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [T32AI095213, U19AI057319, P01AI083215, AI093752, AI083713, AI106934, DE023909]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093752, R01AI083713, U19AI057319, T32AI095213, P01AI083215, R01AI106934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants T32AI095213 (to M. R. T.), U19AI057319 and P01AI083215 (to E. K. J.), AI093752 and AI083713 (to K. A. F.), and AI106934 and DE023909 (to D. M. K.).	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Berg RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084513; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Conrady CD, 2012, MUCOSAL IMMUNOL, V5, P173, DOI 10.1038/mi.2011.63; DAWSON MJ, 1995, BIOCHEM BIOPH RES CO, V214, P152, DOI 10.1006/bbrc.1995.2269; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Johnstone RW, 1998, J BIOL CHEM, V273, P17172, DOI 10.1074/jbc.273.27.17172; Johnstone RW, 2000, ONCOGENE, V19, P6033, DOI 10.1038/sj.onc.1204005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kwak JC, 2003, J BIOL CHEM, V278, P40899, DOI 10.1074/jbc.M308012200; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Luu P, 1997, J VIROL, V71, P6683, DOI 10.1128/JVI.71.9.6683-6691.1997; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schickli JH, 2005, J VIROL, V79, P10678, DOI 10.1128/JVI.79.16.10678-10689.2005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	47	86	86	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23568	23581		10.1074/jbc.M114.554147	http://dx.doi.org/10.1074/jbc.M114.554147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002588	hybrid, Green Published			2022-12-25	WOS:000341505000027
J	Kim, HW; Kim, YH; Han, K; Nam, GE; Kim, GS; Han, BD; Lee, A; Ahn, JY; Ko, BJ				Kim, Hye Won; Kim, Yang-Hyun; Han, Kyungdo; Nam, Ga Eun; Kim, Gwang Seon; Han, Byoung-Duck; Lee, Anna; Ahn, Ji Yong; Ko, Byung Joon			Atrophic Gastritis: A Related Factor for Osteoporosis in Elderly Women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INTESTINAL METAPLASIA; HIP FRACTURE; RISK; CALCIUM; CLASSIFICATION; METAANALYSIS; PREVALENCE; DIAGNOSIS	Purpose: Osteoporosis poses a great threat to the aging society. Hypochlorhydric or achlorhydric conditions are risk factors for osteoporosis. Atrophic gastritis also decreases gastric acid production; however, the role of atrophic gastritis as a related factor for osteoporosis is unclear. We investigated the relationship between atrophic gastritis and osteoporosis in postmenopausal women over 60 years of age. Subjects and Methods: A total of 401 postmenopausal women were included in this cross-sectional study, which was conducted during their medical check-ups. Bone mineral densitometry was measured using a dual energy X-ray absorptiometry. Atrophic gastritis was defined endoscopically if gastric mucosa in the antrum and the body were found to be atrophied and thinned and submucosal vessels could be well visualized. Results: The proportion of people with atrophic gastritis was higher in the osteoporotic group than in the group without osteoporosis. A linear relationship was observed in the proportion of atrophic gastritis according to the categories of normal, osteopenia, and osteoporosis at the lumbar spine (p for trend = 0.039) and femur (p for trend = 0.001). A multiple logistic regression analysis revealed that the presence of atrophic gastritis was associated with an increased odds of osteoporosis after adjusting for age, body mass index, triglyceride, high-density lipoprotein cholesterol, alcohol consumption, and smoking status (odds ratio 1.89, 95% confidence interval 1.15-3.11). Conclusions: Atrophic gastritis is associated with an increased likelihood of osteoporosis in Korean elderly women.	[Kim, Hye Won; Kim, Yang-Hyun; Nam, Ga Eun; Kim, Gwang Seon; Han, Byoung-Duck; Ko, Byung Joon] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Anna] Univ Hawaii Manoa, Coll Language Linguist & Literature, Dept East Asian Languages, Honolulu, HI 96822 USA; [Ahn, Ji Yong] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Ko, Byung Joon] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; University of Hawaii System; University of Hawaii Manoa; University of Ulsan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ahn, JY (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea.	ji110@hanmail.net; basslove1@hanmail.net	Ahn, Ji Yong/AGO-1695-2022; Nam, Ga Eun/AAU-6055-2020; Song, Young Goo/AGV-5104-2022; Nam, Ga Eun/AAA-1577-2021	Song, Young Goo/0000-0002-0733-4156; Nam, Ga Eun/0000-0002-6739-9904; han, byoungduck/0000-0003-2830-1174; Kim, Yang-Hyun/0000-0003-3548-8758				Ahn SY, 2011, DIGEST DIS SCI, V56, P1119, DOI 10.1007/s10620-010-1531-8; AXELSON J, 1991, GUT, V32, P1298, DOI 10.1136/gut.32.11.1298; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; CORREA P, 1988, AM J GASTROENTEROL, V83, P504; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; EASTELL R, 1992, CLIN SCI, V82, P681, DOI 10.1042/cs0820681; Eshmuratov A, 2010, DIGEST DIS SCI, V55, P1364, DOI 10.1007/s10620-009-0891-4; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kakehasi AM, 2009, DIGEST DIS SCI, V54, P819, DOI 10.1007/s10620-008-0417-5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim N, 2008, HELICOBACTER, V13, P245, DOI 10.1111/j.1523-5378.2008.00604.x; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Nguyen TV, 2000, J BONE MINER RES, V15, P322, DOI 10.1359/jbmr.2000.15.2.322; PAAKKONEN M, 1984, ACTA CHIR SCAND, V150, P485; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; Rembiasz K, 2005, DIGEST DIS SCI, V50, P474, DOI 10.1007/s10620-005-2461-8; RICO H, 1992, CALCIFIED TISSUE INT, V51, P251, DOI 10.1007/BF00334483; Scibora LM, 2012, OBES SURG, V22, P654, DOI 10.1007/s11695-012-0596-1; Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	28	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101852	10.1371/journal.pone.0101852	http://dx.doi.org/10.1371/journal.pone.0101852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003598	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700078
J	Jiang, X; Kanda, T; Wu, S; Nakamoto, S; Saito, K; Shirasawa, H; Kiyohara, T; Ishii, K; Wakita, T; Okamoto, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamoto, Shingo; Saito, Kengo; Shirasawa, Hiroshi; Kiyohara, Tomoko; Ishii, Koji; Wakita, Takaji; Okamoto, Hiroaki; Yokosuka, Osamu			Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; IRES-DEPENDENT TRANSLATION; SITE-MEDIATED TRANSLATION; SMALL INTERFERING RNAS; HOST-TARGETING AGENTS; HAV 3C PROTEINASE; ENTRY SITE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 5'-UNTRANSLATED REGION; BETA-LACTONES	Background: Despite the development and availability of hepatitis A virus (HAV) vaccine, HAV infection is still a major cause of acute hepatitis that occasionally leads to fatal liver disease. HAV internal ribosomal entry-site (IRES) is one of the attractive targets of antiviral agents against HAV. The aim of the present study is to evaluate the impact of La, one of the cellular proteins, on HAV IRES-mediated translation and HAV replication. Methods and Findings: We investigated the therapeutic feasibility of siRNAs specific for cellular cofactors for HAV IRES-mediated translation in cell culture. It was revealed that siRNA against La could inhibit HAV IRES activities as well as HAV subgenomic replication. We also found that the Janus kinase (JAK) inhibitors SD-1029 and AG490, which reduce La expression, could inhibit HAV IRES activities as well as HAV replication. Conclusions: Inhibition of La by siRNAs and chemical agents could lead to the efficient inhibition of HAV IRES-mediated translation and HAV replication in cell culture models. La might play important roles in HAV replication and is being exploited as one of the therapeutic targets of host-targeting antivirals.	[Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo; Saito, Kengo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Kiyohara, Tomoko; Ishii, Koji; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Japan; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Japan	Chiba University; Chiba University; National Institute of Infectious Diseases (NIID); Jichi Medical University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat@aol.com	Jiang, Xia/P-4220-2014; Okamoto, Hiroaki/H-4371-2011	Jiang, Xia/0000-0003-4572-0039; Okamoto, Hiroaki/0000-0003-0827-0964; Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Health, Labour and Welfare of Japan [H24-Hepatitis-General-002]; Grants-in-Aid for Scientific Research [25460580] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H24-Hepatitis-General-002)(OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2000, EMBO J, V19, P6230, DOI 10.1093/emboj/19.22.6230; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Basu A, 2001, VIROLOGY, V288, P379, DOI 10.1006/viro.2001.1100; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; Casas N, 2007, INT J FOOD MICROBIOL, V120, P179, DOI 10.1016/j.ijfoodmicro.2007.01.017; Ching KZ, 2002, J GEN VIROL, V83, P53, DOI 10.1099/0022-1317-83-1-53; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; CRANCE JM, 1990, J MED VIROL, V31, P155, DOI 10.1002/jmv.1890310214; Cutolo M, 2013, J INFLAMM RES, V6, P129, DOI 10.2147/JIR.S35901; Das S, 1998, J VIROL, V72, P5638, DOI 10.1128/JVI.72.7.5638-5647.1998; Debing Y, 2014, MED RES REV, V34, P895, DOI 10.1002/med.21292; Debing Y, 2013, ANTIVIR RES, V98, P325, DOI 10.1016/j.antiviral.2013.03.016; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; Gauss-Muller V, 2002, J GEN VIROL, V83, P2183, DOI 10.1099/0022-1317-83-9-2183; Gonzales AJ, 2014, J VET PHARMACOL THER, V37, P317, DOI 10.1111/jvp.12101; Goswami BB, 2004, ANTIVIR RES, V63, P153, DOI 10.1016/j.antiviral.2004.02.004; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Hsu S, 2005, J PHARMACOL EXP THER, V315, P805, DOI 10.1124/jpet.105.090399; Huang YT, 1999, BIOORGAN MED CHEM, V7, P607, DOI 10.1016/S0968-0896(99)00006-1; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Kanda T, 2005, BIOCHEM BIOPH RES CO, V331, P621, DOI 10.1016/j.bbrc.2005.03.212; Kanda T, 2005, BIOCHEM BIOPH RES CO, V330, P1217, DOI 10.1016/j.bbrc.2005.03.105; Kanda T, 2004, BIOCHEM BIOPH RES CO, V318, P341, DOI 10.1016/j.bbrc.2004.03.194; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; Kanda T, 2012, VIRAL IMMUNOL, V25, P379, DOI 10.1089/vim.2012.0021; Kanda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015139; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Kiyohara T, 2009, ARCH VIROL, V154, P1263, DOI 10.1007/s00705-009-0433-6; Kusov Y, 2006, J VIROL, V80, P5599, DOI 10.1128/JVI.01773-05; Lall MS, 2002, J ORG CHEM, V67, P1536, DOI 10.1021/jo0109016; Lall MS, 1999, ORG LETT, V1, P803, DOI 10.1021/ol990148r; Lavanchy D, 2012, J CLIN VIROL, V55, P296, DOI 10.1016/j.jcv.2012.08.022; MADORE SJ, 1984, J BIOL CHEM, V259, P1929; MALCOLM BA, 1995, BIOCHEMISTRY-US, V34, P8172, DOI 10.1021/bi00025a024; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morris TS, 1997, BIOORGAN MED CHEM, V5, P797, DOI 10.1016/S0968-0896(97)88649-X; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Okitsu Kohichiroh, 2010, Genes Cancer, V1, P859, DOI 10.1177/1947601910383417; Redondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052065; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Rosenthal A, 2014, EXPERT OPIN PHARMACO, V15, P1265, DOI 10.1517/14656566.2014.913024; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Sjogren M, 2003, HEPATOLOGY, V38, P554, DOI 10.1053/jhep.2003.50401; Tang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036363; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; VALLBRACHT A, 1984, J GEN VIROL, V65, P609, DOI 10.1099/0022-1317-65-3-609; Venkatramana M, 2003, VIRUS RES, V98, P141, DOI 10.1016/j.virusres.2003.09.004; Wang Q, 2012, VIRUS RES, V167, P302, DOI 10.1016/j.virusres.2012.05.014; WIDELL A, 1986, ANTIVIR RES, V6, P103, DOI 10.1016/0166-3542(86)90030-6; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wu S, 2014, INT J MED SCI, V11, P60, DOI 10.7150/ijms.7728; Yang LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-212; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000; Yin J, 2006, J MOL BIOL, V361, P673, DOI 10.1016/j.jmb.2006.06.047; YOSHIBA M, 1994, LANCET, V343, P288, DOI 10.1016/S0140-6736(94)91132-0; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101993	10.1371/journal.pone.0101993	http://dx.doi.org/10.1371/journal.pone.0101993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999657	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300112
J	Wlodarska-Kowalczuk, M; Jankowska, E; Kotwicki, L; Balazy, P				Wlodarska-Kowalczuk, Maria; Jankowska, Emilia; Kotwicki, Lech; Balazy, Piotr			Evidence of Season-Dependency in Vegetation Effects on Macrofauna in Temperate Seagrass Meadows (Baltic Sea)	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COMMUNITY COMPOSITION; RELATIVE IMPORTANCE; POSIDONIA-OCEANICA; SHOOT-DENSITY; SEDIMENT CHARACTERISTICS; TROPHIC INTERACTIONS; HABITAT COMPLEXITY; SPATIAL VARIATION; MYTILUS-EDULIS	Seagrasses and associated macrophytes are important components of coastal systems as ecosystem engineers, habitat formers, and providers of food and shelter for other organisms. The positive impacts of seagrass vegetation on zoobenthic abundance and diversity (as compared to bare sands) are well documented, but only in surveys performed in summer, which is the season of maximum canopy development. Here we present the results of the first study of the relationship between the seasonal variability of seagrass vegetation and persistence and magnitude of contrasts in faunal communities between vegetated and bare sediments. The composition, abundance, biomass, and diversity of macrozoobenthos in both habitats were compared five times throughout the year in temperate eelgrass meadows in the southern Baltic Sea. Significant positive effects of macrophyte cover on invertebrate density and biomass were recorded only in June, July, and October when the seagrass canopy was relatively well developed. The effects of vegetation cover on faunal species richness, diversity, and composition persisted throughout the year, but the magnitude of these effects varied seasonally and followed changes in macrophyte biomass. The strongest effects were observed in July and coincided with maximums in seagrass biomass and the diversity and biomass of other macrophytes. These observations indicate that in temperate, clearly seasonal systems the assessment of macrophyte impact cannot be based solely on observations performed in just one season, especially when that season is the one in which macrophyte growth is at its maximum. The widely held belief that macrophyte cover strongly influences benthic fauna in marine coastal habitats, which is based on summer surveys, should be revisited and complemented with information obtained in other seasons.	[Wlodarska-Kowalczuk, Maria; Jankowska, Emilia; Kotwicki, Lech; Balazy, Piotr] Polish Acad Sci, Inst Oceanol, Dept Marine Ecol, Sopot, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Wlodarska-Kowalczuk, M (corresponding author), Polish Acad Sci, Inst Oceanol, Dept Marine Ecol, Sopot, Poland.	maria@iopan.gda.pl	Kotwicki, Lech/S-9275-2017; Kotwicki, Lech/CAH-0296-2022; Balazy, Piotr/D-2949-2018	Kotwicki, Lech/0000-0001-5876-5696; Kotwicki, Lech/0000-0001-5876-5696; Balazy, Piotr/0000-0002-1126-3151	European Regional Development Fund [POIS.05.01.00-00-205/09-00]; European Community [266445]; Institute ofOceanology Polish Academy of Sciences	European Regional Development Fund(European Commission); European Community(European Commission); Institute ofOceanology Polish Academy of Sciences	The research leading to these results has received funding from the European Regional Development Fund ("ZOSTERA. Restitution of key elements of the inner Puck Bay ecosystem.", no. POIS.05.01.00-00-205/09-00) and European Community's Seventh Framework Programme (FP7/2007-2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). MWK and LK were supported by the Institute ofOceanology Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arroyo MDC, 2006, MAR ECOL-EVOL PERSP, V27, P417, DOI 10.1111/j.1439-0485.2006.00117.x; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Berkenbusch K, 2000, MAR ECOL PROG SER, V192, P249, DOI 10.3354/meps192249; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Bostrom C, 1999, OECOLOGIA, V120, P162, DOI 10.1007/s004420050845; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bostrom C, 2010, J EXP MAR BIOL ECOL, V390, P106, DOI 10.1016/j.jembe.2010.05.008; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P3, DOI 10.1007/s10152-008-0133-8; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; Brearley A., 2000, BIOL MAR MEDIT, V7, P199; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dalsgaard T, 2000, PROTOCOL HDB NICE NI; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; DUARTE CM, 1989, MAR ECOL PROG SER, V51, P269, DOI 10.3354/meps051269; Folk R.L., 1957, J SEDIMENT RES, V27, P3, DOI [10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D, 10.1306/74d70646-2b21-11d7-8648000102c1865]; Fortino K, 2006, HYDROBIOLOGIA, V559, P463, DOI 10.1007/s10750-005-5325-5; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Fredriksen S, 2010, MAR BIOL RES, V6, P189, DOI 10.1080/17451000903042461; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; Gambi MC, 1998, SCI MAR, V62, P1; Gartner A, 2013, J EXP MAR BIOL ECOL, V439, P143, DOI 10.1016/j.jembe.2012.11.009; Gic-Grusza G., 2009, ATLAS POLISH MARINE; GORE RH, 1981, ESTUAR COAST SHELF S, V12, P485, DOI 10.1016/S0302-3524(81)80007-2; Guidetti P, 2002, MAR ECOL-P S Z N I, V23, P51, DOI 10.1046/j.1439-0485.2002.02722.x; Harley CDG, 2011, OECOLOGIA, V166, P531, DOI 10.1007/s00442-010-1864-1; Hasegawa N, 2008, HYDROBIOLOGIA, V596, P387, DOI 10.1007/s10750-007-9111-4; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Herkul K, 2009, MAR ECOL-EVOL PERSP, V30, P74, DOI 10.1111/j.1439-0485.2009.00307.x; Jankowska E, 2014, ESTUAR COAST SHELF S, V139, P159, DOI 10.1016/j.ecss.2014.01.003; Jephson T, 2008, MAR ECOL PROG SER, V369, P63, DOI 10.3354/meps07646; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KITTING CL, 1984, OECOLOGIA, V62, P145, DOI 10.1007/BF00379006; Kruk-Dowgiallo L., 1998, OCEANOLOGICAL STUDIE, V27, P105; Leidenberger S, 2012, J CRUSTACEAN BIOL, V32, P359, DOI 10.1163/193724012X626485; Nowacki J., 1993, PUCK BAY, P71; Pranovi F, 2000, SCI MAR, V64, P303, DOI 10.3989/scimar.2000.64n3303; REUSCH TBH, 1995, J EXP MAR BIOL ECOL, V192, P257, DOI 10.1016/0022-0981(95)00074-2; REUSCH TBH, 1994, MAR ECOL PROG SER, V108, P265, DOI 10.3354/meps108265; Rueda JL, 2003, ESTUAR COAST SHELF S, V57, P909, DOI 10.1016/S0272-7714(02)00421-3; Rueda JL, 2008, ESTUAR COAST SHELF S, V79, P157, DOI 10.1016/j.ecss.2008.03.018; Sirota L, 2006, MAR ECOL PROG SER, V326, P115, DOI 10.3354/meps326115; STONER AW, 1985, J EXP MAR BIOL ECOL, V94, P19, DOI 10.1016/0022-0981(85)90048-6; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Urra J, 2013, ESTUAR COAST SHELF S, V117, P136, DOI 10.1016/j.ecss.2012.11.005; van Katwijk MM, 2010, BIOL CONSERV, V143, P248, DOI 10.1016/j.biocon.2009.08.014; VANLENT F, 1994, AQUAT BOT, V48, P31, DOI 10.1016/0304-3770(94)90072-8; Vonk JA, 2010, MAR BIOL RES, V6, P282, DOI 10.1080/17451000903233789; Webster PJ, 1998, ESTUAR COAST SHELF S, V47, P351, DOI 10.1006/ecss.1998.0358	53	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100788	10.1371/journal.pone.0100788	http://dx.doi.org/10.1371/journal.pone.0100788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000560	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300015
J	Yeh, ML; Huang, CF; Huang, CI; Liu, SF; Yang, HL; Hsieh, MY; Huang, JF; Dai, CY; Chuang, WL; Yu, ML				Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Liu, Shu-Fen; Yang, Hua-Ling; Hsieh, Ming-Yen; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung			Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy	PLOS ONE			English	Article							VIRUS-INFECTION; NATURAL-HISTORY; PCR ASSAY; DNA; LAMIVUDINE; QUANTIFICATION; MANAGEMENT; UPDATE; CORE	Background: Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little information whether there is detection difference in drug resistant mutations between different viral load assays of HBV. Objectives: This study is aimed to investigate whether there is drug-resistant strains related detection difference between Abbott RealTime HBV (RealTime) and CobasAmpliPrep/CobasTaqMan HBV assays 2.0 (TaqMan). Study Design: One hundred and thirty-four CHB patients who received HBV anti-viral therapy were enrolled. HBV virological markers were tested 3 months apart regularly. Serum HBV DNA levels were determined using the TaqMan and RealTime. YMDD (rt180M and rt204V) mutation was checked in patients who experienced virologic breakthrough (VBT). Results: The correlation of HBV DNA observed between the RealTime and TaqMan was good for all 571 samples (R-2 = 0.797; P<0.001). However, the correlation in the 434 samples with HBV DNA level <3 log(10) IU/ml was not as good as in all samples (R-2 = 0.457). Overall, 21.5% of samples had a detection difference of >= 1 log(10) IU/ml with 91.9% of these having HBV DNA level < 3 log(10) IU/ml. Twenty-four patients experiencedVBT. Three of these patients had acquired the YMDD mutation and exhibited discordant viral load results between the two methods tested. In each case, persistent HBV DNA was detected by RealTime and undetectable with TaqMan. Of the patients who experienced a VBT and had acquired YMDD mutation, 4.7% had undetectable HBV DNA by TaqMan while all were detectable with RealTime. Conclusions: RealTime assay is more sensitive and is little impacted by the development of drug resistant mutation.	[Yeh, Ming-Lun; Huang, Chung-Feng; Liu, Shu-Fen; Yang, Hua-Ling; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-I; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Yang, Hua-Ling; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Huang, Chung-Feng; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Yu, ML (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan.	fish6069@gmail.com	Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051				Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Dai CY, 2013, J ANTIMICROB CHEMOTH, V68, P2332, DOI 10.1093/jac/dkt193; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Garbuglia AR, 2007, J VIROL METHODS, V146, P274, DOI 10.1016/j.jviromet.2007.07.005; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Gray AH, 1997, J VIRAL HEPATITIS, V4, P371, DOI 10.1046/j.1365-2893.1997.00075.x; Lampertico P, 2005, HEPATOLOGY, V42, P1414, DOI 10.1002/hep.20939; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lindh M, 2006, J CLIN MICROBIOL, V44, P2587, DOI 10.1128/JCM.00265-06; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Morris CJ, 2013, J VIROL METHODS, V193, P391, DOI 10.1016/j.jviromet.2013.06.036; Ntziora F, 2009, J CLIN MICROBIOL, V47, P2544, DOI 10.1128/JCM.00045-09; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Paraskevis D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-57; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Yeh ML, 2014, J CLIN VIROL; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956	24	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101790	10.1371/journal.pone.0101790	http://dx.doi.org/10.1371/journal.pone.0101790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000502	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300086
J	Zhang, SL; Zeng, J; Zhang, CB; Li, YL; Zhao, HJ; Cheng, F; Yu, SL; Wang, M; Chen, WX				Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Li, Yilong; Zhao, Haijian; Cheng, Fei; Yu, Songlin; Wang, Mo; Chen, Wenxiang			Commutability of Possible External Quality Assessment Materials for Cardiac Troponin Measurement	PLOS ONE			English	Article							CANDIDATE REFERENCE MATERIALS; I MEASUREMENTS; STANDARDIZATION; HARMONIZATION; ASSAYS; IMMUNOASSAY; MATTERS	Background: The measurement of cardiac troponin is crucial in the diagnosis of myocardial infarction. The performance of troponin measurement is most conveniently monitored by external quality assessment (EQA) programs. The commutability of EQA samples is often unknown and the effectiveness of EQA programs is limited. Methods: Commutability of possible EQA materials was evaluated. Commercial control materials used in an EQA program, human serum pools prepared from patient samples, purified analyte preparations, swine sera from model animals and a set of patient samples were measured for cTnI with 4 assays including Abbott Architect, Beckman Access, Ortho Vitros and Siemens Centaur. The measurement results were logarithm-transformed, and the transformed data for patient samples were pairwise analyzed with Deming regression and 95% prediction intervals were calculated for each pair of assays. The commutability of the materials was evaluated by comparing the logarithmic results of the materials with the limits of the intervals. Matrix-related biases were estimated for noncommutable materials. The impact of matrix-related bias on EQA was analyzed and a possible correction for the bias was proposed. Results: Human serum pools were commutable for all assays; purified analyte preparations were commutable for 2 of the 6 assay pairs; commercial control materials and swine sera were all noncommutable; swine sera showed no reactivity to Vitros assay. The matrix-related biases for noncommutable materials ranged from -83% to 944%. Matrix-related biases of the EQA materials caused major abnormal between-assay variations in the EQA program and correction of the biases normalized the variations. Conclusion: Commutability of materials has major impact on the effectiveness of EQA programs for cTnI measurement. Human serum pools prepared from patient samples are commutable and other materials are mostly noncommutable. EQA programs should include at least one human serum pool to allow proper interpretation of EQA results.	[Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Zhao, Haijian; Cheng, Fei; Wang, Mo; Chen, Wenxiang] Beijing Hosp, Beijing, Peoples R China; [Zhang, Shunli; Zeng, Jie; Zhang, Chuanbao; Zhao, Haijian; Cheng, Fei; Wang, Mo; Chen, Wenxiang] Minist Hlth, Natl Ctr Clin Labs, Beijing, Peoples R China; [Zhang, Shunli; Cheng, Fei; Wang, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Shunli; Cheng, Fei; Wang, Mo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Yilong] Minist Hlth, Beijing Hosp, Dept Lab Med, Beijing, Peoples R China; [Yu, Songlin] Beijing Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, WX (corresponding author), Beijing Hosp, Beijing, Peoples R China.	wchen@bjhmoh.cn			National High Technology Research and Development Program of China (863 Program) [2011AA02A102, 2011AA02A116]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by research grants from the National High Technology Research and Development Program of China (863 Program) (No. 2011AA02A102 and No. 2011AA02A116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Apple FS, 2008, CLIN CHEM, V54, P1982, DOI 10.1373/clinchem.2007.097568; Bunk DM, 2006, CLIN CHEM, V52, P212, DOI 10.1373/clinchem.2005.051359; Candas-Estebanez B, 2012, CLIN CHEM LAB MED, V50, P2237, DOI 10.1515/cclm-2011-0738; Christenson RH, 2001, CLIN CHEM, V47, P431; Christenson RH, 2006, CLIN CHEM, V52, P1685, DOI 10.1373/clinchem.2006.068437; CLSI, 1999, G37A CLSI; CLSI, 2010, G53A CLSI; He HJ, 2011, CLIN CHIM ACTA, V412, P107, DOI 10.1016/j.cca.2010.09.017; HyTest Ltd, 2014, MARK CARD DIS MET SY; Miller WG, 2013, CLIN CHEM, V59, P1291, DOI 10.1373/clinchem.2013.208785; Miller WG, 2011, CLIN CHEM, V57, P1670, DOI 10.1373/clinchem.2011.168641; Miller WG, 2011, CLIN CHEM, V57, P1108, DOI 10.1373/clinchem.2011.164012; Miller WG, 2006, CLIN CHEM, V52, P553, DOI 10.1373/clinchem.2005.063511; Noble JE, 2010, CLIN CHEM LAB MED, V48, P1603, DOI 10.1515/CCLM.2010.316; O'Brien PJ, 1997, CLIN CHEM, V43, P2333; Panteghini M, 2008, CLIN CHEM LAB MED, V46, P1501, DOI 10.1515/CCLM.2008.291; Tate JR, 2014, CLIN CHIM ACTA, V432, P4, DOI 10.1016/j.cca.2013.08.021; Tate JR, 2010, PATHOLOGY, V42, P402, DOI 10.3109/00313025.2010.495246; Tate JR, 2002, CLIN CHIM ACTA, V324, P13, DOI 10.1016/S0009-8981(02)00214-0; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	21	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102046	10.1371/journal.pone.0102046	http://dx.doi.org/10.1371/journal.pone.0102046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000586	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300119
J	Zhao, W; Wang, RJ; Zhang, WZ; Liu, AQ; Cao, JP; Shen, YJ; Yang, FK; Zhang, LX				Zhao, Wei; Wang, Rongjun; Zhang, Weizhe; Liu, Aiqin; Cao, Jianping; Shen, Yujuan; Yang, Fengkun; Zhang, Longxian			MLST Subtypes and Population Genetic Structure of Cryptosporidium andersoni from Dairy Cattle and Beef Cattle in Northeastern China's Heilongjiang Province	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PREVALENCE; IDENTIFICATION; EPIDEMIOLOGY; GENOTYPES; CHILDREN; GIARDIA; HUMANS; PARVUM; WATER	Cattle are the main reservoir host of C. andersoni, which shows a predominance in yearlings and adults of cattle. To understand the subtypes of C. andersoni and the population genetic structure in Heilongjiang Province, fecal specimens were collected from 420 dairy cattle and 405 beef cattle at the age of 12-14 months in eight cattle farms in five areas within this province and were screened for the presence of Cryptosporidium oocysts by microscopy after Sheather's sugar flotation technique. The average prevalence of Cryptosporidium spp. was 19.15% (158/825) and all the Cryptosporidium isolates were identified as C. andersoni by the SSU rRNA gene nested PCR-RFLP using SspI, VspI and MboII restriction enzymes. A total of 50 C. andersoni isolates were randomly selected and sequenced to confirm the RFLP results before they were subtyped by multilocus sequence typing (MLST) at the four microsatellite/minisatellite loci (MS1, MS2, MS3 and MS16). Four, one, two and one haplotypes were obtained at the four loci, respectively. The MLST subtype A4, A4, A4, A1 showed an absolute predominance and a wide distribution among the six MLST subtypes obtained in the investigated areas. Linkage disequilibrium analysis showed the presence of a clonal population genetic structure of C. andersoni in cattle, suggesting the absence of recombination among lineages. The finding of a clonal population genetic structure indicated that the prevalence of C. andersoni in cattle in Heilongjiang Province is not attributed to the introduction of cattle. Thus, prevention and control strategies should be focused on making stricter measures to avoid the occurrence of cross-transmission and reinfection between cattle individuals. These molecular data will also be helpful to explore the source attribution of infection/contamination of C. andersoni and to elucidate its transmission dynamics in Heilongjiang Province, even in China.	[Zhao, Wei; Zhang, Weizhe; Liu, Aiqin; Yang, Fengkun] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Cao, Jianping; Shen, Yujuan] WHO Collaborating Ctr Malaria Schistosomiasis & F, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol, Natl Inst Parasit Dis,Minist Hlth, Shanghai, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Liu, AQ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; zhanglx8999@gmail.com	Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Cao, Jianping/AFL-5468-2022	Zhang, Longxian/0000-0002-5706-131X; Cao, Jianping/0000-0002-1974-0047	National Natural Science Foundation of China [31110103901]; National S & T Major Program for Infectious Disease of China [2012ZX10004-201, 2009ZX10004-201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program for Infectious Disease of China	The study was supported partially by the National Natural Science Foundation of China (No. 31110103901) (Longxian Zhang) and the National S & T Major Program for Infectious Disease of China Nos. 2012ZX10004-201 and 2009ZX10004-201 (Jianping Cao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Elwin K, 2012, INT J PARASITOL, V42, P675, DOI 10.1016/j.ijpara.2012.04.016; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Goldstein ST, 1996, ANN INTERN MED, V124, P459, DOI 10.7326/0003-4819-124-5-199603010-00001; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Liu AQ, 2011, PARASITOL RES, V109, P913, DOI 10.1007/s00436-011-2333-4; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Liu H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-25; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Mor SM, 2009, CLIN INFECT DIS, V48, P698, DOI 10.1086/597033; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Nahrevanian H, 2008, J MICROBIOL IMMUNOL, V41, P74; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Quilez J, 2011, APPL ENVIRON MICROB, V77, P7779, DOI 10.1128/AEM.00751-11; Robinson G, 2012, EXP PARASITOL, V132, P200, DOI 10.1016/j.exppara.2012.06.016; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Sodqi M, 2012, PRESSE MED, V41, P386; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043782; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2014, VET PARASITOL, V200, P50, DOI 10.1016/j.vetpar.2013.11.014; Zhang WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054857; Zhao GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060112	36	25	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102006	10.1371/journal.pone.0102006	http://dx.doi.org/10.1371/journal.pone.0102006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999982	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300114
J	Chami, B; Yeung, AWS; van Vreden, C; King, NJC; Bao, SS				Chami, Belal; Yeung, Amanda W. S.; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan			The Role of CXCR3 in DSS-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; CHEMOKINE RECEPTOR EXPRESSION; COLONY-STIMULATING FACTOR; IFN-GAMMA; TH17 CELLS; NKT CELLS; T-CELLS; PATHOGENESIS; BLOCKADE	Inflammatory bowel disease (IBD) is a group of disorders that are characterized by chronic, uncontrolled inflammation in the intestinal mucosa. Although the aetiopathogenesis is poorly understood, it is widely believed that IBD stems from a dysregulated immune response towards otherwise harmless commensal bacteria. Chemokines induce and enhance inflammation through their involvement in cellular trafficking. Reducing or limiting the influx of these proinflammatory cells has previously been demonstrated to attenuate inflammation. CXCR3, a chemokine receptor in the CXC family that binds to CXCL9, CXCL10 and CXCL11, is strongly overexpressed in the intestinal mucosa of IBD patients. We hypothesised that CXCR3 KO mice would have impaired cellular trafficking, thereby reducing the inflammatory insult by proinflammatory cell and attenuating the course of colitis. To investigate the role of CXCR3 in the progression of colitis, the development of dextran sulfate sodium (DSS)-induced colitis was investigated in CXCR3(-/-) mice over 9 days. This study demonstrated attenuated DSS-induced colitis in CXCR3(-/-) mice at both the macroscopic and microscopic level. Reduced colitis correlated with lower recruitment of neutrophils (p=0.0018), as well as decreased production of IL-6 (p<0.0001), TNF (p=0.0038), and IFN-gamma (p=0.0478). Overall, our results suggest that CXCR3 plays an important role in recruiting proinflammatory cells to the colon during colitis and that CXCR3 may be a therapeutic target to reduce the influx of proinflammatory cells in the inflamed colon.	[Chami, Belal; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia; [Chami, Belal; van Vreden, Caryn; King, Nicholas J. C.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia; [Yeung, Amanda W. S.] Univ New S Wales, Lowy Canc Res Ctr, Ctr Vasc Res, Sydney, NSW, Australia; [King, Nicholas J. C.] Univ Sydney, Sydney Med Sch, Sydney Inst Emerging Infect Dis & Biosecur SEIB, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney	Bao, SS (corresponding author), Univ Sydney, Sydney Med Sch, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia.	bob.bao@sydney.edu.au	Bao, Shisan/AAF-6464-2020; Bao, Shisan/C-6072-2014; King, Nicholas Jonathan Cole/C-4138-2011	Bao, Shisan/0000-0002-6687-3846; King, Nicholas Jonathan Cole/0000-0002-3877-9772; van Vreden, Caryn/0000-0003-4151-3470	Ramaciotti Foundation; Australian Postgraduate Award; University of Sydney International Scholarship; National Research Foundation Free-Standing Doctoral Scholarship	Ramaciotti Foundation; Australian Postgraduate Award(Australian Government); University of Sydney International Scholarship(University of Sydney); National Research Foundation Free-Standing Doctoral Scholarship	This work was supported by the Ramaciotti Foundation. A.W.S.Y. was the recipient of an Australian Postgraduate Award. C.V. is the recipient of the University of Sydney International Scholarship and a National Research Foundation Free-Standing Doctoral Scholarship for Study Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2006, ONCOL REP, V16, P1357; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Boxer Laurence A, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE17, DOI 10.1097/01.mpg.0000313830.01466.21; Chen SC, 2010, ARCH DERMATOL RES, V302, P113, DOI 10.1007/s00403-009-0966-2; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Cohen SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003706; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Danese S, 2006, Eur Rev Med Pharmacol Sci, V10, P3; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; Friswell M, 2010, GUT LIVER, V4, P295, DOI 10.5009/gnl.2010.4.3.295; Goldberg SH, 2001, NEUROPATH APPL NEURO, V27, P127, DOI 10.1046/j.1365-2990.2001.00312.x; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Gunnarsson C, 2012, DIGEST DIS SCI, V57, P3080, DOI 10.1007/s10620-012-2289-y; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Heaton PC, 2012, J PEDIATR GASTR NUTR, V54, P477, DOI 10.1097/MPG.0b013e318239bc79; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kim HS, 2013, MUCOSAL IMMUNOL, V6, P347, DOI 10.1038/mi.2012.77; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lalor SJ, 2013, EUR J IMMUNOL, V43, P2866, DOI 10.1002/eji.201343499; Lazebnik L B, 2011, Eksp Klin Gastroenterol, P3; Lee IA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-7; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Martinez Gomez JM, 2014, PLOS ONE, V9; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nanki T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2823; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Papadakis KA, 2004, CURR ALLERGY ASTHM R, V4, P83, DOI 10.1007/s11882-004-0048-7; PARK CM, 1987, J MICROSC-OXFORD, V145, P115, DOI 10.1111/j.1365-2818.1987.tb01321.x; Park KT, 2011, INFLAMM BOWEL DIS, V17, P1603, DOI 10.1002/ibd.21488; Pedersen J, 2014, WORLD J GASTROENTERO, V20, P64, DOI 10.3748/wjg.v20.i1.64; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; Rose WA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-41; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; STEINBECK MJ, 1986, CELL IMMUNOL, V98, P137, DOI 10.1016/0008-8749(86)90274-1; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Xu YH, 2008, J NEUROIMMUNOL, V200, P53, DOI 10.1016/j.jneuroim.2008.06.008; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yellin M, 2012, ARTHRITIS RHEUM-US, V64, P1730, DOI 10.1002/art.34330; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Yuan YH, 2001, INFLAMM BOWEL DIS, V7, P281, DOI 10.1097/00054725-200111000-00001	53	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101622	10.1371/journal.pone.0101622	http://dx.doi.org/10.1371/journal.pone.0101622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992040	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400099
J	Edgar, R; Drolet, D; Ehrman, JM; Kaczmarska, I				Edgar, Robyn; Drolet, David; Ehrman, James M.; Kaczmarska, Irena			Motile Male Gametes of the Araphid Diatom Tabularia fasciculata Search Randomly for Mates	PLOS ONE			English	Article							SEXUAL REPRODUCTION; SWIMMING BEHAVIOR; LEVY WALKS; PATTERNS; BACILLARIOPHYTA; MOVEMENT; MODELS	Sexuality in the marine araphid diatom Tabularia involves an unusual type of gamete, not only among diatoms but possibly in all of nature. The non-flagellated male gamete is free and vigorously motile, propelled by pseudopodia. However, the cues (if any) in their search for compatible female gametes and the general search patterns to locate them are unknown. We tracked and compared male gamete movements in the presence and absence of receptive female gametes. Path linearity of male movement was not affected by presence of female gametes. Male gametes did not move towards female gametes regardless of their proximity to each other, suggesting that the detection range for a compatible mate is very small compared to known algal examples (mostly spermatozoids) and that mate recognition requires (near) contact with a female gamete. We therefore investigated how male gametes move to bring insight into their search strategy and found that it was consistent with the predictions of a random-walk model with changes in direction coming from an even distribution. We further investigated the type of random walk by determining the best-fit distribution on the tail of the move length distribution and found it to be consistent with a truncated power law distribution with an exponent of 2.34. Although consistent with a Levy walk search pattern, the range of move lengths in the tail was too narrow for Levy properties to emerge and so would be best described as Brownian motion. This is somewhat surprising because female gametes were often outnumbered by male gametes, thus contrary to the assumption that a Brownian search mode may be most optimal with an abundant target resource. This is also the first mathematically analysed search pattern of a non-flagellated protistan gamete, supporting the notion that principles of Brownian motion have wide application in biology.	[Edgar, Robyn] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Drolet, David] Univ Prince Edward Isl, Atlant Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Ehrman, James M.] Mt Allison Univ, Digital Microscopy Facil, Sackville, NB E0A 3C0, Canada; [Edgar, Robyn; Drolet, David; Kaczmarska, Irena] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada	Laval University; University of Prince Edward Island; Mount Allison University; Mount Allison University	Kaczmarska, I (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	iehrman@mta.ca			NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery Grant to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler C.D., 2008, ALGAL CHEM ECOLOGY; Ashworth MP, 2012, PHYCOLOGIA, V51, P684, DOI 10.2216/12-004.1; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Berg H. C., 1983, RANDOM WALKS BIOL; Boakes DE, 2011, J PLANKTON RES, V33, P641, DOI 10.1093/plankt/fbq136; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; COOKSEY B, 1988, J CELL SCI, V91, P523; Davidovich N. A., 2001, P 16 INT DIAT S, P191; Davidovich NA, 2012, PROTIST, V163, P480, DOI 10.1016/j.protis.2011.09.002; Davidovich NA, 2010, FOTTEA, V10, P251, DOI 10.5507/fot.2010.016; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Drebes G., 1977, BOTANICAL MONOGRAPHS, P250; Edwards AM, 2012, PLOS ONE, V7; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fenchel T, 2004, EUR J PROTISTOL, V40, P49, DOI 10.1016/j.ejop.2003.09.001; Garcia M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.035301; Gillard J., 2012, ANGEW CHEM INT EDIT, V51, P1; Govorunova EG, 2005, BIOCHEMISTRY-MOSCOW+, V70, P717, DOI 10.1007/s10541-005-0176-2; Hiltz M, 2000, PHYCOLOGIA, V39, P59, DOI 10.2216/i0031-8884-39-1-59.1; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; James A, 2011, J R SOC INTERFACE, V8, P1233, DOI 10.1098/rsif.2011.0200; Kaczmarska I, 1997, MAR BIOL, V128, P695, DOI 10.1007/s002270050137; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Kaczmarska I, 2009, PHYCOLOGIA, V48, P391, DOI 10.2216/08-74.1; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; LEVANDOWSKY M, 1988, B MAR SCI, V43, P758; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; MacGillivary ML, 2011, THESIS MOUNT ALLISON; MAIER I, 1986, BIOL BULL, V170, P145, DOI 10.2307/1541801; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Mather LA, 2013, THESIS MOUNT ALLISON; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; Medlin LK, 2008, J PHYCOL, V44, P1340, DOI 10.1111/j.1529-8817.2008.00560.x; PODUNAY Y.A., 2014, ALGOLOGIA, V24, P3, DOI DOI 10.15407/ALG24.01.003; Reynold CS, 1984, ECOLOGY FRESHWATER P; Sato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026923; Turchin Peter, 1998; Vandromme P, 2010, ZOOL STUD, V49, P289; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zar JH., 2010, BIOSTAT ANAL	43	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101767	10.1371/journal.pone.0101767	http://dx.doi.org/10.1371/journal.pone.0101767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991803	gold, Green Published			2022-12-25	WOS:000341253400113
J	Kronen, MR; Schoenfelder, KP; Klein, AM; Nystul, TG				Kronen, Maria R.; Schoenfelder, Kevin P.; Klein, Allon M.; Nystul, Todd G.			Basolateral Junction Proteins Regulate Competition for the Follicle Stem Cell Niche in the Drosophila Ovary	PLOS ONE			English	Article							SELF-RENEWAL; ADULT TISSUES; PROLIFERATION; OOGENESIS; INVASION; REPLACEMENT; INHIBITION; EFFICIENT; POLARITY; MODELS	Epithelial stem cells are routinely lost or damaged during adult life and must therefore be replaced to maintain homeostasis. Recent studies indicate that stem cell replacement occurs through neutral competition in many types of epithelial tissues, but little is known about the factors that determine competitive outcome. The epithelial follicle stem cells (FSCs) in the Drosophila ovary are regularly lost and replaced during normal homeostasis, and we show that FSC replacement conforms to a model of neutral competition. In addition, we found that FSCs mutant for the basolateral junction genes, lethal giant larvae (lgl) or discs large (dlg), undergo a biased competition for niche occupancy characterized by increased invasion of neighboring FSCs and reduced loss. Interestingly, FSCs mutant for a third basolateral junction gene, scribble (scrib), do not exhibit biased competition, suggesting that Lgl and Dlg regulate niche competition through a Scrib-independent process. Lastly, we found that FSCs have a unique cell polarity characterized by broadly distributed adherens junctions and the lack of a mature apical domain. Collectively, these observations indicate that Lgl and Dlg promote the differentiation of FSC progeny to a state in which they are less prone to invade the neighboring niche. In addition, we demonstrate that the neutral drift model can be adapted to quantify non-neutral behavior of mutant clones.	[Kronen, Maria R.; Schoenfelder, Kevin P.; Nystul, Todd G.] Univ Calif San Francisco, Ctr Reprod Sci, Dept Anat, San Francisco, CA 94143 USA; [Kronen, Maria R.; Schoenfelder, Kevin P.; Nystul, Todd G.] Univ Calif San Francisco, Ctr Reprod Sci, Dept OB GYN RS, San Francisco, CA 94143 USA; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02163 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Klein, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02163 USA.	allon_klein@hms.harvard.edu; todd.nystul@ucsf.edu	Nystul, Todd/AAA-7344-2022	Nystul, Todd/0000-0002-6250-2394	National Institute of General Medical Sciences [R01GM097158]; Program for Breakthrough Biomedical Research; Sandler Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097158] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Program for Breakthrough Biomedical Research; Sandler Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences, Award Number R01GM097158, and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. A.M.K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chang YC, 2013, P NATL ACAD SCI USA, V110, pE1734, DOI 10.1073/pnas.1300725110; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; de Navascues J, 2012, EMBO J, V31, P2473, DOI 10.1038/emboj.2012.106; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Ferraro F, 2010, ADV EXP MED BIOL, V695, P155, DOI 10.1007/978-1-4419-7037-4_11; Franz A, 2010, DEV BIOL, V338, P136, DOI 10.1016/j.ydbio.2009.11.027; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hartman TR, 2010, J CELL BIOL, V191, P943, DOI 10.1083/jcb.201007142; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Liu YI, 2008, DEV BIOL, V323, P41, DOI 10.1016/j.ydbio.2008.08.011; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Rhiner C, 2009, DEVELOPMENT, V136, P995, DOI 10.1242/dev.033340; Roegiers F, 2009, GENETICS, V182, P407, DOI 10.1534/genetics.109.101808; Sahai-Hernandez P, 2013, DEVELOPMENT, V140, P4490, DOI 10.1242/dev.098558; Sahai-Hernandez P, 2012, WIRES DEV BIOL, V1, P447, DOI 10.1002/wdev.36; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Szafranski P, 2007, DEV DYNAM, V236, P364, DOI 10.1002/dvdy.21020; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Wang ZA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1765; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 2008, COLD SH Q B, V73, P39, DOI 10.1101/sqb.2008.73.014; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; XU T, 1993, DEVELOPMENT, V117, P1223; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhao M, 2008, GENETICS, V178, P1947, DOI 10.1534/genetics.108.086983	40	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101085	10.1371/journal.pone.0101085	http://dx.doi.org/10.1371/journal.pone.0101085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991805	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400041
J	Dong, CT; Huang, ZJ; Martin, MC; Huang, J; Liu, HL; Deng, B; Lai, WH; Liu, L; Yang, YH; Hu, Y; Qin, GM; Zhang, LL; Song, ZB; Wei, DY; Nan, L; Wang, QX; Deng, HX; Zhang, JX; Wong, FY; Yang, W				Dong, Caiting; Huang, Z. Jennifer; Martin, Maria C.; Huang, Jun; Liu, Honglu; Deng, Bin; Lai, Wenhong; Liu, Li; Yang, Yihui; Hu, Ying; Qin, Guangming; Zhang, Linglin; Song, Zhibin; Wei, Daying; Nan, Lei; Wang, Qixing; Deng, Hongxia; Zhang, Jianxun; Wong, Frank Y.; Yang, Wen			The Impact of Social Factors on Human Immunodeficiency Virus and Hepatitis C Virus Co-Infection in a Minority Region of Si-Chuan, the People's Republic of China: A Population-Based Survey and Testing Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; SICHUAN PROVINCE; SOUTHERN CHINA; HIV; HCV; PREVALENCE; EPIDEMIOLOGY; TRANSMISSION	Background: While many human immunodeficiency virus (HIV) studies have been performed in Liangshan, most were focused only on HIV infection and based on a sampling survey. In order to fully understand HIV and hepatitis C virus (HCV) prevalence and related risk factors in this region, this study implemented in 2009, included a survey, physical examination, HIV and HCV test in two towns. Methods: All residents in two towns of the Butuo county were provided a physical examination and blood tests for HIV and HCV, and then followed by an interview for questionnaire. Results: In total, 10,104 residents (92.4%) were enrolled and 9,179 blood samples were collected for HIV and HCV testing, 6,072 were from individuals >14 years old. The rates of HIV, HCV, and HIV/HCV co-infection were 11.4%, 14.0%, and 7.7%, respectively for >14-year-old residents. The 25-34 yr age group had the highest prevalence of HIV, HCV, and HIV/HCV co-infections, reaching 24.4%, 26.2% and 16.0%, respectively. Overall, males had a much higher prevalence of all infections than females (HIV: 16.3% vs. 6.8%, HCV: 24.6% vs. 3.9%, HIV/HCV co-infected: 14.7% vs. 1.1%, respectively; P = 0.000). Approximately half of intravenous drug users tested positive for HIV (48.7%) and 68.4% tested positive for HCV. Logistic regression analysis showed that five factors were significantly associated with HIV and HCV infection: gender (odds ratio [OR] = 5.8), education (OR = 2.29); occupation (student as reference; farmer: OR = 5.02, migrant worker: OR = 6.12); drug abuse (OR = 18.0); and multiple sexual partners (OR = 2.92). Knowledge of HIV was not associated with infection. Conclusion: HIV and HCV prevalence in the Liangshan region is very serious and drug use, multiple sexual partners, and low education levels were the three main risk factors. The government should focus on improving education and personal health awareness while enhancing drug control programs.	[Dong, Caiting; Huang, Jun; Liu, Honglu; Deng, Bin; Lai, Wenhong; Liu, Li; Yang, Yihui; Hu, Ying; Qin, Guangming; Zhang, Linglin; Yang, Wen] Si Chuan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Chengdu, Peoples R China; [Huang, Z. Jennifer] Georgetown Univ, Dept Int Hlth, Washington, DC USA; [Martin, Maria C.] Univ Calif San Francisco, Dept Pediat Adolescent & Young Adult Med, San Francisco, CA 94143 USA; [Song, Zhibin] Liangshan Prefecture Hlth Bur, Dept HIV Control & Prevent, Xichang, Si Chuan, Peoples R China; [Wei, Daying; Nan, Lei; Wang, Qixing] Lianshan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Xichang, Si Chuan, Peoples R China; [Deng, Hongxia; Zhang, Jianxun] Butuo Hlth Bur, Dept HIV Control & Prevent, Butuo, Si Chuan, Peoples R China; [Wong, Frank Y.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA	Georgetown University; University of California System; University of California San Francisco; Emory University	Yang, W (corresponding author), Si Chuan Ctr Dis Control & Prevent, Dept HIV Control & Prevent, Chengdu, Peoples R China.	yangwenn@yeah.net		Wong, Frank Y./0000-0001-5835-9938	Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China" [2009ZX10004-905, 2011ZX10001-002]	Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China"	This study was supported by grants from the Mega-Project for National Science and Technology Development under the "11th and 12th, Five-Year Plan of China" (2009ZX10004-905, 2011ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bao YP, 2012, JAIDS-J ACQ IMM DEF, V60, P438, DOI 10.1097/QAI.0b013e31825694f2; Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x; Dai SY, 2012, J MED VIROL, V84, P1, DOI 10.1002/jmv.22214; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Infectious Disease Experts Call for More Focus on Hepatitis C, 2011, INFECT DIS EXPERTS C; Liangshan Center for Disease Control and Prevention, 2008, SURV REP HIV AIDS LI; Liu Jian-Bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P656; Liu S.-h., 2011, PASSAGE MANHOOD YOUT; Liu SH, 2011, MED ANTHROPOL Q, V25, P395, DOI 10.1111/j.1548-1387.2011.01168.x; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Maimaiti Rena, 2013, J Int Assoc Provid AIDS Care, V12, P58, DOI 10.1177/1545109712446176; Ministry of Health People's Republic of China Joint United Nations Programmme on HIV/ AIDS WHO, 2013, 2011 EST HIV AIDS EP; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Sichuan Center for Disease Control and Prevention, 2012, EP AN REP HIV AIDS S; Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85; SUN X, 2010, INT J EPIDEMIOL S2, V39, P4, DOI DOI 10.1093/IJE/DYQ217; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	22	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101241	10.1371/journal.pone.0101241	http://dx.doi.org/10.1371/journal.pone.0101241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988219	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100071
J	Hallgren, W; Gunturu, UB; Schlosser, A				Hallgren, Willow; Gunturu, Udaya Bhaskar; Schlosser, Adam			The Potential Wind Power Resource in Australia: A New Perspective	PLOS ONE			English	Article							GENERATED ELECTRICITY; UNITED-STATES; REGION	Australia's wind resource is considered to be very good, and the utilization of this renewable energy resource is increasing rapidly: wind power installed capacity increased by 35% from 2006 to 2011 and is predicted to account for over 12% of Australia's electricity generation in 2030. Due to this growth in the utilization of the wind resource and the increasing importance of wind power in Australia's energy mix, this study sets out to analyze and interpret the nature of Australia's wind resources using robust metrics of the abundance, variability and intermittency of wind power density, and analyzes the variation of these characteristics with current and potential wind turbine hub heights. We also assess the extent to which wind intermittency, on hourly or greater timescales, can potentially be mitigated by the aggregation of geographically dispersed wind farms, and in so doing, lessen the severe impact on wind power economic viability of long lulls in wind and power generated. Our results suggest that over much of Australia, areas that have high wind intermittency coincide with large expanses in which the aggregation of turbine output does not mitigate variability. These areas are also geographically remote, some are disconnected from the east coast's electricity grid and large population centers, which are factors that could decrease the potential economic viability of wind farms in these locations. However, on the eastern seaboard, even though the wind resource is weaker, it is less variable, much closer to large population centers, and there exists more potential to mitigate it's intermittency through aggregation. This study forms a necessary precursor to the analysis of the impact of large-scale circulations and oscillations on the wind resource at the mesoscale.	[Hallgren, Willow; Gunturu, Udaya Bhaskar; Schlosser, Adam] MIT, MIT Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hallgren, W (corresponding author), MIT, MIT Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hallgren@mit.edu			MIT Joint Program on the Science and Policy of Global Change	MIT Joint Program on the Science and Policy of Global Change	The authors gratefully acknowledge the financial support for this work provided by the MIT Joint Program on the Science and Policy of Global Change through a number of federal agencies and industrial sponsors (for the complete list, see http://globalchange.mit.edu/sponsors/current.html). The funders of the Joint Program had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005462; Archer CL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002076; Archer CL, 2007, J APPL METEOROL CLIM, V46, P1701, DOI 10.1175/2007JAMC1538.1; Blakers A, 1991, R9317 AUSTR GOV DASE; Calif R, 2014, NONLINEAR PROC GEOPH, V21, P379, DOI 10.5194/npg-21-379-2014; Calif R, 2013, PHYSICA A, V392, P4106, DOI 10.1016/j.physa.2013.04.038; CEC, 2021, CLEAN EN AUSTR REP; Chadee XT, 2014, RENEW SUST ENERG REV, V30, P45, DOI 10.1016/j.rser.2013.09.018; Clarke D, 2013, WIND FARMS S AUSTR; Clarke D, 2013, WIND FARMS NEW S WAL; Coppin P.A., 2003, WIND RESOURCE ASSESS; Davy R., 2003, S E AUSTR WIND POWER; Dear SJ, 1990, W AUSTR WIND ATLAS; Dear SJ, 1991, VICTORIAN COASTAL WI; Electricity Trust of South Australia, 1989, TECHNICAL REPORT; Elliott D., 1987, 87 NASA STI, P24819; Elliott DL, 1991, TECHNICAL REPORT, P7306; Farkas Z., 2011, ARXIV11032198; Gentilli J, 1971, WORLD SURVEY CLIMATO; Geoscience Australia ABARE, 2010, CANB AUSTR EN RES AS; Gunturu UB, 2012, ATMOS CHEM PHYS, V12, P9687, DOI 10.5194/acp-12-9687-2012; Gunturu UB, 2011, 20965 MIT; HENNESSEY JP, 1977, J APPL METEOROL, V16, P119, DOI 10.1175/1520-0450(1977)016<0119:SAOWPS>2.0.CO;2; Hurley PJ, 2001, ATMOS ENVIRON, V35, P1871, DOI 10.1016/S1352-2310(00)00486-6; International Renewable Energy Agency, 2012, IRENA CAS STUD 2013; KAHN E, 1979, ELECTR POW SYST RES, V2, P1, DOI 10.1016/0378-7796(79)90021-X; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; Mason, 2010, TELEGRAPH; McElroy MB, 2009, SCIENCE, V325, P1378, DOI 10.1126/science.1175706; Merz Sinclair Knight, 2010, EN RES 2; Mills D, 2001, THESIS U QUEENSLAND; Oswald J, 2008, ENERG POLICY, V36, P3212, DOI 10.1016/j.enpol.2008.04.033; Panofsky H. A., 1984, ATMOSPHERIC TURBULEN; PARKINSON G, 1986, ATLAS AUSTR RESOURCE, V4; Pryor SC, 2011, P NATL ACAD SCI USA, V108, P8167, DOI 10.1073/pnas.1019388108; Pryor SC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026000; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Schwartz M, 1999, 11 APPL CLIM C AM ME; Steggle N, 2002, PAR P GLOB WIND POW	39	27	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99608	10.1371/journal.pone.0099608	http://dx.doi.org/10.1371/journal.pone.0099608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988222	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100015
J	Narayanaswamy, PB; Hodjat, M; Haller, H; Dumler, I; Kiyan, Y				Narayanaswamy, Pavan B.; Hodjat, Mahshid; Haller, Hermann; Dumler, Inna; Kiyan, Yulia			Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; 26S PROTEASOME; CANCER-THERAPY; UPAR; DEGRADATION; RESISTANCE; DISEASE; SYSTEM; TARGET	DNA damage induced by numerous exogenous or endogenous factors may have irreversible consequences on the cell leading to cell cycle arrest, senescence and cell death. The DNA damage response (DDR) is powerful signaling machinery triggered in response to DNA damage, to provide DNA damage recognition, signaling and repair. Most anticancer drugs induce DNA damage, and DNA repair in turn attenuates therapeutic efficiency of those drugs. Approaches delaying DNA repair are often used to increase efficiency of treatment. Recent data show that ubiquitin-proteasome system is essential for signaling and repair of DNA damage. However, mechanisms providing regulation of proteasome intracellular localization, activity, and recruitment to DNA damage sites are elusive. Even less investigated are the roles of extranuclear signaling proteins in these processes. In this study, we report the involvement of the serine protease urokinase-type plasminogen activator receptor (uPAR) in DDR-associated regulation of proteasome. We show that in vascular smooth muscle cells (VSMC) uPAR activates DNA single strand break repair signaling pathway. We provide evidence that uPAR is essential for functional assembly of the 26S proteasome. We further demonstrate that uPAR mediates DNA damage-induced phosphorylation, nuclear import, and recruitment of the regulatory subunit PSMD6 to proteasome. We found that deficiency of uPAR and PSMD6 delays DNA repair and leads to decreased cell survival. These data may offer new therapeutic approaches for diseases such as cancer, cardiovascular and neurodegenerative disorders.	[Narayanaswamy, Pavan B.; Hodjat, Mahshid; Haller, Hermann; Dumler, Inna; Kiyan, Yulia] Hannover Med Sch, Dept Nephrol, Hannover, Germany	Hannover Medical School	Kiyan, Y (corresponding author), Hannover Med Sch, Dept Nephrol, Hannover, Germany.	kiian.ioulia@mh-hannover.de	Kiyan, Yulia/D-7284-2011	Hodjat, Mahshid/0000-0001-8335-3546; Kiyan, Yulia/0000-0002-2063-6327; Narayanaswamy, Pavan/0000-0001-5135-0527	Deutsche Forschungsgemeinschaft [KI 1376/2-1, KI 1376/2-2]; Deutsche Akademischer Austausch Dienst [A/08/98019]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/), grant numbers: KI 1376/2-1, KI 1376/2-2 and by Deutsche Akademischer Austausch Dienst (https://www.daad.de/en/), fellowship number A/08/98019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Bai J, 2012, ASIAN PAC J CANCER P, V13, P4879, DOI 10.7314/APJCP.2012.13.10.4879; Barakat K, 2012, CURR TOP MED CHEM, V12, P1376, DOI 10.2174/156802612801319070; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Dhawan A, 2001, MUTAT RES-FUND MOL M, V474, P121, DOI 10.1016/S0027-5107(00)00171-8; Espinosa E, 2003, CANCER TREAT REV, V29, P515, DOI 10.1016/S0305-7372(03)00116-6; FALLIERBECKER P, 1990, CELL CULTURE TECHNIQ, P247; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gray K, 2011, BIOCHEM PHARMACOL, V82, P693, DOI 10.1016/j.bcp.2011.06.025; Hayward R, 2013, J PHYSIOL BIOCHEM, V69, P177, DOI 10.1007/s13105-012-0200-0; Hodjat M, 2013, J VASC RES, V50, P109, DOI 10.1159/000343000; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karpov DS, 2013, FEBS LETT, V587, P3108, DOI 10.1016/j.febslet.2013.08.007; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; Lebwohl M, 2005, ANN RHEUM DIS, V64, P83, DOI 10.1136/ard.2004.030791; Lee MY, 2007, BIOCHEM BIOPH RES CO, V360, P483, DOI 10.1016/j.bbrc.2007.06.084; Malla RR, 2012, NEURO-ONCOLOGY, V14, P745, DOI 10.1093/neuonc/nos088; Moiseeva TN, 2013, ONCOTARGET, V4, P1338, DOI 10.18632/oncotarget.1060; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191; Ramadan K, 2011, FEBS LETT, V585, P2868, DOI 10.1016/j.febslet.2011.04.046; Ranek MJ, 2009, CURR HYPERTENS REP, V11, P389, DOI 10.1007/s11906-009-0068-8; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Shushakova N, 2005, J CELL SCI, V118, P2743, DOI 10.1242/jcs.02409; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tsolou A, 2012, IUBMB LIFE, V64, P432, DOI 10.1002/iub.1018; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Vallabhaneni KC, 2011, CARDIOVASC RES, V90, P113, DOI 10.1093/cvr/cvq362; Zhang FG, 2005, RAPID COMMUN MASS SP, V19, P438, DOI 10.1002/rcm.1806	35	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101529	10.1371/journal.pone.0101529	http://dx.doi.org/10.1371/journal.pone.0101529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987841	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100108
J	Olivieri, C; Marota, I; Rizzi, E; Ermini, L; Fusco, L; Pietrelli, A; De Bellis, G; Rollo, F; Luciani, S				Olivieri, Cristina; Marota, Isolina; Rizzi, Ermanno; Ermini, Luca; Fusco, Letizia; Pietrelli, Alessandro; De Bellis, Gianluca; Rollo, Franco; Luciani, Stefania			Positioning the Red Deer (Cervus elaphus) Hunted by the Tyrolean Iceman into a Mitochondrial DNA Phylogeny	PLOS ONE			English	Article							PHYLOGEOGRAPHY; COLONIZATION; POPULATIONS	In the last years several phylogeographic studies of both extant and extinct red deer populations have been conducted. Three distinct mitochondrial lineages (western, eastern and North-African/Sardinian) have been identified reflecting different glacial refugia and postglacial recolonisation processes. However, little is known about the genetics of the Alpine populations and no mitochondrial DNA sequences from Alpine archaeological specimens are available. Here we provide the first mitochondrial sequences of an Alpine Copper Age Cervus elaphus. DNA was extracted from hair shafts which were part of the remains of the clothes of the glacier mummy known as the Tyrolean Iceman or Otzi (5,350-5,100 years before present). A 2,297 base pairs long fragment was sequenced using a mixed sequencing procedure based on PCR amplifications and 454 sequencing of pooled amplification products. We analyzed the phylogenetic relationships of the Alpine Copper Age red deer's haplotype with haplotypes of modern and ancient European red deer. The phylogenetic analyses showed that the haplotype of the Alpine Copper Age red deer falls within the western European mitochondrial lineage in contrast with the current populations from the Italian Alps belonging to the eastern lineage. We also discussed the phylogenetic relationships of the Alpine Copper Age red deer with the populations from Mesola Wood (northern Italy) and Sardinia.	[Olivieri, Cristina; Marota, Isolina; Fusco, Letizia; Rollo, Franco; Luciani, Stefania] Univ Camerino, Sch Biosci & Vet Med, Lab Mol Archaeoanthropol Ancient DNA, I-62032 Camerino, Italy; [Rizzi, Ermanno; Pietrelli, Alessandro; De Bellis, Gianluca] CNR, Inst Biomed Technol, Segrate, Italy; [Ermini, Luca] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of Camerino; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Copenhagen	Luciani, S (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Lab Mol Archaeoanthropol Ancient DNA, I-62032 Camerino, Italy.	stefania.luciani@unicam.it	Ermini, Luca/O-4813-2016; rizzi, ermanno/Q-3399-2016; Pietrelli, Alessandro/J-4389-2016; De Bellis, Gianluca/H-9725-2013	Ermini, Luca/0000-0001-8109-6021; rizzi, ermanno/0000-0002-9898-2326; Pietrelli, Alessandro/0000-0003-0241-8542; Olivieri, Cristina/0000-0002-2957-5452; De Bellis, Gianluca/0000-0002-1622-4477	University of Camerino (Fondo di Ricerca di Ateneo); Italian Research Ministry grants "Futuro in ricerca" [RBFR08U07M_003, RBFR126B8I_003]	University of Camerino (Fondo di Ricerca di Ateneo); Italian Research Ministry grants "Futuro in ricerca"	This study was supported by the University of Camerino (Fondo di Ricerca di Ateneo). ER was supported by Italian Research Ministry grants "Futuro in ricerca" RBFR08U07M_003 and RBFR126B8I_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZI CM, 1974, RADIOCARBON, V16, P10, DOI 10.1017/S0033822200001405; Bagolini B, 1995, MANN EIS NEUE FUNDE, P3; Barker G., 1985, PREHISTORIC FARMING; BIETTI A, 1994, QUATERNARIA NOVA, V4, P9; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Cassoli P.F., 1995, Quaternaria Nova, V4, P101; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Groenman-van Waatering W., 1992, JB ROMISCH GERMANISC, V39, P114; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARTL GB, 1995, Z SAUGETIERKD, V60, P41; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hollemeyer K, 2012, RAPID COMMUN MASS SP, V26, P1735, DOI 10.1002/rcm.6277; Lange J, 1992, MANN EIS, V187, P419; Lorenzini R, 2005, MAMM BIOL, V70, P187, DOI 10.1016/j.mambio.2004.11.018; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; MATTIOLI S, 2001, HYSTRIX, V12, P27; Meiri M, 2013, MOL ECOL, V22, P4711, DOI 10.1111/mec.12420; Mussi M, 2001, EARLIEST ITALY OVERV, P317; Olivieri C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033792; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Rollo F, 1994, ANCIENT DNA NEWSLETT, V2, P21; Rollo F, 1995, MANN EIS, P91; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skog A, 2009, J BIOGEOGR, V36, P66, DOI 10.1111/j.1365-2699.2008.01986.x; Sommer RS, 2008, QUATERNARY SCI REV, V27, P714, DOI 10.1016/j.quascirev.2007.11.016; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zachos FE, 2009, WILDLIFE BIOL, V15, P175, DOI 10.2981/07-075	29	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100136	10.1371/journal.pone.0100136	http://dx.doi.org/10.1371/journal.pone.0100136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988290	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100024
J	Walvekar, AS; Choudhury, R; Punekar, NS				Walvekar, Adhish S.; Choudhury, Rajarshi; Punekar, Narayan S.			Mixed Disulfide Formation at Cys141 Leads to Apparent Unidirectional Attenuation of Aspergillus niger NADP-Glutamate Dehydrogenase Activity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CYSTEINE RESIDUE; AMINO-ACID; SUBSTRATE-SPECIFICITY; REACTIVE CYSTEINE; INHIBITION; IDENTIFICATION; ENZYME; 2-MERCAPTOETHANOL; DEAMIDATION	NADP-Glutamate dehydrogenase from Aspergillus niger (AnGDH) exhibits sigmoid 2-oxoglutarate saturation. Incubation with 2-hydroxyethyl disulfide (2-HED, the disulfide of 2-mercaptoethanol) resulted in preferential attenuation of AnGDH reductive amination (forward) activity but with a negligible effect on oxidative deamination (reverse) activity, when monitored in the described standard assay. Such a disulfide modified AnGDH displaying less than 1.0% forward reaction rate could be isolated after 2-HED treatment. This unique forward inhibited GDH form (FIGDH), resembling a hypothetical 'one-way' active enzyme, was characterized. Kinetics of 2-HED mediated inhibition and protein thiol titrations suggested that a single thiol group is modified in FIGDH. Two site-directed cysteine mutants, C141S and C415S, were constructed to identify the relevant thiol in FIGDH. The forward activity of C141S alone was insensitive to 2-HED, implicating Cys141 in FIGDH formation. It was observed that FIGDH displayed maximal reaction rate only after a pre-incubation with 2-oxoglutarate and NADPH. In addition, compared to the native enzyme, FIGDH showed a four fold increase in K-0.5 for 2-oxoglutarate and a two fold increase in the Michaelis constants for ammonium and NADPH. With no change in the GDH reaction equilibrium constant, the FIGDH catalyzed rate of approach to equilibrium from reductive amination side was sluggish. Altered kinetic properties of FIGDH at least partly account for the observed apparent loss of forward activity when monitored under defined assay conditions. In sum, although Cys141 is catalytically not essential, its covalent modification provides a striking example of converting the biosynthetic AnGDH into a catabolic enzyme.	[Walvekar, Adhish S.; Choudhury, Rajarshi; Punekar, Narayan S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Punekar, NS (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	nsp@iitb.ac.in	Walvekar, Adhish/AAO-1577-2021	Walvekar, Adhish/0000-0001-7344-7653	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported under a project and also research fellowships (to ASW and RC) from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES LD, 1972, BIOCHEMISTRY-US, V11, P4322, DOI 10.1021/bi00773a019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROTHERTON JE, 1980, PHYSIOL CHEM PHYS M, V12, P483; Budavari S., 1997, MERCK INDEX, Vthirteenth; Cho SW, 1999, MOL CELLS, V9, P91; Choudhury R, 2009, MYCOL RES, V113, P1121, DOI 10.1016/j.mycres.2009.07.009; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; COSSON MP, 1976, BIOCHEM BIOPH RES CO, V72, P1304, DOI 10.1016/S0006-291X(76)80157-X; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DeLuna A, 2005, BIOCHEM BIOPH RES CO, V328, P1083, DOI 10.1016/j.bbrc.2005.01.057; DONASCIMENTO KH, 1975, BIOCHEM J, V149, P349, DOI 10.1042/bj1490349; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGEL PC, 1967, BIOCHEM J, V105, P691, DOI 10.1042/bj1050691; Fincham JRS, 2000, GENET RES, V76, P1, DOI 10.1017/S0016672300004602; FRIEDEN C, 1964, J BIOL CHEM, V239, P3522; GAN ZR, 1987, ANAL BIOCHEM, V162, P265, DOI 10.1016/0003-2697(87)90036-4; HAEFFNERGORMLEY L, 1992, ARCH BIOCHEM BIOPHYS, V292, P179, DOI 10.1016/0003-9861(92)90066-6; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; JONES KM, 1993, MOL GEN GENET, V240, P286, DOI 10.1007/BF00277068; Karaca M, 2011, NEUROCHEM INT, V59, P510, DOI 10.1016/j.neuint.2011.03.024; Khan MIH, 2005, BIOSCI BIOTECH BIOCH, V69, P1802, DOI 10.1271/bbb.69.1802; KLEMME JH, 1976, ARCH MICROBIOL, V107, P189, DOI 10.1007/BF00446838; KOUNDAL KR, 1983, PHYTOCHEMISTRY, V22, P2183, DOI 10.1016/S0031-9422(00)80142-9; KREBS HA, 1977, ADV ENZYME REGUL, V15, P375, DOI 10.1016/0065-2571(77)90026-7; KURAMITS.HK, 1966, BIOCHEM BIOPH RES CO, V23, P329, DOI 10.1016/0006-291X(66)90550-X; LAL M, 1985, CAN J CHEM, V63, P30, DOI 10.1139/v85-005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LEJOHN HB, 1968, J BIOL CHEM, V243, P5126; LEUNG PSK, 1985, J PHYS CHEM-US, V89, P5267, DOI 10.1021/j100270a029; Li Q, 2008, MYCOL RES, V112, P1049, DOI 10.1016/j.mycres.2008.03.004; LILLEY KS, 1992, EUR J BIOCHEM, V207, P533, DOI 10.1111/j.1432-1033.1992.tb17079.x; Lundblad R.L., 1994, TECHNIQUES PROTEIN M; MCPHERSON MJ, 1988, PROTEIN ENG, V2, P147, DOI 10.1093/protein/2.2.147; MICHEL F, 1978, EUR J BIOCHEM, V84, P267, DOI 10.1111/j.1432-1033.1978.tb12165.x; Montero-Moran GM, 2001, BIOCHEMISTRY-US, V40, P10187, DOI 10.1021/bi0105835; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; MUDD SH, 1963, J BIOL CHEM, V238, P2164; NAKAJIMA Y, 1991, J BIOCHEM, V109, P251; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; OLSON JA, 1953, J BIOL CHEM, V202, P841; OZTURK DH, 1991, BIOCHEMISTRY-US, V30, P7126, DOI 10.1021/bi00243a013; Paradisi F, 2005, BIOCHEMISTRY-US, V44, P3636, DOI 10.1021/bi047679u; PONTIS HG, 1981, P NATL ACAD SCI-BIOL, V78, P6667, DOI 10.1073/pnas.78.11.6667; PONTREMOLI S, 1967, P NATL ACAD SCI USA, V58, P286, DOI 10.1073/pnas.58.1.286; RASCHED I, 1982, BIOCHIM BIOPHYS ACTA, V707, P267, DOI 10.1016/0167-4838(82)90360-0; ROBINSON GW, 1967, J BIOL CHEM, V242, P2709; Sharkey MA, 2008, FEMS MICROBIOL LETT, V281, P132, DOI 10.1111/j.1574-6968.2008.01086.x; STOREY KB, 1975, COMP BIOCHEM PHYS B, V52, P169, DOI 10.1016/0305-0491(75)90135-2; WANG XG, 1994, PROTEIN ENG, V7, P1013, DOI 10.1093/protein/7.8.1013; WANG XG, 1995, PROTEIN ENG, V8, P147, DOI 10.1093/protein/8.2.147; Wang XG, 2001, EUR J BIOCHEM, V268, P5791, DOI 10.1046/j.0014-2956.2001.02523.x; Yang SJ, 2005, MOL CELLS, V19, P97; Yoon HY, 2004, BIOCHIMIE, V86, P261, DOI 10.1016/j.biochi.2004.04.005	55	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101662	10.1371/journal.pone.0101662	http://dx.doi.org/10.1371/journal.pone.0101662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987966	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100125
J	Asok, A; Bernard, K; Rosen, JB; Dozier, M; Roth, TL				Asok, Arun; Bernard, Kristin; Rosen, Jeffrey B.; Dozier, Mary; Roth, Tania L.			Infant-Caregiver Experiences Alter Telomere Length in the Brain	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; EARLY-LIFE STRESS; CELL-PROLIFERATION; OXIDATIVE STRESS; RAT MODEL; AMYGDALA; MALTREATMENT; ADOLESCENT; BEHAVIOR; ANXIETY	Following adverse childhood experiences, high quality maternal care can protect against accelerated telomere shortening in peripheral cells. It is less clear, however, how telomere length in the brain is influenced by early caregiving experiences. Using rats, we investigated if quality of care (i.e., aversive or nurturing care outside of the homecage) during the first seven days of postnatal (PN) life affected telomere length in the adult brain (PN90) of male and female rats. At PN90, we found that nurturing care outside of the homecage was associated with longer telomeres in the medial prefrontal cortex relative to nurturing care inside the homecage (i.e., normal maternal care) and aversive care outside of the homecage. Further, pups exposed to aversive care outside of the homecage demonstrated longer telomeres in the amygdala relative to pups exposed to nurturing care inside the homecage. These effects were specific to females. No differences in telomere length between caregiving conditions were observed in the ventral hippocampus. Thus, positive and negative early-life experiences result in long-term, sex-specific changes of telomeres in the brain.	[Asok, Arun; Rosen, Jeffrey B.; Dozier, Mary; Roth, Tania L.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Bernard, Kristin] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA	University of Delaware; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Roth, TL (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	troth@psych.udel.edu	Dozier, Mary/AAN-9486-2020	Asok, Arun/0000-0001-9056-8799	University of Delaware Research Foundation; NIGMS [1P20GM103653]; Brain & Behavior Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103653] Funding Source: NIH RePORTER	University of Delaware Research Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by University of Delaware Research Foundation, NIGMS (1P20GM103653), and The Brain & Behavior Research Foundation to T.L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asok A, 2013, DEV PSYCHOPATHOL, V25, P577, DOI 10.1017/S0954579413000011; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blaze J, 2013, INT J DEV NEUROSCI, V31, P804, DOI 10.1016/j.ijdevneu.2013.10.001; Blaze J, 2013, DEV NEUROSCI-BASEL, V35, P306, DOI 10.1159/000350716; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Botha Martmari, 2012, BMC Res Notes, V5, P697, DOI 10.1186/1756-0500-5-697; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Champagne FA, 2013, BEHAV NEUROSCI, V127, P628, DOI 10.1037/a0034186; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Cicchetti D, 2005, ANNU REV CLIN PSYCHO, V1, P409, DOI 10.1146/annurev.clinpsy.1.102803.144029; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; D'Andrea I, 2010, BEHAV BRAIN RES, V215, P71, DOI 10.1016/j.bbr.2010.06.030; Dabouras V, 2004, NEUROSCI LETT, V368, P68, DOI 10.1016/j.neulet.2004.06.066; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Eitan E, 2014, TRENDS NEUR IN PRESS; Elvsashagen T, 2011, J AFFECT DISORDERS, V135, P43, DOI 10.1016/j.jad.2011.08.006; Epel ES, 2013, CLIN PSYCHOL SCI, V1, P75, DOI 10.1177/2167702612460234; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Flanary B, 2005, REJUV RES, V8, P82, DOI 10.1089/rej.2005.8.82; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Ganzel BL, 2013, DEV PSYCHOPATHOL, V25, P879, DOI 10.1017/S0954579413000242; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Gilles EE, 1996, PEDIATR NEUROL, V15, P114, DOI 10.1016/0887-8994(96)00153-1; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Kawamura T, 2006, NEUROREPORT, V17, P1515, DOI 10.1097/01.wnr.0000236849.53682.6d; Koss WA, 2014, SYNAPSE, V68, P61, DOI 10.1002/syn.21716; Kosten TA, 2006, BRAIN RES, V1087, P142, DOI 10.1016/j.brainres.2006.03.009; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Kroenke CH, 2011, PSYCHOSOM MED, V73, P533, DOI 10.1097/PSY.0b013e318229acfc; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Raineki C, 2010, BIOL PSYCHIAT, V67, P1137, DOI 10.1016/j.biopsych.2009.12.019; Roth TL, 2011, J CHILD PSYCHOL PSYC, V52, P398, DOI 10.1111/j.1469-7610.2010.02282.x; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; Roth TL, 2014, DEV PSYCHOB IN PRESS; Sachs BD, 2013, INT J NEUROPSYCHOPH, V16, P2081, DOI 10.1017/S1461145713000321; Saul ML, 2014, DEV PSYCHOBIOL, V56, P517, DOI 10.1002/dev.21115; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shalev I, 2014, MOL PSYCHIA IN PRESS; Thomas P, 2008, MECH AGEING DEV, V129, P183, DOI 10.1016/j.mad.2007.12.004; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wikgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034292; Zeichner SL, 1999, BLOOD, V93, P2824; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhou JZ, 2014, BMB REP, V47, P8, DOI 10.5483/BMBRep.2014.47.1.284; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	66	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101437	10.1371/journal.pone.0101437	http://dx.doi.org/10.1371/journal.pone.0101437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983884	gold, Green Published			2022-12-25	WOS:000339635000108
J	Bennet, M; McCarthy, A; Fix, D; Edwards, MR; Repp, F; Vach, P; Dunlop, JWC; Sitti, M; Buller, GS; Klumpp, S; Faivre, D				Bennet, Mathieu; McCarthy, Aongus; Fix, Dmitri; Edwards, Matthew R.; Repp, Felix; Vach, Peter; Dunlop, John W. C.; Sitti, Metin; Buller, Gerald S.; Klumpp, Stefan; Faivre, Damien			Influence of Magnetic Fields on Magneto-Aerotaxis	PLOS ONE			English	Article							BAND FORMATION; BACTERIA; OXYGEN; CHEMOTAXIS; RESPONSES	The response of cells to changes in their physico-chemical micro-environment is essential to their survival. For example, bacterial magnetotaxis uses the Earth's magnetic field together with chemical sensing to help microorganisms move towards favoured habitats. The studies of such complex responses are lacking a method that permits the simultaneous mapping of the chemical environment and the response of the organisms, and the ability to generate a controlled physiological magnetic field. We have thus developed a multi-modal microscopy platform that fulfils these requirements. Using simultaneous fluorescence and high-speed imaging in conjunction with diffusion and aerotactic models, we characterized the magneto-aerotaxis of Magnetospirillum gryph is waldense. We assessed the influence of the magnetic field (orientation; strength) on the formation and the dynamic of a micro-aerotactic band (size, dynamic, position). As previously described by models of magnetotaxis, the application of a magnetic field pointing towards the anoxic zone of an oxygen gradient results in an enhanced aerotaxis even down to Earth's magnetic field strength. We found that neither a ten-fold increase of the field strength nor a tilt of 45 degrees resulted in a significant change of the aerotactic efficiency. However, when the field strength is zeroed or when the field angle is tilted to 90 degrees, the magneto-aerotaxis efficiency is drastically reduced. The classical model of magneto-aerotaxis assumes a response proportional to the cosine of the angle difference between the directions of the oxygen gradient and that of the magnetic field. Our experimental evidence however shows that this behaviour is more complex than assumed in this model, thus opening up new avenues for research.	[Bennet, Mathieu; Fix, Dmitri; Repp, Felix; Vach, Peter; Dunlop, John W. C.; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [McCarthy, Aongus; Buller, Gerald S.] Heriot Watt Univ, Sch Engn & Phys Sci, Inst Photon & Quantum Sci, Edinburgh, Midlothian, Scotland; [McCarthy, Aongus; Buller, Gerald S.] Heriot Watt Univ, Sch Engn & Phys Sci, SUPA, Edinburgh, Midlothian, Scotland; [Edwards, Matthew R.; Sitti, Metin] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society; Heriot Watt University; Heriot Watt University; University of Edinburgh; Carnegie Mellon University; Max Planck Society	Faivre, D (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Sci Pk Golm, Potsdam, Germany.	Damien.Faivre@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Sitti, Metin/AGP-6288-2022; McCarthy, Aongus/B-4965-2013; Dunlop, John W C/A-1997-2012; faivre, damien/D-3713-2009; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; McCarthy, Aongus/0000-0002-0124-0060; Dunlop, John W C/0000-0003-2741-6383; faivre, damien/0000-0001-6191-3389; Klumpp, Stefan/0000-0003-0584-2146; bennet, mathieu/0000-0002-1292-7984; Buller, Gerald/0000-0003-0441-2830; Edwards, Matthew/0000-0002-9701-0736	Max Planck Society; ERC through a Starting Grant [256915-MB2]; UK Engineering and Physical Sciences Research Council; National Science Foundation under a CPS Medium Project [CNS-1135850]; National Science Foundation Graduate Research Fellowship Program [0946825I]; EPSRC [EP/K015338/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K015338/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC through a Starting Grant; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation under a CPS Medium Project; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research was supported by the Max Planck Society and the ERC through a Starting Grant to DaF (256915-MB2). AMcC and GSB acknowledge the support of the UK Engineering and Physical Sciences Research Council. MRE and MS acknowledge the support of the National Science Foundation under a CPS Medium Project (CNS-1135850) and of the National Science Foundation Graduate Research Fellowship Program under Grant No. 0946825I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Alexandre G, 1999, J BACTERIOL, V181, P6730, DOI 10.1128/JB.181.21.6730-6738.1999; ARMITAGE JP, 1992, ANNU REV PHYSIOL, V54, P683, DOI 10.1146/annurev.ph.54.030192.003343; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bennet MA, 2011, LAB CHIP, V11, P3821, DOI 10.1039/c1lc20391f; Berg HC, 1972, NATURE, V239; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cussler EL, 1985, AICHE J, V31, P523, DOI [10.1002/aic.690310333, DOI 10.1002/AIC.690310333]; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Engelmann TW, 1881, PFLUGERS ARCH GESAMM, P285, DOI [10.1007/BF01661982, DOI 10.1007/BF01661982]; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Fischer JP, 2006, FEMS MICROBIOL ECOL, V55, P186, DOI 10.1111/j.1574-695X.2005.00024.x; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Lefevre CT, 2009, APPL ENVIRON MICROB, V75, P3835, DOI 10.1128/AEM.00165-09; Mazzag BC, 2003, BIOPHYS J, V85, P3558, DOI 10.1016/S0006-3495(03)74775-4; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Murray JD, INTERDISCIPLINARY AP, V17, P1; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Romagnoli S, 2002, J BACTERIOL, V184, P5590, DOI 10.1128/JB.184.20.5590-5598.2002; SCHLEIFER KH, 1991, SYST APPL MICROBIOL, V14, P379, DOI 10.1016/S0723-2020(11)80313-9; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; Thar R, 2005, APPL ENVIRON MICROB, V71, P3682, DOI 10.1128/AEM.71.7.3682-3691.2005; Vach PJ, 2013, NANO LETT, V13, P5373, DOI 10.1021/nl402897x; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zhulin IB, 1996, J BACTERIOL, V178, P5199, DOI 10.1128/jb.178.17.5199-5204.1996	30	39	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101150	10.1371/journal.pone.0101150	http://dx.doi.org/10.1371/journal.pone.0101150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983865	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000058
J	Zhou, Y; Sun, JJ; Li, CJ; Wang, YH; Li, L; Cai, HF; Lan, XY; Lei, CZ; Zhao, X; Chen, H				Zhou, Yang; Sun, Jiajie; Li, Congjun; Wang, Yanhong; Li, Lan; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Chen, Hong			Characterization of Transcriptional Complexity during Adipose Tissue Development in Bovines of Different Ages and Sexes	PLOS ONE			English	Article							NONCODING RNA; ADIPOCYTE DIFFERENTIATION; ENDOCRINE ORGAN; GENE-EXPRESSION; CANCER; OBESITY; INFLAMMATION; OVERWEIGHT; ANDROGENS; STEROIDS	Background: Adipose tissue has long been recognized to play an extremely important role in development. In bovines, it not only serves a fundamental function but also plays a key role in the quality of beef and, consequently, has drawn much public attention. Age and sex are two key factors that affect the development of adipose tissue, and there has not yet been a global study detailing the effects of these two factors on expressional differences of adipose tissues. Results: In this study, total RNA from the back fat of fetal bovines, adult bulls, adult heifers and adult steers were used to construct libraries for Illumina next-generation sequencing. We detected the expression levels of 12,233 genes, with over 3,000 differently expressed genes when comparing fetal and adult patterns and an average of 1000 differently expressed genes when comparing adult patterns. Multiple Gene Ontology terms and pathways were found to be significantly enriched for these differentially expressed genes. Of the 12,233 detected genes, a total of 4,753 genes (38.85%) underwent alternative splicing events, and over 50% were specifically expressed in each library. Over 4,000 novel transcript units were discovered for one library, whereas only approximately 30% were considered to have coding ability, which supplied a large amount of information for the lncRNA study. Additionally, we detected 56,564 (fetal bovine), 65,154 (adult bull), 78,061 (adult heifer) and 86,965 (adult steer) putative single nucleotide polymorphisms located in coding regions of the four pooled libraries. Conclusion: Here, we present, for the first time, a complete dataset involving the spatial and temporal transcriptome of bovine adipose tissue using RNA-seq. These data will facilitate the understanding of the effects of age and sex on the development of adipose tissue and supply essential information towards further studies on the genomes of beef cattle and other related mammals.	[Zhou, Yang; Sun, Jiajie; Li, Lan; Cai, Hanfang; Lan, Xianyong; Lei, Chuzhao; Zhao, Xin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Agr Mol Biol, Yangling, Shaanxi, Peoples R China; [Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wang, Yanhong] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; United States Department of Agriculture (USDA); Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Agr Mol Biol, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Wang, Yanbo/HFZ-8018-2022; Zhao, Xin/M-4312-2015; wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Li, Cong-jun/J-8572-2014	Zhao, Xin/0000-0002-1078-7332; Li, Cong-jun/0000-0003-1389-9820	National Natural Science Foundation of China [31272408]; National 863 Program of China [2013AA102505]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle Industrial Technology System [CARS-38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle Industrial Technology System	This study was supported by the National Natural Science Foundation of China (Grant No. 31272408), National 863 Program of China (Grant No. 2013AA102505), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), and Program of National Beef Cattle Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 2001, ANN STAT, V29, P1165; BERG RT, 1979, CAN J ANIM SCI, V59, P359, DOI 10.4141/cjas79-044; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Blouin K, 2010, CLIN ENDOCRINOL, V72, P176, DOI 10.1111/j.1365-2265.2009.03645.x; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Choi B, 2010, LIVEST SCI, V131, P218, DOI 10.1016/j.livsci.2010.04.004; De Maddalena C, 2012, J CELL PHYSIOL, V227, P3744, DOI 10.1002/jcp.24096; Dieudonne MN, 1998, AM J PHYSIOL-CELL PH, V274, pC1645, DOI 10.1152/ajpcell.1998.274.6.C1645; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Fritsche S, 1998, J ANIM SCI, V76, P1621; Gaucher EA, 2003, GENETICS, V163, P1549; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Masek T, 2010, ITALIAN J ANIMAL SCI, V9; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Medrano J, 2010, COMP ANAL BOVINE MIL; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nie L, 2012, AM J TRANSL RES, V4, P127; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rubin GL, 2000, CANCER RES, V60, P1604; Schutte AE, 2006, J HUM HYPERTENS, V20, P850, DOI 10.1038/sj.jhh.1002065; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	54	24	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101261	10.1371/journal.pone.0101261	http://dx.doi.org/10.1371/journal.pone.0101261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983926	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000079
J	Tabone-Eglinger, S; Calderin-Sollet, Z; Pinon, P; Aebischer, N; Wehrle-Haller, M; Jacquier, MC; Boettiger, D; Wehrle-Haller, B				Tabone-Eglinger, Severine; Calderin-Sollet, Zuleika; Pinon, Perrine; Aebischer, Nicole; Wehrle-Haller, Monique; Jacquier, Marie-Claude; Boettiger, David; Wehrle-Haller, Bernhard			Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive	FASEB JOURNAL			English	Article						stem cell factor; adhesion and spreading; integrin; fibronectin; mast cells	GASTROINTESTINAL STROMAL TUMORS; HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; BONE-MARROW; GERMLINE MUTATION; DOMINANT ROLE; BCR-ABL; ADHESION; DOMAIN	Kit ligand (KitL) and its tyrosine kinase receptor c-kit are critical for germ cells, melanocytes, mastocytes, and hematopoietic stem cells. Alternative splicing of KitL generates membrane-bound KitL (mb-KitL) or soluble KitL, providing survival or cell migration, respectively. Here we analyzed whether c-kit can function both as an adhesion and signaling receptor to mb-KitL presented by the environmental niche. At contacts between fibroblasts and MC/9 mast cells, mb-KitL, and c-kit formed ligand/receptor clusters that formed stable complexes, which resisted dissociation by c-kit blocking mAbs and provided cell anchorage under physiological shear stresses. Clusters recruited tyrosine-phosphorylated proteins and induced spatially restricted F-actin polymerization. Mutational analysis of c-kit demonstrated kinase-independent mb-KitL/c-kit clustering, anchorage, F-actin polymerization, and Tyr567-dependent cluster phosphorylation. Kinase inhibition of c-kit by imatinib reduced cluster coalescence, but allowed cluster phosphorylation and F-actin polymerization, which required PI3K recruitment and a newly identified juxtamembrane residue. Synergies between integrin and c-kit-mediated spreading and adhesion of MC/9 cells were studied in vitro on immobilized-KitL/fibronectin surfaces. While c-kit blocking antibodies prevented spreading, imatinib blocked spreading induced by soluble-but not immobilized KitL. Thus, "mechanical" activation of c-kit provides signaling, niche-anchorage, and synergies with integrin-mediated adhesion, which is independent of kinase function and resistant to c-kit kinase inhibitors.-Tabone-Eglinger, S., Calderin-Sollet, Z., Pinon, P., Aebischer, N., Wehrle-Haller, M., Jacquier, M.-C., Boettiger, D., Wehrle-Haller, B. Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive.	[Tabone-Eglinger, Severine; Calderin-Sollet, Zuleika; Pinon, Perrine; Aebischer, Nicole; Wehrle-Haller, Monique; Jacquier, Marie-Claude; Wehrle-Haller, Bernhard] Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Boettiger, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Geneva; University of Pennsylvania	Wehrle-Haller, B (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	bernhard.wehrle-haller@unige.ch		TABONE-eglinger, Severine/0000-0003-4247-1321	Nevus Outreach; Geneva Cancer League; Swiss National Science foundation [31003A-130742]; Connective Tissue Cancer Network (CONTICANET); Connective Tissue Cancer Network (University of Lyon, France); Dr. Henri Dubois-Ferriere, Dinu Lipatti Foundation (Geneva, Switzerland)	Nevus Outreach; Geneva Cancer League; Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Connective Tissue Cancer Network (CONTICANET); Connective Tissue Cancer Network (University of Lyon, France); Dr. Henri Dubois-Ferriere, Dinu Lipatti Foundation (Geneva, Switzerland)	The authors thank Thomas Matthes and Jozsef Kiss for critical reading of the manuscript and Jean-Yves Blay for discussion. This work was supported by research grants from Nevus Outreach, the Geneva Cancer League, and the Swiss National Science foundation (31003A-130742) to B.W.H. S.T.E. was supported by the Connective Tissue Cancer Network (CONTICANET; University of Lyon, France) and the Dr. Henri Dubois-Ferriere, Dinu Lipatti Foundation (Geneva, Switzerland). The authors declare no conflicts of interest.	ADACHI S, 1992, BLOOD, V79, P650; Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Agosti V, 2009, EXP HEMATOL, V37, P159, DOI 10.1016/j.exphem.2008.10.009; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barker JE, 1997, EXP HEMATOL, V25, P542; Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D; Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; DASTYCH J, 1994, J IMMUNOL, V152, P213; Dastych J, 1998, AM J PHYSIOL-CELL PH, V275, pC1291, DOI 10.1152/ajpcell.1998.275.5.C1291; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; FehlnerGardiner CC, 1996, DIFFERENTIATION, V60, P317, DOI 10.1046/j.1432-0436.1996.6050317.x; Fewkes NM, 2010, BLOOD, V115, P4120, DOI 10.1182/blood-2009-10-248898; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; KINASHI T, 1994, BLOOD, V83, P1033; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; Maeyama H, 2001, GASTROENTEROLOGY, V120, P210; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paulhe F, 2009, FASEB J, V23, P3037, DOI 10.1096/fj.09-129577; Puissant A, 2012, J MOL CELL BIOL, V4, P207, DOI 10.1093/jmcb/mjs010; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Robson ME, 2004, CLIN CANCER RES, V10, P1250, DOI 10.1158/1078-0432.CCR-03-0110; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Scheijen B, 2002, ONCOGENE, V21, P3314, DOI 10.1038/sj.onc.1205317; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Tabone-Eglinger S, 2012, FASEB J, V26, P3738, DOI 10.1096/fj.12-206045; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; TO LB, 1994, BLOOD, V84, P2930; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Wehrle-Haller Bernhard, 2007, Methods Mol Biol, V370, P173; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	63	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4441	4456		10.1096/fj.14-249425	http://dx.doi.org/10.1096/fj.14-249425			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002122				2022-12-25	WOS:000342222700022
J	Sakaguchi, M; Murata, H; Aoyama, Y; Hibino, T; Putranto, EW; Ruma, IMW; Inoue, Y; Sakaguchi, Y; Yamamoto, K; Kinoshita, R; Futami, J; Kataoka, K; Iwatsuki, K; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Aoyama, Yumi; Hibino, Toshihiko; Putranto, Endy Widya; Ruma, I. Made Winarsa; Inoue, Yusuke; Sakaguchi, Yoshihiko; Yamamoto, Ken-ichi; Kinoshita, Rie; Futami, Junichiro; Kataoka, Ken; Iwatsuki, Keiji; Huh, Nam-ho			DNAX-activating Protein 10 (DAP10) Membrane Adaptor Associates with Receptor for Advanced Glycation End Products (RAGE) and Modulates the RAGE-triggered Signaling Pathway in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Biology; Keratinocyte; Psoriasis; Receptor for Advanced Glycation End Products (RAGE)	SKIN INFLAMMATION; ANTAGONIST DEFICIENCY; PUSTULAR PSORIASIS; TISSUE HOMEOSTASIS; BREAST-CANCER; CELLS; IL-22; EXPRESSION; S100A9; INTERLEUKIN-22	Background: RAGE receptor plays a critical role in many inflammatory disorders. Results: Functional interaction between RAGE and DAP10 coordinately regulates S100A8/A9-mediated cell survival. Conclusion: DAP10 membrane adaptor is critically involved in RAGE-mediated survival signaling upon S100A8/A9 binding. Significance: This is the first report demonstrating that RAGE-mediated survival signaling is critically regulated by DAP10 interaction. The receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of many inflammatory, degenerative, and hyperproliferative diseases, including cancer. Previously, we revealed mechanisms of downstream signaling from ligand-activated RAGE, which recruits TIRAP/MyD88. Here, we showed that DNAX-activating protein 10 (DAP10), a transmembrane adaptor protein, also binds to RAGE. By artificial oligomerization of RAGE alone or RAGE-DAP10, we found that RAGE-DAP10 heterodimer formation resulted in a marked enhancement of Akt activation, whereas homomultimeric interaction of RAGE led to activation of caspase 8. Normal human epidermal keratinocytes exposed to S100A8/A9, a ligand for RAGE, at a nanomolar concentration mimicked the pro-survival response of RAGE-DAP10 interaction, although at a micromolar concentration, the cells mimicked the pro-apoptotic response of RAGE-RAGE. In transformed epithelial cell lines, A431 and HaCaT, in which endogenous DAP10 was overexpressed, and S100A8/A9, even at a micromolar concentration, led to cell growth and survival due to RAGE-DAP10 interaction. Functional blocking of DAP10 in the cell lines abrogated the Akt phosphorylation from S100A8/A9-activated RAGE, eventually leading to an increase in apoptosis. Finally, S100A8/A9, RAGE, and DAP10 were overexpressed in the psoriatic epidermis. Our findings indicate that the functional interaction between RAGE and DAP10 coordinately regulates S100A8/A9-mediated survival and/or apoptotic response of keratinocytes.	[Sakaguchi, Masakiyo; Murata, Hitoshi; Putranto, Endy Widya; Ruma, I. Made Winarsa; Yamamoto, Ken-ichi; Huh, Nam-ho] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, Okayama 7008558, Japan; [Aoyama, Yumi; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, Okayama 7008558, Japan; [Hibino, Toshihiko] Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Inoue, Yusuke] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan; [Kinoshita, Rie; Futami, Junichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Dept Biotechnol, Okayama 7008530, Japan; [Kataoka, Ken] Okayama Univ Sci, Dept Life Sci, Fac Sci, Kita Ku, Okayama 7000005, Japan	Okayama University; Okayama University; Shiseido Company, Limited; Gunma University; University of Miyazaki; Okayama University; Okayama University of Science	Sakaguchi, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	Ruma, I Made Winarsa/L-6118-2016; Inoue, Yusuke/O-6207-2018; MURATA, Hitoshi/B-2327-2011; Ruma, I Made Winarsa/AAV-1375-2021; Sakaguchi, Masakiyo/B-2280-2011; Ruma, I Made Winarsa/AAN-6971-2020; Futami, Junichiro/B-2578-2011	Ruma, I Made Winarsa/0000-0002-9468-1104; Inoue, Yusuke/0000-0002-9710-7482; Ruma, I Made Winarsa/0000-0002-9468-1104; Futami, Junichiro/0000-0002-0020-2855	Ministry of Health, Labor and Welfare (Research for Intractable Diseases); Ministry of Education, Culture, Sports, Science, and Technology of Japan [26290039]; Takeda Science Foundation; Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research [26106725] Funding Source: KAKEN	Ministry of Health, Labor and Welfare (Research for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Health, Labor and Welfare (Research for Intractable Diseases) (to N. H.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research (B), 26290039 (to M. S.), the Takeda Science Foundation (to M. S.), and the Research Foundation for Pharmaceutical Sciences (to M. S.).	Anfossi N, 2003, EUR J IMMUNOL, V33, P3514, DOI 10.1002/eji.200324573; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Aochi S, 2011, J AM ACAD DERMATOL, V64, P879, DOI 10.1016/j.jaad.2010.02.049; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Chu PY, 2010, J BIOL CHEM, V285, P29279, DOI 10.1074/jbc.C110.114124; Cowen EW, 2012, ARCH DERMATOL, V148, P381, DOI 10.1001/archdermatol.2011.3014; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gonzalez I, 2013, IMMUNOBIOLOGY, V218, P790, DOI 10.1016/j.imbio.2012.09.005; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hibino T, 2013, CANCER RES, V73, P172, DOI 10.1158/0008-5472.CAN-11-3843; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Horiuchi S, 2005, ANN NY ACAD SCI, V1043, P671, DOI 10.1196/annals.1333.076; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jesus AA, 2011, ARTHRITIS RHEUM-US, V63, P4007, DOI 10.1002/art.30588; Jono T, 2002, FEBS LETT, V511, P170, DOI 10.1016/S0014-5793(01)03325-7; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Minkis K, 2012, ARCH DERMATOL, V148, P747, DOI 10.1001/archdermatol.2011.3208; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Pradip D, 2013, AM J CANCER RES, V3, P173; Pricci F, 2000, KIDNEY INT, V58, pS31, DOI 10.1046/j.1523-1755.2000.07706.x; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Shepherd J, 2004, J INVEST DERMATOL, V122, P665, DOI 10.1111/j.0022-202X.2004.22305.x; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhuang Y, 2012, CANCER IMMUNOL IMMUN, V61, P1965, DOI 10.1007/s00262-012-1241-5; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	64	29	29	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23389	23402		10.1074/jbc.M114.573071	http://dx.doi.org/10.1074/jbc.M114.573071			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002577	Green Published, hybrid			2022-12-25	WOS:000341505000014
J	Torres, JA; de las Heras, M; Maroto, AS; Vivanco, F; Sastre, J; Pastor-Vargas, C				Torres, Jose Alberto; de las Heras, Manuel; Maroto, Aroa Sanz; Vivanco, Fernando; Sastre, Joaquin; Pastor-Vargas, Carlos			Molecular and Immunological Characterization of the First Allergenic Lipocalin in Hamster THE MAJOR ALLERGEN FROM SIBERIAN HAMSTER (PHODOPUS SUNGORUS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Allergy; Asthma; Immunoglobulin E (IgE); Inflammation; Hamster; Lipocalin; Pet Allergy	IDENTIFICATION; SENSITIZATION; ANAPHYLAXIS; ALBUMINS; PETS	Background: Exposure to uncommon pets such as a Siberian hamster has been described as a new risk factor for the development of allergic disease. Results: For the first time, we have cloned and characterized an allergen from Siberian hamster. Conclusion: The recombinant allergen shows a similar pattern of IgE binding and biological activity compared with salivary gland extract. Significance: The recombinant form will be useful for clinical applications. The most frequent pet allergy is to cat and dog, but in recent years, it has become increasingly popular to have other pets, and the risk of exposure to new allergens is more prevalent. The list of new pets includes hamsters, and one of the most popular hamsters is the Siberian hamster (Phodopus sungorus). The aim of this study was the characterization and cloning of the major allergen from this hamster. The study of its allergenicity and cross-reactivity could improve the specific diagnosis and treatment for hamster-allergic patients. Thirteen Siberian hamster-allergic patients were recruited at the outpatient clinic. Protein extracts were prepared from the hair, urine, and salivary glands of four hamster species (European, golden, Siberian, and Roborovski). IgE-binding proteins were detected by immunoblotting and identified by mass spectrometry. The recombinant protein was produced in Escherichia coli and then purified by metal chelate affinity chromatography. The allergenic properties of the recombinant protein were tested by ELISA and immunoblotting, and biological activity was tested according to capacity for basophil activation. Three IgE-binding proteins were identified in extracts obtained from Siberian hamster hair, urine, and salivary glands. All proteins corresponded to the same protein, which was identified as a lipocalin. This lipocalin had no cross-reactivity with common and golden hamsters. The recombinant allergen was cloned and purified, showing similar IgE reactivity in vitro to Siberian hamster protein extracts. Also, the recombinant allergen was capable of producing biological activation in vivo. The major Siberian hamster allergen was cloned, and allergenic properties were characterized, providing a new tool for specific diagnosis of allergy to Siberian hamster.	[de las Heras, Manuel] Hosp Fdn Jimenez Diaz, Dept Allergy, Madrid 28040, Spain; [Maroto, Aroa Sanz; Vivanco, Fernando; Pastor-Vargas, Carlos] Univ Autonoma Madrid, Inst Invest Sanitarias, Dept Immunol, Fdn Jiminez Diaz, Madrid 28040, Spain; [Vivanco, Fernando] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Sastre, Joaquin] Inst Salud Carlos III, CIBERES, Madrid 28029, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Pastor-Vargas, C (corresponding author), Hosp Fdn Jimenez Diaz, Dept Immunol, Avda Reyes Catolicos 2, Madrid 28040, Spain.	cpastor@fjd.es	Pastor Vargas, Carlos/B-4112-2010; Vivanco, Fernando/Q-6866-2016	Pastor Vargas, Carlos/0000-0002-4678-7967; S. Maroto, Aroa/0000-0002-4971-2127	RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos [RD12/0013/0013]; Allergopharma (Merck Serono)	RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos; Allergopharma (Merck Serono)	This work was supported by RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos Grant RD12/0013/0013 and Allergopharma (Merck Serono).	[Anonymous], 1989, ALLERGY, V44, P1; Berto JM, 2002, ALLERGY, V57, P155, DOI 10.1046/j.0105-4538.2001.00001.x; Botros HG, 1996, IMMUNOLOGY, V88, P340, DOI 10.1046/j.1365-2567.1996.d01-669.x; Cases B, 2010, INT ARCH ALLERGY IMM, V153, P215, DOI 10.1159/000314361; Chruszcz M, 2013, BBA-GEN SUBJECTS, V1830, P5375, DOI 10.1016/j.bbagen.2013.06.016; Custovic A, 1998, ALLERGY, V53, P115, DOI 10.1111/j.1398-9995.1998.tb05011.x; Diaz-Perales A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00492; DREBORG S, 1983, ALLERGY, V38, P167, DOI 10.1111/j.1398-9995.1983.tb01602.x; Hilger C, 2011, CLIN EXP ALLERGY, V41, P899, DOI 10.1111/j.1365-2222.2011.03726.x; Liccardi G, 2011, J INVEST ALLERG CLIN, V21, P137; Lim DL, 2004, CLIN EXP ALLERGY, V34, P1122, DOI 10.1111/j.1365-2222.2004.01992.x; Manso L, 2010, J INVEST ALLERG CLIN, V20, P537; Niitsuma T, 2003, ALLERGY, V58, P1081, DOI 10.1034/j.1398-9995.2003.00242.x; Pastor C, 2009, INT ARCH ALLERGY IMM, V149, P291, DOI 10.1159/000205574; Pecquet C, 2012, EUR J DERMATOL, V22, P14, DOI 10.1684/ejd.2011.1555; Torres JA, 2012, INT ARCH ALLERGY IMM, V157, P109, DOI 10.1159/000324956	16	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23382	23388		10.1074/jbc.M114.579060	http://dx.doi.org/10.1074/jbc.M114.579060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993820	hybrid, Green Published			2022-12-25	WOS:000341505000013
J	Stocki, P; Chapman, DC; Beach, LA; Williams, DB				Stocki, Pawel; Chapman, Daniel C.; Beach, Lori A.; Williams, David B.			Depletion of Cyclophilins B and C Leads to Dysregulation of Endoplasmic Reticulum Redox Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; VITAMIN-K EPOXIDE; CYCLOSPORINE-A; FK506-BINDING PROTEIN; OXIDATIVE STRESS; REDUCTASE; BINDING; ERP57; NEPHROTOXICITY; SECRETION	Protein folding within the endoplasmic reticulum is assisted by molecular chaperones and folding catalysts that include members of the protein-disulfide isomerase and peptidyl-prolyl isomerase families. In this report, we examined the contributions of the cyclophilin subset of peptidyl-prolyl isomerases to protein folding and identified cyclophilin C as an endoplasmic reticulum (ER) cyclophilin in addition to cyclophilin B. Using albumin and transferrin as models of cis-proline-containing proteins in human hepatoma cells, we found that combined knockdown of cyclophilins B and C delayed transferrin secretion but surprisingly resulted in more efficient oxidative folding and secretion of albumin. Examination of the oxidation status of ER protein-disulfide isomerase family members revealed a shift to a more oxidized state. This was accompanied by a >5-fold elevation in the ratio of oxidized to total glutathione. This "hyperoxidation" phenotype could be duplicated by incubating cells with the cyclophilin inhibitor cyclosporine A, a treatment that triggered efficient ER depletion of cyclophilins B and C by inducing their secretion to the medium. To identify the pathway responsible for ER hyperoxidation, we individually depleted several enzymes that are known or suspected to deliver oxidizing equivalents to the ER: Ero1 alpha beta, VKOR, PRDX4, or QSOX1. Remarkably, none of these enzymes contributed to the elevated oxidized to total glutathione ratio induced by cyclosporine A treatment. These findings establish cyclophilin C as an ER cyclophilin, demonstrate the novel involvement of cyclophilins B and C in ER redox homeostasis, and suggest the existence of an additional ER oxidative pathway that is modulated by ER cyclophilins.	[Stocki, Pawel; Chapman, Daniel C.; Beach, Lori A.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Williams, DB (corresponding author), Univ Toronto, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca			Canadian Cancer Society; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Cancer Society and the Canadian Institutes of Health Research.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Bergeron MJ, 2011, J BIOL CHEM, V286, P11242, DOI 10.1074/jbc.M110.171728; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; De Hornedo JP, 2007, NEFROLOGIA, V27, P565; DELORGERIL M, 1994, TRANSPLANTATION, V58, P193; Fearon P, 2011, J INVEST DERMATOL, V131, P1085, DOI 10.1038/jid.2010.415; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; Kang K, 2009, ANTIOXID REDOX SIGN, V11, P2553, DOI [10.1089/ars.2009.2465, 10.1089/ARS.2009.2465]; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Krauskopf A, 2002, BRIT J PHARMACOL, V135, P977, DOI 10.1038/sj.bjp.0704544; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lee J, 2010, TOX RESEARCH, V26, P163, DOI 10.5487/TR.2010.26.3.163; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LODISH HF, 1991, J BIOL CHEM, V266, P14835; Louhelainen M, 2006, J HYPERTENS, V24, P947, DOI 10.1097/01.hjh.0000222766.37971.9f; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Margittai E, 2010, FEBS LETT, V584, P2995, DOI 10.1016/j.febslet.2010.05.055; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Ruddock LW, 2012, ANTIOXID REDOX SIGN, V16, P1129, DOI 10.1089/ars.2011.4481; Rudolf J, 2013, BIOCHEM J, V454, P181, DOI 10.1042/BJ20130360; RUPP K, 1994, J BIOL CHEM, V269, P2501; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tariq M, 1999, NEPHROL DIAL TRANSPL, V14, P923, DOI 10.1093/ndt/14.4.923; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; WANG CY, 1994, TRANSPLANTATION, V58, P940, DOI 10.1097/00007890-199410270-00014; WATKINS PB, 1990, J AM ACAD DERMATOL, V23, P1301, DOI 10.1016/0190-9622(90)70358-O; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zhong Z, 1998, AM J PHYSIOL-RENAL, V275, pF595, DOI 10.1152/ajprenal.1998.275.4.F595; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	71	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23086	23096		10.1074/jbc.M114.570911	http://dx.doi.org/10.1074/jbc.M114.570911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990953	Green Published, hybrid			2022-12-25	WOS:000341017200046
J	Iwamoto, K; Hamada, H; Eguchi, Y; Okamoto, M				Iwamoto, Kazunari; Hamada, Hiroyuki; Eguchi, Yukihiro; Okamoto, Masahiro			Stochasticity of Intranuclear Biochemical Reaction Processes Controls the Final Decision of Cell Fate Associated with DNA Damage	PLOS ONE			English	Article							GROWTH ARREST; P53 PULSES; APOPTOSIS; MECHANISM; DEATH; MODEL; GENE; DOWNSTREAM; ACTIVATION; INDUCTION	A massive integrative mathematical model of DNA double-strand break (DSB) generation, DSB repair system, p53 signaling network, and apoptosis induction pathway was constructed to explore the dominant factors of unknown criteria of cell fate decision. In the proposed model, intranuclear reactions were modeled as stochastic processes and cytoplasmic reactions as deterministic processes, and both reaction sets were simulated simultaneously. The simulated results at the single-cell level showed that the model generated several sustained oscillations ( pulses) of p53, Mdm2, ATM, and Wip1, and cell-to-cell variability in the number of p53 pulses depended on IR intensity. In cell populations, the model generated damped p53 oscillations, and IR intensity affected the amplitude of the first p53 oscillation. Cells were then subjected to the same IR dose exhibiting apoptosis induction variability. These simulated results are in quantitative agreement with major biological findings observed in human breast cancer epithelial MCF7, NIH3T3, and fibrosarcoma cells, demonstrating that the proposed model was concededly biologically appropriate. Statistical analysis of the simulated results shows that the generation of multiple p53 pulses is a prerequisite for apoptosis induction. Furthermore, cells exhibited considerable individual variability in p53 dynamics, which correlated with intrinsic apoptosis induction. The simulated results based on the proposed model demonstrated that the stochasticity of intranuclear biochemical reaction processes controls the final decision of cell fate associated with DNA damage. Applying stochastic simulation to an exploration of intranuclear biochemical reaction processes is indispensable in enhancing the understanding of the dynamic characteristics of biological multi-layered systems of higher organisms.	[Iwamoto, Kazunari] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Iwamoto, Kazunari] Japan Soc Promot Sci, Tokyo, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Dept Syst Life Sci, Fukuoka 812, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Hamada, Hiroyuki; Okamoto, Masahiro] Kyushu Univ, Synthet Syst Biol Res Ctr, Fukuoka 812, Japan; [Eguchi, Yukihiro] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University; Kyushu University; Kyushu University	Hamada, H (corresponding author), Kyushu Univ, Dept Syst Life Sci, Fukuoka 812, Japan.	hamada@brs.kyushu-u.ac.jp		Iwamoto, Kazunari/0000-0001-9794-9420	Research Fellowship of the Japan Society for the Promotion of Science; JSPS KAKENHI [23119001]; Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University	Research Fellowship of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University	The research of KI was supported by the Research Fellowship of the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-pd/index.html). The work of HH MO was supported by JSPS KAKENHI Grant (23119001; http://www.syn-biol.com/). The work of HH was supported by the Research Grant for Young Investigators of Faculty of Agriculture, Kyushyu University (http://www.agr.kyushu-u.ac.jp/investigation/faculty_subsidy/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Cance E., 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Datta R, 2000, J BIOL CHEM, V275, P31733, DOI 10.1074/jbc.M910231199; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Guerrero M, 2002, PHYS MED BIOL, V47, P3197, DOI 10.1088/0031-9155/47/17/310; Hamada H, 2013, BIOSYSTEMS, V111, P208, DOI 10.1016/j.biosystems.2013.02.007; Hamada H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004795; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Kim KH, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4822103; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kren BT, 1996, EMBO J, V10, P819; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li G, 1998, BRIT J DERMATOL, V139, P3; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pellegata NS, 1996, P NATL ACAD SCI USA, V93, P15209, DOI 10.1073/pnas.93.26.15209; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101333	10.1371/journal.pone.0101333	http://dx.doi.org/10.1371/journal.pone.0101333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003668	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700025
J	Toyoda, S; Yoshimura, T; Mizuta, J; Miyazaki, J				Toyoda, Shuichi; Yoshimura, Takuji; Mizuta, Junya; Miyazaki, Jun-ichi			Auto-Regulation of the Sohlh1 Gene by the SOHLH2/SOHLH1/SP1 Complex: Implications for Early Spermatogenesis and Oogenesis	PLOS ONE			English	Article							DNA-BINDING; C-MYC; DEVELOPMENTAL EXPRESSION; SIGNALING PATHWAY; KIT EXPRESSION; TRANSCRIPTION; SP1; MAX; SPERMATOGONIA; ACTIVATION	Tissue-specific basic helix-loop-helix (bHLH) transcription factor proteins often play essential roles in cellular differentiation. The bHLH proteins SOHLH2 and SOHLH1 are expressed specifically in spermatogonia and oocytes and are required for early spermatogonial and oocyte differentiation. We previously reported that knocking out Sohlh2 causes defects in spermatogenesis and oogenesis similar to those in Sohlh1-null mice, and that Sohlh1 is downregulated in the gonads of Sohlh2-null mice. We also demonstrated that SOHLH2 and SOHLH1 can form a heterodimer. These observations led us to hypothesize that the SOHLH2/SOHLH1 heterodimer regulates the Sohlh1 promoter. Here, we show that SOHLH2 and SOHLH1 synergistically upregulate the Sohlh1 gene through E-boxes upstream of the Sohlh1 promoter. Interestingly, we identified an SP1-binding sequence, called a GC-box, adjacent to these E-boxes, and found that SOHLH1 could bind to SP1. Furthermore, chromatin-immunoprecipitation analysis using testes from mice on postnatal day 8 showed that SOHLH1 and SP1 bind to the Sohlh1 promoter region in vivo. Our findings suggest that an SOHLH2/SOHLH1/SP1 ternary complex autonomously and cooperatively regulates Sohlh1 gene transcription through juxtaposed E-and GC-boxes during early spermatogenesis and oogenesis.	[Toyoda, Shuichi; Yoshimura, Takuji; Mizuta, Junya; Miyazaki, Jun-ichi] Osaka Univ, Div Stem Cell Regulat Res, Grad Sch Med, Osaka, Japan; [Yoshimura, Takuji] Osaka Univ, Sch Med, Inst Expt Anim Sci, Lab Reprod Engn, Osaka, Japan	Osaka University; Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Div Stem Cell Regulat Res, Grad Sch Med, Osaka, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yoshimura, Takuji/0000-0002-7856-0679	Japanese Society for the Promotion of Science [22590190]; Grants-in-Aid for Scientific Research [25460364] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid (No. 22590190) from the Japanese Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Biesiada E, 1999, MOL CELL BIOL, V19, P2577; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Choi Y, 2008, BIOL REPROD, V79, P1176, DOI 10.1095/biolreprod.108.071217; Ding XY, 2013, MOL REPROD DEV, V80, P70, DOI 10.1002/mrd.22138; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; FISHER F, 1993, EMBO J, V12, P5075, DOI 10.1002/j.1460-2075.1993.tb06201.x; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lee TL, 2006, GENOMICS, V88, P18, DOI 10.1016/j.ygeno.2006.03.008; Li H, 2009, BIOL REPROD, V81, P996, DOI 10.1095/biolreprod.109.078808; Ma WL, 2008, BIOL REPROD, V79, P289, DOI 10.1095/biolreprod.107.067082; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Park GH, 1998, BLOOD, V92, P4138, DOI 10.1182/blood.V92.11.4138.423k44_4138_4149; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Swanson HI, 1999, NUCLEIC ACIDS RES, V27, P3205, DOI 10.1093/nar/27.15.3205; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; VANPELT AMM, 1995, BIOL REPROD, V53, P570, DOI 10.1095/biolreprod53.3.570; Worrad DM, 1997, MOL REPROD DEV, V46, P268, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;268::AID-MRD5&gt;3.0.CO;2-N; Yoshimura T, 2007, GENE EXPR PATTERNS, V8, P27, DOI 10.1016/j.modgep.2007.08.003	33	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101681	10.1371/journal.pone.0101681	http://dx.doi.org/10.1371/journal.pone.0101681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003626	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700052
J	Vazacova, K; Munzbergova, Z				Vazacova, Kristyna; Muenzbergova, Zuzana			The Importance of Species Traits for Species Distribution on Oceanic Islands	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; SEED DISPERSAL; GENETIC-STRUCTURE; EUROPEAN FORESTS; PLANT DISPERSAL; RANGE; GRASSLAND; POPULATION; LANDSCAPE; SCALE	Understanding species' ability to colonize new habitats is a key knowledge allowing us to predict species' survival in the changing landscapes. However, most studies exploring this topic observe distribution of species in landscapes which are under strong human influence being fragmented only recently and ignore the fact that the species distribution in these landscapes is far from equilibrium. Oceanic islands seem more appropriate systems for studying the relationship between species traits and its distribution as they are fragmented without human contribution and as they remained unchanged for a long evolutionary time. In our study we compared the values of dispersal as well as persistence traits among 18 species pairs from the Canary Islands differing in their distribution within the archipelago. The data were analyzed both with and without phylogenetic correction. The results demonstrate that no dispersal trait alone can explain the distribution of the species in the system. They, however, also suggest that species with better dispersal compared to their close relatives are better colonizers. Similarly, abundance of species in the archipelago seems to be an important predictor of species colonization ability only when comparing closely related species. This implies that analyses including phylogenetic correction may provide different insights than analyses without such a correction and both types of analyses should be combined to understand the importance of various plant traits for species colonization ability.	[Vazacova, Kristyna; Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Vazacova, Kristyna; Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Vazacova, K (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	vazacova@seznam.cz	Münzbergová, Zuzana/F-6321-2013	Münzbergová, Zuzana/0000-0002-4026-6220	GACR [P505/10/0593]; GAUK [48807]; Mobility Fund of the Charles University in Prague; MSMT; RVO [67985939]	GACR(Grant Agency of the Czech Republic); GAUK; Mobility Fund of the Charles University in Prague; MSMT(Ministry of Education, Youth & Sports - Czech Republic); RVO	This project was supported by GACR P505/10/0593, GAUK 48807, Mobility Fund of the Charles University in Prague and partly by MSMT and RVO 67985939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1990, J BIOGEOGR, V17, P327, DOI 10.2307/2845128; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; [Anonymous], S PLUS 2000 PROF ED; Arechavaleta M., 2010, LISTA ESPECIES SILVE; Boedeltje G, 2003, J ECOL, V91, P855, DOI 10.1046/j.1365-2745.2003.00820.x; Bonet A, 2004, PLANT ECOL, V174, P257, DOI 10.1023/B:VEGE.0000049106.96330.9c; BRAMWELL D, 1979, PLANTS ISLANDS; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; Bramwell D, 1985, BOTANICA MACARONESIC, V14, P3, DOI DOI 10.1002/aps3.1032; CARLQUIST S, 1967, B TORREY BOT CLUB, V94, P129, DOI 10.2307/2484044; Carlquist S, 1965, ISLAND LIFE NATURAL; Castroviejo S., 1986, FLORA IBRICA PLANTAS; Caujape-Castells J., 2011, The biology of island floras, P284; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Chylova T, 2008, PRESLIA, V80, P183; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Couvreur M, 2004, SEED SCI RES, V14, P147, DOI 10.1079/SSR2004164; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; Aguilar MJA, 2010, BIODIVERS CONSERV, V19, P3089, DOI 10.1007/s10531-010-9881-2; Duarte MC, 2008, BIODIVERS CONSERV, V17, P453, DOI 10.1007/s10531-007-9226-y; EVENARI M, 1977, FLORA, V166, P223; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez-Palacios JM, 2000, ACTA PHYTOGEOGRAPHIC, V85, P41; Gabrielova J, 2013, FOLIA GEOBOT, V48, P449, DOI 10.1007/s12224-012-9145-x; Gallagher RV, 2013, ECOGRAPHY, V36, P531, DOI 10.1111/j.1600-0587.2012.07514.x; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; Goodwin NB, 2005, OIKOS, V110, P209, DOI 10.1111/j.0030-1299.2005.13859.x; GRIME JP, 1987, NEW PHYTOL, V106, P283; Hansen DM, 2012, J BIOGEOGR, V39, P1935, DOI 10.1111/jbi.12014; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heinken T, 2002, FORSTWISS CENTRALBL, V121, P179, DOI 10.1046/j.1439-0337.2002.02029.x; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Hewitt N, 2002, J BIOGEOGR, V29, P351, DOI 10.1046/j.1365-2699.2002.00679.x; Hill G, 2003, WIND PROSPECTING CAN; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Kelly CK, 1996, PHILOS T R SOC B, V351, P1261, DOI 10.1098/rstb.1996.0109; Kelly CK, 1996, J VEG SCI, V7, P417, DOI 10.2307/3236285; Klotz S, 2002, BIOLFLOR DATENBANK B; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Knevel I.C., 2005, LEDA TRAITBASE COLLE; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lanta V, 2011, PERSPECT PLANT ECOL, V13, P189, DOI 10.1016/j.ppees.2011.05.003; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Lindborg R, 2007, J ECOL, V95, P555, DOI 10.1111/j.1365-2745.2007.01232.x; Lindborg R, 2012, ECOGRAPHY, V35, P356, DOI 10.1111/j.1600-0587.2011.07286.x; Malo JE, 2000, J RANGE MANAGE, V53, P322, DOI 10.2307/4003440; Marini L, 2012, DIVERS DISTRIB, V18, P898, DOI 10.1111/j.1472-4642.2012.00893.x; Maurer K, 2003, BASIC APPL ECOL, V4, P307, DOI 10.1078/1439-1791-00162; Medail F, 1999, PLANT ECOL, V140, P221, DOI 10.1023/A:1009775327616; Melendo M, 2003, FLORA, V198, P260, DOI 10.1078/0367-2530-00099; Munzbergova Z, 2013, PLANT BIOLOGY, V15, P195, DOI 10.1111/j.1438-8677.2012.00601.x; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Nogales M, 2001, J BIOGEOGR, V28, P1137, DOI 10.1046/j.1365-2699.2001.00622.x; Nogales M, 1999, ECOSCIENCE, V6, P56, DOI 10.1080/11956860.1999.11952193; Olesen J., 2004, ECOLOGIA INSULAR ISL, P229; Ortiz JE, 2006, J QUATERNARY SCI, V21, P287, DOI 10.1002/jqs.962; Parisod C, 2008, HEREDITY, V101, P536, DOI 10.1038/hdy.2008.95; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Percy DM, 2002, AM J BOT, V89, P854, DOI 10.3732/ajb.89.5.854; Piqueray J, 2011, LANDSCAPE ECOL, V26, P823, DOI 10.1007/s10980-011-9611-5; Pocock MJO, 2006, J ECOL, V94, P581, DOI 10.1111/j.1365-2745.2006.01123.x; Purschke O, 2012, OECOLOGIA, V168, P773, DOI 10.1007/s00442-011-2142-6; Riba M, 2009, NEW PHYTOL, V183, P667, DOI 10.1111/j.1469-8137.2009.02948.x; Romermann C, 2005, THE LEDA TRAITBASE C, P124; Saar L, 2012, DIVERS DISTRIB, V18, P808, DOI 10.1111/j.1472-4642.2012.00885.x; Sadeh A, 2009, EVOL ECOL, V23, P373, DOI 10.1007/s10682-007-9232-2; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Schonfelder I., 2002, KOSMOS ATLAS MITTELM; Schonfelder P, 2002, KVETENA KANARSKYCH O; Schwartz MW, 2006, ECOLOGY, V87, P1611, DOI 10.1890/0012-9658(2006)87[1611:PEAARO]2.0.CO;2; Statsoft I, 2013, STAT 12 0; Stevens VM, 2013, EVOL APPL, V6, P630, DOI 10.1111/eva.12049; STRATTON DA, 1989, BIOTROPICA, V21, P308, DOI 10.2307/2388281; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Talavera M, 2011, MOL PHYLOGENET EVOL, V61, P659, DOI 10.1016/j.ympev.2011.08.005; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson K, 2005, LEDA TRAITBASE COLLE, P122; Tremlova K, 2007, ECOLOGY, V88, P965, DOI 10.1890/06-0924; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Van der Pijl L, 1982, PRINCIPLES DISPERSAL; Van der Veken S, 2007, J BIOGEOGR, V34, P1723, DOI 10.1111/j.1365-2699.2007.01738.x; Vargas P, 2014, BOT J LINN SOC, V174, P349, DOI 10.1111/boj.12142; Vazacova K, 2013, FOLIA GEOBOT, P1; Wald EJ, 2005, AM MIDL NAT, V154, P342, DOI 10.1674/0003-0031(2005)154[0342:DOLSEE]2.0.CO;2; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; WESTOBY M, 1995, J ECOL, V83, P727, DOI 10.2307/2261640; WESTOBY M, 1995, J ECOL, V83, P892; Zhou M, 2000, J GEOPHYS RES-OCEANS, V105, P21893, DOI 10.1029/2000JC900096	91	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101046	10.1371/journal.pone.0101046	http://dx.doi.org/10.1371/journal.pone.0101046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003737	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700016
J	Bird, MJ; Needham, K; Frazier, AE; van Rooijen, J; Leung, J; Hough, S; Denham, M; Thornton, ME; Parish, CL; Nayagam, BA; Pera, M; Thorburn, DR; Thompson, LH; Dottori, M				Bird, Matthew J.; Needham, Karina; Frazier, Ann E.; van Rooijen, Jorien; Leung, Jessie; Hough, Shelley; Denham, Mark; Thornton, Matthew E.; Parish, Clare L.; Nayagam, Bryony A.; Pera, Martin; Thorburn, David R.; Thompson, Lachlan H.; Dottori, Mirella			Functional Characterization of Friedreich Ataxia iPS-Derived Neuronal Progenitors and Their Integration in the Adult Brain	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COMPLEX I; IRON; DEFICIENCY; FRATAXIN; GENE; DIFFERENTIATION; FIBROBLASTS; DISEASE	Friedreich ataxia (FRDA) is an autosomal recessive disease characterised by neurodegeneration and cardiomyopathy that is caused by an insufficiency of the mitochondrial protein, frataxin. Our previous studies described the generation of FRDA induced pluripotent stem cell lines (FA3 and FA4 iPS) that retained genetic characteristics of this disease. Here we extend these studies, showing that neural derivatives of FA iPS cells are able to differentiate into functional neurons, which don't show altered susceptibility to cell death, and have normal mitochondrial function. Furthermore, FA iPS-derived neural progenitors are able to differentiate into functional neurons and integrate in the nervous system when transplanted into the cerebellar regions of host adult rodent brain. These are the first studies to describe both in vitro and in vivo characterization of FA iPS-derived neurons and demonstrate their capacity to survive long term. These findings are highly significant for developing FRDA therapies using patient-derived stem cells.	[Bird, Matthew J.; Frazier, Ann E.; Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bird, Matthew J.; Frazier, Ann E.; Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bird, Matthew J.; Dottori, Mirella] Univ Melbourne, Dept Elect & Elect Engn, Ctr Neural Engn, Melbourne, Vic, Australia; [Needham, Karina] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia; [van Rooijen, Jorien; Leung, Jessie; Hough, Shelley; Denham, Mark; Pera, Martin; Dottori, Mirella] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Thornton, Matthew E.] Childrens Hosp Los Angeles, Saban Res Inst, Div Maternal Fetal Med, Los Angeles, CA 90027 USA; [Parish, Clare L.; Pera, Martin; Thompson, Lachlan H.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Nayagam, Bryony A.] Univ Melbourne, Dept Audiol & Speech Pathol, Melbourne, Vic, Australia; [Pera, Martin] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Children's Hospital Los Angeles; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne	Dottori, M (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Ctr Neural Engn, Melbourne, Vic, Australia.	mdottori@unimelb.edu.au	PERA, MARTIN/A-9812-2012; Thornton, Matt/HGF-1319-2022; Denham, Mark/N-9268-2016; Thorburn, David R/G-6266-2013; Thompson, Lachlan/B-4545-2013	PERA, MARTIN/0000-0001-6239-0428; Thornton, Matt/0000-0002-1083-2703; Denham, Mark/0000-0001-5279-5915; Bird, Matthew/0000-0003-3185-0780; Nayagam, Bryony/0000-0003-1069-6059; thorburn, david/0000-0002-7725-9470; Frazier, Ann/0000-0002-6491-3437; Thompson, Lachlan/0000-0003-2632-0304; Parish, Clare/0000-0001-8212-9884; Needham, Karina/0000-0002-3869-5448; Dottori, Mirella/0000-0003-0598-4195	Friedreich's Ataxia Research Association USA; Friedreich's Ataxia Research Association Australasia; Australian Mitochondrial Disease Foundation; Australian National Health and Medical Research Council; Victorian Government's Operational Infrastructure Support Program; Viertel charitable foundation; Brain Foundation Award	Friedreich's Ataxia Research Association USA; Friedreich's Ataxia Research Association Australasia; Australian Mitochondrial Disease Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Viertel charitable foundation; Brain Foundation Award	These studies were supported by the Friedreich's Ataxia Research Association USA (www.curefa.org) and Australasia (www.fara.org.au/) (MD), the Australian Mitochondrial Disease Foundation (www.amdf.org.au/) (MJB), an Australian Postgraduate Award (http://services.unimelb.edu.au/scholarships/research/local/available/apa) (MJB), a Principal Research Fellowship (DRT), Career Development Awards (AEF, LHT) and a Medical Research Council Peter Doherty Fellowship (BAN) all from the Australian National Health and Medical Research Council (www.nhmrc.gov.au/), a Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructureprogram), a senior medical research fellowship (CLP) provided by the Viertel charitable foundation (www.anz.com.au/personal/private-bank./scholarshipsfellowships/), and a Brain Foundation Award (brainfoundation.org.au). The authors would also like to thank Brian Mendenhall from the USC High Performance Computing Cluster for installing and testing high content analysis software. The authors declare no conflict of interest relating to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Coyne L, 2011, NEUROCHEM INT, V59, P404, DOI 10.1016/j.neuint.2011.01.022; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Denham M, 2011, METHODS MOL BIOL, V793, P99, DOI 10.1007/978-1-61779-328-8_7; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Eigentler A, 2013, STEM CELLS DEV, V22, P3271, DOI 10.1089/scd.2013.0126; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Meijering EHW, 2001, MED IMAGE ANAL, V5, P111, DOI 10.1016/S1361-8415(00)00040-2; Needham K, 2014, STEM CELL RES, V12, P241, DOI 10.1016/j.scr.2013.10.011; Nikkhah G, 2000, NEUROMETH, V36, P207, DOI 10.1007/978-1-59259-690-4_12; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Selak MA, 2011, MITOCHONDRION, V11, P342, DOI 10.1016/j.mito.2010.12.003; Sommer C, 2011, BIOM IM NAN MACR IEE; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U	38	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101718	10.1371/journal.pone.0101718	http://dx.doi.org/10.1371/journal.pone.0101718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000412	Green Published, gold			2022-12-25	WOS:000338637300078
J	Goehring, KC; Kennedy, AD; Prieto, PA; Buck, RH				Goehring, Karen C.; Kennedy, Adam D.; Prieto, Pedro A.; Buck, Rachael H.			Direct Evidence for the Presence of Human Milk Oligosaccharides in the Circulation of Breastfed Infants	PLOS ONE			English	Article							NEUTRAL OLIGOSACCHARIDES; MASS-SPECTROMETRY; BOVINE-MILK; IN-VITRO; URINARY-EXCRETION; QUANTIFICATION; CHROMATOGRAPHY; CONSUMPTION; LACTATION; LACTOSE	Background: It has been hypothesized that human milk oligosaccharides (HMOs) confer systemic health benefits to breastfed infants; however, plausible mechanisms for some effects, such as systemic immunomodulation, require HMOs to access the bloodstream of the developing infant. While small concentrations of HMOs have been detected in the urine of breastfed infants there are no published studies of these oligosaccharides accessing the plasma compartment of breastfed infants. Here we determined the relative fractions of several ingested HMOs in infant urine and plasma. Plasma from formula-fed infants was used as a control. Methods: Using gas chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry/tandem mass spectrometry (LC/MS/MS), and high performance liquid chromatography (HPLC), we analyzed the urine and plasma from 17 healthy formula-fed infants and 16 healthy breast-fed infants (and the milk from their mothers). Results: Multiple HMOs were detected in the urine and plasma of breastfed infants, but not in formula-fed infants. Levels of 2'-fucosyllactose (2'FL), 3FL and lacto-N-neotetraose (LNnT) in both plasma (r = 0.98, p<0.001; r = 0.75, p = 0.002; r = 0.71, p = 0.004) and urine (r = 0.81, p<0.001; r = 0.56, p = 0.026; NS) correlated significantly with concentrations in the corresponding breast milk. The relative fractions of HMOs were low, 0.1% of milk levels for plasma and 4% of milk levels for urine. Within the breastfed cohort, there were significant differences between secretor and nonsecretor groups in levels of several fucosylated HMOs. Conclusion: At least some ingested HMOs are absorbed intact into the circulation and excreted in the urine and their concentrations in these fluids correlate with levels of the corresponding mother's milk. While relative fractions of absorbed HMOs were low, these levels have been shown to have biological effects in vitro, and could explain some of the postulated benefits of human milk.	[Goehring, Karen C.; Prieto, Pedro A.; Buck, Rachael H.] Abbott Nutr, Dept Global Discovery Res, Columbus, OH 43229 USA; [Kennedy, Adam D.] Metabolon Inc, Durham, NC USA	Metabolon	Buck, RH (corresponding author), Abbott Nutr, Dept Global Discovery Res, Columbus, OH 43229 USA.	rachael.buck@abbott.com		Prieto, Pedro/0000-0001-9549-3730	Abbott Nutrition; Metabolon, Inc.	Abbott Nutrition(Abbott Laboratories); Metabolon, Inc.	This research was funded by Abbott Nutrition http://abbottnutrition.com/. The funder Abbott Nutrition provided support in the form of salaries for authors KCG, PAP, and RHB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Metabolon, Inc., provided support in the form of a salary for author ADK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Bode L, 2004, THROMB HAEMOSTASIS, V92, P1402, DOI 10.1160/TH04-01-0055; Bode L, 2004, J LEUKOCYTE BIOL, V76, P820, DOI 10.1189/jlb.0304198; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; de Kivit S, 2011, EUR J PHARMACOL, V668, pS124, DOI 10.1016/j.ejphar.2011.05.086; De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979; De Leoz ML, 2013, ANAL BIOANAL CHEM; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Dotz V, 2014, GLYCOBIOLOGY, V24, P185, DOI 10.1093/glycob/cwt099; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Eiwegger T, 2004, PEDIATR RES, V56, P536, DOI 10.1203/01.PDR.0000139411.35619.B4; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fanaro S, 2005, ACTA PAEDIATR, V94, P22, DOI 10.1080/08035320510043538; Fong B, 2011, J AGR FOOD CHEM, V59, P9788, DOI 10.1021/jf202035m; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gnoth MJ, 2001, J BIOL CHEM, V276, P34363, DOI 10.1074/jbc.M104805200; IP S, 2007, EVID REP TECHNOL ASS, V153, P1; Jantscher-Krenn E, 2012, MINERVA PEDIATR, V64, P83; Kramer MS, 2003, AM J CLIN NUTR, V78, P291, DOI 10.1093/ajcn/78.2.291; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Espinosa RM, 2007, BRIT J NUTR, V98, pS74, DOI 10.1017/S0007114507838062; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Naaraing MA, 2003, J CLIN INVEST, V115, P3256; Ninonuevo MR, 2009, NUTR REV, V67, pS216, DOI 10.1111/j.1753-4887.2009.00243.x; Penttila IA, 2010, J PEDIATR-US, V156, pS21, DOI 10.1016/j.jpeds.2009.11.016; Prieto PA, 2005, FOODS FOODS INGREDIE, V219, P1018; Prieto PA, 2012, ADV NUTR, V3, p456S, DOI 10.3945/an.111.001529; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Radzanowski G, 2013, FASEB J, V27; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Sotgiu S, 2006, Int J Biomed Sci, V2, P114; Stepans MBF, 2006, BREASTFEED MED, V1, P207, DOI 10.1089/bfm.2006.1.207; Takei M, 2010, TOXICOL SCI, V118, P643, DOI 10.1093/toxsci/kfq211; THURL S, 1993, Z ERNAHRUNGSWISS, V32, P262, DOI 10.1007/BF01611164; Thurl S, 1996, ANAL BIOCHEM, V235, P202, DOI 10.1006/abio.1996.0113; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Vohr B.R, 2002, J PERINATOL, V22, P354; Yamamoto K, 2012, BIOSCI BIOTECH BIOCH, V76, P1815, DOI 10.1271/bbb.120401; Yang B, 2012, OPEN GLYCOSCIENCE, V5, P19, DOI DOI 10.2174/1875398101205010019; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	54	144	150	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101692	10.1371/journal.pone.0101692	http://dx.doi.org/10.1371/journal.pone.0101692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999728	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300073
J	Pascopella, L; Franks, J; Marks, SM; Salcedo, K; Schmitz, K; Colson, PW; Hirsch-Moverman, Y; Flood, J; Sayles, J				Pascopella, Lisa; Franks, Julie; Marks, Suzanne M.; Salcedo, Katya; Schmitz, Kjersti; Colson, Paul W.; Hirsch-Moverman, Yael; Flood, Jennifer; Sayles, Jennifer			Opportunities for Tuberculosis Diagnosis and Prevention among Persons Living with HIV: A Cross-Sectional Study of Policies and Practices at Four Large Ryan White Program-Funded HIV Clinics	PLOS ONE			English	Article							INFECTION; GUIDELINES; CARE	Objective: We describe the frequency and attributes of tuberculosis testing and treatment at four publicly-funded HIV clinics. Methods: We abstracted medical records from a random sample of 600 HIV-infected patients having at least one clinic visit in 2009 at four clinics in New York and Los Angeles Metropolitan Statistical areas. We described testing and treatment for tuberculosis infection (TBI), 2008-2010, and estimated adjusted odds ratios (aORs). We interviewed key informants and described clinic policies and practices. Results: Of 600 patients, 500 were eligible for testing, and 393 (79%) were tested 2008-2010; 107 (21%) did not receive at least one tuberculin skin test or interferon gamma release assay. Results were positive in 20 (5%) patients, negative in 357 (91%), and unknown in 16 (4%). Fourteen (70%) of 20 patients with TBI initiated treatment at the clinics; only three were documented to have completed treatment. Three hundred twenty three (54%) patients had chest radiography, 346 (58%) had tuberculosis symptom screening, and three had tuberculosis disease (117 per 100,000 person-years, 95% confidence interval (CI) = 101-165). Adjusting for site, non-Hispanic ethnicity (aOR = 4.9, 95% CI = 2.6-9.5), and employment (aOR = 1.9, 95% CI = 1.0-3.4) were associated with TBI testing; female gender (aOR = 2.0, 95% CI = 1.4-3.3), non-black race (aOR = 1.7, 95% CI = 1.3-2.5), and unemployment (aOR = 1.5, 95% CI = 1.1-2.1) were associated with chest radiography. Clinics evaluated TBI testing performance annually and identified challenges to TB prevention. Conclusions: Study clinics routinely tested patients for TBI, but did not always document treatment. In a population with a high TB rate, ensuring treatment of TBI may enhance TB prevention.	[Pascopella, Lisa; Salcedo, Katya; Flood, Jennifer] Calif Dept Publ Hlth, TB Control Branch, Div Communicable Dis Control, Ctr Infect Dis, Richmond, CA 94804 USA; [Franks, Julie; Schmitz, Kjersti; Colson, Paul W.; Hirsch-Moverman, Yael] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA; [Marks, Suzanne M.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Sayles, Jennifer] Los Angeles Cty Dept Publ Hlth, Off AIDS Programs & Policy, Los Angeles, CA USA	California Department of Public Health; Columbia University; Centers for Disease Control & Prevention - USA; Los Angeles County Department of Public Health	Pascopella, L (corresponding author), Calif Dept Publ Hlth, TB Control Branch, Div Communicable Dis Control, Ctr Infect Dis, Richmond, CA 94804 USA.	lisa.pascopella@cdph.ca.gov			Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention	Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded through the Tuberculosis Epidemiologic Studies Consortium, Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or funding agencies.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; Backus LI, 2010, ARCH INTERN MED, V170, P1239, DOI 10.1001/archinternmed.2010.234; Centers for Disease Control and Prevention, LAT TUB INF GUID PRI; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P333; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Heath Resources and Services Administration HAB, 2010, GOING DIST RYAN WHIT; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Lee LM, 2006, INT J TUBERC LUNG D, V10, P209; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, EMERG INFECT DIS, V19, P400, DOI 10.3201/eid1903.121521; Sterling T, RIFAPENTINE ISONIAZI; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; US Department of Health Services Health and Human Resources (HHS) Health Resources and Service Administration, GUIDE HIV AIDS CLIN	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101313	10.1371/journal.pone.0101313	http://dx.doi.org/10.1371/journal.pone.0101313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000260	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300035
J	Umesh, V; Rape, AD; Ulrich, TA; Kumar, S				Umesh, Vaibhavi; Rape, Andrew D.; Ulrich, Theresa A.; Kumar, Sanjay			Microenvironmental Stiffness Enhances Glioma Cell Proliferation by Stimulating Epidermal Growth Factor Receptor Signaling	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GLIOBLASTOMA-MULTIFORME; EXTRACELLULAR-MATRIX; EGF RECEPTOR; MYOSIN-II; PHASE-II; INHIBITOR; INVASION; ACID; MECHANOTRANSDUCTION	The aggressive and rapidly lethal brain tumor glioblastoma (GBM) is associated with profound tissue stiffening and genomic lesions in key members of the epidermal growth factor receptor (EGFR) pathway. Previous studies from our laboratory have shown that increasing microenvironmental stiffness in culture can strongly enhance glioma cell behaviors relevant to tumor progression, including proliferation, yet it has remained unclear whether stiffness and EGFR regulate proliferation through common or independent signaling mechanisms. Here we test the hypothesis that microenvironmental stiffness regulates cell cycle progression and proliferation in GBM tumor cells by altering EGFR-dependent signaling. We began by performing an unbiased reverse phase protein array screen, which revealed that stiffness modulates expression and phosphorylation of a broad range of signals relevant to proliferation, including members of the EGFR pathway. We subsequently found that culturing human GBM tumor cells on progressively stiffer culture substrates both dramatically increases proliferation and facilitates passage through the G1/S checkpoint of the cell cycle, consistent with an EGFR-dependent process. Western Blots showed that increasing microenvironmental stiffness enhances the expression and phosphorylation of EGFR and its downstream effector Akt. Pharmacological loss-of-function studies revealed that the stiffness-sensitivity of proliferation is strongly blunted by inhibition of EGFR, Akt, or PI3 kinase. Finally, we observed that stiffness strongly regulates EGFR clustering, with phosphorylated EGFR condensing into vinculin-positive focal adhesions on stiff substrates and dispersing as microenvironmental stiffness falls to physiological levels. Our findings collectively support a model in which tissue stiffening promotes GBM proliferation by spatially and biochemically amplifying EGFR signaling.	[Umesh, Vaibhavi; Rape, Andrew D.; Ulrich, Theresa A.; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kumar, S (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu			National Institutes of Health NRSA postdoctoral fellowship [1F32CA174361]; National Institutes of Health [1DP2OD004213, 1U54CA143836]; National Science Foundation [CMMI PESO 1105539]; National Cancer Institute [2P30CA016672]; NATIONAL CANCER INSTITUTE [F32CA174361, U54CA143836, P30CA016672] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER; Directorate For Engineering [1105539] Funding Source: National Science Foundation	National Institutes of Health NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	A.R. gratefully acknowledges the support of a National Institutes of Health NRSA postdoctoral fellowship (1F32CA174361). S.K. gratefully acknowledges support from the National Institutes of Health (1DP2OD004213 and 1U54CA143836) and National Science Foundation (CMMI PESO 1105539). The MD Anderson RPPA Core facility is funded by a grant through the National Cancer Institute (2P30CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2013, ARCH IMMUNOL THER EX, V61, P25, DOI 10.1007/s00005-012-0203-0; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Belot N, 2001, GLIA, V36, P375, DOI 10.1002/glia.1124; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Berens ME, 1999, BIOL ONCOLOGY INVASI, V1, P208; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; de l'Hortet AC, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/476910; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Friedlander DR, 1996, CANCER RES, V56, P1939; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; GRUNT TW, 1991, J CELL SCI, V100, P657; Halatsch ME, 2004, J NEUROSURG, V100, P523, DOI 10.3171/jns.2004.100.3.0523; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Ivkovic S, 2012, MOL BIOL CELL, V23, P533, DOI 10.1091/mbc.E11-01-0039; Jones TS, 2011, TOXICOL PATHOL, V39, P158, DOI 10.1177/0192623310387617; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; KANESKI CR, 1991, PROSTATE, V18, P47, DOI 10.1002/pros.2990180105; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kook SH, 2011, J APPL PHYSIOL, V111, P1575, DOI 10.1152/japplphysiol.00348.2011; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lui VWY, 2002, ANTICANCER RES, V22, P1; Mih JD, 2012, J CELL SCI, V125, P5974, DOI 10.1242/jcs.108886; Mishima K, 2001, CANCER RES, V61, P5349; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PAULUS W, 1993, AM J PATHOL, V143, P154; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shinojima N, 2003, CANCER RES, V63, P6962; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Srikanth M, 2013, NEURO-ONCOLOGY, V15, P319, DOI 10.1093/neuonc/nos316; Stabley D, 2013, INTEGR BIOL-UK, V5, P659, DOI 10.1039/c3ib20239a; Stepanenko AA, 2014, GENE, V540, P263, DOI 10.1016/j.gene.2014.02.053; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2013, J CLIN ONCOL, V31; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	66	78	79	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101771	10.1371/journal.pone.0101771	http://dx.doi.org/10.1371/journal.pone.0101771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000176	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300083
J	Verma, HK; Shukla, P; Alfatah, M; Khare, AK; Upadhyay, U; Ganesan, K; Singh, J				Verma, Hemant Kumar; Shukla, Poonam; Alfatah, Md.; Khare, Asheesh Kumar; Upadhyay, Udita; Ganesan, Kaliannan; Singh, Jagmohan			High Level Constitutive Expression of Luciferase Reporter by lsd90 Promoter in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; PICHIA-PASTORIS; HETEROLOGOUS PROTEINS; INDUCIBLE EXPRESSION; SYSTEM; GENE; THIAMINE	Because of a large number of molecular similarities with higher eukaryotes, the fission yeast Schizosaccharomyces pombe has been considered a potentially ideal host for expressing human proteins having therapeutic and pharmaceutical applications. However, efforts in this direction are hampered by lack of a strong promoter. Here, we report the isolation and characterization of a strong, constitutive promoter from S. pombe. A new expression vector was constructed by cloning the putative promoter region of the lsd90 gene (earlier reported to be strongly induced by heat stress) into a previously reported high copy number vector pJH5, which contained an ARS element corresponding to the mat2P flanking region and a truncated URA3m selectable marker. The resulting vector was used to study and compare the level of expression of the luciferase reporter with that achieved with the known vectors containing regulatable promoter nmt1 and the strong constitutive promoter adh1 in S. pombe and the methanol-inducible AOX1 promoter in Pichia pastoris. Following growth in standard media the new vector containing the putative lsd90 promoter provided constitutive expression of luciferase, at a level, which was 19-, 39- and 10-fold higher than that achieved with nmt1, adh1 and AOX1 promoters, respectively. These results indicate a great potential of the new lsd90 promoter-based vector for commercial scale expression of therapeutic proteins in S. pombe.	[Verma, Hemant Kumar; Shukla, Poonam; Alfatah, Md.; Khare, Asheesh Kumar; Upadhyay, Udita; Ganesan, Kaliannan; Singh, Jagmohan] Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Chandigarh, India.	jag@imtech.res.in	Singh, Jagmohan/CAF-5276-2022; Upadhyay, Udita/R-4111-2019	MISHRA, POONAM/0000-0002-5410-5217	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The Council of Scientific and Industrial Research (CSIR), New Delhi, India is acknowledged for fellowship to Hemant Kumar Verma. This work was supported by intra-mural support from the Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; David SM, 2005, EUKARYOT CELL, V4, P1539; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fujita Y, 2006, FEMS YEAST RES, V6, P883, DOI 10.1111/j.1567-1364.2006.00093.x; Giga-Hama Y, 1999, BIOTECHNOL APPL BIOC, V30, P235; Higgins DR, 1998, METH MOL B, V103, P1; Hollis RP, 2000, APPL ENVIRON MICROB, V66, P1676, DOI 10.1128/AEM.66.4.1676-1679.2000; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; Idiris A, 2010, APPL MICROBIOL BIOT, V85, P667, DOI 10.1007/s00253-009-2151-0; Johnson B.F, 1989, MOL BIOL FISSION YEA, P243; Kumar R, 2004, YEAST, V21, P1343, DOI 10.1002/yea.1184; Leskinen P, 2003, YEAST, V20, P1109, DOI 10.1002/yea.1024; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukaiyama H, 2009, APPL MICROBIOL BIOT, V85, P155, DOI 10.1007/s00253-009-2130-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; SMERDON GR, 1995, GENE, V165, P313, DOI 10.1016/0378-1119(95)00495-R; Takegawa K, 2009, BIOTECHNOL APPL BIOC, V53, P227, DOI 10.1042/BA20090048; Verma HK, 2012, PLASMID, V68, P186, DOI 10.1016/j.plasmid.2012.07.001; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; Yoeyong L, 2005, BIOTECHNOL LETT, V27, P1529	32	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101201	10.1371/journal.pone.0101201	http://dx.doi.org/10.1371/journal.pone.0101201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999979	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300026
J	Wang, PP; An, FM; Zhuang, XJ; Liu, J; Zhao, LY; Zhang, B; Liu, L; Lin, PP; Li, MC				Wang, Peipei; An, Fengmei; Zhuang, Xingjun; Liu, Jiao; Zhao, Liyan; Zhang, Bin; Liu, Liang; Lin, Pingping; Li, Mingchun			Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCADIAN-RHYTHMS; DNA-SYNTHESIS; EXPRESSION; TARGET; LUNG; EFFICACY; KINASE	The epidermal growth factor receptor (EGFR), a ubiquitously expressed receptor tyrosine kinase, is recognized as a key mediator of tumorigenesis in many human epithelial tumors. Erlotinib is tyrosine kinase inhibitor approved by FDA for use in oncology. It inhibits the intracellular phosphorylation of tyrosine kinase associated with the EGFR to restrain the development of the tumor. To investigate the antitumor effect of erlotinib at different dosing times and the underlying molecular mechanism via the PI3K/AKT pathway, we established a mouse model of Lewis lung cancer xenografts. The tumor-bearing mice were housed four or five per cage under standardized light-dark cycle conditions (light on at 7:00 AM, 500 Lux, off at 7:00 PM, 0 Lux) with food and water provided ad libitum. The mice were observed for quality of life, their body weight and tumor volume measured, and the tumor growth curves drawn. After being bled, the mice were sacrificed by cervical dislocation. The tumor masses were removed at different time points and weighed. The mRNA expression of EGFR, AKT, Cyclin D1 and CDK-4 were assayed by quantitative real-time PCR (qRT-PCR). Protein expression levels of AKT, P-AKT and Cyclin D1 were determined by Western blot analysis. The results suggest that erlotinib has a significant antitumor effect on xenografts of non-small cell lung cancer in mice, and its efficacy and toxicity is dependent on the time of day of administration. Its molecular mechanism of action might be related to the EGFR-AKT-Cyclin D1-CDK-4 pathway which plays a crucial role in the development of pathology. Therefore, our findings suggest that the time of day of administration of Erlotinib may be a clinically important variable.	[Wang, Peipei; Liu, Jiao; Zhang, Bin; Liu, Liang; Lin, Pingping] Qingdao Univ, Coll Med, Dept Pharmacol, Qingdao 266071, Peoples R China; [An, Fengmei] 401 Hosp Chinese Peoples Liberat Army, Hand Surg Ctr Whole Army, Qingdao, Peoples R China; [Zhuang, Xingjun] 401 Hosp Chinese Peoples Liberat Army, Dept Oncol, Qingdao, Peoples R China; [Zhao, Liyan; Li, Mingchun] 401 Hosp Chinese Peoples Liberat Army, Dept Pharm, Qingdao, Peoples R China	Qingdao University	Li, MC (corresponding author), 401 Hosp Chinese Peoples Liberat Army, Dept Pharm, Qingdao, Peoples R China.	lmc401y@163.com						Abolmaali K, 2009, SURGERY, V146, P269, DOI 10.1016/j.surg.2009.05.005; Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; ASCHOFF J, 1963, ANNU REV PHYSIOL, V25, P581, DOI 10.1146/annurev.ph.25.030163.003053; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Eriguchi M, 2003, BIOMED PHARMACOTHER, V57, p92S, DOI 10.1016/j.biopha.2003.08.012; Filipski E, 1999, J PHARMACOL EXP THER, V289, P231; Grunwald Viktor, 2002, Current Problems in Cancer, V26, P109; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Herberman RB, 2002, SEMIN ONCOL, V29, P27, DOI 10.1053/sonc.2002.33079; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; HRUSHESKY WJM, 1985, SCIENCE, V228, P73, DOI 10.1126/science.3883493; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; Lemmer B, 2007, ADV DRUG DELIVER REV, V59, P825, DOI 10.1016/j.addr.2007.08.001; Liu W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/651207; Mendelsohn J, 2001, ENDOCR-RELAT CANCER, V8, P3, DOI 10.1677/erc.0.0080003; Modi Shanu, 2002, Curr Oncol Rep, V4, P47, DOI 10.1007/s11912-002-0047-6; Morshed K, 2007, ACTA OTO-LARYNGOL, V127, P760, DOI 10.1080/00016480601001957; Ohdo S, 1997, JPN J PHARMACOL, V75, P283, DOI 10.1254/jjp.75.283; Ohdo S, 2007, J PHARMACOL SCI, V103, P155, DOI 10.1254/jphs.FMJ06003X6; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Patel DM, 2011, INT J PHARM INVESTIG, V1, P172, DOI 10.4103/2230-973X.85969; Paz-Ares L, 2006, J CLIN ONCOL, V24, p369S; Perez-Soler R, 2006, CLIN LUNG CANCER, V8, pS7, DOI 10.3816/CLC.2006.s.008; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Wei QC, 2008, ANN SURG ONCOL, V15, P1193, DOI 10.1245/s10434-007-9771-3; Xian LJ, 2002, CHRONOBIOL INT, V19, P69, DOI 10.1081/CBI-120002590; Xu Fei, 2011, Chin J Cancer, V30, P701, DOI 10.5732/cjc.011.10107	31	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101720	10.1371/journal.pone.0101720	http://dx.doi.org/10.1371/journal.pone.0101720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000529	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300079
J	Wang, Y; Sun, CK; Li, TW; Xu, H; Zhou, Y; Dan, HX; Jiang, L; Zeng, X; Li, LJ; Li, J; Liao, G; Chen, QM				Wang, Yun; Sun, Chongkui; Li, Taiwen; Xu, Hao; Zhou, Yu; Dan, Hongxia; Jiang, Lu; Zeng, Xin; Li, Longjiang; Li, Jing; Liao, Ga; Chen, Qianming			Integrative Approach Detected Association between Genetic Variants of microRNA Binding Sites of TLRs Pathway Genes and OSCC Susceptibility in Chinese Han Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MESSENGER-RNA; CANCER; TOLL; EXPRESSION; TRAF6; INFLAMMATION; PROGRESSION; RECEPTORS; DISEASE	Oral squamous cell carcinoma (OSCC) is a leading malignancy worldwide; the overall 5-year survival rate is approximately 50%. A variety of proteins in Toll-like receptors (TLRs) pathway have been related with the risk of OSCC. However, the influence of genetic variations in TLRs pathway genes on OSCC susceptibility is unclear. Previous studies mainly focused on the coding region of genes, while the UTR region remains unstudied. In the current study, a bioinformatics approach was performed to select candidate single nucleotide polymorphisms (SNPs) on microRNA binding sites of TLRs pathway genes related with OSCC. After screening 90 OSCC related TLRs pathway genes, 16 SNPs were selected for genotyping. We found that rs5030486, the polymorphisms on 3' UTR of TRAF6, was significantly associated with OSCC risk. AG genotype of TRAF6 was strongly associated with a decreased risk of OSCC (OR = 0.252; 95% CI = 0.106, 0.598; p = 0.001). In addition, AG genotype was also related with a reduced risk of OSCC progression both in univariable analysis (HR = 0.303, 95% CI = 0.092, 0.995) and multivariable analysis (HR = 0.272, 95% CI = 0.082, 0.903). Furthermore, after detecting the mRNA expression level of TRAF6 in 24 OSCC patients, we found that TRAF6 expression level was significantly different between patients carrying different genotypes at locus rs5030486 (p = 0.013), indicating that rs5030486 of TRAF6 might contribute to OSCC risk by altering TRAF6 expression level. In general, these data indicated that SNP rs5030486 could be a potential bio-marker for OSCC risk and our results might provide new insights into the association of polymorphisms within the non-coding area of genes with cancers.	[Wang, Yun; Sun, Chongkui; Li, Taiwen; Xu, Hao; Zhou, Yu; Dan, Hongxia; Jiang, Lu; Zeng, Xin; Li, Longjiang; Li, Jing; Liao, Ga; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Xu, Hao] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Li, J; Liao, G (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	lijing1984@scu.edu.cn; liaoga@Gmail.com	Li, Taiwen/GQP-1715-2022; xu, Hao/AAJ-2460-2020; Sun, Chongkui/Q-1534-2019	Sun, Chongkui/0000-0003-0362-4129; Dan, Hongxia/0000-0002-9765-0012; Li, Long-jiang/0000-0003-1446-0692; XU, Hao/0000-0002-5665-0139; Li, Taiwen/0000-0001-7940-8196	National Natural Science Foundation of China [81321002, 81072218, 81270040, 81102060, 81200791, 81001208, 81302371]; Doctoral Program of the Ministry of Education of China [20110181110055, 20100181120057]; International Science and Technology Cooperation Program of China [2012DFA31370]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of the Ministry of Education of China(Ministry of Education, China); International Science and Technology Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81321002, 81072218, 81270040, 81102060, 81200791, 81001208, 81302371, 81321002), Doctoral Program of the Ministry of Education of China (No. 20110181110055, 20100181120057) and the International Science and Technology Cooperation Program of China (No. 2012DFA31370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kauppila JH, 2013, BRIT J CANCER, V108, P638, DOI 10.1038/bjc.2012.589; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kim S, 2011, ANN NY ACAD SCI, V1217, P191, DOI 10.1111/j.1749-6632.2010.05882.x; Kim VN, 2005, MOL CELLS, V19, P1; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kotrashetti VS, 2013, BIOTECH HISTOCHEM, V88, P311, DOI 10.3109/10520295.2013.785592; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Paleja B, 2013, HUM IMMUNOL, V74, P927, DOI 10.1016/j.humimm.2013.04.018; Pinto A, 2011, CANCER IMMUNOL IMMUN, V60, P1211, DOI 10.1007/s00262-011-1057-8; Pisani P, 1996, Cancer Treat Res, V86, P113; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Santarpia M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-163; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; Stadler ME, 2008, HEMATOL ONCOL CLIN N, V22, P1099, DOI 10.1016/j.hoc.2008.08.007; Sun ZJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-33; Wu YY, 2013, INT J ORAL SCI, V5, P212, DOI 10.1038/ijos.2013.65; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yao F, 2013, TUMOR BIOL, V34, P3201, DOI 10.1007/s13277-013-0890-0; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhong L, 2013, TUMOR BIOL, V34, P231, DOI 10.1007/s13277-012-0543-8	37	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101695	10.1371/journal.pone.0101695	http://dx.doi.org/10.1371/journal.pone.0101695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999832	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300074
J	Waltrick, D; Jones, SM; Simpfendorfer, CA; Awruch, CA				Waltrick, Daniela; Jones, Susan M.; Simpfendorfer, Colin A.; Awruch, Cynthia A.			Endocrine Control of Embryonic Diapause in the Australian Sharpnose Shark Rhizoprionodon taylori	PLOS ONE			English	Article							SKATE RAJA-ERINACEA; STEROID-HORMONES; REPRODUCTIVE-BIOLOGY; SERUM CONCENTRATIONS; PROGESTERONE PRODUCTION; SEASONAL REPRODUCTION; FEMALE ELASMOBRANCHS; VIVIPAROUS DOGFISH; CORPUS-LUTEUM; CYCLE	The reproductive cycle of the Australian sharpnose shark, Rhizoprionodon taylori, includes a temporary suspension of development at the commencement of embryogenesis termed embryonic diapause. This study investigated levels of 17 beta-estradiol (E-2), testosterone (T) and progesterone (P-4) in plasma samples of mature wild female R. taylori captured throughout the reproductive cycle and correlated them with internal morphological changes. Levels of T were elevated through most of the embryonic diapause period, suggesting a role of this hormone in the maintenance of this condition. Increasing plasma T concentrations from late diapause to early active development were associated with a possible role of androgens in the termination of embryonic diapause. As in other elasmobranchs, a concomitant increase of E-2 with ovarian follicle size indicated a direct role of this hormone in regulating vitellogenesis, while a peak in P-4 suggested this hormone is associated with preovulation and ovulation. Additionally, significant correlations between photoperiod or water temperature and maximum follicular diameter and hepatosomatic index suggest that these abiotic factors may also play a role triggering and regulating the synchrony and timing of reproductive events.	[Waltrick, Daniela; Simpfendorfer, Colin A.; Awruch, Cynthia A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Waltrick, Daniela; Simpfendorfer, Colin A.; Awruch, Cynthia A.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Jones, Susan M.; Awruch, Cynthia A.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Awruch, Cynthia A.] Consejo Nacl Invest Cient & Tecn, CENPAT, Patagonian Natl Ctr, Puerto Madryn, Chubut, Argentina	James Cook University; James Cook University; University of Tasmania; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Waltrick, D (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	daniela.waltrick@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Waltrick, Daniela/0000-0002-5436-4577	Winifred Violet Scott foundation [Sco-2.181/51]; Australian National Network of Marine Science (ANNIMS); School of Earth and Environmental Sciences, James Cook University	Winifred Violet Scott foundation; Australian National Network of Marine Science (ANNIMS); School of Earth and Environmental Sciences, James Cook University	The major funding for this research was provided by the Winifred Violet Scott foundation (Sco-2.181/51). Additionally, this research received funds from the Australian National Network of Marine Science (ANNIMS) through the postgraduate mobility award and the School of Earth and Environmental Sciences, James Cook University, through the postgraduate research scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMS, 2012, DAT OBT 23 FEBR 2012; ANGELINI F, 1984, Bollettino di Zoologia, V51, P121; Atkins N, 2007, BIOL J LINN SOC, V90, P735, DOI 10.1111/j.1095-8312.2007.00770.x; Awruch CA, 2008, J EXP ZOOL PART A, V309A, P184, DOI 10.1002/jez.445; Awruch CA, 2008, MAR ECOL PROG SER, V355, P277, DOI 10.3354/meps07227; Callard Ian P., 2005, P283; CALLARD IP, 1989, J EXP ZOOL, P12; CALLARD IP, 1993, ENVIRON BIOL FISH, V38, P175, DOI 10.1007/BF00842914; CALLARD IP, 1992, AM ZOOL, V32, P264; CALLARD IP, 1991, J STEROID BIOCHEM, V40, P571, DOI 10.1016/0960-0760(91)90278-D; Carrier JC, 2004, CRC MAR BIOL SER, P269; CASTRO JI, 1993, ENVIRON BIOL FISH, V36, P219, DOI 10.1007/BF00001717; CHIEFFI G., 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P275, DOI 10.1016/0016-6480(62)90098-9; CLIFF G, 1988, S AFR J MARINE SCI, V7, P255, DOI 10.2989/025776188784379035; CRAIK JCA, 1978, J MAR BIOL ASSOC UK, V58, P719, DOI 10.1017/S0025315400041369; CRAIK JCA, 1978, GEN COMP ENDOCR, V35, P455, DOI 10.1016/0016-6480(78)90141-7; CURLEWIS JD, 1992, REPROD FERT DEVELOP, V4, P1, DOI 10.1071/RD9920001; Desmarais JA, 2004, BIOL REPROD, V70, P662, DOI 10.1095/biolreprod.103.023572; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Ewert MA, 2004, EGG INCUBATION ITS E, P173; FORESMAN KR, 1978, BIOL REPROD, V18, P490, DOI 10.1095/biolreprod18.3.490; Gelsleichter J, 2004, CRC MAR BIOL SER, P287; Girling JE, 2003, GEN COMP ENDOCR, V133, P100, DOI 10.1016/S0016-6480(03)00147-3; Guarino FM, 1998, GEN COMP ENDOCR, V111, P261, DOI 10.1006/gcen.1998.7098; Hastings M, 2006, ANN NY ACAD SCI, V453, P182; Heupel MR, 1999, J EXP ZOOL, V284, P586, DOI 10.1002/(SICI)1097-010X(19991001)284:5<586::AID-JEZ14>3.0.CO;2-B; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; Koob TJ, 1999, J EXP ZOOL, V284, P557; KOOB TJ, 1986, BIOL REPROD, V35, P267, DOI 10.1095/biolreprod35.2.267; LANCE V, 1969, GEN COMP ENDOCR, V13, P255, DOI 10.1016/0016-6480(69)90247-0; Last PR, 2009, SHARKS RAYS AUSTR; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Lucifora LO, 2002, ICES J MAR SCI, V59, P553, DOI 10.1006/jmsc.2002.1183; Lutton BV, 2005, ELASMOBRANCH OVARY R, P562; MANIRE CA, 1995, GEN COMP ENDOCR, V97, P366, DOI 10.1006/gcen.1995.1036; Marshall LJ, 2007, MAR FRESHWATER RES, V58, P104, DOI 10.1071/MF05165; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; Mull CG, 2010, GEN COMP ENDOCR, V166, P379, DOI 10.1016/j.ygcen.2009.12.009; Mull CG, 2008, COMP BIOCHEM PHYS A, V151, P717, DOI 10.1016/j.cbpa.2008.08.029; MURPHY BD, 1983, BIOL REPROD, V28, P497, DOI 10.1095/biolreprod28.2.497; Musick John A., 2005, P45; Nicol S, 2005, GEN COMP ENDOCR, V144, P204, DOI 10.1016/j.ygcen.2005.05.013; Norris DO, 2007, ENDOCRINOLOGY MAMMAL, P322; PEREZ L, 1993, J EXP ZOOL, V266, P31, DOI 10.1002/jez.1402660105; Ptak GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033027; R Development Core Team, 2012, R LANG ENV STAT COMP; RASMUSSEN L E L, 1990, NOAA Technical Report NMFS, P143; RASMUSSEN LEL, 1992, AUST J MAR FRESH RES, V43, P273; RASMUSSEN LEL, 1993, ENVIRON BIOL FISH, V38, P167, DOI 10.1007/BF00842913; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Savicky P, 2009, PSPEARMAN SPEARMANS; Shanbhag BA, 2001, GEN COMP ENDOCR, V123, P73, DOI 10.1006/gcen.2001.7647; SIMPFENDORFER CA, 1992, AUST J MAR FRESH RES, V43, P67, DOI 10.1071/MF9920067; Simpfendorfer CA, 1993, BIOL FAMILY CARCHARH; Snelson FF, 1997, GEN COMP ENDOCR, V108, P67, DOI 10.1006/gcen.1997.6949; SORBERA LA, 1995, AM J PHYSIOL-REG I, V269, pR389, DOI 10.1152/ajpregu.1995.269.2.R389; Sulikowski JA, 2005, ENVIRON BIOL FISH, V72, P429, DOI 10.1007/s10641-004-2866-9; SUMPTER JP, 1979, J FISH BIOL, V15, P687, DOI 10.1111/j.1095-8649.1979.tb03678.x; TEWINKEL LE, 1972, J MORPHOL, V136, P433, DOI 10.1002/jmor.1051360404; Tricas TC, 2000, GEN COMP ENDOCR, V118, P209, DOI 10.1006/gcen.2000.7466; TSANG P, 1987, J EXP ZOOL, V241, P377, DOI 10.1002/jez.1402410313; TSANG PCW, 1987, GEN COMP ENDOCR, V66, P182, DOI 10.1016/0016-6480(87)90266-8; USNO, 2011, ASTR APPL DEP DAT OB; Waltrick D, 2012, REV FISH BIOL FISHER, V22, P849, DOI 10.1007/s11160-012-9267-5; Yamaguchi A., 2006, ARIAKE BAY KYUSHU JA	65	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101234	10.1371/journal.pone.0101234	http://dx.doi.org/10.1371/journal.pone.0101234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992673	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000341253400056
J	Bartz, RR; Fu, P; Suliman, HB; Crowley, SD; MacGarvey, NC; Welty-Wolf, K; Piantadosi, CA				Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.; Crowley, Stephen D.; MacGarvey, Nancy Chou; Welty-Wolf, Karen; Piantadosi, Claude A.			Staphylococcus aureus Sepsis Induces Early Renal Mitochondrial DNA Repair and Mitochondrial Biogenesis in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; HEME OXYGENASE; BLOOD-FLOW; DAMAGE; 8-OXOGUANINE; DYSFUNCTION; METABOLISM; MODEL	Acute kidney injury (AKI) contributes to the high morbidity and mortality of multi-system organ failure in sepsis. However, recovery of renal function after sepsis-induced AKI suggests active repair of energy-producing pathways. Here, we tested the hypothesis in mice that Staphyloccocus aureus sepsis damages mitochondrial DNA (mtDNA) in the kidney and activates mtDNA repair and mitochondrial biogenesis. Sepsis was induced in wild-type C57Bl/6J and Cox-8 Gfp-tagged mitochondrial-reporter mice via intraperitoneal fibrin clots embedded with S. aureus. Kidneys from surviving mice were harvested at time zero (control), 24, or 48 hours after infection and evaluated for renal inflammation, oxidative stress markers, mtDNA content, and mitochondrial biogenesis markers, and OGG1 and UDG mitochondrial DNA repair enzymes. We examined the kidneys of the mitochondrial reporter mice for changes in staining density and distribution. S. aureus sepsis induced sharp amplification of renal Tnf, Il-10, and Ngal mRNAs with decreased renal mtDNA content and increased tubular and glomerular cell death and accumulation of protein carbonyls and 8-OHdG. Subsequently, mtDNA repair and mitochondrial biogenesis was evidenced by elevated OGG1 levels and significant increases in NRF-1, NRF-2, and mtTFA expression. Overall, renal mitochondrial mass, tracked by citrate synthase mRNA and protein, increased in parallel with changes in mitochondrial GFP-fluorescence especially in proximal tubules in the renal cortex and medulla. Sub-lethal S. aureus sepsis thus induces widespread renal mitochondrial damage that triggers the induction of the renal mtDNA repair protein, OGG1, and mitochondrial biogenesis as a conspicuous resolution mechanism after systemic bacterial infection.	[Bartz, Raquel R.; Fu, Ping; Suliman, Hagir B.; Piantadosi, Claude A.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA; [Crowley, Stephen D.] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA; [MacGarvey, Nancy Chou] Drexel Coll Med, Dept Med, Philadelphia, PA USA; [Bartz, Raquel R.; Welty-Wolf, Karen; Piantadosi, Claude A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Welty-Wolf, Karen; Piantadosi, Claude A.] Duke Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA	Duke University; Duke University; Drexel University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Bartz, RR (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27708 USA.	Raquel.bartz@dm.duke.edu			National Institutes of Health [K08GM087429, NIHRO1GM084116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084116, K08GM087429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health K08GM087429 (RRB) and NIHRO1GM084116 (CAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Arai T, 2002, CARCINOGENESIS, V23, P2005, DOI 10.1093/carcin/23.12.2005; Bagshaw SM, 2007, CRIT CARE MED, V35, P1592, DOI 10.1097/01.CCM.0000266684.17500.2F; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bartz RR, 2011, AM J RESP CRIT CARE, V183, P226, DOI 10.1164/rccm.200911-1709OC; Bolisetty S, 2013, AM J PHYSL RENAL PHY; Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chouteau JM, 2011, AM J PHYSIOL-LUNG C, V301, pL892, DOI 10.1152/ajplung.00210.2011; CLARK JB, 1974, BIOCHEM J, V140, P25, DOI 10.1042/bj1400025; CLARK JB, 1970, J BIOL CHEM, V245, P4724; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; HARRIS SI, 1982, J BIOL CHEM, V257, P6996; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Jaloszynski P, 2007, BIOCHEM BIOPH RES CO, V364, P966, DOI 10.1016/j.bbrc.2007.10.123; JONES DP, 1986, ANNU REV PHYSIOL, V48, P33; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kaliman PA, 2003, B EXP BIOL MED+, V135, P37, DOI 10.1023/A:1023485626795; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Langenberg C, 2006, KIDNEY INT, V69, P1996, DOI 10.1038/sj.ki.5000440; Langenberg C, 2005, CRIT CARE, V9, pR363, DOI 10.1186/cc3540; Leach M, 1998, BRIT J PHARMACOL, V125, P817, DOI 10.1038/sj.bjp.0702123; Lee SY, 2012, CRIT CARE MED, V40, P2997, DOI 10.1097/CCM.0b013e31825b912d; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Messner UK, 1999, KIDNEY INT, V55, P2322, DOI 10.1046/j.1523-1755.1999.00473.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Nishimura S, 2002, FREE RADICAL BIO MED, V32, P813, DOI 10.1016/S0891-5849(02)00778-5; Nowak G, 1998, AM J PHYSIOL-RENAL, V274, pF509, DOI 10.1152/ajprenal.1998.274.3.F509; Palsamy P, 2011, BIOCH BIOPHYS ACTA; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Ruchko MV, 2011, FREE RADICAL BIO MED, V50, P1107, DOI 10.1016/j.freeradbiomed.2010.10.692; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; TAYLOR DE, 1995, ARCH BIOCHEM BIOPHYS, V316, P70, DOI 10.1006/abbi.1995.1011; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tsuruya K, 2003, DNA REPAIR, V2, P211, DOI 10.1016/S1568-7864(02)00214-8; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Zhang Y, 2011, ANTIOXID REDOX SIGNA	45	31	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100912	10.1371/journal.pone.0100912	http://dx.doi.org/10.1371/journal.pone.0100912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988481	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100051
J	Chen, Z; Chen, M; Xu, ZS; Li, LC; Chen, XP; Ma, YZ				Chen Zhu; Chen Ming; Xu Zhao-shi; Li Lian-cheng; Chen Xue-ping; Ma You-zhi			Characteristics and Expression Patterns of the Aldehyde Dehydrogenase (ALDH) Gene Superfamily of Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							PLANT CRATEROSTIGMA-PLANTAGINEUM; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; EVOLUTIONARY FATE; STRESS TOLERANCE; TOBACCO PLANTS; SALT TOLERANCE; PROTEIN; RICE; SEQUENCE	Recent genomic sequencing of the foxtail millet, an abiotic, stress-tolerant crop, has provided a great opportunity for novel gene discovery and functional analysis of this popularly-grown grass. However, few stress-mediated gene families have been studied. Aldehyde dehydrogenases (ALDHs) comprise a gene superfamily encoding NAD (P)(+)-dependent enzymes that play the role of "aldehyde scavengers'', which indirectly detoxify cellular ROS and reduce the effect of lipid peroxidation meditated cellular toxicity under various environmental stresses. In the current paper, we identified a total of 20 ALDH genes in the foxtail millet genome using a homology search and a phylogenetic analysis and grouped them into ten distinct families based on their amino acid sequence identity. Furthermore, evolutionary analysis of foxtail millet reveals that both tandem and segmental duplication contributed significantly to the expansion of its ALDH genes. The exon-intron structures of members of the same family in foxtail millet or the orthologous genes in rice display highly diverse distributions of their exonic and intronic regions. Also, synteny analysis shows that the majority of foxtail millet and rice ALDH gene homologs exist in the syntenic blocks between the two, implying that these ALDH genes arose before the divergence of cereals. Semiquantitative and real-time quantitative PCR data reveals that a few SiALDH genes are expressed in an organ-specific manner and that the expression of a number of foxtail millet ALDH genes, such as, SiALDH7B1, SiALDH12A1 and SiALDH18B2 are upregulated by osmotic stress, cold, H2O2, and phytohormone abscisic acid (ABA). Furthermore, the transformation of SiALDH2B2, SiALDH10A2, SiALDH5F1, SiALDH22A1, and SiALDH3E2 into Escherichia coli (E. coli) was able to improve their salt tolerance. Taken together, our results show that genome-wide identification characteristics and expression analyses provide unique opportunities for assessing the functional roles of foxtail millet ALDH genes in stress responses.	[Chen Zhu; Chen Xue-ping] Univ Sci & Technol China, Dept Chem, Hefei 230026, Anhui, Peoples R China; [Chen Zhu; Chen Ming; Xu Zhao-shi; Li Lian-cheng; Ma You-zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Chen, XP (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei 230026, Anhui, Peoples R China.	chenxp08@ustc.edu.cn; mayouzhi@caas.cn	Chen, Zhu/W-6748-2018	chen, zhu/0000-0002-9974-0716	National Key Project for Research on Transgenic Biology [2013ZX08002-002]; National 863 High-tech Project [2012AA10A309]	National Key Project for Research on Transgenic Biology; National 863 High-tech Project(National High Technology Research and Development Program of China)	This work was supported by the National Key Project for Research on Transgenic Biology (2013ZX08002-002) and the National 863 High-tech Project (2012AA10A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achary VMM, 2008, ECOTOX ENVIRON SAFE, V70, P300, DOI 10.1016/j.ecoenv.2007.10.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; Fitzgerald TL, 2009, PLANT BIOLOGY, V11, P119, DOI 10.1111/j.1438-8677.2008.00161.x; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grabber JH, 2000, J AGR FOOD CHEM, V48, P6106, DOI 10.1021/jf0006978; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nakamura T, 1997, PLANT J, V11, P1115, DOI 10.1046/j.1365-313X.1997.11051115.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; Razavizadeh R, 2009, EFFECTS SALT STRESS; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valverde F, 1999, FEBS LETT, V449, P153, DOI 10.1016/S0014-5793(99)00430-5; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; Wen YQ, 2012, PLANTA, V236, P525, DOI 10.1007/s00425-012-1624-z; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yamada A, 2002, PLANT CELL PHYSIOL, V43, P1043, DOI 10.1093/pcp/pcf120; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033514	69	27	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101136	10.1371/journal.pone.0101136	http://dx.doi.org/10.1371/journal.pone.0101136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988301	Green Published, gold			2022-12-25	WOS:000341354100064
J	Heenan, A; Troje, NF				Heenan, Adam; Troje, Nikolaus F.			Both Physical Exercise and Progressive Muscle Relaxation Reduce the Facing-the-Viewer Bias in Biological Motion Perception	PLOS ONE			English	Article							ATTENTIONAL BIAS; SOCIAL PHOBIA; ANXIETY; THREAT; POINT; METAANALYSIS; ORIENTATION; STRESS; GENDER	Biological motion stimuli, such as orthographically projected stick figure walkers, are ambiguous about their orientation in depth. The projection of a stick figure walker oriented towards the viewer, therefore, is the same as its projection when oriented away. Even though such figures are depth-ambiguous, however, observers tend to interpret them as facing towards them more often than facing away. Some have speculated that this facing-the-viewer bias may exist for sociobiological reasons: Mistaking another human as retreating when they are actually approaching could have more severe consequences than the opposite error. Implied in this hypothesis is that the facing-towards percept of biological motion stimuli is potentially more threatening. Measures of anxiety and the facing-the-viewer bias should therefore be related, as researchers have consistently found that anxious individuals display an attentional bias towards more threatening stimuli. The goal of this study was to assess whether physical exercise (Experiment 1) or an anxiety induction/reduction task (Experiment 2) would significantly affect facing-the-viewer biases. We hypothesized that both physical exercise and progressive muscle relaxation would decrease facing-the-viewer biases for full stick figure walkers, but not for bottom-or top-half-only human stimuli, as these carry less sociobiological relevance. On the other hand, we expected that the anxiety induction task (Experiment 2) would increase facing-the-viewer biases for full stick figure walkers only. In both experiments, participants completed anxiety questionnaires, exercised on a treadmill (Experiment 1) or performed an anxiety induction/reduction task (Experiment 2), and then immediately completed a perceptual task that allowed us to assess their facing-theviewer bias. As hypothesized, we found that physical exercise and progressive muscle relaxation reduced facing-the-viewer biases for full stick figure walkers only. Our results provide further support that the facing-the-viewer bias for biological motion stimuli is related to the sociobiological relevance of such stimuli.	[Heenan, Adam; Troje, Nikolaus F.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Troje, Nikolaus F.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Troje, Nikolaus F.] Canadian Inst Adv Res, Toronto, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Canadian Institute for Advanced Research (CIFAR)	Heenan, A (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	adam.heenan@queensu.ca		Troje, Niko/0000-0002-1533-2847	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Advanced Research (CIfAR); Canadian Action and Perception Network (CAPnet)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIfAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Action and Perception Network (CAPnet)	This research was supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Institute for Advanced Research (CIfAR), and the Canadian Action and Perception Network (CAPnet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRKE MS, 1978, COGNITIVE THER RES, V2, P323, DOI 10.1007/BF01172650; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson H., 1975, RELAXATION RESPONSE; Bourne, 2011, ANXIETY PHOBIA WORKB; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; CICONE MV, 1978, J SOC ISSUES, V34, P5, DOI 10.1111/j.1540-4560.1978.tb02537.x; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; DRISCOLL R, 1976, PSYCHOL REC, V26, P87, DOI 10.1007/BF03394364; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Gray KLH, 2009, COGNITION, V113, P105, DOI 10.1016/j.cognition.2009.06.009; Heenan A, 2012, CAN J EXP PSYCHOL, V66, P302; Heeren A, 2012, COGNITIVE THER RES, V36, P512, DOI 10.1007/s10608-011-9394-7; HOLLAND JC, 1991, J CLIN ONCOL, V9, P1004, DOI 10.1200/JCO.1991.9.6.1004; Jackson S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003982; Kilts CD, 2006, NEUROPSYCHOPHARMACOL, V31, P2243, DOI 10.1038/sj.npp.1301053; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Langer MS, 2001, PERCEPTION, V30, P403, DOI 10.1068/p3178; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Manera V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037514; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Musa CZ, 2000, EUR PSYCHIAT, V15, P59, DOI 10.1016/S0924-9338(00)00210-8; OST LG, 1988, BEHAV RES THER, V26, P13, DOI 10.1016/0005-7967(88)90029-0; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-00002; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schouten B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056978; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Singer N, 2012, EMOTION, V12, P960, DOI 10.1037/a0027070; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Troje N., 2008, UNDERSTANDING EVENTS, P308, DOI [10.1093/acprof:oso/9780195188370.003.0014, DOI 10.1093/ACPR0T0S0/9780195188370.003.0014]; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Van de Cruys S, 2013, ACTA PSYCHOL, V144, P548, DOI 10.1016/j.actpsy.2013.09.010; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.392	47	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99902	10.1371/journal.pone.0099902	http://dx.doi.org/10.1371/journal.pone.0099902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987956	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100021
J	Takeda, D; Hasegawa, T; Ueha, T; Imai, Y; Sakakibara, A; Minoda, M; Kawamoto, T; Minamikawa, T; Shibuya, Y; Akisue, T; Sakai, Y; Kurosaka, M; Komori, T				Takeda, Daisuke; Hasegawa, Takumi; Ueha, Takeshi; Imai, Yusuke; Sakakibara, Akiko; Minoda, Masaya; Kawamoto, Teruya; Minamikawa, Tsutomu; Shibuya, Yasuyuki; Akisue, Toshihiro; Sakai, Yoshitada; Kurosaka, Masahiro; Komori, Takahide			Transcutaneous Carbon Dioxide Induces Mitochondrial Apoptosis and Suppresses Metastasis of Oral Squamous Cell Carcinoma In Vivo	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; LYMPH-NODE METASTASIS; MATRIX METALLOPROTEINASE-2; CLINICAL-SIGNIFICANCE; EXPRESSION; TRANSPLANTATION; TONGUE; CANCER; VEGF; MATRIX-METALLOPROTEINASE-9	Squamous cell carcinoma (SCC) is the main histological type of oral cancer. Its growth rate and incidence of metastasis to regional lymph nodes is influenced by various factors, including hypoxic conditions. We have previously reported that transcutaneous CO2 induces mitochondrial apoptosis and decreases lung metastasis by reoxygenating sarcoma cells. However, previous studies have not determined the sequential mechanism by which transcutaneous CO2 suppresses growth of epithelial tumors, including SCCs. Moreover, there is no report that transcutaneous CO2 suppresses lymphogenous metastasis using human cell lines xenografts. In this study, we examined the effects of transcutaneous CO2 on cancer apoptosis and lymphogenous metastasis using human SCC xenografts. Our results showed that transcutaneous CO2 affects expressions of PGC-1 alpha and TFAM and protein levels of cleavage products of caspase-3, caspase-9 and PARP, which relatives mitochondrial apoptosis. They also showed that transcutaneous CO2 significantly inhibits SCC tumor growth and affects expressions of HIF-1 alpha, VEGF, MMP-2 and MMP-9, which play essential roles in tumor angiogenesis, invasion and metastasis. In conclusion, transcutaneous CO2 suppressed tumor growth, increased mitochondrial apoptosis and decreased the number of lymph node metastasis in human SCC by decreasing intra-tumoral hypoxia and suppressing metastatic potential with no observable effect in vivo. Our findings indicate that transcutaneous CO2 could be a novel therapeutic tool for treating human SCC.	[Takeda, Daisuke; Hasegawa, Takumi; Imai, Yusuke; Sakakibara, Akiko; Minamikawa, Tsutomu; Shibuya, Yasuyuki; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan; [Ueha, Takeshi] NeoChemir, Kobe, Hyogo, Japan; [Minoda, Masaya; Kawamoto, Teruya; Akisue, Toshihiro; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan; [Sakai, Yoshitada] Kobe Univ, Grad Sch Med, Div Rehabil Med, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Hasegawa, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 657, Japan.	hasetaku@med.kobe-u.ac.jp	Akisue, Toshihiro/V-6187-2019	Akisue, Toshihiro/0000-0003-3708-4095; Kawamoto, Teruya/0000-0003-1845-7482	Japan Society for the Promotion of Science [24792209]; Grants-in-Aid for Scientific Research [24593028] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a Grant-in-Aid for Young Scientists (B) Number 24792209 from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley NJP, 2002, CANCER RES, V62, P2493; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Comerford KM, 2002, CANCER RES, V62, P3387; de Vicente JC, 2005, ORAL ONCOL, V41, P283, DOI 10.1016/j.oraloncology.2004.08.013; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Harada R, 2013, EXP CELL RES, V319, P1988, DOI 10.1016/j.yexcr.2013.05.019; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Kang FW, 2013, EXP THER MED, V5, P112, DOI 10.3892/etm.2012.779; Komatsubara Hideki, 2002, Kobe Journal of Medical Sciences, V48, P145; Komatsubara Hideki, 2005, Kobe Journal of Medical Sciences, V51, P67; Liang XH, 2008, ANTICANCER RES, V28, P1659; Ling W, 2013, J ORAL MAXIL SURG, V71, P775, DOI 10.1016/j.joms.2012.09.026; Matsui T, 1998, ORAL ONCOL, V34, P253; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Miyazaki Y, 2008, INT J ONCOL, V32, P145; Oe K, 2011, BIOCHEM BIOPH RES CO, V407, P148, DOI 10.1016/j.bbrc.2011.02.128; Oguni A, 2010, INT J ORAL MAX SURG, V39, P42, DOI 10.1016/j.ijom.2009.10.006; Okada Y, 2010, ODONTOLOGY, V98, P52, DOI 10.1007/s10266-009-0117-4; Onishi Y, 2012, J CANC SCI THERAPY, V4, P7, DOI 10.4172/1948-5956.1000136; Onishi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03916; Onishi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049189; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Perez-Sayans M, 2011, CANCER LETT, V313, P1, DOI 10.1016/j.canlet.2011.08.017; Qiao B, 2010, INT J ONCOL, V37, P663, DOI 10.3892/ijo_00000715; Resch K L, 1994, Wien Med Wochenschr, V144, P45; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sakai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024137; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Shemirani B, 2002, ORAL ONCOL, V38, P251, DOI 10.1016/S1368-8375(01)00052-5; Shigeta T, 2008, ORAL SURG ORAL MED O, V105, P486, DOI 10.1016/j.tripleo.2007.06.016; Smith BD, 2000, J CLIN ONCOL, V18, P2046, DOI 10.1200/JCO.2000.18.10.2046; Sugiura T, 2009, INT J ONCOL, V34, P673, DOI 10.3892/ijo_00000193; Sun R, 2008, CHINESE MED J-PEKING, V121, P1891, DOI 10.1097/00029330-200810010-00007; Tamamura R, 2013, ACTA HISTOCHEM, V115, P113, DOI 10.1016/j.acthis.2012.05.001; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Uehara M, 2009, ORAL ONCOL, V45, P241, DOI 10.1016/j.oraloncology.2008.05.007; Umeda M, 2001, BRIT J ORAL MAX SURG, V39, P376, DOI 10.1054/bjom.2000.0590; Yang An-Kui, 2008, Ai Zheng, V27, P1315; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yasuda A, 2011, ORAL ONCOL, V47, P334, DOI 10.1016/j.oraloncology.2011.03.001; Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035; Zhou CX, 2010, AUST DENT J, V55, P385, DOI 10.1111/j.1834-7819.2010.01258.x	45	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100530	10.1371/journal.pone.0100530	http://dx.doi.org/10.1371/journal.pone.0100530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988190	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100031
J	Palczewski, G; Amengual, J; Hoppel, CL; von Lintig, J				Palczewski, Grzegorz; Amengual, Jaume; Hoppel, Charles L.; von Lintig, Johannes			Evidence for compartmentalization of mammalian carotenoid metabolism	FASEB JOURNAL			English	Article						BCO1; BCO2; beta-carotene; zeaxanthin; vitamin A	BETA-CAROTENE; RETINOIC ACID; VITAMIN-A; EXCENTRIC CLEAVAGE; IN-VITRO; MACULAR DEGENERATION; ENZYMATIC CLEAVAGE; ESCHERICHIA-COLI; RAT-LIVER; IDENTIFICATION	The critical role of retinoids (vitamin A and its derivatives) for vision, reproduction, and survival has been well established. Vitamin A is produced from dietary carotenoids such as beta-carotene by centric cleavage via the enzyme BCO1. The biochemical and molecular identification of a second structurally related beta-carotene metabolizing enzyme, BCO2, has led to a prolonged debate about its relevance in vitamin A biology. While BCO1 cleaves provitamin A carotenoids, BCO2 is more promiscuous and also metabolizes non-provitamin A carotenoids such as zeaxanthin into long-chain apo-carotenoids. Herein we demonstrate, in cell lines, that human BCO2 is associated with the inner mitochondrial membrane. Different human BCO2 isoforms possess cleavable N-terminal leader sequences critical for mitochondrial import. Subfractionation of murine hepatic mitochondria confirmed the localization of BCO2 to the inner mitochondrial membrane. Studies in BCO2-knockout mice revealed that zeaxanthin accumulates in the inner mitochondrial membrane; in contrast, beta-carotene is retained predominantly in the cytoplasm. Thus, we provide evidence for a compartmentalization of carotenoid metabolism that prevents competition between BCO1 and BCO2 for the provitamin and the production of noncanonical beta-carotene metabolites.-Palczewski, G., Amengual, J., Hoppel, C. L., von Lintig, J. Evidence for compartmentalization of mammalian carotenoid metabolism.	[Palczewski, Grzegorz] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Amengual, Jaume; Hoppel, Charles L.; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44106 USA.	jxv99@case.edu		von Lintig, Johannes/0000-0002-2079-2143	U.S. National Institute of Health [EY019641, EY02551]; visual science training program [T32-EY07157]; NATIONAL EYE INSTITUTE [T32EY007157, R01EY019641] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); visual science training program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Marcin Golczak [Case Western Reserve University (CWRU)] for help with LC-MS analysis of carotenoids and apo-carotenoids. The authors thank Dr. Janos Kerner (CWRU) and Dr. Mariana Rosca (CWRU) for help with methods in mitochondrial preparation. The authors thank Hiral Patel (CWRU) for assaying mitochondrial fractions for purity. The authors are grateful to Dr. Philip Kiser (CWRU) for helping with modeling of carotenoid oxygenases. The authors are grateful to Dr. Hisashi Fujioka and the Case Electron Microscopy Core Facility for assistance with immunogold staining and imaging. The authors are grateful to Dr. Hansgeorg Ernst (BASF, Ludwigshafen, Germany) for the gift of apo-carotenoid standards. The authors thank Maryanne Pendergast and the Neurosciences Imaging Center for assistance with confocal microscopy. This work was supported by U.S. National Institute of Health grants EY019641 and EY02551 and the visual science training program T32-EY07157.	Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Borel P, 1998, J LIPID RES, V39, P2250; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Burri BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P110, DOI 10.1016/j.abb.2004.04.028; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; FALOONA GR, 1969, BIOCHEMISTRY-US, V8, P4497, DOI 10.1021/bi00839a041; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLOVER J, 1960, VITAM HORM, V18, P371; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HANSEN S, 1988, BIOCHEMISTRY-US, V27, P200, DOI 10.1021/bi00401a030; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL CL, 1972, J BIOL CHEM, V247, P832; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kowatz T, 2013, ARCH BIOCHEM BIOPHYS, V539, P214, DOI 10.1016/j.abb.2013.05.007; Krinsky N, 2001, NUTR REV, V59, P309; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sabour-Pickett S, 2012, MOL NUTR FOOD RES, V56, P270, DOI 10.1002/mnfr.201100219; SanGiovanni JP, 2012, AM J CLIN NUTR, V96, p1223S, DOI 10.3945/ajcn.112.038240; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tian R, 2010, ANIM GENET, V41, P253, DOI 10.1111/j.1365-2052.2009.01990.x; Tibaduiza EC, 2002, J NUTR, V132, P1368, DOI 10.1093/jn/132.6.1368; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; von Lintig J, 2012, J BIOL CHEM, V287, P1627, DOI 10.1074/jbc.R111.303990; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; WANG XD, 1992, ARCH BIOCHEM BIOPHYS, V293, P298, DOI 10.1016/0003-9861(92)90399-H; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; Wolf G, 2001, NUTR REV, V59, P116; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	66	67	67	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4457	4469		10.1096/fj.14-252411	http://dx.doi.org/10.1096/fj.14-252411			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002123	Green Published			2022-12-25	WOS:000342222700023
J	Xu, Y; Wang, N; Yu, Y; Li, Y; Li, YB; Yu, YB; Zhou, XQ; Sun, ZW				Xu, Ying; Wang, Na; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei			Exposure to Silica Nanoparticles Causes Reversible Damage of the Spermatogenic Process in Mice	PLOS ONE			English	Article							MALE-INFERTILITY; OXIDATIVE STRESS; CARBON NANOTUBES; MALE RATS; IN-VITRO; TOXICITY; KERATINOCYTES; FERTILITY; SYSTEM; SIO2	Environmental exposure to nanomaterials is inevitable, as nanomaterials have become part of our daily life now. In this study, we firstly investigated the effects of silica nanoparticles on the spermatogenic process according to their time course in male mice. 48 male mice were randomly divided into control group and silica nanoparticle group with 24 mice per group, with three evaluation time points (15, 35 and 60 days after the first dose) per group. Mice were exposed to the vehicle control and silica nanoparticles at a dosage of 20 mg/kg every 3 days, five times over a 13-day period, and were sacrificed at 15, 35 and 60 days after the first dose. The results showed that silica nanoparticles caused damage to the mitochondrial cristae and decreased the levels of ATP, resulting in oxidative stress in the testis by days 15 and 35; however, the damage was repaired by day 60. DNA damage and the decreases in the quantity and quality of epididymal sperm were found by days 15 and 35; but these changes were recovered by day 60. In contrast, the acrosome integrity and fertility in epididymal sperm, the numbers of spermatogonia and sperm in the testes, and the levels of three major sex hormones were not significantly affected throughout the 60-day period. The results suggest that nanoparticles can cause reversible damage to the sperms in the epididymis without affecting fertility, they are more sensitive than both spermatogonia and spermatocytes to silica nanoparticle toxicity. Considering the spermatogenesis time course, silica nanoparticles primarily influence the maturation process of sperm in the epididymis by causing oxidative stress and damage to the mitochondrial structure, resulting in energy metabolism dysfunction.	[Xu, Ying; Wang, Na; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei] Capital Med Univ, Dept Hlth Toxicol & Hlth Chem, Sch Publ Hlth, Beijing, Peoples R China; [Xu, Ying; Yu, Yang; Li, Yang; Li, Yan-Bo; Yu, Yong-Bo; Zhou, Xian-Qing; Sun, Zhi-Wei] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing, Peoples R China; [Wang, Na] Capital Med Univ, Dept Lab Anim Sci, Sch Basic Med Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhou, XQ (corresponding author), Capital Med Univ, Dept Hlth Toxicol & Hlth Chem, Sch Publ Hlth, Beijing, Peoples R China.	xqzhou@ccmu.edu.cn; zwsun@ccmu.edu.cn	Yu, Yongbo/AAE-9353-2019		National Natural Science Foundation of China [81172704]; Human Resources Development of the Beijing Education Committee [PHR201006110]; Innovative Team Project of the Beijing Education Committee [PHR201107116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Human Resources Development of the Beijing Education Committee; Innovative Team Project of the Beijing Education Committee	The study was supported by the National Natural Science Foundation of China (No. 81172704), the Human Resources Development of the Beijing Education Committee (No. PHR201006110) and from the Innovative Team Project of the Beijing Education Committee (No. PHR201107116). Their websites are: http://www.nsfc.gov.cn, http://www.bjedu.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JG, 1987, J ANDROL, V8, P338; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; [陈秋菊 Chen Qiuju], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P811; Duan C, 2003, CYTOGENET GENOME RES, V103, P352, DOI 10.1159/000076824; Fan Yi-Ou, 2006, Wei Sheng Yan Jiu, V35, P549; Hayes AW, 1994, PRINCIPLES METHODS T, P937; Hong WenXu, 2011, Journal of Environment and Health, V28, P1048; HOWARDS SS, 1995, NEW ENGL J MED, V332, P312, DOI 10.1056/NEJM199502023320507; Jiang QG, 1994, MALE MAN REPROD TOXI, P215; Kong Lu, 2011, Asian Journal of Ecotoxicology, V6, P655; Li C, 2009, TOXICOL LETT, V185, P1, DOI 10.1016/j.toxlet.2008.11.012; Li X, 2007, J BIOMED MATER RES B, V83B, P431, DOI 10.1002/jbm.b.30813; Lin BC, 2008, J PREVENTIVE MED CHI, V26, P172; Lin Ben-cheng, 2007, Asian Journal of Ecotoxicology, V2, P195; Liu TL, 2011, BIOMATERIALS, V32, P1657, DOI 10.1016/j.biomaterials.2010.10.035; Nagy A, 2003, MANIPULATING MOUSE E, P415; Ozaki T., 2002, Archives of Gynecology and Obstetrics, V266, P114, DOI 10.1007/s004040000112; [曲秋莲 Qu Qiulian], 2010, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V34, P306; Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Ramdhan DH, 2009, TOXICOL LETT, V191, P103, DOI 10.1016/j.toxlet.2009.08.013; Rao AV, 1997, FREE RADIC BIOL MED, V29, P1015; Roy I, 2003, J AM CHEM SOC, V125, P7860, DOI 10.1021/ja0343095; Saleh RA, 2002, J ANDROL, V23, P737; Sergerie M, 2005, HUM REPROD, V20, P3446, DOI 10.1093/humrep/dei231; Shi C, 2008, EXP GERONTOL, V43, P589, DOI 10.1016/j.exger.2008.02.004; Sun L, 2011, TOXICOL IN VITRO, V25, P1619, DOI 10.1016/j.tiv.2011.06.012; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Wang B, 2012, J NANOSCI NANOTECHNO, V12, P293, DOI 10.1166/jnn.2012.5127; Wang SG, 2011, ENVIRON MOL MUTAGEN, V52, P614, DOI 10.1002/em.20660; WATANABE T, 1991, MUTAT RES, V262, P93, DOI 10.1016/0165-7992(91)90113-I; Xu C, 2005, REPROD BIOL THEORY P, P19; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Yoshida S, 2009, INT J ANDROL, V32, P337, DOI 10.1111/j.1365-2605.2007.00865.x; Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061346; Zhang Y, 2011, J FUJIAN MED U, V45, P122	37	52	56	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101572	10.1371/journal.pone.0101572	http://dx.doi.org/10.1371/journal.pone.0101572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003337	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700040
J	Lai, NS; Tsai, TY; Koo, M; Huang, KY; Tung, CH; Lu, MC				Lai, Ning-Sheng; Tsai, Tzung-Yi; Koo, Malcolm; Huang, Kuang-Yung; Tung, Chien-Hsueh; Lu, Ming-Chi			Patterns of Ambulatory Medical Care Utilization and Rheumatologist Consultation Predating the Diagnosis of Systemic Lupus Erythematosus: A National Population-Based Study	PLOS ONE			English	Article							COLLEGE-OF-RHEUMATOLOGY; CLINICS CLASSIFICATION CRITERIA; AUTOANTIBODIES; MANIFESTATIONS; PREVALENCE; ONSET; FEATURES; DISEASE; REGION	Objective: To investigate the records of ambulatory medical care from patients predating the diagnosis of systemic lupus erythematosus (SLE) using nationwide, population-based claims data. Methods: The frequencies and costs of ambulatory medical care utilization in 337 newly-diagnosed SLE cases between 2004 and 2010, identified from Taiwan's National Health Insurance Research Database, were compared with 1,348 controls who were frequency matched for sex, age, and the catastrophic illness certificate application year of the cases. Results: Patients with SLE had a median frequency of ambulatory medical care utilization compared with controls one year prior to the index date (22 vs. 2, P<0.001). The differences were significant throughout all eight annual periods. Similarly, the inflation-adjusted costs of ambulatory medical care utilization in patients with SLE increased annually over the study period, from a median of US$18 eight years prior to the index date to US$680 one year prior to the index date. Diseases of the respiratory system (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 460-519), digestive system (ICD-9-CM codes 520-579), musculoskeletal system and connective tissue (ICD-9-CM codes 710-739, excluding 710.0), and skin and subcutaneous tissue (ICD-9-CM codes 680-709) were the top four common causes of visits in the 0.5 to 2 year period preceding the index date and percentages of SLE patients suffered from these disorders increased progressively over the study period. Only 56.4% of the patients with SLE had consulted a rheumatologist and most of the serology tests were done within one year predating the index date. Conclusions: Increased frequencies and costs of ambulatory care utilization among Taiwanese patients with SLE occurred several years predating their definitive SLE diagnosis. When multisystemic disorders are presented in young female patients, the possibility of SLE should be considered and screened with tools such as the antinuclear antibody test.	[Lai, Ning-Sheng; Huang, Kuang-Yung; Tung, Chien-Hsueh; Lu, Ming-Chi] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lai, Ning-Sheng; Huang, Kuang-Yung; Lu, Ming-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, Tzung-Yi; Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Tsai, Tzung-Yi] Tzu Chi Coll Technol, Dept Nursing, Hualien, Taiwan; [Tsai, Tzung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University of Science & Technology; National Cheng Kung University; University of Toronto	Lu, MC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.	e360187@yahoo.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan [DTCRD101-E-08]	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan	This work was supported by a grant from the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (DTCRD101-E-08), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2001, SCAND J IMMUNOL, V54, P211, DOI 10.1046/j.1365-3083.2001.00959.x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bernatsky S, 2013, J AUTOIMMUN, V42, P130, DOI 10.1016/j.jaut.2012.12.009; Bertsias GK, 2013, NAT REV RHEUMATOL, V9, P687, DOI 10.1038/nrrheum.2013.103; Bruner BF, 2012, ARTHRITIS RHEUM-US, V64, P3677, DOI 10.1002/art.34651; Cerovec M, 2012, CROAT MED J, V53, P149, DOI 10.3325/cmj.2012.53.149; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ebert EC, 2011, J CLIN GASTROENTEROL, V45, P436, DOI 10.1097/MCG.0b013e31820f81b8; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Heinlen LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009599; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Jolly M, 2006, ARTHRIT RHEUM-ARTHR, V55, P821, DOI 10.1002/art.22233; Kastanioudakis I, 2002, J LARYNGOL OTOL, V116, P103; Kumar K, 2012, RHEUMATOL INT, V32, P73, DOI 10.1007/s00296-010-1556-5; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin YJ, 2008, CLIN IMMUNOL, V129, P36, DOI 10.1016/j.clim.2008.05.011; Lin YC, 2012, RHEUMATOL INT, V32, P1669, DOI 10.1007/s00296-011-1847-5; Lionaki S, 2013, LUPUS, V22, P95, DOI 10.1177/0961203312467668; LU R, 2012, AUTOIMMUNE DIS, V2012; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pons-Estel GJ, 2014, LUPUS, V23, P3, DOI 10.1177/0961203313512883; Pyne D, 2002, ANN RHEUM DIS, V61, P70, DOI 10.1136/ard.61.1.70; Sivaraj RR, 2007, RHEUMATOLOGY, V46, P1757, DOI 10.1093/rheumatology/kem173; Spinillo A, 2012, ANN RHEUM DIS, V71, P918, DOI 10.1136/annrheumdis-2011-154146; Sultan SM, 1999, RHEUMATOLOGY, V38, P917, DOI 10.1093/rheumatology/38.10.917; Torre Olga, 2011, Presse Med, V40, pe19, DOI 10.1016/j.lpm.2010.11.004; VLACHOYIANNOPOULOS PG, 1993, LUPUS, V2, P303, DOI 10.1177/096120339300200505; Wichainun R, 2013, ASIAN PAC J ALLERGY, V31, P292, DOI 10.12932/AP0272.31.4.2013	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101485	10.1371/journal.pone.0101485	http://dx.doi.org/10.1371/journal.pone.0101485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999630	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300048
J	Miettinen, ME; Kinnunen, L; Leiviska, J; Keinanen-Kiukaanniemi, S; Korpi-Hyovalti, E; Niskanen, L; Oksa, H; Saaristo, T; Tuomilehto, J; Vanhala, M; Uusitupa, M; Peltonen, M				Miettinen, Maija E.; Kinnunen, Leena; Leiviska, Jaana; Keinanen-Kiukaanniemi, Sirkka; Korpi-Hyovalti, Eeva; Niskanen, Leo; Oksa, Heikki; Saaristo, Timo; Tuomilehto, Jaakko; Vanhala, Mauno; Uusitupa, Matti; Peltonen, Markku			Association of Serum 25-Hydroxyvitamin D with Lifestyle Factors and Metabolic and Cardiovascular Disease Markers: Population-Based Cross-Sectional Study (FIN-D2D)	PLOS ONE			English	Article							VITAMIN-D STATUS; APOLIPOPROTEIN-A-I; DIABETES PREVENTION PROGRAM; INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; HYPOVITAMINOSIS-D; RISK; MORTALITY; SUPPLEMENTATION; HEALTH	Objectives: Low serum 25-hydroxyvitamin D (25OHD) level has been associated with an increased risk of several chronic diseases. Our aim was to determine lifestyle and clinical factors that are associated with 25OHD level and to investigate connection of 25OHD level with metabolic and cardiovascular disease markers. Design: In total, 2868 Finnish men and women aged 45-74 years participated in FIN-D2D population-based health survey in 2007. Participants that had a serum sample available (98.4%; n = 2822) were included in this study. 25OHD was measured with chemiluminescent microparticle immunoassay method. Results: The mean 25OHD level was 58.2 nmol/l in men (n = 1348) and 57.1 nmol/l in women (n = 1474). Mean 25OHD level was lower in the younger age groups than in the older ones (p<0.0001 both in men and women). This study confirmed that low physical activity (p<0.0001 both in men and women), smoking (p = 0.0002 in men and p = 0.03 in women) and high BMI (p<0.0001 in women) are factors that independently associate with low 25OHD level. Of the metabolic and cardiovascular disease markers high triglyceride concentration (p = 0.02 in men and p = 0.001 in women) and high apolipoprotein B/apolipoprotein A1 ratio (p = 0.04 in men and p = 0.03 in women) were independently associated with low 25OHD level. Conclusions: Higher age did not predict lower 25OHD level in this study population of aged 45-74 years which may derive from a healthy life-style of "active pensioners''. Low physical activity and smoking came up as independent lifestyle factors associated with low 25OHD level. Defining the molecular mechanisms behind the associations of 25OHD with low physical activity and smoking are important objective in future studies. The association of 25OHD with BMI, high triglyceride concentration and apolipoprotein B/apolipoprotein A1 ratio may be related to the role of vitamin D in inflammation, but more detailed studies are needed.	[Miettinen, Maija E.; Kinnunen, Leena; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Leiviska, Jaana] Natl Inst Hlth & Welf, Dis Risk Unit, Helsinki, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Korpi-Hyovalti, Eeva; Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Dept Internal Med, Seinajoki, Finland; [Niskanen, Leo] Finnish Med Agcy, Helsinki, Finland; [Niskanen, Leo] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland; [Oksa, Heikki] Tampere Univ Hosp, Tampere, Finland; [Saaristo, Timo] Pirkanmaa Hosp Dist, Tampere, Finland; [Saaristo, Timo] Finnish Diabet Assoc, Tampere, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Vanhala, Mauno] Cent Finland Cent Hosp, Primary Hlth Care Unit, Jyvaskyla, Finland; [Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Eastern Finland; Tampere University; Tampere University Hospital; Pirkanmaa Hospital District; Danube University Krems; King Abdulaziz University; Central Finland Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Miettinen, ME (corresponding author), Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland.	maija.miettinen@thl.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Peltonen, Markku/F-3037-2015; Kinnunen, Leena/B-7059-2012	Peltonen, Markku/0000-0002-3767-4223; Kinnunen, Leena/0000-0001-8739-4812; Miettinen, Maija E/0000-0002-5587-7227	Finnish Foundation for Cardiovascular Research	Finnish Foundation for Cardiovascular Research	The study was funded by Finnish Foundation for Cardiovascular Research (www.sydantutkimussaatio.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud M, 2013, ENDOCRINOLOGY, V154, P3022, DOI 10.1210/en.2012-2245; Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brock K, 2007, J STEROID BIOCHEM, V103, P786, DOI 10.1016/j.jsbmb.2006.12.048; Brody JS, 2012, INT J CANCER, V131, P2754, DOI 10.1002/ijc.27829; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Foo LH, 2009, OSTEOPOROSIS INT, V20, P417, DOI 10.1007/s00198-008-0667-2; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Harald K, 2007, J EPIDEMIOL COMMUN H, V61, P449, DOI 10.1136/jech.2006.049908; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; HealthyPeople.gov, 2020, NUTR PHYS ACT; Heaney RP, 2009, J AM COLL NUTR, V28, P252, DOI 10.1080/07315724.2009.10719779; Heikkinen AM, 1997, EUR J ENDOCRINOL, V137, P495, DOI 10.1530/eje.0.1370495; Hiraki, 2013, PLOS MED, V10, P1549; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Hypponen E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010801; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Inderjeeth Charles A, 2007, N Z Med J, V120, pU2730; Jaaskelainen T, 2013, EUR J NUTR, V52, P513, DOI 10.1007/s00394-012-0354-0; John WG, 2005, AM J CLIN NUTR, V82, P517, DOI 10.1093/ajcn/82.3.517; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Jorde R, 2010, J INTERN MED, V267, P462, DOI 10.1111/j.1365-2796.2009.02181.x; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Juonala M, 2008, J AM COLL CARDIOL, V52, P293, DOI 10.1016/j.jacc.2008.03.054; Kayaniyil S, 2014, CLIN ENDOCRINOL, V80, P502, DOI 10.1111/cen.12190; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mastaglia SR, 2011, J NUTR HEALTH AGING, V15, P349, DOI 10.1007/s12603-010-0287-3; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; O'Shaughnessy PJ, 2011, J CLIN ENDOCR METAB, V96, P2851, DOI 10.1210/jc.2011-1437; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Prassl R, 2009, EUR BIOPHYS J BIOPHY, V38, P145, DOI 10.1007/s00249-008-0368-y; Querfeld U, 2013, PEDIATR NEPHROL, V28, P605, DOI 10.1007/s00467-012-2377-4; Raitakari OT, 2013, ATHEROSCLEROSIS, V226, P245, DOI 10.1016/j.atherosclerosis.2012.10.049; Rizzo M, 2009, CLIN ENDOCRINOL, V70, P870, DOI 10.1111/j.1365-2265.2008.03407.x; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Saaristo T, 2007, INT J CIRCUMPOL HEAL, V66, P101, DOI 10.3402/ijch.v66i2.18239; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Sathe MN, 2010, NUTR CLIN PRACT, V25, P340, DOI 10.1177/0884533610374198; Scanu AM, 2008, FASEB J, V22, P4044, DOI 10.1096/fj.08-117150; Scragg R, 1992, Ann Epidemiol, V2, P697; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; The National Findiet 2007 Survey, NAT FIND 2007 SURV; UK Department of Health, 1998, NUTR BON HLTH PART R; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zittermann A, 2014, EUR J NUTR, V53, P367, DOI 10.1007/s00394-013-0634-3	65	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100235	10.1371/journal.pone.0100235	http://dx.doi.org/10.1371/journal.pone.0100235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000408	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300007
J	Wynne, C; Lazzari, E; Smith, S; McCarthy, EM; Gabhann, JN; Kallal, LE; Higgs, R; Cryan, SA; Biron, CA; Jefferies, CA				Wynne, Claire; Lazzari, Elisa; Smith, Siobhan; McCarthy, Eoghan M.; Gabhann, Joan Ni; Kallal, Lara E.; Higgs, Rowan; Cryan, Sally Ann; Biron, Christine A.; Jefferies, Caroline A.			TRIM68 Negatively Regulates IFN-beta Production by Degrading TRK Fused Gene, a Novel Driver of IFN-beta Downstream of Anti-Viral Detection Systems	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; PROSTATE-CANCER; FAMILY PROTEINS; IKK-EPSILON; CROSS-TALK; KINASE; IDENTIFICATION; DEGRADATION; EXPRESSION	In recent years members of the tripartite motif-containing (TRIM) family of E3 ubiquitin ligases have been shown to both positively and negatively regulate viral defence and as such are emerging as compelling targets for modulating the anti-viral immune response. In this study we identify TRIM68, a close homologue of TRIM21, as a novel regulator of Toll-like receptor (TLR)-and RIG-I-like receptor (RLR)-driven type I IFN production. Proteomic analysis of TRIM68-containing complexes identified TRK-fused gene (TFG) as a potential TRIM68 target. Overexpression of TRIM68 and TFG confirmed their ability to associate, with TLR3 stimulation appearing to enhance the interaction. TFG is a known activator of NF-kB via its ability to interact with inhibitor of NF-kB kinase subunit gamma (IKK-gamma) and TRAF family member-associated NF-kB activator (TANK). Our data identifies a novel role for TFG as a positive regulator of type I IFN production and suggests that TRIM68 targets TFG for lysosomal degradation, thus turning off TFG-mediated IFN-beta production. Knockdown of TRIM68 in primary human monocytes resulted in enhanced levels of type I IFN and TFG following poly(I: C) treatment. Thus TRIM68 targets TFG, a novel regulator of IFN production, and in doing so turns off and limits type I IFN production in response to anti-viral detection systems.	[Wynne, Claire; Lazzari, Elisa; Smith, Siobhan; McCarthy, Eoghan M.; Gabhann, Joan Ni; Higgs, Rowan; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Wynne, Claire] Dublin Inst Technol, Sch Biol Sci, Dublin, Ireland; [Kallal, Lara E.; Biron, Christine A.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Cryan, Sally Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland; [Cryan, Sally Ann] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Technological University Dublin; Brown University; Royal College of Surgeons - Ireland; Trinity College Dublin	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/AAE-6437-2019; Jefferies, Caroline/AAI-1543-2021	Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Wynne, Claire/0000-0002-0481-8366; Cryan, Sally-Ann/0000-0002-3941-496X	Health Research Board in Ireland [PHD/2007/11]; Science Foundation Ireland [08/IN.1/B2091]; National Institutes of Health [AI055677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055677, R01AI055677] Funding Source: NIH RePORTER	Health Research Board in Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Health Research Board in Ireland (grant PHD/2007/11), Science Foundation Ireland (grant 08/IN.1/B2091) and National Institutes of Health (grant AI055677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1975, J CLIN INVEST, V55, P1067, DOI 10.1172/JCI108007; BENCHETRIT E, 1988, J EXP MED, V167, P1560, DOI 10.1084/jem.167.5.1560; Billaut-Mulot O, 2001, J CLIN INVEST, V108, P861, DOI 10.1172/JCI13469; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; CLARK G, 1969, J IMMUNOL, V102, P117; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Dutton-Regester K, 2012, GENE CHROMOSOME CANC, V51, P452, DOI 10.1002/gcc.21932; Endoh K, 2012, PROSTATE, V72, P626, DOI 10.1002/pros.21466; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Lee NR, 2013, BIOCHEM BIOPH RES CO, V437, P168, DOI 10.1016/j.bbrc.2013.06.061; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li YW, 2012, EPIGENETICS-US, V7, P940, DOI 10.4161/epi.21236; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Miranda C, 2006, J CELL PHYSIOL, V208, P154, DOI 10.1002/jcp.20644; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Qiu H, 2013, VIROLOGICA SINICA, P1; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Sjostrand M, 2012, ANN RHEUM DIS, V71, pA81, DOI 10.1136/annrheumdis-2011-201238.21; Sorensen RB, 2009, J INVEST DERMATOL, V129, P1992, DOI 10.1038/jid.2009.10; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tiseo M, 2011, EXPERT REV ANTICANC, V11, P1677, DOI [10.1586/ERA.11.157, 10.1586/era.11.157]; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Xue QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046825; Yang B, 2013, J IMMUNOL, V190, P3613, DOI 10.4049/jimmunol.1202507; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yu SS, 2011, BIOCHEM BIOPH RES CO, V410, P247, DOI 10.1016/j.bbrc.2011.05.124; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255	55	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101503	10.1371/journal.pone.0101503	http://dx.doi.org/10.1371/journal.pone.0101503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999993	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300051
J	Yi, CH; Zhang, Y; Yu, ZL; Xiao, Y; Wang, JS; Qiu, HJ; Yu, WD; Tang, RR; Yuan, YH; Guo, W; Deng, WG				Yi, Canhui; Zhang, Yong; Yu, Zhenlong; Xiao, Yao; Wang, Jingshu; Qiu, Huijuan; Yu, Wendan; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo			Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-kappa B/p300 Signaling Pathways	PLOS ONE			English	Article							CYCLOOXYGENASE-2 PROMOTER ACTIVATION; NITRIC-OXIDE SYNTHASE; LIVER-CANCER CELLS; POOR SURVIVAL; UP-REGULATION; SKIN-CANCER; IN-VITRO; MELANOMA; EXPRESSION; FLAVONOIDS	Melatonin is a hormone identified in plants and pineal glands of mammals and possesses diverse physiological functions. Fisetin is a bio-flavonoid widely found in plants and exerts antitumor activity in several types of human cancers. However, the combinational effect of melatonin and fisetin on antitumor activity, especially in melanoma treatment, remains unclear. Here, we tested the hypothesis that melatonin could enhance the antitumor activity of fisetin in melanoma cells and identified the underlying molecular mechanisms. The combinational treatment of melanoma cells with fisetin and melatonin significantly enhanced the inhibitions of cell viability, cell migration and clone formation, and the induction of apoptosis when compared with the treatment of fisetin alone. Moreover, such enhancement of antitumor effect by melatonin was found to be mediated through the modulation of the multiply signaling pathways in melanoma cells. The combinational treatment of fisetin with melatonin increased the cleavage of PARP proteins, triggered more release of cytochrome-c from the mitochondrial inter-membrane, enhanced the inhibition of COX-2 and iNOS expression, repressed the nuclear localization of p300 and NF-kappa B proteins, and abrogated the binding of NF-kappa B on COX-2 promoter. Thus, these results demonstrated that melatonin potentiated the anti-tumor effect of fisetin in melanoma cells by activating cytochrome-c-dependent apoptotic pathway and inhibiting COX-2/iNOS and NF-kappa B/p300 signaling pathways, and our study suggests the potential of such a combinational treatment of natural products in melanoma therapy.	[Yi, Canhui; Yu, Zhenlong; Xiao, Yao; Yu, Wendan; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Wang, Jingshu; Qiu, Huijuan; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yong] Guangdong Prov Peoples Hosp 2, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Yi, Canhui; Yu, Zhenlong; Tang, Ranran; Yuan, Yuhui; Guo, Wei; Deng, Wuguo] Dalian Med Univ, Ctr Canc, Affiliated Hosp 1, Dalian, Peoples R China	Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Dalian Medical University	Guo, W (corresponding author), Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China.	wei1015@msn.com; dengwg@sysucc.org.cn		Yuan, Yuhui/0000-0002-7109-6703	National Natural Science Foundation of China [81301721, 81071687, 81272195]; Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University'')	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University'')	This work was supported by the funds from the National Natural Science Foundation of China (81301721, 81071687, 81272195); the Education Department of Liaoning Province, China (the "Program for Pan-Deng scholars''; the "Program for Liaoning Excellent Talents in University''). Authors who received the funding: Wuguo Deng. URLs of funder's website: http://www.nsfc.gov.cn/; or http://www.lnen.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini F, 2007, PROSTAG OTH LIPID M, V83, P320, DOI 10.1016/j.prostaglandins.2007.03.003; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983; Chwirot BW, 2007, MELANOMA RES, V17, P139, DOI 10.1097/CMR.0b013e3280dec6ac; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; DuBois RN, 1996, GASTROENTEROLOGY, V110, P1259, DOI 10.1053/gast.1996.v110.pm8613017; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goldberg MS, 2007, J AM ACAD DERMATOL, V57, P60, DOI 10.1016/j.jaad.2007.02.010; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Johansson CC, 2009, CANCER IMMUNOL IMMUN, V58, P1085, DOI 10.1007/s00262-008-0631-1; Jung JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/879746; Kang SY, 2012, J MICROBIOL, V50, P293, DOI 10.1007/s12275-012-2068-7; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Kundu JK, 2005, MUTAT RES-FUND MOL M, V591, P123, DOI 10.1016/j.mrfmmm.2005.04.019; Lin YJ, 2012, J VIROL METHODS, V182, P93, DOI 10.1016/j.jviromet.2012.03.020; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Massi D, 2001, J PATHOL, V194, P194, DOI 10.1002/1096-9896(200106)194:2<194::AID-PATH851>3.0.CO;2-S; Matsumoto T, 2013, BIOORG MED CHEM LETT, V23, P5178, DOI 10.1016/j.bmcl.2013.07.010; Mercader AG, 2013, ANTI-CANCER AGENT ME, V13, P1217, DOI 10.2174/18715206113139990300; Murakami A, 2013, BIOFACTORS, V39, P221, DOI 10.1002/biof.1054; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Parisotto EB, 2012, J SUPERCRIT FLUID, V61, P101, DOI 10.1016/j.supflu.2011.08.016; Park HH, 2008, ARCH PHARM RES, V31, P1303, DOI 10.1007/s12272-001-2110-5; Park JH, 2013, NUTR CANCER, V65, P1192, DOI 10.1080/01635581.2013.828090; Qu JG, 2013, ONCOL LETT, V6, P347, DOI 10.3892/ol.2013.1413; Rondanelli M, 2013, AGING CLIN EXP RES, V25, P499, DOI 10.1007/s40520-013-0118-6; Sarkar FH, 2007, ACTA PHARMACOL SIN, V28, P1305, DOI 10.1111/j.1745-7254.2007.00689.x; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Stratigos A, 2007, J EUR ACAD DERMATOL, V21, P56, DOI 10.1111/j.1468-3083.2006.01865.x; Takeda S, 2008, DRUG METAB DISPOS, V36, P1917, DOI 10.1124/dmd.108.020909; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wu KK, 2003, THROMB RES, V110, P273, DOI 10.1016/S0049-3848(03)00412-2; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Ying TH, 2012, ARCH TOXICOL, V86, P263, DOI 10.1007/s00204-011-0754-6; Yu SH, 2011, CANCER LETT, V300, P96, DOI 10.1016/j.canlet.2010.09.015; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560	47	60	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e99943	10.1371/journal.pone.0099943	http://dx.doi.org/10.1371/journal.pone.0099943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000190	Green Published, gold			2022-12-25	WOS:000338637300005
J	Chen, ZZ; Gong, X; Lu, Y; Du, SY; Yang, ZH; Bai, J; Li, PY; Wu, HC				Chen, Zhenzhen; Gong, Xin; Lu, Yang; Du, Shouying; Yang, Zhihui; Bai, Jie; Li, Pengyue; Wu, Huichao			Enhancing Effect of Borneol and Muscone on Geniposide Transport across the Human Nasal Epithelial Cell Monolayer	PLOS ONE			English	Article							IN-VITRO; INTRANASAL DELIVERY; MEMBRANE-FLUIDITY; ABSORPTION; CULTURE; ENHANCEMENT; BRAIN; RABBIT; MODEL; MICE	Geniposide is widely used in the treatment of cerebral ischemic stroke and cerebrovascular diseases for its anti-thrombotic and anti-inflammatory effects. Recent studies demonstrated that geniposide could be absorbed promptly and thoroughly by intranasal administration in mice and basically transported into the brain. Here, we explored its transport mechanism and the effect of borneol and muscone on its transport by human nasal epithelial cell (HNEC) monolayer. The cytotoxicity of geniposide, borneol, muscone and their combinations on HNECs was evaluated by the MTT assay. Transcellular transport of geniposide and the influence of borneol and muscone were studied using the HNEC monolayer. Immunostaining and transepithelial electrical resistance were measured to assess the integrity of the monolayer. The membrane fluidity of HNEC was evaluated by fluorescence recovery after photobleaching. Geniposide showed relatively poor absorption in the HNEC monolayer and it was not a P-gp substrate. Geniposide transport in both directions significantly increased when co-administrated with increasing concentrations of borneol and muscone. The enhancing effect of borneol and muscone on geniposide transport across the HNEC may be attributed to the significant enhancement on cell membrane fluidity, disassembly effect on tight junction integrity and the process was reversible. These results indicated that intranasal administration has good potential to treat cerebrovascular diseases.	[Chen, Zhenzhen; Lu, Yang; Du, Shouying; Bai, Jie; Li, Pengyue; Wu, Huichao] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Gong, Xin] Beijing Univ Chinese Med, Dongfang Hosp, Ctr Reprod Endocrinol, Beijing, Peoples R China; [Yang, Zhihui] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; State University System of Florida; University of Florida	Du, SY (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.	dsying607@126.com	Lu, Yang/ABB-8660-2021		National Basic Research Program of China (973 Program) [2012CB724000]; Natural Science Foundation of China [81073057]; Innovation Team Development Program of Beijing University of Chinese Medicine [2011-CXTD-13]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Development Program of Beijing University of Chinese Medicine	This work was supported by the National Basic Research Program of China (973 Program, No. 2012CB724000). This research was also supported by the Natural Science Foundation of China (No. 81073057) and Innovation Team Development Program of Beijing University of Chinese Medicine (No. 2011-CXTD-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agu RU, 2002, INT J PHARM, V237, P179, DOI 10.1016/S0378-5173(02)00039-X; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Cai Z, 2008, J DRUG TARGET, V16, P178, DOI 10.1080/10611860701794395 ; Chen Wen-Kai, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P288; Chen Yan-ming, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P632; Chen ZZ, 2013, INT J PHARMACEUT, V456, P73, DOI 10.1016/j.ijpharm.2013.08.017; Cui Y, 2011, ARCH PHARM RES, V34, P1477, DOI 10.1007/s12272-011-0909-2; Davis SS, 2003, CLIN PHARMACOKINET, V42, P1107, DOI 10.2165/00003088-200342130-00003; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010; Gabbanini S, 2009, J PHARMACEUT BIOMED, V50, P370, DOI 10.1016/j.jpba.2009.05.018; Ghaffarian R, 2013, JOVE-J VIS EXP, DOI 10.3791/50638; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Haratake M, 2013, COLLOID SURFACE B, V107, P90, DOI 10.1016/j.colsurfb.2013.01.070; Illum L, 1996, J DRUG TARGET, V3, P427, DOI 10.3109/10611869609015963; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Kadan S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549345; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Li ZJ, 2010, CURR EYE RES, V35, P565, DOI 10.3109/02713681003718091; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Lu Y, 2012, INT J MOL SCI, V13, P14127, DOI 10.3390/ijms131114127; Lu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P143, DOI 10.1631/jzus.B1000121; MCMARTIN C, 1987, J PHARM SCI-US, V76, P535, DOI 10.1002/jps.2600760709; Merkle HP, 1998, ADV DRUG DELIV REV, V29, P51; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pardeshi CV, 2013, EXPERT OPIN DRUG DEL; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Portnoy E, 2012, MOL PHARM; Qi HP, 2013, EUR J PHARMACOL, V705, P20, DOI 10.1016/j.ejphar.2013.02.031; Reitz M, 2012, STEM CELL TRANSL MED, V1, P866, DOI 10.5966/sctm.2012-0045; Renner DB, 2012, J PHARM PHARMACOL, V64, P1709, DOI 10.1111/j.2042-7158.2012.01555.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ugwoke MI, 2000, INT J PHARM, V205, P43, DOI 10.1016/S0378-5173(00)00484-1; Ugwoke MI, 2001, J PHARM PHARMACOL, V53, P3, DOI 10.1211/0022357011775145; Vadlapudi AD, 2012, INT J PHARMACEUT, V434, P315, DOI 10.1016/j.ijpharm.2012.05.033; van Woensel Matthias, 2013, Cancers (Basel), V5, P1020, DOI 10.3390/cancers5031020; Vilas-Boasa V, 2013, TOXICOL LETT, V220, P259, DOI 10.1016/j.toxlet.2013.05.005; Wang Ning, 2012, Zhong Yao Cai, V35, P1291; WERNER U, 1995, PHARMACEUT RES, V12, P565, DOI 10.1023/A:1016210231121; Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17; Yang JP, 2009, NEUROSCI LETT, V449, P108, DOI 10.1016/j.neulet.2008.10.090; Yoo JW, 2003, PHARMACEUT RES, V20, P1690, DOI 10.1023/A:1026112107100; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004	44	28	35	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101414	10.1371/journal.pone.0101414	http://dx.doi.org/10.1371/journal.pone.0101414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992195	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400068
J	Hogan, DJ; Vincent, TM; Fish, S; Marcusson, EG; Bhat, B; Chau, BN; Zisoulis, DG				Hogan, Daniel J.; Vincent, Thomas M.; Fish, Sarah; Marcusson, Eric G.; Bhat, Balkrishen; Chau, B. Nelson; Zisoulis, Dimitrios G.			Anti-miRs Competitively Inhibit microRNAs in Argonaute Complexes	PLOS ONE			English	Article							IN-VIVO; MESSENGER-RNAS; BIOGENESIS; ROLES; LET-7; SPECIFICITY; MIR-122	MicroRNAs (miRNAs), small RNA molecules that post-transcriptionally regulate mRNA expression, are crucial in diverse developmental and physiological programs and their misregulation can lead to disease. Chemically modified oligonucleotides have been developed to modulate miRNA activity for therapeutic intervention in disease settings, but their mechanism of action has not been fully elucidated. Here we show that the miRNA inhibitors (anti-miRs) physically associate with Argonaute proteins in the context of the cognate target miRNA in vitro and in vivo. The association is mediated by the seed region of the miRNA and is sensitive to the placement of chemical modifications. Furthermore, the targeted miRNAs are stable and continue to be associated with Argonaute. Our results suggest that anti-miRs specifically associate with Argonaute-bound miRNAs, preventing association with target mRNAs, which leads to subsequent stabilization and thus increased expression of the targeted mRNAs.	[Hogan, Daniel J.; Vincent, Thomas M.; Fish, Sarah; Marcusson, Eric G.; Bhat, Balkrishen; Chau, B. Nelson; Zisoulis, Dimitrios G.] Regulus Therapeut, San Diego, CA 92121 USA	Isis Pharmaceuticals Inc	Zisoulis, DG (corresponding author), Regulus Therapeut, San Diego, CA 92121 USA.	nchau@regulusrx.com; dzisoulis@regulusrx.com		Marcusson, Eric/0000-0002-0504-8674	Regulus Therapeutics Inc	Regulus Therapeutics Inc	Funding for these studies was provided by Regulus Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Crooke ST, 2008, ANTISENSE DRUG TECHN, Vxvii; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gebert LFR, 2014, NUCLEIC ACIDS RES, V42, P609, DOI 10.1093/nar/gkt852; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gurtan AM, 2013, GENE DEV, V27, P941, DOI 10.1101/gad.215376.113; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McKay RA, 1996, NUCLEIC ACIDS RES, V24, P411, DOI 10.1093/nar/24.3.411; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	43	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100951	10.1371/journal.pone.0100951	http://dx.doi.org/10.1371/journal.pone.0100951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992387	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400037
J	Liaw, N; Fox, JMD; Siddiqui, AH; Meng, H; Kolega, J				Liaw, Nicholas; Fox, Jennifer M. Dolan; Siddiqui, Adnan H.; Meng, Hui; Kolega, John			Endothelial Nitric Oxide Synthase and Superoxide Mediate Hemodynamic Initiation of Intracranial Aneurysms	PLOS ONE			English	Article							INDUCED ARTERIAL ENLARGEMENT; INTERNAL CAROTID-ARTERY; BASILAR TERMINUS; MATRIX METALLOPROTEINASES; RESISTANCE ARTERIES; CEREBRAL ANEURYSMS; CELL PROLIFERATION; RABBIT MODEL; HIGH-FLOW; IN-VIVO	Background: Hemodynamic insults at arterial bifurcations are believed to play a critical role in initiating intracranial aneurysms. Recent studies in a rabbit model indicate that aneurysmal damage initiates under specific wall shear stress conditions when smooth muscle cells (SMCs) become pro-inflammatory and produce matrix metalloproteinases (MMPs). The mechanisms leading to SMC activation and MMP production during hemodynamic aneurysm initiation are unknown. The goal is to determine if nitric oxide and/or superoxide induce SMC changes, MMP production and aneurysmal remodeling following hemodynamic insult. Methods: Bilateral common carotid artery ligation was performed on rabbits (n = 19, plus 5 sham operations) to induce aneurysmal damage at the basilar terminus. Ligated animals were treated with the nitric oxide synthase (NOS) inhibitor LNAME (n = 7) or the superoxide scavenger TEMPOL (n = 5) and compared to untreated animals (n = 7). Aneurysm development was assessed histologically 5 days after ligation. Changes in NOS isoforms, peroxynitrite, reactive oxygen species (ROS), MMP-2, MMP-9, and smooth muscle a-actin were analyzed by immunohistochemistry. Results: LNAME attenuated ligation-induced IEL loss, media thinning and bulge formation. In untreated animals, immunofluorescence showed increased endothelial NOS (eNOS) after ligation, but no change in inducible or neuronal NOS. Furthermore, during aneurysm initiation ROS increased in the media, but not the intima, and there was no change in peroxynitrite. In LNAME-treated animals, ROS production did not change. Together, this suggests that eNOS is important for aneurysm initiation but not by producing superoxide. TEMPOL treatment reduced aneurysm development, indicating that the increased medial superoxide is also necessary for aneurysm initiation. LNAME and TEMPOL treatment in ligated animals restored a-actin and decreased MMPs, suggesting that eNOS and superoxide both lead to SMC de-differentiation and MMP production. Conclusion: Aneurysm-inducing hemodynamics lead to increased eNOS and superoxide, which both affect SMC phenotype, increasing MMP production and aneurysmal damage.	[Liaw, Nicholas; Fox, Jennifer M. Dolan; Siddiqui, Adnan H.; Meng, Hui] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA; [Liaw, Nicholas] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA; [Fox, Jennifer M. Dolan; Siddiqui, Adnan H.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.] SUNY Buffalo, Dept Radiol, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Mech & Aerosp Engn, Dept Neurosurg, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kolega, J (corresponding author), SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.	kolega@buffalo.edu	Kolega, John/J-8386-2016; Meng, Hui/F-7929-2010; Siddiqui, Adnan H./AAG-9781-2019	Kolega, John/0000-0001-6933-8681; 	National Institute of Neurological Disorders and Stroke [R01NS064592]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064592] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Grant R01NS064592 (H. Meng), http://www.ninds.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2011, LAB INVEST, V91, P619, DOI 10.1038/labinvest.2010.204; Aoki T, 2009, LAB INVEST, V89, P730, DOI 10.1038/labinvest.2009.36; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Briganti F, 2002, NEURORADIOLOGY, V44, P604, DOI 10.1007/s00234-001-0732-4; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FUJIWARA S, 1993, ACTA NEUROCHIR, V120, P20, DOI 10.1007/BF02001464; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Gao L, 2008, STROKE, V39, P2085, DOI 10.1161/STROKEAHA.107.509422; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Gurjar MV, 2001, J APPL PHYSIOL, V91, P1380, DOI 10.1152/jappl.2001.91.3.1380; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; Hoi YM, 2008, J NEUROSURG, V109, P1141, DOI 10.3171/JNS.2008.109.12.1141; JONES GT, 1994, INT J EXP PATHOL, V75, P225; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Mandelbaum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074357; McAdam E, 2012, CARCINOGENESIS, V33, P2035, DOI 10.1093/carcin/bgs241; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; Meng H., 2012, INT REV THROMB, V7, P40; Meng H, 2011, J NEUROSURG, V114, P1095, DOI 10.3171/2010.9.JNS10368; Metaxa E, 2008, AM J PHYSIOL-HEART C, V295, pH736, DOI 10.1152/ajpheart.01156.2007; Metaxa E, 2010, STROKE, V41, P1774, DOI 10.1161/STROKEAHA.110.585992; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Sho E, 2003, EXP MOL PATHOL, V75, P1, DOI 10.1016/S0014-4800(03)00032-7; STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Suzuki MTM, 2011, NEUROCIRUGIA, V22, P251; TIMPERMAN PE, 1995, AM J NEURORADIOL, V16, P329; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wang SW, 1999, ANN CLIN LAB SCI, V29, P192; West NEJ, 2001, ARTERIOSCL THROM VAS, V21, P189, DOI 10.1161/01.ATV.21.2.189; Wolf RL, 2002, NEURORADIOLOGY, V44, P443, DOI 10.1007/s00234-001-0723-5	45	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101721	10.1371/journal.pone.0101721	http://dx.doi.org/10.1371/journal.pone.0101721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992254	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400108
J	Licona-Vera, Y; Ornelas, JF				Licona-Vera, Yuyini; Francisco Ornelas, Juan			Genetic, Ecological and Morphological Divergence between Populations of the Endangered Mexican Sheartail Hummingbird (Doricha eliza)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; SPECIES TREES; DIVERSIFICATION; PHYLOGEOGRAPHY; SIMULATIONS; INFERENCE; RATES	The Mexican Sheartail (Doricha eliza), an endangered hummingbird, is endemic to Mexico where two populations have a disjunct distribution. One population is distributed along the northern tip of the Yucatan Peninsula whereas the other is mostly restricted to central Veracruz. Despite their disjunct distribution, previous work has failed to detect morphological or behavioral differences between these populations. Here we use variation in morphology, mtDNA and nuDNA sequences to determine the degree of morphological and molecular divergence between populations, their divergence time, and historical demography. We use species distribution modeling and niche divergence tests to infer the relative roles of vicariance and dispersal in driving divergence in the genus. Our Bayesian and maximum likelihood phylogenetic analyses revealed that Doricha eliza populations form a monophyletic clade and support their sister relationship with D. enicura. We found marked genetic differentiation, with reciprocal monophyly of haplotypes and highly restricted gene flow, supporting a history of isolation over the last 120,000 years. Genetic divergence between populations is consistent with the lack of overlap in environmental space and slight morphological differences between males. Our findings indicate that the divergence of the Veracruz and Yucatan populations is best explained by a combination of a short period of isolation exacerbated by subsequent divergence in climate conditions, and that rather than vicariance, the two isolated ranges of D. eliza are the product of recent colonization and divergence in isolation.	[Licona-Vera, Yuyini; Francisco Ornelas, Juan] Inst Ecol, AC, Dept Biol, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Ornelas, JF (corresponding author), Inst Ecol, AC, Dept Biol, Xalapa, Veracruz, Mexico.	francisco.ornelas@inecol.mx	Ornelas, Juan Francisco/A-2250-2014	Ornelas, Juan Francisco/0000-0002-1124-1163; Licona-Vera, Yuyini/0000-0001-6616-361X	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [61710, 155686]; INECOL [20030/10563]; Master of Science scholarship [262561]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INECOL; Master of Science scholarship	This project was funded by competitive grants (grant numbers 61710 and 155686) from Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx) and research funds from INECOL (20030/10563) awarded to Juan Francisco Ornelas. Yuyini Licona-Vera was supported by a Master of Science scholarship (no. 262561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Arbelaez-Cortes E, 2013, ZOOTAXA, V3716, P81; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Berns CM, 2013, EVOL BIOL, V40, P246, DOI 10.1007/s11692-012-9206-3; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Calder William A., 1992, Birds of North America, V16, P1; Chaves JA, 2007, MOL PHYLOGENET EVOL, V43, P795, DOI 10.1016/j.ympev.2006.11.006; Clark CJ, 2013, CONDOR, V115, P558, DOI 10.1525/cond.2013.120047; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; des Granges J.-L., 1979, Living Bird, V17, P199; Diaz-Valenzuela R, 2011, CONDOR, V113, P177, DOI 10.1525/cond.2011.090225; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ornelas JF, 2014, J BIOGEOGR, V41, P168, DOI 10.1111/jbi.12184; Fu YX, 1997, GENETICS, V147, P915; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Hammer O, 2022, SOFTWARE NATURAL HIS; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hasumi H, 2004, 1 CLIM SYST RES; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Hosner PA, 2013, J BIOGEOGR, V40, P1094, DOI 10.1111/jbi.12074; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; IUCN, 2013, IUCN RED LIST THREAT; Lande R., 2003, OXFORD SERIES ECOLOG; Lees AC, 2014, GLOBAL ECOL BIOGEOGR, V23, P405, DOI 10.1111/geb.12129; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malpica A, 2014, MOL ECOL, V23, P435, DOI 10.1111/mec.12614; Marino IAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028567; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; McGuire JA, 2009, J ORNITHOL, V150, P155, DOI 10.1007/s10336-008-0330-x; Mertz CE, 1978, SEMIN NUCL MED, V8, P283, DOI [10.1016/0S0001-2998(78)80014-2, DOI 10.1016/0S0001-2998(78)80014-2.]; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Miller MJ, 2011, CONDOR, V113, P806, DOI 10.1525/cond.2011.100226; Navarro AG, 2003, B BRIT ORNITHOLO A S, V123A; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ornelas J. F., 1995, MISCELLANEOUS PUBLIC, V727, P98; Ornelas JF, 2014, LIBRO ROJO FAUNA EST, P148; Ortiz-Pulido R, 2002, WILSON BULL, V114, P153, DOI 10.1676/0043-5643(2002)114[0153:TMSDEM]2.0.CO;2; Ortiz-Pulido Raul, 1998, Ornitologia Neotropical, V9, P223; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ridgway R, 1911, B US NAT MUS, V50, P650; Rodriguez-Gomez F, 2014, J ZOOL SYST EVOL RES, V52, P142, DOI 10.1111/jzs.12047; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Santamaría-Rivero Waldemar, 2013, Huitzil, V14, P139; Schneider S, 1999, GENETICS, V152, P1079; Schuchmann K.-L., 1999, HDB BIRDS WORLD, P468; Scott PE, 1994, BIRDS N AM; SLATKIN M, 1991, GENETICS, V129, P555; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Spellman GM, 2006, P ROY SOC B-BIOL SCI, V273, P3057, DOI 10.1098/rspb.2006.3682; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; TAJIMA F, 1989, GENETICS, V123, P585; Voelker G, 2013, MOL ECOL, V22, P3333, DOI 10.1111/mec.12305; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253	88	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101870	10.1371/journal.pone.0101870	http://dx.doi.org/10.1371/journal.pone.0101870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992589	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400127
J	Swanson, D; Zhang, YF; King, M				Swanson, David; Zhang, Yufeng; King, Marisa			Mechanistic Drivers of Flexibility in Summit Metabolic Rates of Small Birds	PLOS ONE			English	Article							SEASONAL PHENOTYPIC FLEXIBILITY; AEROBIC PERFORMANCE VARIATION; CATABOLIC ENZYME-ACTIVITIES; FLIGHT-MUSCLE SIZE; IN-HOUSE FINCHES; BODY-COMPOSITION; THERMOGENIC CAPACITY; OXYGEN-CONSUMPTION; ORGAN MASSES; INDIVIDUAL VARIATION	Flexible metabolic phenotypes allow animals to adjust physiology to better fit ecological or environmental demands, thereby influencing fitness. Summit metabolic rate (M-sum = maximal thermogenic capacity) is one such flexible trait. Skeletal muscle and heart masses and myocyte metabolic intensity are potential drivers of M-sum flexibility in birds. We examined correlations of skeletal muscle and heart masses and pectoralis muscle citrate synthase (CS) activity (an indicator of cellular metabolic intensity) with M-sum in house sparrows (Passer domesticus) and dark-eyed juncos (Junco hyemalis) to determine whether these traits are associated with M-sum variation. Pectoralis mass was positively correlated with M-sum for both species, but no significant correlation remained for either species after accounting for body mass (M-b) variation. Combined flight and leg muscle masses were also not significantly correlated with M-sum for either species. In contrast, heart mass was significantly positively correlated with M-sum for juncos and nearly so (P = 0.054) for sparrows. Mass-specific and total pectoralis CS activities were significantly positively correlated with M-sum for sparrows, but not for juncos. Thus, myocyte metabolic intensity influences M-sum variation in house sparrows, although the stronger correlation of total (r = 0.495) than mass-specific (r = 0.378) CS activity with M-sum suggests that both pectoralis mass and metabolic intensity impact M-sum. In contrast, neither skeletal muscle masses nor pectoralis metabolic intensity varied with M-sum in juncos. However, heart mass was associated with M-sum variation in both species. These data suggest that drivers of metabolic flexibility are not uniform among bird species.	[Swanson, David; Zhang, Yufeng; King, Marisa] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA	University of South Dakota	Swanson, D (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	david.swanson@usd.edu	Zhang, Yufeng/GZL-1973-2022		U.S. National Science Foundation [IOS-1021218]	U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation (http://www.nsf.gov/dir/index.jsp?org = BIO), grant number IOS-1021218, to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P579, DOI 10.1086/430235; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Battley PF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P435, DOI 10.1086/320432; Box J, 2010, AVIAN BIOL RES, V3, P107, DOI 10.3184/175815510X12823045556835; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Buttemer William A., 2010, Australian Zoologist, V35, P378; Carey C., 1989, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V173, P95; CAREY C, 1978, J COMP PHYSIOL, V125, P101, DOI 10.1007/BF00686746; Chappell MA, 1999, J EXP BIOL, V202, P2269; Christians JK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P250, DOI 10.1086/316661; Clavijo-Baquet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037069; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; Cooper SJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P386, DOI 10.1086/342256; DAWSON WR, 1976, J COMP PHYSIOL, V112, P317, DOI 10.1007/BF00692302; DRIEDZIC WR, 1993, CAN J ZOOL, V71, P1602, DOI 10.1139/z93-226; Guglielmo CG, 2003, PHYSIOL BIOCHEM ZOOL, V76, P84, DOI 10.1086/367942; Hammond KA, 2000, J EXP BIOL, V203, P2053; Hayes JP, 1999, EVOLUTION, V53, P1280, DOI 10.1111/j.1558-5646.1999.tb04540.x; Holloway JC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P219, DOI 10.1086/319666; King MO, 2012, INTEGR COMP BIOL, V52, pE276; Landys-Ciannelli MM, 2003, FUNCT ECOL, V17, P151, DOI 10.1046/j.1365-2435.2003.00715.x; Liknes ET, 2011, J THERM BIOL, V36, P430, DOI 10.1016/j.jtherbio.2011.07.011; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 2002, CONDOR, V104, P548, DOI 10.1650/0010-5422(2002)104[0548:SAITAG]2.0.CO;2; Lill A, 2006, AUST J ZOOL, V54, P23, DOI 10.1071/ZO05029; Liu Jin-Song, 2006, Acta Zoologica Sinica, V52, P469; Maillet D, 2007, J EXP BIOL, V210, P413, DOI 10.1242/jeb.02660; Marsh R L., 1989, ADV COMP ENV PHYSL, V4, P206; MARSH RL, 1981, J COMP PHYSIOL, V141, P417, DOI 10.1007/BF01101461; McFarlan JT, 2009, J EXP BIOL, V212, P2934, DOI 10.1242/jeb.031682; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; OCONNOR TP, 1995, PHYSIOL ZOOL, V68, P985, DOI 10.1086/physzool.68.6.30163790; Oring, 2010, GUIDELINES USE WILD; Pena-Villalobos I, 2014, CURR ZOOL IN PRESS, V60; Petit M, 2014, PHYSL BIOCH IN PRESS, V87; Petit M, 2014, J EXP BIOL, V217, P824, DOI 10.1242/jeb.095703; Petit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068292; Piersma T, 1999, PHYSIOL BIOCHEM ZOOL, V72, P405, DOI 10.1086/316680; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Piersma T., 2011, FLEXIBLE PHENOTYPE B; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; Sears MW, 2006, FUNCT ECOL, V20, P97, DOI 10.1111/j.1365-2435.2006.01067.x; Sgueo C, 2012, J EXP BIOL, V215, P2418, DOI 10.1242/jeb.061168; Swanson D, 2014, J EXP BIOL, V217, P866, DOI 10.1242/jeb.096677; Swanson DL, 2014, J COMP PHYSIOL B, V184, P249, DOI 10.1007/s00360-013-0798-4; Swanson DL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P421, DOI 10.1086/671447; Swanson DL, 2013, J ORNITHOL, V154, P119, DOI 10.1007/s10336-012-0877-4; Swanson DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034271; Swanson DL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P185, DOI 10.1086/658291; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; SWANSON DL, 1990, AUK, V107, P561; Swanson DL, 2006, J EXP BIOL, V209, P466, DOI 10.1242/jeb.02024; Swanson DL, 1999, J AVIAN BIOL, V30, P245, DOI 10.2307/3677350; Swanson DL, 1995, AUK, V112, P870, DOI 10.2307/4089019; SWANSON DL, 1991, PHYSIOL ZOOL, V64, P1578, DOI 10.1086/physzool.64.6.30158232; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 2001, J COMP PHYSIOL B, V171, P475, DOI 10.1007/s003600100197; van de Ven TMFN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P19, DOI 10.1086/667989; Vezina F, 2003, PHYSIOL BIOCHEM ZOOL, V76, P716, DOI 10.1086/376425; Vezina F, 2007, AM J PHYSIOL-REG I, V292, pR1287, DOI 10.1152/ajpregu.00683.2006; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; Wells ME, 2012, J AVIAN BIOL, V43, P481, DOI 10.1111/j.1600-048X.2012.05709.x; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P20866, DOI 10.1073/pnas.0707683104; Zheng WH, 2014, PHYSIOL BIOCHEM ZOOL, V87, P432, DOI 10.1086/675439; Zheng WH, 2008, COMP BIOCHEM PHYS A, V151, P519, DOI 10.1016/j.cbpa.2008.07.009	70	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101577	10.1371/journal.pone.0101577	http://dx.doi.org/10.1371/journal.pone.0101577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992186	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400092
J	Clements, HS; Tambling, CJ; Hayward, MW; Kerley, GIH				Clements, Hayley S.; Tambling, Craig J.; Hayward, Matt W.; Kerley, Graham I. H.			An Objective Approach to Determining the Weight Ranges of Prey Preferred by and Accessible to the Five Large African Carnivores	PLOS ONE			English	Article							HYENA CROCUTA-CROCUTA; KRUGER-NATIONAL-PARK; LION PANTHERA-LEO; SPOTTED HYENA; CARRYING-CAPACITY; LYCAON-PICTUS; SOUTH-AFRICA; PREFERENCES; CONSERVATION; SELECTION	Broad-scale models describing predator prey preferences serve as useful departure points for understanding predator-prey interactions at finer scales. Previous analyses used a subjective approach to identify prey weight preferences of the five large African carnivores, hence their accuracy is questionable. This study uses a segmented model of prey weight versus prey preference to objectively quantify the prey weight preferences of the five large African carnivores. Based on simulations of known predator prey preference, for prey species sample sizes above 32 the segmented model approach detects up to four known changes in prey weight preference (represented by model break-points) with high rates of detection (75% to 100% of simulations, depending on number of break-points) and accuracy (within 1.3 +/- 4.0 to 2.7 +/- 4.4 of known break-point). When applied to the five large African carnivores, using carnivore diet information from across Africa, the model detected weight ranges of prey that are preferred, killed relative to their abundance, and avoided by each carnivore. Prey in the weight ranges preferred and killed relative to their abundance are together termed "accessible prey''. Accessible prey weight ranges were found to be 14-135 kg for cheetah Acinonyx jubatus, 1-45 kg for leopard Panthera pardus, 32-632 kg for lion Panthera leo, 15-1600 kg for spotted hyaena Crocuta crocuta and 10-289 kg for wild dog Lycaon pictus. An assessment of carnivore diets throughout Africa found these accessible prey weight ranges include 88 +/- 2% (cheetah), 82 +/- 3% (leopard), 81 +/- 2% (lion), 97 +/- 2% (spotted hyaena) and 96 +/- 2% (wild dog) of kills. These descriptions of prey weight preferences therefore contribute to our understanding of the diet spectrum of the five large African carnivores. Where datasets meet the minimum sample size requirements, the segmented model approach provides a means of determining, and comparing, the prey weight range preferences of any carnivore species.	[Clements, Hayley S.; Tambling, Craig J.; Hayward, Matt W.; Kerley, Graham I. H.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Hayward, Matt W.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Hayward, Matt W.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; Bangor University	Clements, HS (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	clementshayley@gmail.com	Clements, Hayley/H-8549-2019; Hayward, Matt W./F-3569-2010; Tambling, Craig/H-3554-2019	Clements, Hayley/0000-0002-7015-6532; Hayward, Matt W./0000-0002-5574-1653; Tambling, Craig/0000-0001-9830-5985	National Research Foundation; Nelson Mandela Metropolitan University; Claude Leon Postdoctoral Fellowship	National Research Foundation; Nelson Mandela Metropolitan University; Claude Leon Postdoctoral Fellowship	HS Clements was funded by the National Research Foundation and Nelson Mandela Metropolitan University. CJ Tambling was funded by the National Research Foundation and a Claude Leon Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertram B. C. B., 1979, SERENGETI DYNAMICS E, P221; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Caro T, 1994, CHEETAH SERENGETI PL; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Di Silvestre I, 2000, AFR J ECOL, V38, P102; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Garrott RA, 2007, ECOL APPL, V17, P1588, DOI 10.1890/06-1439.1; Ginsberg JR, 2001, CONSERV BIOL SER, V5, P498; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2007, J WILDLIFE MANAGE, V71, P1567, DOI 10.2193/2006-264; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2011, ACTA OECOL, V37, P314, DOI 10.1016/j.actao.2011.03.003; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hrabar H, 2013, ORYX, V47, P403, DOI 10.1017/S0030605311002018; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jooste E, 2013, EUR J WILDLIFE RES, V59, P487, DOI 10.1007/s10344-013-0696-9; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kruuk H., 1972, SPOTTED HYAENA STUDY; Kruuk H., 1970, ANIMAL POPULATIONS R, P359; Louw J, 2012, S AFR J WILDL RES, V42, P73, DOI 10.3957/056.042.0211; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; Muggeo V, 2008, R NEWS, V8, P20, DOI DOI 10.1159/000323281; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Reich A., 1981, BEHAV ECOLOGY AFRICA; Schaller G. B., 1972, SERENGETI LION STUDY; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Stuart C, 2000, FIELD GUIDE LARGER M; Svengren H, 2010, S AFR J WILDL RES, V40, P121, DOI 10.3957/056.040.0203; Wentworth JC, 2011, ACTA THERIOL, V56, P389, DOI 10.1007/s13364-011-0033-1; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1; Zar J. H., 1996, BIOSTATISTICAL ANAL	45	67	67	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101054	10.1371/journal.pone.0101054	http://dx.doi.org/10.1371/journal.pone.0101054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988433	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100057
J	Dhimolea, E; Wadia, PR; Murray, TJ; Settles, ML; Treitman, JD; Sonnenschein, C; Shioda, T; Soto, AM				Dhimolea, Eugen; Wadia, Perinaaz R.; Murray, Tessa J.; Settles, Matthew L.; Treitman, Jo D.; Sonnenschein, Carlos; Shioda, Toshi; Soto, Ana M.			Prenatal Exposure to BPA Alters the Epigenome of the Rat Mammary Gland and Increases the Propensity to Neoplastic Development	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BISPHENOL-A ALTERS; PERINATAL EXPOSURE; BREAST-CANCER; CARCINOGENESIS; DIETHYLSTILBESTROL; SUSCEPTIBILITY; HYPERPLASIAS; DISORDERS; RISK	Exposure to environmental estrogens (xenoestrogens) may play a causal role in the increased breast cancer incidence which has been observed in Europe and the US over the last 50 years. The xenoestrogen bisphenol A (BPA) leaches from plastic food/beverage containers and dental materials. Fetal exposure to BPA induces preneoplastic and neoplastic lesions in the adult rat mammary gland. Previous results suggest that BPA acts through the estrogen receptors which are detected exclusively in the mesenchyme during the exposure period by directly altering gene expression, leading to alterations of the reciprocal interactions between mesenchyme and epithelium. This initiates a long sequence of altered morphogenetic events leading to neoplastic transformation. Additionally, BPA induces epigenetic changes in some tissues. To explore this mechanism in the mammary gland, Wistar-Furth rats were exposed subcutaneously via osmotic pumps to vehicle or 250 mu g BPA/kg BW/day, a dose that induced ductal carcinomas in situ. Females exposed from gestational day 9 to postnatal day (PND) 1 were sacrificed at PND4, PND21 and at first estrus after PND50. Genomic DNA (gDNA) was isolated from the mammary tissue and immuno-precipitated using anti-5-methylcytosine antibodies. Detection and quantification of gDNA methylation status using the Nimblegen ChIP array revealed 7412 differentially methylated gDNA segments (out of 58207 segments), with the majority of changes occurring at PND21. Transcriptomal analysis revealed that the majority of gene expression differences between BPA- and vehicle-treated animals were observed later (PND50). BPA exposure resulted in higher levels of pro-activation histone H3K4 trimethylation at the transcriptional initiation site of the alpha-lactalbumin gene at PND4, concomitantly enhancing mRNA expression of this gene. These results show that fetal BPA exposure triggers changes in the postnatal and adult mammary gland epigenome and alters gene expression patterns. These events may contribute to the development of pre-neoplastic and neoplastic lesions that manifest during adulthood.	[Dhimolea, Eugen; Wadia, Perinaaz R.; Murray, Tessa J.; Treitman, Jo D.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Settles, Matthew L.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Shioda, Toshi] Massachusetts Gen Hosp, MGH Ctr Canc Res, Charlestown, MA USA	Tufts University; Idaho; University of Idaho; Harvard University; Massachusetts General Hospital	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	ana.soto@tufts.edu	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	NIH National Institute of Environmental Health Sciences [ES015182, ES018822, ES08314]; Susan G. Komen for Cure [FAS0703860, KG090515]; ArtBeCause Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018822, R01ES008314, R21ES015182] Funding Source: NIH RePORTER	NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Susan G. Komen for Cure(Susan G. Komen Breast Cancer Foundation); ArtBeCause Breast Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH National Institute of Environmental Health Sciences award numbers ES015182, ES018822, ES08314, (AS), Susan G. Komen for Cure (FAS0703860 and KG090515) (TS) and the ArtBeCause Breast Cancer Foundation (PW). The content is solely the responsibility of the authors and does not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Barker DJP, 2004, ACTA PAEDIATR, V93, P1559, DOI 10.1080/08035250410024772; Betancourt AM, 2010, ENVIRON HEALTH PERSP, V118, P1614, DOI 10.1289/ehp.1002148; Biles JE, 1997, J AGR FOOD CHEM, V45, P3541, DOI 10.1021/jf970072i; BOYLAN ES, 1983, CANCER RES, V43, P4872; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P519, DOI 10.1007/BF00054160; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; BROTONS JA, 1994, ENV HLTH PERSPECT, V103, P608, DOI DOI 10.1289/EHP.95103608; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; GRUBBS CJ, 1983, J NATL CANCER I, V70, P209; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jenkins S, 2009, ENVIRON HEALTH PERSP, V117, P910, DOI 10.1289/ehp.11751; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lozada KW, 2011, BIOL REPROD, V85, P490, DOI 10.1095/biolreprod.110.090431; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; MARKEY CM, 2003, EVOL DEV, V5, P1, DOI DOI 10.1016/S0960-0760(02)00272-8; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Russo IH, 1996, ENVIRON HEALTH PERSP, V104, P938, DOI 10.2307/3433143; Sallout B, 2003, J Obstet Gynaecol, V23, P555; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Singh M, 2000, LAB INVEST, V80, P221, DOI 10.1038/labinvest.3780025; Skakkebaek NE, 1998, APMIS, V106, P3, DOI 10.1111/j.1699-0463.1998.tb01314.x; Sonnenschein C, 2011, J DEV ORIG HLTH DIS, V2, P9, DOI 10.1017/S2040174411000043; Sonnenschein C., 1999, SOC CELLS CANC CONTR; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Soto AM, 2011, BIOESSAYS, V33, P332, DOI 10.1002/bies.201100025; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Trichopoulos D, 1990, Epidemiology, V1, P95; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Wadia PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063902; Weinberg RA, 2006, BIOL CANC; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Ye X, 2008, TALANTA, V76, P865, DOI 10.1016/j.talanta.2008.04.034	57	69	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99800	10.1371/journal.pone.0099800	http://dx.doi.org/10.1371/journal.pone.0099800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988533	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100019
J	Barrilleaux, BL; Burow, D; Lockwood, SH; Yu, A; Segal, DJ; Knoepfler, PS				Barrilleaux, Bonnie L.; Burow, Dana; Lockwood, Sarah H.; Yu, Abigail; Segal, David J.; Knoepfler, Paul S.			Miz-1 Activates Gene Expression via a Novel Consensus DNA Binding Motif	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; C/EBP-DELTA; MYC; PROTEIN; REPRESSION; FINGERS; DOMAIN; DIFFERENTIATION; NEUROBLASTOMA; SUPPRESSION	The transcription factor Miz-1 can either activate or repress gene expression in concert with binding partners including the Myc oncoprotein. The genomic binding of Miz-1 includes both core promoters and more distal sites, but the preferred DNA binding motif of Miz-1 has been unclear. We used a high-throughput in vitro technique, Bind-n-Seq, to identify two Miz-1 consensus DNA binding motif sequences-ATCGGTAATC and ATCGAT (Mizm1 and Mizm2)-bound by full-length Miz-1 and its zinc finger domain, respectively. We validated these sequences directly as high affinity Miz-1 binding motifs. Competition assays using mutant probes indicated that the binding affinity of Miz-1 for Mizm1 and Mizm2 is highly sequence-specific. Miz-1 strongly activates gene expression through the motifs in a Myc-independent manner. MEME-ChIP analysis of Miz-1 ChIP-seq data in two different cell types reveals a long motif with a central core sequence highly similar to the Mizm1 motif identified by Bind-n-Seq, validating the in vivo relevance of the findings. Miz-1 ChIP-seq peaks containing the long motif are predominantly located outside of proximal promoter regions, in contrast to peaks without the motif, which are highly concentrated within 1.5 kb of the nearest transcription start site. Overall, our results indicate that Miz-1 may be directed in vivo to the novel motif sequences we have identified, where it can recruit its specific binding partners to control gene expression and ultimately regulate cell fate.	[Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Univ Calif Davis Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Lockwood, Sarah H.; Yu, Abigail; Segal, David J.; Knoepfler, Paul S.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Lockwood, Sarah H.; Yu, Abigail; Segal, David J.] Univ Calif Davis, Dept Biochem, Davis, CA 95616 USA; [Barrilleaux, Bonnie L.; Burow, Dana; Knoepfler, Paul S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	National Institutes of Health [1R01GM100782, R01 GM097073]; California Institute for Regenerative Medicine [RN2-00922-1]; California Institute for Regenerative Medicine Bridges Training Grant Award [TB1-01184]; National Institutes of Health T32 Training Grant [CA108459-07]; NATIONAL CANCER INSTITUTE [T32CA108459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782, R01GM097073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); California Institute for Regenerative Medicine Bridges Training Grant Award; National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [grant number 1R01GM100782] and California Institute for Regenerative Medicine [grant number RN2-00922-1] to PK, a National Institutes of Health [grant number R01 GM097073] to DS, a National Institutes of Health T32 Training Grant award [grant number CA108459-07] to BB, and California Institute for Regenerative Medicine Bridges Training Grant Award [grant number TB1-01184] to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Akter J, 2011, CLIN CANCER RES, V17, P6681, DOI 10.1158/1078-0432.CCR-11-0313; Bedard M, 2012, J BIOMOL NMR, V54, P317, DOI 10.1007/s10858-012-9670-1; Bernard D, 2013, J BIOMOL NMR, V57, P103, DOI 10.1007/s10858-013-9770-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Ikegaki N, 2007, CLIN CANCER RES, V13, P6001, DOI 10.1158/1078-0432.CCR-07-0071; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stead MA, 2007, J MOL BIOL, V373, P820, DOI 10.1016/j.jmb.2007.08.026; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Truscott M, 2008, MOL CELL BIOL, V28, P3127, DOI 10.1128/MCB.02089-07; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101151	10.1371/journal.pone.0101151	http://dx.doi.org/10.1371/journal.pone.0101151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983942	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000059
J	Sorberg, A; Gunnell, D; Falkstedt, D; Allebeck, P; Aberg, M; Hemmingsson, T				Sorberg, Alma; Gunnell, David; Falkstedt, Daniel; Allebeck, Peter; Aberg, Maria; Hemmingsson, Tomas			Body Mass Index in Young Adulthood and Suicidal Behavior up to Age 59 in a Cohort of Swedish Men	PLOS ONE			English	Article							RISK-FACTORS; US ADULTS; ASSOCIATION; OBESITY; DEPRESSION; MORTALITY; HEALTH; POPULATION; OVERWEIGHT; SCHIZOPHRENIA	An association of higher body mass index (BMI) with lower risk of attempted and completed suicide has been reported. In contrast, increasing BMI has been found to be associated with depression and other risk factors for suicidal behavior. We aimed to investigate this possible paradox in a cohort comprising 49 000 Swedish men. BMI, mental health, lifestyle and socioeconomic measures were recorded at conscription in 1969-70, at ages 18-20. Information on attempted suicide 1973-2008 and completed suicide 1971-2008 was obtained from national records. Hazard ratios (HR) were estimated by Cox proportional hazard models. We found that each standard deviation (SD) increase in BMI was associated with a 12% lower risk of later suicide attempt (HR 0.88, 95% CI 0.83-0.94). Associations were somewhat weaker for completed suicide and did not reach conventional levels of statistical significance (HR 0.93, 95% CI 0.85-1.01). Adjustment for a wide range of possible confounding factors had little effect on the associations. Lower BMI at conscription was also associated with higher prevalence of psychiatric diagnoses, low emotional control and depressed mood. Our results confirm previous findings regarding the association of higher BMI with a reduced risk of suicide, extending them to show similar findings in relation to suicide attempts. The associations were little affected by adjustment for a range of possible confounding factors. However, we found no evidence that high BMI was associated with an increased risk of depression cross-sectionally or longitudinally.	[Sorberg, Alma; Hemmingsson, Tomas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Falkstedt, Daniel; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Falkstedt, Daniel] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Aberg, Maria] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden; [Aberg, Maria] Univ Gothenburg, Inst Med, Dept Primary Hlth Care, Gothenburg, Sweden; [Hemmingsson, Tomas] Stockholm Univ, Ctr Social Res Alcohol & Drugs, S-10691 Stockholm, Sweden	Karolinska Institutet; University of Bristol; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; University of Gothenburg; Stockholm University	Sorberg, A (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	alma.sorberg@ki.se	Aberg, Maria/R-4001-2016; Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Hemmingsson, Tomas/0000-0001-6156-3964; Sorberg Wallin, Alma/0000-0002-8804-095X; Aberg, Maria/0000-0002-0323-1061; Falkstedt, Daniel/0000-0003-4441-7003	Swedish Council for Health, Working Life and Welfare [2008-0907]; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	Swedish Council for Health, Working Life and Welfare; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by research grants from the Swedish Council for Health, Working Life and Welfare (Project No. 2008-0907; http://www.forte.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; ALLEBECK P, 1988, BRIT MED J, V297, P176, DOI 10.1136/bmj.297.6642.176; ALLEBECK P, 1990, BRIT J PSYCHIAT, V157, P339, DOI 10.1192/bjp.157.3.339; Batty GD, 2010, AM J EPIDEMIOL, V172, P890, DOI 10.1093/aje/kwq274; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Chang SS, 2012, AM J EPIDEMIOL, V175, P804, DOI 10.1093/aje/kwr386; Elovainio M, 2009, J AFFECT DISORDERS, V116, P218, DOI 10.1016/j.jad.2008.12.002; Gao S, 2013, OBESITY, V21, pE334, DOI 10.1002/oby.20143; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Goldney RD, 2009, AUST NZ J PSYCHIAT, V43, P652, DOI 10.1080/00048670902970825; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Gunnell D, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P275; Jee SH, 2011, EUR HEART J, V32, P2773, DOI 10.1093/eurheartj/ehr229; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Kaplan MS, 2007, J NERV MENT DIS, V195, P948, DOI 10.1097/NMD.0b013e3181594833; Karlsson H, 2010, BRAIN BEHAV IMMUN, V24, P868, DOI 10.1016/j.bbi.2010.02.009; Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997; Lawlor DA, 2007, PSYCHOL MED, V37, P1151, DOI 10.1017/S0033291707000384; Lewis G, 2000, BRIT J PSYCHIAT, V177, P416, DOI 10.1192/bjp.177.5.416; Lilieblad B, 1977, RELIABILITET HOS PSY; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; Mansson NO, 1996, INT J EPIDEMIOL, V25, P80, DOI 10.1093/ije/25.1.80; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mukamal KJ, 2007, ARCH INTERN MED, V167, P468, DOI 10.1001/archinte.167.5.468; Mukamal KJ, 2010, EPIDEMIOLOGY, V21, P82, DOI 10.1097/EDE.0b013e3181c1fa2d; Mukamal KJ, 2009, OBESITY, V17, P532, DOI 10.1038/oby.2008.538; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Osler M, 2008, J EPIDEMIOL COMMUN H, V62, P23, DOI 10.1136/jech.2006.053330; Rasmussen F, 1999, ACTA PAEDIATR, V88, P431, DOI 10.1080/08035259950169837; Rebholz CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-56; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sorberg A, 2013, PSYCHOL MED, V43, P49, DOI 10.1017/S0033291712001043; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Zammit S, 2007, ACTA PSYCHIAT SCAND, V116, P378, DOI 10.1111/j.1600-0447.2007.01063.x; Zhang J, 2012, J AFFECT DISORD; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101213	10.1371/journal.pone.0101213	http://dx.doi.org/10.1371/journal.pone.0101213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1UX	24983947	Green Published, gold			2022-12-25	WOS:000339635000069
J	Foster, SR; Blank, K; Hoe, LES; Behrens, M; Meyerhof, W; Peart, JN; Thomas, WG				Foster, Simon R.; Blank, Kristina; Hoe, Louise E. See; Behrens, Maik; Meyerhof, Wolfgang; Peart, Jason N.; Thomas, Walter G.			Bitter taste receptor agonists elicit G-protein-dependent negative inotropy in the murine heart	FASEB JOURNAL			English	Article						Tas2r; GPCR; Langendorff; cardiovascular system	PERFUSED MOUSE HEART; G-BETA-GAMMA; SIGNALING PATHWAYS; ISCHEMIA-REPERFUSION; CELLS; CHLOROQUINE; GUSTDUCIN; CHANNEL; EXPRESSION; MECHANISM	G-protein-coupled receptors (GPCRs) are key mediators in cardiovascular physiology, yet frontline therapies for heart disease target only a small fraction of the cardiac GPCR repertoire. Moreover, there is emerging evidence that GPCRs implicated in taste (Tas1r and Tas2rs) have specific functions beyond the oral cavity. Our recent description of these receptors in heart tissue foreshadows a potential novel role in cardiac cells. In this study, we identified novel agonist ligands for cardiac-Tas2rs to enable the functional investigation of these receptors in heart tissue. Five Tas2rs cloned from heart tissue were screened against a panel of 102 natural or synthetic bitter compounds in a heterologous expression system. We identified agonists for Tas2r108, Tas2r137, and Tas2r143 that were then tested in Langendorff-perfused mouse hearts (from 8-wk-old male C57BL/6 mice). All Tas2r agonists tested exhibited concentration-dependent effects, with agonists for Tas2r108 and Tas2r137, leading to a similar to 40% decrease in left ventricular developed pressure and an increase in aortic pressure, respectively. These responses were abrogated in the presence of G alpha(i) and G beta gamma inhibitors (pertussis toxin and gallein). This study represents the first demonstration of profound Tas2r agonist-induced, G protein-dependent effects on mouse heart function.	[Foster, Simon R.; Thomas, Walter G.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Blank, Kristina; Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr DIfE Potsdam Rehbrucke, Dept Mol Genet, Nuthetal, Germany; [Hoe, Louise E. See; Peart, Jason N.] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia	University of Queensland; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Griffith University; Menzies Health Institute Queensland	Thomas, WG (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	w.thomas@uq.edu.au	Hoe, Louise E See/C-6650-2017; Foster, Simon R./I-1552-2014; Thomas, Walter/I-2208-2015; Behrens, Maik/B-6753-2016	Hoe, Louise E See/0000-0003-0553-205X; Foster, Simon R./0000-0003-3034-1351; Thomas, Walter/0000-0003-0685-2952; Behrens, Maik/0000-0003-2082-8860	Australian National Health and Medical Research Council (NHMRC) [1024726]; National Heart Foundation of Australia [G-12B-6532]; Australian Postgraduate Award; National Heart Foundation of Australia; Australian Research Council	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Postgraduate Award(Australian Government); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council)	This work was supported by project grants awarded to W.G.T. from the Australian National Health and Medical Research Council (NHMRC; 1024726) and the National Heart Foundation of Australia (G-12B-6532); an Australian Postgraduate Award scholarship to S.R.F.; a scholarship from the National Heart Foundation of Australia to L.S.H.; and a Future Fellowship from the Australian Research Council to J.N.P.	Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Assanasen Paraya, 2002, Clin Allergy Immunol, V17, P101; BACQ ZM, 1949, BRIT J PHARM CHEMOTH, V4, P162, DOI 10.1111/j.1476-5381.1949.tb00530.x; Ballestero JA, 2005, MOL PHARMACOL, V68, P822, DOI 10.1124/mol.105.014431; BEAMISH RE, 1945, CAN MED ASSOC J, V53, P236; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Broskova Z, 2013, PHYTOTHER RES, V27, P1018, DOI 10.1002/ptr.4825; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cocco G, 2010, EUR J INTERN MED, V21, P503, DOI 10.1016/j.ejim.2010.09.010; Cosmetic Ingredient Review Expert, 2001, INT J TOXICOL, V20, P23; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Dietrich A, 2011, ADV EXP MED BIOL, V704, P781, DOI 10.1007/978-94-007-0265-3_41; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Enns GM, 2007, NEW ENGL J MED, V356, P2282, DOI 10.1056/NEJMoa066596; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; Headrick JP, 2001, EXP PHYSIOL, V86, P703, DOI 10.1111/j.1469-445X.2001.tb00035.x; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Iguchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023165; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kesavan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061393; KLEINSCHWARTZ W, 1991, VET HUM TOXICOL, V33, P545; KREBS HA, 1983, BIOCHEM J, V214, P657, DOI 10.1042/bj2140657; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Lebret T, 2002, EUR UROL, V41, P608, DOI 10.1016/S0302-2838(02)00175-6; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Lim YJ, 2009, ARCH PHARM RES, V32, P367, DOI 10.1007/s12272-009-1309-8; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Maeda K, 1996, J PHARMACOL EXP THER, V276, P765; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Meens MJPMT, 2012, BRIT J PHARMACOL, V166, P297, DOI 10.1111/j.1476-5381.2011.01774.x; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Millan MJ, 2000, SYNAPSE, V35, P79, DOI 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X; Moore-Morris T, 2009, MOL PHARMACOL, V75, P1108, DOI 10.1124/mol.108.054155; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Ozeck M, 2004, EUR J PHARMACOL, V489, P139, DOI 10.1016/j.ejphar.2004.03.004; Pal D, 2012, CARCINOGENESIS, V33, P2424, DOI 10.1093/carcin/bgs276; Park JY, 2003, ANTIMICROB AGENTS CH, V47, P3464, DOI 10.1128/AAC.47.11.3464-3469.2003; Parvez S, 2006, PHYTOTHER RES, V20, P921, DOI 10.1002/ptr.1954; Peart JN, 2006, AM J PHYSIOL-HEART C, V291, pH1746, DOI 10.1152/ajpheart.00233.2006; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Reichelt ME, 2009, EXP PHYSIOL, V94, P54, DOI 10.1113/expphysiol.2008.043554; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Roosterman D, 1997, J NEUROENDOCRINOL, V9, P741, DOI 10.1046/j.1365-2826.1997.00632.x; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Saha P, 2006, CANCER LETT, V244, P252, DOI 10.1016/j.canlet.2005.12.036; Schwan A. L., 2001, ENCY REAGENTS ORGANI; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shaw RM, 2013, CARDIOVASC RES, V98, P177, DOI 10.1093/cvr/cvt021; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Stas P, 2008, INT J CARDIOL, V127, pE80, DOI 10.1016/j.ijcard.2007.04.055; Storms W, 2005, J ASTHMA, V42, P79, DOI 10.1081/JAS-52017; Swithers SE, 2010, PHYSIOL BEHAV, V100, P55, DOI 10.1016/j.physbeh.2009.12.021; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Tonnesmann E, 2013, IMMUNOPHARM IMMUNOT, V35, P434, DOI 10.3109/08923973.2013.780078; Ueda T, 2003, J NEUROSCI, V23, P7376; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	84	55	56	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4497	4508		10.1096/fj.14-256305	http://dx.doi.org/10.1096/fj.14-256305			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002118				2022-12-25	WOS:000342222700026
J	Avital-Shmilovici, M; Whittaker, J; Weiss, MA; Kent, SBH				Avital-Shmilovici, Michal; Whittaker, Jonathan; Weiss, Michael A.; Kent, Stephen B. H.			Deciphering a Molecular Mechanism of Neonatal Diabetes Mellitus by the Chemical Synthesis of a Protein Diastereomer, [D-Ala(B8)]Human Proinsulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Diabetes; Mutant; Peptide Chemical Synthesis; Protein Folding; Proinsulin; Insulin Receptor	ENDOPLASMIC-RETICULUM STRESS; PHASE PEPTIDE-SYNTHESIS; DISULFIDE-ISOMERASE; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; INSULIN-RECEPTOR; INS GENE; B-CHAIN; LIGATION; MUTATIONS	Background: Human proinsulin provides a model for studies of toxic protein misfolding. Results: Folding efficiency of proinsulin is controlled by stereochemistry at position B8. Conclusion: The sign of a single angle can facilitate or impede disulfide pairing. Significance: A monogenic diabetes syndrome suggests that insulin has evolved to the edge of non-foldability. Misfolding of proinsulin variants in the pancreatic -cell, a monogenic cause of permanent neonatal-onset diabetes mellitus, provides a model for a disease of protein toxicity. A hot spot for such clinical mutations is found at position B8, conserved as glycine within the vertebrate insulin superfamily. We set out to investigate the molecular basis of the aberrant properties of a proinsulin clinical mutant in which residue Gly(B8) is replaced by Ser(B8). Modular total chemical synthesis was used to prepare the wild-type [Gly(B8)]proinsulin molecule and three analogs: [d-Ala(B8)]proinsulin, [l-Ala(B8)]proinsulin, and the clinical mutant [l-Ser(B8)]proinsulin. The protein diastereomer [d-Ala(B8)]proinsulin produced higher folding yields at all pH values compared with the wild-type proinsulin and the other two analogs, but showed only very weak binding to the insulin receptor. The clinical mutant [l-Ser(B8)]proinsulin impaired folding at pH 7.5 even in the presence of protein-disulfide isomerase. Surprisingly, although [l-Ser(B8)]proinsulin did not fold well under the physiological conditions investigated, once folded the [l-Ser(B8)]proinsulin protein molecule bound to the insulin receptor more effectively than wild-type proinsulin. Such paradoxical gain of function (not pertinent in vivo due to impaired secretion of the mutant insulin) presumably reflects induced fit in the native mechanism of hormone-receptor engagement. This work provides insight into the molecular mechanism of a clinical mutation in the insulin gene associated with diabetes mellitus. These results dramatically illustrate the power of total protein synthesis, as enabled by modern chemical ligation methods, for the investigation of protein folding and misfolding.	[Avital-Shmilovici, Michal; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Avital-Shmilovici, Michal; Kent, Stephen B. H.] Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; [Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	University of Chicago; University of Chicago; Case Western Reserve University; Case Western Reserve University	Kent, SBH (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA.	skent@uchicago.edu			National Institutes of Health from the NIDDK [R01 DK069764]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK069764 from the NIDDK (to M. A. W.) with a subcontract to S. B. Kent (University of Chicago). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH) where he serves as Chief Scientific Officer and has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp.; Supported in part by the American Diabetes Association.	Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Avital-Shmilovici M, 2013, J AM CHEM SOC, V135, P3173, DOI 10.1021/ja311408y; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; FREYCHET P, 1974, J CLIN INVEST, V54, P1020, DOI 10.1172/JCI107845; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Luisier S, 2010, CHEM COMMUN, V46, P8177, DOI 10.1039/c0cc03141k; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MITCHELL AR, 1978, J ORG CHEM, V43, P2845, DOI 10.1021/jo00408a022; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Schaeffer RD, 2008, CURR OPIN STRUC BIOL, V18, P4, DOI 10.1016/j.sbi.2007.11.007; Schnolzer M, 2007, INT J PEPT RES THER, V13, P31, DOI 10.1007/s10989-006-9059-7; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shield JPH, 1997, ARCH DIS CHILD-FETAL, V76, pF39, DOI 10.1136/fn.76.1.F39; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sohma Y, 2009, J AM CHEM SOC, V131, P16313, DOI 10.1021/ja9052398; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Villain M, 2001, CHEM BIOL, V8, P673, DOI 10.1016/S1074-5521(01)00044-8; Wang CC, 1998, BIOCHEMISTRY-MOSCOW+, V63, P407; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Winter J, 2002, ANAL BIOCHEM, V310, P148, DOI 10.1016/S0003-2697(02)00287-7; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Zeldovich KB, 2008, ANNU REV PHYS CHEM, V59, P105, DOI 10.1146/annurev.physchem.58.032806.104449; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	58	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23683	23692		10.1074/jbc.M114.572040	http://dx.doi.org/10.1074/jbc.M114.572040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002580	Green Published, hybrid			2022-12-25	WOS:000341505000036
J	Boschker, HTS; Vasquez-Cardenas, D; Bolhuis, H; Moerdijk-Poortvliet, TWC; Moodley, L				Boschker, Henricus T. S.; Vasquez-Cardenas, Diana; Bolhuis, Henk; Moerdijk-Poortvliet, Tanja W. C.; Moodley, Leon			Chemoautotrophic Carbon Fixation Rates and Active Bacterial Communities in Intertidal Marine Sediments	PLOS ONE			English	Article							FATTY-ACIDS; SULFATE REDUCTION; RUBISCO GENOTYPES; HYDROGEN-SULFIDE; SULFUR OXIDATION; MEMBRANE-LIPIDS; SP-NOV; GROWTH; THIOBACILLUS; BEGGIATOA	Chemoautotrophy has been little studied in typical coastal marine sediments, but may be an important component of carbon recycling as intense anaerobic mineralization processes in these sediments lead to accumulation of high amounts of reduced compounds, such as sulfides and ammonium. We studied chemoautotrophy by measuring dark-fixation of C-13-bicarbonate into phospholipid derived fatty acid (PLFA) biomarkers at two coastal sediment sites with contrasting sulfur chemistry in the Eastern Scheldt estuary, the Netherlands. At one site where free sulfide accumulated in the pore water right to the top of the sediment, PLFA labeling was restricted to compounds typically found in sulfur and ammonium oxidizing bacteria. At the other site, with no detectable free sulfide in the pore water, a very different PLFA labeling pattern was found with high amounts of label in branched i- and a-PLFA besides the typical compounds for sulfur and ammonium oxidizing bacteria. This suggests that other types of chemoautotrophic bacteria were also active, most likely Deltaproteobacteria related to sulfate reducers. Maximum rates of chemoautotrophy were detected in first 1 to 2 centimeters of both sediments and chemosynthetic biomass production was high ranging from 3 to 36 mmol C m(-2) d(-1). Average dark carbon fixation to sediment oxygen uptake ratios were 0.22 +/- 0.07 mol C (mol O-2)(-1), which is in the range of the maximum growth yields reported for sulfur oxidizing bacteria indicating highly efficient growth. Chemoautotrophic biomass production was similar to carbon mineralization rates in the top of the free sulfide site, suggesting that chemoautotrophic bacteria could play a crucial role in the microbial food web and labeling in eukaryotic poly-unsaturated PLFA was indeed detectable. Our study shows that dark carbon fixation by chemoautotrophic bacteria is a major process in the carbon cycle of coastal sediments, and should therefore receive more attention in future studies on sediment biogeochemistry and microbial ecology.	[Boschker, Henricus T. S.; Vasquez-Cardenas, Diana; Bolhuis, Henk; Moerdijk-Poortvliet, Tanja W. C.] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands; [Moodley, Leon] Int Res Inst Stavanger IRIS, Marine Environm Grp, Randaberg, Norway	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Boschker, HTS (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands.	eric.boschker@nioz.nl	Bolhuis, Henk/S-2986-2019; moodley, leon/AAH-1674-2019; Bolhuis, Henk/H-8535-2014; Bolhuis, Henk/M-6677-2019	Bolhuis, Henk/0000-0002-4772-1898; Bolhuis, Henk/0000-0002-4772-1898; Moodley, Leon/0000-0002-0617-3514; Vasquez-Cardenas, Diana/0000-0002-8366-2020	Netherlands Organization for Scientific Research (NWO) VIDI [864.04.009]; Darwin Center for Biogeosciences [142.16.3061]; ESF [855.01.130]	Netherlands Organization for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO)); Darwin Center for Biogeosciences; ESF(European Commission)	This work was supported by the following grants: Netherlands Organization for Scientific Research (NWO) VIDI grant number 864.04.009 to HTSB, Darwin Center for Biogeosciences grant number 142.16.3061 to HTSB, and ESF grant number 855.01.130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2008, MICROBES ENVIRON, V23, P81, DOI 10.1264/jsme2.23.81; ALLER RC, 1985, J MAR RES, V43, P615, DOI 10.1357/002224085788440349; BAK F, 1987, ARCH MICROBIOL, V147, P184, DOI 10.1007/BF00415282; Billerbeck M, 2006, MAR ECOL PROG SER, V326, P61, DOI 10.3354/meps326061; BLUMER M, 1969, J BACTERIOL, V99, P366, DOI 10.1128/JB.99.2.366-370.1969; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Boudreau BP, 2006, GEOLOGY, V34, P693, DOI 10.1130/G22771.1; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; de Bie MJM, 2002, FEMS MICROBIOL ECOL, V42, P99, DOI 10.1111/j.1574-6941.2002.tb00999.x; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dijkhuizen L., 1985, COMPREHENSIVE BIOTEC, P409; Dijkman NA, 2006, MAR ECOL PROG SER, V324, P113, DOI 10.3354/meps324113; EDLUND A, 1985, J LIPID RES, V26, P982; Elferink SJWHO, 1998, GEOMICROBIOL J, V15, P3; Elsaied HE, 2007, EXTREMOPHILES, V11, P191, DOI 10.1007/s00792-006-0025-2; ENOKSSON V, 1987, MAR ECOL PROG SER, V36, P181, DOI 10.3354/meps036181; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Giri BJ, 2004, APPL ENVIRON MICROB, V70, P3443, DOI 10.1128/AEM.70.6.3443-3448.2004; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GOTTSCHAL JC, 1979, ARCH MICROBIOL, V121, P241, DOI 10.1007/BF00425062; Hagen KD, 1996, APPL ENVIRON MICROB, V62, P947, DOI 10.1128/AEM.62.3.947-953.1996; HEMPFLING WP, 1967, J BACTERIOL, V93, P874, DOI 10.1128/JB.93.3.874-878.1967; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; JANNASCH HW, 1979, BIOSCIENCE, V29, P592, DOI 10.2307/1307765; Jansen S, 2009, OCEAN DYNAM, V59, P317, DOI 10.1007/s10236-009-0179-4; Jorgensen B.B., 2004, GEOL S AM, V379, P63, DOI DOI 10.1130/0-8137-2379-5.63; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Kelly DP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P441, DOI 10.1007/0-387-30742-7_15; Kelly DP, 1999, ARCH MICROBIOL, V171, P219, DOI 10.1007/s002030050703; KERGER BD, 1986, FEMS MICROBIOL ECOL, V38, P67, DOI 10.1016/0378-1097(86)90144-8; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; Knief C, 2003, ENVIRON MICROBIOL, V5, P1155, DOI 10.1046/j.1462-2920.2003.00510.x; Kristensen E, 1999, CONT SHELF RES, V19, P1331, DOI 10.1016/S0278-4343(99)00024-2; Lenk S, 2011, ENVIRON MICROBIOL, V13, P758, DOI 10.1111/j.1462-2920.2010.02380.x; Lipski A, 2001, SYST APPL MICROBIOL, V24, P377, DOI 10.1078/0723-2020-00049; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Middelburg JJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049725; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; NELSON DC, 1986, APPL ENVIRON MICROB, V52, P225, DOI 10.1128/AEM.52.2.225-233.1986; NELSON DC, 1983, ARCH MICROBIOL, V136, P262, DOI 10.1007/BF00425214; Nigro LM, 2007, FEMS MICROBIOL ECOL, V60, P113, DOI 10.1111/j.1574-6941.2007.00272.x; ODINTSOVA EV, 1993, ARCH MICROBIOL, V160, P152, DOI 10.1007/BF00288718; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; REDFIELD AC, 1958, AM SCI, V46, P205; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR-METH, V1, P63, DOI 10.4319/lom.2011.1.63; Robertson LA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P985, DOI 10.1007/0-387-30742-7_31; Romanenko V. I., 1964, MIKROBIOLOGIYA, V33, P610; Sakata S, 2008, ORG GEOCHEM, V39, P1725, DOI 10.1016/j.orggeochem.2008.08.005; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Schouten S, 2000, P NATL ACAD SCI USA, V97, P14421, DOI 10.1073/pnas.97.26.14421; SKYRING GW, 1987, GEOMICROBIOL J, V5, P295, DOI 10.1080/01490458709385974; Smaal AC, 2009, HELGOLAND MAR RES, V63, P75, DOI 10.1007/s10152-008-0138-3; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; SOROKIN YI, 1972, J CONSEIL, V34, P423; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Thomsen U, 1997, AQUAT MICROB ECOL, V12, P165, DOI 10.3354/ame012165; TIMMERTENHOOR A, 1981, A VAN LEEUW J MICROB, V47, P231; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; TUTTLE JH, 1979, LIMNOL OCEANOGR, V24, P746, DOI 10.4319/lo.1979.24.4.0746; Van Frausum J, 2010, ECOL MODEL, V221, P2054, DOI 10.1016/j.ecolmodel.2010.06.001; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; Wuchter C, 2003, FEMS MICROBIOL LETT, V219, P203, DOI 10.1016/S0378-1097(03)00060-0; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	75	43	44	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101443	10.1371/journal.pone.0101443	http://dx.doi.org/10.1371/journal.pone.0101443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003508	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700032
J	Ozgen, H; Schrimpf, W; Hendrix, J; de Jonge, JC; Lamb, DC; Hoekstra, D; Kahya, N; Baron, W				Ozgen, Hande; Schrimpf, Waldemar; Hendrix, Jelle; de Jonge, Jenny C.; Lamb, Don C.; Hoekstra, Dick; Kahya, Nicoletta; Baron, Wia			The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; PULSED INTERLEAVED EXCITATION; GROWTH-FACTOR INTERACTIONS; LASER-SCANNING MICROSCOPE; BASIC-PROTEIN; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; PARANODAL JUNCTION; MULTIPLE-SCLEROSIS	In the central nervous system, lipid-protein interactions are pivotal for myelin maintenance, as these interactions regulate protein transport to the myelin membrane as well as the molecular organization within the sheath. To improve our understanding of the fundamental properties of myelin, we focused here on the lateral membrane organization and dynamics of peripheral membrane protein 18.5-kDa myelin basic protein (MBP) and transmembrane protein proteolipid protein (PLP) as a function of the typical myelin lipids galactosylceramide (GalC), and sulfatide, and exogenous factors such as the extracellular matrix proteins laminin-2 and fibronectin, employing an oligodendrocyte cell line, selectively expressing the desired galactolipids. The dynamics of MBP were monitored by z-scan point fluorescence correlation spectroscopy (FCS) and raster image correlation spectroscopy (RICS), while PLP dynamics in living cells were investigated by circular scanning FCS. The data revealed that on an inert substrate the diffusion rate of 18.5-kDa MBP increased in GalC-expressing cells, while the diffusion coefficient of PLP was decreased in sulfatide-containing cells. Similarly, when cells were grown on myelination-promoting laminin-2, the lateral diffusion coefficient of PLP was decreased in sulfatide-containing cells. In contrast, PLP's diffusion rate increased substantially when these cells were grown on myelination-inhibiting fibronectin. Additional biochemical analyses revealed that the observed differences in lateral diffusion coefficients of both proteins can be explained by differences in their biophysical, i.e., galactolipid environment, specifically with regard to their association with lipid rafts. Given the persistence of pathological fibronectin aggregates in multiple sclerosis lesions, this fundamental insight into the nature and dynamics of lipid-protein interactions will be instrumental in developing myelin regenerative strategies.	[Ozgen, Hande; de Jonge, Jenny C.; Hoekstra, Dick; Kahya, Nicoletta; Baron, Wia] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Schrimpf, Waldemar; Hendrix, Jelle; Lamb, Don C.] Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci CiPSM, Munich, Germany; [Schrimpf, Waldemar; Hendrix, Jelle; Lamb, Don C.] Univ Munich, Ctr Nanosci CeNS, Munich, Germany	University of Groningen; University of Munich; University of Munich	Kahya, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.	nicoletta.kahya@gmail.com; w.baron@umcg.nl	Lamb, Don C/G-9501-2014; HENDRIX, Jelle/H-1721-2018	Lamb, Don C/0000-0002-0232-1903; HENDRIX, Jelle/0000-0001-5731-1297; Baron, Wia/0000-0002-6673-4766	Netherlands Organization of Scientific Research (NWO) [016.096.329]; Dutch MS Research Foundation ('Stichting MS Research'); Research Foundation Flanders; Deutsche Forschungsgemeinschaft (DFG, DCL) [SFB1032]; Excellence Initiative Nanosystems Initiative Munich (NIM); Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network; Center for NanoScience; EMBO Short Term Fellowship [ASTF 463-2012/EMBO]; NWO [175-010-2009-023]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch MS Research Foundation ('Stichting MS Research'); Research Foundation Flanders(FWO); Deutsche Forschungsgemeinschaft (DFG, DCL); Excellence Initiative Nanosystems Initiative Munich (NIM); Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network; Center for NanoScience; EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Netherlands Organization of Scientific Research (NWO, www.nwo.nl, WB, 016.096.329), the Dutch MS Research Foundation ('Stichting MS Research', www.msresearch.nl, WB, DH), the Research Foundation Flanders (www.fwo.be, JH), and the Deutsche Forschungsgemeinschaft (DFG, DCL) through the collaborative research grant SFB1032 and the Excellence Initiative Nanosystems Initiative Munich (NIM) and Ludwig-Maximilians-Universitat Munich via the LMU Innovative BioImaging Network and the Center for NanoScience. The research visit to Dr. Don C. Lamb's laboratory was supported by an EMBO Short Term Fellowship (www.EMBO.org, ASTF 463-2012/EMBO, HO). Part of the work has been performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO grant 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baron W, 2014, GLIA, V62, P927, DOI 10.1002/glia.22650; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs JM, 2004, J NEUROSCI RES, V76, P342, DOI 10.1002/jnr.20080; Boggs JA, 2008, BBA-GEN SUBJECTS, V1780, P445, DOI 10.1016/j.bbagen.2007.10.015; Boggs JM, 2008, J NEUROSCI RES, V86, P1448, DOI 10.1002/jnr.21603; Boggs JM, 2010, FEBS LETT, V584, P1771, DOI 10.1016/j.febslet.2009.11.074; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosio A, 1998, J NEUROCHEM, V70, P308; BROWN MC, 1993, J NEUROSCI RES, V35, P402, DOI 10.1002/jnr.490350407; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Colognato H, 2005, TRENDS NEUROSCI, V28, P480, DOI 10.1016/j.tins.2005.07.004; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966; DeBruin LS, 2005, J NEUROSCI RES, V80, P211, DOI 10.1002/jnr.20452; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dupree JL, 2010, PROSTAG OTH LIPID M, V91, P118, DOI 10.1016/j.prostaglandins.2009.04.005; DYER CA, 1989, J NEUROSCI RES, V24, P212, DOI 10.1002/jnr.490240212; DYER CA, 1994, J NEUROSCI RES, V39, P97, DOI 10.1002/jnr.490390112; DYER CA, 1991, J NEUROSCI RES, V30, P699, DOI 10.1002/jnr.490300414; Fewou SN, 2010, J NEUROCHEM, V112, P599, DOI 10.1111/j.1471-4159.2009.06464.x; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Heinemann F, 2012, LANGMUIR, V28, P13395, DOI 10.1021/la302596h; Hendrix J, 2014, METHODS MOL BIOL, V1076, P653, DOI 10.1007/978-1-62703-649-8_30; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Jackman N, 2009, PHYSIOLOGY, V24, P290, DOI 10.1152/physiol.00016.2009; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Klunder B, 2008, J NEUROSCI RES, V86, P1007, DOI 10.1002/jnr.21556; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Maier O, 2005, MOL CELL NEUROSCI, V28, P390, DOI 10.1016/j.mcn.2004.09.012; Maier O, 2008, J MOL NEUROSCI, V35, P35, DOI 10.1007/s12031-007-9024-8; Maier O, 2007, GLIA, V55, P885, DOI 10.1002/glia.20510; Ozgen H, 2014, BBA-MOL CELL RES, V1843, P517, DOI 10.1016/j.bbamcr.2013.11.026; PETERSEN NO, 1986, BIOPHYS J, V49, P809, DOI 10.1016/S0006-3495(86)83709-2; Petrasek Z, 2011, OPT EXPRESS, V19, P25006, DOI 10.1364/OE.19.025006; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; Ruan QQ, 2004, BIOPHYS J, V87, P1260, DOI 10.1529/biophysj.103.036483; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Siskova Z, 2006, MOL CELL NEUROSCI, V33, P150, DOI 10.1016/j.mcn.2006.07.001; Smith GST, 2011, J NEUROSCI RES, V89, P467, DOI 10.1002/jnr.22570; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Stoffels JMJ, 2013, CELL MOL LIFE SCI, V70, P4243, DOI 10.1007/s00018-013-1350-0; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x	61	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101834	10.1371/journal.pone.0101834	http://dx.doi.org/10.1371/journal.pone.0101834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003183	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700075
J	Sau, S; Sutradhar, S; Paul, R; Sinha, P				Sau, Soumitra; Sutradhar, Sabyasachi; Paul, Raja; Sinha, Pratima			Budding Yeast Kinetochore Proteins, Chl4 and Ctf19, Are Required to Maintain SPB-Centromere Proximity during G1 and Late Anaphase	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; MICROTUBULE DYNAMICS; MOLECULAR-MECHANISMS; BIPOLAR ATTACHMENT; OUTER KINETOCHORE; NUCLEAR-ENVELOPE; FORCE-GENERATION; FISSION YEAST	In the budding yeast, centromeres stay clustered near the spindle pole bodies (SPBs) through most of the cell cycle. This SPB-centromere proximity requires microtubules and functional kinetochores, which are protein complexes formed on the centromeres and capable of binding microtubules. The clustering is suggested by earlier studies to depend also on protein-protein interactions between SPB and kinetochore components. Previously it has been shown that the absence of nonessential kinetochore proteins of the Ctf19 complex weakens kinetochore-microtubule interaction, but whether this compromised interaction affects centromere/kinetochore positioning inside the nucleus is unknown. We found that in G1 and in late anaphase, SPB-centromere proximity was disturbed in mutant cells lacking Ctf19 complex members, Chl4p and/or Ctf19p, whose centromeres lay further away from their SPBs than those of the wild-type cells. We unequivocally show that the SPB-centromere proximity and distances are not dependent on physical interactions between SPB and kinetochore components, but involve microtubule-dependent forces only. Further insight on the positional difference between wild-type and mutant kinetochores was gained by generating computational models governed by (1) independently regulated, but constant kinetochore microtubule (kMT) dynamics, (2) poleward tension on kinetochore and the antagonistic polar ejection force and (3) length and force dependent kMT dynamics. Numerical data obtained from the third model concurs with experimental results and suggests that the absence of Chl4p and/or Ctf19p increases the penetration depth of a growing kMT inside the kinetochore and increases the rescue frequency of a depolymerizing kMT. Both the processes result in increased distance between SPB and centromere.	[Sau, Soumitra; Sinha, Pratima] Bose Inst, Dept Biochem, Kolkata, India; [Sutradhar, Sabyasachi; Paul, Raja] Indian Assoc Cultivat Sci, Dept Solid State Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Paul, R (corresponding author), Indian Assoc Cultivat Sci, Dept Solid State Phys, Kolkata, India.	ssprp@iacs.res.in; pratima@jcbose.ac.in		Sutradhar, Sabyasachi/0000-0002-5826-5891	Council of Scientific and Industrial Research (CSIR) [37(1094)/02-EMR-II]; Department of Science and Technology (DST), Government of India [SR/S2/CMP-0107/2010]; CSIR [9/15(314)/2006-EMR-I, 09/080(0707)/2010-EMR-I]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Council of Scientific and Industrial Research (CSIR) grant [37(1094)/02-EMR-II] along with Institutional support (partial) by the Department of Science and Technology (DST), Government of India, to P.S and DST India grant [SR/S2/CMP-0107/2010] to R.P.S. Sau and S. Sutradhar were supported by CSIR grants (Sanction Numbers: 9/15(314)/2006-EMR-I and 09/080(0707)/2010-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2009, MOL BIOL CELL, V20, P4131, DOI 10.1091/mbc.E09-05-0359; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Breeden LL, 1997, METHOD ENZYMOL, V283, P332; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho US, 2010, COLD SH Q B, V75, P395, DOI 10.1101/sqb.2010.75.040; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Cui H, 2009, J CELL BIOL, V185, P251, DOI 10.1083/jcb.200810130; Das SP, 2005, BIOCHEM BIOPH RES CO, V337, P167, DOI 10.1016/j.bbrc.2005.09.034; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Gandhi SR, 2011, DEV CELL, V21, P920, DOI 10.1016/j.devcel.2011.09.006; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Ghosh SK, 2004, CURR GENET, V46, P82, DOI 10.1007/s00294-004-0516-6; Ghosh SK, 2001, MOL GENET GENOMICS, V265, P249, DOI 10.1007/s004380000408; Gonen S, 2012, NAT STRUCT MOL BIOL, V19, P925, DOI 10.1038/nsmb.2358; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Guacci V, 1997, MOL BIOL CELL, V8, P957, DOI 10.1091/mbc.8.6.957; Hou HT, 2012, J CELL BIOL, V199, P735, DOI 10.1083/jcb.201208001; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; James P, 1996, GENETICS, V144, P1425; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kitamura E, 2007, GENE DEV, V21, P3319, DOI 10.1101/gad.449407; KOUPRINA N, 1993, GENETICS, V135, P327; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Lahiri S, 2013, FEMS YEAST RES, V13, P375, DOI 10.1111/1567-1364.12041; Le Masson I, 2002, MOL MICROBIOL, V43, P1431; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Poddar A, 1999, MOL MICROBIOL, V31, P349, DOI 10.1046/j.1365-2958.1999.01179.x; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Richmond D, 2013, MOL BIOL CELL, V24, P566, DOI 10.1091/mbc.E12-07-0552; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Roy N, 1997, CURR GENET, V32, P182, DOI 10.1007/s002940050264; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; Sarkar S, 2010, FEMS YEAST RES, V10, P660, DOI 10.1111/j.1567-1364.2010.00655.x; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wolyniak MJ, 2006, MOL BIOL CELL, V17, P2789, DOI 10.1091/mbc.E05-09-0892	68	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101294	10.1371/journal.pone.0101294	http://dx.doi.org/10.1371/journal.pone.0101294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003500	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700023
J	Shukla, A; Sharma, P; Prakash, O; Singh, M; Kalani, K; Khan, F; Bawankule, DU; Luqman, S; Srivastava, SK				Shukla, Aparna; Sharma, Pooja; Prakash, Om; Singh, Monika; Kalani, Komal; Khan, Feroz; Bawankule, Dnyaneshwar Umrao; Luqman, Suaib; Srivastava, Santosh Kumar			QSAR and Docking Studies on Capsazepine Derivatives for Immunomodulatory and Anti-Inflammatory Activity	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; VANILLOID RECEPTOR; CAPSAICIN; INHIBITORS; BIOACTIVITIES; DISCOVERY; ANTAGONIST; INDUCTION; TARGET	Capsazepine, an antagonist of capsaicin, is discovered by the structure and activity relationship. In previous studies it has been found that capsazepine has potency for immunomodulation and anti-inflammatory activity and emerging as a favourable target in quest for efficacious and safe anti-inflammatory drug. Thus, a 2D quantitative structural activity relationship (QSAR) model against target tumor necrosis factor-alpha (TNF-alpha) was developed using multiple linear regression method (MLR) with good internal prediction (r(2) = 0.8779) and external prediction (r(pred)(2) = 0.5865) using Discovery Studio v3.5 (Accelrys, USA). The predicted activity was further validated by in vitro experiment. Capsazepine was tested in lipopolysaccharide (LPS) induced inflammation in peritoneal mouse macrophages. Anti-inflammatory profile of capsazepine was assessed by its potency to inhibit the production of inflammatory mediator TNF-alpha. The in vitro experiment indicated that capsazepine is an efficient anti-inflammatory agent. Since, the developed QSAR model showed significant correlations between chemical structure and anti-inflammatory activity, it was successfully applied in the screening of forty-four virtual derivatives of capsazepine, which finally afforded six potent derivatives, CPZ-29, CPZ-30, CPZ-33, CPZ-34, CPZ-35 and CPZ36. To gain more insights into the molecular mechanism of action of capsazepine and its derivatives, molecular docking and in silico absorption, distribution, metabolism, excretion and toxicity (ADMET) studies were performed. The results of QSAR, molecular docking, in silico ADMET screening and in vitro experimental studies provide guideline and mechanistic scope for the identification of more potent anti-inflammatory & immunomodulatory drug.	[Shukla, Aparna; Sharma, Pooja; Prakash, Om; Khan, Feroz] CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India; [Singh, Monika; Bawankule, Dnyaneshwar Umrao; Luqman, Suaib] CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India; [Kalani, Komal; Srivastava, Santosh Kumar] CSIR Cent Inst Med & Aromat Plants, Div Analyt Chem, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Khan, F (corresponding author), CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, PO CIMAP,Kukrail Picn Spot Rd, Lucknow, Uttar Pradesh, India.	f.khan@cimap.res.in	Khan, Feroz/AHC-3474-2022; Bawankule, Dnyaneshwar/AAD-8093-2022; Luqman, Suaib/M-5541-2015	Khan, Feroz/0000-0002-2704-5925; Bawankule, Dnyaneshwar/0000-0003-0677-0981; PRAKASH, OM/0000-0001-7893-8873	'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India; CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India [SR/FT/LS-25/2010]	'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India; CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India	This study was supported by the 'Science and Engineering Research Board (SERB), Department of Science & Technology (DST)', New Delhi, India for the financial support at CSIR - Central Institute of Medicinal and Aromatic Plants, Lucknow, India (SR/FT/LS-25/2010 dated May 2, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Alam S, 2014, DRUG DES DEV THER, V8, P183, DOI 10.2147/DDDT.S51577; Appendino G, 2003, EXPERT OPIN THER PAT, V13, P1825, DOI 10.1517/eotp.13.12.1825.22908; Bawankule D. U., 2008, Inflammopharmacology, V16, P272, DOI 10.1007/s10787-008-8012-0; Brown E, 2008, METAL IONS BIOL MED, V10, P583; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chao Q, 1999, J MED CHEM, V42, P3860, DOI 10.1021/jm9805900; Chen CW, 2003, BRIT J PHARMACOL, V140, P1077, DOI 10.1038/sj.bjp.0705533; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Cheng JF, 2004, BIOORG MED CHEM LETT, V14, P2411, DOI 10.1016/j.bmcl.2004.03.022; Cheng JF, 2003, BIOORG MED CHEM LETT, V13, P3647, DOI 10.1016/j.bmcl.2003.08.025; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; FRANCOCERECEDA A, 1988, N-S ARCH PHARMACOL, V337, P649; Fujita M, 2002, BIOORG MED CHEM LETT, V12, P1897, DOI 10.1016/S0960-894X(02)00332-3; Fujita M, 2002, BIOORG MED CHEM LETT, V12, P1607, DOI 10.1016/S0960-894X(02)00228-7; Fujita M, 2002, BIOORGAN MED CHEM, V10, P3113, DOI 10.1016/S0968-0896(02)00224-9; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luqman S, 2011, J MED FOOD, V14, P1344, DOI 10.1089/jmf.2010.0236; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Meena A, 2011, CHEM BIOL DRUG DES, V78, P567, DOI 10.1111/j.1747-0285.2011.01173.x; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oh GS, 2001, INT IMMUNOPHARMACOL, V1, P777, DOI 10.1016/S1567-5769(01)00012-1; SRINIVASAN MR, 1989, INDIAN J EXP BIOL, V27, P910; Szallasi A, 1999, PHARMACOL REV, V51, P159; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; UCHIDA M, 1991, JPN J PHARMACOL, V55, P279, DOI 10.1254/jjp.55.279; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; Yadav DK, 2010, DRUG DES DEV THER, V4, P173	31	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100797	10.1371/journal.pone.0100797	http://dx.doi.org/10.1371/journal.pone.0100797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003344	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700013
J	Aghili, F; Gamper, HA; Eikenberg, J; Khoshgoftarmanesh, AH; Afyuni, M; Schulin, R; Jansa, J; Frossard, E				Aghili, Forough; Gamper, Hannes A.; Eikenberg, Jost; Khoshgoftarmanesh, Amir H.; Afyuni, Majid; Schulin, Rainer; Jansa, Jan; Frossard, Emmanuel			Green Manure Addition to Soil Increases Grain Zinc Concentration in Bread Wheat	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; NUTRITION; GENOTYPES; DEFICIENCY; CROPS; YIELD; COLONIZATION; EXUDATION; BENEFITS; RELEASE	Zinc (Zn) deficiency is a major problem for many people living on wheat-based diets. Here, we explored whether addition of green manure of red clover and sunflower to a calcareous soil or inoculating a non-indigenous arbuscular mycorrhizal fungal (AMF) strain may increase grain Zn concentration in bread wheat. For this purpose we performed a multifactorial pot experiment, in which the effects of two green manures (red clover, sunflower), ZnSO4 application, soil gamma-irradiation (elimination of naturally occurring AMF), and AMF inoculation were tested. Both green manures were labeled with Zn-65 radiotracer to record the Zn recoveries in the aboveground plant biomass. Application of ZnSO4 fertilizer increased grain Zn concentration from 20 to 39 mg Zn kg(-1) and sole addition of green manure of sunflower to soil raised grain Zn concentration to 31 mg Zn kg(-1). Adding the two together to soil increased grain Zn concentration even further to 54 mg Zn kg(-1). Mixing green manure of sunflower to soil mobilized additional 48 mu g Zn (kg soil)(-1) for transfer to the aboveground plant biomass, compared to the total of 132 mu g Zn (kg soil)(-1) taken up from plain soil when neither green manure nor ZnSO4 were applied. Green manure amendments to soil also raised the DTPA-extractable Zn in soil. Inoculating a non-indigenous AMF did not increase plant Zn uptake. The study thus showed that organic matter amendments to soil can contribute to a better utilization of naturally stocked soil micronutrients, and thereby reduce any need for major external inputs.	[Aghili, Forough; Gamper, Hannes A.; Frossard, Emmanuel] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland; [Eikenberg, Jost] Paul Scherrer Inst, Radioanalyt Lab, Villigen, Switzerland; [Khoshgoftarmanesh, Amir H.; Afyuni, Majid] Isfahan Univ Technol, Dept Soil Sci, Coll Agr, Esfahan, Iran; [Schulin, Rainer] ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Terr Ecosyst, Zurich, Switzerland; [Jansa, Jan] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Isfahan University of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Aghili, F (corresponding author), ETH, Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Agr Sci, Zurich, Switzerland.	forough.aghili@usys.ethz.ch	Jansa, Jan/H-3161-2014; Gamper, Hannes A./N-4937-2017; Aghili, Forough/AAN-7003-2021	Jansa, Jan/0000-0002-0331-1774; Gamper, Hannes A./0000-0002-8185-3472; 	Swiss National Science Foundation (SNF) [123920]; Swiss Agency for Development and Cooperation (SDC); J.E. Purkyne Fellowship; long-term development program [RVO61388971]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC); J.E. Purkyne Fellowship; long-term development program	This study was supported by the grant 123920 of the Swiss National Science Foundation (SNF) and the Swiss Agency for Development and Cooperation (SDC) in the framework of Research Partnerships with Developing Countries. The funding body and host institutions had no role in study-design, data collection, analysis, and manuscript preparation. JJ was further supported by the J.E. Purkyne Fellowship and the long-term development program RVO61388971.	Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; [Anonymous], 2010, KEYS SOIL TAXONOMY; Barker SJ, 1998, PLANT J, V15, P791, DOI 10.1046/j.1365-313X.1998.00252.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Burt R, 2004, 42 USDA NAT RES CONS; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cavagnaro TR, 2008, PLANT SOIL, V304, P315, DOI 10.1007/s11104-008-9559-7; Cavagnaro TR, 2004, NEW PHYTOL, V161, P485, DOI 10.1111/j.1469-8137.2004.00967.x; Curtis, 2002, BREAD WHEAT IMPROVEM; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Daneshbakhsh B, 2013, J PLANT PHYSIOL, V170, P41, DOI 10.1016/j.jplph.2012.08.016; Diesing WE, 2008, EUR J SOIL SCI, V59, P716, DOI 10.1111/j.1365-2389.2008.01032.x; FITTER AH, 1991, EXPERIENTIA, V47, P350, DOI 10.1007/BF01972076; Gao XP, 2009, J ENVIRON QUAL, V38, P2315, DOI 10.2134/jeq2009.0043; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gramlich A, 2013, J AGR FOOD CHEM, V61, P10409, DOI 10.1021/jf401117d; Hoffland E, 2006, PLANT SOIL, V283, P155, DOI 10.1007/s11104-005-3937-1; Hogland DR, 1938, WATER CULTURE METHOD; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; JONER EJ, 1995, SOIL BIOL BIOCHEM, V27, P1153, DOI 10.1016/0038-0717(95)00047-I; Kalayci M, 1999, FIELD CROP RES, V63, P87, DOI 10.1016/S0378-4290(99)00028-3; Karami M, 2009, J AGR FOOD CHEM, V57, P10876, DOI 10.1021/jf902074f; Kariman K, 2014, NEW PHYTOL, V201, P1413, DOI 10.1111/nph.12600; Khoshgoftar AH, 2006, J PLANT NUTR, V29, P1543, DOI 10.1080/01904160600848771; Lehmann A, 2014, SOIL BIOL BIOCHEM, V69, P123, DOI 10.1016/j.soilbio.2013.11.001; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Marschner B, 2002, SOIL BIOL BIOCHEM, V34, P459, DOI 10.1016/S0038-0717(01)00203-6; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; Mostafazadeh-Fard B, 2009, J IRRIG DRAIN ENG, V135, P32, DOI 10.1061/(ASCE)0733-9437(2009)135:1(32); Nazeri NK, 2013, PLANT SOIL, V373, P699, DOI 10.1007/s11104-013-1838-2; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Oliveira RS, 2005, MYCORRHIZA, V16, P23, DOI 10.1007/s00572-005-0010-0; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Rengel Z, 1999, PLANT SCI, V143, P221, DOI 10.1016/S0168-9452(99)00029-1; Rhoades J. D., 1996, Methods of soil analysis. Part 3 - chemical methods., P417; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Ryan MH, 2003, PLANT SOIL, V250, P225, DOI 10.1023/A:1022839930134; Sadeghzadeh B, 2013, J SOIL SCI PLANT NUT, V13, P905, DOI 10.4067/S0718-95162013005000072; SCHENCK NC, 1982, MYCOLOGIA, V74, P77, DOI 10.2307/3792631; Soltani S, 2014, BIOL FERT SOILS, V50, P239, DOI 10.1007/s00374-013-0851-1; THOMPSON JP, 1990, SOIL BIOL BIOCHEM, V22, P229, DOI 10.1016/0038-0717(90)90092-E; Ueno D, 2007, NEW PHYTOL, V174, P304, DOI 10.1111/j.1469-8137.2007.02056.x; van de Voorde TFJ, 2012, SOIL BIOL BIOCHEM, V55, P1, DOI 10.1016/j.soilbio.2012.05.020; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080	50	36	37	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101487	10.1371/journal.pone.0101487	http://dx.doi.org/10.1371/journal.pone.0101487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999738	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300049
J	Koning, H; van Oosterhout, AJM; Brouwer, U; den Boef, LE; Gras, R; Reinders-Luinge, M; Brandsma, CA; van der Toorn, M; Hylkema, MN; Willemse, BWM; Sayers, I; Koppelman, GH; Nawijn, MC				Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; Reinders-Luinge, Marjan; Brandsma, Corry-Anke; van der Toorn, Marco; Hylkema, Machteld N.; Willemse, Brigitte W. M.; Sayers, Ian; Koppelman, Gerard H.; Nawijn, Martijn C.			Mouse Protocadherin-1 Gene Expression Is Regulated by Cigarette Smoke Exposure In Vivo	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; AIRWAY; ASTHMA; FAMILY; CELLS	Protocadherin-1 (PCDH1) is a novel susceptibility gene for airway hyperresponsiveness, first identified in families exposed to cigarette smoke and is expressed in bronchial epithelial cells. Here, we asked how mouse Pcdh1 expression is regulated in lung structural cells in vivo under physiological conditions, and in both short-term cigarette smoke exposure models characterized by airway inflammation and hyperresponsiveness and chronic cigarette smoke exposure models. Pcdh1 gene-structure was investigated by Rapid Amplification of cDNA Ends. Pcdh1 mRNA and protein expression was investigated by qRT-PCR, western blotting using isoform-specific antibodies. We observed 87% conservation of the Pcdh1 nucleotide sequence, and 96% conservation of the Pcdh1 protein sequence between men and mice. We identified a novel Pcdh1 isoform encoding only the intracellular signalling motifs. Cigarette smoke exposure for 4 consecutive days markedly reduced Pcdh1 mRNA expression in lung tissue (3 to 4-fold), while neutrophilia and airway hyperresponsiveness was induced. Moreover, Pcdh1 mRNA expression in lung tissue was reduced already 6 hours after an acute cigarette-smoke exposure in mice. Chronic exposure to cigarette smoke induced loss of Pcdh1 protein in lung tissue after 2 months, while Pcdh1 protein levels were no longer reduced after 9 months of cigarette smoke exposure. We conclude that Pcdh1 is highly homologous to human PCDH1, encodes two transmembrane proteins and one intracellular protein, and is regulated by cigarette smoke exposure in vivo.	[Koning, Henk; Willemse, Brigitte W. M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; van der Toorn, Marco; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands; [Reinders-Luinge, Marjan; Brandsma, Corry-Anke; Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Koning, Henk; van Oosterhout, Antoon J. M.; Brouwer, Uilke; den Boef, Lisette E.; Gras, Renee; Reinders-Luinge, Marjan; Brandsma, Corry-Anke; van der Toorn, Marco; Hylkema, Machteld N.; Willemse, Brigitte W. M.; Sayers, Ian; Koppelman, Gerard H.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Nottingham	Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands.	g.h.koppelman@umcg.nl	Koppelman, Gerard/AAG-9187-2020	Sayers, Ian/0000-0001-5601-5410; Koppelman, Gerard/0000-0001-8567-3252; Nawijn, Martijn/0000-0003-3372-6521; van der Toorn, Marco/0000-0002-8540-3874	Netherlands' Lung Foundation [NAF 3.2.09.055]; Stichting Astmabestrijding [SAB 2010/043]; EU-funded FP6 project Gabriel; University Medical Center Groningen	Netherlands' Lung Foundation; Stichting Astmabestrijding; EU-funded FP6 project Gabriel; University Medical Center Groningen	This study was supported by research grants from the Netherlands' Lung Foundation (project NAF 3.2.09.055), the Stichting Astmabestrijding (SAB 2010/043) and the EU-funded FP6 project Gabriel (a multidisciplinary study to identify the genetic and environmental causes of asthma). GHK has received grant support from the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Davies Donna E, 2009, Proc Am Thorac Soc, V6, P678, DOI 10.1513/pats.200907-067DP; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Ierodiakonou D, 2011, EUR RESPIR J, V38, P1044, DOI 10.1183/09031936.00194710; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Koning H, 2012, FASEB J, V26, P439, DOI 10.1096/fj.11-185207; Koppelman GH, 2006, CURR ALLERGY ASTHM R, V6, P103, DOI 10.1007/s11882-006-0047-y; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Matsumoto K, 1998, EUR RESPIR J, V12, P387, DOI 10.1183/09031936.98.12020387; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Seymour Brian W P, 2003, Clin Dev Immunol, V10, P35, DOI 10.1080/10446670310001598483; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e98197	10.1371/journal.pone.0098197	http://dx.doi.org/10.1371/journal.pone.0098197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992194	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400004
J	Rani, DS; Dhandapany, PS; Nallari, P; Narasimhan, C; Thangaraj, K				Rani, Deepa Selvi; Dhandapany, Perundurai S.; Nallari, Pratibha; Narasimhan, Calambur; Thangaraj, Kumarasamy			A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT) Gene in an Indian Multigenerational Family with Dilated Cardiomyopathy (FDCM)	PLOS ONE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SOUTH-ASIA; TNNT2 MUTATIONS; TAIL DOMAIN; PROTEIN; FEATURES; MYBPC3; TNNI3	Cardiomyopathy is a major cause of heart failure and sudden cardiac death; several mutations in sarcomeric protein genes have been associated with this disease. Our aim in the present study is to investigate the genetic variations in Troponin T (cTnT) gene and its association with dilated cardiomyopathy (DCM) in south-Indian patients. Analyses of all the exons and exon-intron boundaries of cTnT in 147 DCM and in 207 healthy controls had revealed a total of 15 SNPs and a 5 bp INDEL; of which, polymorphic SNPs were compared with the HapMap population data. Interestingly, a novel R144W mutation, that substitutes polar-neutral tryptophan for a highly conserved basic arginine in cTnT, altering the charge drastically, was identified in a DCM, with a family history of sudden-cardiac death (SCD). This mutation was found within the tropomyosin (TPM1) binding domain, and was evolutionarily conserved across species, therefore it is expected to have a significant impact on the structure and function of the protein. Family studies had revealed that the R144W is co-segregating with disease in the family as an autosomal dominant trait, but it was completely absent in 207 healthy controls and in 162 previously studied HCM patients. Further screening of the proband and three of his family members (positive for R144W mutant) with eight other genes beta-MYH7, MYBPC3, TPM1, TNNI3, TTN, ACTC, MYL2 and MYL3, did not reveal any disease causing mutation, proposing the absence of compound heterozygosity. Therefore, we strongly suggest that the novel R144W unique/private mutant identified in this study is associated with FDCM. This is furthermore signifying the unique genetic architecture of Indian population.	[Rani, Deepa Selvi; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India; [Dhandapany, Perundurai S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India; [Narasimhan, Calambur] CARE Hosp, Dept Cardiol, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Icahn School of Medicine at Mount Sinai; Osmania University	Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.	thangs@ccmb.res.in		Thangaraj, Kumarasamy/0000-0002-0075-0106; Perundurai, Dhandapany/0000-0001-7831-9570	Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India; Network project grant, Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India [CardioMed-BSC0122]	Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India; Network project grant, Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India	DSR and KT, supported by the Council of Scientific and Industrial Research (CSIR), Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana, India. KT supported by Network project grant (CardioMed-BSC0122), Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi, India. DSR and PN acknowledge OU-DST-PURSE, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Judge DP, 2009, JAMA-J AM MED ASSOC, V302, P2471, DOI 10.1001/jama.2009.1787; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; Li YY, 1997, J MOL CELL CARDIOL, V29, P2699, DOI 10.1006/jmcc.1997.0501; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Ramachandran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070704; Rangaraju A, 2012, EXP CLIN CARDIOL, V17, P26; Rani DS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-69; Rani DS, 2012, DNA CELL BIOL, V31, P616, DOI 10.1089/dna.2011.1366; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Santorelli FM, 1996, AM J HUM GENET, V58, P933; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serio A, 2012, HERZ, V37, P822, DOI 10.1007/s00059-012-3707-9; SUGRUE DD, 1992, ANN INTERN MED, V117, P117, DOI 10.7326/0003-4819-117-2-117; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WILES HB, 1991, AM J CARDIOL, V68, P1372, DOI 10.1016/0002-9149(91)90248-J	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101451	10.1371/journal.pone.0101451	http://dx.doi.org/10.1371/journal.pone.0101451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992688	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400072
J	Sansone, C; Braca, A; Ercolesi, E; Romano, G; Palumbo, A; Casotti, R; Francone, M; Ianora, A				Sansone, Clementina; Braca, Alessandra; Ercolesi, Elena; Romano, Giovanna; Palumbo, Anna; Casotti, Raffaella; Francone, Maria; Ianora, Adrianna			Diatom-Derived Polyunsaturated Aldehydes Activate Cell Death in Human Cancer Cell Lines but Not Normal Cells	PLOS ONE			English	Article							ADENOCARCINOMA A549 CELLS; GROWTH-INHIBITION; MARINE DIATOMS; APOPTOSIS; COPEPOD; REPRODUCTION; SEA; CALANOIDA; DEFENSE; SUCCESS	Diatoms are an important class of unicellular algae that produce bioactive polyunsaturated aldehydes (PUAs) that induce abortions or malformations in the offspring of invertebrates exposed to them during gestation. Here we compare the effects of the PUAs 2-trans,4-trans-decadienal (DD), 2-trans,4- trans-octadienal (OD) and 2-trans,4-trans-heptadienal (HD) on the adenocarcinoma cell lines lung A549 and colon COLO 205, and the normal lung/brunch epithelial BEAS-2B cell line. Using the viability MTT/Trypan blue assays, we show that PUAs have a toxic effect on both A549 and COLO 205 tumor cells but not BEAS-2B normal cells. DD was the strongest of the three PUAs tested, at all time-intervals considered, but HD was as strong as DD after 48 h. OD was the least active of the three PUAs. The effect of the three PUAs was somewhat stronger for A549 cells. We therefore studied the death signaling pathway activated in A549 showing that cells treated with DD activated Tumor Necrosis Factor Receptor 1 (TNFR1) and Fas Associated Death Domain (FADD) leading to necroptosis via caspase-3 without activating the survival pathway Receptor-Interacting Protein (RIP). The TNFR1/FADD/caspase pathway was also observed with OD, but only after 48 h. This was the only PUA that activated RIP, consistent with the finding that OD causes less damage to the cell compared to DD and HD. In contrast, cells treated with HD activated the Fas/FADD/caspase pathway. This is the first report that PUAs activate an extrinsic apoptotic machinery in contrast to other anticancer drugs that promote an intrinsic death pathway, without affecting the viability of normal cells from the same tissue type. These findings have interesting implications also from the ecological viewpoint considering that HD is one of the most common PUAs produced by diatoms.	[Sansone, Clementina; Braca, Alessandra; Ercolesi, Elena; Romano, Giovanna; Palumbo, Anna; Casotti, Raffaella; Francone, Maria; Ianora, Adrianna] Staz Zoolog Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Ianora, A (corresponding author), Staz Zoolog Anton Dohrn, Naples, Italy.	adrianna.ianora@szn.it	Casotti, Raffaella/I-9833-2019; Romano, Giovanna/F-4561-2015; Sansone, Clementina/P-3936-2014; Casotti, Raffaella/H-1697-2016; Ianora, Adrianna/O-3408-2019; Braca, Alessandra/A-5910-2015	Casotti, Raffaella/0000-0002-9876-4601; Romano, Giovanna/0000-0002-4898-7153; Sansone, Clementina/0000-0002-3007-8154; Casotti, Raffaella/0000-0002-9876-4601; Braca, Alessandra/0000-0003-3669-0536; Palumbo, Anna/0000-0002-5972-5589	Stazione Zoologica Anton Dohrn; Italian National Operative Project [PON01_02093]	Stazione Zoologica Anton Dohrn; Italian National Operative Project	This work was funded by the Stazione Zoologica Anton Dohrn and by the Italian National Operative Project PON01_02093 Study of new technologies and technological platforms for the improvement of production processes of active pharmaceutical ingredients of industrial interest and search for new bioactive molecules from natural sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Ask J, 2006, J PLANKTON RES, V28, P683, DOI 10.1093/plankt/fbl005; Balestra C, 2011, AQUAT MICROB ECOL, V63, P123, DOI 10.3354/ame01486; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carotenuto Y, 2011, J EXP MAR BIOL ECOL, V396, P99, DOI 10.1016/j.jembe.2010.10.012; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; Ceballos S, 2003, J EXP MAR BIOL ECOL, V294, P189, DOI 10.1016/S0022-0981(03)00263-6; Cheah SC, 2013, MOLECULES, V18, P8764, DOI 10.3390/molecules18088764; Chen QY, 2010, ONCOL REP, V23, P397, DOI 10.3892/or_00000648; Ciniglia C, 2010, ALLELOPATHY J, V26, P301; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6133, DOI 10.1016/S0040-4039(02)01285-6; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6137, DOI 10.1016/S0040-4039(02)01283-2; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Halsband-Lenk C, 2005, PROG OCEANOGR, V67, P332, DOI 10.1016/j.pocean.2005.09.003; Hung JY, 2008, CLIN EXP PHARMACOL P, V35, P141, DOI 10.1111/j.1440-1681.2007.04795.x; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2011, HYDROBIOLOGIA, V666, P265, DOI 10.1007/s10750-010-0420-7; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Phetteplace KL, 2010, TRYPAN BLUE ASSAY ST; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Poulet SA, 2007, J EXP MAR BIOL ECOL, V352, P187, DOI 10.1016/j.jembe.2007.07.019; Poulet SA, 2003, MAR BIOL, V143, P889, DOI 10.1007/s00227-003-1142-4; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Sughra K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012683; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Zhang YL, 2013, AM J CHINESE MED, V41, P1137, DOI 10.1142/S0192415X13500778	41	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101220	10.1371/journal.pone.0101220	http://dx.doi.org/10.1371/journal.pone.0101220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992192	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400052
J	Maskey, M; Lowry, J; Rodgers, J; McConachie, H; Parr, JR				Maskey, Morag; Lowry, Jessica; Rodgers, Jacqui; McConachie, Helen; Parr, Jeremy R.			Reducing Specific Phobia/Fear in Young People with Autism Spectrum Disorders (ASDs) through a Virtual Reality Environment Intervention	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; COMORBID PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; CHILDREN; ADOLESCENTS; SYMPTOMS; YOUTH; RESPONSES; EMOTIONS; SKILLS	Anxiety is common in children with autism spectrum disorders (ASD), with specific fears and phobias one of the most frequent subtypes. Specific fears and phobias can have a serious impact on young people with ASD and their families. In this study we developed and evaluated a unique treatment combining cognitive behaviour therapy (CBT) with graduated exposure in a virtual reality environment (VRE). Nine verbally fluent boys with an ASD diagnosis and no reported learning disability, aged 7 to 13 years old, were recruited. Each had anxiety around a specific situation (e. g. crowded buses) or stimulus (e. g. pigeons). An individualised scene was recreated in our 'wrap-around' VRE. In the VRE participants were coached by a psychologist in cognitive and behavioural techniques (e.g. relaxation and breathing exercises) while the exposure to the phobia/fear stimulus was gradually increased as the child felt ready. Each child received four 20-30 minute sessions. After participating in the study, eight of the nine children were able to tackle their phobia situation. Four of the participants completely overcame their phobia. Treatment effects were maintained at 12 months. These results provide evidence that CBT with VRE can be a highly effective treatment for specific phobia/fear for some young people with ASD.	[Maskey, Morag; Rodgers, Jacqui; Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lowry, Jessica; McConachie, Helen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Maskey, M (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	morag.maskey@ncl.ac.uk; Jeremy.parr@ncl.ac.uk		Rodgers, Jacqui/0000-0002-1759-316X	Newcastle University	Newcastle University	Dr Morag Maskey has a Daphne Jackson Fellowship sponsored by Newcastle University (http://www.daphnejackson.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis A., 2008, LEEDS RELIABLE CHANG; [Anonymous], 2005, EMOTIONAL DEV RECENT; Arnold LE, 2003, J AM ACAD CHILD PSY, V42, P1443, DOI 10.1097/00004583-200312000-00011; Ashburner J, 2010, RES AUTISM SPECT DIS, V4, P18, DOI 10.1016/j.rasd.2009.07.002; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Chalfant AM, 2007, J AUTISM DEV DISORD, V37, P1842, DOI 10.1007/s10803-006-0318-4; de Bruin EI, 2007, J AUTISM DEV DISORD, V37, P877, DOI 10.1007/s10803-006-0215-x; Drahota A, 2011, J AUTISM DEV DISORD, V41, P257, DOI 10.1007/s10803-010-1037-4; Eaves LC, 2006, AUTISM, V10, P229, DOI 10.1177/1362361306063288; Fabri M, 2007, LECT NOTES COMPUT SC, V4552, P275; Gjevik E, 2011, J AUTISM DEV DISORD, V41, P761, DOI 10.1007/s10803-010-1095-7; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; IALONGO N, 1995, J CHILD PSYCHOL PSYC, V36, P427, DOI 10.1111/j.1469-7610.1995.tb01300.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Joshi G, 2010, J AUTISM DEV DISORD, V40, P1361, DOI 10.1007/s10803-010-0996-9; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Lind SE, 2014, NEUROPSYCHOLOGY, V28, P55, DOI 10.1037/neu0000005; Low J, 2009, BRIT J DEV PSYCHOL, V27, P425, DOI 10.1348/026151008X334728; Maskey M, 2013, J AUTISM DEV DISORD, V43, P851, DOI 10.1007/s10803-012-1622-9; Mattila ML, 2010, J AUTISM DEV DISORD, V40, P1080, DOI 10.1007/s10803-010-0958-2; Mayes SD, 2013, RES AUTISM SPECT DIS, V7, P151, DOI 10.1016/j.rasd.2012.08.002; McConachie H, 2009, ARCH DIS CHILD, V94, P38, DOI 10.1136/adc.2007.126326; McConachie H, 2013, AUTISM; McPheeters ML, 2011, J AUTISM DEV DISORD, V41, P646, DOI 10.1007/s10803-010-1085-9; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; Moore M, 2000, J AUTISM DEV DISORD, V30, P359, DOI 10.1023/A:1005535602064; Moree BN, 2010, RES AUTISM SPECT DIS, V4, P346, DOI 10.1016/j.rasd.2009.10.015; National Institute for Health and Care Excellence (NICE), 2011, REC REF DIAGN CHILDR, V128; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; Ollendick TH, 2006, HDB INTERVENTIONS WO, P3; Ozsivadjian Ann, 2011, Clin Child Psychol Psychiatry, V16, P203, DOI 10.1177/1359104511404749; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Puleo CM, 2011, J AUTISM DEV DISORD, V41, P275, DOI 10.1007/s10803-010-1047-2; Rieffe C, 2007, J AUTISM DEV DISORD, V37, P455, DOI 10.1007/s10803-006-0171-5; Rothbaum BO, 1999, BEHAV MODIF, V23, P507, DOI 10.1177/0145445599234001; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Silverman WK, 1996, ANXIETY DISORDERS IN; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; Sofronoff K, 2005, J CHILD PSYCHOL PSYC, V46, P1152, DOI 10.1111/j.1469-7610.2005.00411.x; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Strickland DC, 2007, TOP LANG DISORD, V27, P226, DOI 10.1097/01.TLD.0000285357.95426.72; van Steensel FJA, 2013, J AUTISM DEV DISORD, P1; Wallace S, 2010, AUTISM, V14, P199, DOI 10.1177/1362361310363283; Witwer AN, 2010, J DEV PHYS DISABIL, V22, P367, DOI 10.1007/s10882-010-9194-0; Wood JJ, 2010, CLIN PSYCHOL-SCI PR, V17, P281, DOI 10.1111/j.1468-2850.2010.01220.x	49	84	89	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100374	10.1371/journal.pone.0100374	http://dx.doi.org/10.1371/journal.pone.0100374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24987957	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100029
J	McCreesh, N; Booth, M				McCreesh, Nicky; Booth, Mark			The Effect of Increasing Water Temperatures on Schistosoma mansoni Transmission and Biomphalaria pfeifferi Population Dynamics: An Agent-Based Modelling Study	PLOS ONE			English	Article							CLIMATE-CHANGE; MALARIA RESURGENCE; LONG-TERM; IMPACT; EPIDEMIOLOGY; PLANORBIDAE; GASTROPODA; UGANDA; AIR	Introduction: There is increasing interest in the control and elimination of schistosomiasis. Little is known, however, about the likely effects of increasing water-body temperatures on transmission. Methods: We have developed an agent-based model of the temperature-sensitive stages of the Schistosoma and intermediate host snail life-cycles, parameterised using data from S. mansoni and Biomphalaria pfeifferi laboratory and field-based observations. Infection risk is calculated as the number of cercariae in the model, adjusted for their probability of causing infection. Results: The number of snails in the model is approximately constant between 15-31 degrees C. Outside this range, snail numbers drop sharply, and the snail population cannot survive outside the range 14-32 degrees C. Mean snail generation time decreases with increasing temperature from 176 days at 14 degrees C to 46 days at 26 degrees C. Human infection risk is highest between 16-18 degrees C and 1 pm and 6-10 pm in calm water, and 20-25 degrees C and 12-4 pm in flowing water. Infection risk increases sharply when temperatures increase above the minimum necessary for sustained transmission. Conclusions: The model suggests that, in areas where S. mansoni is already endemic, warming of the water at transmission sites will have differential effects on both snails and parasites depending on abiotic properties of the water-body. Snail generation times will decrease in most areas, meaning that snail populations will recover faster from natural population reductions and from snail-control efforts. We suggest a link between the ecological properties of transmission sites and infection risk which could significantly affect the outcomes of interventions designed to alter water contact behaviour proposing that such interventions are more likely to reduce infection levels at river locations than lakes, where infection risk remains high for longer. In cooler areas where snails are currently found, increasing temperatures may significantly increase infection risk, potentially leading to new, high-intensity foci of infection.	[McCreesh, Nicky; Booth, Mark] Univ Durham, Sch Med Pharm & Hlth, Durham, England	Durham University	McCreesh, N (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Durham, England.	Nicky.mccreesh@durham.ac.uk	Booth, Mark/D-2266-2011	Booth, Mark/0000-0002-5507-888X; McCreesh, Nicky/0000-0003-1409-8531	European Union [266327]	European Union(European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 266327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON CC, 1984, T ROY SOC TROP MED H, V78, P49, DOI 10.1016/0035-9203(84)90171-8; BROWN DS, 1994, FRESHWATER SNAILS AF; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; CHU KY, 1970, B WORLD HEALTH ORGAN, V42, P575; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; de Moira AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000820; GHANDOUR A M, 1973, International Journal for Parasitology, V3, P789, DOI 10.1016/0020-7519(73)90070-2; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; IPCC, 1990, CLIM CHANG IPCC IMPL; John R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-110; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Kariuki HC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-107; Kazibwe F, 2006, HYDROBIOLOGIA, V568, P433, DOI 10.1007/s10750-006-0224-y; KLOOS H, 1988, SOC SCI MED, V26, P803, DOI 10.1016/0277-9536(88)90174-8; LOREAU M, 1987, J MOLLUS STUD, V53, P249, DOI 10.1093/mollus/53.3.249; LOREAU M, 1987, J MOLLUS STUD, V53, P171, DOI 10.1093/mollus/53.2.171; Mangal TD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001438; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; McCreesh Nicky, 2014, PLoS One, V9, pe87892, DOI 10.1371/journal.pone.0087892; McCreesh N, 2013, TRENDS PARASITOL, V29, P548, DOI 10.1016/j.pt.2013.08.007; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Portner H.-O., 2022, SUMMARY POLICYMAKERS; SHIFF CJ, 1975, INT J PARASITOL, V5, P119, DOI 10.1016/0020-7519(75)90109-5; Stensgaard AS, 2013, ACTA TROP, V128, P378, DOI 10.1016/j.actatropica.2011.11.010; UPATHAM ES, 1972, J HELMINTHOL, V46, P271, DOI 10.1017/S0022149X0002441X; WHO WMO UNEP, 2003, CLIMATE CHANGE HLTH; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	32	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101462	10.1371/journal.pone.0101462	http://dx.doi.org/10.1371/journal.pone.0101462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987963	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100093
J	Mun, S; Lee, J; Kim, YJ; Kim, HS; Han, K				Mun, Seyoung; Lee, Jungnam; Kim, Yun-Ji; Kim, Heui-Soo; Han, Kyudong			Chimpanzee-Specific Endogenous Retrovirus Generates Genomic Variations in the Chimpanzee Genome	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; MEDIATED DELETION; DNA-SEQUENCE; INSERTIONS; L1; IDENTIFICATION; SUBFAMILIES; CHROMOSOME; EVOLUTION; FAMILY	Endogenous retroviruses (ERVs), eukaryotic transposable elements, exist as proviruses in vertebrates including primates and contribute to genomic changes during the evolution of their host genomes. Many studies about ERVs have focused on the elements residing in the human genome but only a few studies have focused on the elements which exist in non-human primate genomes. In this study, we identified 256 chimpanzee-specific endogenous retrovirus copies (PtERVs: Pan troglodyte endogenous retroviruses) from the chimpanzee reference genome sequence through comparative genomics. Among the chimpanzee-specific ERV copies, 121 were full-length chimpanzee-specific ERV elements while 110 were chimpanzee-specific solitary LTR copies. In addition, we found eight potential retrotransposition-competent full-length chimpanzee-specific ERV copies containing an intact env gene, and two of them were polymorphic in chimpanzee individuals. Through computational analysis and manual inspection, we found that some of the chimpanzee-specific ERVs have propagated via non-classical PtERV insertion (NCPI), and at least one of the PtERVs may have played a role in creating an alternative transcript of a chimpanzee gene. Based on our findings in this study, we state that the chimpanzee-specific ERV element is one of the sources of chimpanzee genomic variations, some of which might be related to the alternative transcripts in the chimpanzee population.	[Mun, Seyoung; Lee, Jungnam; Kim, Yun-Ji; Han, Kyudong] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Mun, Seyoung; Kim, Yun-Ji; Han, Kyudong] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Mun, Seyoung; Kim, Yun-Ji; Han, Kyudong] DKU Theragen Inst NGS Anal DTiNa, Cheonan, South Korea; [Lee, Jungnam] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Lee, Jungnam] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Kim, Heui-Soo] Pusan Natl Univ, Coll Nat Sci, Dept Biol Sci, Pusan, South Korea	Dankook University; Dankook University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University	Han, K (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.	jim97@dankook.ac.kr	Kim, Heui-Soo/ABF-3773-2021; Han, Kyudong/AAF-1788-2019	Kim, Heui-Soo/0000-0002-5226-6594; Han, Kyudong/0000-0001-6791-2408; Mun, Seyoung/0000-0002-9669-4494	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2011-0009080]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research (2011-0009080) program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.F.A. Smit RHPG, 2014, REPEATMASKER OP 4 0; Anderssen S, 1997, VIROLOGY, V234, P14, DOI 10.1006/viro.1997.8590; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buzdin A, 2003, GENOMICS, V81, P149, DOI 10.1016/S0888-7543(02)00027-7; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; COPELAND NG, 1983, CELL, V33, P379, DOI 10.1016/0092-8674(83)90419-1; Griffiths DJ, 2001, GENOME BIOL, V2; Hall T., 2013, IBIS BIOSCIENCES; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; KAPLAN N, 1985, GENETICS, V109, P459; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Khodosevich K, 2002, COMP FUNCT GENOM, V3, P494, DOI 10.1002/cfg.216; Kim DS, 2011, BIOINFORMATICS, V27, P14, DOI 10.1093/bioinformatics/btq612; Kim RN, 2011, FUNCT INTEGR GENOMIC, V11, P507, DOI 10.1007/s10142-011-0220-9; Kim Yun-Ji, 2012, Genomics & Informatics, V10, P226, DOI 10.5808/GI.2012.10.4.226; KJELLMAN C, 1995, GENE, V161, P163, DOI 10.1016/0378-1119(95)00248-5; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavrentieva I, 1998, HUM GENET, V102, P107, DOI 10.1007/s004390050662; LEIBMOSCH C, 1993, GENOMICS, V18, P261, DOI 10.1006/geno.1993.1464; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nakagawa K, 1996, IMMUNOL REV, V152, P193, DOI 10.1111/j.1600-065X.1996.tb00917.x; PASCALE E, 1993, J MOL EVOL, V36, P9, DOI 10.1007/BF02407302; Polavarapu N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r51; Rassool FV, 2003, CANCER LETT, V193, P1, DOI 10.1016/S0304-3835(02)00692-4; Sayers EW, 2010, NUCLEIC ACIDS RES, V40, pD13; Shaw D, 2013, DOUGS RANDOM SAMPLIN; Shin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060605; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; Spencer TE, 2012, SOC REPROD FERTIL S, V67, P95; Sperber G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S4; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Udaka T, 2007, AM J MED GENET A, V143A, P721, DOI 10.1002/ajmg.a.31441; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; VOLIVA CF, 1984, J MOL BIOL, V178, P795, DOI 10.1016/0022-2836(84)90312-7; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101195	10.1371/journal.pone.0101195	http://dx.doi.org/10.1371/journal.pone.0101195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987855	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100068
J	Nikolaisen, J; Nilsson, LIH; Pettersen, IKN; Willems, PHGM; Lorens, JB; Koopman, WJH; Tronstad, KJ				Nikolaisen, Julie; Nilsson, Linn I. H.; Pettersen, Ina K. N.; Willems, Peter H. G. M.; Lorens, James B.; Koopman, Werner J. H.; Tronstad, Karl J.			Automated Quantification and Integrative Analysis of 2D and 3D Mitochondrial Shape and Network Properties	PLOS ONE			English	Article							HELA-CELLS; COMPLEX-I; MORPHOLOGY; DYNAMICS; PHOSPHORYLATION; MOTILITY; ELECTRON; CHAIN	Mitochondrial morphology and function are coupled in healthy cells, during pathological conditions and (adaptation to) endogenous and exogenous stress. In this sense mitochondrial shape can range from small globular compartments to complex filamentous networks, even within the same cell. Understanding how mitochondrial morphological changes (i.e. "mitochondrial dynamics'') are linked to cellular (patho) physiology is currently the subject of intense study and requires detailed quantitative information. During the last decade, various computational approaches have been developed for automated 2-dimensional (2D) analysis of mitochondrial morphology and number in microscopy images. Although these strategies are well suited for analysis of adhering cells with a flat morphology they are not applicable for thicker cells, which require a three-dimensional (3D) image acquisition and analysis procedure. Here we developed and validated an automated image analysis algorithm allowing simultaneous 3D quantification of mitochondrial morphology and network properties in human endothelial cells (HUVECs). Cells expressing a mitochondria-targeted green fluorescence protein (mitoGFP) were visualized by 3D confocal microscopy and mitochondrial morphology was quantified using both the established 2D method and the new 3D strategy. We demonstrate that both analyses can be used to characterize and discriminate between various mitochondrial morphologies and network properties. However, the results from 2D and 3D analysis were not equivalent when filamentous mitochondria in normal HUVECs were compared with circular/spherical mitochondria in metabolically stressed HUVECs treated with rotenone (ROT). 2D quantification suggested that metabolic stress induced mitochondrial fragmentation and loss of biomass. In contrast, 3D analysis revealed that the mitochondrial network structure was dissolved without affecting the amount and size of the organelles. Thus, our results demonstrate that 3D imaging and quantification are crucial for proper understanding of mitochondrial shape and topology in non-flat cells. In summary, we here present an integrative method for unbiased 3D quantification of mitochondrial shape and network properties in mammalian cells.	[Nikolaisen, Julie; Nilsson, Linn I. H.; Pettersen, Ina K. N.; Lorens, James B.; Tronstad, Karl J.] Univ Bergen, Dept Biomed, Bergen, Norway; [Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 286, NL-6525 ED Nijmegen, Netherlands	University of Bergen; Radboud University Nijmegen	Tronstad, KJ (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	karl.tronstad@biomed.uib.no	Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009; Willems, P.H.G.M./L-4759-2015; Lorens, James/B-9737-2017	Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Lorens, James/0000-0002-6782-3349; Tronstad, Karl Johan/0000-0003-3496-3123	Norwegian Research Council [214187/F20]; Norwegian Health Association; Bergen Medical Research Foundation; Department of Biomedicine; "Tjomsland legacy" (University of Bergen); Centres for Systems Biology Research initiative from NWO (Netherlands Organization for Scientific Research) [CSBR09/013V]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Health Association; Bergen Medical Research Foundation; Department of Biomedicine; "Tjomsland legacy" (University of Bergen); Centres for Systems Biology Research initiative from NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The work was funded by grants from the Norwegian Research Council (214187/F20), Norwegian Health Association, Bergen Medical Research Foundation, the Department of Biomedicine and "Tjomsland legacy" (University of Bergen). The research of PHGMW and WJHK was supported by the Centres for Systems Biology Research initiative (CSBR09/013V) from NWO (Netherlands Organization for Scientific Research). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Biggs DS, 2010, CURR PROTOC CYTOM, V19, P11; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Distelmaier F, 2012, ANTIOXID REDOX SIGN, V17, P1657, DOI 10.1089/ars.2011.4294; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Egner A, 2002, P NATL ACAD SCI USA, V99, P3370, DOI 10.1073/pnas.052545099; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier AE, 2006, BIOL CHEM, V387, P1551, DOI 10.1515/BC.2006.193; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Giedt RJ, 2012, ANN BIOMED ENG, V40, P1903, DOI 10.1007/s10439-012-0568-6; Hagland H, 2007, EXPERT OPIN THER TAR, V11, P1055, DOI 10.1517/14728222.11.8.1055; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lee Ji-Sook, 2014, J Biomol Tech, V25, P31, DOI 10.7171/jbt.14-2501-002; Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613; Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Matthews GD, 2010, J CELL SCI, V123, P351, DOI 10.1242/jcs.060749; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitra K, 2010, CURR PROTOC CELL BIO, V25, P21; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pucci B, 2008, J CELL PHYSIOL, V217, P442, DOI 10.1002/jcp.21513; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Song W, 2008, METHODS, V46, P295, DOI 10.1016/j.ymeth.2008.10.003; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tronstad KJ, 2014, CURR PHARM DES; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Willems PHGM, 2009, INT J BIOCHEM CELL B, V41, P1773, DOI 10.1016/j.biocel.2009.01.012; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036377	47	40	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101365	10.1371/journal.pone.0101365	http://dx.doi.org/10.1371/journal.pone.0101365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988307	Green Published, gold			2022-12-25	WOS:000341354100080
J	Williams, GR; Shutler, D; Burgher-MacLellan, KL; Rogers, REL				Williams, Geoffrey R.; Shutler, Dave; Burgher-MacLellan, Karen L.; Rogers, Richard E. L.			Infra-Population and -Community Dynamics of the Parasites Nosema apis and Nosema ceranae, and Consequences for Honey Bee (Apis mellifera) Hosts	PLOS ONE			English	Article							MICROSPORIDIAN PARASITE; WIDESPREAD DISPERSAL; BOMBUS SPP.; INFECTION; HYMENOPTERA; VIRULENCE; PATHOGEN; ORIGIN; PCR	Nosema spp. fungal gut parasites are among myriad possible explanations for contemporary increased mortality of western honey bees (Apis mellifera, hereafter honey bee) in many regions of the world. Invasive Nosema ceranae is particularly worrisome because some evidence suggests it has greater virulence than its congener N. apis. N. ceranae appears to have recently switched hosts from Asian honey bees (Apis cerana) and now has a nearly global distribution in honey bees, apparently displacing N. apis. We examined parasite reproduction and effects of N. apis, N. ceranae, and mixed Nosema infections on honey bee hosts in laboratory experiments. Both infection intensity and honey bee mortality were significantly greater for N. ceranae than for N. apis or mixed infections; mixed infection resulted in mortality similar to N. apis parasitism and reduced spore intensity, possibly due to inter-specific competition. This is the first long-term laboratory study to demonstrate lethal consequences of N. apis and N. ceranae and mixed Nosema parasitism in honey bees, and suggests that differences in reproduction and intra-host competition may explain apparent heterogeneous exclusion of the historic parasite by the invasive species.	[Williams, Geoffrey R.; Shutler, Dave] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Williams, Geoffrey R.] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland; [Williams, Geoffrey R.] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Burgher-MacLellan, Karen L.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Rogers, Richard E. L.] Wildwood Labs, Kentville, NS, Canada	Acadia University; Dalhousie University; University of Bern; Swiss Federal Research Station Agroscope; Agriculture & Agri Food Canada	Williams, GR (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	geoffrey.r.williams@gmail.com	Williams, Geoffrey/C-9637-2015	Williams, Geoffrey/0000-0002-0093-1126	Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship; NSERC Discovery Grant; Bayer CropScience	Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bayer CropScience(Bayer AG)	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship to G.R.W. and a NSERC Discovery Grant to D.S. Additional financial assistance was provided by Bayer CropScience for consumable expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Burgher-MacLellan KL, 2010, CAN ENTOMOL, V142, P271, DOI 10.4039/n10-010; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chaimanee V, 2010, J INVERTEBR PATHOL, V105, P207, DOI 10.1016/j.jip.2010.06.005; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Chen YW, 2012, J INVERTEBR PATHOL, V111, P264, DOI 10.1016/j.jip.2012.08.014; Copley TR, 2012, APIDOLOGIE, V43, P753, DOI 10.1007/s13592-012-0147-8; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Crawley MJ, 2009, STAT INTRO USING R A; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2006, J APICULT RES, V45, P230; FRIES I, 1993, BEE WORLD, V74, P5, DOI 10.1080/0005772X.1993.11099149; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, J APICULT RES, V48, P217, DOI 10.3896/IBRA.1.48.3.12; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, J INVERTEBR PATHOL, V113, P35, DOI 10.1016/j.jip.2013.01.001; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; Klee J, 2006, J INVERTEBR PATHOL, V91, P98, DOI 10.1016/j.jip.2005.10.012; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kraus B, 1997, NATURWISSENSCHAFTEN, V84, P217, DOI 10.1007/s001140050382; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Poulin R., 2006, EVOLUTIONARY ECOLOGY; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Solter LF, 2002, J INVERTEBR PATHOL, V81, P103, DOI 10.1016/S0022-2011(02)00155-6; Tay WT, 2005, J EUKARYOT MICROBIOL, V52, P505, DOI 10.1111/j.1550-7408.2005.00057.x; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Villa JD, 2013, APIDOLOGIE, V44, P511, DOI 10.1007/s13592-013-0201-1; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Williams GR, 2010, CAN ENTOMOL, V142, P584, DOI 10.4039/n10-029; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams GR, 2010, J INVERTEBR PATHOL, V104, P4, DOI 10.1016/j.jip.2010.01.009; Winston M., 1987, The biology of the honey bee.	67	52	53	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e99465	10.1371/journal.pone.0099465	http://dx.doi.org/10.1371/journal.pone.0099465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987989	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100013
J	Zhang, YQ; Wang, XM; Wu, AL; Ren, Y				Zhang, Yu-Qu; Wang, Xu-Mei; Wu, A-Li; Ren, Yi			Merging Fargesia dracocephala into Fargesia decurvata (Bambusoideae, Poaceae): Implications from Morphological and ITS Sequence Analyses	PLOS ONE			English	Article							THAMNOCALAMUS GROUP; ALLIES GRAMINEAE; EVOLUTION; GENE	Aims: Fargesia decurvata is closely allied with F. dracocephala and differs in 5 major characters (i.e. the culm sheath blade base shape, the width of the culm sheath blade base, the auricle shape, and the lower surface of leaf blade) in Fargesia. It is difficult to distinguish these two species because of existing of transitional statements of characters. The aims of this paper are to (i) investigate whether the variation of the characters is continuous or not; (ii) reveal whether the publishment of F. dracocephala was the result of discontinuous sampling of F. decurvata or not. Methods: Ten populations of F. decurvata and F. dracocephala were investigated in their entire distribution (including type localities). The statements of 5 major characters were measured from 693 annual and 693 perennial culms of 231 individuals in 10 populations, and analyzed at population, individual and culm levels. UPGMA cluster analysis was carried out based on 29 characters from 10 populations of F. decurvata and F. dracocephala and 2 populations of F. qinlingensis as outgroup. The ITS sequences were also sequenced and analyzed. Important Findings: Five major characters exhibited great variation not only at population level, but at individual level within a population, even the culm level within an individual and in different parts of the same culm. Cluster analyses showed that 10 populations of F. decurvata and F. dracocephala were not divided into two species, but they were well separated with outgroup. There was no difference in floral organ between F. decurvata and F. dracocephala. MP and NJ trees based on ITS sequences showed the same results with the cluster analysis on morphological characters. All the facts indicated that the publishment of F. dracocephala was the result of discontinuous sampling of F. decurvata, and F. dracocephala should be treated as the synonym of F. decurvata.	[Zhang, Yu-Qu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Wang, Xu-Mei] Xi An Jiao Tong Univ, Sch Pharm, Xian 710049, Peoples R China; [Wu, A-Li] Shaanxi Changqing Natl Nat Reserve, Huayang, Peoples R China	Shaanxi Normal University; Xi'an Jiaotong University	Ren, Y (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	renyi@snnu.edu.cn		zhang, Yuqu/0000-0003-1517-9229	Giant Panda International Cooperation Project of the State Forestry Administration of China [WH0630]	Giant Panda International Cooperation Project of the State Forestry Administration of China	Funding came from the Giant Panda International Cooperation Project of the State Forestry Administration of China (WH0630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; BARBER HN, 1955, EVOLUTION, V9, P1, DOI 10.2307/2405353; Chen JK, 1986, J WUHAN BOT RES, V4, P377; Davis P. H., 1963, PRINCIPLES ANGIOSPER; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Gallego MT, 2005, NOVA HEDWIGIA, V80, P301, DOI 10.1127/0029-5035/2005/0080-0301; Grang V, 1985, EVOLUTIONARY PROCESS; Guo ZH, 2002, MOL PHYLOGENET EVOL, V22, P20, DOI 10.1006/mpev.2001.1039; Guo ZH, 2004, MOL PHYLOGENET EVOL, V30, P1, DOI 10.1016/S1055-7903(03)00161-1; Guo ZH, 2001, J PLANT RES, V114, P315, DOI 10.1007/PL00013993; Harper JL, 1982, PLANT COMMUNITY WORK, P11; HEYWOOD V. H., 1959, SYST ASS PUBLICATION, V3, P87; Hinchliff CE, 2009, AM J BOT, V96, P1487, DOI 10.3732/ajb.0800252; Hodkinson TR, 2000, J PLANT RES, V113, P259, DOI 10.1007/PL00013936; Hsu PS, 1986, GUANGXI FLORA, V6, P201; Hsu PS, 1987, B BOT RES, V7, P81; Keng PC, 1989, J BAMB RES, V8, P17; Keng PC, 1982, J BAMBOO RES, V1, P1; Kosnar J, 2010, AM J BOT, V97, P1229, DOI 10.3732/ajb.1000029; Kumar M, 2011, AFR J BIOTECHNOL, V10, P4532; Lai GH, 1999, J WUHAN BOT RES, V17, P319; Lai GH, 2001, B BOT RES, V21, P182; Li DZ, 2006, FLORA CHINA, V22, P74; Lu JL, 1981, J HENAN COLL AGR, V74, P70; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 1982, GROWTH BIOL THOUGHT; Munro W., 1868, T LINNEAN SOC LONDON, V26, P1, DOI DOI 10.1111/J.1096-3642.1968.TB00502.X; NOOTEBOOM HP, 1992, TAXON, V41, P318, DOI 10.2307/1222338; Renvoize SA, 1997, LINNEAN SOC, P95; Roalson EH, 2000, SYST BOT, V25, P323, DOI 10.2307/2666645; Ruiz-Sanchez E, 2011, TAXON, V60, P89, DOI 10.1002/tax.601008; Stapleton CMA, 1997, LINNEAN SOC, P251; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YC, 1989, ACTA PHYTOTAXONOMICA, V27, P81; Tarciso VP, 2011, BRITT, V63, P102; White T., 1990, PCR PROTOCOLS GUIDE, P315; Xiang QY, 1989, B BOT RES, V9, P125; Yang ZY, 2007, PHYTOMEDICINE, V14, P416, DOI 10.1016/j.phymed.2007.04.009; Yano O, 2004, J PLANT RES, V117, P409, DOI 10.1007/s10265-004-0173-3; Yi T. P., 1985, Journal of Bamboo Research, V4, P20; Yi TP, 1990, J BAMB RES, V9, P27; Yi TP, 1996, FLORA REIPUBLICAE PO, V9, P387; Yi TP, 1985, B BOT RES, V5, P121	44	3	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101362	10.1371/journal.pone.0101362	http://dx.doi.org/10.1371/journal.pone.0101362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988081	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100078
J	Gomez-Ramos, A; Sanchez-Sanchez, R; Muhaisen, A; Rabano, A; Soriano, E; Avila, J				Gomez-Ramos, Alberto; Sanchez-Sanchez, Rafael; Muhaisen, Ashraf; Rabano, Alberto; Soriano, Eduardo; Avila, Jesus			Similarities and Differences between Exome Sequences Found in a Variety of Tissues from the Same Individual	PLOS ONE			English	Article							DETECTABLE CLONAL MOSAICISM; GENETIC-VARIATION; GENOME; DNA; MUTATIONS; CANCER; FRAMEWORK; DATABASE	DNA is the most stable nucleic acid and most important store of genetic information. DNA sequences are conserved in virtually all the cells of a multicellular organism. To analyze the sequences of various individuals with distinct pathological disorders, DNA is routinely isolated from blood, independently of the tissue that is the target of the disease. This approach has proven useful for the identification of familial diseases where mutations are present in parental germinal cells. With the capacity to compare DNA sequences from distinct tissues or cells, present technology can be used to study whether DNA sequences in tissues are invariant. Here we explored the presence of specific SNVs (Single Nucleotide Variations) in various tissues of the same individual. We tested for the presence of tissue-specific exonic SNVs, taking blood exome as a control. We analyzed the chromosomal location of these SNVs. The number of SNVs per chromosome was found not to depend on chromosome length, but mainly on the number of protein-coding genes per chromosome. Although similar but not identical patterns of chromosomal distribution of tissue-specific SNVs were found, clear differences were detected. This observation supports the notion that each tissue has a specific SNV exome signature.	[Gomez-Ramos, Alberto; Avila, Jesus] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Sanchez-Sanchez, Rafael] Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain; [Rabano, Alberto] Fdn CIEN, Vallecas, Spain; [Muhaisen, Ashraf; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Muhaisen, Ashraf; Soriano, Eduardo; Avila, Jesus] Inst Recerca Hosp Univ Vall dHebron VHIR, Barcelona, Spain; [Gomez-Ramos, Alberto; Muhaisen, Ashraf; Soriano, Eduardo; Avila, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario Reina Sofia - Cordoba; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED	Avila, J (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	jesus.avila@cbm.csic.es	Soriano, Eduardo/AAB-3216-2019; Avila, Jesus/I-2610-2015; Gomez-Ramos, Alberto/K-3907-2014	Soriano, Eduardo/0000-0002-3204-9285; Avila, Jesus/0000-0002-6288-0571; Gomez-Ramos, Alberto/0000-0001-9502-9241; Sanchez-Sanchez, Rafael/0000-0002-9821-0211	BBVA Foundation; MICINN-MINECO; MICINNN-MINECO [BFU2008-3980, SAF2011-24841]	BBVA Foundation(BBVA Foundation); MICINN-MINECO; MICINNN-MINECO	This study was supported by the grants of BBVA Foundation and MICINN-MINECO. The authors would also like to acknowledge the help of Reina Sofia Foundation, the CIEN Foundation, CIBERNED (ISCIII), and grants BFU2008-3980 (ES) and SAF2011-24841 (JA) from MICINNN-MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cech TR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006742; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Eberwine J, 2014, NAT METHODS, V11, P25, DOI 10.1038/nmeth.2769; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Linnarsson S, 2012, NAT METHODS, V9, P339, DOI 10.1038/nmeth.1934; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi YW, 2012, GENES BRAIN BEHAV, V11, P170, DOI 10.1111/j.1601-183X.2011.00756.x; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402	25	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101412	10.1371/journal.pone.0101412	http://dx.doi.org/10.1371/journal.pone.0101412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984015	gold, Green Published			2022-12-25	WOS:000339635000101
J	Jia, ZJ; Sun, Y; Liu, SS; Liu, Y; Yang, TX				Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin			COX-2 but Not mPGES-1 Contributes to Renal PGE2 Induction and Diabetic Proteinuria in Mice with Type-1 Diabetes	PLOS ONE			English	Article							PROSTAGLANDIN E-2 BIOSYNTHESIS; E SYNTHASE-1; OXIDATIVE STRESS; MESANGIAL CELLS; INHIBITION; RATS; STREPTOZOTOCIN; EXPRESSION; KIDNEY; NEPHROPATHY	Prostaglandin E2 (PGE2) has been implicated to play a pathogenic role in diabetic nephropathy (DN) but its source remains unlcear. To elucidate whether mPGES-1, the best characterized PGE2 synthase, was involved in the development of DN, we examined the renal phenotype of mPGES-1 KO mice subjected to STZ-induced type-1 diabetes. After STZ treatment, mPGES1 WT and KO mice presented the similar onset of diabetes as shown by similar elevation of blood glucose. Meanwhile, both genotypes of mice exhibited similar increases of urinary and renal PGE2 production. In parallel with this comparable diabetic status, the kidney injury indices including the urinary albumin excretion, kidney weight and the kidney histology (PAS staining) did not show any difference between the two genotypes. By Western-blotting and quantitative qRT-PCR, mPGES-1, mPGES-2, cPGES and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) remain unaltered following six weeks of diabetes. Finally, a selective COX-2 inhibitor celecoxib (50 mg/kg/day) was applied to the STZ-treated KO mice, which resulted in significant reduction of urinary albumin excretion (KO/STZ: 141.5+/-38.4 vs. KO/STZ + Celebrex: 48.7+/-20.8 ug/24 h, p<0.05) and the blockade of renal PGE2 induction (kidney: KO/STZ: 588.7+/-89.2 vs. KO/STZ + Celebrex: 340.8+/-58.7 ug/24 h, p<0.05; urine: KO/STZ 1667.6+/-421.4 vs. KO/STZ + Celebrex 813.6+/-199.9 pg/24 h, p<0.05), without affecting the blood glucose levels and urine volume. Taken together, our data suggests that an as yet unidentified prostaglanind E synthase but not mPGES-1 may couple with COX-2 to mediate increased renal PGE2 sythsesis in DN.	[Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Jia, Zhanjun; Sun, Ying; Liu, Shanshan; Liu, Ying; Yang, Tianxin] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Yang, Tianxin] Sun Yat Sen Univ, Sch Med, Inst Hypertens, Guangzhou 510275, Guangdong, Peoples R China	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sun Yat Sen University	Yang, TX (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	Tianxin.Yang@hsc.utah.edu		Sun, Ying/0000-0002-1720-8540	VA Merit Review; National Institutes of Health [DK079162]; National Natural Science Foundation of China [31330037]; American Heart Association [11SDG7480006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079162] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by VA Merit Review (T. Yang), National Institutes of Health Grant DK079162 (T. Yang), and National Natural Science Foundation of China Grant No. 31330037 (T. Yang), and an American Heart Association Scientist Develop Grant (11SDG7480006) to Z. Jia. T. Yang is an Established Investigator from American Heart Association and Research Career Scientist in Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breyer MD, 1996, J AM SOC NEPHROL, V7, P8; Chiasson JF, 2011, BIOORG MED CHEM LETT, V21, P1488, DOI 10.1016/j.bmcl.2011.01.006; CRAVEN PA, 1989, J LAB CLIN MED, V113, P674; DERUBERTIS FR, 1993, AM J KIDNEY DIS, V22, P727, DOI 10.1016/S0272-6386(12)80439-2; ENSOR CM, 1995, J LIPID MEDIAT CELL, V12, P313, DOI 10.1016/0929-7855(95)00040-W; Francois H, 2005, CELL METAB, V2, P201, DOI 10.1016/j.cmet.2005.08.005; GERRARD JM, 1980, J LAB CLIN MED, V95, P950; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HOMMEL E, 1987, DIABETOLOGIA, V30, P78; Ishibashi R, 1999, KIDNEY INT, V56, P589, DOI 10.1046/j.1523-1755.1999.00566.x; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Jia ZJ, 2008, HYPERTENSION, V52, P952, DOI 10.1161/HYPERTENSIONAHA.108.111229; Jia ZJ, 2006, CIRC RES, V99, P1243, DOI 10.1161/01.RES.0000251306.40546.08; Jia ZJ, 2011, KIDNEY INT, V79, P77, DOI 10.1038/ki.2010.331; Jia ZJ, 2010, AM J PHYSIOL-RENAL, V299, pF155, DOI 10.1152/ajprenal.90702.2008; Jia ZJ, 2010, HYPERTENSION, V55, P539, DOI 10.1161/HYPERTENSIONAHA.109.144840; Jia ZJ, 2009, AM J PHYSIOL-RENAL, V297, pF1689, DOI 10.1152/ajprenal.00117.2009; Komers R, 2007, CLIN EXP PHARMACOL P, V34, P36, DOI 10.1111/j.1440-1681.2007.04534.x; Korners R, 2001, J CLIN INVEST, V107, P889, DOI 10.1172/JCI10228; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Makino H, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019782.37851.BF; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Mohamed R, 2013, LAB INVEST, V93, P933, DOI 10.1038/labinvest.2013.85; Moore AH, 2004, J NEUROIMMUNOL, V148, P32, DOI 10.1016/j.jneuroim.2003.11.001; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Nasrallah R, 2007, AM J PHYSIOL-RENAL, V292, pF278, DOI 10.1152/ajprenal.00089.2006; Nasrallah R, 2009, AM J NEPHROL, V30, P346, DOI 10.1159/000229304; Paliege A, 2004, AM J PHYSIOL-RENAL, V287, pF152, DOI 10.1152/ajprenal.00287.2003; Parazzoli S, 2012, J BIOL CHEM, V287, P32246, DOI 10.1074/jbc.M112.364612; Quilley J, 2011, AM J PHYSIOL-HEART C, V300, pH2316, DOI 10.1152/ajpheart.01259.2010; SCHAMBELAN M, 1985, J CLIN INVEST, V75, P404, DOI 10.1172/JCI111714; Schneider A, 2004, KIDNEY INT, V65, P1205, DOI 10.1111/j.1523-1755.2004.00493.x; Soodvilai S, 2009, AM J PHYSIOL-RENAL, V296, pF1129, DOI 10.1152/ajprenal.90478.2008; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang J, 2010, BIOORG MED CHEM LETT, V20, P1604, DOI 10.1016/j.bmcl.2010.01.060; WILLIAMS B, 1993, J CLIN INVEST, V92, P2889, DOI 10.1172/JCI116911; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	41	25	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e93182	10.1371/journal.pone.0093182	http://dx.doi.org/10.1371/journal.pone.0093182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984018	Green Published, gold, Green Submitted			2022-12-25	WOS:000339635000001
J	Swarbrick, CMD; Roman, N; Cowieson, N; Patterson, EI; Nanson, J; Siponen, MI; Berglund, H; Lehtio, L; Forwood, JK				Swarbrick, Crystall M. D.; Roman, Noelia; Cowieson, Nathan; Patterson, Edward I.; Nanson, Jeffrey; Siponen, Marina I.; Berglund, Helena; Lehtio, Lari; Forwood, Jade K.			Structural Basis for Regulation of the Human Acetyl-CoA Thioesterase 12 and Interactions with the Steroidogenic Acute Regulatory Protein-related Lipid Transfer (START) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A (Acetyl-CoA); ADP; Allosteric Regulation; ATP; Metabolism; ACOT12; START Domain; Thioesterase	RAT-LIVER; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; BETA-OXIDATION; CELL-GROWTH; HYDROLASE; METABOLISM; CHAIN; ENZYMES	Background: The regulation of ACOT12 by ADP and ATP is thought to occur through oligomerization. Results: The structures of apo-ACOT12 and ADP-bound ACOT12 reveal new insights into regulation. Conclusion: ACOT12 is a homotrimer and neither ADP nor ATP alter the oligomeric state of the protein. Significance: These findings provide the first structural insights in the regulation of this enzyme family. Acetyl-CoA plays a fundamental role in cell signaling and metabolic pathways, with its cellular levels tightly controlled through reciprocal regulation of enzymes that mediate its synthesis and catabolism. ACOT12, the primary acetyl-CoA thioesterase in the liver of human, mouse, and rat, is responsible for cleavage of the thioester bond within acetyl-CoA, producing acetate and coenzyme A for a range of cellular processes. The enzyme is regulated by ADP and ATP, which is believed to be mediated through the ligand-induced oligomerization of the thioesterase domains, whereby ATP induces active dimers and tetramers, whereas apo- and ADP-bound ACOT12 are monomeric and inactive. Here, using a range of structural and biophysical techniques, it is demonstrated that ACOT12 is a trimer rather than a tetramer and that neither ADP nor ATP exert their regulatory effects by altering the oligomeric status of the enzyme. Rather, the binding site and mechanism of ADP regulation have been determined to occur through two novel regulatory regions, one involving a large loop that links the thioesterase domains (Phe(154)-Thr(178)), defined here as RegLoop1, and a second region involving the C terminus of thioesterase domain 2 (Gln(304)-Gly(326)), designated RegLoop2. Mutagenesis confirmed that Arg(312) and Arg(313) are crucial for this mode of regulation, and novel interactions with the START domain are presented together with insights into domain swapping within eukaryotic thioesterases for substrate recognition. In summary, these experiments provide the first structural insights into the regulation of this enzyme family, revealing an alternate hypothesis likely to be conserved throughout evolution.	[Swarbrick, Crystall M. D.; Roman, Noelia; Patterson, Edward I.; Nanson, Jeffrey; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Cowieson, Nathan] Australian Synchrotron, Clayton, Vic 3168, Australia; [Siponen, Marina I.; Berglund, Helena; Lehtio, Lari] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden	Charles Sturt University; Karolinska Institutet	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Nanson, Jeffrey D/E-6313-2017	Nanson, Jeffrey D/0000-0003-1306-1948; Swarbrick, Crystall/0000-0002-9337-3361; Forwood, Jade/0000-0003-3267-9997; Lehtio, Lari/0000-0001-7250-832X; Roman, Noelia/0000-0003-0856-2131; Patterson, Edward/0000-0003-3465-0848				Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BROWN MS, 1980, J LIPID RES, V21, P505; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Horibata Y, 2013, J LIPID RES, V54, P2049, DOI 10.1194/jlr.M030163; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; ISOHASHI F, 1983, BIOCHEMISTRY-US, V22, P584, DOI 10.1021/bi00272a010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; MATSUNAGA T, 1985, EUR J BIOCHEM, V152, P331, DOI 10.1111/j.1432-1033.1985.tb09202.x; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Rosano C, 2002, ACTA CRYSTALLOGR D, V58, P524, DOI 10.1107/S0907444901021874; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; SOLING HD, 1985, EUR J BIOCHEM, V147, P111, DOI 10.1111/j.1432-1033.1985.tb08726.x; Suematsu N, 2002, ACTA BIOCHIM POL, V49, P937; Suematsu N, 2001, EUR J BIOCHEM, V268, P2700, DOI 10.1046/j.1432-1327.2001.02162.x; Suematsu N, 2006, ACTA BIOCHIM POL, V53, P553; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WIELAND O, 1964, ADV ENZYME REGUL, V2, P85, DOI 10.1016/S0065-2571(64)80007-8; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053	38	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24263	24274		10.1074/jbc.M114.589408	http://dx.doi.org/10.1074/jbc.M114.589408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002576	Green Published, hybrid			2022-12-25	WOS:000341505600023
J	Chen, C; Zhang, BY; Yu, SL; Sun, F; Ruan, QL; Zhang, WH; Shao, LY; Chen, S				Chen, Chen; Zhang, Bingyan; Yu, Shenglei; Sun, Feng; Ruan, Qiaoling; Zhang, Wenhong; Shao, Lingyun; Chen, Shu			The Incidence and Risk Factors of Meningitis after Major Craniotomy in China: A Retrospective Cohort Study	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; BACTERIAL-MENINGITIS; NEUROSURGICAL PROCEDURES; ANTIBIOTIC-PROPHYLAXIS; WOUND-INFECTION; POSTOPERATIVE MENINGITIS; SURGERY	Background: Meningitis after neurosurgery can result in severe morbidity and high mortality. Incidence varies among regions and limited data are focused on meningitis after major craniotomy. Aim: This retrospective cohort study aimed to determine the incidence, risk factors and microbiological spectrum of postcraniotomy meningitis in a large clinical center of Neurosurgery in China. Methods: Patients who underwent neurosurgeries at the Department of Neurosurgery in Huashan Hospital, the largest neurosurgery center in Asia and the Pacific, between 1st January and 31st December, 2008 were selected. Individuals with only shunts, burr holes, stereotactic surgery, transsphenoidal or spinal surgery were excluded. The complete medical records of each case were reviewed, and data on risk factors were extracted and evaluated for meningitis. Results: A total of 65 meningitides were identified among 755 cases in the study, with an incidence of 8.60%. The risk of meningitis was increased by the presence of diabetes mellitus (odds ratio [OR], 6.27; P = 0.009), the use of external ventricular drainage (OR, 4.30; P = 0.003) and the use of lumbar drainage (OR, 17.23; P<0.001). The isolated microorganisms included Acinetobacter baumannii, Enterococcus sp, Streptococcus intermedius and Klebsiella pneumonia. Conclusions: Meningitis remains an important source of morbidity and mortality after major craniotomy. Diabetic patients or those with cerebral spinal fluid shunts carry significant high risk of infection. Thus, identification of the risk factors as soon as possible will help physicians to improve patient care.	[Chen, Chen; Zhang, Bingyan; Yu, Shenglei; Sun, Feng; Ruan, Qiaoling; Zhang, Wenhong; Shao, Lingyun; Chen, Shu] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University	Shao, LY (corresponding author), Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai 200433, Peoples R China.	lingyun26@fudan.edu.cn; shuchen@fudan.edu.cn			Scientific Project of Science and Technology Commission of Shanghai Municipality [114119b1900]	Scientific Project of Science and Technology Commission of Shanghai Municipality	The study was funded by the research grant of Scientific Project of Science and Technology Commission of Shanghai Municipality (Fund No. 114119b1900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2003, NURS J INDIA, V94, P212; Agarwal Mesna, 2003, Nurs J India, V94, P197; BALCH RE, 1967, J NEUROSURG, V26, P41, DOI 10.3171/jns.1967.26.1part1.0041; Barker FG, 2002, NEUROSURGERY, V51, P391, DOI 10.1097/00006123-200208000-00017; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Briggs S, 2004, SCAND J INFECT DIS, V36, P165, DOI 10.1080/00365540410027193; BUCKWOLD FJ, 1977, J NEUROSURG, V46, P494, DOI 10.3171/jns.1977.46.4.0494; Buffet-Bataillon S, 2013, AM J INFECT CONTROL, V41, P1290, DOI 10.1016/j.ajic.2013.02.006; Coplin WM, 1999, J NEUROL NEUROSUR PS, V67, P468, DOI 10.1136/jnnp.67.4.468; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Erdem I, 2008, NEUROL INDIA, V56, P433, DOI 10.4103/0028-3886.44629; Erman T, 2005, SURG NEUROL, V63, P107, DOI 10.1016/j.surneu.2004.04.024; Federico G, 2001, SCAND J INFECT DIS, V33, P533, DOI 10.1080/00365540110026557; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Huang CR, 2001, INFECTION, V29, P75, DOI 10.1007/s15010-001-0087-0; Khan FY, 2012, J HOSP INFECT, V80, P176, DOI 10.1016/j.jhin.2011.08.021; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Mao Y, 2011, WORLD NEUROSURG, V75, P369, DOI 10.1016/j.wneu.2011.02.002; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; QUADERY LA, 1977, ACTA NEUROCHIR, V39, P133, DOI 10.1007/BF01406722; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Scheithauer S, 2010, INFECTION, V38, P205, DOI 10.1007/s15010-010-0006-3; Sneh-Arbib O, 2013, EUR J CLIN MICROBIOL, V32, P1511, DOI 10.1007/s10096-013-1904-y; Srinivas D, 2011, NEUROL INDIA, V59, P195, DOI 10.4103/0028-3886.79136; TENNEY JH, 1985, J NEUROSURG, V62, P243, DOI 10.3171/jns.1985.62.2.0243; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Wang C, 2008, NEUROSURGERY, V62, P947, DOI 10.1227/01.neu.0000318181.80040.99; WRIGHT RL, 1966, J NEUROSURG, V25, P125	32	58	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101961	10.1371/journal.pone.0101961	http://dx.doi.org/10.1371/journal.pone.0101961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003204	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700093
J	Edzuka, T; Yamada, L; Kanamaru, K; Sawada, H; Goshima, G				Edzuka, Tomoya; Yamada, Lixy; Kanamaru, Kyoko; Sawada, Hitoshi; Goshima, Gohta			Identification of the Augmin Complex in the Filamentous Fungus Aspergillus nidulans	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; SPINDLE-POLE-BODY; MICROTUBULE NUCLEATION; MITOTIC SPINDLE; GENERATION; COMPONENT; REVEALS; GENES; YEAST	Augmin is a protein complex that binds to spindle microtubules (MTs), recruits the potent MT nucleator, gamma-tubulin, and thereby promotes the centrosome-independent MT generation within mitotic and meiotic spindles. Augmin is essential for acentrosomal spindle assembly, which is commonly observed during mitosis in plants and meiosis in female animals. In many animal somatic cells that possess centrosomes, the centrosome- and augmin-dependent mechanisms work cooperatively for efficient spindle assembly and cytokinesis. Yeasts have lost the augmin genes during evolution. It is hypothesized that their robust MT nucleation from the spindle pole body (SPB), the centrosome-equivalent structure in fungi, compensates for the lack of augmin. Intriguingly, however, a gene homologous to an augmin subunit (Aug6/AUGF) has been found in the genome of filamentous fungi, which has the SPB as a robust MT nucleation centre. Here, we aimed to clarify if the augmin complex is present in filamentous fungi and to identify its role in mitosis. By analysing the Aug6-like gene in the filamentous fungus Aspergillus nidulans, we found that it forms a large complex with several other proteins that share weak but significant homology to known augmin subunits. In A. nidulans, augmin was enriched at the SPB and also associated with spindle MTs during mitosis. However, the augmin gene disruptants did not exhibit growth defects under normal, checkpoint-deficient, or MT-destabilised conditions. Moreover, we obtained no evidence that A. nidulans augmin plays a role in gamma-tubulin recruitment or in mitotic cell division. Our study uncovered the conservation of the augmin complex in the fungal species, and further suggests that augmin has several functions, besides mitotic spindle MT nucleation, that are yet to be identified.	[Edzuka, Tomoya; Goshima, Gohta] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yamada, Lixy; Sawada, Hitoshi] Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba, Mie, Japan; [Kanamaru, Kyoko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Goshima, G (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	goshima@bio.nagoya-u.ac.jp		Kanamaru, Kyoko/0000-0003-3964-7891	Japan Society for Promotion of Science	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Next Generation grant (Japan Society for Promotion of Science) to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2012, EUKARYOT CELL, V11, P638, DOI 10.1128/EC.00028-12; BALLANCE DJ, 1985, GENE, V36, P321, DOI 10.1016/0378-1119(85)90187-8; Duncan T, 2011, CHROMOSOME RES, V19, P321, DOI 10.1007/s10577-011-9205-8; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fujita A, 2002, MOL BIOL CELL, V13, P2360, DOI 10.1091/mbc.02-01-0603; Gibeaux R, 2012, J CELL SCI, V125, P5830, DOI 10.1242/jcs.111005; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Motoyama T, 1996, MOL GEN GENET, V251, P442, DOI 10.1007/BF02172373; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Osmani SA, 2004, FUNGAL GENET BIOL, V41, P401, DOI 10.1016/j.fgb.2003.11.009; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Veith D, 2005, J CELL SCI, V118, P3705, DOI 10.1242/jcs.02501; Wainman A, 2009, GENE DEV, V23, P1876, DOI 10.1101/gad.532209; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Yamada L, 2009, J BIOL CHEM, V284, P9402, DOI 10.1074/jbc.M809672200	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101471	10.1371/journal.pone.0101471	http://dx.doi.org/10.1371/journal.pone.0101471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003582	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700033
J	Pineda-Pena, AC; Schrooten, Y; Vinken, L; Ferreira, F; Li, GD; Trovao, NS; Khouri, R; Derdelinckx, I; De Munter, P; Kucherer, C; Kostrikis, LG; Nielsen, C; Littsola, K; Wensing, A; Stanojevic, M; Paredes, R; Balotta, C; Albert, J; Boucher, C; Gomez-Lopez, A; Van Wijngaerden, E; Van Ranst, M; Vercauteren, J; Vandamme, AM; Van Laethem, K				Pineda-Pena, Andrea-Clemencia; Schrooten, Yoeri; Vinken, Lore; Ferreira, Fossie; Li, Guangdi; Trovao, Nidia Sequeira; Khouri, Ricardo; Derdelinckx, Inge; De Munter, Paul; Kuecherer, Claudia; Kostrikis, Leondios G.; Nielsen, Claus; Littsola, Kirsi; Wensing, Annemarie; Stanojevic, Maja; Paredes, Roger; Balotta, Claudia; Albert, Jan; Boucher, Charles; Gomez-Lopez, Arley; Van Wijngaerden, Eric; Van Ranst, Marc; Vercauteren, Jurgen; Vandamme, Anne-Mieke; Van Laethem, Kristel			Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic	PLOS ONE			English	Article							TRANSMISSION NETWORK; GENOTYPING SYSTEM; SUBTYPE B; SEQUENCES; PREVALENCE; MUTATIONS; EUROPE	We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region, its clinical impact and its association with transmission clusters. We included 778 patients from the AIDS Reference Center in Leuven (Belgium) diagnosed from 1998 to 2012. Resistance testing was performed using population-based sequencing and TDR was estimated using the WHO-2009 surveillance list. Phylogenetic analysis was performed using maximum likelihood and Bayesian techniques. The cohort was predominantly Belgian (58.4%), men who have sex with men (MSM) (42.8%), and chronically infected (86.5%). The overall TDR prevalence was 9.6% (95% confidence interval (Cl): 7.7-11.9), 6.5% (CI: 5.0-8.5) for nucleoside reverse transcriptase inhibitors (NRTI), 2.2% (CI: 1.4-3.5) for non-NRTI (NNRTI), and 2.2% (CI: 1.4-3.5) for protease inhibitors. A significant parabolic trend of NNRTI-TDR was found (p = 0.019). Factors significantly associated with TDR in univariate analysis were male gender, Belgian origin, MSM, recent infection, transmission clusters and subtype B, while multivariate and Bayesian network analysis singled out subtype B as the most predictive factor of TDR. Subtype B was related with transmission clusters with TDR that included 42.6% of the TDR patients. Thanks to resistance testing, 83% of the patients with TDR who started therapy had undetectable viral load whereas half of the patients would likely have received a suboptimal therapy without this test. In conclusion, TDR remained stable and a NNRTI up-and-down trend was observed. While the presence of clusters with TDR is worrying, we could not identify an independent, non-sequence based predictor for TDR or transmission clusters with TDR that could help with guidelines or public health measures.	[Pineda-Pena, Andrea-Clemencia; Schrooten, Yoeri; Vinken, Lore; Ferreira, Fossie; Li, Guangdi; Trovao, Nidia Sequeira; Khouri, Ricardo; Van Ranst, Marc; Vercauteren, Jurgen; Vandamme, Anne-Mieke; Van Laethem, Kristel] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium; [Pineda-Pena, Andrea-Clemencia; Gomez-Lopez, Arley] Univ Rosario, Clin & Mol Infect Dis Grp, Fac Sci & Math, Bogota, Colombia; [Schrooten, Yoeri; Van Ranst, Marc; Van Laethem, Kristel] Univ Hosp Leuven, AIDS Reference Lab, Leuven, Belgium; [Derdelinckx, Inge; De Munter, Paul; Van Wijngaerden, Eric] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Derdelinckx, Inge; De Munter, Paul; Van Wijngaerden, Eric] Univ Hosp Leuven, Leuven, Belgium; [Kuecherer, Claudia] Robert Koch Inst, Berlin, Germany; [Kostrikis, Leondios G.] Univ Cyprus, Nicosia, Cyprus; [Nielsen, Claus] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Littsola, Kirsi] Natl Inst Hlth & Welf, Helsinki, Finland; [Wensing, Annemarie] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Stanojevic, Maja] Univ Belgrade, Fac Med, Belgrade, Serbia; [Paredes, Roger] IrsiCaixa Fdn, Badalona, Spain; [Balotta, Claudia] Luigi Sacco Univ Hosp, Milan, Italy; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Boucher, Charles] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Unidade Microbiol, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	KU Leuven; Universidad del Rosario; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Robert Koch Institute; University of Cyprus; Statens Serum Institut; Finland National Institute for Health & Welfare; Utrecht University; Utrecht University Medical Center; University of Belgrade; Institut de Recerca de la Sida - IrsiCaixa; University of Milan; Luigi Sacco Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Van Laethem, K (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium.	kristel.vanlaethem@uzleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Van Ranst, Marc/P-7522-2017; Van Wijngaerden, Eric/AAB-9187-2021; KOSTRIKIS, LEONDIOS G/A-5330-2016; Khouri, Ricardo/M-3184-2018; Trovão, Nídia/GPX-3458-2022; De Munter, Paul/AAB-5725-2021; Pineda-Peña, Andrea-Clemencia/N-9809-2015; Van Laethem, Kristel/R-6282-2016; Vercauteren, Jurgen/P-7676-2019; Li, Guangdi/AAU-6951-2020; Balotta, Claudia/L-7295-2017	Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Ranst, Marc/0000-0002-1674-4157; Van Wijngaerden, Eric/0000-0001-8926-099X; KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Khouri, Ricardo/0000-0001-5664-4436; De Munter, Paul/0000-0002-5944-3530; Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; Van Laethem, Kristel/0000-0001-6036-2271; Vercauteren, Jurgen/0000-0003-0698-4736; Sequeira Trovao, Nidia/0000-0002-2106-1166; Balotta, Claudia/0000-0002-1107-9119; Stanojevic, Maja/0000-0002-4643-4272	AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) [G069214N]; European Community under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'' [223131]; University of Leuven [PF/10/018]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia; ERACOL	AIDS Reference Laboratory of Leuven from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO)(FWO); European Community under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)''; University of Leuven(KU Leuven); Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ERACOL	This work was supported in part by the AIDS Reference Laboratory of Leuven that receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System; by the Fonds voor Wetenschappelijk Onderzoek - Flanders (FWO) grant G069214N; and by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'' grant agreement No 223131; by the University of Leuven (Program Financing no. PF/10/018); by the Doctoral Research Training Program "Francisco Jose de Caldas'' by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, Republic of Colombia and by ERACOL, a scholarship for academic exchange in medicine and the health sciences between Europe and Latin America to A.C.P.P. The computational resources and services used in this work were provided by the Hercules Foundation and the Flemish Government - department EWI-FWO Krediet aan Navorsers (Theys, KAN2012 1.5.249.12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; [Anonymous], 2011, US ASS REC INF EST H; [Anonymous], INFECT GENET EVOL; [Anonymous], MMWR; [Anonymous], EPIDEMIOLOGY HIV 1 T; [Anonymous], HIV AIDS SURV EUR 20; [Anonymous], J ANTIMICRO IN PRESS; [Anonymous], DIR OP SANT PUBL SUR; [Anonymous], 8 EUR HIV DRUG RES W; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Callegaro A, 2011, INFECT GENET EVOL, V11, P624, DOI 10.1016/j.meegid.2011.01.019; Carr JK, 2005, JAIDS-J ACQ IMM DEF, V39, P570; Castro E, 2010, AIDS RES HUM RETROV, V26, P1233, DOI 10.1089/aid.2010.0083; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508; Derdelinckx I, 2004, JAIDS-J ACQ IMM DEF, V37, P1664, DOI 10.1097/00126334-200412150-00022; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Frentz D, 2011, JAIDS-J ACQ IMM DEF, V58, pE135, DOI 10.1097/QAI.0b013e3182364c80; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maes B, 2004, J VIROL METHODS, V119, P45, DOI 10.1016/j.jviromet.2004.02.005; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Readhead AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040533; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Ruelle J, 2013, AIDS RES HUM RETROV, V29, P1306, DOI [10.1089/aid.2013.0108, 10.1089/AID.2013.0108]; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Vaerenbergh K, 2001, ANTIVIR THER, V6, P63; Vercauteren J, 2008, AIDS RES HUM RETROV, V24, P355, DOI 10.1089/aid.2007.0212; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	47	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101738	10.1371/journal.pone.0101738	http://dx.doi.org/10.1371/journal.pone.0101738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003369	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700059
J	Konno, T; Hayashi, K; Fujino, N; Nagata, Y; Hodatsu, A; Masuta, E; Sakata, K; Nakamura, H; Kawashiri, MA; Yamagishi, M				Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nagata, Yoji; Hodatsu, Akihiko; Masuta, Eiichi; Sakata, Kenji; Nakamura, Hiroyuki; Kawashiri, Masa-aki; Yamagishi, Masakazu			High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; COLLEGE-OF-CARDIOLOGY; ENDOMYOCARDIAL BIOPSY; HYPERTENSIVE HEARTS; FIBROSIS; ASSOCIATION; QUANTIFICATION; DIAGNOSIS; IMPACT	Background: Myocardial scarring can be assessed by cardiac magnetic resonance imaging with late gadolinium enhancement and by endomyocardial biopsy. However, accuracy of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens remains unknown in hypertrophic cardiomyopathy. We investigated whether late gadolinium enhancement in the whole heart reflects microscopic myocardial scarring in the small biopsied specimens in hypertrophic cardiomyopathy. Methods and Results: Twenty-one consecutive patients with hypertrophic cardiomyopathy who were examined both by cardiac magnetic resonance imaging and by endomyocardial biopsy were retrospectively studied. The right interventricular septum was the target site for endomyocardial biopsy in all patients. Late gadolinium enhancement in the ventricular septum had an excellent sensitivity (100%) with a low specificity (40%) for predicting microscopic myocardial scarring in biopsied specimens. The sensitivity of late gadolinium enhancement in the whole heart remained 100% with a specificity of 27% for predicting microscopic myocardial scarring in biopsied specimens. Quantitative assessments of fibrosis revealed that the extent of late gadolinium enhancement in the whole heart was the only independent variable related to the microscopic collagen fraction in biopsied specimens (beta = 0.59, 95% confident interval: 0.15 - 1.0, p = 0.012). Conclusions: Although there was a compromise in the specificity, the sensitivity of late gadolinium enhancement was excellent for prediction of microscopic myocardial scarring in hypertrophic cardiomyopathy. Moreover, the severity of late gadolinium enhancement was independently associated with the quantitative collagen fraction in biopsied specimens in hypertrophic cardiomyopathy. These findings indicate that late gadolinium enhancement can reflect both the presence and the extent of microscopic myocardial scarring in the small biopsied specimens in hypertrophic cardiomyopathy.	[Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nagata, Yoji; Hodatsu, Akihiko; Masuta, Eiichi; Sakata, Kenji; Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan; [Konno, Tetsuo; Nakamura, Hiroyuki; Yamagishi, Masakazu] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Publ Hlth, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Konno, T (corresponding author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan.	konnokontetsu@staff.kanazawa-u.ac.jp	KAWASHIRI, Masaaki/ABA-7159-2020	KAWASHIRI, Masaaki/0000-0002-5759-1353	Ministry of Education, Science and Culture of Japan [24790748]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science and Culture of Japan to TK; Research Project Number: 24790748 (URL: http://kaken.nii.ac.jp/d/p/24790748.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Basso C, 2009, EUR HEART J, V30, P1627, DOI 10.1093/eurheartj/ehp121; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Delcre SDL, 2013, INT J CARDIOL, V167, P1038, DOI 10.1016/j.ijcard.2012.03.074; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; HOSHINO T, 1983, CIRCULATION, V67, P1109, DOI 10.1161/01.CIR.67.5.1109; John BT, 2004, HEART RHYTHM, V1, P141, DOI 10.1016/j.hrthm.2004.02.021; Karamitsos TD, 2011, EUR J HEART FAIL, V13, P927, DOI 10.1093/eurjhf/hfr084; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Mori M, 2011, J CARDIOL, V57, P89, DOI 10.1016/j.jjcc.2010.08.006; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; SAKAKIBARA S, 1962, JPN HEART J, V3, P537; Schalla S, 2010, EUR J HEART FAIL, V12, P227, DOI 10.1093/eurjhf/hfq004; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; TANAKA M, 1986, BRIT HEART J, V55, P575; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Yamada T, 2013, J CARD FAIL, V19, P557, DOI 10.1016/j.cardfail.2013.05.018; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Yoshida A, 2013, EUR J HEART FAIL, V15, P166, DOI 10.1093/eurjhf/hfs206; Zimmermann O, 2006, EUR J HEART FAIL, V8, P162, DOI 10.1016/j.ejheart.2005.06.001	32	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101465	10.1371/journal.pone.0101465	http://dx.doi.org/10.1371/journal.pone.0101465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000555	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300047
J	Li, SH; Chen, JZ; Xu, HY; Long, J; Xie, XB; Zhang, YJ				Li, Shuhua; Chen, Juanzhi; Xu, Huiyong; Long, Jie; Xie, Xiaobin; Zhang, Yajie			The Targeted Transduction of MMP-Overexpressing Tumor Cells by ACPP-HPMA Copolymer-Coated Adenovirus Conjugates	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; HUMAN IMMUNODEFICIENCY VIRUS; OVARIAN-CARCINOMA CELLS; GROWTH-FACTOR RECEPTOR; IN-VIVO; GENE DELIVERY; TAT PEPTIDE; NEUTRALIZING ANTIBODIES; INTRACELLULAR DELIVERY; PENETRATING PEPTIDES	We have designed and tested a new way to selectively deliver HPMA polymer-coated adenovirus type 5 (Ad5) particles into matrix metalloproteinase (MMP)-overexpressing tumor cells. An activatable cell penetrating peptide (ACPP) was designed and attached to the reactive 4-nitrophenoxy groups of HPMA polymers by the C-terminal amino acid (asparagine, N). ACPPs are activatable cell penetrating peptides (CPPs) with a linker between polycationic and polyanionic domains, and MMP-mediated cleavage releases the CPP portion and its attached cargo to enable cell entry. Our data indicate that the transport of these HPMA polymer conjugates by a single ACPP molecule to the cytoplasm occurs via a nonendocytotic and concentration-independent process. The uptake was observed to finish within 20 minutes by inverted fluorescence microscopy. In contrast, HPMA polymer-coated Ad5 without ACPPs was internalized solely by endocytosis. The optimal formulation was not affected by the presence of Ad5 neutralizing antibodies during transduction, and ACPP/polymercoated Ad5 also retained high targeting capability to several MMP-overexpressing tumor cell types. For the first time, ACPP-mediated cytoplasmic delivery of polymer-bound Ad5 to MMP-overexpressing tumor cells was demonstrated. These findings are significant, as they demonstrate the use of a polymer-based system for the targeted delivery into MMP-overexpressing solid tumors and highlight how to overcome major cellular obstacles to achieve intracellular macromolecular delivery.	[Li, Shuhua; Chen, Juanzhi; Xu, Huiyong; Zhang, Yajie] Southern Med Univ, Sch Basic Med Sci, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China; [Li, Shuhua; Long, Jie; Xie, Xiaobin; Zhang, Yajie] Guangzhou Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Chen, Juanzhi; Xu, Huiyong] Southern Med Univ, Nanfang Hosp, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China	Zhang, YJ (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Pathol & Stomatol, Guangzhou, Guangdong, Peoples R China.	yajie.zhang@163.com			National Nature Science Foundation of China [30971146, 81201960]; International Cooperation and Exchanges Projects of Guangdong Province, China [2010B050700023]; Medical Scientific Research Foundation of Guangdong Province, China [A2013244]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Projects of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This work was funded by the National Nature Science Foundation of China (grant Nos. 30971146 and 81201960). This work was also supported by International Cooperation and Exchanges Projects of Guangdong Province, China (No. 2010B050700023) and Medical Scientific Research Foundation of Guangdong Province, China (No. A2013244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtarzi H, 2011, J DRUG TARGET, V19, P690, DOI 10.3109/1061186X.2010.547585; Benihoud K, 1999, CURR OPIN BIOTECH, V10, P440, DOI 10.1016/S0958-1669(99)00007-5; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Caron NJ, 2001, MOL THER, V3, P310, DOI 10.1006/mthe.2001.0279; Chillon M, 1998, GENE THER, V5, P995, DOI 10.1038/sj.gt.3300665; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; Dodds E, 1999, J NEUROCHEM, V72, P2105, DOI 10.1046/j.1471-4159.1999.0722105.x; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Fisher KD, 2007, J DRUG TARGET, V15, P546, DOI 10.1080/10611860701501014; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Han J, 2010, NANOTECHNOLOGY, V21, P105; Hitt MM, 2006, CELL BIOL LAB HDB, V1, P435; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kasman LM, 2009, MOL PHARMACEUT, V6, P1612, DOI 10.1021/mp9000958; Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043; La Rocca G, 2004, BRIT J CANCER, V90, P1414, DOI 10.1038/sj.bjc.6601725; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Mattila T, 2003, BRIT J CANCER, V89, P1270; Mi ZB, 2000, MOL THER, V2, P339, DOI 10.1006/mthe.2000.0137; Mie M, 2003, BIOCHEM BIOPH RES CO, V310, P730, DOI 10.1016/j.bbrc.2003.09.071; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; Morrison J, 2009, HUM GENE THER, V20, P239, DOI 10.1089/hum.2008.167; Moy P, 1996, MOL BIOTECHNOL, V6, P105, DOI 10.1007/BF02740767; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Nori A, 2003, J CONTROL RELEASE, V91, P53, DOI 10.1016/S0168-3659(03)00213-X; Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Park JW, 2010, J CONTROL RELEASE, V142, P238, DOI 10.1016/j.jconrel.2009.11.001; Peng ZH, 2008, IDRUGS, V11, P346; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; REJMANOVA P, 1977, MAKROMOL CHEM, V178, P2159, DOI 10.1002/macp.1977.021780803; RIHOVA B, 1989, BIOMATERIALS, V10, P335, DOI 10.1016/0142-9612(89)90075-6; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Romanczuk H, 1999, HUM GENE THER, V10, P2615, DOI 10.1089/10430349950016654; Searle PF, 1998, GENE THER, V5, P725, DOI 10.1038/sj.gt.3300686; Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275; Snyder EL, 2001, CURR OPIN MOL THER, V3, P147; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Subr V, 2009, J CONTROL RELEASE, V135, P152, DOI 10.1016/j.jconrel.2008.12.009; Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Torchilin VP, 2003, CURR PROTEIN PEPT SC, V4, P133, DOI 10.2174/1389203033487298; Toyoda K, 2001, J CEREBR BLOOD F MET, V21, P1125, DOI 10.1097/00004647-200109000-00010; Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069; Willemsen RA, 2010, PHARM RES-DORDR, V27, P2274, DOI 10.1007/s11095-010-0088-8; Xiang QY, 2012, EUR J PHARM BIOPHARM, V80, P379, DOI 10.1016/j.ejpb.2011.10.020; Yang Y, 2012, BIOMATERIALS, V33, P2260, DOI 10.1016/j.biomaterials.2011.12.007; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zhao M, 2002, BIOCONJUGATE CHEM, V13, P840, DOI 10.1021/bc0255236	62	6	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100670	10.1371/journal.pone.0100670	http://dx.doi.org/10.1371/journal.pone.0100670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000246	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300012
J	Jenum, S; Grewal, HMS; Hokey, DA; Kenneth, J; Vaz, M; Doherty, TM; Jahnsen, FL				Jenum, Synne; Grewal, Harleen M. S.; Hokey, David A.; Kenneth, John; Vaz, Mario; Doherty, Timothy Mark; Jahnsen, Frode Lars		TB Trials Study Grp	The Frequencies of IFN gamma+IL2+TNF alpha plus PPD-Specific CD4+CD45RO+T-Cells Correlate with the Magnitude of the QuantiFERON (R) Gold In-Tube Response in a Prospective Study of Healthy Indian Adolescents	PLOS ONE			English	Article							T-CELL RESPONSES; TUBERCULOSIS-SPECIFIC CD4(+); INTERFERON-GAMMA RESPONSES; BCG VACCINATION; LATENT TUBERCULOSIS; PREDICTIVE-VALUE; RELEASE ASSAYS; MYCOBACTERIUM; PROTECTION; INFECTION	Background: QuantiFERON-TB Gold In-Tube (QFT) is an IFN gamma-release assay used in the diagnosis of Mycobacterium tuberculosis (MTB) infection. The risk of TB progression increases with the magnitude of the MTB-specific IFN gamma-response. QFT reversion, also associated with low Tuberculin Skin Test responses, may therefore represent a transient immune response with control of M. tuberculosis infection. However, studies at the single cell level have suggested that the quality (polyfunctionality) of the T-cell response is more important than the quantity of cytokines produced. Objective: To explore the quality and/or magnitude of mycobacteria-specific T-cell responses associated with QFT reversion and persistent QFT-positivity. Methods: Multi-color flowcytometry on prospectively collected peripheral blood mononuclear cells was applied to assess mycobacteria-specific T-cell responses in 42 QFT positive Indian adolescents of whom 21 became QFT negative (reverters) within one year. Ten QFT consistent negatives were also included as controls. Results: There was no difference in the qualitative PPD-specific CD4+ T-cell response between QFT consistent positives and reverters. However, compared with QFT consistent positives, reverters displayed lower absolute frequencies of polyfunctional (IFN gamma+IL2+TNF alpha+) CD4+ T-cells at baseline, which were further reduced to the point where they were not different to QFT negative controls one year later. Moreover, absolute frequencies of these cells correlated well with the magnitude of the QFT-response. Conclusion: Whereas specific polyfunctional CD4+ T-cells have been suggested to protect against TB progression, our data do not support that higher relative or absolute frequencies of PPD-specific polyfunctional CD4+ T-cells in peripheral blood can explain the reduced risk of TB progression observed in QFT reverters. On the contrary, absolute frequencies of these cells correlated with the QFT-response, suggesting that this readout reflects antigenic load.	[Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pathol, N-0027 Oslo, Norway; [Jenum, Synne; Jahnsen, Frode Lars] Univ Oslo, N-0027 Oslo, Norway; [Grewal, Harleen M. S.] Univ Bergen, Fac Med & Dent, Dept Clin Sci, N-5020 Bergen, Norway; [Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Hokey, David A.] Aeras, Rockville, MD USA; [Kenneth, John] St Johns Res Inst, Div Infect Dis, Bangalore, Karnataka, India; [Vaz, Mario] St Johns Med Coll, Bangalore, Karnataka, India; [Vaz, Mario] St Johns Res Inst, Bangalore, Karnataka, India; [Doherty, Timothy Mark] GlaxoSmithKline Pharma, Vaccines, Copenhagen, Denmark	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; GlaxoSmithKline	Jenum, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway.	Synne.Jenum@rr-research.no	Grewal, Harleen/ABC-5831-2020; Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Jenum, Synne/0000-0001-8187-775X	Research Council of Norway [179342, 192534, 179573]; University of Bergen, Norway, Aeras, USA; St. John's Research Institute, India; Foundation for Innovative New Diagnostics	Research Council of Norway(Research Council of Norway); University of Bergen, Norway, Aeras, USA; St. John's Research Institute, India; Foundation for Innovative New Diagnostics	This study was supported by the Research Council of Norway (http://www.forskningsradet.no/en/), grants 179342 and 192534, the University of Bergen, Norway (http://www.uib.no/en), Aeras, USA (http://www.aeras.org/) and St. John's Research Institute, India (http://www.sjri.res.in/). Synne Jenum received a doctoral stipend covered by grant 179342 (Research council of Norway), administered and coordinated by University of Bergen, Norway. The work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573. QFT kits were supported in part by Foundation for Innovative New Diagnostics (http://www.finddiagnostics.org/). Larry Geiter, formerly at Aeras contributed to the initial protocol development of the Adolescent Cohort Study. Ravi Anantha and Lew Barker, also at Aeras, reviewed the manuscript prior to submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Franken WPJ, 2008, INT J TUBERC LUNG D, V12, P1286; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim YJ, 2012, AIDS RES HUM RETROV, V28, P838, DOI [10.1089/aid.2011.0360, 10.1089/AID.2011.0360]; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Streitz M, 2012, CYTOM PART B-CLIN CY, V82B, P360, DOI [10.1002/cyto.b.21027, 10.1002/cyto.b.21041, 10.1002/cyto.b.21040, 10.1002/cyto.b.21051, 10.1002/cyto.b.21038]; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Turner J, 2000, INFECT IMMUN, V68, P1706, DOI 10.1128/IAI.68.3.1706-1709.2000; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101224	10.1371/journal.pone.0101224	http://dx.doi.org/10.1371/journal.pone.0101224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992314	Green Published, gold			2022-12-25	WOS:000341253400053
J	Bhat, RK; Rudnick, W; Antony, JM; Maingat, F; Ellestad, KK; Wheatley, BM; Tonjes, RR; Power, C				Bhat, Rakesh K.; Rudnick, Wallis; Antony, Joseph M.; Maingat, Ferdinand; Ellestad, Kristofor K.; Wheatley, Blaise M.; Toenjes, Ralf R.; Power, Christopher			Human Endogenous Retrovirus-K(II) Envelope Induction Protects Neurons during HIV/AIDS	PLOS ONE			English	Article							K HERV-K; NEURAL CELL-LINES; MULTIPLE-SCLEROSIS; JAAGSIEKTE SHEEP; HIV-INFECTION; HUMAN GENOME; W ENV; EXPRESSION; VIRUS; GLYCOPROTEIN	Human endogenous retroviruses (HERVs) are differentially expressed depending on the cell type and physiological circumstances. HERV-K has been implicated in the pathogenesis of several diseases although the functional consequences of its expression remain unknown. Human immunodeficiency virus (HIV) infection causes neuroinflammation with neuronal damage and death. Herein, we investigated HERV-K(II)/(HML-2) envelope (Env) expression and its actions in the brain during HIV/AIDS. HERV-K(II) Env expression was assessed in healthy brain tissues, autopsied HIV HIV- infected (HIV+) and uninfected (HIV-) brains and in neural cell cultures by real time RT-PCR, massively parallel (deep) sequencing, immunoblotting and immunohistochemistry. Neuronal and neural stem cells expressing HERV-K(II) Env were analyzed in assays of host responses including cellular viability, immune responses and neurobehavioral outcomes. Deep sequencing of human brain transcriptomes disclosed that RNA sequences encoded by HERV-K were among the most abundant HERV sequences detected in human brain. Comparison of different cell types revealed that HERV-K(II) env RNA abundance was highest in cultured human neurons but was suppressed by epidermal growth factor exposure. HERV-K(II) Env immunoreactivity was increased in the cerebral cortex from persons with HIV/AIDS, principally localized in neurons. Human neuronal cells transfected with HERV-K(II) Env exhibited increased NGF and BDNF expression. Expression of HERV-K(II) Env in neuronal cells increased cellular viability and prevented neurotoxicity mediated by HIV-1 Vpr. Intracerebral delivery of HERV-K(II) Env expressed by neural stem cells suppressed TNF-alpha expression and microglial activation while also improving neurobehavioral deficits in vpr/RAG1(-/-) mice. HERV-K(II) Env was highly expressed in human neurons, especially during HIV/AIDS, but in addition exerted neuroprotective effects. These findings imply that HERV gene products might exert adaptive effects in circumstances of pathophysiological stress, perhaps underlying the conservation of HERVs within the human genome.	[Bhat, Rakesh K.; Rudnick, Wallis; Antony, Joseph M.; Maingat, Ferdinand; Ellestad, Kristofor K.; Power, Christopher] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Wheatley, Blaise M.] Univ Alberta, Dept Surg Neurosurg, Edmonton, AB, Canada; [Toenjes, Ralf R.] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	University of Alberta; University of Alberta; Paul Ehrlich Institute	Power, C (corresponding author), Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Bhat, Rakesh Kumar/AID-0687-2022; Antony, Joseph Mathew/W-7552-2019; Bhat, Rakesh/B-4320-2009	Bhat, Rakesh Kumar/0000-0001-7649-0470; Antony, Joseph Mathew/0000-0002-5700-7719; Power, Christopher/0000-0002-5131-9711; Rudnick, Wallis/0000-0003-3457-4216	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by Canadian Institutes of Health Research to (CP) and none of the authors have financial interests related to the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2010, FASEB J, V24, P4343, DOI 10.1096/fj.10-162313; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; BECKER Y, 1995, VIRUS GENES, V9, P211, DOI 10.1007/BF01702877; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Carlson NG, 1999, J IMMUNOL, V163, P3963; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; CROW TJ, 1987, J PSYCHIAT RES, V21, P479, DOI 10.1016/0022-3956(87)90096-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deslauriers AM, 2011, J IMMUNOL, V187, P4788, DOI 10.4049/jimmunol.1004111; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fuchs NV, 2011, J VIROL, V85, P3436, DOI 10.1128/JVI.02539-10; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kim DE, 2006, RADIOLOGY, V241, P822, DOI 10.1148/radiol.2413050466; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; Mallet Francois, 2004, Journal de la Societe de Biologie, V198, P399; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; Moonen G, 1996, ACTA NEUROL BELG, V96, P203; Na H, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-44; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Palmarini M, 1999, J VIROL, V73, P6964, DOI 10.1128/JVI.73.8.6964-6972.1999; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Rakoff-Nahoum S, 2006, AIDS RES HUM RETROV, V22, P52, DOI 10.1089/aid.2006.22.52; Reynier F, 2009, SCAND J IMMUNOL, V70, P295, DOI 10.1111/j.1365-3083.2009.02271.x; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Silva C, 2003, ANN NEUROL, V54, P605, DOI 10.1002/ana.10729; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SNYDER EY, 1995, P ASSOC AM PHYSICIAN, V107, P195; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Tonjes RR, 1997, VIROLOGY, V233, P280, DOI 10.1006/viro.1997.8614; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yolken RH, 2000, BRAIN RES REV, V31, P193, DOI 10.1016/S0165-0173(99)00037-5	58	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e97984	10.1371/journal.pone.0097984	http://dx.doi.org/10.1371/journal.pone.0097984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988390	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100009
J	Cole, K; Roessler, CG; Mule, EA; Benson-Xu, EJ; Mullen, JD; Le, BA; Tieman, AM; Birone, C; Brown, M; Hernandez, J; Neff, S; Williams, D; Allaire, M; Orville, AM; Sweet, RM; Soares, AS				Cole, Krystal; Roessler, Christian G.; Mule, Elizabeth A.; Benson-Xu, Emma J.; Mullen, Jeffrey D.; Le, Benjamin A.; Tieman, Alanna M.; Birone, Claire; Brown, Maria; Hernandez, Jesus; Neff, Sherry; Williams, Daniel; Allaire, Marc; Orville, Allen M.; Sweet, Robert M.; Soares, Alexei S.			A Linear Relationship between Crystal Size and Fragment Binding Time Observed Crystallographically: Implications for Fragment Library Screening Using Acoustic Droplet Ejection	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; PROTEIN; REFINEMENT; CRYSTALLIZATION; DIFFUSION	High throughput screening technologies such as acoustic droplet ejection (ADE) greatly increase the rate at which X-ray diffraction data can be acquired from crystals. One promising high throughput screening application of ADE is to rapidly combine protein crystals with fragment libraries. In this approach, each fragment soaks into a protein crystal either directly on data collection media or on a moving conveyor belt which then delivers the crystals to the X-ray beam. By simultaneously handling multiple crystals combined with fragment specimens, these techniques relax the automounter duty-cycle bottleneck that currently prevents optimal exploitation of third generation synchrotrons. Two factors limit the speed and scope of projects that are suitable for fragment screening using techniques such as ADE. Firstly, in applications where the high throughput screening apparatus is located inside the X-ray station (such as the conveyor belt system described above), the speed of data acquisition is limited by the time required for each fragment to soak into its protein crystal. Secondly, in applications where crystals are combined with fragments directly on data acquisition media (including both of the ADE methods described above), the maximum time that fragments have to soak into crystals is limited by evaporative dehydration of the protein crystals during the fragment soak. Here we demonstrate that both of these problems can be minimized by using small crystals, because the soak time required for a fragment hit to attain high occupancy depends approximately linearly on crystal size.	[Cole, Krystal; Mule, Elizabeth A.; Benson-Xu, Emma J.; Mullen, Jeffrey D.; Le, Benjamin A.; Tieman, Alanna M.] Brookhaven Natl Lab, Off Educ Programs, Upton, NY 11973 USA; [Roessler, Christian G.; Allaire, Marc; Orville, Allen M.; Sweet, Robert M.; Soares, Alexei S.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Birone, Claire] Babylon Jr Senior High Sch, Babylon, NY USA; [Brown, Maria] Sayville High Sch, West Sayville, NY USA; [Hernandez, Jesus] Queens Metropolitan High Sch, Forest Hills, NY USA; [Neff, Sherry] Shoreham Wading River High Sch, Shoreham, NY USA; [Williams, Daniel] Shelter Isl High Sch, Shelter Isl, NY USA; [Cole, Krystal] SUNY Coll Purchase, Purchase, NY 10577 USA; [Mule, Elizabeth A.] Freeport High Sch, Freeport, NY USA; [Benson-Xu, Emma J.] Georgetown Day Sch, Washington, DC USA; [Mullen, Jeffrey D.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA; [Le, Benjamin A.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Tieman, Alanna M.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Orville, Allen M.; Sweet, Robert M.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; University of Oregon; University System of Georgia; Georgia Institute of Technology; University of Delaware; United States Department of Energy (DOE); Brookhaven National Laboratory	Soares, AS (corresponding author), Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA.	soares@bnl.gov		Orville, Allen M./0000-0002-7803-1777	Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development [11-008]; Office of Biological and Environmental Research of the US Department of Energy; National Center for Research Resources [P41RR012408]; National Institute of General Medical Sciences of the National Institutes of Health [P41GM103473]; Office of Basic Energy Sciences of the US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P41GM111244] Funding Source: NIH RePORTER	Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development(United States Department of Energy (DOE)); Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Personnel for this study were recruited largely through the 2010 and 2012 summer session of the Science Undergraduate Laboratory Internships Program (SULI), supported through the U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS). Major ongoing financial support for acoustic droplet ejection applications was through the Brookhaven National Laboratory/U.S. Department of Energy, Laboratory Directed Research and Development Grant 11-008 and from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cipriani F, 2012, ACTA CRYSTALLOGR D, V68, P1393, DOI 10.1107/S0907444912031459; Collins PM, 2007, ACTA CRYSTALLOGR D, V63, P415, DOI 10.1107/S090744490605270X; DAHLQUIST FW, 1968, BIOCHEMISTRY-US, V7, P3269, DOI 10.1021/bi00849a033; Danley DE, 2006, ACTA CRYSTALLOGR D, V62, P569, DOI 10.1107/S0907444906012601; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; Ellson R., 2003, JALA J ASS LAB AUTOM, V8, P29; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Hodgson KO, 2009, WORKSH NAT I HLTH NA; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; McNae IW, 2005, CRYSTALLOGR REV, V11, P61, DOI DOI 10.1080/08893110500078639; Otwinowski Z, 2001, CRYSTALLOGRAPHY BIOL, V2; RANDMEIR T, 1969, BIOCHEMISTRY-US, V8, P4206, DOI 10.1021/bi00838a044; Roessler CG, 2013, J SYNCHROTRON RADIAT, V20, P805, DOI 10.1107/S0909049513020372; Seemann KM, 2012, J PHYS CHEM B, V116, P9873, DOI 10.1021/jp2103512; Soares AS, 2011, BIOCHEMISTRY-US, V50, P4399, DOI 10.1021/bi200549x; Soares AS, 2003, ACTA CRYSTALLOGR D, V59, P1716, DOI 10.1107/S0907444903015403; Tanley SWM, 2012, ACTA CRYSTALLOGR D, V68, P601, DOI 10.1107/S0907444912006907; Villasenor AG, 2012, ACTA CRYSTALLOGR D, V68, P893, DOI 10.1107/S0907444912016617; Villasenor AG, 2010, ACTA CRYSTALLOGR D, V66, P568, DOI 10.1107/S0907444910005512; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yin XY, 2014, ACTA CRYSTALLOGR D, V70, P1177, DOI 10.1107/S1399004713034603; Yu B, 1999, P NATL ACAD SCI USA, V96, P103, DOI 10.1073/pnas.96.1.103	24	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101036	10.1371/journal.pone.0101036	http://dx.doi.org/10.1371/journal.pone.0101036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988328	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100056
J	Friebe, A; Evans, AL; Arnemo, JM; Blanc, S; Brunberg, S; Fleissner, G; Swenson, JE; Zedrosser, A				Friebe, Andrea; Evans, Alina L.; Arnemo, Jon M.; Blanc, Stephane; Brunberg, Sven; Fleissner, Guenther; Swenson, Jon E.; Zedrosser, Andreas			Factors Affecting Date of Implantation, Parturition, and Den Entry Estimated from Activity and Body Temperature in Free-Ranging Brown Bears	PLOS ONE			English	Article							BLACK URSUS-AMERICANUS; REPRODUCTIVE SUCCESS; DENNING CHRONOLOGY; HIBERNATION; ARCTOS; EVOLUTION; SIZE; PROGESTERONE; CONSTRAINTS; PHYSIOLOGY	Knowledge of factors influencing the timing of reproduction is important for animal conservation and management. Brown bears (Ursus arctos) are able to vary the birth date of their cubs in response to their fat stores, but little information is available about the timing of implantation and parturition in free-ranging brown bears. Body temperature and activity of pregnant brown bears is higher during the gestation period than during the rest of hibernation and drops at parturition. We compared mean daily body temperature and activity levels of pregnant and nonpregnant females during preimplantation, gestation, and lactation. Additionally we tested whether age, litter size, primiparity, environmental conditions, and the start of hibernation influence the timing of parturition. The mean date of implantation was 1 December (SD = 12), the mean date of parturition was 26 January (SD = 12), and the mean duration of the gestation period was 56 days (SD = 2). The body temperature of pregnant females was higher during the gestation and lactation periods than that of nonpregnant bears. The body temperature of pregnant females decreased during the gestation period. Activity recordings were also used to determine the date of parturition. The parturition dates calculated with activity and body temperature data did not differ significantly and were the same in 50% of the females. Older females started hibernation earlier. The start of hibernation was earlier during years with favorable environmental conditions. Dates of parturition were later during years with good environmental conditions which was unexpected. We suggest that free-ranging pregnant brown bears in areas with high levels of human activities at the beginning of the denning period, as in our study area, might prioritize investing energy in early denning than in early parturition during years with favorable environmental conditions, as a strategy to prevent disturbances caused by human.	[Friebe, Andrea; Fleissner, Guenther] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Dept Biosci, D-60054 Frankfurt, Germany; [Evans, Alina L.] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Hedmark Coll, Dept Forestry & Wildlife Management, Fac Appl Ecol, Elverum, Norway; [Blanc, Stephane] UDS, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien,UMR 7178, Strasbourg, France; [Brunberg, Sven; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resources Management, As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Zedrosser, Andreas] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Bo I Telemark, Norway; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Vienna, Austria; [Arnemo, Jon M.] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Goethe University Frankfurt; Inland Norway University of Applied Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Norwegian University of Life Sciences; Norwegian Institute Nature Research; University College of Southeast Norway; University of Natural Resources & Life Sciences, Vienna; Swedish University of Agricultural Sciences	Friebe, A (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Dept Biosci, D-60054 Frankfurt, Germany.	andrea.friebe@bearproject.info	Evans, Alina/AAH-8881-2019; Swenson, Jon/AAE-2890-2019		Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway; Austrian Science Foundation [P20182]; Scandinavian Brown Bear Research Project [168]	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Research Council of Norway(Research Council of Norway); Austrian Science Foundation(Austrian Science Fund (FWF)); Scandinavian Brown Bear Research Project	The authors thank the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, the Research Council of Norway, and the Austrian Science Foundation (project P20182) for funding the Scandinavian Brown Bear Research Project. This is scientific paper no. 168 from the Scandinavian Brown Bear Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT GL, 1983, J MAMMAL, V64, P305, DOI 10.2307/1380562; Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Beecham JJ, 1980, POPULATION CHARACTER; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bieber C, 2014, FUNCT ECOL, V28, P167, DOI 10.1111/1365-2435.12173; Bridges AS, 2011, URSUS, V22, P1, DOI 10.2192/URSUS-D-10-00008.1; Bridges AS, 2002, WILDLIFE SOC B, V30, P1253; Bunnell F.L., 1981, P75; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dehnhard M, 2006, THERIOGENOLOGY, V66, P1755, DOI 10.1016/j.theriogenology.2006.01.012; Dittrich L., 1963, Z SAUGETIERKD, V28, P129; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Elfstrom M, 2009, URSUS, V20, P85, DOI 10.2192/09GR005.1; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; FORESMAN KR, 1983, J REPROD FERTIL, V68, P235; Friebe A, 2001, URSUS-SERIES, V12, P37; Friebe A, 2013, EUR J WILDLIFE RES, V59, P731, DOI 10.1007/s10344-013-0728-5; Gervasi V, 2006, WILDLIFE SOC B, V34, P1314, DOI 10.2193/0091-7648(2006)34[1314:AIMTMA]2.0.CO;2; Goldstein MI, 2010, J WILDLIFE MANAGE, V74, P35, DOI 10.2193/2008-490; HENSEL RJ, 1969, J WILDLIFE MANAGE, V33, P357, DOI 10.2307/3799836; HISSA R, 1994, COMP BIOCHEM PHYS A, V109, P781, DOI 10.1016/0300-9629(94)90222-4; Hissa R, 1997, ANN ZOOL FENN, V34, P267; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Iibuchi R, 2009, JPN J VET RES, V57, P13; Judd S.L., 1986, INT C BEAR RES MANAG, V6, P111, DOI 10.2307/3872814; Kordek W.S., 1980, Bear Biology Association Conference Series, P159; Laske Timothy G., 2011, BMC Physiology, V11, P13, DOI 10.1186/1472-6793-11-13; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Martin J, 2013, J ANIM ECOL, V82, P290, DOI 10.1111/j.1365-2656.2012.02038.x; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCMILLIN JM, 1976, BIOL REPROD, V15, P163, DOI 10.1095/biolreprod15.2.163; MEAD RA, 1993, J EXP ZOOL, V266, P629, DOI 10.1002/jez.1402660611; MILLER SD, 1990, INT C BEAR, V8, P279; NELSON RA, 1973, MAYO CLIN PROC, V48, P733; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Ordiz A, 2008, ECOLOGY, V89, P3327, DOI 10.1890/07-1921.1; PALMER SS, 1988, BIOL REPROD, V38, P1044, DOI 10.1095/biolreprod38.5.1044; Quest M, 2001, THESIS FREIE U BERLI; RAMSAY MA, 1986, AM NAT, V127, P735, DOI 10.1086/284522; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Reynolds H.V., 1976, IUCN Publs (New Series), VNo. 40, P403; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Robbins CT, 2012, J MAMMAL, V93, P540, DOI 10.1644/11-MAMM-A-155.1; Rogers L, 1976, EFFECT MAST BERRY CR, P431; Rogers L. L., 1987, WILDLIFE MONOGR, V97, P3; Ruby NF, 2003, J BIOL RHYTHM, V18, P275, DOI 10.1177/0748730403254971; Ryan CW, 1997, REPROD SURVIVAL DENN; Sahlen E, 2011, URSUS, V22, P152, DOI 10.2192/URSUS-D-10-00007.1; Sahlen V., 2013, THESIS NORWEGIAN U L; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; Sato M, 2000, J VET MED SCI, V62, P415, DOI 10.1292/jvms.62.415; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; SCHOOLEY RL, 1994, J MAMMAL, V75, P466, DOI 10.2307/1382569; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Servheen C., 1983, INT C BEAR RES MANAG, V5, P201, DOI 10.2307/3872539; Shimozuru M, 2013, J MAMMAL, V94, P618, DOI 10.1644/12-MAMM-A-246.1; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Spady TJ, 2007, MAMMAL REV, V37, P21, DOI 10.1111/j.1365-2907.2007.00096.x; Steyaert SMJG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0624; Steyaert SMJG, 2013, J ANIMAL EC IN PRESS; Stringham SF, 1990, BEARS THEIR BIOL MAN, V8, P433, DOI DOI 10.2307/3872948; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Thom MD, 2004, EVOLUTION, V58, P175; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; TSUBOTA T, 1990, INT C BEAR, V8, P125; Tsubota T, 2001, REPRODUCTION, V121, P587, DOI 10.1530/reprod/121.4.587; Tsubota T, 1987, INT C BEAR RES MANAG, V7, P355, DOI DOI 10.2307/3872643; Tsubota Toshio, 1993, Journal of Reproduction and Development, V39, P325, DOI 10.1262/jrd.39.325; VANDAELE LJ, 1990, INT C BEAR, V8, P257; Ware JV, 2012, ZOO BIOL, V31, P255, DOI 10.1002/zoo.20424; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Wimsatt W.A., 1963, DELAYED IMPLANTATION, P49; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1	82	42	43	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101410	10.1371/journal.pone.0101410	http://dx.doi.org/10.1371/journal.pone.0101410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988486	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100083
J	Li, C; Bi, XY; Huang, Y; Zhao, JJ; Li, ZY; Zhou, JG; Zhang, M; Huang, Z; Zhao, H; Cai, JQ				Li, Cong; Bi, Xinyu; Huang, Ying; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Zhang, Meng; Huang, Zhen; Zhao, Hong; Cai, Jianqiang			Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; POOR-PROGNOSIS; DLC-1 GENE; EXPRESSION; LOCUS; RISK; POPULATION; CHINESE; GROWTH	Recent genome-wide association studies (GWAS) have identified several common susceptibility loci associated with the risk of hepatocellular carcinoma (HCC) or chronic hepatitis B infection (CHB). However, the relationship between these genetic variants and survival of patients with hepatitis B virus (HBV)-related HCC is still unknown. In this study, 22 single nucleotide polymorphisms (SNPs) were genotyped among 330 HBV-related HCC patients using the MassARRAY system from Sequenom. Cox proportional hazards regression was used to examine the effects of genotype on survival time under an additive model with age, sex, smoking status and clinical stage as covariates. We identified four SNPs on 6p21 (rs1419881 T>C, rs7453920 G>A, rs3997872 G>A and rs7768538 T>C), and two SNPs on 8p12 (rs2275959 C>T and rs7821974 C>T) significantly associated with survival time of HBV-related HCC patients. Our results suggest that HCC or CHB susceptibility loci might also affect the prognosis of patients with HBV-related HCC.	[Li, Cong; Bi, Xinyu; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Huang, Zhen; Zhao, Hong; Cai, Jianqiang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Li, Cong; Bi, Xinyu; Huang, Ying; Zhao, Jianjun; Li, Zhiyu; Zhou, Jianguo; Zhang, Meng; Huang, Zhen; Zhao, Hong; Cai, Jianqiang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Huang, Ying; Zhang, Meng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhao, H (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China.	zhaohong9@sina.com; caijianqiang188@sina.com			National Natural Science Foundation of China [81201967]; Beijing Natural Science Foundation [7132-193]; Beijing Nova Program [2009A69]; State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period) [2012ZX10002-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period)	This study was supported by grants from the National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7132-193), Beijing Nova Program (No. 2009A69), and the State Key Project on Infectious Diseases of China (China National Science and Technology Major Project Grant during the Twelfth Five-year Plan Period No. 2012ZX10002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2013, J MED GENET, V50, P725, DOI 10.1136/jmedgenet-2013-101724; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Diepolder HM, 2014, GUT; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fares Nadim, 2013, Rev Prat, V63, P216; Ferlay J., 2013, IARC CANCERBASE, V11; Flecken T, 2014, HEPATOLOGY, V59, P1415, DOI 10.1002/hep.26731; He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kang MY, 2014, GENE, V536, P59, DOI 10.1016/j.gene.2013.11.087; Kim YJ, 2013, HUM MOL GENET, V22, P4233, DOI 10.1093/hmg/ddt266; KRISHNAN BR, 1995, GENOMICS, V30, P53; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Liao R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-3; Liu LF, 2011, VIRAL IMMUNOL, V24, P397, DOI 10.1089/vim.2011.0027; Matoba K, 2005, INT J CANCER, V115, P231, DOI 10.1002/ijc.20860; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Pan QZ, 2013, CANCER IMMUNOL IMMUN, V62, P1675, DOI 10.1007/s00262-013-1471-1; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wong CM, 2003, CANCER RES, V63, P7646; Wu X, 2006, ONCOGENE, V25, P1832, DOI 10.1038/sj.onc.1209191; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	35	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101586	10.1371/journal.pone.0101586	http://dx.doi.org/10.1371/journal.pone.0101586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987808	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100116
J	Ma, MJ; Ma, Z; Du, GZ				Ma, Miaojun; Ma, Zhen; Du, Guozhen			Effects of Water Level on Three Wetlands Soil Seed Banks on the Tibetan Plateau	PLOS ONE			English	Article							ALPINE MEADOW; VEGETATION; MARSH; DYNAMICS; PLANT; DEPTH; ESTABLISHMENT; REPRODUCTION; EMERGENCE; REGIME	Background: Although the effect of water level on germination in soil seed banks has been documented in many ecosystems, the mechanism is not fully understood, and to date no empirical studies on this subject exist. Further, no work has been done on the effect of water level on seed banks of drying and saline-alkaline wetlands in alpine areas on the Tibetan Plateau. Methodology: We examined the effects of water level (0 cm, 5 cm and 10 cm) on seed germination and seedling establishment from soil seed banks at 0-5 cm and 5-10 cm depths in typical, drying, and saline-alkaline wetlands. We also explore the potential role of soil seed bank in restoration of drying and saline-alkaline wetlands. Principal Findings: Species richness decreased with increase in water level, but there almost no change in seed density. A huge difference exists in species composition of the seed bank among different water levels in all three wetlands, especially between 0 cm and 5 cm and 0 cm and 10 cm. Similarity of species composition between seed bank and plant community was higher in 0 cm water level in drying wetland than in the other two wetlands. The similarity was much higher in 0 cm water level than in 5 cm and 10 cm water levels in all three wetlands. Species composition of the alpine wetland plant community changed significantly after drying and salinization, however, species composition of the seed bank was unchanged regardless of the environment change. Conclusions/Significance: Water level greatly affects seed bank recruitment and plant community establishment. Further, different water levels in restored habitats are likely to determine its species composition of the plant community. The seed bank is important in restoration of degraded wetlands. Successful restoration of drying and salinization wetlands could depend on the seed bank.	[Ma, Miaojun; Ma, Zhen; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozdu@lzu.edu.cn	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574	Natural Science Foundation of China [41101527]; Research Fund for the Doctoral Program of Higher Education of China [20110211120026]; Natural Science Foundation of Gansu Province, China [1308RJZA114]; Fundamental Research Funds for the Central Universities [lzujbky-2013-204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Gansu Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was funded by the Natural Science Foundation of China (Grant No. 41101527), the Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110211120026), the Natural Science Foundation of Gansu Province, China (Grant No. 1308RJZA114), and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2013-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy VJ, 1999, PLANT ECOL, V140, P177, DOI 10.1023/A:1009779411686; Baskin C. C., 1998, Seeds: ecology, biogeography, and evolution of dormancy and germination.; Bekker RM, 1998, SEED SCI RES, V8, P399, DOI 10.1017/S0960258500004323; BONIS A, 1995, OIKOS, V74, P81, DOI 10.2307/3545677; Capon SJ, 2007, WETLANDS, V27, P904, DOI 10.1672/0277-5212(2007)27[904:EOFOSE]2.0.CO;2; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Farrell JM, 2010, HYDROBIOLOGIA, V647, P127, DOI 10.1007/s10750-009-0035-z; Fenner M, 1985, SEED ECOLOGY; GALINATO MI, 1986, AQUAT BOT, V26, P89; GERRITSEN J, 1989, ECOLOGY, V70, P750, DOI 10.2307/1940225; Griffith AB, 2003, PLANT ECOL, V167, P117, DOI 10.1023/A:1023952907092; Holzel N, 2001, J VEG SCI, V12, P209, DOI 10.2307/3236605; Hong JM, 2012, ECOL ENG, V42, P192, DOI 10.1016/j.ecoleng.2012.01.004; Johnson S, 2004, AQUAT BOT, V79, P311, DOI 10.1016/j.aquabot.2004.05.003; Klimkowska A, 2010, PERSPECT PLANT ECOL, V12, P245, DOI 10.1016/j.ppees.2010.02.004; Leck, 1989, ECOLOGY SOIL SEED BA; Liu GH, 2005, AQUAT BOT, V81, P1, DOI 10.1016/j.aquabot.2004.07.001; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080220; Ma MJ, 2012, ECOL ENG, V44, P18, DOI 10.1016/j.ecoleng.2012.03.017; Ma MJ, 2011, PLANT SOIL, V346, P19, DOI 10.1007/s11104-011-0790-2; Ma MJ, 2010, PLANT SOIL, V336, P291, DOI 10.1007/s11104-010-0480-5; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Ma MJ, 2009, ARCT ANTARCT ALP RES, V41, P469, DOI 10.1657/1938-4246-41.4.999; Nicol JM, 2003, PLANT ECOL, V168, P191, DOI 10.1023/A:1024430919811; Shibayama Y, 2007, AQUAT BOT, V87, P320, DOI 10.1016/j.aquabot.2007.07.004; SMITH LM, 1983, J APPL ECOL, V20, P673, DOI 10.2307/2403534; Smith SM, 2002, RESTOR ECOL, V10, P138, DOI 10.1046/j.1526-100X.2002.10115.x; VANDERVALK AG, 1978, ECOLOGY, V59, P322, DOI 10.2307/1936377; Volder A, 1997, AQUAT BOT, V58, P113, DOI 10.1016/S0304-3770(97)00018-1; Wang GD, 2013, AQUAT BOT, V106, P35, DOI 10.1016/j.aquabot.2012.12.008; Xiao C, 2010, AQUAT BOT, V92, P28, DOI 10.1016/j.aquabot.2009.09.004	32	10	13	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101458	10.1371/journal.pone.0101458	http://dx.doi.org/10.1371/journal.pone.0101458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984070	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000112
J	Chen, X; Quan, YR; Wang, HB; Luo, H				Chen, Xi; Quan, Yaru; Wang, Hongbin; Luo, Hong			Trehalase Regulates Neuroepithelial Stem Cell Maintenance and Differentiation in the Drosophila Optic Lobe	PLOS ONE			English	Article							GENE-EXPRESSION; LARVAL BRAIN; MELANOGASTER; JAK/STAT; NOTCH; PROLIFERATION; METABOLISM; PATHWAYS; DIVISION; PATTERN	As one of the major hydrolases in Drosophila, trehalase (Treh) catalyzes the hydrolysis of trehalose into glucose providing energy for flight muscle activity. Treh is highly conserved from bacteria to humans, but little is known about its function during animal development. Here, we analyze the function of Treh in Drosophila optic lobe development. In the optic lobe, neuroepithelial cells (NEs) first divide symmetrically to expand the stem cell pool and then differentiate into neuroblasts, which divide asymmetrically to generate medulla neurons. We find that the knockdown of Treh leads to a loss of the lamina and a smaller medulla. Analyses of Treh RNAi-expressing clones and loss-of-function mutants indicate that the lamina and medulla phenotypes result from neuroepithelial disintegration and premature differentiation into medulla neuroblasts. Although the principal role of Treh is to generate glucose, the Treh loss-of-function phenotype cannot be rescued by exogenous glucose. Thus, our results indicate that in addition to being a hydrolase, Treh plays a role in neuroepithelial stem cell maintenance and differentiation during Drosophila optic lobe development.	[Chen, Xi; Quan, Yaru; Wang, Hongbin; Luo, Hong] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Quan, Yaru] Natl Inst Food & Drug Control, Inst Biol Prod Control, Beijing, Peoples R China	Tsinghua University; National Institute of Food & Drug Control - China	Chen, X (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chenxi5566a@163.com; luohong@mail.tsinghua.edu.cn			National Science Foundation of China [30671035]; National Basic Sciences Research Program of Ministry of Science and Technology of China [2007CB947203]; National Basic Research Program of Ministry of Science and Technology of China [2013CB835100]; Tsinghua University Initiative Scientific Research Program [20111080956]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Sciences Research Program of Ministry of Science and Technology of China; National Basic Research Program of Ministry of Science and Technology of China; Tsinghua University Initiative Scientific Research Program	This work was supported by grants from National Science Foundation of China (grant number: 30671035, http://www.nsfc.gov.cn/), National Basic Sciences Research Program of Ministry of Science and Technology of China (grant number: 2007CB947203, http://www.most.gov.cn) to H. Luo, and National Basic Research Program of Ministry of Science and Technology of China (grant number: 2013CB835100, http://www.most.gov.cn), the Tsinghua University Initiative Scientific Research Program (grant number: 20111080956, http://www.moe.gov.cn) to Y. Zhong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini BM, 2004, MYCOTA, V3, P291; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURTON RS, 1986, BIOCHEM GENET, V24, P715, DOI 10.1007/BF00499004; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Meinertzhagen Ian A., 1993, P1363; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OLIVER MJ, 1978, BIOCHEM GENET, V16, P927, DOI 10.1007/BF00483744; Orihara-Ono M, 2011, DEV BIOL, V351, P163, DOI 10.1016/j.ydbio.2010.12.044; Ouyang YH, 2009, BIOCHEM BIOPH RES CO, V379, P621, DOI 10.1016/j.bbrc.2008.12.134; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SACKTOR B, 1968, P NATL ACAD SCI USA, V60, P1007, DOI 10.1073/pnas.60.3.1007; Takahashi T, 1999, J NEUROSCI, V19, P10357; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Wang HB, 2013, GENETICS, V195, P1291, DOI 10.1534/genetics.113.155945; Wang W, 2011, BIOCHEM BIOPH RES CO, V410, P714, DOI 10.1016/j.bbrc.2011.05.119; Wang W, 2011, DEV BIOL, V350, P414, DOI 10.1016/j.ydbio.2010.12.002; Weng M, 2012, DEV NEUROBIOL, V72, P1376, DOI 10.1002/dneu.20995; Wyatt G.R., 1967, ADV INSECT PHYSIOL, V4, P287, DOI DOI 10.1016/S0065-2806(08)60210-6; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101433	10.1371/journal.pone.0101433	http://dx.doi.org/10.1371/journal.pone.0101433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003205	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700030
J	Tejero, R; Navarro, A; Campayo, M; Vinolas, N; Marrades, RM; Cordeiro, A; Ruiz-Martinez, M; Santasusagna, S; Molins, L; Ramirez, J; Monzo, M				Tejero, Rut; Navarro, Alfons; Campayo, Marc; Vinolas, Nuria; Marrades, Ramon M.; Cordeiro, Anna; Ruiz-Martinez, Marc; Santasusagna, Sandra; Molins, Laureano; Ramirez, Josep; Monzo, Mariano			miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC MARKER; FAMILY; TRANSITION; EXPRESSION; MICRORNAS; INVASION; CLUSTER; ZEB1	Background: Several treatments in non-small cell lung cancer (NSCLC) are histology-dependent, and the need for histology-related markers is increasing. MicroRNAs (miRNAs) are promising molecular markers in multiple cancers and show differences in expression depending on histological subtype. The miRNA family miR-200 has been associated with the regulation of epithelial-mesenchymal (EMT)/mesenchymal-epithelial transition (MET). EMT involves profound phenotypic changes that include the loss of cell-cell adhesion, the loss of cell polarity, and the acquisition of migratory and invasive properties that facilitates metastasis. A dual role for the miR-200 family in the prognosis of several tumors has been related to tumor cell origin. However, the prognostic role and function of miR-200 family in early-stage NSCLC adenocarcinoma and squamous cell carcinoma (SCC) have not been well established. Methods: miRNA expression was determined using TaqMan assays in 155 tumors from resected NSCLC patients. Functional studies were conducted in three NSCLC cell lines: H23, A-549 and HCC-44. Results: High miR-200c expression was associated with shorter overall survival (OS) in the entire cohort (p = 0.024). High miR-200c (p = 0.0004) and miR-141 (p = 0.009) expression correlated with shorter OS in adenocarcinoma - but not in SCC. In the multivariate analysis, a risk score based on miR-141 and miR-200c expression emerged as an independent prognostic factor for OS in the entire cohort (OR, 2.787; p = 0.033) and in adenocarcinoma patients (OR, 10.649; p = 0.002). Functional analyses showed that miR-200c, was related to mesenchymal-epithelial transition (MET) and affected cell migration and E-cadherin levels, while overexpression of miR-141 reduced KLF6 protein levels and produced an increase of secretion of VEGFA in vitro (H23, p = 0.04; A-549, p = 0.03; HCC-44, p = 0.02) and was associated with higher blood microvessel density in patient tumor samples (p<0.001). Conclusion: High miR-141 and miR-200c expression are associated with shorter OS in NSCLC patients with adenocarcinoma through MET and angiogenesis.	[Tejero, Rut; Navarro, Alfons; Cordeiro, Anna; Ruiz-Martinez, Marc; Santasusagna, Sandra; Monzo, Mariano] Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med,IDIBAPS, Barcelona, Spain; [Campayo, Marc; Vinolas, Nuria] Univ Barcelona, Dept Med Oncol, ICMHO, Hosp Clin Barcelona, Barcelona, Spain; [Marrades, Ramon M.] Univ Barcelona, Dept Pneumol, ICT, Hosp Clin Barcelona,IDIBAPS,CIBER Enfermedades Re, Barcelona, Spain; [Ramirez, Josep] Univ Barcelona, Dept Pathol, CDB, Hosp Clin Barcelona,IDIBAPS,CIBERES, Barcelona, Spain; [Molins, Laureano] Univ Barcelona, Hosp Clin Barcelona, Dept Thorac Surg, ICT, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Navarro, A (corresponding author), Univ Barcelona, Mol Oncol & Embryol Lab, Human Anat Unit, Sch Med,IDIBAPS, Barcelona, Spain.	anavarroponz@ub.edu; mmonzo@ub.edu	Navarro, Alfons/C-2453-2015; MArrades, Ramón M/AFU-6757-2022	Navarro, Alfons/0000-0001-6071-0926; Ruiz Martinez, Marc/0000-0002-9106-6536; Campayo, Marc/0000-0002-9874-4707; Tejero-Villalba, Rut/0000-0001-5134-4813; Santasusagna Canal, Sandra/0000-0002-4919-4577; Cordeiro, Anna/0000-0001-6012-1259; MONZO, MARIANO/0000-0003-2322-4851	Instituto de Salud Carlos III [FIS-PI0900547]; SDCSD of University of Barcelona; AECC-Catalunya	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); SDCSD of University of Barcelona; AECC-Catalunya	This work was supported by grants from Instituto de Salud Carlos III (FIS-PI0900547), SDCSD of University of Barcelona and AECC-Catalunya 2013. Rut Tejero, Anna Cordeiro, Marc Ruiz-Martinez are APIF fellows of University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artells R, 2011, ANAT REC, V294, P462, DOI 10.1002/ar.21333; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Campayo M, 2012, EUR RESP J; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chen J, 2011, METALLOGENIC SETTING, P1; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Diaz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018856; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; KAWAI T, 1988, AM J CLIN PATHOL, V89, P455, DOI 10.1093/ajcp/89.4.455; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Navarro A, 2010, YONSEI MED J, V51, P622, DOI 10.3349/ymj.2010.51.5.622; Pacurari M, 2013, INT J ONCOL, V43, P548, DOI 10.3892/ijo.2013.1963; Patel JD, 2007, J CLIN ONCOL, V25; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Siegel R, 2012, CANCER STAT 2012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Travis WD., 2004, TRAVIS WB WHO CLASSI; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; UPTON MP, 1986, AM J SURG PATHOL, V10, P560, DOI 10.1097/00000478-198608000-00006; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, P1; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-186; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110	37	112	119	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101899	10.1371/journal.pone.0101899	http://dx.doi.org/10.1371/journal.pone.0101899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003366	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700086
J	Zhu, J; Luz-Madrigal, A; Haynes, T; Zavada, J; Burke, AK; Del Rio-Tsonis, K				Zhu, Jie; Luz-Madrigal, Agustin; Haynes, Tracy; Zavada, Julia; Burke, Amy K.; Del Rio-Tsonis, Katia			beta-Catenin Inactivation Is a Pre-Requisite for Chick Retina Regeneration	PLOS ONE			English	Article							TADPOLE TAIL REGENERATION; CILIARY MARGINAL ZONE; OPTIC CUP; PIGMENT EPITHELIUM; ZEBRAFISH RETINA; MUSCLE REGENERATION; CELL PROLIFERATION; SIGNALING PATHWAYS; VERTEBRATE RETINA; WNT/BETA-CATENIN	In the present study we explored the role of beta-catenin in mediating chick retina regeneration. The chick can regenerate its retina by activating stem/progenitor cells present in the ciliary margin (CM) of the eye or via transdifferentiation of the retinal pigmented epithelium (RPE). Both modes require fibroblast growth factor 2 (FGF2). We observed, by immunohistochemistry, dynamic changes of nuclear beta-catenin in the CM and RPE after injury (retinectomy). beta-catenin nuclear accumulation was transiently lost in cells of the CM in response to injury alone, while the loss of nuclear beta-catenin was maintained as long as FGF2 was present. However, nuclear beta-catenin positive cells remained in the RPE in response to injury and were BrdU-/p27+, suggesting that nuclear beta-catenin prevents those cells from entering the cell cycle. If FGF2 is present, the RPE undergoes dedifferentiation and proliferation concomitant with loss of nuclear beta-catenin. Moreover, retinectomy followed by disruption of active beta-catenin by using a signaling inhibitor (XAV939) or over-expressing a dominant negative form of Lef-1 induces regeneration from both the CM and RPE in the absence of FGF2. Our results imply that beta-catenin protects cells of the CM and RPE from entering the cell cycle in the developing eye, and specifically for the RPE during injury. Thus inactivation of beta-catenin is a pre-requisite for chick retina regeneration.	[Zhu, Jie; Luz-Madrigal, Agustin; Haynes, Tracy; Zavada, Julia; Burke, Amy K.; Del Rio-Tsonis, Katia] Miami Univ, Dept Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Del Rio-Tsonis, K (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	delriok@miamioh.edu		LUZ MADRIGAL, AGUSTIN/0000-0002-7504-2753	NIA [AG024937]; NEI [EY017319]; Sigma Xi grant; CONACYT [162930, 142523]; DUOS scholarship from Miami University; USS; NATIONAL EYE INSTITUTE [R01EY017319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024937] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Sigma Xi grant; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DUOS scholarship from Miami University; USS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA grant AG024937 and NEI grant EY017319 to KDRT; Sigma Xi grant to JZ; CONACYT 162930 and 142523 to ALM; and USS and DUOS scholarship from Miami University to Julia Z and Amy KB, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Sabanero K, 2012, BIOCHEM J, V447, P321, DOI 10.1042/BJ20120813; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Belecky-Adams Teri L, 2012, Methods Mol Biol, V884, P71, DOI 10.1007/978-1-61779-848-1_5; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canto-Soler MV, 2006, DEV BIOL, V294, P119, DOI 10.1016/j.ydbio.2006.02.033; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Silva MRD, 2007, DEV BIOL, V304, P272, DOI 10.1016/j.ydbio.2006.12.033; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gallina D, 2014, EXP EYE RES, V123, P121, DOI 10.1016/j.exer.2013.06.019; Gorsuch RA, 2014, EXP EYE RES, V123, P131, DOI 10.1016/j.exer.2013.07.012; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P2202, DOI 10.1167/iovs.04-1419; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Haynes T, 2004, CURR NEUROVASC RES, V1, P231, DOI 10.2174/1567202043362216; Haynes T, 2007, P NATL ACAD SCI USA, V104, P20380, DOI 10.1073/pnas.0708202104; Haynes T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3312; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kitamoto J, 2010, MOL VIS, V16, P2701; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kubota R, 2004, DEV DYNAM, V229, P529, DOI 10.1002/dvdy.20000; La Torre Anna, 2012, Methods Mol Biol, V884, P229, DOI 10.1007/978-1-61779-848-1_16; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Loftus SK, 2001, DNA RES, V8, P221, DOI 10.1093/dnares/8.5.221; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Meyers JR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-30; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PARK CM, 1991, DEV BIOL, V148, P322, DOI 10.1016/0012-1606(91)90341-Y; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Sodhi D, 2005, J HEPATOL, V43, P132, DOI 10.1016/j.jhep.2005.02.019; Spence JR, 2007, DEV DYNAM, V236, P1161, DOI 10.1002/dvdy.21115; Spence JR, 2007, MOL VIS, V13, P57; Spence JR, 2004, DEVELOPMENT, V131, P4607, DOI 10.1242/dev.01298; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023; Venters SJ, 2011, MOL VIS, V17, P3347; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Westenskow PD, 2010, INVEST OPHTH VIS SCI, V51, P5328, DOI 10.1167/iovs.09-5015; Yang HJ, 2009, DEV DYNAM, V238, P2823, DOI 10.1002/dvdy.22116; Yoshikawa T, 2012, PIGM CELL MELANOMA R, V25, P66, DOI 10.1111/j.1755-148X.2011.00935.x; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zhu J. G., 2012, ENG OPTIM, P1, DOI DOI 10.1109/ESARS.2012.6387393	77	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101748	10.1371/journal.pone.0101748	http://dx.doi.org/10.1371/journal.pone.0101748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003522	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700060
J	Huber, K; Brigide, P; Bretas, EB; Canniatti-Brazaca, SG				Huber, Karina; Brigide, Priscila; Bretas, Eloa Bolis; Canniatti-Brazaca, Solange Guidolin			Effect of Thermal Processing and Maceration on the Antioxidant Activity of White Beans	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; PHENOLIC-ACIDS; METHANOLIC EXTRACT; CHLOROGENIC ACID; SEED COAT; FLAVONOIDS; CAPACITY; POLYPHENOLS; COMPONENTS; PROFILES	Phenolic compounds, which naturally occur in beans, are known to have antioxidant activity, which may be partially lost during the processing of this legume. This study evaluated the effect of thermal processing and maceration on the phenolic acid and flavonoids profile and content and on the antioxidant activity of white beans. According to the results obtained from the 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) method, there were no significant differences among treatment groups analysed. When was using 1,1-diphenyl-2-pycrylhydrazyl method (DPPH), beans cooked without maceration present the higher antioxidant activity, and raw beans the lower. The phenolic acids found in greater amounts were gallic acid and chlorogenic acid. Kaempferol was only detected in the soaked and cooked samples; catechin and kaempferol-3-rutinoside were found in the highest concentrations. Quercetin and kaempferol-3-glucoside were not affected by the cooking process, either with or without maceration. In general, the heat treatment increased the antioxidant activity.	[Huber, Karina; Brigide, Priscila; Bretas, Eloa Bolis; Canniatti-Brazaca, Solange Guidolin] Univ Sao Paulo, Luiz De Queiroz Coll Agr, Agrifood Ind Food & Nutr Dept, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Canniatti-Brazaca, SG (corresponding author), Univ Sao Paulo, Luiz De Queiroz Coll Agr, Agrifood Ind Food & Nutr Dept, Piracicaba, SP, Brazil.	sgcbraza@usp.br	Canniatti-Brazaca, Solange G/B-7693-2012	Canniatti-Brazaca, Solange G/0000-0001-5397-7112	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The funders (schoolarship CAPES) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2004, J AGR FOOD CHEM, V52, P4595, DOI 10.1021/jf0352879; Aguilera Y, 2011, FOOD RES INT, V44, P774, DOI 10.1016/j.foodres.2011.01.004; Amarowicz R, 2008, EUR J LIPID SCI TECH, V110, P865, DOI 10.1002/ejlt.200800114; Aparicio-Fernandez X, 2005, J FOOD SCI, V70, pS73, DOI 10.1111/j.1365-2621.2005.tb09068.x; Arabbi PR, 2004, J AGR FOOD CHEM, V52, P1124, DOI 10.1021/jf0499525; Arts MJTJ, 2004, FOOD CHEM, V88, P567, DOI 10.1016/j.foodchem.2004.02.008; Beninger CW, 2003, J AGR FOOD CHEM, V51, P7879, DOI 10.1021/jf0304324; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Campos-Vega R, 2010, FOOD RES INT, V43, P461, DOI 10.1016/j.foodres.2009.09.004; Cardador-Martinez A, 2006, PLANT FOOD HUM NUTR, V61, P161, DOI 10.1007/s11130-006-0026-4; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Diaz-Batalla L, 2006, J AGR FOOD CHEM, V54, P2045, DOI 10.1021/jf051706l; Dinelli G, 2006, FOOD CHEM, V99, P105, DOI 10.1016/j.foodchem.2005.07.028; Elizabeth RGN, 2007, FOOD CHEM, V103, P521, DOI 10.1016/j.foodchem.2006.08.021; Espinosa-Alonso LG, 2006, J AGR FOOD CHEM, V54, P4436, DOI 10.1021/jf060185e; Fernandez-Panchon MS, 2008, CRIT REV FOOD SCI, V48, P649, DOI 10.1080/10408390701761845; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Howes MJR, 2003, PHYTOTHER RES, V17, P1, DOI 10.1002/ptr.1280; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Khadem S, 2010, MOLECULES, V15, P7985, DOI 10.3390/molecules15117985; Kosinska A, 2011, EUR FOOD RES TECHNOL, V233, P213, DOI 10.1007/s00217-011-1506-9; Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001; Lee CW, 2011, BIOMOL THER, V19, P181, DOI 10.4062/biomolther.2011.19.2.181; Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014; Lin LZ, 2008, FOOD CHEM, V107, P399, DOI 10.1016/j.foodchem.2007.08.038; Luthria DL, 2006, J FOOD COMPOS ANAL, V19, P205, DOI 10.1016/j.jfca.2005.09.003; Madhujith T, 2005, J FOOD SCI, V70, pS85, DOI 10.1111/j.1365-2621.2005.tb09071.x; Orhan I, 2007, Z NATURFORSCH C, V62, P829; Ranilla LG, 2007, J AGR FOOD CHEM, V55, P90, DOI 10.1021/jf062785j; Ranilla LG, 2009, J AGR FOOD CHEM, V57, P5734, DOI 10.1021/jf900527v; Rauter AP, 2012, FOOD CHEM, V132, P1930, DOI 10.1016/j.foodchem.2011.12.028; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Romani A, 2004, J AGR FOOD CHEM, V52, P3838, DOI 10.1021/jf0307402; SOARES Sergio Eduardo, 2002, Rev. Nutr., V15, P71, DOI 10.1590/S1415-52732002000100008; Statistical Analysis System Institute, 1998, SAS QC SOFTW US REF; Vadivel V, 2012, LWT-FOOD SCI TECHNOL, V47, P255, DOI 10.1016/j.lwt.2012.01.014; Valdes ST, 2011, LWT-FOOD SCI TECHNOL, V44, P2104, DOI 10.1016/j.lwt.2011.06.014; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; Xu BJ, 2008, J FOOD SCI, V73, pH19, DOI 10.1111/j.1750-3841.2007.00625.x; Xu BJ, 2009, J AGR FOOD CHEM, V57, P4754, DOI 10.1021/jf900695s; Yeh CT, 2003, J AGR FOOD CHEM, V51, P1474, DOI 10.1021/jf0208132	43	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99325	10.1371/journal.pone.0099325	http://dx.doi.org/10.1371/journal.pone.0099325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991931	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400010
J	Manchini, MT; Serra, AJ; Feliciano, RDS; Santana, ET; Antonio, EL; de Carvalho, PDC; Montemor, J; Crajoinas, RO; Girardi, ACC; Tucci, PJF; Silva, JA				Manchini, Martha Trindade; Serra, Andrey Jorge; Feliciano, Regiane dos Santos; Santana, Eduardo Tadeu; Antonio, Ednei Luis; Camillo de Carvalho, Paulo de Tarso; Montemor, Jairo; Crajoinas, Renato Oliveira; Costa Girardi, Adriana Castello; Ferreira Tucci, Paulo Jose; Silva, Jose Antonio, Jr.			Amelioration of Cardiac Function and Activation of Anti-Inflammatory Vasoactive Peptides Expression in the Rat Myocardium by Low Level Laser Therapy	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELL PROLIFERATION; HEART-FAILURE; INFARCT SIZE; MESSENGER-RNA; GROWTH-FACTOR; B2 RECEPTORS; KININ B1; IRRADIATION	Low-level laser therapy (LLLT) has been used as an anti-inflammatory treatment in several disease conditions, even when inflammation is a secondary consequence, such as in myocardial infarction (MI). However, the mechanism by which LLLT is able to protect the remaining myocardium remains unclear. The present study tested the hypothesis that LLLT reduces inflammation after acute MI in female rats and ameliorates cardiac function. The potential participation of the Renin-Angiotensin System (RAS) and Kallikrein-Kinin System (KKS) vasoactive peptides was also evaluated. LLLT treatment effectively reduced MI size, attenuated the systolic dysfunction after MI, and decreased the myocardial mRNA expression of interleukin-1 beta and interleukin-6 in comparison to the non-irradiated rat tissue. In addition, LLLT treatment increased protein and mRNA levels of the Mas receptor, the mRNA expression of kinin B2 receptors and the circulating levels of plasma kallikrein compared to non-treated post-MI rats. On the other hand, the kinin B1 receptor mRNA expression decreased after LLLT. No significant changes were found in the expression of vascular endothelial growth factor (VEGF) in the myocardial remote area between laser-irradiated and non-irradiated post-MI rats. Capillaries density also remained similar between these two experimental groups. The mRNA expression of the inducible nitric oxide synthase (iNOS) was increased three days after MI, however, this effect was blunted by LLLT. Moreover, endothelial NOS mRNA content increased after LLLT. Plasma nitric oxide metabolites (NOx) concentration was increased three days after MI in non-treated rats and increased even further by LLLT treatment. Our data suggest that LLLT diminishes the acute inflammation in the myocardium, reduces infarct size and attenuates left ventricle dysfunction post-MI and increases vasoactive peptides expression and nitric oxide (NO) generation.	[Manchini, Martha Trindade; Serra, Andrey Jorge; Feliciano, Regiane dos Santos; Santana, Eduardo Tadeu; Camillo de Carvalho, Paulo de Tarso; Silva, Jose Antonio, Jr.] Univ Nove Julho, UNINOVE, Sao Paulo, Brazil; [Antonio, Ednei Luis; Montemor, Jairo; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, UNIFESP, Sao Paulo, Brazil; [Crajoinas, Renato Oliveira; Costa Girardi, Adriana Castello] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Silva, JA (corresponding author), Univ Nove Julho, UNINOVE, Sao Paulo, Brazil.	josejr@uninove.br	Girardi, Adriana/C-4827-2012; Girardi, Adriana C. C./B-4334-2014; de Tarso C de Carvalho, Paulo/G-5333-2011; Silva, Jose Antonio/AAA-8100-2019; Antonio, Ednei/AGG-9987-2022; Serra, Andrey Jorge/E-7460-2015; Tucci, Paulo/D-1441-2015	Girardi, Adriana/0000-0003-3715-6917; Girardi, Adriana C. C./0000-0003-3715-6917; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Silva, Jose Antonio/0000-0001-6904-9185; Antonio, Ednei/0000-0002-8254-5762; Serra, Andrey Jorge/0000-0002-5407-8183; Tucci, Paulo/0000-0001-9793-670X; Manchini, Martha/0000-0001-5785-0899	Sao Paulo Research Foundation (FAPESP); CNPq [477458/2009-2, 309715/2011-3, 479395/2012-8];  [2009/54225-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the grant #2009/54225-8, Sao Paulo Research Foundation (FAPESP), and the CNPq #477458/2009-2, #309715/2011-3 and #479395/2012-8 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Araujo RC, 2006, BIOL CHEM, V387, P431, DOI 10.1515/BC.2006.057; Bader M, 2013, PFLUG ARCH EUR J PHY, V465, P79, DOI 10.1007/s00424-012-1120-0; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Chen CH, 2008, LASER SURG MED, V40, P46, DOI 10.1002/lsm.20589; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; de Almeida P, 2012, LASER MED SCI, V27, P453, DOI 10.1007/s10103-011-0957-3; De Mello W, 2003, REGUL PEPTIDES, V114, P87, DOI 10.1016/S0167-0115(03)00121-6; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; dos Santos AA, 2013, INT J CARDIOL, V167, P357, DOI 10.1016/j.ijcard.2011.12.097; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Feng J, 2012, CELL SIGNAL, V24, P1116, DOI 10.1016/j.cellsig.2012.01.013; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gross ER, 2006, CARDIOVASC RES, V70, P212, DOI 10.1016/j.cardiores.2005.12.019; Hamblin MR, 2010, LASER SURG MED, V42, P447, DOI 10.1002/lsm.20959; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; JOHNSTON CI, 1994, HYPERTENSION, V23, P258, DOI 10.1161/01.HYP.23.2.258; Kanashiro RM, 2006, J CARD FAIL, V12, P163, DOI 10.1016/j.cardfail.2005.09.007; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; KOIDE A, 1993, J PHYSIOL-LONDON, V467, pP125; Kompa AR, 2008, J PHARMACOL EXP THER, V325, P741, DOI 10.1124/jpet.107.133546; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; LAFOLLETTE L, 1987, J LAB CLIN MED, V110, P318; LINZ W, 1993, J HYPERTENS, V11, pS96; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2013, NEUROPEPTIDES, V47, P289, DOI 10.1016/j.npep.2013.09.002; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Marcondes S., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P33, DOI 10.2174/1568016052773351; Marketou M, 2010, AM J HYPERTENS, V23, P562, DOI 10.1038/ajh.2010.20; Oliveira FAM, 2012, PHOTOMED LASER SURG, V30, P705, DOI 10.1089/pho.2012.3272; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Meotti FC, 2012, BRIT J PHARMACOL, V166, P1127, DOI 10.1111/j.1476-5381.2012.01830.x; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Nadu AP, 2008, J AM SOC HYPERTENS, V2, P341, DOI 10.1016/j.jash.2008.04.012; Nozawa E, 2006, BRAZ J MED BIOL RES, V39, P687, DOI 10.1590/S0100-879X2006000500016; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Oron U, 2001, CIRCULATION, V103, P296; Pereira MG, 2009, EUR J APPL PHYSIOL, V105, P843, DOI 10.1007/s00421-008-0967-4; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Potier L, 2013, J PHARMACOL EXP THER, V346, P23, DOI 10.1124/jpet.113.203927; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Santos AA, 2009, J CARD FAIL, V15, P163, DOI 10.1016/j.cardfail.2008.10.017; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Scholkens BA, 1996, IMMUNOPHARMACOLOGY, V33, P209, DOI 10.1016/0162-3109(96)00061-6; Sharma JN, 2008, THESCIENTIFICWORLDJO, V8, DOI 10.1100/tsw.2008.53; Silva MP, 2011, REV BRAS FISIOTER, V15, P1; Silveira KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066082; Souza APS, 2013, CLIN SCI, V125, P449, DOI 10.1042/CS20120519; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Szymanska J, 2013, J PHYSIOL PHARMACOL, V64, P387; Tsai WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038235; van Nieuwenhoven FA, 2013, VASC PHARMACOL, V58, P182, DOI 10.1016/j.vph.2012.07.003; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Whittaker P, 2000, LASER SURG MED, V27, P29, DOI 10.1002/1096-9101(2000)27:1<29::AID-LSM4>3.0.CO;2-8; Xu XH, 2008, J MOL CELL CARDIOL, V44, P114, DOI 10.1016/j.yjmcc.2007.10.004; Yang ZK, 2011, PHOTOMED LASER SURG, V29, P391, DOI 10.1089/pho.2010.2866; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	72	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101270	10.1371/journal.pone.0101270	http://dx.doi.org/10.1371/journal.pone.0101270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991808	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400057
J	Shiomi, H; Tsuda, S; Suzuki, H; Yomo, T				Shiomi, Hideaki; Tsuda, Soichiro; Suzuki, Hiroaki; Yomo, Tetsuya			Liposome-Based Liquid Handling Platform Featuring Addition, Mixing, and Aliquoting of Femtoliter Volumes	PLOS ONE			English	Article							MEMBRANE-FUSION; VESICLES; MICROFLUIDICS; GENERATION; CHEMISTRY; FISSION; BIOLOGY; DEVICES	This paper describes the utilization of giant unilamellar vesicles (GUVs) as a platform for handling chemical and biochemical reagents. GUVs with diameters of 5 to 10 mm and containing chemical/biochemical reagents together with inert polymers were fused with electric pulses (electrofusion). After reagent mixing, the fused GUVs spontaneously deformed to a budding shape, separating the mixed solution into sub-volumes. We utilized a microfluidic channel and optical tweezers to select GUVs of interest, bring them into contact, and fuse them together to mix and aliquot the reaction product. We also show that, by lowering the ambient temperature close to the phase transition temperature T-m of the lipid used, daughter GUVs completely detached (fission). This process performs all the liquid-handing features used in bench-top biochemistry using the GUV, which could be advantageous for the membrane-related biochemical assays.	[Shiomi, Hideaki; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Tsuda, Soichiro] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland; [Tsuda, Soichiro; Suzuki, Hiroaki; Yomo, Tetsuya] ERATO, JST, Tokyo, Japan; [Suzuki, Hiroaki] Chuo Univ, Fac Sci & Engn, Tokyo 112, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Osaka University; University of Glasgow; Chuo University; Osaka University	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Hiroaki/T-8989-2019	Suzuki, Hiroaki/0000-0002-8899-0955	JSPS KAKENHI Grant [24710116, 24115514]; Grants-in-Aid for Scientific Research [26289038] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Numbers 24710116 and 24115514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Boal D., 2012, MECH CELL; Caschera F, 2011, LANGMUIR, V27, P13082, DOI 10.1021/la202648h; Chiu DT, 2009, ACCOUNTS CHEM RES, V42, P649, DOI 10.1021/ar8002464; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Christensen AL, 2013, LAB CHIP, V13, P3613, DOI 10.1039/c3lc50492a; DOBEREINER HG, 1993, BIOPHYS J, V65, P1396; He MY, 2004, ANAL CHEM, V76, P1222, DOI 10.1021/ac035196a; Karlsson A, 2003, ANAL CHEM, V75, P2529, DOI 10.1021/ac0340206; Kelly BT, 2007, CHEM COMMUN, P1773, DOI 10.1039/b616252e; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Leirer C, 2009, BIOPHYS CHEM, V143, P106, DOI 10.1016/j.bpc.2009.04.002; Lentz BR, 2007, EUR BIOPHYS J BIOPHY, V36, P315, DOI 10.1007/s00249-006-0097-z; Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540; Malloggi F, 2010, LANGMUIR, V26, P2369, DOI 10.1021/la9028047; Mazutis L, 2009, ANAL CHEM, V81, P4813, DOI 10.1021/ac900403z; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Pantazatos DP, 1999, J MEMBRANE BIOL, V170, P27, DOI 10.1007/s002329900535; Paterson DJ, 2014, LAB CHIP, V14, P1806, DOI 10.1039/c4lc00199k; Peters RJRW, 2014, ANGEW CHEM INT EDIT, V53, P146, DOI 10.1002/anie.201308141; Robinson T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816712; Schaerli Y, 2009, MOL BIOSYST, V5, P1392, DOI 10.1039/b907578j; Shui LL, 2009, SOFT MATTER, V5, P2708, DOI 10.1039/b908498c; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Sunami T, 2010, LANGMUIR, V26, P15098, DOI 10.1021/la102689v; Tan YC, 2006, SENSOR ACTUAT B-CHEM, V114, P350, DOI 10.1016/j.snb.2005.06.008; Tanaka T, 2004, LANGMUIR, V20, P5160, DOI 10.1021/la049681s; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Yeagle P. L, 2010, STRUCTURE BIOL MEMBR	29	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101820	10.1371/journal.pone.0101820	http://dx.doi.org/10.1371/journal.pone.0101820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991878	Green Submitted, Green Published, gold			2022-12-25	WOS:000341253400122
J	Zielke, DE; Werner, D; Schaffner, F; Kampen, H; Fonseca, DM				Zielke, Dorothee E.; Werner, Doreen; Schaffner, Francis; Kampen, Helge; Fonseca, Dina M.			Unexpected Patterns of Admixture in German Populations of Aedes japonicus japonicus (Diptera: Culicidae) Underscore the Importance of Human Intervention	PLOS ONE			English	Article							RIFT-VALLEY FEVER; INVASIVE MOSQUITOS; GENETIC-VARIATION; 1ST RECORD; THEOBALD; ALBOPICTUS; ESTABLISHMENT; SPREAD; INFORMATION; SOFTWARE	The mosquito Aedes japonicus japonicus, originally restricted to temperate East Asia, is now widespread in North America and more recently has become established in Europe. To ascertain the putative number of separate introductions to Europe and examine patterns of expansion we analyzed the genetic makeup of Ae. j. japonicus populations from five cemeteries in North Rhine-Westphalia and Rhineland-Palatinate, two western German federal states, as well as of specimens from populations in Belgium, Switzerland, and Austria/Slovenia. To do so, we genotyped individual specimens at seven preexisting polymorphic microsatellite loci and sequenced part of the nad4 mitochondrial locus. We found evidence of two different genotypic signatures associated with different nad4 mitochondrial haplotypes, indicating at least two genetically differentiated populations of Ae. j. japonicus in Europe (i.e. two distinct genotypes). Belgian, Swiss, and Austrian/Slovenian populations all share the same genotypic signature although they have become differentiated since isolation. Contrary to expectations, the German Ae. j. japonicus are not closely related to those in Belgium which are geographically nearest but are also highly inbred. German populations have a unique genotype but also evidence of mixing between the two genotypes. Also unexpectedly, the populations closest to the center of the German infestation had the highest levels of admixture indicating that separate introductions did not expand and merge but instead their expansion was driven by punctuated human-mediated transport. Critically, the resulting admixed populations have higher genetic diversity and appear invasive as indicated by their increased abundance and recent spread across western Germany.	[Zielke, Dorothee E.; Werner, Doreen] Leibniz Ctr Agr Landscape Res, Muncheberg, Germany; [Schaffner, Francis] Univ Zurich, Inst Parasitol, Natl Ctr Vector Entomol, CH-8057 Zurich, Switzerland; [Schaffner, Francis] Avia GIS, Zoersel, Belgium; [Kampen, Helge] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Zurich; Friedrich Loeffler Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zielke, DE (corresponding author), Leibniz Ctr Agr Landscape Res, Muncheberg, Germany.	zielke@zalf.de	Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022	Fonseca, Dina Madeira/0000-0003-4726-7100; Schaffner, Francis/0000-0001-9166-7617	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food [2810HS022]; Robert Koch Institute [1362/1-982]; USDA Hatch [NJ08194]; Multistate funds [NE-1043]	German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) through the Federal Office for Agriculture and Food; Robert Koch Institute; USDA Hatch(United States Department of Agriculture (USDA)); Multistate funds	This work was supported by the German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV: www.bmelv.de/DE/Startseite/startseite_node.html) through the Federal Office for Agriculture and Food (BLE: www.ble.de/DE/00_Home/homepage_node.html), grant number 2810HS022, by the Robert Koch Institute, grant number 1362/1-982, by a USDA Hatch Grant #NJ08194: www.usda.gov/wps/portal/usda/usdahome, and NE-1043 Multistate funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J MED ENTOMOL, V42, P511; Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1; Becker Norbert, 2011, European Mosquito Bulletin, V29, P88; Cameron EC, 2010, J MED ENTOMOL, V47, P527, DOI 10.1603/ME09259; Chikhi N., 2004, 5000 CNRS UMR U MONT; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egizi A, 2014, BIOL INVASI IN PRESS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Fonseca DM, 2001, J MED ENTOMOL, V38, P135, DOI 10.1603/0022-2585-38.2.135; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Ibanez-Justicia Adolfo, 2014, Journal of the European Mosquito Control Association, V32, P9; Kampen H, 2014, J EUR MOSQ CONTROL A, V31, P36; Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y; Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LAIRD M, 1994, J AM MOSQUITO CONTR, V10, P14; Larish LB, 2005, J AM MOSQUITO CONTR, V21, P318, DOI 10.2987/8756-971X(2005)21[318:IAEOAF]2.0.CO;2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Neitzel DF, 2009, J AM MOSQUITO CONTR, V25, P367, DOI 10.2987/09-0015.1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Pritchard JK, 2000, GENETICS, V155, P945; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS KG, 1993, GENETICS, V135, P843; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1; Schaffner F., 2001, MOSQUITOES EUROPE ID; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schaffner Francis, 2003, European Mosquito Bulletin, V16, P7; Schneider Katharina, 2011, European Mosquito Bulletin, V29, P129; Seidel Bernhard, 2012, Entomologische Zeitschrift, V122, P223; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Thielman A, 2006, J MED ENTOMOL, V43, P138, DOI 10.1603/0022-2585(2006)043[0138:EOOJDC]2.0.CO;2; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2001, MOL ECOL, V10, P2151, DOI 10.1046/j.0962-1083.2001.01363.x; Turell MJ, 2013, J AM MOSQUITO CONTR, V29, P133, DOI 10.2987/12-6316r.1; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Werner D, 2013, PARASITOL RES, V112, P3665, DOI 10.1007/s00436-013-3564-3; Widdel AK, 2005, AM J TROP MED HYG, V73, P744, DOI 10.4269/ajtmh.2005.73.744; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	58	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99093	10.1371/journal.pone.0099093	http://dx.doi.org/10.1371/journal.pone.0099093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992470	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341253400006
J	Rodriguez, EA; Correa, MM; Ospina, S; Atehortua, SL; Jimenez, JN				Rodriguez, Erika A.; Correa, Margarita M.; Ospina, Sigifredo; Atehortua, Santiago L.; Natalia Jimenez, J.			Differences in Epidemiological and Molecular Characteristics of Nasal Colonization with Staphylococcus aureus (MSSA-MRSA) in Children from a University Hospital and Day Care Centers	PLOS ONE			English	Article							METHICILLIN-RESISTANT; HEALTHY-CHILDREN; MULTIPLEX PCR; CARRIAGE; SEQUENCE; RISK; PREVALENCE; VIRULENCE; GENES; POPULATION	Background: Clinical significance of Staphylococcus aureus colonization has been demonstrated in hospital settings; however, studies in the community have shown contrasting results regarding the relevance of colonization in infection by community-associated MRSA (CA-MRSA). In Colombia there are few studies on S. aureus colonization. The aim of this study was to determine the molecular and epidemiological characteristics of nasal colonization by S. aureus (MSSA-MRSA) in children from a university hospital and day care centers (DCCs) of Medellin, Colombia. Methods: An observational cross-sectional study was conducted in 400 children (200 in each setting), aged 0 months to 5 years, during 2011. Samples were collected from each nostril and epidemiological information was obtained from the parents. Genotypic analysis included spa typing, PFGE, MLST, SCCmec typing, detection of genes for virulence factors and agr groups. Results: Frequency of S. aureus colonization was 39.8% (n = 159) (hospital 44.5% and DCCs 35.0%) and by MRSA, 5.3% (n = 21) (hospital 7.0% and DCCs 3.5%). Most S. aureus colonized children were older than two years (p = 0.005), the majority of them boys (59.1%), shared a bedroom with a large number of people (p = 0.028), with history of beta-Lactamase inhibitors usage (p = 0.020). MSSA strains presented the greatest genotypic diversity with 15 clonal complexes (CC). MRSA isolates presented 6 CC, most of them (47.6%) belonged to CC8-SCCmec IVc and were genetically related to previously reported infectious MRSA strains. Conclusion: Differences in epidemiological and molecular characteristics between populations may be useful for the understanding of S. aureus nasal colonization dynamics and for the design of strategies to prevent S. aureus infection and dissemination. The finding of colonizing MRSA with similar molecular characteristics of those causing infection demonstrates the dissemination capacity of S. aureus and the risk of infection among the child population.	[Rodriguez, Erika A.; Correa, Margarita M.; Natalia Jimenez, J.] Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia; [Rodriguez, Erika A.; Natalia Jimenez, J.] Univ Antioquia, Escuela Microbiol, Grp Invest Microbiol Basica & Aplicada MICROBA, Medellin, Colombia; [Ospina, Sigifredo; Atehortua, Santiago L.] San Vicente Fdn, Univ Hosp, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Jimenez, JN (corresponding author), Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Colombia.	nataliajiudea@gmail.com	Rodríguez, Erika A./T-4200-2017	Rodríguez, Erika A./0000-0002-8582-8776; Jimenez, J Natalia/0000-0002-9183-1912	Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia [CIMB-032-11]; Estrategia para la Sostenibilidad de Grupos [EO1624]	Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia; Estrategia para la Sostenibilidad de Grupos	This research was supported by the Comite para el Desarrollo de la Investigacion - CODI, Universidad de Antioquia, Project: CIMB-032-11 and received support from Estrategia para la Sostenibilidad de Grupos 2011-2012, Code EO1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2013, MICROB PATHOGENESIS, V54, P26, DOI 10.1016/j.micpath.2012.09.001; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Bitterman Y, 2010, EUR J CLIN MICROBIOL, V29, P391, DOI 10.1007/s10096-009-0869-3; Blumental S, 2013, J ANTIMICROB CHEMOTH, V68, P1517, DOI 10.1093/jac/dkt080; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Ciftci IH, 2007, ACTA PAEDIATR, V96, P1043, DOI 10.1111/j.1651-2227.2007.00315.x; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gardella N, 2011, INFECT GENET EVOL, V11, P1066, DOI 10.1016/j.meegid.2011.03.019; Ghasemzadeh-Moghaddam H, 2011, INT J MED MICROBIOL, V301, P347, DOI 10.1016/j.ijmm.2010.10.004; Halablab MA, 2010, EPIDEMIOL INFECT, V138, P702, DOI 10.1017/S0950268809991233; Horowitz IN, 2012, AM J INFECT CONTROL, V40, P118, DOI 10.1016/j.ajic.2011.03.027; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lebon A, 2010, J CLIN MICROBIOL, V48, P1995, DOI 10.1128/JCM.00022-10; Liu M, 2010, CURR MICROBIOL, V61, P435, DOI 10.1007/s00284-010-9635-0; Liu QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037005; Lo WT, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-51; Lo WT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015791; Mathema Barun, 2008, V431, P285; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Milstone AM, 2011, CLIN INFECT DIS, V53, P853, DOI 10.1093/cid/cir547; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Jimenez JN, 2013, INT J MED MICROBIOL, V303, P76, DOI 10.1016/j.ijmm.2012.12.003; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; Jimenez JN, 2011, MEM I OSWALDO CRUZ, V106, P980, DOI 10.1590/S0074-02762011000800013; Pathak A, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-100; Portillo BC, 2010, INFECTIO, P73; Rebollo-Pérez Juan, 2011, Rev. salud pública, V13, P824; Regev-Yochay G, 2009, PEDIATR INFECT DIS J, V28, P960, DOI 10.1097/INF.0b013e3181a90883; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2003, J CLIN MICROBIOL, V41, P456, DOI 10.1128/JCM.41.1.456-459.2003; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Torano G, 2001, ENFERM INFEC MICR CL, V19, P367, DOI 10.1016/S0213-005X(01)72668-7; Tovar C, 2011, REV CHIL INFECT S2, V28, pS60; van Trijp MJCA, 2010, DIAGN MICR INFEC DIS, V66, P222, DOI 10.1016/j.diagmicrobio.2009.08.021; Velazquez-Guadarrama N, 2009, CLIN INVEST MED, V32, pE57; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	59	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101417	10.1371/journal.pone.0101417	http://dx.doi.org/10.1371/journal.pone.0101417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987854	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100084
J	Shen, L; Cui, AF; Xue, Y; Cui, Y; Dong, XY; Gao, Y; Yang, H; Fang, FD; Chang, YS				Shen, Lian; Cui, Anfang; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng			Hepatic Differentiated Embryo-Chondrocyte-expressed Gene 1 (Dec1) Inhibits Sterol Regulatory Element-binding Protein-1c (Srebp-1c) Expression and Alleviates Fatty Liver Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid Synthesis; Liver Metabolism; Metabolic Disease; Metabolism; Transcription Repressor; DEC1; NAFLD; SREBP-1c	CIRCADIAN CLOCK; TRANSCRIPTION FACTOR; NOVO LIPOGENESIS; MOLECULAR CLOCK; LXR-ALPHA; MICE; STEATOSIS; DISEASE; ADIPOGENESIS; INSULIN	Background: Increased SREBP-1c level contributes to excessive triglyceride accumulation in liver of NAFLD patients. Results:Dec1 represses Srebp-1c gene expression, thereby reducing hepatic lipogenesis and ameliorating fatty liver phenotype. Conclusion:Dec1 negatively regulates hepatic lipid synthesis. Significance:Dec1 is a negative regulator of Srebp-1c expression and integrates circadian clock and hepatic lipid metabolism. Hepatic steatosis, characterized by ectopic hepatic triglyceride accumulation, is considered as the early manifestation of non-alcoholic fatty liver diseases (NAFLD). Increased SREBP-1c level and activity contribute to excessive hepatic triglyceride accumulation in NAFLD patients; however, negative regulators of Srebp-1c are not well defined. In this study, we show that Dec1, a critical regulator of circadian rhythm, negatively regulates hepatic Srebp-1c expression. Hepatic Dec1 expression levels are markedly decreased in NAFLD mouse models. Restored Dec1 gene expression levels in NAFLD mouse livers decreased the expression of Srebp-1c and lipogenic genes, subsequently ameliorating the fatty liver phenotype. Conversely, knockdown of Dec1 expression by an adenovirus expressing Dec1-specific shRNA led to an increase in hepatic TG content in normal mouse livers. Correspondingly, expression levels of lipogenic genes, including Srebp-1c, Fas, and Acc, were increased in livers of mice with Dec1 knockdown. Moreover, a functional lipogenesis assay suggested that Dec1 overexpression repressed lipid synthesis in primary hepatocytes. Finally, a luciferase reporter gene assay indicates that DEC1 inhibits Srebp-1c gene transcription via the E-box mapped to the promoter region. Chromatin immunoprecipitation confirmed that DEC1 proteins bound to the identified E-box element. Our studies indicate that DEC1 is an important regulator of Srebp-1c expression and links circadian rhythm to hepatic lipogenesis. Activation of Dec1 can alleviate the nonalcoholic fatty liver phenotype.	[Shen, Lian; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Shen, Lian; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Cui, Anfang] Jining Med Univ, Dept Biochem, Jining 272067, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jining Medical University	Chang, YS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	changy@ibms.pumc.edu.cn			Major State Basic Research Development Program of China 973 Program [2012CB517504]; National Natural Science Foundation of China [81170763]	Major State Basic Research Development Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program of China 973 Program Grant 2012CB517504 and National Natural Science Foundation of China Grant 81170763.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Nakayama H, 2007, METABOLISM, V56, P470, DOI 10.1016/j.metabol.2006.11.004; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Ozaki N, 2012, GENES CELLS, V17, P109, DOI 10.1111/j.1365-2443.2011.01574.x; Patel DD, 2001, J LIPID RES, V42, P328; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yamada K, 2005, FEBS LETT, V579, P1509, DOI 10.1016/j.febslet.2005.01.060; Yamada K, 2003, J BIOL CHEM, V278, P30719, DOI 10.1074/jbc.M301597200; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230	37	17	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23332	23342		10.1074/jbc.M113.526343	http://dx.doi.org/10.1074/jbc.M113.526343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993831	Green Published, hybrid			2022-12-25	WOS:000341505000009
J	Coca, R; Soler, F; Cortes-Castell, E; Gil-Guillen, V; Fernandez-Belda, F				Coca, Ramon; Soler, Fernando; Cortes-Castell, Ernesto; Gil-Guillen, Vicente; Fernandez-Belda, Francisco			Inhibition Mechanism of the Intracellular Transporter Ca2+-Pump from Sarco-Endoplasmic Reticulum by the Antitumor Agent Dimethyl-Celecoxib	PLOS ONE			English	Article							CYCLOOXYGENASE-2 GENE-EXPRESSION; SARCOPLASMIC-RETICULUM; IN-VITRO; CALCIUM; ATPASE; CA2+; CA2+-ATPASE; CANCER; VISUALIZATION; THAPSIGARGIN	Dimethyl-celecoxib is a celecoxib analog that lacks the capacity as cyclo-oxygenase-2 inhibitor and therefore the life-threatening effects but retains the antineoplastic properties. The action mechanism at the molecular level is unclear. Our in vitro assays using a sarcoplasmic reticulum preparation from rabbit skeletal muscle demonstrate that dimethyl-celecoxib inhibits Ca (2+)-ATPase activity and ATP-dependent Ca2+ transport in a concentration-dependent manner. Celecoxib was a more potent inhibitor of Ca2+-ATPase activity than dimethyl-celecoxib, as deduced from the half-maximum effect but dimethyl-celecoxib exhibited higher inhibition potency when Ca2+ transport was evaluated. Since Ca2+ transport was more sensitive to inhibition than Ca2+-ATPase activity the drugs under study caused Ca2+/Pi uncoupling. Dimethyl-celecoxib provoked greater uncoupling and the effect was dependent on drug concentration but independent of Ca2+-pump functioning. Dimethyl-celecoxib prevented Ca2+ binding by stabilizing the inactive Ca2+-free conformation of the pump. The effect on the kinetics of phosphoenzyme accumulation and the dependence of the phosphoenzyme level on dimethyl-celecoxib concentration were independent of whether or not the Ca2+-pump was exposed to the drug in the presence of Ca2+ before phosphorylation. This provided evidence of non-preferential interaction with the Ca2+-free conformation. Likewise, the decreased phosphoenzyme level in the presence of dimethyl-celecoxib that was partially relieved by increasing Ca2+ was consistent with the mentioned effect on Ca2+ binding. The kinetics of phosphoenzyme decomposition under turnover conditions was not altered by dimethyl-celecoxib. The dual effect of the drug involves Ca2+-pump inhibition and membrane permeabilization activity. The reported data can explain the cytotoxic and anti-proliferative effects that have been attributed to the celecoxib analog. Ligand docking simulation predicts interaction of celecoxib and dimethyl-celecoxib with the intracellular Ca2+ transporter at the inhibition site of hydroquinones.	[Coca, Ramon; Gil-Guillen, Vicente] Univ Miguel Hernandez, Dept Med Clin, Alicante, Spain; [Soler, Fernando; Fernandez-Belda, Francisco] Univ Murcia, Dept Bioquim & Biol Mol A, Murcia, Spain; [Cortes-Castell, Ernesto] Univ Miguel Hernandez, Dept Farmacol Pediat & Quim Organ, Alicante, Spain	Universidad Miguel Hernandez de Elche; University of Murcia; Universidad Miguel Hernandez de Elche	Fernandez-Belda, F (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Campus Espinardo, Murcia, Spain.	fbelda@um.es	Cortés-Castell, Ernesto/H-8528-2019; Guillén, Vicente Francisco Gil/AAE-8201-2019; Soler, Fernando/S-1441-2019	Gil-Guillen, Vicente F/0000-0003-3793-9786; Coca Zuniga, Ramon/0000-0001-5014-5644; CORTES CASTELL, ERNESTO/0000-0002-8079-1695	University of Murcia; University Miguel Hernandez	University of Murcia; University Miguel Hernandez	This study was supported by research funds from the University of Murcia and University Miguel Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; Chuang HC, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-38; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Deye J, 2009, BIOORGAN MED CHEM, V17, P1353, DOI 10.1016/j.bmc.2008.12.010; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Elam C, 2011, EUR J MED CHEM, V46, P1512, DOI 10.1016/j.ejmech.2011.01.069; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harris RE, 2000, CANCER RES, V60, P2101; INESI G, 1988, METHOD ENZYMOL, V157, P154; INESI G, 1980, J BIOL CHEM, V255, P3025; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kardosh A, 2005, CANCER BIOL THER, V4, P571, DOI 10.4161/cbt.4.5.1699; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lax A, 2002, AM J PHYSIOL-CELL PH, V283, pC85, DOI 10.1152/ajpcell.00580.2001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTONOSI A, 1964, J BIOL CHEM, V239, P648; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Parrett ML, 1997, INT J ONCOL, V10, P503; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Reddy BS, 1996, CANCER RES, V56, P4566; Ristimaki A, 1997, CANCER RES, V57, P1276; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; SCHWARZENBACH G, 1957, HELV CHIM ACTA, V40, P1886, DOI 10.1002/hlca.19570400640; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Soler F, 2012, J BIOENERG BIOMEMBR, V44, P597, DOI 10.1007/s10863-012-9462-z; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Song XQ, 2002, J NATL CANCER I, V94, P585; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Williams CS, 2000, CANCER RES, V60, P6045; WU KD, 1995, AM J PHYSIOL-CELL PH, V269, pC775, DOI 10.1152/ajpcell.1995.269.3.C775; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhu JX, 2002, JNCI-J NATL CANCER I, V94, P1745	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102083	10.1371/journal.pone.0102083	http://dx.doi.org/10.1371/journal.pone.0102083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003576	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700105
J	Sun, YP; Zheng, YH; Liu, WJ; Zheng, YL; Zhang, ZG				Sun, Yang-peng; Zheng, You-hua; Liu, Wen-jing; Zheng, Yu-liang; Zhang, Zhi-guang			Synovium Fragment-Derived Cells Exhibit Characteristics Similar to Those of Dissociated Multipotent Cells in Synovial Fluid of the Temporomandibular Joint	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; HUMAN ADIPOSE-TISSUE; ADULT HUMAN BONE; CARTILAGE DEFECTS; STROMAL CELLS; IN-VITRO; INTRAARTICULAR INJECTION; KNEE OSTEOARTHRITIS; RHEUMATIC-DISEASES	Multipotent mesenchymal stem cells (MSCs) found in the synovial fluid (SFMSCs) of the tempromandibular joint (TMJ) remain poorly understood. During TMJ arthrocentesis, we discovered that synovial fluid collected from some patients with TMJ disorders contained not only SFMSCs but also synovium fragments (SFs). In this study, we attempted to characterize both the SFMSCs and SF-derived cells (SFCs) in order to further understand the role of MSCs in the synovial fluid of the TMJ. The SFs were membranous and translucent and consisted of several cell layers, indicating that their origin was only from the intima. SFCs were obtained by digestion of the SFs and subsequently expanded in vitro. SFMSCs were enriched by centrifugation of the synovial fluid and expanded in vitro. SFCs and SFMSCs displayed a similar fibroblast-like, spindle-shaped morphology, and we observed that some SFMSCs grew out of small tissue masses in culture. Flow cytometric analysis showed that both groups of cells expressed similar surface markers, including CD90, CD44, CD105, and CD73. However, both were negative for Stro-1, CD146, CD45, CD34, CD11b, CD19, and HLA-DR. Immunofluorescent staining showed that both SFs and SFMSCs expressed vascular cell adhesion molecule 1. Both SFCs and SFMSCs could be induced to differentiate down osteogenic, chondrogenic, adipogenic, and neurogenic lineages in vitro. Together, our results indicate that the intima is the most likely tissue origin of SFMSCs in the TMJ. Moreover, the SFs are composed of only intima and thus offer an improved source of synovium-derived MSCs compared to synovium specimens obtained by surgery, which contain both intima and subintima.	[Sun, Yang-peng; Zheng, You-hua; Liu, Wen-jing; Zheng, Yu-liang; Zhang, Zhi-guang] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Hosp Stomatol,Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, ZG (corresponding author), Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch Stomatol, Hosp Stomatol,Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	kouqiangzzg@hotmail.com			Science Foundation of the Key Hospital Clinical Program of the Ministry of China [(2010)439]; National Science Foundation of China [81271115]	Science Foundation of the Key Hospital Clinical Program of the Ministry of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Science Foundation of the Key Hospital Clinical Program of the Ministry of China[(2010)439] and the National Science Foundation of China (81271115), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Chen K, 2013, INT J ORAL MAX SURG, V42, P240, DOI 10.1016/j.ijom.2012.05.030; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edwards JCW, 2000, ARTHRITIS RES, V2, P344, DOI 10.1186/ar110; Emadedin M, 2012, ARCH IRAN MED, V15, P422, DOI 012157/AIM.0010; Fickert S, 2003, OSTEOARTHR CARTILAGE, V11, P790, DOI 10.1016/S1063-4584(03)00167-5; Fukiage K, 2008, BIOCHEM BIOPH RES CO, V365, P406, DOI 10.1016/j.bbrc.2007.10.149; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Harvanova D, 2011, FOLIA BIOL-PRAGUE, V57, P119; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005; Lee DH, 2012, OSTEOARTHR CARTILAGE, V20, P106, DOI 10.1016/j.joca.2011.11.010; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XX, 2005, STEM CELLS DEV, V14, P65, DOI 10.1089/scd.2005.14.65; Luyten FR, 2006, BEST PRACT RES CL RH, V20, P829, DOI 10.1016/j.berh.2006.06.009; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Neidhart M, 2003, ARTHRITIS RHEUM, V48, P1873, DOI 10.1002/art.11166; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z; Ringe J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2572; Russell KC, 2013, TISSUE ENG PT A, V19, P2253, DOI [10.1089/ten.tea.2012.0649, 10.1089/ten.TEA.2012.0649]; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; SIMMONS PJ, 1991, BLOOD, V78, P55; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747; Xu Y, 2012, J ORAL REHABIL, V39, P719, DOI 10.1111/j.1365-2842.2012.02307.x; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022622; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101896	10.1371/journal.pone.0101896	http://dx.doi.org/10.1371/journal.pone.0101896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003199	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700084
J	Wen, L; Zhu, MD; Madigan, MC; You, JJ; King, NJC; Billson, FA; McClellan, K; Sutton, G; Petsoglou, C				Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; King, Nicholas J. C.; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con			Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Pro-Inflammatory Cytokine-Stimulated Human Corneal Epithelial Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; KAPPA-B; ENDOTHELIAL-CELLS; GLIAL ACTIVATION; IMMUNE-RESPONSES; INTERFERON-GAMMA; IFN-GAMMA; WEST-NILE; IN-VIVO	Purpose: To investigate the modulatory effect of rat bone marrow mesenchymal stem cells (MSC) on human corneal epithelial cells (HCE-T) stimulated with pro-inflammatory cytokines interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in an in vitro co-cultured model. Methods: HCE-T alone and co-cultured with MSC were stimulated with IFN-gamma/TNF for 24 and 48 hours or left untreated. The expression of intracellular adhesion molecule (ICAM)-1, human leukocyte antigen ABC, DR and G (HLA-ABC, HLA-DR, HLA-G) were investigated by flow cytometry. Subcellular localization of nuclear factor-kappa B (NF-kappa B) and expression of indoleamine 2,3-dioxygenase (IDO) were assessed by immunofluorescence staining and western blot. The concentration of transforming growth factor beta 1 (TGF-beta 1) in the conditioned media from different cultures was evaluated by enzyme-linked immunosorbent assay. NF-kappa B and TGF-beta 1 signaling pathway blocking experiments were performed to analyze associations between the expression of cell surface molecules and the NF-kappa B transcription pathway, and the expression of IDO and TGF-beta 1 signaling pathway. Results: IFN-gamma/TNF treatment significantly up-regulated expression of ICAM-1, HLA-ABC, and induced de novo expression of HLA-DR and IDO on HCE-T cultured alone, while HLA-G expression remained unaffected. Up-regulation was significantly inhibited by co-culture with MSC. Increased TGF-beta 1 secretion was detected in 48 h IFN-gamma/TNF-stimulated MSC monocultures and HCE-T/MSC co-cultures. MSC attenuated the activation of cytokine-induced NF-kappa B and IDO induction. Blockade of NF-kappa B transcription pathway by BMS-345541 significantly reduced the up-regulation of ICAM-1, HLA-ABC, HLA-DR and IDO expression, while blockade of TGF-beta 1 signaling pathways reversed the modulatory effect of MSC on IDO expression. Conclusions: MSC reduced the expression of adhesion and immunoregulatory molecules on pro-inflammatory cytokine-stimulated HCE-T via the NF-kappa B transcription pathway. MSC attenuated expression of IDO through both NF-kappa B transcription and TGF-beta 1 signaling pathways. Co-culture of HCEC with MSC therefore provides a useful in vitro model to study the anti-inflammatory properties of MSC on corneal epithelium.	[Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Wen, Li; Zhu, Meidong; Madigan, Michele C.; You, Jingjing; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Univ Sydney, Discipline Clin Ophthalmol, Sydney, NSW 2006, Australia; [Zhu, Meidong; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Lions New South Wales Eye Bank, NSW Organ & Tissue Donat Serv, Sydney, NSW, Australia; [Zhu, Meidong; Billson, Francis A.; McClellan, Kathryn; Sutton, Gerard; Petsoglou, Con] Sydney Eye Hosp, Sydney, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [King, Nicholas J. C.] Univ Sydney, Discipline Pathol, Sch Med Sci, Camperdown, NSW, Australia; [King, Nicholas J. C.] Univ Sydney, Bosch Inst, Sydney Med Sch, Camperdown, NSW, Australia; [Billson, Francis A.] Sight Life Fdn, Sydney, NSW, Australia; [Sutton, Gerard] Vis Eye Inst, Chatswood, NSW, Australia; [Sutton, Gerard] Univ Auckland, Auckland 1, New Zealand	University of Sydney; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Auckland	Zhu, MD (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	meidong.zhu@sydney.edu.au	King, Nicholas Jonathan Cole/C-4138-2011; You, Jingjing/AAO-2671-2020; Petsoglou, Constantinos/GLN-8047-2022	King, Nicholas Jonathan Cole/0000-0002-3877-9772; Sutton, Gerard/0000-0002-0645-018X; , Jingjing You/0000-0002-2461-0140	Lions NSW Eye Bank; Sydney Foundation for Medical Research; Save Sight Institute Special Stem Cell Research Grant; Sydney Eye Hospital Foundation	Lions NSW Eye Bank; Sydney Foundation for Medical Research; Save Sight Institute Special Stem Cell Research Grant; Sydney Eye Hospital Foundation	The study was supported by Sydney Eye Hospital Foundation, Lions NSW Eye Bank, Sydney Foundation for Medical Research, Save Sight Institute Special Stem Cell Research Grant. These funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bell LV, 2011, PARASITE IMMUNOL, V33, P244, DOI 10.1111/j.1365-3024.2010.01272.x; Bellner L, 2011, INVEST OPHTH VIS SCI, V52, P3246, DOI 10.1167/iovs.10-6219; Chang JH, 2012, SURV OPHTHALMOL, V57, P415, DOI 10.1016/j.survophthal.2012.01.007; Cho M, 2001, AM J PHYSIOL-HEART C, V280, pH2357, DOI 10.1152/ajpheart.2001.280.5.H2357; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DOUGLAS MW, 1994, IMMUNOLOGY, V82, P561; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Flores B, 2012, J ALZHEIMERS DIS, V32, P417, DOI 10.3233/JAD-2012-120721; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu SF, 2009, MOL VIS, V15, P99; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Jiang TS, 2010, MOL VIS, V16, P1304; Kao WWY, 1996, CORNEA, V15, P397, DOI 10.1097/00003226-199607000-00010; Kesson AM, 2002, VIRAL IMMUNOL, V15, P273, DOI 10.1089/08828240260066224; Kim JY, 2010, INT IMMUNOPHARMACOL, V10, P1185, DOI 10.1016/j.intimp.2010.06.025; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lan YN, 2012, INVEST OPHTH VIS SCI, V53, P3638, DOI 10.1167/iovs.11-9311; Lee YJ, 2010, AM J CHINESE MED, V38, P585, DOI 10.1142/S0192415X1000807X; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Liu J, 2004, TRANSPL P, V36, P3272, DOI 10.1016/j.transproceed.2004.11.090; Luu NT, 2013, STEM CELLS, V13; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Macchiarulo A, 2009, AMINO ACIDS, V37, P219, DOI 10.1007/s00726-008-0137-3; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Mailankot M, 2008, INVEST OPHTH VIS SCI, V49, P5466, DOI 10.1167/iovs.08-2374; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Oh JY, 2012, EMBO MOL MED, V4, P435, DOI 10.1002/emmm.201200221; Oh JY, 2009, CURR EYE RES, V34, P85, DOI 10.1080/02713680802607740; Oh JY, 2009, CYTOKINE, V46, P100, DOI 10.1016/j.cyto.2008.12.011; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Pennino D, 2013, J ALLERGY CLIN IMMUN, V131, P562, DOI 10.1016/j.jaci.2012.09.036; Reinshagen H, 2011, ACTA OPHTHALMOL, V89, P741, DOI 10.1111/j.1755-3768.2009.01812.x; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sadrai Z, 2011, INVEST OPHTH VIS SCI, V52, P2525, DOI 10.1167/iovs.10-5658; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Serbecic N, 2006, EXP EYE RES, V82, P416, DOI 10.1016/j.exer.2005.07.016; Tchedre K, 2013, EYE CONTACT LENS, V39, P394, DOI 10.1097/ICL.0b013e3182a2f8d9; Uwaydat S, 2011, CURR EYE RES, V36, P787, DOI 10.3109/02713683.2010.544441; Vitkovic L, 2001, NEUROIMMUNOMODULAT, V9, P295, DOI 10.1159/000059387; Wen L, 2014, CHIN J CELL STEM CEL, V4, P5; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Ye J, 2006, EYE, V20, P482, DOI 10.1038/sj.eye.6701913; Yomogida S, 2008, INT J MOL MED, V22, P205, DOI 10.3892/ijmm_00000010; You JJ, 2012, EXP EYE RES, V99, P55, DOI 10.1016/j.exer.2012.03.012; Yuan WH, 1998, J CELL PHYSIOL, V177, P174, DOI 10.1002/(SICI)1097-4652(199810)177:1<174::AID-JCP18>3.0.CO;2-D; Zaher SS, 2011, INVEST OPHTH VIS SCI, V52, P2640, DOI 10.1167/iovs.10-5793; Zhang R, 2013, J NEUROINFLAMM, V10, P1742	60	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101841	10.1371/journal.pone.0101841	http://dx.doi.org/10.1371/journal.pone.0101841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003339	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700076
J	Bormann, T; Wolfer, SA; Hachmann, W; Lagreze, WA; Konieczny, L				Bormann, Tobias; Wolfer, Sascha A.; Hachmann, Wibke; Lagreze, Wolf A.; Konieczny, Lars			An Eye Movement Study on the Role of the Visual Field Defect in Pure Alexia	PLOS ONE			English	Article							HEMIANOPIC DYSLEXIA; WORD; IMPAIRMENT; AGRAPHIA; ANATOMY	Pure alexia is a severe impairment of word reading which is usually accompanied by a right-sided visual field defect. Patients with pure alexia exhibit better preserved writing and a considerable word length effect, claimed to result from a serial letter processing strategy. Two experiments compared the eye movements of four patients with pure alexia to controls with simulated visual field defects (sVFD) when reading single words. Besides differences in response times and differential effects of word length on word reading in both groups, fixation durations and the occurrence of a serial, letter-by-letter fixation strategy were investigated. The analyses revealed quantitative and qualitative differences between pure alexic patients and unimpaired individuals reading with sVFD. The patients with pure alexia read words slower and exhibited more fixations. The serial, letter-by-letter fixation strategy was observed only in the patients but not in the controls with sVFD. It is argued that the VFD does not cause pure alexic reading.	[Bormann, Tobias] Neurol Univ Klin Freiburg, Freiburg, Germany; [Wolfer, Sascha A.; Konieczny, Lars] Univ Freiburg, D-79106 Freiburg, Germany; [Wolfer, Sascha A.] Inst Deutsch Sprache, Mannheim, Germany; [Hachmann, Wibke] Univ Trento, Trento, Trento, Italy; [Lagreze, Wolf A.] Univ Augenklin Freiburg, Freiburg, Germany	University of Freiburg; University of Freiburg; Institut fur Deutsche Sprache (IDS); University of Trento; University of Freiburg	Bormann, T (corresponding author), Neurol Univ Klin Freiburg, Freiburg, Germany.	tobias.bormann@uniklinik-freiburg.de	Wolfer, Sascha/AHD-5519-2022	Bormann, Tobias/0000-0001-5502-6505	Albert Ludwigs University Freiburg	Albert Ludwigs University Freiburg	The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby J., 2011, PSYCHOL READING; Baayen R Harald, 1993, CELEX LEXICAL DATA B; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; BALOTA DA, 1993, J MEM LANG, V32, P573, DOI 10.1006/jmla.1993.1029; BEHRMANN M, 1990, BRAIN LANG, V39, P405, DOI 10.1016/0093-934X(90)90148-A; Behrmann M, 1998, NEUROPSYCHOLOGIA, V36, P1115, DOI 10.1016/S0028-3932(98)00005-0; Behrmann M, 2001, NEUROPSYCHOLOGIA, V39, P983, DOI 10.1016/S0028-3932(01)00021-5; BEHRMANN M, 1995, COGN NEUROPSYCHOL, V12, P409, DOI 10.1080/02643299508252004; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; Bormann T, NEUROCASE IN PRESS; Caplan LR, 1988, HDB CLIN NEUROLOGY, V53, P409; Chialant D, 1998, COGN NEUROPSYCHOL, V15, P167, DOI 10.1080/026432998381258; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; De Bleser R., 2004, LEMO LEXIKON MODELLO; DERENZI E, 1987, BRAIN, V110, P1099, DOI 10.1093/brain/110.5.1099; Farah M., 2004, VISUAL AGNOSIA; FARAH MJ, 1991, COGN NEUROPSYCHOL, V8, P313, DOI 10.1080/02643299108253376; GREENBLATT SH, 1976, BRAIN LANG, V3, P229, DOI 10.1016/0093-934X(76)90019-5; GREENBLATT SH, 1973, BRAIN, V96, P307, DOI 10.1093/brain/96.2.307; GROCHOWICKI M, 1991, BRIT J OPHTHALMOL, V75, P624, DOI 10.1136/bjo.75.10.624; Heister J, 2011, PSYCHOL RUNDSCH, V62, P10, DOI 10.1026/0033-3042/a000029; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Leff AP, 2006, J NEUROL NEUROSUR PS, V77, P1004, DOI 10.1136/jnnp.2005.086983; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Miozzo M, 1998, COGN NEUROPSYCHOL, V15, P203, DOI 10.1080/026432998381267; Mycroft RH, 2009, NEUROPSYCHOLOGIA, V47, P1733, DOI 10.1016/j.neuropsychologia.2009.02.014; PATTERSON K, 1982, Q J EXP PSYCHOL-A, V34, P411, DOI 10.1080/14640748208400852; Pflugshaupt T, 2009, BRAIN, V132, P1907, DOI 10.1093/brain/awp141; Rayner K, 2005, PSYCHOL SCI, V16, P530, DOI 10.1111/j.0956-7976.2005.01570.x; Rayner K., 1989, PSYCHOL READING; Riddoch MJ., 1993, BORB BIRMINGHAM OBJE; Roberts DJ, 2013, CEREB CORTEX, V23, P2568, DOI 10.1093/cercor/bhs224; Rosazza C, 2007, COGN NEUROPSYCHOL, V24, P393, DOI 10.1080/02643290701377877; Schiefer U, 2007, CLIN NEURO OPHTH, P19; Schofield TM, 2009, CURR OPIN NEUROL, V22, P36, DOI 10.1097/WCO.0b013e32831f1b2c; Schuett S, 2008, NEUROPSYCHOLOGIA, V46, P2445, DOI 10.1016/j.neuropsychologia.2008.04.016; Sheldon CA, 2012, NEUROPSYCHOLOGIA, V50, P841, DOI 10.1016/j.neuropsychologia.2012.01.020; Starrfelt R, 2013, BEHAV NEUROL, V26, P167, DOI [10.1155/2013/271815, 10.3233/BEN-2012-129002]; Starrfelt R., 2014, ALEXIA DIAGNOSIS TRE; Starrfelt R, 2009, CEREB CORTEX, V19, P2880, DOI 10.1093/cercor/bhp059; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; Warrington EK., 1991, VISUAL OBJECT SPACE; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891; ZIHL J, 1996, NEUROLOGICAL DISORDE, P201; Zihl J, 1999, REHABILITATION VISUA	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100898	10.1371/journal.pone.0100898	http://dx.doi.org/10.1371/journal.pone.0100898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999811	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300017
J	Espinosa-Gongora, C; Moodley, A; Lipinska, U; Broens, EM; Hermans, K; Butaye, P; Devriese, LA; Haesebrouck, F; Guardabassi, L				Espinosa-Gongora, Carmen; Moodley, Arshnee; Lipinska, Urszula; Broens, Els M.; Hermans, Katleen; Butaye, Patrick; Devriese, Luc A.; Haesebrouck, Freddy; Guardabassi, Luca			Phenotypes and Genotypes of Old and Contemporary Porcine Strains Indicate a Temporal Change in the S-aureus Population Structure in Pigs	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CRYSTAL VIOLET REACTIONS; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; SLAUGHTER PIGS; ST398; MRSA; PREVALENCE; ANIMALS	Introduction: Staphylococcus aureus sequence type ST398 has recently gained attention due to the spread of methicillin-resistant strains among people exposed to livestock. The aim of this study was to explore temporal changes in the population structure of S. aureus in pigs over the last 40 years with particular reference to the occurrence of ST398. Methods: We analysed a unique collection of 91 porcine strains isolated in six countries between 1973 and 2009 using a biotyping scheme described in the 1970's in combination with spa typing and multi-locus sequence typing (MLST). The collection comprised 32 historical isolates from 1973-1974 (n = 19) and from 1991-2003 (n = 13), and 59 contemporary isolates from 2004-2009. The latter isolates represented the most common MLST types (ST1, ST9, ST97 and ST433) and spa types isolated from pigs in Europe. Results and Discussion: S. aureus sequence type ST398 was not found among old isolates from the 1970's or from 19912003, suggesting that this lineage was absent or present at low frequencies in pigs in the past. This hypothesis is supported by the observed association of ST398 with the ovine ecovar, which was not described in pigs by studies carried out in the 1970's. In addition, various phenotypic and genotypic differences were observed between old and contemporary isolates. Some biotypes commonly reported in pigs in the 1970's were either absent (human ecovar) or rare (biotype A) among contemporary isolates. Nine clonal lineages found among old porcine isolates are occasionally reported in pigs today (ST8, ST30, ST97, ST387, ST1092, ST2468) or have never been described in this animal host (ST12, ST133, ST1343). These results indicate that the population structure of porcine S. aureus has changed over the last 40 years and confirm the current theory that S. aureus ST398 does not originate from pigs.	[Espinosa-Gongora, Carmen; Moodley, Arshnee; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Lipinska, Urszula; Hermans, Katleen; Butaye, Patrick; Devriese, Luc A.; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Broens, Els M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Vet Microbiol Diagnost Ctr, Utrecht, Netherlands; [Butaye, Patrick] Ctr Etud & Rech Vet & Agrochim, Ctr Onderzoek Diergeneeskunde & Agrochem, Unit Gen Bacteriol, Brussels, Belgium	University of Copenhagen; Ghent University; Utrecht University	Guardabassi, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	lg@sund.ku.dk	Haesebrouck, Freddy/M-3857-2014; Butaye, Patrick/AAJ-8240-2020	Haesebrouck, Freddy/0000-0002-1709-933X; Moodley, Arshnee/0000-0002-6469-3948; Butaye, Patrick/0000-0003-0780-6384; Espinosa-Gongora, Carmen/0000-0002-9536-0548; Guardabassi, Luca/0000-0002-2389-5084				Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; AKATOV AK, 1983, ZH MIKROB EPID IMMUN, P29; [Anonymous], 2009, EFSA J, V7; Argudin MA, 2010, APPL ENVIRON MICROB, V76, P652, DOI 10.1128/AEM.01721-09; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Aspiroz C, 2012, ENFERM INFEC MICR CL, V30, P18, DOI 10.1016/j.eimc.2011.07.013; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bagcigil FA, 2007, VET MICROBIOL, V121, P307, DOI 10.1016/j.vetmic.2006.12.007; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; DEVRIESE LA, 1984, J APPL BACTERIOL, V56, P215, DOI 10.1111/j.1365-2672.1984.tb01341.x; DEVRIESE LA, 1976, RES VET SCI, V21, P284, DOI 10.1016/S0034-5288(18)33337-X; DIMITRACOPOULOS G, 1977, APPL ENVIRON MICROB, V34, P461, DOI 10.1128/AEM.34.5.461-464.1977; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FREEMAN R, 1990, EPIDEMIOL INFECT, V105, P493, DOI 10.1017/S0950268800048111; FREEMAN R, 1994, J CLIN PATHOL, V47, P283, DOI 10.1136/jcp.47.3.283; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gomez-Sanz E, 2011, COMP IMMUNOL MICROB, V34, P447, DOI [10.1016/j.cimid.2011.08.002, 10.1016/j.cimid.2010.06.006]; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; HAJEK V, 1971, ZENTRALBL BAKT P INF, V217, P176; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hartmeyer GN, 2010, SCAND J INFECT DIS, V42, P318, DOI 10.3109/00365540903510708; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Lozano C, 2011, EMERG INFECT DIS, V17, P138, DOI 10.3201/eid1701.100307; MEYER W, 1966, ZENTBL BAKTERIOLOG P, V201, P465; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; OEDING P, 1972, ACTA PATHOLOG MICROB, VB 80, P525; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van der Wolf PJ, 2012, VET MICROBIOL, V158, P136, DOI 10.1016/j.vetmic.2012.01.025; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, GENOTYPE DIVERSITY S; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Verhegghe M., 2012, ZOONOSES PUBLIC HLTH; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; WITTE W, 1978, J HYG EPID MICROB IM, V22, P177	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101988	10.1371/journal.pone.0101988	http://dx.doi.org/10.1371/journal.pone.0101988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000530	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300111
J	Hou, DP; Wang, QS; Jiang, CH; Tian, C; Li, HQ; Ji, B				Hou, Dapeng; Wang, Qiushi; Jiang, Cuihua; Tian, Cui; Li, Huaqing; Ji, Bo			Evaluation of the Short-Term Effects of Antimicrobial Stewardship in the Intensive Care Unit at a Tertiary Hospital in China	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; RESTRICTION POLICY; IMPACT; SURVEILLANCE; STATES; SUSCEPTIBILITY; PATTERNS; PROGRAM; SYSTEMS	Antibiotic abuse can lead to antibiotic resistance, which is a severe problem in China. The purpose of this study is to evaluate the short-term effects of antimicrobial stewardship strategies, including formulary restriction, preauthorization, perioperative quinolone restriction, and control of total antibiotic consumption in the ICU at a tertiary hospital in China. After implementation of antimicrobial stewardship, the total antibiotic consumption in the ICU significantly decreased. The defined daily doses (DDDs) per 100 patient-days decreased from 197.65 to 143.41; however, the consumption of cephalosporins increased from 53.65 to 63.17 DDDs. Significant improvements in resistance to amikacin, gentamicin, ciprofloxacin, ofloxacin, ceftriaxone, ceftazidime, and piperacillin in Enterobacteriaceae and resistance to ceftazidime, imipenem, and meropenem in non-fermenting Gram-negative rods were observed. In addition, the initial use of no antibiotics or of a single antibiotic significantly increased (P<0.001) and the use of two antibiotics in combination significantly decreased (P<0.001). Our results demonstrate that implementation of antimicrobial stewardship in a short period in the ICU dramatically reduced antibiotic consumption and significantly improved antibiotic resistance, which leads to more reasonable antibiotic selections by ICU physicians.	[Hou, Dapeng; Wang, Qiushi; Jiang, Cuihua; Tian, Cui; Li, Huaqing] Taishan Med Coll, Affiliated Hosp, Dept Intens Care Unit, Tai An, Shandong, Peoples R China; [Ji, Bo] Taishan Med Coll, Affiliated Hosp, Dept Thorac Surg, Tai An, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Hou, DP (corresponding author), Taishan Med Coll, Affiliated Hosp, Dept Intens Care Unit, Tai An, Shandong, Peoples R China.	hdptyfy@163.com; jibotyty@163.com						Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bassetti M, 2000, INT J ANTIMICROB AG, V16, P295, DOI 10.1016/S0924-8579(00)00249-1; Belongia EA, 2005, EMERG INFECT DIS, V11, P912; Bliziotis IA, 2005, CLIN INFECT DIS, V41, P149, DOI 10.1086/430912; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Clinical and Laboratory Standards Institute, 2005, PERF STAND ANT SUS S; Cook PP, 2008, INFECT CONT HOSP EP, V29, P716, DOI 10.1086/589813; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Kaki R, 2011, J ANTIMICROB CHEMOTH, V66, P1223, DOI 10.1093/jac/dkr137; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005; Meyer E, 2006, INFECTION, V34, P303, DOI 10.1007/s15010-006-6619-x; Mohr JF, 2004, INT J ANTIMICROB AG, V24, P346, DOI 10.1016/j.ijantimicag.2004.06.002; Ntagiopoulos PG, 2007, INT J ANTIMICROB AG, V30, P360, DOI 10.1016/j.ijantimicag.2007.05.012; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Wang H, 2005, DIAGN MICR INFEC DIS, V51, P201, DOI 10.1016/j.diagmicrobio.2004.09.001; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	20	28	29	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101447	10.1371/journal.pone.0101447	http://dx.doi.org/10.1371/journal.pone.0101447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000225	Green Published, gold, Green Submitted			2022-12-25	WOS:000338637300044
J	Hu, F; Xu, L; Liu, ZH; Ge, MM; Ruan, DY; Wang, HL				Hu, Fan; Xu, Li; Liu, Zhi-Hua; Ge, Meng-Meng; Ruan, Di-Yun; Wang, Hui-Li			Developmental Lead Exposure Alters Synaptogenesis through Inhibiting Canonical Wnt Pathway In Vivo and In Vitro	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SIGNALING PATHWAY; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; NERVOUS-SYSTEM; DICKKOPF-1; PLASTICITY; RECEPTORS; HIPPOCAMPUS; ACTIVATION	Lead (Pb) exposure has been implicated in the impairment of synaptic plasticity in the developing hippocampus, but the mechanism remains unclear. Here, we investigated whether developmental lead exposure affects the dendritic spine formation through Wnt signaling pathway in vivo and in vitro. Sprague-Dawley rats were exposed to lead throughout the lactation period and Golgi-Cox staining method was used to examine the spine density of pyramidal neurons in the hippocampal CA1 area of rats. We found that lead exposure significantly decreased the spine density in both 14 and 21 days-old pups, accompanied by a significant age-dependent decline of the Wnt7a expression and stability of its downstream protein (beta-catenin). Furthermore, in cultured hippocampal neurons, lead (0.1 and 1 mu M lead acetate) significantly decreased the spine density in a dose-dependent manner. Exogenous Wnt7a application attenuated the decrease of spine density and increased the stability of the downstream molecules in Wnt signaling pathway. Together, our results suggest that lead has a negative impact on spine outgrowth in the developing hippocampus through altering the canonical Wnt pathway.	[Hu, Fan; Xu, Li; Liu, Zhi-Hua; Ge, Meng-Meng; Ruan, Di-Yun; Wang, Hui-Li] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China; [Ruan, Di-Yun] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Hefei University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, HL (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China.	wanghl@hfut.edu.cn		Hu, Fan/0000-0001-9951-6557	National Key Basic Research Program of China (973 Program) [2012CB525003]; National Science Foundation of China [31200851, 21307024]; Program for New Century Excellent Talents in University [NCET-12-0835]; Specialized Research Fund for the Doctoral Program of Higher Education [20130111110024]; China Postdoctoral Science Foundation [2013M531500]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2012CB525003, www.973.gov.cn), the National Science Foundation of China (No. 31200851 and 21307024, www.nsfc.gov.cn), the Program for New Century Excellent Talents in University (NCET-12-0835, www.dost.moe.edu.cn), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130111110024, www.cutech.edu.cn/cn), and the China Postdoctoral Science Foundation (2013M531500, www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ALFANO DP, 1982, EXP NEUROL, V75, P275, DOI 10.1016/0014-4886(82)90160-1; Bihaqi SW, 2013, NEUROTOXICOLOGY, V39, P95, DOI 10.1016/j.neuro.2013.07.010; Byun Y. H., 2013, PLOS ONE, V8; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen SP, 1999, TOXICOLOGY, V132, P67, DOI 10.1016/S0300-483X(98)00139-5; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hu F, 2008, BRAIN RES BULL, V77, P77, DOI 10.1016/j.brainresbull.2008.06.007; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Koyama Y, 2013, NEUROCHEM INT, V63, P35, DOI 10.1016/j.neuint.2013.04.009; Li CC, 2008, TOXICOL APPL PHARM, V229, P351, DOI 10.1016/j.taap.2008.01.039; Liu M., 2012, PLOS ONE, V7; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loikkanen J, 2003, TOXICOL LETT, V144, P235, DOI 10.1016/S0378-4274(03)00220-0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; Mike A, 2000, BRAIN RES, V873, P112, DOI 10.1016/S0006-8993(00)02533-6; Miller TE, 1998, TOXICOL SCI, V42, P129, DOI 10.1093/toxsci/42.2.129; Neal AP, 2011, NEUROTOXICOLOGY, V32, P281, DOI 10.1016/j.neuro.2010.12.013; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Nihei MK, 2000, NEUROSCIENCE, V99, P233, DOI 10.1016/S0306-4522(00)00192-5; OTUAMA LA, 1976, TOXICOL APPL PHARM, V36, P1, DOI 10.1016/0041-008X(76)90021-1; PETIT TL, 1983, NEUROTOXICOLOGY, V4, P79; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Ruan DY, 1998, BRAIN RES, V806, P196, DOI 10.1016/S0006-8993(98)00739-2; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Toscano CD, 2005, BRAIN RES REV, V49, P529, DOI 10.1016/j.brainresrev.2005.02.004; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Wang HL, 2006, EUR J NEUROSCI, V23, P1111, DOI 10.1111/j.1460-9568.2006.04645.x; Wang HL, 2008, ENVIRON HEALTH PERSP, V116, P1401, DOI 10.1289/ehp.11400; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wang L, 2007, NEUROTOXICOLOGY, V28, P499, DOI 10.1016/j.neuro.2006.11.003; Yu SS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-51; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	56	33	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101894	10.1371/journal.pone.0101894	http://dx.doi.org/10.1371/journal.pone.0101894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999626	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300096
J	Lowerre-Barbieri, S; Villegas-Rios, D; Walters, S; Bickford, J; Cooper, W; Muller, R; Trotter, A				Lowerre-Barbieri, Susan; Villegas-Rios, David; Walters, Sarah; Bickford, Joel; Cooper, Wade; Muller, Robert; Trotter, Alexis			Spawning Site Selection and Contingent Behavior in Common Snook, Centropomus undecimalis	PLOS ONE			English	Article							POPULATION-STRUCTURE; SPATIAL-DISTRIBUTION; RELATIVE ABUNDANCE; DIEL BEHAVIOR; LIFE-HISTORY; RED TIDE; FISH; FISHERIES; STOCK; AGGREGATIONS	Reproductive behavior affects spatial population structure and our ability to manage for sustainability in marine and diadromous fishes. In this study, we used fishery independent capture-based sampling to evaluate where Common Snook occurred in Tampa Bay and if it changed with spawning season, and passive acoustic telemetry to assess fine scale behavior at an inlet spawning site (2007-2009). Snook concentrated in three areas during the spawning season only one of which fell within the expected spawning habitat. Although in lower numbers, they remained in these areas throughout the winter months. Acoustically-tagged snook (n = 31) showed two seasonal patterns at the spawning site: Most fish occurred during the spawning season but several fish displayed more extended residency, supporting the capture-based findings that Common Snook exhibit facultative catadromy. Spawning site selection for iteroparous, multiple-batch spawning fishes occurs at the lifetime, annual, or intra-annual temporal scales. In this study we show colonization of a new spawning site, indicating that lifetime spawning site fidelity of Common Snook is not fixed at this fine spatial scale. However, individuals did exhibit annual and intra-seasonal spawning site fidelity to this new site over the three years studied. The number of fish at the spawning site increased in June and July (peak spawning months) and on new and full lunar phases indicating within population variability in spawning and movement patterns. Intra-seasonal patterns of detection also differed significantly with sex. Common Snook exhibited divergent migration tactics and habitat use at the annual and estuarine scales, with contingents using different overwintering habitat. Migration tactics also varied at the spawning site at the intra-seasonal scale and with sex. These results have important implications for understanding how reproductive behavior affects spatio-temporal patterns of fish abundance and their resilience to disturbance events and fishing pressure.	[Lowerre-Barbieri, Susan; Walters, Sarah; Bickford, Joel; Cooper, Wade; Muller, Robert; Trotter, Alexis] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA; [Villegas-Rios, David] Inst Marine Res IIM CSIC, Dept Ecol & Marine Resources, Vigo, Pontevedra, Spain	Florida Fish & Wildlife Conservation Commission; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Lowerre-Barbieri, S (corresponding author), Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA.	Susan.Barbieri@myfwc.com	Villegas Ríos, David/G-3091-2016	Villegas Ríos, David/0000-0001-5660-5322	US Fish and Wildlife Service Sport Fish Restoration program [F-59]	US Fish and Wildlife Service Sport Fish Restoration program(US Fish & Wildlife Service)	This project was supported by Grant F-59 from the US Fish and Wildlife Service Sport Fish Restoration program. http://wsfrprograms.fws.gov/Subpages/GrantPrograms/SFR/SFR.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2009, MAR ECOL PROG SER, V389, P213, DOI 10.3354/meps08198; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Adams AJ, 2011, ENVIRON BIOL FISH, P1; Ager L.A., 1976, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V30, P158; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Barbour AB, 2012, MARINE ECOLOGY PROGR; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bijoux JP, 2013, MAR ECOL PROG SER, V475, P233, DOI 10.3354/meps10113; Blewett David A., 2009, Florida Scientist, V72, P310; Blewett David A., 2006, Gulf and Caribbean Research, V18, P1; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cardinale M, 2011, FISH FISH, V12, P289, DOI 10.1111/j.1467-2979.2010.00393.x; Chapman P, 1982, FINAL REPORT SPORTFI; CLARK J, 1968, T AM FISH SOC, V97, P320, DOI 10.1577/1548-8659(1968)97[320:SMOSBC]2.0.CO;2; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; Colin PL, 1996, COPEIA, P189, DOI 10.2307/1446955; Danylchuk AJ, 2011, MAR BIOL, V158, P1981, DOI 10.1007/s00227-011-1707-6; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; Daverat F, 2012, MAR ECOL PROG SER, V465, P267, DOI 10.3354/meps09910; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Frank KT, 2001, J SEA RES, V45, P173, DOI 10.1016/S1385-1101(01)00056-9; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Hedger RD, 2008, ICES J MAR SCI, V65, P1248, DOI 10.1093/icesjms/fsn109; Hjort J., 1914, P RAPPORTS PROCRS VE; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kraus RT, 2004, MAR ECOL PROG SER, V279, P247, DOI 10.3354/meps279247; Kucera CJ, 2002, J FISH BIOL, V61, P726, DOI 10.1006/jfbi.2002.2097; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; LEVINS RICHARD, 1968; Ley JA, 2013, FISH RES, V144, P60, DOI 10.1016/j.fishres.2012.10.008; Lowerre-Barbieri SK, 1998, CAN J FISH AQUAT SCI, V55, P2244, DOI 10.1139/cjfas-55-10-2244; Lowerre-Barbieri SK, 2003, T AM FISH SOC, V132, P940, DOI 10.1577/T02-001; Lowerre-Barbieri SK, 2013, MAR ECOL PROG SER, V481, P181, DOI 10.3354/meps10224; Lowerre-Barbieri SK, 2009, MAR ECOL PROG SER, V394, P231, DOI 10.3354/meps08262; Lozano C, 2012, J FISH BIOL, V81, P1665, DOI 10.1111/j.1095-8649.2012.03426.x; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; Maunder MN, 2013, FISH RES, V146, P96, DOI 10.1016/j.fishres.2013.03.021; McDowall RM, 1997, REV FISH BIOL FISHER, V7, P443, DOI 10.1023/A:1018404331601; Meyer CG, 2007, AQUAT LIVING RESOUR, V20, P291, DOI 10.1051/alr:2008002; Miles NG, 2014, MAR FRESHWATER RES, V65, P12, DOI 10.1071/MF12340; Muller RG, 2014, 2013 STOCK ASSESSMEN; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Peters KM, 1998, B MAR SCI, V62, P509; Petitgas P, 2010, ICES J MARINE SCI; QUINTEROHUNTER I, 1991, BIOTECH HISTOCHEM, V66, P169, DOI 10.3109/10520299109109964; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Semmens JM, 2010, MAR ECOL PROG SER, V403, P193, DOI 10.3354/meps08469; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Smedbol RK, 2002, FISH RES, V55, P161; Smedbol RK, 2001, J FISH BIOL, V59, P109, DOI 10.1006/jfbi.2001.1765; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Syedang H, 2010, ENVIRON BIOL FISH, V89, P383, DOI 10.1007/s10641-010-9669-y; Taylor RG, 1998, J FISH BIOL, V53, P502, DOI 10.1006/jfbi.1998.0721; Taylor RG, 2000, FISH B-NOAA, V98, P612; Thibault I, 2007, MAR ECOL PROG SER, V344, P219, DOI 10.3354/meps06944; Trotter AA, 2012, T AM FISH SOC, V141, P1016, DOI 10.1080/00028487.2012.675903; TUCKER JW, 1987, PROG FISH CULT, V49, P49, DOI 10.1577/1548-8640(1987)49&lt;49:SATSCA&gt;2.0.CO;2; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Volpe AV, 1959, TECHNICAL SERIES FLO, P38; Walsh CT, 2012, ECOL FRESHW FISH, V21, P145, DOI 10.1111/j.1600-0633.2011.00534.x; Walters S, 2013, MAR ECOL PROG SER, V479, P191, DOI 10.3354/meps10219; Winner BL, 2010, T AM FISH SOC, V139, P62, DOI 10.1577/T08-215.1; Wood S, 2013, GEN ADDITIVE MIXED M; Yanes-Roca C, 2009, AQUACULTURE, V287, P335, DOI 10.1016/j.aquaculture.2008.10.043; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Young JM, 2014, MAR ECOL PROG SER, V505, P227, DOI 10.3354/meps10774; Zuur Alain F., 2009, P1	75	37	37	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101809	10.1371/journal.pone.0101809	http://dx.doi.org/10.1371/journal.pone.0101809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999986	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300090
J	Du, WX; Gao, J; Wang, TT; Wang, JK				Du, Wenxin; Gao, Jing; Wang, Tingting; Wang, Jinke			Single-Nucleotide Mutation Matrix: A New Model for Predicting the NF-kappa B DNA Binding Sites	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; SPECIFICITIES; FABRICATION; MICROARRAYS; ALGORITHM; SEQUENCES; PROTEINS; PATTERNS; MOTIFS; P50	In this study, we established a single nucleotide mutation matrix (SNMM) model based on the relative binding affinities of NF-kappa B p50 homodimer to a wild-type binding site (GGGACTTTCC) and its all single-nucleotide mutants detected with the double-stranded DNA microarray. We evaluated this model by scoring different groups of 10-bp DNA sequences with this model and analyzing the correlations between the scores and the relative binding affinities detected with three wet experiments, including the electrophoresis mobility shift assay (EMSA), the protein-binding microarray (PBM) and the systematic evolution of ligands by exponential enrichment-sequencing (SELEX-Seq). The results revealed that the SNMM scores were strongly correlated with the detected binding affinities. We also scored the DNA sequences with other three models, including the principal coordinate (PC) model, the position weight matrix scoring algorithm (PWMSA) model and the Match model, and analyzed the correlations between the scores and the detected binding affinities. In comparison with these models, the SNMM model achieved reliable results. We finally determined 0.747 as the optimal threshold for predicting the NF-kappa B DNA-binding sites with the SNMM model. The SNMM model thus provides a new alternative model for scoring the relative binding affinities of NF-kappa B to the 10-bp DNA sequences and predicting the NF-kappa B DNA-binding sites.	[Du, Wenxin; Gao, Jing; Wang, Tingting; Wang, Jinke] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, JK (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	wangjinke@seu.edu.cn	wang, tingting/AAK-2640-2020; Wang, Jinke/AAT-7832-2021		National Natural Science Foundation of China [61171030]; Technology Support Program of Jiangsu [BE2012741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Support Program of Jiangsu	This work was supported by the grants from the National Natural Science Foundation of China ( 61171030) and the Technology Support Program of Jiangsu (BE2012741). The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000026; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076109; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nijnik A, 2003, NUCLEIC ACIDS RES, V31, P1497, DOI 10.1093/nar/gkg231; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Wang J, 2003, J BIOCHEM BIOPH METH, V55, P215, DOI 10.1016/S0165-022X(03)00048-4; Wang JK, 2003, MOLECULES, V8, P153, DOI 10.3390/80100153; Wang JK, 2003, ANAL BIOCHEM, V316, P192, DOI 10.1016/S0003-2697(03)00049-6; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Zhou F, 2014, ANAL BIOCHEM, V448, P105, DOI 10.1016/j.ab.2013.12.003; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	32	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101490	10.1371/journal.pone.0101490	http://dx.doi.org/10.1371/journal.pone.0101490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992458	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400078
J	Gustine, DD; Brinkman, TJ; Lindgren, MA; Schmidt, JI; Rupp, TS; Adams, LG				Gustine, David D.; Brinkman, Todd J.; Lindgren, Michael A.; Schmidt, Jennifer I.; Rupp, T. Scott; Adams, Layne G.			Climate-Driven Effects of Fire on Winter Habitat for Caribou in the Alaskan-Yukon Arctic	PLOS ONE			English	Article							LANDSCAPE CHARACTERISTICS; NORTHWEST-TERRITORIES; VEGETATION-RESPONSE; SEWARD PENINSULA; LICHEN ABUNDANCE; FEMALE CARIBOU; TUNDRA FIRE; DYNAMICS; IMPACTS; DENSITY	Climatic warming has direct implications for fire-dominated disturbance patterns in northern ecosystems. A transforming wildfire regime is altering plant composition and successional patterns, thus affecting the distribution and potentially the abundance of large herbivores. Caribou (Rangifer tarandus) are an important subsistence resource for communities throughout the north and a species that depends on terrestrial lichen in late-successional forests and tundra systems. Projected increases in area burned and reductions in stand ages may reduce lichen availability within caribou winter ranges. Sufficient reductions in lichen abundance could alter the capacity of these areas to support caribou populations. To assess the potential role of a changing fire regime on winter habitat for caribou, we used a simulation modeling platform, two global circulation models (GCMs), and a moderate emissions scenario to project annual fire characteristics and the resulting abundance of lichen-producing vegetation types (i.e., spruce forests and tundra >60 years old) across a modeling domain that encompassed the winter ranges of the Central Arctic and Porcupine caribou herds in the Alaskan-Yukon Arctic. Fires were less numerous and smaller in tundra compared to spruce habitats throughout the 90-year projection for both GCMs. Given the more likely climate trajectory, we projected that the Porcupine caribou herd, which winters primarily in the boreal forest, could be expected to experience a greater reduction in lichen-producing winter habitats (-21%) than the Central Arctic herd that wintered primarily in the arctic tundra (-11%). Our results suggest that caribou herds wintering in boreal forest will undergo fire-driven reductions in lichen-producing habitats that will, at a minimum, alter their distribution. Range shifts of caribou resulting from fire-driven changes to winter habitat may diminish access to caribou for rural communities that reside in fire-prone areas.	[Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Brinkman, Todd J.; Lindgren, Michael A.; Schmidt, Jennifer I.; Rupp, T. Scott] Univ Alaska, Scenarios Network Alaska & Arctic Planning, Fairbanks, AK 99701 USA	United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	Gustine, DD (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	dgustine@usgs.gov	Schmidt, Jennifer/W-1638-2019	Schmidt, Jennifer/0000-0002-0945-3204	USGS Ecosystem Mission Area; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	USGS Ecosystem Mission Area; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is part of the U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKI JZ, 1993, CAN J ZOOL, V71, P1221, DOI 10.1139/z93-167; Arthur SM, 2009, EFFECTS OIL FIELD DE; Barrett CM, 2013, ECOLOGY, V94, P389, DOI 10.1890/12-0840.1; Barrett K, 2011, ECOL APPL, V21, P2380, DOI 10.1890/10-0896.1; Barrett K, 2012, REMOTE SENS LETT, V3, P729, DOI 10.1080/2150704X.2012.676741; Barrier TA, 2012, ECOSCIENCE, V19, P177, DOI 10.2980/19-2-3508; Bret-Harte MS, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0490; Brinkman T.J., 2013, WILDLIFE PROFESSIONA, V7, P38; Cahoon SMP, 2012, GLOBAL CHANGE BIOL, V18, P469, DOI 10.1111/j.1365-2486.2011.02528.x; Cameron RD, 2005, ARCTIC, V58, P1; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Collins WB, 2011, J WILDLIFE MANAGE, V75, P369, DOI 10.1002/jwmg.39; Duffy PA, 2005, ECOL APPL, V15, P1317, DOI 10.1890/04-0739; Duffy PA, 2006, INTERACTIONS CLIMATE; Duffy PA, 2007, INT J WILDLAND FIRE, V16, P277, DOI 10.1071/WF06034; Fauria MM, 2008, PHILOS T R SOC B, V363, P2317, DOI 10.1098/rstb.2007.2202; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Field CB, 2008, ECOLOGICAL IMPACTS C; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Gustine DD, 2014, RAPID COMMUN MASS SP, V28, P625, DOI 10.1002/rcm.6825; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2011, ECOL APPL, V21, P3211, DOI 10.1890/11-0387.1; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hinkes MT, 2005, J WILDLIFE MANAGE, V69, P1147, DOI 10.2193/0022-541X(2005)069[1147:IOPGOC]2.0.CO;2; Hu FS, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001270; Hummel M., 2008, CARIBOU N SHARED FUT, DOI DOI 10.1139/er-2013-0042; IPCC, 2013, CLIM CHANG 2013 PHYS, P127; Jandt R, 2008, ARCT ANTARCT ALP RES, V40, P89, DOI 10.1657/1523-0430(06-122)[JANDT]2.0.CO;2; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Joly K, 2003, CAN J ZOOL, V81, P1192, DOI 10.1139/Z03-109; Joly K, 2007, ARCTIC, V60, P401; Joly K, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00012.1; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; Kasischke ES., 2006, GEOPHYS RES LETT, V33; Klein David R., 2005, P597; KLEIN DR, 1982, J RANGE MANAGE, V35, P390, DOI 10.2307/3898326; Kochtubajda B, 2006, ARCTIC, V59, P211; Kofinas G, 2000, POLAR RES, V19, P3, DOI 10.1111/j.1751-8369.2000.tb00323.x; Kofinas G., 2005, ANTHROPOLOGICA, V49, P179; Kofinas GP, 2010, CAN J FOREST RES, V40, P1347, DOI 10.1139/X10-108; LANDHAUSSER SM, 1993, J ECOL, V81, P665, DOI 10.2307/2261664; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenart EA, 2011, CARIBOU MANAGEMENT R, P299; Maier JAK, 2005, CAN J FOREST RES, V35, P2233, DOI 10.1139/X05-123; Martin P.D., 2009, WILDLIFE RESPONSES E, P138; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McMullen C. P., 2009, CLIM CHANG SCI COMP; McNeeley SM, 2011, GLOBAL ENVIRON CHANG, V21, P464, DOI 10.1016/j.gloenvcha.2011.02.003; Nagy JA, 2011, ECOL APPL, V21, P2334, DOI 10.1890/10-1410.1; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Nelson JL, 2008, ECOSYSTEMS, V11, P156, DOI 10.1007/s10021-007-9114-z; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Racine C, 2004, ARCT ANTARCT ALP RES, V36, P1, DOI 10.1657/1523-0430(2004)036[0001:TFAVCA]2.0.CO;2; Rupp TS, 2006, ECOL APPL, V16, P1730, DOI 10.1890/1051-0761(2006)016[1730:STIOVF]2.0.CO;2; Rupp TS, 2007, EARTH INTERACT, V11, DOI 10.1175/EI189.1; Rupp TS, 2000, LANDSCAPE ECOL, V15, P383, DOI 10.1023/A:1008168418778; Rupp TS, 2000, GLOBAL CHANGE BIOL, V6, P541, DOI 10.1046/j.1365-2486.2000.00337.x; Russell D.E., 1984, P117; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; SCHAEFER JA, 1991, WILDLIFE MONOGR, P1; SCOTTER G. W., 1697, CAN FIELD NAT, V81, P31; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; SKOGLAND T, 1986, J WILDLIFE MANAGE, V50, P314, DOI 10.2307/3801919; Skoog RO, 1968, THESIS U CALIFORNIA; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tews J, 2007, ECOL MODEL, V207, P85, DOI 10.1016/j.ecolmodel.2007.04.011; Thomas D., 1998, TECHNICAL REPORT SER, V312; Thomas DC, 1998, TECHNICAL REPORT SER, V311; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Tveraa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056450; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; U.S. Geological Survey, 2005, N AM LAND COV 250 M; Valkenburg P, 2001, ALCES-N AM MOOSE CON, V37, P457; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White Robert G., 1992, P407; Witter LA, 2012, ECOL APPL, V22, P1838, DOI 10.1890/11-0569.1; Wolfe S.A., 2000, THESIS U ALASKA FAIR; Zamin TJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034027	85	28	29	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100588	10.1371/journal.pone.0100588	http://dx.doi.org/10.1371/journal.pone.0100588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991804	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400025
J	Steiner, M; Claes, L; Ignatius, A; Simon, U; Wehner, T				Steiner, Malte; Claes, Lutz; Ignatius, Anita; Simon, Ulrich; Wehner, Tim			Numerical Simulation of Callus Healing for Optimization of Fracture Fixation Stiffness	PLOS ONE			English	Article							TIBIAL SHAFT; INTERFRAGMENTARY MOTION; INTRAMEDULLARY NAIL; PLATE REMOVAL; BLOOD-FLOW; LOCKING; BONE; DYNAMIZATION; REFRACTURE; STABILITY	The stiffness of fracture fixation devices together with musculoskeletal loading defines the mechanical environment within a long bone fracture, and can be quantified by the interfragmentary movement. In vivo results suggested that this can have acceleratory or inhibitory influences, depending on direction and magnitude of motion, indicating that some complications in fracture treatment could be avoided by optimizing the fixation stiffness. However, general statements are difficult to make due to the limited number of experimental findings. The aim of this study was therefore to numerically investigate healing outcomes under various combinations of shear and axial fixation stiffness, and to detect the optimal configuration. A calibrated and established numerical model was used to predict fracture healing for numerous combinations of axial and shear fixation stiffness under physiological, superimposed, axial compressive and translational shear loading in sheep. Characteristic maps of healing outcome versus fixation stiffness (axial and shear) were created. The results suggest that delayed healing of 3 mm transversal fracture gaps will occur for highly flexible or very rigid axial fixation, which was corroborated by in vivo findings. The optimal fixation stiffness for ovine long bone fractures was predicted to be 1000-2500 N/mm in the axial and >300 N/mm in the shear direction. In summary, an optimized, moderate axial stiffness together with certain shear stiffness enhances fracture healing processes. The negative influence of one improper stiffness can be compensated by adjustment of the stiffness in the other direction.	[Steiner, Malte; Claes, Lutz; Ignatius, Anita; Wehner, Tim] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Simon, Ulrich] Univ Ulm, Sci Comp Ctr Ulm, D-89069 Ulm, Germany	Ulm University; Ulm University	Steiner, M (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	malte.steiner@uni-ulm.de	Ignatius, Anita/M-6012-2013; Claes, Lutz/O-4697-2014	Ignatius, Anita/0000-0002-4782-1979; 	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	This study was intramurally funded by the Center of Musculoskeletal Research Ulm, University of Ulm, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Beaupre GS, 1996, J ORTHOP TRAUMA, V10, P87, DOI 10.1097/00005131-199602000-00003; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P1746, DOI 10.2106/00004623-200111000-00020; Bhandari M, 2001, J BONE JOINT SURG BR, V83B, P62, DOI 10.1302/0301-620X.83B1.10986; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bishop NE, 2006, CLIN ORTHOP RELAT R, P307, DOI 10.1097/01.blo.0000191272.34786.09; Bottlang M, 2011, J ORTHOP TRAUMA, V25, pS21, DOI 10.1097/BOT.0b013e318207885b; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P12, DOI 10.2106/JBJS.J.00780; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P1652, DOI 10.2106/JBJS.I.01111; Brinker MR, 2004, J BONE JOINT SURG AM, V86A, P290, DOI 10.2106/00004623-200402000-00011; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; CLAES L, 1981, ARCH ORTHOP TRAUM SU, V98, P257, DOI 10.1007/BF00378878; Claes L, 2002, LANGENBECK ARCH SURG, V387, P146, DOI 10.1007/s00423-002-0306-x; CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8; Claes LE, 1998, CLIN ORTHOP RELAT R, pS132; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Dailey HL, 2012, CLIN BIOMECH, V27, P182, DOI 10.1016/j.clinbiomech.2011.08.009; Davison BL, 2003, ORTHOPEDICS, V26, P157; Dobele S, 2010, LANGENBECK ARCH SURG, V395, P421, DOI 10.1007/s00423-010-0636-z; Duda GN, 2002, CLIN ORTHOP RELAT R, P163; Duda GN, 1998, J BIOMECH, V31, P201, DOI 10.1016/S0021-9290(97)00127-9; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Epari DR, 2007, J BONE JOINT SURG AM, V89A, P1575, DOI 10.2106/JBJS.F.00247; Gardner TN, 1997, CLIN ORTHOP RELAT R, P216; GOODSHIP AE, 1993, J BIOMECH, V26, P1027, DOI 10.1016/S0021-9290(05)80002-8; Grasa J, 2010, ANN BIOMED ENG, V38, P605, DOI 10.1007/s10439-009-9889-5; Heller MO, 2005, MATERIALWISS WERKST, V36, P775, DOI 10.1002/mawe.200500969; Hente R, 2004, J ORTHOP RES, V22, P709, DOI 10.1016/j.orthres.2003.11.007; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; KENWRIGHT J, 1991, J BONE JOINT SURG BR, V73, P654, DOI 10.1302/0301-620X.73B4.2071654; Larsson S, 2001, CLIN ORTHOP RELAT R, P240; Lujan TJ, 2010, J ORTHOP TRAUMA, V24, P156, DOI 10.1097/BOT.0b013e3181be6720; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Ochs BG, 2012, UNFALLCHIRURG, V115, P323, DOI 10.1007/s00113-012-2155-6; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Penzkofer R, 2009, ARCH ORTHOP TRAUM SU, V129, P525, DOI 10.1007/s00402-008-0700-0; Perren S M, 1969, Acta Orthop Scand Suppl, V125, P19; Plecko M, 2013, INJURY, V44, P1346, DOI 10.1016/j.injury.2012.10.022; Praemer A, 1992, MUSCULOSKELETAL COND; RHINELANDER FW, 1974, CLIN ORTHOP RELAT R, P34; Schell H, 2008, J BIOMECH, V41, P3066, DOI 10.1016/j.jbiomech.2008.06.038; Simon U, 2011, COMPUT METHOD BIOMEC, V14, P79, DOI 10.1080/10255842.2010.499865; Steiner M, 2014, J ORTHOP RE IN PRESS; Steiner M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0389; STRACHAN RK, 1990, J BONE JOINT SURG BR, V72, P391, DOI 10.1302/0301-620X.72B3.2341434; TRIFFITT PD, 1993, J ORTHOPAED RES, V11, P49, DOI 10.1002/jor.1100110107; Wehner T, 2011, CLIN BIOMECH, V26, P147, DOI 10.1016/j.clinbiomech.2010.09.009; Wehner T, 2010, CLIN BIOMECH, V25, P606, DOI 10.1016/j.clinbiomech.2010.03.003; Wehner T, 2009, CLIN BIOMECH, V24, P299, DOI 10.1016/j.clinbiomech.2008.12.007; Wolf S, 1998, CLIN BIOMECH, V13, P359, DOI 10.1016/S0268-0033(98)00097-7; YAMAGISHI M, 1955, J BONE JOINT SURG AM, V37, P1035, DOI 10.2106/00004623-195537050-00013	54	32	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101370	10.1371/journal.pone.0101370	http://dx.doi.org/10.1371/journal.pone.0101370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991809	gold, Green Published, Green Submitted			2022-12-25	WOS:000341253400065
J	Wang, C; Niu, LN; Wang, YJ; Jiao, K; Liu, Y; Zhou, W; Shen, LJ; Fang, M; Li, M; Zhang, X; Tay, FR; Chen, JH				Wang, Chen; Niu, Li-na; Wang, Ying-jie; Jiao, Kai; Liu, Yan; Zhou, Wei; Shen, Li-juan; Fang, Ming; Li, Meng; Zhang, Xiang; Tay, Franklin R.; Chen, Ji-hua			Bonding of Resin Cement to Zirconia with High Pressure Primer Coating	PLOS ONE			English	Article							FIXED DENTAL PROSTHESES; LUTING CEMENTS; SURFACE MODIFICATION; OXIDE CERAMICS; HEMA-FREE; STRENGTH; SOLVENT; MONOMER; SILANE; TEMPERATURE	Objectives: To investigate the effect of air-drying pressure during ceramic primer coating on zirconia/resin bonding and the surface characteristics of the primed zirconia. Methods: Two ceramic primers (Clearfil Ceramic Primer, CCP, Kuraray Medical Inc. and Z-Prime Plus, ZPP, Bisco Inc.) were applied on the surface of air-abraded zirconia (Katana zirconia, Noritake) and dried at 4 different air pressures (0.1-0.4 MPa). The primed zirconia ceramic specimens were bonded with a resin-based luting agent (SA Luting Cement, Kuraray). Micro-shear bond strengths of the bonded specimens were tested after 3 days of water storage or 5,000x thermocycling (n = 12). Failure modes of the fractured specimens were examined with scanning electron miscopy. The effects of air pressure on the thickness of the primer layers and the surface roughness (S-a) of primed zirconia were evaluated using spectroscopic ellipsometry (n = 6), optical profilometry and environmental scanning electron microscopy (ESEM) (n = 6), respectively. Results: Clearfil Ceramic Primer air-dried at 0.3 and 0.4 MPa, yielding significantly higher mu SBS than gentle air-drying subgroups (p < 0.05). Compared to vigorous drying conditions, Z-Prime Plus air-dried at 0.2 MPa exhibited significantly higher mSBS (p < 0.05). Increasing air-drying pressure reduced the film thickness for both primers. Profilometry measurements and ESEM showed rougher surfaces in the high pressure subgroups of CCP and intermediate pressure subgroup of ZPP. Conclusion: Air-drying pressure influences resin/zirconia bond strength and durability significantly. Higher air-drying pressure (0.3-0.4 MPa) for CCP and intermediate pressure (0.2 MPa) for ZPP are recommended to produce strong, durable bonds between resin cement and zirconia ceramics.	[Wang, Chen; Niu, Li-na; Liu, Yan; Zhou, Wei; Shen, Li-juan; Fang, Ming; Li, Meng; Zhang, Xiang; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Wang, Ying-jie] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Jiao, Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Tay, Franklin R.] Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA 30912 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University System of Georgia; Augusta University	Tay, FR (corresponding author), Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA 30912 USA.	tayfranklin7@gmail.com; jhchen@fmmu.edu.cn	meng, li/GVT-2063-2022; niu, lina/GWR-3585-2022	Chen, Ji-hua/0000-0002-1151-0693; jiao, kai/0000-0002-1901-8329; Tay, Franklin/0000-0003-3769-0626	Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]; Major Program of National Natural Science Foundation of China [81130078]; early stage of State Key Development Program of Basic Research Program of China [2012CB526704]; young investigator supporting grant of China [13QNP138]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); early stage of State Key Development Program of Basic Research Program of China; young investigator supporting grant of China	This study was financially supported by Supported by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051), the Major Program of National Natural Science Foundation of China (No. 81130078), the early stage of State Key Development Program of Basic Research Program of China (No. 2012CB526704) and young investigator supporting grant of China (No. 13QNP138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Tara M, 2011, J DENT, V39, P208, DOI 10.1016/j.jdent.2010.12.005; Aboushelib MN, 2011, J ADHES DENT, V13, P255, DOI 10.3290/j.jad.a19241; Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1; Atsu SS, 2006, J PROSTHET DENT, V95, P430, DOI 10.1016/j.prosdent.2006.03.016; Attia A, 2011, J PROSTHET DENT, V106, P319, DOI 10.1016/S0022-3913(11)60137-6; Bail M, 2012, J MATER SCI-MATER M, V23, P629, DOI 10.1007/s10856-011-4541-y; Carriere D, 2004, LANGMUIR, V20, P3449, DOI 10.1021/la036249m; Queiroz JRC, 2012, DENT MATER, V28, P189, DOI 10.1016/j.dental.2011.10.009; Chen CF, 2012, DENT MATER, V28, pE127, DOI 10.1016/j.dental.2012.04.020; Chen L, 2013, J PROSTHET DENT, V110, P402, DOI 10.1016/j.prosdent.2013.04.005; Chen L, 2012, AM J DENT, V25, P103; Felizardo Klíssia Romero, 2011, Braz. Dent. J., V22, P468, DOI 10.1590/S0103-64402011000600005; Hiraishi N, 2007, DENT MATER, V23, P498, DOI 10.1016/j.dental.2006.03.007; Ikeda T, 2008, DENT MATER, V24, P1316, DOI 10.1016/j.dental.2008.02.009; Inokoshi M, 2013, J DENT, V41, P170, DOI 10.1016/j.jdent.2012.10.017; Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6; Kern M, 2009, J DENT RES, V88, P817, DOI 10.1177/0022034509340881; Kern M, 2009, J ADHES SCI TECHNOL, V23, P1097, DOI 10.1163/156856109X432721; Kim MJ, 2011, J DENT, V39, P795, DOI 10.1016/j.jdent.2011.08.012; Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159; Kumbuloglu O, 2006, OPER DENT, V31, P248, DOI 10.2341/05-22; Gomes AL, 2013, J DENT, V41, P31, DOI 10.1016/j.jdent.2012.09.013; Luthy H, 2006, DENT MATER, V22, P195, DOI 10.1016/j.dental.2005.04.016; Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005; Monticelli F, 2006, DENT MATER, V22, P1024, DOI 10.1016/j.dental.2005.11.024; Ozcan M, 2004, DENT MATER, V20, P586, DOI 10.1016/j.dental.2003.10.003; Papacchini F, 2007, J ADHES DENT, V9, P391; Papia E, 2014, J BIOMED MATER RES B, V102, P395, DOI 10.1002/jbm.b.33013; Perdigao J, 2013, OPER DENT, V38, P168, DOI 10.2341/11-489-L; Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008; Piascik JR, 2012, DENT MATER, V28, P604, DOI 10.1016/j.dental.2012.01.008; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Sasse M, 2013, INT J COMPUT DENT, V16, P109; Spohr AM, 2008, PHOTOMED LASER SURG, V26, P203, DOI 10.1089/pho.2007.2130; Tanaka R, 2008, J DENT RES, V87, P666, DOI 10.1177/154405910808700705; Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022; Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214; Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040; Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Yoshida K, 2006, J BIOMED MATER RES B, V77B, P28, DOI 10.1002/jbm.b.30424; Zandparsa R, 2014, J PROSTHODONT, V23, P117, DOI 10.1111/jopr.12075	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101174	10.1371/journal.pone.0101174	http://dx.doi.org/10.1371/journal.pone.0101174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992678	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400048
J	De Martino, A; De Martino, D; Mulet, R; Pagnani, A				De Martino, Andrea; De Martino, Daniele; Mulet, Roberto; Pagnani, Andrea			Identifying All Moiety Conservation Laws in Genome-Scale Metabolic Networks	PLOS ONE			English	Article							CHEMICAL-REACTION SYSTEMS; ESCHERICHIA-COLI; BIOCHEMICAL NETWORKS; NULL SPACE; ALGORITHM; RECONSTRUCTION; ESSENTIALITY; ORGANIZATION; SIZE	The stoichiometry of a metabolic network gives rise to a set of conservation laws for the aggregate level of specific pools of metabolites, which, on one hand, pose dynamical constraints that cross-link the variations of metabolite concentrations and, on the other, provide key insight into a cell's metabolic production capabilities. When the conserved quantity identifies with a chemical moiety, extracting all such conservation laws from the stoichiometry amounts to finding all non-negative integer solutions of a linear system, a programming problem known to be NP-hard. We present an efficient strategy to compute the complete set of integer conservation laws of a genome-scale stoichiometric matrix, also providing a certificate for correctness and maximality of the solution. Our method is deployed for the analysis of moiety conservation relationships in two large-scale reconstructions of the metabolism of the bacterium E. coli, in six tissue-specific human metabolic networks, and, finally, in the human reactome as a whole, revealing that bacterial metabolism could be evolutionarily designed to cover broader production spectra than human metabolism. Convergence to the full set of moiety conservation laws in each case is achieved in extremely reduced computing times. In addition, we uncover a scaling relation that links the size of the independent pool basis to the number of metabolites, for which we present an analytical explanation.	[De Martino, Andrea] CNR IPCF, Unita Roma Sapienza, Rome, Italy; [De Martino, Andrea] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [De Martino, Andrea; De Martino, Daniele] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Mulet, Roberto] Univ Havana, Fac Phys, Henri Poincare Grp Complex Syst, Havana, Cuba; [Mulet, Roberto] Univ Havana, Fac Phys, Dept Theoret Phys, Havana, Cuba; [Pagnani, Andrea] Politecn Torino, DISAT, Turin, Italy; [Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Pagnani, Andrea] Human Genet Fdn, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Universidad de la Habana; Universidad de la Habana; Polytechnic University of Turin; Polytechnic University of Turin	De Martino, D (corresponding author), Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.	daniele.demartino@roma1.infn.it	De Martino, Daniele/GQA-9589-2022; de martino, daniele/L-6519-2017; De Martino, Andrea/AAY-4120-2020; Pagnani, Andrea/J-2363-2015	Pagnani, Andrea/0000-0002-6509-0807; De Martino, Daniele/0000-0002-5214-4706; Mulet, Roberto/0000-0001-5168-5116; De Martino, Andrea/0000-0001-7590-6542	DREAM Seed Project of the Italian Institute of Technology (IIT); IIT/Sapienza Lab "Nanomedicine"	DREAM Seed Project of the Italian Institute of Technology (IIT); IIT/Sapienza Lab "Nanomedicine"	Work was supported by the DREAM Seed Project of the Italian Institute of Technology (IIT) and by the joint IIT/Sapienza Lab "Nanomedicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Baldassi C, 2007, P NATL ACAD SCI USA, V104, P11079, DOI 10.1073/pnas.0700324104; Beard D. A., 2008, CHEM BIOPHYSICS; Behre J, 2012, METHODS MOL BIOL, V804, P377, DOI 10.1007/978-1-61779-361-5_20; Braunstein A, 2005, RANDOM STRUCT ALGOR, V27, P201, DOI 10.1002/rsa.20057; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; COLEMAN TF, 1986, SIAM J ALGEBRA DISCR, V7, P527, DOI 10.1137/0607059; CONTEJEAN E, 1994, INFORM COMPUT, V113, P143, DOI 10.1006/inco.1994.1067; CONTI P, 1991, LECT NOTES COMPUT SC, V539, P130; De Martino A, 2007, J STAT MECH-THEORY E, V2007; Eisenbrand F, 2006, OPER RES LETT, V34, P564, DOI 10.1016/j.orl.2005.09.008; Famili I, 2003, BIOPHYS J, V85, P16, DOI 10.1016/S0006-3495(03)74450-6; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Gevorgyan A, 2008, BIOINFORMATICS, V24, P2245, DOI 10.1093/bioinformatics/btn425; Heinrich R., 1996, REGULATION CELLULAR; Henk Martin, 1997, RESULTS MATH, V32, P298, DOI [10.1007/BF03322141, DOI 10.1007/BF03322141]; Imielinski M, 2006, BIOPHYS J, V90, P2659, DOI 10.1529/biophysj.105.069278; Imielinski M, 2005, BIOINFORMATICS, V21, P2008, DOI 10.1093/bioinformatics/bti245; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Kim J., 1983, INT JOINT C ART INT, P190; Koch I, 2010, MOL INFORM, V29, P838, DOI 10.1002/minf.201000086; Krauth W, 1998, LECT NOTES PHYS, V501, P1; KRAUTH W, 1987, J PHYS A-MATH GEN, V20, pL745, DOI 10.1088/0305-4470/20/11/013; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Martelli C, 2009, P NATL ACAD SCI USA, V106, P2607, DOI 10.1073/pnas.0813229106; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Mulet R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268701; Nikolaev EV, 2005, BIOPHYS J, V88, P37, DOI 10.1529/biophysj.104.043489; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papadimitrou C, 2000, COMBINATORIAL OPTIMI; Papin JA, 2002, J THEOR BIOL, V215, P67, DOI 10.1006/jtbi.2001.2499; Pasechnik DV, 2001, THEOR COMPUT SCI, V263, P37, DOI 10.1016/S0304-3975(00)00229-2; Pearl J., 1982, P AM ASS ART INT NAT, P133; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ricci Tersenghi F, 2009, JSTAT, V2009; Sauro HM, 2004, BIOPHYS CHEM, V109, P1, DOI 10.1016/j.bpc.2003.08.009; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schrijver A., 1998, THEORY LINEAR INTEGE; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; SCHUSTER S, 1995, J PHYS CHEM-US, V99, P8017, DOI 10.1021/j100020a026; SCHUSTER S, 1991, J CHEM SOC FARADAY T, V87, P2561, DOI 10.1039/ft9918702561; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vallabhajosyula RR, 2006, BIOINFORMATICS, V22, P346, DOI 10.1093/bioinformatics/bti800; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Yedidia JS, 2000, ADV NEURAL INFORM PR, V13, P689; Yeung M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-363; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	54	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100750	10.1371/journal.pone.0100750	http://dx.doi.org/10.1371/journal.pone.0100750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988199	Green Published, gold, Green Submitted			2022-12-25	WOS:000341354100039
J	Fan, GQ; Du, GH; Li, HJ; Lin, F; Sun, ZY; Yang, W; Feng, C; Zhu, GC; Li, YS; Chen, Y; Jiao, H; Zhou, FK				Fan, Guangqin; Du, Guihua; Li, Huijun; Lin, Fen; Sun, Ziyong; Yang, Wei; Feng, Chang; Zhu, Gaochun; Li, Yanshu; Chen, Ying; Jiao, Huan; Zhou, Fankun			The Effect of the Hemochromatosis (HFE) Genotype on Lead Load and Iron Metabolism among Lead Smelter Workers	PLOS ONE			English	Article							HIGHER BLOOD LEAD; HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; H63D MUTATIONS; GENE-MUTATIONS; MOUSE-LIVER; POPULATION; DEFICIENCY; EXPRESSION; CHILDREN	Background: Both an excess of toxic lead (Pb) and an essential iron disorder have been implicated in many diseases and public health problems. Iron metabolism genes, such as the hemochromatosis (HFE) gene, have been reported to be modifiers for lead absorption and storage. However, the HFE gene studies among the Asian population with occupationally high lead exposure are lacking. Objectives: To explore the modifying effects of the HFE genotype (wild-type, H63D variant and C282Y variant) on the Pb load and iron metabolism among Asian Pb-workers with high occupational exposure. Methods: Seven hundred and seventy-one employees from a lead smelter manufacturing company were tested to determine their Pb intoxication parameters, iron metabolic indexes and identify the HFE genotype. Descriptive and multivariate analyses were conducted. Results: Forty-five H63D variant carriers and no C282Y variant carrier were found among the 771 subjects. Compared with subjects with the wild-type genotype, H63D variant carriers had higher blood lead levels, even after controlling for factors such as age, sex, marriage, education, smoking and lead exposure levels. Multivariate analyses also showed that the H63D genotype modifies the associations between the blood lead levels and the body iron burden/transferrin. Conclusions: No C282Y variant was found in this Asian population. The H63D genotype modified the association between the lead and iron metabolism such that increased blood lead is associated with a higher body iron content or a lower transferrin in the H63D variant. It is indicated that H63D variant carriers may be a potentially highly vulnerable sub-population if they are exposed to high lead levels occupationally.	[Fan, Guangqin; Du, Guihua; Lin, Fen; Feng, Chang; Zhu, Gaochun; Li, Yanshu; Chen, Ying; Jiao, Huan; Zhou, Fankun] Nanchang Univ, Sch Publ Hlth, Dept Occupat Hlth & Toxicol, Nanchang, Peoples R China; [Li, Huijun; Sun, Ziyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Lab, Wuhan 430074, Peoples R China; [Lin, Fen] Gannan Med Univ, Sch Med, Dept Prevent Med, Ganzhou, Peoples R China; [Yang, Wei] Univ Nevada, Sch Community Hlth Sci, Nevada Ctr Hlth Stat & Informat, Reno, NV 89557 USA	Nanchang University; Huazhong University of Science & Technology; Gannan Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fan, GQ (corresponding author), Nanchang Univ, Sch Publ Hlth, Dept Occupat Hlth & Toxicol, Nanchang, Peoples R China.	fanfgq@126.com			National Nature Science Foundation of China [30960324, 81273120, 21267017]; Jiangxi Provincial Natural Science Foundation [20132BAB205069]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation	This work was supported by The National Nature Science Foundation of China (Nos. 30960324, 81273120, 21267017), Jiangxi Provincial Natural Science Foundation (No. 20132BAB205069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN GS, 1993, NEUROTOXICOLOGY, V14, P273; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Barnum-Huckins K, 2000, CELL BIOL INT, V24, P71, DOI 10.1006/cbir.1999.0456; BARTON JC, 1994, J LAB CLIN MED, V124, P193; BARTON JC, 1978, J LAB CLIN MED, V92, P536; Beutler E, 1997, AM J HUM GENET, V61, P762; Bradman A, 2001, ENVIRON HEALTH PERSP, V109, P1079, DOI 10.2307/3454964; Burke W, 2000, GENET MED, V2, P271, DOI 10.1097/00125817-200009000-00001; Cardoso EMP, 1998, J INTERN MED, V243, P203; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gao A, 2010, SCI TOTAL ENVIRON, V408, P4052, DOI 10.1016/j.scitotenv.2010.04.024; Geier A, 2004, LIVER INT, V24, P285, DOI 10.1111/j.1478-3231.2004.0928.x; Giambattistelli F, 2012, NEUROBIOL AGING, V33, P1633, DOI 10.1016/j.neurobiolaging.2011.03.005; Gochee PA, 2002, GASTROENTEROLOGY, V122, P646, DOI 10.1016/S0016-5085(02)80116-0; Hammad TA, 1996, ANN EPIDEMIOL, V6, P30, DOI 10.1016/1047-2797(95)00097-6; Hopkins MR, 2008, ENVIRON HEALTH PERSP, V116, P1261, DOI 10.1289/ehp.11233; Jahanshad N, 2012, P NATL ACAD SCI USA, V109, pE851, DOI 10.1073/pnas.1105543109; Leong I, 2003, AM J CLIN NUTR, V78, P1203, DOI 10.1093/ajcn/78.6.1203; Lin A, 2007, TISSUE ANTIGENS, V70, P252, DOI 10.1111/j.1399-0039.2007.00877.x; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; MARCUS AH, 1987, ENVIRON RES, V44, P221, DOI 10.1016/S0013-9351(87)80230-X; Njajou OT, 2003, EUR J HUM GENET, V11, P225, DOI 10.1038/sj.ejhg.5200955; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Sassi R, 2004, ANN GENET-PARIS, V47, P325, DOI 10.1016/j.anngen.2004.05.001; Scinicariello F, 2007, ENVIRON HEALTH PERSP, V115, P35, DOI 10.1289/ehp.9448; SIX KM, 1972, J LAB CLIN MED, V79, P128; Weyermann M, 1997, ARCH ENVIRON HEALTH, V52, P233, DOI 10.1080/00039899709602892; Whitfield JB, 2007, ENVIRON HEALTH PERSP, V115, P1224, DOI 10.1289/ehp.8847; Wright RO, 2003, J PEDIATR-US, V142, P9, DOI 10.1067/mpd.2003.mpd0344; Wright RO, 2004, ENVIRON HEALTH PERSP, V112, P746, DOI 10.1289/ehp.6581; Zhao Y, 2007, J TOXICOL ENV HEAL A, V70, P1986, DOI 10.1080/15287390701550946; Zhu GC, 2013, TOXICOL LETT, V216, P108, DOI 10.1016/j.toxlet.2012.11.024	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101537	10.1371/journal.pone.0101537	http://dx.doi.org/10.1371/journal.pone.0101537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988074	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100110
J	Hirano, K; Okuno, A; Hobo, T; Ordonio, R; Shinozaki, Y; Asano, K; Kitano, H; Matsuoka, M				Hirano, Ko; Okuno, Ayako; Hobo, Tokunori; Ordonio, Reynante; Shinozaki, Yusuke; Asano, Kenji; Kitano, Hidemi; Matsuoka, Makoto			Utilization of Stiff Culm Trait of Rice smos1 Mutant for Increased Lodging Resistance	PLOS ONE			English	Article								Although the introduction of semi-dwarf trait into rice has led to improved lodging resistance making it capable of supporting high grain yield, lodging still remains a concern when attempting to further increase the grain yield of rice. However, improving the lodging resistance in rice by depending on the semi-dwarf trait alone is possible only up to a certain limit, beyond which other traits may be needed for reinforcement. To search for alternative traits relating to high lodging resistance, we identified 9 rice mutant lines possessing improved culm strength. To evaluate whether such lines can be useful for breeding lodging resistant rice, small organ size1 (smos1) mutant having increased lodging resistance but low tiller number and low grain yield, was chosen as a representative for a breeding trial. smos1 was crossed with ST-4 (from the Stock rice collection of Nagoya University Togo field #4), a cultivar with high tiller number and high grain yield, and from their progeny, LRC1 (lodging resistance candidate-1) was selected. Although the low tiller number trait of smos1 was not fully reversed in LRC1, this was compensated by an increase in grain weight per panicle, thereby resulting in high grain yield per plant. This important attribute of LRC1 was further enhanced by the improved lodging resistance trait inherited from smos1. Such improved lodging resistance in LRC1 and smos1 was revealed to be mainly due to increased culm diameter and culm thickness, which led to a high section modulus (SM) value, a parameter defining the physical strength of the culm. Since smos1 possesses high breaking-type lodging resistance which is different from semi-dwarf plants with high bending-type lodging resistance, an alternative approach of using thick culm lines for the creation of rice with increased lodging resistance is hereby proposed.	[Hirano, Ko; Okuno, Ayako; Hobo, Tokunori; Ordonio, Reynante; Shinozaki, Yusuke; Asano, Kenji; Kitano, Hidemi; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement) [RBS2003]; Ministry of Education, Science, Sports and Culture of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based for Agricultural Improvement, RBS2003) and Grants-in-Aid from the NC-CARP project, the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya K, 2014, PLANT CELL PHYSL; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; GRAFIUS JE, 1954, AGRON J, V46, P414, DOI 10.2134/agronj1954.00021962004600090006x; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; HOSHIKAWA K, 1990, JPN J CROP SCI, V59, P809, DOI 10.1626/jcs.59.809; Islam MS, 2007, FIELD CROP RES, V101, P240, DOI 10.1016/j.fcr.2006.12.002; Kashiwagi T., 2007, Japanese Journal of Crop Science, V76, P1, DOI 10.1626/jcs.76.1; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kono M, 1995, SCI RICE PLANT PHYSL, V2, P971; Okuno A, 2014, PLOS ONE, V19; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Ookawa T, 2010, PLANT PROD SCI, V13, P56; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; WATANABE T, 1997, SCI RICE PLANT, V3, P567; Zhang BS, 2011, J GENET GENOMICS, V38, P411, DOI 10.1016/j.jgg.2011.08.002	15	32	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e96009	10.1371/journal.pone.0096009	http://dx.doi.org/10.1371/journal.pone.0096009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987959	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100005
J	Somervuo, P; Kvist, J; Ikonen, S; Auvinen, P; Paulin, L; Koskinen, P; Holm, L; Taipale, M; Duplouy, A; Ruokolainen, A; Saarnio, S; Siren, J; Kohonen, J; Corander, J; Frilander, MJ; Ahola, V; Hanski, I				Somervuo, Panu; Kvist, Jouni; Ikonen, Suvi; Auvinen, Petri; Paulin, Lars; Koskinen, Patrik; Holm, Liisa; Taipale, Minna; Duplouy, Anne; Ruokolainen, Annukka; Saarnio, Suvi; Siren, Jukka; Kohonen, Jukka; Corander, Jukka; Frilander, Mikko J.; Ahola, Virpi; Hanski, Ilkka			Transcriptome Analysis Reveals Signature of Adaptation to Landscape Fragmentation	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHAPERONE-MEDIATED AUTOPHAGY; GENE-EXPRESSION; LIFE-HISTORY; DISPERSAL RATE; DROSOPHILA; FLIGHT; METAPOPULATION; EVOLUTION; PROTEINS	We characterize allelic and gene expression variation between populations of the Glanville fritillary butterfly (Melitaea cinxia) from two fragmented and two continuous landscapes in northern Europe. The populations exhibit significant differences in their life history traits, e. g. butterflies from fragmented landscapes have higher flight metabolic rate and dispersal rate in the field, and higher larval growth rate, than butterflies from continuous landscapes. In fragmented landscapes, local populations are small and have a high risk of local extinction, and hence the long-term persistence at the landscape level is based on frequent re-colonization of vacant habitat patches, which is predicted to select for increased dispersal rate. Using RNA-seq data and a common garden experiment, we found that a large number of genes (1,841) were differentially expressed between the landscape types. Hexamerin genes, the expression of which has previously been shown to have high heritability and which correlate strongly with larval development time in the Glanville fritillary, had higher expression in fragmented than continuous landscapes. Genes that were more highly expressed in butterflies from newly-established than old local populations within a fragmented landscape were also more highly expressed, at the landscape level, in fragmented than continuous landscapes. This result suggests that recurrent extinctions and re-colonizations in fragmented landscapes select a for specific expression profile. Genes that were significantly up-regulated following an experimental flight treatment had higher basal expression in fragmented landscapes, indicating that these butterflies are genetically primed for frequent flight. Active flight causes oxidative stress, but butterflies from fragmented landscapes were more tolerant of hypoxia. We conclude that differences in gene expression between the landscape types reflect genomic adaptations to landscape fragmentation. A	[Somervuo, Panu; Kvist, Jouni; Koskinen, Patrik; Holm, Liisa; Duplouy, Anne; Ruokolainen, Annukka; Saarnio, Suvi; Siren, Jukka; Ahola, Virpi; Hanski, Ilkka] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Somervuo, Panu; Kvist, Jouni; Auvinen, Petri; Paulin, Lars; Holm, Liisa; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Genome Biol Program, Helsinki, Finland; [Ikonen, Suvi] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [Taipale, Minna] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, Stockholm, Sweden; [Taipale, Minna] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Taipale, Minna] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Siren, Jukka; Kohonen, Jukka; Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; University of Helsinki; University of Helsinki; University of Helsinki	Hanski, I (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ilkka.hanski@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Duplouy, Anne/J-2182-2015; Frilander, Mikko J/B-6660-2009	Auvinen, Petri/0000-0002-3947-4778; Frilander, Mikko J/0000-0002-1732-4808; Kvist, Jouni/0000-0002-4089-8877; Taipale, Minna/0000-0002-1905-2551; Siren, Jukka/0000-0002-2680-0597; Duplouy, Anne/0000-0002-7147-5199; Koskinen, Patrik/0000-0003-1485-4990	Finnish National Research Council [250444, 256453, 251170]; European Research Council [232826, 239784]	Finnish National Research Council; European Research Council(European Research Council (ERC)European Commission)	This research has been supported by grants to IH from the Finnish National Research Council (250444 and 256453) and the European Research Council (232826), and to JC from the Finnish National Research Council (251170) and the European Research Council (239784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 2000, ADV NEUR IN, V12, P209; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Blanco E, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-94; Bonte D, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P161; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Duplouy A, 2013, ECOL EVOL, V3, P5141, DOI 10.1002/ece3.885; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Fraichard S, 2010, DEV BIOL, V340, P504, DOI 10.1016/j.ydbio.2010.02.008; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Gibson MC, 1999, DEVELOPMENT, V126, P1591; Gkouvitsas T, 2009, INSECT MOL BIOL, V18, P253, DOI 10.1111/j.1365-2583.2009.00866.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I., 2005, SHRINKING WORLD ECOL; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Hanski IA, 2011, P NATL ACAD SCI USA, V108, P14397, DOI 10.1073/pnas.1110020108; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kvist J, 2013, MOL ECOL, V22, P602, DOI 10.1111/j.1365-294X.2012.05521.x; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Manohar D, 2010, J INSECT PHYSIOL, V56, P1224, DOI 10.1016/j.jinsphys.2010.03.026; Marden JH, 2013, EVOLUTION, V67, P1105, DOI 10.1111/evo.12004; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Niven JE, 2005, BIOL LETTERS, V1, P346, DOI 10.1098/rsbl.2005.0311; Ojanen SP, 2013, ECOL EVOL, V3, P3713, DOI 10.1002/ece3.733; Ou CY, 2007, DEV BIOL, V308, P106, DOI 10.1016/j.ydbio.2007.05.008; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronce Ophelie, 2004, P227, DOI 10.1016/B978-012323448-3/50012-X; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Saastamoinen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081289; Saastamoinen M, 2009, P ROY SOC B-BIOL SCI, V276, P1313, DOI 10.1098/rspb.2008.1464; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schiffers K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0083; SHIRRAS AD, 1989, P NATL ACAD SCI USA, V86, P4559, DOI 10.1073/pnas.86.12.4559; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Siren J, 2011, MOL BIOL EVOL, V28, P673, DOI 10.1093/molbev/msq236; Stec Wojciech J, 2011, J Signal Transduct, V2011, P894510, DOI 10.1155/2011/894510; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhao HW, 2011, J BIOL CHEM, V286, P6211, DOI 10.1074/jbc.M110.181206; Zheng CZ, 2009, PHILOS T R SOC B, V364, P1519, DOI 10.1098/rstb.2009.0005; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221; Zhou XG, 2007, DEVELOPMENT, V134, P601, DOI 10.1242/dev.02755; Zhu L, 2013, INSECT BIOCHEM MOLEC, V43, P664, DOI 10.1016/j.ibmb.2013.04.004	79	21	22	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101467	10.1371/journal.pone.0101467	http://dx.doi.org/10.1371/journal.pone.0101467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988207	Green Published, gold			2022-12-25	WOS:000341354100095
J	Reitman, ZJ; Duncan, CG; Poteet, E; Winters, A; Yan, LJ; Gooden, DM; Spasojevic, I; Boros, LG; Yang, SH; Yan, H				Reitman, Zachary J.; Duncan, Christopher G.; Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Gooden, David M.; Spasojevic, Ivan; Boros, Laszlo G.; Yang, Shao-Hua; Yan, Hai			Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Glutamine; Metabolic Tracer; Metabolomics; Tumor Metabolism	ALPHA-KETOGLUTARATE; GROWTH; ACID; 2-HYDROXYGLUTARATE; CARBOXYLATION; LIPOGENESIS; INHIBITION; ACTIVATION; GLIOMA; CELLS	Background: Somatic IDH1 mutations are common in several types of cancer. Results: IDH1 mutation increases the proportion of palmitate derived from [C-13]glutamine under hypoxic conditions. Conclusion: IDH1 mutation can stimulate tumor cell reductive glutamine metabolism. Significance: IDH1 mutation may cause the unique glutamine-dependent metabolic phenotype observed in tumors. Mutations in the cytosolic NADP(+)-dependent isocitrate dehydrogenase (IDH1) occur in several types of cancer, and altered cellular metabolism associated with IDH1 mutations presents unique therapeutic opportunities. By altering IDH1, these mutations target a critical step in reductive glutamine metabolism, the metabolic pathway that converts glutamine ultimately to acetyl-CoA for biosynthetic processes. While IDH1-mutated cells are sensitive to therapies that target glutamine metabolism, the effect of IDH1 mutations on reductive glutamine metabolism remains poorly understood. To explore this issue, we investigated the effect of a knock-in, single-codon IDH1-R132H mutation on the metabolism of the HCT116 colorectal adenocarcinoma cell line. Here we report the R132H-isobolome by using targeted C-13 isotopomer tracer fate analysis to trace the metabolic fate of glucose and glutamine in this system. We show that introduction of the R132H mutation into IDH1 up-regulates the contribution of glutamine to lipogenesis in hypoxia, but not in normoxia. Treatment of cells with a d-2-hydroxyglutarate (d-2HG) ester recapitulated these changes, indicating that the alterations observed in the knocked-in cells were mediated by d-2HG produced by the IDH1 mutant. These studies provide a dynamic mechanistic basis for metabolic alterations observed in IDH1-mutated tumors and uncover potential therapeutic targets in IDH1-mutated cancers.	[Reitman, Zachary J.; Duncan, Christopher G.; Yan, Hai] Duke Univ Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gooden, David M.] Duke Univ Med Ctr, Small Mol Synth Facil, Dept Chem, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ Med Ctr, Dept Med, Durham, NC 27710 USA; [Reitman, Zachary J.] MedStar Union Mem Hosp, Dept Med, Baltimore, MD 21218 USA; [Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Yang, Shao-Hua] Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Boros, Laszlo G.] SIDMAP LLC, Los Angeles, CA 90064 USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA	Duke University; Duke University; Duke University; Union Memorial Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Yang, SH (corresponding author), Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu; hai.yan@dm.duke.edu		Reitman, Zachary/0000-0002-9122-9550; Yan, Liang-Jun/0000-0002-5815-5430; Duncan, Christopher/0000-0001-7205-2414	National Institutes of Health [R01CA140316, R01NS054687, R01NS054651]; American Cancer Society [RSG-10-126-01-CCE]; Pediatric Brain Tumor Foundation Institute Grant; Voices Against Brain Cancer Foundation Grant; James S. McDonnell Foundation Grant; V Foundation; Accelerate Brain Cancer Cure Foundation Grant; NIH [T32 CA059365-15, T32 AG020494]; Pediatric Brain Tumor Foundation at Duke; NATIONAL CANCER INSTITUTE [T32CA059365, R01CA140316, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054687, R01NS054651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pediatric Brain Tumor Foundation Institute Grant; Voices Against Brain Cancer Foundation Grant; James S. McDonnell Foundation Grant; V Foundation; Accelerate Brain Cancer Cure Foundation Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation at Duke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health Grant R01CA140316, American Cancer Society RSG-10-126-01-CCE, a Pediatric Brain Tumor Foundation Institute Grant, a Voices Against Brain Cancer Foundation Grant, a James S. McDonnell Foundation Grant, The V Foundation, and an Accelerate Brain Cancer Cure Foundation Grant (to H. Y.), as well as by National Institutes of Health Grant R01NS054687 and R01NS054651 (to S. H. Y.). Under agreements between Duke University, Agios Pharmaceuticals, Blueprint Medicines, and Personal Genome Diagnostics, H. Y. and D. D. B. are entitled to a share of the royalties received by the University on sales of products related to genes described in this manuscript. S. H. Y. and H. Y. are co-founders and own stocks of Beijing Pangenomics Technology, Co. Ltd. Z. J. R. receives licensing fees from cell lines reported in this work from Sanofi Aventis. This is managed by a conflict of interest agreement at Duke University.; Supported by NIH Postdoctoral Grant T32 CA059365-15 and by the Pediatric Brain Tumor Foundation at Duke.; Predoctoral trainee supported by NIH Grant T32 AG020494.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Boros LG, 2003, BLOOD, V102, P3556, DOI 10.1182/blood-2003-05-1537; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foster R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045061; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	34	65	67	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23318	23328		10.1074/jbc.M114.575183	http://dx.doi.org/10.1074/jbc.M114.575183			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24986863	Green Published, hybrid			2022-12-25	WOS:000341505000005
J	Zahringer, U; Ittig, S; Lindner, B; Moll, H; Schombel, U; Gisch, N; Cornelis, GR				Zaehringer, Ulrich; Ittig, Simon; Lindner, Buko; Moll, Hermann; Schombel, Ursula; Gisch, Nicolas; Cornelis, Guy R.			NMR-based Structural Analysis of the Complete Rough-type Lipopolysaccharide Isolated from Capnocytophaga canimorsus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolipid Structure; Gram-negative Bacteria; High-performance Liquid Chromatography (HPLC); Lipopolysaccharide (LPS); Nuclear Magnetic Resonance (NMR); Capnocytophaga canimorsus; DHPC Micelles	BORDETELLA-PERTUSSIS ENDOTOXIN; ESCHERICHIA-COLI; FLAVOBACTERIUM-MENINGOSEPTICUM; ANTIMICROBIAL PEPTIDES; BACTERIAL-ENDOTOXINS; CHEMICAL-STRUCTURE; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; SULFONOLIPIDS; CONFIGURATION	Background: Rough-type LPS of C. canimorsus is biologically active, whereas lipid A is not. Results: Purified C. canimorsus rough-type LPS could be analyzed in intact form by NMR. Conclusion: Inactive lipid A becomes active in case the core oligosaccharide is attached. Significance: This study provides evidence that lipid A is not the sole part of the LPS structure responsible for endotoxic activity. We here describe the NMR analysis of an intact lipopolysaccharide (LPS, endotoxin) in water with 1,2-dihexanoyl-sn-glycero-3-phosphocholine as detergent. When HPLC-purified rough-type LPS of Capnocytophaga canimorsus was prepared, C-13,N-15 labeling could be avoided. The intact LPS was analyzed by homonuclear (H-1) and heteronuclear (H-1,C-13, and H-1,P-31) correlated one- and two-dimensional NMR techniques as well as by mass spectrometry. It consists of a penta-acylated lipid A with an -linked phosphoethanolamine attached to C-1 of GlcN (I) in the hybrid backbone, lacking the 4-phosphate. The hydrophilic core oligosaccharide was found to be a complex hexasaccharide with two mannose (Man) and one each of 3-deoxy-d-manno-oct-2-ulosonic acid (Kdo), Gal, GalN, and l-rhamnose residues. Position 4 of Kdo is substituted by phosphoethanolamine, also present in position 6 of the branched Man(I) residue. This rough-type LPS is exceptional in that all three negative phosphate residues are masked by positively charged ethanolamine substituents, leading to an overall zero net charge, which has so far not been observed for any other LPS. In biological assays, the corresponding isolated lipid A was found to be endotoxically almost inactive. By contrast, the intact rough-type LPS described here expressed a 20,000-fold increased endotoxicity, indicating that the core oligosaccharide significantly contributes to the endotoxic potency of the whole rough-type C. canimorsus LPS molecule. Based on these findings, the strict view that lipid A alone represents the toxic center of LPS needs to be reassessed.	[Zaehringer, Ulrich; Lindner, Buko; Moll, Hermann; Schombel, Ursula; Gisch, Nicolas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem Bioanalyt Chem, D-23845 Borstel, Germany; [Ittig, Simon; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Cornelis, Guy R.] Univ Namur, Dept Biol, B-5000 Namur, Belgium	Forschungszentrum Borstel; University of Basel; University of Namur	Ittig, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	simon.ittig@unibas.ch		Gisch, Nicolas/0000-0003-3260-5269	Cluster of Excellence "Inflammation at Interfaces" [EXC306]; Werner Siemens Foundation; European Research Council 5 Grant [AdG 2011-293605-CAPCAN]	Cluster of Excellence "Inflammation at Interfaces"; Werner Siemens Foundation; European Research Council 5 Grant	This work was supported in part by the Cluster of Excellence "Inflammation at Interfaces" (EXC306).; Supported by the Werner Siemens Foundation.; Recipient of European Research Council 5 Grant AdG 2011-293605-CAPCAN.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; BOCK K, 1994, EUR J BIOCHEM, V225, P1029, DOI 10.1111/j.1432-1033.1994.1029b.x; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chamorro C, 2012, BBA-BIOMEMBRANES, V1818, P2171, DOI 10.1016/j.bbamem.2012.04.004; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GODCHAUX W, 1980, J BACTERIOL, V144, P592, DOI 10.1128/JB.144.2.592-602.1980; GODCHAUX W, 1984, J BIOL CHEM, V259, P2982; Gomi K, 2002, J IMMUNOL, V168, P2939, DOI 10.4049/jimmunol.168.6.2939; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HASE S, 1976, EUR J BIOCHEM, V63, P101, DOI 10.1111/j.1432-1033.1976.tb10212.x; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; Ittig S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002667; Janda JM, 2006, EMERG INFECT DIS, V12, P340, DOI 10.3201/eid1202.050783; JANSSON PE, 1989, CARBOHYD RES, V188, P169, DOI 10.1016/0008-6215(89)84069-8; Kato H, 1998, J BACTERIOL, V180, P3891, DOI 10.1128/JB.180.15.3891-3899.1998; KAWAI Y, 1988, EUR J BIOCHEM, V171, P73, DOI 10.1111/j.1432-1033.1988.tb13760.x; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kohara J, 2006, PROTEIN EXPRES PURIF, V49, P276, DOI 10.1016/j.pep.2006.05.015; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBBAR S, 1994, CARBOHYD RES, V259, P257, DOI 10.1016/0008-6215(94)84061-X; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Mally M, 2009, MICROBES INFECT, V11, P509, DOI 10.1016/j.micinf.2009.02.005; Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164; Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Meng J, 2011, SCI CHINA PHYS CHEM, V54, P187, DOI 10.1007/s11433-010-4225-5; Moll H, 1997, CARBOHYD RES, V304, P91, DOI 10.1016/S0008-6215(97)00210-3; Oehler RL, 2009, LANCET INFECT DIS, V9, P439, DOI 10.1016/S1473-3099(09)70110-0; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71; PITTA TP, 1989, J BACTERIOL, V171, P952, DOI 10.1128/jb.171.2.952-957.1989; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; Richter W, 2011, INNATE IMMUN-LONDON, V17, P427, DOI 10.1177/1753425910372434; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schweda EKH, 2008, INNATE IMMUN-LONDON, V14, P199, DOI 10.1177/1753425908095958; Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243; Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vasl J, 2009, J IMMUNOL, V183, P5138, DOI 10.4049/jimmunol.0901544; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang W, 2008, ANGEW CHEM INT EDIT, V47, P9870, DOI 10.1002/anie.200803474; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; ZAHRINGER U, 1993, TETRAHEDRON, V49, P4193, DOI 10.1016/S0040-4020(01)85737-9; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	52	19	20	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23963	23976		10.1074/jbc.M114.571489	http://dx.doi.org/10.1074/jbc.M114.571489			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993825	hybrid, Green Published			2022-12-25	WOS:000341505000061
J	Laderoute, KR; Calaoagan, JM; Chao, WR; Dinh, D; Denko, N; Duellman, S; Kalra, J; Liu, XH; Papandreou, I; Sambucetti, L; Boros, LG				Laderoute, Keith R.; Calaoagan, Joy M.; Chao, Wan-ru; Dinh, Dominc; Denko, Nicholas; Duellman, Sarah; Kalra, Jessica; Liu, Xiaohe; Papandreou, Ioanna; Sambucetti, Lidia; Boros, Laszlo G.			5 '-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; CELL-GROWTH; NUTRIENT; ISOTOPOMER; METABOLISM	Rapid tumor growth can establish metabolically stressed microenvironments that activate 5'-AMP-activated protein kinase (AMPK), a ubiquitous regulator of ATP homeostasis. Previously, we investigated the importance of AMPK for the growth of experimental tumors prepared from HRAS-transformed mouse embryo fibroblasts and for primary brain tumor development in a rat model of neurocarcinogenesis. Here, we used triple-negative human breast cancer cells in which AMPK activity had been knocked down to investigate the contribution of AMPK to experimental tumor growth and core glucose metabolism. We found that AMPK supports the growth of fast-growing orthotopic tumors prepared from MDA-MB-231 and DU4475 breast cancer cells but had no effect on the proliferation or survival of these cells in culture. We used in vitro and in vivo metabolic profiling with [C-13] glucose tracers to investigate the contribution of AMPK to core glucose metabolism in MDA-MB-231 cells, which have a Warburg metabolic phenotype; these experiments indicated that AMPK supports tumor glucose metabolism in part through positive regulation of glycolysis and the nonoxidative pentose phosphate cycle. We also found that AMPK activity in the MDA-MB-231 tumors could systemically perturb glucose homeostasis in sensitive normal tissues (liver and pancreas). Overall, our findings suggest that the contribution of AMPK to the growth of aggressive experimental tumors has a critical microenvironmental component that involves specific regulation of core glucose metabolism.	[Laderoute, Keith R.; Calaoagan, Joy M.; Chao, Wan-ru; Dinh, Dominc; Duellman, Sarah; Liu, Xiaohe; Sambucetti, Lidia] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA; [Denko, Nicholas; Papandreou, Ioanna] Ohio State Univ, Dept Radiat Oncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kalra, Jessica] Langara Coll, Dept Biol, Vancouver, BC V5W 2Z6, Canada; [Boros, Laszlo G.] UCLA Sch Med, Dept Pediat, Torrance, CA 90509 USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Boros, Laszlo G.] SIDMAP LLC, Los Angeles, CA 90064 USA	SRI International; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Laderoute, KR (corresponding author), SRI Int, Biosci Div, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	keith.laderoute@sri.com	denko, nicholas/F-8444-2010; Papandreou, Ioanna/G-1703-2014	, Keith/0000-0002-5121-8072	National Institutes of Health from NCI [HHSN261200800001E, CA73807]; NATIONAL CANCER INSTITUTE [R01CA163581, R01CA073807] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants HHSN261200800001E and CA73807 from NCI.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Boren J, 2001, J BIOL CHEM, V276, P37747; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Boros LG, 1997, CANCER RES, V57, P4242; Cairns RA, 2009, CLIN CANCER RES, V15, P7170, DOI 10.1158/1078-0432.CCR-09-1676; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gucalp A, 2011, CHEMOTHER RES PRACT, DOI DOI 10.1155/2011/696208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang TC, 2011, INT J CANCER, V128, P2230, DOI 10.1002/ijc.25558; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; LANGLOIS AJ, 1979, CANCER RES, V39, P2604; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Lin ZW, 2000, AM J PHYSIOL-ENDOC M, V278, pE958, DOI 10.1152/ajpendo.2000.278.5.E958; Liu HB, 2010, CANCER RES, V70, P6368, DOI 10.1158/0008-5472.CAN-09-4615; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Saggar JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00154; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sonko BJ, 2011, FOOD CHEM TOXICOL, V49, P2968, DOI 10.1016/j.fct.2011.07.047; STACKPOLE CW, 1981, NATURE, V289, P798, DOI 10.1038/289798a0; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zhao J, 2009, NEUROSCI BULL, V25, P94, DOI 10.1007/s12264-009-1113-y	39	44	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22850	22864		10.1074/jbc.M114.576371	http://dx.doi.org/10.1074/jbc.M114.576371			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24993821	Green Published, hybrid			2022-12-25	WOS:000341017200027
J	Spadaro, D; Tapia, R; Jond, L; Sudol, M; Fanning, AS; Citi, S				Spadaro, Domenica; Tapia, Rocio; Jond, Lionel; Sudol, Marius; Fanning, Alan S.; Citi, Sandra			ZO Proteins Redundantly Regulate the Transcription Factor DbpA/ZONAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL TIGHT JUNCTIONS; CELL-PROLIFERATION; GENE-EXPRESSION; FACTOR ZONAB/DBPA; HIPPO PATHWAY; FUNCTIONAL INTERACTION; CONTACT INHIBITION; YAP ONCOPROTEIN; ALPHA-CATENIN; CINGULIN	The localization and activities of DbpA/ZONAB and YAP transcription factors are in part regulated by the density-dependent assembly of epithelial junctions. DbpA activity and cell proliferation are inhibited by exogenous overexpression of the tight junction (TJ) protein ZO-1, leading to a model whereby ZO-1 acts by sequestering DbpA at the TJ. However, mammary epithelial cells and mouse tissues knock-out for ZO-1 do not show increased proliferation, as predicted by this model. To address this discrepancy, we examined the localization and activity of DbpA and YAP in Madin-Darby canine kidney cells depleted either of ZO-1, or one of the related proteins ZO-2 and ZO-3 (ZO proteins), or all three together. Depletion of only one ZO protein had no effect on DbpA localization and activity, whereas depletion of ZO-1 and ZO-2, which is associated with reduced ZO-3 expression, resulted in increased DbpA localization in the cytoplasm. Only depletion of ZO-2 reduced the nuclear import of YAP. Mammary epithelial (Eph4) cells KO for ZO-1 showed junctional DbpA, demonstrating that ZO-1 is not required to sequester DbpA at junctions. However, further depletion of ZO-2 in Eph4 ZO-1KO cells, which do not express ZO-3, caused decreased junctional localization and expression of DbpA, which were rescued by the proteasome inhibitor MG132. In vitro binding assays showed that full-length ZO-1 does not interact with DbpA. These results show that ZO-2 is implicated in regulating the nuclear shuttling of YAP, whereas ZO proteins redundantly control the junctional retention and stability of DbpA, without affecting its shuttling to the nucleus.	[Spadaro, Domenica; Tapia, Rocio; Jond, Lionel; Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1211 Geneva, Switzerland; [Sudol, Marius] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med Nephrol, New York, NY 10029 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Geneva; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill	Citi, S (corresponding author), 4 Blvd Yvoy, CH-1211 Geneva 4, Switzerland.	sandra.citi@unige.ch		Citi, Sandra/0000-0002-6537-4818	Swiss National Fund [31003A103637, 31003A116763]; Swiss Cancer League [KFS-2813-08-2011]; Section of Biology of the Faculty of Sciences of the University of Geneva; Breast Cancer Coalition from the Pennsylvania Department of Health [RFA 50709, RFA 60707]; National Institutes of Health, NIDDK [DK061397]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, R56DK061397] Funding Source: NIH RePORTER	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Section of Biology of the Faculty of Sciences of the University of Geneva; Breast Cancer Coalition from the Pennsylvania Department of Health; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Swiss National Fund Grants 31003A103637 and 31003A116763, Swiss Cancer League Grant KFS-2813-08-2011 (to S. C.), and the Section of Biology of the Faculty of Sciences of the University of Geneva.; Supported by Breast Cancer Coalition Grants RFA 50709 and RFA 60707 from the Pennsylvania Department of Health. Present address: Dept. of Physiology, National University of Singapore, Laboratory of Cancer Signaling and Domainopathies, Yong Loo Li School of Medicine, Block MD9, 2 Medical Dr. #04-01, Singapore 117597. E-mail: phsms@nus.edu.sg.; Supported by the National Institutes of Health, NIDDK Grant DK061397.	Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Capaldo CT, 2011, MOL BIOL CELL, V22, P1677, DOI 10.1091/mbc.E10-08-0677; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Citi S, 2001, CELL CELL INTERACTIO, V256, P153; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kavanagh E, 2006, J CELL SCI, V119, P5098, DOI 10.1242/jcs.03297; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Remue E, 2010, FEBS LETT, V584, P4175, DOI 10.1016/j.febslet.2010.09.020; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Spadaro D, 2012, ESSAYS BIOCHEM, V53, P83, DOI [10.1042/BSE0530083, 10.1042/bse0530083]; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	46	23	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22500	22511		10.1074/jbc.M114.556449	http://dx.doi.org/10.1074/jbc.M114.556449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24986862	hybrid, Green Published			2022-12-25	WOS:000340593500059
J	Odagiri, F; Inoue, H; Sugihara, M; Suzuki, T; Murayama, T; Shioya, T; Konishi, M; Nakazato, Y; Daida, H; Sakurai, T; Morimoto, S; Kurebayashi, N				Odagiri, Fuminori; Inoue, Hana; Sugihara, Masami; Suzuki, Takeshi; Murayama, Takashi; Shioya, Takao; Konishi, Masato; Nakazato, Yuji; Daida, Hiroyuki; Sakurai, Takashi; Morimoto, Sachio; Kurebayashi, Nagomi			Effects of Candesartan on Electrical Remodeling in the Hearts of Inherited Dilated Cardiomyopathy Model Mice	PLOS ONE			English	Article							RECEPTOR BLOCKER; K+ CURRENTS; ANGIOTENSIN; FAILURE; EXPRESSION; INFARCTION; LOSARTAN; SYSTEM	Inherited dilated cardiomyopathy (DCM) is characterized by dilatation and dysfunction of the ventricles, and often results in sudden death or heart failure (HF). Although angiotensin receptor blockers (ARBs) have been used for the treatment of HF, little is known about the effects on postulated electrical remodeling that occurs in inherited DCM. The aim of this study was to examine the effects of candesartan, one of the ARBs, on cardiac function and electrical remodeling in the hearts of inherited DCM model mice (TNNT2 Delta K210). DCM mice were treated with candesartan in drinking water for 2 months from 1 month of age. Control, non-treated DCM mice showed an enlargement of the heart with prolongation of QRS and QT intervals, and died at t(1/2) of 70 days. Candesartan dramatically extended the lifespan of DCM mice, suppressed cardiac dilatation, and improved the functional parameters of the myocardium. It also greatly suppressed prolongation of QRS and QT intervals and action potential duration (APD) in the left ventricular myocardium and occurrence of ventricular arrhythmia. Expression analysis revealed that down-regulation of Kv4.2 (I-to channel protein), KChIP2 (auxiliary subunit of Kv4.2), and Kv1.5 (I-Kur channel protein) in DCM was partially reversed by candesartan administration. Interestingly, non-treated DCM heart had both normal-sized myocytes with moderately decreased I-to and I-Kur and enlarged cells with greatly reduced K+ currents (I-to, I-Kur I-K1 and I-ss). Treatment with candesartan completely abrogated the emergence of the enlarged cells but did not reverse the Ito, and IKur in normal-sized cells in DCM hearts. Our results indicate that candesartan treatment suppresses structural remodeling to prevent severe electrical remodeling in inherited DCM.	[Odagiri, Fuminori; Sugihara, Masami; Suzuki, Takeshi; Murayama, Takashi; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan; [Odagiri, Fuminori; Sugihara, Masami; Suzuki, Takeshi; Nakazato, Yuji; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Inoue, Hana; Konishi, Masato] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Shioya, Takao] Saga Univ, Fac Med, Dept Physiol, Saga 840, Japan; [Morimoto, Sachio] Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 812, Japan	Juntendo University; Juntendo University; Tokyo Medical University; Saga University; Kyushu University	Kurebayashi, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan.	nagomik@juntendo.ac.jp	Inoue, Hana/AFN-8856-2022	Inoue, Hana/0000-0002-2278-5617; Morimoto, Sachio/0000-0001-9171-3636	Ministry of Education, Culture, Sports, Science and Technology (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences;  [23136514];  [S1311011]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences; ; 	This study was supported by a Grant-in Aid (23136514, S1311011) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities (2011-2015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors also thank the Vehicle Racing Commemorative Foundation (http://www.vecof.or.jp/index.html) and the Institute of Seizon and Life Sciences (http://seizon.umin.jp/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozal W, 2010, FREE RADICAL RES, V44, P1369, DOI 10.3109/10715762.2010.509399; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Bru-Mercier G, 2003, J MOL CELL CARDIOL, V35, P153, DOI 10.1016/S0022-2828(02)00290-0; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; GOLDBERG MR, 1995, HYPERTENSION, V25, P37, DOI 10.1161/01.HYP.25.1.37; Hongo K, 2009, J PHYSIOL SCI, V59, P24; Inada Y, 1997, CLIN EXP HYPERTENS, V19, P1079, DOI 10.3109/10641969709083206; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Morimoto S, 2009, CIRC RES, V105, P313, DOI 10.1161/CIRCRESAHA.109.204180; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nieminen T, 2010, ANN NONINVAS ELECTRO, V15, P276, DOI 10.1111/j.1542-474X.2010.00376.x; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Otten E, 2010, NETH HEART J, V18, P478, DOI 10.1007/BF03091819; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Qin M, 2012, J MOL CELL CARDIOL, V53, P880, DOI 10.1016/j.yjmcc.2012.10.003; Rivard K, 2008, CARDIOVASC RES, V78, P53, DOI 10.1093/cvr/cvn020; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Shimoni Y, 2003, AM J PHYSIOL-HEART C, V284, pH1168, DOI 10.1152/ajpheart.00748.2002; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Sugihara M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055514, 10.1371/journal.pone.0061483]; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; TAKIMOTO K, 1994, CIRC RES, V75, P1006, DOI 10.1161/01.RES.75.6.1006; Thuringer D, 1996, CARDIOVASC RES, V31, P747, DOI 10.1016/0008-6363(96)00018-1; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Yu HG, 1999, CIRCULATION, V99, P1898, DOI 10.1161/01.CIR.99.14.1898; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329	31	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101838	10.1371/journal.pone.0101838	http://dx.doi.org/10.1371/journal.pone.0101838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000405	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300093
J	Sun, QQ; Wang, XJ; Yang, WG				Sun, Qian-Quan; Wang, Xinjun; Yang, Weiguo			Laserspritzer: A Simple Method for Optogenetic Investigation with Subcellular Resolutions	PLOS ONE			English	Article							CHANNELRHODOPSIN VARIANTS; EXCITATORY CONNECTIONS; PYRAMIDAL NEURONS; NEURAL CIRCUITS; MOTOR CORTEX; LAYER 5; NEOCORTEX; INPUT; ORGANIZATION; STIMULATION	To build a detailed circuit diagram in the brain, one needs to measure functional synaptic connections between specific types of neurons. A high-resolution circuit diagram should provide detailed information at subcellular levels such as soma, distal and basal dendrites. However, a limitation lies in the difficulty of studying long-range connections between brain areas separated by millimeters. Brain slice preparations have been widely used to help understand circuit wiring within specific brain regions. The challenge exists because long-range connections are likely to be cut in a brain slice. The optogenetic approach overcomes these limitations, as channelrhodopsin 2 (ChR2) is efficiently transported to axon terminals that can be stimulated in brain slices. Here, we developed a novel fiber optic based simple method of optogenetic stimulation: the laserspritzer approach. This method facilitates the study of both long-range and local circuits within brain slice preparations. This is a convenient and low cost approach that can be easily integrated with a slice electrophysiology setup, and repeatedly used upon initial validation. Our data with direct ChR2 mediated-current recordings demonstrates that the spatial resolution of the laserspritzer is correlated with the size of the laserspritzer, and the resolution lies within the 30 mm range for the 5 micrometer laserspritzer. Using olfactory cortical slices, we demonstrated that the laserspritzer approach can be applied to selectively activate monosynaptic perisomatic GABAergic basket synapses, or long-range intracortical glutamatergic inputs formed on different subcellular domains within the same cell (e.g. distal and proximal dendrites). We discuss significant advantages of the laserspritzer	[Sun, Qian-Quan; Wang, Xinjun; Yang, Weiguo] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Wang, Xinjun; Yang, Weiguo] Univ Wyoming, Grad Neurosci Program, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Sun, QQ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	neuron@uwyo.edu	Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022	Sun, Qian-Quan/0000-0002-5807-9327	National Institutes of Health [1R21NS082958-01A1, 1R21 NS084182-01, 1R15NS081628-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS081628, R21NS082958, R21NS084182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the National Institutes of Health Grants 1R21NS082958-01A1, 1R21 NS084182-01 and 1R15NS081628-01A1 to QQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden Edward S, 2011, F1000 Biol Rep, V3, P11, DOI 10.3410/B3-11; Cardin JA, 2012, J PHYSIOL-PARIS, V106, P104, DOI 10.1016/j.jphysparis.2011.09.005; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Feldmeyer D, 2000, J PHYSIOL-LONDON, V525, P31, DOI 10.1111/j.1469-7793.2000.00031.x; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin John Y, 2013, Methods Mol Biol, V998, P401, DOI 10.1007/978-1-62703-351-0_31; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Xiong WH, 2012, J NEUROSCI METH, V210, P119, DOI 10.1016/j.jneumeth.2012.07.019; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	32	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101600	10.1371/journal.pone.0101600	http://dx.doi.org/10.1371/journal.pone.0101600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992677	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400096
J	Ariel, G; Ophir, Y; Levi, S; Ben-Jacob, E; Ayali, A				Ariel, Gil; Ophir, Yotam; Levi, Sagi; Ben-Jacob, Eshel; Ayali, Amir			Individual Pause-and-Go Motion Is Instrumental to the Formation and Maintenance of Swarms of Marching Locust Nymphs	PLOS ONE			English	Article							COLLECTIVE MOTION; STOCHASTICITY; CANNIBALISM; RESPONSES; MOVEMENT; NEURON; SYSTEM; NOISE; FIELD; DCMD	The principal interactions leading to the emergence of order in swarms of marching locust nymphs was studied both experimentally, using small groups of marching locusts in the lab, and using computer simulations. We utilized a custom tracking algorithm to reveal fundamental animal-animal interactions leading to collective motion. Uncovering this behavior introduced a new agent-based modeling approach in which pause-and-go motion is pivotal. The behavioral and modeling findings are largely based on motion-related visual sensory inputs obtained by the individual locust. Results suggest a generic principle, in which intermittent animal motion can be considered as a sequence of individual decisions as animals repeatedly reassess their situation and decide whether or not to swarm. This interpretation implies, among other things, some generic characteristics regarding the build-up and emergence of collective order in swarms: in particular, that order and disorder are generic meta-stable states of the system, suggesting that the emergence of order is kinetic and does not necessarily require external environmental changes. This work calls for further experimental as well as theoretical investigation of the neural mechanisms underlying locust coordinative behavior.	[Ariel, Gil; Levi, Sagi] Bar Ilan Univ, Dept Math, Ramat Gan, Israel; [Ophir, Yotam; Ayali, Amir] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Ben-Jacob, Eshel; Ayali, Amir] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Tel Aviv University; Rice University; Tel Aviv University	Ariel, G (corresponding author), Bar Ilan Univ, Dept Math, Ramat Gan, Israel.	arielg@math.biu.ac.il; ayali@post.tau.ac.il	Ayali, Amir/B-1050-2008	Ayali, Amir/0000-0001-6152-2927	EU Marie-Curie IRG grant; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Center for Theoretical Biological Physics - NSF at Rice University [PHY-1308264]; Israel's Ministry of Agriculture [891-0277-13]; Israel Science Foundation [792/12]	EU Marie-Curie IRG grant; Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Center for Theoretical Biological Physics - NSF at Rice University; Israel's Ministry of Agriculture; Israel Science Foundation(Israel Science Foundation)	GA's research has been partially supported by an EU Marie-Curie IRG grant. EBJ's research has been supported by the Tauber Family Foundation and the Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University, and the Center for Theoretical Biological Physics sponsored by the NSF (Grant PHY-1308264) at Rice University. AA's research has been supported by grant no. 891-0277-13 from Israel's Ministry of Agriculture. AA would like to thank the Israel Science Foundation, grant 792/12, for partial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Bazazi S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002498; Bazazi S, 2011, P ROY SOC B-BIOL SCI, V278, P356, DOI 10.1098/rspb.2010.1447; Ben-Jacob E, 2012, TRENDS MICROBIOL, V20, P403, DOI 10.1016/j.tim.2012.06.001; Beni G, 1993, ROBOTS BIOL SYSTEMS, V102, P703, DOI [DOI 10.1007/978-3-642-58069-7_38, 10.1007/978-3-642-58069-7, DOI 10.1007/978-3-642-58069-7]; Bhattacharya K, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093019; Bode NWF, 2010, J THEOR BIOL, V267, P292, DOI 10.1016/j.jtbi.2010.08.034; Bonabeau E, 1999, SWARM INTELLIGENCE N, V4; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Buhl J, 2011, BEHAV ECOL SOCIOBIOL, V65, P265, DOI 10.1007/s00265-010-1041-x; Dick PC, 2014, J NEUROPHYSIOL, V111, P1736, DOI 10.1152/jn.00499.2013; Dorigo M, 2004, AUTON ROBOT, V17, P111, DOI 10.1023/B:AURO.0000034008.48988.2b; Edelstein-Keshet L, 1998, J MATH BIOL, V36, P515, DOI 10.1007/s002850050112; Ellis P. E., 1964, Behaviour, V23, P193, DOI 10.1163/156853964X00148; Ellis PE, 1951, ANTILOCUST B, P7; Fish Frank E., 2010, P90, DOI 10.1201/b10190-5; Fuchs E, 2003, J NEUROBIOL, V57, P152, DOI 10.1002/neu.10261; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Hansen MJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1715, DOI 10.1007/s00265-011-1179-1; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Huepe C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168701; Judge SJ, 1997, J EXP BIOL, V200, P2209; Klarreich E, 2006, SCI NEWS, V170, P347; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; OBRIEN WJ, 1990, AM SCI, V78, P152; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Ribak G, 2012, J COMP PHYSIOL A, V198, P541, DOI 10.1007/s00359-012-0728-z; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; Simmons PJ, 2013, J EXP BIOL, V216, P2266, DOI 10.1242/jeb.083360; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Topaz CM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002642; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Uvarov B. P., 1921, Bulletin of Entomological Research London, V12, P135, DOI 10.1017/S0007485300044989; Uvarov BP, 1966, HDB GEN ACRIDOLOGY, V1; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	43	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101636	10.1371/journal.pone.0101636	http://dx.doi.org/10.1371/journal.pone.0101636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988464	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100123
J	Dijkstra, N; Kraal, P; Kuypers, MMM; Schnetger, B; Slomp, CP				Dijkstra, Nikki; Kraal, Peter; Kuypers, Marcel M. M.; Schnetger, Bernhard; Slomp, Caroline P.			Are Iron-Phosphate Minerals a Sink for Phosphorus in Anoxic Black Sea Sediments?	PLOS ONE			English	Article							AUTHIGENIC APATITE FORMATION; ANAEROBIC METHANE OXIDATION; WATER-COLUMN ANOXIA; ORGANIC-MATTER; SULFATE REDUCTION; MARINE-SEDIMENTS; CARBON; PRESERVATION; BURIAL; ZONE	Phosphorus (P) is a key nutrient for marine organisms. The only long-term removal pathway for P in the marine realm is burial in sediments. Iron (Fe) bound P accounts for a significant proportion of this burial at the global scale. In sediments underlying anoxic bottom waters, burial of Fe-bound P is generally assumed to be negligible because of reductive dissolution of Fe(III) (oxyhydr) oxides and release of the associated P. However, recent work suggests that Fe-bound P is an important burial phase in euxinic (i.e. anoxic and sulfidic) basin sediments in the Baltic Sea. In this study, we investigate the role of Fe-bound P as a potential sink for P in Black Sea sediments overlain by oxic and euxinic bottom waters. Sequential P extractions performed on sediments from six multicores along two shelf-to-basin transects provide evidence for the burial of Fe-bound P at all sites, including those in the euxinic deep basin. In the latter sediments, Fe-bound P accounts for more than 20% of the total sedimentary P pool. We suggest that this P is present in the form of reduced Fe-P minerals. We hypothesize that these minerals may be formed as inclusions in sulfur-disproportionating Deltaproteobacteria. Further research is required to elucidate the exact mineral form and formation mechanism of this P burial phase, as well as its role as a sink for P in sulfide-rich marine sediments.	[Dijkstra, Nikki; Kraal, Peter; Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Schnetger, Bernhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	Utrecht University; Max Planck Society; Carl von Ossietzky Universitat Oldenburg	Dijkstra, N (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands.	n.dijkstra@uu.nl	Slomp, Caroline P/A-9406-2012; Kraal, Peter/H-4899-2019	Slomp, Caroline P/0000-0002-7272-0109; Schnetger, Bernhard/0000-0003-1638-3977; Kraal, Peter/0000-0002-6650-5680	Netherlands Organisation for Scientific Research (NWO) [86405.004, 822.01013]; Max-Planck-Gesellschaft; European Research Council under the European Community [278364]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Max-Planck-Gesellschaft(Max Planck Society); European Research Council under the European Community(European Research Council (ERC))	This research was funded by the Netherlands Organisation for Scientific Research (NWO Vidi grant 86405.004 and Open Competition grant 822.01013), the Max-Planck-Gesellschaft and the European Research Council under the European Community's Seventh Framework Programme for ERC Starting Grant #278364 to C.P. Slomp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Arthur MA, 1998, PALEOCEANOGRAPHY, V13, P395, DOI 10.1029/98PA01161; Basen M, 2011, ENVIRON MICROBIOL, V13, P1370, DOI 10.1111/j.1462-2920.2011.02443.x; Byrne ME, 2010, P NATL ACAD SCI USA, V107, P12263, DOI 10.1073/pnas.1001290107; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; CLINE JD, 1969, ENVIRON SCI TECHNOL, V3, P838, DOI 10.1021/es60032a004; Creveling JR, 2014, GEOL SOC AM BULL, V126, P145, DOI 10.1130/B30819.1; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; Dellwig O, 2010, GEOCHIM COSMOCHIM AC, V74, P7100, DOI 10.1016/j.gca.2010.09.017; Foncelius S.H., 1974, BLACK SEA GEOLOGY CH, P144; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; Gieskes J, 1986, WATER CHEM PROCEDURE; Goldhammer T, 2010, NAT GEOSCI, V3, P557, DOI [10.1038/ngeo913, 10.1038/NGEO913]; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Ingall E, 1997, MAR GEOL, V139, P219, DOI 10.1016/S0025-3227(96)00112-0; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Jorgensen BB, 2001, DEEP-SEA RES PT I, V48, P2097, DOI 10.1016/S0967-0637(01)00007-3; Kraal P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096859; Kraal P, 2010, CHEM GEOL, V277, P167, DOI 10.1016/j.chemgeo.2010.08.003; Kraal P, 2009, GEOCHIM COSMOCHIM AC, V73, P3277, DOI 10.1016/j.gca.2009.02.026; Lefevre CT, 2009, ENVIRON MICROBIOL, V11, P1646, DOI 10.1111/j.1462-2920.2009.01887.x; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; Lyons T.W, 1991, BLACK SEA OCEANOGRAP, V4, P401, DOI DOI 10.1007/978-94-011-2608-3_25; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; Marz C, 2008, MAR GEOL, V255, P118, DOI 10.1016/j.margeo.2008.05.013; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moodley L, 2005, GEOLOGY, V33, P889, DOI 10.1130/G21731.1; MOORE PB, 1971, AM MINERAL, V56, P1; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; NEMBRINI GP, 1983, GEOCHIM COSMOCHIM AC, V47, P1459, DOI 10.1016/0016-7037(83)90304-6; Ozsoy E, 1997, EARTH-SCI REV, V42, P231, DOI 10.1016/S0012-8252(97)81859-4; Pierrou U., 1976, Ecological Bulletins, Swedish Natural Science Research Council, P75; POLAT SC, 1995, CONT SHELF RES, V15, P1115; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; REDFIELD AC, 1958, AM SCI, V46, P205; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; Reichart GJ, 1997, PALAEOGEOGR PALAEOCL, V134, P149, DOI 10.1016/S0031-0182(97)00071-0; Reitner J, 2005, PALAEOGEOGR PALAEOCL, V227, P18, DOI 10.1016/j.palaeo.2005.04.033; Ross D., 1974, BLACK SEA GEOLOGY CH, P183; ROUZIES D, 1993, HYPERFINE INTERACT, V77, P19, DOI 10.1007/BF02320295; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Sarazin G, 1999, WATER RES, V33, P290, DOI 10.1016/S0043-1354(98)00168-7; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; SHAFFER G, 1986, NATURE, V321, P515, DOI 10.1038/321515a0; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Strickland TDH, 1972, PRACTICAL HDB SEAWAT; Strokal M, 2013, REG ENVIRON CHANGE, V13, P179, DOI 10.1007/s10113-012-0328-z; Teodoru CR, 2007, MAR CHEM, V105, P52, DOI 10.1016/j.marchem.2006.12.013; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; Van Santvoort PJM, 2002, AQUAT GEOCHEM, V8, P153, DOI 10.1023/A:1024271706896; Zaitsev Y.P., 1997, MARINE BIOL DIVERSIT; Zhu KL, 2010, RES MICROBIOL, V161, P276, DOI 10.1016/j.resmic.2010.02.003	58	39	40	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101139	10.1371/journal.pone.0101139	http://dx.doi.org/10.1371/journal.pone.0101139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988389	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100065
J	Lahti, J; Holstila, A; Lahelma, E; Rahkonen, O				Lahti, Jouni; Holstila, Ansku; Lahelma, Eero; Rahkonen, Ossi			Leisure-Time Physical Activity and All-Cause Mortality	PLOS ONE			English	Article							HEALTH BEHAVIORS; COHORT; INTENSITY; CANCER; MEN; METAANALYSIS; FINLAND; DOMAINS; IMPACT; WOMEN	Background: Physical inactivity is a major public health problem associated with increased mortality risk. It is, however, poorly understood whether vigorous physical activity is more beneficial for reducing mortality risk than activities of lower intensity. The aim of this study was to examine associations of the intensity and volume of leisure-time physical activity with all-cause mortality among middle-aged women and men while considering sociodemographic and health related factors as covariates. Methods: Questionnaire survey data collected in 2000-02 among 40-60-year-old employees of the City of Helsinki (N = 8960) were linked with register data on mortality (74% gave permission to the linkage) providing a mean follow-up time of 12-years. The analysis included 6429 respondents (79% women). The participants were classified into three groups according to intensity of physical activity: low moderate, high moderate and vigorous. The volume of physical activity was classified into three groups according to tertiles. Cox regression analysis was used to calculate hazard ratios (HR) and 95% confidence intervals (CIs) for all-cause mortality. Results: During the follow up 205 participants died. Leisure-time physical activity was associated with reduced risk of mortality. After adjusting for covariates the vigorous group (HR = 0.54, 95% CI 0.34-0.86) showed a reduced risk of mortality compared with the low moderate group whereas for the high moderate group the reductions in mortality risk (HR = 0.72, 95% CI 0.48-1.08) were less clear. Adjusting for the volume of physical activity did not affect the point estimates. Higher volume of leisure-time physical activity was also associated with reduced mortality risk; however, adjusting for the covariates and the intensity of physical activity explained the differences. Conclusions: For healthy middle-aged women and men who engage in some physical activity vigorous exercise may provide further health benefits preventing premature deaths.	[Lahti, Jouni; Holstila, Ansku; Lahelma, Eero; Rahkonen, Ossi] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland	University of Helsinki	Lahti, J (corresponding author), Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland.	jouni.mm.lahti@helsinki.fi	Lahelma, Eero/ABC-8716-2020; Lahti, Jouni/AAG-1771-2020	Lahelma, Eero/0000-0002-1064-1333; Rahkonen, Ossi/0000-0002-7202-3274	University of Helsinki; Ministry of Education and Culture [6303383]; Juho Vainio Foundation [4702850]; Academy of Finland [1257362]	University of Helsinki; Ministry of Education and Culture; Juho Vainio Foundation; Academy of Finland(Academy of Finland)	The study was funded by the University of Helsinki (www.helsinki.fi/university/), theMinistry of Education and Culture (www.minedu.fi/OPM/?lang = en) grant #6303383, the Juho Vainio Foundation (www.juhovainionsaatio.fi/pages/in-english/home.php) grant #4702850 and the Academy of Finland (www.aka.fi/en-GB/A/) grant #1257362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Johnsen NF, 2013, EPIDEMIOLOGY, V24, P717, DOI 10.1097/EDE.0b013e31829e3dda; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Laaksonen M, 2001, EUR J PUBLIC HEALTH, V11, P294, DOI 10.1093/eurpub/11.3.294; Laaksonen M, 2008, J CLIN EPIDEMIOL, V61, P900, DOI 10.1016/j.jclinepi.2007.09.010; Lahelma E, 2005, EUR J PUBLIC HEALTH, V15, P504, DOI 10.1093/eurpub/cki022; Lahelma E, 2013, INT J EPIDEMIOL, V42, P722, DOI 10.1093/ije/dys039; Lahti J, 2010, SCAND J MED SCI SPOR, V20, P191, DOI 10.1111/j.1600-0838.2009.00886.x; Lahti J, 2010, PREV MED, V50, P246, DOI 10.1016/j.ypmed.2010.02.007; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Martinez-Gonzalez MA, 2001, MED SCI SPORT EXER, V33, P1142, DOI 10.1097/00005768-200107000-00011; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Official Statistics of Finland (OSF), 2013, CAUS DEATH; PEKKANEN J, 1995, BRIT MED J, V311, P589, DOI 10.1136/bmj.311.7005.589; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SCHOFIELD A, 1988, BRIT J ADDICT, V83, P761; Slattery ML, 2004, SPORTS MED, V34, P239, DOI 10.2165/00007256-200434040-00004; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Ware J., 1993, SF 36 HLTH SURVEY MA; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	31	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101548	10.1371/journal.pone.0101548	http://dx.doi.org/10.1371/journal.pone.0101548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BA	24988295	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100112
J	Li, J; Shen, FH; Guan, CW; Wang, WW; Sun, XZ; Fu, XL; Huang, M; Jin, J; Huang, ZY				Li, Jia; Shen, Feihai; Guan, Cuiwen; Wang, Wenwen; Sun, Xiaozhe; Fu, Xinlu; Huang, Min; Jin, Jing; Huang, Zhiying			Activation of Nrf2 Protects against Triptolide-Induced Hepatotoxicity	PLOS ONE			English	Article							TRIPTERYGIUM-WILFORDII; CARBON-TETRACHLORIDE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SULFORAPHANE; CYTOTOXICITY; PATHWAY; CELLS; RATS	Triptolide, the major active component of Tripterygium wilfordii Hook f. (TWHF), has a wide range of pharmacological activities. However, the toxicities of triptolide, particularly the hepatotoxicity, limit its clinical application. The hepatotoxicity of triptolide has not been well characterized yet. The aim of this study was to investigate the role of NF-E2-related factor 2 (Nrf2) in triptolide-induced toxicity and whether activation of Nrf2 could protect against triptolide-induced hepatotoxicity. The results showed that triptolide caused oxidative stress and cell damage in HepG2 cells, and these toxic effects could be aggravated by Nrf2 knockdown or be counteracted by overexpression of Nrf2. Treatment with a typical Nrf2 agonist, sulforaphane (SFN), attenuated triptolide-induced liver dysfunction, structural damage, glutathione depletion and decrease in antioxidant enzymes in BALB/C mice. Moreover, the hepatoprotective effect of SFN on triptolide-induced liver injury was associated with the activation of Nrf2 and its downstream targets. Collectively, these results indicate that Nrf2 activation protects against triptolide-induced hepatotoxicity.	[Li, Jia; Shen, Feihai; Guan, Cuiwen; Wang, Wenwen; Sun, Xiaozhe; Huang, Min; Jin, Jing; Huang, Zhiying] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jia] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China; [Fu, Xinlu; Huang, Zhiying] Sun Yat Sen Univ, Ctr Lab Anim, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Jin, J (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	jinjing@mail.sysu.edu.cn; hzhiying@mail.sysu.edu.cn			Natural Science Foundation of China [81102886]; National Science and Technology Pillar Program of China [2008BAI55B03]; Guangzhou Medical University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Pillar Program of China; Guangzhou Medical University	This study was supported by grants obtained from the Natural Science Foundation of China (Grant: 81102886), the Key Projects in the National Science and Technology Pillar Program of China (Grant No. 2008BAI55B03), and the Doctor's Startup Project of Guangzhou Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2008, BIOSCI BIOTECH BIOCH, V72, P1176, DOI 10.1271/bbb.70545; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Balasubramanian Thirumalaiswamy, 2013, J Tradit Complement Med, V3, P175, DOI 10.4103/2225-4110.114904; Chae HJ, 2014, NUTR RES PRACT, V8, P40, DOI 10.4162/nrp.2014.8.1.40; Choi C, 2003, BIOSCI BIOTECH BIOCH, V67, P1916, DOI 10.1271/bbb.67.1916; Curtis DK, 2010, TOXICOL APPL PHARM, V244, P57; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Guerrero-Beltran CE, 2010, TOXICOL LETT, V192, P278, DOI 10.1016/j.toxlet.2009.11.007; Fu Q, 2011, FITOTERAPIA, V82, P1241, DOI 10.1016/j.fitote.2011.08.019; GUO J, 1981, CHINESE MED J-PEKING, V94, P405; Hong D, 2004, CHINESE HERBAL MED, V27, P115; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li J, 2012, TOXICOL LETT, V213, P194, DOI 10.1016/j.toxlet.2012.07.008; Li L S, 1982, Zhonghua Yi Xue Za Zhi, V62, P581; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lu H, 1999, TRANSPLANT P, V31, P2056, DOI 10.1016/S0041-1345(99)00262-6; Mei ZN, 2005, PHARMACOL RES, V51, P345, DOI 10.1016/j.phrs.2004.10.007; Movahedian Ahmad, 2014, Adv Biomed Res, V3, P12, DOI 10.4103/2277-9175.124641; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Rubio V, 2011, TOXICOL IN VITRO, V25, P521, DOI 10.1016/j.tiv.2010.10.021; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003; Tan KP, 2008, FREE RADICAL BIO MED, V45, P1663, DOI 10.1016/j.freeradbiomed.2008.09.010; Xiu JW, 2007, J CAPITAL MED U, V28, P220; Yao JC, 2008, BIOL PHARM BULL, V31, P592, DOI 10.1248/bpb.31.592; ZHENG YL, 1994, ACTA PHARM SINIC, V15, P540; Zhi C, 2011, CHINESE J EXPT TRADI, V17, P243; 骆永伟, 2009, [毒理学杂志, Journal of Toxicology], V23, P74	33	66	79	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100685	10.1371/journal.pone.0100685	http://dx.doi.org/10.1371/journal.pone.0100685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988078	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100038
J	Meise, K; Mueller, B; Zein, B; Trillmich, F				Meise, Kristine; Mueller, Birte; Zein, Beate; Trillmich, Fritz			Applicability of Single-Camera Photogrammetry to Determine Body Dimensions of Pinnipeds: Galapagos Sea Lions as an Example	PLOS ONE			English	Article							ELEPHANT SEAL; SIZE; MASS; DIMORPHISM; WHALES	Morphological features correlate with many life history traits and are therefore of high interest to behavioral and evolutionary biologists. Photogrammetry provides a useful tool to collect morphological data from species for which measurements are otherwise difficult to obtain. This method reduces disturbance and avoids capture stress. Using the Galapagos sea lion (Zalophus wollebaeki) as a model system, we tested the applicability of single-camera photogrammetry in combination with laser distance measurement to estimate morphological traits which may vary with an animal's body position. We assessed whether linear morphological traits estimated by photogrammetry can be used to estimate body length and mass. We show that accurate estimates of body length (males: +/- 2.0%, females: +/- 2.6%) and reliable estimates of body mass are possible (males: +/- 6.8%, females: 14.5%). Furthermore, we developed correction factors that allow the use of animal photos that diverge somewhat from a flat-out position. The product of estimated body length and girth produced sufficiently reliable estimates of mass to categorize individuals into 10 kg-classes of body mass. Data of individuals repeatedly photographed within one season suggested relatively low measurement errors (body length: 2.9%, body mass: 8.1%). In order to develop accurate sex-and age-specific correction factors, a sufficient number of individuals from both sexes and from all desired age classes have to be captured for baseline measurements. Given proper validation, this method provides an excellent opportunity to collect morphological data for large numbers of individuals with minimal disturbance.	[Meise, Kristine; Mueller, Birte; Zein, Beate; Trillmich, Fritz] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany	University of Bielefeld	Meise, K (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	kristine.meise@uni-bielefeld.de		Zein, Beate/0000-0002-5487-8535	German Research Foundation [TR 105/18, TR 105/18-2]; Ethological Society; German Academic Exchange Service; Volkswagen Foundation; Friends of Galapagos, Switzerland; Deutsche Forschungsgemeinschaft; Bielefeld University Library	German Research Foundation(German Research Foundation (DFG)); Ethological Society; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Volkswagen Foundation(Volkswagen); Friends of Galapagos, Switzerland; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University Library	This study was funded by the German Research Foundation (TR 105/18, TR 105/18-2; http://www.dfg.de/), the Ethological Society (http://www.etholges.org/), the German Academic Exchange Service (https://www.daad.de/en/index.html), the Volkswagen Foundation(http://www.volkswagenstiftung.de/) and the Friends of Galapagos, Switzerland. The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; [Anonymous], 1994, SEXUAL SELECTION; Bell CM, 1997, MAR MAMMAL SCI, V13, P669, DOI 10.1111/j.1748-7692.1997.tb00090.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Breuer T, 2007, AM J PHYS ANTHROPOL, V134, P369, DOI 10.1002/ajpa.20678; Clutton-Brock T.H., 1988, P325; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Coltman DW, 1998, PHYSIOL ZOOL, V71, P387, DOI 10.1086/515418; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; DEUTSCH CJ, 1990, CAN J ZOOL, V68, P2580, DOI 10.1139/z90-360; Durban JW, 2006, MAR MAMMAL SCI, V22, P735, DOI 10.1111/j.1748-7692.2006.00068.x; HALEY MP, 1991, MAR MAMMAL SCI, V7, P157, DOI 10.1111/j.1748-7692.1991.tb00562.x; Jaquet N, 2006, MAR MAMMAL SCI, V22, P862, DOI 10.1111/j.1748-7692.2006.00060.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Kurita H, 2012, PRIMATES, V53, P7, DOI 10.1007/s10329-011-0280-4; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; McDonell W., 1972, Journal Wildl Dis, V8, P287; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McFadden Katherine W., 2006, Aquatic Mammals, V32, P31, DOI 10.1578/AM.32.1.2006.31; Meise K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1001, DOI 10.1007/s00265-013-1526-5; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; R Development Core Team, 2010, LANG ENV STAT COMP; Shrader AM, 2006, S AFR J WILDL RES, V36, P1; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Trillmich F., 1991, PINNIPEDS NINO RESPO, V88, P66; Trillmich F, 2014, SOC ECOL INTERACT GA, P61, DOI 10.1007/978-3-319-02769-2_3; Webster T, 2010, MAR MAMMAL SCI, V26, P296, DOI 10.1111/j.1748-7692.2009.00326.x; Willisch CS, 2013, MAMM BIOL, V78, P351, DOI 10.1016/j.mambio.2013.02.004; Zein B, 2013, THESIS U BIELEFELD; [No title captured]	34	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101197	10.1371/journal.pone.0101197	http://dx.doi.org/10.1371/journal.pone.0101197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987983	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100069
J	Mu, TT; Chen, SY; Zhang, YC; Guo, P; Chen, H; Meng, FD				Mu, Taotao; Chen, Siying; Zhang, Yinchao; Guo, Pan; Chen, He; Meng, Fandong			Motor Oil Classification Based on Time-Resolved Fluorescence	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VIRGIN OLIVE OIL; CRUDE OILS; NIR SPECTROSCOPY; ADULTERATION; CHEMOMETRICS; PREDICTION; LIFETIME; SAMPLES; CANCER	A time-resolved fluorescence (TRF) technique is presented for classifying motor oils. The system is constructed with a third harmonic Nd:YAG laser, a spectrometer, and an intensified charge coupled device (ICCD) camera. Steady-state and time-resolved fluorescence (TRF) measurements are reported for several motor oils. It is found that steady-state fluorescence is insufficient to distinguish the motor oil samples. Then contour diagrams of TRF intensities (CDTRFIs) are acquired to serve as unique fingerprints to identify motor oils by using the distinct TRF of motor oils. CDTRFIs are preferable to steady-state fluorescence spectra for classifying different motor oils, making CDTRFIs a particularly choice for the development of fluorescence-based methods for the discrimination and characterization of motor oils. The two-dimensional fluorescence contour diagrams contain more information, not only the changing shapes of the LIF spectra but also the relative intensity. The results indicate that motor oils can be differentiated based on the new proposed method, which provides reliable methods for analyzing and classifying motor oils.	[Mu, Taotao; Chen, Siying; Zhang, Yinchao; Guo, Pan; Chen, He; Meng, Fandong] Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China	Beijing Institute of Technology	Chen, SY (corresponding author), Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China.	csy@bit.edu.cn	CHEN, SI/GZL-4800-2022					Al-Ghouti MA, 2010, TALANTA, V81, P1096, DOI 10.1016/j.talanta.2010.02.003; Balabin RM, 2008, FUEL, V87, P2745, DOI 10.1016/j.fuel.2008.02.014; Balabin RM, 2011, MICROCHEM J, V98, P121, DOI 10.1016/j.microc.2010.12.007; Bassbasi M, 2013, FUEL, V104, P798, DOI 10.1016/j.fuel.2012.05.058; Blanco M, 2002, TRAC-TREND ANAL CHEM, V21, P240, DOI 10.1016/S0165-9936(02)00404-1; CAMAGNI P, 1988, IEEE T GEOSCI REMOTE, V26, P22, DOI 10.1109/36.2995; Chen ZW, 2012, ABSTRACTS PAPERS AM; Chung H, 2003, APPL SPECTROSC, V57, P545, DOI 10.1366/000370203321666579; Cooper JB, 2011, APPL SPECTROSC, V65, P187, DOI 10.1366/10-06076; Cramer JA, 2009, ENERG FUEL, V23, P1132, DOI 10.1021/ef8007739; De Peinder P, 2008, APPL SPECTROSC, V62, P414, DOI 10.1366/000370208784046849; Gharekhan AH, 2012, APPL SPECTROSC, V66, P820, DOI 10.1366/11-06515; Giruts MV, 2013, PETROL CHEM+, V53, P209, DOI 10.1134/S096554411304004X; Guan L, 2008, ANAL CHIM ACTA, V628, P117, DOI 10.1016/j.aca.2008.09.004; Guedes CLB, 2006, INT J PHOTOENERGY, V2006, DOI 10.1155/IJP/2006/48462; Hegazi E, 2002, TALANTA, V56, P989, DOI 10.1016/S0039-9140(01)00589-6; Hegazi E, 2001, APPL SPECTROSC, V55, P202, DOI 10.1366/0003702011951515; Ionita I, 2009, OPTOELECTRON ADV MAT, V3, P1122; Khanmohammadi M, 2013, FUEL, V111, P96, DOI 10.1016/j.fuel.2013.04.001; KUDASHEVA FK, 1989, IZV VUZ KHIM KH TEKH, V32, P63; Mu TT, 2014, ANAL METHODS-UK, V6, P940, DOI 10.1039/c3ay41552j; Pantoja PA, 2011, ENERG FUEL, V25, P3598, DOI 10.1021/ef200567x; Poulli KI, 2007, FOOD CHEM, V105, P369, DOI 10.1016/j.foodchem.2006.12.021; Poulli KI, 2006, ANAL BIOANAL CHEM, V386, P1571, DOI 10.1007/s00216-006-0729-2; Ralston CY, 1996, APPL SPECTROSC, V50, P1563, DOI 10.1366/0003702963904601; Ryder AG, 2004, APPL SPECTROSC, V58, P613, DOI 10.1366/000370204774103462; Ryder AG, 2002, SPECTROCHIM ACTA A, V58, P1025, DOI 10.1016/S1386-1425(01)00579-0; Wan W., 2013, J PETROLEUM ENG TECH, V3, P18; Wang CY, 2006, SPECTROSC SPECT ANAL, V26, P728; WANG X, 1994, APPL SPECTROSC, V48, P977, DOI 10.1366/0003702944029703; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Yuvaraj M, 2014, J PHOTOCH PHOTOBIO B, V130, P153, DOI 10.1016/j.jphotobiol.2013.11.006; Zhao Y, 2009, SPECTROSC SPECT ANAL, V29, P3335, DOI 10.3964/j.issn.1000-0593(2009)12-3335-04	33	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100555	10.1371/journal.pone.0100555	http://dx.doi.org/10.1371/journal.pone.0100555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988439	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100034
J	Eren, MK; Tabor, V				Eren, Mehtap Kilic; Tabor, Vedrana			The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence	PLOS ONE			English	Article							CELL-CYCLE ARREST; RAS-INDUCED SENESCENCE; REPLICATIVE LIFE-SPAN; DNA-DAMAGE RESPONSE; PREMATURE SENESCENCE; HUMAN FIBROBLASTS; FACTOR 1-ALPHA; HUMAN CANCER; P53; SUPPRESSION	Oncogene induced senescence (OIS) is a sustained anti-proliferative response acutely induced in primary cells via activation of mitogenic oncogenes such as Ras/BRAF. This mechanism acts as an initial barrier preventing normal cells transformation into malignant cell. Besides oncogenic activation and DNA damage response (DDR), senescence is modulated by a plethora of other factors, and one of the most important one is oxygen tension of the tissue. The aim of this study was to determine the impact of hypoxia on Ras(V12)-induced senescence in human diploid fibroblasts (HDFs). We showed here that hypoxia prevents execution of oncogene induced senescence (OIS), through a strong down-regulation of senescence hallmarks, such as SA-beta-galactosidase, H3K9me3, HP1 gamma, p53, p21(CIP1) and p16(INK4a) in association with induction of hypoxia inducible factor-1 alpha (HIF-1 alpha). In addition, hypoxia also decreased marks of H-Ras(V12)-induced DDR in both cell lines through down-regulation of ATM/ATR, Chk1 and Chk2 phosphorylation as well as decreased gamma-H2AX positivity. Utilizing shRNA system targeting HIF-1a we show that HIF-1a is directly involved in down regulation of p53 and its target p21(CIP1) but not p16(INK4a). In line with this finding we found that knock down of HIF-1a leads to a strong induction of apoptotic response, but not restoration of senescence in Ras expressing HDFs in hypoxia. This indicates that HIF-1a is an important player in early steps of tumorigenesis, leading to suppression of senescence through its negative regulation of p53 and p21(CIP1). In our work we describe a mechanism through which hypoxia and specifically HIF-1 alpha preclude cells from maintaining senescence-driven anti proliferative response. These findings indicate the possible mechanism through which hypoxic environment helps premalignant cells to evade impingement of cellular failsafe pathways.	[Eren, Mehtap Kilic] Adnan Menderes Univ Med Sch, Dept Med Biol, Aydin, Turkey; [Eren, Mehtap Kilic] ADU BILTEM, Aydin, Turkey; [Tabor, Vedrana] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Adnan Menderes University; Karolinska Institutet	Eren, MK (corresponding author), Adnan Menderes Univ Med Sch, Dept Med Biol, Aydin, Turkey.	mkilic@adu.edu.tr		Tabor, Vedrana/0000-0001-9224-208X	TUBITAK [108S379, Cost -BM0703 CANGENIN]; Adnan Menderes University Scientific Research Foundation; Swedish Cancer Society (Cancerfonden); TUBITAK, Scientific and Technological Research Council of Turkey	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Adnan Menderes University Scientific Research Foundation(Adnan Menderes University); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); TUBITAK, Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	MK-E: TUBITAK (108S379, Cost -BM0703 CANGENIN) and Adnan Menderes University Scientific Research Foundation. V.T. Swedish Cancer Society (Cancerfonden). (http://www.tubitak.gov.tr/en) for TUBITAK (as grant supplier) The Scientific and Technological Research Council of Turkey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Benanti JA, 2004, CELL CYCLE, V3, P715; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; BOS JL, 1989, CANCER RES, V49, P4682; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kilic M., 2008, APOPTOSIS CELLULAR O, P273, DOI [10.3109/9781420020502-17, DOI 10.3109/9781420020502-17]; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ravi R, 2000, GENE DEV, V14, P34; Rodier F, 2009, CELL CYCLE, V8, P3632; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Welford SM, 2011, MOL CANCER RES, V9, P538, DOI 10.1158/1541-7786.MCR-11-0065	45	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101064	10.1371/journal.pone.0101064	http://dx.doi.org/10.1371/journal.pone.0101064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984035	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000052
J	Su, B; Gao, LQ; Baranowski, C; Gillard, B; Wang, JM; Ransom, R; Ko, HK; Gelman, IH				Su, Bing; Gao, Lingqiu; Baranowski, Catherine; Gillard, Bryan; Wang, Jianmin; Ransom, Ryan; Ko, Hyun-Kyung; Gelman, Irwin H.			A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CELL-MIGRATION; RUNX2; EXPRESSION; PROTEIN; INVASIVENESS; PROGRESSION; MECHANISMS; BINDING; MODELS	Activation of the PI3K/AKT signal pathway is a known driving force for the progression to castration-recurrent prostate cancer (CR-CaP), which constitutes the major lethal phenotype of CaP. Here, we identify using a genomic shRNA screen the PI3K/AKT-inactivating downstream target, FOXO4, as a potential CaP metastasis suppressor. FOXO4 protein levels inversely correlate with the invasive potential of a panel of human CaP cell lines, with decreased mRNA levels correlating with increased incidence of clinical metastasis. Knockdown (KD) of FOXO4 in human LNCaP cells causes increased invasion in vitro and lymph node (LN) metastasis in vivo without affecting indices of proliferation or apoptosis. Increased Matrigel invasiveness was found by KD of FOXO1 but not FOXO3. Comparison of differentially expressed genes affected by FOXO4-KD in LNCaP cells in culture, in primary tumors and in LN metastases identified a panel of upregulated genes, including PIP, CAMK2N1, PLA2G16 and PGC, which, if knocked down by siRNA, could decrease the increased invasiveness associated with FOXO4 deficiency. Although only some of these genes encode FOXO promoter binding sites, they are all RUNX2-inducible, and RUNX2 binding to the PIP promoter is increased in FOXO4-KD cells. Indeed, the forced expression of FOXO4 reversed the increased invasiveness of LNCaP/shFOXO4 cells; the forced expression of FOXO4 did not alter RUNX2 protein levels, yet it decreased RUNX2 binding to the PIP promoter, resulting in PIP downregulation. Finally, there was a correlation between FOXO4, but not FOXO1 or FOXO3, downregulation and decreased metastasis-free survival in human CaP patients. Our data strongly suggest that increased PI3K/AKT-mediated metastatic invasiveness in CaP is associated with FOXO4 loss, and that mechanisms to induce FOXO4 re-expression might suppress CaP metastatic aggressiveness.	[Su, Bing] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China; [Su, Bing; Gao, Lingqiu; Baranowski, Catherine; Ransom, Ryan; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Gillard, Bryan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Wang, Jianmin] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Ko, Hyun-Kyung] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Yale University	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org	Ko, Hyun-Kyung/H-7596-2017; wang, jian/GVS-0711-2022	Ko, Hyun-Kyung/0000-0002-7896-362X; 	Department of Defense [PC040256, PC061246]; National Cancer Institute [CA94108]; National Cancer Center Support Grant [2P30 CA016056]; National Natural Science Foundation of China [81272380]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center Support Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	IHG was supported by Department of Defense, (www.army.mil) grants PC040256 and PC061246, National Cancer Institute (www.cancer.gov) grant CA94108 (I.H.G.), and National Cancer Center Support Grant 2P30 CA016056. BS was supported by National Natural Science Foundation of China No. 81272380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Azzouni F, 2012, UROL CLIN N AM, V39, P435, DOI 10.1016/j.ucl.2012.07.002; Baniwal SK, 2012, J CELL PHYSIOL, V227, P2276, DOI 10.1002/jcp.22966; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Bjerke GA, 2013, ONCOGENE IN PRESS; Blyth K, 2010, BLOOD CELL MOL DIS, V45, P117, DOI 10.1016/j.bcmd.2010.05.007; Bu YH, 2011, INT J CANCER, V128, P1836, DOI 10.1002/ijc.25524; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee MJ, 2009, GASTROENTEROLOGY, V137, P1138, DOI 10.1053/j.gastro.2009.04.015; Lin D, 2013, CURR OPIN UROL, V23, P214, DOI 10.1097/MOU.0b013e32835e9f07; Little GH, 2014, CANCER RES, V74, P2857, DOI 10.1158/0008-5472.CAN-13-2003; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sharifi N, 2013, ENDOCRINOLOGY, V154, P4010, DOI 10.1210/en.2013-1466; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Shukla S, 2013, PROSTATE, V73, P1507, DOI 10.1002/pros.22698; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiolloy S, 2011, SEMIN CANCER BIOL, V21, P89, DOI 10.1016/j.semcancer.2010.12.008; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Webber MM, 1997, PROSTATE, V30, P136, DOI 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M; Yang JY, 2011, CURR DRUG TARGETS, V12, P1284, DOI 10.2174/138945011796150299; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yun SJ, 2012, PROSTATE CANCER P D, V15, P369, DOI 10.1038/pcan.2012.31; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	44	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101411	10.1371/journal.pone.0101411	http://dx.doi.org/10.1371/journal.pone.0101411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983969	gold, Green Submitted, Green Published			2022-12-25	WOS:000339635000100
J	Zhang, N; Ying, MD; Wu, YP; Zhou, ZH; Ye, ZM; Li, H; Lin, DS				Zhang, Ning; Ying, Mei-Dan; Wu, Yong-Ping; Zhou, Zhi-Hong; Ye, Zhao-Ming; Li, Hang; Lin, Ding-Sheng			Hyperoside, a Flavonoid Compound, Inhibits Proliferation and Stimulates Osteogenic Differentiation of Human Osteosarcoma Cells	PLOS ONE			English	Article							CANCER-STEM-CELLS; APOPTOSIS; THERAPY; HYPERIN; BETA	Osteosarcoma, one of the most common malignant bone tumours, is generally considered a differentiation disease caused by genetic and epigenetic disruptions in the terminal differentiation of osteoblasts. Novel therapies based on the non-cytotoxic induction of cell differentiation-responsive pathways could represent a significant advance in treating osteosarcoma; however, effective pharmaceuticals to induce differentiation are lacking. In the present study, we investigated the effect of hyperoside, a flavonoid compound, on the osteoblastic differentiation of U2OS and MG63 osteosarcoma cells in vitro. Our results demonstrated that hyperoside inhibits the proliferation of osteosarcoma cells by inducing G(0)/G(1) arrest in the cell cycle, without causing obvious cell death. Cell migration assay further suggested that hyperoside could inhibit the invasion potential of osteosarcoma cells. Additionally, osteopontin and runt-related transcription factor 2 protein levels and osteocalcin activation were upregulated dramatically in hyperoside-treated osteosarcoma cells, suggesting that hyperoside may stimulates osteoblastic differentiation in osteosarcoma cells. This differentiation was accompanied by the activation of transforming growth factor (TGF)-beta and bone morphogenetic protein-2, suggesting that the hyperoside-induced differentiation involves the TGF-beta signalling pathway. To our knowledge, this study is the first to evaluate the differentiation effect of hyperoside in osteosarcoma cells and assess the possible potential for hyperoside treatment as a future therapeutic approach for osteosarcoma differentiation therapy.	[Zhang, Ning; Wu, Yong-Ping; Ye, Zhao-Ming; Li, Hang] Zhejiang Univ, Sch Med, Dept Orthopaed, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Mei-Dan] Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhi-Hong] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Lin, Ding-Sheng] Affiliated Second Hosp, Wenzhou Med College, Dept Orthopaed, Wenzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University	Ye, ZM (corresponding author), Zhejiang Univ, Sch Med, Dept Orthopaed, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	yezhaominghz@163.com; zrorthopaedics@gmail.com			Zhejiang Provincial Natural Science Foundation of China [LY13H160021, Y2100897]; TCM Young Scientists of Zhejiang [2012ZQ018]; Science and Technology Bureau of Zhejiang Province [2014C33218]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); TCM Young Scientists of Zhejiang; Science and Technology Bureau of Zhejiang Province	This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China No. LY13H160021; Y2100897, TCM Young Scientists of Zhejiang No. 2012ZQ018, the Science and Technology Bureau of Zhejiang Province No. 2014C33218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; BONEWALD LF, 1992, J BIOL CHEM, V267, P8943; Bruland OS, 1997, EUR J CANCER, V33, P1725, DOI 10.1016/S0959-8049(97)00252-9; Burns BS, 2001, CLIN ORTHOP RELAT R, P259; Cao F, 2006, EUR J PHARM SCI, V29, P385, DOI 10.1016/j.ejps.2006.07.007; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Lee S, 2004, ARCH PHARM RES, V27, P628, DOI 10.1007/BF02980162; Li ZL, FREE RADIC BIOL MED, V57, P132; Liu PPL, 1996, ONCOLOGY, V53, P275; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Luo P, 2010, ONCOGENE, V29, P2772, DOI 10.1038/onc.2010.50; Luo PH, 2007, STEM CELLS, V25, P2628, DOI 10.1634/stemcells.2007-0264; NODA M, 1995, ANN NY ACAD SCI, V760, P242, DOI 10.1111/j.1749-6632.1995.tb44634.x; Nozaki K, 1999, J VET MED SCI, V61, P649, DOI 10.1292/jvms.61.649; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pensak MJ, 2013, CURR PHARM DESIGN, V19, P3466, DOI 10.2174/1381612811319190012; Pitha-Rowe I, 2003, LEUKEMIA, V17, P1723, DOI 10.1038/sj.leu.2403065; Sun H, 2013, FITOTERAPIA, V84, P174, DOI 10.1016/j.fitote.2012.11.010; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Testi AM, 2005, BLOOD, V106, P447, DOI 10.1182/blood-2004-05-1971; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang L, 2013, INT J ONCOL, V43, P1095, DOI 10.3892/ijo.2013.2030; Wang WQ, 1996, ACTA PHARM SINIC, V17, P341; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Xiao YY, 2006, INT J PHARMACEUT, V319, P162, DOI 10.1016/j.ijpharm.2006.03.037; Xiao YY, 2006, INT J PHARMACEUT, V307, P77, DOI 10.1016/j.ijpharm.2005.10.001; Ying M, 2013, ONCOGENE; Ying MD, 2008, J PHARMACOL EXP THER, V325, P758, DOI 10.1124/jpet.107.135657; Ying MD, 2013, MOL CANCER THER, V12, P195, DOI 10.1158/1535-7163.MCT-12-0433; Zenmyo M, 2001, HUM PATHOL, V32, P410, DOI 10.1053/hupa.2001.23524; Zou YP, 2004, J AGR FOOD CHEM, V52, P5032, DOI 10.1021/jf049571r	41	44	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e98973	10.1371/journal.pone.0098973	http://dx.doi.org/10.1371/journal.pone.0098973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983940	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000009
J	van Rijen, MML; Bosch, T; Verkade, EJM; Schouls, L; Kluytmans, JAJW				van Rijen, Miranda M. L.; Bosch, Thijs; Verkade, Erwin J. M.; Schouls, Leo; Kluytmans, Jan A. J. W.		CAM Study Grp	Livestock-Associated MRSA Carriage in Patients without Direct Contact with Livestock	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL COLONIZATION; ST398; PREVALENCE; EMERGENCE; HUMANS; ORIGIN	Background: Livestock-associated MRSA (MC398) has emerged and is related to an extensive reservoir in pigs and veal calves. Individuals with direct contact with these animals and their family members are known to have high MC398 carriage rates. Until now it was assumed that MC398 does not spread to individuals in the community without pig or veal calf exposure. To test this, we identified the proportion of MC398 in MRSA positive individuals without contact with pigs/veal calves or other known risk factors (MRSA of unknown origin; MUO). Methods: In 17 participating hospitals, we determined during two years the occurrence of MC398 in individuals without direct contact with livestock and no other known risk factor (n = 271) and tested in a post analysis the hypothesis whether hospitals in pig-dense areas have higher proportions of MC398 of all MUO. Results: Fifty-six individuals (20.7%) without animal contact carried MC398. In hospitals with high pig-densities in the adherence area, the proportion of MC398 of all MUO was higher than this proportion in hospitals without pigs in the surroundings. Conclusions: One fifth of the individuals carrying MUO carried MC398. So, MC398 is found in individuals without contact to pigs or veal calves. The way of transmission from the animal reservoir to these individuals is unclear, probably by human-to-human transmission or by exposure to the surroundings of the stables. Further research is needed to investigate the way of transmission.	[van Rijen, Miranda M. L.; Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Bosch, Thijs; Schouls, Leo] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Verkade, Erwin J. M.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Kluytmans, Jan A. J. W.] VUmc Med Univ, Dept Med Microbiol & Infect ControlJK, Amsterdam, Netherlands	Amphia Hospital; Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Rijen, MML (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	mvrijen@amphia.nl; jankluytmans@gmail.com	Kluytmans - van den Bergh, Marjolein/A-7267-2016; Verweij, Paul/H-8108-2014	Kluytmans - van den Bergh, Marjolein/0000-0002-6576-6408; Verweij, Paul/0000-0002-8600-9860	Netherlands Organisation for Health Research and Development [125020007]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development [grant number 125020007]. ZonMw is a non-profit organisation working for the Ministry of Health, Welfare and Sport (VWS) and the Dutch Organisation for Scientific Research (NOW). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.zonmw.nl/nl/	Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; Dutch Workingparty on Infection Prevention, 2007, MRSA HOSP; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Fanoy E, 2009, EUROSURVEILLANCE, V14; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Infectieziekten Bulletin, 2012, INFECTIEZIEKTEN B; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065594; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924	35	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100294	10.1371/journal.pone.0100294	http://dx.doi.org/10.1371/journal.pone.0100294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	25000521	Green Submitted, gold, Green Published			2022-12-25	WOS:000338512200024
J	Ovchinnikov, KV; Kristiansen, PE; Uzelac, G; Topisirovic, L; Kojic, M; Nissen-Meyer, J; Nes, IF; Diep, DB				Ovchinnikov, Kirill V.; Kristiansen, Per E.; Uzelac, Gordana; Topisirovic, Ljubisa; Kojic, Milan; Nissen-Meyer, Jon; Nes, Ingolf F.; Diep, Dzung B.			Defining the Structure and Receptor Binding Domain of the Leaderless Bacteriocin LsbB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptide (AMP); Nuclear Magnetic Resonance (NMR); Peptide Interaction; Receptor; Structural Biology; Zn-dependent Protease; Bacteriocin Receptor; Leaderless Bacteriocin	LACTIC-ACID BACTERIA; TORSION ANGLE DYNAMICS; CLASS-II BACTERIOCINS; ANTIMICROBIAL PEPTIDE; 2-PEPTIDE BACTERIOCIN; NMR; ENTEROCOCCUS; PROTEIN; SPECTROSCOPY; MECHANISMS	Background: The bacteriocin LsbB targets a membrane-bound zinc-dependent peptidase. Results: The structure of LsbB was resolved by NMR. The C-terminal unstructured domains of LsbB and several other related bacteriocins were responsible for receptor binding. Conclusion: A subgroup of leaderless bacteriocins has been found to share a similar mechanism in receptor recognition. Significance: The study highlights the structure-function relationship of LsbB. LsbB is a class II leaderless lactococcal bacteriocin of 30 amino acids. In the present work, the structure and function relationship of LsbB was assessed. Structure determination by NMR spectroscopy showed that LsbB has an N-terminal -helix, whereas the C-terminal of the molecule remains unstructured. To define the receptor binding domain of LsbB, a competition assay was performed in which a systematic collection of truncated peptides of various lengths covering different parts of LsbB was used to inhibit the antimicrobial activity of LsbB. The results indicate that the outmost eight-amino acid sequence at the C-terminal end is likely to contain the receptor binding domain because only truncated fragments from this region could antagonize the antimicrobial activity of LsbB. Furthermore, alanine substitution revealed that the tryptophan in position 25 (Trp(25)) is crucial for the blocking activity of the truncated peptides, as well as for the antimicrobial activity of the full-length bacteriocin. LsbB shares significant sequence homology with five other leaderless bacteriocins, especially at their C-terminal halves where all contain a conserved KXXXGXXPWE motif, suggesting that they might recognize the same receptor as LsbB. This notion was supported by the fact that truncated peptides with sequences derived from the C-terminal regions of two LsbB-related bacteriocins inhibited the activity of LsbB, in the same manner as found with the truncated version of LsbB. Taken together, these structure-function studies provide strong evidence that the receptor-binding parts of LsbB and sequence-related bacteriocins are located in their C-terminal halves.	[Ovchinnikov, Kirill V.; Nes, Ingolf F.; Diep, Dzung B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Kristiansen, Per E.; Nissen-Meyer, Jon] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Uzelac, Gordana; Topisirovic, Ljubisa; Kojic, Milan] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade 11000, Serbia	Norwegian University of Life Sciences; University of Oslo; University of Belgrade	Diep, DB (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	dzung.diep@nmbu.no	Kojic, Milan/I-4528-2019; Kristiansen, Per Eugen/L-5798-2019; Diep, Dzung B./AAK-1419-2021; Nissen-Meyer, Jon/Y-8727-2019; Diệp, Dzũng/ABG-9262-2020	Kojic, Milan/0000-0001-5645-750X; Diep, Dzung/0000-0001-7661-5501	Norwegian University of Life Sciences; Norwegian Centennial Chair program; Ministry of Education, Science and Technological Development of the Republic of Serbia [173019]	Norwegian University of Life Sciences; Norwegian Centennial Chair program; Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by a quota scholarship from Norwegian University of Life Sciences and a grant from the Norwegian Centennial Chair program (to K. V. O.) and by Grant 173019 from the Ministry of Education, Science and Technological Development of the Republic of Serbia (to G. U., L. T., and M. K.).	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Benmechernene Zineb, 2013, Recent Pat DNA Gene Seq, V7, P66; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cintas LM, 2000, J BACTERIOL, V182, P6806, DOI 10.1128/JB.182.23.6806-6814.2000; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Diep DB, 1995, MOL MICROBIOL, V18, P631, DOI 10.1111/j.1365-2958.1995.mmi_18040631.x; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; Gajic O, 2003, J BIOL CHEM, V278, P34291, DOI 10.1074/jbc.M211100200; Galvez A, 1998, ARCH MICROBIOL, V171, P59, DOI 10.1007/s002030050678; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haugen HS, 2011, APPL ENVIRON MICROB, V77, P1966, DOI 10.1128/AEM.02488-10; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLO H, 1991, J BACTERIOL, V173, P3879, DOI 10.1128/JB.173.12.3879-3887.1991; HURD RE, 1991, J MAGN RESON, V91, P648, DOI 10.1016/0022-2364(91)90395-A; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Johnsen L, 2005, J BIOL CHEM, V280, P9243, DOI 10.1074/jbc.M412712200; Keeler J., 2010, UNDERSTANDING NMR SP; Keller R., 2004, COMPUTER AIDED RESON, V1; Kjos M, 2011, APPL ENVIRON MICROB, V77, P3335, DOI 10.1128/AEM.02602-10; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kristiansen PE, 2005, J BIOL CHEM, V280, P22945, DOI 10.1074/jbc.M501620200; Liu XJ, 2011, J AGR FOOD CHEM, V59, P5602, DOI 10.1021/jf104751v; Lohans CT, 2014, J ANTIBIOT, V67, P23, DOI 10.1038/ja.2013.81; Lohans CT, 2013, BIOCHEMISTRY-US, V52, P3987, DOI 10.1021/bi400359z; Nes IF, 1996, ANTON LEEUW INT J G, V70, P113, DOI 10.1007/BF00395929; Nes IF, 2007, J BACTERIOL, V189, P1189, DOI 10.1128/JB.01254-06; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Nissen-Meyer J, 2010, PROBIOTICS ANTIMICRO, V2, P52, DOI 10.1007/s12602-009-9021-z; Oppegard C, 2010, MICROBIOL-SGM, V156, P1883, DOI 10.1099/mic.0.038430-0; Rihakova J, 2009, APPL ENVIRON MICROB, V75, P1811, DOI 10.1128/AEM.02266-08; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder AB, 2014, J SCI FOOD AGR, V94, P28, DOI 10.1002/jsfa.6293; Uzelac G, 2013, J BACTERIOL, V195, P5614, DOI 10.1128/JB.00859-13; Wang YJ, 1999, BIOCHEMISTRY-US, V38, P15438, DOI 10.1021/bi991351x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zendo T, 2013, BIOSCI BIOTECH BIOCH, V77, P893, DOI 10.1271/bbb.130014	42	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23838	23845		10.1074/jbc.M114.579698	http://dx.doi.org/10.1074/jbc.M114.579698			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993828	hybrid, Green Published			2022-12-25	WOS:000341505000050
J	Pandyarajan, V; Phillips, NB; Cox, GP; Yang, YW; Whittaker, J; Ismail-Beigi, F; Weiss, MA				Pandyarajan, Vijay; Phillips, Nelson B.; Cox, Gabriela P.; Yang, Yanwu; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Weiss, Michael A.			Biophysical Optimization of a Therapeutic Protein by Nonstandard Mutagenesis STUDIES OF AN IODO-INSULIN DERIVATIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Hormone; Insulin; Nuclear Magnetic Resonance (NMR); Protein Design; Protein Stability; Nonstandard Mutagenesis; Protein Allostery	RECEPTOR-BINDING; B-CHAIN; LIGAND INTERACTIONS; BIOLOGICAL-ACTIVITY; MONOMERIC INSULINS; CIRCULAR-DICHROISM; PUMP THERAPY; AGE-GROUP; HEXAMER; THYROXINE	Background: Therapeutic engineering of insulin analogs is ordinarily limited by a trade-off between pharmacokinetics and stability. Results: Substitution of Tyr(B26) in a rapid-acting insulin analog by 3-iodo-Tyr(B26) enhances its biophysical and pharmaceutical properties. Conclusion: An unnatural amino acid substitution circumvents insulin pharmacokinetic/stability trade-off. Significance: Nonstandard mutagenesis can optimize the molecular properties of therapeutic proteins. Insulin provides a model for the therapeutic application of protein engineering. A paradigm in molecular pharmacology was defined by design of rapid-acting insulin analogs for the prandial control of glycemia. Such analogs, a cornerstone of current diabetes regimens, exhibit accelerated subcutaneous absorption due to more rapid disassembly of oligomeric species relative to wild-type insulin. This strategy is limited by a molecular trade-off between accelerated disassembly and enhanced susceptibility to degradation. Here, we demonstrate that this trade-off may be circumvented by nonstandard mutagenesis. Our studies employed Lys(B28), Pro(B29)-insulin (lispro) as a model prandial analog that is less thermodynamically stable and more susceptible to fibrillation than is wild-type insulin. We have discovered that substitution of an invariant tyrosine adjoining the engineered sites in lispro (Tyr(B26)) by 3-iodo-Tyr (i) augments its thermodynamic stability (G(u) 0.5 +/- 0.2 kcal/mol), (ii) delays onset of fibrillation (lag time on gentle agitation at 37 degrees C was prolonged by 4-fold), (iii) enhances affinity for the insulin receptor (1.5 +/- 0.1-fold), and (iv) preserves biological activity in a rat model of diabetes mellitus. H-1 NMR studies suggest that the bulky iodo-substituent packs within a nonpolar interchain crevice. Remarkably, the 3-iodo-Tyr(B26) modification stabilizes an oligomeric form of insulin pertinent to pharmaceutical formulation (the R-6 zinc hexamer) but preserves rapid disassembly of the oligomeric form pertinent to subcutaneous absorption (T-6 hexamer). By exploiting this allosteric switch, 3-iodo-Tyr(B26)-lispro thus illustrates how a nonstandard amino acid substitution can mitigate the unfavorable biophysical properties of an engineered protein while retaining its advantages.	[Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Cox, Gabriela P.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem Med & Biomed Engn, Cleveland, OH 44016 USA.	michael.weiss@case.edu		Pandyarajan, Vijay/0000-0002-8835-5601	National Institutes of Health [DK04949, DK079233]; institutional National Institutes of Health (NIH) Grant [T32 GM007250]; individual NIH Fellowship [F30 DK094685-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK079233, F30DK094685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional National Institutes of Health (NIH) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); individual NIH Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK04949 and DK079233 (to M. A. W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology. In relation to unrelated insulin analogs, M. A. W. and F. I.-B. have stock in Thermalin Diabetes, LLC Cleveland, OH, for which N. B. P. and J. W. are consultants. M. A. W. is the Chief Scientific Officer and a Director.; A predoctoral fellow of the Case Western Reserve University Medical Scientist Training Program supported by institutional National Institutes of Health (NIH) Grant T32 GM007250 and individual NIH Fellowship F30 DK094685-04.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bharucha T, 2005, J PAEDIATR CHILD H, V41, P522, DOI 10.1111/j.1440-1754.2005.00696.x; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J., 1987, GALENICS INSULIN PHY, V36, P40; BREMS DN, 1992, PROTEIN ENG, V5, P519, DOI 10.1093/protein/5.6.519; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Chemburkar SR, 2010, TETRAHEDRON, V66, P1955, DOI 10.1016/j.tet.2009.12.044; Choh H. L., 1978, HORMONAL PROTEINS PE, V6, P107; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; DEREWENDA U, 1989, BRIT MED BULL, V45, P4, DOI 10.1093/oxfordjournals.bmb.a072320; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; FRANK BH, 1983, DIABETES, V32, P705, DOI 10.2337/diab.32.8.705; FREYCHET P, 1971, BIOCHEM BIOPH RES CO, V43, P400, DOI 10.1016/0006-291X(71)90767-4; Groenhof G, 2013, ANGEW CHEM INT EDIT, V52, P12489, DOI 10.1002/anie.201309174; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; KAARSHOLM NC, 1989, BIOCHEMISTRY-US, V28, P4427, DOI 10.1021/bi00436a046; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; Kupper FC, 2011, ANGEW CHEM INT EDIT, V50, P11598, DOI 10.1002/anie.201100028; Landau Z, 2014, DIABETES-METAB RES, V30, P686, DOI 10.1002/dmrr.2536; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; LINDE S, 1981, H-S Z PHYSIOL CHEM, V362, P573, DOI 10.1515/bchm2.1981.362.1.573; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pace CN, 2000, PROTEINS, P1; PEAVY DE, 1984, ENDOCRINOLOGY, V114, P1818, DOI 10.1210/endo-114-5-1818; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; ROY M, 1989, J BIOL CHEM, V264, P19081; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sandler B, 2004, J BIOL CHEM, V279, P55801, DOI 10.1074/jbc.M410124200; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; Shalitin S, 2008, HORM RES, V70, P14, DOI 10.1159/000129673; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; THUROW H, 1984, DIABETOLOGIA, V27, P212; TRUESDALE VW, 1995, MAR CHEM, V48, P143, DOI 10.1016/0304-4203(94)00052-F; Venturi S., 2011, CURR CHEM BIOL, V5, P155, DOI [10.2174/187231311796765012, DOI 10.2174/187231311796765012]; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; West AP, 1997, J PHYS ORG CHEM, V10, P347, DOI 10.1002/(SICI)1099-1395(199705)10:5<347::AID-POC893>3.0.CO;2-X; Wheeler HL, 1909, J BIOL CHEM, V7, P1; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	82	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23367	23381		10.1074/jbc.M114.588277	http://dx.doi.org/10.1074/jbc.M114.588277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993826	hybrid, Green Published			2022-12-25	WOS:000341505000012
J	Yin, LS; Trenh, P; Guce, A; Wieczorek, M; Lange, S; Sticht, J; Jiang, W; Bylsma, M; Mellins, ED; Freund, C; Stern, LJ				Yin, Liusong; Trenh, Peter; Guce, Abigail; Wieczorek, Marek; Lange, Sascha; Sticht, Jana; Jiang, Wei; Bylsma, Marissa; Mellins, Elizabeth D.; Freund, Christian; Stern, Lawrence J.			Susceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Conformational Change; Enzyme Kinetics; Enzyme Mechanism; Major Histocompatibility Complex (MHC); Protein-Protein Interaction; DM Susceptibility	MHC CLASS-II; SMALL-ANGLE SCATTERING; T-CELL EPITOPES; ANTIGEN PRESENTATION; KINETIC STABILITY; BIOLOGICAL MACROMOLECULES; CUTTING EDGE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HYDROGEN-BONDS	Background: HLA-DM-mediated peptide exchange is a key factor in epitope selection, but how HLA-DM selects peptides for editing is not known. Results: Peptide complexes sensitive to HLA-DM editing exhibited conformational alterations. Conclusion: HLA-DM efficiently identifies unstable complexes by sensing MHCII-peptide conformations. Significance: These data emphasize HLA-DM as a conformational editor and provide novel mechanistic insight into its function. HLA-DM mediates the exchange of peptides loaded onto MHCII molecules during antigen presentation by a mechanism that remains unclear and controversial. Here, we investigated the sequence and structural determinants of HLA-DM interaction. Peptides interacting nonoptimally in the P1 pocket exhibited low MHCII binding affinity and kinetic instability and were highly susceptible to HLA-DM-mediated peptide exchange. These changes were accompanied by conformational alterations detected by surface plasmon resonance, SDS resistance assay, antibody binding assay, gel filtration, dynamic light scattering, small angle x-ray scattering, and NMR spectroscopy. Surprisingly, all of those changes could be reversed by substitution of the P9 pocket anchor residue. Moreover, MHCII mutations outside the P1 pocket and the HLA-DM interaction site increased HLA-DM susceptibility. These results indicate that a dynamic MHCII conformational determinant rather than P1 pocket occupancy is the key factor determining susceptibility to HLA-DM-mediated peptide exchange and provide a molecular mechanism for HLA-DM to efficiently target unstable MHCII-peptide complexes for editing and exchange those for more stable ones.	[Yin, Liusong; Trenh, Peter; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Program Immunol & Microbiol, Worcester, MA 01605 USA; [Guce, Abigail; Bylsma, Marissa; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Wieczorek, Marek; Lange, Sascha; Sticht, Jana; Freund, Christian] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Jiang, Wei; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Med Ctr, Stanford, CA 94305 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Free University of Berlin; Stanford University	Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, ASC9 2055, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu		Mellins, Elizabeth/0000-0003-2577-139X	National Institutes of Health from NCRR [AI48833, AI57319, AI095813, UL1 RR025744]; Lucile Packard Foundation for Children's Health; Deutsche Forschungsgemeinschaft [FR 1325/11-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, R21AI095813, R37AI038996, R01AI048833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; Lucile Packard Foundation for Children's Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI48833 and AI57319 (to L. J. S.), AI095813 (to E. D. M.), and UL1 RR025744 from NCRR (to W. J. and E. D. M.). This work was also supported by the Lucile Packard Foundation for Children's Health (to W. J. and E. D. M.) and Deutsche Forschungsgemeinschaft Grant FR 1325/11-1 (to C. F.).	Amria S, 2008, EUR J IMMUNOL, V38, P1961, DOI 10.1002/eji.200738100; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Anderson MW, 2005, BIOCHEMISTRY-US, V44, P5617, DOI 10.1021/bi048675s; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Busch R, 1998, J IMMUNOL, V160, P734; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Doebele RC, 2003, J IMMUNOL, V170, P4683, DOI 10.4049/jimmunol.170.9.4683; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Ferrante A, 2013, IMMUNOLOGY, V138, P85, DOI 10.1111/imm.12030; Ferrante A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00386; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; Ferrante A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003722; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Hanvesakul R, 2007, AM J TRANSPLANT, V7, P1148, DOI 10.1111/j.1600-6143.2007.01743.x; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kremer AN, 2012, BLOOD, V120, P3246, DOI 10.1182/blood-2011-12-399311; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Narayan K, 2009, MOL IMMUNOL, V46, P3157, DOI 10.1016/j.molimm.2009.07.001; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Painter CA, 2012, IMMUNOL REV, V250, P144, DOI 10.1111/imr.12003; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Pu Z, 2002, P NATL ACAD SCI USA, V99, P8844, DOI 10.1073/pnas.092260499; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schlundt A, 2012, J MOL BIOL, V423, P294, DOI 10.1016/j.jmb.2012.07.008; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schulze MSED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069228; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Smith HJ, 2011, TRANSPLANTATION, V91, P279, DOI 10.1097/TP.0b013e318203862d; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; SVERGUN DI, 1982, STUD BIOPHYS, V87, P277; Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wolpl A, 1998, TISSUE ANTIGENS, V51, P258; Yin LS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00336; Yin LS, 2014, J IMMUNOL METHODS, V406, P21, DOI 10.1016/j.jim.2014.02.008; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	75	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23449	23464		10.1074/jbc.M114.585539	http://dx.doi.org/10.1074/jbc.M114.585539			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002586	Green Published, hybrid			2022-12-25	WOS:000341505000019
J	Sun, L; Meng, YX; Xie, YC; Zhang, H; Zhang, Z; Wang, XX; Jiang, B; Li, W; Li, Y; Yang, Z				Sun, Liang; Meng, Yunxiao; Xie, Yanchen; Zhang, Hua; Zhang, Zheng; Wang, Xiaoxia; Jiang, Bin; Li, Wei; Li, Yao; Yang, Ze			CTLA4 Variants and Haplotype Contribute Genetic Susceptibility to Myasthenia Gravis in Northern Chinese Population	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; ACETYLCHOLINE-RECEPTOR; JAPANESE PATIENTS; POLYMORPHISM; ASSOCIATION; PROMOTER; REGION; ONSET; HLA; EXPRESSION	Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4), a critical negative regulator of the T-cell response, has been considered a candidate for many autoimmune diseases. Evidence from Caucasians supported a genetic predisposition of CTLA4 to myasthenia gravis (MG), but the contribution in East Asians has not been established. Objectives: To investigate the role of CTLA4 variants in the susceptibility to MG and the contribution to subtypes of MG. Methods: Six autoimmune disease-related risk alleles of CTLA4 (rs1863800, rs733618, rs4553808, rs5742909, rs231775, and rs3087243) were investigated for MG in northern Chinese. 168 patients with MG (mean age 37.1 +/- 20.5 years, 64 men and 104 women) and 233 healthy controls (mean age 53.3 +/- 8.7 years, 96 men and 137 women) were screened, and the contribution of CTLA4 to the general risk of MG and each subgroup was explored. Results: rs1863800*C, rs733618*C, and rs231775*G were significantly associated with the whole cohort of patients with MG after permutation correction for multiple-testing adjustment (P = 0.027, 0.001, and 0.032, respectively). A risk haplotype (CCACG) [odds ratio (OR) = 1.535, range = 1.150-2.059, P = 0.004)] was also identified. The stratified subtype analysis indicated that the positive contribution was possibly derived from early onset MG (EOMG), seropositive MG (SPMG), female patients, and MG without thymoma. No association was observed in juvenile MG/LOMG, and MG coupled with thymoma. Conclusion: A predisposing effect of rs1863800*C, rs733618*C, and rs231775*G of CTLA4 gene to general risk of MG in Chinese was demonstrated for the first time, which was likely derived from EOMG, SPMG, MG without thymoma and the female patients.	[Sun, Liang; Wang, Xiaoxia; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Sun, Liang; Wang, Xiaoxia; Yang, Ze] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Meng, Yunxiao] Tsinghua Univ, Dept Pathol, Peking Union Med Coll Hosp, Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Xie, Yanchen; Jiang, Bin; Li, Yao] Capital Med Univ, Dept Neurol, Beijing Friendship Hosp, Beijing, Peoples R China; [Zhang, Hua; Li, Wei] Minist Hlth, Dept Neurol, Beijing Hosp, Beijing, Peoples R China; [Zhang, Zheng] Ningxia Med Univ, Dept Publ Hlth, Yinchuan, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tsinghua University; Capital Medical University; Beijing Hospital; Ningxia Medical University	Xie, YC (corresponding author), Capital Med Univ, Dept Neurol, Beijing Friendship Hosp, Beijing, Peoples R China.	drycxie@gmail.com; yang.ze@live.cn	Xie, Yanchen/GXM-9448-2022	Xie, Yanchen/0000-0002-7879-0554	Beijing Nova program [Z121107002512058]; Natural Science Foundation of China [81061120527, 30700242]	Beijing Nova program(Beijing Municipal Science & Technology Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by Beijing Nova program (Z121107002512058), Natural Science Foundation of China (81061120527, 30700242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Awata T, 1998, DIABETES, V47, P128, DOI 10.2337/diab.47.1.128; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; CHEN WH, 1993, J NEUROL NEUROSUR PS, V56, P382, DOI 10.1136/jnnp.56.4.382; CHIU HC, 1987, NEUROLOGY, V37, P1854, DOI 10.1212/WNL.37.12.1854; Chuang WY, 2005, ANN NEUROL, V58, P644, DOI 10.1002/ana.20577; Chuang WY, 2013, J AUTOIMMUN; Donner H, 1998, DIABETES, V47, P1158, DOI 10.2337/diabetes.47.7.1158; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Gonzalez-Escribano MF, 1999, TISSUE ANTIGENS, V53, P296, DOI 10.1034/j.1399-0039.1999.530311.x; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Huang D, 1998, J NEUROIMMUNOL, V88, P192, DOI 10.1016/S0165-5728(98)00119-2; Kawaguchi N, 2004, J NEUROL SCI, V224, P43, DOI 10.1016/j.jns.2003.09.016; Kemp EH, 1998, CLIN ENDOCRINOL, V49, P609; Kotsa K, 1997, CLIN ENDOCRINOL, V46, P551, DOI 10.1046/j.1365-2265.1997.1710996.x; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Lee YH, 2005, HUM GENET, V116, P361, DOI 10.1007/s00439-004-1244-1; Ligers A, 1999, J NEUROIMMUNOL, V97, P182, DOI 10.1016/S0165-5728(99)00072-7; Ligers A, 2001, GENES IMMUN, V2, P145, DOI 10.1038/sj.gene.6363752; Lindstrom JM, 1998, NEUROLOGY, V51, P933; Maniaol AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036603; MATSUKI K, 1990, J CLIN INVEST, V86, P392, DOI 10.1172/JCI114724; Maurer M, 2002, IMMUNOGENETICS, V54, P1, DOI 10.1007/s00251-002-0429-9; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Nagvekar N, 1998, J CLIN INVEST, V101, P2268, DOI 10.1172/JCI2068; Ngo ST, 2014, FRONT NEUROENDOCRINO; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; OOSTERHUIS HJGH, 1981, CLIN NEUROL NEUROSUR, V83, P105, DOI 10.1016/0303-8467(81)90014-7; Poulas K, 2001, LANCET, V357, P234, DOI 10.1016/S0140-6736(05)71337-4; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Quintero-Ronderos P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/593720; Reinhardt C, 2000, ANN NEUROL, V48, P603; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Sallakci N, 2005, CLIN EXP DERMATOL, V30, P546, DOI 10.1111/j.1365-2230.2005.01846.x; Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B; Shinomiya N, 2004, CLIN IMMUNOL, V110, P154, DOI 10.1016/j.clim.2003.10.004; Simmonds MJ, 2004, CLIN EXP IMMUNOL, V136, P1, DOI 10.1111/j.1365-2249.2004.02424.x; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun L, 2006, DIABETIC MED, V23, P1085, DOI 10.1111/j.1464-5491.2006.01949.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang XB, 2008, J INTERN MED, V263, P61, DOI 10.1111/j.1365-2796.2007.01879.x; Wang XB, 2002, GENES IMMUN, V3, P46, DOI 10.1038/sj.gene.6363816; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Waterman EA, 1998, CLIN ENDOCRINOL, V49, P251, DOI 10.1046/j.1365-2265.1998.00537.x; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41; Zhang P, 2012, J EUR ACAD DERMATOL, V26, P399, DOI 10.1111/j.1468-3083.2011.04261.x; Zhang XF, 2007, J NEUROL NEUROSUR PS, V78, P386, DOI 10.1136/jnnp.2006.100545	53	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101986	10.1371/journal.pone.0101986	http://dx.doi.org/10.1371/journal.pone.0101986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003519	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700096
J	Childs, LM; England, WE; Young, MJ; Weitz, JS; Whitaker, RJ				Childs, Lauren M.; England, Whitney E.; Young, Mark J.; Weitz, Joshua S.; Whitaker, Rachel J.			CRISPR-Induced Distributed Immunity in Microbial Populations	PLOS ONE			English	Article							SHORT PALINDROMIC REPEATS; ADAPTIVE IMMUNITY; STREPTOCOCCUS-THERMOPHILUS; ANTAGONISTIC COEVOLUTION; BACTERIAL-POPULATIONS; ACQUIRED-RESISTANCE; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; PHAGE; BACTERIOPHAGE	In bacteria and archaea, viruses are the primary infectious agents, acting as virulent, often deadly pathogens. A form of adaptive immune defense known as CRISPR-Cas enables microbial cells to acquire immunity to viral pathogens by recognizing specific sequences encoded in viral genomes. The unique biology of this system results in evolutionary dynamics of host and viral diversity that cannot be fully explained by the traditional models used to describe microbe-virus coevolutionary dynamics. Here, we show how the CRISPR-mediated adaptive immune response of hosts to invading viruses facilitates the emergence of an evolutionary mode we call distributed immunity - the coexistence of multiple, equally-fit immune alleles among individuals in a microbial population. We use an eco-evolutionary modeling framework to quantify distributed immunity and demonstrate how it emerges and fluctuates in multi-strain communities of hosts and viruses as a consequence of CRISPR-induced coevolution under conditions of low viral mutation and high relative numbers of viral protospacers. We demonstrate that distributed immunity promotes sustained diversity and stability in host communities and decreased viral population density that can lead to viral extinction. We analyze sequence diversity of experimentally coevolving populations of Streptococcus thermophilus and their viruses where CRISPR-Cas is active, and find the rapid emergence of distributed immunity in the host population, demonstrating the importance of this emergent phenomenon in evolving microbial communities.	[Childs, Lauren M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [England, Whitney E.; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [Young, Mark J.] Montana State Univ, Thermal Biol Inst, Bozeman, MT USA; [Young, Mark J.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Whitaker, Rachel J.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu; rwhitaker@life.illinois.edu	England, Whitney/AAA-5016-2019	England, Whitney/0000-0001-6712-0101; Childs, Lauren/0000-0003-3904-3895	NSF [DEB-0816885]; Institute for Advanced Computing Applications and Technologies at the University of Illinois; National Institutes of Health [5T32AI078876]; James S. McDonnell Foundation; Burroughs Wellcome Fund; Division Of Environmental Biology [0816885] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078876] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Institute for Advanced Computing Applications and Technologies at the University of Illinois; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RJW acknowledges support from NSF DEB-0816885 and a fellowship from the Institute for Advanced Computing Applications and Technologies at the University of Illinois. WEE acknowledges support from National Institutes of Health training grant 5T32AI078876. JSW acknowledges the support of a grant from the James S. McDonnell Foundation and support from a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Childs LM, 2012, EVOLUTION, V66, P2015, DOI 10.1111/j.1558-5646.2012.01595.x; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drake JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000520; Fisher R.A., 1930, GENETICAL THEORY NAT; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Gandon S, 2014, J EVOLUTION BIOL, V27, P303, DOI 10.1111/jeb.12291; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haerter JO, 2012, MBIO, V3, DOI 10.1128/mBio.00126-12; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.128102; Held N. L., 2013, CRISPR CAS SYSTEMS, P221, DOI DOI 10.1007/978-3-642-34657-6; Held NL, 2013, ENVIRON MICROBIOL, V15, P3065, DOI 10.1111/1462-2920.12146; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x; LEVIN BR, 1988, PHILOS T R SOC B, V319, P459, DOI 10.1098/rstb.1988.0059; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOLINEUX IJ, 1991, NEW BIOL, V3, P230; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rho M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002441; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09	64	47	47	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101710	10.1371/journal.pone.0101710	http://dx.doi.org/10.1371/journal.pone.0101710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000306	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300077
J	Kang, N; Cauraugh, JH				Kang, Nyeonju; Cauraugh, James H.			Bimanual Force Variability and Chronic Stroke: Asymmetrical Hand Control	PLOS ONE			English	Article							MOTOR CORTEX EXCITABILITY; FINGER EXTENSION; INCREASES; COORDINATION; SURVIVORS; MOVEMENT; DEFICITS	The purpose of this study was to investigate force variability generated by both the paretic and non-paretic hands during bimanual force control. Nine chronic stroke individuals and nine age-matched individuals with no stroke history performed a force control task with both hands simultaneously. The task involved extending the wrist and fingers at 5%, 25%, and 50% of maximum voluntary contraction. Bimanual and unimanual force variability during bimanual force control was determined by calculating the coefficient of variation. Analyses revealed two main findings: (a) greater bimanual force variability in the stroke group than the control group and (b) increased force variability by the paretic hands during bimanual force control in comparison to the non-paretic hands at the 5% and 25% force production conditions. A primary conclusion is that post stroke bimanual force variability is asymmetrical between hands.	[Kang, Nyeonju; Cauraugh, James H.] Univ Florida, Motor Behav Lab, Appl Physiol & Kinesiol Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Cauraugh, JH (corresponding author), Univ Florida, Motor Behav Lab, Appl Physiol & Kinesiol Dept, Gainesville, FL 32611 USA.	cauraugh@ufl.edu	Kang, Nyeonju/AAX-1879-2021		American Heart Association [00093013]	American Heart Association(American Heart Association)	Funding from the American Heart Association is gratefully acknowledged in supporting this research with a grant to JHC (#00093013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Bellew JW, 2002, AGING CLIN EXP RES, V14, P35; Blennerhassett JM, 2006, ARCH PHYS MED REHAB, V87, P418, DOI 10.1016/j.apmr.2005.11.018; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Chang SH, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.10; Davids K, 2006, HUMAN SYSTEM VARIABI; Duncan PW, 2003, NEUROLOGY, V60, P291, DOI 10.1212/01.WNL.0000041493.65665.D6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Inui N, 2002, HUM MOVEMENT SCI, V21, P131, DOI 10.1016/S0167-9457(02)00094-5; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Lang CE, 2009, J NEUROPHYSIOL, V102, P451, DOI 10.1152/jn.91310.2008; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lodha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083468; Lodha N, 2012, NEUROPSYCHOLOGIA, V50, P2536, DOI 10.1016/j.neuropsychologia.2012.06.025; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; Maki Y, 2008, NEUROIMAGE, V42, P1295, DOI 10.1016/j.neuroimage.2008.06.045; Massie CL, 2013, NEUROREHABILITATION, V33, P185, DOI 10.3233/NRE-130944; Massie CL, 2013, CLIN NEUROPHYSIOL, V124, P371, DOI 10.1016/j.clinph.2012.07.026; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; Prodoehl J, 2010, EXP BRAIN RES, V200, P67, DOI 10.1007/s00221-009-1966-3; Quaney BM, 2005, NEUROREHAB NEURAL RE, V19, P338, DOI 10.1177/1545968305282269; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Sleimen-Malkoun R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-11; Sosnov JJ, 2006, EXP BRAIN RES, V174, P86, DOI 10.1007/s00221-006-0422-x; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Trlep M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-43; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Wetter S, 2005, ARCH PHYS MED REHAB, V86, P776, DOI 10.1016/j.apmr.2004.08.009	33	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101817	10.1371/journal.pone.0101817	http://dx.doi.org/10.1371/journal.pone.0101817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000185	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300091
J	Zhalnina, KV; Dias, R; Leonard, MT; de Quadros, PD; Camargo, FAO; Drew, JC; Farmerie, WG; Daroub, SH; Triplett, EW				Zhalnina, Kateryna V.; Dias, Raquel; Leonard, Michael T.; de Quadros, Patricia Dorr; Camargo, Flavio A. O.; Drew, Jennifer C.; Farmerie, William G.; Daroub, Samira H.; Triplett, Eric W.			Genome Sequence of Candidatus Nitrososphaera evergladensis from Group I.1b Enriched from Everglades Soil Reveals Novel Genomic Features of the Ammonia-Oxidizing Archaea	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; STRESS-RESPONSE; NITROSOMONAS-EUROPAEA; COPPER RESISTANCE; NITROUS-OXIDE; SYSTEM; DIVERSITY; OXIDATION; BACTERIA; NITRIFICATION	The activity of ammonia-oxidizing archaea (AOA) leads to the loss of nitrogen from soil, pollution of water sources and elevated emissions of greenhouse gas. To date, eight AOA genomes are available in the public databases, seven are from the group I.1a of the Thaumarchaeota and only one is from the group I.1b, isolated from hot springs. Many soils are dominated by AOA from the group I.1b, but the genomes of soil representatives of this group have not been sequenced and functionally characterized. The lack of knowledge of metabolic pathways of soil AOA presents a critical gap in understanding their role in biogeochemical cycles. Here, we describe the first complete genome of soil archaeon Candidatus Nitrososphaera evergladensis, which has been reconstructed from metagenomic sequencing of a highly enriched culture obtained from an agricultural soil. The AOA enrichment was sequenced with the high throughput next generation sequencing platforms from Pacific Biosciences and Ion Torrent. The de novo assembly of sequences resulted in one 2.95 Mb contig. Annotation of the reconstructed genome revealed many similarities of the basic metabolism with the rest of sequenced AOA. Ca. N. evergladensis belongs to the group I.1b and shares only 40% of whole-genome homology with the closest sequenced relative Ca. N. gargensis. Detailed analysis of the genome revealed coding sequences that were completely absent from the group I.1a. These unique sequences code for proteins involved in control of DNA integrity, transporters, two-component systems and versatile CRISPR defense system. Notably, genomes from the group I.1b have more gene duplications compared to the genomes from the group I.1a. We suggest that the presence of these unique genes and gene duplications may be associated with the environmental versatility of this group.	[Zhalnina, Kateryna V.; Dias, Raquel; Leonard, Michael T.; Drew, Jennifer C.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [de Quadros, Patricia Dorr; Camargo, Flavio A. O.] Univ Fed Rio Grande do Sul, Dept Soil Sci, Porto Alegre, RS, Brazil; [Farmerie, William G.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Genome Sequencing Serv Lab, Gainesville, FL USA; [Daroub, Samira H.] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA	State University System of Florida; University of Florida; Universidade Federal do Rio Grande do Sul; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Triplett, EW (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	ewt@ufl.edu	de Quadros, Patricia Dorr/X-4347-2019; Dörr de Quadros, Patricia/H-5668-2016; Camargo, Flavio A O/J-6914-2013	de Quadros, Patricia Dorr/0000-0002-7742-5723; Dörr de Quadros, Patricia/0000-0002-7742-5723; Zhalnina, Kateryna/0000-0002-1893-1888; Daroub, Samira/0000-0003-0814-4618; camargo, flavio/0000-0003-1080-0549; Drew, Jennifer/0000-0002-4037-108X	National Science Foundation [MCB-0454030]; United States Department of Agriculture [2005-35319-16300, 00067345]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Science Foundation (grant number MCB-0454030); and the United States Department of Agriculture (grant numbers 2005-35319-16300, 00067345). University of Florida, Interdisciplinary Center for Biotechnology Research, Electron Microscopy and Bio-Imaging lab for assistance with SEM and TEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beaumont HJE, 2004, J BACTERIOL, V186, P4417, DOI 10.1128/JB.186.13.4417-4421.2004; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Berube PM, 2012, J BACTERIOL, V194, P3448, DOI 10.1128/JB.00133-12; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Damste JSS, 2012, APPL ENVIRON MICROB, V78, P6866, DOI 10.1128/AEM.01681-12; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Koning B, 2010, ARCHAEA, V2010, DOI 10.1155/2010/960298; de Koning B, 2009, BIOCHEM SOC T, V37, P52, DOI 10.1042/BST0370052; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettema TJG, 2006, MICROBIOL-SGM, V152, P1969, DOI 10.1099/mic.0.28724-0; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fried L, 2013, J BACTERIOL, V195, P807, DOI 10.1128/JB.02051-12; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Giner-Lamia J, 2012, PLANT PHYSIOL, V159, P1806, DOI 10.1104/pp.112.200659; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Kirchman DL, 2012, P NATL ACAD SCI USA, V109, P17732, DOI 10.1073/pnas.1215654109; Klotz MG, 2008, FEMS MICROBIOL LETT, V278, P146, DOI 10.1111/j.1574-6968.2007.00970.x; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Li XF, 2009, PLANT SOIL, V324, P209, DOI 10.1007/s11104-009-9947-7; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Maezato Yukari, 2012, Life-Basel, V2, P229, DOI 10.3390/life2030229; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Muller V, 2005, CURR OPIN MICROBIOL, V8, P729, DOI 10.1016/j.mib.2005.10.011; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Norton JM, 2002, ARCH MICROBIOL, V177, P139, DOI 10.1007/s00203-001-0369-z; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Orell A, 2013, ARCHAEA, V2013, DOI 10.1155/2013/289236; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park SJ, 2012, J BACTERIOL, V194, P6948, DOI 10.1128/JB.01869-12; Park SJ, 2012, J BACTERIOL, V194, P6940, DOI 10.1128/JB.01857-12; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Petitjean C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-226; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Pitcher A, 2010, ISME J, V4, P542, DOI 10.1038/ismej.2009.138; Quillaguaman J, 2010, APPL MICROBIOL BIOT, V85, P1687, DOI 10.1007/s00253-009-2397-6; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Ragan MA, 1996, FEMS MICROBIOL LETT, V144, P151, DOI 10.1111/j.1574-6968.1996.tb08522.x; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Rees A, 1999, MAR ECOL PROG SER, V187, P295, DOI 10.3354/meps187295; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rowland JL, 2013, J BACTERIOL, V195, P3724, DOI 10.1128/JB.00546-13; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Shan Yue, 2012, Subcell Biochem, V64, P159, DOI 10.1007/978-94-007-5055-5_8; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Smit A, 2000, GENOME RES, V10, P1468, DOI 10.1101/gr.145600; Snyder JC, 2010, APPL ENVIRON MICROB, V76, P7251, DOI 10.1128/AEM.01109-10; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor M, 2013, TRENDS BIOTECHNOL, V31, P63, DOI 10.1016/j.tibtech.2012.09.003; Tortosa P, 2001, J BACTERIOL, V183, P451, DOI 10.1128/JB.183.2.451-460.2001; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Vajrala N, 2013, P NATL ACAD SCI USA, V110, P1006, DOI 10.1073/pnas.1214272110; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wende A, 2009, J BACTERIOL, V191, P3852, DOI 10.1128/JB.01642-08; White MF, 2003, BIOCHEM SOC T, V31, P690, DOI 10.1042/BST0310690.; Whittaker M, 2000, BBA-BIOENERGETICS, V1459, P346, DOI 10.1016/S0005-2728(00)00171-7; Yin YB, 2010, P NATL ACAD SCI USA, V107, P6310, DOI 10.1073/pnas.0911237107; Zaparty M, 2008, J BACTERIOL, V190, P2231, DOI 10.1128/JB.01524-07; Zart D, 2000, ANTON LEEUW INT J G, V77, P49, DOI 10.1023/A:1002077726100; Zhalnina K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00104; Zhalnina K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00210; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	113	55	59	4	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101648	10.1371/journal.pone.0101648	http://dx.doi.org/10.1371/journal.pone.0101648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999826	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300066
J	Bonanno, A; Giannoulaki, M; Barra, M; Basilone, G; Machias, A; Genovese, S; Goncharov, S; Popov, S; Rumolo, P; Di Bitetto, M; Aronica, S; Patti, B; Fontana, I; Giacalone, G; Ferreri, R; Buscaino, G; Somarakis, S; Pyrounaki, MM; Tsoukali, S; Mazzola, S				Bonanno, Angelo; Giannoulaki, Marianna; Barra, Marco; Basilone, Gualtiero; Machias, Athanassios; Genovese, Simona; Goncharov, Sergey; Popov, Sergey; Rumolo, Paola; Di Bitetto, Massimiliano; Aronica, Salvatore; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Somarakis, Stylianos; Pyrounaki, Maria-Myrto; Tsoukali, Stavroula; Mazzola, Salvatore			Habitat Selection Response of Small Pelagic Fish in Different Environments. Two Examples from the Oligotrophic Mediterranean Sea	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; SARDINE SARDINOPS-SAGAX; HUMBOLDT CURRENT SYSTEM; EARLY-LIFE HISTORY; SPAWNING HABITAT; EUROPEAN ANCHOVY; AEGEAN SEA; CALIFORNIA CURRENT; POTENTIAL HABITAT; SICILIAN CHANNEL	A number of scientific papers in the last few years singled out the influence of environmental conditions on the spatial distribution of fish species, highlighting the need for the fisheries scientific community to investigate, besides biomass estimates, also the habitat selection of commercially important fish species. The Mediterranean Sea, although generally oligotrophic, is characterized by high habitat variability and represents an ideal study area to investigate the adaptive behavior of small pelagics under different environmental conditions. In this study the habitat selection of European anchovy Engraulis encrasicolus and European sardine Sardina pilchardus is analyzed in two areas of the Mediterranean Sea that largely differentiate in terms of environmental regimes: the Strait of Sicily and the North Aegean Sea. A number of environmental parameters were used to investigate factors influencing anchovy and sardine habitat selection. Acoustic surveys data, collected during the summer period 2002-2010, were used for this purpose. The quotient analysis was used to identify the association between high density values and environmental variables; it was applied to the entire dataset in each area in order to identify similarities or differences in the "mean'' spatial behavioral pattern for each species. Principal component analysis was applied to selected environmental variables in order to identify those environmental regimes which drive each of the two ecosystems. The analysis revealed the effect of food availability along with bottom depth selection on the spatial distribution of both species. Furthermore PCA results highlighted that observed selectivity for shallower waters is mainly associated to specific environmental processes that locally increase productivity. The common trends in habitat selection of the two species, as observed in the two regions although they present marked differences in hydrodynamics, seem to be driven by the oligotrophic character of the study areas, highlighting the role of areas where the local environmental regimes meet 'the ocean triad hypothesis'.	[Bonanno, Angelo; Barra, Marco; Basilone, Gualtiero; Genovese, Simona; Rumolo, Paola; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Mazzola, Salvatore] CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Mazara Dell Vallo, TP, Italy; [Bonanno, Angelo; Barra, Marco; Basilone, Gualtiero; Genovese, Simona; Rumolo, Paola; Aronica, Salvatore; Patti, Bernardo; Fontana, Ignazio; Giacalone, Giovanni; Ferreri, Rosalia; Buscaino, Giuseppa; Mazzola, Salvatore] CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Naples, Italy; [Giannoulaki, Marianna; Machias, Athanassios; Somarakis, Stylianos; Pyrounaki, Maria-Myrto; Tsoukali, Stavroula] Inst Marine Biol Resources, Hellenic Ctr Marine Res, Iraklion, Greece; [Goncharov, Sergey; Popov, Sergey] Russian Fed Res Inst Fisheries & Oceanog VNIRO, Moscow, Russia; [Di Bitetto, Massimiliano] CNR, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Hellenic Centre for Marine Research; Research lnstitute of Fisheries & Oceanography; Consiglio Nazionale delle Ricerche (CNR)	Bonanno, A (corresponding author), CNR, Inst Coastal & Marine Environm IAMC, Detached Units Capo Granitola TP, Mazara Dell Vallo, TP, Italy.	angelo.bonanno@cnr.it	Ferreri, Rosalia/AAQ-8033-2020; Barra, Marco/AAY-1562-2020; Genovese, Simona/ABH-1171-2020; Rumolo, Paola/AAY-1671-2020; Basilone, Gualtiero/D-2896-2017; Bonanno, Angelo/H-9025-2013; Patti, Bernardo/ABG-7214-2020; Rumolo, Paola/L-8109-2014; buscaino, giuseppa/O-8705-2015	Ferreri, Rosalia/0000-0001-7339-4942; Barra, Marco/0000-0002-8621-504X; Rumolo, Paola/0000-0002-1726-1077; Basilone, Gualtiero/0000-0002-5732-5055; Bonanno, Angelo/0000-0002-3868-751X; Rumolo, Paola/0000-0002-1726-1077; Patti, Bernardo/0000-0003-0193-5628; Giacalone, Giovanni/0000-0001-8172-4710; buscaino, giuseppa/0000-0002-4848-4185; aronica, salvatore/0000-0003-3489-1473; Fontana, Ignazio/0000-0002-0527-9827; Mazzola, Salvatore/0000-0002-4622-8129	Commission of the European Union through the MEDIAS Project; Italian Data Collection Program; Greece Data Collection Program	Commission of the European Union through the MEDIAS Project; Italian Data Collection Program; Greece Data Collection Program	This study was supported by the Commission of the European Union through the MEDIAS Project, Italian Data Collection Program, and Greece Data Collection Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Asch RG, 2013, DEEP-SEA RES PT I, V71, P79, DOI 10.1016/j.dsr.2012.08.006; Bakun A., 1996, OCEAN PROCESSES MARI; Basilone G, 2006, FISH OCEANOGR, V15, P271, DOI 10.1111/j.1365-2419.2005.00391.x; Basilone G, 2004, FISH RES, V68, P9, DOI 10.1016/j.fishres.2004.02.012; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Bellier E, 2007, FISH OCEANOGR, V16, P1, DOI 10.1111/j.1365-2419.2006.00410.x; Bernal M, 2007, PROG OCEANOGR, V74, P210, DOI 10.1016/j.pocean.2007.04.018; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bonanno A, 2013, HYDROBIOLOGIA, V701, P273, DOI 10.1007/s10750-012-1285-8; Brankart J.M.., 1994, TECHNICAL REPORT; Brochier T, 2008, PROG OCEANOGR, V79, P313, DOI 10.1016/j.pocean.2008.10.004; Bustos CA, 2008, REV BIOL MAR OCEANOG, V43, P381; Cardinale M, 2009, REPORT SGMED 09 02 1; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P12; Claramunt G, 2012, REV BIOL MAR OCEANOG, V47, P227, DOI 10.4067/S0718-19572012000200006; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Cuttitta A, 2004, HYDROBIOLOGIA, V527, P177, DOI 10.1023/B:HYDR.0000043299.65829.2f; Dimmlich WF, 2009, J FISH BIOL, V75, P1560, DOI 10.1111/j.1095-8649.2009.02361.x; Dimmlich WF, 2004, FISH OCEANOGR, V13, P310, DOI 10.1111/j.1365-2419.2004.00296.x; Dopolo MT, 2008, AFR J MAR SCI, V30, P133, DOI 10.2989/AJMS.2008.30.1.13.463; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Ganias K, 2007, MAR BIOL, V151, P1559, DOI 10.1007/s00227-006-0601-0; Garcia A, 1996, SCI MAR, V60, P155; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Giannoulaki M, 2008, HYDROBIOLOGIA, V612, P225, DOI 10.1007/s10750-008-9498-6; Giannoulaki M, 2011, FISH OCEANOGR, V20, P367, DOI 10.1111/j.1365-2419.2011.00590.x; GRASS Development Team, 2012, GRASS 6 4 US MAN; Isari S, 2006, J PLANKTON RES, V28, P241, DOI 10.1093/plankt/fbi058; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; MOREL A, 1978, DEEP-SEA RES, V25, P673, DOI 10.1016/0146-6291(78)90623-9; Motos L, 1996, SCI MAR, V60, P117; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; PALOMERA I, 1992, MAR ECOL PROG SER, V79, P215; Paramo J, 2003, AQUAT LIVING RESOUR, V16, P239, DOI 10.1016/S0990-7440(03)00043-3; Patti B., 2004, Chemistry and Ecology, V20, P365; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; Pierre P, 2006, SCI MAR, V70, P161, DOI 10.3989/scimar.2006.70s1161; Tugores MP, 2011, MAR ECOL PROG SER, V443, P181, DOI 10.3354/meps09366; Placenti F, 2013, J MARINE SYST, V121, P36, DOI 10.1016/j.jmarsys.2013.03.012; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Reiss CS, 2008, FISH OCEANOGR, V17, P126, DOI 10.1111/j.1365-2419.2008.00469.x; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Sammari C, 1999, DEEP-SEA RES PT I, V46, P1671, DOI 10.1016/S0967-0637(99)00026-6; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Somarakis S, 2004, ICES J MAR SCI, V61, P944, DOI 10.1016/j.icesjms.2004.07.018; Somarakis S, 2007, MAR BIOL, V152, P1143, DOI 10.1007/s00227-007-0761-6; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Tsagarakis K, 2008, HYDROBIOLOGIA, V612, P215, DOI 10.1007/s10750-008-9500-3; Twatwa NM, 2005, AFR J MAR SCI, V27, P487, DOI 10.2989/18142320509504107; van der Lingen CD, 2003, BIG FISH BANG, P303; van der Lingen CD, 2004, 21 GLOBEC, V21; Weber ED, 2010, MAR ECOL PROG SER, V406, P251, DOI 10.3354/meps08544; ZERVAKIS V, 2002, MEDITERR MAR SCI, V3, P5, DOI DOI 10.12681/MMS.254; Zwolinski JP, 2011, ICES J MAR SCI, V68, P867, DOI 10.1093/icesjms/fsr038; Zwolinski JP, 2010, ICES J MAR SCI, V67, P1553, DOI 10.1093/icesjms/fsq068	61	48	49	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101498	10.1371/journal.pone.0101498	http://dx.doi.org/10.1371/journal.pone.0101498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992576	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400079
J	Li, CY; Chen, J; Lu, BM; Shi, Z; Wang, HL; Zhang, B; Zhao, KL; Qi, W; Bao, JK; Wang, Y				Li, Chunyang; Chen, Jie; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku; Wang, Yi			Molecular Switch Role of Akt in Polygonatum odoratum Lectin-Induced Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer A549 Cells	PLOS ONE			English	Article							MELANOMA A375 CELLS; CONCANAVALIN-A; PATHWAY; THERAPY; DEATH; BIOLOGY; P53	Polygonatum odoratum lectin (POL), isolated from traditional Chinese medicine herb (Mill.) Druce, has drawn rising attention due to its wide biological activities. In the present study, anti-tumor effects, including apoptosis- and autophagy-inducing properties of POL, were determined by a series of cell biology methods such as MTT, cellular morphology observation, flow cytometry, immunoblotting. Herein, we found that POL could simultaneously induce apoptosis and autophagy in human non-small cell lung cancer A549 cells. POL initiated apoptosis through inhibiting Akt-NF-kappa B pathway, while POL triggered autophagy via suppressing Akt-mTOR pathway, suggesting the molecular switch role of Akt in regulating between POL-induced apoptosis and autophagy. Moreover, ROS was involved in POL-induced inhibition of Akt expression, and might therefore mediate both apoptosis and autophagy in A549 cells. In addition, POL displayed no significant cytotoxicity toward normal human embryonic lung fibroblast HELF cells. Due to the anti-tumor activities, POL might become a potent anticancer drug in future therapy, which might pave the way for exploring GNA-related lectins into effective drugs in cancer treatment.	[Li, Chunyang; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; [Li, Chunyang; Lu, Bangmin; Shi, Zheng; Wang, Hailian; Zhang, Bin; Zhao, Kailiang; Qi, Wei; Bao, Jinku] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China; [Chen, Jie] Sichuan Acad Med Sci, Cent Lab Clin Med, Chengdu, Peoples R China; [Chen, Jie; Wang, Hailian; Wang, Yi] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wang, Hailian] Sichuan Acad Med Sci, Inst Organ Transplantat, Chengdu, Peoples R China; [Wang, Yi] Sichuan Acad Med Sci, Dept Pharm, Chengdu, Peoples R China; [Wang, Yi] Nationwide Childrens Hosp, Ctr Perinatal Res, Columbus, OH USA	Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Bao, JK (corresponding author), Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China.	jinkubao@yahoo.com; Yi.Wang@nationwidechildrens.org	Zhao, Kailiang/AAE-2828-2021; Wang, Yi/GLU-8903-2022; Wang, Yi/GSD-4852-2022	Zhao, Kailiang/0000-0001-8149-1494; Wang, Yi/0000-0001-9921-0304	National Natural Science Foundation of China [81373311, 31300674, 30970643, 81173093, J1103518]; Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China [2011JTD0026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China	This work was supported in part by the National Natural Science Foundation of China (No. 81373311, No. 31300674, No. 30970643, No. 81173093 and No. J1103518), the Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China (No. 2011JTD0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Cheng Y, 2013, PHARMACOL REV, V65, P1162, DOI 10.1124/pr.112.007120; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Kessel D, 2007, CANCER LETT, V249, P294, DOI 10.1016/j.canlet.2006.09.009; Lee YC, 2010, EUR J PHARMACOL, V632, P23, DOI 10.1016/j.ejphar.2010.01.009; Lei HY, 2007, AUTOPHAGY, V3, P402, DOI 10.4161/auto.4280; Li CY, 2013, CELL PROLIFERAT, V46, P272, DOI 10.1111/cpr.12034; Li CY, 2011, INT J BIOCHEM CELL B, V43, P701, DOI 10.1016/j.biocel.2011.01.020; Li CY, 2011, PROCESS BIOCHEM, V46, P533, DOI 10.1016/j.procbio.2010.10.005; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2010, BIOCHIMIE, V92, P1934, DOI 10.1016/j.biochi.2010.08.009; Liu B, 2009, BBA-GEN SUBJECTS, V1790, P840, DOI 10.1016/j.bbagen.2009.04.020; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Meng L, 2009, CURR CHEM BIOL, V3, P324, DOI [10.2174/2212796810903030324, DOI 10.2174/2212796810903030324, DOI 10.2174/187231309789054913]; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Shi Z, 2013, COMPUT BIOL CHEM, V47, P56, DOI 10.1016/j.compbiolchem.2013.07.001; Shi Z, 2013, CANCER LETT, V337, P149, DOI 10.1016/j.canlet.2013.06.004; Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Damme EJM, 2011, ADV EXP MED BIOL, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; Wang Y, 2012, HORM METAB RES, V44, P33, DOI 10.1055/s-0031-1295416; Wang Y, 2012, EXP BIOL MED, V237, P287, DOI 10.1258/ebm.2011.011251; Xu HL, 2012, J MOL MODEL, V18, P27, DOI 10.1007/s00894-011-1022-7; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001	31	32	33	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101526	10.1371/journal.pone.0101526	http://dx.doi.org/10.1371/journal.pone.0101526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992302	gold, Green Submitted, Green Published			2022-12-25	WOS:000341253400084
J	Wang, SC; Lin, XL; Li, J; Zhang, TT; Wang, HY; Shi, JW; Yang, S; Zhao, WT; Xie, RY; Wei, F; Qin, YJ; Chen, L; Yang, J; Yao, KT; Xiao, D				Wang, Sheng-Chun; Lin, Xiao-Lin; Li, Jing; Zhang, Ting-Ting; Wang, Hui-Yan; Shi, Jun-Wen; Yang, Sheng; Zhao, Wen-Tao; Xie, Rao-Ying; Wei, Fang; Qin, Yu-Juan; Chen, Lin; Yang, Jie; Yao, Kai-Tai; Xiao, Dong			MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; TUMOR-SUPPRESSOR; LIPID-METABOLISM; MIR-122 EXPRESSION; DOWN-REGULATION; CANCER-CELLS; CYCLE ARREST; IN-VIVO; LIVER; METASTASIS	The loss of microRNA-122 (miR-122) expression is strongly associated with increased invasion and metastasis, and poor prognosis of hepatocellular carcinoma (HCC), however, the underlying mechanisms remain poorly understood. In the present study, we observed that miR-122 over-expression in HCC cell lines Sk-hep-1 and Bel-7402 triggered the mesenchymal-epithelial transition (MET), as demonstrated by epithelial-like morphological changes, up-regulated epithelial proteins (E-cadherin, ZO-1, alpha-catenin, occludin, BVES, and MST4), and down-regulated mesenchymal proteins (vimentin and fibronectin). The over-expression of miRNA-122 also caused cytoskeleton disruption, RhoA/Rock pathway inactivation, enhanced cell adhesion, and suppression of migration and invasion of Sk-hep-1 and Bel-7402 cells, whereas, these effects could be reversed through miR-122 inhibition. Additional studies demonstrated that the inhibition of wild-type RhoA function induced MET and inhibited cell migration and invasion, while RhoA over-expression reversed miR-122-induced MET and inhibition of migration and invasion of HCC cells, suggesting that miR-122 induced MET and suppressed the migration and invasion of HCC cells by targeting RhoA. Moreover, our results demonstrated that HNF4 alpha up-regulated its target gene miR-122 that subsequently induced MET and inhibited cell migration and invasion, whereas miR-122 inhibition reversed these HNF4 alpha-induced phenotypes. These results revealed functional and mechanistic links among the tumor suppressors HNF4 alpha, miR-122, and RhoA in EMT and invasive and metastatic phenotypes of HCC. Taken together, our study provides the first evidence that the HNF4 alpha/miR-122/RhoA axis negatively regulates EMT and the migration and invasion of HCC cells.	[Wang, Sheng-Chun; Lin, Xiao-Lin; Li, Jing; Zhang, Ting-Ting; Wang, Hui-Yan; Shi, Jun-Wen; Yang, Sheng; Zhao, Wen-Tao; Xie, Rao-Ying; Wei, Fang; Qin, Yu-Juan; Chen, Lin; Yang, Jie; Yao, Kai-Tai; Xiao, Dong] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong] Southern Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Xiao, Dong] Southern Med Univ, Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	Ktyao@fimmu.com; Xiao_d@hotmail.com	wang, shengchun/AAL-7101-2020	Wang, Shengchun/0000-0003-2296-1577; Chen, Lin/0000-0002-7552-8673	National Natural Science Foundation of China [81172587, 81372896, 81100573]; Natural Science Foundation of Guangdong Province of China [9151063101000015, S2012010009212]; Science and Technology Planning Project of Guangdong Province of China [2009B060300008]; Fundamental Research Funds for the Central Universities of China [10ykpy21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81172587 and 81372896, to D. Xiao; Grant No. 81100573, to T. Du), the Natural Science Foundation of Guangdong Province of China (Grant No. 9151063101000015, to J.-S. Jia; Grant No. S2012010009212, to K Xu), the Science and Technology Planning Project of Guangdong Province of China (Grant No. 2009B060300008, to D. Xiao), and Fundamental Research Funds for the Central Universities of China (Grant No. 10ykpy21, to K Xu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Cheng IK, 2012, J PATHOL; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Deng XG, 2014, LIVER INT, V34, P281, DOI 10.1111/liv.12239; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gou LT, 2011, J MOL MED, V89, P817, DOI 10.1007/s00109-011-0753-3; Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003; Hsu SH, 2013, AM J PATHOL, V183, P1719, DOI 10.1016/j.ajpath.2013.08.004; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Hu TH, 2013, ONCOL REP, V30, P1707, DOI 10.3892/or.2013.2608; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Li XR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-205; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Ma LN, 2010, CANCER BIOL THER, V9, P554, DOI 10.4161/cbt.9.7.11267; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079655; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Waidmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045652; Wang DS, 2007, J GASTROEN HEPATOL, V22, P1916, DOI 10.1111/j.1440-1746.2006.04534.x; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Yang YM, 2012, HEPATOLOGY, V56, P2209, DOI 10.1002/hep.25912; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zeisel MB, 2013, J HEPATOL, V58, P821, DOI 10.1016/j.jhep.2012.10.010; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	51	90	97	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101330	10.1371/journal.pone.0101330	http://dx.doi.org/10.1371/journal.pone.0101330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992599	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400063
J	Alvarez-Arellano, L; Cortes-Reynosa, P; Sanchez-Zauco, N; Salazar, E; Torres, J; Maldonado-Bernal, C				Alvarez-Arellano, Lourdes; Cortes-Reynosa, Pedro; Sanchez-Zauco, Norma; Salazar, Eduardo; Torres, Javier; Maldonado-Bernal, Carmen			TLR9 and NF-kappa B Are Partially Involved in Activation of Human Neutrophils by Helicobacter pylori and Its Purified DNA	PLOS ONE			English	Article							BACTERIAL-DNA; STREPTOCOCCUS-PNEUMONIAE; SIGNALING PATHWAYS; GENE-EXPRESSION; IMMUNE-RESPONSE; GASTRIC-CANCER; CPG-DNA; INTERLEUKIN-8; INFECTION; RECEPTOR	Helicobacter pylori infection represents one of the most common bacterial infections worldwide. The inflammatory response to this bacterium involves a large influx of neutrophils to the lamina propria of the gastric mucosa. However, little is known about the receptors and molecular mechanisms involved in activation of these neutrophils. In this study, we aimed to determine the role of toll-like receptor 9 (TLR9) in the response of human neutrophils to H. pylori and purified H. pylori DNA (Hp-DNA). Neutrophils were isolated from the blood of adult volunteers and challenged with either H. pylori or Hp-DNA. We found that both, H. pylori and Hp-DNA induced increased expression and release of IL-8. Furthermore, we showed that TLR9 is involved in the induction of IL-8 production by H. pylori and Hp-DNA. IL-8 production induced by H. pylori but not by Hp-DNA was partially mediated by NF-kappa B. In conclusion, this study showed for first time that both, H. pylori and Hp-DNA activate TLR9 and induce a different inflammatory response that leads to activation of neutrophils.	[Alvarez-Arellano, Lourdes; Sanchez-Zauco, Norma; Torres, Javier; Maldonado-Bernal, Carmen] Inst Mexicano Seguro Social, Hosp Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Alvarez-Arellano, Lourdes] Univ Nacl Autonoma Mexico, Lab Neuroinmunobiol, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Cortes-Reynosa, Pedro; Salazar, Eduardo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico; [Sanchez-Zauco, Norma; Maldonado-Bernal, Carmen] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Inmunol & Prote, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Hospital Infantil de Mexico Federico Gomez	Maldonado-Bernal, C (corresponding author), Inst Mexicano Seguro Social, Hosp Pediat, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	cmaldobe@yahoo.com		Alvarez-Arellano, Lourdes/0000-0002-3469-1407; Sanchez-Zauco, Norma/0000-0001-8375-1499; Maldonado-Bernal, Carmen/0000-0003-0663-2888	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/C2007/053]	Instituto Mexicano del Seguro Social	This work was supported by Instituto Mexicano del Seguro Social, grant FIS/IMSS/PROT/C2007/053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 2001, CURR OPIN INFECT DIS, V14, P273, DOI 10.1097/00001432-200106000-00005; Alvarez ME, 2006, J IMMUNOL, V177, P4037, DOI 10.4049/jimmunol.177.6.4037; Alvarez-Arellano L, 2007, FEMS IMMUNOL MED MIC, V51, P473, DOI 10.1111/j.1574-695X.2007.00327.x; Sanchez-Zauco NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064623; Bass JIF, 2008, LAB INVEST, V88, P926, DOI 10.1038/labinvest.2008.59; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Collison KS, 2002, J LEUKOCYTE BIOL, V71, P433; El Kebir D, 2008, ARCH IMMUNOL THER EX, V56, P41, DOI 10.1007/s00005-008-0008-3; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fujita Y, 2005, HELICOBACTER, V10, P567, DOI 10.1111/j.1523-5378.2005.00364.x; Gianfagna F, 2008, CURR GENOMICS, V9, P361, DOI 10.2174/138920208785699544; Grande R, 2012, J APPL MICROBIOL, V113, P669, DOI 10.1111/j.1365-2672.2012.05351.x; Agren J, 2006, SCAND J IMMUNOL, V64, P61, DOI 10.1111/j.1365-3083.2006.01779.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Lindau D, 2013, EUR J IMMUNOL, V43, P2101, DOI 10.1002/eji.201142143; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rieke C, 2011, BIOL CHEM, V392, P387, DOI 10.1515/BC.2011.029; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schroder AK, 2006, HUM IMMUNOL, V67, P676, DOI 10.1016/j.humimm.2006.05.004; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suzuki T, 2004, SCAND J GASTROENTERO, V39, P313, DOI 10.1080/00365520310008610; Taguchi A, 2005, CANCER EPIDEM BIOMAR, V14, P2487, DOI 10.1158/1055-9965.EPI-05-0326; Trevani AS, 2003, EUR J IMMUNOL, V33, P3164, DOI 10.1002/eji.200324334; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yanai A, 2008, INFECT IMMUN, V76, P781, DOI 10.1128/IAI.01046-07	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101342	10.1371/journal.pone.0101342	http://dx.doi.org/10.1371/journal.pone.0101342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987851	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100076
J	Gilbert, MJ; Kik, M; Timmerman, AJ; Severs, TT; Kusters, JG; Duim, B; Wagenaar, JA				Gilbert, Maarten J.; Kik, Marja; Timmerman, Arjen J.; Severs, Tim T.; Kusters, Johannes G.; Duim, Birgitta; Wagenaar, Jaap A.			Occurrence, Diversity, and Host Association of Intestinal Campylobacter, Arcobacter, and Helicobacter in Reptiles	PLOS ONE			English	Article							FETUS; IDENTIFICATION; HYOINTESTINALIS; SALMONELLA; MATRIX	Campylobacter, Arcobacter, and Helicobacter species have been isolated from many vertebrate hosts, including birds, mammals, and reptiles. Multiple studies have focused on the prevalence of these Epsilonproteobacteria genera in avian and mammalian species. However, little focus has been given to the presence within reptiles, and their potential zoonotic and pathogenic roles. In this study, occurrence, diversity, and host association of intestinal Epsilonproteobacteria were determined for a large variety of reptiles. From 2011 to 2013, 444 cloacal swabs and fecal samples originating from 417 predominantly captive-held reptiles were screened for Epsilonproteobacteria. Campylobacter, Arcobacter, and Helicobacter genus specific PCRs were performed directly on all samples. All samples were also cultured on selective media and screened for the presence of Epsilonproteobacteria. Using a tiered approach of AFLP, atpA, and 16S rRNA sequencing, 432 Epsilonproteobacteria isolates were characterized at the species level. Based on PCR, Campylobacter, Arcobacter, and Helicobacter were detected in 69.3% of the reptiles; 82.5% of the chelonians, 63.8% of the lizards, and 58.0% of the snakes were positive for one or more of these genera. Epsilonproteobacteria were isolated from 22.1% of the reptiles and were isolated most frequently from chelonians (37.0%), followed by lizards (19.6%) and snakes (3.0%). The most commonly isolated taxa were Arcobacter butzleri, Arcobacter skirrowii, reptile-associated Campylobacter fetus subsp. testudinum, and a putative novel Campylobacter taxon. Furthermore, a clade of seven related putative novel Helicobacter taxa was isolated from lizards and chelonians. This study shows that reptiles carry various intestinal Epsilonproteobacteria taxa, including several putative novel taxa.	[Gilbert, Maarten J.; Timmerman, Arjen J.; Duim, Birgitta; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kik, Marja] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Severs, Tim T.; Kusters, Johannes G.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Duim, Birgitta; Wagenaar, Jaap A.] WHO Collaborating Ctr Campylobacter, OIE Reference Lab Campylobacteriosis, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Gilbert, MJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	m.j.gilbert@uu.nl						Benejat L, 2014, LETT APPL MICROBIOL, V58, P338, DOI 10.1111/lam.12194; Bertrand S., 2008, Eurosurveillance, V13, P18902; Coldham T, 2011, APPL ENVIRON MICROB, V77, P1581, DOI 10.1128/AEM.01960-10; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; de Boer RF, 2013, J CLIN MICROBIOL, V51, P253, DOI 10.1128/JCM.01716-12; Debruyne L, 2008, CAMPYLOBACTER, 3RD EDITION, P3; Dingle KE, 2010, J CLIN MICROBIOL, V48, P977, DOI 10.1128/JCM.01439-09; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; EDMONDS P, 1987, J CLIN MICROBIOL, V25, P685, DOI 10.1128/JCM.25.4.685-691.1987; Fitzgerald C, 2014, INT J SYST EVOL MICR, DOI 10.1099; Girling S., 2004, BSAVA MANUAL REPTILE; Harmon KM, 1996, LETT APPL MICROBIOL, V23, P241, DOI 10.1111/j.1472-765X.1996.tb00074.x; HARVEY S, 1985, J CLIN MICROBIOL, V21, P260, DOI 10.1128/JCM.21.2.260-261.1985; Maiwald M., 2004, MOL MICROBIOLOGY DIA, P379; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Miller WG, 2014, LETT APPL MICROBIOL, DOI 10.1111; Miller WG, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00045; Nachamkin I, 2008, CAMPYLOBACTER, 3RD EDITION, P1; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; On SLW, 1996, J APPL BACTERIOL, V81, P425; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Patrick ME, 2013, EMERG INFECT DIS, V19, P1678, DOI 10.3201/eid1910.130883; Richards JM, 2004, J ZOO WILDLIFE MED, V35, P562, DOI 10.1638/03-070; Scheelings TF, 2011, J WILDLIFE DIS, V47, P1, DOI 10.7589/0090-3558-47.1.1; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Solnick JV, 2001, CLIN MICROBIOL REV, V14, P59, DOI 10.1128/CMR.14.1.59-97.2001; Stacy BA, 2010, J VET DIAGN INVEST, V22, P660, DOI 10.1177/104063871002200431; Tu ZC, 2004, J CLIN MICROBIOL, V42, P4405, DOI 10.1128/JCM.42.9.4405-4407.2004; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vitt LJ, 2013, HERPETOLOGY INTRO BI; Wang CM, 2013, VET MICROBIOL, V164, P67, DOI 10.1016/j.vetmic.2013.01.008	32	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101599	10.1371/journal.pone.0101599	http://dx.doi.org/10.1371/journal.pone.0101599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988130	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100119
J	Kim, S; Lee, YC; Cho, DH; Lee, HU; Huh, YS; Kim, GJ; Kim, HS				Kim, Sora; Lee, Young-Chul; Cho, Dae-Hyun; Lee, Hyun Uk; Huh, Yun Suk; Kim, Geun-Joong; Kim, Hee-Sik			A Simple and Non-Invasive Method for Nuclear Transformation of Intact-walled Chlamydomonas reinhardtii	PLOS ONE			English	Article							FUNCTIONALIZED MAGNESIUM PHYLLOSILICATES; OLEAGINOUS CHLORELLA SP; ORGANO-BUILDING BLOCKS; GREEN-ALGA; BACTERIAL TRANSFORMATION; GENETIC-TRANSFORMATION; ANTIMICROBIAL ACTIVITY; EUKARYOTIC MICROALGAE; BIOFUEL PRODUCTION; AMINOCLAY	Genetic engineering in microalgae is gaining attraction but nuclear transformation methods available so far are either inefficient or require special equipment. In this study, we employ positively charged nanoparticles, 3-aminopropyl-functionalized magnesium phyllosilicate (aminoclay, approximate unit cell composition of [H2N(CH2)(3)](8)Si8Mg6O12(OH)(4)), for nuclear transformation into eukaryotic microalgae. TEM and EDX analysis of the process of transformation reveals that aminoclay coats negatively-charged DNA biomolecules and forms a self-assembled hybrid nanostructure. Subsequently, when this nanostructure is mixed with microalgal cells and plated onto selective agar plates with high friction force, cell wall is disrupted facilitating delivery of plasmid DNA into the cell and ultimately to the nucleus. This method is not only simple, inexpensive, and non-toxic to cells but also provides efficient transformation (5.03x10(2) transformants/mg DNA), second only to electroporation which needs advanced instrumentation. We present optimized parameters for efficient transformation including pre-treatment, friction force, concentration of foreign DNA/aminoclay, and plasticity of agar plates. It is also confirmed the successful integration and stable expression of foreign gene in Chlamydomonas reinhardtii through molecular methods.	[Kim, Sora; Kim, Hee-Sik] Univ Sci & Technol, Taejon, South Korea; [Lee, Young-Chul] Gachon Univ, Dept BioNano Technol, Songnam, South Korea; [Cho, Dae-Hyun; Kim, Hee-Sik] Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Res Ctr, Taejon, South Korea; [Lee, Hyun Uk] Korea Basic Sci Inst, Div Mat Sci, Taejon, South Korea; [Huh, Yun Suk] Inha Univ, Dept Biol Engn, Coll Engn, Inchon, South Korea; [Kim, Geun-Joong] Chonnam Natl Univ, Dept Biol Sci, Coll Nat Sci, Kwangju, South Korea	Gachon University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Basic Science Institute (KBSI); Inha University; Chonnam National University	Lee, YC (corresponding author), Gachon Univ, Dept BioNano Technol, Songnam, South Korea.	dreamdbs@gachon.ac.kr; hkim@kribb.re.kr	Zhou, Xuewen/E-5782-2015	Dae-Hyun, Cho/0000-0001-8975-2468	Advanced Biomass R&D Center (ABC) of Global Frontier Project - Ministry of Education, Science and Technology [ABC-2011-0031351, ABC-2010-0029728]; Intelligent Synthetic Biology Center of the Global Frontier project from the MEST [20110031950]	Advanced Biomass R&D Center (ABC) of Global Frontier Project - Ministry of Education, Science and Technology; Intelligent Synthetic Biology Center of the Global Frontier project from the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Advanced Biomass R&D Center (ABC) of Global Frontier Project funded by the Ministry of Education, Science and Technology (ABC-2011-0031351 and ABC-2010-0029728). This work was also supported by the Intelligent Synthetic Biology Center of the Global Frontier project (20110031950) from the MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha TS, 2012, WORLD J MICROB BIOT, V28, P1771, DOI 10.1007/s11274-011-0991-0; Chandrasekaran G, 2011, APPL CLAY SCI, V53, P729, DOI 10.1016/j.clay.2011.07.001; Choi HA, 2013, J MICROBIOL METH, V95, P97, DOI 10.1016/j.mimet.2013.07.018; Choi MH, 2014, ECOTOX ENVIRON SAFE, V102, P34, DOI 10.1016/j.ecoenv.2014.01.005; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Coll JM, 2006, SPAN J AGRIC RES, V4, P316; Farooq W, 2013, GREEN CHEM, V15, P749, DOI 10.1039/c3gc36767c; Han HK, 2011, ACS APPL MATER INTER, V3, P2564, DOI 10.1021/am200406k; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hwangbo K, 2014, PLANT BIOTECHNOL REP, V8, P135, DOI 10.1007/s11816-013-0302-3; Kim SI, 2013, WORLD J MICROB BIOT, V29, P1129, DOI 10.1007/s11274-013-1262-z; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Kindle KL, 1998, MOL BIOL CHLOROPLAST, P41; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; Lee YC, 2014, BIORESOURCE TECHNOL, V153, P365, DOI 10.1016/j.biortech.2013.11.103; Lee YC, 2014, RSC ADV, V4, P4122, DOI 10.1039/c3ra46602g; Lee YC, 2013, APPL CLAY SCI, V83-84, P474, DOI 10.1016/j.clay.2012.10.007; Lee YC, 2013, RSC ADV, V3, P12802, DOI 10.1039/c3ra23266b; Lee YC, 2013, BIORESOURCE TECHNOL, V132, P440, DOI 10.1016/j.biortech.2013.01.102; Lee YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01292; Lee YC, 2013, BIOSENS BIOELECTRON, V42, P373, DOI 10.1016/j.bios.2012.10.092; Lee YC, 2011, J HAZARD MATER, V196, P101, DOI 10.1016/j.jhazmat.2011.08.077; Lee YC, 2011, J HAZARD MATER, V190, P652, DOI 10.1016/j.jhazmat.2011.03.093; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Mann S, 1997, CHEM MATER, V9, P2300, DOI 10.1021/cm970274u; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w; Patil AJ, 2005, J MATER CHEM, V15, P3838, DOI 10.1039/b504288g; Patil AJ, 2004, ANGEW CHEM INT EDIT, V43, P4928, DOI 10.1002/anie.200453868; Patil AJ, 2003, ADV MATER, V15, P1816, DOI 10.1002/adma.200305426; Patil AJ, 2007, NANO LETT, V7, P2660, DOI 10.1021/nl071052q; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Qin S, 2012, BIOTECHNOL ADV, V30, P1602, DOI 10.1016/j.biotechadv.2012.05.004; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Shimogawara K, 1998, GENETICS, V148, P1821; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Vickery JL, 2009, MOL BIOSYST, V5, P744, DOI 10.1039/b903652k; Wayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053618; Wilharm G, 2010, J MICROBIOL METH, V80, P215, DOI 10.1016/j.mimet.2009.12.002; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Yoshida N, 2001, FEMS MICROBIOL LETT, V195, P133, DOI 10.1111/j.1574-6968.2001.tb10510.x; Yoshida N, 2009, APPL MICROBIOL BIOT, V83, P791, DOI 10.1007/s00253-009-2042-4; Zemke-White WL, 2000, J EXP MAR BIOL ECOL, V245, P57, DOI 10.1016/S0022-0981(99)00151-3	44	23	25	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101018	10.1371/journal.pone.0101018	http://dx.doi.org/10.1371/journal.pone.0101018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988123	gold, Green Submitted, Green Published			2022-12-25	WOS:000341354100054
J	Wang, B; Yu, Y; Wang, L				Wang, Bo; Yu, Yun; Wang, Long			Penicillium fusisporum and P. zhuangii, Two New Monoverticillate Species with Apical-Swelling Stipes of Section Aspergilloides Isolated from Plant Leaves in China	PLOS ONE			English	Article								Two new Penicillium species isolated from plant leaves are reported here, namely, P. fusisporum (type strain AS3.15338(T) = NRRL 62805(T) = CBS 137463(T)) and P. zhuangii (type strain AS3.15341(T) = NRRL 62806(T) = CBS 137464(T)). P. fusisporum is characterized by fast growth rate, apical-swelling monoverticillate penicilli, verrucose stipes, fusiform to oblong conidia about 3.5-462-2.5 mu m and cinnamon-colored sclerotia. While P. zhuangii presents a moderate growth rate, it also bears apical-swelling monoverticillate penicilli but its stipes are smooth-walled, and produces ovoid to globose smooth-walled conidia about 3-3.5 mu m. Both species belong to section Aspergilloides, and P. fusisporum is related to "P. thomii var. flavescens'', while P. zhuangii is morphologically similar to P. lividum. Phylogenetic analyses of sequences of calmodulin and beta-tubulin genes both show that the two new taxa form distinct monophyletic clades.	[Wang, Bo] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Yu, Yun] Yangtze Univ, Coll Life Sci, Jinzhou, Hubei, Peoples R China; [Wang, Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Northwest A&F University - China; Yangtze University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wl_dgk@hotmail.com			National Natural Science Foundation of China (NSFC) [31270539]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (NSFC no. 31270539 to LW, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1956, J GEN APPL MICROBIOL, V2, P50; Barreto MC, 2011, FUNGAL DIVERS, V49, P23, DOI 10.1007/s13225-011-0090-4; CHRISTENSEN M, 1961, MYCOLOGIA, V53, P451, DOI 10.2307/3756303; Frisvad JC, 2004, STUD MYCOL, P1; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kulik MM, 1968, AGR HDB, V351; Nakase T, 1993, RIKEN REV, V3, P33; Peterson SW, 2000, INTEGRATION MODERN T, P163; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; Pitt J.I., 2000, INTEGRATION MODERN T, P9; PITT JI, 1985, MYCOTAXON, V22, P197; Pitt JI., 2000, INTEGRATION MODERN T, P225; Raper KB, 1949, MANUAL PENICILLIA; Ridgway R., 1912, COLOR STANDARDS COLO; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang B, 2013, MYCOLOGIA, V105, P1547, DOI 10.3852/13-022; Wang L, 2012, MYCOTAXON, V120, P373, DOI 10.5248/120.373; White T., 1990, PCR PROTOCOLS GUIDE, P315	21	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101454	10.1371/journal.pone.0101454	http://dx.doi.org/10.1371/journal.pone.0101454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988489	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100091
J	Clark, MA; Goheen, MM; Spidale, NA; Kasthuri, RS; Fulford, A; Cerami, C				Clark, Martha A.; Goheen, Morgan M.; Spidale, Nicholas A.; Kasthuri, Raj S.; Fulford, Anthony; Cerami, Carla			RBC Barcoding Allows for the Study of Erythrocyte Population Dynamics and P-falciparum Merozoite Invasion	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITE INVASION; FLOW-CYTOMETRY; INSIGHTS; LIGAND; ASSAY; MATURATION; INFECTION; BIOTIN; ANEMIA	Plasmodium falciparum invasion of host erythrocytes is essential for the propagation of the blood stage of malaria infection. Additionally, the brief extracellular merozoite stage of P. falciparum represents one of the rare windows during which the parasite is directly exposed to the host immune response. Therefore, efficient invasion of the host erythrocyte is necessary not only for productive host erythrocyte infection, but also for evasion of the immune response. Host traits, such as hemoglobinopathies and differential expression of erythrocyte invasion ligands, can protect individuals from malaria by impeding parasite erythrocyte invasion. Here we combine RBC barcoding with flow cytometry to study P. falciparum invasion. This novel high-throughput method allows for the (i) direct comparison of P. falciparum invasion into different erythrocyte populations and (ii) assessment of the impact of changing erythrocyte population dynamics on P. falciparum invasion.	[Clark, Martha A.; Goheen, Morgan M.; Spidale, Nicholas A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Kasthuri, Raj S.] Univ N Carolina, Div Hematol, Chapel Hill, NC USA; [Fulford, Anthony] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cerami, Carla] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Cerami, Carla] Med Res Council Keneba, Serrekunda, Gambia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Cerami, C (corresponding author), London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England.	ccerami@unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Cerami, Carla/0000-0002-7634-0955	National Institute of Child Health and Human Development [U01HD061235]; NCI Center [P30CA06086]; NCI [CA16086-36]; Lineberger Comprehensive Cancer Center; UNC Department of Pathology & Laboratory Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061235] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lineberger Comprehensive Cancer Center; UNC Department of Pathology & Laboratory Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institute of Child Health and Human Development under award number U01HD061235 (to CC). The UNC Flow Cytometry Core Facility is supported in part by an NCI Center Core Grant number P30CA06086. The UNC Microscopy Core facility is supported by NCI grant CA16086-36 and the Lineberger Comprehensive Cancer Center Core Grant and the UNC Department of Pathology & Laboratory Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiane AS, 2013, CLIN VACCINE IMMUNOL, V20, P1238, DOI 10.1128/CVI.00135-13; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; Boyle MJ, 2013, INT J PARASITOL, V43, P1, DOI 10.1016/j.ijpara.2012.11.002; Brandao MM, 2009, CLIN HEMORHEOL MICRO, V43, P217, DOI 10.3233/CH-2009-1211; BREUER WV, 1983, BIOCHIM BIOPHYS ACTA, V755, P263, DOI 10.1016/0304-4165(83)90213-1; Clark M, 2013, BRIT J HAEMATOL, V161, P262, DOI 10.1111/bjh.12234; Cordero JF, 2004, CELL BIOL INT, V28, P423, DOI 10.1016/j.cellbi.2004.03.002; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Cromer D, 2009, J THEOR BIOL, V257, P533, DOI 10.1016/j.jtbi.2008.12.019; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Lopez-Perez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047913; Nagababu E, 2008, FREE RADICAL RES, V42, P824, DOI 10.1080/10715760802459879; Pattanapanyasat K, 1996, CYTOMETRY, V25, P287, DOI 10.1002/(SICI)1097-0320(19961101)25:3&lt;287::AID-CYTO10&gt;3.0.CO;2-S; Pattanapanyasat K, 1999, BLOOD, V93, P3116; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; SANSONE G, 1963, Pathologica, V55, P371; Shapiro HM, 2013, CURR PROTOC CYTOM ED; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Walker P S, 2010, Immunohematology, V26, P60; WHO, WORLD MAL REP 2011; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	31	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101041	10.1371/journal.pone.0101041	http://dx.doi.org/10.1371/journal.pone.0101041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984000	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000339635000051
J	Hess, KC; Liu, JJ; Manfredi, G; Muhlschlegel, FA; Buck, J; Levin, LR; Barrientos, A				Hess, Kenneth C.; Liu, Jingjing; Manfredi, Giovanni; Muehlschlegel, Fritz A.; Buck, Jochen; Levin, Lonny R.; Barrientos, Antoni			A mitochondrial CO2-adenylyl cyclase-cAMP signalosome controls yeast normoxic cytochrome c oxidase activity	FASEB JOURNAL			English	Article						Cyrl; mitochondrial energy metabolism; normoxic Cox5a; hypoxic Cox5b	SOLUBLE ADENYLYL-CYCLASE; OXYGEN-REGULATED ISOFORMS; SACCHAROMYCES-CEREVISIAE; PROTEIN-PHOSPHORYLATION; CARBONIC-ANHYDRASE; ATP; RESPIRATION; EXPRESSION; SUBUNITS; TRANSCRIPTION	Mitochondria, the major source of cellular energy in the form of ATP, respond to changes in substrate availability and bioenergetic demands by employing rapid, short-term, metabolic adaptation mechanisms, such as phosphorylation-dependent protein regulation. In mammalian cells, an intramitochondrial CO2-adenylyl cyclase (AC)-cyclic AMP (cAMP)-protein kinase A (PKA) pathway regulates aerobic energy production. One target of this pathway involves phosphorylation of cytochrome c oxidase (COX) subunit 4-iso-form 1 (COX4i1), which modulates COX allosteric regulation by ATP. However, the role of the CO2-sAC-cAMP-PKA signalosome in regulating COX activity and mitochondrial metabolism and its evolutionary conservation remain to be fully established. We show that in Saccharomyces cerevisiae, normoxic COX activity measured in the presence of ATP is 55% lower than in the presence of ADP. Moreover, the adenylyl cyclase Cyr1 activity is present in mitochondria, and it contributes to the ATP-mediated regulation of COX through the normoxic subunit Cox5a, homologue of human COX4i1, in a bicarbonate-sensitive manner. Furthermore, we have identified 2 phosphorylation targets in Cox5a (T65 and S43) that modulate its allosteric regulation by ATP. These residues are not conserved in the Cox5b-containing hypoxic enzyme, which is not regulated by ATP. We conclude that across evolution, a CO2-sAC-cAMP-PKA axis regulates normoxic COX activity.-Hess, K. C., Liu, J., Manfredi, G., Muhlschlegel, F. A., Buck, J., Levin, L. R., Barrientos, A. A mitochondrial CO2-adenylyl cyclase-cAMP signalosome controls yeast normoxic cytochrome c oxidase activity.	[Hess, Kenneth C.; Buck, Jochen; Levin, Lonny R.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Manfredi, Giovanni] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA; [Liu, Jingjing; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Muehlschlegel, Fritz A.] Univ Kent, Sch Biosci, Canterbury, Kent, England	Cornell University; Cornell University; University of Miami; University of Miami; University of Kent	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.miami.edu	Levin, Lonny R/A-7215-2011; Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356	Muscular Dystrophy Association; U.S. National Institutes of Health (NIH) [GM-071775, GM-088999A, GM-062328, HD-059913]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999, R01GM107442, R01GM105781, R01GM071775, R01GM062328] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Flavia Fontanesi and Dr. Iliana Soto for critically reading the manuscript. The authors thank Dr. Christof Taxis (Philipps Universitat Marburg, Marburg, Germany) for providing the cyr1 yeast mutant strain. This study was supported by the Muscular Dystrophy Association (to A.B. and G.M.) and by U.S. National Institutes of Health (NIH) grants GM-071775 (to A.B.); GM-088999A (to G.M.); and GM-062328 and HD-059913 (to J.B. and L.R.L.). J.B. and L.R.L. own equity interest in CEP Biotech (Tamarac, FL, USA), which has licensed commercialization of a panel of monoclonal antibodies directed against sAC. The other authors declare no conflicts of interest.	Acin-Perez R, 2011, J BIOL CHEM, V286, P30423, DOI 10.1074/jbc.M111.266379; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Appukuttan A, 2012, CARDIOVASC RES, V93, P340, DOI 10.1093/cvr/cvr306; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Barrientos A, 2012, AGING-US, V4, P578, DOI 10.18632/aging.100485; Belotti F, 2012, BBA-MOL CELL RES, V1823, P1208, DOI 10.1016/j.bbamcr.2012.04.016; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Burke PV, 1998, J EXP BIOL, V201, P1163; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Das J, 2004, MOL BIOL EVOL, V21, P1572, DOI 10.1093/molbev/msh161; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; DODGSON SJ, 1980, P NATL ACAD SCI-BIOL, V77, P5562, DOI 10.1073/pnas.77.9.5562; Elleuche S, 2010, MICROBIOL-SGM, V156, P23, DOI 10.1099/mic.0.032581-0; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; Follmann K, 1998, BIOCHEM MOL BIOL INT, V45, P1047; FRAENKEL DG, 1985, P NATL ACAD SCI USA, V82, P4740, DOI 10.1073/pnas.82.14.4740; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; Horvat S, 2006, J NEUROCHEM, V99, P937, DOI 10.1111/j.1471-4159.2006.04134.x; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Jain P, 2003, ANTIMICROB AGENTS CH, V47, P3195, DOI 10.1128/AAC.47.10.3195-3201.2003; Jungbluth M, 2012, EUKARYOT CELL, V11, P1021, DOI 10.1128/EC.05240-11; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Liu JJ, 2013, ANTIOXID REDOX SIGN, V19, P1916, DOI 10.1089/ars.2012.4589; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MCENTEE CM, 1993, MOL GEN GENET, V241, P213, DOI 10.1007/BF00280219; MITTS MR, 1991, MOL CELL BIOL, V11, P4591, DOI 10.1128/MCB.11.9.4591; MITTS MR, 1990, MOL CELL BIOL, V10, P3873, DOI 10.1128/MCB.10.8.3873; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; MULLER G, 1989, BIOCHEMISTRY-US, V28, P9968; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Poyton RO, 1999, RESP PHYSIOL, V115, P119, DOI 10.1016/S0034-5687(99)00028-6; RAHMAN MU, 1995, BIOCHEM BIOPH RES CO, V214, P188, DOI 10.1006/bbrc.1995.2273; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; RODEL G, 1985, J BACTERIOL, V161, P7; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sander M, 1997, BIOCHEMISTRY-US, V36, P6100, DOI 10.1021/bi970048y; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201	74	24	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4369	4380		10.1096/fj.14-252890	http://dx.doi.org/10.1096/fj.14-252890			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002117	Green Published			2022-12-25	WOS:000342222700016
J	Salvi, F; Agniswamy, J; Yuan, HL; Vercammen, K; Pelicaen, R; Cornelis, P; Spain, JC; Weber, IT; Gadda, G				Salvi, Francesca; Agniswamy, Johnson; Yuan, Hongling; Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre; Spain, Jim C.; Weber, Irene T.; Gadda, Giovanni			The Combined Structural and Kinetic Characterization of a Bacterial Nitronate Monooxygenase from Pseudomonas aeruginosa PAO1 Establishes NMO Class I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Structure; Flavoprotein; Pseudomonas Aeruginosa (P; Aeruginosa); Toxin; 3-Nitropropionate; TIM Barrel; Nitronate Monooxygenase; Oxidoreductase; Propionate 3-Nitronate	3-NITROPROPIONIC ACID; 2-NITROPROPANE DIOXYGENASE; OXIDATION; ALIGNMENT; SEQUENCE; DETOXIFICATION; GENERATION; INHIBITOR; SUBSTRATE; MODEL	Background: The annotation of >4,900 genes for nitronate monooxygenase, which detoxifies a deadly toxin, is inaccurate due to the lack of functional data. Results: The protein PA4202 from Pseudomonas aeruginosa is characterized structurally and biochemically as the first bacterial nitronate monooxygenase. Conclusion: Four conserved motifs are identified in PA4202. Significance: New classes of enzymes are established based on the functional annotation of PA4202. Nitronate monooxygenase (NMO) oxidizes the mitochondrial toxin propionate 3-nitronate (P3N) to malonate semialdehyde. The enzyme has been previously characterized biochemically in fungi, but no structural information is available. Based on amino acid similarity 4,985 genes are annotated in the GenBank(TM) as NMO. Of these, 4,424 (i.e. 89%) are bacterial genes, including several Pseudomonads that have been shown to use P3N as growth substrate. Here, we have cloned and expressed the gene pa4202 of Pseudomonas aeruginosa PAO1, purified the resulting protein, and characterized it. The enzyme is active on P3N and other alkyl nitronates, but cannot oxidize nitroalkanes. P3N is the best substrate at pH 7.5 and atmospheric oxygen with k(cat)(app)/K-m(app) of 12 x 10(6) m(-1) s(-1), k(cat)(app) of 1300 s(-1), and K-m(app) of 110 m. Anerobic reduction of the enzyme with P3N yields a flavosemiquinone, which is formed within 7.5 ms, consistent with this species being a catalytic intermediate. Absorption spectroscopy, mass spectrometry, and x-ray crystallography demonstrate a tightly, non-covalently bound FMN in the active site of the enzyme. Thus, PA4202 is the first NMO identified and characterized in bacteria. The x-ray crystal structure of the enzyme was solved at 1.44 , showing a TIM barrel-fold. Four motifs in common with the biochemically characterized NMO from Cyberlindnera saturnus are identified in the structure of bacterial NMO, defining Class I NMO, which includes bacterial, fungal, and two animal NMOs. Notably, the only other NMO from Neurospora crassa for which biochemical evidence is available lacks the four motifs, defining Class II NMO.	[Salvi, Francesca; Yuan, Hongling; Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Agniswamy, Johnson; Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA; [Spain, Jim C.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30302 USA; [Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, Brussels, Belgium; [Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre] VIB, Dept Struct Biol Brussels, B-1050 Brussels, Belgium	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia Institute of Technology; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Weber, IT (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30302 USA.	iweber@gsu.edu; ggadda@gsu.edu	Cornelis, Pierre/H-3058-2019; Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Agniswamy, Johnson/0000-0002-3053-5677; Pelicaen, Rudy/0000-0002-0890-6320; Salvi, Francesca/0000-0001-5294-1310	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER; Direct For Biological Sciences [1121695] Funding Source: National Science Foundation	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	X-ray data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) beamline BM-22 at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. We thank Shirley Nishino for the construct of pa4202 and Chung-Dar Lu, Crystal Smitherman, and Jacob Ball for critically reading the manuscript.	Allison R D, 1979, Methods Enzymol, V63, P3; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Chomeheon P, 2005, J NAT PROD, V68, P1103, DOI 10.1021/np050036a; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzpatrick PF, 2005, ARCH BIOCHEM BIOPHYS, V433, P157, DOI 10.1016/j.abb.2004.08.021; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Francis K, 2008, BIOCHEMISTRY-US, V47, P9136, DOI 10.1021/bi801013e; Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195; Francis K, 2012, ARCH BIOCHEM BIOPHYS, V521, P84, DOI 10.1016/j.abb.2012.03.015; Gadda G, 2000, ARCH BIOCHEM BIOPHYS, V382, P138, DOI 10.1006/abbi.2000.2009; Gadda G, 2010, ARCH BIOCHEM BIOPHYS, V493, P53, DOI 10.1016/j.abb.2009.06.018; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Hamilton BF, 2000, CONT NEUROS, P21; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li YH, 2011, BIOCHEM BIOPH RES CO, V405, P344, DOI 10.1016/j.bbrc.2010.12.050; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Mathews F. P., 1940, POISONING SHEEP GOAT; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mijatovic S, 2008, ARCH BIOCHEM BIOPHYS, V473, P61, DOI 10.1016/j.abb.2008.02.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Nielsen A. T., 1969, CHEM NITRO NITROSO G; Nishino SF, 2010, APPL ENVIRON MICROB, V76, P3590, DOI 10.1128/AEM.00267-10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panter K. E., 2011, USDA B, V415; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Segel I.H., 1975, ENZYME KINETICS; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smitherman C, 2013, BIOCHEMISTRY-US, V52, P2694, DOI 10.1021/bi400030d; TARAZONA JV, 1987, VET HUM TOXICOL, V29, P437; Tsang TM, 2009, NEUROCHEM RES, V34, P1261, DOI 10.1007/s11064-008-9904-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMS MC, 1979, AM J VET RES, V40, P403; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	50	29	32	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23764	23775		10.1074/jbc.M114.577791	http://dx.doi.org/10.1074/jbc.M114.577791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002579	Green Published, hybrid			2022-12-25	WOS:000341505000044
J	Azam, S; Rathore, A; Shah, TM; Telluri, M; Amindala, B; Ruperao, P; Katta, MAVSK; Varshney, RK				Azam, Sarwar; Rathore, Abhishek; Shah, Trushar M.; Telluri, Mohan; Amindala, BhanuPrakash; Ruperao, Pradeep; Katta, Mohan A. V. S. K.; Varshney, Rajeev K.			An Integrated SNP Mining and Utilization (ISMU) Pipeline for Next Generation Sequencing Data	PLOS ONE			English	Article							CHICKPEA CICER-ARIETINUM; NUCLEOTIDE POLYMORPHISM DISCOVERY; READ ALIGNMENT; TRANSCRIPTOME; CROP; DIVERSITY; ANNOTATION; SOFTWARE; GENOTYPE; FORMAT	Open source single nucleotide polymorphism (SNP) discovery pipelines for next generation sequencing data commonly requires working knowledge of command line interface, massive computational resources and expertise which is a daunting task for biologists. Further, the SNP information generated may not be readily used for downstream processes such as genotyping. Hence, a comprehensive pipeline has been developed by integrating several open source next generation sequencing (NGS) tools along with a graphical user interface called Integrated SNP Mining and Utilization (ISMU) for SNP discovery and their utilization by developing genotyping assays. The pipeline features functionalities such as pre-processing of raw data, integration of open source alignment tools (Bowtie2, BWA, Maq, NovoAlign and SOAP2), SNP prediction (SAMtools/SOAPsnp/CNS2snp and CbCC) methods and interfaces for developing genotyping assays. The pipeline outputs a list of high quality SNPs between all pairwise combinations of genotypes analyzed, in addition to the reference genome/sequence. Visualization tools (Tablet and Flapjack) integrated into the pipeline enable inspection of the alignment and errors, if any. The pipeline also provides a confidence score or polymorphism information content value with flanking sequences for identified SNPs in standard format required for developing marker genotyping (KASP and Golden Gate) assays. The pipeline enables users to process a range of NGS datasets such as whole genome re-sequencing, restriction site associated DNA sequencing and transcriptome sequencing data at a fast speed. The pipeline is very useful for plant genetics and breeding community with no computational expertise in order to discover SNPs and utilize in genomics, genetics and breeding studies. The pipeline has been parallelized to process huge datasets of next generation sequencing.	[Azam, Sarwar; Rathore, Abhishek; Shah, Trushar M.; Telluri, Mohan; Amindala, BhanuPrakash; Ruperao, Pradeep; Katta, Mohan A. V. S. K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru, Andhra Pradesh, India; [Ruperao, Pradeep] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Queensland	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom, Patancheru, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Shah, Trushar/0000-0002-0091-7981; Amindala, BhanuPrakash/0000-0001-8825-1370	CGIAR Generation Challenge Program (GCP), Mexico	CGIAR Generation Challenge Program (GCP), Mexico(CGIAR)	CGIAR Generation Challenge Program (GCP), Mexico funded this project. This work has been undertaken as a part of CGIAR Research Programme on Dryland Cereals and CGIAR Research Programme on Grain Legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Azam S, 2012, AM J BOT, V99, P186, DOI 10.3732/ajb.1100419; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Deng XT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-267; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deschamps S, 2010, PLANT GENOME-US, V3, P53, DOI 10.3835/plantgenome2009.09.0026; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Marshall DJ, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-19; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Michael TP, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0001in; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Rachit KS, 2012, DNA RES, V19, P449, DOI 10.1093/dnares/dss025; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-469; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113	54	10	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101754	10.1371/journal.pone.0101754	http://dx.doi.org/10.1371/journal.pone.0101754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003610	Green Published, gold			2022-12-25	WOS:000339242700061
J	Xia, F; Dong, FL; Yang, Y; Huang, AF; Chen, S; Sun, D; Xiong, SD; Zhang, JP				Xia, Fei; Dong, Fulu; Yang, Yi; Huang, Anfei; Chen, Si; Sun, Di; Xiong, Sidong; Zhang, Jinping			Dynamic Transcription of Long Non-Coding RNA Genes during CD4+T Cell Development and Activation	PLOS ONE			English	Article							GENOME; CHROMATIN; IDENTIFICATION; ANNOTATION; REVEALS	Background: Recent evidence shows that long non-coding RNA (LncRNA) play important regulatory roles in many biology process, including cell development, activation and oncogenesis. However, the roles of these LncRNAs in the development and activation of CD4+ T cells, which is an important component of immune response, remain unknown. Results: To predict the function of LncRNA in the development and activation of CD4+ T cells, first, we examined the expression profiles of LncRNAs and mRNAs in CD4(-) CD8(-) (DN), CD4(+)CD8(+)(DP), CD4(+)CD8(-), and activated CD4(+)CD8(-) T cells in a microarray analysis and verified these results by real time PCRs (qPCR). We found that the expression of hundreds of LncRNAs significantly changed in each process of developmental transition, including DN into DP, DP into CD4(+)CD8(-), and CD4(+)CD8(-) into activated CD4(+) T cells. A Kendall distance analysis suggested that the expression of LncRNAs in DN, DP, CD4(+)CD8(-) T cells and activated CD4(+) T cells were correlated with the expression of mRNAs in these T cells. The Blat algorithm and GO analysis suggested that LncRNAs may exert important roles in the development and activation of CD4+ T cells. These roles included proliferation, homeostasis, maturation, activation, migration, apoptosis and calcium ion transportation. Conclusion: The present study found that the expression profiles of LncRNAs in different stages of CD4(+) T cells are distinguishable. LncRNAs are involved in the key biological process in CD4(+) T cell development and activation.	[Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China; Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Zhang, JP (corresponding author), Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China.	j_pzhang@suda.edu.cn	zhang, jin/GXV-9154-2022		Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Jiangsu Provincial Innovative Research Team; Soochow University [Q413401810, Q313406711]; National Natural Science Foundation of China [31270939, 31200660]; Fulu Dong [81300553]; Natural Science Foundation of Jiangsu Province [BK2012617]; Natural Science Foundation of Jiangsu High education [13KJA310004]	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Jiangsu Provincial Innovative Research Team; Soochow University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fulu Dong; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu High education	This work is Supported by grants from the Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University, Jiangsu Provincial Innovative Research Team, and intramural research funding to Jinping Zhang (Q413401810, Q313406711) from Soochow University, National Natural Science Foundation of China to Jinping Zhang (No: 31270939), Fei Xia (No: 31200660) and Fulu Dong (81300553), Natural Science Foundation of Jiangsu Province to Jinping Zhang (BK2012617) and Major Natural Science Foundation of Jiangsu High education to Jinping Zhang (13KJA310004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang RQ, 2011, CRIT REV IMMUNOL, V31, P447, DOI 10.1615/CritRevImmunol.v31.i6.10; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Wierzbicki AT, 2012, CURR OPIN PLANT BIOL, V15, P517, DOI 10.1016/j.pbi.2012.08.008; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37	31	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101588	10.1371/journal.pone.0101588	http://dx.doi.org/10.1371/journal.pone.0101588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003630	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700043
J	Xu, Q; Xu, X; Shi, Y; Xu, JC; Huang, BR				Xu, Qian; Xu, Xiao; Shi, Yang; Xu, Jichen; Huang, Bingru			Transgenic Tobacco Plants Overexpressing a Grass PpEXP1 Gene Exhibit Enhanced Tolerance to Heat Stress	PLOS ONE			English	Article							MAIZE PRIMARY ROOT; EXPANSIN GENE; CELL-WALLS; SUPEROXIDE-DISMUTASE; HIGH-TEMPERATURE; ALPHA-EXPANSIN; GROWTH; EXPRESSION; ELONGATION; IDENTIFICATION	Heat stress is a detrimental abiotic stress limiting the growth of many plant species and is associated with various cellular and physiological damages. Expansins are a family of proteins which are known to play roles in regulating cell wall elongation and expansion, as well as other growth and developmental processes. The in vitro roles of expansins regulating plant heat tolerance are not well understood. The objectives of this study were to isolate and clone an expansin gene in a perennial grass species (Poa pratensis) and to determine whether over-expression of expansin may improve plant heat tolerance. Tobacco (Nicotiana tabacum) was used as the model plant for gene transformation and an expansin gene PpEXP1 from Poa pratensis was cloned. Sequence analysis showed PpEXP1 belonged to a-expansins and was closely related to two expansin genes in other perennial grass species (Festuca pratensis and Agrostis stolonifera) as well as Triticum aestivum, Oryza sativa, and Brachypodium distachyon. Transgenic tobacco plants over-expressing PpEXP1 were generated through Agrobacterium-mediated transformation. Under heat stress (42 degrees C) in growth chambers, transgenic tobacco plants over-expressing the PpEXP1 gene exhibited a less structural damage to cells, lower electrolyte leakage, lower levels of membrane lipid peroxidation, and lower content of hydrogen peroxide, as well as higher chlorophyll content, net photosynthetic rate, relative water content, activity of antioxidant enzyme, and seed germination rates, compared to the wild-type plants. These results demonstrated the positive roles of PpEXP1 in enhancing plant tolerance to heat stress and the possibility of using expansins for genetic modification of cool-season perennial grasses in the development of heat-tolerant germplasm and cultivars.	[Xu, Qian; Xu, Xiao; Shi, Yang; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Beijing Forestry University; Rutgers State University New Brunswick	Xu, JC (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jcxu282@sina.com; huang@aesop.rutgers.edu			National Natural Science Foundation of China [31128016]; Beijing Natural Science Foundation [5112015]; Rutgers Center for Turfgrass Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Rutgers Center for Turfgrass Science	National Natural Science Foundation of China (#31128016), Beijing Natural Science Foundation (#5112015), and Rutgers Center for Turfgrass Science for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Chiang CM, 2014, J PLANT BIOCHEM BIOT, V23, P266, DOI 10.1007/s13562-013-0210-1; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Gallois P, 1995, Methods Mol Biol, V49, P39; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Hu LW, 2007, PHYSIOL PLANTARUM, V130, P560, DOI 10.1111/j.1399-3054.2007.00912.x; Huang J, 2000, PLANTA, V211, P467, DOI 10.1007/s004250000311; Jespersen D, 2013, INT TURFS SOC RES J, V12, P459; Kam MJ, 2005, J PLANT BIOL, V48, P304, DOI 10.1007/BF03030527; Keller E, 1995, PLANT J, V8, P795, DOI 10.1046/j.1365-313X.1995.8060795.x; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Li F, 2013, J BIOTECHNOL, V163, P281, DOI 10.1016/j.jbiotec.2012.11.008; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; LI ZC, 1993, PLANTA, V191, P349, DOI 10.1007/BF00195692; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Mathews S, 2000, AM J BOT, V87, P96, DOI 10.2307/2656688; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nilsen ET, 1996, FIELD CROP RES, P192; Ookawara R, 2005, ANN BOT-LONDON, V96, P693, DOI 10.1093/aob/mci221; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Rachmilevitch S DM, 2006, PLANT ENV INTERACTIO; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Xu JC, 2008, ENVIRON EXP BOT, V63, P240, DOI 10.1016/j.envexpbot.2007.11.011; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; YANESHITA M, 1993, THEOR APPL GENET, V87, P129, DOI 10.1007/BF00223756; Yang KA, 2006, PLANT SCI, V171, P175, DOI 10.1016/j.plantsci.2006.03.013; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhou P, 2011, CROP SCI, V51, P333, DOI 10.2135/cropsci2010.07.0391	51	60	63	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100792	10.1371/journal.pone.0100792	http://dx.doi.org/10.1371/journal.pone.0100792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003197	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700012
J	Andersson, H; Andersson, B; Eklund, D; Ngoh, E; Persson, A; Svensson, K; Lerm, M; Blomgran, R; Stendahl, O				Andersson, Henrik; Andersson, Blanka; Eklund, Daniel; Ngoh, Eyler; Persson, Alexander; Svensson, Kristoffer; Lerm, Maria; Blomgran, Robert; Stendahl, Olle			Apoptotic Neutrophils Augment the Inflammatory Response to Mycobacterium tuberculosis Infection in Human Macrophages	PLOS ONE			English	Article							INTRACELLULAR PATHOGENS; CELL-DEATH; ACTIVATION; RECEPTOR; GROWTH; MECHANISM; AUTOPHAGY; MICE	Macrophages in the lung are the primary cells being infected by Mycobacterium tuberculosis (Mtb) during the initial manifestation of tuberculosis. Since the adaptive immune response to Mtb is delayed, innate immune cells such as macrophages and neutrophils mount the early immune protection against this intracellular pathogen. Neutrophils are short-lived cells and removal of apoptotic cells by resident macrophages is a key event in the resolution of inflammation and tissue repair. Since anti-inflammatory activity is not compatible with effective immunity to intracellular pathogens, we therefore investigated how uptake of apoptotic neutrophils modulates the function of Mtb-activated human macrophages. We show that Mtb infection exerts a potent proinflammatory activation of human macrophages with enhanced gene activation and release of proinflammatory cytokines and that this response was augmented by apoptotic neutrophils. The enhanced macrophage response is linked to apoptotic neutrophil-driven activation of the NLRP3 inflammasome and subsequent IL-1 beta signalling. We also demonstrate that apoptotic neutrophils not only modulate the inflammatory response, but also enhance the capacity of infected macrophages to control intracellular growth of virulent Mtb. Taken together, these results suggest a novel role for apoptotic neutrophils in the modulation of the macrophage-dependent inflammatory response contributing to the early control of Mtb infection.	[Andersson, Henrik; Andersson, Blanka; Eklund, Daniel; Ngoh, Eyler; Persson, Alexander; Svensson, Kristoffer; Lerm, Maria; Blomgran, Robert; Stendahl, Olle] Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Stendahl, O (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Microbiol & Mol Med, Dept Clin & Expt Med, Linkoping, Sweden.	Olle.Stendahl@liu.se	Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Lerm, Maria/0000-0002-5092-9892; Blomgran, Robert/0000-0002-2767-8175; Eklund, Daniel/0000-0002-6045-4800; Persson, Alexander/0000-0002-9631-2169; Andersson, Henrik/0000-0002-6020-5177	Swedish Research Council, Sida; Swedish Heart & Lung Foundation; County Council of Ostergotland; T & R Soderberg Foundations	Swedish Research Council, Sida(Swedish Research Council); Swedish Heart & Lung Foundation(Swedish Heart-Lung Foundation); County Council of Ostergotland; T & R Soderberg Foundations	This work was supported by the Swedish Research Council, Sida, the Swedish Heart & Lung Foundation, the County Council of Ostergotland and the T & R Soderberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Dutta RK, 2012, INT J BIOCHEM CELL B, V44, P942, DOI 10.1016/j.biocel.2012.02.021; Eklund D, 2014, J INFECT DIS, V209, P749, DOI 10.1093/infdis/jit572; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Filardy AA, 2010, J IMMUNOL, V185, P2044, DOI 10.4049/jimmunol.1000017; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HALL SE, 1994, J IMMUNOL, V153, P3218; Hedlund S, 2010, HUM IMMUNOL, V71, P535, DOI 10.1016/j.humimm.2010.02.022; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kisich KO, 2002, INFECT IMMUN, V70, P4591, DOI 10.1128/IAI.70.8.4591-4599.2002; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Nunes MP, 1998, J IMMUNOL, V160, P1313; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Rosseels V, 2006, INFECT IMMUN, V74, P3684, DOI 10.1128/IAI.01521-05; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Watson RWG, 1996, J IMMUNOL, V156, P3986; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	35	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101514	10.1371/journal.pone.0101514	http://dx.doi.org/10.1371/journal.pone.0101514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000410	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300054
J	Ankarfeldt, MZ; Angquist, L; Stocks, T; Jakobsen, MU; Overvad, K; Halkjaer, J; Saris, WHM; Astrup, A; Sorensen, TIA				Ankarfeldt, Mikkel Z.; Angquist, Lars; Stocks, Tanja; Jakobsen, Marianne U.; Overvad, Kim; Halkjaer, Jytte; Saris, Wim H. M.; Astrup, Arne; Sorensen, Thorkild I. A.			Body Characteristics, Dietary Protein and Body Weight Regulation. Reconciling Conflicting Results from Intervention and Observational Studies?	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; MIDDLE-AGED MEN; WAIST CIRCUMFERENCE; GLYCEMIC INDEX; DATABASE; SIMULATION; MORTALITY; HEALTH; TRIALS	Background/Objectives: Physiological evidence indicates that high-protein diets reduce caloric intake and increase thermogenic response, which may prevent weight gain and regain after weight loss. Clinical trials have shown such effects, whereas observational cohort studies suggest an association between greater protein intake and weight gain. In both types of studies the results are based on average weight changes, and show considerable diversity in both directions. This study investigates whether the discrepancy in the evidence could be due to recruitment of overweight and obese individuals into clinical trials. Subjects/Methods: Data were available from the European Diet, Obesity and Genes (DiOGenes) post-weight-loss weight-maintenance trial and the Danish Diet, Cancer and Health (DCH) cohort. Participants of the DCH cohort were matched with participants from the DiOGenes trial on gender, diet, and body characteristics. Different subsets of the DCH-participants, comparable with the trial participants, were analyzed for weight maintenance according to the randomization status (high or low protein) of the matched trial participants. Results: Trial participants were generally heavier, had larger waist circumference and larger fat mass than the participants in the entire DCH cohort. A better weight maintenance in the high-protein group compared to the low protein group was observed in the subgroups of the DCH cohort matching body characteristics of the trial participants. Conclusion: This modified observational study, minimized the differences between the RCT and observational data with regard to dietary intake, participant characteristics and statistical analysis. Compared with low protein diet the high protein diet was associated with better weight maintenance when individuals with greater body mass index and waist circumference were analyzed. Selecting subsets of large-scale observational cohort studies with similar characteristics as participants in clinical trials may reconcile the otherwise conflicting results.	[Ankarfeldt, Mikkel Z.; Angquist, Lars; Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ankarfeldt, Mikkel Z.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Stocks, Tanja] Lund Univ, Dept Clin Sci Malmo Diabet & Cardiovasc Dis Genet, Lund, Sweden; [Stocks, Tanja] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Jakobsen, Marianne U.; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Halkjaer, Jytte] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Saris, Wim H. M.] Univ Maastricht, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Astrup, Arne] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports NEXS, Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Fac Med & Hlth Sci, Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Lund University; Umea University; Aarhus University; Danish Cancer Society; Maastricht University; Maastricht University Medical Centre (MUMC); University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Ankarfeldt, MZ (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark.	mikkelza@gmail.com	Jakobsen, Marianne Uhre/I-8550-2018; Astrup, Arne/B-1407-2015	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Angquist, Lars/0000-0002-9516-4424; Astrup, Arne/0000-0001-8968-8996; Overvad, Kim/0000-0001-6429-7921	Danish Council for Strategic Research [09-067111]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work is carried out as a part of the research program of Gene-diet interactions in obesity (GENDINOB). GENDINOB is supported by the Danish Council for Strategic Research (Grant 09-067111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Ankarfeldt MZ, 2014, INT J OBES IN PRESS; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Britton A, 1998, HEALTH TECHNOL ASSES, V2, pi; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Deeks J J, 2003, Health Technol Assess, V7, piii; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Everitt B. S., 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Guo S, 2010, PROPENSITY SCORE ANA; Halkjaer J, 2011, INT J OBESITY, V35, P1104, DOI 10.1038/ijo.2010.254; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Johnson RA, 2007, APPL MULTIVARIATE ST; Lajous M, 2013, AM J EPIDEMIOL, V178, P382, DOI 10.1093/aje/kws478; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; MacLehose R R, 2000, Health Technol Assess, V4, P1; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Michaelsen KF, 2014, AM J CLIN NUTR, V99, p718S, DOI 10.3945/ajcn.113.072603; Munsters MJ, 2013, APPL PHYSIOL NUTR ME, V38, P1107, DOI 10.1139/apnm-2012-0409; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Tannen RL, 2008, PHARMACOEPIDEM DR S, V17, P671, DOI 10.1002/pds.1584; Tannen RL, 2007, J CLIN EPIDEMIOL, V60, P686, DOI 10.1016/j.jclinepi.2006.10.012; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Tannen RL, 2006, J CLIN EPIDEMIOL, V59, P254, DOI 10.1016/j.jclinepi.2005.08.008; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300; Weiner MG, 2008, PHARMACOEPIDEM DR S, V17, P661, DOI 10.1002/pds.1585	35	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101134	10.1371/journal.pone.0101134	http://dx.doi.org/10.1371/journal.pone.0101134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992329	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400045
J	Choi, JW; Liao, XP; Stothard, P; Chung, WH; Jeon, HJ; Miller, SP; Choi, SY; Lee, JK; Yang, B; Lee, KT; Han, KJ; Kim, HC; Jeong, D; Oh, JD; Kim, N; Kim, TH; Lee, HK; Lee, SJ				Choi, Jung-Woo; Liao, Xiaoping; Stothard, Paul; Chung, Won-Hyong; Jeon, Heoyn-Jeong; Miller, Stephen P.; Choi, So-Young; Lee, Jeong-Koo; Yang, Bokyoung; Lee, Kyung-Tai; Han, Kwang-Jin; Kim, Hyeong-Cheol; Jeong, Dongkee; Oh, Jae-Don; Kim, Namshin; Kim, Tae-Hun; Lee, Hak-Kyo; Lee, Sung-Jin			Whole-Genome Analyses of Korean Native and Holstein Cattle Breeds by Massively Parallel Sequencing	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; NITRIC-OXIDE SYNTHASE; MAMMARY-GLAND; MILK-PRODUCTION; BLACK ANGUS; BOS-TAURUS; SNP; IDENTIFICATION; EXPRESSION; SIGNATURES	A main goal of cattle genomics is to identify DNA differences that account for variations in economically important traits. In this study, we performed whole-genome analyses of three important cattle breeds in Korea-Hanwoo, Jeju Heugu, and Korean Holstein-using the Illumina HiSeq 2000 sequencing platform. We achieved 25.5-, 29.6-, and 29.5-fold coverage of the Hanwoo, Jeju Heugu, and Korean Holstein genomes, respectively, and identified a total of 10.4 million single nucleotide polymorphisms (SNPs), of which 54.12% were found to be novel. We also detected 1,063,267 insertions-deletions (InDels) across the genomes (78.92% novel). Annotations of the datasets identified a total of 31,503 nonsynonymous SNPs and 859 frameshift InDels that could affect phenotypic variations in traits of interest. Furthermore, genome-wide copy number variation regions (CNVRs) were detected by comparing the Hanwoo, Jeju Heugu, and previously published Chikso genomes against that of Korean Holstein. A total of 992, 284, and 1881 CNVRs, respectively, were detected throughout the genome. Moreover, 53, 65, 45, and 82 putative regions of homozygosity (ROH) were identified in Hanwoo, Jeju Heugu, Chikso, and Korean Holstein respectively. The results of this study provide a valuable foundation for further investigations to dissect the molecular mechanisms underlying variation in economically important traits in cattle and to develop genetic markers for use in cattle breeding.	[Choi, Jung-Woo; Miller, Stephen P.] Univ Guelph, Ctr Genet Improvement Livestock Anim & Poultry Sc, Guelph, ON N1G 2W1, Canada; [Liao, Xiaoping; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Chung, Won-Hyong; Kim, Namshin] Korea Bioinformat Ctr, Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Choi, Jung-Woo; Jeon, Heoyn-Jeong; Lee, Kyung-Tai; Kim, Tae-Hun] Natl Inst Anim Sci, Rural Dev Adm, Div Anim Genom & Bioinformat, Suwon, South Korea; [Choi, So-Young; Lee, Jeong-Koo; Lee, Sung-Jin] Kangwon Natl Univ, Coll Anim Life Sci, Chunchon, South Korea; [Yang, Bokyoung] TheragenEtex, Theragen BiO Inst, Suwon, South Korea; [Han, Kwang-Jin] Natl Agr Cooperat Fed, Dairy Cattle Improvement Ctr, Goyang Si, South Korea; [Kim, Hyeong-Cheol] Natl Inst Anim Sci, Rural Dev Adm, Hanwoo Expt Stn, Chunchon, Gangwon Do, South Korea; [Jeong, Dongkee] Jeju Natl Univ, Dept Biotechnol, Cheju, South Korea; [Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Dept Biotechnol, Anseong, South Korea	University of Guelph; University of Alberta; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kangwon National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Jeju National University; Hankyong National University	Lee, HK (corresponding author), Hankyong Natl Univ, Dept Biotechnol, Anseong, South Korea.	breedlee@empas.com; sjlee@kangwon.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Lee, Sung-Jin/0000-0001-9348-8356	BioGreen 21 Program [PJ008196]; Cooperative Research Program for Agriculture Science AMP; Technology Development, Rural Development Administration [PJ009153012014, PJ006405]; Animal Promotion Resource Institute, Jeju and Kangwon National University, Republic of Korea [120131448]; Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle"	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science AMP; Technology Development, Rural Development Administration; Animal Promotion Resource Institute, Jeju and Kangwon National University, Republic of Korea; Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle"	This research was supported by the grant from the BioGreen 21 Program (No. PJ008196), the Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration (No. PJ009153012014, PJ006405), Animal Promotion Resource Institute, Jeju and Kangwon National University (No. 120131448), Republic of Korea. Xiaoping Liao was funded by the Genome Canada project entitled "Whole Genome Selection Through Genome Wide Imputation in Beef Cattle". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Choi JW, 2013, MAMM GENOME, V24, P151, DOI 10.1007/s00335-013-9449-z; Choi TJ, 2009, THESIS; Dadi H, 2012, ASIAN AUSTRAL J ANIM, V25, P1223, DOI 10.5713/ajas.2012.12122; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iizuka T, 1998, PEDIATR RES, V44, P197, DOI 10.1203/00006450-199808000-00010; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jo C., 2012, Animal Frontiers, V2, P32, DOI 10.2527/af.2012-0060; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Lee KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-519; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao SF, 2009, J DAIRY SCI, V92, P1124, DOI 10.3168/jds.2008-1521; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mc Parland S, 2007, J DAIRY SCI, V90, P4411, DOI 10.3168/jds.2007-0227; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MERCHEN NR, 1992, J ANIM SCI, V70, P3238, DOI 10.2527/1992.70103238x; Ministry for Food Agriculture Forestry and Fisheries, 2013, 2012 DAIR HERD IMPR; National Institute of Animal Science, 2012, STAT LOC LIV BREEDS; National Institute of Animal Science (NIAS), 2011, NAT I AN SCI NIAS AN; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seo KS, 2007, VET DERMATOL, V18, P392, DOI 10.1111/j.1365-3164.2007.00634.x; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zaragoza R, 2005, BIOCHEM J, V391, P581, DOI 10.1042/BJ20050507; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	48	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101127	10.1371/journal.pone.0101127	http://dx.doi.org/10.1371/journal.pone.0101127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992012	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400043
J	Green, RE; Bower, AS; Lugo-Fernandez, A				Green, Rebecca E.; Bower, Amy S.; Lugo-Fernandez, Alexis			First Autonomous Bio-Optical Profiling Float in the Gulf of Mexico Reveals Dynamic Biogeochemistry in Deep Waters	PLOS ONE			English	Article							INHERENT OPTICAL-PROPERTIES; DISSOLVED ORGANIC-MATTER; TEMPORAL VARIABILITY; CONTINENTAL-MARGIN; NORTH-ATLANTIC; OCEAN; PHYTOPLANKTON; SCATTERING; PARTICLES; BIOMASS	Profiling floats equipped with bio-optical sensors well complement ship-based and satellite ocean color measurements by providing highly-resolved time-series data on the vertical structure of biogeochemical processes in oceanic waters. This is the first study to employ an autonomous profiling (APEX) float in the Gulf of Mexico for measuring spatiotemporal variability in bio-optics and hydrography. During the 17-month deployment (July 2011 to December 2012), the float mission collected profiles of temperature, salinity, chlorophyll fluorescence, particulate backscattering (b(bp)), and colored dissolved organic matter (CDOM) fluorescence from the ocean surface to a depth of 1,500 m. Biogeochemical variability was characterized by distinct depth trends and local "hot spots", including impacts from mesoscale processes associated with each of the water masses sampled, from ambient deep waters over the Florida Plain, into the Loop Current, up the Florida Canyon, and eventually into the Florida Straits. A deep chlorophyll maximum (DCM) occurred between 30 and 120 m, with the DCM depth significantly related to the unique density layer rho = 1023.6 (R-2 = 0.62). Particulate backscattering, b(bp), demonstrated multiple peaks throughout the water column, including from phytoplankton, deep scattering layers, and resuspension. The bio-optical relationship developed between b(bp) and chlorophyll (R-2 = 0.49) was compared to a global relationship and could significantly improve regional ocean-color algorithms. Photooxidation and autochthonous production contributed to CDOM distributions in the upper water column, whereas in deep water, CDOM behaved as a semi-conservative tracer of water masses, demonstrating a tight relationship with density (R-2 = 0.87). In the wake of the Deepwater Horizon oil spill, this research lends support to the use of autonomous drifting profilers as a powerful tool for consideration in the design of an expanded and integrated observing network for the Gulf of Mexico.	[Green, Rebecca E.; Lugo-Fernandez, Alexis] Bur Ocean Energy Management, Environm Studies Sect, New Orleans, LA 70123 USA; [Bower, Amy S.] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Green, RE (corresponding author), Bur Ocean Energy Management, Environm Studies Sect, New Orleans, LA 70123 USA.	rebecca.green@boem.gov		Bower, Amy/0000-0003-0902-4984	Bureau of Ocean Energy Management (BOEM) [M10PC00112]	Bureau of Ocean Energy Management (BOEM)	This project was funded by Bureau of Ocean Energy Management (BOEM) Contract M10PC00112 to Leidos, Inc. with subcontract to ASB (www.boem.gov). BOEM employees, REG and ALF, were involved in the study design, data analysis, decision to publish, and preparation of the manuscript.	Barnard A. H., 2013, OCEAN NEWS TECHNOL, V19, P16; BIGGS DC, 1994, J GEOPHYS RES-OCEANS, V99, P7371, DOI 10.1029/93JC02153; Biggs Douglas C., 2001, Gulf of Mexico Science, V19, P7; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Boss E, 2008, LIMNOL OCEANOGR, V53, P2112, DOI 10.4319/lo.2008.53.5_part_2.2112; Boss E, 2001, J GEOPHYS RES-OCEANS, V106, P9499, DOI 10.1029/2000JC900008; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; Conmy RN, 2004, MAR CHEM, V89, P127, DOI 10.1016/j.marchem.2004.02.010; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; D'Sa EJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031192; Davis RE, 2001, J ATMOS OCEAN TECH, V18, P982, DOI 10.1175/1520-0426(2001)018<0982:PAAOAI>2.0.CO;2; DeRada S, 2009, OCEANS 2009 MTS IEEE, P1; El-Sayed S.Z., 1972, CHEM PRIMARY PRODUCT, P8; Estapa ML, 2013, BIOGEOSCIENCES, V10, P5517, DOI 10.5194/bg-10-5517-2013; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GARDNER WD, 1990, DEEP-SEA RES, V37, P401, DOI 10.1016/0198-0149(90)90016-O; Green RE, 2003, LIMNOL OCEANOGR, V48, P2377, DOI 10.4319/lo.2003.48.6.2377; Green RE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004594; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; HOBSON LA, 1972, DEEP-SEA RES, V19, P297, DOI 10.1016/0011-7471(72)90023-X; Huot Y, 2008, BIOGEOSCIENCES, V5, P495, DOI 10.5194/bg-5-495-2008; Jochens AE, 2013, MAR TECHNOL SOC J, V47, P118, DOI 10.4031/MTSJ.47.1.11; Kaltenberg A. M., 2007, Gulf of Mexico Science, V25, P97; Leben RR, 2005, GEOPH MONOG SERIES, V161, P181; Lohrenz S, 2014, US GULF MEX CARB CYC, P28; Montgomery RB, 1941, J MAR RES, V4, P198; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; MULLERKARGER FE, 1991, J GEOPHYS RES-OCEANS, V96, P12645, DOI 10.1029/91JC00787; National Oceanographic and Atmospheric Administration, 2013, GULF MEX DAT ATL BOT; National Oceanographic and Atmospheric Administration, 2011, 25 NOAA NOS OR R; National Research Council, 2013, EC SERV APPR ASS IMP; Nelson N.B., 2002, BIOGEOCHEMISTRY MARI, P547; Nelson NB, 1998, DEEP-SEA RES PT I, V45, P931, DOI 10.1016/S0967-0637(97)00106-4; NOWLIN WD, 1967, J MAR RES, V25, P29; Operational Science Advisory Team, 2010, SUMM REP SUBS SUBS O; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Robbins LL, 2014, US GULF MEX CARB CYC, P17; Rossby T, 1986, J ATMOS OCEAN TECH, V3, P672, DOI 10.1175/1520-0426(1986)003<0672:TRS>2.0.CO;2; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Stramski D, 2001, APPL OPTICS, V40, P2929, DOI 10.1364/AO.40.002929; Swan CM, 2009, DEEP-SEA RES PT I, V56, P2175, DOI 10.1016/j.dsr.2009.09.002; Xing XG, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007632; Xing XG, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006899; Xue Z, 2013, BIOGEOSCIENCES, V10, P7219, DOI 10.5194/bg-10-7219-2013; Zhang XD, 2009, OPT EXPRESS, V17, P5698, DOI 10.1364/OE.17.005698	48	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101658	10.1371/journal.pone.0101658	http://dx.doi.org/10.1371/journal.pone.0101658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992646	Green Published, gold			2022-12-25	WOS:000341253400103
J	Jakola, AS; Berntsen, EM; Christensen, P; Gulati, S; Unsgard, G; Kvistad, KA; Solheim, O				Jakola, Asgeir S.; Berntsen, Erik M.; Christensen, Pal; Gulati, Sasha; Unsgard, Geirmund; Kvistad, Kjell A.; Solheim, Ole			Surgically Acquired Deficits and Diffusion Weighted MRI Changes after Glioma Resection - A Matched Case-Control Study with Blinded Neuroradiological Assessment	PLOS ONE			English	Article							GRADE II GLIOMAS; HEMORRHAGIC TRANSFORMATION; 5-AMINOLEVULINIC ACID; TENSOR TRACTOGRAPHY; MALIGNANT GLIOMA; AWAKE CRANIOTOMY; 3D ULTRASOUND; SURGERY; STROKE; EXTENT	Background: Acquired deficits following glioma resection may not only occur due to accidental resection of normal brain tissue. The possible importance of ischemic injuries in causing neurological deficits after brain tumor surgery is not much studied. We aimed to study the volume and frequency of early postoperative circulatory changes (i.e. infarctions) detected by diffusion weighted resonance imaging (DWI) in patients with surgically acquired neurological deficits compared to controls. Methods: We designed a 1:1 matched case-control study in patients with diffuse gliomas (WHO grade II-IV) operated with 3D ultrasound guided resection. 42 consecutive patients with acquired postoperative dysphasia and/or new motor deficits were compared to 42 matched controls without acquired deficits. Controls were matched with respect to histopathology, preoperative tumor volumes, and eloquence of location. Two independent radiologists blinded for clinical status assessed the postoperative DWI findings. Results: Postoperative peri-tumoral infarctions were more often seen in patients with acquired deficits (63% versus 41%, p = 0.046) and volumes of DWI abnormalities were larger in cases than in controls with median 1.08 cm(3) (IQR 0-2.39) versus median 0 cm(3) (IQR 0-1.67), p = 0.047. Inter-rater agreement was substantial (67/82, k = 0.64, p < 0.001) for diagnosing radiological significant DWI abnormalities. Conclusion: Peri-tumoral infarctions were more common and were larger in patients with acquired deficits after glioma surgery compared to glioma patients without deficits when assessed by early postoperative DWI. Infarctions may be a frequent and underestimated cause of acquired deficits after glioma resection. DWI changes may be an attractive endpoint in brain tumor surgery with both good inter-rater reliability among radiologists and clinical relevance.	[Jakola, Asgeir S.; Gulati, Sasha; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] Natl Ctr Ultrasound & Image Guided Therapy, Trondheim, Norway; [Berntsen, Erik M.; Christensen, Pal; Kvistad, Kjell A.] St Olavs Univ Hosp, Dept Radiol, Trondheim, Norway; [Berntsen, Erik M.; Kvistad, Kjell A.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Unsgard, Geirmund] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018; Berntsen, Erik Magnus/AAM-7134-2020	Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817				Alexandrov AV, 1997, STROKE, V28, P1198, DOI 10.1161/01.STR.28.6.1198; Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Barone DG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009685.pub2; Belhawi SMK, 2011, EUR RADIOL, V21, P1526, DOI 10.1007/s00330-011-2081-y; Berntsen EM, 2010, NEUROSURGERY, V67, P251, DOI 10.1227/01.NEU.0000371731.20246.AC; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dutzmann S, 2012, J NEUROONCOLOGY, P1; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Gempt J, 2013, J NEUROSURG, V118, P801, DOI 10.3171/2012.12.JNS12125; Gil-Robles S, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09236; Girot M, 2003, CEREBROVASC DIS, V16, P122, DOI 10.1159/000070591; Gulati S, 2009, MINIM INVAS NEUROSUR, V52, P17, DOI 10.1055/s-0028-1104566; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Jakola AS, 2012, JAMA-J AM MED ASSOC, P1; Jakola AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028592; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Kelly PJ, 2001, NEUROLOGY, V56, P914, DOI 10.1212/WNL.56.7.914; Khan RB, 2006, NEUROSURGERY, V59, P60, DOI 10.1227/01.NEU.0000219218.43128.FC; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Kumabe T, 2007, J NEUROSURG, V106, P263, DOI 10.3171/jns.2007.106.2.263; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Marks MP, 1996, RADIOLOGY, V199, P403, DOI 10.1148/radiology.199.2.8668785; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Neuloh G, 2007, NEUROPHYSIOL CLIN, V37, P383, DOI 10.1016/j.neucli.2007.09.002; Oppenlander ME, 2014, J NEUROSURG; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Singer MB, 1998, STROKE, V29, P133, DOI 10.1161/01.STR.29.1.133; Smith JS, 2005, J NEUROSURG, V103, P428, DOI 10.3171/jns.2005.103.3.0428; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Solheim O, 2014, J NEUROSURG; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Ulmer S, 2006, NEUROLOGY, V67, P1668, DOI 10.1212/01.wnl.0000242894.21705.3c; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Unsgard G, 2011, ACTA NEUROCHIR SUPPL, V109, P181, DOI 10.1007/978-3-211-99651-5_28; Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	41	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101805	10.1371/journal.pone.0101805	http://dx.doi.org/10.1371/journal.pone.0101805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992634	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400119
J	Piir, K; Tamm, T; Kisly, I; Tammsalu, T; Remme, J				Piir, Kerli; Tamm, Tiina; Kisly, Ivan; Tammsalu, Triin; Remme, Jaanus			Stepwise Splitting of Ribosomal Proteins from Yeast Ribosomes by LiCl	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOMES; EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; 50-S SUBUNIT; MATURATION; INITIATION; RNA; IDENTIFICATION; PROTEOMICS; PATHWAY	Structural studies have revealed that the core of the ribosome structure is conserved among ribosomes of all kingdoms. Kingdom-specific ribosomal proteins (r-proteins) are located in peripheral parts of the ribosome. In this work, the interactions between rRNA and r-proteins of eukaryote Saccharomyces cerevisiae ribosome were investigated applying LiCl induced splitting and quantitative mass spectrometry. R-proteins were divided into four groups according to their binding properties to the rRNA. Most yeast r-proteins are removed from rRNA by 0.5-1 M LiCl. Eukaryote-specific r-proteins are among the first to dissociate. The majority of the strong binders are known to be required for the early ribosome assembly events. As compared to the bacterial ribosome, yeast r-proteins are dissociated from rRNA at lower ionic strength. Our results demonstrate that the nature of protein-RNA interactions in the ribosome is not conserved between different kingdoms.	[Piir, Kerli; Tamm, Tiina; Kisly, Ivan; Tammsalu, Triin; Remme, Jaanus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu	Remme, J (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	jremme@ut.ee	Tamm, Tiina/D-4004-2014; Remme, Jaanus/L-1830-2019; Remme, Jaanus/A-4614-2011	Remme, Jaanus/0000-0002-4011-6580; Remme, Jaanus/0000-0002-4011-6580; Kisly, Ivan/0000-0002-4479-2447; Tamm, Tiina/0000-0001-9943-2097	Estonian Research Foundation [9289]; Estonian Research Council Institutional Research [14021]	Estonian Research Foundation; Estonian Research Council Institutional Research	This work was supported by Estonian Research Foundation Grant Nr. 9289 and Estonian Research Council Institutional Research Grant Nr. 14021 (URL:www.etag.ee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; ELBARADI TTAL, 1984, EUR J BIOCHEM, V144, P393, DOI 10.1111/j.1432-1033.1984.tb08477.x; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; HEROLD M, 1987, J BIOL CHEM, V262, P8826; HOMANN HE, 1971, EUR J BIOCHEM, V20, P249, DOI 10.1111/j.1432-1033.1971.tb01388.x; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Pulk A, 2010, MOL MICROBIOL, V75, P801, DOI 10.1111/j.1365-2958.2009.07002.x; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; WYSTUP G, 1979, EUR J BIOCHEM, V100, P101, DOI 10.1111/j.1432-1033.1979.tb02038.x	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101561	10.1371/journal.pone.0101561	http://dx.doi.org/10.1371/journal.pone.0101561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991888	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400090
J	Liu, Q; Spitsbergen, JM; Cariou, R; Huang, CY; Jiang, N; Goetz, G; Hutz, RJ; Tonellato, PJ; Carvan, MJ				Liu, Qing; Spitsbergen, Jan M.; Cariou, Ronan; Huang, Chun-Yuan; Jiang, Nan; Goetz, Giles; Hutz, Reinhold J.; Tonellato, Peter J.; Carvan, Michael J., III			Histopathologic Alterations Associated with Global Gene Expression Due to Chronic Dietary TCDD Exposure in Juvenile Zebrafish	PLOS ONE			English	Article							2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; RAINBOW-TROUT; PATHOLOGICAL ALTERATIONS; SPECIES-DIFFERENCES; BLOOD-FLOW; TOXICITY; DIOXIN; DISEASE; EMBRYO; CELLS	The goal of this project was to investigate the effects and possible developmental disease implication of chronic dietary TCDD exposure on global gene expression anchored to histopathologic analysis in juvenile zebrafish by functional genomic, histopathologic and analytic chemistry methods. Specifically, juvenile zebrafish were fed Biodiet starter with TCDD added at 0, 0.1, 1, 10 and 100 ppb, and fish were sampled following 0, 7, 14, 28 and 42 d after initiation of the exposure. TCDD accumulated in a dose-and time-dependent manner and 100 ppb TCDD caused TCDD accumulation in female (15.49 ppb) and male (18.04 ppb) fish at 28 d post exposure. Dietary TCDD caused multiple lesions in liver, kidney, intestine and ovary of zebrafish and functional dysregulation such as depletion of glycogen in liver, retrobulbar edema, degeneration of nasal neurosensory epithelium, underdevelopment of intestine, and diminution in the fraction of ovarian follicles containing vitellogenic oocytes. Importantly, lesions in nasal epithelium and evidence of endocrine disruption based on alternatively spliced vasa transcripts are two novel and significant results of this study. Microarray gene expression analysis comparing vehicle control to dietary TCDD revealed dysregulated genes involved in pathways associated with cardiac necrosis/cell death, cardiac fibrosis, renal necrosis/cell death and liver necrosis/cell death. These baseline toxicological effects provide evidence for the potential mechanisms of developmental dysfunctions induced by TCDD and vasa as a biomarker for ovarian developmental disruption.	[Liu, Qing; Hutz, Reinhold J.; Carvan, Michael J., III] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53211 USA; [Liu, Qing; Carvan, Michael J., III] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Spitsbergen, Jan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Cariou, Ronan] LUNAM Univ, Oniris, Lab Etud Residus & Contaminants Aliments LABERCA, Nantes, France; [Huang, Chun-Yuan; Tonellato, Peter J.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Jiang, Nan] Roche NimbleGen Inc, Madison, WI USA; [Goetz, Giles] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Tonellato, Peter J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Tonellato, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Oregon State University; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; University of Wisconsin System; University of Wisconsin Milwaukee; Roche Holding; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Carvan, MJ (corresponding author), Univ Wisconsin, Dept Biol Sci, Lapham Hall, Milwaukee, WI 53211 USA.	carvanmj@uwm.edu	Liu, Qing/M-2162-2018; Cariou, Ronan/M-5549-2014; JIANG, NAN/AHB-1945-2022	Cariou, Ronan/0000-0002-4669-1834; Carvan, Michael/0000-0002-9190-9417	University of Wisconsin Sea Grant Institute from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; State of Wisconsin; UWM Children's Environmental Health Sciences Core Center (NIEHS) [2P30ES004184]; Shaw Fund of the Greater Milwaukee Foundation;  [NA060AR4170011];  [R/BT-21]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES004184] Funding Source: NIH RePORTER	University of Wisconsin Sea Grant Institute from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; State of Wisconsin; UWM Children's Environmental Health Sciences Core Center (NIEHS); Shaw Fund of the Greater Milwaukee Foundation; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the University of Wisconsin Sea Grant Institute under grants from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce, and from the State of Wisconsin. Federal grant number NA060AR4170011, project number R/BT-21. This work was also supported by the UWM Children's Environmental Health Sciences Core Center (NIEHS 2P30ES004184), and the Shaw Fund of the Greater Milwaukee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 1999, TOXICOL APPL PHARM, V159, P41, DOI 10.1006/taap.1999.8719; Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; Antignac JP, 2006, ANAL BIOANAL CHEM, V384, P271, DOI 10.1007/s00216-005-0129-z; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Bello SM, 2004, TOXICOL SCI, V78, P258, DOI 10.1093/toxsci/kfh065; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carvalho PSM, 2004, ENVIRON SCI TECHNOL, V38, P6300, DOI 10.1021/es034857i; Carvan MJ, 2007, ZEBRAFISH, V4, P9, DOI 10.1089/zeb.2006.9998; Carvan MJ, 2005, BIOCH MOLEC, V6, P3; Collins LL, 2008, TOXICOL SCI, V103, P125, DOI 10.1093/toxsci/kfn017; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1002/etc.5620170319; Heiden TCK, 2008, REPROD TOXICOL, V25, P47, DOI 10.1016/j.reprotox.2007.07.013; Heiden TK, 2006, TOXICOL SCI, V90, P490, DOI 10.1093/toxsci/kfj085; Heiden TK, 2005, TOXICOL SCI, V87, P497, DOI 10.1093/toxsci/kfi201; Hill A, 2004, J FISH BIOL, V64, P911, DOI 10.1111/j.1095-8649.2004.0352.x; Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; Humblet O, 2008, ENVIRON HEALTH PERSP, V116, P1443, DOI 10.1289/ehp.11579; Hutz R J, 2006, Tren Reprod Bio, V2, P1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito T, 2008, TOXICOL LETT, V177, P31, DOI 10.1016/j.toxlet.2007.12.011; Ivanovski O, 2009, Prilozi, V30, P71; Ivnitski I, 2001, TERATOLOGY, V64, P201, DOI 10.1002/tera.1065; Kim SY, 2005, EXP MOL MED, V37, P58, DOI 10.1038/emm.2005.8; King Heiden TC, 2009, TOXICOL SCI, V109, P75, DOI 10.1093/toxsci/kfp048; KLEEMAN JM, 1988, FUND APPL TOXICOL, V10, P206, DOI 10.1016/0272-0590(88)90304-1; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Lanham KA, 2012, TOXICOL SCI, V127, P360, DOI 10.1093/toxsci/kfs103; Laurent C, 2005, CHEMOSPHERE, V60, P929, DOI 10.1016/j.chemosphere.2005.01.041; Liu Q, 2013, AQUAT TOXICOL, V140, P356, DOI 10.1016/j.aquatox.2013.06.018; Lonergan KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009162; Marchand P, 2010, CHEMOSPHERE, V80, P634, DOI 10.1016/j.chemosphere.2010.04.057; Markowski VP, 2001, ENVIRON HEALTH PERSP, V109, P621, DOI 10.2307/3455037; Murante FG, 2000, TOXICOL SCI, V54, P374, DOI 10.1093/toxsci/54.2.374; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nyska A, 2005, TOXICOL PATHOL, V33, P371, DOI 10.1080/01926230590930209; RYAN JJ, 1984, ENVIRON SCI TECHNOL, V18, P719, DOI 10.1021/es00127a015; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Seo BW, 1999, NEUROTOXICOL TERATOL, V21, P231, DOI 10.1016/S0892-0362(98)00049-X; SPITSBERGEN JM, 1988, J TOXICOL ENV HEALTH, V23, P359, DOI 10.1080/15287398809531120; SPITSBERGEN JM, 1991, AQUAT TOXICOL, V19, P41, DOI 10.1016/0166-445X(91)90027-7; Steenland K, 1999, J NATL CANCER I, V91, P779, DOI 10.1093/jnci/91.9.779; Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192; Teraoka H, 2009, TOXICOL APPL PHARM, V234, P33, DOI 10.1016/j.taap.2008.09.021; Turyk ME, 2012, ENVIRON HEALTH PERSP, V120, P11, DOI 10.1289/ehp.1003396; UNKILA M, 1995, INT J BIOCHEM CELL B, V27, P443, DOI 10.1016/1357-2725(95)00023-I; WANNEMACHER R, 1992, CHEMOSPHERE, V24, P1361, DOI 10.1016/0045-6535(92)90059-Z; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; Yamauchi M, 2006, AQUAT TOXICOL, V80, P166, DOI 10.1016/j.aquatox.2006.08.006; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	60	12	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100910	10.1371/journal.pone.0100910	http://dx.doi.org/10.1371/journal.pone.0100910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988445	Green Published, gold			2022-12-25	WOS:000341354100050
J	Merino, H; Singla, DK				Merino, Hilda; Singla, Dinender K.			Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; INDUCED CARDIOMYOPATHY; MYOCYTE DIFFERENTIATION; INDUCED CARDIOTOXICITY; INHIBIT APOPTOSIS; OXIDATIVE STRESS; MECHANISMS; CARDIOMYOCYTES; PROLIFERATION; REGENERATION	Doxorubicin (DOX), an effective chemotherapeutic drug used in the treatment of various cancers, is limited in its clinical applications due to cardiotoxicity. Recent studies suggest that transplanted adult stem cells inhibit DOX-induced cardiotoxicity. However, the effects of transplanted embryonic stem (ES) and induced pluripotent stem (iPS) cells are completely unknown in DOX-induced left ventricular dysfunction following myocardial infarction (MI). In brief, C57BL/6 mice were divided into five groups: Sham, DOX-MI, DOX-MI+ cell culture (CC) media, DOX-MI+ ES cells, and DOX-MI+ iPS cells. Mice were injected with cumulative dose of 12 mg/kg of DOX and 2 weeks later, MI was induced by coronary artery ligation. Following ligation, 5x10(4) ES or iPS cells were delivered into the peri-infarct region. At day 14 post-MI, echocardiography was performed, mice were sacrificed, and hearts were harvested for further analyses. Our data reveal apoptosis was significantly inhibited in ES and iPS cell transplanted hearts compared with respective controls (DOX-MI+ES: 0.48 +/- 0.06% and DOX-MI+iPS: 0.33 +/- 0.05% vs. DOX-MI: 1.04 +/- 0.07% and DOX-MI+CC: 0.96 +/- 0.21%; p<0.05). Furthermore, a significant increase in levels of Notch-1 (p<0.05), Hes1 (p<0.05), and pAkt (p<0.05) were observed whereas a decrease in the levels of PTEN (p<0.05), a negative regulator of Akt, was evident following stem cell transplantation. Moreover, hearts transplanted with stem cells demonstrated decreased vascular and interstitial fibrosis (p<0.05) as well as MMP-9 expression (p<0.01) compared with controls. Additionally, heart function was significantly improved (p<0.05) in both cell-transplanted groups. In conclusion, our data show that transplantation of ES and iPS cells blunt DOX-induced adverse cardiac remodeling, which is associated with improved cardiac function, and these effects are mediated by the Notch pathway.	[Merino, Hilda; Singla, Dinender K.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA.	Dinender.Singla@ucf.edu			National Institutes of Health [1R01HL090646-01, 5R01HL094467-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090646, R01HL094467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, from grants from the National Institutes of Health [1R01HL090646-01, and 5R01HL094467-02 to DKS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no additional funding sources for this study.	Agbulut O, 2003, CARDIOVASC RES, V58, P451, DOI 10.1016/S0008-6363(03)00281-5; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Garbade J, 2009, J CARDIAC SURG, V24, P591, DOI 10.1111/j.1540-8191.2009.00844.x; Geisberg CA, 2010, CURR HYPERTENS REP, V12, P404, DOI 10.1007/s11906-010-0146-y; Glass C, 2012, CELL TRANSPLANT, V21, P1931, DOI 10.3727/096368911X627561; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Gopinath S, 2010, BIOCHEM BIOPH RES CO, V395, P367, DOI 10.1016/j.bbrc.2010.04.021; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Horenstein MS, 2000, MOL GENET METAB, V71, P436, DOI 10.1006/mgme.2000.3043; Ichihara S, 2007, BIOCHEM BIOPH RES CO, V359, P27, DOI 10.1016/j.bbrc.2007.05.027; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Kumar D, 2002, HERZ, V27, P662, DOI 10.1007/s00059-002-2430-3; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Menna P, 2010, CHEM RES TOXICOL, V23, P6, DOI 10.1021/tx9003424; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Miranda CJ, 2003, BLOOD, V102, P2574, DOI 10.1182/blood-2003-03-0869; Nemir M., 2012, EUR HEART J; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Oliveira Maira S, 2013, J Cancer Sci Ther, V5, P52; Psaltis PJ, 2011, INT J CARDIOVAS IMAG, V27, P25, DOI 10.1007/s10554-010-9657-5; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Singla DK, 2009, ANTIOXID REDOX SIGN, V11, P1857, DOI [10.1089/ars.2009.2491, 10.1089/ARS.2009.2491]; Singla DK, 2012, CELL TRANSPLANT, V21, P1919, DOI 10.3727/096368911X627552; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; Singla DK, 2006, J MOL CELL CARDIOL, V40, P195, DOI 10.1016/j.yjmcc.2005.09.001; Singla DK, 2005, BIOCHEM BIOPH RES CO, V335, P637, DOI 10.1016/j.bbrc.2005.06.105; Singla DK, 2014, CELL TRANSPLANT; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Yan BB, 2013, MOL PHARMACEUT, V10, P3425, DOI 10.1021/mp400258d	44	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101024	10.1371/journal.pone.0101024	http://dx.doi.org/10.1371/journal.pone.0101024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988225	Green Published, gold			2022-12-25	WOS:000341354100055
J	Oi, N; Yuan, J; Malakhova, M; Luo, K; Li, Y; Ryu, J; Zhang, L; Bode, AM; Xu, Z; Li, Y; Lou, Z; Dong, Z				Oi, N.; Yuan, J.; Malakhova, M.; Luo, K.; Li, Y.; Ryu, J.; Zhang, L.; Bode, A. M.; Xu, Z.; Li, Y.; Lou, Z.; Dong, Z.			Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1	ONCOGENE			English	Article							HUMAN-MALIGNANT MELANOMA; S-PHASE ARREST; RNASE ACTIVITY; CANCER CELLS; KAPPA-B; P53; G3BP; EXPRESSION; PHOSPHORYLATION; GROWTH	Resveratrol (trans-3,5,4'-truhydroxystilbene) possesses a strong anticancer activity exhibited as the induction of apoptosis through p53 activation. However, the molecular mechanism and direct target(s) of resveratrol-induced p53 activation remain elusive. Here, the Ras-GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) was identified as a potential target of resveratrol, and in vitro binding assay results using resveratrol-conjugated Sepharose 4B beads confirmed their direct binding. Depletion of G3BP1 significantly diminishes resveratrol-induced p53 expression and apoptosis. We also found that G3BP1 negatively regulates p53 expression by interacting with ubiquitin-specific protease 10 (USP10), a deubiquitinating enzyme of p53. Disruption of the interaction of p53 with USP10 by G3BP1 interference leads to the suppression of p53 deubiquitination. Resveratrol, on the other hand, directly binds to G3BP1 and prevents the G3BP1/USP10 interaction, resulting in enhanced USP10-mediated deubiquitination of p53, and consequently increased p53 expression. These findings disclose a novel mechanism of resveratrol-induced p53 activation and resveratrol-induced apoptosis by direct targeting of G3BP1.	[Oi, N.; Malakhova, M.; Ryu, J.; Bode, A. M.; Li, Y.; Dong, Z.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Yuan, J.; Luo, K.; Li, Y.; Xu, Z.] Tongji Univ, Res Ctr Translat Med, Sch Med, East Hosp, Shanghai 200092, Peoples R China; [Yuan, J.; Luo, K.; Li, Y.; Xu, Z.] Tongji Univ, Sch Med, East Hosp, Minist Educ China,Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Luo, K.; Li, Y.; Zhang, L.; Lou, Z.] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55902 USA	University of Minnesota System; Tongji University; Ministry of Education, China; Tongji University; Mayo Clinic	Lou, Z (corresponding author), Mayo Clin, Dept Oncol, Div Oncol Res, 200 1st St SW, Rochester, MN 55902 USA.	lou.zhenkun@mayo.edu; zgdong@hi.umn.edu			AgStar Minnesota; Hormel Foundation; National Institutes of Health Grants [CA111536, CA172457, CA166011, R37 CA081064, CA148940, CA108961]; National Basic Research Program of China (973 Program) [2013CB530700]; National Natural Science Foundation of China [81102011, 81222029, 31270806]; Kendall-Mayo Fellowship in Biochemistry, the Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81221001]; Shanghai Science and Technology Committee Modernization of Traditional Chinese Medicine special [11DZ1973801]; NATIONAL CANCER INSTITUTE [R01CA166011, R37CA081064, P50CA108961, R01CA187027, R01CA129344, R21CA172457, R01CA130996, R01CA148940, P30CA015083, R01CA111536] Funding Source: NIH RePORTER	AgStar Minnesota; Hormel Foundation; National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kendall-Mayo Fellowship in Biochemistry, the Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Modernization of Traditional Chinese Medicine special; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Yibin Deng (The Hormel Institute, University of Minnesota, Austin, MN, USA) for kindly providing the expression vectors of shRNA p53. This work was supported by AgStar Minnesota (to ZD), The Hormel Foundation (to ZD) and National Institutes of Health Grants CA111536 (to ZD), CA172457 (to ZD), CA166011 (to ZD), R37 CA081064 (to ZD), CA148940 (to ZL), CA108961 (to ZL), the National Basic Research Program of China (973 Program, Grant No. 2013CB530700), National Natural Science Foundation of China (81102011, 81222029 and 31270806) and Kendall-Mayo Fellowship in Biochemistry, the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81221001) and Shanghai Science and Technology Committee Modernization of Traditional Chinese Medicine special (11DZ1973801).	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Barnes CJ, 2002, CANCER RES, V62, P1251; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Celotti E, 1996, J CHROMATOGR A, V730, P47, DOI 10.1016/0021-9673(95)00962-0; Chen RS, 2002, J AGR FOOD CHEM, V50, P1665, DOI 10.1021/jf011134e; Chow SE, 2010, CANCER GENE THER, V17, P872, DOI 10.1038/cgt.2010.44; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; French J, 2002, HISTOCHEM J, V34, P223, DOI 10.1023/A:1021737413055; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gautier-Bert K, 2003, MOL BIOL REP, V30, P1, DOI 10.1023/A:1022261925117; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hartmann A, 1996, INT J CANCER, V67, P313, DOI 10.1002/(SICI)1097-0215(19960729)67:3<313::AID-IJC1>3.0.CO;2-U; Hsieh TC, 1999, CANCER RES, V59, P2596; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Lev DC, 2003, MOL CANCER THER, V2, P753; Liu YX, 2001, CHINESE MED J-PEKING, V114, P35; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Niles RM, 2003, CANCER LETT, V190, P157, DOI 10.1016/S0304-3835(02)00676-6; Oi N, 2010, CANCER RES, V70, P9755, DOI 10.1158/0008-5472.CAN-10-2858; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pazman C, 2000, DEVELOPMENT, V127, P1715; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; She QB, 2001, CANCER RES, V61, P1604; Sobolev VS, 1999, J AGR FOOD CHEM, V47, P1435, DOI 10.1021/jf9809885; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V409, P171, DOI 10.1016/j.bbrc.2011.04.094; Zhang H, 2012, CANCER SCI, V103, P1848, DOI 10.1111/j.1349-7006.2012.02361.x; Zykova TA, 2008, MOL CARCINOGEN, V47, P797, DOI 10.1002/mc.20437	41	34	35	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 14	2015	34	20					2660	2671		10.1038/onc.2014.194	http://dx.doi.org/10.1038/onc.2014.194			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI1YN	24998844	Green Accepted			2022-12-25	WOS:000354541300012
J	Kim, EY; Sturgill, JL; Hait, NC; Avni, D; Valencia, EC; Maceyka, M; Lima, S; Allegood, J; Huang, WC; Zhang, SJ; Milstien, S; Conrad, D; Spiegel, S				Kim, Eugene Y.; Sturgill, Jamie L.; Hait, Nitai C.; Avni, Dorit; Valencia, Evelyn C.; Maceyka, Michael; Lima, Santiago; Allegood, Jeremy; Huang, Wei-Ching; Zhang, Shijun; Milstien, Sheldon; Conrad, Daniel; Spiegel, Sarah			Role of sphingosine kinase 1 and sphingosine-1-phosphate in CD40 signaling and IgE class switching	FASEB JOURNAL			English	Article						B cells; NF-kappa B; sphingolipids; inflammation	NECROSIS-FACTOR-ALPHA; GERMINAL CENTER FORMATION; B-CELLS; TNF-ALPHA; AIRWAY INFLAMMATION; LYMPHOCYTE EGRESS; MARGINAL ZONE; MOUSE MODEL; IN-VITRO; INHIBITOR	The tumor necrosis factor (TNF) receptor family member CD40 plays an essential role in the activation of antigen-presenting cells, B cell maturation, and immunoglobulin (Ig) class switching critical for adaptive immunity. Although the bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) and the kinase that produces it, sphingosine kinase 1 (SphK1), have long been implicated in the actions of TNF mediated by engagement of TNFR1, nothing is yet known of their role in CD40-mediated events. We have now found that ligation of CD40 activates and translocates SphK1 to the plasma membrane, leading to generation of S1P. SphK1 inhibition in human tonsil B cells, as well as inhibition or deletion of SphK1 in mouse splenic B cells, significantly reduced CD40-mediated Ig class switching and plasma cell differentiation ex vivo. Optimal activation of downstream CD40 signaling pathways, including NF-kappa B, p38, and JNK, also required SphK1. In mice treated with a SphK1 inhibitor or in SphK1(-/-) mice, isotype switching to antigen-specific IgE was decreased in vivo by 70 and 55%, respectively. Our results indicate that SphK1 is important for CD40-mediated B cell activation and regulation of humoral responses and suggest that targeting SphK1 might be a useful therapeutic approach to control antigen-specific IgE production.	[Kim, Eugene Y.; Hait, Nitai C.; Avni, Dorit; Valencia, Evelyn C.; Maceyka, Michael; Lima, Santiago; Allegood, Jeremy; Huang, Wei-Ching; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Sturgill, Jamie L.; Conrad, Daniel] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zhang, Shijun] Virginia Commonwealth Univ, Sch Med, Dept Med Chem, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008	Sturgill, Jamie/0000-0001-8856-3227; Avni, Dorit/0000-0002-0444-881X	U.S. National Institutes of Health (NIH) [R37GM043880, R01 AI50094, U19AI077435]; NIH grant [T32HL094290, P30CA16059, P30NS047463]; NATIONAL CANCER INSTITUTE [R01CA061774, P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI050094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R25GM090084, R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Michael Karin (University of California-San Diego, La Jolla, CA, USA) for kindly providing HEK-CD40 cells. This study was supported by U.S. National Institutes of Health (NIH) grants R37GM043880 and R01 AI50094 (S.S.) and in part by U19AI077435 (S.S. and D.C.). E.Y.K. and S.L. were supported by NIH grant T32HL094290. Flow cytometry was supported in part by NIH grant P30CA16059 to the Virginia Commonwealth University (VCU) Massey Cancer Center, and microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, by NIH grant P30NS047463.	Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Bishop G. A., 2003, CYTOKINE GROWTH FACT, V14, P297; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Caven TH, 2007, CELL IMMUNOL, V247, P49, DOI 10.1016/j.cellimm.2007.07.007; Chan HS, 2013, BBA-MOL CELL BIOL L, V1831, P147, DOI 10.1016/j.bbalip.2012.07.005; Chiba Y, 2010, J PHARMACOL SCI, V114, P304, DOI 10.1254/jphs.10202FP; Cho SW, 1997, CELL IMMUNOL, V180, P36, DOI 10.1006/cimm.1997.1174; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Diesner SC, 2012, IMMUNOL LETT, V141, P210, DOI 10.1016/j.imlet.2011.10.006; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Henry Brian, 2013, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-7091-1368-4_4; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mills DM, 2007, P NATL ACAD SCI USA, V104, P6359, DOI 10.1073/pnas.0700296104; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nishiuma T, 2008, AM J PHYSIOL-LUNG C, V294, pL1085, DOI 10.1152/ajplung.00445.2007; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Rabah D, 2002, IMMUNOLOGY, V106, P503, DOI 10.1046/j.1365-2567.2002.01435.x; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Scherer EQ, 2010, STROKE, V41, P2618, DOI 10.1161/STROKEAHA.110.593327; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sturgill JL, 2011, J NEUROIMMUNOL, V233, P80, DOI 10.1016/j.jneuroim.2010.11.014; Terstappen L, 1990, BLOOD, V9, P1739; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200	56	8	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4347	4358		10.1096/fj.14-251611	http://dx.doi.org/10.1096/fj.14-251611			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25002116	Green Published			2022-12-25	WOS:000342222700014
J	Samad, A; James, A; Wong, J; Mankad, P; Whitehouse, J; Patel, W; Alves-Simoes, M; Siriwardena, AK; Bruce, JIE				Samad, Aysha; James, Andrew; Wong, James; Mankad, Parini; Whitehouse, John; Patel, Waseema; Alves-Simoes, Marta; Siriwardena, Ajith K.; Bruce, Jason I. E.			Insulin Protects Pancreatic Acinar Cells from Palmitoleic Acid-induced Cellular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium ATPase; Calcium Transport; Insulin; Pancreas; PMCA; Pancreatitis	PLASMA-MEMBRANE CA2+-ATPASE; ALCOHOLIC PANCREATITIS; DIABETIC RATS; ETHYL-ESTERS; CA2+ UPTAKE; L-ARGININE; ATP; PHOSPHORYLATION; METABOLISM; RECEPTORS	Background: Palmitoleic acid is a major pancreatitis-inducing agent. Results: Insulin protected cells from palmitoleic acid (POA)-induced ATP depletion, inhibition of the plasma membrane calcium pump (PMCA), cytotoxic Ca2+ overload and necrosis. Conclusion: Insulin protects against acinar cell injury induced by pancreatitis-inducing agents. Significance: This provides an important therapeutic strategy for treating pancreatitis with insulin therapy. Acute pancreatitis is a serious and sometimes fatal inflammatory disease where the pancreas digests itself. The non-oxidative ethanol metabolites palmitoleic acid (POA) and POA-ethylester (POAEE) are reported to induce pancreatitis caused by impaired mitochondrial metabolism, cytosolic Ca2+ ([Ca2+](i)) overload and necrosis of pancreatic acinar cells. Metabolism and [Ca2+](i) are linked critically by the ATP-driven plasma membrane Ca2+-ATPase (PMCA) important for maintaining low resting [Ca2+](i). The aim of the current study was to test the protective effects of insulin on cellular injury induced by the pancreatitis-inducing agents, ethanol, POA, and POAEE. Rat pancreatic acinar cells were isolated by collagenase digestion and [Ca2+](i) was measured by fura-2 imaging. An in situ [Ca2+](i) clearance assay was used to assess PMCA activity. Magnesium green (MgGreen) and a luciferase-based ATP kit were used to assess cellular ATP depletion. Ethanol (100 mm) and POAEE (100 m) induced a small but irreversible Ca2+ overload response but had no significant effect on PMCA activity. POA (50-100 m) induced a robust Ca2+ overload, ATP depletion, inhibited PMCA activity, and consequently induced necrosis. Insulin pretreatment (100 nm for 30 min) prevented the POA-induced Ca2+ overload, ATP depletion, inhibition of the PMCA, and necrosis. Moreover, the insulin-mediated protection of the POA-induced Ca2+ overload was partially prevented by the phosphoinositide-3-kinase (PI3K) inhibitor, LY294002. These data provide the first evidence that insulin directly protects pancreatic acinar cell injury induced by bona fide pancreatitis-inducing agents, such as POA. This may have important therapeutic implications for the treatment of pancreatitis.	[Samad, Aysha; James, Andrew; Wong, James; Mankad, Parini; Whitehouse, John; Patel, Waseema; Alves-Simoes, Marta; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk		James, Andrew/0000-0002-2432-5948; Alves Simoes, Marta/0000-0002-5228-5584	BBSRC New Investigator Grant; Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	BBSRC New Investigator Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a BBSRC New Investigator Grant (to J. I. E. B.) and a Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund (to A. K. S. and J. I. E. B.).	Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2012, P NATL ACAD SCI USA, V109, P12794, DOI 10.1073/pnas.1209014109; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Daly ME, 1998, AM J CLIN NUTR, V67, P1186, DOI 10.1093/ajcn/67.6.1186; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; HALLBERG D, 1977, ACTA CHIR SCAND, V143, P451; HARDIN CD, 1993, AM J PHYSIOL, V265, pH1326, DOI 10.1152/ajpheart.1993.265.4.H1326; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hardt PD, 2008, DIABETES CARE, V31, pS165, DOI 10.2337/dc08-s244; Hegyi P, 2000, J PHYSIOLOGY-PARIS, V94, P51, DOI 10.1016/S0928-4257(99)00103-5; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Kaphalia B. S., 2001, Cellular and Molecular Biology Online Papers, V47, pOL173; Koizumi M, 1998, PANCREAS, V16, P385, DOI 10.1097/00006676-199804000-00028; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE766, DOI 10.1152/ajpendo.00468.2003; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; LEVY P, 1989, GASTROENTEROLOGY, V96, P1165, DOI 10.1016/0016-5085(89)91637-5; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; Mentula P, 2008, PANCREAS, V36, pE21, DOI 10.1097/mpa.0b013e31814b22b5; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Owyang C, 1993, PANCREAS BIOL PATHOB; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Pandol SJ, 2011, ALCOHOL CLIN EXP RES, V35, P830, DOI 10.1111/j.1530-0277.2010.01408.x; Peter H, 2004, WORLD J GASTROENTERO, V10, P2275; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; RENNER IG, 1985, DIGEST DIS SCI, V30, P1005, DOI 10.1007/BF01308298; Roberts Susan R, 2004, Crit Care Nurs Clin North Am, V16, P537, DOI 10.1016/S0899-5885(04)00068-1; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SANKARAN H, 1981, AM J PHYSIOL, V240, pG63, DOI 10.1152/ajpgi.1981.240.1.G63; Seicean Andrada, 2006, J Gastrointestin Liver Dis, V15, P21; Shalbueva N, 2013, GASTROENTEROLOGY, V144, P437, DOI 10.1053/j.gastro.2012.10.037; SVENSSON JO, 1975, SCAND J GASTROENTERO, V10, P487; Takacs T, 2001, PHARMACOL RES, V44, P363, DOI 10.1006/phrs.2001.0843; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; WILLIAMS JA, 1984, AM J PHYSIOL, V246, pG96, DOI 10.1152/ajpgi.1984.246.1.G96; WILLIAMS JA, 1985, DIABETES, V34, P980, DOI 10.2337/diabetes.34.10.980; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zechner D, 2012, DIABETOLOGIA, V55, P1526, DOI 10.1007/s00125-012-2479-3	61	32	34	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23582	23595		10.1074/jbc.M114.589440	http://dx.doi.org/10.1074/jbc.M114.589440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993827	Green Published, hybrid			2022-12-25	WOS:000341505000028
J	Salminen, A; Anashkin, VA; Lahti, M; Tuominen, HK; Lahti, R; Baykov, AA				Salminen, Anu; Anashkin, Viktor A.; Lahti, Matti; Tuominen, Heidi K.; Lahti, Reijo; Baykov, Alexander A.			Cystathionine beta-Synthase (CBS) Domains Confer Multiple Forms of Mg2+-dependent Cooperativity to Family II Pyrophosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; STREPTOCOCCUS-GORDONII; MOORELLA-THERMOACETICA; FLUORIDE INHIBITION; BACILLUS-SUBTILIS; PROTEIN-KINASE; DRTGG DOMAINS; BINDING; MECHANISM; KINETICS	Regulated family II pyrophosphatases (CBS-PPases) contain a nucleotide-binding insert comprising a pair of cystathionine beta-synthase (CBS) domains, termed a Bateman module. By binding with high affinity to the CBS domains, AMP and ADP usually inhibit the enzyme, whereas ATP activates it. Here, we demonstrate that AMP, ADP, and ATP bind in a positively cooperative manner to CBS-PPases from four bacteria: Desulfitobacterium hafniense, Clostridium novyi, Clostridium perfringens, and Eggerthella lenta. Enzyme interaction with substrate as characterized by the Michaelis constant (K-m) also exhibited positive catalytic cooperativity that decreased in magnitude upon nucleotide binding. The degree of both types of cooperativity increased with increasing concentration of the cofactor Mg2+ except for the C. novyi PPase where Mg2+ produced the opposite effect on kinetic cooperativity. Further exceptions from these general rules were ADP binding to C. novyi PPase and AMP binding to E. lenta PPase, neither of which had any effect on activity. A genetically engineered deletion variant of D. hafniense PPase lacking the regulatory insert was fully active but differed from the wild-type enzyme in that it was insensitive to nucleotides and bound substrate non-cooperatively and with a smaller K-m value. These results indicate that the regulatory insert acts as an internal inhibitor and confers dual positive cooperativity to CBS domain-containing PPases, making them highly sensitive regulators of the PPi level in response to the changes in cell energy status that control adenine nucleotide distribution. These regulatory features may be common among other CBS domain-containing proteins.	[Salminen, Anu; Lahti, Matti; Tuominen, Heidi K.; Lahti, Reijo] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Anashkin, Viktor A.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University	Lahti, R (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	reijo.lahti@utu.fi; baykov@genebee.msu.su	Baykov, Alexander/AAH-5301-2021; Tuominen, Heidi/A-7075-2010; Baykov, Alexander A/C-7981-2012; Anashkin, Viktor/C-1893-2014	Tuominen, Heidi/0000-0003-2412-7658; Baykov, Alexander/0000-0002-2495-8200	Russian Foundation for Basic Research [12-04-01002]; Academy of Finland [139031]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grant 139031 and Russian Foundation for Basic Research Grant 12-04-01002.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; BAYKOV AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P238, DOI 10.1016/0003-9861(92)90163-Q; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2013, MICROBIOL MOL BIOL R, V77, P267, DOI 10.1128/MMBR.00003-13; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bisswanger H., 2008, ENZYME KINETICS PRIN; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; FORSEN S, 1995, TRENDS BIOCHEM SCI, V20, P495, DOI 10.1016/S0968-0004(00)89115-X; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Heinonen JK, 2001, BIOL ROLE INORGANIC, P1, DOI DOI 10.1007/978-1-4615-1433-6_1; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jamsen J, 2012, BIOCHEMISTRY-MOSCOW+, V77, P165, DOI 10.1134/S0006297912020071; Jamsen J, 2011, BIOCHEM J, V433, P497, DOI 10.1042/BJ20101204; Jamsen J, 2010, BIOCHEMISTRY-US, V49, P1005, DOI 10.1021/bi9019737; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jeong BC, 2013, J STRUCT BIOL, V183, P40, DOI 10.1016/j.jsb.2013.04.013; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-21; Kuhn NJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P292, DOI 10.1006/abbi.2000.1860; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; MADSEN T, 1992, APPL ENVIRON MICROB, V58, P2874, DOI 10.1128/AEM.58.9.2874-2878.1992; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; Ok SH, 2012, PLANT SIGNAL BEHAV, V7, P664, DOI 10.4161/psb.19945; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; Ricard J, 1989, ALLOSTERIC ENZYMES, P1; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Smith R. M., 1995, NIST CRITICAL STABIL; SPRINGS B, 1981, BIOCHEMISTRY-US, V20, P6384, DOI 10.1021/bi00525a016; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zyryanov AB, 2004, BIOCHEMISTRY-US, V43, P1065, DOI 10.1021/bi0357513	45	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22865	22876		10.1074/jbc.M114.589473	http://dx.doi.org/10.1074/jbc.M114.589473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24986864	Green Published, hybrid			2022-12-25	WOS:000341017200028
J	Kim, H; Choi, JA; Kim, JH				Kim, Hyunju; Choi, Jung-A; Kim, Jae-Hong			Ras Promotes Transforming Growth Factor-beta (TGF-beta)-induced Epithelial-Mesenchymal Transition via a Leukotriene B-4 Receptor-2-linked Cascade in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TGF-BETA; CANCER CELLS; BREAST-CANCER; PANCREATIC-CANCER; TUMOR PROGRESSION; SIGNALING PATHWAY; MOLECULAR-WEIGHT; OVARIAN-CANCER; UP-REGULATION	Inflammation and inflammatory mediators are inextricably linked with epithelial-mesenchymal transition (EMT) through complex pathways in the tumor microenvironment. However, the mechanism by which inflammatory mediators, such as the lipid inflammatory mediators, eicosanoids, contribute to EMT is largely unknown. In the present study we observed that BLT2, leukotriene B-4 receptor-2, is markedly up-regulated by oncogenic Ras and promotes EMT in response to transforming growth factor-beta (TGF-beta) in mammary epithelial cells. Blockade of BLT2 by the BLT2 inhibitor LY255283 or by siRNA reduced EMT induced by Ras in the presence of TGF-beta. In addition, stimulation of BLT2 by the addition of a BLT2 ligand, such as leukotriene B-4, restored EMT in the presence of TGF-beta in human immortalized mammary epithelial MCF-10A cells. We further searched BLT2 downstream components and identified reactive oxygen species and nuclear factor kappa B as critical components that contribute to EMT. Taken together, these results demonstrate for the first time that a BLT2-linked inflammatory pathway contributes to EMT. This provides valuable insight into the mechanism of EMT in mammary epithelial cells. In addition, considering the implications of EMT with the stemness of cancer cells, our finding may contribute to a better understanding of tumor progression.	[Kim, Hyunju; Choi, Jung-A; Kim, Jae-Hong] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	National Research Foundation - Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea [2012M3A9C5048709, 2012R1A2A2A01044526]; National Research and Development Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1220020]	National Research Foundation - Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by Bio and Medical Technology Development Program Grant 2012M3A9C5048709, Basic Science Research Program Grant 2012R1A2A2A01044526 through the National Research Foundation funded by the Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea, and the National Research and Development Program for Cancer Control Grant 1220020, Ministry for Health and Welfare, Republic of Korea.	Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; CLAIR T, 1987, CANCER RES, V47, P5290; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kabashima-Niibe A, 2013, CANCER SCI, V104, P157, DOI 10.1111/cas.12059; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049186; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P1506, DOI 10.1016/j.bcp.2010.01.018; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pan Y, 2011, J PHARMACOL EXP THER, V339, P82, DOI 10.1124/jpet.111.182055; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Safina AF, 2009, CELL CYCLE, V8, P284, DOI 10.4161/cc.8.2.7590; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Seo JM, 2011, EXP MOL MED, V43, P129, DOI 10.3858/emm.2011.43.3.014; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151	43	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22151	22160		10.1074/jbc.M114.556126	http://dx.doi.org/10.1074/jbc.M114.556126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24990945	Green Published, hybrid			2022-12-25	WOS:000340593500030
J	Machida, RJ; Lin, YY				Machida, Ryuji J.; Lin, Ya-Ying			Four Methods of Preparing mRNA 5 ' End Libraries Using the Illumina Sequencing Platform	PLOS ONE			English	Article							GENE-EXPRESSION; BIAS; CAP; REGIONS	Background: The 5' untranslated regions of mRNA play an important role in their translation. Results: Here, we describe the development of four methods of profiling mRNA 5' ends using the Illumina sequencing platform; the first method utilizes SMART (Switching Mechanism At 5' end of RNA Transcript) technology, while the second involves replacing the 5' cap structure with RNA oligomers via ligation. The third and fourth methods are modifications of SMART, and involve enriching mRNA molecules with (nuclear transcripts) and without (mitochondrial transcripts) 5' end cap structures, respectively. Libraries prepared using SMART technology gave more reproducible results, but the ligation method was advantageous in that it only sequenced mRNAs with a cap structure at the 5' end. Conclusions: These methods are suitable for global mapping of mRNA 5' ends, both with and without cap structures, at a single molecule resolution. In addition, comparison of the present results obtained using different methods revealed the presence of abundant messenger RNAs without a cap structure.	[Machida, Ryuji J.; Lin, Ya-Ying] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	Academia Sinica - Taiwan	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gmail.com; yylinas@gmail.com			Academia Sinica; National Science Council Taiwan [102-2611-M-001-002-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Academia Sinica and National Science Council Taiwan (102-2611-M-001-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARLSON JR, 1985, DEV BIOL, V108, P355, DOI 10.1016/0012-1606(85)90039-9; Illumina Inc., 2013, ILL TECHN NOT SEQUEN; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; MARUYAMA K, 1994, GENE, V138, P171; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Salimullah M, 2011, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5559, DOI 10.1101/PDB.PR0T5559]; Schoenberg DR, 2009, TRENDS BIOCHEM SCI, V34, P435, DOI 10.1016/j.tibs.2009.05.003; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	25	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101812	10.1371/journal.pone.0101812	http://dx.doi.org/10.1371/journal.pone.0101812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003736	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700070
J	Modica, MV; Puillandre, N; Castelin, M; Zhang, Y; Holford, M				Modica, Maria Vittoria; Puillandre, Nicolas; Castelin, Magalie; Zhang, Yu; Holford, Mande			A Good Compromise: Rapid and Robust Species Proxies for Inventorying Biodiversity Hotspots Using the Terebridae (Gastropoda: Conoidea)	PLOS ONE			English	Article							INTEGRATIVE TAXONOMY; DELIMITATION METHOD; DNA; SPECIATION; DISCOVERY; EVOLUTION; MODEL; NEED	Devising a reproducible approach for species delimitation of hyperdiverse groups is an ongoing challenge in evolutionary biology. Speciation processes combine modes of passive and adaptive trait divergence requiring an integrative taxonomy approach to accurately generate robust species hypotheses. However, in light of the rapid decline of diversity on Earth, complete integrative approaches may not be practical in certain species-rich environments. As an alternative, we applied a two-step strategy combining ABGD (Automated Barcode Gap Discovery) and Klee diagrams, to balance speed and accuracy in producing primary species hypotheses (PSHs). Specifically, an ABGD/Klee approach was used for species delimitation in the Terebridae, a neurotoxin-producing marine snail family included in the Conoidea. Delimitation of species boundaries is problematic in the Conoidea, as traditional taxonomic approaches are hampered by the high levels of variation, convergence and morphological plasticity of shell characters. We used ABGD to analyze gaps in the distribution of pairwise distances of 454 COI sequences attributed to 87 morphospecies and obtained 98 to 125 Primary Species Hypotheses (PSHs). The PSH partitions were subsequently visualized as a Klee diagram color map, allowing easy detection of the incongruences that were further evaluated individually with two other species delimitation models, General Mixed Yule Coalescent (GMYC) and Poisson Tree Processes (PTP). GMYC and PTP results confirmed the presence of 17 putative cryptic terebrid species in our dataset. The consensus of GMYC, PTP, and ABGD/Klee findings suggest the combination of ABGD and Klee diagrams is an effective approach for rapidly proposing primary species proxies in hyperdiverse groups and a reliable first step for macroscopic biodiversity assessment.	[Modica, Maria Vittoria] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy; [Puillandre, Nicolas; Castelin, Magalie] Museum Natl Hist Nat, Dept Systemat & Evolut Systemat Adaptat & Evolut, UMR 7138, F-75231 Paris, France; [Castelin, Magalie] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Zhang, Yu] Ernst & Young, New York, NY USA; [Modica, Maria Vittoria; Castelin, Magalie; Holford, Mande] CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA; [Holford, Mande] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Fisheries & Oceans Canada; City University of New York (CUNY) System; Hunter College (CUNY); American Museum of Natural History (AMNH)	Holford, M (corresponding author), CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA.	mholford@hunter.cuny.edu	Modica, Maria Vittoria/P-8407-2018	Modica, Maria Vittoria/0000-0003-2532-6763; Holford, Mande/0000-0001-9476-2687	NSF [1247550]; Alfred P. Sloan Foundation [B2010-37]; Consortium National de Recherche en Genomique; Service de Systematique Moleculaire [2005/67]; Division Of Chemistry [1247550] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding for this work was provided by NSF (Grant 1247550) and The Alfred P. Sloan Foundation (Grant B2010-37) grants to M. H. This work was also supported by the "Consortium National de Recherche en Genomique'' and the "Service de Systematique Moleculaire'' (UMS 2700b CNRS-MNHN) as part of agreement 2005/67 between Genoscope and MNHN for the project "Macrophylogeny of life'' directed by G. Lecointre. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BOUCHET P, 1981, MALACOLOGIA, V21, P363; Bouchet P, 2011, J MOLLUS STUD, V77, P273, DOI 10.1093/mollus/eyr017; Camargo A, 2013, SPECIES PROBLEM ONGO; Cardoso A, 2009, MOL ECOL, V18, P648, DOI 10.1111/j.1365-294X.2008.04048.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Castelin M, 2012, MOL ECOL, V21, P4828, DOI 10.1111/j.1365-294X.2012.05743.x; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Castroviejo-Fisher S, 2009, ZOOTAXA, P16, DOI 10.11646/zootaxa.1980.1.2; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duda TF, 1999, P NATL ACAD SCI USA, V96, P10272, DOI 10.1073/pnas.96.18.10272; Duda TF, 2008, MOL PHYLOGENET EVOL, V49, P867, DOI 10.1016/j.ympev.2008.08.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erwin TL, 2001, ENCY BIODIVERSITY; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2021, SPLITS SPECIES LIMIT; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gibbs J, 2009, ZOOTAXA, P1; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Kantor YI, 2008, ZOOL SCI, V25, P1156, DOI 10.2108/zsj.25.1156; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nagy ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034506; Oliverio M, 1996, VIE MILIEU, V46, P163; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Puillandre N, 2010, SYST BIODIVERS, V8, P371, DOI 10.1080/14772001003748709; R Development Core Team, 2010, LANG ENV STAT COMP; Rambaut A, 2014, TRACER V1 6; Rex M.A., 2010, DEEP SEA BIODIVERSIT, P354; Richer de Forges B, 2005, CENSUS DEEPSEA SPECI, P113; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Stamatakis A, 2014, BIOINFORMATICS; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; TERRYN Y, 2007, COLLECTORS GUIDE REC; Valdecasas AG, 2008, BIOL J LINN SOC, V93, P211; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	55	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102160	10.1371/journal.pone.0102160	http://dx.doi.org/10.1371/journal.pone.0102160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003611	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700115
J	Yao, X; Jennings, S; Ireland, SK; Pham, T; Temple, B; Davis, M; Chen, RW; Davenport, I; Biliran, H				Yao, Xin; Jennings, Scott; Ireland, Shubha Kale; Tri Pham; Temple, Brandi; Davis, Mya; Chen, Renwei; Davenport, Ian; Biliran, Hector			The Anoikis Effector Bit1 Displays Tumor Suppressive Function in Lung Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; INTEGRINS; PROTEIN; CHEMORESISTANCE; DETACHMENT; CARCINOMA; REGULATOR; MATRIX; DEATH; TLE1	The mitochondrial Bit1 (Bcl-2 inhibitor of transcription 1) protein is a part of an apoptotic pathway that is uniquely regulated by integrin-mediated attachment. As an anoikis effector, Bit1 is released into the cytoplasm following loss of cell attachment and induces a caspase-independent form of apoptosis. Considering that anoikis resistance is a critical determinant of transformation, we hypothesized that cancer cells may circumvent the Bit1 apoptotic pathway to attain anchorage-independence and tumorigenic potential. Here, we provide the first evidence of the tumor suppressive effect of Bit1 through a mechanism involving anoikis induction in human lung adenocarcinoma derived A549 cells. Restitution of Bit1 in anoikis resistant A549 cells is sufficient to induce detachment induced-apoptosis despite defect in caspase activation and impairs their anchorage-independent growth. Conversely, stable downregulation of Bit1 in these cells significantly enhances their anoikis resistance and anchorage-independent growth. The Bit1 knockdown cells exhibit significantly enhanced tumorigenecity in vivo. It has been previously shown that the nuclear TLE1 corepressor is a putative oncogene in lung cancer, and we show here that TLE1 blocks Bit1 mediated anoikis in part by sequestering the pro-apoptotic partner of Bit1, the Amino-terminal Enhancer of Split (AES) protein, in the nucleus. Taken together, these findings suggest a tumor suppressive role of the caspase-independent anoikis effector Bit1 in lung cancer. Consistent with its role as a tumor suppressor, we have found that Bit1 is downregulated in human non-small cell lung cancer (NSCLC) tissues.	[Chen, Renwei] Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Ctr Nanomed, Santa Barbara, CA 93106 USA; [Chen, Renwei] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA; [Yao, Xin; Jennings, Scott; Ireland, Shubha Kale; Tri Pham; Temple, Brandi; Davis, Mya; Davenport, Ian; Biliran, Hector] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Xavier University of Louisiana	Biliran, H (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	hbiliran@xula.edu		Glover, Brandi/0000-0002-5760-8143	Louisiana Cancer Research Consortium (LCRC) Start up Grant; NIH [RCMI G12RR026250-03, 1R15CA158677-01A1]; NATIONAL CANCER INSTITUTE [R15CA158677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium (LCRC) Start up Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Louisiana Cancer Research Consortium (LCRC) Start up Grant (HB), NIH RCMI G12RR026250-03 Grant (to Xavier University of Losuiana), and NIH 1R15CA158677-01A1 Grant (HB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Bondar VM, 2002, PROSTATE, V51, P42, DOI 10.1002/pros.10070; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Karmali PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023840; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	24	14	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101564	10.1371/journal.pone.0101564	http://dx.doi.org/10.1371/journal.pone.0101564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003198	Green Published, gold			2022-12-25	WOS:000339242700039
J	Joseph, C; Tseng, CY; Zocchi, G; Tlusty, T				Joseph, Collin; Tseng, Chiao-Yu; Zocchi, Giovanni; Tlusty, Tsvi			Asymmetric Effect of Mechanical Stress on the Forward and Reverse Reaction Catalyzed by an Enzyme	PLOS ONE			English	Article							FORCE; CATCH; MODEL; DYNAMICS; FIELD	The concept of modulating enzymatic activity by exerting a mechanical stress on the enzyme has been established in previous work. Mechanical perturbation is also a tool for probing conformational motion accompanying the enzymatic cycle. Here we report measurements of the forward and reverse kinetics of the enzyme Guanylate Kinase from yeast (Saccharomyces cerevisiae). The enzyme is held in a state of stress using the DNA spring method. The observation that mechanical stress has different effects on the forward and reverse reaction kinetics suggests that forward and reverse reactions follow different paths, on average, in the enzyme's conformational space. Comparing the kinetics of the stressed and unstressed enzyme we also show that the maximum speed of the enzyme is comparable to the predictions of the relaxation model of enzyme action, where we use the independently determined dissipation coefficient gamma approximate to 10(-1) g/s for the enzyme's conformational motion. The present experiments provide a mean to explore enzyme kinetics beyond the static energy landscape picture of transition state theory.	[Joseph, Collin; Tseng, Chiao-Yu; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Tlusty, Tsvi] Inst Adv Study, Princeton, NJ 08540 USA	University of California System; University of California Los Angeles; Institute for Advanced Study - USA	Zocchi, G (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	United States-Israel Binational Science Foundation [201044]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the United States-Israel Binational Science Foundation under grant number 201044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal K C, 1978, Methods Enzymol, V51, P483; Ariyaratne A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011010; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Bartolo D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051910; Blumenfeld L.A., 2012, BIOPHYSICAL THERMODY; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Evans E, 2004, PNAS, V101; FREY CM, 1972, J AM CHEM SOC, V94, P8898, DOI 10.1021/ja00780a042; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; HOPFIELD JJ, 1973, J MOL BIOL, V77, P207, DOI 10.1016/0022-2836(73)90332-X; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lankas F, 2006, STRUCTURE, V14, P1527, DOI 10.1016/j.str.2006.08.004; Li Y, 1996, J BIOL CHEM, V271, P28038, DOI 10.1074/jbc.271.45.28038; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Michaelis L, 1913, BIOCHEM Z, V49, P333; Pereverzev YV, 2011, BIOPHYS J, V101, P2026, DOI 10.1016/j.bpj.2011.09.005; Pereverzev YV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051913; Pereverzev YV, 2005, BIOPHYS J, V89, P1446, DOI 10.1529/biophysj.105.062158; PERUTZ MF, 1972, NATURE, V237, P495, DOI 10.1038/237495a0; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Qu H, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011009; Qu H, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021008; Qu H, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18003; RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068; Simonson T, 2013, J COMPUT CHEM, V34, P836, DOI 10.1002/jcc.23207; Suzuki Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048101; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; Tseng CY, 2013, J AM CHEM SOC, V135, P11879, DOI 10.1021/ja4043565; Tseng CY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061912; von Castelmur E, 2012, P NATL ACAD SCI USA, V109, P13608, DOI 10.1073/pnas.1200697109; Wang Y, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/18003; Wang Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/335103; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	38	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101442	10.1371/journal.pone.0101442	http://dx.doi.org/10.1371/journal.pone.0101442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000118	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300043
J	Klocker, A; Oddo, CM; Camboni, D; Penta, M; Thonnard, JL				Klocker, Anne; Oddo, Calogero Maria; Camboni, Domenico; Penta, Massimo; Thonnard, Jean-Louis			Physical Factors Influencing Pleasant Touch during Passive Fingertip Stimulation	PLOS ONE			English	Article							PERCEIVED ROUGHNESS; PERCEPTION; DISCRIMINATION; AFFERENTS; FRICTION; RECOGNITION; PATTERNS; FINE	Objective: Tactile explorations with the fingertips provide information regarding the physical properties of surfaces and their relative pleasantness. Previously, we performed an investigation in the active touch domain and linked several surface properties (i.e. frictional force fluctuations and net friction) with their pleasantness levels. The aim of the present study was to investigate physical factors being important for pleasantness perception during passive fingertip stimulation. Specifically we were interested to see whether factors, such as surfaces' topographies or their frictional characteristics could influence pleasantness. Furthermore, we ascertained how the stimulus pleasantness level was impacted by (i) the normal force of stimulus application (F-N) and (ii) the stimulus temperature (T-S). Methods and Results: The right index fingertips of 22 blindfolded participants were stimulated using 27 different stimuli, which varied in average roughness (Ra) and T-S. A 4-axis robot moved the stimuli horizontally under participants' fingertips with three levels of F-N. The robot was equipped with force sensors, which recorded the F-N and friction force (F-T) during stimulation. Participants rated each stimulus according to a three-level pleasantness scale, as very pleasant (scored 0), pleasant (scored 1), or unpleasant (scored 2). These ordinal pleasantness ratings were logarithmically transformed into linear and unidimensional pleasantness measures with the Rasch model. Statistical analyses were conducted to investigate a possible link between the stimulus properties (i.e. Ra, F-N, F-T, and T-S) and their respective pleasantness levels. Only the mean Ra and FT values were negatively correlated with pleasantness. No significant correlation was detected between F-N or T-S and pleasantness. Conclusion: Pleasantness perception, resulting from passive fingertip stimulation, seems to be influenced by the surfaces' average roughness levels and average F-T occurring during fingertip stimulation.	[Klocker, Anne; Penta, Massimo; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Oddo, Calogero Maria; Camboni, Domenico] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy; [Thonnard, Jean-Louis] Catholic Univ Louvain, Clin Univ St Luc, Phys & Rehabil Med Dept, B-1200 Brussels, Belgium	Universite Catholique Louvain; Scuola Superiore Sant'Anna; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Thonnard, JL (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	jean-louis.thonnard@uclouvain.be	Oddo, Calogero Maria/K-5358-2019	Oddo, Calogero Maria/0000-0002-1489-5701; CAMBONI, Domenico/0000-0002-6853-475X	Commission of the European Union [EU-FP7-NMP4-SL-2009-228844]; NanoBioTouch; HandBot Italian project [PRIN MIUR 20102YF2RY_004]	Commission of the European Union(European Commission); NanoBioTouch; HandBot Italian project	This work was supported by a grant from the Commission of the European Union under Contract No. EU-FP7-NMP4-SL-2009-228844, NanoBioTouch. This work was supported in part by the HandBot Italian project (PRIN MIUR 20102YF2RY_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00034; Adams MJ, 2007, TRIBOL LETT, V26, P239, DOI 10.1007/s11249-007-9206-0; Adams MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0467; Andre T, 2009, J NEUROSCI METH, V179, P224, DOI 10.1016/j.jneumeth.2009.01.031; Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Chen XJ, 2009, INT J DES, V3, P67; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Gerhardt LC, 2008, J R SOC INTERFACE, V5, P1317, DOI 10.1098/rsif.2008.0034; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Guest S, 2009, ACTA PSYCHOL, V130, P115, DOI 10.1016/j.actpsy.2008.10.007; HELLER MA, 1984, J GEN PSYCHOL, V110, P243, DOI 10.1080/00221309.1984.9709968; Ho HN, 2006, PERCEPT PSYCHOPHYS, V68, P118, DOI 10.3758/BF03193662; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2000, PERCEPTION, V29, P1455, DOI 10.1068/p3044; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V72, P204, DOI 10.1007/BF00248518; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kitada R, 2012, PERCEPTION, V41, P204, DOI 10.1068/p7168; Klocker A, 2012, FRONT NEUROROBOTICS, V6, P1; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; LANDRIGAN DT, 1974, J EXP PSYCHOL, V103, P1124, DOI 10.1037/h0037356; LEDERMAN SJ, 1983, CAN J PSYCHOL, V37, P498, DOI 10.1037/h0080750; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; Major DR, 1895, THOUGHTS DECLINE MAJ, V7, P57, DOI [10.2307/1412037, DOI 10.2307/1412037]; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Oddo CM, 2011, IEEE T ROBOT, V27, P522, DOI 10.1109/TRO.2011.2116930; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Rasch G, 1990, PROBABILISTIC MODELS; RICHARDSON BL, 1981, BRIT J PSYCHOL, V72, P353, DOI 10.1111/j.2044-8295.1981.tb02194.x; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Schmelz M, 2011, EUR J DERMATOL, V21, P43, DOI 10.1684/ejd.2011.1265; Smith AM, 2009, J NEUROPHYSIOL, V102, P3519, DOI 10.1152/jn.00043.2009; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; SRINIVASAN MA, 1990, J NEUROPHYSIOL, V63, P1323, DOI 10.1152/jn.1990.63.6.1323; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Van Kuilenburg J, 2013, P I MECH ENG J-J ENG, V0, P1; VEGABERMUDEZ F, 1991, J NEUROPHYSIOL, V65, P531, DOI 10.1152/jn.1991.65.3.531; Verrillo RT, 1999, SOMATOSENS MOT RES, V16, P352; Wheat HE, 2010, J NEUROPHYSIOL, V103, P950, DOI 10.1152/jn.00502.2009; Wright BD, 1979, BEST TEST DESIGN RAS; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	46	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101361	10.1371/journal.pone.0101361	http://dx.doi.org/10.1371/journal.pone.0101361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000561	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300038
J	Chen, X; Deng, AQ; Zhou, TQ; Ding, F				Chen, Xia; Deng, Aiqing; Zhou, Tianqiu; Ding, Fei			Pretreatment with 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-beta-D-pyranoside Attenuates Cerebral Ischemia/Reperfusion-Induced Injury In Vitro and In Vivo	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; CULTURED HIPPOCAMPAL-NEURONS; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE SYNTHASE; BCL-2 FAMILY PROTEINS; GLUCOSE DEPRIVATION; REPERFUSION INJURY; CORTICAL-NEURONS; CELL-DEATH; COGNITIVE IMPAIRMENT	Salidroside, extracted from the root of Rhodiola rosea L, is known for its pharmacological properties, in particular its neuroprotective effects. 2-(4-Methoxyphenyl) ethyl-2-acetamido-2-deoxy-beta-D- pyranoside (GlcNAc-Sal), an analog of salidroside, was recently synthesized and shown to possess neuroprotective properties. The purpose of the current study was to investigate the neuroprotective effects of GlcNAc-Sal against oxygen-glucose deprivation-reperfusion (OGD-R)-induced neurotoxicity in vitro and global cerebral ischemia-reperfusion (GCI-R) injury in vivo. Cell viability tests and Hoechst 33342 staining confirmed that GlcNAc-Sal pretreatment markedly attenuated OGD-R induced apoptotic cell death in immortalized mouse hippocampal HT22 cells. Western blot, immunofluorescence and PCR analyses revealed that GlcNAc-Sal pretreatment restored the balance of pro-and anti-apoptotic proteins and inhibited the activation of caspase-3 and PARP induced by OGD-R treatment. Further analyses showed that GlcNAc-Sal pretreatment antagonized reactive oxygen species (ROS) generation, iNOS-derived NO production and NO-related apoptotic cell death during OGD-R stimulation. GCI-R was induced by bilateral common carotid artery occlusion (BCCAO) and reperfusion in mice in vivo. Western blot analysis showed that GlcNAc-Sal pretreatment decreased the expression of caspase-3 and increased the expression of Bcl-2 (B-cell lymphoma 2)/Bax (Bcl-2-associated X protein) induced by GCI-R treatment. Our findings suggest that GlcNAc-Sal pretreatment prevents brain ischemia reperfusion injury by the direct or indirect suppression of cell apoptosis and GlcNAc-Sal could be developed as a broad-spectrum agent for the prevention and/or treatment of cerebral ischemic injury.	[Chen, Xia] Nantong Univ, Basic Med Res Ctr, Sch Med, Nantong, Peoples R China; [Deng, Aiqing] Nantong Univ, Affiliated Hosp, Dept Pharm, Nantong, Peoples R China; [Zhou, Tianqiu] Nantong Univ, Affiliated Hosp, Dept Ophthalmol, Nantong, Peoples R China; [Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Ding, F (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	dingfei@ntu.edu.cn			Natural Science Foundation of the Jiangsu Higher Education Institutions of China [12KJD310002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Project supported by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 12KJD310002) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; ArunaDevi R, 2010, NITRIC OXIDE-BIOL CH, V22, P1, DOI 10.1016/j.niox.2009.10.002; Bar-Am O, 2005, FASEB J, V19, P1899, DOI 10.1096/fj.05-3794fje; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Cardenas A, 2000, J NEUROCHEM, V74, P2041, DOI 10.1046/j.1471-4159.2000.0742041.x; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen QG, 2009, PHYTOMEDICINE, V16, P830, DOI 10.1016/j.phymed.2009.03.011; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen X, 2008, BRAIN RES, V1238, P189, DOI 10.1016/j.brainres.2008.07.051; Chen X, 2013, MOL CELL BIOCHEM, V383, P149, DOI 10.1007/s11010-013-1763-y; Chen X, 2009, MOL CELL BIOCHEM, V332, P85, DOI 10.1007/s11010-009-0177-3; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; DELATORRE JC, 1992, BRAIN RES, V582, P186, DOI 10.1016/0006-8993(92)90132-S; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gazzolo Diego, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P108; Griffiths C, 2002, EUR J NEUROSCI, V15, P962, DOI 10.1046/j.1460-9568.2002.01930.x; Gu JH, 2013, PLOS ONE, V8; Guo YB, 2010, CHEM PHARM BULL, V58, P1627, DOI 10.1248/cpb.58.1627; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Heeba GH, 2012, LIFE SCI, V90, P388, DOI 10.1016/j.lfs.2011.12.001; Herrera F, 2007, J NEUROCHEM, V100, P736, DOI 10.1111/j.1471-4159.2006.04228.x; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; Kim DH, 2009, FOOD CHEM TOXICOL, V47, P1473, DOI 10.1016/j.fct.2009.03.028; Koh PO, 2012, J PINEAL RES, V53, P358, DOI 10.1111/j.1600-079X.2012.01005.x; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Kumar P, 2009, PSYCHOPHARMACOLOGY, V207, P257, DOI 10.1007/s00213-009-1652-y; Liu RL, 2012, BRAIN RES, V1469, P164, DOI 10.1016/j.brainres.2012.06.044; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lu J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-105; Mahesh R, 2011, TOXICOL IN VITRO, V25, P177, DOI 10.1016/j.tiv.2010.10.016; Mao GX, 2010, MECH AGEING DEV, V131, P723, DOI 10.1016/j.mad.2010.10.003; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Meng Y, 2011, BIOORGAN MED CHEM, V19, P5577, DOI 10.1016/j.bmc.2011.07.031; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Ohshima M, 2012, EXP NEUROL, V233, P481, DOI 10.1016/j.expneurol.2011.11.025; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; Qu ZQ, 2009, BIOMED ENVIRON SCI, V22, P318, DOI 10.1016/S0895-3988(09)60062-3; Sarti C, 2002, J NEUROL SCI, V203, P263, DOI 10.1016/S0022-510X(02)00302-7; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; van Diermen D, 2009, J ETHNOPHARMACOL, V122, P397, DOI 10.1016/j.jep.2009.01.007; Vasiljevic B, 2012, SRP ARK CELOK LEK, V140, P35, DOI 10.2298/SARH1202035V; Wang J, 2010, ACTA PHARMACOL SIN, V31, P791, DOI 10.1038/aps.2010.71; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang WP, 2006, BRAIN RES, V1084, P210, DOI 10.1016/j.brainres.2006.02.024; Weyhenmeyer B., 2012, Experimental Oncology, V34, P192; Winters L, 2013, NEUROSCIENCE, V238, P87, DOI 10.1016/j.neuroscience.2013.02.001; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yan B, 2007, BEHAV BRAIN RES, V182, P36, DOI 10.1016/j.bbr.2007.05.002; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Yoon SW, 2010, CELL PROLIFERAT, V43, P584, DOI 10.1111/j.1365-2184.2010.00708.x; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zhang JY, 2012, J TRAUMA ACUTE CARE, V72, P982, DOI 10.1097/TA.0b013e3182405459; Zhang P, 2012, NEUROSCIENCE, V201, P297, DOI 10.1016/j.neuroscience.2011.11.005; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhang Wen-sheng, 2004, Zhongguo Zhong Yao Za Zhi, V29, P459; Zhao Q, 2012, NEUROCHEM INT, V60, P134, DOI 10.1016/j.neuint.2011.11.013; Zhao YL, 2008, MOL CELL BIOCHEM, V311, P19, DOI 10.1007/s11010-007-9688-y	63	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e100126	10.1371/journal.pone.0100126	http://dx.doi.org/10.1371/journal.pone.0100126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24991917	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400018
J	Veit, LE; Maranda, L; Fong, J; Nwosu, BU				Veit, Lauren Elizabeth; Maranda, Louise; Fong, Jay; Nwosu, Benjamin Udoka			The Vitamin D Status in Inflammatory Bowel Disease	PLOS ONE			English	Article							PEDIATRIC CROHNS-DISEASE; BONE-MINERAL DENSITY; D DEFICIENCY; YOUNG-ADULTS; RISK-FACTORS; CHILDREN; ADOLESCENTS; PREVALENCE; OBESITY; COLITIS	Context: There is no consensus on the vitamin D status of children and adolescents with inflammatory bowel disease (IBD). Aim: To determine the vitamin D status of patients with IBD by comparing their serum 25(OH)D concentration to that of healthy controls. Hypothesis: Serum 25(OH)D concentration will be lower in patients with IBD compared to controls. Subjects and Methods: A case-controlled retrospective study of subjects with IBD (n = 58) of 2-20 years (male n = 31, age 16.38 +/- 2.21 years; female n = 27, age 16.56 +/- 2.08 years) and healthy controls (n = 116; male n = 49, age 13.90 +/- 4.59 years; female n = 67, age 15.04 +/- 4.12years). Study subject inclusion criteria: diagnosis of Crohn's disease (CD) or ulcerative colitis (UC). Vitamin D deficiency was defined as 25(OH)D of (< 20 ng/mL) (< 50 nmol/L), overweight as BMI of >= 85th but < 95th percentile, and obesity as BMI >= 95th percentile. Data were expressed as mean +/- SD. Results: Patients with CD, UC, and their controls had mean serum 25(OH)D concentrations of 61.69 +/- 24.43 nmol/L, 53.26 +/- 25.51, and 65.32 +/- 27.97 respectively (ANOVA, p = 0.196). The overweight/obese controls had significantly lower 25(OH)D concentration compared to the normal-weight controls (p = 0.031); whereas 25(OH)D concentration was similar between the normal-weight and overweight/obese IBD patients (p = 0.883). There was no difference in 25(OH)D between patients with UC and CD, or between subjects with active IBD and controls. However, IBD subjects with elevated ESR had significantly lower 25(OH)D than IBD subjects with normal ESR (p = 0.025), as well as controls (65.3 +/- 28.0 nmol/L vs. 49.5 +/- 25.23, p = 0.045). Conclusion: There is no difference in mean serum 25(OH)D concentration between children and adolescents with IBD and controls. However, IBD subjects with elevated ESR have significantly lower 25(OH)D than controls. Therefore, IBD subjects with elevated ESR should be monitored for vitamin D deficiency.	[Veit, Lauren Elizabeth; Fong, Jay; Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Dept Quantitat Hlth Sci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org		Collen, Lauren/0000-0002-7769-8123	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA	This work was funded in part by the Faculty Diversity Scholars Program, and the Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Day AS, 2012, WORLD J GASTROENTERO, V18, P5862, DOI 10.3748/wjg.v18.i41.5862; El-Matary W, 2011, DIGEST DIS SCI, V56, P825, DOI 10.1007/s10620-010-1380-5; Gokhale R, 1998, GASTROENTEROLOGY, V114, P902, DOI 10.1016/S0016-5085(98)70309-9; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; ISSENMAN RM, 1993, J PEDIATR GASTR NUTR, V17, P401, DOI 10.1097/00005176-199311000-00012; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Levin AD, 2011, DIGEST DIS SCI, V56, P830, DOI 10.1007/s10620-010-1544-3; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Long MD, 2011, INFLAMM BOWEL DIS, V17, P2162, DOI 10.1002/ibd.21585; Pappa HM, 2006, INFLAMM BOWEL DIS, V12, P1162, DOI 10.1097/01.mib.0000236929.74040.b0; Pappa HM, 2006, PEDIATRICS, V118, P1950, DOI 10.1542/peds.2006-0841; Pappa HM, 2012, J CLIN ENDOCR METAB, V97, P2134, DOI 10.1210/jc.2011-3182; Pappa HM, 2011, J PEDIATR GASTR NUTR, V53, P361, DOI 10.1097/MPG.0b013e3182250b3e; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; SEMERARO LA, 1986, J CLIN GASTROENTEROL, V8, P177, DOI 10.1097/00004836-198604000-00015; Sentongo TA, 2002, AM J CLIN NUTR, V76, P1077, DOI 10.1093/ajcn/76.5.1077; Setty-Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078653; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Suibhne TN, 2012, J CROHNS COLITIS, V6, P182, DOI 10.1016/j.crohns.2011.08.002; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Zwintscher NP, 2014, J PEDIATR SURG, V49, P265, DOI 10.1016/j.jpedsurg.2013.11.033	30	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101583	10.1371/journal.pone.0101583	http://dx.doi.org/10.1371/journal.pone.0101583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992465	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400094
J	Wang, X; Singh, P; Gao, Z; Zhang, XB; Johnson, ZI; Wang, GY				Wang, Xin; Singh, Purnima; Gao, Zheng; Zhang, Xiaobo; Johnson, Zackary I.; Wang, Guangyi			Distribution and Diversity of Planktonic Fungi in the West Pacific Warm Pool	PLOS ONE			English	Article							UPWELLING ECOSYSTEM; ORGANIC-MATTER; MARINE; COMMUNITIES; BACTERIAL; ECOLOGY; YEASTS; LIGHT	Fungi contribute substantially to biogeochemical cycles of terrestrial and marine habitats by decomposing matter and recycling nutrients. Yet, the diversity of their planktonic forms in the open ocean is poorly described. In this study, culture-independent and molecular approaches were applied to investigate fungal diversity and abundance derived from samples collected from a broad swath of the Pacific Warm Pool across major environmental gradients Our results revealed that planktonic fungi were molecularly diverse and their diversity patterns were related to major phytoplankton taxa and various nutrients including nitrate, nitrite, orthophosphate and silicic acid. Over 400 fungal phylotypes were recovered across this region and nearly half of them grouped into two major fungal lineages of Ascomycota and Basidiomycota, whose abundance varied among stations. These results suggest that planktonic fungi are a diverse and integral component of the marine microbial community and should be included in future marine microbial ecosystem models.	[Wang, Xin; Wang, Guangyi] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Singh, Purnima; Wang, Guangyi] Tianjin Univ, Ctr Marine Environm Ecol, Collaborat Innovat Ctr Deep Sea Biol, Sch Environm & Engn, Tianjin 300072, Peoples R China; [Gao, Zheng] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Johnson, Zackary I.] Duke Univ, Nicholas Sch Environm, Marine Lab, Durham, NC USA; [Wang, Guangyi] Calif Baptist Univ, Coll Engn, Riverside, CA USA	University of Hawaii System; University of Hawaii Manoa; Tianjin University; Shandong Agricultural University; Zhejiang University; Duke University; California Baptist University	Wang, GY (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	gywang@tju.edu.cn	Johnson, Zackary I/E-4601-2011; Wang, Xin/B-6258-2015	Johnson, Zackary I/0000-0003-0793-8512; Zhang, Xiaobo/0000-0003-4606-212X	National Oceanic and Atmospheric Administration (NOAA) [NA04OAR4600196, NA09AOR4170060]; US Department of Energy award [DE-FG36-08GO18180]; NSF [OCE05-26462, OCE05-50798]; National Science Foundation of China [31170109]; Shenzhen Development and Reform Commission [835]; Division Of Ocean Sciences [1031064] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); US Department of Energy award(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Development and Reform Commission; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially funded by National Oceanic and Atmospheric Administration (NOAA) grants NA04OAR4600196 (GWY) and NA09AOR4170060 (GWY, by the US Department of Energy award (DE-FG36-08GO18180) (GWY), by NSF Grant OCE05-26462 (ZJ) and OCE05-50798 (ZJ), and funded by National Science Foundation of China grant 31170109 (GYW) and Shenzhen Development and Reform Commission grant 835 (GYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buesing N, 2006, APPL ENVIRON MICROB, V72, P596, DOI 10.1128/AEM.72.1.596-605.2006; Carlile M, 2001, FUNGI; Chen YS, 2009, AQUAT BIOL, V8, P55, DOI 10.3354/ab00207; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Damare S, 2008, MICROB ECOL, V56, P168, DOI 10.1007/s00248-007-9334-y; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao Z, 2008, APPL ENVIRON MICROB, V74, P6091, DOI 10.1128/AEM.01315-08; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Gessner MO, 2007, DRUZHININA IS; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MH, 2011, MAR BIOL, V158, P205, DOI 10.1007/s00227-010-1552-z; Gutierrez MH, 2010, GAYANA, V74, P66; Hynes AM, 2009, LIMNOL OCEANOGR, V54, P1438, DOI 10.4319/lo.2009.54.5.1438; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Kutty SN, 2008, YEAST, V25, P465, DOI 10.1002/yea.1599; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Methvin BR, 2003, J N AM BENTHOL SOC, V22, P554, DOI 10.2307/1468352; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Newell RC, 1982, OCEANOL ACTA, P347; Nikolcheva Liliya G., 2004, Mycological Progress, V3, P41, DOI 10.1007/s11557-006-0075-y; OLSON RJ, 1989, CYTOMETRY, V10, P636, DOI 10.1002/cyto.990100520; Pang KL, 2005, BOT MAR, V48, P332, DOI 10.1515/BOT.2005.046; Raghukumar S, 2004, MARINE MICROBIOLOGY, P91; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; STEELE CW, 1967, PAC SCI, V21, P317; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Vogel C, 2007, WATER RES, V41, P1915, DOI 10.1016/j.watres.2007.02.010; Wang Guangyi, 2012, Prog Mol Subcell Biol, V53, P71, DOI 10.1007/978-3-642-23342-5_4; Wang GY, 2009, MARINE PHYTOPLANKTON, P211; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	40	30	34	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101523	10.1371/journal.pone.0101523	http://dx.doi.org/10.1371/journal.pone.0101523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992154	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400083
J	Luczak, M; Marczak, L; Stobiecki, M				Luczak, Magdalena; Marczak, Lukasz; Stobiecki, Maciej			Optimization of Plasma Sample Pretreatment for Quantitative Analysis Using iTRAQ Labeling and LC-MALDI-TOF/TOF	PLOS ONE			English	Article							LOW-ABUNDANCE PROTEINS; MASS-SPECTROMETRY; SERUM PROTEOME; RATIO COMPRESSION; HIGH-RESOLUTION; CANCER PATIENTS; MOUSE MODEL; DISCOVERY; SEPARATION; PEPTIDES	Shotgun proteomic methods involving iTRAQ (isobaric tags for relative and absolute quantitation) peptide labeling facilitate quantitative analyses of proteomes and searches for useful biomarkers. However, the plasma proteome's complexity and the highly dynamic plasma protein concentration range limit the ability of conventional approaches to analyze and identify a large number of proteins, including useful biomarkers. The goal of this paper is to elucidate the best approach for plasma sample pretreatment for MS-and iTRAQ-based analyses. Here, we systematically compared four approaches, which include centrifugal ultrafiltration, SCX chromatography with fractionation, affinity depletion, and plasma without fractionation, to reduce plasma sample complexity. We generated an optimized protocol for quantitative protein analysis using iTRAQ reagents and an UltrafleXtreme (Bruker Daltonics) MALDI TOF/TOF mass spectrometer. Moreover, we used a simple, rapid, efficient, but inexpensive sample pretreatment technique that generated an optimal opportunity for biomarker discovery. We discuss the results from the four sample pretreatment approaches and conclude that SCX chromatography without affinity depletion is the best plasma sample preparation pretreatment method for proteome analysis. Using this technique, we identified 1,780 unique proteins, including 1,427 that were quantified by iTRAQ with high reproducibility and accuracy.	[Luczak, Magdalena; Marczak, Lukasz; Stobiecki, Maciej] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Luczak, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	magdalu@ibch.poznan.pl	Luczak, Magdalena/E-2936-2012; Marczak, Lukasz/C-9069-2011	Luczak, Magdalena/0000-0002-2182-5699; Marczak, Lukasz/0000-0001-8602-0077	National Science Center, Poland [2012/05/B/NZ2/02189]	National Science Center, Poland(National Science Centre, Poland)	This study has been supported by National Science Center, Poland (2012/05/B/NZ2/02189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bergen HR, 2003, DIS MARKERS, V19, P239; Bortner JD, 2011, J PROTEOME RES, V10, P1151, DOI 10.1021/pr100925p; Brand J, 2006, PROTEOMICS, V6, P3236, DOI 10.1002/pmic.200500864; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Esteban-Fernandez D, 2012, J MASS SPECTROM, V47, P760, DOI 10.1002/jms.3013; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Fuller HR, 2012, INTECH; Gao MX, 2008, PROTEOMICS, V8, P939, DOI 10.1002/pmic.200600099; Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Greening DW, 2010, J PROTEOMICS, V73, P637, DOI 10.1016/j.jprot.2009.09.013; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Gupta MK, 2009, PROTEOMICS, V9, P4834, DOI 10.1002/pmic.200900310; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; Hood BL, 2005, J AM SOC MASS SPECTR, V16, P1221, DOI 10.1016/j.jasms.2005.02.005; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jing LH, 2011, PROTEOMICS, V11, P2763, DOI 10.1002/pmic.201000202; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Kuzyk MA, 2009, PROTEOMICS, V9, P3328, DOI 10.1002/pmic.200800412; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lill J, 2003, MASS SPECTROM REV, V22, P182, DOI 10.1002/mas.10048; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Lowenthal MS, 2005, CLIN CHEM, V51, P1933, DOI 10.1373/clinchem.2005.052944; Luczak M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-25; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Orvisky E, 2006, PROTEOMICS, V6, P2895, DOI 10.1002/pmic.200500443; Ow SY, 2011, PROTEOMICS, V11, P2341, DOI 10.1002/pmic.201000752; Pernemalm M, 2009, PROTEOMICS, V9, P1420, DOI 10.1002/pmic.200800377; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Savitski MM, 2013, J PROTEOME RES, V12, P3586, DOI 10.1021/pr400098r; Shen YF, 2004, ANAL CHEM, V76, P1134, DOI 10.1021/ac034869m; Shirran SL, 2010, J PROTEOMICS, V73, P1391, DOI 10.1016/j.jprot.2010.03.003; Shuford CM, 2010, ANAL CHEM, V82, P10179, DOI 10.1021/ac102248d; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x	55	12	13	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101694	10.1371/journal.pone.0101694	http://dx.doi.org/10.1371/journal.pone.0101694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988083	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100126
J	Liu, H; Yazdani, A; Murray, LM; Beauvais, A; Kothary, R				Liu, Hong; Yazdani, Armin; Murray, Lyndsay M.; Beauvais, Ariane; Kothary, Rashmi			The Smn-Independent Beneficial Effects of Trichostatin A on an Intermediate Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MOTOR-NEURON GENE; SINGLE NUCLEOTIDE; PROTEIN-LEVEL; VALPROIC ACID; SURVIVAL; INCREASES; MICE; INACTIVATION; SEVERITY	Spinal muscular atrophy is an autosomal recessive neuromuscular disease characterized by the progressive loss of alpha motor neurons in the spinal cord. Trichostatin A (TSA) is a histone deacetylase inhibitor with beneficial effects in spinal muscular atrophy mouse models that carry the human SMN2 transgene. It is currently unclear whether TSA specifically targets the SMN2 gene or whether other genes respond to TSA and in turn provide neuroprotection in SMA mice. We have taken advantage of the Smn(2B/-) mouse model that does not harbor the human SMN2 transgene, to test the hypothesis that TSA has its beneficial effects through a non-SMN mediated pathway. TSA increased the median lifespan of Smn(2B/-) mice from twenty days to eight weeks. As well, there was a significant attenuation of weight loss and improved motor behavior. Pen test and righting reflex both showed significant improvement, and motor neurons in the spinal cord of Smn(2B/-) mice were protected from degeneration. Both the size and maturity of neuromuscular junctions were significantly improved in TSA treated Smn(2B/-) mice. Of interest, TSA treatment did not increase the levels of Smn protein in mouse embryonic fibroblasts or myoblasts obtained from the Smn(2B/-) mice. In addition, no change in the level of Smn transcripts or protein in the brain or spinal cord of TSA-treated SMA model mice was observed. Furthermore, TSA did not increase Smn protein levels in the hind limb muscle, heart, or liver of Smn(2B/-) mice. We therefore conclude that TSA likely exerts its effects independent of the endogenous mouse Smn gene. As such, identification of the pathways regulated by TSA in the Smn(2B/-) mice could lead to the development of novel therapeutics for treating SMA.	[Liu, Hong; Yazdani, Armin; Murray, Lyndsay M.; Beauvais, Ariane; Kothary, Rashmi] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Yazdani, Armin; Murray, Lyndsay M.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Kothary, R (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310	Canadian Institutes of Health Research [MOP-298871]; Families of Spinal Muscular Atrophy [KT1415]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Families of Spinal Muscular Atrophy	Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) grant number MOP-298871 and Families of Spinal Muscular Atrophy (http://www.fsma.org) grant number KT1415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Bowerman M, 2012, NEUROMUSCULAR DISORD, V22, P263, DOI 10.1016/j.nmd.2011.09.007; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Boyer JG, 2014, HUM MOL GENET, P1; Boyer JG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-24; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Germain-Desprez D, 2001, GENE, V279, P109, DOI 10.1016/S0378-1119(01)00758-2; Hahnen E, 2006, J NEUROCHEM, V98, P193, DOI 10.1111/j.1471-4159.2006.03868.x; Hammond SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015887; Hayashi M, 2002, BRAIN DEV-JPN, V24, P770, DOI 10.1016/S0387-7604(02)00103-1; HUANG KW, 1983, J NEUROL SCI, V61, P249, DOI 10.1016/0022-510X(83)90009-6; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Liu H, 2010, J NEUROSCI RES, V88, P111, DOI 10.1002/jnr.22189; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Miyabara EH, 2012, PFLUG ARCH EUR J PHY, V463, P733, DOI 10.1007/s00424-012-1087-x; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Murray L, 2014, JOVE-J VIS EXP, DOI 10.3791/51162; Murray LM, 2013, NEUROBIOL DIS, V49, P57, DOI 10.1016/j.nbd.2012.08.019; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Piepers S, 2011, J NEUROL NEUROSUR PS, V82, P850, DOI 10.1136/jnnp.2009.200253; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Soler-Botija C, 2003, J NEUROPATH EXP NEUR, V62, P420, DOI 10.1093/jnen/62.4.420; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024	35	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101225	10.1371/journal.pone.0101225	http://dx.doi.org/10.1371/journal.pone.0101225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984019	Green Submitted, gold, Green Published			2022-12-25	WOS:000339635000071
J	Rivera, D; Mejias, V; Jauregui, BM; Costa-Tenorio, M; Lopez-Archilla, AI; Peco, B				Rivera, Desiree; Mejias, Violeta; Jauregui, Berta M.; Costa-Tenorio, Marga; Isabel Lopez-Archilla, Ana; Peco, Begona			Spreading Topsoil Encourages Ecological Restoration on Embankments: Soil Fertility, Microbial Activity and Vegetation Cover	PLOS ONE			English	Article							SEMIARID MEDITERRANEAN ENVIRONMENTS; SEED BANK; AGRICULTURAL MANAGEMENT; MOTORWAY SLOPES; WATER EROSION; PLANT; RESPIRATION; CARBON; COMMUNITY; REVEGETATION	The construction of linear transport infrastructure has severe effects on ecosystem functions and properties, and the restoration of the associated roadslopes contributes to reduce its impact. This restoration is usually approached from the perspective of plant cover regeneration, ignoring plant-soil interactions and the consequences for plant growth. The addition of a 30 cm layer of topsoil is a common practice in roadslope restoration projects to increase vegetation recovery. However topsoil is a scarce resource. This study assesses the effects of topsoil spreading and its depth (10 to 30 cm) on two surrogates of microbial activity (beta-glucosidase and phosphatase enzymes activity and soil respiration), and on plant cover, plant species richness and floristic composition of embankment vegetation. The study also evaluates the differences in selected physic-chemical properties related to soil fertility between topsoil and the original embankment substrate. Topsoil was found to have higher values of organic matter (11%), nitrogen (44%), assimilable phosphorous (50%) and silt content (54%) than the original embankment substrate. The topsoil spreading treatment increased microbial activity, and its application increased beta-glucosidase activity (45%), phosphatase activity (57%) and soil respiration (60%). Depth seemed to affect soil respiration, beta-glucosidase and phosphatase activity. Topsoil application also enhanced the species richness of restored embankments in relation to controls. Nevertheless, the depth of the spread topsoil did not significantly affect the resulting plant cover, species richness or floristic composition, suggesting that both depths could have similar effects on short-term recovery of the vegetation cover. A significant implication of these results is that it permits the application of thinner topsoil layers, with major savings in this scarce resource during the subsequent slope restoration work, but the quality of topsoil relative to the original substrate should be previously assessed on a site by site basis.	[Rivera, Desiree; Mejias, Violeta; Isabel Lopez-Archilla, Ana; Peco, Begona] Univ Autonoma Madrid, Dept Ecol, Madrid, Spain; [Jauregui, Berta M.] OHL Construcc, Direcc Tecn, Madrid, Spain; [Costa-Tenorio, Marga] Univ Complutense, Dept Biol Vegetal 1, E-28040 Madrid, Spain	Autonomous University of Madrid; Complutense University of Madrid	Peco, B (corresponding author), Univ Autonoma Madrid, Dept Ecol, Madrid, Spain.	begonna.peco@uam.es	Peco, Begoña/C-1197-2012	Peco, Begoña/0000-0003-2149-1438; Lopez Archilla, Ana Isabel/0000-0002-3673-6189	Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups; REMEDINAL 2 from the Spanish Ministry of Science and Innovation; Ministry of Science and Innovation; Science and Innovation Ministry	Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI); Madrid Regional Government grants for research groups; REMEDINAL 2 from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Innovation Ministry	Grants were received from the Ministry of Science and Innovation's Centre for Industrial and Technology Development (CDTI). The project is jointly funded by Madrid Regional Government grants for research groups, REMEDINAL 2 from the Spanish Ministry of Science and Innovation, and assistance from the Torres Quevedo Sub-program for the employment of Dr. BMJ by OHL, under the auspices of the Ministry of Science and Innovation. Thanks also go to the Science and Innovation Ministry for the Salvador de Madariaga Mobility grant awarded to BP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1992, METHOD MICROBIOL, V24, P1, DOI 10.1016/S0580-9517(08)70084-9; Alvear M., 2006, J SOIL SCI PLANT NUT, V2, P38, DOI [10.4067/S0718-27912006000200004, DOI 10.4067/S0718-27912006000200004]; Araujo Ademir S. F., 2009, Sustainability, V1, P268, DOI 10.3390/su1020268; ARNOLD G, 1992, PLANT SOIL, V142, P41, DOI 10.1007/BF00010173; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Bergstrom DW, 1998, SOIL SCI SOC AM J, V62, P1302, DOI 10.2136/sssaj1998.03615995006200050022x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bochet E, 2004, RESTOR ECOL, V12, P166, DOI 10.1111/j.1061-2971.2004.0325.x; Bochet E, 2010, LAND DEGRAD DEV, V21, P110, DOI 10.1002/ldr.911; Bochet E, 2007, RESTOR ECOL, V15, P88, DOI 10.1111/j.1526-100X.2006.00193.x; Bowen CK, 2005, ARID LAND RES MANAG, V19, P267, DOI 10.1080/15324980590951441; Castillo-Monroy AP, 2010, THESIS, P67; Cerda A, 2007, SCI TOTAL ENVIRON, V378, P151, DOI 10.1016/j.scitotenv.2007.01.041; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Cottenie A., 1975, Pedologie, V25, P134; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; de la Riva EG, 2011, J VEG SCI, V22, P292, DOI 10.1111/j.1654-1103.2010.01248.x; Dick A, 1992, SOIL MICROBIAL ECOLO, P95; Dorr H., 1987, TELLUS B, V39, P114, DOI [10.3402/tellusb.v39i1-2.15329, DOI 10.1111/J.1600-0889.1987.TB00276.X, DOI 10.3402/TELLUSB.V39I1-2.15329]; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Garcia-Fayos P, 2000, J VEG SCI, V11, P77, DOI 10.2307/3236778; Garcia-Orenes F, 2010, SOIL TILL RES, V109, P110, DOI 10.1016/j.still.2010.05.005; Gonzalez-Alday J, 2009, ECOL ENG, V35, P1062, DOI 10.1016/j.ecoleng.2009.03.007; Hall SL, 2010, RESTOR ECOL, V18, P834, DOI 10.1111/j.1526-100X.2008.00509.x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holmes PM, 2001, RESTOR ECOL, V9, P71, DOI 10.1046/j.1526-100x.2001.009001071.x; Jasper DA, 2007, RESTOR ECOL, V15, pS74, DOI 10.1111/j.1526-100X.2007.00295.x; Jensen LS, 1996, SOIL BIOL BIOCHEM, V28, P1297, DOI 10.1016/S0038-0717(96)00136-8; Jochimsen ME, 2001, ECOL ENG, V17, P187, DOI 10.1016/S0925-8574(00)00158-0; JORDAN D, 1995, BIOL FERT SOILS, V19, P297, DOI 10.1007/BF00336098; King JA, 2002, COMMUN SOIL SCI PLAN, V33, P403, DOI 10.1081/CSS-120002753; Lagomarsino A, 2009, ECOL INDIC, V9, P518, DOI 10.1016/j.ecolind.2008.07.003; LAKANEN E., 1971, Acta Agralia Fennica, V123, P223; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2011, SOIL BIOL BIOCHEM, V43, P1746, DOI 10.1016/j.soilbio.2011.04.023; Maestre FT, 2009, APPL SOIL ECOL, V41, P342, DOI 10.1016/j.apsoil.2008.12.007; Makoi JHJR, 2008, AFR J BIOTECHNOL, V7, P181; Matesanz S, 2006, RESTOR ECOL, V14, P297, DOI 10.1111/j.1526-100X.2006.00132.x; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Mitchell DJ, 2003, SOIL USE MANAGE, V19, P182, DOI 10.1079/SUM2002165; Mola I, 2011, RESTOR ECOL, V19, P83, DOI 10.1111/j.1526-100X.2009.00547.x; Moro MJ, 2000, ANN BOT-LONDON, V86, P1065, DOI 10.1006/anbo.2000.1269; Moynahan OS, 2002, RESTOR ECOL, V10, P77, DOI 10.1046/j.1526-100X.2002.10108.x; Ortega M, 1997, J BIOGEOGR, V24, P177, DOI 10.1046/j.1365-2699.1997.00080.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rokich DP, 2000, RESTOR ECOL, V8, P196, DOI 10.1046/j.1526-100x.2000.80027.x; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shannon C.E., 1963, MATH THEORY COMMUNIC; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Smilauer P, 1993, CANODRAW 3 0; SPELLERBERG IF, 1998, ECOLOGICAL EFFECTS N; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tejada M, 2007, SOIL TILL RES, V93, P197, DOI 10.1016/j.still.2006.04.002; TERBRAAK CJF, 1990, CANOCO FORTRAN PROGR; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson K., 1997, SOIL SEED BANKS N W; Tormo J, 2007, RESTOR ECOL, V15, P97, DOI 10.1111/j.1526-100X.2006.00194.x; Traba J, 2006, J VEG SCI, V17, P5, DOI 10.1111/j.1654-1103.2006.tb02417.x; Traba J, 2004, SEED SCI RES, V14, P297, DOI 10.1079/SSR2004179; Turner BL, 2002, APPL SOIL ECOL, V20, P157, DOI 10.1016/S0929-1393(02)00020-3; Turner BL, 2002, SOIL BIOL BIOCHEM, V34, P27, DOI 10.1016/S0038-0717(01)00144-4; Valladares F, 2008, J VEG SCI, V19, P381, DOI 10.3170/2008-8-18378; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Zhang ZQ, 2001, RESTOR ECOL, V9, P378, DOI 10.1046/j.1526-100X.2001.94007.x; Zornoza R, 2006, SOIL BIOL BIOCHEM, V38, P2125, DOI 10.1016/j.soilbio.2006.01.010	79	30	32	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101413	10.1371/journal.pone.0101413	http://dx.doi.org/10.1371/journal.pone.0101413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984137	Green Submitted, Green Published, gold			2022-12-25	WOS:000339635000102
J	Ritchie, SR; Thomas, MG; Rainey, PB				Ritchie, Stephen R.; Thomas, Mark G.; Rainey, Paul B.			The Genetic Structure of Staphylococcus aureus Populations from the Southwest Pacific	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONES; EPIDEMIOLOGY; BACTEREMIA; GENOTYPES; CARRIAGE; STRAINS; EBURST; MODELS	The genetic structure of Staphylococcus aureus populations sampled from diverse regions of the globe have been the subject of numerous investigations. Here we describe the structure of S. aureus populations collected from the Southwest Pacific. Multi-locus sequence typing was performed on 467 isolates obtained from people with nasal colonization or bacteremia in Auckland (NZ), and patients predominantly affected by skin and soft tissue infection in Samoa, Fiji and Tonga. The predominant sequence types (STs) varied between Auckland (ST5), Fiji (ST30), and Samoa (ST1), however, the overall genetic diversity within each region did not differ significantly between locations. Divergent Clonal Complex 75 (CC75) strains were isolated in Auckland and Fiji. When diversity of the Southwest Pacific populations was compared with those previously described from Asia, Europe, North America and Africa no significant differences were detected. With the exception of CC75 strains, the global collection of S. aureus encompasses relatively little diversity, with novel STs arising locally from a small number of widespread lineages.	[Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ, NZ Inst Adv Study, Auckland, New Zealand; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Ritchie, Stephen R.; Thomas, Mark G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Massey University; Massey University; University of Auckland; Max Planck Society	Ritchie, SR (corresponding author), Massey Univ, NZ Inst Adv Study, Auckland, New Zealand.	s.ritchie@auckland.ac.nz	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Ritchie, Stephen/0000-0001-5001-8899	Health Research Council of New Zealand; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland	This work was supported by the Health Research Council of New Zealand (http://www.hrc.govt.nz/) (SR) and The University of Auckland (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesana-Slater J, 2011, EMERG INFECT DIS, V17, P1023, DOI [10.3201/eid/1706.101083, 10.3201/eid1706.101083]; Anderson M, 2008, PERMANOVA SOFTWARE S; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hill PC, 2001, PEDIATR INFECT DIS J, V20, P868, DOI 10.1097/00006454-200109000-00009; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Jennings B, 2007, HASTINGS CENT REP, V37, P6; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Larsen J, 2012, J CLIN MICROBIOL, V50, P2538, DOI 10.1128/JCM.00290-12; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; McVean G, 2002, GENETICS, V160, P1231; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Melles DC, 2008, J CLIN MICROBIOL, V46, P235, DOI 10.1128/JCM.00887-07; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Ritchie SR, 2011, NZ MED J, V124, P4609; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Ruimy R, 2009, J BACTERIOL, V191, P5577, DOI 10.1128/JB.00493-09; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith EM, 2013, INFECT GENETICS EVOL; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tong SYC, 2010, J INFECT DIS, V202, P760, DOI 10.1086/655396; Tong SYC, 2009, J INFECT DIS, V199, P1461, DOI 10.1086/598218; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2; Williamson DA, 2013, PEDIATR INFECT DIS J, V32, P923, DOI 10.1097/INF.0b013e3182905f3d; Williamson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062020	46	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100300	10.1371/journal.pone.0100300	http://dx.doi.org/10.1371/journal.pone.0100300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003509	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700005
J	Barazzoni, R; Cappellari, GG; Semolic, A; Chendi, E; Ius, M; Situlin, R; Zanetti, M; Vinci, P; Guarnieri, G				Barazzoni, Rocco; Cappellari, Gianluca Gortan; Semolic, Annamaria; Chendi, Enrico; Ius, Mario; Situlin, Roberta; Zanetti, Michela; Vinci, Pierandrea; Guarnieri, Gianfranco			The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index - Results from the North-East Italy MoMa Population Study	PLOS ONE			English	Article							RISK-FACTORS; HEMATOCRIT; SENSITIVITY; VISCOSITY; GLUCOSE; OBESITY	Objective: Increments in red blood cell count (RBC), hemoglobin (Hb) and hematocrit (Ht) levels are reportedly associated with higher insulin resistance (IR). Obesity may cause IR, but underlying factors remain incompletely defined, and interactions between obesity, hematological parameters and IR are incompletely understood. We therefore determined whether: 1) BMI and obesity per se are independently associated with higher RBC, hemoglobin and hematocrit; 2) hematological parameters independently predict insulin resistance in obese individuals. Design and Methods: We investigated the associations between BMI, hematological parameters and insulin resistance as reflected by homeostasis model assessment (HOMA) in a general population cohort from the North-East Italy MoMa epidemiological study (M/F = 865/971, age = 49 +/- 61). Results: In all subjects, age-, sex- and smoking-adjusted hematological parameters were positively associated with BMI in linear regression (P<0.05), but not after adjustment for HOMA or waist circumference (WC) and potential metabolic confounders. No associations were found between hematological parameters and BMI in lean, overweight or obese subgroups. Associations between hematological parameters and HOMA were conversely independent of BMI in all subjects and in lean and overweight subgroups (P<0.01), but not in obese subjects alone. Conclusions: In a North-East Italy general population cohort, obesity per se is not independently associated with altered RBC, Hb and Ht, and the association between BMI and hematological parameters is mediated by their associations with abdominal fat and insulin resistance markers. High hematological parameters could contribute to identify insulin resistance in non-obese individual, but they do not appear to be reliable insulin resistance biomarkers in obese subjects.	[Barazzoni, Rocco; Cappellari, Gianluca Gortan; Semolic, Annamaria; Chendi, Enrico; Ius, Mario; Situlin, Roberta; Zanetti, Michela; Vinci, Pierandrea; Guarnieri, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	University of Trieste	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	barazzon@units.it		SITULIN, ROBERTA/0000-0003-0826-4003; ZANETTI, MICHELA/0000-0002-2634-6363; Gortan Cappellari, Gianluca/0000-0002-0438-5003	European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia	European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia	This work received financial support from the European Regional Development Fund under the Regional Operational Programme of Friuli Venezia Giulia - Objective "Regional Competitiveness and Employment" 2007/2013. Friuli-Venezia Giulia Region supported biochemical analyses at Pordenone hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2001, DIABETOLOGIA, V44, P1232, DOI 10.1007/s001250100634; BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; BERSCH N, 1982, J CLIN ENDOCR METAB, V55, P1209, DOI 10.1210/jcem-55-6-1209; Catalano C, 1997, EUR J CLIN INVEST, V27, P634, DOI 10.1046/j.1365-2362.1997.1770714.x; Fessler MB, 2013, J LIPID RES, V54, P3177, DOI 10.1194/jlr.P037614; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; Hanley AJG, 2009, J CLIN ENDOCR METAB, V94, P3824, DOI 10.1210/jc.2009-0719; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NORDBY G, 1995, AM J HYPERTENS, V8, P439, DOI 10.1016/0895-7061(95)00044-P; Tamariz LJ, 2008, AM J EPIDEMIOL, V168, P1153, DOI 10.1093/aje/kwn243; WANNAMETHEE G, 1994, THROMB HAEMOSTASIS, V72, P58	14	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101590	10.1371/journal.pone.0101590	http://dx.doi.org/10.1371/journal.pone.0101590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000394	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300061
J	Fiore, APZP; Osaki, LH; Gama, P				Fiore, Ana P. Z. P.; Osaki, Luciana H.; Gama, Patricia			Transforming Growth Factor beta 1 Increases p27 Levels via Synthesis and Degradation Mechanisms in the Hyperproliferative Gastric Epithelium in Rats	PLOS ONE			English	Article							UBIQUITIN-MEDIATED DEGRADATION; INHIBITS CELL-PROLIFERATION; ANAPHASE-PROMOTING COMPLEX; TGF-BETA; PROTEASOMAL DEGRADATION; MESENCHYMAL TRANSITION; HELICOBACTER-PYLORI; CDK INHIBITORS; SUCKLING RATS; ADULT RATS	Throughout postnatal development, the gastric epithelium expresses Transforming Growth Factor beta1 (TGF beta 1), but it is also exposed to luminal peptides that are part of milk. During suckling period, fasting promotes the withdrawal of milk-born molecules while it stimulates gastric epithelial cell proliferation. Such response can be reversed by exogenous TGF beta 1, as it directly affects cell cycle through the regulation of p27 levels. We used fasting condition to induce the hyperproliferation of gastric epithelial cells in 14-day-old Wistar rats, and evaluated the effects of TGF beta 1 gavage on p27 expression, phosphorylation at threonine 187 (phospho-p27(Thr187)) and degradation. p27 protein level was reduced during fasting when compared to suckling counterparts, while phospho-p27(Thr187)/p27 ratio was increased. TGF beta 1 gavage reversed this response, which was confirmed through immunostaining. By using a neutralizing antibody against TGF beta 1, we found that it restored the p27 and phosphorylation levels detected during fasting, indicating the specific role of the growth factor. We noted that neither fasting nor TGF beta 1 changed p27 expression, but after cycloheximide administration, we observed that protein synthesis was influenced by TGF beta 1. Next, we evaluated the capacity of the gastric mucosa to degrade p27 and we recorded a higher concentration of the remaining protein in pups treated with TGF beta 1, suggesting augmented stability under this condition. Thus, we showed for the first time that luminal TGF beta 1 increased p27 levels in the rat gastric mucosa by up-regulating translation and reducing protein degradation. We concluded that such mechanisms might be used by rapidly proliferating cells to respond to milk-born TGF beta 1 and food restriction.	[Fiore, Ana P. Z. P.; Osaki, Luciana H.; Gama, Patricia] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Gama, P (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	patgama@usp.br	Osaki, Luciana H/I-3624-2012; Fiore, Ana P Z P/I-3257-2012; Gama, Patricia/D-4756-2012	Gama, Patricia/0000-0002-1863-893X; Osaki, Luciana/0000-0003-0665-7567; Zen Petisco Fiore, Ana Paula/0000-0002-0498-6589	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/05393-2, 2011/17415-3]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2008/05393-2; 2011/17415-3). APZPF was recipient of CAPES PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares EP, 2007, HISTOL HISTOPATHOL, V22, P147, DOI 10.14670/HH-22.147; ALVARES EP, 1993, BRAZ J MED BIOL RES, V26, P869; ALVARES EP, 1992, BRAZ J MED BIOL RES, V25, P641; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Sa ERD, 2008, REGUL PEPTIDES, V146, P293, DOI 10.1016/j.regpep.2007.11.001; Deneme MA, 2006, J SURG RES, V136, P280, DOI 10.1016/j.jss.2006.08.020; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fujisawa T, 2004, GROWTH FACTORS, V22, P51, DOI 10.1080/0897719042000201659; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Gama P, 1998, J GASTROENTEROL, V33, P32, DOI 10.1007/PL00009964; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Kannan A, 2014, EUR J CANCER, V50, P204, DOI 10.1016/j.ejca.2013.08.016; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Koldovsky O, 1995, PHYSIOL RES, V44, P349; Kuzushita N, 2005, GASTROENTEROLOGY, V129, P1544, DOI 10.1053/j.gastro.2005.07.056; Lecanda J, 2007, CANCER RES, V67, P1007, DOI 10.1158/0008-5472.CAN-06-0235; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Massague J, 2012, FEBS LETT, V586, P1833, DOI 10.1016/j.febslet.2012.05.030; Masuda T, 2002, CANCER RES, V62, P3819; Mierzejewski P, 2006, NEUROPHARMACOLOGY, V51, P367, DOI 10.1016/j.neuropharm.2006.04.001; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Myung N, 2000, CANCER LETT, V153, P129, DOI 10.1016/S0304-3835(00)00359-1; Naef M, 1997, INT J CANCER, V71, P131; Nakamura Y, 2009, J NUTR, V139, P1463, DOI 10.3945/jn.109.108761; Nam KT, 2012, LAB INVEST, V92, P883, DOI 10.1038/labinvest.2012.47; Ogias D, 2010, NUTRITION, V26, P224, DOI 10.1016/j.nut.2009.03.014; Ogias D, 2010, AM J PHYSIOL-GASTR L, V298, pG117, DOI 10.1152/ajpgi.00245.2009; Osaki LH, 2011, CELL PROLIFERAT, V44, P174, DOI 10.1111/j.1365-2184.2011.00733.x; Osaki LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066651; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parekh TV, 2002, CANCER RES, V62, P2778; Pavlides SC, 2013, ENDOCRINOLOGY, V154, P4030, DOI 10.1210/en.2013-1757; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Pillaire MJ, 1999, EXP EYE RES, V68, P193, DOI 10.1006/exer.1998.0583; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; Qiao XX, 2010, CELL CYCLE, V9, P3904, DOI 10.4161/cc.9.19.13585; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Rokutan K, 1998, AM J PHYSIOL-GASTR L, V275, pG526, DOI 10.1152/ajpgi.1998.275.3.G526; Sa ERD, 2003, DEV DYNAM, V227, P450, DOI 10.1002/dvdy.10320; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen ZL, 2013, SCAND J GASTROENTERO, V48, P466, DOI 10.3109/00365521.2013.772226; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Torquati A, 2004, SURGERY, V136, P310, DOI 10.1016/j.surg.2004.05.005; Tsutsumi S, 2002, EXP BIOL MED, V227, P402, DOI 10.1177/153537020222700606; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang W, 2004, ONCOGENE, V23, P1064, DOI 10.1038/sj.onc.1207204; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wen S, 2012, ONCOGENE, V31, P1771, DOI 10.1038/onc.2011.362; Wu WKK, 2010, CANCER LETT, V295, P144, DOI 10.1016/j.canlet.2010.04.025; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71	68	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101965	10.1371/journal.pone.0101965	http://dx.doi.org/10.1371/journal.pone.0101965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000203	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300108
J	Gingras, B; Pohler, G; Fitch, WT				Gingras, Bruno; Pohler, Gerald; Fitch, W. Tecumseh			Exploring Shamanic Journeying: Repetitive Drumming with Shamanic Instructions Induces Specific Subjective Experiences but No Larger Cortisol Decrease than Instrumental Meditation Music	PLOS ONE			English	Article							SALIVARY CORTISOL; SEX-DIFFERENCES; RELAXING MUSIC; HEART-RATE; RELAXATION; RESPONSES; IMAGERY; INCREASES; STRESS; STATES	Exposure to repetitive drumming combined with instructions for shamanic journeying has been associated with physiological and therapeutic effects, such as an increase in salivary immunoglobulin A. In order to assess whether the combination of repetitive drumming and shamanic instructions is specifically associated with these effects, we compared the effect of listening to either repetitive drumming or instrumental meditation music for 15 minutes on salivary cortisol concentration and on self-reported physiological and psychological states. For each musical style, two groups of participants were exposed to two conditions: instructions for shamanic journeying or relaxation instructions. A total of 39 participants (24 females) inexperienced in shamanic journeying completed the experiment. Salivary cortisol concentrations were measured before and after exposure to music. In addition, participants filled out a mood questionnaire before and after the experiment and completed a post experiment questionnaire on their experiences. A significant decrease in the concentration in salivary cortisol was observed across all musical styles and instructions, indicating that exposure to 15 minutes of either repetitive drumming or instrumental meditation music, while lying down, was sufficient to induce a decrease in cortisol levels. However, no differences were observed across conditions. Significant differences in reported emotional states and subjective experiences were observed between the groups. Notably, participants exposed to repetitive drumming combined with shamanic instructions reported experiencing heaviness, decreased heart rate, and dreamlike experiences significantly more often than participants exposed to repetitive drumming combined with relaxation instructions. Our findings suggest that the subjective effects specifically attributed to repetitive drumming and shamanic journeying may not be reflected in differential endocrine responses.	[Gingras, Bruno; Pohler, Gerald; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna	Gingras, B (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	brunogingras@gmail.com	Campailla, Jasmin/AAK-2420-2021		European Research Council (ERC) Advanced Grant SOMACCA [230604]; University of Vienna	European Research Council (ERC) Advanced Grant SOMACCA; University of Vienna	This research was supported by European Research Council (ERC) Advanced Grant SOMACCA [grant number 230604] and a University of Vienna startup grant to W.T.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg J, 1990, GEDANKEN HEILEN KRAF; Atsumi T, 2007, PSYCHIAT RES, V150, P89, DOI 10.1016/j.psychres.2005.12.012; Banks SL, 1998, J MUSCULOSKELET PAIN, V6, P23, DOI 10.1300/J094v06n04_03; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; BLIZARD DA, 1975, BIOL PSYCHOL, V3, P49, DOI 10.1016/0301-0511(75)90005-8; Boersma P., 2021, PRAAT DOING PHONETIC; Bonny HL, 1999, NORD J MUSIC THER, V8, P171; Borkenau P., 2008, NEO FFI NEO FUNF FAK, V2.; Cowan T., 1996, SHAMANISM SPIRITUAL; Cruess DG, 2000, J BEHAV MED, V23, P107, DOI 10.1023/A:1005419917023; Eliade M., 2004, SHAMANISM ARCHAIC TE; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; GATCHEL RJ, 1976, J CONSULT CLIN PSYCH, V44, P381, DOI 10.1037/0022-006X.44.3.381; Goodman F. D., 1990, SPIRITS RIDE WIND TR; Goodman FD, 1999, ANTHROPOL CONSCIOUS, V10, P54, DOI [10.1525/ac.1999.10.1.54, DOI 10.1525/AC.1999.10.1.54]; Grosche P, 2011, IEEE T AUDIO SPEECH, V19, P1688, DOI 10.1109/TASL.2010.2096216; Guttman G, 1988, RES B, V27; Harner M, 1997, SHAMANIC JOURNEY SER, V6; Harner M, 1997, SHAMANIC JOURNEY SER, V1; HARNER Michael, 1982, WAY SHAMAN GUIDE POW; Harner S., 2010, J FDN SHAMANIC STUD, V23, P31; Harner S, 2001, SHAMANISM, V14, P19; Haubenhofer DK, 2007, SOC ANIM, V15, P127, DOI 10.1163/156853007X187090; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; Hodges D.A., 2010, HDB MUSIC EMOTION TH, P279; Kanji N, 1997, COMPLEMENT THER MED, V5, P162, DOI [10.1016/S0965-2299(97)80060-X, DOI 10.1016/S0965-2299(97)80060-X]; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kjellgren A, 2010, INT J TRANSPERS, V29, P1; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Luthe W, 1969, AUTOGENIC THERAPY ME; Maurer RL, 1997, AM J CLIN HYPN, V40, P130, DOI 10.1080/00029157.1997.10403417; MCFARLAND RA, 1991, INT J PSYCHOPHYSIOL, V11, P295, DOI 10.1016/0167-8760(91)90024-R; MOCKEL M, 1995, DEUT MED WOCHENSCHR, V120, P745, DOI 10.1055/s-2008-1055403; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; NEHER A, 1961, ELECTROEN CLIN NEURO, V13, P449, DOI 10.1016/0013-4694(61)90014-1; NEHER A, 1962, HUM BIOL, V34, P151; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; NOLL R, 1985, CURR ANTHROPOL, V26, P443, DOI 10.1086/203305; Palme R, 1997, Z SAUGETIERKD, V62, P192; Pawlow LA, 2002, BIOL PSYCHOL, V60, P1, DOI 10.1016/S0301-0511(02)00010-8; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Pohler G, 1989, ENTSPANNUNG STRESSAB; Pohler G, 2009, PROMED KOMPLEMENTAR, V16, P26; Rock AJ, 2005, ANTHROPOL CONSCIOUS, V16, P72, DOI 10.1525/ac.2005.16.2.72; Rock AJ, 2006, ANTHROPOL CONSCIOUS, V17, P65, DOI 10.1525/ac.2006.17.1.65; SAPOLSKY R M, 1992, P287; Schultz J, 1973, AUTOGENE TRAINING; Shanti O, 2003, LISTENING HEART; SHAPIRO S, 1980, BIOFEEDBACK SELF-REG, V5, P249, DOI 10.1007/BF00998600; Silbernagel S, 1991, TASCHENBUCH PHYSL; Steyer, 1997, MEHRDIMENSIONALE BEF; Steyer R., 1994, DIAGNOSTICA, V40, P320; Sumioka H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03034; Szabo Csaba, 2004, MUSIC THER TODAY, V1, P1; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; TART CT, 1972, SCIENCE, V176, P1203, DOI 10.1126/science.176.4040.1203; Thoma MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070156; Vandana B, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/379645; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; Vuckovic NH, 2007, ALTERN THER HEALTH M, V13, P18; Walsh R, 1990, SPIRIT SHAMANISM; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036; WINKELMAN M, 1986, ETHOS, V14, P174, DOI 10.1525/eth.1986.14.2.02a00040; Woodside L. N., 1997, ANTHR CONSCIOUSNESS, V8, P69, DOI [DOI 10.1525/AC.1997.8.2-3.69, 10.1525/ac.1997.8.2-3.69]; Wooten HR, 2007, J HEART CTR THER, V10, P3	69	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e102103	10.1371/journal.pone.0102103	http://dx.doi.org/10.1371/journal.pone.0102103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7WB	24999623	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300120
J	LaBonty, M; Szmygiel, C; Byrnes, LE; Hughes, S; Woollard, A; Cram, EJ				LaBonty, Melissa; Szmygiel, Cleo; Byrnes, Lauren E.; Hughes, Samantha; Woollard, Alison; Cram, Erin J.			CACN-1/Cactin Plays a Role in Wnt Signaling in C-elegans	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; BETA-CATENIN; RECIPROCAL ASYMMETRY; GENE-EXPRESSION; AXIS FORMATION; SEAM CELLS; KAPPA-B; PROTEIN; POP-1; CACTIN	Wnt signaling is tightly regulated during animal development and controls cell proliferation and differentiation. In C. elegans, activation of Wnt signaling alters the activity of the TCF/LEF transcription factor, POP-1, through activation of the Wnt/b-catenin or Wnt/b-catenin asymmetry pathways. In this study, we have identified CACN-1 as a potential regulator of POP-1 in C. elegans larval development. CACN-1/Cactin is a well-conserved protein of unknown molecular function previously implicated in the regulation of several developmental signaling pathways. Here we have used activation of POPTOP, a POP-1-responsive reporter construct, as a proxy for Wnt signaling. POPTOP requires POP-1 and SYS-1/b-catenin for activation in L4 uterine cells. RNAi depletion experiments show that CACN-1 is needed to prevent excessive activation of POPTOP and for proper levels and/or localization of POP-1. Surprisingly, high POPTOP expression correlates with increased levels of POP-1 in uterine nuclei, suggesting POPTOP may not mirror endogenous gene expression in all respects. Genetic interaction studies suggest that CACN-1 may act partially through LIT-1/NLK to alter POP-1 localization and POPTOP activation. Additionally, CACN-1 is required for proper proliferation of larval seam cells. Depletion of CACN-1 results in a loss of POP-1 asymmetry and reduction of terminal seam cell number, suggesting an adoption of the anterior, differentiated fate by the posterior daughter cells. These findings suggest CACN-1/Cactin modulates Wnt signaling during larval development.	[LaBonty, Melissa; Szmygiel, Cleo; Byrnes, Lauren E.; Cram, Erin J.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Hughes, Samantha; Woollard, Alison] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Northeastern University; University of Oxford	Cram, EJ (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	e.cram@neu.edu		Hughes, Samantha/0000-0001-8447-2563	National Institutes of Health; AICR grant [08-0458, 12-0028]; Worldwide Cancer Research [12-0028] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR grant; Worldwide Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM085077 from the National Institutes of Health to E. J.C. and AICR grants 08-0458 and 12-0028 to A. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NM, 2009, DEV BIOL, V331, P350, DOI 10.1016/j.ydbio.2009.05.538; Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Atzei P, 2010, J BIOL CHEM, V285, P36804, DOI 10.1074/jbc.M110.139113; Atzei P, 2010, GENE EXPR PATTERNS, V10, P199, DOI 10.1016/j.gep.2010.03.003; Baldwin KL, 2013, FEBS LETT, V587, P873, DOI 10.1016/j.febslet.2013.02.041; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bhambhani C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004133; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Chang WR, 2004, DEVELOPMENT, V131, P1425, DOI 10.1242/dev.01012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gleason JE, 2010, DEV BIOL, V348, P58, DOI 10.1016/j.ydbio.2010.09.005; Gorrepati L, 2013, DEVELOPMENT, V140, P2093, DOI 10.1242/dev.091124; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Hope IA, 2003, GENE, V304, P43, DOI 10.1016/S0378-1119(02)01175-7; Hope IA., 1999, C ELEGANS PRACTICAL; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huang SY, 2007, DEVELOPMENT, V134, P2685, DOI 10.1242/dev.008268; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ji N, 2013, CELL, V155, P869, DOI 10.1016/j.cell.2013.09.060; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kalis AK, 2010, GENETICS, V185, P523, DOI 10.1534/genetics.110.116038; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kerins JA, 2010, DEV DYNAM, V239, P1555, DOI 10.1002/dvdy.22274; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Lam N, 2006, CURR BIOL, V16, P287, DOI 10.1016/j.cub.2005.12.015; Lin PH, 2000, MECH DEVELOP, V94, P57, DOI 10.1016/S0925-4773(00)00314-2; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu J, 2008, DEV CELL, V14, P751, DOI 10.1016/j.devcel.2008.02.015; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maduro MF, 2005, DEV BIOL, V284, P509, DOI 10.1016/j.ydbio.2005.05.016; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maduro MF, 2010, DEV DYNAM, V239, P1315, DOI 10.1002/dvdy.22233; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Oldenbroek M, 2013, DEVELOPMENT, V140, P4614, DOI 10.1242/dev.096313; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Phillips BT, 2007, P NATL ACAD SCI USA, V104, P3231, DOI 10.1073/pnas.0611507104; Ren HY, 2010, DEV BIOL, V345, P144, DOI 10.1016/j.ydbio.2010.07.002; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; Shtutman M, 2008, CELL CYCLE, V7, P2377, DOI 10.4161/cc.6362; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Szatanek T, 2012, MOL MICROBIOL, V84, P566, DOI 10.1111/j.1365-2958.2012.08044.x; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Tannoury H, 2010, DEV BIOL, V341, P176, DOI 10.1016/j.ydbio.2010.02.025; Timmons Lisa, 2006, V351, P119; Yang XD, 2011, DEVELOPMENT, V138, P4255, DOI 10.1242/dev.069054	68	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101945	10.1371/journal.pone.0101945	http://dx.doi.org/10.1371/journal.pone.0101945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999833	gold, Green Submitted, Green Published			2022-12-25	WOS:000338637300106
J	Lin, M; Zhong, TY; Chen, YG; Wang, JZ; Wu, JR; Lin, F; Tong, X; Yang, HT; Hu, XM; Hu, R; Zhan, XF; Yang, H; Luo, ZY; Li, WY; Yang, LY				Lin, Min; Zhong, Tian-Yu; Chen, Yi-Guo; Wang, Jian-Zhong; Wu, Jiao-Ren; Lin, Fen; Tong, Xin; Yang, Hui-Tian; Hu, Xiao-Mei; Hu, Rong; Zhan, Xiao-Fen; Yang, Hui; Luo, Zhao-Yun; Li, Wen-Yu; Yang, Li-Ye			Molecular Epidemiological Characterization and Health Burden of Thalassemia in Jiangxi Province, P. R. China	PLOS ONE			English	Article							HEMOGLOBIN GENE DISORDERS; BETA-THALASSEMIA; DISEASE; ALPHA; POPULATIONS; FREQUENCY; FEATURES; REGION	Background: Thalassemia is the most common inherited disease in southern China. However, this disorder is usually ignored by Jiangxi provincial health system and government due to lack of epidemiological data. Materials and Methods: A total of 9489 samples from Hakka Han and Gan-speaking Han in three geographical areas of Jiangxi Province were analyzed for both complete blood cell (CBC) count and reverse dot blot (RDB) gene chip for thalassemia. Results: 1182 cases of suspected thalassemia carriers with microcytosis (MCV, 82 fL) were found by CBC count, and were tested by RDB gene chip to reveal a total of 594 mutant chromosomes, including 433 a-thalassemia mutant chromosomes and 172 b-thalassemia mutant chromosomes. Our results indicated a higher prevalence of thalassemia with the heterozygote frequency of 9.49% in southern Jiangxi province, whereas the low frequency was found in middle (3.90%) and northern Jiangxi (2.63%). Conclusions: Based on the epidemiological data, the estimated numbers of pregnancies in Jiangxi province in which the fetus is at risk for b-thalassemia major or intermedia, Bart's hydrops fetalis and Hb H disease are 34 (95% CI, 16 to 58), 79 (95% CI, 50 to 114) and 39 (95% CI, 27 to 58) per year, respectively. We suggested that prevention network of thalassemia should be established, especially in high prevalent southern Jiangxi (Hakka Han), including establishment of thalassemia database collection, hematological analysis laboratories, genetic counselling clinics, prenatal diagnosis centers and neonatal screening centers.	[Lin, Min; Wu, Jiao-Ren; Lin, Fen; Tong, Xin; Yang, Hui-Tian; Hu, Rong; Zhan, Xiao-Fen; Yang, Hui; Luo, Zhao-Yun; Li, Wen-Yu; Yang, Li-Ye] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Zhong, Tian-Yu; Hu, Xiao-Mei] Gannan Med Univ, Affiliated Hosp 1, Med Lab, Ganzhou, Jiangxi, Peoples R China; [Chen, Yi-Guo] Jiangxi Prov Peoples Hosp, Med Lab, Nanchang, Jiangxi, Peoples R China; [Wang, Jian-Zhong] Iron Ind Ltd Corp Xinyu, Cent Hosp, Med Lab, Xinyu, Jiangxi, Peoples R China	Southern Medical University - China; Gannan Medical University	Yang, LY (corresponding author), Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com	Zhong, Tianyu/K-7444-2016	Zhong, Tianyu/0000-0003-1934-0032	National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong Province [2011B031800329]; Clinical Key Department Project of Guangdong Province (Laboratory Medicine); Natural Science Foundation for Young Scientists of Jiangxi Province [20122BAB215006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong Province; Clinical Key Department Project of Guangdong Province (Laboratory Medicine); Natural Science Foundation for Young Scientists of Jiangxi Province	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong Province (contract/grant number 2011B031800329 to Min Lin), Clinical Key Department Project of Guangdong Province (Laboratory Medicine), and Natural Science Foundation for Young Scientists of Jiangxi Province (contract/grant number 20122BAB215006 to Tian-Yu Zhong). Reagent discounts and reagent gifts were from Hybribio Biotechnology Limited Corp. The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Das SK, 2001, HOMO, V52, P93, DOI 10.1078/0018-442X-00022; FUCHAROEN S, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P16; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Giambona A, 2011, BLOOD CELL MOL DIS, V46, P282, DOI 10.1016/j.bcmd.2011.01.006; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; KANOKPONGSAKDI S, 1990, PRENATAL DIAG, V10, P809, DOI 10.1002/pd.1970101208; Leung T N, 2011, Hong Kong Med J, V17, P432; Lin F, 2013, J MOL DIAGN THER, V4, P107; Lin HJ, 2010, INT J LAB HEMATOL, V32, P1, DOI 10.1111/j.1751-553X.2008.01095.x; Lin M, 2013, HEMOGLOBIN, V37, P454, DOI 10.3109/03630269.2013.807285; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Liu SC, 2011, HEMOGLOBIN, V35, P228, DOI 10.3109/03630269.2011.572524; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Song T, 2008, BASIC CLIN MED, V8, P878; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xu Liang-pu, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P403, DOI 10.3760/cma.j.issn.1003-9406.2013.04.005; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578	26	32	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101505	10.1371/journal.pone.0101505	http://dx.doi.org/10.1371/journal.pone.0101505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000193	Green Submitted, Green Published, gold			2022-12-25	WOS:000338637300052
J	Nuss, P; Eckelman, MJ				Nuss, Philip; Eckelman, Matthew J.			Life Cycle Assessment of Metals: A Scientific Synthesis	PLOS ONE			English	Article							CRITICALITY; RESOURCES; IMPACT	We have assembled extensive information on the cradle-to-gate environmental burdens of 63 metals in their major use forms, and illustrated the interconnectedness of metal production systems. Related cumulative energy use, global warming potential, human health implications and ecosystem damage are estimated by metal life cycle stage (i.e., mining, purification, and refining). For some elements, these are the first life cycle estimates of environmental impacts reported in the literature. We show that, if compared on a per kilogram basis, the platinum group metals and gold display the highest environmental burdens, while many of the major industrial metals (e.g., iron, manganese, titanium) are found at the lower end of the environmental impacts scale. If compared on the basis of their global annual production in 2008, iron and aluminum display the largest impacts, and thallium and tellurium the lowest. With the exception of a few metals, environmental impacts of the majority of elements are dominated by the purification and refining stages in which metals are transformed from a concentrate into their metallic form. Out of the 63 metals investigated, 42 metals are obtained as co-products in multi output processes. We test the sensitivity of varying allocation rationales, in which the environmental burden are allocated to the various metal and mineral products, on the overall results. Monte-Carlo simulation is applied to further investigate the stability of our results. This analysis is the most comprehensive life cycle comparison of metals to date and allows for the first time a complete bottom-up estimate of life cycle impacts of the metals and mining sector globally. We estimate global direct and indirect greenhouse gas emissions in 2008 at 3.4 Gt CO2-eq per year and primary energy use at 49 EJ per year (9.5% of global use), and report the shares for all metals to both impact categories.	[Nuss, Philip] Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA; [Eckelman, Matthew J.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA	Yale University; Northeastern University	Nuss, P (corresponding author), Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, New Haven, CT 06511 USA.	philip@nuss.me	Nuss, Philip/ABF-6000-2020	Nuss, Philip/0000-0001-9936-6886	Yale Criticality Project	Yale Criticality Project	This research was funded by the Yale Criticality Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT S, 2000, ULLMANNS ENCY IND CH; Allwood JM, 2010, ENVIRON SCI TECHNOL, V44, P1888, DOI 10.1021/es902909k; Althaus H.-J., 2007, LIFE CYCLE INVENTORI; Althaus HJ, 2005, INT J LIFE CYCLE ASS, V10, P43, DOI 10.1065/lca2004.11.181.5; Andrae ASG, 2008, ENVIRON SCI TECHNOL, V42, P3084, DOI 10.1021/es0709829; [Anonymous], 2011, MAGMATIC NI CU PGE D, V17, P1, DOI DOI 10.5382/REV.17; [Anonymous], 2006, ENV MAN LIF CYCL ASS, DOI [10.1136/bmj.332.7550.1107, DOI 10.1016/J.ECOLIND.2011.01.007]; ASHBY MF, 2012, CES EDUPACK ECODESIG; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; *BEST, 2013, BERYLL FACTS FIG; *BIO INT SERV, 2010, ENV IMP SOM RAW MAT; Cardarelli F., 2008, MAT HDB CONCISE DESK; Chapman P.F., 1983, METAL RESOURCES ENER, DOI 10.1016/C2013-0-04151-5; *CHIN SOC RAR EART, 2010, CHIN RAR EARTH YB 20; Classen M., 2009, ECOINVENT, V1; COOPE B, 2006, SPAINS CELESITE CELE; *CPM, 2010, CPM LCA DAT; CUNEY M, 2012, NONRENEWABLE RESOURC, P91; CUNNINGHAM LD, 2004, FLOW STUDIES RECYCLI; DAHMUS J, 2004, ENV ANAL MACHINING A; DEVITO SC, 2000, KIRK OTHMER ENCY CHE; Doka G., 2008, ZRICH; Du XY, 2011, ENVIRON SCI TECHNOL, V45, P4096, DOI 10.1021/es102836s; *EC, 2004, MERC FLOWS EUR WORLD; ecoinvent, 2010, EC LIF CYCL INV DAT; ELSHKAKI A, 2013, J CLEAN PROD; Erdmann L, 2011, ENVIRON SCI TECHNOL, V45, P7620, DOI 10.1021/es200563g; *EUR COMM, 2011, ELCD COR DAT VERS IL; European Commission (EC), 2014, REP CRIT RAW MAT EU; European Commission-Ad-hoc working group on defining critical raw materials, 2010, CRITICAL RAW MAT EU; GAMBOGI J, 2011, ZIRCONIUM HAFNIUM 20; Giegrich J., 2012, INDIKATOREN KENNZAHL; Goedkoop M., 2008, SIMAPRO DATABASE MAN; Goedkoop M., 2009, RECIPE 2008 LIFE CYC; *GPM, 2012, CPM PLAT GROUP MET Y; Graedel T E, 2015, Proc Natl Acad Sci U S A, V112, P6295, DOI 10.1073/pnas.1312752110; Graedel TE, 2012, MRS BULL, V37, P325, DOI 10.1557/mrs.2012.34; Graedel TE, 2012, ENVIRON SCI TECHNOL, V46, P1063, DOI 10.1021/es203534z; Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x; Graf GG, 2000, ULLMANNS ENCY IND CH; *GRANT DES, 2012, GRANT CES SEL MAT SE; GREBER JF, 2000, ULLMANNS ENCY IND CH; Greenfield A, 2013, RESOUR CONSERV RECY, V74, P1, DOI 10.1016/j.resconrec.2013.02.010; Gruber PW, 2011, J IND ECOL, V15, P760, DOI 10.1111/j.1530-9290.2011.00359.x; GRUND SC, 2000, ULLMANNS ENCY IND CH; Gupta C. K., 2004, EXTRACTIVE METALLURG; GUPTA CK, 2004, CHEM METALLURGY; HAUSSINGER P, 2000, NOBLE CASES ULLMANNS; Hibbins S., 2000, KIRK OTHMER ENCY CHE; Hluchan S. E., 2006, ULLMANNS ENCY IND CH, P483; *IAMGOLD CORP, 2009, NIOB TOUR PRES; *IEA, 2007, TRACK IND EN EFF CO2; IEA, 2020, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264109834-en, DOI 10.1787/9789264109834-EN]; IEA, 2008, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264041431-EN, DOI 10.1787/9789264041431-EN]; *INFOMINE, 2011, CALC MET PROD MARK F; Integrated Pollution Prevention and Control (IPPC), 2001, REF DOC BEST AV TECH; International Energy Agency, 2020, WORLD EN OUTL; KELLENBERGER D, 2007, LIFE CYCLE INVENTORY; Kenny M., 2007, ULLMANNS ENCY IND CH; Kleijn R, 2011, ENERGY, V36, P5640, DOI 10.1016/j.energy.2011.07.003; KRESSE R, 2000, ULLMANNS ENCY IND CH; LAZNICKA P, 2006, GIANT METALLIC DEPOS; LIDDELL N, 2011, VANADIUM SECTOR REV; LUNDBERG M, 2012, ENV ANAL ZIRCONIUM A; MACMILLAN JP, 2000, ULLMANNS ENCY IND CH; Matthey J, 2013, PLATINUM 2013; McGill I., 2000, ULLMANNS ENCY IND CH; MCNEIL D, 2013, BERYLLIUM; Micke H., 2000, ULLMANNS ENCY IND CH; MILLENSIFER TA, 2000, KIRK OTHMER ENCY CHE; MILLER GL, 1954, VACUUM, V4, P168; MUNNOCH S, 2012, HAFNIUM; Nassar NT, 2012, ENVIRON SCI TECHNOL, V46, P1071, DOI 10.1021/es203535w; National Renewable Energy Laboratory (NREL), 2008, US LIF CYCL INV DAT; National Research Council Minerals, 2008, MINERALS CRITICAL MI, DOI [10.17226/12034, DOI 10.17226/12034]; Naumov A. V., 2007, Russian Journal of Non-Ferrous Metals, V48, P10, DOI 10.3103/S1067821207010038; NIELSEN RH, 2000, ULLMANNS ENCY IND CH; Norgate T, 2010, MINER ENG, V23, P65, DOI 10.1016/j.mineng.2009.10.002; Norgate TE, 2007, J CLEAN PROD, V15, P838, DOI 10.1016/j.jclepro.2006.06.018; Norgate T, 2011, MINER ENG, V24, P1563, DOI 10.1016/j.mineng.2011.08.007; Nuss P, 2014, ENVIRON SCI TECHNOL, V48, P4171, DOI 10.1021/es405044w; *PE INT, 2012, GABI 6 LIF CYCL INV; PETZOW G, 2000, ULLMANNS ENCY IND CH; *RMG, 2006, RAW MAT DAT SOFTW MI; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Schmidt G., 2013, DESCRIPTION CRITICAL; Smith RD., 2005, ARTILLERY DUKES BURG; STOLL W, 2000, ULLMANNS ENCY IND CH; SUTHERLAND CA, 2000, ULLMANNS ENCY IND CH; SUTTER J, 2007, LIFE CYCLE INVENTORI; *THOMS REUT, 2012, WORLD SILV SURV 2012; *TU DELFT, 2001, IDEMAT LIF CYCL INV; *UBA, 2010, PROBAS LEB KLUSD; United States Geological Survey (USGS), 2022, MINERAL COMMODITY SU, DOI DOI 10.3133/MCS2022; *USBM, 1985, MIN FACTS PROBL; USGS, 2012, MIN COMM SUMM 2012; *USGS, 1999, MET PRIC US 1998; *USGS, 2011, ZIRC HAFN; [USGS USGS National Minerals Information Center], 2012, 2012 MIN YB; *USGS, 2008, 2008 MIN YB; *USGS, 2013, MIN COMM SUMM 2013; USGS, 2011, MIN COMM SUMM 2011; USGS (U.S. Geological Survey), 2010, 2010 MIN YB; VANDERVOET E, 2013, ENV RISK CHALLENGES; Verhoef E. V., 2004, Journal of Industrial Ecology, V8, P23, DOI 10.1162/1088198041269382; VERMAAK CF, 1995, PLATINUM GROUP METAL; VRANA LM, 2000, KIRK OTHMER ENCY CHE; Wang WW, 2011, HYDROMETALLURGY, V108, P100, DOI 10.1016/j.hydromet.2011.03.001; WOOLERY M, 2000, KIRK OTHMER ENCY CHE; World Bank, 2012, WORLD DAT BANK; YELLISHETTY M, 2012, NONRENEWABLE RESOURC, P229, DOI DOI 10.1007/978-90-481-8679-2_12	111	296	298	17	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101298	10.1371/journal.pone.0101298	http://dx.doi.org/10.1371/journal.pone.0101298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	24999810	Green Published, Green Submitted, gold			2022-12-25	WOS:000338637300033
J	Gawri, R; Moir, J; Ouellet, J; Beckman, L; Steffen, T; Roughley, P; Haglund, L				Gawri, Rahul; Moir, Janet; Ouellet, Jean; Beckman, Lorne; Steffen, Thomas; Roughley, Peter; Haglund, Lisbet			Physiological Loading Can Restore the Proteoglycan Content in a Model of Early IVD Degeneration	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; EXTRACELLULAR-MATRIX; PROTEIN CHONDROADHERIN; DYNAMIC COMPRESSION; ARTICULAR-CARTILAGE; LIMITED NUTRITION; NUCLEUS PULPOSUS; FRAGMENTATION; BIOLOGY; SENESCENCE	A hallmark of early IVD degeneration is a decrease in proteoglycan content. Progression will eventually lead to matrix degradation, a decrease in weight bearing capacity and loss of disc height. In the final stages of IVD degradation, fissures appear in the annular ring allowing extrusion of the NP. It is crucial to understand the interplay between mechanobiology, disc composition and metabolism to be able to provide exercise recommendations to patients with early signs of disc degeneration. This study evaluates the effect of physiological loading compared to no loading on matrix homeostasis in bovine discs with induced degeneration. Bovine discs with trypsin-induced degeneration were cultured for 14 days in a bioreactor under dynamic loading with maintained metabolic activity. Chondroadherin abundance and structure was used to confirm that a functional matrix was preserved in the chosen loading environment. No change was observed in chondroadherin integrity and a non-significant increase in abundance was detected in trypsin-treated loaded discs compared to unloaded discs. The proteoglycan concentration in loaded trypsin-treated discs was significantly higher than in unloaded disc and the newly synthesised proteoglycans were of the same size range as those found in control samples. The proteoglycan showed an even distribution throughout the NP region, similar to that of control discs. Significantly more newly synthesised type II collagen was detected in trypsin-treated loaded discs compared to unloaded discs, demonstrating that physiological load not only stimulates aggrecan production, but also that of type II collagen. Taken together, this study shows that dynamic physiological load has the ability to repair the extracellular matrix depletion typical of early disc degeneration.	[Gawri, Rahul; Moir, Janet; Beckman, Lorne; Steffen, Thomas; Haglund, Lisbet] McGill Univ, Orthopaed Res Lab, Montreal, PQ, Canada; [Roughley, Peter] McGill Univ, Shriners Hosp Children, Montreal, PQ, Canada; [Ouellet, Jean] McGill Scoliosis & Spine Grp, Montreal, PQ, Canada	McGill University; McGill University	Haglund, L (corresponding author), McGill Univ, Orthopaed Res Lab, Montreal, PQ, Canada.	lisbet.haglund@mcgill.ca	Gawri, Rahul/I-3784-2019; Haglund, Lisbet/N-3095-2013	Gawri, Rahul/0000-0001-9415-1739; Haglund, Lisbet/0000-0002-1288-2149	AOSpine [SRN_2011_04_10498]	AOSpine	This work was supported by a grant AOSpine, SRN_2011_04_10498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akhatib B, 2013, J BIOL CHEM, V288, P19280, DOI 10.1074/jbc.M112.443010; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; BJORNSSON S, 1993, ANAL BIOCHEM, V210, P292, DOI 10.1006/abio.1993.1198; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chan SCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072489; Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Haglund L, 2011, TISSUE ENG C; Haglund L, 2013, J BIOL CHEM, V288, P995, DOI 10.1074/jbc.M112.430512; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; Haglund L, 2009, SPINE, V34, P1513, DOI 10.1097/BRS.0b013e3181a8d001; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Jim B, 2011, EURSPINE J; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Korecki CL, 2009, J ORTHOP RES, V27, P800, DOI 10.1002/jor.20814; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Liebscher T, 2010, SPINE; Malonzo C, 2013, J TISSUE ENG REGEN M; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; MCNALLY DS, 1992, J BIOMED ENG, V14, P495, DOI 10.1016/0141-5425(92)90102-Q; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Mort John S., 2007, V135, P201; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Roberts S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-24; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wuertz K, 2009, JORTHOPRES	39	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101233	10.1371/journal.pone.0101233	http://dx.doi.org/10.1371/journal.pone.0101233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992586	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400055
J	Wang, JH; Cai, YR; Dong, YJ; Nong, JY; Zhou, LJ; Liu, GM; Su, D; Li, X; Wu, SF; Chen, XJ; Qin, N; Zeng, X; Zhang, HQ; Zhang, ZD; Zhang, SC				Wang, Jinghui; Cai, Yiran; Dong, Yujie; Nong, Jingying; Zhou, Lijuan; Liu, Guimei; Su, Dan; Li, Xi; Wu, Shafei; Chen, Xuejing; Qin, Na; Zeng, Xuan; Zhang, Haiqing; Zhang, Zongde; Zhang, Shucai			Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; EML4-ALK FUSION; KRAS MUTATIONS; CANCER; IMMUNOHISTOCHEMISTRY; FEATURES; CLASSIFICATION; IDENTIFICATION; GENE; EGFR	EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectives of this study were to determine the frequency of ALK rearrangements in a large cohort of patients with primary lung adenocarcinoma and to analyze the association of ALK rearrangements with clinicopathological characteristics and clinical outcomes. The roles of fluorescence in situ hybridization (FISH), Ventana immunohistochemistry (IHC), and reverse transcriptase polymerase chain reaction (RT-PCR) in the detection of ALK rearrangements were evaluated. The ALK rearrangement was detected in 430 specimens from individual patients with primary lung adenocarcinoma using FISH and Ventana IHC based on tissue microarrays. The EGFR status was detected in all of the specimens through DNA sequencing. An RT-PCR was performed on 200 of the specimens and confirmed by sequencing. Of the 430 patients, 46 (10.7%) harbored ALK rearrangements. The ALK rearrangements were associated with a younger age and the EGFR wild type in comparison with ALK-negative patients. The sensitivity and specificity of the Ventana IHC were 100% and 98.2%, respectively, and the concordance rate between the FISH and the Ventana IHC was 98.4%. The sensitivity and specificity of RT-PCR were 95.5% and 87.0%, respectively, and the concordance rate between the FISH and the RT-PCR was 89.0%. The Cox analysis indicated that an early stage and EGFR-activating mutations were independently associated with a longer OS. This study demonstrated that ALK rearrangements are associated with a younger age and the EGFR wild type rather than with other clinicopathological factors. Although the FISH and Ventana IHC have better concordance, and RT-PCR is a more sensitive method and can identify different variants or partners, the IHC and RT-PCR need to be further evaluated in clinical trials to identify their roles in guiding patients' targeted therapy using crizotinib.	[Wang, Jinghui; Nong, Jingying; Li, Xi; Qin, Na; Zhang, Shucai] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Med Oncol, Beijing, Peoples R China; [Cai, Yiran; Dong, Yujie; Zhou, Lijuan; Su, Dan; Chen, Xuejing; Zhang, Haiqing] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Pathol, Beijing, Peoples R China; [Liu, Guimei] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Radiotherapy, Beijing, Peoples R China; [Wu, Shafei; Zeng, Xuan] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China; [Wu, Shafei; Zeng, Xuan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Zongde] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistance TB Res, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistance TB Res, Beijing, Peoples R China.	zzd417@163.com; zhangshucai6304@aliyun.com	su, dan/GYJ-1940-2022; Zhou, Li/GSE-4531-2022		National Science and Technology Major Project of China [2013ZX10003003, 2012ZX10003002]; Beijing health systems of high-level health and technical personnel training plan [2009-3-51]	National Science and Technology Major Project of China; Beijing health systems of high-level health and technical personnel training plan	This work was supported by the National Science and Technology Major Project of China (2013ZX10003003 and 2012ZX10003002), and Beijing health systems of high-level health and technical personnel training plan (2009-3-51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2011, J THORAC ONCOL, V6, P411, DOI 10.1097/JTO.0b013e31820cf068; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Koh Y, 2011, J THORAC ONCOL, V6, P905, DOI 10.1097/JTO.0b013e3182111461; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee HJ, 2012, J THORAC IMAG, V27, P340, DOI 10.1097/RTI.0b013e3182688d62; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Minca EC, 2013, J MOL DIAGN, V15, P341, DOI 10.1016/j.jmoldx.2013.01.004; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Rosell R, 2012, ANN ONCOL, V23, P529; Sanders HR, 2011, CANCER GENET-NY, V204, P45, DOI 10.1016/j.cancergencyto.2010.08.024; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Togashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031323; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wang R, 2012, CLIN CANCER RES, V18, P4725, DOI 10.1158/1078-0432.CCR-12-0677; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821	34	46	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101551	10.1371/journal.pone.0101551	http://dx.doi.org/10.1371/journal.pone.0101551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992725	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400088
J	Zhou, TQ; Zhu, J; Yang, YP; Gorman, J; Ofek, G; Srivatsan, S; Druz, A; Lees, CR; Lu, G; Soto, C; Stuckey, J; Burton, DR; Koff, WC; Connors, M; Kwon, PD				Zhou, Tongqing; Zhu, Jiang; Yang, Yongping; Gorman, Jason; Ofek, Gilad; Srivatsan, Sanjay; Druz, Aliaksandr; Lees, Christopher R.; Lu, Gabriel; Soto, Cinque; Stuckey, Jonathan; Burton, Dennis R.; Koff, Wayne C.; Connors, Mark; Kwon, Peter D.			Transplanting Supersites of HIV-1 Vulnerability	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; RESPIRATORY SYNCYTIAL VIRUS; HUMAN MONOCLONAL-ANTIBODY; STRUCTURE-BASED DESIGN; N-GLYCAN RECOGNITION; ENVELOPE GLYCOPROTEIN; COMPUTATIONAL DESIGN; VACCINE DEVELOPMENT; EPITOPE-SCAFFOLDS	One strategy for isolating or eliciting antibodies against a specific target region on the envelope glycoprotein trimer (Env) of the human immunodeficiency virus type 1 (HIV-1) involves the creation of site transplants, which present the target region on a heterologous protein scaffold with preserved antibody-binding properties. If the target region is a supersite of HIV-1 vulnerability, recognized by a collection of broadly neutralizing antibodies, this strategy affords the creation of "supersite transplants", capable of binding (and potentially eliciting) antibodies similar to the template collection of effective antibodies. Here we transplant three supersites of HIV-1 vulnerability, each targeted by effective neutralizing antibodies from multiple donors. To implement our strategy, we chose a single representative antibody against each of the target supersites: antibody 10E8, which recognizes the membrane-proximal external region (MPER) on the HIV-1 gp41 glycoprotein; antibody PG9, which recognizes variable regions one and two (V1V2) on the HIV-1 gp120 glycoprotein; and antibody PGT128 which recognizes a glycopeptide supersite in variable region 3 (glycan V3) on gp120. We used a structural alignment algorithm to identify suitable acceptor proteins, and then designed, expressed, and tested antigenically over 100-supersite transplants in a 96-well microtiter-plate format. The majority of the supersite transplants failed to maintain the antigenic properties of their respective template supersite. However, seven of the glycan V3-supersite transplants exhibited nanomolar affinity to effective neutralizing antibodies from at least three donors and recapitulated the mannose(9)-N-linked glycan requirement of the template supersite. The binding of these transplants could be further enhanced by placement into self-assembling nanoparticles. Essential elements of the glycan V3 supersite, embodied by as few as 3 N-linked glycans and similar to 25 Env residues, can be segregated into acceptor scaffolds away from the immune-evading capabilities of the rest of HIV-1 Env, thereby providing a means to focus the immune response on the scaffolded supersite.	[Zhou, Tongqing; Zhu, Jiang; Yang, Yongping; Gorman, Jason; Ofek, Gilad; Srivatsan, Sanjay; Druz, Aliaksandr; Lees, Christopher R.; Lu, Gabriel; Soto, Cinque; Stuckey, Jonathan; Kwon, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Design, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Koff, Wayne C.] IAVI, New York, NY USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwon, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Cheng, Yushao/E-6256-2011; Gorman, Jason/AGG-9417-2022	Zhou, Tongqing/0000-0002-3935-4637; Gorman, Jason/0000-0002-3775-6560	Intramural Research Program of the Vaccine Research Center; National Institute of Allergy and Infectious Diseases; National Institutes of Health; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by grants from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www. iavi. org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakraborty K, 2006, BIOCHEM J, V399, P483, DOI 10.1042/BJ20060588; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gerhardt S, 2009, J MOL BIOL, V394, P905, DOI 10.1016/j.jmb.2009.10.008; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jakuschev S, 2009, ALGORITHMS, V2, P498, DOI 10.3390/a2010498; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Moseri A, 2010, VIROLOGY, V401, P293, DOI 10.1016/j.virol.2010.03.007; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stanfield RL, 2011, J MOL BIOL, V414, P460, DOI 10.1016/j.jmb.2011.10.014; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu J, 2008, PROTEINS, V72, P1171, DOI 10.1002/prot.22005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e99881	10.1371/journal.pone.0099881	http://dx.doi.org/10.1371/journal.pone.0099881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992528	Green Published, Green Submitted, gold			2022-12-25	WOS:000341253400014
J	Elfrink, MEC; Moll, HA; Kiefte-de Jong, JC; Jaddoe, VWV; Hofman, A; ten Cate, JM; Veerkamp, JSJ				Elfrink, Marlies E. C.; Moll, Henriette A.; Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.; Hofman, Albert; ten Cate, Jacob M.; Veerkamp, Jaap S. J.			Pre- and Postnatal Determinants of Deciduous Molar Hypomineralisation in 6-Year-Old Children. The Generation R Study	PLOS ONE			English	Article							2ND PRIMARY MOLARS; LOW-BIRTH-WEIGHT; INCISOR-HYPOMINERALISATION; DEVELOPMENTAL DEFECTS; ENAMEL DEFECTS; RISK-FACTORS; PREVALENCE; ETIOLOGY; DIOXINS; CARIES	Background: Deciduous Molar Hypomineralisation (DMH) and Molar Incisor Hypomineralisation (MIH) are common developmental disturbances in pediatric dentistry. Their occurrence is related. The same determinants as suggested for MIH are expected for DMH, though somewhat earlier in life. Perinatal medical problems may influence the prevalence of DMH but this has not been studied sufficiently. Objective: This study aimed to identify possible determinants of DMH in a prospective cohort study among 6-year-old children. Study Design: This study was embedded in the Generation R Study, a population-based prospective cohort study from fetal life until young adulthood. The the data were used to identify the determinants of DMH. Clinical photographs of clean, moist teeth were taken with an intra-oral camera in 6690 children (mean age 6.2 years; 49.9% girls). Data on possible determinants that had occurred during pregnancy and/or the child's first year of life were on the basis of manual standardized measurements (like length and weight) and questionnaires. Multivariate analyse with backward and forward selection was performed. Results: A number of factors in the pre-, peri-and postnatal phase were found to be associated with DMH. After multivariate logistic regression analyses, Dutch ethnic background, low birth weight, maternal alcohol consumption during pregnancy, and fever episodes in the first year of the child's life were found to play a role in the development of DMH in 6-year-old children. Conclusion: This study shows that Dutch ethnicity, low birth weight, alcohol consumption by the mother during pregnancy and any fever in the first year of the child's life are associated with DMH. Not only childhood factors but also prenatal lifestyle factors need to be taken into account when studying determinants for DMH.	[Elfrink, Marlies E. C.; ten Cate, Jacob M.; Veerkamp, Jaap S. J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol & Pedodontol, Amsterdam, Netherlands; [Elfrink, Marlies E. C.; ten Cate, Jacob M.; Veerkamp, Jaap S. J.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Moll, Henriette A.; Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Generat R Study Grp, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; Hofman, Albert] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Elfrink, MEC (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol & Pedodontol, Amsterdam, Netherlands.	m.elfrink@acta.nl	Kiefte-de Jong, Jessica/GLV-3216-2022; Veerkamp, Jaap/AAI-5937-2020	Kiefte-de Jong, Jessica/0000-0002-8136-0918; 	ErasmusMC Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); GABA, Therwil, Switzerland; Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam; VU University Amsterdam, Amsterdam, The Netherlands	ErasmusMC Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); GABA, Therwil, Switzerland; Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam; VU University Amsterdam, Amsterdam, The Netherlands(Netherlands Government)	Unrestricted financial support was given by the ErasmusMC Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw), and for the dental part of the research an additional and unrestricted grant of GABA, Therwil, Switzerland and financial support from the Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi R, 2012, IRAN J PEDIATR, V22, P245; Aine L, 2000, J ORAL PATHOL MED, V29, P403, DOI 10.1034/j.1600-0714.2000.290806.x; Alaluusua S, 1996, ENVIRON TOXICOL PHAR, V1, P193, DOI 10.1016/1382-6689(96)00007-5; Alaluusua S, 2010, EUR ARCH PAEDIATR DE, V11, P53, DOI 10.1007/BF03262713; [Anonymous], 2004, STAND OND IND 2003; [Anonymous], 2004, ALL NED 2004; Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9; Biondi Ana M, 2012, Acta odontol. latinoam., V25, P224; BUTLER PM, 1967, ARCH ORAL BIOL, V12, P1245, DOI 10.1016/0003-9969(67)90126-4; Crombie F, 2009, INT J PAEDIATR DENT, V19, P73, DOI 10.1111/j.1365-263X.2008.00966.x; Elfrink M, 2012, ORALPROPHYLAXE KINDE, V34, P166; Elfrink MEC, 2008, CARIES RES, V42, P282, DOI 10.1159/000135674; Elfrink MEC, 2012, J DENT RES, V91, P551, DOI 10.1177/0022034512440450; Elfrink MEC, 2009, EUR ARCH PAEDIATR DE, V10, P5, DOI 10.1007/BF03262693; Elfrink MEC, 2010, INT J PAEDIATR DENT, V20, P151, DOI 10.1111/j.1365-263X.2009.01026.x; Elfrink ME, 2013, DRUG SAFETY IN PRESS; Fagrell TG, 2011, SWED DENT J, V35, P57; Ghanim A, 2012, INT J PAEDIAT DENT; Ghanim AM, 2012, EUR ARCH PAEDIATR DE, V13, P111, DOI 10.1007/BF03262856; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P48, DOI 10.1111/j.1365-263X.2012.01223.x; Ghanim A, 2011, INT J PAEDIATR DENT, V21, P413, DOI 10.1111/j.1365-263X.2011.01143.x; Hargreaves J A, 1989, Adv Dent Res, V3, P110; Jaddoe VWV, 2007, ANN EPIDEMIOL, V17, P834, DOI 10.1016/j.annepidem.2007.04.001; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59; Jasulaityte L, 2008, EUR ARCH PAEDIATR DE, V9, P218, DOI 10.1007/BF03262638; Jimenez-Farfan D, 2005, BIRTH DEFECTS RES A, V73, P980, DOI 10.1002/bdra.20198; Laisi S, 2008, EUR ARCH PAEDIATR DE, V9, P224, DOI 10.1007/BF03262639; Laisi S, 2009, J DENT RES, V88, P132, DOI 10.1177/0022034508328334; Parikh DR, 2012, EUR ARCH PAEDIATR DE, V13, P21, DOI 10.1007/BF03262836; Rugg-Gunn AJ, 1998, CARIES RES, V32, P181, DOI 10.1159/000016451; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stockley L, 2008, PUBLIC HEALTH NUTR, V11, P807, DOI 10.1017/S1368980008002346; Strand Bjorn Heine, 2003, Tidsskr Nor Laegeforen, V123, P2849; Troe E.J.W.M., 2008, ETHNIC DIFFERENCES F; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; Vello MA, 2010, ORAL DIS, V16, P257, DOI 10.1111/j.1601-0825.2009.01629.x; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P114; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P110; William V, 2006, PEDIATR DENT, V28, P224	41	39	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e91057	10.1371/journal.pone.0091057	http://dx.doi.org/10.1371/journal.pone.0091057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988443	gold, Green Published, Green Submitted			2022-12-25	WOS:000341354100002
J	Park, JY; Zhang, X; Nguyen, N; Souza, RF; Spechler, SJ; Cheng, E				Park, Jason Y.; Zhang, Xi; Nathalie Nguyen; Souza, Rhonda F.; Spechler, Stuart J.; Cheng, Edaire			Proton Pump Inhibitors Decrease Eotaxin-3 Expression in the Proximal Esophagus of Children with Esophageal Eosinophilia	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; CONSENSUS RECOMMENDATIONS; SWALLOWED FLUTICASONE; GENE-EXPRESSION; SQUAMOUS-CELLS; ESOMEPRAZOLE; HEALTHY	Objective: Besides reducing gastric acid secretion, proton pump inhibitors (PPIs) suppress Th2-cytokine-stimulated expression of an eosinophil chemoattractant (eotaxin-3) by esophageal epithelial cells through acid-independent, anti-inflammatory mechanisms. To explore acid-inhibitory and acid-independent, anti-inflammatory PPI effects in reducing esophageal eosinophilia, we studied eotaxin-3 expression by the proximal and distal esophagus of children with esophageal eosinophilia before and after PPI therapy. In vitro, we studied acid and bile salt effects on IL-13-stimulated eotaxin-3 expression by esophageal epithelial cells. Design: Among 264 children with esophageal eosinophilia seen at a tertiary pediatric hospital from 2008 through 2012, we identified 10 with esophageal biopsies before and after PPI treatment alone. We correlated epithelial cell eotaxin-3 immunostaining with eosinophil numbers in those biopsies. In vitro, we measured eotaxin-3 protein secretion by esophageal squamous cells stimulated with IL-13 and exposed to acid and/or bile salt media, with or without omeprazole. Results: There was strong correlation between peak eosinophil numbers and peak eotaxin-3-positive epithelial cell numbers in esophageal biopsies. Eotaxin-3 expression decreased significantly with PPIs only in the proximal esophagus. In esophageal cells, exposure to acid-bile salt medium significantly suppressed IL-13-induced eotaxin-3 secretion; omeprazole added to the acid-bile salt medium further suppressed that eotaxin-3 secretion, but not as profoundly as at pH-neutral conditions. Conclusion: In children with esophageal eosinophilia, PPIs significantly decrease eotaxin-3 expression in the proximal but not the distal esophagus. In esophageal squamous cells, acid and bile salts decrease Th2 cytokine-stimulated eotaxin-3 secretion profoundly, possibly explaining the disparate PPI effects on the proximal and distal esophagus. In the distal esophagus, where acid reflux is greatest, a PPI-induced reduction in acid reflux (an effect that could increase eotaxin-3 secretion induced by Th2 cytokines) might mask the acid-independent, anti-inflammatory PPI effect of decreasing cytokine-stimulated eotaxin-3 secretion.	[Park, Jason Y.; Zhang, Xi] Eugene McDermott Ctr Human Growth & Dev, Childrens Med Ctr, Dept Pathol, Esophageal Dis Ctr, Dallas, TX USA; [Park, Jason Y.; Zhang, Xi; Nathalie Nguyen; Souza, Rhonda F.; Spechler, Stuart J.; Cheng, Edaire] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cheng, Edaire] VA North Texas Hlth Care Syst, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX 75216 USA; [Nathalie Nguyen; Cheng, Edaire] Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA; [Souza, Rhonda F.; Spechler, Stuart J.] VA North Texas Hlth Care Syst, Harold C Simmons Comprehens Canc Ctr, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Cheng, E (corresponding author), VA North Texas Hlth Care Syst, Esophageal Dis Ctr, Dept Internal Med, Dallas, TX 75216 USA.	edaire.cheng@utsouthwestern.edu		Park, Jason/0000-0001-6797-4000	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health [R01-DK63621, R01-CA134571, K12-HD068369, K08-DK099383]; NASPGHAN Foundation/AstraZeneca Award; AGA Research Scholar Award; AAP Resident Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA134571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621, K08DK099383] Funding Source: NIH RePORTER	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASPGHAN Foundation/AstraZeneca Award; AGA Research Scholar Award; AAP Resident Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Departments of Veterans Affairs (RFS, SJS), the National Institutes of Health (R01-DK63621 to RFS and SJS, R01-CA134571 to RFS and SJS, K12-HD068369 to EC, K08-DK099383 to EC), NASPGHAN Foundation/AstraZeneca Award (EC), AGA Research Scholar Award (EC), and AAP Resident Research Grant (NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cortes JR, 2009, J ALLERGY CLIN IMMUN, V124, P607, DOI 10.1016/j.jaci.2009.06.023; DeBrosse CW, 2011, J ALLERGY CLIN IMMUN, V128, P132, DOI 10.1016/j.jaci.2011.05.006; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Dranove JE, 2009, J PEDIATR, V154, P96, DOI 10.1016/j.jpeds.2008.07.042; Frazzoni M, 2011, ALIMENT PHARM THER, V33, P601, DOI 10.1111/j.1365-2036.2010.04550.x; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; Hirano I, 2007, AM J GASTROENTEROL, V102, P668, DOI 10.1111/j.1572-0241.2006.00936.x; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Kauer WKH, 1997, SURGERY, V122, P874, DOI 10.1016/S0039-6060(97)90327-5; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P366, DOI 10.1038/ajg.2012.443; Molina-Infante J, 2013, GASTROENTEROLOGY, V144, pS484; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Olsen EA, 2013, CURR OPIN ANESTHESIO, V26, P677, DOI 10.1097/ACO.0000000000000016; Peterson KA, 2010, DIGEST DIS SCI, V55, P1313, DOI 10.1007/s10620-009-0859-4; RICHTER JE, 1992, DIGEST DIS SCI, V37, P849, DOI 10.1007/BF01300382; Sasaki T, 2005, EUR J PHARMACOL, V509, P201, DOI 10.1016/j.ejphar.2004.12.042; Sayej WN, 2009, J PEDIATR GASTR NUTR, V49, P393, DOI 10.1097/MPG.0b013e31819c4b3e; Schroeder S, 2013, J PEDIATR GASTR NUTR, V56, P166, DOI 10.1097/MPG.0b013e3182716b7a; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; Straumann A, 2005, INFLAMM BOWEL DIS, V11, P720, DOI 10.1097/01.MIB.0000172557.39767.53; Straumann A, 2003, GASTROENTEROLOGY, V125, P1660, DOI 10.1053/j.gastro.2003.09.024; VANDENPLAS Y, 1991, PEDIATRICS, V88, P834; Zhang HY, 2008, AM J PHYSIOL-GASTR L, V295, pG470, DOI 10.1152/ajpgi.90262.2008; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	32	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101391	10.1371/journal.pone.0101391	http://dx.doi.org/10.1371/journal.pone.0101391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988451	Green Published, Green Submitted, gold			2022-12-25	WOS:000341354100082
J	Wagh, K; Bhatia, A; Greenbaum, BD; Bhanot, G				Wagh, Kshitij; Bhatia, Aatish; Greenbaum, Benjamin D.; Bhanot, Gyan			Bird to Human Transmission Biases and Vaccine Escape Mutants in H5N1 Infections	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; HEMAGGLUTININ; EVOLUTION; ADAPTATION; MUTATIONS; SELECTION; BINDING; THREAT; EGYPT	Background: The avian influenza A H5N1 virus occasionally infects humans, with high mortality rates. Although all current human infections are from avian-to-human transmission, it has been shown that H5N1 can be evolved to transmit between mammals, and is therefore a pandemic threat. For H5N1 surveillance, it is of interest to identify the avian isolates most likely to infect humans. In this study, we develop a method to identify mutations significantly associated with avian to human transmission. Method: Using protein sequences for the surface glycoprotein hemagglutinin from avian and human H5N1 isolates in China, Egypt, and Indonesia from the years 1996-2011, we used Principle Component Analysis and a Maximum Likelihood Multinomial method to identify mutations associated with avian to human transmission. In each geographic region, transmission bias residues were identified using two signatures: a) significantly different amino-acid frequencies in human isolates compared to avian isolates from the same year, and b) significantly low probability of neutral evolution of the human isolates from the avian viral pool of the previous year. Results: In each geographic region, we find specific transmission bias mutations associated with human infections. These mutations are located in antigenic regions and receptor binding, glycosylation and polybasic cleavage sites of HA. We show that human isolates derive from a limited, subset of the avian pool characterized by geography specific mutations. In Egypt, two of three PCA clusters have very few human isolates but are highly enriched in mutations associated with a vaccine escape mutant H5N1 avian sub-clade that is known to be resistant to the Mexican H5N2 vaccine Furthermore, at these transmission bias associated residues, the mutations characteristic of these two clusters are distinct from those associated with the cluster enriched in human isolates, suggesting that vaccine resistant avian strains are unable to infect humans. Our results are relevant for surveillance and vaccination strategies for human H5N1 infections.	[Wagh, Kshitij; Bhatia, Aatish; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Wagh, Kshitij; Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Greenbaum, Benjamin D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Greenbaum, Benjamin D.; Bhanot, Gyan] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bhanot, G (corresponding author), Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA.	gyanbhanot@gmail.com	Wagh, Kshitij/ABB-5002-2020		Kavli Institute for Theoretical Physics at the University of California at Santa Barbara [NSF PHY11-25915]; Aspen Center for Physics through NSF [1066293]	Kavli Institute for Theoretical Physics at the University of California at Santa Barbara(University of California System); Aspen Center for Physics through NSF	BG was the Eric and Wendy Schmidt Member of the Institute for Advanced Study when this work was begun and would like to thank them for their support. GB thanks the Kavli Institute for Theoretical Physics at the University of California at Santa Barbara and the Aspen Center for Physics for partial support through NSF grant numbers NSF PHY11-25915 and 1066293 respectively, during the time this work was done. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2012, VIRUS GENES, V45, P14, DOI 10.1007/s11262-012-0758-1; Arafa A, 2012, ARCH VIROL, V157, P1931, DOI 10.1007/s00705-012-1385-9; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Cuong CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-99; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Duvvuri Venkata R. S. K., 2009, Genomics Proteomics & Bioinformatics, V7, P47, DOI 10.1016/S1672-0229(08)60032-7; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jones E., 2001, SCIPY OPEN SOURCE SC; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sambhara S, 2010, ANNU REV MED, V61, P187, DOI 10.1146/annurev.med.050908.132031; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Terregino C, 2010, AVIAN PATHOL, V39, P215, DOI 10.1080/03079451003781858; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; World Health Organization, CUM NUMB CONF HUM CA; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	28	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e100754	10.1371/journal.pone.0100754	http://dx.doi.org/10.1371/journal.pone.0100754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988306	Green Submitted, gold, Green Published			2022-12-25	WOS:000341354100040
J	Bari, MF; Weickert, MO; Sivakumar, K; James, SG; Snead, DRJ; Tan, BK; Randeva, HS; Bastie, CC; Vatish, M				Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; James, Sean G.; Snead, David R. J.; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile; Vatish, Manu			Elevated Soluble CD163 in Gestational Diabetes Mellitus: Secretion from Human Placenta and Adipose Tissue	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; INSULIN-RESISTANCE; MACROPHAGE ACCUMULATION; SKELETAL-MUSCLE; PREGNANT-WOMEN; OBESITY; IDENTIFICATION; OVERWEIGHT; EXPRESSION; MANAGEMENT	Recently soluble CD163 (sCD163), a cleaved form of the macrophage receptor CD163, was identified as a macrophage-specific risk-predictor for developing Type 2 Diabetes. Here, we investigate circulating levels of sCD163 in gestational diabetes mellitus (GDM). Furthermore, given the role of the placenta in the pathogenesis of GDM, we assessed placental contribution to sCD163 secretion. Paired maternal (venous) and umbilical vein blood samples from GDM (n = 18) and Body Mass Index (BMI) matched control women (n = 20) delivered by caesarean section at 39-40 week gestation were assessed for circulating levels of sCD163, Tumour necrosis factor alpha (TNF-alpha) and Interleukin 6 (IL-6). Media from explant culture of maternal subcutaneous fat and corresponding placental tissues were assayed for these same molecules. CD163 positive cell numbers were determined in placental and adipose tissues of GDM and control women. We found significantly elevated circulating sCD163 levels in GDM mothers (688.4 +/- 46.9 ng/ml vs. 505.6 +/- 38.6 ng/ml) and their offspring (418.2 +/- 26.6 ng/ml vs. 336.3 +/- 24.4 ng/ml [p<0.05 for both]) as compared to controls, together with elevated circulating TNF-alpha and IL-6 levels. Moreover, both GDM placentae (268.1 +/- 10.8 ng/ml/mg vs. 187.6 +/- 20.6 ng/ml/mg) and adipose explants (41.1 +/- 2.7 ng/ml/mg vs. 26.6 +/- 2.4 ng/ml/mg) released significantly more sCD163 than controls. Lastly, significantly more CD163 positive cells were observed in GDM placentae (25.7 +/- 1.1 vs. 22.1 +/- 1.2) and adipose tissue (19.1 +/- 1.1 vs 12.7 +/- 0.9) compared to controls. We describe elevated sCD163 levels in GDM and identify human placenta as a novel source of sCD163 suggesting that placental tissues might contribute to the increased levels of circulating sCD163 in GDM pregnancies.	[Bari, Muhammad Furqan] Dow Int Med Coll, Dept Pathol, Karachi, Pakistan; [Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile] Warwick Med Sch, Div Reprod & Metab, Coventry, W Midlands, England; [Bari, Muhammad Furqan; Weickert, Martin O.; Sivakumar, Kavitha; Tan, Bee Kang; Randeva, Harpal Singh; Bastie, Claire Cecile] Warwick Med Sch, Div Vasc Hlth, Coventry, W Midlands, England; [Weickert, Martin O.; James, Sean G.; Snead, David R. J.; Randeva, Harpal Singh] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Pathol, Coventry, W Midlands, England; [Weickert, Martin O.; James, Sean G.; Snead, David R. J.; Randeva, Harpal Singh] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Endocrinol, Coventry, W Midlands, England; [Bastie, Claire Cecile] Albert Einstein Coll Med, Dept Med & Endocrinol, Bronx, NY 10467 USA; [Vatish, Manu] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	Dow University of Health Sciences; University of Warwick; University of Warwick; University of Warwick; University of Warwick; Yeshiva University; Albert Einstein College of Medicine; University of Oxford	Vatish, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	manu.vatish@obs-gyn.ox.ac.uk	Vatish, Manu/B-4458-2018; vatish, manu/AAY-8750-2020	vatish, manu/0000-0002-6012-2574; Bastie, Claire/0000-0001-8178-4748; Weickert, Martin O/0000-0002-4070-8164	Nuffield Department of Obstetrics & Gynaecology, University of Oxford; National Institutes of Health [DK81412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412] Funding Source: NIH RePORTER	Nuffield Department of Obstetrics & Gynaecology, University of Oxford; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by Nuffield Department of Obstetrics & Gynaecology, University of Oxford (MV) and the National Institutes of Health (DK81412)(CCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Endo S, 2006, GYNECOL ENDOCRINOL, V22, P343, DOI 10.1080/09513590600724836; GABBE SG, 1986, OBSTET GYNECOL, V67, P121; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kracmerova J, 2014, J CLIN ENDOCRINOLOGY; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Paidas MJ, 2004, J THROMB HAEMOST, V2, P1009, DOI 10.1111/j.1538-7836.2004.00681.x; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Tan BK, 2007, J CLIN ENDOCR METAB, V92, P2764, DOI 10.1210/jc.2007-0091; Tang ZH, 2013, ENDOCRINOLOGY, V154, P471, DOI 10.1210/en.2012-1575; Virjee S, 2001, J ROY SOC MED, V94, P502, DOI 10.1177/014107680109401003; Walker JD, 2008, DIABETIC MED, V25, P1025, DOI 10.1111/j.1464-5491.2008.02532.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	33	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e101327	10.1371/journal.pone.0101327	http://dx.doi.org/10.1371/journal.pone.0101327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983948	Green Published, gold			2022-12-25	WOS:000339635000089
J	Barnea, ER; Lubman, DM; Liu, YH; Absalon-Medina, V; Hayrabedyan, S; Todorova, K; Gilbert, RO; Guingab, J; Barder, TJ				Barnea, Eytan R.; Lubman, David M.; Liu, Yan-Hui; Absalon-Medina, Victor; Hayrabedyan, Soren; Todorova, Krassimira; Gilbert, Robert O.; Guingab, Joy; Barder, Timothy J.			Insight into PreImplantation Factor (PIF*) Mechanism for Embryo Protection and Development: Target Oxidative Stress and Protein Misfolding (PDI and HSP) through Essential RIPK Binding Site	PLOS ONE			English	Article							GROWTH-FACTOR-I; STATISTICAL-MODEL; PEP-FOLD; PREGNANCY; APOPTOSIS; EXPRESSION; BOVINE; THIOREDOXIN; RECEPTOR; SUBUNIT	Background: Endogenous PIF, upon which embryo development is dependent, is secreted only by viable mammalian embryos, and absent in non-viable ones. Synthetic PIF (sPIF) administration promotes singly cultured embryos development and protects against their demise caused by embryo-toxic serum. To identify and characterize critical sPIF-embryo protein interactions novel biochemical and bio-analytical methods were specifically devised. Methods: FITC-PIF uptake/binding by cultured murine and equine embryos was examined and compared with scrambled FITC-PIF (control). Murine embryo (d10) lysates were fractionated by reversed-phase HPLC, fractions printed onto microarray slides and probed with Biotin-PIF, IDE and Kv1.3 antibodies, using fluorescence detection. sPIF-based affinity column was developed to extract and identify PIF-protein interactions from lysates using peptide mass spectrometry (LC/MS/MS). In silico evaluation examined binding of PIF to critical targets, using mutation analysis. Results: PIF directly targets viable cultured embryos as compared with control peptide, which failed to bind. Multistep Biotin-PIF targets were confirmed by single-step PIF-affinity column based isolation. PIF binds protein disulfide isomerases a prolyl-4-hydroxylase beta-subunit, (PDI, PDIA4, PDIA6-like) containing the antioxidant thioredoxin domain. PIF also binds protective heat shock proteins (70&90), co-chaperone, BAG-3. Remarkably, PIF targets a common RIPK site in PDI and HSP proteins. Further, single PIF amino acid mutation significantly reduced peptide-protein target bonding. PIF binds promiscuous tubulins, neuron backbones and ACTA-1,2 visceral proteins. Significant anti-IDE, while limited anti-Kv1.3b antibody-binding to Biotin-PIF positive lysates HPLC fractions were documented. Conclusion: Collectively, data identifies PIF shared targets on PDI and HSP in the embryo. Such are known to play a critical role in protecting against oxidative stress and protein misfolding. PIF-affinity-column is a novel utilitarian method for small molecule targets direct identification. Data reveals and completes the understanding of mechanisms involved in PIF-induced autotrophic and protective effects on the embryo.	[Barnea, Eytan R.] SIEP Soc Invest Early Pregnancy, Cherry Hill, NJ 08003 USA; [Barnea, Eytan R.] BioIncept LLC, Res & Dev, Cherry Hill, NJ USA; [Barnea, Eytan R.] UMDNJ Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod, Camden, NJ USA; [Lubman, David M.; Liu, Yan-Hui] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Absalon-Medina, Victor; Gilbert, Robert O.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Hayrabedyan, Soren; Todorova, Krassimira] Bulgarian Acad Sci, Inst Biol & Immunol Reprod, BU-1113 Sofia, Bulgaria; [Guingab, Joy] Banyan Biomarkers, Chem Biol & Prote, Alachua, FL USA; [Barder, Timothy J.] Eprogen, Res & Dev, Downers Grove, IL USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan; Cornell University; Bulgarian Academy of Sciences; Banyan Biomarkers Inc.	Barnea, ER (corresponding author), SIEP Soc Invest Early Pregnancy, Cherry Hill, NJ 08003 USA.	barnea@earlypregnancy.org	Barnea, Eytan/AAK-9467-2021; Hayrabedyan, Soren B/M-7527-2013; Barnea, Eytan/AAC-9910-2021; Gilbert, Robert/J-9107-2012	Barnea, Eytan/0000-0003-4677-4370; Hayrabedyan, Soren B/0000-0002-2147-1982; Gilbert, Robert/0000-0002-1528-243X; Todorova, Krassimira/0000-0002-4841-9156				Almogi-Hazan O., 2014, ROLE NITRIC OXIDE TO; Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2004, AM J REPROD IMMUNOL, V51, P319, DOI 10.1111/j.1600-0897.2004.00159.x; Barnea ER, 1999, AM J REPROD IMMUNOL, V42, P95; BARNEA ER, 1994, AM J REPROD IMMUNOL, V32, P133, DOI 10.1111/j.1600-0897.1994.tb01103.x; Barnea ER, 2007, ANN NY ACAD SCI, V1110, P602, DOI 10.1196/annals.1423.064; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Block J, 2007, THERIOGENOLOGY, V67, P1518, DOI 10.1016/j.theriogenology.2007.03.012; Brison Daniel R., 2000, Hum Fertil (Camb), V3, P36, DOI 10.1080/1464727002000198671; COULAM CB, 1995, AM J REPROD IMMUNOL, V34, P88, DOI 10.1111/j.1600-0897.1995.tb00923.x; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Jeong DW, 2004, MOL CELLS, V17, P156; Jousan FD, 2008, MOL REPROD DEV, V75, P681, DOI 10.1002/mrd.20830; Kawamura K, 2005, ENDOCRINOLOGY, V146, P4105, DOI 10.1210/en.2004-1646; Kawamura K, 2007, BIOL REPROD, V76, P611, DOI 10.1095/biolreprod.106.058008; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kobayashi M, 2000, ANTIOXID REDOX SIGN, V2, P653, DOI 10.1089/ars.2000.2.4-653; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Matwee C, 2001, MOL HUM REPROD, V7, P829, DOI 10.1093/molehr/7.9.829; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Migliara G, 2014, SIICA FLOR IT; Muller M, 2013, DGPM GERM C PER MED; Muller M, 2014, PREIMPLANTATION FACT; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paidas MJ, 2012, AM J REPROD IMMUNOL, V68, P456, DOI 10.1111/j.1600-0897.2012.01170.x; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; ROUSSEV RG, 1995, AM J REPROD IMMUNOL, V33, P68, DOI 10.1111/j.1600-0897.1995.tb01140.x; Roussev RG, 1996, AM J REPROD IMMUNOL, V35, P281; Roussev RG, 2013, REPROD BIOMED ONLINE, V26, P79, DOI 10.1016/j.rbmo.2012.09.017; Ruan L, 2011, ARTERIOSCL THROM VAS, V31, P392, DOI 10.1161/ATVBAHA.110.213181; Shainer R, 2013, C PAPERS MED, V2013, P1; Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Turner K, 1997, J REPROD FERTIL, V111, P259, DOI 10.1530/jrf.0.1110259; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wei ZX, 2001, MOL REPROD DEV, V60, P457, DOI 10.1002/mrd.1110; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xu JS, 2004, HUM REPROD, V19, P2919, DOI 10.1093/humrep/deh497	47	27	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100263	10.1371/journal.pone.0100263	http://dx.doi.org/10.1371/journal.pone.0100263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24983882	gold, Green Published, Green Submitted			2022-12-25	WOS:000339635000018
J	Grassilli, E; Ianzano, L; Bonomo, S; Missaglia, C; Cerrito, MG; Giovannoni, R; Masiero, L; Lavitrano, M				Grassilli, Emanuela; Ianzano, Leonarda; Bonomo, Sara; Missaglia, Carola; Cerrito, Maria Grazia; Giovannoni, Roberto; Masiero, Laura; Lavitrano, Marialuisa			GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PANCREATIC-CANCER; ACTIVATION; PATHWAYS; REPAIR; GLYCOGEN-SYNTHASE-KINASE-3-BETA; MAINTENANCE; INHIBITION; APOPTOSIS; GROWTH	Glycogen Synthase Kinase-3 alpha (GSK3A) and beta (GSK3B) isoforms are encoded by distinct genes, are 98% identical within their kinase domain and perform similar functions in several settings; however, they are not completely redundant and, depending on the cell type and differentiative status, they also play unique roles. We recently identified a role for GSK3B in drug resistance by demonstrating that its inhibition enables necroptosis in response to chemotherapy in p53-null drug-resistant colon carcinoma cells. We report here that, similarly to GSK3B, also GSK3A silencing/inhibition does not affect cell proliferation or cell cycle but only abolishes growth after treatment with DNA-damaging chemotherapy. In particular, blocking GSK3A impairs DNA repair upon exposure to DNA-damaging drugs. As a consequence, p53-null cells overcome their inability to undergo apoptosis and mount a necroptotic response, characterized by absence of caspase activation and RIP1-independent, PARP-dependent AIF nuclear re-localization. We therefore conclude that GSK3A is redundant with GSK3B in regulating drug-resistance and chemotherapy-induced necroptosis and suggest that inhibition of only one isoform, or rather partial inhibition of overall cellular GSK3 activity, is enough to re-sensitize drug-resistant cells to chemotherapy.	[Grassilli, Emanuela; Ianzano, Leonarda; Bonomo, Sara; Missaglia, Carola; Cerrito, Maria Grazia; Giovannoni, Roberto; Masiero, Laura; Lavitrano, Marialuisa] Univ Milano Bicocca, Dept Surg & Traslat Med, Sch Med, Monza, Italy; [Grassilli, Emanuela] BiOnSil Srl, Monza, Italy	University of Milano-Bicocca	Grassilli, E (corresponding author), Univ Milano Bicocca, Dept Surg & Traslat Med, Sch Med, Via Cadore 48, Monza, Italy.	emanuela.grassilli@unimib.it; marialuisa.lavitrano@unimib.it	grassilli, emanuela/ABB-7845-2020; Cerrito, Maria Grazia/AAA-1190-2019; Giovannoni, Roberto/A-1413-2009; Grassilli, Emanuela/L-7296-2013	grassilli, emanuela/0000-0001-5387-5925; Cerrito, Maria Grazia/0000-0002-3347-5817; Giovannoni, Roberto/0000-0002-7706-0672; Grassilli, Emanuela/0000-0001-5387-5925; Lavitrano, Marialuisa/0000-0003-4852-1318	MIUR [PON01_02782]; University of Milano-Bicocca	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Milano-Bicocca	All authors are supported by PON01_02782 from MIUR and F. A. R. grants from the University of Milano-Bicocca to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Grassilli E, 2004, J BIOL CHEM, V279, P21318, DOI 10.1074/jbc.M313532200; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ivanov A, 2003, J CELL SCI, V116, P4095, DOI 10.1242/jcs.00740; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Madhunapantula SV, 2013, PIGM CELL MELANOMA R, V26, P886, DOI DOI 10.1111/PCMR.12156; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Piazza F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-526; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Schutz SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025341; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Tanioka T, 2011, J BIOL CHEM, V286, P29388, DOI 10.1074/jbc.M110.192732; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P237, DOI 10.1097/FPC.0b013e32833c6107; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398	28	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e100947	10.1371/journal.pone.0100947	http://dx.doi.org/10.1371/journal.pone.0100947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	24984063	Green Published, Green Submitted, gold			2022-12-25	WOS:000339635000042
J	Liu, XD; Yao, J; Tripathi, DN; Ding, Z; Xu, Y; Sun, M; Zhang, J; Bai, S; German, P; Hoang, A; Zhou, L; Jonasch, D; Zhang, X; Conti, CJ; Efstathiou, E; Tannir, NM; Eissa, NT; Mills, GB; Walker, CL; Jonasch, E				Liu, X-D; Yao, J.; Tripathi, D. N.; Ding, Z.; Xu, Y.; Sun, M.; Zhang, J.; Bai, S.; German, P.; Hoang, A.; Zhou, L.; Jonasch, D.; Zhang, X.; Conti, C. J.; Efstathiou, E.; Tannir, N. M.; Eissa, N. T.; Mills, G. B.; Walker, C. L.; Jonasch, E.			Autophagy mediates HIF2 alpha degradation and suppresses renal tumorigenesis	ONCOGENE			English	Article							REGULATE AUTOPHAGY; CELL CARCINOMA; DIRECT BINDING; INHIBITION; UBIQUITIN; PROTEIN; P62; PHOSPHORYLATION; MECHANISMS; BECLIN-1	Autophagy is a conserved process involved in lysosomal degradation of protein aggregates and damaged organelles. The role of autophagy in cancer is a topic of intense debate, and the underlying mechanism is still not clear. The hypoxia-inducible factor 2 alpha (HIF2 alpha), an oncogenic transcription factor implicated in renal tumorigenesis, is known to be degraded by the ubiquitin-proteasome system (UPS). Here, we report that HIF2 alpha is in part constitutively degraded by autophagy. HIF2 alpha interacts with autophagy-lysosome system components. Inhibition of autophagy increases HIF2 alpha, whereas induction of autophagy decreases HIF2 alpha. The E3 ligase von Hippel-Lindau and autophagy receptor protein p62 are required for autophagic degradation of HIF2 alpha. There is a compensatory interaction between the UPS and autophagy in HIF2 alpha degradation. Autophagy inactivation redirects HIF2 alpha to proteasomal degradation, whereas proteasome inhibition induces autophagy and increases the HIF2 alpha-p62 interaction. Importantly, clear-cell renal cell carcinoma (ccRCC) is frequently associated with monoallelic loss and/or mutation of autophagy-related gene ATG7, and the low expression level of autophagy genes correlates with ccRCC progression. The protein levels of ATG7 and beclin 1 are also reduced in ccRCC tumors. This study indicates that autophagy has an anticancer role in ccRCC tumorigenesis, and suggests that constitutive autophagic degradation of HIF2 alpha is a novel tumor suppression mechanism.	[Liu, X-D; Sun, M.; Bai, S.; German, P.; Hoang, A.; Zhou, L.; Zhang, X.; Efstathiou, E.; Tannir, N. M.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Unit 1374, Houston, TX 77030 USA; [Yao, J.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Tripathi, D. N.; Zhang, J.; Jonasch, D.; Walker, C. L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Ding, Z.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Xu, Y.; Eissa, N. T.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Conti, C. J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Unit 1374, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xliu10@mdanderson.org; ejonasch@mdanderson.org	Tripathi, Durga Nand/H-3247-2019	Tripathi, Durga Nand/0000-0001-8736-4808; Liu, xiande/0000-0002-9639-0458	Nanomedicine Roadmap Initiative Grant; Renee Kaye Cure Fur Cancer Grant; MD Anderson Cancer Center Kidney Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA143811, P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	Nanomedicine Roadmap Initiative Grant; Renee Kaye Cure Fur Cancer Grant; MD Anderson Cancer Center Kidney Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge the TCGA Research network. This work was supported by the Nanomedicine Roadmap Initiative Grant, the Renee Kaye Cure Fur Cancer Grant and the MD Anderson Cancer Center Kidney Cancer Research Program.	Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding ZY, 2012, J BIOMOL SCREEN, V17, P572, DOI 10.1177/1087057112436557; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hacker KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003801; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Jonasch E, 2012, MOL CANCER RES, V10, P859, DOI 10.1158/1541-7786.MCR-12-0117; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim J, 2009, CLIN CANCER RES, V15, P81, DOI 10.1158/1078-0432.CCR-08-0170; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Prasad SR, 2006, RADIOGRAPHICS, V26, P1795, DOI 10.1148/rg.266065010; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	45	54	57	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 7	2015	34	19					2450	2460		10.1038/onc.2014.199	http://dx.doi.org/10.1038/onc.2014.199			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CH7BK	24998849	Green Accepted			2022-12-25	WOS:000354190400004
J	Iyer, S; Han, L; Bartell, SM; Kim, HN; Gubrij, I; de Cabo, R; O'Brien, CA; Manolagas, SC; Almeida, M				Iyer, Srividhya; Han, Li; Bartell, Shoshana M.; Kim, Ha-Neui; Gubrij, Igor; de Cabo, Rafael; O'Brien, Charles A.; Manolagas, Stavros C.; Almeida, Maria			Sirtuin1 (Sirt1) Promotes Cortical Bone Formation by Preventing beta-Catenin Sequestration by FoxO Transcription Factors in Osteoblast Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Apoptosis; Cell Proliferation; Osteoporosis; Wnt Signaling	LIFE-SPAN; MUSCLE ATROPHY; DISEASE; REGULATOR; MAINTENANCE; RESVERATROL; PROTEINS; ESTROGEN; INSIGHTS; PROTECTS	Background: Sirt1 activity, like osteoblast number and bone mass, declines with age. Results: Mice with Sirt1 deletion in osteoprogenitor cells have low cortical bone mass due to decreased bone formation resulting from increased -catenin sequestration by FoxOs. Conclusion: Sirt1 increases Wnt signaling and bone formation by a mechanism involving FoxOs. Significance: Sirt1 in osteoprogenitor cells could be a therapeutic target for osteoporosis. A decline of the levels and activity of Sirtuin1 (Sirt1), a NAD(+) class III histone deacetylase, with age contributes to the development of several diseases including type 2 diabetes, neurodegeneration, inflammation, and cancer. The anti-aging effects of Sirt1 evidently result from the deacetylation of many transcription factors and co-factors including members of the Forkhead box O (FoxO) family and -catenin. Wnt/-catenin is indispensable for osteoblast generation. FoxOs, on the other hand, sequester -catenin and inhibit osteoprogenitor proliferation. Here, we have deleted Sirt1 in osteoprogenitors expressing Osterix1 (Osx1)-Cre and their descendants. Sirt1(Osx1) mice had lower cortical thickness in femora and vertebrae because of reduced bone formation at the endocortical surface. In line with this, osteoprogenitor cell cultures from the Sirt1(Osx1) mice exhibited lower alkaline phosphatase activity and mineralization, as well as decreased proliferation and increased apoptosis. These changes were associated with decreased Wnt/-catenin signaling and expression of cyclin D1 and resulted from increased binding of FoxOs to -catenin. These findings demonstrate that Sirt1-induced deacetylation of FoxOs unleashes Wnt signaling. A decline in Sirt1 activity in osteoblast progenitors with aging may, therefore, contribute to the age-related loss of bone mass. Together with evidence that Sirt1 activators increase bone mass in aged mice, our results also suggest that Sirt1 could be a therapeutic target for osteoporosis.	[Iyer, Srividhya; Han, Li; Bartell, Shoshana M.; Kim, Ha-Neui; O'Brien, Charles A.; Manolagas, Stavros C.; Almeida, Maria] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Gubrij, Igor] Univ Arkansas Med Sci, Div Pulm & Crit Care, Little Rock, AR 72205 USA; [de Cabo, Rafael] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Almeida, M (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, 4301 W Markham St 587, Little Rock, AR 72205 USA.	schullermaria@uams.edu	de Cabo, Rafael/E-7996-2010; O'Brien, Charles A./AAL-5078-2020; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Iyer, Srividhya/0000-0002-8953-373X; Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health Grants [R01 AR56679, P01 AG13918, F32 AR061956-02]; Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant [I01 BX001405]; University of Arkansas for Medical Sciences Tobacco Funds; Translational Research Institute Grant [1UL1RR029884]; Intramural Research Program of the NIA, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061956, R01AR056679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918, ZIAAG000361, ZIAAG000363] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001405] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant; University of Arkansas for Medical Sciences Tobacco Funds; Translational Research Institute Grant; Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR56679 (to M. A.), P01 AG13918 (to S. C. M.), F32 AR061956-02 (to S. M. B.); Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant I01 BX001405 (to S. C. M.); and University of Arkansas for Medical Sciences Tobacco Funds and Translational Research Institute Grant 1UL1RR029884.; Supported by the Intramural Research Program of the NIA, National Institutes of Health.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Almeida M, 2011, BONE, V49, P319, DOI 10.1016/j.bone.2011.05.023; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lee D, 2013, J BIOL CHEM, V288, P30515, DOI 10.1074/jbc.M113.489716; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Moore RL, 2012, J ENDOCRINOL, V213, P37, DOI 10.1530/JOE-11-0217; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Trinei M, 2009, AGING-US, V1, P503, DOI 10.18632/aging.100057; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083	45	88	93	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24069	24078		10.1074/jbc.M114.561803	http://dx.doi.org/10.1074/jbc.M114.561803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002589	hybrid, Green Published			2022-12-25	WOS:000341505600007
J	Roach, EJ; Kimber, MS; Khursigara, CM				Roach, Elyse J.; Kimber, Matthew S.; Khursigara, Cezar M.			Crystal Structure and Site-directed Mutational Analysis Reveals Key Residues Involved in Escherichia coli ZapA Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cell Division; Crystal Structure; Electron Microscopy (EM); Escherichia coli (E coli)	CELL-DIVISION PROTEIN; FTSZ-RING; DIVISOME; PROTOFILAMENTS; DYNAMICS; PROMOTES	Background: ZapA and FtsZ interact prior to bacterial cell division to stabilize the Z-ring. Results: The structure of E. coli ZapA reveals a charged -helix important for FtsZ interactions. Conclusion: Key residues in the charged -helix of ZapA are important for FtsZ filament bundling. Significance: ZapA facilitates FtsZ filament bundling and Z-ring stability in dividing bacterial cells. FtsZ is an essential cell division protein in Escherichia coli, and its localization, filamentation, and bundling at the mid-cell are required for Z-ring stability. Once assembled, the Z-ring recruits a series of proteins that comprise the bacterial divisome. Zaps (FtsZ-associated proteins) stabilize the Z-ring by increasing lateral interactions between individual filaments, bundling FtsZ to provide a scaffold for divisome assembly. The x-ray crystallographic structure of E. coli ZapA was determined, identifying key structural differences from the existing ZapA structure from Pseudomonas aeruginosa, including a charged -helix on the globular domains of the ZapA tetramer. Key helix residues in E. coli ZapA were modified using site-directed mutagenesis. These ZapA variants significantly decreased FtsZ bundling in protein sedimentation assays when compared with WT ZapA proteins. Electron micrographs of ZapA-bundled FtsZ filaments showed the modified ZapA variants altered the number of FtsZ filaments per bundle. These in vitro results were corroborated in vivo by expressing the ZapA variants in an E. coli zapA strain. In vivo, ZapA variants that altered FtsZ bundling showed an elongated phenotype, indicating improper cell division. Our findings highlight the importance of key ZapA residues that influence the extent of FtsZ bundling and that ultimately affect Z-ring formation in dividing cells.	[Roach, Elyse J.; Kimber, Matthew S.; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	ckhursig@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Roach, Elyse/0000-0003-0079-8510; Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [371639, 327280]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada Discovery Grants 371639 (to C. M. K.) and 327280 (to M. S. K.).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Buddelmeijer N, 2002, CURR OPIN MICROBIOL, V5, P553, DOI 10.1016/S1369-5274(02)00374-0; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Vicente M, 1996, MOL MICROBIOL, V20, P1, DOI 10.1111/j.1365-2958.1996.tb02482.x; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; WARD JE, 1985, CELL, V42, P941, DOI 10.1016/0092-8674(85)90290-9	51	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23276	23286		10.1074/jbc.M114.561928	http://dx.doi.org/10.1074/jbc.M114.561928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002581	Green Published, hybrid			2022-12-25	WOS:000341505000002
J	Zheng, SD; Lan, PF; Liu, XM; Ye, KQ				Zheng, Sanduo; Lan, Pengfei; Liu, Ximing; Ye, Keqiong			Interaction between Ribosome Assembly Factors Krr1 and Faf1 Is Essential for Formation of Small Ribosomal Subunit in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KH-DOMAIN; FUNCTIONAL-ANALYSIS; 90S PRERIBOSOME; RNA-BINDING; U3 SNORNA; BOX C/D; PROTEIN; BIOGENESIS; PROCESSOME; HOMOLOG	Ribosome formation in Saccharomyces cerevisiae requires a large number of transiently associated assembly factors that coordinate processing and folding of pre-rRNA and binding of ribosomal proteins. Krr1 and Faf1 are two interacting proteins present in early 90 S precursor particles of the small ribosomal subunit. Here, we determined a co-crystal structure of the core domain of Krr1 bound to a 19-residue fragment of Faf1 at 2.8 angstrom resolution. The structure reveals that Krr1 consists of two packed K homology (KH) domains, KH1 and KH2, and resembles archaeal Dim2-like proteins. We show that KH1 is a divergent KH domain that lacks the RNA-binding GXXG motif and is involved in binding another assembly factor, Kri1. KH2 contains a canonical RNA-binding surface and additionally associates with an alpha-helix of Faf1. Specific disruption of the Krr1-Faf1 interaction impaired early 18 S rRNA processing at sites A0, A1, and A2 and caused cell lethality, but it did not prevent incorporation of the two proteins into pre-ribosomes. The Krr1-Faf1 interaction likely maintains a critical conformation of 90 S pre-ribosomes required for pre-rRNA processing. Our results illustrate the versatility of KH domains in protein interaction and provide insight into the role of Krr1-Faf1 interaction in ribosome biogenesis.	[Zheng, Sanduo] Beijing Normal Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Lan, Pengfei; Ye, Keqiong] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Lan, Pengfei; Ye, Keqiong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zheng, Sanduo; Lan, Pengfei; Liu, Ximing; Ye, Keqiong] Natl Inst Biol Sci Beijing, Beijing 102206, Peoples R China; [Ye, Keqiong] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ye, KQ (corresponding author), Natl Inst Biol Sci Beijing, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn		Liu, Ximing/0000-0001-8617-2943	National Natural Science Foundation of China [31325007]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010203]; Ministry of Science and Technology of China (National Basic Research Program of China) [2010CB835402]; Beijing Municipal Government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China (National Basic Research Program of China)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Beijing Municipal Government	This work was supported by National Natural Science Foundation of China Grant 31325007, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010203, Ministry of Science and Technology of China (National Basic Research Program of China) Grant 2010CB835402, and the Beijing Municipal Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chan HYE, 2001, MOL BIOL CELL, V12, P1409, DOI 10.1091/mbc.12.5.1409; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Gromadka R, 2000, ACTA BIOCHIM POL, V47, P993, DOI 10.18388/abp.2000_3953; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jia MZ, 2007, PROTEINS, V69, P428, DOI 10.1002/prot.21381; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Karkusiewicz W, 2004, BIOCHEM BIOPH RES CO, V319, P349, DOI 10.1016/j.bbrc.2004.05.012; Kondoh H, 2000, GENES CELLS, V5, P525, DOI 10.1046/j.1365-2443.2000.00344.x; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu J, 2013, RNA, V19, P1815, DOI 10.1261/rna.040808.113; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Rempola B, 2006, BIOCHEM BIOPH RES CO, V346, P546, DOI 10.1016/j.bbrc.2006.05.140; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Segerstolpe A, 2013, NUCLEIC ACIDS RES, V41, P1178, DOI 10.1093/nar/gks1129; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Yamada H, 2007, RNA, V13, P1977, DOI 10.1261/rna.553807; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540; Zhang LM, 2013, RNA, V19, P701, DOI 10.1261/rna.037580.112	63	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22692	22703		10.1074/jbc.M114.584490	http://dx.doi.org/10.1074/jbc.M114.584490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990943	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000341017200015
J	Li, JB; Bi, LP; Hulke, M; Li, TG				Li, Jibiao; Bi, Lipeng; Hulke, Michelle; Li, Tiangang			Fish Oil and Fenofibrate Prevented Phosphorylation-dependent Hepatic Sortilin 1 Degradation in Western Diet-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; INDUCED INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN RECEPTOR; BETA-CELL DYSFUNCTION; VASCULAR FUNCTION; VLDL PRODUCTION; T-CELLS; INFLAMMATION; ALPHA; ATHEROSCLEROSIS	Obesity and diabetes are associated with hepatic triglyceride overproduction and hypertriglyceridemia. Recent studies have found that the cellular trafficking receptor sortilin 1 (Sort1) inhibits hepatic apolipoprotein B secretion and reduces plasma lipid levels in mice, and its hepatic expression was negatively associated with plasma lipids in humans. This study investigated the regulation of hepatic Sort1 under diabetic conditions and by lipid-lowering fish oil and fenofibrate. Results showed that hepatic Sort1 protein, but not mRNA, was markedly lower in Western diet-fed mice. Knockdown of hepatic Sort1 increased plasma triglyceride in mice. Feeding mice a fish oil-enriched diet completely restored hepatic Sort1 levels in Western diet-fed mice. Fenofibrate also restored hepatic Sort1 protein levels in Western diet-fed wild type mice, but not in peroxisome proliferator-activated receptor alpha(PPAR alpha) knock-out mice. PPAR alpha ligands did not induce Sort1 in hepatocytes in vitro. Instead, fish oil and fenofibrate reduced circulating and hepatic fatty acids in mice, and n-3 polyunsaturated fatty acids prevented palmitate inhibition of Sort1 protein in HepG2 cells. LC/MS/MS analysis revealed that Sort1 phosphorylation at serine 793 was increased in obese mice and in palmitate-treated HepG2 cells. Mutations that abolished phosphorylation at Ser-793 increased Sort1 stability and prevented palmitate inhibition of Sort1 ubiquitination and degradation in HepG2 cells. In summary, therapeutic strategies that prevent posttranslational hepatic Sort1 down-regulation in obesity and diabetes may be beneficial in improving dyslipidemia.	[Li, Jibiao; Bi, Lipeng; Hulke, Michelle; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Li, Jibiao/A-5627-2017		National Institutes of Health (NIH); NCRR [5P20RR021940-07]; NIH; NIGMS [8 P20 GM103549-07]; Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics; American Diabetes Association Junior Faculty Award; National Institutes of Health [U24 DK059630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics; American Diabetes Association Junior Faculty Award(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCRR, Grant 5P20RR021940-07 and NIH, NIGMS, Grant 8 P20 GM103549-07 (to T. L.) and the Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics. This work was also supported by an American Diabetes Association Junior Faculty Award (to T. L.). The University of Cincinnati Mouse Metabolic Phenotyping Center is supported by National Institutes of Health Grant U24 DK059630.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bordin P, 1998, EUR J CLIN NUTR, V52, P104, DOI 10.1038/sj.ejcn.1600522; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Denys A, 2001, J LIPID RES, V42, P2015; Ding YL, 2012, ARTERIOSCL THROM VAS, V32, P1596, DOI 10.1161/ATVBAHA.112.249847; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Mikami N, 2012, J FOOD SCI, V77, pH114, DOI 10.1111/j.1750-3841.2012.02687.x; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Murali G, 2012, J LIPID RES, V53, P2186, DOI 10.1194/jlr.M029843; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Park Y, 2003, J LIPID RES, V44, P455, DOI 10.1194/jlr.M200282-JLR200; Reaven GM, 2002, DIABETES OBES METAB, V4, pS13, DOI 10.1046/j.1462-8902.2001.00037.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Steinberg HO, 2002, DIABETOLOGIA, V45, P623, DOI 10.1007/s00125-002-0800-2; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tripathy D, 2003, DIABETOLOGIA, V46, P300, DOI 10.1007/s00125-002-1027-y; Weitz D, 2010, CARDIOL REV, V18, P258, DOI 10.1097/CRD.0b013e3181ea0de0; Whyte C, 2012, J NUTR BIOCHEM, V23, P1378, DOI 10.1016/j.jnutbio.2011.08.005; Yaqoob P, 2010, CURR OPIN CLIN NUTR, V13, P156, DOI 10.1097/MCO.0b013e328335725b; Zuliani G, 2009, CURR PHARM DESIGN, V15, P4087, DOI 10.2174/138161209789909773	50	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22437	22449		10.1074/jbc.M114.548933	http://dx.doi.org/10.1074/jbc.M114.548933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24986865	hybrid, Green Published			2022-12-25	WOS:000340593500053
J	Morken, NH; Travlos, GS; Wilson, RE; Eggesbo, M; Longnecker, MP				Morken, Nils-Halvdan; Travlos, Gregory S.; Wilson, Ralph E.; Eggesbo, Merete; Longnecker, Matthew P.			Maternal Glomerular Filtration Rate in Pregnancy and Fetal Size	PLOS ONE			English	Article							NORWEGIAN MOTHER; CHILD COHORT; PERFLUOROALKYL SUBSTANCES; POLYFLUOROALKYL COMPOUNDS; BIRTH-WEIGHT; PLASMA; GROWTH; WOMEN; EQUATIONS; VOLUME	Background: The relationship of maternal glomerular filtration rate (GFR) in pregnancy to fetal size needs to be better characterized as it impacts an ongoing debate about confounding effect of maternal GFR in investigations of important environmental contaminants. We aimed to characterize the size of the association between maternal GFR and infant birth weight. Materials and Methods: A sub-cohort of 953 selected women (470 women with and 483 women without preeclampsia) in the Norwegian Mother and Child Cohort (MoBa), recruited during 2003-2007 were analyzed. GFR in the second trimester was estimated based on plasma creatinine. Birth weight was ascertained from the Medical Birth Registry of Norway. Multivariate linear regression was used to evaluate the association between maternal GFR in second trimester (estimated by the Cockroft-Gault [GFR-CG] and the modification of diet in renal disease [GFR-MDRD] formulas) and infant birth weight. Partial correlation coefficients were also calculated. Results: Maternal GFR-CG (beta: 0.73 g/ml/min, p = 0.04) and GFR-MDRD (beta: 0.83 g/ml/min, p = 0.04) were associated with infant birth weight in models adjusted for maternal weight in kilograms, preeclampsia, and gestational age at delivery (days). Partial correlation coefficients for the association between infant birth weight and GFR were 0.07 for both formulas. Although the birth weight-GFR association was stronger among the women with preeclampsia, the difference from women without preeclampsia was not statistically significant. Conclusion: These data support an association between GFR during pregnancy and infant birth weight, and indicate that GFR may confound selected epidemiologic associations.	[Morken, Nils-Halvdan] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Morken, Nils-Halvdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Travlos, Gregory S.; Wilson, Ralph E.] NIEHS, Cellular & Mol Pathol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Eggesbo, Merete] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Longnecker, Matthew P.] NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Morken, NH (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	nils-halvdan.morken@kk.uib.no		Longnecker, Matthew/0000-0001-6073-5322; Eggesbo, Merete/0000-0002-0006-5336	University of Bergen; Unger-Vetlesen Medical Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044008] Funding Source: NIH RePORTER	University of Bergen; Unger-Vetlesen Medical Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Nils-Halvdan Morken was supported with funding from the University of Bergen and the Unger-Vetlesen Medical Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2009, HYPERTENS PREGNANCY, V28, P243, DOI 10.1080/10641950801986720; Akahori Y, 2012, GYNECOL OBSTET INVES, V73, P162, DOI 10.1159/000332391; Al-Delaimy WK, 2006, BIOMARKERS, V11, P370, DOI 10.1080/13547500600799748; Alper AB, 2011, AM J PERINAT, V28, P425, DOI 10.1055/s-0030-1268712; Calafat AM, 2007, ENVIRON SCI TECHNOL, V41, P2237, DOI 10.1021/es062686m; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; Clark S, 2003, INT J EPIDEMIOL, V32, P125, DOI 10.1093/ije/dyg023; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; DUNLOP W, 1981, BRIT J OBSTET GYNAEC, V88, P1, DOI 10.1111/j.1471-0528.1981.tb00929.x; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; Duvekot J J, 1994, Obstet Gynecol Surv, V49, P830, DOI 10.1097/00006254-199412000-00007; DUVEKOT JJ, 1995, OBSTET GYNECOL, V85, P361, DOI 10.1016/0029-7844(94)00417-C; GIBSON HM, 1973, J OBSTET GYN BR COMM, V80, P1067; Halldorsson TI, 2012, ENVIRON HEALTH PERSP, V120, P668, DOI 10.1289/ehp.1104034; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Johnson P SP, 2013, C INT SOC ENV EP ISE; Knopp R H, 1985, Diabetes, V34 Suppl 2, P71; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Loccisano A, 2012, TOXICOLOGICAL SCI S, V97; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Maisonet M, 2012, ENVIRON HEALTH PERSP, V120, P1432, DOI 10.1289/ehp.1003096; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Smith MC, 2008, BJOG-INT J OBSTET GY, V115, P109, DOI 10.1111/j.1471-0528.2007.01529.x; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Starling AP, 2014, AM J EPIDEMIOL, V179, P824, DOI 10.1093/aje/kwt432; Starling AP, 2014, ENVIRON INT, V62, P104, DOI 10.1016/j.envint.2013.10.004; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459; Zhou HB, 2007, EPIDEMIOLOGY, V18, P461, DOI 10.1097/EDE.0b013e31806462d3	32	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101897	10.1371/journal.pone.0101897	http://dx.doi.org/10.1371/journal.pone.0101897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003331	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700085
J	Cheema, MU; Damkier, HH; Nielsen, J; Poulsen, ET; Enghild, JJ; Fenton, RA; Praetorius, J				Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Fenton, Robert A.; Praetorius, Jeppe			Distal Renal Tubules Are Deficient in Aggresome Formation and Autophagy upon Aldosterone Administration	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; SODIUM TRANSPORT; PROTEIN; PLASMA; MINERALOCORTICOIDS; ACTIVATION; MECHANISM; EXCRETION; APOPTOSIS; BLOCKADE	Prolonged elevations of plasma aldosterone levels are associated with renal pathogenesis. We hypothesized that renal distress could be imposed by an augmented aldosterone-induced protein turnover challenging cellular protein degradation systems of the renal tubular cells. Cellular accumulation of specific protein aggregates in rat kidneys was assessed after 7 days of aldosterone administration. Aldosterone induced intracellular accumulation of 60 s ribosomal protein L22 in protein aggregates, specifically in the distal convoluted tubules. The mineralocorticoid receptor inhibitor spironolactone abolished aldosterone-induced accumulation of these aggregates. The aldosterone-induced protein aggregates also contained proteasome 20 s subunits. The partial de-ubiquitinase ataxin-3 was not localized to the distal renal tubule protein aggregates, and the aggregates only modestly colocalized with aggresome transfer proteins dynactin p62 and histone deacetylase 6. Intracellular protein aggregation in distal renal tubules did not lead to development of classical juxta-nuclear aggresomes or to autophagosome formation. Finally, aldosterone treatment induced foci in renal cortex of epithelial vimentin expression and a loss of E-cadherin expression, as signs of cellular stress. The cellular changes occurred within high, but physiological aldosterone concentrations. We conclude that aldosterone induces protein accumulation in distal renal tubules; these aggregates are not cleared by autophagy that may lead to early renal tubular damage.	[Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Fenton, Robert A.; Praetorius, Jeppe] Aarhus Univ, Membranes Ctr, Dept Biomed, Aarhus, Denmark; [Cheema, Muhammad Umar; Damkier, Helle Hasager; Nielsen, Jakob; Fenton, Robert A.; Praetorius, Jeppe] Aarhus Univ, InterPrET Pilot Ctr, Aarhus, Denmark; [Poulsen, Ebbe Toftgaard; Enghild, Jan J.] Aarhus Univ, iNano, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Praetorius, J (corresponding author), Aarhus Univ, Membranes Ctr, Dept Biomed, Aarhus, Denmark.	jp@ana.au.dk	Fenton, Robert/AFR-6983-2022; Praetorius, Jeppe/AAU-7893-2020; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Praetorius, Jeppe/0000-0001-6109-247X; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Damkier, Helle/0000-0001-7518-4017; Enghild, Jan Johannes/0000-0001-9292-9172	Graduate School of Health Sciences, Aarhus University; Water and Salt Research Center at Aarhus University - (Danish National Research Foundation); Lundbeck Foundation; Danish Heart Association	Graduate School of Health Sciences, Aarhus University; Water and Salt Research Center at Aarhus University - (Danish National Research Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Heart Association	Muhammad Umar Cheema was supported by a PhD stipend co-financed by Graduate School of Health Sciences, Aarhus University and the Water and Salt Research Center at Aarhus University (established and supported by the Danish National Research Foundation). Financial support for running costs were granted by the Lundbeck Foundation and the Danish Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts A, 2008, MOL BIOL CELL; Bernini G, 2008, J HYPERTENS, V26, P981, DOI 10.1097/HJH.0b013e3282f61f8c; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Cheema MU, 2013, PHYSL REPORTS, V1; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; EDELMAN IS, 1963, P NATL ACAD SCI USA, V50, P1169, DOI 10.1073/pnas.50.6.1169; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; HANDLER JS, 1969, J BIOL CHEM, V244, P3194; Hol EM, 2006, EXPERT REV NEUROTHER, V6, P1337, DOI 10.1586/14737175.6.9.1337; Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x; HORISBERGER JD, 1983, AM J PHYSIOL, V245, pF89, DOI 10.1152/ajprenal.1983.245.1.F89; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Nagase M, 2010, CLIN EXP NEPHROL, V14, P303, DOI 10.1007/s10157-010-0298-8; Nagata S, 2010, PEPTIDES, V31, P889, DOI 10.1016/j.peptides.2010.02.008; Nielsen J, 2007, AM J PHYSIOL-RENAL, V292, pF382, DOI 10.1152/ajprenal.00212.2005; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Patni H, 2007, AM J PHYSIOL-RENAL, V293, pF1065, DOI 10.1152/ajprenal.00147.2007; PFLEIDERER S, 1993, CLIN INVESTIGATOR, V71, P972; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rosenbaek LL, 2012, J PHYSIOL-LONDON, V590, P6121, DOI 10.1113/jphysiol.2012.240986; SHARP GWG, 1965, J BIOL CHEM, V240, P4816; SIMPSON SA, 1954, EXPERIENTIA, V10, P132, DOI 10.1007/BF02158515; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; YAQOOB M, 1994, Q J MED, V87, P601	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e101258	10.1371/journal.pone.0101258	http://dx.doi.org/10.1371/journal.pone.0101258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000288	Green Submitted, gold, Green Published			2022-12-25	WOS:000338637300028
J	Endmann, A; Kluender, K; Kapp, K; Riede, O; Oswald, D; Talman, EG; Schroff, M; Kleuss, C; Ruiters, MHJ; Juhls, C				Endmann, Anne; Klunder, Katharina; Kapp, Kerstin; Riede, Oliver; Oswald, Detlef; Talman, Eduard G.; Schroff, Matthias; Kleuss, Christiane; Ruiters, Marcel H. J.; Juhls, Christiane			Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSES; PARTICLE MORPHOGENESIS; EXPRESSION CONSTRUCTS; MEDIATED IMMUNIZATION; ANTIBODY-RESPONSES; ENVELOPE PROTEINS; HUMORAL RESPONSE; GENE DELIVERY; T-CELL; MICE	Currently marketed vaccines against hepatitis B virus (HBV) based on the small (S) hepatitis B surface antigen (HBsAg) fail to induce a protective immune response in about 10% of vaccinees. DNA vaccination and the inclusion of PreS1 and PreS2 domains of HBsAg have been reported to represent feasible strategies to improve the efficacy of HBV vaccines. Here, we evaluated the immunogenicity of SAINT-18-formulated MIDGE-Th1 vectors encoding the S or the large (L) protein of HBsAg in mice and pigs. In both animal models, vectors encoding the secretion-competent S protein induced stronger humoral responses than vectors encoding the L protein, which was shown to be retained mainly intracellularly despite the presence of a heterologous secretion signal. In pigs, SAINT-18-formulated MIDGE-Th1 vectors encoding the S protein elicited an immune response of the same magnitude as the licensed protein vaccine Engerix-B, with S protein-specific antibody levels significantly higher than those considered protective in humans, and lasting for at least six months after the third immunization. Thus, our results provide not only the proof of concept for the SAINT-18-formulated MIDGE-Th1 vector approach but also confirm that with a cationic-lipid formulation, a DNA vaccine at a relatively low dose can elicit an immune response similar to a human dose of an aluminum hydroxide-adjuvanted protein vaccine in large animals.	[Endmann, Anne; Klunder, Katharina; Kapp, Kerstin; Riede, Oliver; Oswald, Detlef; Schroff, Matthias; Kleuss, Christiane; Juhls, Christiane] MOLOGEN AG, Berlin, Germany; [Talman, Eduard G.; Ruiters, Marcel H. J.] Synvolux Therapeut BV, Groningen, Netherlands; [Ruiters, Marcel H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Mologen AG; University of Groningen	Endmann, A (corresponding author), MOLOGEN AG, Berlin, Germany.	endmann@mologen.com			Federal Ministry for Education and Research (BMBF), Germany [0315723]; Ministry of Economic Affairs (AgentschapNL), The Netherlands [09001]	Federal Ministry for Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Ministry of Economic Affairs (AgentschapNL), The Netherlands	This study was supported by grants received from the Federal Ministry for Education and Research (BMBF, www.bmbf.de), Germany (ERA-Net EuroTransBio-4, grant no. 0315723 to MOLOGEN AG) and from the Ministry of Economic Affairs (AgentschapNL (EZ), http://www.rvo.nl), The Netherlands (grant no. 09001 to Synvolux Therapeutics B.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov AK, 2009, P NATL ACAD SCI USA, V106, P18936, DOI 10.1073/pnas.0908842106; Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.jbiotec.2004.01.015; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; BRUSS V, 1995, J VIROL, V69, P6652, DOI 10.1128/JVI.69.11.6652-6657.1995; Cooper C, 2011, EXPERT REV VACCINES, V10, P417, DOI [10.1586/ERV.10.162, 10.1586/erv.10.162]; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; Davis HL, 1996, P NATL ACAD SCI USA, V93, P7213, DOI 10.1073/pnas.93.14.7213; Endmann A, 2014, VACCINE IN PRESS; Endmann A, 2010, VACCINE, V28, P3642, DOI 10.1016/j.vaccine.2010.03.034; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Ge GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041573; Geissler M, 1997, GASTROENTEROLOGY, V112, P1307, DOI 10.1016/S0016-5085(97)70145-8; Gilca V, 2013, VACCINE, V31, P448, DOI 10.1016/j.vaccine.2012.11.037; Jones CD, 1999, VACCINE, V17, P2528, DOI 10.1016/S0264-410X(99)00061-4; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Luxembourg A, 2008, VACCINE, V26, P4025, DOI 10.1016/j.vaccine.2008.05.021; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MICHEL ML, 1995, P NATL ACAD SCI USA, V92, P5307, DOI 10.1073/pnas.92.12.5307; Moreno S, 2004, VACCINE, V22, P1709, DOI 10.1016/j.vaccine.2003.09.051; NEURATH AR, 1987, MOL IMMUNOL, V24, P561, DOI 10.1016/0161-5890(87)90036-8; NEURATH AR, 1986, VACCINE, V4, P35, DOI 10.1016/S0264-410X(86)80001-9; Obeng-Adjei N, 2013, CANCER GENE THER, V20, P652, DOI 10.1038/cgt.2013.65; Panjaworayan N, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-136; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Prange R, 1999, VACCINE, V17, P617, DOI 10.1016/S0264-410X(98)00243-6; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Raz R, 2001, ISRAEL MED ASSOC J, V3, P328; Rendi-Wagner P, 2006, VACCINE, V24, P2781, DOI 10.1016/j.vaccine.2006.01.007; Rottinghaus ST, 2003, VACCINE, V21, P4604, DOI 10.1016/S0264-410X(03)00447-X; Schirmbeck R, 2001, J MOL MED-JMM, V79, P343, DOI 10.1007/s001090100227; Shapira MY, 2001, J HEPATOL, V34, P123, DOI 10.1016/S0168-8278(00)00082-9; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Tacket CO, 1999, VACCINE, V17, P2826, DOI 10.1016/S0264-410X(99)00094-8; Tong NKC, 2005, KIDNEY INT, V68, P2298, DOI 10.1111/j.1523-1755.2005.00689.x; VanDerWoude I, 1997, P NATL ACAD SCI USA, V94, P1160, DOI 10.1073/pnas.94.4.1160; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; WHO, 2009, WKLY EPIDEMIOL REC, V40, P20; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2014	9	7							e101715	10.1371/journal.pone.0101715	http://dx.doi.org/10.1371/journal.pone.0101715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3RT	24992038	Green Published, gold, Green Submitted			2022-12-25	WOS:000341253400107
J	Manguan-Garcia, C; Pintado-Berninches, L; Carrillo, J; Machado-Pinilla, R; Sastre, L; Perez-Quilis, C; Esmoris, I; Gimeno, A; Garcia-Gimenez, JL; Pallardo, FV; Perona, R				Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Carrillo, Jaime; Machado-Pinilla, Rosario; Sastre, Leandro; Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.; Perona, Rosario			Expression of the Genetic Suppressor Element 24.2 (GSE24.2) Decreases DNA Damage and Oxidative Stress in X-Linked Dyskeratosis Congenita Cells	PLOS ONE			English	Article							BONE-MARROW FAILURE; TELOMERASE ACTIVITY; LIPID-PEROXIDATION; END-PROTECTION; MUTATIONS; CANCER; LENGTH; 53BP1; ACCUMULATION; REPLICATION	The predominant X-linked form of Dyskeratosis congenita results from mutations in DKC1, which encodes dyskerin, a protein required for ribosomal RNA modification that is also a component of the telomerase complex. We have previously found that expression of an internal fragment of dyskerin (GSE24.2) rescues telomerase activity in X-linked dyskeratosis congenita (X-DC) patient cells. Here we have found that an increased basal and induced DNA damage response occurred in X-DC cells in comparison with normal cells. DNA damage that is also localized in telomeres results in increased heterochromatin formation and senescence. Expression of a cDNA coding for GSE24.2 rescues both global and telomeric DNA damage. Furthermore, transfection of bacterial purified or a chemically synthesized GSE24.2 peptide is able to rescue basal DNA damage in X-DC cells. We have also observed an increase in oxidative stress in X-DC cells and expression of GSE24.2 was able to diminish it. Altogether our data indicated that supplying GSE24.2, either from a cDNA vector or as a peptide reduces the pathogenic effects of Dkc1 mutations and suggests a novel therapeutic approach.	[Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Carrillo, Jaime; Machado-Pinilla, Rosario; Sastre, Leandro; Perona, Rosario] Inst Invest Biomed CSIC UAM, Madrid, Spain; [Manguan-Garcia, Cristina; Machado-Pinilla, Rosario; Sastre, Leandro; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.; Perona, Rosario] CIBER Enfermedades Raras, Valencia, Spain; [Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.] Biomed Res Inst INCLIVA, Valencia, Spain; [Perez-Quilis, Carme; Esmoris, Isabel; Gimeno, Amparo; Luis Garcia-Gimenez, Jose; Pallardo, Federico V.] Univ Valencia, Dept Physiol, Fac Med & Dent, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia	Perona, R (corresponding author), Inst Invest Biomed CSIC UAM, Madrid, Spain.	RPerona@iib.uam.es	Pallardo, Federico V./T-1156-2017; García, Jaime Carrillo/AAC-5144-2020	Pallardo, Federico V./0000-0003-3715-1980; Carrillo Garcia, Jaime/0000-0002-2861-3015; Pintado-Berninches, Laura/0000-0002-3331-7130; Garcia-Gimenez, Jose Luis/0000-0001-7547-7872; Sastre, Leandro/0000-0003-3613-5938; Gimeno, Amparo/0000-0002-8112-5221	Ministerio de Ciencia e Innovacion [PI11-0949, PI12/02263 FIS, SAF2008-01338]; Generalitat Valenciana [PROMETEO2010/074]; Fundacion Salud; CIBER de Enfermedades Raras	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion Salud; CIBER de Enfermedades Raras	This work was supported by grants: PI11-0949 and PI12/02263 FIS, SAF2008-01338 from the Ministerio de Ciencia e Innovacion. Grants, PROMETEO2010/074 from Generalitat Valenciana and Fundacion Salud 2000 to FVP. CMG, JLGG and CPQ are supported by CIBER de Enfermedades Raras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2006, CLIN CHIM ACTA, V374, P176, DOI 10.1016/j.cca.2006.06.029; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Carrillo J, 2013, CLIN TRANSL ONCOL; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Hartwig FF, 2013, AGEING RES REV, V12, P642, DOI 10.1016/j.arr.2013.03.003; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Machado-Pinilla R, 2008, BLOOD, V111, P2606, DOI 10.1182/blood-2007-04-083261; Machado-Pinilla R, 2012, CLIN TRANSL ONCOL, V14, P755, DOI 10.1007/s12094-012-0865-4; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Perona R, 2008, CLIN TRANSL ONCOL, V10, P538, DOI 10.1007/s12094-008-0248-5; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Tchirkov A, 2003, HUM MOL GENET, V12, P227, DOI 10.1093/hmg/ddg023; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; Xu C, 2012, FEBS LETT, V586, P3920, DOI 10.1016/j.febslet.2012.09.030; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Young NS, 2012, HEMATOLOGY, V17, pS18, DOI 10.1179/102453312X13336169155132; Zeng XL, 2012, HUM MOL GENET, V21, P721, DOI 10.1093/hmg/ddr504; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	49	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101424	10.1371/journal.pone.0101424	http://dx.doi.org/10.1371/journal.pone.0101424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987982	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100085
J	Mora, M; Hanzu, FA; Pradas-Juni, M; Aranda, GB; Halperin, I; Puig-Domingo, M; Aguilo, S; Fernandez-Rebollo, E				Mora, Mireia; Hanzu, Felicia A.; Pradas-Juni, Marta; Aranda, Gloria B.; Halperin, Irene; Puig-Domingo, Manuel; Aguilo, Sira; Fernandez-Rebollo, Eduardo			New Splice Site Acceptor Mutation in AIRE Gene in Autoimmune Polyendocrine Syndrome Type 1	PLOS ONE			English	Article							CANDIDIASIS-ECTODERMAL-DYSTROPHY; SYNDROME TYPE-I; REGULATOR GENE; PROTEIN; PREDICTION; NONSENSE; DISEASE; THYMUS; SP100; TIME	Autoimmune polyglandular syndrome type 1 (APS-1, OMIM 240300) is a rare autosomal recessive disorder, characterized by the presence of at least two of three major diseases: hypoparathyroidism, Addison's disease, and chronic mucocutaneous candidiasis. We aim to identify the molecular defects and investigate the clinical and mutational characteristics in an index case and other members of a consanguineous family. We identified a novel homozygous mutation in the splice site acceptor (SSA) of intron 5 (c.653-1G>A) in two siblings with different clinical outcomes of APS-1. Coding DNA sequencing revealed that this AIRE mutation potentially compromised the recognition of the constitutive SSA of intron 5, splicing upstream onto a nearby cryptic SSA in intron 5. Surprisingly, the use of an alternative SSA entails the uncovering of a cryptic donor splice site in exon 5. This new transcript generates a truncated protein (p.A214fs67X) containing the first 213 amino acids and followed by 68 aberrant amino acids. The mutation affects the proper splicing, not only at the acceptor but also at the donor splice site, highlighting the complexity of recognizing suitable splicing sites and the importance of sequencing the intron-exon junctions for a more precise molecular diagnosis and correct genetic counseling. As both siblings were carrying the same mutation but exhibited a different APS-1 onset, and one of the brothers was not clinically diagnosed, our finding highlights the possibility to suspect mutations in the AIRE gene in cases of childhood chronic candidiasis and/or hypoparathyroidism otherwise unexplained, especially when the phenotype is associated with other autoimmune diseases.	[Mora, Mireia; Hanzu, Felicia A.; Aranda, Gloria B.; Halperin, Irene] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Mora, Mireia; Hanzu, Felicia A.; Aranda, Gloria B.; Halperin, Irene] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Lab Endocrine Disorders, Barcelona, Spain; [Mora, Mireia; Hanzu, Felicia A.; Pradas-Juni, Marta; Aranda, Gloria B.; Fernandez-Rebollo, Eduardo] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain; [Pradas-Juni, Marta; Fernandez-Rebollo, Eduardo] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Puig-Domingo, Manuel] Univ Autonoma Barcelona, Dept Endocrinol & Nutr, Hosp Germans Trias & Pujol Res Inst & Hosp, Badalona, Spain; [Aguilo, Sira] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Fernandez-Rebollo, E (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain.	edu.ferrebo@gmail.com	Puig-Domingo, Manel/S-2169-2019; , EFR1981/AAV-6334-2020; Mora, Mireia/R-6696-2018	Puig-Domingo, Manel/0000-0002-6744-7195; , EFR1981/0000-0002-4378-7590; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Mora, Mireia/0000-0002-5887-5016; Halperin Rabinovich, Irene/0000-0003-3151-5990	IDIBAPS [01/2012]; FPI [BES-2011-044579, SAF2010-19527]; BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC) [229673]	IDIBAPS; FPI(Spanish Government); BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC)	This work was sponsored by the STARTUP 01/2012 grant from IDIBAPS. MP-J is a recipient of a FPI grant BES-2011-044579 (SAF2010-19527) and EF-R is a recipient of a BIOTRACK Postdoctoral Fellowship in IDIBAPS (EC FP7/2009-2013) under the agreement no. 229673. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an initiative of ISCIII (Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, GENOME RES, V7, P820, DOI 10.1101/gr.7.8.820; Akirav EM, 2011, NAT REV ENDOCRINOL, V7, P25, DOI 10.1038/nrendo.2010.200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1996, AM J HUM GENET, V59, P879; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cervato S, 2009, CLIN ENDOCRINOL, V70, P421, DOI 10.1111/j.1365-2265.2008.03318.x; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Guldner HH, 1999, J CELL SCI, V112, P733; Gylling M, 2003, J CLIN ENDOCR METAB, V88, P4602, DOI 10.1210/jc.2003-030700; Halonen M, 2002, J CLIN ENDOCR METAB, V87, P2568, DOI 10.1210/jc.87.6.2568; Husebye ES, 2009, J INTERN MED, V265, P514, DOI 10.1111/j.1365-2796.2009.02090.x; Ishii T, 2000, J CLIN ENDOCR METAB, V85, P2922, DOI 10.1210/jc.85.8.2922; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kluger N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00232; Liston Adrian, 2005, Novartis Found Symp, V267, P180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez Lopez Ma M, 2006, An Pediatr (Barc), V64, P583; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Stenson P. D., 2013, HUM GENET; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Weiler FG, 2012, ARQ BRAS ENDOCRINOL, V56, P54, DOI 10.1590/S0004-27302012000100009; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	38	10	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101616	10.1371/journal.pone.0101616	http://dx.doi.org/10.1371/journal.pone.0101616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24988226	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100120
J	Staab, M; Ohl, M; Zhu, CD; Klein, AM				Staab, Michael; Ohl, Michael; Zhu, Chao-Dong; Klein, Alexandra-Maria			A Unique Nest-Protection Strategy in a New Species of Spider Wasp	PLOS ONE			English	Article							HYMENOPTERA; POMPILIDAE; BEHAVIOR; HYDROCARBONS; RECOGNITION; PHYLOGENY; DIVERSITY; EVOLUTION; HISTORY; FOREST	Hymenoptera show a great variation in reproductive potential and nesting behavior, from thousands of eggs in sawflies to just a dozen in nest-provisioning wasps. Reduction in reproductive potential in evolutionary derived Hymenoptera is often facilitated by advanced behavioral mechanisms and nesting strategies. Here we describe a surprising nesting behavior that was previously unknown in the entire animal kingdom: the use of a vestibular cell filled with dead ants in a new spider wasp (Hymenoptera: Pompilidae) species collected with trap nests in South-East China. We scientifically describe the 'Bone-house Wasp' as Deuteragenia ossarium sp. nov., named after graveyard bone-houses or ossuaries. We show that D. ossarium nests are less vulnerable to natural enemies than nests of other sympatric trap-nesting wasps, suggesting an effective nest protection strategy, most likely by utilizing chemical cues emanating from the dead ants.	[Staab, Michael; Klein, Alexandra-Maria] Univ Freiburg, Inst Earth & Environm Sci, Dept Nat Conservat & Landscape Ecol, D-79106 Freiburg, Germany; [Staab, Michael; Klein, Alexandra-Maria] Univ Luneburg, Inst Ecol, Ecosyst Funct Grp, D-21335 Luneburg, Germany; [Ohl, Michael] Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany; [Zhu, Chao-Dong] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	University of Freiburg; Leuphana University Luneburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Chinese Academy of Sciences; Institute of Zoology, CAS	Staab, M (corresponding author), Univ Freiburg, Inst Earth & Environm Sci, Dept Nat Conservat & Landscape Ecol, Hugstetter Str 55, D-79106 Freiburg, Germany.	michael.staab@nature.uni-freiburg.de	ZHU, Chao-Dong/E-5961-2011; Staab, Michael/I-6544-2019; Klein, Alexandra-Maria/J-5871-2016	ZHU, Chao-Dong/0000-0002-9347-3178; Staab, Michael/0000-0003-0894-7576; Klein, Alexandra-Maria/0000-0003-2139-8575	German Research Foundation [FOR 891/2, KL 1849/6-1]; National Natural Science Foundation of China [J1210002]	German Research Foundation(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was granted by the German Research Foundation (FOR 891/2, KL 1849/6-1, www.dfg.de) to MS and AMK, and by the National Natural Science Foundation of China (J1210002, www.nsfc.gov.cn) to CDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asis JD, 2007, J INSECT BEHAV, V20, P289, DOI 10.1007/s10905-007-9080-5; Auko TH, 2013, TROP ZOOL, V26, P140, DOI 10.1080/03946975.2013.835636; Baer B, 2009, INSECT SOC, V56, P289, DOI 10.1007/s00040-009-0026-0; Barthelemy C, 2012, J HYMENOPT RES, V28, P13, DOI 10.3897/JHR.28.3010; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Day MC, 1988, HYMENOPTERA POMPILID; Evans H. E., 1962, Behaviour Leiden, V19, P239, DOI 10.1163/156853962X00041; Franzen M, 2007, ANN ZOOL FENN, V44, P405; Geissler C, 2012, CATENA, V91, P85, DOI 10.1016/j.catena.2010.10.009; HASSELL MP, 1984, ANNU REV ENTOMOL, V29, P89, DOI 10.1146/annurev.en.29.010184.000513; Holldobler B., 1990, pi; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; KROMBEIN KV, 1967, TRAP NESTING WASPS B; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; LELEI A S, 1986, Entomologicheskoe Obozrenie, V65, P799; LELEJ AS, 2012, FAR EAST ENTOMOL NOV, P1; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; Martin SJ, 2009, BIOL J LINN SOC, V96, P732, DOI 10.1111/j.1095-8312.2008.01158.x; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Morato EF, 2006, NEOTROP ENTOMOL, V35, P285, DOI 10.1590/S1519-566X2006000300001; Oksanen J., 2013, VEGAN COMMUNITY ECOL; ONeill K.M, 2001, CORNELL S ARTHR BIOL; Paivinen J, 2003, OECOLOGIA, V134, P587, DOI 10.1007/s00442-002-1141-z; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Pitts JP, 2006, ZOOL SCR, V35, P63, DOI 10.1111/j.1463-6409.2005.00217.x; R Core Team, 2021, R LANG ENV STAT COMP; Schmidt JO, 2004, J KANSAS ENTOMOL SOC, V77, P402, DOI 10.2317/E-39.1; Seidelmann K, 1999, APIDOLOGIE, V30, P19, DOI 10.1051/apido:19990103; Shimizu A, 2004, J KANSAS ENTOMOL SOC, V77, P383, DOI 10.2317/E-30.1; Shimizu Akira, 2003, Entomological Science, V6, P165, DOI 10.1046/j.1343-8786.2003.00015.x; Shimizu A, 2010, ZOOL J LINN SOC-LOND, V160, P88, DOI 10.1111/j.1096-3642.2009.00592.x; Shimizu Akira, 2002, Entomological Science, V5, P219; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; WCISLO W T, 1988, Journal of Insect Behavior, V1, P247, DOI 10.1007/BF01054524; Zuur Alain F., 2009, P1	40	11	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101592	10.1371/journal.pone.0101592	http://dx.doi.org/10.1371/journal.pone.0101592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24987876	Green Published, gold			2022-12-25	WOS:000341354100117
J	Koundourakis, NE; Androulakis, NE; Malliaraki, N; Tsatsanis, C; Venihaki, M; Margioris, AN				Koundourakis, Nikolaos E.; Androulakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.			Discrepancy between Exercise Performance, Body Composition, and Sex Steroid Response after a Six-Week Detraining Period in Professional Soccer Players	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENDURANCE; ADAPTATIONS; STRENGTH; HORMONE; TESTOSTERONE; SPRINT; POWER; MEN; PROTEIN	Purpose: The aim of this study was to examine the effects of a six-week off-season detraining period on exercise performance, body composition, and on circulating sex steroid levels in soccer players. Methods: Fifty-five professional male soccer players, members of two Greek Superleague Teams (Team A, n = 23; Team B, n = 22), participated in the study. The first two weeks of the detraining period the players abstained from any physical activity. The following four weeks, players performed low-intensity (50%-60% of VO(2)max) aerobic running of 20 to 30 minutes duration three times per week. Exercise performance testing, anthropometry, and blood sampling were performed before and after the six-week experimental period. Results: Our data showed that in both teams A and B the six-week detraining period resulted in significant reductions in maximal oxygen consumption (60,31 +/- 2,52 vs 57,67 +/- 2,54; p<0.001, and 60,47 +/- 4,13 vs 58,30 +/- 3,88; p<0.001 respectively), squat-jump (39,70 +/- 3,32 vs 37,30 +/- 3,08; p<0.001, and 41,05 +/- 3,34 vs 38,18 +/- 3,03; p<0.001 respectively), and countermovement-jump (41,04 +/- 3,99 vs 39,13 +/- 3,26; p<0.001 and 42,82 +/- 3,60 vs 40,09 +/- 2,79; p<0.001 respectively), and significant increases in 10-meters sprint (1,74<0,063 vs 1,79 +/- 0,064; p<0.001, and 1,73 +/- 0,065 vs 1,78 +/- 0,072; p<0.001 respectively), 20-meters sprint (3,02 +/- 0,05 vs 3,06 +/- 0,06; p<0.001, and 3,01 +/- 0,066 vs 3,06 +/- 0,063; p<0.001 respectively), body fat percentage (Team A; p<0.001, Team B; p<0.001), and body weight (Team A; p<0.001, Team B; p<0.001). Neither team displayed any significant changes in the resting concentrations of total-testosterone, free-testosterone, dehydroepiandrosterone-sulfate, Delta 4-androstenedione, estradiol, luteinizing hormone, follicle-stimulating hormone, and prolactin. Furthermore, sex steroids levels did not correlate with exercise performance parameters. Conclusion: Our results suggest that the six-week detraining period resulted in a rapid loss of exercise performance adaptations and optimal body composition status, but did not affect sex steroid resting levels. The insignificant changes in sex steroid concentration indicate that these hormones were a non-contributing parameter for the observed negative effects of detraining on exercise performance and body composition.	[Koundourakis, Nikolaos E.; Malliaraki, Niki; Tsatsanis, Christos; Venihaki, Maria; Margioris, Andrew N.] Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece; [Androulakis, Nikolaos E.] Univ Hosp, Dept Hematol Lab, Iraklion, Greece; [Malliaraki, Niki; Margioris, Andrew N.] Univ Hosp, Iraklion, Greece	University of Crete; University of Patras; University of Patras	Koundourakis, NE (corresponding author), Univ Crete, Sch Med, Dept Clin Chem Biochem, Iraklion, Greece.	nkoyndoy@hotmail.com	Tsatsanis, Christos/AAM-9362-2020; Tsatsanis, Christos/C-2516-2018; Koundourakis, Nikolaos E/AAA-7667-2021	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151; Androulakis, Nikolaos/0000-0001-8842-2360; Koundourakis, Nikolaos/0000-0002-3385-4956				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alison B1 MD, 2004, PRINCIPLES GENDER SP, P759; Amigo N, 1998, J SPORT MED PHYS FIT, V38, P298; ANDERSON KE, 1987, LIFE SCI, V40, P1761, DOI 10.1016/0024-3205(87)90086-5; Benardot D, 2006, ADV SPORTS NUTR, P309; Borer T, 2003, EXERCISE ENDOCRINOLO; Caldwell BP, 2009, J STRENGTH COND RES, V23, P1370, DOI 10.1519/JSC.0b013e3181a4e82f; Cangemi R, 2010, AGING CELL, V9, P236, DOI 10.1111/j.1474-9726.2010.00553.x; COYLE EF, 1984, J APPL PHYSIOL, V57, P1857, DOI 10.1152/jappl.1984.57.6.1857; Day DS, 2005, J CLIN ENDOCR METAB, V90, P3312, DOI 10.1210/jc.2004-1344; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; GEORGIADIS EI, 1992, HORM METAB RES, V24, P488, DOI 10.1055/s-2007-1003369; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; Hackney A C, 1989, Br J Sports Med, V23, P194; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hall HL, 1999, CLIN J SPORT MED, V9, P203, DOI 10.1097/00042752-199910000-00004; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; HORTOBAGYI T, 1993, MED SCI SPORT EXER, V25, P929; Hoshikawa Y, 2004, J SPORTS SCI, V22, P531; HOUMARD JA, 1992, INT J SPORTS MED, V13, P572, DOI 10.1055/s-2007-1024567; Izquierdo M, 2007, J STRENGTH COND RES, V21, P768; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kalapotharakos VI, 2011, J STRENGTH COND RES, V25, P1502, DOI 10.1519/JSC.0b013e3181da85a9; Kraemer WJ, 2002, J STRENGTH COND RES, V16, P373; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; LaForgia J, 1999, EUR J CLIN NUTR, V53, P126, DOI 10.1038/sj.ejcn.1600689; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; MARTIN WH, 1986, J AM COLL CARDIOL, V7, P982, DOI 10.1016/S0735-1097(86)80215-7; Maughan RJ, 1997, J SPORT SCI, V15, P265; McArdle W, 2009, EXERCISE PHYSL ENERG, P192; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; NELSON AG, 1990, PHYS THER, V70, P287, DOI 10.1093/ptj/70.5.287; NEUFER PD, 1989, SPORTS MED, V8, P302, DOI 10.2165/00007256-198908050-00004; Ormsbee MJ, 2012, J STRENGTH COND RES, V26, P2087, DOI 10.1519/JSC.0b013e31823b874c; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; Ostojic SM., 2003, J EXERC PHYSL ONLINE, V6, P3; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Phillips GB, 1996, EUR J ENDOCRINOL, V134, P201, DOI 10.1530/eje.0.1340201; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Reilly T., 2003, SCI SOCCER; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Stolen T, 2005, SPORTS MED, V35, P501; Stone MH, 2003, J STRENGTH COND RES, V17, P140; Thorstensson, 1976, Acta Physiol Scand Suppl, V443, P1; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; Wang PT, 2006, CHINESE J PHYSIOL, V49, P251	53	65	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87803	10.1371/journal.pone.0087803	http://dx.doi.org/10.1371/journal.pone.0087803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586293	Green Published, gold, Green Submitted			2022-12-25	WOS:000331711900019
J	Ou, X; Liu, ML; Luo, HR; Dong, LQ; Liu, F				Ou, Xiang; Liu, Meilian; Luo, Hairong; Dong, Lily Q.; Liu, Feng			Ursolic Acid Inhibits Leucine-Stimulated mTORC1 Signaling by Suppressing mTOR Localization to Lysosome	PLOS ONE			English	Article							AMINO-ACIDS; RAG GTPASES; TSC1-TSC2 COMPLEX; MAMMALIAN TARGET; SKELETAL-MUSCLE; ACTIVATION; GROWTH; CELL; PATHWAY; RAPTOR	Ursolic acid (UA), a pentacyclic triterpenoid widely found in medicinal herbs and fruits, has been reported to possess a wide range of beneficial properties including anti-hyperglycemia, anti-obesity, and anti-cancer. However, the molecular mechanisms underlying the action of UA remain largely unknown. Here we show that UA inhibits leucine-induced activation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway in C2C12 myotubes. The UA-mediated inhibition of mTORC1 is independent of Akt, tuberous sclerosis complex 1/2 (TSC1/2), and Ras homolog enriched in brain (Rheb), suggesting that UA negatively regulates mTORC1 signaling by targeting at a site downstream of these mTOR regulators. UA treatment had no effect on the interaction between mTOR and its activator Raptor or inhibitor Deptor, but suppressed the binding of RagB to Raptor and inhibited leucine-induced mTOR lysosomal localization. Taken together, our study identifies UA as a direct negative regulator of the mTORC1 signaling pathway and suggests a novel mechanism by which UA exerts its beneficial function.	[Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Key Lab Diabet Immunol, Ctr Diabet, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Central South University; Central South University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China.	liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022		NIH RO1 grant [DK100697]; National Nature Science Foundation of China [81130015]; National Basic Research Program of China [2014CB910500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100697] Funding Source: NIH RePORTER	NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH RO1 grant (DK100697, http://grants.nih.gov/grants/funding/r01.htm), a grant from the National Nature Science Foundation of China (81130015, http://www.nsfc.gov.cn/nsfc/cen/00/download.html), and a grant from the National Basic Research Program of China (2014CB910500, http://www.most.gov.cn/kjjh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani A, 2013, CURR MED CHEM, V20, P908; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Babcock JT, 2011, CURR DRUG TARGETS, V12, P1223; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Gao N, 2012, BRIT J PHARMACOL, V165, P1813, DOI 10.1111/j.1476-5381.2011.01684.x; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Leng SL, 2013, INT J CANCER, V133, P2781, DOI 10.1002/ijc.28301; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu ZQ, 2002, J CLIN ENDOCR METAB, V87, P5553, DOI 10.1210/jc.2002-020424; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang TT, 2009, NEUROSCI LETT, V465, P177, DOI 10.1016/j.neulet.2009.08.026; Yeh CT, 2010, MOL NUTR FOOD RES, V54, P1285, DOI 10.1002/mnfr.200900414; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	46	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95393	10.1371/journal.pone.0095393	http://dx.doi.org/10.1371/journal.pone.0095393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	25003527	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900138
J	Kim, MC; Lee, SW; Ryu, DY; Cui, FJ; Bhak, J; Kim, Y				Kim, Myung-Chul; Lee, Seung-Woo; Ryu, Doug-Young; Cui, Feng-Ji; Bhak, Jong; Kim, Yongbaek			Identification and Characterization of MicroRNAs in Normal Equine Tissues by Next Generation Sequencing	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXPRESSION; HORSE; RNA; PRINCIPLES; DISORDERS; MIR-17-92; CARTILAGE; GENOMICS; PLANT	The role of microRNAs (miRNAs) as a post-transcriptional gene regulator has been elucidated in a broad range of organisms including domestic animals. Characterization of miRNAs in normal tissues is an important step to investigate the functions of miRNAs in various physiological and pathological conditions. Using Illumina Next Generation Sequencing (NGS) technology, we identified a total of 292 known and 329 novel miRNAs in normal horse tissues including skeletal muscle, colon and liver. Distinct sets of miRNAs were differentially expressed in a tissue-specific manner. The miRNA genes were distributed across all the chromosomes except chromosomes 29 and 31 in the horse reference genome. In some chromosomes, multiple miRNAs were clustered and considered to be polycistronic transcript. A base composition analysis showed that equine miRNAs had a higher frequency of A+U than G+C. Furthermore, U tended to be more frequent at the 59 end of miRNA sequences. This is the first experimental study that identifies and characterizes the global miRNA expression profile in normal horse tissues. The present study enriches the horse miRNA database and provides useful information for further research dissecting biological functions of miRNAs in horse.	[Kim, Myung-Chul; Cui, Feng-Ji; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea; [Lee, Seung-Woo; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Lab Environm Hlth, Seoul, South Korea; [Ryu, Doug-Young; Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul, South Korea; [Bhak, Jong] Theragen Bio Inst, Suwon, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Vet Med, Clin Pathol Lab, Seoul, South Korea.	yongbaek@snu.ac.kr			Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [1111594]; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University	This study was supported by Bio-industry Technology Development Program (Grant no. 1111594) of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. Myung-Chul Kim and Seung-Woo Lee were additionally supported by the Brain Korea 21 Plus Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2012, PARASITOL RES, V110, P2373, DOI 10.1007/s00436-011-2773-x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrey E, 2010, EQUINE VET J, V42, P561, DOI 10.1111/j.2042-3306.2010.00267.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boggs RM, 2008, MAMM GENOME, V19, P561, DOI 10.1007/s00335-008-9128-7; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chowdhary BP, 2008, ANIM REPROD SCI, V107, P208, DOI 10.1016/j.anireprosci.2008.04.010; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Fleischhacker SN, 2013, VET J, V197, P688, DOI 10.1016/j.tvjl.2013.03.027; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; FREESTONE JF, 1991, EQUINE VET J, V23, P86, DOI 10.1111/j.2042-3306.1991.tb02726.x; GALUPPO LD, 1995, AM J VET RES, V56, P518; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lacourt M, 2012, OSTEOARTHR CARTILAGE, V20, P572, DOI 10.1016/j.joca.2012.02.004; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mair T., 2002, MANUAL EQUINE GASTRO; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; McKenzie E, 2011, EQUINE VET J, V43, P637, DOI 10.1111/j.2042-3306.2011.00468.x; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Thatcher EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-253; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; West HJ, 1996, EQUINE VET J, V28, P146, DOI 10.1111/j.2042-3306.1996.tb01607.x; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	48	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2014	9	4							e93662	10.1371/journal.pone.0093662	http://dx.doi.org/10.1371/journal.pone.0093662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6LC	24988450	Green Published, Green Submitted, gold			2022-12-25	WOS:000334103000099
J	Zhang, XY; Zhang, T; Young, AA; Li, XS				Zhang, Xingyu; Zhang, Tao; Young, Alistair A.; Li, Xiaosong			Applications and Comparisons of Four Time Series Models in Epidemiological Surveillance Data	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; NEURAL-NETWORK; HYBRID ARIMA; PREDICTION; FORECAST; FEVER	Public health surveillance systems provide valuable data for reliable predication of future epidemic events. This paper describes a study that used nine types of infectious disease data collected through a national public health surveillance system in mainland China to evaluate and compare the performances of four time series methods, namely, two decomposition methods (regression and exponential smoothing), autoregressive integrated moving average (ARIMA) and support vector machine (SVM). The data obtained from 2005 to 2011 and in 2012 were used as modeling and forecasting samples, respectively. The performances were evaluated based on three metrics: mean absolute error (MAE), mean absolute percentage error (MAPE), and mean square error (MSE). The accuracy of the statistical models in forecasting future epidemic disease proved their effectiveness in epidemiological surveillance. Although the comparisons found that no single method is completely superior to the others, the present study indeed highlighted that the SVMs outperforms the ARIMA model and decomposition methods in most cases.	[Zhang, Xingyu; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xingyu; Young, Alistair A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	Sichuan University; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com		Zhang, Xingyu/0000-0001-8108-1997; Young, Alistair/0000-0001-5702-4220	National Special Foundation for Health Research of China [200802133]	National Special Foundation for Health Research of China	The entire study and the paper were financially supported by the National Special Foundation for Health Research of China (grant no. 200802133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowerman B. L., 1993, FORECASTING TIME SER; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christodoulos C, 2011, TECHNOL FORECAST SOC, V78, P163, DOI 10.1016/j.techfore.2010.08.007; Davision AC, 1997, BOOTSTRAP METHODS TH, P23; Farrington C, 2003, MONITORING HLTH POPU, V2003, P203; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Gonzalez-Parra G, 2009, COMMUN NONLINEAR SCI, V14, P3967, DOI 10.1016/j.cnsns.2009.02.023; Grahn T., 1995, J TIMES SERIES ANAL, V16, P509, DOI [DOI 10.1111/J.1467-9892.1995.TB00251.X, 10.1111/j.1467-9892.1995.tb00251.x]; Hamilton J.D., 2020, TIME SERIES ANAL, DOI 10.2307/j.ctv14jx6sm; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Hong WC, 2006, INT J ADV MANUF TECH, V28, P154, DOI 10.1007/s00170-004-2340-z; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu Q, 2011, BMC INFECT DIS, V11; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; MOGHRAM I, 1989, IEEE T POWER SYST, V4, P1484, DOI 10.1109/59.41700; Muller K.-R., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P999, DOI 10.1007/BFb0020283; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pai PF, 2005, INT J ADV MANUF TECH, V27, P205, DOI 10.1007/s00170-004-2139-y; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P602, DOI 10.1017/S0950268811001026; Tay FEH, 2002, NEUROCOMPUTING, V48, P847, DOI 10.1016/S0925-2312(01)00676-2; Tay FEH, 2001, OMEGA-INT J MANAGE S, V29, P309, DOI 10.1016/S0305-0483(01)00026-3; Thiessen U, 2003, CHEMOMETR INTELL LAB, V69, P35, DOI 10.1016/S0169-7439(03)00111-4; Thomason M., 1999, J COMPUT FINANC, V7, P36; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wei W. W.-S., 1994, TIME SERIES ANAL; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang X-G, 2000, ACTA AUTOMATICA SIN, V26, P32; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	37	122	129	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88075	10.1371/journal.pone.0088075	http://dx.doi.org/10.1371/journal.pone.0088075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505382	Green Submitted, gold, Green Published			2022-12-25	WOS:000330829200110
J	Wang, QM; Liu, SP; Tang, Y; Liu, QH; Yao, YJ				Wang, Qingmin; Liu, Shupeng; Tang, Ying; Liu, Qiuhong; Yao, Yongjie			MPT64 Protein from Mycobacterium tuberculosis Inhibits Apoptosis of Macrophages through NF-kB-miRNA21-Bcl-2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BCL-2 UP-REGULATION; ANTIGEN MPT64; MICRORNAS; EXPRESSION; VIRULENT; IMMUNITY; NECROSIS; PLAYERS	MPT64 is one of the secreted proteins from Mycobacterium tuberculosis. Little is known about its role in infection by Mycobacterium tuberculosis. In this study, we demonstrated that MPT64 could dose-dependently inhibit the apoptosis of RAW264.7 macrophages induced by PPD-BCG. Quantitative real-time PCR results showed that the expression of bcl-2 increased in macrophages treated with MPT64 compared with PPD-treated cells. Furthermore, the results provided strong evidence that bcl-2 up-regulation was positively controlled by miRNA-21. Finally, NF-kappa B was identified as the transcription factor for miRNA-21 using a ChIP assay. It can be concluded from our study that MPT64 could inhibit the apoptosis of RAW264.7 macrophages through the NF-kappa B-miRNA21-Bcl-2 pathway.	[Wang, Qingmin; Tang, Ying; Liu, Qiuhong; Yao, Yongjie] Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China; [Liu, Shupeng] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Wang, QM (corresponding author), Naval Med Res Inst, Div Aviat Med, Shanghai, Peoples R China.	wqm_8888@hotmail.com	Woo, Patrick Chiu Yat/C-4449-2009; Lau, Susanna Kar Pui/C-4321-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; liu, fei/0000-0003-1175-4070; Lau, Susanna Kar Pui/0000-0002-1383-7374	National Natural Science Foundation [31070121]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This article is supported by the grants of National Natural Science Foundation (Nos. 31070121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061925; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hossein A, 2004, J NEUROSCI, V24, P2963; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Lin XJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/258695; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Mogga SJ, 2002, SCAND J IMMUNOL, V56, P383, DOI 10.1046/j.1365-3083.2002.01140.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001; Yamamoto T, 2006, YAKUGAKU ZASSHI, V126, P1235, DOI 10.1248/yakushi.126.1235; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	36	73	78	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2014	9	7							e100949	10.1371/journal.pone.0100949	http://dx.doi.org/10.1371/journal.pone.0100949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7WB	25000291	gold, Green Published, Green Submitted			2022-12-25	WOS:000338637300020
J	Arancibia, S; Espinoza, C; Salazar, F; Del Campo, M; Tampe, R; Zhong, TY; De Ioannes, P; Moltedo, B; Ferreira, J; Lavelle, EC; Manubens, A; De Ioannes, AE; Becker, MI				Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ferreira, Jorge; Lavelle, Ed C.; Manubens, Augusto; De Ioannes, Alfredo E.; Ines Becker, Maria			A Novel Immunomodulatory Hemocyanin from the Limpet Fissurella latimarginata Promotes Potent Anti-Tumor Activity in Melanoma	PLOS ONE			English	Article							RAPANA-THOMASIANA-HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; DENDRITIC CELLS; BLADDER-CANCER; IMMUNE-RESPONSE; SUBUNIT ORGANIZATION; CONJUGATE VACCINES; RECENT PROGRESS; N-GLYCANS; IN-VIVO	Hemocyanins, the huge oxygen-transporting glycoproteins of some mollusks, are used as immunomodulatory proteins with proven anti-cancer properties. The biodiversity of hemocyanins has promoted interest in identifying new anti-cancer candidates with improved immunological properties. Hemocyanins promote Th1 responses without known side effects, which make them ideal for long-term sustained treatment of cancer. In this study, we evaluated a novel hemocyanin from the limpet/gastropod Fissurella latimarginata (FLH). This protein has the typical hollow, cylindrical structure of other known hemocyanins, such as the keyhole limpet hemocyanin (KLH) and the Concholepas hemocyanin (CCH). FLH, like the KLH isoforms, is composed of a single type of polypeptide with exposed N- and O-linked oligosaccharides. However, its immunogenicity was significantly greater than that of KLH and CCH, as FLH induced a stronger humoral immune response and had more potent anti-tumor activity, delaying tumor growth and increasing the survival of mice challenged with B16F10 melanoma cells, in prophylactic and therapeutic settings. Additionally, FLH-treated mice demonstrated increased IFN-gamma production and higher numbers of tumor-infiltrating CD4(+) lymphocytes. Furthermore, in vitro assays demonstrated that FLH, but not CCH or KLH, stimulated the rapid production of pro-inflammatory cytokines (IL-6, IL-12, IL-23 and TNF-alpha) by dendritic cells, triggering a pro-inflammatory milieu that may explain its enhanced immunological activity. Moreover, this effect was abolished when deglycosylated FLH was used, suggesting that carbohydrates play a crucial role in the innate immune recognition of this protein. Altogether, our data demonstrate that FLH possesses increased anti-tumor activity in part because it activates a more potent innate immune response in comparison to other known hemocyanins. In conclusion, FLH is a potential new marine adjuvant for immunization and possible cancer immunotherapy.	[Arancibia, Sergio; Espinoza, Cecilia; Salazar, Fabian; Del Campo, Miguel; Tampe, Ricardo; Zhong, Ta-Ying; De Ioannes, Pablo; Moltedo, Bruno; Ines Becker, Maria] Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile; [Ferreira, Jorge; Ines Becker, Maria] Univ Chile, Inst Ciencias Biomed ICBM, Clin & Mol Pharmacol Program, Santiago, Chile; [Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Manubens, Augusto; De Ioannes, Alfredo E.] Biosonda Corp, Dept Res & Dev, Santiago, Chile	Universidad de Chile; Trinity College Dublin	Becker, MI (corresponding author), Fdn Ciencia & Tecnol Desarrollo FUCITED, Santiago, Chile.	mariaines.becker@fucited.cl	Becker, María/R-8252-2019; Salazar, Fabian/AAW-2488-2020; Lavelle, Ed/A-1716-2008; Brito de Azevedo, Eduardo/M-4266-2013; Hortal, Joaquin/A-1531-2008; Lobo, Jorge/E-2309-2013; Gabriel, Rosalina/F-1598-2013; Coelho dos Santos, Ana Margarida/E-7598-2010; Patino, Jairo/J-9595-2014; Borges, Paulo/B-2780-2008	Lavelle, Ed/0000-0002-3167-1080; Brito de Azevedo, Eduardo/0000-0001-5172-7742; Hortal, Joaquin/0000-0002-8370-8877; Lobo, Jorge/0000-0002-3152-4769; Gabriel, Rosalina/0000-0002-3550-8010; Manubens, Augusto/0000-0002-7931-4314; Coelho dos Santos, Ana Margarida/0000-0002-9197-792X; Patino, Jairo/0000-0001-5532-166X; Borges, Paulo/0000-0002-8448-7623; Salazar Lizama, Fabian/0000-0001-5139-2292	Fundacion COPEC-Universidad Catolica [CQ057]; FONDECYT [1110651]	Fundacion COPEC-Universidad Catolica; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was partially supported by research grants from Fundacion COPEC-Universidad Catolica No. CQ057 and FONDECYT 1110651 to Maria Ines Becker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancibia S., 2012, HEMOCYANINS IMMUNOTH, VINTECH; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; CEROTTINI JC, 1971, J IMMUNOL, V106, P732; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dolashka-Angelova P, 2008, IMMUNOL INVEST, V37, P822, DOI 10.1080/08820130802403366; Gathuru JK, 2005, VACCINE, V23, P4727, DOI 10.1016/j.vaccine.2005.05.007; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gebauer W, 1999, ARCH BIOCHEM BIOPHYS, V372, P128, DOI 10.1006/abbi.1999.1478; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Harris Jr, 1999, METH MOL B, V117, P13; HERSCOWITZ HB, 1972, IMMUNOLOGY, V22, P51; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Junankar SR, 2006, J INVEST DERM SYMP P, V11, P36, DOI 10.1038/sj.jidsymp.5650024; Kato K, 1972, BIOCHEM BIOPH RES CO, V371, P698; Kim SK, 2000, VACCINE, V19, P530, DOI 10.1016/S0264-410X(00)00195-X; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lamm DL, 2003, J CLIN ONCOL, V21, P4259, DOI 10.1200/JCO.2003.08.099; Lammers RJM, 2012, J CLIN ONCOL, V30, P2273, DOI 10.1200/JCO.2011.39.2936; Leyton P, 2005, J CHIL CHEM SOC, V50, P725, DOI 10.4067/S0717-97072005000400014; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MULE JJ, 1986, J IMMUNOL, V136, P3899; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; Oliva H, 2002, HYBRIDOMA HYBRIDOM, V21, P365, DOI 10.1089/153685902761022715; Paccagnella M, 2004, MICRON, V35, P21, DOI 10.1016/j.micron.2003.10.007; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Ponder WF, 2008, PHYLOGENY EVOLUTION; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ragupathi G, 2002, VACCINE, V20, P1030, DOI 10.1016/S0264-410X(01)00451-0; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Rizvi I, 2007, AM J SURG, V194, P628, DOI 10.1016/j.amjsurg.2007.08.005; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Shimizu K, 2001, CANCER RES, V61, P2618; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Strioga M, 2013, INNATE IMMUN-LONDON, V19, P98, DOI 10.1177/1753425912449549; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tchorbanov A, 2008, INT IMMUNOPHARMACOL, V8, P1033, DOI 10.1016/j.intimp.2008.03.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Vliet SJ, 2008, J IMMUNOL, V181, P3148, DOI 10.4049/jimmunol.181.5.3148; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Zhang SL, 1996, CANCER RES, V56, P3315	60	56	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e87240	10.1371/journal.pone.0087240	http://dx.doi.org/10.1371/journal.pone.0087240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	25003186	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000202
J	Wang, J; Bian, YJ; Wang, ZR; Li, D; Wang, CM; Li, QZ; Gao, XJ				Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun			MicroRNA-152 Regulates DNA Methyltransferase 1 and Is Involved in the Development and Lactation of Mammary Glands in Dairy Cows	PLOS ONE			English	Article							GENE-EXPRESSION; METHYLATION; MILK; TARGETS; CANCER; CELLS; DNMT1; GROWTH; RNAS; 3B	MicroRNAs (miRNAs) are a class of small non-coding, endogenous regulatory RNAs that function by controlling gene expression at the post-transcriptional level. Using small RNA sequencing and qRT-PCR techniques, we found that the expression of miR-152 was significantly increased during lactation in the mammary glands of dairy cows producing high quality milk compared with that in cows producing low quality milk. Furthermore, DNA methyltransferase 1 (DNMT1), which is a target of miR-152, was inversely correlated with the expression levels of miR-152 in the mammary glands of dairy cows. Dairy cow mammary epithelial cells (DCMECs) were used as in vitro cell models to study the function of miR-152. The forced expression of miR-152 in DCMECs resulted in a marked reduction of DNMT1 at both mRNA and protein levels. This in turn led to a decrease in global DNA methylation and increased the expression of two lactation-related genes, serine/threonine protein kinase Akt (Akt) and peroxisome proliferator-activated receptor gamma (Ppar gamma). In contrast, inhibition of miR-152 showed the opposite results. By using an electronic Coulter counter (CASY-TT) and flow cytometer, we discovered that miR-152 enhanced the viability and multiplication capacity of DCMECs. In conclusion, miR-152 plays an important role in the development and lactation processes in the mammary glands of dairy cows. Our data provide insights into dairy cow mammary gland development and lactation.	[Wang, Jie; Bian, Yanjie; Wang, Zhuoran; Li, Dan; Wang, Chunmei; Li, Qingzhang; Gao, Xuejun] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	wangcm-1@163.com		HONG, SEUNGUG/0000-0002-6228-3312; Bose, Shambunath/0000-0003-0737-5713; Wang, jing-hua/0000-0002-2034-7429	Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hassler MR, 2012, BIOCHIMIE, V94, P2297, DOI 10.1016/j.biochi.2012.05.029; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061658; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Xiang Y, 2013, ONCOGENE; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	41	90	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2014	9	7							e101358	10.1371/journal.pone.0101358	http://dx.doi.org/10.1371/journal.pone.0101358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BA	24475077	Green Submitted, Green Published, gold			2022-12-25	WOS:000341354100077
J	Wang, YP; Nie, JX; Yap, PT; Li, G; Shi, F; Geng, XJ; Guo, L; Shen, DG				Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Geng, Xiujuan; Guo, Lei; Shen, Dinggang		Alzheimers Dis Neuroimaging Initia	Knowledge-Guided Robust MRI Brain Extraction for Diverse Large-Scale Neuroimaging Studies on Humans and Non-Human Primates	PLOS ONE			English	Article							SKULL STRIPPING PROBLEM; ALZHEIMERS-DISEASE; AUTOMATIC SEGMENTATION; GRAY-MATTER; IMAGES; CLASSIFICATION; REGISTRATION; ALGORITHM; VOLUMES; CORTEX	Accurate and robust brain extraction is a critical step in most neuroimaging analysis pipelines. In particular, for the large-scale multi-site neuroimaging studies involving a significant number of subjects with diverse age and diagnostic groups, accurate and robust extraction of the brain automatically and consistently is highly desirable. In this paper, we introduce population-specific probability maps to guide the brain extraction of diverse subject groups, including both healthy and diseased adult human populations, both developing and aging human populations, as well as non-human primates. Specifically, the proposed method combines an atlas-based approach, for coarse skull-stripping, with a deformable-surface-based approach that is guided by local intensity information and population-specific prior information learned from a set of real brain images for more localized refinement. Comprehensive quantitative evaluations were performed on the diverse large-scale populations of ADNI dataset with over 800 subjects (55 similar to 90 years of age, multi-site, various diagnosis groups), OASIS dataset with over 400 subjects (18 similar to 96 years of age, wide age range, various diagnosis groups), and NIH pediatrics dataset with 150 subjects (5 similar to 18 years of age, multi-site, wide age range as a complementary age group to the adult dataset). The results demonstrate that our method consistently yields the best overall results across almost the entire human life span, with only a single set of parameters. To demonstrate its capability to work on non-human primates, the proposed method is further evaluated using a rhesus macaque dataset with 20 subjects. Quantitative comparisons with popularly used state-of-the-art methods, including BET, Two-pass BET, BET-B, BSE, HWA, ROBEX and AFNI, demonstrate that the proposed method performs favorably with superior performance on all testing datasets, indicating its robustness and effectiveness.	[Wang, Yaping; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Shaanxi Provinc, Peoples R China; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Wang, Yaping; Nie, Jingxin; Yap, Pew-Thian; Li, Gang; Shi, Feng; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Geng, Xiujuan] NIDA, Neuroimaging Res Branch, Baltimore, MD USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Northwestern Polytechnical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Li, Gang/D-3324-2013; Geng, Xiujuan/AAR-4306-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382; Geng, Xiujuan/0000-0003-4953-0208	NIH [EB008374, EB006733, EB009634, AG041721, MH100217, AG042599]; National Natural Science Foundation of China [61273362, 61333017]; National Research Foundation grant of Korea [2012-005741]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB006733, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217, P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021910, K01AG030514, P50AG005681, R01AG041721, P01AG003991, P30AG010129, R01AG042599, U01AG024904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation grant of Korea(National Research Foundation of Korea); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants EB008374, EB006733, EB009634, AG041721, MH100217, AG042599, National Natural Science Foundation of China (No. 61273362, No. 61333017), and National Research Foundation grant of Korea (No. 2012-005741). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. ADNI data collection and sharing for this project was supported by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904), P30 AG010129, K01 AG030514, the Dana Foundation. OASIS data collection and sharing for this project was supported by P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MS, 1998, IEEE T MED IMAGING, V17, P98, DOI 10.1109/42.668699; BOMANS M, 1990, IEEE T MED IMAGING, V9, P177, DOI 10.1109/42.56342; BRUMMER ME, 1993, IEEE T MED IMAGING, V12, P153, DOI 10.1109/42.232244; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chiverton J, 2007, COMPUT BIOL MED, V37, P342, DOI 10.1016/j.compbiomed.2006.04.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fennema-Notestine C, 2006, HUM BRAIN MAPP, V27, P99, DOI 10.1002/hbm.20161; Germond L, 2000, ARTIF INTELL MED, V20, P77, DOI 10.1016/S0933-3657(00)00054-3; Hahn HK, 2000, LECT NOTES COMPUT SC, V1935, P134; HOHNE KH, 1992, J COMPUT ASSIST TOMO, V16, P285, DOI 10.1097/00004728-199203000-00019; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huh S, 2002, COMPUT BIOL MED, V32, P311, DOI 10.1016/S0010-4825(02)00023-9; Iglesias JE, 2011, IEEE T MED IMAGING; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee C, 1998, COMPUT BIOL MED, V28, P309, DOI 10.1016/S0010-4825(98)00013-4; Lemieux L, 1999, MAGN RESON MED, V42, P127, DOI 10.1002/(SICI)1522-2594(199907)42:1<127::AID-MRM17>3.0.CO;2-O; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Miura N, 2002, J COMPUT ASSIST TOMO, V26, P927, DOI 10.1097/00004728-200211000-00012; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rehm K, 2004, NEUROIMAGE, V22, P1262, DOI 10.1016/j.neuroimage.2004.03.011; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rodrigue KM, 2004, J NEUROSCI, V24, P956, DOI 10.1523/JNEUROSCI.4166-03.2004; Sadananthan SA, 2010, NEUROIMAGE, V49, P225, DOI 10.1016/j.neuroimage.2009.08.050; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vercauteren T., 2007, LNCS, V10, P319, DOI DOI 10.1016/J.NEUR0IMAGE.2008.10.040; Wang Y, 2012, GROUPWISE SEGMENTATI, P185; Wang YP, 2013, I S BIOMED IMAGING, P1364; Wang YP, 2011, LECT NOTES COMPUT SC, V6893, P635, DOI 10.1007/978-3-642-23626-6_78; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuang AH, 2006, NEUROIMAGE, V32, P79, DOI 10.1016/j.neuroimage.2006.03.019	49	298	308	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e77810	10.1371/journal.pone.0077810	http://dx.doi.org/10.1371/journal.pone.0077810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489639	Green Submitted, Green Published, gold			2022-12-25	WOS:000330570000002
J	Zhang, ZX; Zhao, H; Tang, J; Li, Z; Li, Z; Chen, DM; Lin, WX				Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong			A Proteomic Study on Molecular Mechanism of Poor Grain-Filling of Rice (Oryza sativa L.) Inferior Spikelets	PLOS ONE			English	Article							STARCH BIOSYNTHETIC-ENZYMES; JAPONICA/INDICA HYBRID RICE; 14-3-3 PROTEINS; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; PLANT-METABOLISM; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENT POSITIONS; BARLEY GRAINS	Cultivars of rice (Oryza sativa L.), especially of the type with large spikelets, often fail to reach the yield potential as expected due to the poor grain-filling on the later flowering inferior spikelets (in contrast to the earlier-flowering superior spikelets). The present study showed that the size and grain weight of superior spikelets (SS) was greater than those of inferior spikelets (IS), and the carbohydrate supply should not be the major problem for the poor grain-filling because there was adequate amount of sucrose in IS at the initial grain-filling stage. High resolution two-dimensional gel electrophoresis (2-DE) in combination with Coomassie-brilliant blue (CBB) and Pro-Q Diamond phosphoprotein fluorescence stain revealed that 123 proteins in abundance and 43 phosphoproteins generated from phosphorylation were significantly different between SS and IS. These proteins and phosphoproteins were involved in different cellular and metabolic processes with a prominently functional skew toward metabolism and protein synthesis/destination. Expression analyses of the proteins and phosphoproteins associated with different functional categories/subcategories indicated that the starch synthesis, central carbon metabolism, N metabolism and cell growth/division were closely related to the poor grain-filling of IS. Functional and expression pattern studies also suggested that 14-3-3 proteins played important roles in IS poor grain-filling by regulating the activity of starch synthesis enzymes. The proteome and phosphoproteome obtained from this study provided a better understanding of the molecular mechanism of the IS poor grain-filling. They were also expected to be highly useful for improving the grain filling of rice.	[Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wenxiong181@163.com		liu, chun ming/0000-0002-7271-362X; Hoi, Maggie Pui Man/0000-0003-2630-3707; Zhang, Zhao/0000-0002-7323-5500; Song, Yin/0000-0002-6037-777X	National Natural Science Foundation of China [31271670]; Provincial Natural Science Foundation of Fujian, China [2012J01075, 2013J01092]; Department of Education Science and Technology Project of Fujian, China [JK2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Department of Education Science and Technology Project of Fujian, China	This work was sponsored by the National Natural Science Foundation of China (No. 31271670), Provincial Natural Science Foundation of Fujian, China (No. 2012J01075, 2013J01092), and Department of Education Science and Technology Project of Fujian, China (No. JK2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; Colleoni C., 2003, Journal of Applied Glycoscience, V50, P207; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Kato T, 2007, PLANT PROD SCI, V10, P442, DOI 10.1626/pps.10.442; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Lin XM, 2008, J PROTEOME RES, V7, P1235, DOI 10.1021/pr7005928; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; MOHAPATRA PK, 1993, AUST J PLANT PHYSIOL, V20, P231, DOI 10.1071/PP9930231; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Ramasamy S, 1997, FIELD CROP RES, V51, P65, DOI 10.1016/S0378-4290(96)01039-8; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Song JianMin, 2009, Acta Agronomica Sinica, V35, P1445, DOI 10.3724/SP.J.1006.2009.01445; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Tao LongXing, 2003, Chinese Journal of Rice Science, V17, P149; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Teo CJ, 2011, ACTA PHYSIOL PLANT, V33, P2259, DOI 10.1007/s11738-011-0765-1; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; van Dongen JT, 2004, PLANT PHYSIOL, V135, P1809, DOI 10.1104/pp.104.040980; Vassileva V. N., 2005, PLANT BIOTECHNOL, V22, P171; Wojtaszek P, 1997, J EXP BOT, V48, P2015, DOI 10.1093/jexbot/48.317.2015; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1976, ANNU REV PLANT PHYS, P46; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZhiXing, 2012, Australian Journal of Crop Science, V6, P316; Zhang ZX, 2012, PLANT SCI, V185, P259, DOI 10.1016/j.plantsci.2011.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QS, 1988, ACTA AGRON SIN, V3, P182; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	70	98	104	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89140	10.1371/journal.pone.0089140	http://dx.doi.org/10.1371/journal.pone.0089140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586550	Green Submitted, Green Published, gold			2022-12-25	WOS:000331717900056
